PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Nichol, D; Christian, M; Steel, JH; White, R; Parker, MG				Nichol, Donna; Christian, Mark; Steel, Jennifer H.; White, Roger; Parker, Malcolm G.			RIP140 expression is stimulated by estrogen-related receptor alpha during adipogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PPAR-GAMMA; TRANSCRIPTIONAL REGULATION; COREPRESSOR RIP140; ADIPOCYTE DIFFERENTIATION; NEGATIVE-FEEDBACK; RESPONSE ELEMENTS; NUCLEAR RECEPTORS; GENE-EXPRESSION; C/EBP FAMILY; IN-VIVO	RIP140 is a corepressor for nuclear receptors that regulates energy expenditure in adipose tissue by suppressing the expression of clusters of metabolic genes involved in glucose and lipid metabolism. The gene encoding RIP140/Nrip1 contains only one coding exon but has multiple promoters and 5' non-coding exons that are subject to alternative splicing. In adipocytes we have defined a promoter, referred to as P2, that is preferentially utilized and activated during adipogenesis. Expression studies and chromatin immunoprecipitation experiments indicate that estrogen-related receptor alpha(ERR alpha), the level of which increases during adipogenesis in parallel with RIP140, stimulates transcription from the P2 promoter. Further analysis indicates that ERR alpha is capable of activating RIP140 gene transcription by two mechanisms, directly by binding to an estrogen receptor element/ERR element at -650/-633 and indirectly through Sp1 binding sites in the proximal promoter. Thus, the up-regulation of RIP140 by ERR alpha during adipogenesis may provide an inhibitory feedback mechanism to control the expression of many nuclear receptor target genes.	Imperial Coll, Fac Med, Inst Reprod & Dev Biol, London W12 0NN, England	Imperial College London	Parker, MG (corresponding author), Imperial Coll, Fac Med, Inst Reprod & Dev Biol, Du Cane Rd, London W12 0NN, England.	m.parker@imperial.ac.uk	Steel, Jennifer/B-4737-2013	Steel, Jennifer/0000-0003-4439-0090; Christian, Mark/0000-0002-1616-4179	Wellcome Trust [061930] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Augereau P, 2006, MOL PHARMACOL, V69, P1338, DOI 10.1124/mol.105.017376; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Barry JB, 2006, MOL ENDOCRINOL, V20, P302, DOI 10.1210/me.2005-0313; Barry JB, 2005, CANCER RES, V65, P6120, DOI 10.1158/0008-5472.CAN-05-0922; Bourdeau V, 2004, MOL ENDOCRINOL, V18, P1411, DOI 10.1210/me.2003-0441; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; CASTET A, 2006, MOL ENDOCRINOL; CAVAILLES V, 1995, EMBO J, V14, P3741, DOI 10.1002/j.1460-2075.1995.tb00044.x; Christian M, 2005, MOL CELL BIOL, V25, P9383, DOI 10.1128/MCB.25.21.9383-9391.2005; Darlington GJ, 1998, J BIOL CHEM, V273, P30057, DOI 10.1074/jbc.273.46.30057; Elbashir SM, 2002, METHODS, V26, P199, DOI 10.1016/S1046-2023(02)00023-3; Fajas L, 1999, MOL CELL BIOL, V19, P5495; Fajas L, 2002, DEV CELL, V3, P39, DOI 10.1016/S1534-5807(02)00190-9; FAWELL SE, 1990, CELL, V60, P953, DOI 10.1016/0092-8674(90)90343-D; Fu MG, 2005, MOL ENDOCRINOL, V19, P2437, DOI 10.1210/me.2004-0539; Heinemeyer T, 1999, NUCLEIC ACIDS RES, V27, P318, DOI 10.1093/nar/27.1.318; Ise R, 2005, FEBS LETT, V579, P1732, DOI 10.1016/j.febslet.2005.02.033; Johnston SD, 1997, MOL ENDOCRINOL, V11, P342, DOI 10.1210/me.11.3.342; Kalaitzidis D, 2005, TRENDS ENDOCRIN MET, V16, P46, DOI 10.1016/j.tem.2005.01.004; Kamalakaran S, 2005, J BIOL CHEM, V280, P21491, DOI 10.1074/jbc.M409176200; Kamei Y, 2003, P NATL ACAD SCI USA, V100, P12378, DOI 10.1073/pnas.2135217100; Kerley JS, 2001, BIOCHEM BIOPH RES CO, V285, P969, DOI 10.1006/bbrc.2001.5274; Leonardsson G, 2004, P NATL ACAD SCI USA, V101, P8437, DOI 10.1073/pnas.0401013101; Lin CY, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r66; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Lin JD, 2003, J BIOL CHEM, V278, P30843, DOI 10.1074/jbc.M303643200; Linhart HG, 2001, P NATL ACAD SCI USA, V98, P12532, DOI 10.1073/pnas.211416898; Lu DS, 2001, CANCER RES, V61, P6755; Luo JM, 2003, MOL CELL BIOL, V23, P7947, DOI 10.1128/MCB.23.22.7947-7956.2003; Morrison RF, 2000, J NUTR, V130, p3116S, DOI 10.1093/jn/130.12.3116S; Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005; Pettersson K, 1996, MECH DEVELOP, V54, P211, DOI 10.1016/0925-4773(95)00479-3; Powelka AM, 2006, J CLIN INVEST, V116, P125, DOI 10.1172/JCI26040; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; RITTENHOUSE J, 1984, ANAL BIOCHEM, V138, P442, DOI 10.1016/0003-2697(84)90836-4; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Safe S, 2004, PROG NUCLEIC ACID RE, V77, P1, DOI 10.1016/S0079-6603(04)77001-4; SAFFER JD, 1991, MOL CELL BIOL, V11, P2189, DOI 10.1128/MCB.11.4.2189; SASTRY M, 1993, BIOCHEMISTRY-US, V32, P6588, DOI 10.1021/bi00077a012; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Sladek R, 1997, MOL CELL BIOL, V17, P5400, DOI 10.1128/MCB.17.9.5400; Soukas A, 2001, J BIOL CHEM, V276, P34167, DOI 10.1074/jbc.M104421200; Steel JH, 1998, EUR J HISTOCHEM, V42, P143; Tong Q, 2005, MOL CELL BIOL, V25, P706, DOI 10.1128/MCB.25.2.706-715.2005; Tong Q, 2000, SCIENCE, V290, P134, DOI 10.1126/science.290.5489.134; Vega RB, 1997, J BIOL CHEM, V272, P31693, DOI 10.1074/jbc.272.50.31693; Viguerie N, 2002, J CLIN ENDOCR METAB, V87, P630, DOI 10.1210/jc.87.2.630; White KA, 2003, J BIOL CHEM, V278, P43889, DOI 10.1074/jbc.C300374200; White R, 2000, NAT MED, V6, P1368, DOI 10.1038/82183; Willy PJ, 2004, P NATL ACAD SCI USA, V101, P8912, DOI 10.1073/pnas.0401420101; Yang NY, 1996, J BIOL CHEM, V271, P5795, DOI 10.1074/jbc.271.10.5795; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168; Yu C, 2005, J BIOL CHEM, V280, P13600, DOI 10.1074/jbc.M409468200	56	47	48	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32140	32147		10.1074/jbc.M604803200	http://dx.doi.org/10.1074/jbc.M604803200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16923809	hybrid			2022-12-27	WOS:000241414500011
J	Darnell, GA; Schroder, WA; Gardner, J; Harrich, D; Yu, H; Medcalf, RL; Warrilow, D; Antalis, TM; Sonza, S; Suhrbier, A				Darnell, Grant A.; Schroder, Wayne A.; Gardner, Joy; Harrich, David; Yu, Hong; Medcalf, Robert L.; Warrilow, David; Antalis, Toni M.; Sonza, Secondo; Suhrbier, Andreas			SerpinB2 is an inducible host factor involved in enhancing HIV-1 transcription and replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PLASMINOGEN-ACTIVATOR INHIBITOR; LONG TERMINAL REPEAT; NF-KAPPA-B; MICROARRAY ANALYSIS REVEALS; PRIMARY HUMAN MACROPHAGES; RETINOBLASTOMA PROTEIN; EPITHELIAL-CELLS; HUMAN-MONOCYTES; REVERSE TRANSCRIPTION	The serine protease inhibitor SerpinB2 (plasminogen activator inhibitor-2) is a major product of activated monocytes and macrophages and is substantially induced during most inflammatory processes. Distinct from its widely described extracellular role as an inhibitor of urokinase plasminogen activator, SerpinB2 has recently been shown to have an intracellular role as a retinoblastoma protein (Rb)-binding protein that inhibits Rb degradation. Here we show that HIV-1 infection and gp120 treatment of human peripheral blood mononuclear cells resulted in induction of SerpinB2. Furthermore, SerpinB2 expression in THP-1 monocyte/macrophage, Jurkat T, and HeLa cell lines increased replication of HIV-1 and enhanced transcription from the HIV-1 long terminal repeat (LTR) promoter by 3-10-fold. Increased HIV-1 gene expression and transcription was also observed in activated macrophages from SerpinB2 (+/+) mice compared with macrophages from SerpinB2(-/-) mice. The SerpinB2-mediated elevation of Rb protein levels appeared to be responsible for enhancing transcription from the core promoter region of the LTR by relieving HDM2-mediated inhibition of Sp1 and/or by increasing the Sp1/Sp3 expression ratios. This is the first report associating HIV-1 replication with SerpinB2 expression and illustrates that SerpinB2 is a potentially important inducible host factor that significantly promotes HIV-1 replication.	Royal Brisbane Hosp, Queensland Inst Med Res, Brisbane, Qld 4029, Australia; Monash Univ, Australian Ctr Blood Dis, Melbourne, Vic 3800, Australia; Univ Maryland, Sch Med, Dept Physiol, Rockville, MD 20854 USA; Macfarlane Burnet Ctr Med Res, Melbourne, Vic, Australia	QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; Monash University	Suhrbier, A (corresponding author), Royal Brisbane Hosp, Queensland Inst Med Res, PO, Brisbane, Qld 4029, Australia.	Andreas.Suhrbier@qimr.edu.au	Medcalf, Robert L/E-9632-2011; Harrich, David/H-6668-2016	Suhrbier, Andreas/0000-0001-8986-9025; Harrich, David/0000-0003-3690-0150	NATIONAL CANCER INSTITUTE [R01CA098369, P30CA134274] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA098369, P30 CA134274, R01-CA098369] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AKIYAMA H, 1993, NEUROSCI LETT, V164, P233, DOI 10.1016/0304-3940(93)90899-V; Alfano M, 2003, J LEUKOCYTE BIOL, V74, P750, DOI 10.1189/jlb.0403176; Angelici E, 1996, AIDS, V10, P283, DOI 10.1097/00002030-199603000-00007; Antalis TM, 1998, J EXP MED, V187, P1799, DOI 10.1084/jem.187.11.1799; Apolloni A, 2003, J VIROL, V77, P9912, DOI 10.1128/JVI.77.18.9912-9921.2003; Apt D, 1996, VIROLOGY, V224, P281, DOI 10.1006/viro.1996.0530; Aziz S, 2005, JAIDS-J ACQ IMM DEF, V38, P23, DOI 10.1097/00126334-200501010-00005; Badou A, 2000, J VIROL, V74, P10551, DOI 10.1128/JVI.74.22.10551-10562.2000; Bossis G, 2002, FEBS LETT, V516, P257, DOI 10.1016/S0014-5793(02)02566-8; Buyru N, 2003, CLIN APPL THROMB-HEM, V9, P333, DOI 10.1177/107602960300900409; Bystrom J, 2004, BLOOD, V103, P868, DOI 10.1182/blood-2003-08-2778; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Chaussabel D, 2003, BLOOD, V102, P672, DOI 10.1182/blood-2002-10-3232; Darnell GA, 2005, J VIROL, V79, P4246, DOI 10.1128/JVI.79.7.4246-4256.2005; Darnell GA, 2003, MOL CELL BIOL, V23, P6520, DOI 10.1128/MCB.23.18.6520-6532.2003; De Falco G, 2003, ONCOGENE, V22, P6214, DOI 10.1038/sj.onc.1206637; Detweiler CS, 2001, P NATL ACAD SCI USA, V98, P5850, DOI 10.1073/pnas.091110098; Devadas K, 2004, J IMMUNOL, V173, P6735, DOI 10.4049/jimmunol.173.11.6735; Dougherty KM, 1999, P NATL ACAD SCI USA, V96, P686, DOI 10.1073/pnas.96.2.686; Fernandez-Soria V, 2006, INT J ONCOL, V28, P143; Follows GA, 2003, EMBO J, V22, P2798, DOI 10.1093/emboj/cdg250; GARCIA JA, 1989, EMBO J, V8, P765, DOI 10.1002/j.1460-2075.1989.tb03437.x; GARCIA JA, 1988, EMBO J, V7, P3143, DOI 10.1002/j.1460-2075.1988.tb03181.x; Gorry PR, 2005, CURR HIV RES, V3, P53, DOI 10.2174/1570162052772951; Haga H, 2002, J HUM GENET, V47, P605, DOI 10.1007/s100380200092; Hammill D, 2005, BIOCHEM BIOPH RES CO, V335, P377, DOI 10.1016/j.bbrc.2005.07.084; HARRICH D, 1989, J VIROL, V63, P2585, DOI 10.1128/JVI.63.6.2585-2591.1989; HARRICH D, 1990, EMBO J, V9, P4417, DOI 10.1002/j.1460-2075.1990.tb07892.x; HERBEIN G, 1994, CLIN EXP IMMUNOL, V95, P442, DOI 10.1111/j.1365-2249.1994.tb07016.x; Hooker CW, 2003, J CLIN VIROL, V26, P229, DOI 10.1016/S1386-6532(02)00121-X; Johnson BJ, 2005, J BIOL CHEM, V280, P4037, DOI 10.1074/jbc.M411569200; Johnson-Pais T, 2001, P NATL ACAD SCI USA, V98, P2211, DOI 10.1073/pnas.051415898; Kedzierska K, 2003, REV MED VIROL, V13, P39, DOI 10.1002/rmv.369; Komano J, 2005, JPN J INFECT DIS, V58, P125; Kramer-Hammerle S, 2005, VIRUS RES, V111, P194, DOI 10.1016/j.virusres.2005.04.009; KRISHNAMURTI C, 1989, AM J TROP MED HYG, V40, P102, DOI 10.4269/ajtmh.1989.40.102; KRUITHOF EKO, 1995, BLOOD, V86, P4007, DOI 10.1182/blood.V86.11.4007.bloodjournal86114007; Kundu M, 1997, J BIOL CHEM, V272, P29468, DOI 10.1074/jbc.272.47.29468; Lee C, 2005, J LEUKOCYTE BIOL, V78, P1016, DOI 10.1189/jlb.0105056; Li L, 2004, BIOCHEM CELL BIOL, V82, P460, DOI 10.1139/O04-045; Macaluso M, 2006, CELL DEATH DIFFER, V13, P1515, DOI 10.1038/sj.cdd.4401835; MAJELLO B, 1994, NUCLEIC ACIDS RES, V22, P4914, DOI 10.1093/nar/22.23.4914; Medcalf RL, 2005, FEBS J, V272, P4858, DOI 10.1111/j.1742-4658.2005.04879.x; Mikhail Meriet, 2003, AIDS Rev, V5, P230; Mirlashari MR, 2001, THROMB RES, V102, P375, DOI 10.1016/S0049-3848(01)00256-0; Misse D, 2001, BLOOD, V98, P541, DOI 10.1182/blood.V98.3.541; Montemurro P, 2001, J INFECT DIS, V183, P1055, DOI 10.1086/319280; Nicolas M, 2003, BIOCHEM J, V371, P265, DOI 10.1042/BJ20021166; Nitkiewicz J, 2004, J NEUROVIROL, V10, P400, DOI 10.1080/13550280490890097; Park JM, 2005, IMMUNITY, V23, P319, DOI 10.1016/j.immuni.2005.08.010; PERKINS ND, 1993, EMBO J, V12, P3551, DOI 10.1002/j.1460-2075.1993.tb06029.x; Perrier P, 2004, J IMMUNOL, V172, P7031, DOI 10.4049/jimmunol.172.11.7031; Praus M, 1999, GENE THER, V6, P227, DOI 10.1038/sj.gt.3300802; Reiter LS, 1997, INT J CANCER, V70, P461, DOI 10.1002/(SICI)1097-0215(19970207)70:4<461::AID-IJC14>3.0.CO;2-I; Rodriguez-Inigo E, 2005, J MED VIROL, V77, P17, DOI [10.1002/jmv.20409, 10.1002/JMV.20409]; Rohr O, 2003, J LEUKOCYTE BIOL, V74, P736, DOI 10.1189/jlb.0403180; SAFFER JD, 1991, MOL CELL BIOL, V11, P2189, DOI 10.1128/MCB.11.4.2189; Schols D, 1996, J VIROL, V70, P4953, DOI 10.1128/JVI.70.8.4953-4960.1996; Sdek P, 2004, J BIOL CHEM, V279, P53317, DOI 10.1074/jbc.M406062200; Shafren DR, 1999, J VIROL, V73, P7193, DOI 10.1128/JVI.73.9.7193-7198.1999; Shioji G, 2005, J HUM GENET, V50, P507, DOI 10.1007/s10038-005-0285-1; Silverman GA, 2004, CELL MOL LIFE SCI, V61, P301, DOI 10.1007/s00018-003-3240-3; Singh M, 2005, J BIOL CHEM, V280, P37868, DOI 10.1074/jbc.M504877200; Sonza S, 2002, J VIROL, V76, P12611, DOI 10.1128/JVI.76.24.12611-12621.2002; Taoufik Y, 1997, BLOOD, V89, P2842, DOI 10.1182/blood.V89.8.2842; Tapias A, 2005, BBA-GENE STRUCT EXPR, V1730, P126, DOI 10.1016/j.bbaexp.2005.06.002; Theodore TS, 1996, AIDS RES HUM RETROV, V12, P191, DOI 10.1089/aid.1996.12.191; Tyner JW, 2005, NAT MED, V11, P1180, DOI 10.1038/nm1303; Uchida CH, 2005, EMBO J, V24, P160, DOI 10.1038/sj.emboj.7600486; Veazey RS, 2005, NAT MED, V11, P469, DOI 10.1038/nm0505-469; Wahl SM, 1999, J INFECT DIS, V179, pS457, DOI 10.1086/314814; Wahl SM, 2000, J LEUKOCYTE BIOL, V68, P303; Welker R, 2000, J VIROL, V74, P1168, DOI 10.1128/JVI.74.3.1168-1177.2000; Whitaker LL, 1998, MOL CELL BIOL, V18, P4032, DOI 10.1128/MCB.18.7.4032; Xiao Y, 2001, J PERIODONTAL RES, V36, P25, DOI 10.1034/j.1600-0765.2001.00608.x; Yedavalli VSRK, 2003, J BIOL CHEM, V278, P6404, DOI 10.1074/jbc.M209162200; Yu H, 2002, BLOOD, V99, P2810, DOI 10.1182/blood.V99.8.2810	77	18	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31348	31358		10.1074/jbc.M604220200	http://dx.doi.org/10.1074/jbc.M604220200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16923810	Bronze			2022-12-27	WOS:000241235300019
J	Kotaka, M; Ren, J; Lockyer, M; Hawkins, AR; Stammers, DK				Kotaka, Masayo; Ren, Jingshan; Lockyer, Michael; Hawkins, Alastair R.; Stammers, David K.			Structures of R- and T-state Escherichia coli aspartokinase III - Mechanisms of the allosteric transition and inhibition by lysine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE ASPARTOKINASE; HOMOSERINE DEHYDROGENASE; CRYSTAL-STRUCTURE; PHENYLALANINE-HYDROXYLASE; CATALYTIC ACTIVITY; SUBUNIT STRUCTURE; ASPARTATE FAMILY; KINASE; ENZYMES; DOMAIN	Aspartokinase III (AKIII) from Escherichia coli catalyzes an initial commitment step of the aspartate pathway, giving biosynthesis of certain amino acids including lysine. We report crystal structures of AKIII in the inactive T-state with bound feedback allosteric inhibitor lysine and in the R-state with aspartate and ADP. The structures reveal an unusual configuration for the regulatory ACT domains, in which ACT2 is inserted into ACT1 rather than the expected tandem repeat. Comparison of R-and T-state AKIII indicates that binding of lysine to the regulatory ACT1 domain in R-state AKIII instigates a series of changes that release a "latch", the beta 15-alpha K loop, from the catalytic domain, which in turn undergoes large rotational rearrangements, promoting tetramer formation and completion of the transition to the T-state. Lysine-induced allosteric transition in AKIII involves both destabilizing the R-state and stabilizing the T-state tetramer. Rearrangement of the catalytic domain blocks the ATP-binding site, which is therefore the structural basis for allosteric inhibition of AKIII by lysine.	Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Oxford OX3 7BN, England; Arrow Therapeut Ltd, London SE1 1DA, England; Univ Newcastle Upon Tyne, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	University of Oxford; Wellcome Centre for Human Genetics; AstraZeneca; Newcastle University - UK	Stammers, DK (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Oxford OX3 7BN, England.	daves@strubi.ox.ac.uk	Ren, Jingshan/AAT-7729-2021; Kotaka, Masayo/C-4483-2009	Ren, Jingshan/0000-0003-4015-1404; Kotaka, Masayo/0000-0001-9692-3843				Aravind L, 1999, J MOL BIOL, V287, P1023, DOI 10.1006/jmbi.1999.2653; Blanco J, 2002, ACTA CRYSTALLOGR D, V58, P352, DOI 10.1107/S0907444901020728; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CASSAN M, 1986, J BIOL CHEM, V261, P1052; Chipman DM, 2001, CURR OPIN STRUC BIOL, V11, P694, DOI 10.1016/S0959-440X(01)00272-X; COHEN GN, 1969, J BACTERIOL, V99, P791, DOI 10.1128/JB.99.3.791-801.1969; FALCOZKELLY F, 1969, EUR J BIOCHEM, V8, P146, DOI 10.1111/j.1432-1033.1969.tb00507.x; FALCOZKELLY F, 1972, EUR J BIOCHEM, V28, P507, DOI 10.1111/j.1432-1033.1972.tb01938.x; FUNKHOUSER JD, 1974, J BIOL CHEM, V249, P5478; FUNKHOUSER JD, 1974, J BIOL CHEM, V249, P7580; Fusetti F, 1998, J BIOL CHEM, V273, P16962, DOI 10.1074/jbc.273.27.16962; Gallagher DT, 1998, STRUCTURE, V6, P465, DOI 10.1016/S0969-2126(98)00048-3; Gil-Ortiz F, 2003, J MOL BIOL, V331, P231, DOI 10.1016/S0022-2836(03)00716-2; Grant GA, 1996, PROTEIN SCI, V5, P34; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; Helmstaedt K, 2001, MICROBIOL MOL BIOL R, V65, P404, DOI 10.1128/MMBR.65.3.404-421.2001; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kaplun A, 2006, J MOL BIOL, V357, P951, DOI 10.1016/j.jmb.2005.12.077; Keng YF, 1996, ARCH BIOCHEM BIOPHYS, V335, P73, DOI 10.1006/abbi.1996.0483; Kikuchi Y, 1999, FEMS MICROBIOL LETT, V173, P211, DOI 10.1111/j.1574-6968.1999.tb13504.x; Kobe B, 1999, NAT STRUCT BIOL, V6, P442, DOI 10.1038/8247; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liberles JS, 2005, AMINO ACIDS, V28, P1, DOI 10.1007/s00726-004-0152-y; Marco-Marin C, 2003, J MOL BIOL, V334, P459, DOI 10.1016/j.jmb.2003.09.038; Mas-Droux C, 2006, PLANT CELL, V18, P1681, DOI 10.1105/tpc.105.040451; NILES EG, 1973, BIOCHEMISTRY-US, V12, P1715, DOI 10.1021/bi00733a009; Ogawa-Miyata Y, 2001, BIOSCI BIOTECH BIOCH, V65, P1149, DOI 10.1271/bbb.65.1149; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ramon-Maiques S, 2000, J MOL BIOL, V299, P463, DOI 10.1006/jmbi.2000.3779; Ramon-Maiques S, 2002, STRUCTURE, V10, P329, DOI 10.1016/S0969-2126(02)00721-9; RICHAUD C, 1974, EUR J BIOCHEM, V48, P147, DOI 10.1111/j.1432-1033.1974.tb03752.x; RICHAUD C, 1973, EUR J BIOCHEM, V40, P619, DOI 10.1111/j.1432-1033.1973.tb03234.x; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; SCHUDSON M, 1995, FORBES MEDIA CRITIC, V2, P76; STADTMAN ER, 1961, J BIOL CHEM, V236, P2033; STUART DI, 1979, J MOL BIOL, V134, P109, DOI 10.1016/0022-2836(79)90416-9; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Thompson JR, 2005, BIOCHEMISTRY-US, V44, P5763, DOI 10.1021/bi047944b; VERON M, 1972, EUR J BIOCHEM, V28, P520, DOI 10.1111/j.1432-1033.1972.tb01939.x; Viola RE, 2001, ACCOUNTS CHEM RES, V34, P339, DOI 10.1021/ar000057q; Walter TS, 2005, ACTA CRYSTALLOGR D, V61, P651, DOI 10.1107/S0907444905007808; WAMPLER DE, 1968, BIOCHEMISTRY-US, V7, P1661, DOI 10.1021/bi00845a007	43	53	63	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31544	31552		10.1074/jbc.M605886200	http://dx.doi.org/10.1074/jbc.M605886200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16905770				2022-12-27	WOS:000241235300040
J	Lam-Yuk-Tseung, S; Picard, V; Gros, P				Lam-Yuk-Tseung, Steven; Picard, Virginie; Gros, Philippe			Identification of a tyrosine-based motif (YGSI) in the amino terminus of Nramp1 (Slc11a1) that is important for lysosomal targeting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON TRANSPORTER DMT1; MICROCYTIC ANEMIA; NATURAL-RESISTANCE; PLASMA-MEMBRANE; INTRACELLULAR PARASITES; SUBCELLULAR-LOCALIZATION; RECYCLING-ENDOSOMES; SORTING SIGNALS; MUTATION; INFECTION	In macrophages, Nramp1 (Slc11a1) is expressed in lysosomes and restricts replication of intracellular pathogens by removing divalent metals (Mn2+ and Fe2+) from the phagolysosome. Nramp2 (DMT1, Slc11a2) is expressed both at the duodenal brush border where it mediates uptake of dietary iron and ubiquitously at the plasma membrane/ recycling endosomes of many cell types where it transports transferrin-associated iron across the endosomal membrane. In Nramp2, a carboxyl-terminal cytoplasmic motif ((YLLNT559)-Y-555) is critical for internalization and recycling of the transporter from the plasma membrane. Here we studied the subcellular trafficking properties of Nramp1 and investigated the cis-acting sequences responsible for targeting to lysosomes. For this, we constructed and studied Nramp1/Nramp2 chimeric proteins where homologous domains of each protein were exchanged. Chimeras exchanging the amino- (upstream TM1) and carboxyl-terminal (downstream TM12) cytoplasmic segments of both transporters were stably expressed in porcine LLC-PK1 kidney cells and were studied with respect to expression, maturation, stability, cell surface targeting, transport activity, and subcellular localization. An Nramp2 isoform II chimera bearing the amino terminus of Nramp1 was not expressed at the cell surface but was targeted to lysosomes. This lysosomal targeting was abolished by single alanine substitutions at Tyr(15) and Ile(18) of a (15)YGSI(18) motif present in the amino terminus of Nramp1. These results identify YGSI as a tyrosine-based sorting signal responsible for lysosomal targeting of Nramp1.	McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Ctr Host Resistance, Montreal, PQ H3G 1Y6, Canada	McGill University; McGill University	Gros, P (corresponding author), McGill Univ, Dept Biochem, 3655 Promenade Sir William Osler, Montreal, PQ H3G 1Y6, Canada.	gros@mcgill.ca						Abel L, 1998, J INFECT DIS, V177, P133, DOI 10.1086/513830; Awomoyi AA, 2002, J INFECT DIS, V186, P1808, DOI 10.1086/345920; Bellamy R, 1998, NEW ENGL J MED, V338, P640, DOI 10.1056/NEJM199803053381002; Boll W, 1996, EMBO J, V15, P5789, DOI 10.1002/j.1460-2075.1996.tb00965.x; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Canonne-Hergaux F, 2001, BLOOD, V98, P3823, DOI 10.1182/blood.V98.13.3823; Canonne-Hergaux F, 1999, BLOOD, V93, P4406, DOI 10.1182/blood.V93.12.4406.412k21_4406_4417; Canonne-Hergaux FS, 2002, KIDNEY INT, V62, P147, DOI 10.1046/j.1523-1755.2002.00405.x; CELLIER M, 1995, P NATL ACAD SCI USA, V92, P10089, DOI 10.1073/pnas.92.22.10089; Cuellar-Mata P, 2002, J BIOL CHEM, V277, P2258, DOI 10.1074/jbc.M105508200; Fleming MD, 1997, NAT GENET, V16, P383, DOI 10.1038/ng0897-383; Fleming MD, 1998, P NATL ACAD SCI USA, V95, P1148, DOI 10.1073/pnas.95.3.1148; Forbes JR, 2003, BLOOD, V102, P1884, DOI 10.1182/blood-2003-02-0425; Forbes JR, 2001, TRENDS MICROBIOL, V9, P397, DOI 10.1016/S0966-842X(01)02098-4; Govoni G, 1999, INFECT IMMUN, V67, P2225, DOI 10.1128/IAI.67.5.2225-2232.1999; Gruenheid S, 1999, J EXP MED, V189, P831, DOI 10.1084/jem.189.5.831; GRUENHEID S, 1995, GENOMICS, V25, P514, DOI 10.1016/0888-7543(95)80053-O; Gruenheid S, 1997, J EXP MED, V185, P717, DOI 10.1084/jem.185.4.717; GUARNIERI FG, 1993, J BIOL CHEM, V268, P1941; Gunshin H, 2005, BLOOD, V106, P2221, DOI 10.1182/blood-2005-03-1192; Gunshin H, 2005, J CLIN INVEST, V115, P1258, DOI [10.1172/JCI200524356, 10.1172/JCI24356]; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; HARTER C, 1992, J CELL BIOL, V117, P311, DOI 10.1083/jcb.117.2.311; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Honing S, 1996, EMBO J, V15, P5230, DOI 10.1002/j.1460-2075.1996.tb00908.x; Iolascon A, 2006, BLOOD, V107, P349, DOI 10.1182/blood-2005-06-2477; Jabado N, 2000, J EXP MED, V192, P1237, DOI 10.1084/jem.192.9.1237; Jabado N, 2003, P NATL ACAD SCI USA, V100, P6127, DOI 10.1073/pnas.0937287100; Lam-Yuk-Tseung S, 2006, BIOCHEMISTRY-US, V45, P2294, DOI 10.1021/bi052307m; Lam-Yuk-Tseung S, 2005, BLOOD CELL MOL DIS, V35, P212, DOI 10.1016/j.bcmd.2005.05.008; Lam-Yuk-Tseung S, 2005, BIOCHEMISTRY-US, V44, P12149, DOI 10.1021/bi050911r; Lam-Yuk-Tseung S, 2003, BLOOD, V101, P3699, DOI 10.1182/blood-2002-07-2108; Lam-Yuk-Tseung S, 2006, BLOOD CELL MOL DIS, V36, P347, DOI 10.1016/j.bcmd.2006.01.011; MALO D, 1994, GENOMICS, V23, P51, DOI 10.1006/geno.1994.1458; Mims MP, 2005, BLOOD, V105, P1337, DOI 10.1182/blood-2004-07-2966; Ohno H, 1996, J BIOL CHEM, V271, P29009, DOI 10.1074/jbc.271.46.29009; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Picard V, 2000, J BIOL CHEM, V275, P35738, DOI 10.1074/jbc.M005387200; Priwitzerova M, 2005, BLOOD, V106, P3985, DOI 10.1182/blood-2005-04-1550; Rohrer J, 1996, J CELL BIOL, V132, P565, DOI 10.1083/jcb.132.4.565; Searle S, 1998, J CELL SCI, V111, P2855; Tabuchi M, 2002, MOL BIOL CELL, V13, P4371, DOI 10.1091/mbc.E02-03-0165; Touret N, 2004, BLOOD, V104, P1526, DOI 10.1182/blood-2004-02-0731; Touret N, 2003, J BIOL CHEM, V278, P25548, DOI 10.1074/jbc.M212374200; VIDAL S, 1995, J LEUKOCYTE BIOL, V58, P382, DOI 10.1002/jlb.58.4.382; Vidal SM, 1996, J IMMUNOL, V157, P3559; VIDAL SM, 1993, CELL, V73, P469, DOI 10.1016/0092-8674(93)90135-D	47	15	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31677	31688		10.1074/jbc.M601828200	http://dx.doi.org/10.1074/jbc.M601828200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16905747	Bronze			2022-12-27	WOS:000241235300053
J	Olivares, AO; Chang, WK; Mooseker, MS; Hackney, DD; De La Cruz, EM				Olivares, Adrian O.; Chang, Wakam; Mooseker, Mark S.; Hackney, David D.; De La Cruz, Enrique M.			The tail domain of myosin Va modulates actin binding to one head	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING; KINETIC MECHANISM; OXYGEN-EXCHANGE; ATPASE ACTIVITY; ACTOMYOSIN-VI; MOTOR; CALCIUM; MEROMYOSIN; MODEL; ADP	Calcium activates full-length myosin Va steady-state enzymatic activity and favors the transition from a compact, folded "off" state to an extended "on" state. However, little is known of how a head-tail interaction alters the individual actin and nucleotide binding rate and equilibrium constants of the ATPase cycle. We measured the effect of calcium on nucleotide and actin filament binding to full-length myosin Va purified from chick brains. Both heads of nucleotide-free myosin Va bind actin strongly, independent of calcium. In the absence of calcium, bound ADP weakens the affinity of one head for actin filaments at equilibrium and upon initial encounter. The addition of calcium allows both heads of myosin Va(.)ADP to bind actin strongly. Calcium accelerates ADP binding to actomyosin independent of the tail but minimally affects ATP binding. Although O-18 exchange and product release measurements favor a mechanism in which actin-activated P-i release from myosin Va is very rapid, independent of calcium and the tail domain, both heads do not bind actin strongly during steady-state cycling, as assayed by pyrene actin fluorescence. In the absence of calcium, inclusion of ADP favors formation of a long lived myosin Va(.)ADP state that releases ADP slowly, even after mixing with actin. Our results suggest that calcium activates myosin Va by allowing both heads to interact with actin and exchange bound nucleotide and indicate that regulation of actin binding by the tail is a nucleotide-dependent process favored by linked conformational changes of the motor domain.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Dept Cell Biol, New Haven, CT 06520 USA; Yale Univ, Dept Mol Cellular & Dev Biol & Pathol, New Haven, CT 06520 USA; Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA	Yale University; Yale University; Yale University; Carnegie Mellon University	De La Cruz, EM (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 208114, New Haven, CT 06520 USA.	enrique.delacruz@yale.edu	Olivares, Adrian/D-7717-2012	Olivares, Adrian/0000-0002-0895-7988	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F31AR051614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK025387, R01DK025387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073823] Funding Source: NIH RePORTER; NIAMS NIH HHS [1F31AR051614-01] Funding Source: Medline; NIDDK NIH HHS [DK25387] Funding Source: Medline; NIGMS NIH HHS [GM073823] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baker JE, 2004, P NATL ACAD SCI USA, V101, P5542, DOI 10.1073/pnas.0307247101; Cameron LC, 1998, ARCH BIOCHEM BIOPHYS, V355, P35, DOI 10.1006/abbi.1998.0700; Cheney RE, 1998, METHOD ENZYMOL, V298, P3, DOI 10.1016/S0076-6879(98)98003-X; CHENEY RE, 1993, CELL, V75, P13, DOI 10.1016/0092-8674(93)90675-G; De la Cruz EM, 2000, BIOCHEMISTRY-US, V39, P14196, DOI 10.1021/bi001701b; De la Cruz EM, 2000, BIOPHYS J, V79, P1524, DOI 10.1016/S0006-3495(00)76403-4; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; De La Cruz EM, 2005, J MOL BIOL, V346, P557, DOI 10.1016/j.jmb.2004.11.065; De La Cruz EM, 2004, CURR OPIN CELL BIOL, V16, P61, DOI 10.1016/j.ceb.2003.11.011; De la Cruz EM, 2001, J BIOL CHEM, V276, P32373, DOI 10.1074/jbc.M104136200; GEEVES MA, 1984, J MUSCLE RES CELL M, V5, P351, DOI 10.1007/BF00818255; Hackney DD, 2005, P NATL ACAD SCI USA, V102, P18338, DOI 10.1073/pnas.0505288102; HACKNEY DD, 1984, P NATL ACAD SCI-BIOL, V81, P5345, DOI 10.1073/pnas.81.17.5345; Hannemann DE, 2005, BIOCHEMISTRY-US, V44, P8826, DOI 10.1021/bi0473509; Krementsov DN, 2004, J CELL BIOL, V164, P877, DOI 10.1083/jcb.200310065; Krendel M, 2005, PHYSIOLOGY, V20, P239, DOI 10.1152/physiol.00014.2005; Li XD, 2004, BIOCHEM BIOPH RES CO, V315, P538, DOI 10.1016/j.bbrc.2004.01.084; Liu J, 2006, NATURE, V442, P208, DOI 10.1038/nature04719; Martin SR, 2004, FEBS LETT, V567, P166, DOI 10.1016/j.febslet.2004.04.053; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Menetrey J, 2005, NATURE, V435, P779, DOI 10.1038/nature03592; Nascimento AAC, 1996, J BIOL CHEM, V271, P17561, DOI 10.1074/jbc.271.29.17561; Nyitrai M, 2004, PHILOS T R SOC B, V359, P1867, DOI 10.1098/rstb.2004.1560; Nyitrai M, 2003, BIOCHEM J, V370, P839, DOI 10.1042/BJ20021519; Nyitrai M, 2002, BIOCHEM J, V365, P19, DOI 10.1042/BJ20020099; Olivares AO, 2005, P NATL ACAD SCI USA, V102, P13719, DOI 10.1073/pnas.0507068102; Prochniewicz E, 2004, BIOCHEMISTRY-US, V43, P10642, DOI 10.1021/bi049914e; Purcell TJ, 2005, P NATL ACAD SCI USA, V102, P13873, DOI 10.1073/pnas.0506441102; Reck-Peterson SL, 2000, BBA-MOL CELL RES, V1496, P36, DOI 10.1016/S0167-4889(00)00007-0; Reck-Peterson SL, 2001, J CELL BIOL, V153, P1121, DOI 10.1083/jcb.153.5.1121; Rief M, 2000, P NATL ACAD SCI USA, V97, P9482, DOI 10.1073/pnas.97.17.9482; Robblee JP, 2005, BIOCHEMISTRY-US, V44, P10238, DOI 10.1021/bi050232g; Robblee JP, 2004, J BIOL CHEM, V279, P38608, DOI 10.1074/jbc.M403504200; Rock RS, 2001, P NATL ACAD SCI USA, V98, P13655, DOI 10.1073/pnas.191512398; Rosenfeld SS, 2004, J BIOL CHEM, V279, P40100, DOI 10.1074/jbc.M402583200; SLEEP JA, 1980, J BIOL CHEM, V255, P4094; SLEEP JA, 1978, J BIOL CHEM, V253, P5235; Stafford WF, 2001, J MOL BIOL, V307, P137, DOI 10.1006/jmbi.2000.4490; Tauhata SBF, 2001, J BIOL CHEM, V276, P39812, DOI 10.1074/jbc.M102583200; Thirumurugan K, 2006, NATURE, V442, P212, DOI 10.1038/nature04865; Uemura S, 2004, NAT STRUCT MOL BIOL, V11, P877, DOI 10.1038/nsmb806; Veigel C, 2002, NAT CELL BIOL, V4, P59, DOI 10.1038/ncb732; Volkmann N, 2005, MOL CELL, V19, P595, DOI 10.1016/j.molcel.2005.07.015; Wang F, 2004, J BIOL CHEM, V279, P2333, DOI 10.1074/jbc.C300488200; WEBB MR, 1986, J BIOL CHEM, V261, P5557; Wells AL, 1999, NATURE, V401, P505, DOI 10.1038/46835; Yengo CM, 2004, BIOCHEMISTRY-US, V43, P2605, DOI 10.1021/bi035510v	47	27	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31326	31336		10.1074/jbc.M603898200	http://dx.doi.org/10.1074/jbc.M603898200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16921171				2022-12-27	WOS:000241235300017
J	Eckman, EA; Adams, SK; Troendle, FJ; Stodola, BA; Kahn, MA; Fauq, AH; Xiao, HD; Bernstein, KE; Eckman, CB				Eckman, Elizabeth A.; Adams, Stephanie K.; Troendle, Frederick J.; Stodola, Becky A.; Kahn, Murad A.; Fauq, Abdul H.; Xiao, Hong D.; Bernstein, Kenneth E.; Eckman, Christopher B.			Regulation of steady-state beta-amyloid levels in the brain by neprilysin and endothelin-converting enzyme but not angiotensin-converting enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; A-BETA; IN-VIVO; NEUTRAL ENDOPEPTIDASE-24.11; THERAPEUTIC STRATEGIES; NONPEPTIDIC INHIBITORS; DEGRADING ENZYMES; HEART-FAILURE; PEPTIDE; PROTEIN	The deposition of beta-amyloid in the brain is a pathological hallmark of Alzheimer disease (AD). Normally, the accumulation of beta-amyloid is prevented in part by the activities of several degradative enzymes, including the endothelin-converting enzymes, neprilysin, insulin-degrading enzyme, and plasmin. Recent reports indicate that another metalloprotease, angiotensin-converting enzyme (ACE), can degrade beta-amyloid in vitro and in cellular overexpression experiments. In addition, ACE gene variants are linked to AD risk in several populations. Angiotensin-converting enzyme, neprilysin and endothelin-converting enzyme function as vasopeptidases and are the targets of drugs designed to treat cardiovascular disorders, and ACE inhibitors are commonly prescribed. We investigated the potential physiological role of ACE in regulating endogenous brain beta-amyloid levels for two reasons: first, to determine whether beta-amyloid degradation might be the mechanism by which ACE is associated with AD, and second, to determine whether ACE inhibitor drugs might block beta-amyloid degradation in the brain and potentially increase the risk for AD. We analyzed beta-amyloid accumulation in brains from ACE-deficient mice and in mice treated with ACE inhibitors and found that ACE deficiency did not alter steady-state beta-amyloid concentration. In contrast, beta-amyloid levels are significantly elevated in endothelin-converting enzyme and neprilysin knock-out mice, and inhibitors of these enzymes cause a rapid increase in beta-amyloid concentration in the brain. The results of these studies do not support a physiological role for ACE in the degradation of beta-amyloid in the brain but confirm roles for endothelin-converting enzyme and neprilysin and indicate that reductions in these enzymes result in additive increases in brain amyloid beta-peptide levels.	Mayo Clin Jacksonville, Dept Neurosci, Coll Med, Jacksonville, FL 32224 USA; Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA	Mayo Clinic; Emory University	Eckman, CB (corresponding author), Mayo Clin Jacksonville, Dept Neurosci, Coll Med, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.	eckman@mayo.edu	Eckman, Elizabeth/AAL-7316-2021; Khan, Murad Ali/H-7094-2016	Khan, Murad Ali/0000-0002-8286-5504; Bernstein, Kenneth/0000-0001-8097-3272; Eckman, Elizabeth/0000-0002-5391-4960	NINDS NIH HHS [R01NS042192, R01NS048554] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048554, R01NS042192] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARREGUI A, 1982, J NEUROCHEM, V38, P1490, DOI 10.1111/j.1471-4159.1982.tb07930.x; ASAMIODAKA A, 1995, BIOCHEMISTRY-US, V34, P10272, DOI 10.1021/bi00032a022; BARNES JM, 1990, J CARDIOVASC PHARM, V16, P234, DOI 10.1097/00005344-199008000-00009; BARNES NM, 1991, EUR J PHARMACOL, V200, P289, DOI 10.1016/0014-2999(91)90584-D; Cole J, 2002, CIRC RES, V90, P87, DOI 10.1161/hh0102.102360; De Lombaert S, 2000, J MED CHEM, V43, P488, DOI 10.1021/jm990507o; DELOMBAERT S, 1994, BIOCHEM BIOPH RES CO, V204, P407, DOI 10.1006/bbrc.1994.2473; DELOMBAERT S, 1995, BIOORG MED CHEM LETT, V5, P151, DOI 10.1016/0960-894X(94)00475-U; Eckman EA, 2001, J BIOL CHEM, V276, P24540, DOI 10.1074/jbc.M007579200; Eckman EA, 2005, BIOCHEM SOC T, V33, P1101, DOI 10.1042/BST0331101; Eckman EA, 2003, J BIOL CHEM, V278, P2081, DOI 10.1074/jbc.C200642200; Emoto N, 2005, HYPERTENSION, V45, P1145, DOI 10.1161/01.HYP.0000168944.29525.da; EMOTO N, 1995, J BIOL CHEM, V270, P15262, DOI 10.1074/jbc.270.25.15262; Ertekin-Taner N, 2005, HUM MOL GENET, V14, P447, DOI 10.1093/hmg/ddi041; Facchinetti P, 2003, NEUROSCIENCE, V118, P627, DOI 10.1016/S0306-4522(02)01002-3; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Fauq AH, 2004, SYNTHETIC COMMUN, V34, P775, DOI 10.1081/SCC-120028350; Fukami S, 2002, NEUROSCI RES, V43, P39, DOI 10.1016/S0168-0102(02)00015-9; Golde TE, 2005, BRAIN PATHOL, V15, P84, DOI 10.1111/j.1750-3639.2005.tb00104.x; Hemming ML, 2005, J BIOL CHEM, V280, P37644, DOI 10.1074/jbc.M508460200; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hu JG, 2001, J BIOL CHEM, V276, P47863, DOI 10.1074/jbc.M104068200; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; Laws SM, 2003, J NEUROCHEM, V84, P1215, DOI 10.1046/j.1471-4159.2003.01615.x; Lehmann DJ, 2005, AM J EPIDEMIOL, V162, P305, DOI 10.1093/aje/kwi202; LU B, 1995, J EXP MED, V181, P2271, DOI 10.1084/jem.181.6.2271; Melchor JP, 2003, J NEUROSCI, V23, P8867; Mellin V, 2005, J CARDIOVASC PHARM, V46, P390, DOI 10.1097/01.fjc.0000175457.48031.8b; Menard J, 2001, ADV PROTEIN CHEM, V56, P13; Miller BC, 2003, P NATL ACAD SCI USA, V100, P6221, DOI 10.1073/pnas.1031520100; Molinaro G, 2002, CURR OPIN PHARMACOL, V2, P131, DOI 10.1016/S1471-4892(02)00138-8; Oba R, 2005, EUR J NEUROSCI, V21, P733, DOI 10.1111/j.1460-9568.2005.03912.x; Ohrui T, 2004, NEUROLOGY, V63, P1324, DOI 10.1212/01.WNL.0000140705.23869.E9; Ohrui T, 2004, J AM GERIATR SOC, V52, P649, DOI 10.1111/j.1532-5415.2004.52178_7.x; RIVIERE PJM, 1989, BRIT J PHARMACOL, V98, P236, DOI 10.1111/j.1476-5381.1989.tb16887.x; RUPREHT J, 1983, NEUROSCI LETT, V41, P331, DOI 10.1016/0304-3940(83)90472-X; Russell FD, 1999, CIRC RES, V84, P891; Savaskan E, 2001, NEUROBIOL AGING, V22, P541, DOI 10.1016/S0197-4580(00)00259-1; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Trapani AJ, 2000, J CARDIOVASC PHARM, V36, pS40, DOI 10.1097/00005344-200036051-00015; Tucker HM, 2004, NEUROSCI LETT, V368, P285, DOI 10.1016/j.neulet.2004.07.011; Turner AJ, 2004, ANN NY ACAD SCI, V1035, P1, DOI 10.1196/annals.1332.001; Valdenaire O, 1999, EUR J BIOCHEM, V264, P341, DOI 10.1046/j.1432-1327.1999.00602.x; Weber MA, 2001, LANCET, V358, P1525, DOI 10.1016/S0140-6736(01)06584-9; Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P1439, DOI 10.1001/archneur.57.10.1439; Xiao HD, 2004, AM J PATHOL, V165, P1019, DOI 10.1016/S0002-9440(10)63363-9; Yanagisawa H, 1998, DEVELOPMENT, V125, P825; Yanagisawa H, 2000, J CLIN INVEST, V105, P1373, DOI 10.1172/JCI7447	49	163	171	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30471	30478		10.1074/jbc.M605827200	http://dx.doi.org/10.1074/jbc.M605827200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16912050	hybrid			2022-12-27	WOS:000241075900022
J	Gallegos, LL; Kunkel, MT; Newton, AC				Gallegos, Lisa L.; Kunkel, Maya T.; Newton, Alexandra C.			Targeting protein kinase C activity reporter to discrete intracellular regions reveals spatiotemporal differences in agonist-dependent signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GREEN FLUORESCENT PROTEIN; PHOSPHOLIPASE-C; PLASMA-MEMBRANE; GOLGI-COMPLEX; RECEPTOR AGONISTS; PHORBOL ESTERS; LIVING CELLS; PHOSPHORYLATION; ACTIVATION; EPSILON	Protein kinase C (PKC) family members transduce an abundance of diverse intracellular signals. Here we address the role of spatial and temporal segregation in signal specificity by measuring the activity of endogenous PKC at defined intracellular locations in real time in live cells. We targeted a genetically encoded fluorescence resonance energy transfer-based reporter for PKC activity, C kinase activity reporter(CKAR)( Violin, J. D., Zhang, J., Tsien, R. Y., and Newton, A. C. ( 2003) J. Cell Biol. 161, 899 - 909), to the plasma membrane, Golgi, cytosol, mitochondria, or nucleus by fusing appropriate targeting sequences to the NH2 or COOH terminus of CKAR. Measuring the phosphorylation of the reporter in the presence of PKC inhibitors, activators, and/or phosphatase inhibitors shows that activity at each region is under differential control by phosphatase activity; nuclear activity is completely suppressed by phosphatases, whereas membrane-associated activity is the least suppressed by phosphatases. UTP stimulation of endogenous P2Y receptors in COS 7 cells reveals spatiotemporally divergent PKC responses. Imaging the second messengers Ca2+ and diacylglycerol (DAG) reveal that PKC activity at each location is driven by an initial spike in Ca2+, followed by location-specific diacylglycerol generation. In response to UTP, phosphorylation of GolgiCKAR was sustained the longest, driven by the persistence of DAG, whereas phosphorylation of CytoCKAR was of the shortest duration, driven by high phosphatase activity. Our data reveal that the magnitude and duration of PKC signaling is location-specific and controlled by the level of phosphatase activity and persistence of DAG at each location.	Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Newton, AC (corresponding author), Univ Calif San Diego, 9500 Gilman Dr 0721, La Jolla, CA 92039 USA.	anewton@ucsd.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043154, R37GM043154] Funding Source: NIH RePORTER; NIDDK NIH HHS [P01 DK54441] Funding Source: Medline; NIGMS NIH HHS [GM-43154] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abdel-Raheem IT, 2005, BRIT J PHARMACOL, V145, P415, DOI 10.1038/sj.bjp.0706207; BALBOA MA, 1994, J BIOL CHEM, V269, P10511; Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759; BILLAH MM, 1990, BIOCHEM J, V269, P281, DOI 10.1042/bj2690281; Carrasco S, 2004, MOL BIOL CELL, V15, P2932, DOI 10.1091/mbc.E03-11-0844; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; Dale LB, 2001, J BIOL CHEM, V276, P35900, DOI 10.1074/jbc.M103847200; England K, 2000, BIOCHEM J, V352, P19, DOI 10.1042/0264-6021:3520019; Fulton D, 2004, J BIOL CHEM, V279, P30349, DOI 10.1074/jbc.M402155200; Giorgione JR, 2006, J BIOL CHEM, V281, P1660, DOI 10.1074/jbc.M510251200; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HANNUN YA, 1985, J BIOL CHEM, V260, P39; HARRISON SM, 1987, BIOCHIM BIOPHYS ACTA, V925, P133, DOI 10.1016/0304-4165(87)90102-4; Insel PA, 2001, CLIN EXP PHARMACOL P, V28, P351, DOI 10.1046/j.1440-1681.2001.03452.x; Kajimoto T, 2004, J BIOL CHEM, V279, P12668, DOI 10.1074/jbc.M312350200; Kanaji S, 2000, J CELL BIOL, V151, P277, DOI 10.1083/jcb.151.2.277; Kang MS, 2005, J MOL CELL CARDIOL, V38, P753, DOI 10.1016/j.yjmcc.2005.02.017; Kashiwagi K, 2002, J BIOL CHEM, V277, P18037, DOI 10.1074/jbc.M111761200; Kelley GG, 2006, J BIOL CHEM, V281, P2639, DOI 10.1074/jbc.M507681200; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; LEHEL C, 1995, P NATL ACAD SCI USA, V92, P1406, DOI 10.1073/pnas.92.5.1406; Majumder PK, 2005, ONCOGENE, V24, P7465, DOI 10.1038/sj.onc.1209096; Makkerh JPS, 1996, CURR BIOL, V6, P1025, DOI 10.1016/S0960-9822(02)00648-6; Murthy KS, 2004, AM J PHYSIOL-CELL PH, V287, pC1679, DOI 10.1152/ajpcell.00257.2004; NAOR Z, 1990, ENDOCR REV, V11, P326, DOI 10.1210/edrv-11-2-326; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; Ohmori S, 2000, J BIOL CHEM, V275, P26449, DOI 10.1074/jbc.M003588200; ORR JW, 1992, BIOCHEMISTRY-US, V31, P4661, DOI 10.1021/bi00134a018; Saito K, 2003, FEBS LETT, V541, P126, DOI 10.1016/S0014-5793(03)00324-7; Sakai N, 1997, J CELL BIOL, V139, P1465, DOI 10.1083/jcb.139.6.1465; Sasaki K, 2003, J BIOL CHEM, V278, P30945, DOI 10.1074/jbc.M212167200; Schultz A, 2003, CELL DEATH DIFFER, V10, P662, DOI 10.1038/sj.cdd.4401235; Song C, 2001, J BIOL CHEM, V276, P2752, DOI 10.1074/jbc.M008324200; Thore S, 2005, J CELL SCI, V118, P4463, DOI 10.1242/jcs.02577; Vermeulen K, 2003, CELL PROLIFERAT, V36, P165, DOI 10.1046/j.1365-2184.2003.00267.x; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Wang QMJ, 1999, J BIOL CHEM, V274, P37233, DOI 10.1074/jbc.274.52.37233; Wang WL, 2003, J BIOL CHEM, V278, P37705, DOI 10.1074/jbc.M304619200; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2	41	144	146	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30947	30956		10.1074/jbc.M603741200	http://dx.doi.org/10.1074/jbc.M603741200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16901905	hybrid			2022-12-27	WOS:000241075900071
J	Lu, GW; Maeda, H; Reddy, SV; Kurihara, N; Leach, R; Anderson, JL; Roodman, GD				Lu, Ganwei; Maeda, Hidefumi; Reddy, Sakamuri V.; Kurihara, Noriyoshi; Leach, Robin; Anderson, Judith L.; Roodman, G. David			Cloning and characterization of the annexin II receptor on human marrow stromal cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOCLAST-STIMULATING FACTOR; HUMAN-BONE MARROW; A2 HETEROTETRAMER; GENE FAMILY; MEMBRANE; CULTURES; IDENTIFICATION; RESORPTION; DIFFERENTIATION; PRECURSORS	Annexin II is a heterotetramer, consisting of two 11-kDa (p11) and two 36-kDa (p36) subunits, that is produced by osteoclasts and stimulates osteoclast formation. However, its receptor is unknown. We showed that annexin II binds to normal primary human marrow stromal cells and the Paget's marrow-derived PSV10 stromal cell line to induce osteoclast formation. I-125-Labeled annexin II binding assays with PSV10 cells demonstrated that there was a single class of annexin II receptors with a K-d of 5.79 nM and B-max of 2.13 x 10(5) receptors/cell. Annexin III or annexin V did not bind this receptor. Using I-125-labeled annexin II binding to screen NIH3T3 transfected with a human marrow cDNA expression library, we identified a putative annexin II receptor clone, which encoded a novel 26-kDa type I membrane receptor protein when expressed in HEK 293 cells. HEK 293 cells transformed with the cloned annexin II receptor cDNA showed a similar binding affinity to annexin II as that observed in PSV10 cells. Chemical cross-linking experiments with biotinylated annexin II and intact PSV10 cells identified a 55-kDa band on Western blot analysis that reacted with both an anti-p11 antibody and streptavidin but not anti-p36 antibody. A rabbit polyclonal antibody raised against the putative recombinant annexin II receptor also recognized the same 26-kDa protein band detected in PSV10 cells. Importantly, the annexin II receptor antibody dose-dependently blocked the stimulatory effects of annexin II on human osteoclast formation, demonstrating that the receptor mediates the effects of annexin II on osteoclast formation.	VA Pittsburgh Healthcare Syst, Med Hematol Oncol 151U, Pittsburgh, PA 15240 USA; Univ Pittsburgh, Pittsburgh, PA 15240 USA; Kyushu Univ Hosp, Fukuoka 8128581, Japan; Med Univ S Carolina, Childrens Res Inst, Dept Pediat, Charleston, SC 29425 USA; Univ Texas, Hlth Sci Ctr, San Antonio, TX 78229 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Kyushu University; Medical University of South Carolina; University of Texas System; University of Texas Health San Antonio	Roodman, GD (corresponding author), VA Pittsburgh Healthcare Syst, Med Hematol Oncol 151U, Univ Dr C, Pittsburgh, PA 15240 USA.	roodmangd@upmc.edu	Reddy, Sakamuri/H-6419-2019	Leach, Robin/0000-0002-3201-5579	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044603, R01AR041336] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013625] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR41336, AR44603] Funding Source: Medline; NIA NIH HHS [AG13625] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Burger A, 1996, J MOL BIOL, V257, P839, DOI 10.1006/jmbi.1996.0205; Choi SJ, 2001, J BONE MINER RES, V16, P814, DOI 10.1359/jbmr.2001.16.5.814; DAVIES J, 1989, J CELL BIOL, V109, P1817, DOI 10.1083/jcb.109.4.1817; Davis RG, 1995, J IMMUNOL METHODS, V188, P91, DOI 10.1016/0022-1759(95)00207-3; Fey MF, 1996, BBA-GENE STRUCT EXPR, V1306, P160, DOI 10.1016/0167-4781(95)00238-3; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Hajjar KA, 1996, J BIOL CHEM, V271, P21652, DOI 10.1074/jbc.271.35.21652; HARDER T, 1992, GENE, V113, P269, DOI 10.1016/0378-1119(92)90406-F; KUKITA T, 1989, LAB INVEST, V60, P532; KURIHARA N, 1990, ENDOCRINOLOGY, V126, P2733, DOI 10.1210/endo-126-5-2733; Kurihara N, 2001, J BIOL CHEM, V276, P41035, DOI 10.1074/jbc.M100233200; Kwon MJ, 2005, FRONT BIOSCI-LANDMRK, V10, P300, DOI 10.2741/1529; Laumonnier Y, 2006, BLOOD, V107, P3342, DOI 10.1182/blood-2005-07-2840; Lee KH, 1999, FEBS LETT, V442, P143, DOI 10.1016/S0014-5793(98)01643-3; Lewit-Bentley A, 2000, CELL BIOL INT, V24, P799, DOI 10.1006/cbir.2000.0629; Li FH, 2005, J BONE MINER RES, V20, P1161, DOI 10.1359/JBMR.050207; Liu L, 1997, CELL SIGNAL, V9, P299, DOI 10.1016/S0898-6568(97)89891-9; MACDONALD BR, 1987, ENDOCRINOLOGY, V120, P2326, DOI 10.1210/endo-120-6-2326; Menaa C, 1999, J CLIN INVEST, V103, P1605, DOI 10.1172/JCI6374; Mitaku S, 2002, BIOINFORMATICS, V18, P608, DOI 10.1093/bioinformatics/18.4.608; Mitaku S, 1999, BIOPHYS CHEM, V82, P165, DOI 10.1016/S0301-4622(99)00116-7; Mizwicki MT, 2004, J CELL BIOCHEM, V91, P852, DOI 10.1002/jcb.10783; Munz B, 1997, J INVEST DERMATOL, V108, P307, DOI 10.1111/1523-1747.ep12286470; Oba Y, 2003, J BONE MINER RES, V18, P1332, DOI 10.1359/jbmr.2003.18.7.1332; PFEILSCHIFTER J, 1989, J BONE MINER RES, V4, P113, DOI 10.1002/jbmr.5650040116; RAYNAL P, 1994, BBA-REV BIOMEMBRANES, V1197, P63, DOI 10.1016/0304-4157(94)90019-1; Reddy S, 1998, J CELL PHYSIOL, V177, P636, DOI 10.1002/(SICI)1097-4652(199812)177:4<636::AID-JCP14>3.3.CO;2-8; Reddy SV, 2004, CRIT REV EUKAR GENE, V14, P255, DOI 10.1615/CritRevEukaryotGeneExpr.v14.i4.20; Reddy SV, 1998, CRIT REV EUKAR GENE, V8, P1; Roodman GD, 1999, EXP HEMATOL, V27, P1229, DOI 10.1016/S0301-472X(99)00061-2; Schlessinger J, 2004, SCIENCE, V306, P1506, DOI 10.1126/science.1105396; Siever DA, 1997, INT J BIOCHEM CELL B, V29, P1219, DOI 10.1016/S1357-2725(97)00057-5; TAKAHASHI N, 1989, J CLIN INVEST, V83, P543, DOI 10.1172/JCI113916; TAKAHASHI S, 1994, J BIOL CHEM, V269, P28696; WAISMAN DM, 1995, MOL CELL BIOCHEM, V149, P301, DOI 10.1007/BF01076592; [No title captured]	37	22	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30542	30550		10.1074/jbc.M607072200	http://dx.doi.org/10.1074/jbc.M607072200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16895901	hybrid			2022-12-27	WOS:000241075900030
J	Oria-Hernandez, J; Riveros-Rosas, H; Ramirez-Silva, L				Oria-Hernandez, Jesus; Riveros-Rosas, Hector; Ramirez-Silva, Leticia			Dichotomic phylogenetic tree of the pyruvate kinase family - K+-dependent and -independent enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR MAGNETIC-RESONANCE; INDUCED CONFORMATIONAL CHANGE; MONOVALENT CATIONS; REGULATORY PROPERTIES; ESCHERICHIA-COLI; RABBIT MUSCLE; ANGSTROM RESOLUTION; UNIVALENT CATIONS; SKELETAL-MUSCLE; CHEMICAL RESCUE	K+ dependence was assumed to be a feature of all pyruvate kinases until it was discovered that some enzymes express K+-independent activity. Almost all the K+-independent pyruvate kinases have Lys at position 117, instead of the Glu present in the K+-dependent muscle enzyme. Mutagenesis studies show that the internal positive charge substitutes for the K+ requirement (Laughlin, L. T. & Reed, G. H. ( 1997) Arch. Biochem. Biophys. 348, 262 - 267). In this work a phylogenetic analysis of pyruvate kinase was performed to ascertain the abundance of K+-independent activities and to explore whether the K+ activating effect is related to the evolutionary history of the enzyme. Of the 230 studied sequences, 46% have Lys at position 117, and the rest have Glu. Pyruvate kinases with Lys(117) and Glu(117) are separated in two clusters. All of the enzymes of the Glu117 cluster that have been characterized are K+-dependent, whereas those of the Lys117 cluster are K+-independent. Thus, there is a strict correlation between the dichotomy of the tree and the dependence of activity on K+.77% of the pyruvate kinases that possess Lys(117) have Lys(113)/Gln(114); they also have Ile, Val, or Leu at position 120. These residues are replaced by Glu117 and Thr(113)/Lys(114)/Thr(120) in 80% of K+-dependent pyruvate kinases. Structural analysis indicates that these residues are in a hinge region involved in the acquisition of the catalytic conformation of the enzyme. The route of conversion from K+-independent to K+-dependent pyruvate kinases is described. A plausible explanation of how enzymes developed K+ dependence is put forth.	Univ Nacl Autonoma Mexico, Fac Med, Dept Bioquim, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Ramirez-Silva, L (corresponding author), Univ Nacl Autonoma Mexico, Fac Med, Dept Bioquim, Apartado Postal 70-159, Mexico City 04510, DF, Mexico.	lramirez@bq.unam.mx	Riveros-Rosas, Hector/ABD-6638-2020; Oria-Hernández, Jesús/AAG-1243-2019; Riveros-Rosas, Hector/B-6607-2008	Riveros-Rosas, Hector/0000-0003-0194-2537; Oria-Hernández, Jesús/0000-0001-7147-1879; Riveros-Rosas, Hector/0000-0003-0194-2537				Ahmad A, 2001, BIOCHEMISTRY-US, V40, P1945, DOI 10.1021/bi001933a; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersson CE, 2002, J MOL BIOL, V315, P409, DOI 10.1006/jmbi.2001.5248; Asanuma N, 2001, MICROBIOL-UK, V147, P681, DOI 10.1099/00221287-147-3-681; BARANOWSKA B, 1975, MOL CELL BIOCHEM, V6, P197, DOI 10.1007/BF01732078; Belogurov GA, 2002, J BIOL CHEM, V277, P49651, DOI 10.1074/jbc.M210341200; Benson DA, 2000, NUCLEIC ACIDS RES, V28, P15, DOI 10.1093/nar/28.1.15; BUSTO F, 1988, BIOCHEM CELL BIOL, V66, P148, DOI 10.1139/o88-020; CALLENS M, 1991, MOL BIOCHEM PARASIT, V47, P19, DOI 10.1016/0166-6851(91)90144-U; Chen J, 2003, NUCLEIC ACIDS RES, V31, P474, DOI 10.1093/nar/gkg086; Di Cera E, 2004, CR BIOL, V327, P1065, DOI 10.1016/j.crvi.2004.07.011; Di Cera E, 2006, J BIOL CHEM, V281, P1305, DOI 10.1074/jbc.R500023200; DOOLITTLE WF, 1994, P NATL ACAD SCI USA, V91, P6721, DOI 10.1073/pnas.91.15.6721; Du WS, 2000, EUR J BIOCHEM, V267, P222, DOI 10.1046/j.1432-1327.2000.00994.x; ERNEST I, 1994, MOL BIOCHEM PARASIT, V64, P43, DOI 10.1016/0166-6851(94)90133-3; Iliffe-Lee ER, 2002, MOL MICROBIOL, V44, P819, DOI 10.1046/j.1365-2958.2002.02924.x; JETTEN MSM, 1994, APPL ENVIRON MICROB, V60, P2501, DOI 10.1128/AEM.60.7.2501-2507.1994; Johnsen U, 2003, J BIOL CHEM, V278, P25417, DOI 10.1074/jbc.M210288200; KACHMAR JF, 1953, J BIOL CHEM, V200, P669; KAHN A, 1982, METHOD ENZYMOL, V90, P131; KAYNE FJ, 1971, ARCH BIOCHEM BIOPHYS, V143, P232, DOI 10.1016/0003-9861(71)90204-9; KAYNE FJ, 1965, J AM CHEM SOC, V87, P897, DOI 10.1021/ja01082a035; KAYNE FJ, 1970, J AM CHEM SOC, V92, P220, DOI 10.1021/ja00704a048; Knowles VL, 2001, J BIOL CHEM, V276, P20966, DOI 10.1074/jbc.M008878200; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Larsen TM, 1998, BIOCHEMISTRY-US, V37, P6247, DOI 10.1021/bi980243s; Larsen TM, 2001, HANDBOOK ON METALLOPROTEINS, P9; Larsen TM, 1997, ARCH BIOCHEM BIOPHYS, V345, P199, DOI 10.1006/abbi.1997.0257; LARSEN TM, 1994, BIOCHEMISTRY-US, V33, P6301, DOI 10.1021/bi00186a033; Laughlin LT, 1997, ARCH BIOCHEM BIOPHYS, V348, P262, DOI 10.1006/abbi.1997.0448; Loria JP, 1998, BIOCHEMISTRY-US, V37, P6967, DOI 10.1021/bi972454n; Maeda T, 2003, PARASITOL RES, V89, P259, DOI 10.1007/s00436-002-0739-8; MALCOVATI M, 1982, METHOD ENZYMOL, V90, P170; McCartney SA, 2005, J BIOL CHEM, V280, P33206, DOI 10.1074/jbc.M506876200; MEIXNERMONORI B, 1984, CAN J MICROBIOL, V30, P16, DOI 10.1139/m84-003; MILDVAN AS, 1966, J BIOL CHEM, V241, P1178; MUIRHEAD H, 1987, BIOCHEM SOC T, V15, P996, DOI 10.1042/bst0150996; Munoz ME, 2003, COMP BIOCHEM PHYS B, V135, P197, DOI 10.1016/S1096-4959(03)00081-2; Nairn J, 1998, PROTEIN EXPRES PURIF, V14, P247, DOI 10.1006/prep.1998.0938; NOWAK T, 1972, BIOCHEMISTRY-US, V11, P2819, DOI 10.1021/bi00765a014; Oria-Hernandez J, 2005, J BIOL CHEM, V280, P37924, DOI 10.1074/jbc.M508490200; Qi GY, 2005, BIOINFORMATICS, V21, P2832, DOI 10.1093/bioinformatics/bti420; RamirezSilva L, 1997, EUR J BIOCHEM, V250, P583, DOI 10.1111/j.1432-1033.1997.0583a.x; RAUSHEL FM, 1980, BIOCHEMISTRY-US, V19, P5481, DOI 10.1021/bi00565a003; REUBEN J, 1971, J BIOL CHEM, V246, P6227; RHODES N, 1986, BIOCHEM J, V234, P705, DOI 10.1042/bj2340705; SAKAI H, 1986, J BIOCHEM-TOKYO, V99, P1157, DOI 10.1093/oxfordjournals.jbchem.a135579; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schramm A, 2000, J BACTERIOL, V182, P2001, DOI 10.1128/JB.182.7.2001-2009.2000; SORGER GJ, 1965, P NATL ACAD SCI USA, V54, P1614, DOI 10.1073/pnas.54.6.1614; Steiner P, 1998, GENE, V220, P31, DOI 10.1016/S0378-1119(98)00418-1; SUELTER CH, 1966, BIOCHEMISTRY-US, V5, P131, DOI 10.1021/bi00865a017; SUELTER CH, 1970, SCIENCE, V168, P789, DOI 10.1126/science.168.3933.789; SUELTER CH, 1963, J BIOL CHEM, V238, pC4109; Susan-Resiga D, 2003, J BIOL CHEM, V278, P40943, DOI 10.1074/jbc.M306068200; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TSAO MU, 1975, MICROBIOS, V12, P125; VALENTINI G, 1979, ITAL J BIOCHEM, V28, P345; Walsh DA, 2005, CURR BIOL, V15, pR237, DOI 10.1016/j.cub.2005.03.034; Wilbanks SM, 1998, BIOCHEMISTRY-US, V37, P7456, DOI 10.1021/bi973046m; Williams DM, 2000, J BIOL CHEM, V275, P38127, DOI 10.1074/jbc.C000606200; YAMADA T, 1975, J BACTERIOL, V124, P562, DOI 10.1128/JB.124.1.562-563.1975	62	23	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30717	30724		10.1074/jbc.M605310200	http://dx.doi.org/10.1074/jbc.M605310200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16905543	hybrid			2022-12-27	WOS:000241075900048
J	Grishin, A; Li, H; Levitan, ES; Zaks-Makhina, E				Grishin, Anatoly; Li, Hui; Levitan, Edwin S.; Zaks-Makhina, Elena			Identification of gamma-aminobutyric acid receptor-interacting factor 1 (TRAK2) as a trafficking factor for the K+ channel Kir2.1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECTIFYING POTASSIUM CHANNEL; SELECTIVE GOLGI EXPORT; COIL DOMAIN PROTEINS; O-GLCNAC; SURFACE EXPRESSION; TRANSPORT SIGNALS; CLONING; FAMILY; BRAIN; STOICHIOMETRY	To identify proteins that regulate potassium channel activity and expression, we performed functional screening of mammalian cDNA libraries in yeast that express the mammalian K+ channel Kir2.1. Growth of Kir2.1-expressing yeast in media with low K+ concentration is a function of K+ uptake via Kir2.1 channels. Therefore, the host strain was transformed with a human cDNA library, and cDNA clones that rescued growth at low K+ concentration were selected. One of these clones was identical to the protein of unknown function isolated previously as gamma-aminobutyric acid receptor-interacting factor 1 (GRIF-1) ( Beck, M., Brickley, K., Wilkinson, H., Sharma, S., Smith, M., Chazot, P., Pollard, S., and Stephenson, F.( 2002) J. Biol. Chem. 277, 30079-30090). GRIF-1 specifically enhanced Kir2.1-dependent growth in yeast and Kir2.1-mediated Rb-86(+) efflux in HEK293 cells. Quantitative microscopy and flow cytometry analysis of immunolabeled surface Kir2.1 channel showed that GRIF-1 significantly increased the number of Kir2.1 channels in the plasma membrane of COS and HEK293 cells. Physical interaction of Kir2.1 channel and GRIF-1 was demonstrated by co-immunoprecipitation from HEK293 lysates and yeast two-hybrid assay. In vivo association of Kir2.1 and GRIF-1 was demonstrated by co-immunoprecipitation from brain lysate. Yeast two-hybrid assays showed that an N-terminal region of GRIF-1 interacts with a C-terminal region of Kir2.1. These results indicate that GRIF-1 binds to Kir2.1 and facilitates trafficking of this channel to the cell surface.	Univ Pittsburgh, Sch Med, Dept Pharmacol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Levitan, ES (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol, 220 Lothrop St, Pittsburgh, PA 15261 USA.	levitan@server.pharm.pitt.edu			NHLBI NIH HHS [HL80632, HL55312] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055312, R01HL080632] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Anderson CL, 2006, CIRCULATION, V113, P365, DOI 10.1161/CIRCULATIONAHA.105.570200; Beck M, 2002, J BIOL CHEM, V277, P30079, DOI 10.1074/jbc.M200438200; Brickley K, 2005, J BIOL CHEM, V280, P14723, DOI 10.1074/jbc.M409095200; Chatelain FC, 2005, NEURON, V47, P833, DOI 10.1016/j.neuron.2005.08.022; Chu PJ, 2006, J BIOL CHEM, V281, P365, DOI 10.1074/jbc.M508897200; Deutsch C, 2003, NEURON, V40, P265, DOI 10.1016/S0896-6273(03)00506-3; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Gilbert SL, 2006, NAT GENET, V38, P245, DOI 10.1038/ng1715; Griffith LC, 2001, CURR BIOL, V11, pR226, DOI 10.1016/S0960-9822(01)00111-7; Hadano S, 2001, GENOMICS, V71, P200, DOI 10.1006/geno.2000.6392; Hofherr A, 2005, J CELL SCI, V118, P1935, DOI 10.1242/jcs.02322; Iyer SPN, 2003, J BIOL CHEM, V278, P5399, DOI 10.1074/jbc.M209384200; Khidekel N, 2004, P NATL ACAD SCI USA, V101, P13132, DOI 10.1073/pnas.0403471101; Leonoudakis D, 2004, J BIOL CHEM, V279, P22331, DOI 10.1074/jbc.M400285200; Leyland ML, 2004, J BIOL CHEM, V279, P43427, DOI 10.1074/jbc.M407575200; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Ma D, 2002, NEURON, V33, P715, DOI 10.1016/S0896-6273(02)00614-1; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; Michelsen K, 2005, EMBO REP, V6, P717, DOI 10.1038/sj.embor.7400480; Minor DL, 1999, CELL, V96, P879, DOI 10.1016/S0092-8674(00)80597-8; Nagaya N, 1999, RECEPTOR CHANNEL, V6, P229; Nakamura RL, 1997, J BIOL CHEM, V272, P1011, DOI 10.1074/jbc.272.2.1011; Nehring RB, 2000, J NEUROSCI, V20, P156, DOI 10.1523/JNEUROSCI.20-01-00156.2000; Roti ECR, 2002, J BIOL CHEM, V277, P47779, DOI 10.1074/jbc.M206638200; Sampson LJ, 2003, J BIOL CHEM, V278, P41988, DOI 10.1074/jbc.M307479200; Shikano S, 2005, NAT CELL BIOL, V7, P985, DOI 10.1038/ncb1297; Stockklausner C, 2003, J BIOL CHEM, V278, P17000, DOI 10.1074/jbc.M212243200; Stowers RS, 2002, NEURON, V36, P1063, DOI 10.1016/S0896-6273(02)01094-2; TANG WM, 1995, MOL BIOL CELL, V6, P1231, DOI 10.1091/mbc.6.9.1231; Wible BA, 1998, J BIOL CHEM, V273, P11745, DOI 10.1074/jbc.273.19.11745; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007; Zaks-Makhina E, 2004, MOL PHARMACOL, V65, P214, DOI 10.1124/mol.65.1.214; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	34	38	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					30104	30111		10.1074/jbc.M602439200	http://dx.doi.org/10.1074/jbc.M602439200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16895905	hybrid			2022-12-27	WOS:000240896300071
J	Carroll, MC; Outten, CE; Proescher, JB; Rosenfeld, L; Watson, WH; Whitson, LJ; Hart, PJ; Jensen, LT; Culotta, VC				Carroll, Mark C.; Outten, Caryn E.; Proescher, Jody B.; Rosenfeld, Leah; Watson, Walter H.; Whitson, Lisa J.; Hart, P. John; Jensen, Laran T.; Culotta, Valeria Cizewski			The effects of glutaredoxin and copper activation pathways on the disulfide and stability of Cu, Zn superoxide dismutase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; PROTEIN S-GLUTATHIONYLATION; CU,ZN-SUPEROXIDE DISMUTASE; ESCHERICHIA-COLI; SOD1; CHAPERONE; MUTATIONS; SUPEROXIDE-DISMUTASE-1; AGGREGATION; BINDING	Mutations in Cu, Zn superoxide dismutase (SOD1) can cause amyotrophic lateral sclerosis (ALS) through mechanisms proposed to involve SOD1 misfolding, but the intracellular factors that modulate folding and stability of SOD1 are largely unknown. By using yeast and mammalian expression systems, we demonstrate here that SOD1 stability is governed by post-translational modification factors that target the SOD1 disulfide. Oxidation of the human SOD1 disulfide in vivo was found to involve both the copper chaperone for SOD1 (CCS) and the CCS-independent pathway for copper activation. When both copper pathways were blocked, wild type SOD1 stably accumulated in yeast cells with a reduced disulfide, whereas ALS SOD1 mutants A4V, G93A, and G37R were degraded. We describe here an unprecedented role for the thiol oxidoreductase glutaredoxin in reducing the SOD1 disulfide and destabilizing ALS mutants. Specifically, the major cytosolic glutaredoxin of yeast was seen to reduce the intramolecular disulfide of ALS SOD1 mutant A4V SOD1 in vivo and in vitro. By comparison, glutaredoxin was less reactive toward the disulfide of wild type SOD1. The apo-form of A4V SOD1 was highly reactive with glutaredoxin but not SOD1 containing both copper and zinc. Glutaredoxin therefore preferentially targets the immature form of ALS mutant SOD1 lacking metal co-factors. Overall, these studies implicate a critical balance between cellular reductants such as glutaredoxin and copper activation pathways in controlling the disulfide and stability of SOD1 in vivo.	Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA; Univ Texas, Hlth Sci Ctr, Dept Biochem, San Antonio, TX 78229 USA; Univ Texas, Hlth Sci Ctr, Xray Crystallog Core Lab, San Antonio, TX 78229 USA; Univ Texas, Hlth Sci Ctr, Geriatr Res Educ & Clin Ctr, Dept Vet Affairs,S Texas Vet Hlth Care Syst, San Antonio, TX 78229 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Geriatric Research Education & Clinical Center; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Culotta, VC (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, 615 N Wolfe St,Rm E7626, Baltimore, MD 21205 USA.	vculotta@jhsph.edu	Outten, Caryn E./I-9433-2019	Outten, Caryn E./0000-0003-0335-6531; Proescher, Jody/0000-0002-8100-7866; Jensen, Laran/0000-0003-3199-1743	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K22ES012260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM050016, R01GM050016, F32GM066594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039112] Funding Source: NIH RePORTER; NIEHS NIH HHS [K22 ES012260, ES012260, ES 07141] Funding Source: Medline; NIGMS NIH HHS [F32 GM066594, R37 GM050016, GM50016, R01 GM050016] Funding Source: Medline; NINDS NIH HHS [R01 NS039112, NS39112, R01 NS039112-05] Funding Source: Medline; PHS HHS [F32 66594] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Adachi T, 2004, J BIOL CHEM, V279, P29857, DOI 10.1074/jbc.M313320200; Antonyuk S, 2005, PROTEIN SCI, V14, P1201, DOI 10.1110/ps.041256705; Arnesano F, 2004, J BIOL CHEM, V279, P47998, DOI 10.1074/jbc.M406021200; Assfalg M, 2003, J MOL BIOL, V330, P145, DOI 10.1016/S0022-2836(03)00533-3; Banci L, 2006, J BIOL CHEM, V281, P2333, DOI 10.1074/jbc.M506497200; Bartnikas TB, 2003, J BIOL CHEM, V278, P33602, DOI 10.1074/jbc.M305435200; BORCHELT DR, 1995, J BIOL CHEM, V270, P3234, DOI 10.1074/jbc.270.7.3234; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; Brown NM, 2004, P NATL ACAD SCI USA, V101, P5518, DOI 10.1073/pnas.0401175101; Carmel-Harel O, 2000, ANNU REV MICROBIOL, V54, P439, DOI 10.1146/annurev.micro.54.1.439; Carroll MC, 2004, P NATL ACAD SCI USA, V101, P5964, DOI 10.1073/pnas.0308298101; Casareno RLB, 1998, J BIOL CHEM, V273, P23625, DOI 10.1074/jbc.273.37.23625; Choi J, 2005, J BIOL CHEM, V280, P11648, DOI 10.1074/jbc.M414327200; Cleveland DW, 2000, NAT MED, V6, P1320, DOI 10.1038/82122; Corson LB, 1998, P NATL ACAD SCI USA, V95, P6361, DOI 10.1073/pnas.95.11.6361; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; Di Noto L, 2005, J BIOL CHEM, V280, P39907, DOI 10.1074/jbc.M506247200; Doucette PA, 2004, J BIOL CHEM, V279, P54558, DOI 10.1074/jbc.M409744200; Draculic T, 2000, MOL MICROBIOL, V36, P1167, DOI 10.1046/j.1365-2958.2000.01948.x; Elam JS, 2003, NAT STRUCT BIOL, V10, P461, DOI 10.1038/nsb935; Fernandes AP, 2004, ANTIOXID REDOX SIGN, V6, P63, DOI 10.1089/152308604771978354; FLOHE L, 1984, METHOD ENZYMOL, V105, P93; FORMAN HJ, 1973, J BIOL CHEM, V248, P2645; Furukawa Y, 2005, J BIOL CHEM, V280, P17266, DOI 10.1074/jbc.M500482200; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; Furukawa Y, 2006, P NATL ACAD SCI USA, V103, P7148, DOI 10.1073/pnas.0602048103; HOLMGREN A, 1976, P NATL ACAD SCI USA, V73, P2275, DOI 10.1073/pnas.73.7.2275; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P283; Hoppe G, 2004, EXP EYE RES, V78, P1085, DOI 10.1016/j.exer.2004.02.001; Jensen LT, 2005, J BIOL CHEM, V280, P41373, DOI 10.1074/jbc.M509142200; Jonsson PA, 2006, BRAIN, V129, P451, DOI 10.1093/brain/awh704; Lamb AL, 2001, NAT STRUCT BIOL, V8, P751, DOI 10.1038/nsb0901-751; Lee S, 2003, NAT STRUCT BIOL, V10, P725, DOI 10.1038/nsb961; Liu HB, 2000, BIOCHEMISTRY-US, V39, P8125, DOI 10.1021/bi000846f; Luikenhuis S, 1998, MOL BIOL CELL, V9, P1081, DOI 10.1091/mbc.9.5.1081; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Pedrajas JR, 2002, BIOCHEM J, V364, P617, DOI 10.1042/BJ20020570; Petrovic N, 1996, J BIOL CHEM, V271, P28331, DOI 10.1074/jbc.271.45.28331; Rodriguez JA, 2002, J BIOL CHEM, V277, P15932, DOI 10.1074/jbc.M112088200; Rodriguez-Manzaneque MT, 1999, MOL CELL BIOL, V19, P8180; Schmidt PJ, 1999, J BIOL CHEM, V274, P36952, DOI 10.1074/jbc.274.52.36952; Shelton MD, 2005, ANTIOXID REDOX SIGN, V7, P348, DOI 10.1089/ars.2005.7.348; Slekar KH, 1996, J BIOL CHEM, V271, P28831, DOI 10.1074/jbc.271.46.28831; STEINKUHLER C, 1994, BIOCHEM J, V302, P687, DOI 10.1042/bj3020687; Strange RW, 2006, J MOL BIOL, V356, P1152, DOI 10.1016/j.jmb.2005.11.081; Strange RW, 2003, J MOL BIOL, V328, P877, DOI 10.1016/S0022-2836(03)00355-3; Subramaniam JR, 2002, NAT NEUROSCI, V5, P301, DOI 10.1038/nn823; Tiwari A, 2003, J BIOL CHEM, V278, P5984, DOI 10.1074/jbc.M210419200; Valentine J. S., 1981, METAL IONS BIOL, P291; Valentine JS, 2003, P NATL ACAD SCI USA, V100, P3617, DOI 10.1073/pnas.0730423100; Wang J, 2003, HUM MOL GENET, V12, P2753, DOI 10.1093/hmg/ddg312; Wang J, 2005, NEUROBIOL DIS, V20, P943, DOI 10.1016/j.nbd.2005.06.005; Wang J, 2006, J NEUROCHEM, V96, P1277, DOI 10.1111/j.1471-4159.2005.03642.x; Zhang QH, 2005, BIOCHEMISTRY-US, V44, P9079, DOI 10.1021/bi050378f; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718	56	44	44	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					28648	28656		10.1074/jbc.M600138200	http://dx.doi.org/10.1074/jbc.M600138200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16880213	hybrid, Green Accepted			2022-12-27	WOS:000240680500018
J	Chang, CF; Chou, HT; Lin, YJ; Lee, SJ; Chuang, JL; Chuang, DT; Huang, TH				Chang, Chi-Fon; Chou, Hui-Ting; Lin, Yi-Jan; Lee, Shin-Jye; Chuang, Jacinta L.; Chuang, David T.; Huang, Tai-huang			Structure of the subunit binding domain and dynamics of the di-domain region from the core of human branched chain alpha-ketoacid dehydrogenase complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-BEARING DOMAIN; DIHYDROLIPOYL ACETYLTRANSFERASE COMPONENT; MULTIENZYME COMPLEX; ESCHERICHIA-COLI; LIPOIC ACID; BACILLUS-STEAROTHERMOPHILUS; 3-DIMENSIONAL STRUCTURE; CHEMICAL-SHIFT; BACKBONE DYNAMICS; PYRUVATE	The homo-24-meric dihydrolipoyl transacylase (E2) scaffold of the human branched-chain alpha-ketoacid dehydrogenase complex (BCKDC) contains the lipoyl-bearing domain (hbLBD), the subunit-binding domain (hbSBD) and the inner core domain that are linked to carry out E2 functions in substrate channeling and recognition. In this study, we employed NMR techniques to determine the structure of hbSBD and dynamics of several truncated constructs from the E2 component of the human BCKDC, including hbLBD ( residues 1-84), hbSBD ( residues 111-149), and a di-domain (hbDD) (residues 1-166) comprising hbLBD, hbSBD and the interdomain linker. The solution structure of hbSBD consists of two nearly parallel helices separated by a long loop, similar to the structures of the SBD isolated from other species, but it lacks the short 310 helix. The NMR results show that the structures of hbLBD and hbSBD in isolated forms are not altered by the presence of the interdomain linker in hbDD. The linker region is not entirely exposed to solvent, where amide resonances associated with similar to 50% of the residues are observable. However, the tethering of these two domains in hbDD significantly retards the overall rotational correlation times of hbLBD and hbSBD, changing from 5.54 ns and 5.73 ns in isolated forms to 8.37 ns and 8.85 ns in the linked hbDD, respectively. We conclude that the presence of the interdomain linker restricts the motional freedom of the hbSBD more significantly than hbLBD, and that the linker region likely exists as a soft rod rather than a flexible string in solution.	Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75216 USA; Natl Taiwan Normal Univ, Dept Phys, Taipei 106, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; National Taiwan Normal University	Huang, TH (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan.	bmthh@ibms.sinica.edu.tw		Chang, Chi-Fon/0000-0002-2961-0748	NIDDK NIH HHS [DK-26578] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ayed A, 2001, NAT STRUCT BIOL, V8, P756, DOI 10.1038/nsb0901-756; Bracken C, 1999, J MOL BIOL, V285, P2133, DOI 10.1006/jmbi.1998.2429; Brautigam CA, 2006, STRUCTURE, V14, P611, DOI 10.1016/j.str.2006.01.001; Chang CF, 2002, J BIOL CHEM, V277, P15865, DOI 10.1074/jbc.M110952200; Chauhan HJ, 2000, EUR J BIOCHEM, V267, P7158, DOI 10.1046/j.1432-1327.2000.01820.x; Chuang D.T., 2001, METABOLIC MOL BASES, P1971; CHUANG DT, 2001, ENCY MOL MED, V1, P393; Chuang JL, 2002, J BIOL CHEM, V277, P36905, DOI 10.1074/jbc.C200430200; Ciszak EM, 2006, J BIOL CHEM, V281, P648, DOI 10.1074/jbc.M507850200; CLORE GM, 1990, BIOCHEMISTRY-US, V29, P7387, DOI 10.1021/bi00484a006; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DARDEL F, 1993, J MOL BIOL, V229, P1037, DOI 10.1006/jmbi.1993.1103; FARROW NA, 1995, J BIOMOL NMR, V6, P153, DOI 10.1007/BF00211779; Frank RAW, 2005, STRUCTURE, V13, P1119, DOI 10.1016/j.str.2005.04.021; GREEN JDF, 1992, J BIOL CHEM, V267, P23484; GREEN JDF, 1995, J MOL BIOL, V248, P328, DOI 10.1006/jmbi.1995.0225; Gu YQ, 2003, P NATL ACAD SCI USA, V100, P7015, DOI 10.1073/pnas.0732060100; Harris RA, 1997, ADV ENZYME REGUL, V37, P271, DOI 10.1016/S0065-2571(96)00009-X; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; HIYAMA Y, 1988, J AM CHEM SOC, V110, P2378, DOI 10.1021/ja00216a006; Huang YT, 2001, J MOL BIOL, V307, P1075, DOI 10.1006/jmbi.2001.4539; ISHIMA R, 1995, J MAGN RESON SER B, V108, P73, DOI 10.1006/jmrb.1995.1104; KALIA YN, 1993, J MOL BIOL, V230, P323, DOI 10.1006/jmbi.1993.1145; KAY LE, 1992, J MAGN RESON, V97, P359, DOI 10.1016/0022-2364(92)90320-7; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kouza M, 2005, BIOPHYS J, V89, P3353, DOI 10.1529/biophysj.105.065151; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lefevre JF, 1996, BIOCHEMISTRY-US, V35, P2674, DOI 10.1021/bi9526802; Lessard IAD, 1996, BIOCHEMISTRY-US, V35, P16863, DOI 10.1021/bi961683r; Mande SS, 1996, STRUCTURE, V4, P277, DOI 10.1016/S0969-2126(96)00032-9; MATTEVI A, 1992, SCIENCE, V255, P1544, DOI 10.1126/science.1549782; Milne JLS, 2002, EMBO J, V21, P5587, DOI 10.1093/emboj/cdf574; Milne JLS, 2006, J BIOL CHEM, V281, P4364, DOI 10.1074/jbc.M504363200; Naik MT, 2004, PROTEIN SCI, V13, P2483, DOI 10.1110/ps.04783104; Naik MT, 2002, FEBS LETT, V530, P133, DOI 10.1016/S0014-5793(02)03444-0; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; PERHAM RN, 1991, BIOCHEMISTRY-US, V30, P8501, DOI 10.1021/bi00099a001; RADFORD SE, 1989, J BIOL CHEM, V264, P767; Reed LJ, 2001, J BIOL CHEM, V276, P38329, DOI 10.1074/jbc.R100026200; REED LJ, 1985, CURR TOP CELL REGUL, V27, P41; REED LJ, 1974, ACCOUNTS CHEM RES, V7, P40, DOI 10.1021/ar50074a002; Ricaud PM, 1996, J MOL BIOL, V264, P179, DOI 10.1006/jmbi.1996.0632; ROBIEN MA, 1992, BIOCHEMISTRY-US, V31, P3463, DOI 10.1021/bi00128a021; RUSSELL GC, 1991, BIOCHIM BIOPHYS ACTA, V1076, P225, DOI 10.1016/0167-4838(91)90271-Z; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Zhou ZH, 2001, P NATL ACAD SCI USA, V98, P14802, DOI 10.1073/pnas.011597698	46	12	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					28345	28353		10.1074/jbc.M605005200	http://dx.doi.org/10.1074/jbc.M605005200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16861235	hybrid			2022-12-27	WOS:000240534400072
J	Myerburg, MM; Butterworth, MB; McKenna, EE; Peters, KW; Frizzell, RA; Kleyman, TR; Pilewski, JM				Myerburg, Mike M.; Butterworth, Michael B.; McKenna, Erin E.; Peters, Kathryn W.; Frizzell, Raymond A.; Kleyman, Thomas R.; Pilewski, Joseph M.			Airway surface liquid volume regulates ENaC by altering the serine protease-protease inhibitor balance - A mechanism for sodium hyperabsorption in cystic fibrosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL NA+ CHANNEL; FACTOR ACTIVATOR INHIBITOR; RESPIRATORY EPITHELIA; POTENTIAL DIFFERENCE; PERICILIARY LIQUID; ION-TRANSPORT; EXPRESSION; IDENTIFICATION; STIMULATION; ALDOSTERONE	Efficient clearance of mucus and inhaled pathogens from the lung is dependent on an optimal airway surface liquid (ASL) volume, which is maintained by the regulated transport of sodium and chloride across the airway epithelium. Accumulating evidence suggests that impaired mucus clearance in cystic fibrosis (CF) airways is a result of ASL depletion caused by excessive Na+ absorption through the epithelial sodium channel ( ENaC). However, the cellular mechanisms that result in increased ENa Cactivity in CF airways are not completely understood. Recently, proteases were shown to modulate the activity of ENaC, but the relevance of this mechanism to the physiologic regulation of ASL volume is unknown. Using primary human airway epithelial cells, we demonstrate that: (i) protease inhibitors are present in the ASL and prevent the activation of near-silent ENaC, (ii) when the ASL volume is increased, endogenous protease inhibitors become diluted, allowing for proteolytic activation of near-silent channels, and (iii) in CF, the normally present near-silent pool of ENaC is constitutively active and the alpha subunit undergoes increased proteolytic processing. These findings indicate that the ASL volume modulates the activity of ENaC by modification of the serine protease-protease inhibitor balance and that alterations in this balance contribute to excessive Na+ absorption in cystic fibrosis.	Univ Pittsburgh, Med Ctr, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Renal Electrolyte Div, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Pilewski, JM (corresponding author), Univ Pittsburgh, Med Ctr, Div Pulm Allergy & Crit Care Med, 628 NW Montefiore Univ Hosp,3459 5th Ave, Pittsburgh, PA 15213 USA.	pilewskijm@upmc.edu	Pilewski, Joseph/AAF-5149-2021		NHLBI NIH HHS [K08 HL087932, T32 HL007653] Funding Source: Medline; NIDDK NIH HHS [DK72506, DK56490, DK065161, DK54814] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL087932, T32HL007653] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054814, P50DK056490, P30DK072506, R01DK065161, R56DK065161] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adebamiro A, 2005, J GEN PHYSIOL, V126, P339, DOI 10.1085/jgp.200509285; BOUCHER RC, 1986, J CLIN INVEST, V78, P1245, DOI 10.1172/JCI112708; Bridges RJ, 2001, AM J PHYSIOL-LUNG C, V281, pL16, DOI 10.1152/ajplung.2001.281.1.L16; Butterworth MB, 2005, AM J PHYSIOL-RENAL, V289, pF969, DOI 10.1152/ajprenal.00390.2003; Butterworth MB, 2005, J GEN PHYSIOL, V125, P81, DOI 10.1085/jgp.2004.09124; Caldwell RA, 2005, AM J PHYSIOL-LUNG C, V288, pL813, DOI 10.1152/ajplung.00435.2004; Caldwell RA, 2004, AM J PHYSIOL-CELL PH, V286, pC190, DOI 10.1152/ajpcell.00342.2003; Carattino MD, 2006, J BIOL CHEM, V281, P18901, DOI 10.1074/jbc.M604109200; Chraibi A, 1998, J GEN PHYSIOL, V111, P127, DOI 10.1085/jgp.111.1.127; de la Rosa DA, 2002, J GEN PHYSIOL, V119, P427, DOI 10.1085/jgp.20028559; Devor DC, 2000, AM J PHYSIOL-CELL PH, V279, pC461, DOI 10.1152/ajpcell.2000.279.2.C461; Devor DC, 1999, AM J PHYSIOL-CELL PH, V276, pC827, DOI 10.1152/ajpcell.1999.276.4.C827; Donaldson SH, 2002, J BIOL CHEM, V277, P8338, DOI 10.1074/jbc.M105044200; Ergonul Z, 2006, AM J PHYSIOL-RENAL, V291, pF683, DOI 10.1152/ajprenal.00422.2005; Fajac I, 1998, EUR RESPIR J, V12, P1295, DOI 10.1183/09031936.98.12061295; Fajac I, 2004, THORAX, V59, P971, DOI 10.1136/thx.2003.020933; Fan B, 2005, J BIOL CHEM, V280, P34513, DOI 10.1074/jbc.M502119200; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; Jayaraman S, 2001, P NATL ACAD SCI USA, V98, P8119, DOI 10.1073/pnas.131087598; JIANG CW, 1993, SCIENCE, V262, P424, DOI 10.1126/science.8211164; Joo NS, 2006, J BIOL CHEM, V281, P7392, DOI 10.1074/jbc.M512766200; Joo NS, 2004, J BIOL CHEM, V279, P38854, DOI 10.1074/jbc.M407077200; Joo NS, 2002, J BIOL CHEM, V277, P50710, DOI 10.1074/jbc.M208826200; Kawaguchi T, 1997, J BIOL CHEM, V272, P27558, DOI 10.1074/jbc.272.44.27558; Knight KK, 2006, P NATL ACAD SCI USA, V103, P2805, DOI 10.1073/pnas.0511184103; KNOWLES M, 1981, NEW ENGL J MED, V305, P1489, DOI 10.1056/NEJM198112173052502; KNOWLES MR, 1983, SCIENCE, V221, P1067, DOI 10.1126/science.6308769; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Liang XB, 2006, J BIOL CHEM, V281, P16323, DOI 10.1074/jbc.M601360200; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Marlor CW, 1997, J BIOL CHEM, V272, P12202, DOI 10.1074/jbc.272.18.12202; Matsui H, 1998, J CLIN INVEST, V102, P1125, DOI 10.1172/JCI2687; Matsui H, 2000, J CLIN INVEST, V105, P1419, DOI 10.1172/JCI4546; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; Michlig S, 2005, J BIOL CHEM, V280, P38264, DOI 10.1074/jbc.M506308200; Morimoto T, 2006, AM J PHYSIOL-RENAL, V291, pF663, DOI 10.1152/ajprenal.00514.2005; Planes C, 2005, AM J PHYSIOL-LUNG C, V288, pL1099, DOI 10.1152/ajplung.00332.2004; Planes C, 2002, J BIOL CHEM, V277, P47318, DOI 10.1074/jbc.M209158200; Satlin LM, 2001, AM J PHYSIOL-RENAL, V280, pF1010, DOI 10.1152/ajprenal.2001.280.6.F1010; Sheng S, 2006, AM J PHYSIOL-RENAL, V290, pF1488, DOI 10.1152/ajprenal.00439.2005; Shimomura T, 1997, J BIOL CHEM, V272, P6370, DOI 10.1074/jbc.272.10.6370; STUTTS MJ, 1995, SCIENCE, V269, P847, DOI 10.1126/science.7543698; Tarran R, 2006, J GEN PHYSIOL, V127, P591, DOI 10.1085/jgp.200509468; Tarran R, 2005, J BIOL CHEM, V280, P35751, DOI 10.1074/jbc.M505832200; Tarran R, 2001, J GEN PHYSIOL, V118, P223, DOI 10.1085/jgp.118.2.223; Tong ZY, 2004, AM J PHYSIOL-LUNG C, V287, pL928, DOI 10.1152/ajplung.00160.2004; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329; Wang H, 2006, J BIOL CHEM, V281, P14129, DOI 10.1074/jbc.M512511200	49	92	95	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					27942	27949		10.1074/jbc.M606449200	http://dx.doi.org/10.1074/jbc.M606449200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16873367	hybrid			2022-12-27	WOS:000240534400030
J	Schultz, A; Nottrott, S; Hartmuth, K; Luhrmann, R				Schultz, Annemarie; Nottrott, Stephanie; Hartmuth, Klaus; Luehrmann, Reinhard			RNA structural requirements for the association of the spliceosomal hPrp31 protein with the U4 and U4atac small nuclear ribonucleoproteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMINANT RETINITIS-PIGMENTOSA; U6; SNRNA; YEAST; LOCALIZATION; EXISTENCE; INTERACT; U4/U6.U5; COMPLEX; GENE	The kink-turn, a stem I-internal loop-stem II structure of the 5' stem-loop of U4 and U4atac small nuclear (sn) RNAs bound by 15.5K protein is required for binding of human Prp31 protein (hPrp31) during U4 and U4atac snRNP assembly. In box C/D snoRNPs a similar kink-turn with bound 15.5K protein is required for selective binding of proteins NOP56 and NOP58. Here we analyzed RNA structural requirements for association of hPrp31 with U4 snRNP in vitro by hydroxyl radical footprinting. hPrp31 induced protection of the terminal penta-loop, as well as of stems I and II flanking the kink-turn. Similar protection was found with U4/U6 snRNA duplex prebound with 15.5K protein. A detailed mutational analysis of the U4 snRNA elements by electrophoretic mobility shift analysis revealed that stem I could not be shortened, although it tolerated sequence alterations. However, introduction of a third Watson-Crick base pair into stem II significantly reduced hPrp31 binding. While stem I of U4atac snRNA showed relaxed binding requirements, its stem II requirements were likewise restricted to two base pairs. In contrast, as shown previously, stem II of the kink-turn motif in box C/D snoRNAs is comprised of three base pairs, and NOP56 and NOP58 require a G-C pair at the central position. This indicates that hPrp31 binding specificity is achieved by the recognition of the two base pair long stem II of the U4 and U4atac snRNAs and suggests how discrimination is achieved by RNA structural elements during assembly of U4/U6 and U4atac/U6atac snRNPs and box C/D snoRNPs.	Max Planck Inst Biophys Chem, Dept Cellular Biochem, D-37077 Gottingen, Germany	Max Planck Society	Luhrmann, R (corresponding author), Max Planck Inst Biophys Chem, Dept Cellular Biochem, Fassberg 11, D-37077 Gottingen, Germany.	reinhard.luehrmann@mpi-bpc.mpg.de						BRINGMANN P, 1984, EMBO J, V3, P1357, DOI 10.1002/j.1460-2075.1984.tb01977.x; BROW DA, 1988, NATURE, V334, P213, DOI 10.1038/334213a0; Brow DA, 2002, ANNU REV GENET, V36, P333, DOI 10.1146/annurev.genet.36.043002.091635; Burge CB, 1999, RNA WORLD, P525; Gautier T, 1997, MOL CELL BIOL, V17, P7088, DOI 10.1128/MCB.17.12.7088; HASHIMOTO C, 1984, NUCLEIC ACIDS RES, V12, P3283, DOI 10.1093/nar/12.7.3283; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Klein DJ, 2001, EMBO J, V20, P4214, DOI 10.1093/emboj/20.15.4214; Kuhn-Holsken E, 2005, RNA, V11, P1915, DOI 10.1261/rna.2176605; Lescoute A, 2006, RNA, V12, P83, DOI 10.1261/rna.2208106; Makarov EM, 2002, SCIENCE, V298, P2205, DOI 10.1126/science.1077783; Makarova OV, 2002, EMBO J, V21, P1148, DOI 10.1093/emboj/21.5.1148; Mougin A, 2002, J MOL BIOL, V317, P631, DOI 10.1006/jmbi.2002.5451; MYSLINSKI E, 1991, BIOCHIMIE, V73, P17, DOI 10.1016/0300-9084(91)90069-D; Nilsen TW, 2003, BIOESSAYS, V25, P1147, DOI 10.1002/bies.10394; Nilsen TW, 1998, COLD SPRING HARBOR M, P279; Nottrott S, 1999, EMBO J, V18, P6119, DOI 10.1093/emboj/18.21.6119; Nottrott S, 2002, EMBO J, V21, P5527, DOI 10.1093/emboj/cdf544; RINKE J, 1985, J MOL BIOL, V185, P721, DOI 10.1016/0022-2836(85)90057-9; Schaffert N, 2004, EMBO J, V23, P3000, DOI 10.1038/sj.emboj.7600296; Schneider C, 2002, MOL CELL BIOL, V22, P3219, DOI 10.1128/MCB.22.10.3219-3229.2002; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Vidovic I, 2000, MOL CELL, V6, P1331, DOI 10.1016/S1097-2765(00)00131-3; Vithana EN, 2001, MOL CELL, V8, P375, DOI 10.1016/S1097-2765(01)00305-7; Watkins NJ, 2000, CELL, V103, P457, DOI 10.1016/S0092-8674(00)00137-9; Watkins NJ, 2002, MOL CELL BIOL, V22, P8342, DOI 10.1128/MCB.22.23.8342-8352.2002; Will CL, 2001, CURR OPIN CELL BIOL, V13, P290, DOI 10.1016/S0955-0674(00)00211-8	27	33	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					28278	28286		10.1074/jbc.M603350200	http://dx.doi.org/10.1074/jbc.M603350200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16857676	hybrid, Green Published			2022-12-27	WOS:000240534400065
J	Gerken, TA; Raman, J; Fritz, TA; Jamison, O				Gerken, Thomas A.; Raman, Jayalakshmi; Fritz, Timothy A.; Jamison, Oliver			Identification of common and unique peptide substrate preferences for the UDP-GalNAc: Polypeptide alpha-N-acetylgalactosaminyltransferases T1 and T2 derived from oriented random peptide substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEIGHBORING RESIDUE GLYCOSYLATION; MUCIN TANDEM REPEAT; O-GLYCOSYLATION; D-GALACTOSAMINE; LECTIN DOMAIN; CDNA CLONING; MOLECULAR-CLONING; FAMILY; EXPRESSION; SEQUENCE	A large family of UDP-GalNAc:polypeptide alpha-N-acetylgalactosaminyltransferases (ppGalNAc Ts) catalyzes the first step of mucin-type protein O-glycosylation by transferring GalNAc to serine and threonine residues of acceptor polypeptides. The acceptor peptide substrate specificity and specific protein targets of the individual ppGalNAc T family members remain poorly characterized and poorly understood, despite the fact that mutations in two individual isoforms are deleterious to man and the fly. In this work a series of oriented random peptide substrate libraries, based on the GAGAXXX-TXXXAGAGK sequence motif (where X = randomized positions), have been used to obtain the first comprehensive determination of the peptide substrate specificities of the mammalian ppGalNAc T1 and T2 isoforms. ppGalNAc T-glycosylated random peptides were isolated by lectin affinity chromatography, and transferase amino acid preferences were determined by Edman amino acid sequencing. The results reveal common and unique position-sensitive features for both transferases, consistent with previous reports of the preferences of ppGalNAc T1 and T2. The random peptide substrates also reveal additional specific features that have never been described before that are consistent with the x-ray crystal structures of the two transferases and furthermore are reflected in a data base analysis of in vivo O-glycosylation sites. By using the transferase-specific preferences, optimum and selective acceptor peptide substrates have been generated for each transferase. This approach represents a relatively complete, facile, and reproducible method for obtaining ppGalNAc T peptide substrate specificity. Such information will be invaluable for identifying isoform-specific peptide acceptors, creating isoform-specific substrates, and predicting O-glycosylation sites.	Case Western Reserve Univ, Dept Pediat, Sch Med, WA Bernbaum Ctr Cyst Fibrosis Res, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Biochem, Sch Med, WA Bernbaum Ctr Cyst Fibrosis Res, Cleveland, OH 44106 USA; NIDDK, Sect Biol Chem, NIH, Bethesda, MD 20892 USA	Case Western Reserve University; Case Western Reserve University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Gerken, TA (corresponding author), Case Western Reserve Univ, Dept Pediat, Sch Med, WA Bernbaum Ctr Cyst Fibrosis Res, BRB,2109 Adelbert Rd, Cleveland, OH 44106 USA.	txg2@cwru.edu			NATIONAL CANCER INSTITUTE [R01CA078834] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA 78834, R01 CA078834] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bennett EP, 1998, J BIOL CHEM, V273, P30472, DOI 10.1074/jbc.273.46.30472; Bennett EP, 1999, J BIOL CHEM, V274, P25362, DOI 10.1074/jbc.274.36.25362; Bennett EP, 1999, FEBS LETT, V460, P226, DOI 10.1016/S0014-5793(99)01268-5; Brokx RD, 2003, BIOCHEMISTRY-US, V42, P13817, DOI 10.1021/bi0353070; Cheng LM, 2004, FEBS LETT, V566, P17, DOI 10.1016/j.febslet.2004.03.108; Clausen H, 1996, GLYCOBIOLOGY, V6, P635, DOI 10.1093/glycob/6.6.635; Elhammer AP, 1999, GLYCOCONJUGATE J, V16, P171, DOI 10.1023/A:1026465232149; Freire T, 2004, BIOCHEM J, V382, P501, DOI 10.1042/BJ20031877; Freire T, 2003, BIOCHEM BIOPH RES CO, V312, P1309, DOI 10.1016/j.bbrc.2003.11.060; Freire T, 2003, INT J PARASITOL, V33, P47, DOI 10.1016/S0020-7519(02)00231-X; Fritz TA, 2006, J BIOL CHEM, V281, P8613, DOI 10.1074/jbc.M513590200; Fritz TA, 2004, P NATL ACAD SCI USA, V101, P15307, DOI 10.1073/pnas.0405657101; Gerken TA, 2004, BIOCHEMISTRY-US, V43, P9888, DOI 10.1021/bi049178e; Gerken TA, 2004, BIOCHEMISTRY-US, V43, P4137, DOI 10.1021/bi036306a; Gerken TA, 2002, J BIOL CHEM, V277, P49850, DOI 10.1074/jbc.M205851200; Gerken TA, 1997, J BIOL CHEM, V272, P9709; Guo JM, 2002, FEBS LETT, V524, P211, DOI 10.1016/S0014-5793(02)03007-7; Hagen F, 2001, TRENDS GLYCOSCI GLYC, V13, P463, DOI 10.4052/tigg.13.463; Hagen FK, 1998, J BIOL CHEM, V273, P8268, DOI 10.1074/jbc.273.14.8268; Hagen FK, 1997, J BIOL CHEM, V272, P13843, DOI 10.1074/jbc.272.21.13843; Hanisch FG, 2000, GLYCOBIOLOGY, V10, P439, DOI 10.1093/glycob/10.5.439; Hanisch FG, 2001, GLYCOBIOLOGY, V11, P731, DOI 10.1093/glycob/11.9.731; Hansen JE, 1998, GLYCOCONJUGATE J, V15, P115, DOI 10.1023/A:1006960004440; Hassan H, 2000, J BIOL CHEM, V275, P38197, DOI 10.1074/jbc.M005783200; HOMA FL, 1993, J BIOL CHEM, V268, P12609; HOMA FL, 1995, PROTEIN EXPRES PURIF, V6, P141, DOI 10.1006/prep.1995.1017; Iwasaki H, 2003, J BIOL CHEM, V278, P5613, DOI 10.1074/jbc.M211097200; Kato K, 2006, J BIOL CHEM, V281, P18370, DOI 10.1074/jbc.M602469200; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; OCONNELL BC, 1992, J BIOL CHEM, V267, P25010; Pratt MR, 2004, CHEM BIOL, V11, P1009, DOI 10.1016/j.chembiol.2004.05.009; Schwientek T, 2002, J BIOL CHEM, V277, P22623, DOI 10.1074/jbc.M202684200; Stwora-Wojczyk MM, 2004, INT J PARASITOL, V34, P309, DOI 10.1016/j.ijpara.2003.11.016; Ten Hagen BG, 1998, J BIOL CHEM, V273, P27749; Ten Hagen KG, 2002, J BIOL CHEM, V277, P22616, DOI 10.1074/jbc.M201807200; Ten Hagen KG, 1999, J BIOL CHEM, V274, P27867; Ten Hagen KG, 2003, J BIOL CHEM, V278, P35039, DOI 10.1074/jbc.M303836200; Ten Hagen KG, 2003, GLYCOBIOLOGY, V13, p1R, DOI 10.1093/glycob/cwg007; Ten Hagen KG, 2001, J BIOL CHEM, V276, P17395, DOI 10.1074/jbc.M009638200; Tenno M, 2002, J BIOL CHEM, V277, P47088, DOI 10.1074/jbc.M207369200; Tenno M, 2002, BIOCHEM BIOPH RES CO, V298, P755, DOI 10.1016/S0006-291X(02)02549-4; Toba S, 2000, BBA-GENE STRUCT EXPR, V1493, P264, DOI 10.1016/S0167-4781(00)00180-9; Topaz O, 2004, NAT GENET, V36, P579, DOI 10.1038/ng1358; Wandall HH, 1997, J BIOL CHEM, V272, P23503, DOI 10.1074/jbc.272.38.23503; Wang H, 2003, BIOCHEM BIOPH RES CO, V300, P738, DOI 10.1016/S0006-291X(02)02908-X; White KE, 2000, GENE, V246, P347, DOI 10.1016/S0378-1119(00)00050-0; WHITE T, 1995, J BIOL CHEM, V270, P24156, DOI 10.1074/jbc.270.41.24156; Yoshida A, 1997, J BIOL CHEM, V272, P16884, DOI 10.1074/jbc.272.27.16884; Young WW, 2003, GLYCOBIOLOGY, V13, P549, DOI 10.1093/glycob/cwg062; Zhang Y, 2003, J BIOL CHEM, V278, P573, DOI 10.1074/jbc.M203094200; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	52	72	73	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32403	32416		10.1074/jbc.M605149200	http://dx.doi.org/10.1074/jbc.M605149200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16912039	hybrid			2022-12-27	WOS:000241414500038
J	Schmidl, M; Adam, N; Surmann-Schmitt, C; Hattori, T; Stock, M; Dietz, U; de Crombrugghe, B; Poschl, E; von der Mark, K				Schmidl, Martina; Adam, Nadia; Surmann-Schmitt, Cordula; Hattori, Takako; Stock, Michael; Dietz, Uwe; de Crombrugghe, Benoit; Poeschl, Ernst; von der Mark, Klaus			Twisted gastrulation modulates bone morphogenetic protein-induced collagen II and X expression in chondrocytes in vitro and in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPEMANN ORGANIZER; BMP ANTAGONIST; DIFFERENTIATED PHENOTYPE; CARTILAGE DEVELOPMENT; INDIAN HEDGEHOG; DIRECT BINDING; MOUSE LIMB; CELL-LINE; C-FOS; CHORDIN	Twisted gastrulation (TSG) is an extracellular modulator of bone morphogenetic protein (BMP) activity and regulates dorsoventral axis formation in early Drosophila and Xenopus development. Studies on tsg-deficient mice also indicated a role of this protein in skeletal growth, but the mechanism of TSG activity in this process has not yet been investigated. Here we show for the first time by in situ hybridization and immunohistochemistry that TSG is strongly expressed in bovine and mouse growth plate cartilage as well as in fetal ribs, vertebral cartilage, and cartilage anlagen of the skull. Furthermore we provide evidence that TSG is directly involved in BMP-regulated chondrocyte differentiation and maturation. In vitro, TSG impaired the dose-dependent BMP-2 stimulation of collagen II and X expression in cultures of MC615 chondrocytes and primary mouse chondrocytes. In the presence of chordin, a BMP antagonist, the inhibitory effect of TSG was further enhanced. TSG also inhibited BMP2-stimulated phosphorylation of Smad factors in chondrocytes, confirming the role of TSG as a modulator of BMP signaling. For analysis of TSG functions in cartilage development in vivo, the gene was overexpressed in transgenic mice under the control of the cartilage-specific Col2a1 promoter. As a result, Col10a1 expression was significantly reduced in the growth plates of transgenic embryos and newborns in comparison with wild type littermates as shown by in situ hybridization and by real time PCR analysis. The data suggest that TSG is an important modulator of BMP-regulated cartilage development and chondrocyte differentiation.	Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr Mol Med, Dept Expt Med 1, D-91054 Erlangen, Germany; Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77030 USA	University of Erlangen Nuremberg; University of Texas System; UTMD Anderson Cancer Center	von der Mark, K (corresponding author), Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr Mol Med, Dept Expt Med 1, Glueckstr 6, D-91054 Erlangen, Germany.	kvdmark@molmed.uni-erlangen.de	Stock, Michael/B-9829-2009; Surmann-Schmitt, Cordula/B-9792-2009; von+der+Mark, Klaus/AAJ-1443-2020	Stock, Michael/0000-0002-3322-0961	NIAMS NIH HHS [P01 AR042919] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR042919] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abreu JG, 2002, GENE, V287, P39, DOI 10.1016/S0378-1119(01)00827-7; Balemans W, 2002, DEV BIOL, V250, P231, DOI 10.1006/dbio.2002.0779; Blitz IL, 2003, DEVELOPMENT, V130, P4975, DOI 10.1242/dev.00709; Brunet LJ, 1998, SCIENCE, V280, P1455, DOI 10.1126/science.280.5368.1455; Canalis E, 2003, ENDOCR REV, V24, P218, DOI 10.1210/er.2002-0023; Capdevila J, 1998, DEV BIOL, V197, P205, DOI 10.1006/dbio.1997.8824; Capdevila J, 2001, ANNU REV CELL DEV BI, V17, P87, DOI 10.1146/annurev.cellbio.17.1.87; Chang CB, 2001, NATURE, V410, P483, DOI 10.1038/35068583; CHEN P, 1991, EXP CELL RES, V195, P509, DOI 10.1016/0014-4827(91)90403-H; De Robertis EM, 2000, NAT REV GENET, V1, P171, DOI 10.1038/35042039; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; Dietz UH, 1999, DEV DYNAM, V216, P233, DOI 10.1002/(SICI)1097-0177(199911)216:3<233::AID-DVDY2>3.0.CO;2-G; Duprez D, 1996, MECH DEVELOP, V57, P145, DOI 10.1016/0925-4773(96)00540-0; Enomoto-Iwamoto M, 1998, J CELL BIOL, V140, P409, DOI 10.1083/jcb.140.2.409; Fainsod A, 1997, MECH DEVELOP, V63, P39, DOI 10.1016/S0925-4773(97)00673-4; Gazzerro E, 2005, ENDOCRINOLOGY, V146, P3875, DOI 10.1210/en.2005-0053; Gebhard S, 2004, MATRIX BIOL, V23, P309, DOI 10.1016/j.matbio.2004.05.010; Grimsrud CD, 2001, J ORTHOPAED RES, V19, P18, DOI 10.1016/S0736-0266(00)00017-6; Harland RM, 2001, NATURE, V410, P423, DOI 10.1038/35068657; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Iemura S, 1998, P NATL ACAD SCI USA, V95, P9337, DOI 10.1073/pnas.95.16.9337; Jones CM, 1998, DEV BIOL, V194, P12, DOI 10.1006/dbio.1997.8752; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Katagiri T, 1998, DEV GENET, V22, P340, DOI 10.1002/(SICI)1520-6408(1998)22:4<340::AID-DVG4>3.0.CO;2-6; KIRSCH T, 1991, EUR J BIOCHEM, V196, P575, DOI 10.1111/j.1432-1033.1991.tb15852.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larrain J, 2001, DEVELOPMENT, V128, P4439; Larrain J, 2000, DEVELOPMENT, V127, P821; MALLEINGERIN F, 1993, P NATL ACAD SCI USA, V90, P3289, DOI 10.1073/pnas.90.8.3289; Marques G, 1997, CELL, V91, P417, DOI 10.1016/S0092-8674(00)80425-0; MASON ED, 1994, GENE DEV, V8, P1489, DOI 10.1101/gad.8.13.1489; Millet C, 2001, MECH DEVELOP, V106, P85, DOI 10.1016/S0925-4773(01)00423-3; Minina E, 2001, DEVELOPMENT, V128, P4523; Nakayama N, 2004, DEVELOPMENT, V131, P229, DOI 10.1242/dev.00901; Nakayama N, 2001, DEV BIOL, V232, P372, DOI 10.1006/dbio.2001.0200; NISWANDER L, 1993, NATURE, V361, P68, DOI 10.1038/361068a0; Nosaka T, 2003, MOL CELL BIOL, V23, P2969, DOI 10.1128/MCB.23.8.2969-2980.2003; Oelgeschlager M, 2000, NATURE, V405, P757, DOI 10.1038/35015500; Oelgeschlager M, 2003, DEVELOPMENT, V130, P4047, DOI 10.1242/dev.00633; Ohyama A, 2001, MECH DEVELOP, V100, P331, DOI 10.1016/S0925-4773(00)00525-6; Pathi S, 1999, DEV BIOL, V209, P239, DOI 10.1006/dbio.1998.9181; Petryk A, 2005, BONE, V36, P617, DOI 10.1016/j.bone.2005.01.018; Petryk A, 2004, DEV BIOL, V267, P374, DOI 10.1016/j.ydbio.2003.11.015; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Piccolo S, 1997, CELL, V91, P407, DOI 10.1016/S0092-8674(00)80424-9; Pizette S, 1999, DEVELOPMENT, V126, P883; Pizette S, 2000, DEV BIOL, V219, P237, DOI 10.1006/dbio.2000.9610; Poschl E, 1996, EMBO J, V15, P5154, DOI 10.1002/j.1460-2075.1996.tb00899.x; Ray RP, 2001, CELL, V104, P801, DOI 10.1016/S0092-8674(01)00275-6; Reddi AH, 2001, ARTHRITIS RES, V3, P1; Riemer S, 2002, J CELL BIOCHEM, V86, P688, DOI 10.1002/jcb.10260; Ross JJ, 2001, NATURE, V410, P479, DOI 10.1038/35068578; SASAI Y, 1995, NATURE, V376, P333, DOI 10.1038/376333a0; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; Scott IC, 2001, NATURE, V410, P475, DOI 10.1038/35068572; Scott IC, 2000, DEV DYNAM, V217, P449, DOI 10.1002/(SICI)1097-0177(200004)217:4<449::AID-DVDY12>3.0.CO;2-8; Scott IC, 1999, DEV BIOL, V213, P283, DOI 10.1006/dbio.1999.9383; Shukunami C, 1998, EXP CELL RES, V241, P1, DOI 10.1006/excr.1998.4045; SMITH WC, 1993, NATURE, V361, P547, DOI 10.1038/361547a0; Thomas DP, 2000, J CELL SCI, V113, P439; Valcourt U, 1999, EXP CELL RES, V251, P264, DOI 10.1006/excr.1999.4584; Volk SW, 1998, J BONE MINER RES, V13, P1521, DOI 10.1359/jbmr.1998.13.10.1521; Wang CKL, 2004, DEV BIOL, V269, P109, DOI 10.1016/j.ydbio.2004.01.016; Weisser A, 2002, EXP CELL RES, V279, P1, DOI 10.1006/excr.2002.5580; Xie J, 2005, DEVELOPMENT, V132, P383, DOI 10.1242/dev.01577; Yi SE, 2000, DEVELOPMENT, V127, P621; Zakin L, 2005, DEVELOPMENT, V132, P2489, DOI 10.1242/dev.01822; Zakin L, 2004, DEVELOPMENT, V131, P413, DOI 10.1242/dev.00946; Zhang DH, 2002, J BONE MINER RES, V17, P293, DOI 10.1359/jbmr.2002.17.2.293; Zheng QP, 2003, J CELL BIOL, V162, P833, DOI 10.1083/jcb.200211089; ZHOU G, 1995, J CELL SCI, V108, P3677; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	72	29	37	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31790	31800		10.1074/jbc.M603419200	http://dx.doi.org/10.1074/jbc.M603419200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16905550	Bronze			2022-12-27	WOS:000241235300066
J	Uchiyama, S; Shimizu, T; Shirasawa, T				Uchiyama, Satoshi; Shimizu, Takahiko; Shirasawa, Takuji			CuZn-SOD deficiency causes ApoB degradation and induces hepatic lipid accumulation by impaired lipoprotein secretion in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY LIVER-DISEASE; MANGANESE SUPEROXIDE-DISMUTASE; TRIGLYCERIDE TRANSFER PROTEIN; NONALCOHOLIC STEATOHEPATITIS; STRESS; EXPRESSION; INJURY; GENE; ANTIOXIDANTS; PEROXIDATION	Elevated hepatic reactive oxygen species play an important role in pathogenesis of liver diseases, such as alcohol- induced liver injury, hepatitis C virus infection, and nonalcoholic steato-hepatitis. In the present study, we investigated and compared the hepatic lipid metabolisms of liver-specific Sod2 (superoxide dismutase 2) knock-out (Sod2 KO), Sod1 knock-out (Sod1 KO), and Sod1/liver-specific Sod2 double knock- out mice (double KO). We observed significant increases in lipid peroxidation and triglyceride ( TG) in the liver of Sod1 KO and double KO mice but not in the liver of Sod2 KO mice. We also found that high fat diet enhanced fatty changes of the liver in Sod1 KO and double KO mice but not in Sod2 KO mice. These data indicated that CuZn-SOD deficiency caused lipid accumulation in the liver. To investigate the molecular mechanism of hepatic lipid accumulation in CuZn-SOD-deficient mice, we measured TG secretion rate from liver using Triton WR1339. We found significant decrease of TG secretion in CuZn-SOD-deficient mice. Furthermore, we observed marked degradation of apolipoprotein B (apoB) in the liver and plasma of CuZn-SOD-deficient mice, indicating that degradation of apoB impairs secretion of lipoprotein from the liver. Our data suggest that oxidative stress enhances hepatic lipid accumulation by impaired lipoprotein secretion due to the degradation of apoB in liver.	Tokyo Metropolitan Inst Gerontol, Res Team Mol Biomarkers, Itabashi Ku, Tokyo 1730015, Japan; Tokyo Univ Agr & Technol, United Grad Sch Agr Sci, Fuchu, Tokyo 1838509, Japan; Tokyo Metropolitan Univ, Grad Sch Sci, Tokyo 1138421, Japan; Anti Aging Sci Inc, Tokyo 1000011, Japan	Tokyo Metropolitan Institute of Gerontology; Tokyo University of Agriculture & Technology; Tokyo Metropolitan University	Shirasawa, T (corresponding author), Tokyo Metropolitan Inst Gerontol, Res Team Mol Biomarkers, Itabashi Ku, Tokyo 1730015, Japan.	sirasawa@tmig.or.jp						Adams LA, 2005, CAN MED ASSOC J, V172, P899, DOI 10.1503/cmaj.045232; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Busuttil RA, 2005, CANCER RES, V65, P11271, DOI 10.1158/0008-5472.CAN-05-2980; Charlton N, 2002, HEPATOLOGY, V35, P898, DOI 10.1053/jhep.2002.32527; Elchuri S, 2005, ONCOGENE, V24, P367, DOI 10.1038/sj.onc.1208207; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Fisher EA, 2002, J BIOL CHEM, V277, P17377, DOI 10.1074/jbc.R100068200; FONG LG, 1987, J LIPID RES, V28, P1466; Hashimoto R, 2000, BBA-MOL CELL BIOL L, V1483, P236, DOI 10.1016/S1388-1981(99)00167-5; Hussain MM, 2003, J LIPID RES, V44, P22, DOI 10.1194/jlr.R200014-JLR200; Ikegami T, 2002, BIOCHEM BIOPH RES CO, V296, P729, DOI 10.1016/S0006-291X(02)00933-6; Kaplowitz N, 2006, HEPATOLOGY, V43, pS235, DOI 10.1002/hep.20958; Kessova IG, 2003, HEPATOLOGY, V38, P1136, DOI 10.1053/jhep.2003.50450; Laurent A, 2004, HEPATOLOGY, V39, P1277, DOI 10.1002/hep.20177; Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Liao W, 2003, J LIPID RES, V44, P978, DOI 10.1194/jlr.M300020-JLR200; Musso G, 2003, HEPATOLOGY, V37, P909, DOI 10.1053/jhep.2003.50132; Nieto N, 1999, HEPATOLOGY, V30, P987, DOI 10.1002/hep.510300433; Nyska A, 2002, TOXICOL PATHOL, V30, P620, DOI 10.1080/01926230290166724; Pan MH, 2004, J CLIN INVEST, V113, P1277, DOI 10.1172/JCI200419197; Portincasa P, 2005, CLIN BIOCHEM, V38, P203, DOI 10.1016/j.clinbiochem.2004.10.014; Sanyal AJ, 2005, NAT CLIN PRACT GASTR, V2, P46, DOI 10.1038/ncpgasthep0084; Stiles B, 2004, P NATL ACAD SCI USA, V101, P2082, DOI 10.1073/pnas.0308617100; Videla LA, 2004, CLIN SCI, V106, P261, DOI 10.1042/CS20030285; Weltman MD, 1998, HEPATOLOGY, V27, P128, DOI 10.1002/hep.510270121; Xia XG, 2006, PLOS GENET, V2, P73, DOI 10.1371/journal.pgen.0020010; Xian-Cheng J, 2005, J BIOL CHEM, V280, P18336, DOI 10.1074/jbc.M500007200; Yesilova Z, 2005, AM J GASTROENTEROL, V100, P850, DOI 10.1111/j.1572-0241.2005.41500.x; Yu Andy S, 2002, Rev Gastroenterol Disord, V2, P11; Zelko IN, 2002, FREE RADICAL BIO MED, V33, P337, DOI 10.1016/S0891-5849(02)00905-X	31	116	120	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31713	31719		10.1074/jbc.M603422200	http://dx.doi.org/10.1074/jbc.M603422200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16921198	Bronze			2022-12-27	WOS:000241235300057
J	Hahn, JY; Cho, HJ; Bae, JW; Yuk, HS; Kim, KI; Park, KW; Koo, BK; Chae, IH; Shin, CS; Oh, BH; Choi, YS; Park, YB; Kim, HS				Hahn, Joo-Yong; Cho, Hyun-Ju; Bae, Jang-Whan; Yuk, Hyung-Sun; Kim, Kwang-Il; Park, Kyung-Woo; Koo, Bon-Kown; Chae, In-Ho; Shin, Chan-Soo; Oh, Byung-Hee; Choi, Yun-Shik; Park, Young-Bae; Kim, Hyo-Soo			beta-Catenin overexpression reduces myocardial infarct size through differential effects on cardiomyocytes and cardiac fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; SURVIVIN EXPRESSION; CELL-PROLIFERATION; ENDOTHELIAL-CELL; G(1) CYCLIN; CANCER; ANGIOGENESIS; HYPERTROPHY; INHIBITION; APOPTOSIS	beta-Catenin is a transcriptional regulator of several genes involved in survival and proliferation. Although previous studies suggest that beta-catenin may be involved in the process of preconditioning and healing after myocardial infarction (MI),little is known regarding the role of beta-catenin in cardiomyocytes and cardiac fibroblasts. We investigated the role of beta-catenin in cardiomyocytes and cardiac fibroblasts and whether beta-catenin overexpression could reduce MI size. Adenovirus-mediated gene transfer of nonphosphorylatable constitutively active beta-catenin (Ad-catenin) decreased apoptosis in cardiomyocytes and cardiac fibroblasts with increased expression of survivin and Bcl-2. Although Ad-catenin increased the percentage of cells in the S phase with enhanced expression of cyclin D1 and E2 in both cell types, the increase in cell number was only evident in cardiac fibroblasts, whereas hypertrophy and binuclear cells were more prominent in cardiomyocytes. All of these effects of beta-catenin gene transfer were blocked by inhibition of its nuclear translocation. Furthermore, Ad-catenin enhanced the expression of vascular endothelial growth factor in both cells and induced differentiation of cardiac fibroblasts into myofibroblasts. In a rat MI model, injection of Ad-catenin into the infarct border zone resulted in a significantly decreased MI size with anti-apoptotic effect and cell cycle activation in both cardiomyocytes and myofibroblasts. beta-Catenin may play an important role in the healing process after MI by promoting survival and cell cycle not only in cardiomyocytes but also in cardiac fibroblasts with its differentiation into myofibroblasts.	Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 110744, South Korea; Seoul Natl Univ Hosp, Natl Res Lab Cardiovasc Stem Cell, Seoul 110744, South Korea; Seoul Natl Univ Hosp, Hormone Res Ctr, Seoul 110744, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Kim, HS (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 110744, South Korea.	hyosoo@snu.ac.kr	Chae, In-Ho/J-5682-2012; Kim, Hyo Soo/J-2753-2012; Park, Young-Bae/J-5490-2012; Shin, Chan Soo/I-7320-2012; Hahn, Joo-Yong/AAU-7250-2020; Kim, Kwang-il/D-8024-2012; Oh, Byung-Hee/G-9875-2011; Koo, Bon-Kwon/J-5374-2012; Kim, Kwang-il/AAP-7315-2021; Park, Kyung Woo/AAX-3046-2020	Shin, Chan Soo/0000-0002-5829-4465; Hahn, Joo-Yong/0000-0002-4412-377X; Kim, Kwang-il/0000-0002-6658-047X; Oh, Byung-Hee/0000-0002-9945-4306; Kim, Kwang-il/0000-0002-6658-047X; 				Antos CL, 2002, P NATL ACAD SCI USA, V99, P907, DOI 10.1073/pnas.231619298; Barandon L, 2005, CIRC RES, V96, P1299, DOI 10.1161/01.RES.0000171895.06914.2c; Barandon L, 2003, CIRCULATION, V108, P2282, DOI 10.1161/01.CIR.0000093186.22847.4C; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Bergmann MW, 2004, J MOL CELL CARDIOL, V37, P681, DOI 10.1016/j.yjmcc.2004.05.025; Botrugno OA, 2004, MOL CELL, V15, P499, DOI 10.1016/j.molcel.2004.07.009; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cho HJ, 2005, ARTERIOSCL THROM VAS, V25, P1154, DOI 10.1161/01.ATV.0000164312.20008.93; Choi JH, 2004, J BIOL CHEM, V279, P49430, DOI 10.1074/jbc.M402088200; Conacci-Sorrell M, 2002, J CLIN INVEST, V109, P987, DOI 10.1172/JCI200215429; Gualberto A, 1998, P NATL ACAD SCI USA, V95, P5166, DOI 10.1073/pnas.95.9.5166; Gudas JM, 1999, MOL CELL BIOL, V19, P612; GUMBINER BM, 1995, CURR OPIN CELL BIOL, V7, P634, DOI 10.1016/0955-0674(95)80104-9; Hayakawa K, 2003, CIRCULATION, V108, P104, DOI 10.1161/01.CIR.0000074225.62168.68; Kaga S, 2006, J MOL CELL CARDIOL, V40, P138, DOI 10.1016/j.yjmcc.2005.09.009; Kim KI, 2006, ARTERIOSCL THROM VAS, V26, P91, DOI 10.1161/01.ATV.0000193569.12490.4b; Kim PJ, 2003, LANCET, V362, P205, DOI 10.1016/S0140-6736(03)13910-4; Li FQ, 1997, J MOL CELL CARDIOL, V29, P1553, DOI 10.1006/jmcc.1997.0403; Masszi A, 2004, AM J PATHOL, V165, P1955, DOI 10.1016/S0002-9440(10)63247-6; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; Park KW, 2003, ARTERIOSCL THROM VAS, V23, P1364, DOI 10.1161/01.ATV.0000081633.53390.B4; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Polakis P, 2000, GENE DEV, V14, P1837; Rogers JH, 1999, J CLIN INVEST, V104, P567, DOI 10.1172/JCI6713; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Santini D, 2004, J CLIN PATHOL, V57, P1321, DOI 10.1136/jcp.2004.018986; Shin CS, 2005, J BONE MINER RES, V20, P2200, DOI 10.1359/JBMR.050809; Skurk C, 2005, CIRC RES, V96, P308, DOI 10.1161/01.RES.0000156273.30274.f7; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; THAIK CM, 1995, J CLIN INVEST, V96, P1093, DOI 10.1172/JCI118095; Tong HY, 2002, CIRC RES, V90, P377, DOI 10.1161/01.RES.0000012567.95445.55; Yang HM, 2004, CIRCULATION, V110, P301, DOI 10.1161/01.CIR.0000135467.43430.16; Youn TJ, 2002, EUR J HEART FAIL, V4, P713, DOI 10.1016/S1388-9842(02)00120-4; Young CS, 2003, DIFFERENTIATION, V71, P477, DOI 10.1046/j.1432-0436.2003.7108002.x; Yun MS, 2005, J CELL SCI, V118, P313, DOI 10.1242/jcs.01601	36	98	104	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30979	30989		10.1074/jbc.M603916200	http://dx.doi.org/10.1074/jbc.M603916200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16920707	hybrid			2022-12-27	WOS:000241075900074
J	Iskander, K; Li, J; Han, SH; Zheng, B; Jaiswal, AK				Iskander, Karim; Li, Jessica; Han, Shuhua; Zheng, Biao; Jaiswal, Anil K.			NQO1 and NQO2 regulation of humoral immunity and autoimmunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NAD(P)H-QUINONE OXIDOREDUCTASE-1 NQO1; DT-DIAPHORASE; PROTEASOMAL DEGRADATION; B-CELLS; GENE; MICE; POLYMORPHISM; DISRUPTION; EXPRESSION; APOPTOSIS	NAD(P) H: quinone oxidoreductase 1 (NQO1)and NRH: quinone oxidoreductase 2 (NQO2) are cytosolic enzymes that catalyze metabolic reduction of quinones and derivatives. NQO1-null and NQO2-null mice were generated that showed decreased lymphocytes in peripheral blood, myeloid hyperplasia, and increased sensitivity to skin carcinogenesis. In this report, we investigated the in vivo role of NQO1 and NQO2 in immune response and autoimmunity. Both NQO1-null and NQO2-null mice showed decreased B-cells in blood, lower germinal center response, altered B cell homing, and impaired primary and secondary immune responses. NQO1-null and NQO2-null mice also showed susceptibility to autoimmune disease as revealed by decreased apoptosis in thymocytes and predisposition to collagen-induced arthritis. Further experiments showed accumulation of NADH and NRH, cofactors for NQO1 and NQO2, indicating altered intracellular redox status. The studies also demonstrated decreased expression and lack of activation of immune-related factor NF-kappa B. Microarray analysis showed altered chemokines and chemokine receptors. These results suggest that the loss of NQO1 and NQO2 leads to altered intracellular redox status, decreased expression and activation of NF-kappa B, and altered chemokines. The results led to the conclusion that NQO1 and NQO2 are endogenous factors in the regulation of immune response and autoimmunity.	Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA; Baylor Coll Med, Dept Immunol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Jaiswal, AK (corresponding author), Baylor Coll Med, Dept Pharmacol, 1 Baylor Plaza, Houston, TX 77030 USA.	ajaiswal@bcm.tmc.edu			NIEHS NIH HHS [R01 ES07943] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007943] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Asher G, 2005, GENE DEV, V19, P316, DOI 10.1101/gad.319905; Carter RH, 2006, MAYO CLIN PROC, V81, P377, DOI 10.4065/81.3.377; Choi Y, 1999, CLIN IMMUNOL, V93, P34, DOI 10.1006/clim.1999.4767; Chun HJ, 2002, NATURE, V419, P395, DOI 10.1038/nature01063; Corcoran LM, 2005, CURR TOP MICROBIOL, V290, P105; De Silva S, 2005, ARTHRITIS RHEUM-US, V52, P333, DOI 10.1002/art.20736; DHAKSHINAMOORTH.S, 2005, J BIOL CHEM, V279, P50810; Fleisher TA, 2004, J ALLERGY CLIN IMMUN, V114, P227, DOI 10.1016/j.jaci.2004.06.001; Gaikwad A, 2001, J BIOL CHEM, V276, P22559, DOI 10.1074/jbc.M101053200; Iskander K, 2005, CANCER RES, V65, P2054, DOI 10.1158/0008-5472.CAN-04-3157; Iskander K, 2004, CANCER RES, V64, P5925, DOI 10.1158/0008-5472.CAN-04-0763; Iskander K, 2005, CHEM-BIOL INTERACT, V153, P147, DOI 10.1016/j.cbi.2005.03.019; Kabe Y, 2005, ANTIOXID REDOX SIGN, V7, P395, DOI 10.1089/ars.2005.7.395; Kato Y, 1997, CELL IMMUNOL, V177, P103, DOI 10.1006/cimm.1997.1103; Kelsey KT, 1997, BRIT J CANCER, V76, P852, DOI 10.1038/bjc.1997.474; KLAIDMAN LK, ANAL BIOCH, V228, P312; LAZZARINO G, 1989, ANAL BIOCHEM, V181, P239, DOI 10.1016/0003-2697(89)90236-4; Long DJ, 2000, CANCER RES, V60, P5913; Long DJ, 2002, CANCER RES, V62, P3030; Long DJ, 2002, J BIOL CHEM, V277, P46131, DOI 10.1074/jbc.M208675200; Mahoney JA, 2005, CURR OPIN IMMUNOL, V17, P583, DOI 10.1016/j.coi.2005.09.018; Nakken B, 2003, SCAND J IMMUNOL, V58, P478, DOI 10.1046/j.1365-3083.2003.01323.x; Nie YC, 2004, J EXP MED, V200, P1145, DOI 10.1084/jem.20041185; Radjendirane V, 1998, J BIOL CHEM, V273, P7382, DOI 10.1074/jbc.273.13.7382; Ross D, 2004, METHOD ENZYMOL, V382, P115; ROSVOLD EA, 1995, PHARMACOGENETICS, V5, P199, DOI 10.1097/00008571-199508000-00003; Schulz WA, 1998, PHARMACOGENETICS, V8, P453, DOI 10.1097/00008571-199810000-00011; Siegel D, 1999, PHARMACOGENETICS, V9, P113, DOI 10.1097/00008571-199902000-00015; Siegel D, 2001, MOL PHARMACOL, V59, P263, DOI 10.1124/mol.59.2.263; Sneller MC, 1997, BLOOD, V89, P1341, DOI 10.1182/blood.V89.4.1341; TRAVER RD, 1992, CANCER RES, V52, P797; Viau M, 2005, CLIN IMMUNOL, V114, P17, DOI 10.1016/j.clim.2004.08.019; Wang XW, 2006, P NATL ACAD SCI USA, V103, P4204, DOI 10.1073/pnas.0507044103; Wiencke JK, 1997, CANCER EPIDEM BIOMAR, V6, P87; Yokochi T, 1996, FEMS IMMUNOL MED MIC, V15, P1; Zheng B, 2003, J IMMUNOL, V171, P4979, DOI 10.4049/jimmunol.171.10.4979	36	60	65	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30917	30924		10.1074/jbc.M605809200	http://dx.doi.org/10.1074/jbc.M605809200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16905546	hybrid			2022-12-27	WOS:000241075900067
J	Kawano, M; Kumagai, K; Nishijima, M; Hanada, K				Kawano, Miyuki; Kumagai, Keigo; Nishijima, Masahiro; Hanada, Kentaro			Efficient trafficking of ceramide from the endoplasmic reticulum to the Golgi apparatus requires a VAMP-associated protein-interacting FFAT motif of CERT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYSTEROL-BINDING-PROTEIN; HAMSTER OVARY CELLS; MEMBRANE-PROTEIN; SPHINGOMYELIN SYNTHESIS; SERINE PALMITOYLTRANSFERASE; GOODPASTURE ANTIGEN; MOLECULAR MACHINERY; RAT-LIVER; VAP-A; COMPLEX	Ceramide is synthesized at the endoplasmic reticulum ( ER) and transported to the Golgi apparatus by CERT for its conversion to sphingomyelin in mammalian cells. CERT has a pleckstrin homology (PH) domain for Golgi targeting and a START domain catalyzing the intermembrane transfer of ceramide. The region between the two domains contains a short peptide motif designated FFAT, which is supposed to interact with the ER-resident proteins VAP-A and VAP-B. Both VAPs were actually co-immunoprecipitated with CERT, and the CERT/VAP interaction was abolished by mutations in the FFAT motif. These mutations did not affect the Golgi targeting activity of CERT. Whereas mutations of neither the FFAT motif nor the PH domain inhibited the ceramide transfer activity of CERT in a cell-free system, they impaired the ER-to-Golgi transport of ceramide in intact and in semi-intact cells at near endogenous expression levels. By contrast, when overexpressed, both the FFAT motif and the PH domain mutants of CERT substantially supported the transport of ceramide from the ER to the site where sphingomyelin is produced. These results suggest that the Golgi-targeting PH domain and ER-interacting FFAT motif of CERT spatially restrict the random ceramide transfer activity of the START domain in cells.	Natl Inst Infect Dis, Dept Biochem & Cell Biol, Shinjuku Ku, Tokyo 1628640, Japan; Natl Inst Infect Dis, CREST, Tokyo 1628640, Japan	National Institute of Infectious Diseases (NIID); Japan Science & Technology Agency (JST); National Institute of Infectious Diseases (NIID)	Hanada, K (corresponding author), Natl Inst Infect Dis, Dept Biochem & Cell Biol, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.	hanak@nih.go.jp	Kumagai, Keigo/AAG-1385-2021	KAWANO-KAWADA, Miyuki/0000-0002-1168-9291; Kumagai, Keigo/0000-0002-1663-2905; Hanada, Kentaro/0000-0003-1383-2781				Amarilio R, 2005, J BIOL CHEM, V280, P5934, DOI 10.1074/jbc.M409566200; Ardail D, 2003, BIOCHEM J, V371, P1013, DOI 10.1042/BJ20021834; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Ettayebi K, 2003, J VIROL, V77, P11790, DOI 10.1128/JVI.77.21.11790-11797.2003; Fukasawa M, 1999, J CELL BIOL, V144, P673, DOI 10.1083/jcb.144.4.673; Funakoshi T, 2000, J BIOL CHEM, V275, P29938, DOI 10.1074/jbc.M004470200; Futerman AH, 2005, TRENDS CELL BIOL, V15, P312, DOI 10.1016/j.tcb.2005.04.006; FUTERMAN AH, 1991, BIOCHEM J, V280, P295, DOI 10.1042/bj2800295; Gao L, 2004, J VIROL, V78, P3480, DOI 10.1128/JVI.78.7.3480-3488.2004; Hamamoto I, 2005, J VIROL, V79, P13473, DOI 10.1128/JVI.79.21.13473-13482.2005; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hanada K, 1998, J BIOL CHEM, V273, P33787, DOI 10.1074/jbc.273.50.33787; HANADA K, 1990, J BIOL CHEM, V265, P22137; Hanada K, 2006, MOL CELL BIOCHEM, V286, P23, DOI 10.1007/s11010-005-9044-z; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; Kagiwada S, 1998, J BACTERIOL, V180, P1700, DOI 10.1128/JB.180.7.1700-1708.1998; Kumagai K, 2005, J BIOL CHEM, V280, P6488, DOI 10.1074/jbc.M409290200; Lagace TA, 1999, J LIPID RES, V40, P109; Lapierre LA, 1999, J CELL SCI, V112, P3723; Lehto M, 2003, BBA-MOL CELL BIOL L, V1631, P1, DOI 10.1016/S1388-1981(02)00364-5; Lev S, 2004, EXP CELL RES, V297, P1, DOI 10.1016/j.yexcr.2004.02.033; Levine T, 2004, TRENDS CELL BIOL, V14, P483, DOI 10.1016/j.tcb.2004.07.017; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; Litvak V, 2005, NAT CELL BIOL, V7, P225, DOI 10.1038/ncb1221; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Mogelsvang S, 2004, TRAFFIC, V5, P338, DOI 10.1111/j.1398-9219.2004.00186.x; Nishimura Y, 1999, BIOCHEM BIOPH RES CO, V254, P21, DOI 10.1006/bbrc.1998.9876; Perry RJ, 2006, MOL BIOL CELL, V17, P2604, DOI 10.1091/mbc.E06-01-0060; Ponting CP, 1999, TRENDS BIOCHEM SCI, V24, P130, DOI 10.1016/S0968-0004(99)01362-6; Raya A, 1999, J BIOL CHEM, V274, P12642, DOI 10.1074/jbc.274.18.12642; Raya A, 2000, J BIOL CHEM, V275, P40392, DOI 10.1074/jbc.M002769200; RIDGWAY ND, 1995, J LIPID RES, V36, P1345; RIDGWAY ND, 1992, J CELL BIOL, V116, P307, DOI 10.1083/jcb.116.2.307; SKEHEL PA, 1995, SCIENCE, V269, P1580, DOI 10.1126/science.7667638; Skehel PA, 2000, P NATL ACAD SCI USA, V97, P1101, DOI 10.1073/pnas.97.3.1101; Soussan L, 1999, J CELL BIOL, V146, P301, DOI 10.1083/jcb.146.2.301; Ternes P, 2002, J BIOL CHEM, V277, P25512, DOI 10.1074/jbc.M202947200; Tu H, 1999, VIROLOGY, V263, P30, DOI 10.1006/viro.1999.9893; Wang PY, 2005, SCIENCE, V307, P1472, DOI 10.1126/science.1107710; Weir ML, 1998, BIOCHEM J, V333, P247, DOI 10.1042/bj3330247; Wyles JP, 2002, J BIOL CHEM, V277, P29908, DOI 10.1074/jbc.M201191200; Wyles JP, 2004, EXP CELL RES, V297, P533, DOI 10.1016/j.yexcr.2004.03.052; Yasuda S, 2003, J BIOL CHEM, V278, P4176, DOI 10.1074/jbc.M209602200	44	220	227	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					30279	30288		10.1074/jbc.M605032200	http://dx.doi.org/10.1074/jbc.M605032200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16895911	hybrid			2022-12-27	WOS:000240896300088
J	Graeff, R; Liu, Q; Kriksunov, IA; Hao, Q; Lee, HC				Graeff, Richard; Liu, Qun; Kriksunov, Irina A.; Hao, Quan; Lee, Hon Cheung			Acidic residues at the active sites of CD38 and ADP-ribosyl cyclase determine nicotinic acid adenine dinucleotide phosphate (NAADP) synthesis and hydrolysis activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC-ACINAR; CA2+; ACTIVATION; MOLECULE; SURFACE; LOCALIZATION; GLYCOPROTEIN; EXPRESSION; PROTEIN; ENZYME	Nicotinic acid adenine dinucleotide phosphate (NAADP) is a novel metabolite of NADP that has now been established as a Ca2+ messenger in many cellular systems. Its synthesis is catalyzed by multifunctional enzymes, CD38 and ADP-ribosyl cyclase (cyclase). The degradation pathway for NAADP is unknown and no enzyme that can specifically hydrolyze it has yet been identified. Here we show that CD38 can, in fact, hydrolyze NAADP to ADP-ribose 2'-phosphate. This activity was low at neutrality but greatly increased at acidic pH. This novel pH dependence suggests that the hydrolysis is determined by acidic residues at the active site. X-ray crystallography of the complex of CD38 with one of its substrates, NMN, showed that the nicotinamide moiety was in close contact with Glu146 at 3.27 angstrom and Asp(155) at 2.52 angstrom. Changing Glu(146) to uncharged Gly and Ala, and Asp(155) to Gln and Asn, by site-directed mutagenesis indeed eliminated the strong pH dependence. Changing Asp(155) to Glu, in contrast, preserved the dependence. The specificity of the two acidic residues was further demonstrated by changing the adjacent Asp(147) to Val, which had minimal effect on the pH dependence. Crystallography confirmed that Asp(147) was situated and directed away from the bound substrate. Synthesis of NAADP catalyzed by CD38 is known to have strong preference for acidic pH, suggesting that Glu(146) and Asp(155) are also critical determinants. This was shown to be case by mutagensis. Likewise, using similar approaches, Glu(98) of the cyclase, which is equivalent to Glu(146) in CD38, was found to be responsible for controlling the pH dependence of NAADP synthesis by the cyclase. Based on these findings, a catalytic model is proposed.	Cornell Univ, MacCHESS, Cornell High Energy Synchrotron Source, Ithaca, NY 14853 USA; Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA; Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China	Cornell University; University of Minnesota System; University of Minnesota Twin Cities; University of Hong Kong	Hao, Q (corresponding author), Cornell Univ, MacCHESS, Cornell High Energy Synchrotron Source, Ithaca, NY 14853 USA.	qh22@cornell.edu; leehc@tc.umn.edu	Lee, Hon Cheung/C-4329-2009; Liu, Qun/A-8757-2011; Hao, Quan/C-4304-2009; Graeff, Richard Milton/B-3425-2011	Liu, Qun/0000-0002-1179-290X; Hao, Quan/0000-0002-9642-0514	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061568] Funding Source: NIH RePORTER; NCRR NIH HHS [RR01646] Funding Source: Medline; NIGMS NIH HHS [GM061568] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aarhus R, 1995, J BIOL CHEM, V270, P30327, DOI 10.1074/jbc.270.51.30327; Adebanjo OA, 1999, NAT CELL BIOL, V1, P409, DOI 10.1038/15640; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Basile G, 2005, P NATL ACAD SCI USA, V102, P14509, DOI 10.1073/pnas.0503691102; Beck A, 2006, FASEB J, V20, P962, DOI 10.1096/fj.05-5538fje; Berridge G, 2002, BIOCHEM J, V365, P295, DOI 10.1042/BJ20020180; Billington RA, 2002, J PHYSIOL-LONDON, V544, P107, DOI 10.1113/jphysiol.2002.030098; Churchill GC, 2003, CURR BIOL, V13, P125, DOI 10.1016/S0960-9822(03)00002-2; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; CLAPPER DL, 1987, J BIOL CHEM, V262, P9561; Fernandez JE, 1998, J BIOL REG HOMEOS AG, V12, P81; Ferrero E, 1999, J LEUKOCYTE BIOL, V65, P151, DOI 10.1002/jlb.65.2.151; Gasser A, 2006, J BIOL CHEM, V281, P2489, DOI 10.1074/jbc.M506525200; Gasser A, 2006, J BIOL CHEM, V281, P16906, DOI 10.1074/jbc.M601347200; Graeff R, 2002, BIOCHEM J, V367, P163, DOI 10.1042/BJ20020644; Graeff R, 2001, J BIOL CHEM, V276, P12169, DOI 10.1074/jbc.M011299200; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; JACKSON DG, 1990, J IMMUNOL, V144, P2811; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Khoo KM, 1999, BRAIN RES, V821, P17, DOI 10.1016/S0006-8993(98)01347-X; Kinnear NP, 2004, J BIOL CHEM, V279, P54319, DOI 10.1074/jbc.M406132200; KOGUMA T, 1994, BBA-MOL CELL RES, V1223, P160, DOI 10.1016/0167-4889(94)90087-6; Kolisek M, 2005, MOL CELL, V18, P61, DOI 10.1016/j.molcel.2005.02.033; Lee HC, 2000, CHEM IMMUNOL, V75, P39; LEE HC, 1991, CELL REGUL, V2, P203, DOI 10.1091/mbc.2.3.203; Lee HC, 2003, CURR BIOL, V13, pR186, DOI 10.1016/S0960-9822(03)00120-9; LEE HC, 1995, J BIOL CHEM, V270, P2152, DOI 10.1074/jbc.270.5.2152; LEE HC, 1993, BIOCHEM BIOPH RES CO, V191, P639, DOI 10.1006/bbrc.1993.1265; Lee HC, 1997, PHYSIOL REV, V77, P1133, DOI 10.1152/physrev.1997.77.4.1133; Lee HC, 1997, J BIOL CHEM, V272, P4172, DOI 10.1074/jbc.272.7.4172; Lee HC, 2001, ANNU REV PHARMACOL, V41, P317, DOI 10.1146/annurev.pharmtox.41.1.317; Lee HC, 2005, J BIOL CHEM, V280, P33693, DOI 10.1074/jbc.R500012200; LEE HC, 2002, CYCLIC ADP RIBOSE NA; Liu Q, 2005, STRUCTURE, V13, P1331, DOI 10.1016/j.str.2005.05.012; MALAVASI F, 1992, INT J CLIN LAB RES, V22, P73, DOI 10.1007/BF02591400; MALAVASI F, 1994, IMMUNOL TODAY, V15, P95, DOI 10.1016/0167-5699(94)90148-1; Mehta K, 1996, FASEB J, V10, P1408, DOI 10.1096/fasebj.10.12.8903511; Munshi C, 2000, J BIOL CHEM, V275, P21566, DOI 10.1074/jbc.M909365199; Munshi C, 1999, J BIOL CHEM, V274, P30770, DOI 10.1074/jbc.274.43.30770; Munshi CB, 1997, METHOD ENZYMOL, V280, P318; Munshi CB, 2002, J BIOL CHEM, V277, P49453, DOI 10.1074/jbc.M209313200; MUNSHI CB, 2002, CYCLIC ADP RIBOSE NA, P81; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Prasad GS, 1996, PROTEINS, V24, P138, DOI 10.1002/(SICI)1097-0134(199601)24:1<138::AID-PROT10>3.3.CO;2-K; STATES DJ, 1992, TRENDS BIOCHEM SCI, V17, P495, DOI 10.1016/0968-0004(92)90337-9; Togashi K, 2006, EMBO J, V25, P1804, DOI 10.1038/sj.emboj.7601083; Yalcintepe L, 2005, EXP CELL RES, V303, P14, DOI 10.1016/j.yexcr.2004.09.010; Yamada M, 1997, BRAIN RES, V756, P52, DOI 10.1016/S0006-8993(97)00117-0; Yamamoto-Katayama S, 2002, J MOL BIOL, V316, P711, DOI 10.1006/jmbi.2001.5386; Yamasaki M, 2005, CURR BIOL, V15, P874, DOI 10.1016/j.cub.2005.04.033; Yamasaki M, 2004, J BIOL CHEM, V279, P7234, DOI 10.1074/jbc.M311088200	51	61	62	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					28951	28957		10.1074/jbc.M604370200	http://dx.doi.org/10.1074/jbc.M604370200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16861223	hybrid			2022-12-27	WOS:000240680500049
J	Kahn, TG; Schwartz, YB; Dellino, GI; Pirrotta, V				Kahn, Tatyana G.; Schwartz, Yuri B.; Dellino, Gaetano I.; Pirrotta, Vincenzo			Polycomb complexes and the propagation of the methylation mark at the Drosophila Ubx gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; H3 LYSINE 9; RESPONSE ELEMENT; GAGA FACTOR; CHROMATIN COMPLEXES; BINDING-SITES; ENHANCER; HP1; MAINTENANCE; REQUIRES	Polycomb group proteins are transcriptional repressors that control many developmental genes. The Polycomb group protein Enhancer of Zeste has been shown in vitro to methylate specifically lysine 27 and lysine 9 of histone H3 but the role of this modification in Polycomb silencing is unknown. We show that H3 trimethylated at lysine 27 is found on the entire Ubx gene silenced by Polycomb. However, Enhancer of Zeste and other Polycomb group proteins stay primarily localized at their response elements, which appear to be the least methylated parts of the silenced gene. Our results suggest that, contrary to the prevailing view, the Polycomb group proteins and methyltransferase complexes are recruited to the Polycomb response elements independently of histone methylation and then loop over to scan the entire region, methylating all accessible nucleosomes. We propose that the Polycomb chromodomain is required for the looping mechanism that spreads methylation over a broad domain, which in turn is required for the stability of the Polycomb group protein complex. Both the spread of methylation from the Polycomb response elements, and the silencing effect can be blocked by the gypsy insulator.	Rutgers State Univ, Dept Mol Biol & Biochem, Nelson Labs, Piscataway, NJ 08854 USA; Univ Geneva, Dept Zool, CH-1211 Geneva, Switzerland	Rutgers State University New Brunswick; University of Geneva	Pirrotta, V (corresponding author), Rutgers State Univ, Dept Mol Biol & Biochem, Nelson Labs, 604 Allison Rd, Piscataway, NJ 08854 USA.	pirrotta@biology.rutgers.edu	Dellino, Gaetano Ivan/AAF-6405-2020	DELLINO, GAETANO IVAN/0000-0002-8673-4560				Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Blackwood EM, 1998, SCIENCE, V281, P60, DOI 10.1126/science.281.5373.60; Breiling A, 2001, NATURE, V412, P651, DOI 10.1038/35088090; Busturia A, 2001, DEVELOPMENT, V128, P2163; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; CHAN CS, 1994, EMBO J, V13, P2553, DOI 10.1002/j.1460-2075.1994.tb06545.x; CHIANG A, 1995, DEVELOPMENT, V121, P1681; Cowell IG, 2002, CHROMOSOMA, V111, P22, DOI 10.1007/s00412-002-0182-8; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; DECOCK JGR, 1991, NUCLEIC ACIDS RES, V19, P3289, DOI 10.1093/nar/19.12.3289; Dellino GI, 2004, MOL CELL, V13, P887, DOI 10.1016/S1097-2765(04)00128-5; Ebert A, 2004, GENE DEV, V18, P2973, DOI 10.1101/gad.323004; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Gelbart W, 2003, NUCLEIC ACIDS RES, V31, P172, DOI 10.1093/nar/gkg094; Horard B, 2000, MOL CELL BIOL, V20, P3187, DOI 10.1128/MCB.20.9.3187-3197.2000; Katsani KR, 1999, EMBO J, V18, P698, DOI 10.1093/emboj/18.3.698; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Mallin DR, 1998, GENETICS, V148, P331; Mishra RK, 2001, MOL CELL BIOL, V21, P1311, DOI 10.1128/MCB.21.4.1311-1318.2001; Morillon A, 2005, MOL CELL, V18, P723, DOI 10.1016/j.molcel.2005.05.009; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Ng J, 2000, MOL CELL BIOL, V20, P3069, DOI 10.1128/MCB.20.9.3069-3078.2000; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Peirson SN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng073; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; PIRROTTA V, 1995, CURR OPIN GENET DEV, V5, P466, DOI 10.1016/0959-437X(95)90050-Q; Pirrotta V, 1998, CELL, V93, P333, DOI 10.1016/S0092-8674(00)81162-9; PIRROTTA V, 1996, EPIGENETIC MECH GENE, P489; Poux S, 2001, DEVELOPMENT, V128, P75; QIAN S, 1993, EMBO J, V12, P3865, DOI 10.1002/j.1460-2075.1993.tb06065.x; Rastegar M, 2004, MOL CELL BIOL, V24, P8090, DOI 10.1128/MCB.24.18.8090-8103.2004; RASTELLI L, 1993, EMBO J, V12, P1513, DOI 10.1002/j.1460-2075.1993.tb05795.x; Ringrose L, 2004, MOL CELL, V16, P641, DOI 10.1016/j.molcel.2004.10.015; Ringrose L, 2003, DEV CELL, V5, P759, DOI 10.1016/S1534-5807(03)00337-X; ROUGVIE AE, 1990, MOL CELL BIOL, V10, P6041, DOI 10.1128/MCB.10.11.6041; Saurin AJ, 2001, NATURE, V412, P655, DOI 10.1038/35088096; Schwartz YB, 2005, MOL CELL BIOL, V25, P432, DOI 10.1128/MCB.25.1.432-439.2005; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; SHOPLAND LS, 1995, GENE DEV, V9, P2756, DOI 10.1101/gad.9.22.2756; Sigrist CJA, 1997, GENETICS, V147, P209; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Strutt H, 1997, EMBO J, V16, P3621, DOI 10.1093/emboj/16.12.3621; Tie F, 2003, MOL CELL BIOL, V23, P3352, DOI 10.1128/MCB.23.9.3352-3362.2003; Tie F, 2001, DEVELOPMENT, V128, P275; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; TSUKIYAMA T, 1994, NATURE, V367, P525, DOI 10.1038/367525a0; Wang L, 2004, MOL CELL, V14, P637, DOI 10.1016/j.molcel.2004.05.009; ZHANG CC, 1992, P NATL ACAD SCI USA, V89, P7511, DOI 10.1073/pnas.89.16.7511	50	77	81	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					29064	29075		10.1074/jbc.M605430200	http://dx.doi.org/10.1074/jbc.M605430200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16887811	hybrid			2022-12-27	WOS:000240680500061
J	Korotkova, N; Cota, E; Lebedin, Y; Monpouet, S; Guignot, J; Servin, AL; Matthews, S; Moseley, SL				Korotkova, Natalia; Cota, Ernesto; Lebedin, Yuri; Monpouet, Severine; Guignot, Julie; Servin, Alain L.; Matthews, Steve; Moseley, Steve L.			A subfamily of Dr adhesins of Escherichia coli bind independently to decay-accelerating factor and the N-domain of carcinoembryonic antigen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROSS-REACTING ANTIGEN; NONTYPABLE HAEMOPHILUS-INFLUENZAE; AFA-3 GENE-CLUSTER; NEISSERIA-GONORRHOEAE; CEA FAMILY; CELLULAR ADHESION; EPITHELIAL-CELLS; PICHIA-PASTORIS; TYPE-1 FIMBRIAE; TERMINAL DOMAIN	Escherichia coli expressing the Dr family of adhesins adheres to epithelial cells by binding to decay-accelerating factor (DAF) and carcinoembryonic antigen (CEA)-related cell surface proteins. The attachment of bacteria expressing Dr adhesins toDAF induces clustering of DAF around bacterial cells and also recruitment of CEA-related cell adhesion molecules. CEA, CEACAM1, and CEACAM6 have been shown to serve as receptors for some Dr adhesins (AfaE-I, AfaE-III, DraE, and DaaE). We demonstrate that AfaE-I, AfaE-V, DraE, and DaaE adhesins bind to the N-domain of CEA. To identify the residues involved in the N-CEA/DraE interaction, we performed SPR binding analyses of naturally occurring variants and a number of randomly generated mutants in DraE and N-CEA. Additionally, we used chemical shift mapping by NMR to determine the surface of DraE involved in N-CEA binding. These results show a distinct CEA binding site located primarily in the A, B, E, and D strands of the Dr adhesin. Interestingly, this site is located opposite to the beta-sheet encompassing the previously determined binding site for DAF, which implies that the adhesin can bind simultaneously to both receptors on the epithelial cell surface. The recognition of CEACAMs from a highly diverse DrCEA subfamily of Dr adhesins indicates that interaction with these receptors plays an important role in niche adaptation of E. coli strains expressing Dr adhesins.	Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London SW7 2AZ, England; Xema Medica Co, Moscow 105043, Russia; INSERM, U756, Fac Pharm, F-92296 Chatenay Malabry, France	University of Washington; University of Washington Seattle; Imperial College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Moseley, SL (corresponding author), Univ Washington, Dept Microbiol, Box 957242, Seattle, WA 98195 USA.	moseley@u.washington.edu	Cota, Ernesto/A-5292-2009	Korotkova, Natalia/0000-0002-8696-4892; Guignot, Julie/0000-0001-8890-4028; Matthews, Steve/0000-0003-0676-0927	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064229] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-064229, R01 DK064229] Funding Source: Medline; Wellcome Trust [079819] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome TrustEuropean Commission)		Anderson KL, 2004, MOL CELL, V15, P647, DOI 10.1016/j.molcel.2004.08.003; Berger CN, 2004, MOL MICROBIOL, V52, P963, DOI 10.1111/j.1365-2958.2004.04033.x; Boehm MK, 1996, J MOL BIOL, V259, P718, DOI 10.1006/jmbi.1996.0353; Bos MP, 1999, J EXP MED, V190, P331, DOI 10.1084/jem.190.3.331; Bos MP, 1998, P NATL ACAD SCI USA, V95, P9584, DOI 10.1073/pnas.95.16.9584; Carnoy C, 1997, MOL MICROBIOL, V23, P365, DOI 10.1046/j.1365-2958.1997.2231590.x; Das M, 2005, INFECT IMMUN, V73, P6119, DOI 10.1128/IAI.73.9.6119-6126.2005; FOXMAN B, 1995, J INFECT DIS, V172, P1536, DOI 10.1093/infdis/172.6.1536; Garcia MI, 1996, MOL MICROBIOL, V19, P683, DOI 10.1046/j.1365-2958.1996.394935.x; Gray-Owen SD, 2003, SCAND J INFECT DIS, V35, P614, DOI 10.1080/00365540310016042; Guignot J, 2000, INFECT IMMUN, V68, P3554, DOI 10.1128/IAI.68.6.3554-3563.2000; Hammarstrom S, 1999, SEMIN CANCER BIOL, V9, P67, DOI 10.1006/scbi.1998.0119; HEFTA LJF, 1992, CANCER RES, V52, P5647; Hellwig S, 1999, BIOTECHNOL APPL BIOC, V30, P267; Hill DJ, 2003, MOL MICROBIOL, V48, P117, DOI 10.1046/j.1365-2958.2003.03433.x; Hill DJ, 2001, MOL MICROBIOL, V39, P850, DOI 10.1046/j.1365-2958.2001.02233.x; Hunter I, 1996, BIOCHEM J, V320, P847, DOI 10.1042/bj3200847; Jouve M, 1997, INFECT IMMUN, V65, P4082, DOI 10.1128/IAI.65.10.4082-4089.1997; Kansau I, 2004, INFECT IMMUN, V72, P3733, DOI 10.1128/IAI.72.7.3733-3742.2004; KODERA Y, 1993, BRIT J CANCER, V68, P130, DOI 10.1038/bjc.1993.300; Krop-Watorek A, 1998, BIOCHEM BIOPH RES CO, V242, P79, DOI 10.1006/bbrc.1997.7920; LEUSCH HG, 1991, INFECT IMMUN, V59, P2051, DOI 10.1128/IAI.59.6.2051-2057.1991; Maniatis T., 1982, MOL CLONING LAB MANU; Markel G, 2004, J IMMUNOL, V173, P3732, DOI 10.4049/jimmunol.173.6.3732; McCaw SE, 2004, INFECT IMMUN, V72, P2742, DOI 10.1128/IAI.72.5.2742-2752.2004; MEDOF ME, 1987, J EXP MED, V165, P848, DOI 10.1084/jem.165.3.848; Metze D, 1996, J INVEST DERMATOL, V106, P64, DOI 10.1111/1523-1747.ep12327258; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; NOWICKI B, 1990, INFECT IMMUN, V58, P279, DOI 10.1128/IAI.58.1.279-281.1990; NOWICKI B, 1988, INFECT IMMUN, V56, P1057, DOI 10.1128/IAI.56.5.1057-1060.1988; Obrink B, 1997, CURR OPIN CELL BIOL, V9, P616, DOI 10.1016/S0955-0674(97)80114-7; Pettigrew D, 2004, J BIOL CHEM, V279, P46851, DOI 10.1074/jbc.M409284200; Plancon L, 2003, CELL MICROBIOL, V5, P681, DOI 10.1046/j.1462-5822.2003.00308.x; Powell RM, 1997, J VIROL, V71, P9306, DOI 10.1128/JVI.71.12.9306-9312.1997; Prall F, 1996, J HISTOCHEM CYTOCHEM, V44, P35, DOI 10.1177/44.1.8543780; SAUTER SL, 1991, INFECT IMMUN, V59, P2485, DOI 10.1128/IAI.59.7.2485-2493.1991; SAUTER SL, 1993, J BIOL CHEM, V268, P15510; Selvarangan R, 2000, INFECT IMMUN, V68, P1391, DOI 10.1128/IAI.68.3.1391-1399.2000; Servin AL, 2005, CLIN MICROBIOL REV, V18, P264, DOI 10.1128/CMR.18.2.264-292.2005; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Taheri M, 2000, J BIOL CHEM, V275, P26935; Tan KM, 2002, EMBO J, V21, P2076, DOI 10.1093/emboj/21.9.2076; Toleman M, 2001, CELL MICROBIOL, V3, P33, DOI 10.1046/j.1462-5822.2001.00089.x; Van Loy CP, 2002, MOL MICROBIOL, V45, P439; Virji M, 2000, MOL MICROBIOL, V36, P784, DOI 10.1046/j.1365-2958.2000.01885.x; Virji M, 1999, MOL MICROBIOL, V34, P538, DOI 10.1046/j.1365-2958.1999.01620.x; Virji M, 1996, MOL MICROBIOL, V22, P929, DOI 10.1046/j.1365-2958.1996.01548.x; Watt SM, 2001, BLOOD, V98, P1469, DOI 10.1182/blood.V98.5.1469; You YH, 1998, ANTICANCER RES, V18, P3193	49	40	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					29120	29130		10.1074/jbc.M605681200	http://dx.doi.org/10.1074/jbc.M605681200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16882658	Green Accepted, hybrid			2022-12-27	WOS:000240680500066
J	Preston, RJS; Ajzner, E; Razzari, C; Karageorgi, S; Dua, S; Dahlback, B; Lane, DA				Preston, Roger J. S.; Ajzner, Eva; Razzari, Cristina; Karageorgi, Stalo; Dua, Sonia; Dahlback, Bjorn; Lane, David A.			Multifunctional specificity of the protein C/activated protein C Gla domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THROMBIN-THROMBOMODULIN COMPLEX; CARBOXYGLUTAMIC ACID DOMAIN; K-DEPENDENT PROTEINS; COFACTOR ACTIVITY; ANTICOAGULANT ACTIVITY; PHOSPHOLIPID-BINDING; ACTIVATED RECEPTOR-1; MEMBRANE-BINDING; SENSITIVE REGION; SITE	Activated protein C (APC) has potent anticoagulant and antiinflammatory properties that are mediated in part by its interactions with its cofactor protein S and the endothelial cell protein C receptor (EPCR). The protein C/APC Gla domain is implicated in both interactions. We sought to identify how the protein C Gla domain enables specific protein-protein interactions in addition to its conserved role in phospholipid binding. The human prothrombin Gla domain, which cannot bind EPCR or support protein S cofactor activity, has 22/45 residues that are not shared with the human protein C Gla domain. We hypothesized that the unique protein C/APC Gla domain residues were responsible for mediating the specific interactions. To assess this, we generated 13 recombinant protein C/APC variants incorporating the prothrombin residue substitutions. Despite anticoagulant activity similar to wild-type APC in the absence of protein S, APC variants APC(PT33 -39) (N33S/V34S/D35T/D36A/L38D/A39V) and APC(PT36/38/39) (D36A/L38D/A39V) were not stimulated by protein S, whereas APC(PT35/36) (D35T/D36A) exhibited reduced protein S sensitivity. Moreover, PC(PT8/10) (L8V/H10K) displayed negligible EPCR affinity, despite normal binding to anionic phospholipid vesicles and factor Va proteolysis in the presence and absence of protein S. A single residue variant, PC(PT8), also failed to bind EPCR. Factor VIIa, which also possesses Leu-8, bound soluble EPCR with similar affinity to wild-type protein C, collectively confirming Leu-8 as the critical residue for EPCR recognition. These results reveal the specific Gla domain residues responsible for mediating protein C/APC molecular recognition with both its cofactor and receptor and further illustrate the multifunctional potential of Gla domains.	Univ London Imperial Coll Sci Technol & Med, Dept Haematol, Div Investigat Sci, London W12 0NN, England; Lund Univ, Univ Hosp, Dept Lab Med, Div Clin Chem, S-20502 Malmo, Sweden; Mangiagalli & Regina Elena Fdn, Inst Ricovero & Cura Carattere Sci Nat Pubbl Magg, Dept Med & Med Specialties, I-20122 Milan, Italy; Univ Milan, I-20122 Milan, Italy	Imperial College London; Lund University; Skane University Hospital; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan	Preston, RJS (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Haematol, Div Investigat Sci, Hammersmith Hosp Campus, London W12 0NN, England.	roger.preston@imperial.ac.uk		Preston, Roger/0000-0003-0108-4077; Dahlback, Bjorn/0000-0003-1546-0328				Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Castellino FJ, 1997, METHOD ENZYMOL, V282, P369; Cheng T, 2003, NAT MED, V9, P338, DOI 10.1038/nm826; CHRISTIANSEN WT, 1994, BIOCHEMISTRY-US, V33, P14993, DOI 10.1021/bi00254a007; CHRISTIANSEN WT, 1995, BIOCHEMISTRY-US, V34, P10376, DOI 10.1021/bi00033a008; Dahlback B, 2003, J THROMB HAEMOST, V1, P1525, DOI 10.1046/j.1538-7836.2003.00299.x; DAHLBACK B, 1990, J BIOL CHEM, V265, P8127; Esmon CT, 1999, HAEMATOLOGICA, V84, P363; ESMON CT, 1993, METHOD ENZYMOL, V222, P359; FAY PJ, 1991, J BIOL CHEM, V266, P20139; FOSTER D, 1984, P NATL ACAD SCI-BIOL, V81, P4766, DOI 10.1073/pnas.81.15.4766; FUKUDOME K, 1995, J BIOL CHEM, V270, P5571, DOI 10.1074/jbc.270.10.5571; FUKUDOME K, 1994, J BIOL CHEM, V269, P26486; Giri TK, 1999, THROMB HAEMOSTASIS, V82, P1627, DOI 10.1055/s-0037-1614890; Giri TK, 1998, THROMB HAEMOSTASIS, V80, P798; Hackeng TM, 2000, BIOCHEM J, V349, P757, DOI 10.1042/bj3490757; He XH, 1998, J BIOL CHEM, V273, P27449, DOI 10.1074/jbc.273.42.27449; He XH, 1999, J BIOL CHEM, V274, P4970, DOI 10.1074/jbc.274.8.4970; HEMKER HC, 1995, THROMB HAEMOSTASIS, V74, P134; Huang MD, 2003, NAT STRUCT BIOL, V10, P751, DOI 10.1038/nsb971; Joyce DE, 2001, J BIOL CHEM, V276, P11199, DOI 10.1074/jbc.C100017200; Knobe KE, 1999, PROTEINS, V35, P218, DOI 10.1002/(SICI)1097-0134(19990501)35:2<218::AID-PROT8>3.0.CO;2-2; McDonald JF, 1997, BIOCHEMISTRY-US, V36, P5120, DOI 10.1021/bi9626160; Mille-Baker B, 2003, BLOOD, V101, P1416, DOI 10.1182/blood-2002-08-2353; Mosnier LO, 2003, BIOCHEM J, V373, P65, DOI 10.1042/BJ20030341; Oganesyan V, 2002, J BIOL CHEM, V277, P24851, DOI 10.1074/jbc.C200163200; Perera L, 2000, BIOPHYS J, V79, P2925, DOI 10.1016/S0006-3495(00)76530-1; Preston RJS, 2005, FEBS J, V272, P97, DOI 10.1111/j.1432-1033.2004.04401.x; Regan LM, 1997, J BIOL CHEM, V272, P26279, DOI 10.1074/jbc.272.42.26279; REITSMA PH, 1995, THROMB HAEMOSTASIS, V73, P876; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; Saller F, 2005, BLOOD, V105, P122, DOI 10.1182/blood-2004-06-2176; SELIGSOHN U, 1984, NEW ENGL J MED, V310, P559, DOI 10.1056/NEJM198403013100904; Sere KM, 2004, BLOOD, V104, P3624, DOI 10.1182/blood-2004-03-1146; Smirnov MD, 1998, J BIOL CHEM, V273, P9031, DOI 10.1074/jbc.273.15.9031; StearnsKurosawa DJ, 1996, P NATL ACAD SCI USA, V93, P10212, DOI 10.1073/pnas.93.19.10212; Stenberg Y, 1998, EUR J BIOCHEM, V251, P558, DOI 10.1046/j.1432-1327.1998.2510558.x; Sun YH, 2003, BLOOD, V101, P2277, DOI 10.1182/blood-2002-06-1691; TAYLOR FB, 1987, J CLIN INVEST, V79, P918, DOI 10.1172/JCI112902; Villoutreix BO, 2001, J COMPUT AID MOL DES, V15, P13, DOI 10.1023/A:1011158717139; WALKER FJ, 1979, BIOCHIM BIOPHYS ACTA, V571, P333, DOI 10.1016/0005-2744(79)90103-7; WALKER FJ, 1984, SEMIN THROMB HEMOST, V10, P131, DOI 10.1055/s-2007-1004415; Yegneswaran S, 1997, J BIOL CHEM, V272, P25013, DOI 10.1074/jbc.272.40.25013	43	97	106	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					28850	28857		10.1074/jbc.M604966200	http://dx.doi.org/10.1074/jbc.M604966200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16867987	hybrid, Green Published			2022-12-27	WOS:000240680500039
J	Majka, J; Binz, SK; Wold, MS; Burgers, PMJ				Majka, Jerzy; Binz, Sara K.; Wold, Marc S.; Burgers, Peter M. J.			Replication protein a directs loading of the DNA damage checkpoint clamp to 5 '-DNA junctions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; CELL NUCLEAR ANTIGEN; FACTOR-C; SACCHAROMYCES-CEREVISIAE; IN-VITRO; TRANSLESION SYNTHESIS; EXCISION-REPAIR; ATP UTILIZATION; BINDING DOMAIN; COMPLEX	The heterotrimeric checkpoint clamp comprises the Saccharomyces cerevisiae Rad17, Mec3, and Ddc1 subunits (Rad17/3/1, the 9-1-1 complex in humans). This DNA damage response factor is loaded onto DNA by the Rad24-RFC (replication factor C-like complex with Rad24) clamp loader and ATP. Although Rad24-RFC alone does not bind to naked partial double-stranded DNA, coating of the single strand with single-stranded DNA-binding protein RPA (replication protein A) causes binding of Rad24-RFC via interactions with RPA. However, RPA-mediated binding is abrogated when the DNA is coated with RPA containing a rpa1-K45E (rfa1-t11) mutation. These properties allowed us to determine the role of RPA in clamp-loading specificity. The Rad17/3/1 clamp is loaded with comparable efficiency onto naked primer/template DNA with either a 3'-junction or a 5'-junction. Remarkably, when the DNA was coated with RPA, loading of Rad17/3/1 at 3'-junctions was completely inhibited, thereby providing specificity to loading at 5'-junctions. However, Rad17/3/1 loaded at 5'-junctions can slide across double-stranded DNA to nearby 3'-junctions and thereby affect the activity of proteins that act at 3'-termini. These studies show a unique specificity of the checkpoint loader for 5'-junctions of RPA-coated DNA. The implications of this specificity for checkpoint function are discussed.	Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; Univ Iowa, Carvel Coll Med, Dept Biochem, Iowa City, IA 52242 USA	Washington University (WUSTL); University of Iowa	Burgers, PMJ (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, 660 S Euclid Ave, St Louis, MO 63110 USA.	burgers@biochem.wustl.edu	Wold, Marc/F-5806-2010; Burgers, Peter M/AAW-6621-2021	Wold, Marc/0000-0002-4580-1624	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044721, R01GM032431] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM44721, GM32431, R01 GM032431] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allen BL, 1998, NUCLEIC ACIDS RES, V26, P3877, DOI 10.1093/nar/26.17.3877; Bae KH, 2003, NUCLEIC ACIDS RES, V31, P3006, DOI 10.1093/nar/gkg422; Bermudez VP, 2003, P NATL ACAD SCI USA, V100, P1633, DOI 10.1073/pnas.0437927100; Bochkarev A, 1997, NATURE, V385, P176, DOI 10.1038/385176a0; Bochkareva E, 2002, EMBO J, V21, P1855, DOI 10.1093/emboj/21.7.1855; BURGERS PMJ, 1993, J BIOL CHEM, V268, P19923; Bylund GO, 2005, MOL CELL BIOL, V25, P5445, DOI 10.1128/MCB.25.13.5445-5455.2005; Clerici M, 2004, MOL CELL BIOL, V24, P10126, DOI 10.1128/MCB.24.23.10126-10144.2004; Ellison V, 2003, PLOS BIOL, V1, P231, DOI 10.1371/journal.pbio.0000033; FORTUNE JM, 2006, IN PRESS NUCL ACIDS; Garg P, 2005, J BIOL CHEM, V280, P23446, DOI 10.1074/jbc.C500173200; Giannattasio M, 2004, EMBO J, V23, P429, DOI 10.1038/sj.emboj.7600051; Gomes XV, 2001, J BIOL CHEM, V276, P34768, DOI 10.1074/jbc.M011631200; Gomes XV, 2000, J BIOL CHEM, V275, P14541, DOI 10.1074/jbc.275.19.14541; Green CM, 2000, CURR BIOL, V10, P39, DOI 10.1016/S0960-9822(99)00263-8; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Kai M, 2003, MUTAT RES-FUND MOL M, V532, P59, DOI 10.1016/j.mrfmmm.2003.08.010; Kai M, 2003, GENE DEV, V17, P64, DOI 10.1101/gad.1043203; Kantake N, 2003, J BIOL CHEM, V278, P23410, DOI 10.1074/jbc.M302995200; Kim HS, 2001, MOL CELL BIOL, V21, P3725, DOI 10.1128/MCB.21.11.3725-3737.2001; Kobayashi M, 2006, J BIOL CHEM, V281, P4308, DOI 10.1074/jbc.M511090200; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Longhese MP, 2003, MUTAT RES-FUND MOL M, V532, P41, DOI 10.1016/j.mrfmmm.2003.08.009; Majka J, 2003, P NATL ACAD SCI USA, V100, P2249, DOI 10.1073/pnas.0437148100; Majka J, 2004, J BIOL CHEM, V279, P20921, DOI 10.1074/jbc.M400898200; Majka J, 2004, PROG NUCLEIC ACID RE, V78, P227, DOI 10.1016/S0079-6603(04)78006-X; Matsumoto Y, 2001, PROG NUCLEIC ACID RE, V68, P129; Paulovich AG, 1998, GENETICS, V150, P75; Pellicioli A, 2001, MOL CELL, V7, P293, DOI 10.1016/S1097-2765(01)00177-0; Rouse J, 2002, MOL CELL, V9, P857, DOI 10.1016/S1097-2765(02)00507-5; Sabbioneda S, 2005, J BIOL CHEM, V280, P38657, DOI 10.1074/jbc.M507638200; Schmidt SLG, 2001, J BIOL CHEM, V276, P34784, DOI 10.1074/jbc.M011633200; Sibenaller ZA, 1998, BIOCHEMISTRY-US, V37, P12496, DOI 10.1021/bi981110+; Soustelle C, 2002, GENETICS, V161, P535; Sun ZX, 1996, GENE DEV, V10, P395, DOI 10.1101/gad.10.4.395; Toueille M, 2004, NUCLEIC ACIDS RES, V32, P3316, DOI 10.1093/nar/gkh652; Umezu K, 1998, GENETICS, V148, P989; Wang WS, 2004, P NATL ACAD SCI USA, V101, P16762, DOI 10.1073/pnas.0407686101; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Yuzhakov A, 1999, EMBO J, V18, P6189, DOI 10.1093/emboj/18.21.6189; Zou L, 2003, P NATL ACAD SCI USA, V100, P13827, DOI 10.1073/pnas.2336100100; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	43	150	152	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					27855	27861		10.1074/jbc.M605176200	http://dx.doi.org/10.1074/jbc.M605176200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16864589	hybrid			2022-12-27	WOS:000240534400021
J	Rofougaran, R; Vodnala, M; Hofer, A				Rofougaran, Reza; Vodnala, Munender; Hofer, Anders			Enzymatically active mammalian ribonucleotide reductase exists primarily as an alpha(6)beta(2) octamer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALLOSTERIC REGULATION; DIPHOSPHATE REDUCTASE; SUBUNIT INTERACTION; CALF THYMUS; DNA-DAMAGE; PROTEIN R1; ELECTROPHORETIC MOBILITY; COMPREHENSIVE MODEL; RECOMBINANT MOUSE; PURIFICATION	Ribonucleotide reductase synthesizes deoxyribonucleotides, which are essential building blocks for DNA synthesis. The mammalian ribonucleotide reductase is described as an alpha(2)beta(2) complex consisting of R1 (alpha) and R2 (beta) proteins. ATP stimulates and dATP inhibits enzyme activity by binding to an allosteric site called the activity site on the R1 protein. Despite the opposite effects by ATP and dATP on enzyme activity, both nucleotides induce formation of R1 oligomers. By using a new technique termed Gas-phase Electrophoretic-Mobility Macromolecule Analysis (GEMMA), we have found that the ATP/dATP-induced R1 oligomers have a defined size (hexamers) and can interact with the R2 dimer to form an enzymatically active protein complex (alpha(6)beta(2)). The newly discovered alpha(6)beta(2) complex can either be in an active or an inhibited state depending on whether ATP or dATP is bound. Our results suggest that this protein complex is the major form of ribonucleotide reductase at physiological levels of R1-R2 protein and nucleotides.	Umea Univ, Dept Med Biochem & Biophys, SE-90187 Umea, Sweden	Umea University	Hofer, A (corresponding author), Umea Univ, Dept Med Biochem & Biophys, SE-90187 Umea, Sweden.	anders.hofer@medchem.umu.se		Hofer, Anders/0000-0003-2890-2957; Vodnala, Munender/0000-0002-6219-6243				Bacher G, 2001, J MASS SPECTROM, V36, P1038, DOI 10.1002/jms.208; Birgander PL, 2005, J BIOL CHEM, V280, P14997, DOI 10.1074/jbc.M500565200; BROWN NC, 1969, J MOL BIOL, V46, P25, DOI 10.1016/0022-2836(69)90055-2; Chabes A, 2000, J BIOL CHEM, V275, P17747, DOI 10.1074/jbc.M000799200; Chabes A, 2003, CELL, V112, P391, DOI 10.1016/S0092-8674(03)00075-8; DAVIS R, 1994, J BIOL CHEM, V269, P23171; ENGSTROM Y, 1979, BIOCHEMISTRY-US, V18, P2941, DOI 10.1021/bi00581a004; Eriksson M, 1997, STRUCTURE, V5, P1077, DOI 10.1016/S0969-2126(97)00259-1; ERIKSSON S, 1979, BIOCHEMISTRY-US, V18, P2948, DOI 10.1021/bi00581a005; ERIKSSON S, 1981, J BIOL CHEM, V256, P193; Hakansson P, 2006, J BIOL CHEM, V281, P7834, DOI 10.1074/jbc.M512894200; Hofer A, 1998, J BIOL CHEM, V273, P34098, DOI 10.1074/jbc.273.51.34098; Ingemarson R, 1996, BIOCHEMISTRY-US, V35, P8603, DOI 10.1021/bi960184n; Kashlan OB, 2003, BIOCHEMISTRY-US, V42, P1696, DOI 10.1021/bi020634d; Kashlan OB, 2002, BIOCHEMISTRY-US, V41, P462, DOI 10.1021/bi011653a; Kaufman SL, 1996, ANAL CHEM, V68, P1895, DOI 10.1021/ac951128f; Kaufman SL, 2000, ANAL CHIM ACTA, V406, P3, DOI 10.1016/S0003-2670(99)00597-8; LYCKSELL PO, 1994, BIOCHEMISTRY-US, V33, P2838, DOI 10.1021/bi00176a013; MANN GJ, 1991, BIOCHEMISTRY-US, V30, P1939, DOI 10.1021/bi00221a030; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Reichard P, 2000, J BIOL CHEM, V275, P33021, DOI 10.1074/jbc.M005337200; Sobott F, 2002, CURR OPIN STRUC BIOL, V12, P729, DOI 10.1016/S0959-440X(02)00400-1; THELANDER L, 1980, J BIOL CHEM, V255, P7426; THELANDER L, 1973, J BIOL CHEM, V248, P4591; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361	25	79	81	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					27705	27711		10.1074/jbc.M605573200	http://dx.doi.org/10.1074/jbc.M605573200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16861739	hybrid			2022-12-27	WOS:000240534400006
J	Rosengren, KJ; Zhang, S; Lin, F; Daly, NL; Scott, DJ; Hughes, RA; Bathgate, RAD; Craik, DJ; Wade, JD				Rosengren, K. Johan; Zhang, Suode; Lin, Feng; Daly, Norelle L.; Scott, Daniel J.; Hughes, Richard A.; Bathgate, Ross A. D.; Craik, David J.; Wade, John D.			Solution structure and characterization of the LGR8 receptor binding surface of insulin-like peptide 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RELAXIN-LIKE FACTOR; IN-VITRO; INSL3; FIELD; ACTIVATION; PROTEIN; CHAIN	Insulin-like peptide 3 (INSL3), a member of the relaxin peptide family, is produced in testicular Leydig cells and ovarian thecal cells. Gene knock-out experiments have identified a key biological role in initiating testes descent during fetal development. Additionally, INSL3 has an important function in mediating male and female germ cell function. These actions are elicited via its recently identified receptor, LGR8, a member of the leucine-rich repeat-containing G-protein- coupled receptor family. To identify the structural features that are responsible for the interaction of INSL3 with its receptor, its solution structure was determined by NMR spectroscopy together with in vitro assays of a series of B-chain alanine-substituted analogs. Synthetic human INSL3 was found to adopt a characteristic relaxin/ insulin-like fold in solution but is a highly dynamic molecule. The four termini of this two-chain peptide are disordered, and additional conformational exchange is evident in the molecular core. Alanine-substituted analogs were used to identify the key residues of INSL3 that are responsible for the interaction with the ectodomain of LGR8. These include Arg(B16) and Val(B19), with His(B12) and Arg(B20) playing a secondary role, as evident from the synergistic effect on the activity in double and triple mutants involving these residues. Together, these amino acids combine with the previously identified critical residue, Trp(B27), to form the receptor binding surface. The current results provide clear direction for the design of novel specific agonists and antagonists of this receptor.	Univ Melbourne, Howard Florey Inst Expt Physiol & Med, Parkville, Vic 3010, Australia; Univ Melbourne, Dept Pharmacol, Parkville, Vic 3010, Australia; Univ Kalmar, Dept Chem & Biomed Sci, SE-39281 Kalmar, Sweden; Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; Linnaeus University; University of Kalmar; University of Queensland	Wade, JD (corresponding author), Univ Melbourne, Howard Florey Inst Expt Physiol & Med, Parkville, Vic 3010, Australia.	j.wade@hfi.unimelb.edu.au	Bathgate, Ross/ABE-6471-2020; Rosengren, K. Johan/P-4450-2016; Craik, David/B-1695-2010; Daly, Norelle L/D-4302-2013; Scott, Daniel J/B-9880-2017	Bathgate, Ross/0000-0001-6301-861X; Rosengren, K. Johan/0000-0002-5007-8434; Craik, David/0000-0003-0007-6796; Daly, Norelle L/0000-0002-4697-6602; Scott, Daniel J/0000-0001-6332-2793; Wade, John/0000-0002-1352-6568				Adham IM, 2002, MOL ENDOCRINOL, V16, P244, DOI 10.1210/me.16.2.244; ALTIERI AS, 1995, J AM CHEM SOC, V117, P7566, DOI 10.1021/ja00133a039; Bathgate RAD, 2006, BIOCHEMISTRY-US, V45, P1043, DOI 10.1021/bi052233e; BATHGATE RAD, 2005, PHARMACOL REV, V58, P7; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bullesbach EE, 2005, J BIOL CHEM, V280, P14051, DOI 10.1074/jbc.M500030200; Bullesbach EE, 2005, J BIOL CHEM, V280, P14586, DOI 10.1074/jbc.M414443200; Bullesbach EE, 2004, BIOCHEMISTRY-US, V43, P8021, DOI 10.1021/bi049601j; Bullesbach EE, 1999, BIOCHEMISTRY-US, V38, P3073, DOI 10.1021/bi982687u; BULLESBACH EE, 1995, J BIOL CHEM, V270, P16011, DOI 10.1074/jbc.270.27.16011; BURKHARDT E, 1994, GENOMICS, V20, P13, DOI 10.1006/geno.1994.1121; CHEN WB, 1995, ANAL BIOCHEM, V226, P349, DOI 10.1006/abio.1995.1235; Del Borgo MP, 2006, J BIOL CHEM, V281, P13068, DOI 10.1074/jbc.M600472200; EIGENBROT C, 1991, J MOL BIOL, V221, P15, DOI 10.1016/0022-2836(91)90796-9; FU P, 2004, J PEPT RES, V63, P1; Ivell R, 2003, MOL HUM REPROD, V9, P175, DOI 10.1093/molehr/gag025; Kawamura K, 2004, P NATL ACAD SCI USA, V101, P7323, DOI 10.1073/pnas.0307061101; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kumagai J, 2002, J BIOL CHEM, V277, P31283, DOI 10.1074/jbc.C200398200; Linge JP, 1999, J BIOMOL NMR, V13, P51, DOI 10.1023/A:1008365802830; Muda M, 2005, MOL HUM REPROD, V11, P591, DOI 10.1093/molehr/gah205; Nef S, 2000, GENE DEV, V14, P3075, DOI 10.1101/gad.843800; Nef S, 1999, NAT GENET, V22, P295, DOI 10.1038/10364; Olsen HB, 1998, J MOL BIOL, V284, P477, DOI 10.1006/jmbi.1998.2175; Rosengren KJ, 2006, J BIOL CHEM, V281, P5845, DOI 10.1074/jbc.M511210200; Smith KJ, 2001, J PEPT SCI, V7, P495, DOI 10.1002/psc.344; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; Zimmermann S, 1999, MOL ENDOCRINOL, V13, P681, DOI 10.1210/me.13.5.681	28	61	66	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					28287	28295		10.1074/jbc.M603829200	http://dx.doi.org/10.1074/jbc.M603829200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16867980	hybrid			2022-12-27	WOS:000240534400066
J	Khanna, H; Akimoto, M; Siffroi-Fernandez, S; Friedman, JS; Hicks, D; Swaroop, A				Khanna, Hemant; Akimoto, Masayuki; Siffroi-Fernandez, Sandrine; Friedman, James S.; Hicks, David; Swaroop, Anand			Retinoic acid regulates the expression of photoreceptor transcription factor NRL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN RETINOBLASTOMA CELLS; THYROID-HORMONE RECEPTOR; DEVELOPING MOUSE RETINA; GENE-EXPRESSION; ROD PHOTORECEPTORS; LEUCINE-ZIPPER; CONE PHOTORECEPTORS; PROMOTER ACTIVITY; RHODOPSIN GENE; HOMEOBOX GENE	NRL (neural retina leucine zipper) is a key basic motif-leucine zipper (bZIP) transcription factor, which orchestrates rod photoreceptor differentiation by activating the expression of rod-specific genes. The deletion of Nrl in mice results in functional cones that are derived from rod precursors. However, signaling pathways modulating the expression or activity of NRL have not been elucidated. Here, we show that retinoic acid ( RA), a diffusible factor implicated in rod development, activates the expression of NRL in serum-deprived Y79 human retinoblastoma cells and in primary cultures of rat and porcine photoreceptors. The effect of RA is mimicked by TTNPB, a RA receptor agonist, and requires new protein synthesis. DNaseI footprinting and electrophoretic mobility shift assays ( EMSA) using bovine retinal nuclear extract demonstrate that RA response elements (RAREs) identified within the Nrl promoter bind to RA receptors. Furthermore, in transiently transfected Y79 and HEK293 cells the activity of Nrl-promoter driving a luciferase reporter gene is induced by RA, and this activation is mediated by RAREs. Our data suggest that signaling by RA via RA receptors regulates the expression of NRL, providing a framework for delineating early steps in photoreceptor cell fate determination.	Univ Michigan, WK Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48105 USA; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48105 USA; Kyoto Univ Hosp, Translat Res Ctr, Sakyo Ku, Kyoto 6068507, Japan; CNRS, UMR 7518, Lab Neurobiol Rhythms, Ctr Neurochim, F-67084 Strasbourg, France	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Kyoto University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Swaroop, A (corresponding author), Univ Michigan, WK Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, 1000 Wall St, Ann Arbor, MI 48105 USA.	swaroop@umich.edu	Akimoto, Masayuki/AAP-3676-2020	Swaroop, Anand/0000-0002-1975-1141; Akimoto, Masayuki/0000-0002-5899-2925	NATIONAL EYE INSTITUTE [R01EY011115] Funding Source: NIH RePORTER; NEI NIH HHS [F31 EY007003, P30 EY007003, EY011115, R01 EY011115, R01 EY011115-10, EY007003] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Akhmedov NB, 2000, P NATL ACAD SCI USA, V97, P5551, DOI 10.1073/pnas.97.10.5551; Akimoto M, 2006, P NATL ACAD SCI USA, V103, P3890, DOI 10.1073/pnas.0508214103; ALTSHULER D, 1993, DEVELOPMENT, V119, P1317; Bessant DAR, 1999, NAT GENET, V21, P355, DOI 10.1038/7678; Boatright JH, 2002, VISION RES, V42, P933, DOI 10.1016/S0042-6989(02)00037-8; Brivanlou AH, 2002, SCIENCE, V295, P813, DOI 10.1126/science.1066355; Cayouette M, 2003, NEURON, V40, P897, DOI 10.1016/S0896-6273(03)00756-6; Chau KY, 2000, J BIOL CHEM, V275, P37264, DOI 10.1074/jbc.M002763200; Chen JC, 2005, J NEUROSCI, V25, P118, DOI 10.1523/JNEUROSCI.3571-04.2005; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; Chen Y, 2003, MOL VIS, V9, P345; Cheng H, 2004, HUM MOL GENET, V13, P1563, DOI 10.1093/hmg/ddh173; Coolen M, 2005, DEV GENES EVOL, V215, P327, DOI 10.1007/s00427-005-0476-y; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; DELEEUW AM, 1990, J NEUROCYTOL, V19, P253, DOI 10.1007/BF01217303; DIPOLO A, 1995, P NATL ACAD SCI USA, V92, P4016, DOI 10.1073/pnas.92.9.4016; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Forrest D, 2002, CURR OPIN NEUROBIOL, V12, P49, DOI 10.1016/S0959-4388(02)00289-1; Furukawa T, 1999, NAT GENET, V23, P466, DOI 10.1038/70591; Grondona JM, 1996, DEVELOPMENT, V122, P2173; Haider NB, 2000, NAT GENET, V24, P127, DOI 10.1038/72777; Haider NB, 2001, HUM MOL GENET, V10, P1619, DOI 10.1093/hmg/10.16.1619; Harris VK, 2001, ONCOGENE, V20, P1730, DOI 10.1038/sj.onc.1204249; HICKS D, 1992, J NEUROSCI, V12, P2022; Hyatt GA, 1996, P NATL ACAD SCI USA, V93, P13298, DOI 10.1073/pnas.93.23.13298; Janssen JJM, 1999, CURR EYE RES, V19, P338, DOI 10.1076/ceyr.19.4.338.5307; KALTER H, 1959, PHYSIOL REV, V39, P69, DOI 10.1152/physrev.1959.39.1.69; Kastner P, 1997, DEVELOPMENT, V124, P313; KELLEY MW, 1994, DEVELOPMENT, V120, P2091; KIM T, 1996, SCIENCE, V273, P1719; Kumar R, 1996, J BIOL CHEM, V271, P29612, DOI 10.1074/jbc.271.47.29612; Lahiri DK, 2000, BRAIN RES PROTOC, V5, P257, DOI 10.1016/S1385-299X(00)00021-0; Lerner LE, 2002, J BIOL CHEM, V277, P25877, DOI 10.1074/jbc.M201407200; Lerner LE, 2001, J BIOL CHEM, V276, P34999, DOI 10.1074/jbc.M103301200; Levine EM, 2000, CELL MOL LIFE SCI, V57, P224, DOI 10.1007/PL00000686; Li AM, 2003, INVEST OPHTH VIS SCI, V44, P996, DOI 10.1167/iovs.02-0434; Li AM, 2002, INVEST OPHTH VIS SCI, V43, P1375; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Mitton KP, 2000, J BIOL CHEM, V275, P29794, DOI 10.1074/jbc.M003658200; Mitton KP, 2003, HUM MOL GENET, V12, P365, DOI 10.1093/hmg/ddg035; Mori M, 2001, INVEST OPHTH VIS SCI, V42, P1312; Ng L, 2001, NAT GENET, V27, P94, DOI 10.1038/83829; Nishida A, 2003, NAT NEUROSCI, V6, P1255, DOI 10.1038/nn1155; Nishiguchi KM, 2004, P NATL ACAD SCI USA, V101, P17819, DOI 10.1073/pnas.0408183101; Peng GH, 2005, HUM MOL GENET, V14, P747, DOI 10.1093/hmg/ddi070; Pittler SJ, 2004, J BIOL CHEM, V279, P19800, DOI 10.1074/jbc.M401864200; Rattner A, 1999, ANNU REV GENET, V33, P89, DOI 10.1146/annurev.genet.33.1.89; Rehemtulla A, 1996, P NATL ACAD SCI USA, V93, P191, DOI 10.1073/pnas.93.1.191; Roberts MR, 2006, P NATL ACAD SCI USA, V103, P6218, DOI 10.1073/pnas.0509981103; Roberts MR, 2005, INVEST OPHTH VIS SCI, V46, P2897, DOI 10.1167/iovs.05-0093; SANDALTZOPOULOS R, 1994, NUCLEIC ACIDS RES, V22, P1511, DOI 10.1093/nar/22.8.1511; Swain PK, 2001, J BIOL CHEM, V276, P36824, DOI 10.1074/jbc.M105855200; Swain PK, 1997, NEURON, V19, P1329, DOI 10.1016/S0896-6273(00)80423-7; SWAROOP A, 1992, P NATL ACAD SCI USA, V89, P266, DOI 10.1073/pnas.89.1.266; Swaroop A, 1999, HUM MOL GENET, V8, P299, DOI 10.1093/hmg/8.2.299; Tan E, 2001, INVEST OPHTH VIS SCI, V42, P589; Traverso V, 2003, INVEST OPHTH VIS SCI, V44, P4550, DOI 10.1167/iovs.03-0460; Vazquez D., 1979, MOL BIOL BIOCH BIOPH, Vi-x, P1, DOI [10.1007/978-3-642-81309-2, DOI 10.1007/978-3-642-81309-2]; Whitaker SL, 2004, J BIOL CHEM, V279, P49010, DOI 10.1074/jbc.M406080200; Williams DS, 2002, VISION RES, V42, P455, DOI 10.1016/S0042-6989(01)00228-0; Young TL, 2004, NEURON, V41, P867, DOI 10.1016/S0896-6273(04)00141-2; Zhang JK, 2004, NAT GENET, V36, P351, DOI 10.1038/ng1318	63	49	52	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2006	281	37					27327	27334		10.1074/jbc.M605500200	http://dx.doi.org/10.1074/jbc.M605500200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082PB	16854989	Green Accepted, hybrid			2022-12-27	WOS:000240397700059
J	Risinger, GM; Hunt, TS; Updike, DL; Bullen, EC; Howard, EW				Risinger, George M., Jr.; Hunt, Tamara S.; Updike, Dawn L.; Bullen, Elizabeth C.; Howard, Eric W.			Matrix metalloproteinase-2 expression by vascular smooth muscle cells is mediated by both stimulatory and inhibitory signals in response to growth factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; FACTOR-I; GENE-EXPRESSION; FACTOR RECEPTOR; FACTOR-BB; IGF-I; PHOSPHATIDYLINOSITOL 3-KINASE; TYROSINE PHOSPHORYLATION; TARGETED OVEREXPRESSION; ENDOTHELIAL-CELLS	In response to growth factors, vascular smooth muscle cells (VSMCs) undergo a phenotypic modulation from a contractile, non-proliferative state to an activated, migratory state. This transition is characterized by changes in their gene expression profile, particularly by a significant down-regulation of contractile proteins. Platelet-derived growth factor (PDGF)-BB has long been known to initiate VSMC de-differentiation and mitogenesis. Insulin-like growth factor (IGF)-I, on the other hand, has differing effects depending on the model studied. Here, we report that both IGF-I and PDGF-BB stimulated VSMC de-differentiation of rat heart-derived SMCs in culture, although only PDGF-BB was capable of inducing proliferation. Although both PDGF-BB and IGF-I stimulation resulted in decreased smooth muscle alpha-actin expression and increased matrix metalloproteinase (MMP)-2 expression, the response to IGF-I was significantly more rapid. The increased MMP-2 expression in response to both growth factors was due to increased transcription rates and was dependent on the action of phosphatidylinositol 3-kinase (PI3K) and its downstream effector, Akt. Both PDGF-BB and IGF-I activated PI3K/ Akt to similar degrees; however, only PDGF-BB concomitantly stimulated an inhibitory signaling pathway that antagonized the effects of Akt but did not alter the extent or duration of Akt activation. Together, these findings suggest that changes in MMP-2 expression are part of the program of VSMC phenotypic modulation and that both PDGF-BB and IGF-I, despite their different abilities to induce proliferation in this model, are capable of inducing VSMC activation.	Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Howard, EW (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, BMSB 566,940 Stanton L Young Blvd, Oklahoma City, OK 73104 USA.	eric-howard@ouhsc.edu			NHLBI NIH HHS [HL-62268] Funding Source: Medline; NIGMS NIH HHS [GM-63638] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063638] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARNQVIST HJ, 1995, METABOLISM, V44, P58, DOI 10.1016/0026-0495(95)90222-8; Auge N, 2004, CIRCULATION, V110, P571, DOI 10.1161/01.CIR.0000136995.83451.1D; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; BANSKOTA NK, 1989, MOL ENDOCRINOL, V3, P1183, DOI 10.1210/mend-3-8-1183; Bayes-Genis A, 2000, CIRC RES, V86, P125, DOI 10.1161/01.RES.86.2.125; Bendeck MP, 1996, CIRC RES, V78, P38, DOI 10.1161/01.RES.78.1.38; BENDECK MP, 1994, CIRC RES, V75, P539, DOI 10.1161/01.RES.75.3.539; Berk BC, 2001, PHYSIOL REV, V81, P999, DOI 10.1152/physrev.2001.81.3.999; BORNFELDT KE, 1994, J CLIN INVEST, V93, P1266, DOI 10.1172/JCI117081; Bottles KD, 1999, BBA-GEN SUBJECTS, V1428, P147, DOI 10.1016/S0304-4165(99)00059-8; Brodt P, 2001, J BIOL CHEM, V276, P33608, DOI 10.1074/jbc.M102754200; Cheng L, 1998, CIRCULATION, V98, P2195, DOI 10.1161/01.CIR.98.20.2195; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Dandre F, 2004, AM J PHYSIOL-HEART C, V286, pH2042, DOI 10.1152/ajpheart.00625.2003; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Goodall S, 2002, EUR J VASC ENDOVASC, V24, P72, DOI 10.1053/ejvs.2002.1675; Hayashi K, 2004, J BIOL CHEM, V279, P40807, DOI 10.1074/jbc.M405100200; Hayashi K, 1998, J BIOL CHEM, V273, P28860, DOI 10.1074/jbc.273.44.28860; Hayashi K, 1999, J CELL BIOL, V145, P727, DOI 10.1083/jcb.145.4.727; HultgardhNilsson A, 1997, CARDIOVASC RES, V34, P418, DOI 10.1016/S0008-6363(97)00030-8; Imai Y, 1999, ENDOCRINOLOGY, V140, P4228, DOI 10.1210/en.140.9.4228; Jenkins GM, 1998, CIRCULATION, V97, P82, DOI 10.1161/01.CIR.97.1.82; Johnson C, 2004, ARTERIOSCL THROM VAS, V24, P54, DOI 10.1161/01.ATV.0000100402.69997.C3; Johnson S, 1999, AM J PHYSIOL-LUNG C, V277, pL1109, DOI 10.1152/ajplung.1999.277.6.L1109; Kaplan-Albuquerque N, 2003, J BIOL CHEM, V278, P39830, DOI 10.1074/jbc.M305991200; Kenagy RD, 1997, CIRCULATION, V96, P3555; KHORSANDI MJ, 1992, J CLIN INVEST, V90, P1926, DOI 10.1172/JCI116070; Koul D, 2001, ONCOGENE, V20, P6669, DOI 10.1038/sj.onc.1204799; Kuemmerle JF, 2003, AM J PHYSIOL-GASTR L, V284, pG411, DOI 10.1152/ajpgi.00310.2002; Kumar MS, 2003, ARTERIOSCL THROM VAS, V23, P737, DOI 10.1161/01.ATV.0000065197.07635.BA; Kuzuya M, 2003, CIRCULATION, V108, P1375, DOI 10.1161/01.CIR.0000086463.15540.3C; LEMIRE JM, 1994, AM J PATHOL, V144, P1068; Li Hongyan, 2002, Journal of Cardiovascular Pharmacology and Therapeutics, V7, P227, DOI 10.1177/107424840200700405; Liao JH, 2003, J BIOL CHEM, V278, P31871, DOI 10.1074/jbc.M301931200; Longo GM, 2002, J CLIN INVEST, V110, P625, DOI 10.1172/JCI200215334; MA X, 1998, AM J PHYSIOL, V274, P1206; Martinez A, 2004, BIOCHEM J, V383, P413, DOI 10.1042/BJ20040920; Newby AC, 2005, PHYSIOL REV, V85, P1, DOI 10.1152/physrev.00048.2003; Newby AC, 1999, CARDIOVASC RES, V41, P345, DOI 10.1016/S0008-6363(98)00286-7; Newby AC, 1996, CURR OPIN CARDIOL, V11, P574, DOI 10.1097/00001573-199611000-00004; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; OWENS GK, 1995, PHYSIOL REV, V75, P487; Park BK, 2001, CANCER RES, V61, P7647; PAULY RR, 1994, CIRC RES, V75, P41, DOI 10.1161/01.RES.75.1.41; PHELPS ED, 2005, AM J PHYSIOL, V290, pC352; Rao RS, 1997, CARDIOVASC RES, V36, P118, DOI 10.1016/S0008-6363(97)00156-9; Reusch HP, 2001, J BIOL CHEM, V276, P33630, DOI 10.1074/jbc.M105322200; Saga H, 1999, EXP CELL RES, V247, P279, DOI 10.1006/excr.1998.4339; SASAOKA T, 1994, J BIOL CHEM, V269, P13689; Shah PK, 2001, CIRCULATION, V104, P1878, DOI 10.1161/circ.104.16.1878; Sorby M, 1996, J BIOL CHEM, V271, P10963; Tack I, 2002, DIABETES, V51, P182, DOI 10.2337/diabetes.51.1.182; Thyberg J, 1998, HISTOL HISTOPATHOL, V13, P871, DOI 10.14670/HH-13.871; Thyberg J, 1996, INT REV CYTOL, V169, P183, DOI 10.1016/S0074-7696(08)61987-7; Uzui H, 2000, ATHEROSCLEROSIS, V149, P51, DOI 10.1016/S0021-9150(99)00295-6; Vinals F, 1999, MOL CELL BIOL, V19, P2763; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Wen JK, 2002, LIFE SCI, V70, P799, DOI 10.1016/S0024-3205(01)01446-1; Zempo N, 1996, ARTERIOSCL THROM VAS, V16, P28, DOI 10.1161/01.ATV.16.1.28; Zhang DL, 2004, J BIOL CHEM, V279, P19683, DOI 10.1074/jbc.M313145200; Zhao GS, 2001, ENDOCRINOLOGY, V142, P623, DOI 10.1210/en.142.2.623; Zhu BH, 2001, ENDOCRINOLOGY, V142, P3598, DOI 10.1210/en.142.8.3598	62	54	57	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2006	281	36					25915	25925		10.1074/jbc.M513513200	http://dx.doi.org/10.1074/jbc.M513513200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	080LO	16854986	hybrid			2022-12-27	WOS:000240249500006
J	Hou, ZJ; Ye, J; Haska, CL; Matherly, LH				Hou, Zhanjun; Ye, Jun; Haska, Christina L.; Matherly, Larry H.			Transmembrane domains 4, 5, 7, 8, and 10 of the human reduced folate carrier are important structural or functional components of the transmembrane channel for folate substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-SCANNING MUTAGENESIS; FOLIC-ACID; METHOTREXATE RESISTANCE; CELLULAR PHARMACOLOGY; MEMBRANE-TRANSPORT; LACTOSE PERMEASE; BINDING DOMAIN; MECHANISM; PROTEIN; GENE	The human reduced folate carrier (hRFC) facilitates membrane transport of folates and antifolates. hRFC is characterized by 12 transmembrane domains (TMDs). To identify residues or domains involved in folate binding, we used substituted cysteine (Cys) accessibility methods (SCAM) with sodium (2-sulfonatoethyl) methanethiosulfonate (MTSES). We previously showed that residues in TMD11 of hRFC were involved in substrate binding, whereas those in TMD12 were not (Hou, Z., Stapels, S. E., Haska, C. L., and Matherly, L. H. (2005) J. Biol. Chem. 280, 36206-36213). In this study, 232 Cys-substituted mutants spanning TMDs 1 - 10 and conserved stretches within the TMD6-7 (residues 204-217) and TMD10-11 connecting loop domains were transiently expressed in hRFC-null HeLa cells. All Cys-substituted mutants showed moderate to high levels of expression on Western blots, and only nine mutants including R133C, I134C, A135C, Y136C, S138C, G163C, Y281C, R373C, and S313C were inactive for methotrexate transport. MTSES did not inhibit transport by any of the mutants in TMDs 1, 3, 6, and 9 or for positions 204-217. Whereas most of the mutants in TMDs 2, 4, 5, 7, 8, and 10, and in the TMD10-11 connecting loop were insensitive to MTSES, this reagent inhibited methotrexate transport (25-75%) by 26 mutants in these TMDs. For 13 of these (Y126C, S137C, V160C, S168C, W274C, S278C, V284C, V288C, A311C, T314C, Y376C, Q377C, and V380C), inhibition was prevented by leucovorin, another hRFC substrate. Combined with our previous findings, these results implicate amino acids in TMDs 4, 5, 7, 8, 10, and 11, but not in TMDs 1, 2, 3, 6, 9, or 12, as important structural or functional components of the putative hydrophilic cavity for binding of anionic folate substrates.	Wayne State Univ, Dev Therapeut Program, Karmanos Canc Inst, Sch Med, Detroit, MI 48201 USA; Wayne State Univ, Canc Biol Program, Sch Med, Detroit, MI 48201 USA; Wayne State Univ, Dept Pharmacol, Sch Med, Detroit, MI 48201 USA; Wayne State Univ, Dept Biochem & Mol Biol, Sch Med, Detroit, MI 48201 USA	Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; Wayne State University; Wayne State University	Matherly, LH (corresponding author), Wayne State Univ, Dev Therapeut Program, Karmanos Canc Inst, Sch Med, 110 E Warren Ave, Detroit, MI 48201 USA.	matherly@kci.wayne.edu	Ye, Jun/J-8823-2012; /S-1117-2019		NCI NIH HHS [CA53535] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Abramson J, 2004, CURR OPIN STRUC BIOL, V14, P413, DOI 10.1016/j.sbi.2004.07.005; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Bailey LB, 2003, J NUTR, V133, p1961S, DOI 10.1093/jn/133.6.1961S; BRIGLE KE, 1995, J BIOL CHEM, V270, P22974, DOI 10.1074/jbc.270.39.22974; Cao W, 2004, BIOCHEM J, V378, P201, DOI 10.1042/BJ20031288; Cao W, 2003, BIOCHEM J, V374, P27, DOI 10.1042/BJ20030301; DeLano W.L, PYMOL MOL GRAPHICS S; Flintoff WF, 2003, J BIOL CHEM, V278, P40867, DOI 10.1074/jbc.M302102200; Frillingos S, 1998, FASEB J, V12, P1281, DOI 10.1096/fasebj.12.13.1281; FRY DW, 1982, J BIOL CHEM, V257, P1890; Ge Yubin, 2006, Proceedings of the American Association for Cancer Research Annual Meeting, V47, P1015; Gifford AJ, 2002, LEUKEMIA, V16, P2379, DOI 10.1038/sj.leu.2402655; GOLDMAN ID, 1985, PHARMACOL THERAPEUT, V28, P77, DOI 10.1016/0163-7258(85)90083-X; Goldman ID, 2002, SEMIN ONCOL, V29, P3, DOI 10.1053/sonc.2002.37461; Guo W, 1999, CLIN CANCER RES, V5, P621; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; Hou ZJ, 2005, J BIOL CHEM, V280, P36206, DOI 10.1074/jbc.M507295200; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Jansen G, 1998, J BIOL CHEM, V273, P30189, DOI 10.1074/jbc.273.46.30189; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Liu XY, 2003, BIOCHEM J, V369, P31, DOI 10.1042/BJ20020419; Liu XY, 2001, BIOCHEM J, V358, P511, DOI 10.1042/0264-6021:3580511; Liu XY, 2002, BBA-BIOMEMBRANES, V1564, P333, DOI 10.1016/S0005-2736(02)00467-4; Loo TW, 1999, BBA-BIOMEMBRANES, V1461, P315, DOI 10.1016/S0005-2736(99)00165-0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lucock M, 2000, MOL GENET METAB, V71, P121, DOI 10.1006/mgme.2000.3027; Marchant JS, 2002, J BIOL CHEM, V277, P33325, DOI 10.1074/jbc.M205955200; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Matherly LH, 2003, VITAM HORM, V66, P403, DOI 10.1016/S0083-6729(03)01012-4; ROST B, 1994, PROTEINS, V19, P55, DOI 10.1002/prot.340190108; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Rothem L, 2002, BIOCHEM J, V367, P741, DOI 10.1042/BJ20020801; Sadlish H, 2002, J BIOL CHEM, V277, P42105, DOI 10.1074/jbc.M206459200; Saier M H Jr, 1999, J Mol Microbiol Biotechnol, V1, P257; Sharina IG, 2001, MOL PHARMACOL, V59, P1022, DOI 10.1124/mol.59.5.1022; Stokstad ELR, 1990, FOLIC ACID METABOLIS, P1; Tse A, 1998, J BIOL CHEM, V273, P25953, DOI 10.1074/jbc.273.40.25953; Vardy E, 2004, PROTEIN SCI, V13, P1832, DOI 10.1110/ps.04657704; Whetstine JR, 2002, BIOCHEM J, V367, P629, DOI 10.1042/BJ20020512; Wilson GG, 1998, NEURON, V20, P1269, DOI 10.1016/S0896-6273(00)80506-1; Witt TL, 2002, BBA-BIOMEMBRANES, V1567, P56, DOI 10.1016/S0005-2736(02)00583-7; Wong SC, 1999, J BIOL CHEM, V274, P10388, DOI 10.1074/jbc.274.15.10388; Xu M, 1996, J GEN PHYSIOL, V107, P195, DOI 10.1085/jgp.107.2.195; Zhao R, 2000, CLIN CANCER RES, V6, P3304; Zhao R, 1998, J BIOL CHEM, V273, P19065, DOI 10.1074/jbc.273.30.19065; Zhao RB, 1999, BIOCHEM PHARMACOL, V58, P1615, DOI 10.1016/S0006-2952(99)00257-9; Zhao RB, 2004, CLIN CANCER RES, V10, P8735, DOI 10.1158/1078-0432.CCR-04-0932; Zhao RB, 1998, J BIOL CHEM, V273, P7873, DOI 10.1074/jbc.273.14.7873; Zhao RB, 1999, MOL PHARMACOL, V56, P68, DOI 10.1124/mol.56.1.68	50	25	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33588	33596		10.1074/jbc.M607049200	http://dx.doi.org/10.1074/jbc.M607049200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16923800	hybrid			2022-12-27	WOS:000241621400068
J	Ito, K; Nakajima, Y; Onohara, Y; Takeo, M; Nakashima, K; Matsubara, F; Ito, T; Yoshimoto, T				Ito, Kiyoshi; Nakajima, Yoshitaka; Onohara, Yuko; Takeo, Masahide; Nakashima, Kanako; Matsubara, Futoshi; Ito, Takashi; Yoshimoto, Tadashi			Crystal structure of aminopeptidase N (proteobacteria alanyl aminopeptidase) from Escherichia coli and conformational change of methionine 260 involved in substrate recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIPEPTIDYL PEPTIDASE-IV; BOMBYX-MORI; BINDING; ENZYME; PURIFICATION; GENE; SPECIFICITY; EXPRESSION; MECHANISM; FAMILIES	Aminopeptidase N from Escherichia coli is a broad specificity zinc exopeptidase belonging to aminopeptidase clan MA, family M1. The structures of the ligand-free form and the enzymebestatin complex were determined at 1.5- and 1.6-A resolution, respectively. The enzyme is composed of four domains: an N-terminal beta-domain (Met(1)-Asp(193)), a catalytic domain (Phe(194)-Gly(444)), a middle beta-domain (Thr(445)-Trp(546)), and a C-terminal alpha-domain (Ser(547)-Ala(870)). The structure of the catalytic domain exhibits similarity to thermolysin, and a metal-binding motif ( HEXXHX18E) is found in the domain. The zinc ion is coordinated by His(297), His(301), Glu(320), and a water molecule. The groove on the catalytic domain that contains the active site is covered by the C-terminal alpha-domain, and a large cavity is formed inside the protein. However, there exists a small hole at the center of the C-terminal alpha-domain. The N terminus of bestatin is recognized by Glu(121) and Glu(264), which are located in the N-terminal and catalytic domains, respectively. Glu(298) and Tyr(381), located near the zinc ion, are considered to be involved in peptide cleavage. A difference revealed between the ligand-free form and the enzyme-bestatin complex indicated that Met(260) functions as a cushion to accept substrates with different N-terminal residue sizes, resulting in the broad substrate specificity of this enzyme.	Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 8528521, Japan	Nagasaki University	Yoshimoto, T (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, 1-14 Bunkyo Machi, Nagasaki 8528521, Japan.	yosimoto@nagasaki-u.ac.jp	Ito, Kiyoshi/E-9652-2011					Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chandu D, 2003, MICROBIOL-SGM, V149, P3437, DOI 10.1099/mic.0.26518-0; DELMAS B, 1992, NATURE, V357, P417, DOI 10.1038/357417a0; Engel M, 2003, P NATL ACAD SCI USA, V100, P5063, DOI 10.1073/pnas.0230620100; Fenn TD, 2003, J APPL CRYSTALLOGR, V36, P944, DOI 10.1107/S0021889803006721; FOGLINO M, 1986, GENE, V49, P303, DOI 10.1016/0378-1119(86)90366-5; Fulop V, 1998, CELL, V94, P161, DOI 10.1016/S0092-8674(00)81416-6; HANGAUER DG, 1984, BIOCHEMISTRY-US, V23, P5730, DOI 10.1021/bi00319a011; Hiramatsu H, 2003, BIOCHEM BIOPH RES CO, V302, P849, DOI 10.1016/S0006-291X(03)00258-4; HOLMES MA, 1981, BIOCHEMISTRY-US, V20, P6912, DOI 10.1021/bi00527a026; HOOPER NM, 1994, FEBS LETT, V354, P1, DOI 10.1016/0014-5793(94)01079-X; Huang K, 1997, J BIOCHEM, V122, P779; JIANG WP, 1992, FEBS LETT, V312, P110, DOI 10.1016/0014-5793(92)80916-5; Kabashima T, 1996, J BIOCHEM-TOKYO, V120, P1111; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KITAZONO A, 1992, J BACTERIOL, V174, P7919, DOI 10.1128/JB.174.24.7919-7925.1992; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kyrieleis OJP, 2005, J MOL BIOL, V349, P787, DOI 10.1016/j.jmb.2005.03.070; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Luciani N, 1998, BIOCHEMISTRY-US, V37, P686, DOI 10.1021/bi971705p; MCCAMAN MT, 1982, ARCH BIOCHEM BIOPHYS, V213, P384, DOI 10.1016/0003-9861(82)90564-1; McRee DE, 1992, J MOL GRAPHICS, V10, P44, DOI DOI 10.1016/0263-7855(92)80022-6; Nakanishi K, 2002, FEBS LETT, V519, P215, DOI 10.1016/S0014-5793(02)02708-4; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pelmenschikov V, 2002, J BIOL INORG CHEM, V7, P284, DOI 10.1007/s007750100295; Rasmussen HB, 2003, NAT STRUCT BIOL, V10, P19, DOI 10.1038/nsb882; Rudberg PC, 2002, J BIOL CHEM, V277, P1398, DOI 10.1074/jbc.M106577200; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Thunnissen MMGM, 2001, NAT STRUCT BIOL, V8, P131, DOI 10.1038/84117; Yaoi K, 1999, FEBS LETT, V463, P221, DOI 10.1016/S0014-5793(99)01626-9; YEAGER CL, 1992, NATURE, V357, P420, DOI 10.1038/357420a0; YOSHIMOTO T, 1988, AGR BIOL CHEM TOKYO, V52, P217; YOSHIMOTO T, 1980, J BIOL CHEM, V255, P4786	37	117	123	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33664	33676		10.1074/jbc.M605203200	http://dx.doi.org/10.1074/jbc.M605203200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16885166	hybrid			2022-12-27	WOS:000241621400074
J	Morishita, H; Umitsu, M; Murata, Y; Shibata, N; Udaka, K; Higuchi, Y; Akutsu, H; Yamaguchi, T; Yagi, T; Ikegami, T				Morishita, Hirofumi; Umitsu, Masataka; Murata, Yoji; Shibata, Naoki; Udaka, Keiko; Higuchi, Yoshiki; Akutsu, Hideo; Yamaguchi, Tohru; Yagi, Takeshi; Ikegami, Takahisa			Structure of the cadherin-related neuronal receptor/protocadherin-alpha first extracellular cadherin domain reveals diversity across cadherin families	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CELL-ADHESION; GENOMIC ORGANIZATION; RESONANCE ASSIGNMENTS; PROTOCADHERIN-ALPHA; BACKBONE DYNAMICS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; GENE-CLUSTER; SEQUENCE; EVOLUTION	The recent explosion in genome sequencing has revealed the great diversity of the cadherin superfamily. Within the superfamily, protocadherins, which are expressed mainly in the nervous system, constitute the largest subgroup. Nevertheless, the structures of only the classical cadherins are known. Thus, to broaden our understanding of the adhesion repertoire of the cadherin superfamily, we determined the structure of the N-terminal first extracellular cadherin domain of the cadherin-related neuronal receptor/protocadherin-alpha 4. The hydrophobic pocket essential for homophilic adhesiveness in the classical cadherins was not found, and the functional significance of this structural domain was supported by exchanging the first extracellular cadherin domains of protocadherin and classical cadherin. Moreover, potentially crucial variations were observed mainly in the loop regions. These included the protocadherin-specific disulfide-bonded Cys-X-5-Cys motif, which showed Ca2+-induced chemical shifts, and the RGD motif, which has been suggested to be involved in heterophilic cell adhesion via the active form of beta 1 integrin. Our findings reveal that the adhesion repertoire of the cadherin superfamily is far more divergent than would be predicted by studying the classical cadherins alone.	Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; Osaka Univ, KOKORO Biol Grp, Labs Integrated Biol, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; Osaka Univ, Grad Sch Med, Course Med Biosignaling, Suita, Osaka 5650871, Japan; Kochi Med Sch, Dept Immunol, Kochi 7838505, Japan; Natl Inst Physiol Sci, Aichi 4448585, Japan; Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Saitama 3320012, Japan; Shionogi & Co Ltd, Discovery Res Lab, Osaka 5530002, Japan	Osaka University; Osaka University; Osaka University; Kochi University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Japan Science & Technology Agency (JST); Shionogi & Company Limited	Yagi, T (corresponding author), Osaka Univ, Inst Prot Res, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	yagi@fbs.osaka-u.ac.jp; tiik@protein.osaka-u.ac.jp	Morishita, Hirofumi/J-9619-2015; Shibata, Naoki/AFK-9971-2022; Ikegami, Takahisa/I-9626-2017	Morishita, Hirofumi/0000-0002-1045-1337; Shibata, Naoki/0000-0002-5096-1104; Ikegami, Takahisa/0000-0002-1429-1844; Murata, Yoji/0000-0002-9576-7030; Akutsu, Hideo/0000-0001-7236-5285				Aiyar A, 2000, Methods Mol Biol, V132, P221; Armon A, 2001, J MOL BIOL, V307, P447, DOI 10.1006/jmbi.2000.4474; Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559; Cavanagh J., 1996, PROTEIN NMR SPECTROS; Chappuis-Flament S, 2001, J CELL BIOL, V154, P231, DOI 10.1083/jcb.200103143; Copie V, 1998, J MOL BIOL, V277, P663; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Esumi S, 2005, NAT GENET, V37, P171, DOI 10.1038/ng1500; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Frank M, 2002, CURR OPIN CELL BIOL, V14, P557, DOI 10.1016/S0955-0674(02)00365-4; Gooding JM, 2004, BIOESSAYS, V26, P497, DOI 10.1002/bies.20033; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Koch AW, 2004, CELL MOL LIFE SCI, V61, P1884, DOI 10.1007/s00018-004-4006-2; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; Koradi R, 1996, J MOL GRAPHICS, V14, P29; Lambert M, 2000, J CELL SCI, V113, P2207; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8; Maerz AL, 2001, J VIROL, V75, P6635, DOI 10.1128/JVI.75.14.6635-6644.2001; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; Mutoh T, 2004, EXP CELL RES, V294, P494, DOI 10.1016/j.yexcr.2003.11.019; Nagar B, 1996, NATURE, V380, P360, DOI 10.1038/380360a0; NERI D, 1989, BIOCHEMISTRY-US, V28, P7510, DOI 10.1021/bi00445a003; Nollet F, 2000, J MOL BIOL, V299, P551, DOI 10.1006/jmbi.2000.3777; Noonan JP, 2004, GENOME RES, V14, P354, DOI 10.1101/gr.2133704; OVERDUIN M, 1995, SCIENCE, V267, P386, DOI 10.1126/science.7824937; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Patel SD, 2003, CURR OPIN STRUC BIOL, V13, P690, DOI 10.1016/j.sbi.2003.10.007; Pertz O, 1999, EMBO J, V18, P1738, DOI 10.1093/emboj/18.7.1738; Poumbourios P, 2003, J BIOL CHEM, V278, P42149, DOI 10.1074/jbc.M305223200; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Senzaki K, 1999, CELL, V99, P635, DOI 10.1016/S0092-8674(00)81552-4; Shan WS, 2004, J BIOL CHEM, V279, P55914, DOI 10.1074/jbc.M407827200; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; Shapiro L, 1999, NEURON, V23, P427, DOI 10.1016/S0896-6273(00)80796-5; SHAPIRO L, 1995, P NATL ACAD SCI USA, V92, P6793, DOI 10.1073/pnas.92.15.6793; Shapiro L, 1998, CURR OPIN NEUROBIOL, V8, P593, DOI 10.1016/S0959-4388(98)80086-X; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; Sugino H, 2004, BIOCHEM BIOPH RES CO, V316, P437, DOI 10.1016/j.bbrc.2004.02.067; Sugino H, 2000, GENOMICS, V63, P75, DOI 10.1006/geno.1999.6066; Suzuki ST, 2000, EXP CELL RES, V261, P13, DOI 10.1006/excr.2000.5039; Tada MN, 2004, GENE, V340, P197, DOI 10.1016/j.gene.2004.07.014; Takagi J, 2002, IMMUNOL REV, V186, P141, DOI 10.1034/j.1600-065X.2002.18613.x; TAKEICHI M, 1988, DEVELOPMENT, V102, P639; Tamura K, 1998, NEURON, V20, P1153, DOI 10.1016/S0896-6273(00)80496-1; Tasic B, 2002, MOL CELL, V10, P21, DOI 10.1016/S1097-2765(02)00578-6; Tepass U, 2000, NAT REV MOL CELL BIO, V1, P91, DOI 10.1038/35040042; Torshin I.V., 2002, MED SCI MONITOR, V8, P301; Tsumoto K, 1998, J IMMUNOL METHODS, V219, P119, DOI 10.1016/S0022-1759(98)00127-6; Umitsu M, 2005, J BIOMOL NMR, V31, P365, DOI 10.1007/s10858-005-2450-4; VANDEWIELVANKEMENADE E, 1992, J CELL BIOL, V117, P461, DOI 10.1083/jcb.117.2.461; Wojtowicz WM, 2004, CELL, V118, P619, DOI 10.1016/j.cell.2004.08.021; Wu Q, 2001, GENOME RES, V11, P389, DOI 10.1101/gr.167301; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yagi T, 2000, GENE DEV, V14, P1169; Yanase H, 2004, GENOMICS, V83, P717, DOI 10.1016/j.ygeno.2003.09.022	59	60	60	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33650	33663		10.1074/jbc.M603298200	http://dx.doi.org/10.1074/jbc.M603298200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16916795	hybrid			2022-12-27	WOS:000241621400073
J	Hershko, T; Korotayev, K; Polager, S; Ginsberg, D				Hershko, Tzippi; Korotayev, Katya; Polager, Shirley; Ginsberg, Doron			E2F1 modulates p38 MAPK phosphorylation via transcriptional regulation of ASK1 and Wip1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							URACIL-DNA GLYCOSYLASE; TUMOR SUPPRESSORS; SIGNALING PATHWAY; UP-REGULATION; UV-RADIATION; APOPTOSIS; P53; EXPRESSION; PPM1D; PHOSPHATASE	The E2F family of transcription factors regulates a diverse array of cellular functions, including cell proliferation, cell differentiation, and apoptosis. Recent studies indicate that E2F can also regulate transcription of upstream components of signal transduction pathways. We show here that E2F1 modulates the activity of the p38 MAPK pathway via E2F1-induced transient up-regulation of p38 MAPK phosphorylation. The mechanism by which E2F1 modulates p38 MAPK phosphorylation involves transcriptional induction of the kinase ASK1, a member of the MAPKKK family that phosphorylates p38 MKKs. Subsequent E2F-dependent down-regulation of the p38 signaling pathway is achieved through E2F-induced up-regulation of Wip1, a phosphatase that dephosphorylates and inactivates p38. Both ASK1 and Wip1 are essential mediators of the E2F-p38 connection: knock down of ASK1 inhibits E2F1-induced phosphorylation of p38, whereas knock down of Wip1 prolongs E2F1-induced p38 phosphorylation. Furthermore, Wip1 knock down enhances E2F1-induced apoptosis. Therefore, our data reveal a novel link between a central signaling pathway and the transcription factor E2F and identify Wip1 as a modulator of E2F1-induced apoptosis.	Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel; Weizmann Inst Sci, Dept Mol & Cell Biol, IL-76100 Rehovot, Israel	Bar Ilan University; Weizmann Institute of Science	Ginsberg, D (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel.	ginsbed@mail.biu.ac.il		ginsberg, doron/0000-0002-1257-4920				Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Berkovich E, 2003, ONCOGENE, V22, P161, DOI 10.1038/sj.onc.1206144; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Bulavin DV, 2004, NAT GENET, V36, P343, DOI 10.1038/ng1317; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Bulavin DV, 2002, NAT GENET, V31, P210, DOI 10.1038/ng894; Carrassa L, 2003, CELL CYCLE, V2, P604, DOI 10.4161/cc.2.6.503; Chaussepied M, 2004, MOL CELL, V16, P831, DOI 10.1016/j.molcel.2004.11.003; CHAUSSEPIED M, 2005, CELL CYCLE, V4; Dasgupta P, 2004, J BIOL CHEM, V279, P38762, DOI 10.1074/jbc.M312273200; DeGregori J, 2002, BBA-REV CANCER, V1602, P131, DOI 10.1016/S0304-419X(02)00051-3; Engelberg D, 2004, SEMIN CANCER BIOL, V14, P271, DOI 10.1016/j.semcancer.2004.04.006; Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048; Haug T, 1998, NUCLEIC ACIDS RES, V26, P1449, DOI 10.1093/nar/26.6.1449; Hershko T, 2005, CELL DEATH DIFFER, V12, P377, DOI 10.1038/sj.cdd.4401575; Hershko T, 2004, J BIOL CHEM, V279, P8627, DOI 10.1074/jbc.M312866200; Hirasawa A, 2003, CLIN CANCER RES, V9, P1995; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Ishida S, 2001, MOL CELL BIOL, V21, P4684, DOI 10.1128/MCB.21.14.4684-4699.2001; Ivanova IA, 2006, ONCOGENE, V25, P430, DOI 10.1038/sj.onc.1208999; Jamshidi-Parsian A, 2005, GENE, V344, P67, DOI 10.1016/j.gene.2004.09.030; Li J, 2002, NAT GENET, V31, P133, DOI 10.1038/ng888; Lu XB, 2005, GENE DEV, V19, P1162, DOI 10.1101/gad.1291305; Lu XB, 2004, MOL CELL, V15, P621, DOI 10.1016/j.molcel.2004.08.007; Ma YH, 2002, ARCH BIOCHEM BIOPHYS, V399, P212, DOI 10.1006/abbi.2002.2761; Matsukawa J, 2004, J BIOCHEM, V136, P261, DOI 10.1093/jb/mvh134; Moroni MC, 2001, NAT CELL BIOL, V3, P552, DOI 10.1038/35078527; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Polager S, 2002, ONCOGENE, V21, P437, DOI 10.1038/sj.onc.1205102; Powers JT, 2004, MOL CANCER RES, V2, P203; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Rogoff HA, 2004, MOL CELL BIOL, V24, P2968, DOI 10.1128/MCB.24.7.2968-2977.2004; Rogoff HA, 2002, MOL CELL BIOL, V22, P5308, DOI 10.1128/MCB.22.15.5308-5318.2002; Saito-Ohara F, 2003, CANCER RES, V63, P1876; Saklatvala J, 2004, CURR OPIN PHARMACOL, V4, P372, DOI 10.1016/j.coph.2004.03.009; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Stanelle J, 2002, NUCLEIC ACIDS RES, V30, P1859, DOI 10.1093/nar/30.8.1859; Sumbayev VV, 2005, ARCH BIOCHEM BIOPHYS, V436, P406, DOI 10.1016/j.abb.2005.02.021; Takahashi Y, 2000, GENE DEV, V14, P804; Takekawa M, 2000, EMBO J, V19, P6517, DOI 10.1093/emboj/19.23.6517; Tashiro E, 2003, CANCER RES, V63, P424; Vigo E, 1999, MOL CELL BIOL, V19, P6379; Wang S, 1999, EMBO J, V18, P1559, DOI 10.1093/emboj/18.6.1559; Young AP, 2003, ONCOGENE, V22, P7209, DOI 10.1038/sj.onc.1206804	45	45	48	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31309	31316		10.1074/jbc.M601758200	http://dx.doi.org/10.1074/jbc.M601758200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16912047	Bronze			2022-12-27	WOS:000241235300015
J	Marasco, EK; Vay, K; Schmidt-Dannert, C				Marasco, Erin K.; Vay, Kimleng; Schmidt-Dannert, Claudia			Identification of carotenoid cleavage dioxygenases from Nostoc sp PCC 7120 with different cleavage activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-PAUCIMOBILIS TMY1009; VITAMIN-A FORMATION; BETA-CAROTENE; MOLECULAR-IDENTIFICATION; OXIDATIVE CLEAVAGE; DIRECTED EVOLUTION; ESCHERICHIA-COLI; BIOSYNTHESIS; ENZYMES; CLONING	Carotenoid cleavage dioxygenases (CCDs) are a class of enzymes that oxidatively cleave carotenoids into apocarotenoids. Dioxygenases have been identified in plants and animals and produce a wide variety of cleavage products. Despite what is known about apocarotenoids in higher organisms, very little is known about apocarotenoids and CCDs in microorganisms. This study surveyed cleavage activities of ten putative carotenoid cleavage dioxygenases from five different cyanobacteria in recombinant Escherichia coli cells producing different carotenoid substrates. Three CCD homologs identified in Nostoc sp. PCC 7120 were purified, and their cleavage activities were investigated. Two of the three enzymes showed cleavage of beta,beta-carotene at the 9,10 and 15,15 ' positions, respectively. The third enzyme did not cleave full-length carotenoids but cleaved the apocarotenoid beta-apo-8 '-carotenal at the 9,10 position. 9,10-Apocarotenoid cleavage specificity has previously not been described. The diversity of carotenoid cleavage activities identified in one cyanobacteria suggests that CCDs not only facilitate the degradation of photosynthetic pigments but generate apocarotenals with yet to be determined biological roles in microorganisms.	Univ Minnesota, Dept Biochem Mol Biol & Biophys, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Schmidt-Dannert, C (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, 1479 Gortner Ave, St Paul, MN 55108 USA.	schmi232@umn.edu			NIGMS NIH HHS [T32 GM08347] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008347] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; Booker J, 2004, CURR BIOL, V14, P1232, DOI 10.1016/j.cub.2004.06.061; Bouvier F, 2005, TRENDS PLANT SCI, V10, P187, DOI 10.1016/j.tplants.2005.02.007; Bouvier F, 2003, SCIENCE, V300, P2089, DOI 10.1126/science.1085162; Bouvier F, 2003, PLANT CELL, V15, P47, DOI 10.1105/tpc.006536; BRITTON G, 1995, CAROTENOIDS TODAY CH, P73; During A, 1996, ANAL BIOCHEM, V241, P199, DOI 10.1006/abio.1996.0400; Gunasekaran K, 2003, J MOL BIOL, V332, P143, DOI 10.1016/S0022-2836(03)00893-3; Hockelmann C, 2005, FLAVOUR FRAG J, V20, P387, DOI 10.1002/ffj.1464; Holger S, 2006, J BIOL CHEM, V281, P9845, DOI 10.1074/jbc.M511668200; Jung KH, 2003, MOL MICROBIOL, V47, P1513, DOI 10.1046/j.1365-2958.2003.03395.x; KAMODA S, 1993, BIOSCI BIOTECH BIOCH, V57, P926, DOI 10.1271/bbb.57.926; KAMODA S, 1995, BIOSCI BIOTECH BIOCH, V59, P1866, DOI 10.1271/bbb.59.1866; Kamoda S, 1997, BIOSCI BIOTECH BIOCH, V61, P1575, DOI 10.1271/bbb.61.1575; KAMODA S, 1993, BIOSCI BIOTECH BIOCH, V57, P931, DOI 10.1271/bbb.57.931; Kauffmann I, 2001, PROTEIN ENG, V14, P919, DOI 10.1093/protein/14.11.919; Kiefer C, 2001, J BIOL CHEM, V276, P14110, DOI 10.1074/jbc.M011510200; Kloer DP, 2005, SCIENCE, V308, P267, DOI 10.1126/science.1108965; Lakshman MR, 2004, J NUTR, V134, p241S, DOI 10.1093/jn/134.1.241S; Lawrence P, 2006, ANAL CHEM, V78, P1312, DOI 10.1021/ac0516584; Lee PC, 2003, CHEM BIOL, V10, P453, DOI 10.1016/S1074-5521(03)00103-0; Lindqvist A, 2002, J BIOL CHEM, V277, P23942, DOI 10.1074/jbc.M202756200; Mijts BN, 2005, CHEM BIOL, V12, P453, DOI 10.1016/j.chembiol.2005.02.010; MOHREN S, 1983, WATER SCI TECHNOL, V15, P221; Moiseyev G, 2006, J BIOL CHEM, V281, P2835, DOI 10.1074/jbc.M508903200; Nagao A, 2004, J NUTR, V134, p237S, DOI 10.1093/jn/134.1.237S; Nagao A, 2003, ACS SYM SER, V851, P322; Paik J, 2001, J BIOL CHEM, V276, P32160, DOI 10.1074/jbc.M010086200; Poliakov E, 2005, J BIOL CHEM, V280, P29217, DOI 10.1074/jbc.M500409200; PRIM N, 2006, COLLOID SURFACE B, V51, P100; Qin XQ, 1999, P NATL ACAD SCI USA, V96, P15354, DOI 10.1073/pnas.96.26.15354; Redmond TM, 2001, J BIOL CHEM, V276, P6560, DOI 10.1074/jbc.M009030200; Ruch S, 2005, MOL MICROBIOL, V55, P1015, DOI 10.1111/j.1365-2958.2004.04460.x; Schmidt-Dannert C, 2000, NAT BIOTECHNOL, V18, P750, DOI 10.1038/77319; Schwartz SH, 2004, J BIOL CHEM, V279, P46940, DOI 10.1074/jbc.M409004200; Schwartz SH, 2001, J BIOL CHEM, V276, P25208, DOI 10.1074/jbc.M102146200; Schwartz SH, 1997, SCIENCE, V276, P1872, DOI 10.1126/science.276.5320.1872; Takagi S, 2005, J SMALL ANIM PRACT, V46, P504, DOI 10.1111/j.1748-5827.2005.tb00280.x; von Lintig J, 2005, BBA-MOL BASIS DIS, V1740, P122, DOI 10.1016/j.bbadis.2004.11.010; von Lintig J, 2000, J BIOL CHEM, V275, P11915, DOI 10.1074/jbc.275.16.11915; von Lintig J, 2004, J NUTR, V134, p251S, DOI 10.1093/jn/134.1.251S; von Lintig J, 2001, ARCH BIOCHEM BIOPHYS, V385, P47, DOI 10.1006/abbi.2000.2096; Watts KT, 2004, CHEMBIOCHEM, V5, P500, DOI 10.1002/cbic.200300783; Winterhalter P, 1996, ACS SYM SER, V637, P295; Wolf G, 2001, NUTR REV, V59, P116; Wyss A, 2004, J NUTR, V134, p246S, DOI 10.1093/jn/134.1.246S; Yan WM, 2001, GENOMICS, V72, P193, DOI 10.1006/geno.2000.6476	47	63	65	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31583	31593		10.1074/jbc.M606299200	http://dx.doi.org/10.1074/jbc.M606299200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16920703	Bronze			2022-12-27	WOS:000241235300044
J	Wang, JF; Zhang, XQ; Ahlers, BA; Carl, LL; Song, JL; Rothblum, LI; Stahl, RC; Carey, DJ; Cheung, JY				Wang, JuFang; Zhang, Xue-Qian; Ahlers, Belinda A.; Carl, Lois L.; Song, Jianliang; Rothblum, Lawrence I.; Stahl, Richard C.; Carey, David J.; Cheung, Joseph Y.			Cytoplasmic tail of phospholemman interacts with the intracellular loop of the cardiac Na+/Ca2+ exchanger	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADULT-RAT MYOCYTES; PROTEIN-KINASE-C; SARCOLEMMAL NA+-CA2+ EXCHANGER; SODIUM-CALCIUM EXCHANGER; NA-K-ATPASE; FXYD PROTEINS; ALTERS CONTRACTILITY; <CA2+>(I) TRANSIENTS; INTACT MYOCARDIUM; NA/CA EXCHANGER	Phospholemman (PLM), a member of the FXYD family of small ion transport regulators, inhibits cardiac Na+/Ca2+ exchanger (NCX1). NCX1 is made up of N-terminal domain consisting of the first five transmembrane segments ( residues 1-217), a large intracellular loop (residues 218-764), and a C-terminal domain comprising the last four transmembrane segments (residues 765-938). Using glutathione S-transferase (GST) pull-down assay, we demonstrated that the intracellular loop, but not the N- or C-terminal transmembrane domains of NCX1, was associated with PLM. Further analysis using protein constructs of GST fused to various segments of the intracellular loop of NCX1 suggest that PLM bound to residues 218-371 and 508-764 but not 371-508. Split Na+/Ca2+ exchangers consisting of N- or C-terminal domains with different lengths of the intracellular loop were co-expressed with PLM in HEK293 cells that are devoid of endogenous PLM and NCX1. Although expression of N- terminal but not C-terminal domain alone resulted in correct membrane targeting, co-expression of both N- and C-terminal domains was required for correct membrane targeting and functional exchange activity. NCX1 current measurements indicate that PLM decreased NCX1current only when the split exchangers contained residues 218-358 of the intracellular loop. Co-immunoprecipitation experiments with PLM and split exchangers suggest that PLM associated with the N- terminal domain of NCX1 when it contained intracellular loop residues 218-358. TM43, a PLM mutant with its cytoplasmic tail truncated, did not co-immunoprecipitate with wild-type NCX1 when co-expressed in HEK293 cells, confirming little to no interaction between the transmembrane domains of PLM and NCX1. We conclude that PLM interacted with the intracellular loop of NCX1, most likely at residues 218-358.	Penn State Univ, Dept Cellular & Mol Physiol, Milton S Hershey Med Ctr, Hershey, PA 17033 USA; Penn State Univ, Dept Med, Milton S Hershey Med Ctr, Hershey, PA 17033 USA; Geisinger Med Ctr, Weis Ctr Res, Danville, PA 17822 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Geisinger Medical Center	Cheung, JY (corresponding author), Penn State Univ, Dept Cellular & Mol Physiol, Milton S Hershey Med Ctr, MC H166, Hershey, PA 17033 USA.	jyc1@psu.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077814, R01HL058672, R01HL074854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021925, R01NS041363] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-58672, HL-74854, R01 HL074854, R01 HL058672, HL-77814, R01 HL077814] Funding Source: Medline; NIDDK NIH HHS [DK-46678] Funding Source: Medline; NIGMS NIH HHS [R01 GM069841, GM-69841] Funding Source: Medline; NINDS NIH HHS [R01 NS021925, NS-21925, R01 NS041363, NS-41363] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahlers BA, 2005, J BIOL CHEM, V280, P19875, DOI 10.1074/jbc.M414703200; Beevers AJ, 2006, PROTEIN SCI, V15, P1127, DOI 10.1110/ps.051899406; Beguin P, 2002, EMBO J, V21, P3264, DOI 10.1093/emboj/cdf330; Beguin P, 2001, EMBO J, V20, P3993, DOI 10.1093/emboj/20.15.3993; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Chen ZH, 1998, CIRC RES, V82, P367, DOI 10.1161/01.RES.82.3.367; Crambert G, 2002, P NATL ACAD SCI USA, V99, P11476, DOI 10.1073/pnas.182267299; Davis CE, 2004, NEUROCHEM RES, V29, P177, DOI 10.1023/B:NERE.0000010447.24128.ac; Despa S, 2005, CIRC RES, V97, P252, DOI 10.1161/01.RES.0000176532.97731.e5; Dostanic I, 2004, J BIOL CHEM, V279, P54053, DOI 10.1074/jbc.M410737200; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; Fuller W, 2004, FASEB J, V18, P197, DOI 10.1096/fj.03-0213fje; Geering K, 2006, AM J PHYSIOL-RENAL, V290, pF241, DOI 10.1152/ajprenal.00126.2005; He ZP, 2000, AM J PHYSIOL-CELL PH, V278, pC661, DOI 10.1152/ajpcell.2000.278.4.C661; Iwamoto T, 1998, BIOCHEMISTRY-US, V37, P17230, DOI 10.1021/bi981521q; Jia LG, 2005, AM J PHYSIOL-HEART C, V288, pH1982, DOI 10.1152/ajpheart.00142.2004; Katanosaka Y, 2005, J BIOL CHEM, V280, P5764, DOI 10.1074/jbc.M410240200; LEVITSKY DO, 1994, J BIOL CHEM, V269, P22847; Li CM, 2004, J BIOL CHEM, V279, P38895, DOI 10.1074/jbc.M406697200; LI ZP, 1991, J BIOL CHEM, V266, P1014; LINDEMANN JP, 1986, J BIOL CHEM, V261, P4860; Lindzen M, 2006, J BIOL CHEM, V281, P5947, DOI 10.1074/jbc.M512063200; LOW W, 1993, FEBS LETT, V316, P63, DOI 10.1016/0014-5793(93)81737-K; Maack C, 2005, CIRC RES, V96, P91, DOI 10.1161/01.RES.0000151334.48676.68; MacLennan DH, 2003, ANN NY ACAD SCI, V986, P472, DOI 10.1111/j.1749-6632.2003.tb07231.x; Mahmmoud YA, 2000, J BIOL CHEM, V275, P35969, DOI 10.1074/jbc.M005168200; Matsuoka S, 1997, J GEN PHYSIOL, V109, P273, DOI 10.1085/jgp.109.2.273; McDonough AA, 1996, AM J PHYSIOL-CELL PH, V270, pC1221, DOI 10.1152/ajpcell.1996.270.4.C1221; Mirza MA, 2004, AM J PHYSIOL-HEART C, V286, pH1322, DOI 10.1152/ajpheart.00997.2003; MOORMAN JR, 1995, NATURE, V377, P737, DOI 10.1038/377737a0; Morales-Mulia M, 2000, BBA-MOL CELL RES, V1496, P252, DOI 10.1016/S0167-4889(00)00023-9; Moran J, 2001, BBA-MOL CELL RES, V1538, P313, DOI 10.1016/S0167-4889(01)00082-9; Nicoll DA, 1999, J BIOL CHEM, V274, P910, DOI 10.1074/jbc.274.2.910; Ottolia M, 2001, J BIOL CHEM, V276, P19603, DOI 10.1074/jbc.M101489200; PALMER CJ, 1991, J BIOL CHEM, V266, P11126; Philipson KD, 2000, ANNU REV PHYSIOL, V62, P111, DOI 10.1146/annurev.physiol.62.1.111; PORZIG H, 1993, AM J PHYSIOL, V265, pC748, DOI 10.1152/ajpcell.1993.265.3.C748; PRESTI CF, 1985, J BIOL CHEM, V260, P3860; Scriven DRL, 2000, BIOPHYS J, V79, P2682, DOI 10.1016/S0006-3495(00)76506-4; Seidler T, 2003, CIRC RES, V93, P132, DOI 10.1161/01.RES.0000081596.90205.E2; Silverman BD, 2005, CARDIOVASC RES, V65, P93, DOI 10.1016/j.cardiores.2004.09.005; Song JL, 2005, AM J PHYSIOL-HEART C, V288, pH2342, DOI 10.1152/ajpheart.01133.2004; Song JL, 2002, AM J PHYSIOL-HEART C, V283, pH576, DOI 10.1152/ajpheart.00197.2002; SWEADNER KJ, 1994, CIRC RES, V74, P669, DOI 10.1161/01.RES.74.4.669; Sweadner KJ, 2000, GENOMICS, V68, P41, DOI 10.1006/geno.2000.6274; Tadros GM, 2002, AM J PHYSIOL-HEART C, V283, pH1616, DOI 10.1152/ajpheart.00186.2002; Therien AG, 1997, J BIOL CHEM, V272, P32628, DOI 10.1074/jbc.272.51.32628; TUCKER AL, 2006, IN PRESS AM J PHYSL; WAALAS SI, 1994, BIOCHEM J, V304, P635; Zhang XQ, 2006, J BIOL CHEM, V281, P7784, DOI 10.1074/jbc.M512092200; Zhang XQ, 2006, J APPL PHYSIOL, V100, P212, DOI 10.1152/japplphysiol.00757.2005; Zhang XQ, 2003, AM J PHYSIOL-HEART C, V284, pH225, DOI 10.1152/ajpheart.00698.2002; Zhang XQ, 2001, AM J PHYSIOL-HEART C, V281, pH2079, DOI 10.1152/ajpheart.2001.281.5.H2079	54	28	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					32004	32014		10.1074/jbc.M606876200	http://dx.doi.org/10.1074/jbc.M606876200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16921169	Green Accepted, Bronze			2022-12-27	WOS:000241235300086
J	Ilouz, R; Kowalsman, N; Eisenstein, M; Eldar-Finkelman, H				Ilouz, Ronit; Kowalsman, Noga; Eisenstein, Miriam; Eldar-Finkelman, Hagit			Identification of novel glycogen synthase kinase-3 beta substrate-interacting residues suggests a common mechanism for substrate recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; STRUCTURAL BASIS; CRYSTAL-STRUCTURE; PEPTIDE INHIBITOR; PHOSPHORYLATION; SPECIFICITY; EXPRESSION; TYROSINE; BINDING; 3-BETA	Substrate recognition and specificity are essential for the reliability and fidelity of protein kinase function. GSK-3 has a unique substrate specificity that requires prior phosphorylation of its substrates. However, how the enzyme selects its phosphorylated substrates is unknown. Here, we combined in silico modeling with mutagenesis and biological studies to identify GSK-3-substrate interaction sites located within its binding cleft. Protein-protein docking of GSK-3 beta and the phosphorylated cAMP responsive element binding protein (pCREB) (using the available experimentally determined structures), identified Phe(67), Gln(89), and Asn(95) of GSK-3 beta as putative binding sites interacting with the CREB phosphorylation motif. Mutations of these residues to alanine impaired GSK-3 beta phosphorylation of several substrates, without abrogating its autocatalytic activity. Subsequently, expression of the GSK-3 beta mutants in cells resulted in decreased phosphorylation of substrates CREB, IRS-1, and beta-catenin, and prevented their suppression of glycogen synthase activity as compared with cells expressing the wildtype GSK-3 beta. Our studies provide important additional understanding of how GSK-3 beta recognizes its substrates: In addition to prior phosphorylation typically required in GSK- 3 substrates, substrate recognition involves interactions with GSK-3 beta residues: Phe(67), Gln(89), and Asn(95), which confer a common basis for substrate binding and selectivity, yet allow for substrate diversity.	Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel; Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Chem Res Support, IL-76100 Rehovot, Israel	Tel Aviv University; Sackler Faculty of Medicine; Weizmann Institute of Science; Weizmann Institute of Science	Eldar-Finkelman, H (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel.	heldar@post.tau.ac.il		Eldar-Finkelman, Hagit/0000-0002-8460-9686				Alto NM, 2003, P NATL ACAD SCI USA, V100, P4445, DOI 10.1073/pnas.0330734100; Bardwell AJ, 2001, J BIOL CHEM, V276, P10374, DOI 10.1074/jbc.M010271200; Bax B, 2001, STRUCTURE, V9, P1143, DOI 10.1016/S0969-2126(01)00679-7; Ben-Zeev E, 2003, PROTEINS, V52, P24, DOI 10.1002/prot.10391; BERCHANSKI A, 2004, PROTEINS, V351, P309; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bertrand JA, 2003, J MOL BIOL, V333, P393, DOI 10.1016/j.jmb.2003.08.031; Bhat R, 2003, J BIOL CHEM, V278, P45937, DOI 10.1074/jbc.M306268200; Brinkworth RI, 2003, P NATL ACAD SCI USA, V100, P74, DOI 10.1073/pnas.0134224100; Cline GW, 2002, DIABETES, V51, P2903, DOI 10.2337/diabetes.51.10.2903; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Cole A, 2004, BIOCHEM J, V377, P249, DOI 10.1042/BJ20031259; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Dajani R, 2003, EMBO J, V22, P494, DOI 10.1093/emboj/cdg068; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Eldar-Finkelman H, 2002, TRENDS MOL MED, V8, P126, DOI 10.1016/S1471-4914(01)02266-3; EldarFinkelman H, 1996, P NATL ACAD SCI USA, V93, P10228, DOI 10.1073/pnas.93.19.10228; FIOL CJ, 1987, J BIOL CHEM, V262, P14042; FIOL CJ, 1994, J BIOL CHEM, V269, P32187; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Gould TD, 2004, J CLIN PSYCHIAT, V65, P10; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Heifetz A, 2002, PROTEIN SCI, V11, P571, DOI 10.1110/ps.26002; HUGHES K, 1993, EMBO J, V12, P803, DOI 10.1002/j.1460-2075.1993.tb05715.x; KATCHALSKIKATZIR E, 1992, P NATL ACAD SCI USA, V89, P2195, DOI 10.1073/pnas.89.6.2195; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; Liberman Z, 2005, J BIOL CHEM, V280, P4422, DOI 10.1074/jbc.M410610200; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Martinez A, 2002, J MED CHEM, V45, P1292, DOI 10.1021/jm011020u; Narayana N, 1997, BIOCHEMISTRY-US, V36, P4438, DOI 10.1021/bi961947+; Padilla A, 1997, J PEPT RES, V49, P210; Plotkin B, 2003, J PHARMACOL EXP THER, V305, P974, DOI 10.1124/jpet.102.047381; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; ROACH PJ, 1991, J BIOL CHEM, V266, P14139; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; TAYLOR SS, 1995, FASEB J, V9, P1255, DOI 10.1096/fasebj.9.13.7557015; ter Haar E, 2001, NAT STRUCT BIOL, V8, P593, DOI 10.1038/89624; THOMAS JA, 1968, ANAL BIOCHEM, V25, P486, DOI 10.1016/0003-2697(68)90127-9; Woodgett J. R., 2003, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V3, P281, DOI 10.2174/1568008033340153; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; WOODGETT JR, 1984, BIOCHIM BIOPHYS ACTA, V788, P339, DOI 10.1016/0167-4838(84)90047-5; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yaffe Michael B, 2004, Methods Mol Biol, V250, P237; Yanagawa S, 2002, EMBO J, V21, P1733, DOI 10.1093/emboj/21.7.1733; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870	45	42	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30621	30630		10.1074/jbc.M604633200	http://dx.doi.org/10.1074/jbc.M604633200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16893889	hybrid			2022-12-27	WOS:000241075900038
J	Elble, RC; Walia, V; Cheng, HC; Connon, CJ; Mundhenk, L; Gruber, AD; Pauli, BU				Elble, Randolph C.; Walia, Vijay; Cheng, Hung-chi; Connon, Che J.; Mundhenk, Lars; Gruber, Achim D.; Pauli, Bendicht U.			The putative chloride channel hCLCA2 has a single C-terminal transmembrane segment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEINS; BREAST-CANCER; FUNCTIONAL-CHARACTERIZATION; STRUCTURE PREDICTION; MOLECULAR-CLONING; BETA(4) INTEGRIN; FAMILY; CELLS; GENE; LUNG	Calcium-activated chloride channel (CLCA) proteins were first described as a family of plasma membrane Cl- channels that could be activated by calcium. Genetic and electrophysiological studies have supported this view. The human CLCA2 protein is expressed as a 943-amino-acid precursor whose N-terminal signal sequence is removed followed by internal cleavage near amino acid position 680. Earlier investigations of transmembrane geometry suggested five membrane passes. However, analysis by the more recently derived simple modular architecture research tool algorithm predicts that a C-terminal 22-amino-acid hydrophobic segment comprises the only transmembrane pass. To resolve this question, we raised an antibody against hCLCA2 and investigated the synthesis, localization, maturation, and topology of the protein. Cell surface biotinylation and endoglycosidase H analysis revealed a 128-kDa precursor confined to the endoplasmic reticulum and a maturely glycosylated 141-kDa precursor at the cell surface by 48 h post-transfection. By 72 h, 109-kDa N-terminal and 35-kDa C-terminal cleavage products were detected at the cell surface but not in the endoplasmic reticulum. Surprisingly, however, the 109-kDa product was spontaneously shed into the medium or removed by acid washes, whereas the precursor and 35-kDa product were retained by the membrane. Two other CLCA family members, bCLCA2 and hCLCA1, also demonstrated preferential release of the N-terminal product. Transfer of the hCLCA2 C-terminal hydrophobic segment to a secreted form of green fluorescent protein was sufficient to target that protein to the plasma membrane. Together, these data indicate that hCLCA2 is mostly extracellular with only a single transmembrane segment followed by a short cytoplasmic tail and is itself unlikely to form a channel.	So Illinois Univ, Sch Med, Dept Pharmacol, Springfield, IL 62794 USA; So Illinois Univ, Sch Med, Inst Canc, Springfield, IL 62794 USA; Natl Cheng Kung Univ, Coll Med, Dept Biochem & Mol Biol, Tainan 70101, Taiwan; Cardiff Univ, Sch Optometry & Vis Sci, Cardiff CF23 9BD, S Glam, Wales; Free Univ Berlin, Dept Vet Pathol, D-14163 Berlin, Germany; Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA	Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; National Cheng Kung University; Cardiff University; Free University of Berlin; Cornell University	Elble, RC (corresponding author), So Illinois Univ, Sch Med, Dept Pharmacol, Springfield, IL 62794 USA.	relble2@siumed.edu	Gruber, Achim D./ABA-4514-2021; Connon, Che/B-3128-2012; Walia, Vijay/F-1647-2013	Connon, Che/0000-0001-8264-6531; 				Abdel-Ghany M, 2003, J BIOL CHEM, V278, P49406, DOI 10.1074/jbc.M309086200; Abdel-Ghany M, 2002, J BIOL CHEM, V277, P34391, DOI 10.1074/jbc.M205307200; Abdel-Ghany M, 2001, J BIOL CHEM, V276, P25438, DOI 10.1074/jbc.M100478200; Agnel M, 1999, FEBS LETT, V455, P295, DOI 10.1016/S0014-5793(99)00891-1; Arribas J, 1996, J BIOL CHEM, V271, P11376, DOI 10.1074/jbc.271.19.11376; Bachelder RE, 1999, J BIOL CHEM, V274, P20733, DOI 10.1074/jbc.274.29.20733; Beckley JR, 2004, J BIOL CHEM, V279, P41634, DOI 10.1074/jbc.M408334200; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Connon CJ, 2004, J HISTOCHEM CYTOCHEM, V52, P415, DOI 10.1177/002215540405200313; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; Cunningham SA, 1995, J BIOL CHEM, V270, P31016, DOI 10.1074/jbc.270.52.31016; Elble RC, 1997, J BIOL CHEM, V272, P27853, DOI 10.1074/jbc.272.44.27853; Elble RC, 2002, J BIOL CHEM, V277, P18586, DOI 10.1074/jbc.M200829200; Elble RC, 2001, J BIOL CHEM, V276, P40510, DOI 10.1074/jbc.M104821200; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; Evans SR, 2004, J BIOL CHEM, V279, P41792, DOI 10.1074/jbc.M408354200; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Gandhi R, 1998, J BIOL CHEM, V273, P32096, DOI 10.1074/jbc.273.48.32096; Gibson A, 2005, J BIOL CHEM, V280, P27205, DOI 10.1074/jbc.M504654200; Grignani F, 1998, CANCER RES, V58, P14; Gruber AD, 1999, AM J PHYSIOL-CELL PH, V276, pC1261; Gruber AD, 1999, CANCER RES, V59, P5488; Gruber AD, 1998, GENOMICS, V54, P200, DOI 10.1006/geno.1998.5562; Gruber AD, 1999, BBA-GENE STRUCT EXPR, V1444, P418, DOI 10.1016/S0167-4781(99)00008-1; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hofmann K., 1993, BIOL CHEM H-S, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Kamada F, 2004, GENES IMMUN, V5, P540, DOI 10.1038/sj.gene.6364124; Komiya T, 1999, BIOCHEM BIOPH RES CO, V255, P347, DOI 10.1006/bbrc.1999.0168; Letunic I, 2002, NUCLEIC ACIDS RES, V30, P242, DOI 10.1093/nar/30.1.242; Loewen ME, 2005, PHYSIOL REV, V85, P1061, DOI 10.1152/physrev.00016.2004; MOHLER KM, 1994, NATURE, V370, P218, DOI 10.1038/370218a0; Pawlowski K, 2006, PROTEINS, V63, P424, DOI 10.1002/prot.20887; Ritzka M, 2004, HUM GENET, V115, P483, DOI 10.1007/s00439-004-1190-y; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; Yamazaki J, 2005, BBA-BIOMEMBRANES, V1715, P132, DOI 10.1016/j.bbamem.2005.08.001	39	30	32	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					29448	29454		10.1074/jbc.M605919200	http://dx.doi.org/10.1074/jbc.M605919200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16873362	hybrid			2022-12-27	WOS:000240896300007
J	Jors, S; Kazanski, V; Foik, A; Krautwurst, D; Harteneck, C				Joers, Simone; Kazanski, Victor; Foik, Anna; Krautwurst, Dietmar; Harteneck, Christian			Receptor-induced activation of Drosophila TRP gamma by polyunsaturated fatty acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-PERMEABLE CATION CHANNEL; CYTOSOLIC PHOSPHOLIPASE A(2); PROTEIN-COUPLED RECEPTOR; STORE-OPERATED CHANNELS; TRANSIENT RECEPTOR; POTENTIAL CHANNELS; HEK-293 CELLS; MELANOGASTER; SUBUNITS; GENE	Cellular calcium homeostasis is regulated by hormones and neurotransmitters, resulting in the activation of a variety of proteins, in particular, channel proteins of the plasma membrane and of intracellular compartments. Such channels are, for example, TRP channels of the TRPC protein family that are activated by various mediators from receptor-stimulated signaling cascades. In Drosophila, two TRPC channels, TRP and TRPL, are involved in phototransduction. In addition, a third Drosophila TRPC channel, TRP gamma, has been identified and described as an auxiliary subunit of TRPL. Beyond it, our data show that heterologously expressed TRP gamma formed a receptor-activated, outwardly rectifying cation channel independent from TRPL coexpression. Analysis of the activation mechanism revealed that TRP gamma is activated by various polyunsaturated fatty acids generated in a phospholipase C- and phospholipase A(2)- dependent manner. The most potent activator of TRP gamma, the stable analogue of arachidonic acid, 5,8,11,14-eicosatetraynoic acid, induced currents in single channel recordings. Here we show that upon heterologous expression TRP gamma forms a homomeric channel complex that is activated by polyunsaturated fatty acids as mediators of receptor- dependent signaling pathways. Reverse transcription PCR analysis showed that TRP gamma is expressed in Drosophila heads and bodies. Its body- wide expression pattern and its activation mechanism suggest that TRP gamma forms a fly cation channel responsible for the regulation of intracellular calcium in a variety of hormonal signaling cascades.	Inst Pharmakol, D-14195 Berlin, Germany; Free Univ Berlin, Fachbereich Biol, D-14195 Berlin, Germany; Deutsch Inst Ernahrungsforsch Potsdam Rehbrucke, Abt Mol Genet, D-14558 Nuthetal, Germany	Free University of Berlin; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE)	Harteneck, C (corresponding author), Inst Pharmakol, Charite Campus Benjamin Franklin,Thielallee 69-73, D-14195 Berlin, Germany.	Christian.Harteneck@charite.de	Krautwurst, Dietmar/AAD-5579-2019	Krautwurst, Dietmar/0000-0002-3350-8682				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Bahner M, 2002, NEURON, V34, P83, DOI 10.1016/S0896-6273(02)00630-X; Balfanz S, 2005, J NEUROCHEM, V93, P440, DOI 10.1111/j.1471-4159.2005.03034.x; Balsinde J, 1999, ANNU REV PHARMACOL, V39, P175, DOI 10.1146/annurev.pharmtox.39.1.175; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; Brody T, 2000, J CELL BIOL, V150, pF83, DOI 10.1083/jcb.150.2.F83; Chiang AS, 2004, CURR BIOL, V14, P263, DOI 10.1016/j.cub.2004.02.003; Chubanov V, 2005, N-S ARCH PHARMACOL, V371, pR53; Chyb S, 1999, NATURE, V397, P255, DOI 10.1038/16703; Clapham DE, 2005, PHARMACOL REV, V57, P427, DOI 10.1124/pr.57.4.6; Finn JT, 1998, BIOPHYS J, V74, P1333, DOI 10.1016/S0006-3495(98)77846-4; Handlogten ME, 2001, J BIOL CHEM, V276, P13941, DOI 10.1074/jbc.M007306200; HARTENECK C, 1995, FEBS LETT, V358, P297, DOI 10.1016/0014-5793(94)01455-A; Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; Hellwig N, 2005, J CELL SCI, V118, P917, DOI 10.1242/jcs.01675; Hewes RS, 2001, GENOME RES, V11, P1126, DOI 10.1101/gr.169901; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Husain S, 1999, BIOCHEM J, V342, P87, DOI 10.1042/0264-6021:3420087; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEURS R, 1994, J NEUROCHEM, V62, P519; Lucas P, 2003, NEURON, V40, P551, DOI 10.1016/S0896-6273(03)00675-5; MacPherson MR, 2005, GENETICS, V169, P1541, DOI 10.1534/genetics.104.035139; Millar NS, 2003, BIOCHEM SOC T, V31, P869, DOI 10.1042/BST0310869; Montell C, 2005, PFLUG ARCH EUR J PHY, V451, P19, DOI 10.1007/s00424-005-1426-2; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; Montell C, 2002, MOL CELL, V9, P229, DOI 10.1016/S1097-2765(02)00448-3; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Nilius B, 2001, PFLUG ARCH EUR J PHY, V443, P227, DOI 10.1007/s004240100676; Okada T, 1999, J BIOL CHEM, V274, P27359, DOI 10.1074/jbc.274.39.27359; Qian F, 2002, DIABETES, V51, pS183, DOI 10.2337/diabetes.51.2007.S183; Radford JC, 2002, J BIOL CHEM, V277, P38810, DOI 10.1074/jbc.M203694200; Riccio A, 2002, MOL BRAIN RES, V109, P95, DOI 10.1016/S0169-328X(02)00527-2; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Torres GE, 1999, J BIOL CHEM, V274, P6653, DOI 10.1074/jbc.274.10.6653; TOYOSHIMA S, 1990, J BIOL CHEM, V265, P14842; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Wicher D, 2006, J BIOL CHEM, V281, P3227, DOI 10.1074/jbc.M511741200; Wu XY, 2002, J BIOL CHEM, V277, P13597, DOI 10.1074/jbc.M110881200; Xu XZS, 2000, NEURON, V26, P647, DOI 10.1016/S0896-6273(00)81201-5; YU FH, 2004, SCI STKE; Zagranichnaya TK, 2005, J BIOL CHEM, V280, P29559, DOI 10.1074/jbc.M505842200; ZHU X, 1995, FEBS LETT, V373, P193, DOI 10.1016/0014-5793(95)01038-G; Zhu X, 1996, CELL, V85, P661, DOI 10.1016/S0092-8674(00)81233-7; Zitt C, 1996, NEURON, V16, P1189, DOI 10.1016/S0896-6273(00)80145-2	45	25	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					29693	29702		10.1074/jbc.M602215200	http://dx.doi.org/10.1074/jbc.M602215200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16901908	hybrid			2022-12-27	WOS:000240896300031
J	Kajiyama, Y; Tian, JM; Locker, J				Kajiyama, Yasuo; Tian, Jianmin; Locker, Joseph			Characterization of distant enhancers and promoters in the albumin-alpha-fetoprotein locus during active and silenced expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR-BINDING; GENE-EXPRESSION; ALPHA-1-FETOPROTEIN GENE; FUNCTIONAL-ANALYSIS; REPRESSION; SITE; REGION; METHYLATION; ELEMENTS; P53	The albumin and alpha-fetoprotein genes are adjacent and express closely related serum proteins. Both genes are strongly expressed in fetal liver, primarily through activation by distant enhancers, but the AFP gene selectively undergoes developmental silencing. We used chromatin immunoprecipitation to study enhancers and promoters during active and silenced gene expression. In adult phenotype cells, the silenced AFP gene was actively repressed at the promoter and two proximal enhancers, characterized by the absence of coactivators and acetylated histone 4, and the presence of corepressors and K9-methylated histone 3. Specific transcription factors, TBP, and RNA polymerase II were all detected on both active and silenced genes, indicating that both states were actively regulated. Surprisingly, promoter-specific factors were also detected on enhancers, especially with reduced chromatin shearing. Under these conditions, an enhancer-specific factor was also detected on the albumin promoter. Association of promoter- and enhancer-specific factors was confirmed by sequential immunoprecipitation. Because no binding was detected on intervening segments, these promoter-enhancer associations suggest looping.	Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Locker, J (corresponding author), Albert Einstein Coll Med, Dept Pathol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	locker@aecom.yu.edu			NCI NIH HHS [CA68440, CA76354] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA068440, R01CA076354] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abelev GI, 1999, SEMIN CANCER BIOL, V9, P95, DOI 10.1006/scbi.1998.0084; BARGONETTI J, 1993, GENE DEV, V7, P2565, DOI 10.1101/gad.7.12b.2565; BELAYEW A, 1982, MOL CELL BIOL, V2, P1427, DOI 10.1128/MCB.2.11.1427; BERNIER D, 1993, MOL CELL BIOL, V13, P1619, DOI 10.1128/MCB.13.3.1619; Boyd KE, 1999, MOL CELL BIOL, V19, P8393; Breiling A, 2001, NATURE, V412, P651, DOI 10.1038/35088090; Cirillo LA, 1998, EMBO J, V17, P244, DOI 10.1093/emboj/17.1.244; Cui RT, 2005, J BIOL CHEM, V280, P39152, DOI 10.1074/jbc.M504655200; de Laat W, 2003, CHROMOSOME RES, V11, P447, DOI 10.1023/A:1024922626726; Dean A, 2006, TRENDS GENET, V22, P38, DOI 10.1016/j.tig.2005.11.001; Dellino GI, 2004, MOL CELL, V13, P887, DOI 10.1016/S1097-2765(04)00128-5; Forsberg EC, 2000, BLOOD, V96, P334, DOI 10.1182/blood.V96.1.334.013k17_334_339; GODBOUT R, 1988, MOL CELL BIOL, V8, P1169, DOI 10.1128/MCB.8.3.1169; GROUPP ER, 1994, J BIOL CHEM, V269, P22178; Gualdi R, 1996, GENE DEV, V10, P1670, DOI 10.1101/gad.10.13.1670; Hatzis P, 2002, MOL CELL, V10, P1467, DOI 10.1016/S1097-2765(02)00786-4; HERBOMEL P, 1989, MOL CELL BIOL, V9, P4750, DOI 10.1128/MCB.9.11.4750; HU JM, 1992, CELL GROWTH DIFFER, V3, P577; INGRAM RS, 1981, P NATL ACAD SCI-BIOL, V78, P4694, DOI 10.1073/pnas.78.8.4694; Kajiyama Y, 2002, MOL CELL BIOL, V22, P6122, DOI 10.1128/MCB.22.17.6122-6130.2002; Kim A, 2004, P NATL ACAD SCI USA, V101, P7028, DOI 10.1073/pnas.0307985101; Li C, 1996, DNA CELL BIOL, V15, P955, DOI 10.1089/dna.1996.15.955; LIU JK, 1991, MOL CELL BIOL, V11, P773, DOI 10.1128/MCB.11.2.773; LIU Y, 1994, NUCLEIC ACIDS RES, V22, P1079, DOI 10.1093/nar/22.6.1079; Locker J, 2002, NUCLEIC ACIDS RES, V30, P3809, DOI 10.1093/nar/gkf484; Melloul D, 2002, DIABETOLOGIA, V45, P309, DOI 10.1007/s00125-001-0728-y; MUGLIA L, 1984, NUCLEIC ACIDS RES, V12, P6751, DOI 10.1093/nar/12.17.6751; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nguyen TT, 2005, MOL CELL BIOL, V25, P2147, DOI 10.1128/MCB.25.6.2147-2157.2005; Patrinos GP, 2004, GENE DEV, V18, P1495, DOI 10.1101/gad.289704; PINKERT CA, 1987, GENE DEV, V1, P268, DOI 10.1101/gad.1.3.268; Samadani U, 1996, MOL CELL BIOL, V16, P6273; SCHULZ WA, 1988, EXP CELL RES, V174, P433, DOI 10.1016/0014-4827(88)90313-8; Senawong T, 2003, J BIOL CHEM, V278, P43041, DOI 10.1074/jbc.M307477200; Spear BT, 1999, SEMIN CANCER BIOL, V9, P109, DOI 10.1006/scbi.1998.0087; Tchenio T, 2001, MOL CELL BIOL, V21, P1953, DOI 10.1128/MCB.21.6.1953-1961.2001; TRONCHE F, 1989, MOL CELL BIOL, V9, P4759, DOI 10.1128/MCB.9.11.4759; TURCOTTE B, 1986, NUCLEIC ACIDS RES, V14, P9827, DOI 10.1093/nar/14.24.9827; VACHER J, 1990, SCIENCE, V250, P1732, DOI 10.1126/science.1702902; Vorachek WR, 2000, J BIOL CHEM, V275, P29031, DOI 10.1074/jbc.M003039200; WEN P, 1994, MOL CELL BIOL, V14, P6616, DOI 10.1128/MCB.14.10.6616; WEN P, 1991, DNA CELL BIOL, V10, P525, DOI 10.1089/dna.1991.10.525; Wolffe AP, 2001, ESSAYS BIOCHEM, V37, P45, DOI 10.1042/bse0370045; Young AP, 2004, ONCOGENE, V23, P814, DOI 10.1038/sj.onc.1207187; ZHANG DE, 1991, J BIOL CHEM, V266, P21179	45	18	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					30122	30131		10.1074/jbc.M603491200	http://dx.doi.org/10.1074/jbc.M603491200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16893898	hybrid			2022-12-27	WOS:000240896300073
J	Liiv, A; O'Connor, M				Liiv, Aivar; O'Connor, Michael			Mutations in the intersubunit bridge regions of 23 S rRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRESSURE-INDUCED DISSOCIATION; ESCHERICHIA-COLI RIBOSOME; ANGSTROM RESOLUTION; PROTEIN-SYNTHESIS; CRYOELECTRON MICROSCOPY; SUBUNIT ASSOCIATION; CRYO-EM; TRANSLATION; MECHANISM; SELECTION	The large and small subunits of the ribosome are joined by a series of bridges that are conserved among mitochondrial, bacterial, and eukaryal ribosomes. In addition to joining the subunits together at the initiation of protein synthesis, a variety of other roles have been proposed for these bridges. These roles include transmission of signals between the functional centers of the two subunits, modulation of tRNA- ribosome and factor-ribosome interactions, and mediation of the relative movement of large and small ribosomal subunits during translocation. The majority of the bridges involve RNA-RNA interactions, and to gain insight into their function, we constructed mutations in the 23 S rRNA regions involved in forming 7 of the 12 intersubunit bridges in the Escherichia coli ribosome. The majority of the mutants were viable in strains expressing mutant rRNA exclusively but had distinct growth phenotypes, particularly at 30 C, and the mutant ribosomes promoted a variety of miscoding errors. Analysis of subunit association activities both in vitro and in vivo indicated that, with the exception of the bridge B5 mutants, at least one mutation at each bridge site affected 70 S ribosome formation. These results confirm the structural data linking bridges with subunit- subunit interactions and, together with the effects on decoding fidelity, indicate that intersubunit bridges function at multiple stages of protein synthesis.	Univ Missouri, Sch Biol Sci, Kansas City, MO 64110 USA; Univ Tartu, Estonian Bioctr, EE-51010 Tartu, Estonia	University of Missouri System; University of Missouri Kansas City; Estonian Biocentre; University of Tartu	O'Connor, M (corresponding author), Univ Missouri, Sch Biol Sci, 5007 Rockhill Rd, Kansas City, MO 64110 USA.	oconnormi@umkc.edu	Liiv, aivar/D-3837-2014					Allen GS, 2005, CELL, V121, P703, DOI 10.1016/j.cell.2005.03.023; Asai T, 1999, P NATL ACAD SCI USA, V96, P1971, DOI 10.1073/pnas.96.5.1971; Asai T, 1999, J BACTERIOL, V181, P3803, DOI 10.1128/JB.181.12.3803-3809.1999; Baierlein R, 1974, Methods Enzymol, V30, P328; Blaha G, 2002, BIOPHYS CHEM, V96, P153, DOI 10.1016/S0301-4622(02)00021-2; BLATTNER FR, 1993, NUCLEIC ACIDS RES, V21, P5408; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-15; Cochella L, 2004, P NATL ACAD SCI USA, V101, P3786, DOI 10.1073/pnas.0307596101; Cukras AR, 2005, J MOL BIOL, V349, P47, DOI 10.1016/j.jmb.2005.03.075; Dallas A, 2001, MOL CELL, V8, P855, DOI 10.1016/S1097-2765(01)00356-2; DOUTHWAITE S, 1985, P NATL ACAD SCI USA, V82, P8330, DOI 10.1073/pnas.82.24.8330; Firpo MA, 1998, NUCLEIC ACIDS RES, V26, P2156, DOI 10.1093/nar/26.9.2156; FRANK J, 1995, NATURE, V376, P441, DOI 10.1038/376441a0; Gao HX, 2003, CELL, V113, P789, DOI 10.1016/S0092-8674(03)00427-6; Gao N, 2005, MOL CELL, V18, P663, DOI 10.1016/j.molcel.2005.05.005; Ghosh S, 2005, RNA, V11, P657, DOI 10.1261/rna.7224305; GODSON GN, 1967, BIOCHIM BIOPHYS ACTA, V149, P476, DOI 10.1016/0005-2787(67)90175-X; Gregory ST, 1998, METH MOL B, V77, P271; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; HIROKAWA G, 2005, RNA NY, V8, P1317; INFANTE AA, 1982, J BIOL CHEM, V257, P80; INFANTE AA, 1971, P NATL ACAD SCI USA, V68, P1780, DOI 10.1073/pnas.68.8.1780; Knight W, 2005, COMPUT BIOL CHEM, V29, P163, DOI 10.1016/j.compbiolchem.2005.01.001; LARSEN B, 1994, J BACTERIOL, V176, P6842, DOI 10.1128/JB.176.22.6842-6851.1994; LEVIEV I, 1995, NUCLEIC ACIDS RES, V23, P1512; Maivali U, 2004, RNA, V10, P600, DOI 10.1261/rna.5220504; Maldonado R, 1998, J BACTERIOL, V180, P1822, DOI 10.1128/JB.180.7.1822-1830.1998; Matadeen R, 1999, STRUCTURE, V7, P1575, DOI 10.1016/S0969-2126(00)88348-3; MIKKOLA R, 1991, BIOCHIMIE, V73, P1551, DOI 10.1016/0300-9084(91)90190-C; O'Connor M, 2004, NUCLEIC ACIDS RES, V32, P5750, DOI 10.1093/nar/gkh913; OCONNOR M, 1995, J MOL BIOL, V254, P838, DOI 10.1006/jmbi.1995.0659; Ogle JM, 2003, TRENDS BIOCHEM SCI, V28, P259, DOI 10.1016/S0968-0004(03)00066-5; Rackham O, 2006, NAT CHEM BIOL, V2, P254, DOI 10.1038/nchembio783; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Sergiev PV, 2005, J MOL BIOL, V353, P116, DOI 10.1016/j.jmb.2005.08.006; Sharma MR, 2003, CELL, V115, P97, DOI 10.1016/S0092-8674(03)00762-1; SIGMUND CD, 1988, METHOD ENZYMOL, V164, P673; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; Tama F, 2003, P NATL ACAD SCI USA, V100, P9319, DOI 10.1073/pnas.1632476100; TAPPRICH WE, 1989, P NATL ACAD SCI USA, V86, P4927, DOI 10.1073/pnas.86.13.4927; Thompson J, 2002, J MOL BIOL, V322, P273, DOI 10.1016/S0022-2836(02)00784-2; VANDIGGELEN OP, 1971, FEBS LETT, V19, P115, DOI 10.1016/0014-5793(71)80492-1; Vila-Sanjurjo A, 2003, P NATL ACAD SCI USA, V100, P8682, DOI 10.1073/pnas.1133380100; Wilson DN, 2005, EMBO J, V24, P251, DOI 10.1038/sj.emboj.7600525; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	45	47	48	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					29850	29862		10.1074/jbc.M603013200	http://dx.doi.org/10.1074/jbc.M603013200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16891309	hybrid			2022-12-27	WOS:000240896300047
J	Owegi, MA; Pappas, DL; Finch, MW; Bilbo, SA; Resendiz, CA; Jacquemin, LJ; Warrier, A; Trombley, JD; McCulloch, KM; Margalef, KLM; Mertz, MJ; Storms, JM; Damin, CA; Parra, KJ				Owegi, Margaret A.; Pappas, Donald L., Jr.; Finch, Mark W.; Bilbo, Sarah A.; Resendiz, Cruz A.; Jacquemin, Lori J.; Warrier, Aswathy; Trombley, John D.; McCulloch, Kathryn M.; Margalef, Katrina L. M.; Mertz, Melissa J.; Storms, Jason M.; Damin, Craig A.; Parra, Karlett J.			Identification of a domain in the V-o subunit d that is critical for coupling of the yeast vacuolar proton-translocating ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO DISSOCIATION; MEMBRANE H+-ATPASE; MUTATIONAL ANALYSIS; SACCHAROMYCES-CEREVISIAE; ELECTRON-MICROSCOPY; ADENOSINE-TRIPHOSPHATASES; 3-DIMENSIONAL STRUCTURE; NONHOMOLOGOUS REGION; THERMUS-THERMOPHILUS; PERIPHERAL STALK	Vacuolar proton-translocating ATPase pumps consist of two domains, V-1 and V-o. Subunit d is a component of Vo located in a central stalk that rotates during catalysis. By generating mutations, we showed that subunit d couples ATP hydrolysis and proton transport. The mutation F94A strongly uncoupled the enzyme, preventing proton transport but not ATPase activity. C-terminal mutations changed coupling as well; ATPase activity was decreased by 59-72%, whereas proton transport was not measurable (E328A) or was moderately reduced (E317A and C329A). Except for W325A, which had low levels of V1Vo, mutations allowed wild-type assembly regardless of the fact that subunits E and d were reduced at the membrane. N- and C-terminal deletions of various lengths were inhibitory and gradually destabilized subunit d, limiting V1Vo formation. Both N and C terminus were required for Vo assembly. The N- terminal truncation 2-19 Delta prevented V1Vo formation, although subunit d was available. The C terminus was required for retention of subunits E and d at the membrane. In addition, the C terminus of its bacterial homolog ( subunit C from T. thermophilus) stabilized the yeast subunit d mutant 310 - 345 Delta and allowed assembly of the rotor structure with subunits A and B. Structural features conserved between bacterial and eukaryotic subunit d and the significance of domain 3 for vacuolar proton-translocating ATPase function are discussed.	Ball State Univ, Dept Chem, Muncie, IN 47306 USA	Ball State University	Parra, KJ (corresponding author), Ball State Univ, Dept Chem, Muncie, IN 47306 USA.	kparrabelky@bsu.edu		McCulloch, Kathryn/0000-0001-9077-3821				Arata Y, 2002, J BIOL CHEM, V277, P3357, DOI 10.1074/jbc.M109967200; BAUERLE C, 1993, J BIOL CHEM, V268, P12749; Boekema EJ, 1997, P NATL ACAD SCI USA, V94, P14291, DOI 10.1073/pnas.94.26.14291; Curtis KK, 2002, J BIOL CHEM, V277, P2716, DOI 10.1074/jbc.M107777200; Curtis KK, 2002, J BIOL CHEM, V277, P8979, DOI 10.1074/jbc.M111708200; DOHERTY RD, 1993, J BIOL CHEM, V268, P16845; DROSE S, 1993, BIOCHEMISTRY-US, V32, P3902, DOI 10.1021/bi00066a008; DSCHIDA WJA, 1995, J BIOL CHEM, V270, P1557, DOI 10.1074/jbc.270.4.1557; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; Fethiere J, 2004, J BIOL CHEM, V279, P40670, DOI 10.1074/jbc.M407086200; Fillingame RH, 2003, FEBS LETT, V555, P29, DOI 10.1016/S0014-5793(03)01101-3; Hirata R, 1997, J BIOL CHEM, V272, P4795, DOI 10.1074/jbc.272.8.4795; Hirata T, 2003, J BIOL CHEM, V278, P23714, DOI 10.1074/jbc.M302756200; HO MN, 1993, J BIOL CHEM, V268, P18286; Imamura H, 2003, P NATL ACAD SCI USA, V100, P2312, DOI 10.1073/pnas.0436796100; Inoue T, 2005, J BIOL CHEM, V280, P27896, DOI 10.1074/jbc.M504890200; Iwata M, 2004, P NATL ACAD SCI USA, V101, P59, DOI 10.1073/pnas.0305165101; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; KANE PM, 1989, J BIOL CHEM, V264, P19236; Kane PM, 1999, J BIOL CHEM, V274, P17275, DOI 10.1074/jbc.274.24.17275; KANE PM, 1995, J BIOL CHEM, V270, P17025; Kane PM, 2000, J EXP BIOL, V203, P81; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P47411, DOI 10.1074/jbc.M108310200; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Liu JZ, 1996, BIOCHEMISTRY-US, V35, P10938, DOI 10.1021/bi9608065; LOTSCHER HR, 1984, BIOCHEMISTRY-US, V23, P4140, DOI 10.1021/bi00313a020; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Makyio H, 2005, EMBO J, V24, P3974, DOI 10.1038/sj.emboj.7600859; Malkus P, 2004, MOL BIOL CELL, V15, P5075, DOI 10.1091/mbc.E04-06-0514; Muller V, 2003, CELL MOL LIFE SCI, V60, P474, DOI 10.1007/s000180300040; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; NELSON H, 1990, P NATL ACAD SCI USA, V87, P3503, DOI 10.1073/pnas.87.9.3503; Nelson N, 1999, PHYSIOL REV, V79, P361, DOI 10.1152/physrev.1999.79.2.361; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Nishi T, 2003, J BIOL CHEM, V278, P46396, DOI 10.1074/jbc.M303924200; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; NOUMI T, 1991, P NATL ACAD SCI USA, V88, P1938, DOI 10.1073/pnas.88.5.1938; Ohira M, 2006, J BIOL CHEM, V281, P22752, DOI 10.1074/jbc.M601441200; OHYA Y, 1991, J BIOL CHEM, V266, P13971; Owegi MA, 2005, J BIOL CHEM, V280, P18393, DOI 10.1074/jbc.M412567200; Parra KJ, 1996, J BIOL CHEM, V271, P19592, DOI 10.1074/jbc.271.32.19592; ROBERTS CJ, 1991, METHOD ENZYMOL, V194, P644; Sambongi Y, 1999, SCIENCE, V286, P1722, DOI 10.1126/science.286.5445.1722; Shao E, 2004, J BIOL CHEM, V279, P48663, DOI 10.1074/jbc.M408278200; Shao E, 2003, J BIOL CHEM, V278, P12985, DOI 10.1074/jbc.M212096200; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; Supekova L, 1996, J EXP BIOL, V199, P1147; Tomashek JJ, 1997, J BIOL CHEM, V272, P26787, DOI 10.1074/jbc.272.42.26787; Wieczorek H, 2000, J EXP BIOL, V203, P127; Wilkens S, 2005, MICRON, V36, P109, DOI 10.1016/j.micron.2004.10.002; Wilkens S, 1999, J BIOL CHEM, V274, P31804, DOI 10.1074/jbc.274.45.31804; Wilkens S, 2004, J BIOL CHEM, V279, P41942, DOI 10.1074/jbc.M407821200; Wilkens S, 2001, J BIOL CHEM, V276, P44064, DOI 10.1074/jbc.M106579200; Xie XS, 1996, J BIOL CHEM, V271, P30980; Xu T, 1999, J BIOL CHEM, V274, P28909, DOI 10.1074/jbc.274.41.28909; Yokoyama K, 2003, J BIOL CHEM, V278, P42686, DOI 10.1074/jbc.M305853200; Yokoyama K, 2003, J BIOL CHEM, V278, P24255, DOI 10.1074/jbc.M303104200; Zhang ZY, 2006, FEBS LETT, V580, P2006, DOI 10.1016/j.febslet.2006.03.001	59	31	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					30001	30014		10.1074/jbc.M605006200	http://dx.doi.org/10.1074/jbc.M605006200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16891312	hybrid			2022-12-27	WOS:000240896300061
J	Cabrita, MA; Jaggi, F; Widjaja, SP; Christofori, G				Cabrita, Miguel A.; Jaeggi, Fabienne; Widjaja, Sandra P.; Christofori, Gerhard			A functional interaction between Sprouty proteins and Caveolin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASE; ERK ACTIVATION; CELL-GROWTH; MAP KINASE; IN-VIVO; TRANSLOCATION DOMAIN; SIGNALING PATHWAYS; DOWN-REGULATION; FGF; ANTAGONIST	Growth factor-mediated signal transduction cascades can be regulated spatio-temporally by signaling modulators, such as Sprouty proteins. The four mammalian Sprouty family members are palmitoylated phosphoproteins that can attenuate or potentiate numerous growth factor-induced signaling pathways. Previously, we have shown that Sprouty-1 and Sprouty-2 associate with Caveolin-1, the major structural protein of caveolae. Like Sprouty, Caveolin-1 inhibits growth factor-induced mitogen-activated protein kinase activation. Here, we demonstrate that all four mammalian Sprouty family members physically interact with Caveolin-1. The C terminus of Caveolin-1 is the major Sprouty-binding site, whereas Sprouty binds Caveolin-1 via its conserved C-terminal domain. A single point mutation in this domain results in loss of Caveolin-1 interaction. Moreover, we demonstrate that the various Sprouty isoforms differ dramatically in their cooperation with Caveolin-1-mediated inhibition of mitogen-activated protein kinase activation and that such cooperation is also highly dependent on the type of growth factor investigated and on cell density. Together, the data suggest that the Sprouty/Caveolin-1 interaction modulates signaling in a growth factor- and Sprouty isoform-specific manner.	Univ Basel, Ctr Biomed, Dept Clin Biol Sci, Inst Biochem & Genet, CH-4058 Basel, Switzerland	University of Basel	Christofori, G (corresponding author), Univ Basel, Ctr Biomed, Dept Clin Biol Sci, Inst Biochem & Genet, Mattenstr 28, CH-4058 Basel, Switzerland.	gerhard.christofori@unibas.ch						Ausubel F.A., 1997, CURRENT PROTOCOLS MO, DOI DOI 10.1.4; Basson MA, 2005, DEV CELL, V8, P229, DOI 10.1016/j.devcel.2004.12.004; Cabrita MA, 2003, THROMB HAEMOSTASIS, V90, P586, DOI 10.1160/TH03-04-0217; Casci T, 1999, CELL, V96, P655, DOI 10.1016/S0092-8674(00)80576-0; Chambers D, 2000, MECH DEVELOP, V91, P361, DOI 10.1016/S0925-4773(99)00288-9; Christofori G, 2003, NAT CELL BIOL, V5, P377, DOI 10.1038/ncb0503-377; Couet J, 1997, J BIOL CHEM, V272, P30429, DOI 10.1074/jbc.272.48.30429; de Alvaro C, 2005, MOL BIOL CELL, V16, P4454, DOI 10.1091/mbc.E05-05-0419; de Maximy AA, 1999, MECH DEVELOP, V81, P213, DOI 10.1016/S0925-4773(98)00241-X; Dikic I, 2003, CURR OPIN CELL BIOL, V15, P128, DOI 10.1016/S0955-0674(03)00004-8; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Egan JE, 2002, P NATL ACAD SCI USA, V99, P6041, DOI 10.1073/pnas.052090899; Engelman JA, 1998, FEBS LETT, V428, P205, DOI 10.1016/S0014-5793(98)00470-0; Engelman JA, 1999, FEBS LETT, V448, P221, DOI 10.1016/S0014-5793(99)00365-8; Fielding CJ, 2001, ADV DRUG DELIVER REV, V49, P251, DOI 10.1016/S0169-409X(01)00140-5; Fong CW, 2003, J BIOL CHEM, V278, P33456, DOI 10.1074/jbc.M301317200; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Furthauer M, 2001, DEVELOPMENT, V128, P2175; Furuchi T, 1998, J BIOL CHEM, V273, P21099, DOI 10.1074/jbc.273.33.21099; Galbiati F, 1998, EMBO J, V17, P6633, DOI 10.1093/emboj/17.22.6633; Glienke J, 2000, MECH DEVELOP, V96, P91, DOI 10.1016/S0925-4773(00)00378-6; GREEN S, 1986, NATURE, V320, P134, DOI 10.1038/320134a0; GREEN S, 1988, NUCLEIC ACIDS RES, V16, P369, DOI 10.1093/nar/16.1.369; Gross I, 2003, J BIOL CHEM, V278, P41420, DOI 10.1074/jbc.M306425200; Gross I, 2001, J BIOL CHEM, V276, P46460, DOI 10.1074/jbc.M108234200; Guy GR, 2003, J CELL SCI, V116, P3061, DOI 10.1242/jcs.00652; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Haglund K, 2005, EMBO REP, V6, P635, DOI 10.1038/sj.embor.7400453; Hall AB, 2003, CURR BIOL, V13, P308, DOI 10.1016/S0960-9822(03)00086-1; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Impagnatiello MA, 2001, J CELL BIOL, V152, P1087, DOI 10.1083/jcb.152.5.1087; Kim HJ, 2004, NAT REV MOL CELL BIO, V5, P441, DOI 10.1038/nrm1400; King JAJ, 2005, BIOCHEM J, V388, P445, DOI 10.1042/BJ20041284; Kramer S, 1999, DEVELOPMENT, V126, P2515; Lee CC, 2004, ONCOGENE, V23, P5193, DOI 10.1038/sj.onc.1207646; Lee SH, 2001, J BIOL CHEM, V276, P4128, DOI 10.1074/jbc.M006922200; Lee SW, 1998, ONCOGENE, V16, P1391, DOI 10.1038/sj.onc.1201661; Leeksma OC, 2002, EUR J BIOCHEM, V269, P2546, DOI 10.1046/j.1432-1033.2002.02921.x; Lim J, 2000, J BIOL CHEM, V275, P32837, DOI 10.1074/jbc.M002156200; Lim J, 2002, MOL CELL BIOL, V22, P7953, DOI 10.1128/MCB.22.22.7953-7966.2002; Liu PS, 2002, J BIOL CHEM, V277, P41295, DOI 10.1074/jbc.R200020200; Mailleux AA, 2001, MECH DEVELOP, V102, P81, DOI 10.1016/S0925-4773(01)00286-6; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mason JM, 2004, MOL BIOL CELL, V15, P2176, DOI 10.1091/mbc.E03-07-0503; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Michou AI, 1999, J VIROL, V73, P1399, DOI 10.1128/JVI.73.2.1399-1410.1999; Minowada G, 1999, DEVELOPMENT, V126, P4465; Nonami A, 2005, GENES CELLS, V10, P887, DOI 10.1111/j.1365-2443.2005.00886.x; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Orlichenko L, 2006, J BIOL CHEM, V281, P4570, DOI 10.1074/jbc.M512088200; Ozaki K, 2005, J CELL SCI, V118, P5861, DOI 10.1242/jcs.02711; Poppleton HM, 2004, BIOCHEM BIOPH RES CO, V323, P98, DOI 10.1016/j.bbrc.2004.08.070; Razani B, 1999, J BIOL CHEM, V274, P26353, DOI 10.1074/jbc.274.37.26353; Razani B, 2001, J BIOL CHEM, V276, P38121; Razani B, 2001, AM J PHYSIOL-CELL PH, V281, pC1241, DOI 10.1152/ajpcell.2001.281.4.C1241; Reich A, 1999, DEVELOPMENT, V126, P4139; Rubin C, 2003, CURR BIOL, V13, P297, DOI 10.1016/S0960-9822(03)00053-8; Rubin C, 2005, J BIOL CHEM, V280, P9735, DOI 10.1074/jbc.M408308200; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd, ed.; Sasaki A, 2001, J BIOL CHEM, V276, P36804, DOI 10.1074/jbc.C100386200; Sasaki A, 2003, CELL CYCLE, V2, P281, DOI 10.4161/cc.2.4.418; Schlessinger J, 2004, SCIENCE, V306, P1506, DOI 10.1126/science.1105396; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shim K, 2005, DEV CELL, V8, P553, DOI 10.1016/j.devcel.2005.02.009; Taketomi T, 2005, NAT NEUROSCI, V8, P855, DOI 10.1038/nn1485; Tefft D, 2002, AM J PHYSIOL-LUNG C, V283, pL700, DOI 10.1152/ajplung.00372.2001; Volonte D, 1999, FEBS LETT, V445, P431, DOI 10.1016/S0014-5793(99)00164-7; Williams TM, 2005, J BIOL CHEM, V280, P25134, DOI 10.1074/jbc.M501186200; Williams TM, 2005, AM J PHYSIOL-CELL PH, V288, pC494, DOI 10.1152/ajpcell.00458.2004; Williams TM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-214; Williams TM, 2004, J BIOL CHEM, V279, P51630, DOI 10.1074/jbc.M409214200; Wong ESM, 2002, EMBO J, V21, P4796, DOI 10.1093/emboj/cdf493; Wong ESM, 2001, J BIOL CHEM, V276, P5866, DOI 10.1074/jbc.M006945200; Wu XL, 2005, P NATL ACAD SCI USA, V102, P14058, DOI 10.1073/pnas.0506714102; Yao Q, 2005, J MOL BIOL, V348, P491, DOI 10.1016/j.jmb.2005.02.003; Yigzaw Y, 2001, J BIOL CHEM, V276, P22742, DOI 10.1074/jbc.M100123200; Yusoff P, 2002, J BIOL CHEM, V277, P3195, DOI 10.1074/jbc.M108368200; Zhang CX, 2005, ARTERIOSCL THROM VAS, V25, P533, DOI 10.1161/01.ATV.0000155461.50450.5a; Zhao YY, 2002, P NATL ACAD SCI USA, V99, P11375, DOI 10.1073/pnas.172360799	80	19	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					29201	29212		10.1074/jbc.M603921200	http://dx.doi.org/10.1074/jbc.M603921200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16877379	hybrid			2022-12-27	WOS:000240680500075
J	Hung, SH; Zhang, W; Pixley, RA; Jameson, BA; Huang, YC; Colman, RF; Colman, RW				Hung, Su-Hwi; Zhang, Wei; Pixley, Robin A.; Jameson, Bradford A.; Huang, Yu Chu; Colman, Roberta F.; Colman, Robert W.			New insights from the structure-function analysis of the catalytic region of human platelet phosphodiesterase 3A - A role for the unique 44-amino acid insert	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; INHIBITED CAMP-PHOSPHODIESTERASE; SUBTILIS ADENYLOSUCCINATE LYASE; SITE-DIRECTED MUTAGENESIS; SERPIN-PROTEASE COMPLEX; CRYSTAL-STRUCTURE; 8-<(4-BROMO-2,3-DIOXOBUTYL)THIO>ADENOSINE 3',5'-CYCLIC-MONOPHOSPHATE; ACTIVE-SITE; INACTIVATION; EXPRESSION	Human phosphodiesterase 3A (PDE3A) degrades cAMP, the major inhibitor of platelet function, thus potentiating platelet function. Of the 11 human PDEs, only PDE3A and 3B have 44-amino acid inserts in the catalytic domain. Their function is not clear. Incubating Sp-adenosine-3', 5'-cyclic-S-(4-bromo-2,3-dioxobutyl) monophosphorothioate (Sp-cAMPS-BDB) with PDE3A irreversibly inactivates the enzyme. High pressure liquid chromatography ( HPLC) analysis of a tryptic digest yielded an octapeptide within the insert of PDE3A ((K)(TYNVTDDK813)-Y-806), suggesting that a substrate-binding site exists within the insert. Because Sp-cAMPS-BDB reacts with nucleophilic residues, mutants Y807A, D811A, and D812A were produced. Sp-cAMPS-BDB inactivates D811A and D812A but not Y807A. A docking model showed that Tyr(807) is 3.3 angstroms from the reactive carbon, whereas Asp(811) and Asp(812) are > 15 angstroms away from Sp-cAMPS-BDB. Y807A has an altered K-m but no change in k(cat). Activity of wild type but not Y807A is inhibited by an anti-insert antibody. These data suggest that Tyr(807) is modified by Sp-cAMPS-BDB and involved in substrate binding. Because the homologous amino acid in PDE3B is Cys(792), we prepared the mutant Y807C and found that its K-m and k(cat) were similar to the wild type. Moreover, Sp-cAMPS-BDB irreversibly inactivates Y807C with similar kinetics to wild type, suggesting that the tyrosine may, like the cysteine, serve as a H donor. Kinetic analyses of nine additional insert mutants reveal that H782A, T810A, Y814A, and C816S exhibit an altered k(cat) but not K-m, indicating that catalysis is modulated. We document a new functional role for the insert in which substrate binding may produce a conformational change. This change would allow the substrate to bind to Tyr(807) and other amino acids in the insert to interact with residues important for catalysis in the active site cleft.	Temple Univ, Sch Med, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19140 USA; Drexel Univ, Coll Med, Dept Biochem, Philadelphia, PA 19104 USA; Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Drexel University; University of Delaware	Colman, RW (corresponding author), Temple Univ, Sch Med, Sol Sherry Thrombosis Res Ctr, 3400 N Broad St, Philadelphia, PA 19140 USA.	colmanr@temple.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL064943] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-64943] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BALDWIN ET, 1993, P NATL ACAD SCI USA, V90, P6796, DOI 10.1073/pnas.90.14.6796; Beebe HG, 1999, ARCH INTERN MED, V159, P2041, DOI 10.1001/archinte.159.17.2041; BOTT R, 1982, BIOCHEMISTRY-US, V21, P6956, DOI 10.1021/bi00269a052; Cheung PP, 1998, ARCH BIOCHEM BIOPHYS, V360, P99, DOI 10.1006/abbi.1998.0915; Cheung PP, 1996, BLOOD, V88, P1321, DOI 10.1182/blood.V88.4.1321.bloodjournal8841321; GRANT PG, 1990, BIOCHEMISTRY-US, V29, P887, DOI 10.1021/bi00456a006; GRANT PG, 1984, BIOCHEMISTRY-US, V23, P1801, DOI 10.1021/bi00303a034; Gum PA, 2003, J AM COLL CARDIOL, V41, P961, DOI 10.1016/S0735-1097(02)03014-0; Huai Q, 2004, P NATL ACAD SCI USA, V101, P9624, DOI 10.1073/pnas.0401120101; Huai Q, 2004, J BIOL CHEM, V279, P13095, DOI 10.1074/jbc.M311556200; Hung SH, 2002, BIOCHEMISTRY-US, V41, P2962, DOI 10.1021/bi0119823; Hung SH, 2002, BIOORG CHEM, V30, P16, DOI 10.1006/bioo.2001.1226; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; JAMES MNG, 1982, P NATL ACAD SCI-BIOL, V79, P6137, DOI 10.1073/pnas.79.20.6137; Jarvis B, 2000, DRUGS, V60, P347, DOI 10.2165/00003495-200060020-00012; Lee ME, 2002, FEBS LETT, V530, P53, DOI 10.1016/S0014-5793(02)03396-3; Lee TT, 1998, BIOCHEMISTRY-US, V37, P8481, DOI 10.1021/bi9805339; Lee TT, 1997, J BIOL CHEM, V272, P458; Levy JH, 2002, ANN THORAC SURG, V73, P325, DOI 10.1016/S0003-4975(01)02719-9; Matetzky S, 2004, CIRCULATION, V109, P3171, DOI 10.1161/01.CIR.0000130846.46168.03; MEIJER A, 1993, CIRCULATION, V87, P1524, DOI 10.1161/01.CIR.87.5.1524; Movsesian MA, 2003, J CARD FAIL, V9, P475, DOI 10.1016/S1071-9164(03)00135-0; Mseeh F, 2000, THROMB RES, V98, P395, DOI 10.1016/S0049-3848(00)00195-X; Omburo GA, 1997, BLOOD, V89, P1019, DOI 10.1182/blood.V89.3.1019; Scapin G, 2004, BIOCHEMISTRY-US, V43, P6091, DOI 10.1021/bi049868i; Tang KM, 1997, BIOCHEM J, V323, P217; Varnerin JP, 2004, PROTEIN EXPRES PURIF, V35, P225, DOI 10.1016/j.pep.2004.01.009; Xu RX, 2000, SCIENCE, V288, P1822, DOI 10.1126/science.288.5472.1822; Ye S, 2001, NAT STRUCT BIOL, V8, P979, DOI 10.1038/nsb1101-979; Zhang KYJ, 2004, MOL CELL, V15, P279, DOI 10.1016/j.molcel.2004.07.005; Zhang W, 2000, BLOOD, V95, P3380, DOI 10.1182/blood.V95.11.3380.011k25_3380_3386; Zhang W, 2001, PROTEIN SCI, V10, P1481, DOI 10.1110/ps.6601	32	9	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					29236	29244		10.1074/jbc.M606558200	http://dx.doi.org/10.1074/jbc.M606558200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16873361	hybrid			2022-12-27	WOS:000240680500079
J	Molina-Sanchez, MD; Martinez-Abarca, F; Toro, N				Molina-Sanchez, Maria Dolores; Martinez-Abarca, Francisco; Toro, Nicolas			Excision of the Sinorhizobium meliloti group II intron RmInt1 as circles in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOBILE GENETIC ELEMENTS; PODOSPORA-ANSERINA; ENCODED PROTEIN; DNA; TRANSPOSITION; MITOCHONDRIA; SENESCENCE; STRAND; YEAST	Excision of group II introns as circles has been described only for a few eukaryotic introns and little is known about the mechanisms involved, the relevance or consequences of the process. We report that splicing of the bacterial group II intron RmInt1 in vivo leads to the formation of both intron lariat and intron RNA circles. We determined that besides being required for the intron splicing reaction, the maturase domain of the intron-encoded protein also controls the balance between lariat and RNA intron circle production. Furthermore, comparison with in vitro self-splicing products indicates that in vivo, the intron-encoded protein appears to promote the use of a correct EBS1/IBS1 intron-exon interaction as well as cleavage at, or next to, the expected 3' splice site. These findings provide new insights on the mechanism of excision of group II introns as circles.	CSIC, Grp Ecol Genet, Estac Expt Zaidin, E-18008 Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ)	Toro, N (corresponding author), CSIC, Grp Ecol Genet, Estac Expt Zaidin, Calle Prof Albareda 1, E-18008 Granada, Spain.	ntoro@eez.csic.es	Molina-Sánchez, Maria Dolores/J-1925-2016; Toro, Nicolas/K-4909-2014; Martinez-Abarca, Francisco/K-9263-2014	Molina-Sánchez, Maria Dolores/0000-0002-3627-9360; Toro, Nicolas/0000-0002-3614-807X; Martinez-Abarca, Francisco/0000-0003-0417-6217				Begel O, 1999, MOL CELL BIOL, V19, P4093; Costa M, 2006, BIOCHIMIE, V88, P711, DOI 10.1016/j.biochi.2005.12.007; Dai LX, 2002, NUCLEIC ACIDS RES, V30, P1091, DOI 10.1093/nar/30.5.1091; Lambowitz AM, 2004, ANNU REV GENET, V38, P1, DOI 10.1146/annurev.genet.38.072902.091600; LAMBOWITZ AM, 1993, ANNU REV BIOCHEM, V62, P587, DOI 10.1146/annurev.bi.62.070193.003103; Lambowitz AM., 1999, GROUP GROUP 2 RIBOZY, P451; Li-Pook-Than J, 2006, NUCLEIC ACIDS RES, V34, P2782, DOI 10.1093/nar/gkl328; LORSCH JR, 1995, NUCLEIC ACIDS RES, V23, P2811, DOI 10.1093/nar/23.15.2811; Martinez-Abarca F, 2000, MOL MICROBIOL, V35, P1405, DOI 10.1046/j.1365-2958.2000.01804.x; Martinez-Abarca F, 2004, NUCLEIC ACIDS RES, V32, P2880, DOI 10.1093/nar/gkh616; MICHEL F, 1995, ANNU REV BIOCHEM, V64, P435, DOI 10.1146/annurev.bi.64.070195.002251; MUELLER MW, 1993, NATURE, V366, P174, DOI 10.1038/366174a0; Munoz-Adelantado E, 2003, J MOL BIOL, V327, P931, DOI 10.1016/S0022-2836(03)00208-0; Murray HL, 2001, MOL CELL, V8, P201, DOI 10.1016/S1097-2765(01)00300-8; OSIEWACZ HD, 1984, CURR GENET, V8, P299, DOI 10.1007/BF00419728; Podar M, 1998, NATURE, V391, P915, DOI 10.1038/36142; SAINSARDCHANET A, 1994, J MOL BIOL, V242, P630, DOI 10.1006/jmbi.1994.1613; San Filippo J, 2002, J MOL BIOL, V324, P933, DOI 10.1016/S0022-2836(02)01147-6; SCHMIDT WM, 1994, J MOL BIOL, V243, P157, DOI 10.1006/jmbi.1994.1642; SELLEM CH, 1993, NATURE, V366, P176, DOI 10.1038/366176a0; Toro N, 2003, ENVIRON MICROBIOL, V5, P143, DOI 10.1046/j.1462-2920.2003.00398.x; Vogel J, 1997, NUCLEIC ACIDS RES, V25, P2030, DOI 10.1093/nar/25.10.2030; Vogel J, 2002, EMBO J, V21, P3794, DOI 10.1093/emboj/cdf359; Zimmerly S, 2001, NUCLEIC ACIDS RES, V29, P1238, DOI 10.1093/nar/29.5.1238	24	30	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					28737	28744		10.1074/jbc.M602695200	http://dx.doi.org/10.1074/jbc.M602695200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16887813	Green Submitted, hybrid			2022-12-27	WOS:000240680500027
J	Pawlak, J; Mackessy, SP; Fry, BG; Bhatia, M; Mourier, G; Fruchart-Gaillard, C; Servent, D; Menez, R; Stura, E; Menez, A; Kini, RM				Pawlak, Joanna; Mackessy, Stephen P.; Fry, Bryan G.; Bhatia, Madhav; Mourier, Gilles; Fruchart-Gaillard, Carole; Servent, Denis; Menez, Renee; Stura, Enrico; Menez, Andre; Kini, R. Manjunatha			Denmotoxin, a three-finger toxin from the colubrid snake Boiga dendrophila (mangrove catsnake) with bird-specific activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; SITE-DIRECTED MUTAGENESIS; ALPHA-NEUROTOXINS; TREE SNAKE; BUNGARUS-CANDIDUS; BINDING-SITE; VENOM; COMPLEX; IDENTIFICATION; SECRETION	Boiga dendrophila (mangrove catsnake) is a colubrid snake that lives in Southeast Asian lowland rainforests and mangrove swamps and that preys primarily on birds. We have isolated, purified, and sequenced a novel toxin from its venom, which we named denmotoxin. It is a monomeric polypeptide of 77 amino acid residues with five disulfide bridges. In organ bath experiments, it displayed potent postsynaptic neuromuscular activity and irreversibly inhibited indirectly stimulated twitches in chick biventer cervicis nerve-muscle preparations. In contrast, it induced much smaller and readily reversible inhibition of electrically induced twitches in mouse hemidiaphragm nerve-muscle preparations. More precisely, the chick muscle alpha(1)beta gamma delta-nicotinic acetylcholine receptor was 100-fold more susceptible compared with the mouse receptor. These data indicate that denmotoxin has a bird-specific postsynaptic activity. We chemically synthesized denmotoxin, crystallized it, and solved its crystal structure at 1.9 angstrom by the molecular replacement method. The toxin structure adopts a non-conventional three-finger fold with an additional (fifth) disulfide bond in the first loop and seven additional residues at its N terminus, which is blocked by a pyroglutamic acid residue. This is the first crystal structure of a three-finger toxin from colubrid snake venom and the first fully characterized bird-specific toxin. Denmotoxin illustrates the relationship between toxin specificity and the primary prey type that constitutes the snake's diet.	Natl Univ Singapore, Fac Sci, Dept Biol Sci, Prot Sci Lab, Singapore 117543, Singapore; Natl Univ Singapore, Fac Sci, Dept Pharmacol, Singapore 117543, Singapore; Univ No Colorado, Sch Biol Sci, Greeley, CO 80639 USA; State Atom Energy Commiss, Dept Ingn Etudes Prot, F-91191 Gif Sur Yvette, France; Virginia Commonwealth Univ, Coll Med, Dept Biochem & Mol Biophys, Richmond, VA 23298 USA	National University of Singapore; National University of Singapore; University of Northern Colorado; CEA; Virginia Commonwealth University	Kini, RM (corresponding author), Natl Univ Singapore, Fac Sci, Dept Biol Sci, Prot Sci Lab, Sci Dr 4, Singapore 117543, Singapore.	dbskinim@nus.edu.sg	Mackessy, Stephen/GPT-0793-2022; Stura, Enrico A./A-2793-2010; Kini, Manjunatha/H-8029-2012; Fruchart Gaillard, Carole/GWV-2801-2022	Stura, Enrico A./0000-0001-6718-2118; Fruchart Gaillard, Carole/0000-0002-3149-4774; Mackessy, Stephen/0000-0003-4515-2545; Servent, Denis/0000-0002-0774-1691; Kini, Manjunatha/0000-0002-6100-3251				Ackermann EJ, 1998, J BIOL CHEM, V273, P10958, DOI 10.1074/jbc.273.18.10958; Antil S, 1999, J BIOL CHEM, V274, P34851, DOI 10.1074/jbc.274.49.34851; Banerjee Y, 2005, J BIOL CHEM, V280, P42601, DOI 10.1074/jbc.M508987200; BARCHAN D, 1992, P NATL ACAD SCI USA, V89, P7717, DOI 10.1073/pnas.89.16.7717; Bourne Y, 2005, EMBO J, V24, P1512, DOI 10.1038/sj.emboj.7600620; BRAZIL VITAL, 1926, MEM INST BUTANTAN, V3, P301; Broaders M, 1999, J NAT TOXINS, V8, P155; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bulbring E, 1997, BRIT J PHARMACOL, V120, P3; BURDEN SJ, 1975, P NATL ACAD SCI USA, V72, P3245, DOI 10.1073/pnas.72.8.3245; CHANG C. C., 1963, ARCH INTERNATL PHARMACODYN THER, V144, P241; Chang CC, 1999, J BIOMED SCI, V6, P368, DOI 10.1159/000025412; DEWEILLE JR, 1991, P NATL ACAD SCI USA, V88, P2437, DOI 10.1073/pnas.88.6.2437; DUFTON MJ, 1988, PHARMACOL THERAPEUT, V36, P1, DOI 10.1016/0163-7258(88)90111-8; Endo T., 1991, P165; ENDO T, 1987, PHARMACOL THERAPEUT, V34, P403, DOI 10.1016/0163-7258(87)90002-7; FIORDALISI JJ, 1994, BIOCHEMISTRY-US, V33, P12962, DOI 10.1021/bi00248a004; Fruchart-Gaillard C, 2002, P NATL ACAD SCI USA, V99, P3216, DOI 10.1073/pnas.042699899; Fry BG, 2003, J MOL EVOL, V57, P446, DOI 10.1007/s00239-003-2497-3; Fry BG, 2003, RAPID COMMUN MASS SP, V17, P2047, DOI 10.1002/rcm.1148; GILSBORG BL, 1960, BR J PHARM CHEMOTHER, V15, P410; Grutter T, 2001, TRENDS BIOCHEM SCI, V26, P459, DOI 10.1016/S0968-0004(01)01921-1; HARVEY AL, 1978, TOXICON, V16, P219, DOI 10.1016/0041-0101(78)90082-X; Hill RE, 2000, TOXICON, V38, P1663, DOI 10.1016/S0041-0101(00)00091-X; Hill RE, 1997, TOXICON, V35, P671, DOI 10.1016/S0041-0101(96)00174-2; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; KARLSSON E, 1984, J PHYSIOLOGY PARIS, V79, P232; Kini RM, 2002, CLIN EXP PHARMACOL P, V29, P815, DOI 10.1046/j.1440-1681.2002.03725.x; Krajewski JL, 2001, MOL PHARMACOL, V60, P725; Kumar TKS, 1997, J BIOMOL STRUCT DYN, V15, P431, DOI 10.1080/07391102.1997.10508957; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEVINSON SR, 1976, TOXICON, V14, P307, DOI 10.1016/0041-0101(76)90027-1; Lewis RJ, 2003, NAT REV DRUG DISCOV, V2, P790, DOI 10.1038/nrd1197; Lumsden N. G., 2004, Autonomic & Autacoid Pharmacology, V24, P107, DOI 10.1111/j.1474-8673.2004.00322.x; Lumsden NG, 2005, TOXICON, V45, P329, DOI 10.1016/j.toxicon.2004.11.003; Lumsden NG, 2004, TOXICON, V43, P819, DOI 10.1016/j.toxicon.2004.03.012; Mackessy SP, 2006, TOXICON, V47, P537, DOI 10.1016/j.toxicon.2006.01.007; Mackessy SP, 2002, J TOXICOL-TOXIN REV, V21, P43, DOI 10.1081/TXR-120004741; Malany S, 2000, BIOCHEMISTRY-US, V39, P15388, DOI 10.1021/bi001825o; MARTINS N, 1917, COLLECT TRAB I BUTAN, V1, P427; MCDOWELL RS, 1992, BIOCHEMISTRY-US, V31, P4766, DOI 10.1021/bi00135a004; MENEZ A, 1980, BIOCHEMISTRY-US, V19, P4166, DOI 10.1021/bi00559a005; Mourier G, 2000, PROTEIN ENG, V13, P217, DOI 10.1093/protein/13.3.217; Mourier G, 2003, MOL PHARMACOL, V63, P26, DOI 10.1124/mol.63.1.26; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NEUMANN D, 1989, P NATL ACAD SCI USA, V86, P7255, DOI 10.1073/pnas.86.18.7255; Nirthanan S, 2003, TOXICON, V41, P397, DOI 10.1016/S0041-0101(02)00388-4; Nirthanan S, 2002, J BIOL CHEM, V277, P17811, DOI 10.1074/jbc.M111152200; Ohno M, 1998, PROG NUCLEIC ACID RE, V59, P307; Osaka H, 2000, J BIOL CHEM, V275, P5478, DOI 10.1074/jbc.275.8.5478; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PILLET L, 1993, J BIOL CHEM, V268, P909; Potter LT, 2001, LIFE SCI, V68, P2541, DOI 10.1016/S0024-3205(01)01050-5; PradoFranceschi J, 1996, TOXICON, V34, P459, DOI 10.1016/0041-0101(95)00146-8; Ricciardi A, 2000, J BIOL CHEM, V275, P18302, DOI 10.1074/jbc.275.24.18302; SERVENT D, 2001, HDB NEUROTOXICOLOGY, P385; Smith CG, 2003, FASEB J, V17, P788, DOI 10.1096/fj.03-0093life; Takacs Z, 2001, MOL BIOL EVOL, V18, P1800, DOI 10.1093/oxfordjournals.molbev.a003967; Teixeira-Clerc F, 2002, J BIOL CHEM, V277, P25741, DOI 10.1074/jbc.M200534200; Torres AM, 2001, BIOCHEM J, V360, P539, DOI 10.1042/0264-6021:3600539; TREMEAU O, 1995, J BIOL CHEM, V270, P9362, DOI 10.1074/jbc.270.16.9362; Tsetlin V, 1999, EUR J BIOCHEM, V264, P281, DOI 10.1046/j.1432-1327.1999.00623.x; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vidal N, 2005, CR BIOL, V328, P1000, DOI 10.1016/j.crvi.2005.10.001; Vidal N, 2002, CR BIOL, V325, P987, DOI 10.1016/S1631-0691(02)01509-3; WANG SS, 1973, J AM CHEM SOC, V95, P1328, DOI 10.1021/ja00785a602; WEINSTEIN SA, 1991, TOXICON, V29, P401, DOI 10.1016/0041-0101(91)90014-I; Williams Janice A., 1993, Biochemical Society Transactions, V21, p73S; Wu PL, 2006, J BIOL CHEM, V281, P7937, DOI 10.1074/jbc.M513035200; Yasuda Osamu, 1994, Artery, V21, P287	70	154	159	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					29030	29041		10.1074/jbc.M605850200	http://dx.doi.org/10.1074/jbc.M605850200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16864572	hybrid			2022-12-27	WOS:000240680500058
J	Varfolomeev, E; Wayson, SM; Dixit, VM; Fairbrother, WJ; Vucic, D				Varfolomeev, Eugene; Wayson, Sarah M.; Dixit, Vishva M.; Fairbrother, Wayne J.; Vucic, Domagoj			The inhibitor of apoptosis protein fusion c-IAP2 center dot MALT1 stimulates NF-kappa B activation independently of TRAF1 AND TRAF2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR RECEPTOR; LYMPHOID-TISSUE LYMPHOMAS; MALT LYMPHOMA; STRUCTURAL BASIS; ML-IAP; MELANOMA INHIBITOR; SIGNALING COMPLEX; UBIQUITIN LIGASE; T(11/18)(Q21,Q21); KINASE	The inhibitors of apoptosis (IAPs) are a family of cell death inhibitors found in viruses and metazoans. All members of the IAP family have at least one baculovirus IAP repeat (BIR) motif that is essential for their anti-apoptotic activity. The t(11, 18)(q21;q21) translocation fuses the BIR domains of c-IAP2 with the paracaspase/MALT1 (mucosa-associated lymphoid tissue) protein, a critical mediator of T cell receptor-stimulated activation of NF-kappa B. The c-IAP2 center dot MALT1 fusion protein constitutively activates the NF-kappa B pathway, and this is considered critical to malignant B cell transformation and lymphoma progression. The BIR domains of c-IAP1 and c-IAP2 interact with tumor necrosis factor receptor-associated factors 1 and 2 (TRAF1 and TRAF2). Here we investigated the importance of TRAF1 and TRAF2 for c-IAP2(.)MALT1-stimulated NF-kappa B activation. We identified a novel epitope within the BIR1 domains of c-IAP1 and c-IAP2 that is crucial for their physical interaction with TRAF1 and TRAF2. The c-IAP2(.)MALT1 fusion protein associates with TRAF1 and TRAF2 using the same binding site. We explored the functional relevance of this interaction and established that binding to TRAF1 and TRAF2 is not required for c-IAP2(.)MALT1-stimulated NF-kappa B activation. Furthermore, gene ablation of TRAF2 or combined down-regulation of TRAF1 and TRAF2 did not affect c-IAP2(.)MALT1 stimulated signaling. However, TRAF1/2-binding mutants of c-IAP2(.)MALT1 still oligomerize and activate NF-kappa B, suggesting that oligomerization might be important for signaling of the fusion protein. Therefore, the t(11, 18)(q21; q21) translocation creating the c-IAP2(.)MALT1 fusion protein activates NF-kappa B and contributes to human malignancy in the absence of signaling adaptors that might otherwise regulate its activity.	Genentech Inc, Dept Prot Engn, San Francisco, CA 94110 USA; Genentech Inc, Dept Physiol Chem, San Francisco, CA 94110 USA	Roche Holding; Genentech; Roche Holding; Genentech	Vucic, D (corresponding author), Genentech Inc, Dept Prot Engn, 1 DNA Way,MS 42, San Francisco, CA 94110 USA.	domagoj@gene.com	dixit, vishva m/A-4496-2012	dixit, vishva m/0000-0001-6983-0326				Akagi T, 1999, ONCOGENE, V18, P5785, DOI 10.1038/sj.onc.1203018; DeLano W.L, PYMOL MOL GRAPHICS S; Dierlamm J, 1999, BLOOD, V93, P3601, DOI 10.1182/blood.V93.11.3601; Franklin MC, 2003, BIOCHEMISTRY-US, V42, P8223, DOI 10.1021/bi034227t; Hofmann K, 1997, TRENDS BIOCHEM SCI, V22, P155, DOI 10.1016/S0968-0004(97)01043-8; Hu SM, 2006, J CLIN INVEST, V116, P174, DOI 10.1172/JCI25641; Isaacson PG, 2005, BEST PRACT RES CL HA, V18, P57, DOI 10.1016/j.beha.2004.08.003; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Lee JS, 2004, PROTEOMICS, V4, P3376, DOI 10.1002/pmic.200401000; Liu ZH, 2000, NATURE, V408, P1004, DOI 10.1038/35050006; Lucas PC, 2001, J BIOL CHEM, V276, P19012, DOI 10.1074/jbc.M009984200; McCarthy JV, 1998, J BIOL CHEM, V273, P16968, DOI 10.1074/jbc.273.27.16968; Miller LK, 1999, TRENDS CELL BIOL, V9, P323, DOI 10.1016/S0962-8924(99)01609-8; Morgan JA, 1999, CANCER RES, V59, P6205; Park YC, 2000, CELL, V101, P777, DOI 10.1016/S0092-8674(00)80889-2; Park YC, 1999, NATURE, V398, P533, DOI 10.1038/19110; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Salvesen GS, 2004, ONCOGENE, V23, P2774, DOI 10.1038/sj.onc.1207522; Samuel T, 2006, J BIOL CHEM, V281, P1080, DOI 10.1074/jbc.M509381200; Shiozaki EN, 2003, MOL CELL, V11, P519, DOI 10.1016/S1097-2765(03)00054-6; Shu HB, 1996, P NATL ACAD SCI USA, V93, P13973, DOI 10.1073/pnas.93.24.13973; Snipas SJ, 2004, BIOL CHEM, V385, P1093, DOI 10.1515/BC.2004.142; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Tang ED, 2003, J BIOL CHEM, V278, P37297, DOI 10.1074/jbc.M303389200; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; Uren AG, 1996, P NATL ACAD SCI USA, V93, P4974, DOI 10.1073/pnas.93.10.4974; Varfolomeev E, 2005, J BIOL CHEM, V280, P40599, DOI 10.1074/jbc.M509560200; Vaux DL, 2005, NAT REV MOL CELL BIO, V6, P287, DOI 10.1038/nrm1621; Vucic D, 2000, CURR BIOL, V10, P1359, DOI 10.1016/S0960-9822(00)00781-8; Vucic D, 2005, BIOCHEM J, V385, P11, DOI 10.1042/BJ20041108; Vucic D, 2002, J BIOL CHEM, V277, P12275, DOI 10.1074/jbc.M112045200; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wu G, 2000, NATURE, V408, P1008, DOI 10.1038/35050012; Ye HT, 2003, BLOOD, V102, P1012, DOI 10.1182/blood-2002-11-3502; Zhou HL, 2005, CANCER CELL, V7, P425, DOI 10.1016/j.ccr.2005.04.012; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	38	66	70	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					29022	29029		10.1074/jbc.M605116200	http://dx.doi.org/10.1074/jbc.M605116200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16891304	hybrid			2022-12-27	WOS:000240680500057
J	Dehm, SM; Tindall, DJ				Dehm, Scott M.; Tindall, Donald J.			Ligand-independent androgen receptor activity is activation function-2-independent and resistant to antiandrogens in androgen refractory prostate cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COOH-TERMINAL INTERACTION; BINDING DOMAIN; NUCLEAR RECEPTORS; EXPRESSION; REGIONS; ANTIGEN; TRANSACTIVATION; TRANSCRIPTION; COACTIVATORS; INTERDOMAIN	Androgen ablation inhibits androgen receptor (AR) activity and is as an effective treatment for advanced prostate cancer (PCa). Invariably, PCa relapses in a form resistant to further hormonal manipulations. Although this stage of the disease is androgen-refractory, or androgen depletion-independent (ADI), most tumors remain AR-dependent through aberrant mechanisms of AR activation. We employed the LNCaP/C4-2 model of PCa progression to study AR activity in androgen-dependent and ADI PCa cells. In this report, we show that the AR is transcriptionally inactive in androgen-dependent LNCaP cells in the absence of androgens. However, in ADI C4-2 cells, the AR displays a high level of constitutive, androgen-independent transcriptional activity. To study the mechanisms of ligand dependent and ligand-independent AR activation in these AR-expressing cells, we generated a reporter system based on swapping the DNA binding domain of the AR with the DNA binding domain of the yeast Gal4 transcription factor. In androgen-dependent PCa cells, the well characterized C-terminal AR activation function-2 (AF-2) domain was critical for strong, ligand-dependent activity. Conversely, in ADI PCa cells, constitutive, ligand-independent AR activity was AF-2-independent but instead dependent on N-terminal AR domains. Importantly, the ligand- and AF-2-independent mode of AR activation observed in ADI PCa cells was completely resistant to the antiandrogen, bicalutamide. Our data thus demonstrate that the AR can inappropriately activate transcription in ADI PCa cells via mechanisms that are resistant to castration and AR antagonism, the two modes of androgen ablation used to treat advanced PCa.	Mayo Clin & Mayo Fdn, Coll Med, Dept Urol Res, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Tindall, DJ (corresponding author), Mayo Clin & Mayo Fdn, Coll Med, Dept Urol Res, 200 1st St SW, Rochester, MN 55905 USA.	tindall.donald@mayo.edu			NCI NIH HHS [CA91956] Funding Source: Medline; NIDDK NIH HHS [DK60920] Funding Source: Medline; PHS HHS [D65236] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA091956] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060920] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Agoulnik IU, 2005, CANCER RES, V65, P7959, DOI 10.1158/0008-5472.CAN-04-3541; Alen P, 1999, MOL CELL BIOL, V19, P6085; Bevan CL, 1999, MOL CELL BIOL, V19, P8383; Bohl CE, 2004, J MED CHEM, V47, P3765, DOI 10.1021/jm0499007; Callewaert L, 2006, CANCER RES, V66, P543, DOI 10.1158/0008-5472.CAN-05-2389; Chamberlain NL, 1996, J BIOL CHEM, V271, P26772, DOI 10.1074/jbc.271.43.26772; Chen L, 2004, NEW ASTRON, V10, P39, DOI 10.1016/j.newast.2004.04.008; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159; Christiaens V, 2002, J BIOL CHEM, V277, P49230, DOI 10.1074/jbc.M209322200; Culig Z, 2004, J STEROID BIOCHEM, V92, P265, DOI 10.1016/j.jsbmb.2004.10.003; Debes JD, 2005, CANCER RES, V65, P5965, DOI 10.1158/0008-5472.CAN-04-2837; Eder IE, 2000, CANCER GENE THER, V7, P997, DOI 10.1038/sj.cgt.7700202; Estebanez-Perpina E, 2005, J BIOL CHEM, V280, P8060, DOI 10.1074/jbc.M407046200; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Gao WQ, 2004, ENDOCRINOLOGY, V145, P5420, DOI 10.1210/en.2004-0627; Gregory CW, 2001, CANCER RES, V61, P4315; Grossmann ME, 2001, JNCI-J NATL CANCER I, V93, P1687, DOI 10.1093/jnci/93.22.1687; Haag P, 2005, J STEROID BIOCHEM, V96, P251, DOI 10.1016/j.jsbmb.2005.04.029; He B, 2002, J BIOL CHEM, V277, P25631, DOI 10.1074/jbc.M202809200; He B, 2000, J BIOL CHEM, V275, P22986, DOI 10.1074/jbc.M002807200; He B, 2004, MOL CELL, V16, P425, DOI 10.1016/j.molcel.2004.09.036; He B, 2002, J BIOL CHEM, V277, P10226, DOI 10.1074/jbc.M111975200; He B, 1999, J BIOL CHEM, V274, P37219, DOI 10.1074/jbc.274.52.37219; He B, 2001, J BIOL CHEM, V276, P42293, DOI 10.1074/jbc.M107492200; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Huang WB, 1999, J BIOL CHEM, V274, P25756, DOI 10.1074/jbc.274.36.25756; Ikonen T, 1997, J BIOL CHEM, V272, P29821, DOI 10.1074/jbc.272.47.29821; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; JENSTER G, 1995, J BIOL CHEM, V270, P7341, DOI 10.1074/jbc.270.13.7341; Lamb DJ, 2001, VITAM HORM, V62, P199, DOI 10.1016/S0083-6729(01)62005-3; Liao XB, 2005, MOL CANCER THER, V4, P505, DOI 10.1158/1535-7163.MCT-04-0313; Litvinov IV, 2003, J CLIN ENDOCR METAB, V88, P2972, DOI 10.1210/jc.2002-022038; Marhefka CA, 2004, J MED CHEM, V47, P993, DOI 10.1021/jm030336u; Matias PM, 2000, J BIOL CHEM, V275, P26164, DOI 10.1074/jbc.M004571200; Metzger E, 2003, EMBO J, V22, P270, DOI 10.1093/emboj/cdg023; Naar AM, 2001, ANNU REV BIOCHEM, V70, P475, DOI 10.1146/annurev.biochem.70.1.475; Roy-Burman P, 2005, CANCER BIOL THER, V4, P4, DOI 10.4161/cbt.4.1.1563; Scherr D, 2003, UROLOGY, V61, P14, DOI 10.1016/S0090-4295(02)02395-6; Shah RB, 2004, CANCER RES, V64, P9209, DOI 10.1158/0008-5472.CAN-04-2442; Slagsvold T, 2000, MOL ENDOCRINOL, V14, P1603, DOI 10.1210/me.14.10.1603; Warnmark A, 2003, MOL ENDOCRINOL, V17, P1901, DOI 10.1210/me.2002-0384; WU HC, 1994, INT J CANCER, V57, P406, DOI 10.1002/ijc.2910570319; Yeung F, 2000, J BIOL CHEM, V275, P40846, DOI 10.1074/jbc.M002755200; Yin DH, 2003, J PHARMACOL EXP THER, V304, P1334, DOI 10.1124/jpet.102.040840; Zegarra-Moro OL, 2002, CANCER RES, V62, P1008; Zhu P, 2006, CELL, V124, P615, DOI 10.1016/j.cell.2005.12.032	47	79	91	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					27882	27893		10.1074/jbc.M605002200	http://dx.doi.org/10.1074/jbc.M605002200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16870607	hybrid			2022-12-27	WOS:000240534400024
J	Denny, PW; Shams-Eldin, H; Price, HP; Smith, DF; Schwarz, RT				Denny, Paul W.; Shams-Eldin, Hosam; Price, Helen. P.; Smith, Deborah F.; Schwarz, Ralph T.			The protozoan inositol phosphorylceramide synthase - A novel drug target that defines a new class of sphingolipid synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; LIPID RAFTS; SCHIZOSACCHAROMYCES-POMBE; LEISHMANIA-MEXICANA; TRYPANOSOMA-CRUZI; ANCHORING MUTANT; AUR1 GENE; BIOSYNTHESIS; SPHINGOMYELIN; PHOSPHATIDYLINOSITOL	Sphingolipids are ubiquitous and essential components of eukaryotic membranes, particularly the plasma membrane. The biosynthetic pathway for the formation of these lipid species is conserved up to the formation of sphinganine. However, a divergence is apparent in the synthesis of complex sphingolipids. In animal cells, ceramide is a substrate for sphingomyelin (SM) production via the enzyme SM synthase. In contrast, fungi utilize phytoceramide in the synthesis of inositol phosphorylceramide (IPC) catalyzed by IPC synthase. Because of the absence of a mammalian equivalent, this essential enzyme represents an attractive target for anti-fungal compounds. In common with the fungi, the kinetoplastid protozoa (and higher plants) synthesize IPC rather than SM. However, orthologues of the gene believed to encode the fungal IPC synthase (AUR1) are not readily identified in the complete genome data bases of these species. By utilizing bioinformatic and functional genetic approaches, we have isolated a functional orthologue of AUR1 in the kinetoplastids, causative agents of a range of important human diseases. Expression of this gene in a mammalian cell line led to the synthesis of an IPC-like species, strongly indicating that IPC synthase activity is reconstituted. Furthermore, the gene product can be specifically inhibited by an anti-fungal-targeting IPC synthase. We propose that the kinetoplastid AUR1 functional orthologue encodes an enzyme that defines a new class of protozoan sphingolipid synthase. The identification and characterization of the protozoan IPC synthase, an enzyme with no mammalian equivalent, will raise the possibility of developing anti-protozoal drugs with minimal toxic side affects.	Univ Durham, Wolfson Res Inst, Ctr Infect Dis, Stockton On Tees TS17 6BH, England; Univ Marburg, Med Ctr Hyg & Med Microbiol, Inst Virol, D-35043 Marburg, Germany; Univ York, Dept Biol, Immunol & Infect Unit, York YO10 5YW, N Yorkshire, England; Univ Sci & Tech Lille Flandres Artois, UMR 8576 CNRS, Unite Glycobiol Struct & Fonctionnelle, Inst Federatif Rech 118, F-59655 Villeneuve Dascq, France	Durham University; Philipps University Marburg; University of York - UK; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille	Denny, PW (corresponding author), Univ Durham, Wolfson Res Inst, Ctr Infect Dis, Queens Campus, Stockton On Tees TS17 6BH, England.	p.w.denny@durham.ac.uk	Denny, Paul/B-8431-2013; Filho, Fernando C/Q-8021-2018	Denny, Paul/0000-0002-5051-1613; Price, Helen/0000-0003-1537-4390	BBSRC [BB/D52396X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D52396X/1] Funding Source: Medline; Wellcome Trust [077503] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		BECKER GW, 1980, J BACTERIOL, V142, P747, DOI 10.1128/JB.142.3.747-754.1980; Bromley PE, 2003, ARCH BIOCHEM BIOPHYS, V417, P219, DOI 10.1016/S0003-9861(03)00339-4; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Croft SL, 2005, TRENDS PARASITOL, V21, P508, DOI 10.1016/j.pt.2005.08.026; Denny PW, 2004, MOL MICROBIOL, V53, P725, DOI 10.1111/j.1365-2958.2004.04208.x; Denny PW, 2004, MOL MICROBIOL, V52, P313, DOI 10.1111/j.1365-2958.2003.03975.x; Denny PW, 2001, FEBS LETT, V491, P148, DOI 10.1016/S0014-5793(01)02172-X; Dickson RC, 1997, J BIOL CHEM, V272, P29620, DOI 10.1074/jbc.272.47.29620; Dickson RC, 1999, BBA-GEN SUBJECTS, V1426, P347, DOI 10.1016/S0304-4165(98)00135-4; Figueiredo JM, 2005, BIOCHEM J, V387, P519, DOI 10.1042/BJ20041842; Futerman AH, 2004, EMBO REP, V5, P777, DOI 10.1038/sj.embor.7400208; Futerman AH, 2005, TRENDS CELL BIOL, V15, P312, DOI 10.1016/j.tcb.2005.04.006; Georgopapadakou NH, 2000, EXPERT OPIN INV DRUG, V9, P1787, DOI 10.1517/13543784.9.8.1787; Ghosh S, 2002, INFECT IMMUN, V70, P6828, DOI 10.1128/IAI.70.12.6828-6838.2002; Haak D, 1997, J BIOL CHEM, V272, P29704, DOI 10.1074/jbc.272.47.29704; Hashida-Okado T, 1998, CURR GENET, V33, P38, DOI 10.1007/s002940050306; HashidaOkado T, 1996, MOL GEN GENET, V251, P236; HEIDLER SA, 1995, ANTIMICROB AGENTS CH, V39, P2765, DOI 10.1128/AAC.39.12.2765; Heidler SA, 2000, BBA-MOL BASIS DIS, V1500, P147, DOI 10.1016/S0925-4439(99)00097-6; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; JOHNSTON M, 1984, MOL CELL BIOL, V4, P1440, DOI 10.1128/MCB.4.8.1440; KANESHIRO ES, 1986, J LIPID RES, V27, P1294; LESTER RL, 1993, ADV LIPID RES, V26, P253; Levine TP, 2000, MOL BIOL CELL, V11, P2267, DOI 10.1091/mbc.11.7.2267; Liebisch G, 2004, BBA-MOL CELL BIOL L, V1686, P108, DOI 10.1016/j.bbalip.2004.09.003; LORENZ MC, 1995, GENE, V158, P113, DOI 10.1016/0378-1119(95)00144-U; Luberto C, 2003, J BIOL CHEM, V278, P32733, DOI 10.1074/jbc.M300932200; Luberto C, 2001, GENE DEV, V15, P201, DOI 10.1101/gad.856001; Magee T, 2002, BIOL RES, V35, P127, DOI 10.4067/S0716-97602002000200003; Nagiec MM, 2003, BIOCHEM BIOPH RES CO, V307, P369, DOI 10.1016/S0006-291X(03)01164-1; Nagiec MM, 1997, J BIOL CHEM, V272, P9809, DOI 10.1074/jbc.272.15.9809; Neuwald AF, 1997, PROTEIN SCI, V6, P1764, DOI 10.1002/pro.5560060817; Nyame AK, 2004, ARCH BIOCHEM BIOPHYS, V426, P182, DOI 10.1016/j.abb.2004.04.004; Pierce SK, 2002, NAT REV IMMUNOL, V2, P96, DOI 10.1038/nri726; Ralton JE, 1998, J BIOL CHEM, V273, P4245, DOI 10.1074/jbc.273.7.4245; Rost B, 1996, METHOD ENZYMOL, V266, P525; Salto ML, 2003, EUKARYOT CELL, V2, P756, DOI 10.1128/EC.2.4.756-768.2003; Schorling S, 2001, MOL BIOL CELL, V12, P3417, DOI 10.1091/mbc.12.11.3417; Segui B, 2002, BIOCHEM J, V366, P23, DOI 10.1042/BJ20020317; Shams-Eldin H, 2002, MOL BIOCHEM PARASIT, V120, P73, DOI 10.1016/S0166-6851(01)00434-0; Shams-Eldin H, 2001, YEAST, V18, P33, DOI 10.1002/1097-0061(200101)18:1<33::AID-YEA648>3.0.CO;2-Z; SINGH BN, 1988, BIOCHEM BIOPH RES CO, V157, P1239, DOI 10.1016/S0006-291X(88)81007-6; Sperling P, 2003, BBA-MOL CELL BIOL L, V1632, P1, DOI 10.1016/S1388-1981(03)00033-7; Zhang K, 2005, MOL MICROBIOL, V55, P1566, DOI 10.1111/j.1365-2958.2005.04493.x; Zufferey R, 2003, J BIOL CHEM, V278, P44708, DOI 10.1074/jbc.M308063200	46	69	75	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					28200	28209		10.1074/jbc.M600796200	http://dx.doi.org/10.1074/jbc.M600796200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16861742	Green Accepted, hybrid			2022-12-27	WOS:000240534400058
J	Drouet, J; Frit, P; Delteil, C; de Villartay, JP; Salles, B; Calsou, P				Drouet, Jerome; Frit, Philippe; Delteil, Christine; de Villartay, Jean-Pierre; Salles, Bernard; Calsou, Patrick			Interplay between Ku, artemis, and the DNA-dependent protein kinase catalytic subunit at DNA ends	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; SEVERE COMBINED IMMUNODEFICIENCY; V(D)J RECOMBINATION; LIGASE-IV; POLY(ADP-RIBOSE) POLYMERASE-1; GENOMIC INSTABILITY; SKIN FIBROBLASTS; REGULATES DNA; CELL-LINE; DAMAGE	Repair of DNA double strand breaks (DSB) by the nonhomologous end-joining pathway in mammals requires at least seven proteins involved in a simplified two-step process: (i) recognition and synapsis of the DNA ends dependent on the DNA-dependent protein kinase (DNA-PK) formed by the Ku70/Ku80 heterodimer and the catalytic subunit DNA-PKcs in association with Artemis; (ii) ligation dependent on the DNA ligase IV (.) XRCC4 (.) Cernunnos-XLF complex. The Artemis protein exhibits exonuclease and endonuclease activities that are believed to be involved in the processing of a subclass of DSB. Here, we have analyzed the interactions of Artemis and nonhomologous end-joining pathway proteins both in a context of human nuclear cell extracts and in cells. DSB-inducing agents specifically elicit the mobilization of Artemis to damaged chromatin together with DNA-PK and XRCC4/ligase IV proteins. DNA-PKcs is necessary for the loading of Artemis on damaged DNA and is the main kinase that phosphorylates Artemis in cells damaged with highly efficient DSB producers. Under kinase-preventive conditions, both in vitro and in cells, Ku-mediated assembly of DNA-PK on DNA ends is responsible for a dissociation of the DNA-PKcs (.) Artemis complex. Conversely, DNA-PKcs kinase activity prevents Artemis dissociation from the DNA-PK (.) DNA complex. Altogether, our data allow us to propose a model in which a DNA-PKcs-mediated phosphorylation is necessary both to activate Artemis endonuclease activity and to maintain its association with the DNA end site. This tight functional coupling between the activation of both DNA-PKcs and Artemis may avoid improper processing of DNA.	CNRS, UMR 5089, Inst Pharmacol & Biol Struct, F-31077 Toulouse 4, France; INSERM, Hop Necker Enfants Malad, U768, Unite Dev Normal & Pathol Syst Immunitaire, F-75015 Paris, France; Univ Paris Descartes, Fac Med Rene Descartes, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Salles, B (corresponding author), CNRS, UMR 5089, Inst Pharmacol & Biol Struct, 205 Route Narbonne, F-31077 Toulouse 4, France.	bernard.salles@ipbs.fr	de Villartay, jean pierre/H-9353-2017; calsou, patrick/AAB-5123-2020; salles, bernard/B-8531-2008	de Villartay, jean pierre/0000-0001-5987-0463; Calsou, Patrick/0000-0001-7951-9806				Ahnesorg P, 2006, CELL, V124, P301, DOI 10.1016/j.cell.2005.12.031; Audebert M, 2004, J BIOL CHEM, V279, P55117, DOI 10.1074/jbc.M404524200; Boskovic J, 2003, EMBO J, V22, P5875, DOI 10.1093/emboj/cdg555; Buck D, 2006, CELL, V124, P287, DOI 10.1016/j.cell.2005.12.030; Calsou P, 2003, J MOL BIOL, V326, P93, DOI 10.1016/S0022-2836(02)01328-1; Calsou P, 1999, J BIOL CHEM, V274, P7848, DOI 10.1074/jbc.274.12.7848; CAVAZZANACALVO M, 1993, J CLIN INVEST, V91, P1214, DOI 10.1172/JCI116282; Chan DW, 1996, J BIOL CHEM, V271, P8936, DOI 10.1074/jbc.271.15.8936; Chen L, 2005, CANCER SCI, V96, P134, DOI 10.1111/j.1349-7006.2005.00019.x; Collis SJ, 2005, ONCOGENE, V24, P949, DOI 10.1038/sj.onc.1208332; Cui XP, 2005, MOL CELL BIOL, V25, P10842, DOI 10.1128/MCB.25.24.10842-10852.2005; Dai Y, 2003, P NATL ACAD SCI USA, V100, P2462, DOI 10.1073/pnas.0437964100; de Villartay JP, 2003, CURR OPIN IMMUNOL, V15, P592, DOI 10.1016/S0952-7915(03)00101-8; Dip R, 2005, FASEB J, V19, P704, DOI 10.1096/fj.04-3041rev; Downs JA, 2004, NAT REV MOL CELL BIO, V5, P367, DOI 10.1038/nrm1367; Drouet J, 2005, J BIOL CHEM, V280, P7060, DOI 10.1074/jbc.M410746200; Elmroth K, 2003, DNA REPAIR, V2, P363, DOI 10.1016/S1568-7864(02)00235-5; Evans PM, 2006, HUM MOL GENET, V15, P1303, DOI 10.1093/hmg/ddl050; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Gell D, 1999, NUCLEIC ACIDS RES, V27, P3494, DOI 10.1093/nar/27.17.3494; Grawunder U, 1998, MOL CELL, V2, P477, DOI 10.1016/S1097-2765(00)80147-1; Gupta S, 2005, NUCLEIC ACIDS RES, V33, P6972, DOI 10.1093/nar/gki990; Hammarsten O, 2000, J BIOL CHEM, V275, P1541, DOI 10.1074/jbc.275.3.1541; Hammarsten O, 1998, P NATL ACAD SCI USA, V95, P525, DOI 10.1073/pnas.95.2.525; Harris R, 2004, J MOL BIOL, V335, P573, DOI 10.1016/j.jmb.2003.10.047; Hoppe BS, 2000, RADIAT RES, V153, P125, DOI 10.1667/0033-7587(2000)153[0125:COTRMC]2.0.CO;2; Jin SF, 1997, J BIOL CHEM, V272, P24763, DOI 10.1074/jbc.272.40.24763; Kim CH, 2002, J PHARMACOL EXP THER, V303, P753, DOI 10.1124/jpet.102.038505; Lees-Miller SP, 2003, BIOCHIMIE, V85, P1161, DOI 10.1016/j.biochi.2003.10.011; Leuther KK, 1999, EMBO J, V18, P1114, DOI 10.1093/emboj/18.5.1114; Li ZY, 1995, CELL, V83, P1079, DOI 10.1016/0092-8674(95)90135-3; Llorca O, 2004, MICRON, V35, P625, DOI 10.1016/j.micron.2004.05.004; Ma YM, 2004, MOL CELL, V16, P701, DOI 10.1016/j.molcel.2004.11.017; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; Ma YM, 2005, J BIOL CHEM, V280, P33839, DOI 10.1074/jbc.M507113200; Marangoni E, 2000, NUCLEIC ACIDS RES, V28, P4778, DOI 10.1093/nar/28.23.4778; Meek K, 2004, IMMUNOL REV, V200, P132, DOI 10.1111/j.0105-2896.2004.00162.x; Mills KD, 2003, IMMUNOL REV, V194, P77, DOI 10.1034/j.1600-065X.2003.00060.x; Moshous D, 2001, CELL, V105, P177, DOI 10.1016/S0092-8674(01)00309-9; Moshous D, 2000, HUM MOL GENET, V9, P583, DOI 10.1093/hmg/9.4.583; Moshous D, 2003, J CLIN INVEST, V111, P381, DOI 10.1172/JCI200316774; Nicolas N, 1996, EUR J IMMUNOL, V26, P1118, DOI 10.1002/eji.1830260524; Nicolas N, 1998, J EXP MED, V188, P627, DOI 10.1084/jem.188.4.627; O'Driscoll M, 2006, NAT REV GENET, V7, P45, DOI 10.1038/nrg1746; ONO M, 1994, NUCLEIC ACIDS RES, V22, P3918, DOI 10.1093/nar/22.19.3918; Pannicke U, 2004, EMBO J, V23, P1987, DOI 10.1038/sj.emboj.7600206; Poinsignon C, 2004, EUR J IMMUNOL, V34, P3146, DOI 10.1002/eji.200425455; Poinsignon C, 2004, J EXP MED, V199, P315, DOI 10.1084/jem.20031142; Povirk LF, 1996, MUTAT RES-FUND MOL M, V355, P71, DOI 10.1016/0027-5107(96)00023-1; Reddy YVR, 2004, J BIOL CHEM, V279, P39408, DOI 10.1074/jbc.M406432200; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Rivera-Calzada A, 2005, STRUCTURE, V13, P243, DOI 10.1016/j.str.2004.12.006; Rooney S, 2004, IMMUNOL REV, V200, P115, DOI 10.1111/j.0105-2896.2004.00165.x; Rooney S, 2004, P NATL ACAD SCI USA, V101, P2410, DOI 10.1073/pnas.0308757101; Rooney S, 2003, J EXP MED, V197, P553, DOI 10.1084/jem.20021891; Rooney S, 2002, MOL CELL, V10, P1379, DOI 10.1016/S1097-2765(02)00755-4; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; SHILOH Y, 1983, CARCINOGENESIS, V4, P917, DOI 10.1093/carcin/4.7.917; Singleton BK, 1999, MOL CELL BIOL, V19, P3267; Veuger SJ, 2003, CANCER RES, V63, P6008; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Wang HC, 2005, CANCER RES, V65, P4020, DOI 10.1158/0008-5472.CAN-04-3055; Wang JH, 2005, DNA REPAIR, V4, P556, DOI 10.1016/j.dnarep.2005.02.001; Weterings E, 2004, DNA REPAIR, V3, P1425, DOI 10.1016/j.dnarep.2004.06.003; Yaneva M, 1997, EMBO J, V16, P5098, DOI 10.1093/emboj/16.16.5098; Zhang XS, 2004, MOL CELL BIOL, V24, P9207, DOI 10.1128/MCB.24.20.9207-9220.2004; Zhang ZM, 2004, STRUCTURE, V12, P495, DOI 10.1016/j.str.2004.02.007	67	61	65	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					27784	27793		10.1074/jbc.M603047200	http://dx.doi.org/10.1074/jbc.M603047200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16857680	hybrid			2022-12-27	WOS:000240534400014
J	Partridge, JD; Scott, C; Tang, Y; Poole, RK; Green, J				Partridge, Jonathan D.; Scott, Colin; Tang, Yue; Poole, Robert K.; Green, Jeffrey			Escherichia coli transcriptome dynamics during the transition from anaerobic to aerobic conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACONITASE-B; POSTTRANSCRIPTIONAL REGULATION; 2-COMPONENT SYSTEM; FUMARASE FUMA; FNR; GENES; OXYGEN; SUPEROXIDE; EXPRESSION; REGULON	Escherichia coli is a metabolically versatile bacterium that is able to grow in the presence and absence of oxygen. Several previous transcript-profiling experiments have compared separate anaerobic and aerobic cultures. Here the process of adaptation was investigated by determining changes in transcript profiles when anaerobic steady-state cultures were perturbed by the introduction of air. Within 5 min of culture aeration the abundances of transcripts associated with anaerobic metabolism were decreased, whereas transcripts associated with aerobic metabolism were increased. In addition to the rapid switch to aerobic central metabolism, transcript profiling, supported by experiments with relevant mutants, revealed transient changes suggesting that the peroxide stress response, methionine biosynthesis, and degradation of putrescine play important roles during the adaptation to aerobic conditions.	Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Green, J (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England.	jeff.green@sheffield.ac.uk	Partridge, Jonathan/GSD-6795-2022; Scott, Colin/A-4682-2009; Tang, Yue/C-7094-2011	Scott, Colin/0000-0001-6110-6982; Partridge, Jonathan/0000-0003-2536-5404	Biotechnology and Biological Sciences Research Council [BBS/B/01472] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Alexeeva S, 2000, J BACTERIOL, V182, P4934, DOI 10.1128/JB.182.17.4934-4940.2000; Barras F, 2005, ADV MICROB PHYSIOL, V50, P41, DOI 10.1016/S0065-2911(05)50002-X; BENOFSKY C, 1973, ANAL BIOCHEM, V53, P452; Bock A., 1996, ESCHERICHIA COLI SAL, V2, P262; BONGAERTS J, 1995, MOL MICROBIOL, V16, P521, DOI 10.1111/j.1365-2958.1995.tb02416.x; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Chattopadhyay MK, 2003, P NATL ACAD SCI USA, V100, P2261, DOI 10.1073/pnas.2627990100; CLARK DP, 1989, FEMS MICROBIOL LETT, V63, P223, DOI 10.1111/j.1574-6968.1989.tb03398.x; Constantinidou C, 2006, J BIOL CHEM, V281, P4802, DOI 10.1074/jbc.M512312200; COTTER PA, 1992, FEMS MICROBIOL LETT, V91, P31; Covert MW, 2004, NATURE, V429, P92, DOI 10.1038/nature02456; Cunningham L, 1998, MICROBIOL-SGM, V144, P2113, DOI 10.1099/00221287-144-8-2113; DORMAN CJ, 1988, J BACTERIOL, V170, P2816, DOI 10.1128/jb.170.6.2816-2826.1988; Evans C. G. T., 1970, METHODS MICROBIOLOGY, V2, DOI [10.1016/S0580-9517(08)70227-7, DOI 10.1016/S0580-9517(08)70227-7]; Flatley J, 2005, J BIOL CHEM, V280, P10065, DOI 10.1074/jbc.M410393200; Gennis R. B., 1996, ESCHERICHIA COLI SAL, P217; Georgellis D, 1999, J BIOL CHEM, V274, P35950, DOI 10.1074/jbc.274.50.35950; Georgellis D, 2001, SCIENCE, V292, P2314, DOI 10.1126/science.1059361; Giel JL, 2006, MOL MICROBIOL, V60, P1058, DOI 10.1111/j.1365-2958.2006.05160.x; Gimenez R, 2003, J BACTERIOL, V185, P6448, DOI 10.1128/JB.185.21.6448-6455.2003; GONZALEZFLECHA B, 1995, J BIOL CHEM, V270, P13681, DOI 10.1074/jbc.270.23.13681; Gort AS, 1999, MOL MICROBIOL, V32, P179, DOI 10.1046/j.1365-2958.1999.01343.x; Govantes F, 2000, MOL MICROBIOL, V38, P1061, DOI 10.1046/j.1365-2958.2000.02215.x; Green J, 2004, NAT REV MICROBIOL, V2, P954, DOI 10.1038/nrmicro1022; GREENE RC, 1996, ESCHERICHIA COLI SAL, P542; GRUER MJ, 1994, MICROBIOL-SGM, V140, P2531, DOI 10.1099/00221287-140-10-2531; Guest John R., 1996, P317; Hondorp ER, 2004, PLOS BIOL, V2, P1738, DOI 10.1371/journal.pbio.0020336; Hoskisson PA, 2005, MICROBIOL-SGM, V151, P3153, DOI 10.1099/mic.0.27924-0; IMLAY JA, 1995, J BIOL CHEM, V270, P19767; Imlay JA, 2002, ADV MICROB PHYSIOL, V46, P111, DOI 10.1016/S0065-2911(02)46003-1; Jordan PA, 1999, BIOCHEM J, V344, P739, DOI 10.1042/0264-6021:3440739; Jung IL, 2003, BIOCHEM BIOPH RES CO, V301, P915, DOI 10.1016/S0006-291X(03)00064-0; Jung IL, 2003, CELL BIOL TOXICOL, V19, P29, DOI 10.1023/A:1022065614490; Kang YS, 2005, J BACTERIOL, V187, P1135, DOI 10.1128/JB.187.3.1135-1160.2005; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kurihara S, 2005, J BIOL CHEM, V280, P4602, DOI 10.1074/jbc.M411114200; LANG E, 1972, FRESEN Z ANAL CHEM, V260, P8, DOI 10.1007/BF00437519; Leichert LI, 2004, PLOS BIOL, V2, P1723, DOI 10.1371/journal.pbio.0020333; LENNOX ES, 1955, VIROLOGY, V1, P190, DOI 10.1016/0042-6822(55)90016-7; Lynch A. Simon, 1996, P361; Martin RG, 1999, MOL MICROBIOL, V34, P431, DOI 10.1046/j.1365-2958.1999.01599.x; Miller J. H, 1972, EXPT MOL GENETICS; MUNRO GF, 1972, J BIOL CHEM, V247, P1272; PARK SJ, 1995, J BACTERIOL, V177, P6255, DOI 10.1128/jb.177.21.6255-6262.1995; Park SJ, 1997, J BACTERIOL, V179, P4138, DOI 10.1128/jb.179.13.4138-4142.1997; Perrenoud A, 2005, J BACTERIOL, V187, P3171, DOI 10.1128/JB.187.9.3171-3179.2005; Pomposiello PJ, 2001, J BACTERIOL, V183, P3890, DOI 10.1128/JB.183.13.3890-3902.2001; Rozen S, 2000, Methods Mol Biol, V132, P365; Salmon K, 2003, J BIOL CHEM, V278, P29837, DOI 10.1074/jbc.M213060200; Sambrook J., 2001, MOL CLONING LAB MANU; Seaver LC, 2004, J BIOL CHEM, V279, P48742, DOI 10.1074/jbc.M408754200; Storz G, 2000, BACTERIAL STRESS RESPONSES, P47; Sutton VR, 2004, J BACTERIOL, V186, P8018, DOI 10.1128/JB.186.23.8018-8025.2004; TABOR CW, 1985, MICROBIOL REV, V49, P81, DOI 10.1128/MMBR.49.1.81-99.1985; Tang Y, 1999, MICROBIOL-SGM, V145, P3069, DOI 10.1099/00221287-145-11-3069; Tang Y, 2005, MOL MICROBIOL, V56, P1149, DOI 10.1111/j.1365-2958.2005.04610.x; Tang Y, 2004, MOL MICROBIOL, V51, P1817, DOI 10.1111/j.1365-2958.2003.03954.x; Tao K, 1999, FEBS LETT, V457, P90, DOI 10.1016/S0014-5793(99)01013-3; Tkachenko A G, 2001, Mikrobiologiia, V70, P487; Travers A, 2005, NAT REV MICROBIOL, V3, P157, DOI 10.1038/nrmicro1088; Tseng CP, 2001, J BACTERIOL, V183, P461, DOI 10.1128/JB.183.2.461-467.2001; Varghese S, 2003, J BACTERIOL, V185, P221, DOI 10.1128/JB.185.1.221-230.2003; Williams CH, 2002, NAT STRUCT BIOL, V9, P447, DOI 10.1038/nsb801; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718; Zheng M, 1999, J BACTERIOL, V181, P4639, DOI 10.1128/JB.181.15.4639-4643.1999; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001	67	85	86	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					27806	27815		10.1074/jbc.M603450200	http://dx.doi.org/10.1074/jbc.M603450200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16857675	hybrid			2022-12-27	WOS:000240534400016
J	Asano, S; Park, JE; Yu, LR; Zhou, M; Sakchaisri, K; Park, CJ; Kang, YH; Thorner, J; Veenstra, TD; Lee, KS				Asano, Satoshi; Park, Jung-Eun; Yu, Li-Rong; Zhou, Ming; Sakchaisri, Krisada; Park, Chong J.; Kang, Young H.; Thorner, Jeremy; Veenstra, Timothy D.; Lee, Kyung S.			Direct phosphorylation and activation of a Nim1-related kinase Gin4 by Elm1 in budding yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREVISIAE CELL-CYCLE; MITOTIC SIGNALING NETWORK; SACCHAROMYCES-CEREVISIAE; PROTEIN-KINASE; GENE-PRODUCT; SEPTIN FUNCTION; EVENTS; MORPHOGENESIS; LOCALIZATION; ORGANIZATION	In budding yeast, Gin4, a Nim1-related kinase, plays an important role in proper organization of the septin ring at the mother-bud neck, a filamentous structure that is critical for diverse cellular processes including mitotic entry and cytokinesis. How Gin4 kinase activity is regulated is not known. Here we showed that a neck-associated Ser/Thr kinase Elm1, which is important for septin assembly, is critical for proper modification of Gin4 and its physiological substrate Shs1. In vitro studies with purified recombinant proteins demonstrated that Elm1 directly phosphorylates and activates Gin4, which in turn phosphorylates Shs1. Consistent with these observations, acute inhibition of Elm1 activity abolished mitotic Gin4 phosphorylation and Gin4-dependent Shs1 modification in vivo. In addition, a gin4 mutant lacking the Elm1-dependent phosphorylation sites exhibited an impaired localization to the bud-neck and, as a result, induced a significant growth defect with an elongated bud morphology. Thus, Elm1 regulates the septin assembly-dependent cellular events by directly phosphorylating and activating the Gin4-dependent pathway(s).	NCI, NIH, Lab Metab, Canc Res Ctr, Bethesda, MD 20892 USA; NCI, Lab Proteom & Analyt Technol, NIH, Ft Detrick, MD 21702 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California Berkeley	Lee, KS (corresponding author), NCI, NIH, Lab Metab, Canc Res Ctr, 9000 Rockville Pike,Bldg 37,Rm 3118, Bethesda, MD 20892 USA.	kyunglee@mail.nih.gov	THORNER, Jeremy/O-6132-2019	THORNER, Jeremy/0000-0002-2583-500X; Yu, Li-Rong/0000-0001-6084-991X	Intramural NIH HHS Funding Source: Medline; NIGMS NIH HHS [GM21841] Funding Source: Medline; DIVISION OF BASIC SCIENCES - NCI [Z01BC010521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM021841, R01GM021841] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DIVISION OF BASIC SCIENCES - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS AEM, 1984, J CELL BIOL, V98, P934, DOI 10.1083/jcb.98.3.934; Altman R, 1997, J CELL BIOL, V138, P119, DOI 10.1083/jcb.138.1.119; Asano S, 2005, EMBO J, V24, P2194, DOI 10.1038/sj.emboj.7600683; Barral Y, 1999, GENE DEV, V13, P176, DOI 10.1101/gad.13.2.176; Bishop AC, 1998, CURR BIOL, V8, P257, DOI 10.1016/S0960-9822(98)70198-8; Bouquin N, 2000, J CELL SCI, V113, P1435; BYERS B, 1976, J CELL BIOL, V69, P717, DOI 10.1083/jcb.69.3.717; Carroll CW, 1998, J CELL BIOL, V143, P709, DOI 10.1083/jcb.143.3.709; Cid VJ, 2001, MOL BIOL CELL, V12, P1645, DOI 10.1091/mbc.12.6.1645; Edgington NP, 1999, MOL CELL BIOL, V19, P1369; FORD SK, 1991, DEV GENET, V12, P281, DOI 10.1002/dvg.1020120405; Frazier JA, 1998, J CELL BIOL, V143, P737, DOI 10.1083/jcb.143.3.737; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; HAARER BK, 1987, MOL CELL BIOL, V7, P3678, DOI 10.1128/MCB.7.10.3678; Hanrahan J, 2003, MOL CELL, V12, P663, DOI 10.1016/j.molcel.2003.08.006; Iwase M, 2004, CELL STRUCT FUNCT, V29, P1, DOI 10.1247/csf.29.1; Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981; KIM HB, 1991, J CELL BIOL, V112, P535, DOI 10.1083/jcb.112.4.535; Koehler CM, 1997, FEBS LETT, V408, P109, DOI 10.1016/S0014-5793(97)00401-8; Longtine MS, 2000, MOL CELL BIOL, V20, P4049, DOI 10.1128/MCB.20.11.4049-4061.2000; Longtine MS, 2003, TRENDS CELL BIOL, V13, P403, DOI 10.1016/S0962-8924(03)00151-X; Longtine MS, 1998, J CELL BIOL, V143, P719, DOI 10.1083/jcb.143.3.719; Mino A, 1998, BIOCHEM BIOPH RES CO, V251, P732, DOI 10.1006/bbrc.1998.9541; Mortensen EM, 2002, MOL BIOL CELL, V13, P2091, DOI 10.1091/mbc.01-10-0500; Okuzaki D, 2001, FEBS LETT, V489, P197, DOI 10.1016/S0014-5793(01)02104-4; Sakchaisri K, 2004, P NATL ACAD SCI USA, V101, P4124, DOI 10.1073/pnas.0400641101; Sherman F, 1986, LAB COURSE MANUAL ME; Shulewitz MJ, 1999, MOL CELL BIOL, V19, P7123; Sreenivasan A, 2003, MOL CELL BIOL, V23, P6327, DOI 10.1128/MCB.23.17.6327-6337.2003; Sreenivasan A, 1999, MOL CELL BIOL, V19, P7983; Sung H, 2005, FEMS YEAST RES, V5, P943, DOI 10.1016/j.femsyr.2005.03.008; Theesfeld CL, 2003, MOL BIOL CELL, V14, P3280, DOI 10.1091/mbc.e03-03-0154; Tjandra H, 1998, CURR BIOL, V8, P991, DOI 10.1016/S0960-9822(07)00419-8; Versele M, 2005, TRENDS CELL BIOL, V15, P414, DOI 10.1016/j.tcb.2005.06.007; Versele M, 2004, MOL BIOL CELL, V15, P4568, DOI 10.1091/mbc.E04-04-0330	35	42	42	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2006	281	37					27090	27098		10.1074/jbc.M601483200	http://dx.doi.org/10.1074/jbc.M601483200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082PB	16861226	Green Published, hybrid			2022-12-27	WOS:000240397700036
J	Halbedel, S; Busse, J; Schmidl, SR; Stulke, J				Halbedel, Sven; Busse, Julia; Schmidl, Sebastian R.; Stuelke, Joerg			Regulatory protein phosphorylation in Mycoplasma pneumoniae - A PP2C-type phosphatase serves to dephosphorylate HPR(Ser-P)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBON CATABOLITE REPRESSION; BACILLUS-SUBTILIS; HPR KINASE/PHOSPHORYLASE; KINASE; CCPA; PHOSPHOENOLPYRUVATE; MUTAGENESIS; TN4001; ENZYME; ROLES	Among the few regulatory events in the minimal bacterium Mycoplasma pneumoniae is the phosphorylation of the HPr phosphocarrier protein of the phosphotransferase system. In the presence of glycerol, HPr is phosphorylated in an ATP-dependent manner by the HPr kinase/phosphorylase. The role of the latter enzyme was studied by constructing a M. pneumoniae hprK mutant defective in HPr kinase/phosphorylase. This mutant strain no longer exhibited HPr kinase activity but, surprisingly, still had phosphatase activity toward serine-phosphorylated HPr (HPr(Ser-P)). An inspection of the genome sequence revealed the presence of a gene (prpC) encoding a presumptive protein serine/threonine phosphatase of the PP2C family. The phosphatase PrpC was purified and its biochemical activity in HPr(Ser-P) dephosphorylation demonstrated. Moreover, a prpC mutant strain was isolated and found to be impaired in HPr(Ser-P) dephosphorylation. Homologues of PrpC are present in many bacteria possessing HPr(Ser-P), suggesting that PrpC may play an important role in adjusting the cellular HPr phosphorylation state and thus controlling the diverse regulatory functions exerted by the different forms of HPr.	Univ Gottingen, Inst Microbiol & Genet, Dept Gen Microbiol, D-37077 Gottingen, Germany	University of Gottingen	Stulke, J (corresponding author), Univ Gottingen, Inst Microbiol & Genet, Dept Gen Microbiol, Grisebachstr 8, D-37077 Gottingen, Germany.	jstuelk@gwdg.de	Stülke, Jörg/AAD-1600-2021	Stulke, Jorg/0000-0001-5881-5390; Halbedel, Sven/0000-0002-5575-8973				Adler E, 1997, MOL MICROBIOL, V23, P57, DOI 10.1046/j.1365-2958.1997.1801552.x; Allen GS, 2003, J MOL BIOL, V326, P1203, DOI 10.1016/S0022-2836(02)01378-5; Bi WL, 1998, ANAL BIOCHEM, V256, P137, DOI 10.1006/abio.1997.2516; Darbon E, 2002, MOL MICROBIOL, V43, P1039, DOI 10.1046/j.1365-2958.2002.02800.x; Das AK, 1996, EMBO J, V15, P6798, DOI 10.1002/j.1460-2075.1996.tb01071.x; DEUTSCHER J, 1995, MOL MICROBIOL, V15, P1049, DOI 10.1111/j.1365-2958.1995.tb02280.x; Dybvig K, 2000, J BACTERIOL, V182, P4343, DOI 10.1128/JB.182.15.4343-4347.2000; Gaidenko TA, 2002, J BACTERIOL, V184, P6109, DOI 10.1128/JB.184.22.6109-6114.2002; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Halbedel S, 2005, FEMS MICROBIOL LETT, V247, P193, DOI 10.1016/j.femsle.2005.05.004; Halbedel S, 2004, J BACTERIOL, V186, P7936, DOI 10.1128/JB.186.23.7936-7943.2004; HEDREYDA CT, 1993, PLASMID, V30, P170, DOI 10.1006/plas.1993.1047; Herro R, 2005, J MOL MICROB BIOTECH, V9, P224, DOI 10.1159/000089650; Himmelreich R, 1996, NUCLEIC ACIDS RES, V24, P4420, DOI 10.1093/nar/24.22.4420; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Irmler A, 2001, P NATL ACAD SCI USA, V98, P12978, DOI 10.1073/pnas.231254998; Ludwig H, 2002, MOL MICROBIOL, V45, P543, DOI 10.1046/j.1365-2958.2002.03034.x; Maniatis T., 1989, MOL CLONING LAB MAN; MASON PW, 1981, J BIOL CHEM, V256, P1861; Merzbacher M, 2004, EUR J BIOCHEM, V271, P367, DOI 10.1046/j.1432-1033.2003.03935.x; Mijakovic I, 2002, P NATL ACAD SCI USA, V99, P13442, DOI 10.1073/pnas.212410399; Monedero V, 2001, EMBO J, V20, P3928, DOI 10.1093/emboj/20.15.3928; Nessler S, 2003, J BACTERIOL, V185, P4003, DOI 10.1128/JB.185.14.4003-4010.2003; Obuchowski M, 2000, J BACTERIOL, V182, P5634, DOI 10.1128/JB.182.19.5634-5638.2000; Obuchowski Michal, 2005, Postepy Biochem, V51, P95; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; Reizer J, 1998, MOL MICROBIOL, V27, P1157, DOI 10.1046/j.1365-2958.1998.00747.x; Schirmer F, 1997, J BACTERIOL, V179, P1329, DOI 10.1128/jb.179.4.1329-1336.1997; Schumacher MA, 2004, CELL, V118, P731, DOI 10.1016/j.cell.2004.08.027; Shi L, 2004, FRONT BIOSCI-LANDMRK, V9, P1382, DOI 10.2741/1318; Steinhauer K, 2002, MICROBIOL-SGM, V148, P3277, DOI 10.1099/00221287-148-10-3277; Stulke J, 1998, MOL MICROBIOL, V28, P865, DOI 10.1046/j.1365-2958.1998.00839.x; STULKE J, 2004, TOPICS CURR GENET, V9, P179; Weiner J, 2003, NUCLEIC ACIDS RES, V31, P6306, DOI 10.1093/nar/gkg841; Zimmerman CU, 2005, FEMS MICROBIOL LETT, V253, P315, DOI 10.1016/j.femsle.2005.09.054	35	36	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2006	281	36					26253	26259		10.1074/jbc.M605010200	http://dx.doi.org/10.1074/jbc.M605010200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	080LO	16857667	hybrid			2022-12-27	WOS:000240249500042
J	Borthwick, K; Jackson, VN; Price, NT; Zammit, VA				Borthwick, Karen; Jackson, Vicky N.; Price, Nigel T.; Zammit, Victor A.			The mitochondrial intermembrane loop region of rat carnitine palmitoyltransferase 1A is a major determinant of its malonyl-CoA sensitivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRAMOLECULAR INTERACTIONS; OUTER MEMBRANES; CPT I; LIVER; INHIBITION; MUSCLE; ACETYLTRANSFERASE; SPECIFICITY; KINETICS; AFFINITY	Carnitine palmitoyltransferase (CPT) 1A adopts a polytopic conformation within the mitochondrial outer membrane, having both the N- and C-terminal segments on the cytosolic aspect of the membrane and a loop region connecting the two transmembrane (TM) segments protruding into the inter membrane space. In this study we demonstrate that the loop exerts major effects on the sensitivity of the enzyme to its inhibitor, malonyl-CoA. Insertion of a 16-residue spacer between the C-terminal part of the loop sequence (i.e. between residues 100 and 101) and TM2 (which is predicted to start at residue 102) increased the sensitivity to malonyl-CoA inhibition of the resultant mutant protein by more than 10-fold. By contrast, the same insertion made between TM1 and the loop had no effects on the kinetic properties of the enzyme, indicating that effects on the catalytic C-terminal segment were specifically induced by loop-TM2 interactions. Enhanced sensitivity was also observed in all mutants in which the native TM2-loop pairing was disrupted either by making chimeras in which the loops and TM2 segments of CPT 1A and CPT 1B were exchanged or by deleting successive 9-residue segments from the loop sequence. The data suggest that the sequence spanning the loop-TM2 boundary determines the disposition of this TM in the membrane so as to alter the conformation of the C-terminal segment and thus affect its interaction with malonyl-CoA.	Univ Warwick, Univ Hosp Coventry & Warwick, Warwick Med Sch, Clin Sci Res Inst, Coventry CV2 2DX, W Midlands, England	University of Warwick	Zammit, VA (corresponding author), Univ Warwick, Univ Hosp Coventry & Warwick, Warwick Med Sch, Clin Sci Res Inst, UHCW Campus,Clifford Bridge Rd, Coventry CV2 2DX, W Midlands, England.	v.a.zammit@warwick.ac.uk						COOK GA, 1984, J BIOL CHEM, V259, P2030; Corkey BE, 2000, J NUTR, V130, p299S, DOI 10.1093/jn/130.2.299S; Faye A, 2005, BIOCHEM J, V387, P67, DOI 10.1042/BJ20041533; Fraser F, 1997, BIOCHEM J, V323, P711, DOI 10.1042/bj3230711; Fraser F, 2001, J BIOL CHEM, V276, P20182, DOI 10.1074/jbc.M101078200; GRANTHAM BD, 1988, BIOCHEM J, V249, P409, DOI 10.1042/bj2490409; GRANTHAM BD, 1986, BIOCHEM J, V239, P485, DOI 10.1042/bj2390485; Hsiao YS, 2004, J BIOL CHEM, V279, P31584, DOI 10.1074/jbc.M403484200; Jackson VN, 2000, J BIOL CHEM, V275, P38410, DOI 10.1074/jbc.M007722200; Jackson VN, 2000, J BIOL CHEM, V275, P19560, DOI 10.1074/jbc.M002177200; Jackson VN, 2001, BIOCHEMISTRY-US, V40, P14629, DOI 10.1021/bi011632g; Jogl G, 2004, ANN NY ACAD SCI, V1033, P17, DOI 10.1196/annals.1320.002; Jogl G, 2003, CELL, V112, P113, DOI 10.1016/S0092-8674(02)01228-X; KOLODZIEJ MP, 1990, BIOCHEM J, V272, P421, DOI 10.1042/bj2720421; Kraegen EW, 2006, AM J PHYSIOL-ENDOC M, V290, pE471, DOI 10.1152/ajpendo.00316.2005; LEMMON MA, 1994, Q REV BIOPHYS, V27, P157, DOI 10.1017/S0033583500004522; LEMMON MA, 1994, NAT STRUCT BIOL, V1, P157, DOI 10.1038/nsb0394-157; Morillas M, 2004, BIOCHEM J, V379, P777, DOI 10.1042/BJ20031373; Obici S, 2003, NAT MED, V9, P756, DOI 10.1038/nm873; ONTKO JA, 1980, BIOCHEM J, V192, P959, DOI 10.1042/bj1920959; Park EA, 1998, MOL CELL BIOCHEM, V180, P27, DOI 10.1023/A:1006874503379; Popot JL, 2000, ANNU REV BIOCHEM, V69, P881, DOI 10.1146/annurev.biochem.69.1.881; Prip-Buus C, 1998, FEBS LETT, V429, P173, DOI 10.1016/S0014-5793(98)00584-5; Shi JY, 1999, J BIOL CHEM, V274, P9421, DOI 10.1074/jbc.274.14.9421; van der Leij FR, 2002, J BIOL CHEM, V277, P26994, DOI 10.1074/jbc.M203189200; WONG SH, 1984, BIOCHIM BIOPHYS ACTA, V792, P103, DOI 10.1016/0005-2760(84)90209-1; Zammit VA, 1999, PROG LIPID RES, V38, P199, DOI 10.1016/S0163-7827(99)00002-8; Zammit VA, 1998, LIPIDS, V33, P371, DOI 10.1007/s11745-998-0217-7; Zammit VA, 1999, BIOCHEM J, V343, P505, DOI 10.1042/0264-6021:3430505; Zammit VA, 1997, ADV ENZYME REGUL, V37, P295, DOI 10.1016/S0065-2571(96)00015-5	30	12	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					32946	32952		10.1074/jbc.M600843200	http://dx.doi.org/10.1074/jbc.M600843200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16908527	hybrid			2022-12-27	WOS:000241621400003
J	Hu, BL; Gilkes, DM; Farooqi, B; Sebti, SM; Chen, JD				Hu, Baoli; Gilkes, Daniele M.; Farooqi, Bilal; Sebti, Said M.; Chen, Jiandong			MDMX overexpression prevents p53 activation by the MDM2 inhibitor nutlin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEGRADATION; PHOSPHORYLATION; UBIQUITINATION; ONCOPROTEIN; EXPRESSION; P53-MDM2; BINDING; PROTEIN; PATHWAY; CELLS	The p53 tumor suppressor plays a key role in maintaining genomic stability and protection against malignant transformation. MDM2 and MDMX are both p53-binding proteins that regulate p53 stability and activity. Recent development of the MDM2 inhibitor Nutlin 3 has greatly facilitated functional analysis of MDM2-p53 binding. We found that although MDMX is homologous to MDM2 and binds to the same region on p53 N terminus, Nutlin does not disrupt p53-MDMX interaction. The ability of Nutlin to activate p53 is compromised in tumor cells overexpressing MDMX. Combination of Nutlin with MDMX siRNA resulted in synergistic activation of p53 and growth arrest. These results suggest that MDMX is also a valid target for p53 activation in tumor cells. Development of novel compounds that are MDMX-specific or optimized for dual-inhibition of MDM2 and MDMX are necessary to achieve full activation of p53 in tumor cells.	H Lee Moffitt Canc Ctr & Res Inst, Mol Oncol Program, Tampa, FL 33612 USA; H Lee Moffitt Canc Ctr & Res Inst, Drug Discovery Program, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute	Chen, JD (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Mol Oncol Program, MRC3057A,12902 Magnolia Dr, Tampa, FL 33612 USA.	jchen@moffitt.usf.edu	Gilkes, Daniele M/AAI-8133-2020	Gilkes, Daniele M/0000-0003-3984-9338; Farooqi, Bilal/0000-0002-2618-7171				Bond GL, 2005, CURR CANCER DRUG TAR, V5, P3, DOI 10.2174/1568009053332627; Bottger V, 1999, ONCOGENE, V18, P189, DOI 10.1038/sj.onc.1202281; Bottger V, 1996, ONCOGENE, V13, P2141; Chen LH, 2005, MOL CANCER THER, V4, P1019, DOI 10.1158/1535-7163.MCT-04-0342; Chen LH, 2005, EMBO J, V24, P3411, DOI 10.1038/sj.emboj.7600812; Chen LH, 2005, MOL CELL BIOL, V25, P6509, DOI 10.1128/MCB.25.15.6509-6520.2005; Danovi D, 2004, MOL CELL BIOL, V24, P5835, DOI 10.1128/MCB.24.13.5835-5843.2004; de Graaf P, 2003, J BIOL CHEM, V278, P38315, DOI 10.1074/jbc.M213034200; Francoz S, 2006, P NATL ACAD SCI USA, V103, P3232, DOI 10.1073/pnas.0508476103; Gu JJ, 2002, J BIOL CHEM, V277, P19251, DOI 10.1074/jbc.C200150200; Jin YT, 2006, EMBO J, V25, P1207, DOI 10.1038/sj.emboj.7601010; Kawai H, 2003, J BIOL CHEM, V278, P45946, DOI 10.1074/jbc.M308295200; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; LeBron C, 2006, EMBO J, V25, P1196, DOI 10.1038/sj.emboj.7601032; Li CG, 2002, MOL CELL BIOL, V22, P7562, DOI 10.1128/MCB.22.21.7562-7571.2002; Linares LK, 2003, P NATL ACAD SCI USA, V100, P12009, DOI 10.1073/pnas.2030930100; Marine JC, 2005, BIOCHEM BIOPH RES CO, V331, P750, DOI 10.1016/j.bbrc.2005.03.151; Okamoto K, 2005, MOL CELL BIOL, V25, P9608, DOI 10.1128/MCB.25.21.9608-9620.2005; Pan Y, 2003, MOL CELL BIOL, V23, P5113, DOI 10.1128/MCB.23.15.5113-5121.2003; Parant J, 2001, NAT GENET, V29, P92, DOI 10.1038/ng714; Patton JT, 2006, CANCER RES, V66, P3169, DOI 10.1158/0008-5472.CAN-05-3832; Pereg Y, 2005, P NATL ACAD SCI USA, V102, P5056, DOI 10.1073/pnas.0408595102; Ramos YFM, 2001, CANCER RES, V61, P1839; Sharp DA, 1999, J BIOL CHEM, V274, P38189, DOI 10.1074/jbc.274.53.38189; Shvarts A, 1996, EMBO J, V15, P5349, DOI 10.1002/j.1460-2075.1996.tb00919.x; Tanimura S, 1999, FEBS LETT, V447, P5, DOI 10.1016/S0014-5793(99)00254-9; Thompson T, 2004, J BIOL CHEM, V279, P53015, DOI 10.1074/jbc.M410233200; Vassilev LT, 2004, CELL CYCLE, V3, P419; Xiong SB, 2006, P NATL ACAD SCI USA, V103, P3226, DOI 10.1073/pnas.0508500103	29	190	197	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33030	33035		10.1074/jbc.C600147200	http://dx.doi.org/10.1074/jbc.C600147200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16905541	hybrid			2022-12-27	WOS:000241621400011
J	Ala, PJ; Gonneville, L; Hillman, MC; Becker-Pasha, M; Wei, M; Reid, BG; Klabe, R; Yue, EW; Wayland, B; Douty, B; Polam, P; Wasserman, Z; Bower, M; Combs, AP; Burn, TC; Hollis, GF; Wynn, R				Ala, Paul J.; Gonneville, Lucie; Hillman, Milton C.; Becker-Pasha, Mary; Wei, Min; Reid, Brian G.; Klabe, Ronald; Yue, Eddy W.; Wayland, Brian; Douty, Brent; Polam, Padmaja; Wasserman, Zelda; Bower, Michael; Combs, Andrew P.; Burn, Timothy C.; Hollis, Gregory F.; Wynn, Richard			Structural basis for inhibition of protein-tyrosine phosphatase 1B by isothiazolidinone heterocyclic phosphonate mimetics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURE-BASED DESIGN; INSULIN SENSITIVITY; PHOSPHOTYROSINE MIMETICS; CRYSTAL-STRUCTURE; POTENT; DISCOVERY; MICE; RECEPTOR; COMPLEX; GLUCOSE	Crystal structures of protein- tyrosine phosphatase 1B in complex with compounds bearing a novel isothiazolidinone (IZD) heterocyclic phosphonate mimetic reveal that the heterocycle is highly complementary to the catalytic pocket of the protein. The heterocycle participates in an extensive network of hydrogen bonds with the backbone of the phosphate-binding loop, Phe(182) of the flap, and the side chain of Arg(221). When substituted with a phenol, the small inhibitor induces the closed conformation of the protein and displaces all waters in the catalytic pocket. Saturated IZD-containing peptides are more potent inhibitors than unsaturated analogs because the IZD heterocycle and phenyl ring directly attached to it bind in a nearly orthogonal orientation with respect to each other, a conformation that is close to the energy minimum of the saturated IZD-phenyl moiety. These results explain why the heterocycle is a potent phosphonate mimetic and an ideal starting point for designing small nonpeptidic inhibitors.	Incyte Corp, Expt Stn, Wilmington, DE 19880 USA	DuPont; Incyte	Ala, PJ (corresponding author), Incyte Corp, Expt Stn, Rte 141 & Henry Clay Rd, Wilmington, DE 19880 USA.	pauljala@gmail.com		Burn, Timothy/0000-0001-6648-4333				Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Asante-Appiah E, 2002, BIOCHEMISTRY-US, V41, P9043, DOI 10.1021/bi0259554; BARFORD D, 1994, J MOL BIOL, V239, P726, DOI 10.1006/jmbi.1994.1409; BARFORD D, 1994, SCIENCE, V263, P1397, DOI 10.1126/science.8128219; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bialy L, 2005, ANGEW CHEM INT EDIT, V44, P3814, DOI 10.1002/anie.200461517; Black E, 2005, BIOORG MED CHEM LETT, V15, P2503, DOI 10.1016/j.bmcl.2005.03.068; Blaskovich MA, 2002, EXPERT OPIN THER PAT, V12, P871; Burke TR, 2003, ACCOUNTS CHEM RES, V36, P426, DOI 10.1021/ar020127o; Combs AP, 2006, J MED CHEM, V49, P3774, DOI 10.1021/jm0600904; Combs AP, 2005, J MED CHEM, V48, P6544, DOI 10.1021/jm0504555; Costantino L, 2004, CURR MED CHEM, V11, P2725, DOI 10.2174/0929867043364315; DUNITZ JD, 1994, SCIENCE, V264, P670, DOI 10.1126/science.264.5159.670; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; Jia ZC, 2001, J MED CHEM, V44, P4584, DOI 10.1021/jm010266w; JIA ZC, 1995, SCIENCE, V268, P1754, DOI 10.1126/science.7540771; Johnson TO, 2002, NAT REV DRUG DISCOV, V1, P696, DOI 10.1038/nrd895; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Liu G, 2003, CURR MED CHEM, V10, P1407, DOI 10.2174/0929867033457296; Loladze VV, 2002, J MOL BIOL, V320, P343, DOI 10.1016/S0022-2836(02)00465-5; Pedersen AK, 2004, ACTA CRYSTALLOGR D, V60, P1527, DOI 10.1107/S0907444904015094; Pei ZH, 2004, CURR PHARM DESIGN, V10, P3481, DOI 10.2174/1381612043382954; Puius YA, 1997, P NATL ACAD SCI USA, V94, P13420, DOI 10.1073/pnas.94.25.13420; Salmeen A, 2000, MOL CELL, V6, P1401, DOI 10.1016/S1097-2765(00)00137-4; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sun JP, 2003, J BIOL CHEM, V278, P12406, DOI 10.1074/jbc.M212491200; Szczepankiewicz BG, 2003, J AM CHEM SOC, V125, P4087, DOI 10.1021/ja0296733; Taylor SD, 2004, EXPERT OPIN INV DRUG, V13, P199, DOI 10.1517/eoid.13.3.199.27347; Uehling DE, 2002, J MED CHEM, V45, P567, DOI 10.1021/jm0101500; Yao ZJ, 1998, BIOORGAN MED CHEM, V6, P1799, DOI 10.1016/S0968-0896(98)00140-0; Zinker BA, 2002, P NATL ACAD SCI USA, V99, P11357, DOI 10.1073/pnas.142298199	32	51	52	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32784	32795		10.1074/jbc.M606873200	http://dx.doi.org/10.1074/jbc.M606873200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16916797	hybrid			2022-12-27	WOS:000241414500077
J	Dean, T; Khatri, A; Potetinova, Z; Willick, GE; Gardella, TJ				Dean, Thomas; Khatri, Ashok; Potetinova, Zhanna; Willick, Gordon E.; Gardella, Thomas J.			Role of amino acid side chains in region 17-31 of parathyroid hormone (PTH) in binding to the PTH receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							(PTH)/PTH-RELATED PROTEIN-RECEPTOR; JUXTAMEMBRANE REGION; PTH/PTHRP RECEPTOR; LIGAND INTERACTION; CROSS-LINKING; ANALOGS; PEPTIDE; DOMAIN; DOCKING; SITE	The principal receptor-binding domain (Ser(17)-Val(31)) of parathyroid hormone (PTH) is predicted to form an amphiphilic alpha-helix and to interact primarily with the N-terminal extracellular domain (N domain) of the PTH receptor (PTHR). We explored these hypotheses by introducing a variety of substitutions in region 17-31 of PTH-(1-31) and assessing, via competition assays, their effects on binding to the wild-type PTHR and to PTHR-delNt, which lacks most of the N domain. Substitutions at Arg(20) reduced affinity for the intact PTHR by 200-fold or more, but altered affinity for PTHR-delNt by 4-fold or less. Similar effects were observed for Glu substitutions at Trp(23), Leu(24), and Leu(28), which together form the hydrophobic face of the predicted amphiphilic alpha-helix. Glu substitutions at Arg(25), Lys(26), and Lys(27) (which forms the hydrophilic face of the helix) caused 4-10-fold reductions in affinity for both receptors. Thus, the side chains of Arg(20), together with those composing the hydrophobic face of the ligand's putative amphiphilic alpha-helix, contribute strongly to PTHR-binding affinity by interacting specifically with the N domain of the receptor. The side chains projecting from the opposite helical face contribute weakly to binding affinity by different mechanisms, possibly involving interactions with the extracellular loop/transmembrane domain region of the receptor. The data help define the roles that side chains in the binding domain of PTH play in the PTH-PTHR interaction process and provide new clues for understanding the overall topology of the bimolecular complex.	Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA; Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; National Research Council Canada	Gardella, TJ (corresponding author), Massachusetts Gen Hosp, Endocrine Unit, Wellman Bldg,Rm 503C,50 Blossom St, Boston, MA 02114 USA.	gardella@helix.mgh.harvard.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK011794] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 11794] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Barbier JR, 2001, BIOCHEMISTRY-US, V40, P8955, DOI 10.1021/bi010460k; BARDEN JA, 1994, BBA-PROTEIN STRUCT M, V1208, P256, DOI 10.1016/0167-4838(94)90111-2; Berlot CH, 2002, J BIOL CHEM, V277, P21080, DOI 10.1074/jbc.M201330200; CHAKRABARTTY A, 1991, NATURE, V351, P586, DOI 10.1038/351586a0; Chen ZG, 2000, BIOCHEMISTRY-US, V39, P12766, DOI 10.1021/bi000882e; COHEN FE, 1991, J BIOL CHEM, V266, P1997; Dean T, 2006, MOL ENDOCRINOL, V20, P931, DOI 10.1210/me.2005-0349; Dong MQ, 2005, MOL ENDOCRINOL, V19, P1821, DOI 10.1210/me.2004-0421; EPAND RM, 1983, MOL CELL BIOCHEM, V57, P41; GARDELLA TJ, 1993, ENDOCRINOLOGY, V132, P2024, DOI 10.1210/en.132.5.2024; Gensure RC, 2005, BIOCHEM BIOPH RES CO, V328, P666, DOI 10.1016/j.bbrc.2004.11.069; Gensure RC, 2003, MOL ENDOCRINOL, V17, P2647, DOI 10.1210/me.2003-0275; Gensure RC, 2001, J BIOL CHEM, V276, P28650, DOI 10.1074/jbc.M100717200; Grace CRR, 2004, P NATL ACAD SCI USA, V101, P12836, DOI 10.1073/pnas.0404702101; Greenberg Z, 2000, BIOCHEMISTRY-US, V39, P8142, DOI 10.1021/bi000195n; Hoare SRJ, 2001, J BIOL CHEM, V276, P7741, DOI 10.1074/jbc.M009395200; Jean-Rene B, 2005, J BIOL CHEM, V280, P23771, DOI 10.1074/jbc.M500817200; Jin L, 2000, J BIOL CHEM, V275, P27238; Luck MD, 1999, MOL ENDOCRINOL, V13, P670, DOI 10.1210/me.13.5.670; Mannstadt M, 1998, J BIOL CHEM, V273, P16890, DOI 10.1074/jbc.273.27.16890; NEUGEBAUER W, 1992, BIOCHEMISTRY-US, V31, P2056, DOI 10.1021/bi00122a023; NUSSBAUM SR, 1980, J BIOL CHEM, V255, P183; Oldenburg KR, 1996, J BIOL CHEM, V271, P17582; Peggion E, 2002, BIOCHEMISTRY-US, V41, P8162, DOI 10.1021/bi0200155; Pellegrini M, 1998, BIOCHEMISTRY-US, V37, P12737, DOI 10.1021/bi981265h; Pellegrini M, 1998, J BIOL CHEM, V273, P10420, DOI 10.1074/jbc.273.17.10420; Reidhaar-Olson JF, 2000, MOL CELL ENDOCRINOL, V160, P135, DOI 10.1016/S0303-7207(99)00211-7; SARGENT DF, 1986, P NATL ACAD SCI USA, V83, P5774, DOI 10.1073/pnas.83.16.5774; Shimizu M, 2000, J BIOL CHEM, V275, P21836, DOI 10.1074/jbc.M909861199; Shimizu M, 2002, BIOCHEMISTRY-US, V41, P13224, DOI 10.1021/bi026162k; Shimizu M, 2001, ENDOCRINOLOGY, V142, P3068, DOI 10.1210/en.142.7.3068; Shimizu N, 2005, J BIOL CHEM, V280, P1797, DOI 10.1074/jbc.M408270200; Shimizu N, 2001, J BIOL CHEM, V276, P49003, DOI 10.1074/jbc.M106827200; Strewler GJ, 2000, NEW ENGL J MED, V342, P177, DOI 10.1056/NEJM200001203420306; Takasu H, 1999, J BONE MINER RES, V14, P11, DOI 10.1359/jbmr.1999.14.1.11; Tan YV, 2006, J BIOL CHEM, V281, P12792, DOI 10.1074/jbc.M513305200; TREGEAR GW, 1973, ENDOCRINOLOGY, V93, P1349, DOI 10.1210/endo-93-6-1349; Wittelsberger A, 2006, BIOCHEMISTRY-US, V45, P2027, DOI 10.1021/bi051833a; YAMAMOTO I, 1988, ENDOCRINOLOGY, V122, P1208, DOI 10.1210/endo-122-4-1208	39	25	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32485	32495		10.1074/JBC.M606179200	http://dx.doi.org/10.1074/JBC.M606179200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16923805	hybrid			2022-12-27	WOS:000241414500046
J	Christen, B; Christen, M; Paul, R; Schmid, F; Folcher, M; Jenoe, P; Meuwly, M; Jenal, U				Christen, Beat; Christen, Matthias; Paul, Ralf; Schmid, Franziska; Folcher, Marc; Jenoe, Paul; Meuwly, Markus; Jenal, Urs			Allosteric control of cyclic di-GMP signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EAL DOMAIN PROTEIN; DIGUANYLATE CYCLASE; RESPONSE REGULATOR; BIOFILM FORMATION; ESCHERICHIA-COLI; ADENYLYL-CYCLASE; GGDEF-DOMAIN; CAULOBACTER-CRESCENTUS; CELLULOSE BIOSYNTHESIS; ACETOBACTER-XYLINUM	Cyclic di-guanosine monophosphate is a bacterial second messenger that has been implicated in biofilm formation, antibiotic resistance, and persistence of pathogenic bacteria in their animal host. Although the enzymes responsible for the regulation of cellular levels of c-di-GMP, diguanylate cyclases (DGC) and phosphodiesterases, have been identified recently, little information is available on the molecular mechanisms involved in controlling the activity of these key enzymes or on the specific interactions of c-di-GMP with effector proteins. By using a combination of genetic, biochemical, and modeling techniques we demonstrate that an allosteric binding site for c-di-GMP (I-site) is responsible for non-competitive product inhibition of DGCs. The I-site was mapped in both multi- and single domain DGC proteins and is fully contained within the GGDEF domain itself. In vivo selection experiments and kinetic analysis of the evolved I-site mutants led to the definition of an RXXD motif as the core c-di-GMP binding site. Based on these results and based on the observation that the I-site is conserved in a majority of known and potential DGC proteins, we propose that product inhibition of DGCs is of fundamental importance for c-di-GMP signaling and cellular homeostasis. The definition of the I-site binding pocket provides an entry point into unraveling the molecular mechanisms of ligand-protein interactions involved in c-di-GMP signaling and makes DGCs a valuable target for drug design to develop new strategies against biofilmrelated diseases.	Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; Univ Basel, Dept Chem, CH-4056 Basel, Switzerland	University of Basel; University of Basel	Jenal, U (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.	urs.jenal@unibas.ch	Christen, Beat/AAC-2974-2021	Christen, Matthias/0000-0001-7724-4562; Christen, Beat/0000-0002-9528-3685				Aldridge P, 1999, MOL MICROBIOL, V32, P379, DOI 10.1046/j.1365-2958.1999.01358.x; Aldridge P, 2003, MOL MICROBIOL, V47, P1695, DOI 10.1046/j.1365-2958.2003.03401.x; Ausmees N, 2001, FEMS MICROBIOL LETT, V204, P163, DOI 10.1111/j.1574-6968.2001.tb10880.x; Baker DA, 2004, MOL MICROBIOL, V52, P1229, DOI 10.1111/j.1365-2958.2004.04067.x; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Brouillette E, 2005, ANTIMICROB AGENTS CH, V49, P3109, DOI 10.1128/AAC.49.8.3109-3113.2005; Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101; Christen M, 2005, J BIOL CHEM, V280, P30829, DOI 10.1074/jbc.M504429200; ELY B, 1991, METHOD ENZYMOL, V204, P372; Galperin MY, 2001, FEMS MICROBIOL LETT, V204, P213, DOI 10.1016/S0378-1097(01)00434-7; Garcia B, 2004, MOL MICROBIOL, V54, P264, DOI 10.1111/j.1365-2958.2004.04269.x; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; HECHT GB, 1995, J BACTERIOL, V177, P6223, DOI 10.1128/jb.177.21.6223-6229.1995; Hickman JW, 2005, P NATL ACAD SCI USA, V102, P14422, DOI 10.1073/pnas.0507170102; Hisert KB, 2005, MOL MICROBIOL, V56, P1234, DOI 10.1111/j.1365-2958.2005.04632.x; Jenal U, 2004, CURR OPIN MICROBIOL, V7, P185, DOI 10.1016/j.mib.2004.02.007; Kirillina O, 2004, MOL MICROBIOL, V54, P75, DOI 10.1111/j.1365-2958.2004.04253.x; Kulesekara H, 2006, P NATL ACAD SCI USA, V103, P2839, DOI 10.1073/pnas.0511090103; Lestrate P, 2003, INFECT IMMUN, V71, P7053, DOI 10.1128/IAI.71.12.7053-7060.2003; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Mendez-Ortiz MM, 2006, J BIOL CHEM, V281, P8090, DOI 10.1074/jbc.M510701200; OCHI Y, 1981, ACTA ENDOCRINOL-COP, V98, P62, DOI 10.1530/acta.0.0980062; OTOOLE GA, 1999, METHOD ENZYMOL, V34, P586; Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504; Pei JM, 2001, PROTEINS, V42, P210, DOI 10.1002/1097-0134(20010201)42:2<210::AID-PROT80>3.0.CO;2-8; Romling U, 2005, MOL MICROBIOL, V57, P629, DOI 10.1111/j.1365-2958.2005.04697.x; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0; ROSS P, 1991, MICROBIOL REV, V55, P35, DOI 10.1128/MMBR.55.1.35-58.1991; Ryjenkov DA, 2005, J BACTERIOL, V187, P1792, DOI 10.1128/JB.187.5.1792-1798.2005; Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005; Simm R, 2005, J BACTERIOL, V187, P6816, DOI 10.1128/JB.187.19.6816-6823.2005; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Sunahara RK, 1998, J BIOL CHEM, V273, P16332, DOI 10.1074/jbc.273.26.16332; Tal R, 1998, J BACTERIOL, V180, P4416, DOI 10.1128/JB.180.17.4416-4425.1998; Tamayo R, 2005, J BIOL CHEM, V280, P33324, DOI 10.1074/jbc.M506500200; Tesmer JJG, 1999, SCIENCE, V285, P756, DOI 10.1126/science.285.5428.756; Tischler AD, 2002, J BACTERIOL, V184, P4104, DOI 10.1128/JB.184.15.4104-4113.2002; Tucker CL, 1998, P NATL ACAD SCI USA, V95, P5993, DOI 10.1073/pnas.95.11.5993; Ulrich LE, 2005, TRENDS MICROBIOL, V13, P52, DOI 10.1016/j.tim.2004.12.006; Zhang GY, 1997, NATURE, V388, P204, DOI 10.1038/40675; Zogaj X, 2001, MOL MICROBIOL, V39, P1452, DOI 10.1046/j.1365-2958.2001.02337.x	44	223	240	3	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					32015	32024		10.1074/jbc.M603589200	http://dx.doi.org/10.1074/jbc.M603589200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16923812	Green Accepted, Bronze			2022-12-27	WOS:000241235300087
J	Jawdekar, GW; Hanzlowsky, A; Hovde, SL; Jelencic, B; Feig, M; Geiger, JH; Henry, RW				Jawdekar, Gauri W.; Hanzlowsky, Andrej; Hovde, Stacy L.; Jelencic, Blanka; Feig, Michael; Geiger, James H.; Henry, R. William			The unorthodox SNAP50 zinc finger domain contributes to cooperative promoter recognition by human SNAP(C)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-III; PROXIMAL SEQUENCE ELEMENT; PROTEIN COMPLEX SNAP(C); BOX-BINDING PROTEIN; SNRNA GENE-TRANSCRIPTION; OCT-1 POU DOMAIN; ACTIVATING PROTEIN; DNA-BINDING; SUBUNIT; ENERGY	Human small nuclear RNA gene transcription by RNA polymerases II and III depends upon promoter recognition by the SNAP(C) general transcription factor. DNA binding by SNAP(C) involves direct DNA contacts by the SNAP190 subunit in cooperation with SNAP50 and SNAP43. The data presented herein shows that SNAP50 plays an important role in DNA binding by SNAP(C) through its zinc finger domain. The SNAP50 zinc finger domain contains 15 cysteine and histidine residues configured in two potential zinc coordination arrangements. Individual alanine substitution of each cysteine and histidine residue demonstrated that eight sites are important for DNA binding by SNAP(C). However, metal binding studies revealed that SNAP(C) contains a single zinc atom indicating that only one coordination site functions as a zinc finger. Of the eight residues critical for DNA binding, four cysteine residues were also essential for both U1 and U6 transcription by RNA polymerase II and III, respectively. Surprisingly, the remaining four residues, although critical for U1 transcription could support partial U6 transcription. DNAbinding studies showed that defects in DNA binding by SNAP(C) alone could be suppressed through cooperative DNA binding with another member of the RNA polymerase III general transcription machinery, TFIIIB. These results suggest that these eight cysteine and histidine residues perform different functions during DNA binding with those residues involved in zinc coordination likely performing a dominant role in domain stabilization and the others involved in DNA binding. These data further define the unorthodox SNAP50 zinc finger region as an evolutionarily conserved DNA binding domain.	Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA; Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University	Geiger, JH (corresponding author), Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA.	henryrw@msu.edu	Feig, Michael/AAI-9540-2021	Geiger, James/0000-0002-9443-4488	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059805, R01GM063894] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01-GM59805, R01-GM063894] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adamczak R, 2004, PROTEINS, V56, P753, DOI 10.1002/prot.20176; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Cabart P, 2002, J BIOL CHEM, V277, P26831, DOI 10.1074/jbc.M203119200; Das A, 2005, MOL CELL BIOL, V25, P7314, DOI 10.1128/MCB.25.16.7314-7322.2005; Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005; Ford E, 1998, GENE DEV, V12, P3528, DOI 10.1101/gad.12.22.3528; Gu LP, 2005, J BIOL CHEM, V280, P27697, DOI 10.1074/jbc.M503206200; Hanzlowsky A, 2006, PROTEIN EXPRES PURIF, V48, P215, DOI 10.1016/j.pep.2006.02.015; Henry RW, 1998, COLD SPRING HARB SYM, V63, P111, DOI 10.1101/sqb.1998.63.111; HENRY RW, 1995, NATURE, V374, P653, DOI 10.1038/374653a0; Henry RW, 1996, EMBO J, V15, P7129, DOI 10.1002/j.1460-2075.1996.tb01104.x; Henry RW, 1998, GENE DEV, V12, P2664, DOI 10.1101/gad.12.17.2664; Hernandez N, 2001, J BIOL CHEM, V276, P26733, DOI 10.1074/jbc.R100032200; Hinkley CS, 2003, J BIOL CHEM, V278, P18649, DOI 10.1074/jbc.M204247200; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; HOLM L, 1994, PROTEINS, V19, P165, DOI 10.1002/prot.340190302; Hu P, 2004, MOL CELL, V16, P81, DOI 10.1016/j.molcel.2004.09.008; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Im W, 1998, COMPUT PHYS COMMUN, V111, P59, DOI 10.1016/S0010-4655(98)00016-2; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; KLUG A, 1995, FASEB J, V9, P597, DOI 10.1096/fasebj.9.8.7768350; Krishna SS, 2003, NUCLEIC ACIDS RES, V31, P532, DOI 10.1093/nar/gkg161; Ma B, 2001, J BIOL CHEM, V276, P5027, DOI 10.1074/jbc.M009301200; Ma BC, 2002, MOL CELL BIOL, V22, P8067, DOI 10.1128/MCB.22.22.8067-8078.2002; Mittal V, 1999, GENE DEV, V13, P1807, DOI 10.1101/gad.13.14.1807; MURPHY S, 1992, MOL CELL BIOL, V12, P3247, DOI 10.1128/MCB.12.7.3247; Sadowski CL, 1996, P NATL ACAD SCI USA, V93, P4289, DOI 10.1073/pnas.93.9.4289; SADOWSKI CL, 1993, GENE DEV, V7, P1535, DOI 10.1101/gad.7.8.1535; Saxena A, 2005, MOL CELL BIOL, V25, P9406, DOI 10.1128/MCB.25.21.9406-9418.2005; Schimanski B, 2005, MOL CELL BIOL, V25, P7303, DOI 10.1128/MCB.25.16.7303-7313.2005; Schramm L, 2000, GENE DEV, V14, P2650, DOI 10.1101/gad.836400; Skolnick J, 1997, J MOL BIOL, V265, P217, DOI 10.1006/jmbi.1996.0720; Stumpff-Kane AW, 2006, PROTEINS, V63, P155, DOI 10.1002/prot.20853; Trainor CD, 2000, J BIOL CHEM, V275, P28157; Wang Y, 1998, MOL CELL BIOL, V18, P1570, DOI 10.1128/MCB.18.3.1570; Wong MW, 1998, MOL CELL BIOL, V18, P368, DOI 10.1128/MCB.18.1.368; YOON JB, 1995, MOL CELL BIOL, V15, P2019; Zhang C, 2005, J MED CHEM, V48, P2325, DOI 10.1021/jm049314d	38	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					31050	31060		10.1074/jbc.M603810200	http://dx.doi.org/10.1074/jbc.M603810200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16901896	hybrid			2022-12-27	WOS:000241075900081
J	Liu, PJ; Barkley, LR; Day, T; Bi, XH; Slater, DM; Alexandrow, MG; Nasheuer, HP; Vaziri, C				Liu, Peijun; Barkley, Laura R.; Day, Tovah; Bi, Xiaohui; Slater, Damien M.; Alexandrow, Mark G.; Nasheuer, Heinz-Peter; Vaziri, Cyrus			The Chk1-mediated S-phase checkpoint targets initiation factor Cdc45 via a Cdc25A/Cdk2-independent mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-ALPHA; CELL-CYCLE; PROTEIN PHOSPHATASE; IONIZING-RADIATION; BETA-TRCP; RETINOBLASTOMA PROTEIN; DAMAGE CHECKPOINT; KINASE COMPLEX; REPLICATION; CDC25A	DNA damage induced by the carcinogen benzo[ a] pyrene dihydrodiol epoxide ( BPDE) induces a Chk1-dependent S-phase checkpoint. Here, we have investigated the molecular basis of BPDE-induced S-phase arrest. Chk1-dependent inhibition of DNA synthesis in BPDE-treated cells occurred without detectable changes in Cdc25A levels, Cdk2 activity, or Cdc7/Dbf4 interaction. Overexpression studies showed that Cdc25A, cyclin A/Cdk2, and Cdc7/Dbf4 were not rate-limiting for DNA synthesis when the BPDE-induced S-phase checkpoint was active. To investigate other potential targets of the S-phase checkpoint, we tested the effects of BPDE on the chromatin association of DNA replication factors. The levels of chromatin-associated Cdc45 (but not soluble Cdc45) were reduced concomitantly with BPDE-induced Chk1 activation and inhibition of DNA synthesis. The chromatin association of Mcm7, Mcm10, and proliferating cell nuclear antigen was unaffected by BPDE treatment. However, the association between Mcm7 and Cdc45 in the chromatin fraction was inhibited in BPDE-treated cells. Chromatin immunoprecipitation analyses demonstrated reduced association of Cdc45 with the beta-globin origin of replication in BPDE-treated cells. The inhibitory effects of BPDE on DNA synthesis, Cdc45/Mcm7 associations, and interactions between Cdc45 and the beta-globin locus were abrogated by the Chk1 inhibitor UCN-01. Taken together, our results show that the association between Cdc45 and Mcm7 at origins of replication is negatively regulated by Chk1 in a Cdk2-independent manner. Therefore, Cdc45 is likely to be an important target of the Chk1-mediated S-phase checkpoint.	Boston Univ, Sch Med, Dept Genet & Genom, Boston, MA 02118 USA; Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; Natl Univ Ireland Univ Coll Galway, Cell Cycle Control Lab, Dept Biochem, Galway, Ireland	Boston University; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Ollscoil na Gaillimhe-University of Galway	Vaziri, C (corresponding author), Boston Univ, Sch Med, Dept Genet & Genom, 715 Albany St,E633, Boston, MA 02118 USA.	cvaziri@bu.edu	Nasheuer, Heinz P./B-9025-2008	Barkley, Laura/0000-0001-8026-5284; Nasheuer, Heinz Peter/0000-0002-9218-9079	NIEHS NIH HHS [ES09558, ES12917] Funding Source: Medline; NIGMS NIH HHS [F32 GM019304-02, F32 GM019304-01A1, F32 GM019304] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009558, R29ES009558, R01ES012917] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM019304] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aladjem MI, 2004, FRONT BIOSCI-LANDMRK, V9, P2540, DOI 10.2741/1415; Alexandrow MG, 2005, J CELL BIOL, V168, P875, DOI 10.1083/jcb.200409055; Avni D, 2003, MOL CELL, V12, P735, DOI 10.1016/S1097-2765(03)00355-1; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Bi XH, 2006, MOL CELL BIOL, V26, P3527, DOI 10.1128/MCB.26.9.3527-3540.2006; Bi XH, 2005, J BIOL CHEM, V280, P22343, DOI 10.1074/jbc.M501562200; Bousset K, 1998, GENE DEV, V12, P480, DOI 10.1101/gad.12.4.480; Busino L, 2004, ONCOGENE, V23, P2050, DOI 10.1038/sj.onc.1207394; Busino L, 2003, NATURE, V426, P87, DOI 10.1038/nature02082; Chou DM, 2002, J BIOL CHEM, V277, P40520, DOI 10.1074/jbc.M207226200; CONNEY AH, 1982, CANCER RES, V42, P4875; Cordeiro-Stone M, 2002, CARCINOGENESIS, V23, P959, DOI 10.1093/carcin/23.6.959; CORDEIROSTONE M, 1986, CARCINOGENESIS, V7, P1775, DOI 10.1093/carcin/7.10.1775; Costanzo V, 2003, MOL CELL, V11, P203, DOI 10.1016/S1097-2765(02)00799-2; DIPPLE A, 1995, CARCINOGENESIS, V16, P437, DOI 10.1093/carcin/16.3.437; Dipple A, 1999, INT J ONCOL, V14, P103; Duncker BP, 2003, MUTAT RES-FUND MOL M, V532, P21, DOI 10.1016/j.mrfmmm.2003.08.007; Falck J, 2002, NAT GENET, V30, P290, DOI 10.1038/ng845; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Furuya K, 2004, GENE DEV, V18, P1154, DOI 10.1101/gad.291104; Garcia V, 2005, DNA REPAIR, V4, P1227, DOI 10.1016/j.dnarep.2005.04.001; Gladden AB, 2003, J BIOL CHEM, V278, P9754, DOI 10.1074/jbc.M212088200; Guo CY, 2002, J BIOL CHEM, V277, P4839, DOI 10.1074/jbc.M110092200; Guo N, 2002, CELL GROWTH DIFFER, V13, P77; Heffernan TP, 2002, MOL CELL BIOL, V22, P8552, DOI 10.1128/MCB.22.24.8552-8561.2002; Izumi M, 2000, NUCLEIC ACIDS RES, V28, P4769, DOI 10.1093/nar/28.23.4769; Jares P, 2000, EMBO REP, V1, P319, DOI 10.1093/embo-reports/kvd076; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; Kanemori Y, 2005, P NATL ACAD SCI USA, V102, P6279, DOI 10.1073/pnas.0501873102; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kukimoto I, 1999, EUR J BIOCHEM, V265, P936, DOI 10.1046/j.1432-1327.1999.00791.x; Larner JM, 1999, NUCLEIC ACIDS RES, V27, P803, DOI 10.1093/nar/27.3.803; Li G, 1998, J CELL BIOL, V140, P975, DOI 10.1083/jcb.140.5.975; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Masai H, 2002, J CELL PHYSIOL, V190, P287, DOI 10.1002/jcp.10070; Masai H, 2000, J BIOL CHEM, V275, P29042, DOI 10.1074/jbc.M002713200; Montagnoli A, 2006, J BIOL CHEM, V281, P10281, DOI 10.1074/jbc.M512921200; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; PAINTER RB, 1985, MUTAT RES, V145, P63, DOI 10.1016/0167-8817(85)90041-0; Parrilla-Castellar E, 2003, J BIOL CHEM, V278, P45507, DOI 10.1074/jbc.C300418200; Petersen P, 2006, MOL CELL BIOL, V26, P1997, DOI 10.1128/MCB.26.5.1997-2011.2006; Pollok S, 2003, BIOCHEM SOC T, V31, P266, DOI 10.1042/bst0310266; ROSENBLATT J, 1992, P NATL ACAD SCI USA, V89, P2824, DOI 10.1073/pnas.89.7.2824; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sorensen CS, 2003, CANCER CELL, V3, P247, DOI 10.1016/S1535-6108(03)00048-5; Sorensen CS, 2004, CELL CYCLE, V3, P941; Sterner JM, 1998, MOL CELL BIOL, V18, P2748, DOI 10.1128/MCB.18.5.2748; Syljuasen RG, 2005, MOL CELL BIOL, V25, P3553, DOI 10.1128/MCB.25.9.3553-3562.2005; Takahashi TS, 2005, GENE DEV, V19, P2295, DOI 10.1101/gad.1339805; Takeda DY, 2005, ONCOGENE, V24, P2827, DOI 10.1038/sj.onc.1208616; TODOROVIC V, 1999, FRONT BIOSCI, V4, P859; Van Hatten RA, 2002, J CELL BIOL, V159, P541, DOI 10.1083/jcb.200207090; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Walter JC, 2000, J BIOL CHEM, V275, P39773, DOI 10.1074/jbc.M008107200; Weiss RS, 2003, MOL CELL BIOL, V23, P791, DOI 10.1128/MCB.23.3.791-803.2003; Wohlschlegel JA, 2002, MOL CELL, V9, P233, DOI 10.1016/S1097-2765(02)00456-2; Yanow SK, 2003, J BIOL CHEM, V278, P41083, DOI 10.1074/jbc.M307144200; Yoshizawa-Sugata N, 2005, J BIOL CHEM, V280, P13062, DOI 10.1074/jbc.M411653200; Zhao H, 2002, P NATL ACAD SCI USA, V99, P14795, DOI 10.1073/pnas.182557299; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	61	73	76	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30631	30644		10.1074/jbc.M602982200	http://dx.doi.org/10.1074/jbc.M602982200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16912045	hybrid			2022-12-27	WOS:000241075900039
J	Modrich, P				Modrich, Paul			Mechanisms in eukaryotic mismatch repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							HUMAN NUCLEAR EXTRACTS; REPLICATION PROTEIN-A; DNA-POLYMERASE-DELTA; SACCHAROMYCES-CEREVISIAE; HUMAN-CELLS; MUTATION AVOIDANCE; PROVOKED EXCISION; EXONUCLEASE-I; TUMOR-CELLS; HETERODIMER		Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	Duke University; Duke University; Howard Hughes Medical Institute	Modrich, P (corresponding author), Duke Univ, Med Ctr, Dept Biochem, HHMI,Box 3711, Durham, NC 27710 USA.	modrich@biochem.duke.edu	Classen, Scott/AAY-8176-2020	Modrich, Paul/0000-0001-8708-9885	NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045190] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [P01 CA92584, P01 CA092584, P01 CA092584-020005] Funding Source: Medline; NIGMS NIH HHS [R01 GM045190, R01 GM45190, R01 GM045190-16] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Acharya S, 1996, P NATL ACAD SCI USA, V93, P13629, DOI 10.1073/pnas.93.24.13629; Cannavo E, 2005, CANCER RES, V65, P10759, DOI 10.1158/0008-5472.CAN-05-2528; Constantin N, 2005, J BIOL CHEM, V280, P39752, DOI 10.1074/jbc.M509701200; Datta A, 2000, MOL CELL, V6, P593, DOI 10.1016/S1097-2765(00)00058-7; DRUMMOND JT, 1995, SCIENCE, V268, P1909, DOI 10.1126/science.7604264; Dzantiev L, 2004, MOL CELL, V15, P31, DOI 10.1016/j.molcel.2004.06.016; Edelmann W, 2000, CANCER RES, V60, P803; FANG WH, 1993, J BIOL CHEM, V268, P11838; Genschel J, 1998, J BIOL CHEM, V273, P19895, DOI 10.1074/jbc.273.31.19895; Genschel J, 2003, MOL CELL, V12, P1077, DOI 10.1016/S1097-2765(03)00428-3; Genschel J, 2002, J BIOL CHEM, V277, P13302, DOI 10.1074/jbc.M111854200; Gu LY, 1998, NUCLEIC ACIDS RES, V26, P1173, DOI 10.1093/nar/26.5.1173; Guo SL, 2004, J BIOL CHEM, V279, P16912, DOI 10.1074/jbc.M313213200; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jin YH, 2005, MOL CELL BIOL, V25, P461, DOI 10.1128/MCB.25.1.461-471.2005; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Lee BI, 1999, J BIOL CHEM, V274, P37763, DOI 10.1074/jbc.274.53.37763; LI GM, 1995, P NATL ACAD SCI USA, V92, P1950, DOI 10.1073/pnas.92.6.1950; Lin YL, 1998, J BIOL CHEM, V273, P1453, DOI 10.1074/jbc.273.3.1453; Longley MJ, 1997, J BIOL CHEM, V272, P10917; Nielsen FC, 2004, ONCOGENE, V23, P1457, DOI 10.1038/sj.onc.1207265; PALOMBO F, 1995, SCIENCE, V268, P1912, DOI 10.1126/science.7604265; Palombo F, 1996, CURR BIOL, V6, P1181, DOI 10.1016/S0960-9822(02)70685-4; Pavlov YI, 2003, CURR BIOL, V13, P744, DOI 10.1016/S0960-9822(03)00284-7; Peltomaki P, 2005, FAM CANCER, V4, P227, DOI 10.1007/s10689-004-7993-0; Peltomaki P, 2003, J CLIN ONCOL, V21, P1174, DOI 10.1200/JCO.2003.04.060; Ramilo C, 2002, MOL CELL BIOL, V22, P2037, DOI 10.1128/MCB.22.7.2037-2046.2002; Raschle M, 1999, J BIOL CHEM, V274, P32368, DOI 10.1074/jbc.274.45.32368; SZANKASI P, 1995, SCIENCE, V267, P1166, DOI 10.1126/science.7855597; THOMAS DC, 1991, J BIOL CHEM, V266, P3744; Tishkoff DX, 1997, P NATL ACAD SCI USA, V94, P7487, DOI 10.1073/pnas.94.14.7487; Tran HT, 1999, MOL CELL BIOL, V19, P2000; Umar A, 1996, CELL, V87, P65, DOI 10.1016/S0092-8674(00)81323-9; Varlet I, 1996, P NATL ACAD SCI USA, V93, P10156, DOI 10.1073/pnas.93.19.10156; Vo AT, 2005, EMBO REP, V6, P438, DOI 10.1038/sj.embor.7400392; Waga S, 1998, MOL CELL BIOL, V18, P4177, DOI 10.1128/MCB.18.7.4177; Wang HX, 2002, J BIOL CHEM, V277, P26143, DOI 10.1074/jbc.M200358200; Wang HX, 2002, J BIOL CHEM, V277, P26136, DOI 10.1074/jbc.M200357200; Wei KC, 2003, GENE DEV, V17, P603, DOI 10.1101/gad.1060603; Wilson DM, 1998, NUCLEIC ACIDS RES, V26, P3762, DOI 10.1093/nar/26.16.3762; Yamaguchi-Iwai Y, 1999, EMBO J, V18, P6619, DOI 10.1093/emboj/18.23.6619; Yuan FH, 2004, J BIOL CHEM, V279, P20935, DOI 10.1074/jbc.M401931200; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027	46	312	318	2	56	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30305	30309		10.1074/jbc.R600022200	http://dx.doi.org/10.1074/jbc.R600022200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16905530	Green Accepted, hybrid			2022-12-27	WOS:000241075900002
J	Takemura, H; Rao, VA; Sordet, O; Furuta, T; Miao, ZH; Meng, L; Zhang, HL; Pommier, Y				Takemura, Haruyuki; Rao, V. Ashutosh; Sordet, Olivier; Furuta, Takahisa; Miao, Ze-Hong; Meng, LingHua; Zhang, Hongliang; Pommier, Yves			Defective Mre11-dependent activation of Chk2 by ataxia telangiectasia mutated in colorectal carcinoma cells in response to replication-dependent DNA double strand breaks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-PHASE CHECKPOINT; RECURRENT OVARIAN-CANCER; TOPOISOMERASE-I; PROTEIN-KINASE; MRE11 COMPLEX; ATM; PHOSPHORYLATION; DAMAGE; CAMPTOTHECIN; REPAIR	The Mre11(.)Rad50(.)Nbs1 (MRN) complex binds DNA double strand breaks to repair DNA and activate checkpoints. We report MRN deficiency in three of seven colon carcinoma cell lines of the NCI Anticancer Drug Screen. To study the involvement of MRN in replication-mediated DNA double strand breaks, we examined checkpoint responses to camptothecin, which induces replication-mediated DNA double strand breaks after replication forks collide with topoisomerase I cleavage complexes. MRN-deficient cells were deficient for Chk2 activation, whereas Chk1 activation was independent of MRN. Chk2 activation was ataxia telangiectasia mutated (ATM)-dependent and associated with phosphorylation of Mre11 and Nbs1. Mre11 complementation in MRN-deficient HCT116 cells restored Chk2 activation as well as Rad50 and Nbs1 levels. Conversely, Mre11 down-regulation by small interference RNA ( siRNA) in HT29 cells inhibited Chk2 activation and down-regulated Nbs1 and Rad50. Proteasome inhibition also restored Rad50 and Nbs1 levels in HCT116 cells suggesting that Mre11 stabilizes Rad50 and Nbs1. Chk2 activation was also defective in three of four MRN-proficient colorectal cell lines because of low Chk2 levels. Thus, six of seven colon carcinoma cell lines from the NCI Anticancer Drug Screen are functionally Chk2-deficient in response to replication-mediated DNA double strand breaks. We propose that Mre11 stabilizes Nbs1 and Rad50 and that MRN activates Chk2 downstream from ATM in response to replication-mediated DNA double strand breaks. Chk2 deficiency in HCT116 is associated with defective S-phase checkpoint, prolonged G(2) arrest, and hypersensitivity to camptothecin. The high frequency of MRN and Chk2 deficiencies may contribute to genomic instability and therapeutic response to camptothecins in colorectal cancers.	NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Pommier, Y (corresponding author), NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH,Dept Hlth & Human Serv, Convent Dr,Bldg 37,Rm 5068, Bethesda, MD 20892 USA.	pommier@nih.gov	Rao, V Ashutosh/A-3569-2013; Sordet, Olivier/M-3271-2014	Rao, V Ashutosh/0000-0001-6817-8049; Sordet, Olivier/0000-0001-6027-4925	NATIONAL CANCER INSTITUTE [Z01BC006150, ZIABC006150] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adams KE, 2006, ONCOGENE, V25, P3894, DOI 10.1038/sj.onc.1209426; Ahn J, 2004, DNA REPAIR, V3, P1039, DOI 10.1016/j.dnarep.2004.03.033; Armstrong DK, 2005, ONCOLOGIST, V10, P686, DOI 10.1634/theoncologist.10-9-686; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Bartek J, 2001, NAT REV MOL CELL BIO, V2, P877, DOI 10.1038/35103059; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bell DW, 1999, SCIENCE, V286, P2528, DOI 10.1126/science.286.5449.2528; BOYD MR, 1995, DRUG DEVELOP RES, V34, P91, DOI 10.1002/ddr.430340203; Bradbury JM, 2003, BIOCHEM SOC T, V31, P40, DOI 10.1042/bst0310040; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; CIPOLLINI G, 2004, ANN ONCOL         S1, V15, P17; Craig AL, 2004, ONCOGENE, V23, P8411, DOI 10.1038/sj.onc.1208035; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; DERZWET MK, 1999, MUTAT RES, V434, P17; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Flatten K, 2005, J BIOL CHEM, V280, P14349, DOI 10.1074/jbc.M411890200; Furuta T, 2003, J BIOL CHEM, V278, P20303, DOI 10.1074/jbc.M300198200; Gatei M, 2000, NAT GENET, V25, P115, DOI 10.1038/75508; Giannini G, 2004, ONCOGENE, V23, P2640, DOI 10.1038/sj.onc.1207409; Giannini G, 2002, EMBO REP, V3, P248, DOI 10.1093/embo-reports/kvf044; GOLDWASSER F, 1995, CANCER RES, V55, P2116; Goldwasser F, 1996, CANCER RES, V56, P4430; Graves PR, 2000, J BIOL CHEM, V275, P5600, DOI 10.1074/jbc.275.8.5600; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; HOLM C, 1989, CANCER RES, V49, P6365; HSIANG YH, 1989, CANCER RES, V49, P5077; HSIANG YH, 1985, J BIOL CHEM, V260, P4873; Ioanoviciu A, 2005, J MED CHEM, V48, P4803, DOI 10.1021/jm050076b; Kobayashi J, 2002, CURR BIOL, V12, P1846, DOI 10.1016/S0960-9822(02)01259-9; Kumar Atul, 2006, Curr Treat Options Oncol, V7, P37, DOI 10.1007/s11864-006-0030-9; Kurz EU, 2004, DNA REPAIR, V3, P889, DOI 10.1016/j.dnarep.2004.03.029; Kwak EL, 2006, CANCER RES, V66, P1923, DOI 10.1158/0008-5472.CAN-05-1237; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lee SB, 2001, CANCER RES, V61, P8062; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; Liu QH, 2000, GENE DEV, V14, P1448; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Machida YJ, 2005, CELL, V123, P13, DOI 10.1016/j.cell.2005.09.019; Marchand C, 2006, MOL CANCER THER, V5, P287, DOI 10.1158/1535-7163.MCT-05-0456; Markman M, 2005, ONCOLOGIST, V10, P695, DOI 10.1634/theoncologist.10-9-695; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Mitchell SK, 2005, INT J GYNECOL CANCER, V15, P793, DOI 10.1111/j.1525-1438.2005.00138.x; Moreno-Herrero F, 2005, NATURE, V437, P440, DOI 10.1038/nature03927; NITISS J, 1988, P NATL ACAD SCI USA, V85, P7501, DOI 10.1073/pnas.85.20.7501; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Penson RT, 2005, ONCOLOGIST, V10, P698, DOI 10.1634/theoncologist.10-9-698; Pichierri P, 2004, EMBO J, V23, P1178, DOI 10.1038/sj.emboj.7600113; Pizzolato JF, 2003, LANCET, V361, P2235, DOI 10.1016/S0140-6736(03)13780-4; Pommier Y, 2006, CLIN CANCER RES, V12, P2657, DOI 10.1158/1078-0432.CCR-06-0743; Pommier Y, 2005, CURR PHARM DESIGN, V11, P2855, DOI 10.2174/1381612054546716; Pommier Y, 2005, TRENDS PHARMACOL SCI, V26, P138, DOI 10.1016/j.tips.2005.01.008; Pommier Y, 2003, MUTAT RES-FUND MOL M, V532, P173, DOI 10.1016/j.mrfmmm.2003.08.016; POMMIER Y, 2006, IN PRESS NAT REV CAN; Rao VA, 2005, MOL CELL BIOL, V25, P8925, DOI 10.1128/MCB.25.20.8925-8937.2005; Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439; Schwarz JK, 2003, MOL CANCER RES, V1, P598; Sergent C, 2002, CANCER CHEMOTH PHARM, V49, P445, DOI 10.1007/s00280-002-0450-6; Shao RG, 1997, CANCER RES, V57, P4029; Shao RG, 1999, EMBO J, V18, P1397, DOI 10.1093/emboj/18.5.1397; Shiloh Y, 2004, NAT CELL BIOL, V6, P923, DOI 10.1038/ncb1004-923; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Staker BL, 2005, J MED CHEM, V48, P2336, DOI 10.1021/jm049146p; Staker BL, 2002, P NATL ACAD SCI USA, V99, P15387, DOI 10.1073/pnas.242259599; Stracker TH, 2004, DNA REPAIR, V3, P845, DOI 10.1016/j.dnarep.2004.03.014; Strumberg D, 2000, MOL CELL BIOL, V20, P3977, DOI 10.1128/MCB.20.11.3977-3987.2000; Taverna P, 2000, CANCER CHEMOTH PHARM, V46, P507, DOI 10.1007/s002800000186; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wu XH, 2000, NATURE, V405, P477, DOI 10.1038/35013089; Yu Q, 2002, CANCER RES, V62, P5743; Yuan SSF, 2002, TOXICOLOGY, V177, P123, DOI 10.1016/S0300-483X(02)00220-2; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zhao S, 2000, NATURE, V405, P473, DOI 10.1038/35013083; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	75	97	105	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30814	30823		10.1074/jbc.M603747200	http://dx.doi.org/10.1074/jbc.M603747200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16905549	hybrid			2022-12-27	WOS:000241075900057
J	Hajjar, E; Perahia, D; Debat, H; Nespoulous, C; Robert, CH				Hajjar, Eric; Perahia, David; Debat, Helene; Nespoulous, Claude; Robert, Charles H.			Odorant binding and conformational dynamics in the odorant-binding protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMPLICIT SOLVENT MODELS; MOLECULAR-DYNAMICS; BETA-LACTOGLOBULIN; FREE-ENERGY; COMPUTER-SIMULATIONS; OLFACTORY RECEPTOR; MEAN FORCE; LIGAND; THERMODYNAMICS; TRANSTHYRETIN	In mammals, the olfactory epithelium secretes odorantbinding proteins ( OBPs), which are lipocalins found freely dissolved in the mucus layer protecting the olfactory neurons. OBPs may act as passive transporters of predominantly hydrophobic odorant molecules across the aqueous mucus layer, or they may play a more active role in which the olfactory neuronal receptor recognizes the OBP- ligand complex. To better understand the molecular events accompanying the initial steps in the olfaction process, we have performed molecular dynamics studies of rat and pig OBPs with the odorant molecule thymol. These calculations provide an atomic level description of conformational changes and pathway intermediates that remain difficult to study directly. A series of eight independent molecular dynamics trajectories of rat OBP permitted the observation of a consensus pathway for ligand unbinding and the calculation of the potential of mean force ( PMF) along this path. Titration microcalorimetry confirmed the specific binding of thymol to this protein with a strong hydrophobic component. In both rat and pig OBPs we observed lipocalin strand pair opening in the presence of ligand, consistent with potential roles of these proteins in olfactive receptor recognition.	Univ Paris 11, CNRS, MIP, UMR8619 Modelisat & Ingn Prot, F-91405 Orsay, France; French Natl Inst Agr Res, NOPA, BOG, F-78352 Jouy En Josas, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Robert, CH (corresponding author), Univ Paris 11, CNRS, MIP, UMR8619 Modelisat & Ingn Prot, Bat 430, F-91405 Orsay, France.		Perahia, David/A-4277-2016	Perahia, David/0000-0001-7480-3349; Robert, Charles/0000-0003-0337-1504; DEBAT, Helene/0000-0003-0020-2748				Beck DAC, 2005, BIOCHEMISTRY-US, V44, P609, DOI 10.1021/bi0486381; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Blanchet MA, 1996, NAT STRUCT BIOL, V3, P934, DOI 10.1038/nsb1196-934; Briand L, 2000, EUR J BIOCHEM, V267, P3079, DOI 10.1046/j.1432-1033.2000.01340.x; BROOKS BR, 1983, J COMPUT CHEM, V93, P2487; Chau PL, 2001, CHEM PHYS LETT, V334, P343, DOI 10.1016/S0009-2614(00)01427-5; Chorny I, 2005, J PHYS CHEM B, V109, P24056, DOI 10.1021/jp055043m; Feig M, 2004, CURR OPIN STRUC BIOL, V14, P217, DOI 10.1016/j.sbi.2004.03.009; Ferrara P, 2002, PROTEINS, V46, P24, DOI 10.1002/prot.10001; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P46, DOI 10.1016/S0167-4838(00)00147-3; Forge V, 2000, J MOL BIOL, V296, P1039, DOI 10.1006/jmbi.1999.3515; Garemyr R, 1999, PROTEINS, V37, P417, DOI 10.1002/(SICI)1097-0134(19991115)37:3<417::AID-PROT9>3.0.CO;2-U; Gilson MK, 1997, BIOPHYS J, V72, P1047, DOI 10.1016/S0006-3495(97)78756-3; Goleblowski J, 2006, J MOL STRUC-THEOCHEM, V763, P165, DOI 10.1016/j.theochem.2006.01.013; Grubmuller H., 1996, SOLVATE 1 0; Hamada D, 1996, NAT STRUCT BIOL, V3, P868, DOI 10.1038/nsb1096-868; JORGENSEN WL, 1990, J AM CHEM SOC, V112, P4768, DOI 10.1021/ja00168a022; Korndorfer IP, 2003, J MOL BIOL, V330, P385, DOI 10.1016/S0022-2836(03)00573-4; Kosztin I, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2166379; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Kuwata K, 2001, J MOL BIOL, V305, P1073, DOI 10.1006/jmbi.2000.4350; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lazar J, 2002, BIOCHEMISTRY-US, V41, P11786, DOI 10.1021/bi0256734; Lazaridis T, 1999, PROTEINS, V35, P133, DOI 10.1002/(SICI)1097-0134(19990501)35:2<133::AID-PROT1>3.0.CO;2-N; Lobel D, 2001, CHEM SENSES, V26, P673, DOI 10.1093/chemse/26.6.673; Lobel D, 1998, EUR J BIOCHEM, V254, P318, DOI 10.1046/j.1432-1327.1998.2540318.x; Matarazzo V, 2002, CHEM SENSES, V27, P691, DOI 10.1093/chemse/27.8.691; Monaco HL, 2000, BBA-PROTEIN STRUCT M, V1482, P65, DOI 10.1016/S0167-4838(00)00140-0; MONACO HL, 1995, SCIENCE, V268, P1039, DOI 10.1126/science.7754382; Nespoulous C, 2004, CHEM SENSES, V29, P189, DOI 10.1093/chemse/bjh017; Norberg J, 2003, Q REV BIOPHYS, V36, P257, DOI 10.1017/S0033583503003895; Paci E, 2005, FEBS J, V272, P4826, DOI 10.1111/j.1742-4658.2005.04898.x; Pelosi P, 1996, J NEUROBIOL, V30, P3; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Pophof B, 2002, NATURWISSENSCHAFTEN, V89, P515, DOI 10.1007/s00114-002-0364-5; Qin BY, 1998, BIOCHEMISTRY-US, V37, P14014, DOI 10.1021/bi981016t; Ramoni R, 2002, BIOCHEM J, V365, P739, DOI 10.1042/BJ20011631; Resat H, 1997, BIOPHYS J, V72, P522, DOI 10.1016/S0006-3495(97)78692-2; ROBERT CH, 1988, BIOCHEMISTRY-US, V27, P6829, DOI 10.1021/bi00418a027; ROUX B, 1995, COMPUT PHYS COMMUN, V91, P275, DOI 10.1016/0010-4655(95)00053-I; Roux B, 1999, BIOPHYS CHEM, V78, P1, DOI 10.1016/S0301-4622(98)00226-9; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Spinelli S, 1998, BIOCHEMISTRY-US, V37, P7913, DOI 10.1021/bi980179e; Swanson JMJ, 2004, BIOPHYS J, V86, P67, DOI 10.1016/S0006-3495(04)74084-9; Tegoni M, 2004, TRENDS BIOCHEM SCI, V29, P257, DOI 10.1016/j.tibs.2004.03.003; Tegoni M, 1996, NAT STRUCT BIOL, V3, P863, DOI 10.1038/nsb1096-863; Vincent F, 2000, J MOL BIOL, V300, P127, DOI 10.1006/jmbi.2000.3820; Woo HJ, 2005, P NATL ACAD SCI USA, V102, P6825, DOI 10.1073/pnas.0409005102; WYMAN J, 1964, ADV PROTEIN CHEM, V19, P223, DOI 10.1016/S0065-3233(08)60190-4	50	41	41	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					29929	29937		10.1074/jbc.M604869200	http://dx.doi.org/10.1074/jbc.M604869200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16849331	hybrid, Green Published			2022-12-27	WOS:000240896300054
J	Han, SW; Ritzenthaler, JD; Sitaraman, SV; Roman, J				Han, ShouWei; Ritzenthaler, Jeff D.; Sitaraman, Shanthi V.; Roman, Jesse			Fibronectin increases matrix metalloproteinase 9 expression through activation of c-Fos via extracellular-regulated kinase and phosphatidylinositol 3-kinase pathways in human lung carcinoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DECOY OLIGONUCLEOTIDE-INHIBITION; FOCAL-ADHESION-KINASE; GENE-EXPRESSION; MATRIX METALLOPROTEINASES; PLASMINOGEN-ACTIVATOR; TRANSCRIPTION FACTORS; CANCER CELLS; TUMOR-GROWTH; KAPPA-B; INTEGRIN	Enhanced expression of matrix metalloproteinase- 9 ( MMP-9) is associated with human lung tumor invasion and/ or metastasis. We have demonstrated that fibronectin (FN), a matrix glycoprotein, stimulates human non-small cell lung carcinoma (NSCLC) cell proliferation. The current study examines the effect of FN on MMP-9 expression in NSCLC cells. We show that FN increases MMP-9 protein, mRNA expression, and gelatinolytic activity in NSCLC cells. The integrin alpha 5 beta 1 mediated the effects of FN because alpha 5 small interfering RNA blocked FN-stimulated MMP- 9 protein expression, and also abrogated FN-induced phosphorylation of ERK and phosphatidylinositol 3-kinase ( PI3K) signals. The inhibitor of ERK, PD98095, and of PI3K, wortmannin, but not that of protein kinase A, H89, of Rho kinase, Y- 27632, of mTOR, rapamycin, or of JNK, SP600125, prevented FN- induced MMP-9 gelatinolytic activity and gene expression. FN enhanced MMP-9 gene promoter activity; however, there was no response to FN in DNA constructs with an AP-1 site mutation. FN increased AP-1 DNA binding activity, and this was abrogated by cyclic AMP response element decoy oligonucleotides, which also diminished FN- induced MMP-9 promoter activity. FN increased the expression of the AP- 1 subunit c- Fos protein, but not in the presence of PD98095 and wortmannin. The AP-1 inhibitor, nordihydroguaiaretic acid, and a c- Fos small interfering RNA eliminated the effect of FN on MMP-9 expression. This study indicates that FN, by binding to the integrin alpha 5 beta 1 receptor, stimulates the expression of MMP- 9 through increased AP- 1/ DNA binding and c- Fos protein expression via ERK and PI3K signaling pathways. The data unveils a novel mechanism by which FN could promote NSCLC cell invasion and metastasis.	Emory Univ, Sch Med, Div Pulm Allergy & Crit Care Med, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Med, Div Digest Dis, Atlanta, GA 30322 USA; Atlant Vet Affairs Med Ctr, Atlanta, GA 30033 USA	Emory University; Emory University	Han, SW (corresponding author), Emory Univ, Sch Med, Div Pulm Allergy & Crit Care Med, Whitehead Biores Bldg,615 Michael St,Suite 205-M, Atlanta, GA 30322 USA.	shan2@emory.edu						Acuff HB, 2006, CANCER RES, V66, P259, DOI 10.1158/0008-5472.CAN-05-2502; Alper O, 2001, MOL CELL BIOCHEM, V218, P55, DOI 10.1023/A:1007205205131; Anderson DG, 2005, SPINE, V30, P1242, DOI 10.1097/01.brs.0000164097.47091.4c; Behren A, 2005, CANCER RES, V65, P11613, DOI 10.1158/0008-5472.CAN-05-2672; Berven LA, 2004, EXP CELL RES, V296, P183, DOI 10.1016/j.yexer.2003.12.032; Chana RS, 2003, KIDNEY INT, V63, P889, DOI 10.1046/j.1523-1755.2003.00828.x; Cheuk BLY, 2004, J SURG RES, V118, P176, DOI 10.1016/S0022-4804(03)00351-2; Cho YS, 2002, P NATL ACAD SCI USA, V99, P15626, DOI 10.1073/pnas.242617799; Cho-Chung YS, 2000, MOL CELL BIOCHEM, V212, P29, DOI 10.1023/A:1007144618589; Cordes N, 2003, BRIT J CANCER, V88, P1470, DOI 10.1038/sj.bjc.6600912; Cowles EA, 2000, J BIOMED MATER RES, V52, P725, DOI 10.1002/1097-4636(20001215)52:4<725::AID-JBM18>3.3.CO;2-F; Esparza J, 1999, BLOOD, V94, P2754, DOI 10.1182/blood.V94.8.2754.420k09_2754_2766; Fujino H, 2005, MOL CANCER THER, V4, P1409, DOI 10.1158/1535-7163.MCT-05-0031; Han SW, 2004, INT J CANCER, V111, P322, DOI 10.1002/ijc.20281; Han SW, 2006, CANCER RES, V66, P315, DOI 10.1158/0008-5472.CAN-05-2367; Han SW, 1996, ENDOCRINOLOGY, V137, P1791, DOI 10.1210/en.137.5.1791; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Homandberg GA, 2002, OSTEOARTHR CARTILAGE, V10, P381, DOI 10.1053/joca.2002.0524; Hoshijima M, 2006, FEBS LETT, V580, P1376, DOI 10.1016/j.febslet.2006.01.061; Hu ZB, 2005, CLIN CANCER RES, V11, P5433, DOI 10.1158/1078-0432.CCR-05-0311; Illario M, 2005, J CLIN ENDOCR METAB, V90, P2865, DOI 10.1210/jc.2004-1520; Jung SH, 2006, INT J CANCER, V118, P490, DOI 10.1002/ijc.21356; Katori H, 2006, J SURG ONCOL, V93, P80, DOI 10.1002/jso.20386; Kijima T, 2003, J CELL MOL MED, V7, P157; Kodate M, 1997, PATHOL INT, V47, P461, DOI 10.1111/j.1440-1827.1997.tb04525.x; Laack E, 2005, LUNG CANCER, V50, P51, DOI 10.1016/j.lungcan.2005.05.011; Labat-Robert J, 2002, SEMIN CANCER BIOL, V12, P187, DOI 10.1016/S1044-579X(02)00022-6; Lakka SS, 2005, J BIOL CHEM, V280, P21882, DOI 10.1074/jbc.M408520200; Lee YN, 2000, BIOCHEMISTRY-US, V39, P4863, DOI 10.1021/bi992272o; Liu WH, 2000, ACTA PHARMACOL SIN, V21, P641; Malemud CJ, 2006, FRONT BIOSCI-LANDMRK, V11, P1696, DOI 10.2741/1915; Matsuo M, 2006, CANCER SCI, V97, P155, DOI 10.1111/j.1349-7006.2006.00152.x; Milde-Langosch K, 2005, EUR J CANCER, V41, P2449, DOI 10.1016/j.ejca.2005.08.008; Miralem T, 2001, ONCOGENE, V20, P5511, DOI 10.1038/sj.onc.1204753; Moore C, 2005, TRANSPL P, V37, P1682, DOI 10.1016/j.transproceed.2005.03.146; Muscella A, 2003, J CELL PHYSIOL, V195, P234, DOI 10.1002/jcp.10242; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nair RR, 2005, BIOCHEM SOC T, V33, P1135, DOI 10.1042/BST0331135; Ohbayashi H, 2002, CURR PROTEIN PEPT SC, V3, P409, DOI 10.2174/1389203023380549; Okamoto T, 2004, BIOL CHEM, V385, P997, DOI 10.1515/BC.2004.130; Park S, 2004, J CELL BIOCHEM, V91, P973, DOI 10.1002/jcb.10768; Pello OM, 2006, J IMMUNOL, V176, P1675, DOI 10.4049/jimmunol.176.3.1675; Rao JS, 2005, MOL CANCER THER, V4, P1399, DOI 10.1158/1535-7163.MCT-05-0082; Ray A, 2005, J IMMUNOL, V175, P4039, DOI 10.4049/jimmunol.175.6.4039; Rintoul RC, 2002, CLIN SCI, V102, P417, DOI 10.1042/CS20010216; Rivera-Marrero CA, 2002, AM J PHYSIOL-LUNG C, V282, pL546, DOI 10.1152/ajplung.00175.2001; Romberger DJ, 1997, INT J BIOCHEM CELL B, V29, P939, DOI 10.1016/S1357-2725(96)00172-0; Samara GJ, 2004, CANCER LETT, V214, P231, DOI 10.1016/j.canlet.2004.04.035; SATO H, 1993, ONCOGENE, V8, P395; Segarra M, 2005, FASEB J, V19, P1875, DOI 10.1096/fj.04-3574fje; SERVE H, 1995, EMBO J, V14, P473, DOI 10.1002/j.1460-2075.1995.tb07023.x; Sharma-Walia N, 2005, J VIROL, V79, P10308, DOI 10.1128/JVI.79.16.10308-10329.2005; Spence HJ, 2006, MOL CELL BIOL, V26, P1480, DOI 10.1128/MCB.26.4.1480-1495.2006; Taimor G, 2004, AM J PHYSIOL-HEART C, V286, pH2369, DOI 10.1152/ajpheart.00741.2003; Takahashi M, 2005, J REPROD DEVELOP, V51, P47, DOI 10.1262/jrd.51.47; Takahra T, 2004, INT J BIOCHEM CELL B, V36, P353, DOI 10.1016/S1357-2725(03)00260-7; Takino T, 2005, J BIOL CHEM, V280, P37772, DOI 10.1074/jbc.M505241200; Thant AA, 2001, CLIN EXP METASTAS, V18, P423, DOI 10.1023/A:1010921730952; Turpeenniemi-Hujanen T, 2005, BIOCHIMIE, V87, P287, DOI 10.1016/j.biochi.2005.01.014; Wang J, 2006, J NEUROCHEM, V96, P148, DOI 10.1111/j.1471-4159.2005.03521.x; Woo JH, 2003, CANCER RES, V63, P3430; Xie B, 1998, J BIOL CHEM, V273, P11576, DOI 10.1074/jbc.273.19.11576; Yang SF, 2005, CLIN CHIM ACTA, V354, P91, DOI 10.1016/j.cccn.2004.11.011; Yoshizaki T, 1998, P NATL ACAD SCI USA, V95, P3621, DOI 10.1073/pnas.95.7.3621; Zhang JH, 2002, NAT GENET, V30, P416, DOI 10.1038/ng859	65	96	103	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					29614	29624		10.1074/jbc.M604013200	http://dx.doi.org/10.1074/jbc.M604013200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16882662	hybrid, Green Published			2022-12-27	WOS:000240896300023
J	McKane, M; Wen, KK; Meyer, A; Rubenstein, PA				McKane, Melissa; Wen, Kuo-Kuang; Meyer, Amanda; Rubenstein, Peter A.			Effect of the substitution of muscle actin-specific subdomain 1 and 2 residues in yeast actin on actin function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; MYOSIN SUBFRAGMENT-1; F-ACTIN; MUTATIONAL ANALYSIS; ATPASE ACTIVITY; N-TERMINUS; POLYMERIZATION; MUTANT; FILAMENT; PROTEIN	Muscle and yeast actins display distinct behavioral characteristics. To better understand the allosteric interactions that regulate actin function, we created a muscle/ yeast hybrid actin containing a muscle- specific outer domain ( subdomains 1 and 2) and a yeast inner domain ( subdomains 3 and 4). Actin with muscle subdomain 1 and the two yeast N- terminal negative charges supported viability. The four negative charge muscleNterminus in a muscle subdomain 1 background caused death, but in the same background actin with three N- terminal acidic residues ( 3Ac/ Sub1) led to sick but viable cells. Addition of three muscle subdomain 2 residues ( 3Ac/ Sub12) produced no further deleterious effects. These hybrid actins caused depolarized cytoskeletons, abnormal vacuoles, and mitochondrial and endocytosis defects. 3Ac/ Sub1 G- actin exchanged bound epsilon ATP more slowly than wild type actin, and the exchange rate for 3Ac/ Sub12 was even slower, similar to that for muscle actin. The mutant actins polymerized faster and produced less stable and shorter filaments than yeast actin, the opposite of that expected for muscle actin. Unlike wild type actin, in the absence of unbound ATP, polymerization led to ADP- F- actin, which rapidly depolymerized. Like yeast actin, the hybrid actins activated muscle myosin S1 ATPase activity only about one- eighth as well as muscle actin, despite having essentially a muscle actin- specific myosinbinding site. Finally, the hybrid actins behaved abnormally in a yeast Arp2/3- dependent polymerization assay. Our results demonstrate a unique sensitivity of yeast to actin N- terminal negative charge density. They also provide insight into the role of each domain in the control of the various functions of actin.	Univ Iowa, Roy A & Lucille A Carver Coll Med, Dept Biochem, Iowa City, IA 52242 USA	University of Iowa	Rubenstein, PA (corresponding author), Univ Iowa, Roy A & Lucille A Carver Coll Med, Dept Biochem, Iowa City, IA 52242 USA.	peter-rubenstein@uiowa.edu		Rubenstein, Peter/0000-0003-1225-4414	NIGMS NIH HHS [GM-33689] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033689] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bobkov AA, 1997, BIOCHEMISTRY-US, V36, P7733, DOI 10.1021/bi963185o; Bryan KE, 2005, J BIOL CHEM, V280, P1696, DOI 10.1074/jbc.M410180200; BUTTERS CA, 1993, J BIOL CHEM, V268, P15565; Buzan JM, 1996, P NATL ACAD SCI USA, V93, P91, DOI 10.1073/pnas.93.1.91; CARLIER MF, 1991, J BIOL CHEM, V266, P1; Chen WZ, 2006, BIOPHYS J, V90, P1308, DOI 10.1529/biophysj.105.064634; CHEN X, 1993, J CELL BIOL, V123, P1185, DOI 10.1083/jcb.123.5.1185; Chik JK, 1996, J MOL BIOL, V263, P607, DOI 10.1006/jmbi.1996.0602; COOK RK, 1992, J BIOL CHEM, V267, P9430; COOK RK, 1993, J BIOL CHEM, V268, P2410; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; Galkin VE, 2002, CURR BIOL, V12, P570, DOI 10.1016/S0960-9822(02)00742-X; GALLWITZ D, 1980, NUCLEIC ACIDS RES, V8, P1043, DOI 10.1093/nar/8.5.1043; Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313; GREER C, 1982, MOL CELL BIOL, V2, P1270, DOI 10.1128/MCB.2.10.1270; Hill KL, 1996, J CELL BIOL, V135, P1535, DOI 10.1083/jcb.135.6.1535; HITCHCOCK SE, 1980, J BIOL CHEM, V255, P5668; HITCHCOCKDEGREGORI SE, 1988, BIOCHEMISTRY-US, V27, P9182, DOI 10.1021/bi00426a016; HOMSHER E, 1992, AM J PHYSIOL, V262, pC714, DOI 10.1152/ajpcell.1992.262.3.C714; Kim E, 1996, BIOCHEMISTRY-US, V35, P16566, DOI 10.1021/bi9623892; Lauer P, 2002, J BACTERIOL, V184, P4177, DOI 10.1128/JB.184.15.4177-4186.2002; Lu XY, 2005, J PHYSIOL-LONDON, V564, P65, DOI 10.1113/jphysiol.2004.078055; McKane M, 2005, J BIOL CHEM, V280, P36494, DOI 10.1074/jbc.M506970200; Melki R, 1996, BIOCHEMISTRY-US, V35, P12038, DOI 10.1021/bi961325o; Miller CJ, 1996, BIOCHEMISTRY-US, V35, P16557, DOI 10.1021/bi962388+; NG R, 1980, P NATL ACAD SCI-BIOL, V77, P3912, DOI 10.1073/pnas.77.7.3912; Okamoto K, 2001, METHOD CELL BIOL, V65, P277, DOI 10.1016/S0091-679X(01)65017-9; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; PRINGLE JR, 1989, METHOD CELL BIOL, V31, P357; Saeki K, 2000, BIOCHEMISTRY-US, V39, P1324, DOI 10.1021/bi991297k; SUTOH K, 1991, P NATL ACAD SCI USA, V88, P7711, DOI 10.1073/pnas.88.17.7711; SUTOH K, 1983, BIOCHEMISTRY-US, V22, P1579, DOI 10.1021/bi00276a009; Wen KK, 2005, J BIOL CHEM, V280, P24168, DOI 10.1074/jbc.M502024200; Wen KK, 2002, J BIOL CHEM, V277, P41101, DOI 10.1074/jbc.M204025200; Wen KK, 2000, J BIOL CHEM, V275, P40594, DOI 10.1074/jbc.M007201200; WERTMAN KF, 1992, GENETICS, V132, P337; Yao XY, 2001, J BIOL CHEM, V276, P25598, DOI 10.1074/jbc.M011797200	37	26	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					29916	29928		10.1074/jbc.M602251200	http://dx.doi.org/10.1074/jbc.M602251200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16882670	hybrid			2022-12-27	WOS:000240896300053
J	Melia, TJ; You, DQ; Tareste, DC; Rothman, JE				Melia, Thomas J.; You, Daoqi; Tareste, David C.; Rothman, James E.			Lipidic antagonists to SNARE-mediated fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-FUSION; TRANSPORT VESICLES; CRYSTAL-STRUCTURE; COMPLEX; BINDING; CORE; SYNAPTOTAGMIN-1; INHIBITION; EXOCYTOSIS; MECHANISM	SNARE proteins mediate the fusion of lipid bilayers by the directed assembly of coiled- coil domains arising from apposing membranes. We have utilized inverted cone-shaped lipids, antagonists of the necessary membrane deformation during fusion to characterize the extent and range of SNARE assembly up to the moment of stalk formation between bilayers. The inverted cone-shaped lipid family of acyl-CoAs specifically inhibits the completion of fusion in an acyl-chain length-dependent manner. Removal of acyl-CoA from the membrane relieves the inhibition and initiates a burst of membrane fusion with rates exceeding any point in the control curves lacking acyl-CoA. This burst indicates the accumulation of semi- assembled fusion complexes. These preformed complexes are resistant to cleavage by botulinum toxin B and thus appear to have progressed beyond the "loosely zippered" state of docked synaptic vesicles. Surprisingly, application of the soluble domain of VAMP2, which blocks SNARE assembly by competing for binding on the available t-SNAREs, blocks recovery from the acylCoA inhibition. Thus, complexes formed in the presence of a lipidic antagonist to fusion are incompletely assembled, suggesting that the formation of tightly assembled SNARE pairs requires progression all the way through to membrane fusion. In this regard, physiologically docked exocytic vesicles may be anchored by a highly dynamic and potentially even reversible SNAREpin.	Columbia Univ, Dept Physiol & Cellular Biophys, Coll Phys & Surg, New York, NY 10032 USA	Columbia University	Melia, TJ (corresponding author), Columbia Univ, Dept Physiol & Cellular Biophys, Coll Phys & Surg, 1150 St Nicholas Ave, New York, NY 10032 USA.	tm2176@columbia.edu	Tareste, David/L-2639-2017; Tareste, David/P-9249-2019	Tareste, David/0000-0002-8744-7598; Tareste, David/0000-0002-8744-7598				Arac D, 2006, NAT STRUCT MOL BIOL, V13, P209, DOI 10.1038/nsmb1056; Bowen ME, 2005, BIOPHYS J, V89, P690, DOI 10.1529/biophysj.104.054064; Chen XC, 2006, BIOPHYS J, V90, P2062, DOI 10.1529/biophysj.105.071415; Chen YA, 2001, NEURON, V30, P161, DOI 10.1016/S0896-6273(01)00270-7; CHERNOMORDIK LV, 1993, FEBS LETT, V318, P71, DOI 10.1016/0014-5793(93)81330-3; Chernomordik LV, 1997, J CELL BIOL, V136, P81, DOI 10.1083/jcb.136.1.81; Curry S, 1998, NAT STRUCT BIOL, V5, P827, DOI 10.1038/1869; Faergeman NJ, 1997, BIOCHEM J, V323, P1; Fasshauer D, 1998, BIOCHEMISTRY-US, V37, P10354, DOI 10.1021/bi980542h; Fix M, 2004, P NATL ACAD SCI USA, V101, P7311, DOI 10.1073/pnas.0401779101; Gelamo EL, 2002, BBA-PROTEIN STRUCT M, V1594, P84, DOI 10.1016/S0167-4838(01)00287-4; GINGELL D, 1978, P791; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; GUNTHERAUSBORN S, 1995, J BIOL CHEM, V270, P29279; Hu C, 2003, SCIENCE, V300, P1745, DOI 10.1126/science.1084909; Hua SY, 1999, NAT NEUROSCI, V2, P1078, DOI 10.1038/16005; KOZLOV MM, 1983, BIOFIZIKA+, V28, P242; Lonart G, 2000, J BIOL CHEM, V275, P27703; Melia TJ, 2002, J CELL BIOL, V158, P929, DOI 10.1083/jcb.200112081; Nagy G, 2006, J NEUROSCI, V26, P632, DOI 10.1523/JNEUROSCI.2589-05.2006; Parlati F, 1999, P NATL ACAD SCI USA, V96, P12565, DOI 10.1073/pnas.96.22.12565; PFANNER N, 1990, J CELL BIOL, V110, P955, DOI 10.1083/jcb.110.4.955; PFANNER N, 1989, CELL, V59, P95, DOI 10.1016/0092-8674(89)90872-6; Poirier MA, 1998, NAT STRUCT BIOL, V5, P765, DOI 10.1038/1799; POWELL GL, 1981, J BIOL CHEM, V256, P2740; Rizo J, 2003, NAT STRUCT BIOL, V10, P417, DOI 10.1038/nsb0603-417; Schuette CG, 2004, P NATL ACAD SCI USA, V101, P2858, DOI 10.1073/pnas.0400044101; Scott BL, 2003, METHOD ENZYMOL, V372, P274; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tamm LK, 2003, CURR OPIN STRUC BIOL, V13, P453, DOI 10.1016/S0959-440X(03)00107-6; Weber T, 2000, J CELL BIOL, V149, P1063, DOI 10.1083/jcb.149.5.1063; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Xu T, 1999, CELL, V99, P713, DOI 10.1016/S0092-8674(00)81669-4; Zhang F, 2004, J BIOL CHEM, V279, P38668, DOI 10.1074/jbc.M404904200	34	30	32	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					29597	29605		10.1074/jbc.M601778200	http://dx.doi.org/10.1074/jbc.M601778200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16887809	hybrid			2022-12-27	WOS:000240896300021
J	Tafesse, FG; Ternes, P; Holthuis, JCM				Tafesse, Fikadu Geta; Ternes, Philipp; Holthuis, Joost C. M.			The multigenic sphingomyelin synthase family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CERAMIDE-PHOSPHOETHANOLAMINE SYNTHESIS; RAT-LIVER; SACCHAROMYCES-CEREVISIAE; PHOSPHATIDYLCHOLINE; DIACYLGLYCEROL; SPHINGOLIPIDS; PROTEIN; GROWTH; IDENTIFICATION; BIOSYNTHESIS		Univ Utrecht, Bijvoet Ctr, Dept Membrane Enzymol, NL-3584 CH Utrecht, Netherlands; Univ Utrecht, Biomembrane Inst, NL-3584 CH Utrecht, Netherlands	Utrecht University; Utrecht University	Holthuis, JCM (corresponding author), Univ Utrecht, Bijvoet Ctr, Dept Membrane Enzymol, HR Kruytgebouw,Padualaan 8, NL-3584 CH Utrecht, Netherlands.	j.c.holthuis@chem.uu.nl	Holthuis, Joost/AAL-9157-2020	Tafesse, Fikadu/0000-0002-8575-4164; Holthuis, Joost/0000-0001-8912-1586; Ternes, Philipp/0000-0003-0886-5474				AdamKlages S, 1996, CELL, V86, P937, DOI 10.1016/S0092-8674(00)80169-5; Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759; Dickson RC, 1998, ANNU REV BIOCHEM, V67, P27, DOI 10.1146/annurev.biochem.67.1.27; Dunn TM, 2004, ANN BOT-LONDON, V93, P483, DOI 10.1093/aob/mch071; ELMENDORF HG, 1994, J CELL BIOL, V124, P449, DOI 10.1083/jcb.124.4.449; FUTERMAN AH, 1990, J BIOL CHEM, V265, P8650; HAMPTON RY, 1989, SCIENCE, V246, P1050, DOI 10.1126/science.2555921; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; HANADA K, 1992, J BIOL CHEM, V267, P23527; Hanada K, 1998, J BIOL CHEM, V273, P33787, DOI 10.1074/jbc.273.50.33787; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Heidler SA, 2000, BBA-MOL BASIS DIS, V1500, P147, DOI 10.1016/S0925-4439(99)00097-6; Holthuis JCM, 2001, PHYSIOL REV, V81, P1689, DOI 10.1152/physrev.2001.81.4.1689; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; JECKEL D, 1992, J CELL BIOL, V117, P259, DOI 10.1083/jcb.117.2.259; KARLANDER SG, 1972, BIOCHIM BIOPHYS ACTA, V270, P117, DOI 10.1016/0005-2760(72)90185-3; Kim CA, 2003, TRENDS BIOCHEM SCI, V28, P625, DOI 10.1016/j.tibs.2003.11.001; Luberto C, 2003, J BIOL CHEM, V278, P32733, DOI 10.1074/jbc.M300932200; Luberto C, 1998, J BIOL CHEM, V273, P14550, DOI 10.1074/jbc.273.23.14550; MALGAT M, 1987, J LIPID RES, V28, P138; MALGAT M, 1986, J LIPID RES, V27, P251; MANDON EC, 1992, J BIOL CHEM, V267, P11144; MARGGRAF WD, 1984, BIOCHIM BIOPHYS ACTA, V793, P346, DOI 10.1016/0005-2760(84)90248-0; MESHARTREE M, 1976, CAN J BIOCHEM CELL B, V54, P578, DOI 10.1139/o76-085; MUEHLENBERG BA, 1972, CAN J BIOCHEM CELL B, V50, P166, DOI 10.1139/o72-022; Nagiec MM, 1997, J BIOL CHEM, V272, P9809, DOI 10.1074/jbc.272.15.9809; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Riboni L, 2001, J BIOL CHEM, V276, P12797, DOI 10.1074/jbc.M011570200; Rietveld A, 1999, J BIOL CHEM, V274, P12049, DOI 10.1074/jbc.274.17.12049; SATOUCHI K, 1993, LIPIDS, V28, P837, DOI 10.1007/BF02536239; Sigal YJ, 2005, BIOCHEM J, V387, P281, DOI 10.1042/BJ20041771; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; ULLMAN MD, 1974, J BIOL CHEM, V249, P1506; VAN HELVOORT A, 1994, J BIOL CHEM, V269, P1763; VOELKER DR, 1982, BIOCHEMISTRY-US, V21, P2753, DOI 10.1021/bi00540a027; Waggoner DW, 1999, BBA-MOL CELL BIOL L, V1439, P299, DOI 10.1016/S1388-1981(99)00102-X; WIEGMANN K, 1994, CELL, V78, P1005, DOI 10.1016/0092-8674(94)90275-5; Yamaoka S, 2004, J BIOL CHEM, V279, P18688, DOI 10.1074/jbc.M401205200; Yang Z, 2005, GENE, V363, P123, DOI 10.1016/j.gene.2005.07.036	42	209	222	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					29421	29425		10.1074/jbc.R600021200	http://dx.doi.org/10.1074/jbc.R600021200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16905542	hybrid, Green Published			2022-12-27	WOS:000240896300002
J	Yacoub, D; Theoret, JF; Villeneuve, L; Abou-Saleh, H; Mourad, W; Allen, BG; Merhi, Y				Yacoub, Daniel; Theoret, Jean-Francois; Villeneuve, Louis; Abou-Saleh, Haissam; Mourad, Walid; Allen, Bruce G.; Merhi, Yahye			Essential role of protein kinase C delta in platelet signaling alpha(IIb)beta(3) activation, and thromboxane A(2) release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATES TYROSINE PHOSPHORYLATION; P-SELECTIN ANTAGONISM; RECEPTOR GAMMA-CHAIN; SYNTAXIN 4; COLLAGEN; THROMBIN; ADHESION; TRANSDUCTION; PKC; SECRETION	The protein kinase C (PKC) family is an essential signaling mediator in platelet activation and aggregation. However, the relative importance of the major platelet PKC isoforms and their downstream effectors in platelet signaling and function remain unclear. Using isolated human platelets, we report that PKC delta, but not PKC alpha or PKC beta, is required for collagen-induced phospholipase C-dependent signaling, activation of alpha(IIb)beta(3), and platelet aggregation. Analysis of PKC delta phosphorylation and translocation to the membrane following activation by both collagen and thrombin indicates that it is positively regulated by alpha(IIb)beta(3) outside-in signaling. Moreover, PKC delta triggers activation of the mitogen-activated protein kinase-kinase (MEK)/extra cellular signal regulated kinase (ERK) and the p38 MAPK signaling. This leads to the subsequent release of thromboxane A(2), which is essential for collagen-induced but not thrombin-induced platelet activation and aggregation. This study adds new insight to the role of PKCs in platelet function, where PKC delta signaling, via the MEK/ERK and p38 MAPK pathways, is required for the secretion of thromboxane A(2).	Montreal Heart Inst, Lab Expt Pathol, Res Ctr, Montreal, PQ H1T 1C8, Canada; Univ Montreal, Montreal, PQ H1T 1C8, Canada	Universite de Montreal; Universite de Montreal	Merhi, Y (corresponding author), Montreal Heart Inst, Lab Expt Pathol, Res Ctr, 5000 Belanger St, Montreal, PQ H1T 1C8, Canada.	yahye.merhi@icm-mhi.org	Allen, Bruce G/B-4693-2008	Allen, Bruce G/0000-0001-9000-9495; Mourad, Walid/0000-0002-1859-9387				BALDASSARE JJ, 1992, J BIOL CHEM, V267, P15585; BANNO Y, 1988, J BIOL CHEM, V263, P11459; Berndt MC, 2001, THROMB HAEMOSTASIS, V86, P178; BLAKE RA, 1994, FEBS LETT, V353, P212, DOI 10.1016/0014-5793(94)01037-4; Blobe GC, 1996, CANCER SURV, V27, P213; Brass LF, 1997, THROMB HAEMOSTASIS, V78, P581; Caron A, 2002, J CARDIOVASC PHARM, V40, P296, DOI 10.1097/00005344-200208000-00015; Cho MJ, 2003, BLOOD, V101, P2646, DOI 10.1182/blood-2002-05-1363; Chung SH, 2000, J BIOL CHEM, V275, P25286, DOI 10.1074/jbc.M004204200; Clemetson KJ, 2001, THROMB HAEMOSTASIS, V86, P189; Clemetson KJ, 2002, PLATELETS, P65; Coughlin SR, 2001, THROMB HAEMOSTASIS, V86, P298; CRABOS M, 1991, BIOCHEM BIOPH RES CO, V178, P878, DOI 10.1016/0006-291X(91)90973-B; Crosby D, 2003, J BIOL CHEM, V278, P24533, DOI 10.1074/jbc.M301847200; Francischetti IMB, 1998, ARCH BIOCHEM BIOPHYS, V353, P239, DOI 10.1006/abbi.1998.0598; GERRARD JM, 1989, BLOOD, V74, P2405; Gibbins J, 1996, J BIOL CHEM, V271, P18095, DOI 10.1074/jbc.271.30.18095; Hato T., 2002, PLATELETS, P105; Hofmann J, 1997, FASEB J, V11, P649, DOI 10.1096/fasebj.11.8.9240967; HYNES RO, 1991, THROMB HAEMOSTASIS, V66, P40; Jaken S, 2000, BIOESSAYS, V22, P245, DOI 10.1002/(SICI)1521-1878(200003)22:3<245::AID-BIES6>3.0.CO;2-X; Jaken S, 1996, CURR OPIN CELL BIOL, V8, P168, DOI 10.1016/S0955-0674(96)80062-7; Law DA, 1999, NATURE, V401, P808, DOI 10.1038/44599; Levy-Toledano S, 1999, HAEMOSTASIS, V29, P4; Libersan D, 2003, THROMB HAEMOSTASIS, V89, P1016, DOI 10.1055/s-0037-1613403; McNicol A, 1998, BIOCHEM PHARMACOL, V55, P1759, DOI 10.1016/S0006-2952(97)00632-1; MORTON LF, 1989, BIOCHEM J, V258, P157, DOI 10.1042/bj2580157; Moussazadeh M, 1998, FEBS LETT, V438, P225, DOI 10.1016/S0014-5793(98)01302-7; Murugappan S, 2005, BLOOD, V106, P550, DOI 10.1182/blood-2004-12-4866; Murugappan S, 2004, J BIOL CHEM, V279, P2360, DOI 10.1074/jbc.M306960200; Nadal-Wollbold F, 2002, FEBS LETT, V531, P475, DOI 10.1016/S0014-5793(02)03587-1; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.43.25526; PAPKOFF J, 1994, MOL CELL BIOL, V14, P463, DOI 10.1128/MCB.14.1.463; Parker PJ, 2004, J CELL SCI, V117, P131, DOI 10.1242/jcs.00982; Poole A, 1997, EMBO J, V16, P2333, DOI 10.1093/emboj/16.9.2333; PROJMOVIC MM, 1998, AM HEART J, V135, pS119; PUMIGLIA KM, 1992, BIOCHEM J, V286, P441, DOI 10.1042/bj2860441; Reed GL, 1999, BLOOD, V93, P2617, DOI 10.1182/blood.V93.8.2617.408k19_2617_2626; RHEE SG, 1989, SCIENCE, V244, P546, DOI 10.1126/science.2541501; Roberts DE, 2004, J BIOL CHEM, V279, P19421, DOI 10.1074/jbc.M308864200; ROTH GJ, 1994, BLOOD, V83, P885; RUGGERI ZM, 1993, THROMB HAEMOSTASIS, V70, P119; SAELMAN EUM, 1994, BLOOD, V83, P1244; Saklatvala J, 1996, J BIOL CHEM, V271, P6586, DOI 10.1074/jbc.271.12.6586; SANTORO SA, 1991, CELL REGUL, V2, P905, DOI 10.1091/mbc.2.11.905; Savage B., 2002, PLATELETS, P215; SIESS W, 1988, BIOCHEM J, V255, P309; Soriani A, 2006, J THROMB HAEMOST, V4, P648, DOI 10.1111/j.1538-7836.2006.01806.x; Theoret JF, 2001, J PHARMACOL EXP THER, V298, P658; TOLENTINO AR, 2002, PLATELETS, P117; TYERS M, 1988, NATURE, V333, P470, DOI 10.1038/333470a0; WALKER TR, 1993, BIOCHEM J, V289, P277, DOI 10.1042/bj2890277; WANG F, 1993, BIOCHEM BIOPH RES CO, V191, P240, DOI 10.1006/bbrc.1993.1208; WOULFE D, 2002, PLATELETS, P197; YANAGA F, 1995, BIOCHEM J, V311, P471, DOI 10.1042/bj3110471	56	76	80	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					30024	30035		10.1074/jbc.M604504200	http://dx.doi.org/10.1074/jbc.M604504200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16895913	hybrid			2022-12-27	WOS:000240896300063
J	Kozak, SL; Marin, M; Rose, KM; Bystrom, C; Kabat, D				Kozak, Susan L.; Marin, Mariana; Rose, Kristine M.; Bystrom, Cory; Kabat, David			The anti-HIV-1 editing enzyme APOBEC3G binds HIV-1 RNA and messenger RNAs that shuttle between polysomes and stress granules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PROTEIN COMPLEX PURIFICATION; MENTAL-RETARDATION PROTEIN; SINGLE-STRANDED-DNA; VIRAL VIF PROTEIN; CYTIDINE DEAMINASE; PUR-ALPHA; STATISTICAL-MODEL; TYPE-1 VIF; TRANSLATION	Deoxycytidine deaminases APOBEC3G(A3G) and APOBEC3F (A3F) (members of the apolipoprotein B mRNA-editing catalytic polypeptide 3 family) have RNA-binding motifs, invade assembling human immunodeficiency virus (HIV-1), and hypermutate reverse transcripts. Antagonistically, HIV-1 viral infectivity factor degrades these enzymes. A3G is enzymatically inhibited by binding RNA within an unidentified large cytosolic ribonucleoprotein, implying that RNA degradation during reverse transcription may activate intravirion A3G at the necessary moment. We purified a biologically active tandem affinity-tagged A3G from human HEK293T cells. Mass spectrometry and coimmunoprecipitation from HEK293T and T lymphocyte extracts identified many RNA-binding proteins specifically associated with A3G and A3F, including poly(A)-binding proteins (PABPs), YB-1, Ro-La, RNA helicases, ribosomal proteins, and Staufen1. Most strikingly, nearly all A3G-associated proteins were known to bind exclusively or intermittently to translating and/ or dormant mRNAs. Accordingly, A3G in HEK293T and T lymphocyte extracts was almost completely in A3G-mRNA-PABP complexes that shifted reversibly between polysomes and dormant pools in response to translational inhibitors. For example arsenite, which inhibits 5'-cap-dependent translational initiation, shifted mRNA-A3G-PABP from polysomes into stress granules in a manner that was blocked and reversed by the elongation inhibitor cycloheximide. Immunofluorescence microscopy showed A3G-mRNA-PABP stress granules only partially overlapping with Staufen1. A3G coimmunoprecipitated HIV-1RNA and many mRNAs. Ribonuclease released nearly all A3G-associated proteins, including A3G homo-oligomers and A3G-A3F hetero-oligomers, but the viral infectivity factor remained bound. Many proteins and RNAs associated with A3G are excluded from A3G-containing virions, implying that A3G competitively partitions into virions based on affinity for HIV-1 RNA.	Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol L224, Portland, OR 97239 USA	Oregon Health & Science University	Kabat, D (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol L224, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	kabat@ohsu.edu			NIAID NIH HHS [AI49729] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049729, R21AI049729] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Afonina E, 1997, J BIOL CHEM, V272, P2307, DOI 10.1074/jbc.272.4.2307; Ansari SA, 1999, J GEN VIROL, V80, P2629, DOI 10.1099/0022-1317-80-10-2629; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Brendel C, 2004, BIOCHEM J, V384, P239, DOI 10.1042/BJ20040812; BURKA ER, 1964, J MOL BIOL, V9, P439, DOI 10.1016/S0022-2836(64)80218-7; Chatel-Chaix L, 2004, MOL CELL BIOL, V24, P2637, DOI 10.1128/MCB.24.7.2637-2648.2004; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chiu YL, 2006, J BIOL CHEM, V281, P8309, DOI 10.1074/jbc.R500021200; Chiu YL, 2005, NATURE, V435, P108, DOI 10.1038/nature03493; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Cullen BR, 2006, J VIROL, V80, P1067, DOI 10.1128/JVI.80.3.1067-1076.2006; Dugre-Brisson S, 2005, NUCLEIC ACIDS RES, V33, P4797, DOI 10.1093/nar/gki794; Forler D, 2003, NAT BIOTECHNOL, V21, P89, DOI 10.1038/nbt773; GABUZDA DH, 1992, J VIROL, V66, P6489, DOI 10.1128/JVI.66.11.6489-6495.1992; Gallia GL, 1999, P NATL ACAD SCI USA, V96, P11572, DOI 10.1073/pnas.96.20.11572; Guo XM, 2004, J VIROL, V78, P12781, DOI 10.1128/JVI.78.23.12781-12787.2004; HELSETH E, 1990, J VIROL, V64, P2416, DOI 10.1128/JVI.64.5.2416-2420.1990; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; KABAT D, 1971, ANAL BIOCHEM, V39, P228, DOI 10.1016/0003-2697(71)90480-5; KABAT D, 1994, J VIROL, V68, P2570, DOI 10.1128/JVI.68.4.2570-2577.1994; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Khan MA, 2005, J VIROL, V79, P5870, DOI 10.1128/JVI.79.9.5870-5874.2005; Kim YK, 2005, CELL, V120, P195, DOI 10.1016/j.cell.2004.11.050; KLIPPEL A, 1994, MOL CELL BIOL, V14, P2675, DOI 10.1128/MCB.14.4.2675; Krasnoselskaya-Riz I, 2002, AIDS RES HUM RETROV, V18, P591, DOI 10.1089/088922202753747941; Lau PP, 2001, BIOCHEM BIOPH RES CO, V282, P977, DOI 10.1006/bbrc.2001.4679; Liddament MT, 2004, CURR BIOL, V14, P1385, DOI 10.1016/j.cub.2004.06.050; Liu BD, 2005, J VIROL, V79, P9579, DOI 10.1128/JVI.79.15.9579-9587.2005; Luo K, 2005, P NATL ACAD SCI USA, V102, P11444, DOI 10.1073/pnas.0502440102; Luo K, 2004, J VIROL, V78, P11841, DOI 10.1128/JVI.78.21.11841-11852.2004; Madani N, 2000, J VIROL, V74, P5982, DOI 10.1128/JVI.74.13.5982-5987.2000; Madani N, 1998, J VIROL, V72, P10251, DOI 10.1128/JVI.72.12.10251-10255.1998; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; MANN DL, 1989, AIDS RES HUM RETROV, V5, P253, DOI 10.1089/aid.1989.5.253; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Marin M, 2000, J VIROL, V74, P8085, DOI 10.1128/JVI.74.17.8085-8093.2000; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Mazroui R, 2002, HUM MOL GENET, V11, P3007, DOI 10.1093/hmg/11.24.3007; Mehle A, 2004, GENE DEV, V18, P2861, DOI 10.1101/gad.1249904; Mehta A, 2002, RNA, V8, P69, DOI 10.1017/S1355838202015649; Mouland AJ, 2000, J VIROL, V74, P5441, DOI 10.1128/JVI.74.12.5441-5451.2000; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nguyen KL, 2004, VIROLOGY, V319, P163, DOI 10.1016/j.virol.2003.11.021; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Ohashi S, 2002, J BIOL CHEM, V277, P37804, DOI 10.1074/jbc.M203608200; PAGE KA, 1992, J VIROL, V66, P524, DOI 10.1128/JVI.66.1.524-533.1992; PAGE KA, 1990, J VIROL, V64, P5270, DOI 10.1128/JVI.64.11.5270-5276.1990; Patel J, 2002, EUR J BIOCHEM, V269, P3076, DOI 10.1046/j.1432-1033.2002.02992.x; Peng G, 2006, J EXP MED, V203, P41, DOI 10.1084/jem.20051512; Platt EJ, 2001, J VIROL, V75, P12266, DOI 10.1128/JVI.75.24.12266-12278.2001; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rose KM, 2005, AIDS RES HUM RETROV, V21, P611, DOI 10.1089/aid.2005.21.611; Rose KM, 2004, J BIOL CHEM, V279, P41744, DOI 10.1074/jbc.M406760200; Schafer A, 2004, VIROLOGY, V328, P163, DOI 10.1016/j.virol.2004.08.006; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Sherrill KW, 2004, J BIOL CHEM, V279, P29066, DOI 10.1074/jbc.M402727200; Shin HJ, 2002, ARCH VIROL, V147, P471, DOI 10.1007/s007050200001; Smith HC, 2004, TRENDS GENET, V20, P224, DOI 10.1016/j.tig.2004.03.012; Sowden M, 1996, J BIOL CHEM, V271, P3011, DOI 10.1074/jbc.271.6.3011; Stefani G, 2004, J NEUROSCI, V24, P7272, DOI 10.1523/JNEUROSCI.2306-04.2004; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Svarovskaia ES, 2004, J BIOL CHEM, V279, P35822, DOI 10.1074/jbc.M405761200; Turelli P, 2005, SCIENCE, V307, P1061, DOI 10.1126/science.1105964; Villace P, 2004, NUCLEIC ACIDS RES, V32, P2411, DOI 10.1093/nar/gkh552; VONSCHWEDLER U, 1993, J VIROL, V67, P4945, DOI 10.1128/JVI.67.8.4945-4955.1993; Wichroski MJ, 2006, PLOS PATHOG, V2, pe41, DOI DOI 10.1371/journal.ppat.0020041; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; Wortman MJ, 2000, J CELL BIOCHEM, V77, P65, DOI 10.1002/(SICI)1097-4644(20000401)77:1<65::AID-JCB7>3.0.CO;2-U; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zennou W, 2004, J VIROL, V78, P12058, DOI 10.1128/JVI.78.21.12058-12061.2004; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004	76	145	147	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					29105	29119		10.1074/jbc.M601901200	http://dx.doi.org/10.1074/jbc.M601901200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16887808	hybrid			2022-12-27	WOS:000240680500065
J	Maia, LF; Soares, MR; Valente, AP; Almeida, FCL; Oliveira, AC; Gomes, AMO; Freitas, MS; Schneemann, A; Johnson, JE; Silva, JL				Maia, Lenize F.; Soares, Marcia R.; Valente, Ana P.; Almeida, Fabio C. L.; Oliveira, Andrea C.; Gomes, Andre M. O.; Freitas, Monica S.; Schneemann, Anette; Johnson, John E.; Silva, Jerson L.			Structure of a membrane-binding domain from a non-enveloped animal virus - Insights into the mechanism of membrane permeability and cellular entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUSION PEPTIDE; FUNCTIONAL IMPLICATIONS; PORE FORMATION; HEMAGGLUTININ; SPECTROSCOPY; PROGRAM; MODELS; HELIX	The gamma 1-peptide is a 21-residue lipid-binding domain from the non-enveloped Flock House virus (FHV). Unlike enveloped viruses, the entry of non-enveloped viruses into cells is believed to occur without membrane fusion. In this study, we performed NMR experiments to establish the solution structure of a membrane-binding peptide from a small non-enveloped icosahedral virus. The three-dimensional structure of the FHV gamma(1)-domain was determined at pH 6.5 and 4.0 in a hydrophobic environment. The secondary and tertiary structures were evaluated in the context of the capacity of the peptide for permeabilizing membrane vesicles of different lipid composition, as measured by fluorescence assays. At both pH values, the peptide has a kinked structure, similar to the fusion domain from the enveloped viruses. The secondary structure was similar in three different hydrophobic environments as follows: water/trifluoroethanol, SDS, and membrane vesicles of different compositions. The ability of the peptide to induce vesicle leakage was highly dependent on the membrane composition. Although the gamma-peptide shares some structural properties to fusion domains of enveloped viruses, it did not induce membrane fusion. Our results suggest that small protein components such as the gamma-peptide in nodaviruses (such as FHV) and VP4 in picornaviruses have a crucial role in conducting nucleic acids through cellular membranes and that their structures resemble the fusion domains of membrane proteins from enveloped viruses.	Univ Fed Rio de Janeiro, Programa Biol Estrutrural, Inst Bioquim Med, BR-21941590 Rio De Janeiro, Brazil; Univ Fed Rio de Janeiro, Ctr Nacl Ressonancia Magnet Nucl Jiri Jonas, BR-21941590 Rio De Janeiro, Brazil; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Scripps Research Institute	Silva, JL (corresponding author), Univ Fed Rio de Janeiro, Programa Biol Estrutrural, Inst Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.	jerson@bioqmed.ufrj.br	Gomes, Andre M.O./C-4009-2014; Valente, Ana Paula/J-3010-2017; Almeida, Fabio/O-4989-2018; Maia, Lenize F./N-9420-2013; de Freitas, Mônica Santos/E-8540-2015; Oliveira, Andrea C/O-6695-2018; Johnson, Johnson/HDL-9124-2022; Silva, Jerson/J-8984-2014; SILVA, JERSON Lima/GRF-1442-2022	Gomes, Andre M.O./0000-0003-1052-8004; Valente, Ana Paula/0000-0001-7219-1123; Almeida, Fabio/0000-0001-6046-7006; Maia, Lenize F./0000-0002-7433-4156; de Freitas, Mônica Santos/0000-0003-3105-7918; Silva, Jerson/0000-0001-9523-9441; SILVA, JERSON Lima/0000-0001-9523-9441; Soares, Marcia/0000-0001-9272-9488				AUE WP, 1976, J CHEM PHYS, V64, P4226, DOI 10.1063/1.431994; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; Bong DT, 1999, CHEM BIOL, V6, P473, DOI 10.1016/S1074-5521(99)80065-9; Chang DK, 1997, J VIROL, V71, P6593, DOI 10.1128/JVI.71.9.6593-6602.1997; CHENG RH, 1994, STRUCTURE, V2, P271; Corcoran JA, 2004, J BIOL CHEM, V279, P51386, DOI 10.1074/jbc.M406990200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; ELLENS H, 1985, BIOCHEMISTRY-US, V24, P3099, DOI 10.1021/bi00334a005; Epand RM, 2003, BBA-BIOMEMBRANES, V1614, P116, DOI 10.1016/S0005-2736(03)00169-X; FISHER AJ, 1993, NATURE, V361, P176, DOI 10.1038/361176a0; FRICKS CE, 1990, J VIROL, V64, P1934, DOI 10.1128/JVI.64.5.1934-1945.1990; Glaser RW, 1999, BIOCHEMISTRY-US, V38, P2560, DOI 10.1021/bi982130e; Han X, 2001, NAT STRUCT BIOL, V8, P715, DOI 10.1038/90434; Harrison Stephen C., 1996, P59; Hinz A, 2005, EUR BIOPHYS J BIOPHY, V34, P285, DOI 10.1007/s00249-004-0450-z; HOPE MJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P55, DOI 10.1016/0005-2736(85)90521-8; Hsu CH, 2002, J BIOL CHEM, V277, P22725, DOI 10.1074/jbc.M200089200; Huang CY, 2002, P NATL ACAD SCI USA, V99, P2788, DOI 10.1073/pnas.052700099; Janshoff A, 1999, BIOCHEMISTRY-US, V38, P5328, DOI 10.1021/bi982976i; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Johnson JE, 1996, P NATL ACAD SCI USA, V93, P27, DOI 10.1073/pnas.93.1.27; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lai AL, 2006, J BIOL CHEM, V281, P5760, DOI 10.1074/jbc.M512280200; LEAR JD, 1988, SCIENCE, V240, P1177, DOI 10.1126/science.2453923; Li YM, 2005, P NATL ACAD SCI USA, V102, P7529, DOI 10.1073/pnas.0408749102; Marheineke K, 1998, FEBS LETT, V441, P49, DOI 10.1016/S0014-5793(98)01523-3; MARION D, 1983, BIOCHEM BIOPH RES CO, V113, P967, DOI 10.1016/0006-291X(83)91093-8; MILLHAUSER GL, 1995, BIOCHEMISTRY-US, V34, P3873, DOI 10.1021/bi00012a001; Nicol F, 2000, BIOPHYS J, V78, P818, DOI 10.1016/S0006-3495(00)76639-2; Nieva JL, 2003, BBA-BIOMEMBRANES, V1614, P104, DOI 10.1016/S0005-2736(03)00168-8; Oliveira AC, 2000, J BIOL CHEM, V275, P16037, DOI 10.1074/jbc.M910145199; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; Rex S, 1996, BIOPHYS CHEM, V58, P75, DOI 10.1016/0301-4622(95)00087-9; Rohl CA, 1996, PROTEIN SCI, V5, P1687, DOI 10.1002/pro.5560050822; Rossmann MG, 2000, VIROLOGY, V269, P239, DOI 10.1006/viro.2000.0258; Schievano E, 2004, BIOCHEMISTRY-US, V43, P9343, DOI 10.1021/bi0496438; Schneemann A, 1998, J VIROL, V72, P8738, DOI 10.1128/JVI.72.11.8738-8746.1998; SCHNEEMANN A, 1992, J VIROL, V66, P6728, DOI 10.1128/JVI.66.11.6728-6734.1992; Schneemann A, 1998, ADV VIRUS RES, V50, P381, DOI 10.1016/S0065-3527(08)60812-X; Schwarcz WD, 2004, CELL MOL BIOL, V50, P419; Shmulevitz M, 2004, J VIROL, V78, P2808, DOI 10.1128/JVI.78.6.2808-2818.2004; Smith AE, 2004, SCIENCE, V304, P237, DOI 10.1126/science.1094823; Tihova M, 2001, J MOL BIOL, V314, P985, DOI 10.1006/jmbi.2000.5238; Wang LT, 2005, PROTEIN SCI, V14, P1661, DOI 10.1110/ps.051390405; WUTHRICK K, 1986, PROTEINS NUCL ACIDS	47	25	25	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					29278	29286		10.1074/jbc.M604689200	http://dx.doi.org/10.1074/jbc.M604689200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16861222	hybrid			2022-12-27	WOS:000240680500083
J	Muller, HK; Wiborg, O; Haase, J				Muller, Heidi Kaastrup; Wiborg, Ove; Haase, Jana			Subcellular redistribution of the serotonin transporter by secretory carrier membrane protein 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARRIER MEMBRANE-PROTEINS; BIOGENIC-AMINE TRANSPORTERS; CELL-SURFACE; SYNTAXIN 1A; KINASE-C; NEUROTRANSMITTER TRANSPORTERS; NOREPINEPHRINE TRANSPORTER; GABA TRANSPORTERS; SCAMP1 FUNCTION; TRAFFICKING	The serotonin transporter (SERT) belongs to the SLC6 family of sodium- and chloride-dependent neurotransmitter transporters responsible for uptake of amino acids and biogenic amines from extracellular spaces. Their activities and subcellular distributions are regulated by various cellular mechanisms, including interactions with other proteins. Using the yeast two-hybrid approach we screened a human brain cDNA library and identified secretory carrier membrane protein 2 (SCAMP2) as a novel SERT-interacting protein. GST-pulldown assays confirmed the physical interaction between SCAMP2 and the N-terminal domain of SERT. In addition, SERT was found to form a complex with SCAMP2 as demonstrated by co-immunoprecipitation from a heterologous expression system and from rat brain homogenate. Co-expression of SERT and SCAMP2 in mammalian cells results in the subcellular redistribution of SERT with a decrease in cell surface SERT and a concomitant reduction in 5-HT uptake activity. Using confocal microscopy we show that in neuronal cells endogenous SERT co-localizes with SCAMP2 in discrete structures also containing the lipid raft marker flotillin-1 and the SNARE protein syntaxin 1A. In contrast, SERT immunoreactivity is clearly segregated from transferrin receptor-containing endosomes. A single amino acid mutation, cysteine-201 to alanine, within the conserved cytoplasmic E peptide of SCAMP2, abolished SCAMP2-mediated down-regulation of SERT, although this mutation had no effect on the physical interaction between SERT and SCAMP2. Taken together, our results suggest that SCAMP2 plays an important role in the regulation of the subcellular distribution of SERT.	Univ Coll Dublin, Sch Biomol & Biomed Sci, Conway Inst, Dublin 4, Ireland; Univ Dublin Trinity Coll, Dublin 2, Ireland; Arhus Psychiat Univ Hosp, Ctr Basic Psychiat Res, DK-8240 Risskov, Denmark	University College Dublin; Trinity College Dublin; Aarhus University	Haase, J (corresponding author), Univ Coll Dublin, Sch Biomol & Biomed Sci, Conway Inst, Dublin 4, Ireland.	jana.haase@ucd.ie	Haase, Jana/C-1210-2008	Haase, Jana/0000-0002-5949-8355; Kaastrup Muller, Heidi/0000-0002-9842-8114				Bauman AL, 2000, J NEUROSCI, V20, P7571; Beckman ML, 1998, J NEUROSCI, V18, P6103; Blakely RD, 2000, CURR OPIN NEUROBIOL, V10, P328, DOI 10.1016/S0959-4388(00)00088-X; BRAND SH, 1991, J BIOL CHEM, V266, P18949; BRAND SH, 1993, EMBO J, V12, P3753, DOI 10.1002/j.1460-2075.1993.tb06053.x; Castle A, 2005, J CELL SCI, V118, P3769, DOI 10.1242/jcs.02503; Chen NH, 2004, PFLUG ARCH EUR J PHY, V447, P519, DOI 10.1007/s00424-003-1064-5; Deken SL, 2000, NAT NEUROSCI, V3, P998, DOI 10.1038/79939; Deken SL, 2003, J NEUROSCI, V23, P1563; Eaton M, 1996, EXP NEUROL, V140, P105, DOI 10.1006/exnr.1996.0121; Fernandez-Chacon R, 2000, J BIOL CHEM, V275, P12752, DOI 10.1074/jbc.275.17.12752; Fernandez-Chacon R, 1999, J BIOL CHEM, V274, P32551, DOI 10.1074/jbc.274.46.32551; Gagescu R, 2000, MOL BIOL CELL, V11, P2775, DOI 10.1091/mbc.11.8.2775; Geerlings A, 2001, J BIOL CHEM, V276, P17584, DOI 10.1074/jbc.M010602200; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Guo ZH, 2002, J BIOL CHEM, V277, P35357, DOI 10.1074/jbc.M202259200; Haase J, 2001, BIOCHEM SOC T, V29, P722, DOI 10.1042/BST0290722; Haass NK, 1996, J CELL BIOL, V134, P731, DOI 10.1083/jcb.134.3.731; Hubbard C, 2000, MOL BIOL CELL, V11, P2933, DOI 10.1091/mbc.11.9.2933; Iversen L, 2000, MOL PSYCHIATR, V5, P357, DOI 10.1038/sj.mp.4000728; Jayanthi LD, 2004, J BIOL CHEM, V279, P19315, DOI 10.1074/jbc.M311172200; Jess U, 2002, BIOCHEM BIOPH RES CO, V294, P272, DOI 10.1016/S0006-291X(02)00460-6; LAURIE SM, 1993, J BIOL CHEM, V268, P19110; Liu LX, 2005, MOL BIOL CELL, V16, P4463, DOI 10.1091/mbc.E05-03-0231; Liu LX, 2002, MOL BIOL CELL, V13, P4266, DOI 10.1091/mbc.E02-03-0136; Magnani F, 2004, J BIOL CHEM, V279, P38770, DOI 10.1074/jbc.M400831200; Mortensen OV, 1999, MOL BRAIN RES, V68, P141, DOI 10.1016/S0169-328X(99)00083-2; Murphy DL, 2004, MOL INTERV, V4, P109, DOI 10.1124/mi.4.2.8; Qian Y, 1997, J NEUROSCI, V17, P45, DOI 10.1523/JNEUROSCI.17-01-00045.1997; Quick MW, 2003, NEURON, V40, P537, DOI 10.1016/S0896-6273(03)00605-6; Robinson MB, 2002, J NEUROCHEM, V80, P1, DOI 10.1046/j.0022-3042.2001.00698.x; RUDNICK G, 1991, MOL PHARMACOL, V40, P421; RUDNICK G, 1992, P NATL ACAD SCI USA, V89, P1817, DOI 10.1073/pnas.89.5.1817; Schloss P, 1998, J PSYCHOPHARMACOL, V12, P115, DOI 10.1177/026988119801200201; Singleton DR, 1997, J CELL SCI, V110, P2099; Sung U, 2003, J NEUROSCI, V23, P1697; Torres GE, 2001, NEURON, V30, P121, DOI 10.1016/S0896-6273(01)00267-7; WALCHSOLIMENA C, 1995, J CELL BIOL, V128, P637, DOI 10.1083/jcb.128.4.637; Zhu CB, 2004, MOL PHARMACOL, V65, P1462, DOI 10.1124/mol.65.6.1462	39	62	63	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					28901	28909		10.1074/jbc.M602848200	http://dx.doi.org/10.1074/jbc.M602848200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16870614	hybrid			2022-12-27	WOS:000240680500044
J	Tan, AHM; Wong, SC; Lam, KP				Tan, Andy Hee-Meng; Wong, Siew-Cheng; Lam, Kong-Peng			Regulation of mouse inducible costimulator (ICOS) expression by Fyn-NFATc2 and ERK signaling in T cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULE ICOS; CUTTING EDGE; TRANSCRIPTIONAL REGULATION; CO-STIMULATION; CD28; DIFFERENTIATION; ACTIVATION; CD4(+); KINASE; NFAT	The inducible costimulator (ICOS), a member of the CD28 family of costimulatory molecules, is rapidly induced upon T cell activation. Although the critical role of ICOS in costimulating T cell responses is well documented, little is known of the intracellular signaling pathways and mechanisms that regulate ICOS expression. Here, we report that Fyn, NFAT, and ERK signaling influence ICOS expression as various chemical inhibitors, such as PP2 that targets Src kinases, U0126 that targets MEK1/2, and cyclosporin A or FK506 that targets calcineurin and thereby affects NFAT, attenuate T cell receptor-mediated ICOS induction. Moreover, ectopic expression of NFATc2 or a constitutively active MEK2 amplifies ICOS transcription and transactivates a 288-bp core region of the icos promoter in luciferase reporter assays. We also identify a site on the icos promoter that is sensitive to ERK signaling and further show that NFATc2 can bind the icos promoter in vivo and that this binding is diminished when Fyn signaling is ablated. The normal activation of ERK but reduced nuclear translocation of NFATc2 in Fyn(-/-) CD4(+) T cells further suggest that Fyn and NFATc2 act in a common axis, separate from that involving ERK, to drive ICOS transcription. Taken together, our findings indicate that Fyn-calcineurin-NFATc2 and MEK2-ERK1/2 are two independent signaling pathways that cooperate to control T cell receptor-mediated ICOS induction.	Singapore Inst Immunol, Lab Immune Regulat, Singapore 138673, Singapore		Lam, KP (corresponding author), Singapore Inst Immunol, Lab Immune Regulat, 61 Biopolis Dr, Singapore 138673, Singapore.	mcblamkp@imcb.a-star.edu.sg	Lam, Kong-Peng/G-5374-2012	Lam, Kong-Peng/0000-0002-1316-4333				Akbari O, 2002, NAT MED, V8, P1024, DOI 10.1038/nm745; Akiba H, 2005, J IMMUNOL, V175, P2340, DOI 10.4049/jimmunol.175.4.2340; Arimura Y, 2002, INT IMMUNOL, V14, P555, DOI 10.1093/intimm/dxf022; Beier KC, 2000, EUR J IMMUNOL, V30, P3707, DOI 10.1002/1521-4141(200012)30:12<3707::AID-IMMU3707>3.0.CO;2-Q; Burr JS, 2001, J IMMUNOL, V166, P5331, DOI 10.4049/jimmunol.166.9.5331; Cannons JL, 2004, IMMUNITY, V21, P693, DOI 10.1016/j.immuni.2004.09.012; Casolaro V, 2000, J BIOL CHEM, V275, P36605, DOI 10.1074/jbc.M007086200; Chambers CA, 2001, TRENDS IMMUNOL, V22, P217, DOI 10.1016/S1471-4906(01)01868-3; CIVIL A, 1995, RES IMMUNOL, V146, P158, DOI 10.1016/0923-2494(96)80250-1; Coyle AJ, 2000, IMMUNITY, V13, P95, DOI 10.1016/S1074-7613(00)00011-X; Coyle AJ, 2004, SPRINGER SEMIN IMMUN, V25, P349, DOI 10.1007/s00281-003-0154-y; Dong C, 2001, J IMMUNOL, V166, P3659, DOI 10.4049/jimmunol.166.6.3659; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; FALTYNEK CR, 1995, BIOCHEMISTRY-US, V34, P12404, DOI 10.1021/bi00038a038; Frauwirth KA, 2002, J CLIN INVEST, V109, P295, DOI 10.1172/JCI200214941; FRUMAN DA, 1995, MOL CELL BIOL, V15, P3857; Gonzalo JA, 2001, NAT IMMUNOL, V2, P597, DOI 10.1038/89739; Grimbacher B, 2003, NAT IMMUNOL, V4, P261, DOI 10.1038/ni902; Harada H, 2003, J CLIN INVEST, V112, P234, DOI 10.1172/JCI200317008; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; Ling V, 2001, GENOMICS, V78, P155, DOI 10.1006/geno.2001.6655; London CA, 2000, J IMMUNOL, V164, P265, DOI 10.4049/jimmunol.164.1.265; Loots GG, 2005, NUCLEIC ACIDS RES, V33, pW56, DOI 10.1093/nar/gki355; LUCAS PJ, 1995, J IMMUNOL, V154, P5757; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; McAdam AJ, 2000, J IMMUNOL, V165, P5035, DOI 10.4049/jimmunol.165.9.5035; McAdam AJ, 2001, NATURE, V409, P102, DOI 10.1038/35051107; Nurieva RI, 2003, IMMUNITY, V18, P801, DOI 10.1016/S1074-7613(03)00144-4; Ozkaynak E, 2001, NAT IMMUNOL, V2, P591, DOI 10.1038/89731; PAGES F, 1994, NATURE, V369, P327, DOI 10.1038/369327a0; PRASAD KVS, 1994, P NATL ACAD SCI USA, V91, P2834, DOI 10.1073/pnas.91.7.2834; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rottman JB, 2001, NAT IMMUNOL, V2, P605, DOI 10.1038/89750; Rudd CE, 2003, NAT REV IMMUNOL, V3, P544, DOI 10.1038/nri1131; Sarafova S, 1999, J BIOL CHEM, V274, P16126, DOI 10.1074/jbc.274.23.16126; Schweitzer AN, 1997, J IMMUNOL, V158, P2713; Shilling RA, 2005, J IMMUNOL, V175, P2061, DOI 10.4049/jimmunol.175.4.2061; STEIN PH, 1994, MOL CELL BIOL, V14, P3392, DOI 10.1128/MCB.14.5.3392; Suh WK, 2004, J IMMUNOL, V172, P5917, DOI 10.4049/jimmunol.172.10.5917; Swallow MM, 1999, IMMUNITY, V11, P423, DOI 10.1016/S1074-7613(00)80117-X; Tafuri A, 2001, NATURE, V409, P105, DOI 10.1038/35051113; Warnatz K, 2006, BLOOD, V107, P3045, DOI 10.1182/blood-2005-07-2955; Wassink L, 2004, J IMMUNOL, V173, P1779, DOI 10.4049/jimmunol.173.3.1779; Whitmire JK, 2000, CURR OPIN IMMUNOL, V12, P448, DOI 10.1016/S0952-7915(00)00119-9; Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582; Zheng Y, 2005, J IMMUNOL, V174, P3117, DOI 10.4049/jimmunol.174.5.3117	49	35	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					28666	28678		10.1074/jbc.M604081200	http://dx.doi.org/10.1074/jbc.M604081200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16880206	hybrid			2022-12-27	WOS:000240680500020
J	Promnares, K; Komenda, J; Bumba, L; Nebesarova, J; Vacha, F; Tichy, M				Promnares, Kamoltip; Komenda, Josef; Bumba, Ladislav; Nebesarova, Jana; Vacha, Frantisek; Tichy, Martin			Cyanobacterial small chlorophyll-binding protein ScpD (HliB) is located on the periphery of photosystem II in the vicinity of PsbH and CP47 subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNECHOCYSTIS-SP PCC-6803; LIGHT-INDUCIBLE PROTEIN; PHOTOSYNTHETIC ELECTRON-TRANSPORT; ELONGATUS STRAIN PCC-7942; OXYGEN-EVOLVING COMPLEX; DNA MICROARRAY ANALYSIS; CAB-LIKE PROTEINS; ARABIDOPSIS-THALIANA; HIGHER-PLANTS; GENE FAMILY	Cyanobacteria contain several genes coding for small one-helix proteins called SCPs or HLIPs with significant sequence similarity to chlorophyll a/b-binding proteins. To localize one of these proteins, ScpD, in the cells of the cyanobacterium Synechocystis sp. PCC 6803, we constructed several mutants in which ScpD was expressed as a His-tagged protein (ScpDHis). Using two-dimensional native-SDS electrophoresis of thylakoid membranes or isolated Photosystem II (PSII), we determined that after high-light treatment most of the ScpDHis protein in a cell is associated with PSII. The ScpDHis protein was present in both monomeric and dimeric PSII core complexes and also in the core subcomplex lacking CP43. However, the association with PSII was abolished in the mutant lacking the PSII subunit PsbH. In a PSII mutant lacking cytochrome b(559), which does not accumulate PSII, ScpDHis is associated with CP47. The interaction of ScpDHis with PsbH and CP47 was further confirmed by electron microscopy of PSII labeled with Ni-NTA Nanogold. Single particle image analysis identified the location of the labeled ScpDHis at the periphery of the PSII core complex in the vicinity of the PsbH and CP47. Because of the fact that ScpDHis did not form any large structures bound to PSII and because of its accumulation in PSII subcomplexes containing CP47 and PsbH we suggest that ScpD is involved in a process of PSII assembly/repair during the turnover of pigment-binding proteins, particularly CP47.	Acad Sci Czech Republ, Lab Photosynth, Inst Microbiol, Trebon 37981, Czech Republic; Univ S Bohemia, Fac Biol Sci, CZ-37005 Ceske Budejovice, Czech Republic; Univ S Bohemia, Inst Biol Phys, Nove Hrady 37333, Czech Republic; Acad Sci Czech Republ, Ctr Biol, CZ-37005 Ceske Budejovice, Czech Republic; Acad Sci Czech Republ, Inst Microbiol, CR-14220 Prague, Czech Republic	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Tichy, M (corresponding author), Acad Sci Czech Republ, Lab Photosynth, Inst Microbiol, Opatovicky Mlyn, Trebon 37981, Czech Republic.	tichym@alga.cz	Bumba, Ladislav/H-2494-2014; Bumba, Ladislav/ABC-9943-2020; Nebesarova, Jana/G-7351-2014; Tichy, Martin/B-6545-2008; Promnares, Kamoltip/S-6106-2019; Komenda, Josef/H-4083-2014; Vacha, Frantisek/G-9555-2014	Bumba, Ladislav/0000-0001-6659-5447; Nebesarova, Jana/0000-0002-0897-7487; Tichy, Martin/0000-0003-2814-1959; Komenda, Josef/0000-0003-4588-0382; Vacha, Frantisek/0000-0002-1738-8764				ADAMSKA I, 1991, PLANT MOL BIOL, V16, P209, DOI 10.1007/BF00020553; Adamska I, 2001, ADV PHOTOSYNTH, V11, P487; Adamska I, 1997, PHYSIOL PLANTARUM, V100, P794, DOI 10.1034/j.1399-3054.1997.1000406.x; ADAMSKA I, 1992, P NATL ACAD SCI USA, V89, P2610, DOI 10.1073/pnas.89.7.2610; ADAMSKA I, 1994, J BIOL CHEM, V269, P30221; Allakhverdiev SI, 2002, PLANT PHYSIOL, V130, P1443, DOI 10.1104/pp.011114; Andersson U, 2003, PLANT PHYSIOL, V132, P811, DOI 10.1104/pp.102.019281; Bhaya D, 2002, FEMS MICROBIOL LETT, V215, P209, DOI 10.1111/j.1574-6968.2002.tb11393.x; Bibby TS, 2001, NATURE, V412, P743, DOI 10.1038/35089098; Binyamin L, 2001, PLANTA, V212, P591, DOI 10.1007/s004250000423; Bruno AK, 2004, J EXP BOT, V55, P2541, DOI 10.1093/jxb/erh273; Bryant D.A., 1991, PHOTOSYNTHETIC APPAR, P257, DOI [10.1016/B978-0-12-715010-9.50014-1, DOI 10.1016/B978-0-12-715010-9.50014-1]; Buchel C, 2001, J MOL BIOL, V312, P371, DOI 10.1006/jmbi.2001.4951; Bumba L, 2005, J STRUCT BIOL, V152, P28, DOI 10.1016/j.jsb.2005.08.001; Bumba L, 2004, EUR J BIOCHEM, V271, P2967, DOI 10.1111/j.1432-1033.2004.04226.x; Casazza AP, 2005, PLANT MOL BIOL, V58, P41, DOI 10.1007/s11103-005-4090-1; DOLGANOV NAM, 1995, P NATL ACAD SCI USA, V92, P636, DOI 10.1073/pnas.92.2.636; EATONRYE JJ, 1991, PLANT MOL BIOL, V17, P1165, DOI 10.1007/BF00028733; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Funk C, 1999, BIOCHEMISTRY-US, V38, P9397, DOI 10.1021/bi990545+; FUNK C, 1995, BIOCHEMISTRY-US, V34, P11133, DOI 10.1021/bi00035a019; GREEN BR, 1991, TRENDS BIOCHEM SCI, V16, P181, DOI 10.1016/0968-0004(91)90072-4; HARAUZ G, 1988, METHOD ENZYMOL, V164, P35; Havaux M, 2003, BBA-BIOENERGETICS, V1557, P21, DOI 10.1016/S0005-2728(02)00391-2; He QF, 2001, J BIOL CHEM, V276, P306, DOI 10.1074/jbc.M008686200; Heddad M, 2000, P NATL ACAD SCI USA, V97, P3741, DOI 10.1073/pnas.050391397; Hihara Y, 2003, J BACTERIOL, V185, P1719, DOI 10.1128/JB.185.5.1719-1725.2003; Hihara Y, 2001, PLANT CELL, V13, P793, DOI 10.1105/tpc.13.4.793; Hutin C, 2003, P NATL ACAD SCI USA, V100, P4921, DOI 10.1073/pnas.0736939100; Jansson S, 2000, PLANT MOL BIOL, V42, P345, DOI 10.1023/A:1006365213954; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; JANSSON S, 1994, BBA-BIOENERGETICS, V1184, P1, DOI 10.1016/0005-2728(94)90148-1; Kanesaki Y, 2002, BIOCHEM BIOPH RES CO, V290, P339, DOI 10.1006/bbrc.2001.6201; KE B, 2001, PHOTSYNTHESIS PHOTOB, P215; KIM S, 1992, FEBS LETT, V314, P67, DOI 10.1016/0014-5793(92)81463-V; Komenda J, 2005, PLANT CELL PHYSIOL, V46, P1477, DOI 10.1093/pcp/pci159; Komenda J, 2004, J BIOL CHEM, V279, P48620, DOI 10.1074/jbc.M405725200; Komenda J, 2002, EUR J BIOCHEM, V269, P610, DOI 10.1046/j.0014-2956.2001.02693.x; Kuhl H, 1999, EUR J BIOCHEM, V266, P453, DOI 10.1046/j.1432-1327.1999.00877.x; KUHLBRANDT W, 1994, NATURE, V367, P614, DOI 10.1038/367614a0; Lagarde D, 2000, APPL ENVIRON MICROB, V66, P64, DOI 10.1128/AEM.66.1.64-72.2000; LERS A, 1991, J BIOL CHEM, V266, P13698; MAYES SR, 1993, BIOCHEMISTRY-US, V32, P1454, DOI 10.1021/bi00057a008; Mikami K, 2002, MOL MICROBIOL, V46, P905, DOI 10.1046/j.1365-2958.2002.03202.x; MOHAMED A, 1993, MOL GEN GENET, V238, P161, DOI 10.1007/BF00279543; Montane MH, 1997, PLANTA, V202, P293, DOI 10.1007/s004250050131; Montane MH, 2000, GENE, V258, P1, DOI 10.1016/S0378-1119(00)00413-3; Nield J, 2000, J BIOL CHEM, V275, P27940; PAKRASI HB, 1988, EMBO J, V7, P325, DOI 10.1002/j.1460-2075.1988.tb02816.x; PAKRASI HB, 1989, PLANT CELL, V1, P591, DOI 10.2307/3868946; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Salem K, 2004, PLANT CELL PHYSIOL, V45, P651, DOI 10.1093/pcp/pch072; Salem K, 2004, J BACTERIOL, V186, P1729, DOI 10.1128/JB.186.6.1729-1736.2004; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Singh AK, 2003, PLANT PHYSIOL, V132, P1825, DOI 10.1104/pp.103.024018; Standfuss R, 2005, EMBO J, V24, P919, DOI 10.1038/sj.emboj.7600585; Suzuki I, 2001, MOL MICROBIOL, V40, P235, DOI 10.1046/j.1365-2958.2001.02379.x; Tichy M, 2003, PHOTOSYNTHETICA, V41, P583, DOI 10.1023/B:PHOT.0000027524.18385.92; van Waasbergen LG, 2002, J BACTERIOL, V184, P2481, DOI 10.1128/JB.184.9.2481-2490.2002; VANHEEL M, 1987, ULTRAMICROSCOPY, V21, P95, DOI 10.1016/0304-3991(87)90010-6; VANHEEL M, 1981, ULTRAMICROSCOPY, V6, P187, DOI 10.1016/0304-3991(81)90059-0; WEDEL N, 1992, FEBS LETT, V314, P61, DOI 10.1016/0014-5793(92)81462-U; WILLIAMS JGK, 1988, METHOD ENZYMOL, V167, P766; Xu H, 2004, J BIOL CHEM, V279, P27971, DOI 10.1074/jbc.M403307200; Xu H, 2002, PLANT MOL BIOL, V49, P149, DOI 10.1023/A:1014900806905	67	61	63	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32705	32713		10.1074/jbc.M606360200	http://dx.doi.org/10.1074/jbc.M606360200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16923804	hybrid			2022-12-27	WOS:000241414500069
J	Tremouilhac, P; Strandberg, E; Wadhwani, P; Ulrich, AS				Tremouilhac, Pierre; Strandberg, Erik; Wadhwani, Parvesh; Ulrich, Anne S.			Synergistic transmembrane alignment of the antimicrobial heterodimer PGLa/magainin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLID-STATE NMR; MAGNETIC-RESONANCE-SPECTROSCOPY; LIPID-BILAYERS; PEPTIDE PGLA; ESCHERICHIA-COLI; XENOPUS-LAEVIS; MAGAININ 2; F-19 NMR; MEMBRANES; ORIENTATION	The antimicrobial activity of amphipathic alpha-helical peptides is usually attributed to the formation of pores in bacterial membranes, but direct structural information about such a membrane-bound state is sparse. Solid state H-2-NMR has previously shown that the antimicrobial peptide PGLa undergoes a concentration-dependent realignment from a surface-bound S-state to a tilted T-state. The corresponding change in helix tilt angle from 98 to 125 was interpreted as the formation of PGLa/magainin hetero-dimers residing on the bilayer surface. Under no conditions so far, has an upright membrane-inserted I-state been observed in which a transmembrane helix alignment would be expected. Here, we have demonstrated that PGLa is able to assume such an I-state in a 1: 1 mixture with magainin 2 at a peptide-to-lipid ratio as low as 1: 100 in dimyristoylphosphatidylcholine/dimyristoylphosphatidylglycerol model membranes. This H-2-NMR analysis is based on seven orientational constraints from Ala-3,3,3-d(3) substituted in a non-perturbing manner for four native Ala residues as well as two Ile and one Gly. The observed helix tilt of 158 is rationalized by the formation of heterodimers. This structurally synergistic effect between the two related peptides from the skin of Xenopus laevis correlates very well with their known functional synergistic mode of action. To our knowledge, this example of PGLa is the first case where an alpha-helical antimicrobial peptide is directly shown to assume a transmembrane state that is compatible with the postulated toroidal wormhole pore structure.	Univ Karlsruhe, Inst Organ Chem, D-76131 Karlsruhe, Germany; Forschungszentrum Karlsruhe, Inst Biol Interfaces, D-76344 Eggenstein Leopoldshafen, Germany	Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology	Ulrich, AS (corresponding author), Univ Karlsruhe, Inst Organ Chem, Fritz Haber Weg 6, D-76131 Karlsruhe, Germany.	anne.ulrich@ibg.fzk.de	Ulrich, Anne S/H-5519-2013	Ulrich, Anne S/0000-0001-5571-9483; Tremouilhac, Pierre/0000-0002-0487-3947; Wadhwani, Parvesh/0000-0002-7290-5154; Strandberg, Erik/0000-0002-2401-7478				Afonin S, 2004, MAGN RESON CHEM, V42, P195, DOI 10.1002/mrc.1340; Bechinger B, 1998, BIOPHYS J, V74, P981, DOI 10.1016/S0006-3495(98)74021-4; BECHINGER B, 1993, PROTEIN SCI, V2, P2077, DOI 10.1002/pro.5560021208; DEWAAL A, 1991, FEBS LETT, V293, P219, DOI 10.1016/0014-5793(91)81191-A; Glaser RW, 2005, BIOPHYS J, V88, P3392, DOI 10.1529/biophysj.104.056424; Glaser RW, 2004, J MAGN RESON, V168, P153, DOI 10.1016/j.jmr.2004.02.008; Glaser RW, 2003, J MAGN RESON, V164, P104, DOI 10.1016/S1090-7807(03)00207-6; GOMES AV, 1993, BIOCHEMISTRY-US, V32, P5365, DOI 10.1021/bi00071a011; Hallock KJ, 2003, BIOPHYS J, V84, P3052, DOI 10.1016/S0006-3495(03)70031-9; Hancock REW, 1999, ANTIMICROB AGENTS CH, V43, P1317, DOI 10.1128/AAC.43.6.1317; Hara T, 2001, BIOCHEMISTRY-US, V40, P12395, DOI 10.1021/bi011413v; HOFFMANN W, 1983, EMBO J, V2, P711, DOI 10.1002/j.1460-2075.1983.tb01489.x; Huang HW, 2000, BIOCHEMISTRY-US, V39, P8347, DOI 10.1021/bi000946l; JURETIC D, 1990, STUD BIOPHYS, V138, P79; Lee DK, 1999, J PHYS CHEM B, V103, P8383, DOI 10.1021/jp9914929; Ludtke SJ, 1996, BIOCHEMISTRY-US, V35, P13723, DOI 10.1021/bi9620621; Marassi FM, 1999, APPL MAGN RESON, V17, P433, DOI 10.1007/BF03162176; Massiot D, 2002, MAGN RESON CHEM, V40, P70, DOI 10.1002/mrc.984; Matsuzaki K, 1998, BBA-REV BIOMEMBRANES, V1376, P391, DOI 10.1016/S0304-4157(98)00014-8; Matsuzaki K, 1999, FEBS LETT, V449, P221, DOI 10.1016/S0014-5793(99)00443-3; Matsuzaki K, 1998, BIOCHEMISTRY-US, V37, P15144, DOI 10.1021/bi9811617; MATSUZAKI K, 1991, BIOCHIM BIOPHYS ACTA, V1063, P162, DOI 10.1016/0005-2736(91)90366-G; Nagle JF, 2000, BBA-REV BIOMEMBRANES, V1469, P159, DOI 10.1016/S0304-4157(00)00016-2; Opella SJ, 2004, CHEM REV, V104, P3587, DOI 10.1021/cr0304121; RICHTER K, 1985, PEPTIDES, V6, P17, DOI 10.1016/0196-9781(85)90345-6; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; SORAVIA E, 1988, FEBS LETT, V228, P337, DOI 10.1016/0014-5793(88)80027-9; Strandberg E, 2006, BIOPHYS J, V90, P1676, DOI 10.1529/biophysj.105.073858; Strandberg E, 2004, CONCEPT MAGN RESON A, V23A, P89, DOI 10.1002/cmr.a.20024; Strandberg E, 2004, BIOPHYS J, V86, P3709, DOI 10.1529/biophysj.103.035402; TREMOUILHAC P, 2006, IN PRESS BIOCH BIOPH; Ulrich A. S., 2006, NMR SPECTROSCOPY BIO, P215; Ulrich AS, 2005, PROG NUCL MAG RES SP, V46, P1, DOI 10.1016/j.pnmrs.2004.11.001; ULRICH AS, 1992, BIOCHEMISTRY-US, V31, P10390, DOI 10.1021/bi00157a029; van der Wel PCA, 2002, BIOPHYS J, V83, P1479, DOI 10.1016/S0006-3495(02)73918-0; van 't Hof W, 2001, BIOL CHEM, V382, P597, DOI 10.1515/BC.2001.072; WESTERHOFF HV, 1995, EUR J BIOCHEM, V228, P257; Wieprecht T, 2000, BIOCHEMISTRY-US, V39, P442, DOI 10.1021/bi992146k; WILLIAMS RW, 1990, BIOCHEMISTRY-US, V29, P4490, DOI 10.1021/bi00470a031; Yang L, 2000, BIOPHYS J, V79, P2002, DOI 10.1016/S0006-3495(00)76448-4; ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449	42	89	90	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32089	32094		10.1074/jbc.M604759200	http://dx.doi.org/10.1074/jbc.M604759200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16877761	hybrid			2022-12-27	WOS:000241414500006
J	Dias, JS; Macedo, AL; Ferreira, GC; Peterson, FC; Volkman, BF; Goodfellow, BJ				Dias, Jorge S.; Macedo, Anjos L.; Ferreira, Gloria C.; Peterson, Francis C.; Volkman, Brian F.; Goodfellow, Brian J.			The first structure from the SOUL/HBP family of heme-binding proteins, murine P22HBP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							5-AMINOLEVULINATE SYNTHASE; MULTIDRUG TRANSPORTER; CRYSTAL-STRUCTURE; CHEMICAL-SHIFT; NMR; DATABASE; RESONANCE; CELLS; N-15; ELECTROSTATICS	Murine p22HBP, a 22-kDa monomer originally identified as a cytosolic heme-binding protein ubiquitously expressed in various tissues, has 27% sequence identity to murine SOUL, a heme-binding hexamer specifically expressed in the retina. In contrast to murine SOUL, which binds one heme per subunit via coordination of the Fe(III)-heme to a histidine, murine p22HBP binds one heme molecule per subunit with no specific axial ligand coordination of the Fe(III)-heme. Using intrinsic protein fluorescence quenching, the values for the dissociation constants of p22HBP for hemin and protoporphyrin-IX were determined to be in the low nanomolar range. The three-dimensional structure of murine p22HBP, the first for a protein from the SOUL/HBP family, was determined by NMR methods to consist of a 9-stranded distorted beta-barrel flanked by two long alpha-helices. Although homologous domains have been found in three bacterial proteins, two of which are transcription factors, the fold determined for p22HBP corresponds to a novel alpha plus beta fold in a eukaryotic protein. Chemical shift mapping localized the tetrapyrrole binding site to a hydrophobic cleft formed by residues from helix alpha(A) and an extended loop. In an attempt to assess the structural basis for tetrapyrrole binding in the SOUL/HBP family, models for the p22HBP-protoporphyrin-IX complex and the SOUL protein were generated by manual docking and automated methods.	Univ Aveiro, Dept Quim, Ctr Invest Mat Ceram & Compositos, P-3810193 Aveiro, Portugal; Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Quim, Ctr Quim Fina & Biotecnol, P-2829516 Caparica, Portugal; Univ S Florida, Coll Med, Dept Mol Med, Tampa, FL 33612 USA; Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA	Universidade de Aveiro; Universidade Nova de Lisboa; State University System of Florida; University of South Florida; Medical College of Wisconsin	Goodfellow, BJ (corresponding author), Univ Aveiro, Dept Quim, Ctr Invest Mat Ceram & Compositos, P-3810193 Aveiro, Portugal.	brian.goodfellow@dq.ua.pt	Goodfellow, Brian J/F-4638-2016; Macedo, Anjos L/D-7216-2013; Dias, Jorge/AAS-4551-2020; Ferreira, Gloria C/A-4709-2012; Volkman, Brian F./ABE-7312-2020; Volkman, Brian F./ABE-7306-2020; da Silva Dias, Jorge/D-7572-2013	Goodfellow, Brian J/0000-0003-3191-7121; Macedo, Anjos L/0000-0002-2613-4838; Dias, Jorge/0000-0001-9725-1882; Ferreira, Gloria C/0000-0001-9279-2217; Volkman, Brian F./0000-0002-6681-5179; Volkman, Brian F./0000-0002-6681-5179; da Silva Dias, Jorge/0000-0001-9725-1882	NIDDK NIH HHS [DK63191] Funding Source: Medline; NIGMS NIH HHS [GM64598] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063191] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM064598] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Babusiak M, 2005, PROTEOMICS, V5, P340, DOI 10.1002/pmic.200400935; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bertini I, 2005, CHEMBIOCHEM, V6, P1536, DOI 10.1002/cbic.200500124; Billeter M, 1995, J BIOMOL NMR, V5, P1; Blackmon BJ, 2002, ARCH BIOCHEM BIOPHYS, V407, P196, DOI 10.1016/S0003-9861(02)00471-X; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dias JS, 2005, J BIOMOL NMR, V32, P338, DOI 10.1007/s10858-005-0470-8; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; Goodfellow BJ, 2001, FEBS LETT, V505, P325, DOI 10.1016/S0014-5793(01)02818-6; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Keller R., 2004, COMPUTER AIDED RESON, V1; Kwon HJ, 2000, NAT STRUCT BIOL, V7, P424; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LATHROP JT, 1993, SCIENCE, V259, P522, DOI 10.1126/science.8424176; Latunde-Dada GO, 2006, TRENDS BIOCHEM SCI, V31, P182, DOI 10.1016/j.tibs.2006.01.005; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Martinez GL, 2000, J ELECTRON MATER, V29, P325, DOI 10.1007/s11664-000-0072-x; Migeotte I, 2005, J EXP MED, V201, P83, DOI 10.1084/jem.20041277; Munakata H, 2004, J BIOCHEM, V136, P233, DOI 10.1093/jb/mvh112; Newberry KJ, 2004, J BIOL CHEM, V279, P20356, DOI 10.1074/jbc.M400960200; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Romanowski MJ, 2002, PROTEINS, V47, P403, DOI 10.1002/prot.10102; Sato E, 2004, BIOCHEMISTRY-US, V43, P14189, DOI 10.1021/bi048742i; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SWILLENS S, 1995, MOL PHARMACOL, V47, P1197; Taketani S, 1998, J BIOL CHEM, V273, P31388, DOI 10.1074/jbc.273.47.31388; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; WUTHRICH K, 1968, P NATL ACAD SCI USA, V61, P1199, DOI 10.1073/pnas.61.4.1199; Xu XP, 2001, J BIOMOL NMR, V21, P321, DOI 10.1023/A:1013324104681; Ye YZ, 2003, BIOINFORMATICS, V19, pII246, DOI 10.1093/bioinformatics/btg1086; Zheleznova EE, 1999, CELL, V96, P353, DOI 10.1016/S0092-8674(00)80548-6; Zylka MJ, 1999, MOL BRAIN RES, V74, P175, DOI 10.1016/S0169-328X(99)00277-6	36	30	31	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31553	31561		10.1074/jbc.M605988200	http://dx.doi.org/10.1074/jbc.M605988200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16905545	Bronze			2022-12-27	WOS:000241235300041
J	Kabe, Y; Ohmori, M; Shinouchi, K; Tsuboi, Y; Hirao, S; Azuma, M; Watanabe, H; Okura, I; Handa, H				Kabe, Yasuaki; Ohmori, Masashi; Shinouchi, Kazuya; Tsuboi, Yasunori; Hirao, Satoshi; Azuma, Motoki; Watanabe, Hajime; Okura, Ichiro; Handa, Hiroshi			Porphyrin accumulation in mitochondria is mediated by 2-oxoglutarate carrier	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFORMANCE AFFINITY BEADS; OXOGLUTARATE CARRIER; HEART-MITOCHONDRIA; DRUG RECEPTORS; PURIFICATION; PHOSPHORESCENCE; PROTEINS; KINETICS; BINDING; SURFACE	Heme (Fe-protoporphyrin IX), an endogenous porphyrin derivative, is an essential molecule in living aerobic organisms and plays a role in a variety of physiological processes such as oxygen transport, respiration, and signal transduction. For the biosynthesis of heme or the mitochondrial heme proteins, heme or its biosynthetic precursor porphyrin must be transported into mitochondria from cytosol. The mechanism of porphyrin accumulation in the mitochondrial inner membrane is unclear. In the present study, we analyzed the mechanism of mitochondrial translocation of porphyrin derivatives. We showed that palladium meso-tetra(4-carboxyphenyl) porphyrin (PdTCPP), a phosphorescent porphyrin derivative, accumulated in the mitochondria of several cell lines. Using affinity latex beads, we showed that 2-oxoglutarate carrier (OGC), the mitochondrial transporter of 2-oxoglutarate, bound to PdTCPP, and in vitro PdTCPP-inhibited 2-oxoglutarate uptake into mitochondria in a competitive manner (K-i = 15 mu M). Interestingly, all types of porphyrin derivatives examined in this study competitively inhibited 2-oxoglutarate uptake into mitochondria, including protoporphyrin IX, coproporphyrin III, and hemin. Furthermore, mitochondrial accumulation of porphyrins was inhibited by 2-oxoglutarate or OGC inhibitor. These results suggested that porphyrin accumulation in mitochondria is mediated by OGC and that porphyrins are able to competitively inhibit 2-oxoglutarate uptake into mitochondria. This is the first report of a putative mechanism for accumulation of porphyrins in the mitochondrial inner membrane.	Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268501, Japan; Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448585, Japan; Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan	Tokyo Institute of Technology; National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); Japan Science & Technology Agency (JST)	Handa, H (corresponding author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268501, Japan.	hhanda@bio.titech.ac.jp	Watanabe, Hajime/S-8957-2019; WATANABE, Hajime/AAJ-8904-2021	Watanabe, Hajime/0000-0001-9657-6554				Bisaccia F, 1996, BBA-PROTEIN STRUCT M, V1292, P281, DOI 10.1016/0167-4838(95)00215-4; BISACCIA F, 1985, BIOCHIM BIOPHYS ACTA, V810, P362, DOI 10.1016/0005-2728(85)90222-1; Brdiczka D, 1986, Adv Exp Med Biol, V194, P55; Capobianco L, 1996, BIOCHEMISTRY-US, V35, P8974, DOI 10.1021/bi960258v; Greenawalt J W, 1974, Methods Enzymol, V31, P310; Hiramoto M, 2002, METHOD ENZYMOL, V353, P81; INDIVERI C, 1987, BIOCHIM BIOPHYS ACTA, V890, P310, DOI 10.1016/0005-2728(87)90158-7; INOMATA Y, 1992, ANAL BIOCHEM, V206, P109, DOI 10.1016/S0003-2697(05)80018-1; INOMATA Y, 1994, J BIOMAT SCI-POLYM E, V5, P293, DOI 10.1163/156856294X00031; Lee SK, 1997, ANAL SCI, V13, P535, DOI 10.2116/analsci.13.535; LOM LW, 1996, ANAL BIOCHEM, V236, P153; Moore MR, 1998, CLIN DERMATOL, V16, P203, DOI 10.1016/S0738-081X(97)00201-0; Nijtmans LGJ, 2000, EMBO J, V19, P2444, DOI 10.1093/emboj/19.11.2444; Ohtsu Y, 2005, ANAL BIOCHEM, V338, P245, DOI 10.1016/j.ab.2004.10.006; PALMIERI F, 1992, BIOCHIM BIOPHYS ACTA, V1101, P223; PALMIERI F, 1972, EUR J BIOCHEM, V29, P408, DOI 10.1111/j.1432-1033.1972.tb02003.x; RUMSEY WL, 1988, SCIENCE, V241, P1649, DOI 10.1126/science.3420417; Shimizu N, 2000, NAT BIOTECHNOL, V18, P877, DOI 10.1038/78496; Srere P A, 1986, Adv Exp Med Biol, V194, P13; TAKETANI S, 1994, J BIOL CHEM, V269, P7527; Tibbetts AS, 2002, ARCH BIOCHEM BIOPHYS, V406, P96, DOI 10.1016/S0003-9861(02)00419-8; Tomohiro T, 2002, BIOCONJUGATE CHEM, V13, P163, DOI 10.1021/bc015560h; VAARTJES WJ, 1997, BIOCHIM BIOPHYS ACTA, V548, P38; VERMA A, 1987, P NATL ACAD SCI USA, V84, P2256, DOI 10.1073/pnas.84.8.2256; VINOGRADOV SA, 1994, BIOPHYS J, V67, P2048, DOI 10.1016/S0006-3495(94)80688-5; WILSON DF, 1992, CANCER RES, V52, P3988; Xu WY, 1996, ANAL CHEM, V68, P2605, DOI 10.1021/ac960083v	27	51	52	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31729	31735		10.1074/jbc.M604729200	http://dx.doi.org/10.1074/jbc.M604729200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16920706	Bronze			2022-12-27	WOS:000241235300059
J	Xu, W; Tanaka, K; Sun, AQ; You, GF				Xu, Wen; Tanaka, Kunihiko; Sun, An-qiang; You, Guofeng			Functional role of the C terminus of human organic anion transporter hOAT1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; MOLECULAR-CLONING; EXPRESSION CLONING; CARBOXYL-TERMINUS; SUBSTRATE-BINDING; LACTOSE PERMEASE; ESCHERICHIA-COLI; RAT-BRAIN; KIDNEY; IDENTIFICATION	Human organic anion transporter hOAT1 plays critical roles in the body disposition of environmental toxins and clinically important drugs. In the present study, we examined the role of the C terminus of hOAT1 in its function. Combined approaches of cell surface biotinylation and transport analysis were employed for such purposes. It was found that deletion of the last 15 amino acids ( residues 536 - 550) or the last 30 amino acids ( residues 521 - 550) had no significant effect on transport activity. However, deletion of the entire C terminus ( residues 506 - 550) completely abolished transport activity. Alanine scanning mutagenesis within the region of amino acids 506 - 520 led to the discovery of two critical amino acids: Glu-506 and Leu-512. Substitution of negatively charged Glu-506 with neutral amino acids alanine or glutamine resulted in complete loss of transport activity. However, such loss of transport activity could be rescued by substitution of Glu-506 with another negatively charged amino acid aspartic acid, suggesting the importance of negative charge at this position for maintaining the correct tertiary structure of the transporter, possibly by forming a salt bridge with a positively charged amino acid. Substitution of Leu-512 with amino acids carrying progressively smaller side chains including isoleucine, valine, and alanine resulted in mutants (L512I, L512V, and L512A) with increasingly impaired transport activity. However, the cell surface expression of these mutants was not affected. Kinetic analysis of mutant L512V revealed that the reduced transport activity of this mutant resulted mainly from a reduced maximum transport velocity V-max without affecting the binding affinity (1/K-m) of the transporter for its substrates, suggesting that the size of the side chain at position 512 critically affects transporter turnover number. Together, our results are the first to highlight the central role of the C terminus of hOAT1 in the function of this transporter.	Rutgers State Univ, Dept Pharmaceut, Piscataway, NJ 08854 USA; Univ Med & Dent New Jersey, Dept Pharmacol, Robert Wood Johnson Med Sch, Piscataway, NJ 08854 USA; Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Icahn School of Medicine at Mount Sinai	You, GF (corresponding author), Rutgers State Univ, Dept Pharmaceut, 160 Frelinghuysen Rd, Piscataway, NJ 08854 USA.	gyou@rci.rutgers.edu			NIDDK NIH HHS [R01-DK 60034] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060034] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; ANDERSON GM, 1992, BIOCHIM BIOPHYS ACTA, V1137, P331, DOI 10.1016/0167-4889(92)90154-4; Bauman PA, 2002, ARCH BIOCHEM BIOPHYS, V404, P80, DOI 10.1016/S0003-9861(02)00232-1; Cha SH, 2000, J BIOL CHEM, V275, P4507, DOI 10.1074/jbc.275.6.4507; Cihlar T, 1999, MOL PHARMACOL, V56, P570, DOI 10.1124/mol.56.3.570; Ekaratanawong S, 2004, J PHARMACOL SCI, V94, P297, DOI 10.1254/jphs.94.297; Hong M, 2004, J BIOL CHEM, V279, P31478, DOI 10.1074/jbc.M404686200; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Kasir J, 1999, J BIOL CHEM, V274, P24873, DOI 10.1074/jbc.274.35.24873; Kilic F, 2003, MOL PHARMACOL, V64, P440, DOI 10.1124/mol.64.2.440; Kusuhara H, 1999, J BIOL CHEM, V274, P13675, DOI 10.1074/jbc.274.19.13675; Kuze K, 1999, J BIOL CHEM, V274, P1519, DOI 10.1074/jbc.274.3.1519; LopezNieto CE, 1997, J BIOL CHEM, V272, P6471, DOI 10.1074/jbc.272.10.6471; Lu R, 1999, AM J PHYSIOL-RENAL, V276, pF295, DOI 10.1152/ajprenal.1999.276.2.F295; Miranda M, 2004, J BIOL CHEM, V279, P30760, DOI 10.1074/jbc.M312774200; Monte JC, 2004, BIOCHEM BIOPH RES CO, V323, P429, DOI 10.1016/j.bbrc.2004.08.112; OLIVARES L, 1994, J BIOL CHEM, V269, P28400; Popp C, 2005, MOL PHARMACOL, V67, P1600, DOI 10.1124/mol.104.008839; Sekine T, 1998, FEBS LETT, V429, P179, DOI 10.1016/S0014-5793(98)00585-7; Sekine T, 1997, J BIOL CHEM, V272, P18526, DOI 10.1074/jbc.272.30.18526; Sweet DH, 1997, J BIOL CHEM, V272, P30088, DOI 10.1074/jbc.272.48.30088; Tanaka K, 2004, J BIOL CHEM, V279, P14961, DOI 10.1074/jbc.M400197200; Vayro S, 1999, AM J PHYSIOL-CELL PH, V276, pC1053, DOI 10.1152/ajpcell.1999.276.5.C1053; Wolff NA, 1997, FEBS LETT, V417, P287, DOI 10.1016/S0014-5793(97)01304-5; You GF, 2004, MED RES REV, V24, P762, DOI 10.1002/med.20014; You GF, 2004, CURR DRUG METAB, V5, P55, DOI 10.2174/1389200043489207; You GF, 2002, MED RES REV, V22, P602, DOI 10.1002/med.10019; Youngblood GL, 2004, AM J PHYSIOL-RENAL, V287, pF236, DOI 10.1152/ajprenal.00012.2004; Zhou FF, 2005, MOL PHARMACOL, V67, P868, DOI 10.1124/mol.104.007583; Zhou FF, 2004, MOL PHARMACOL, V65, P1141, DOI 10.1124/mol.65.5.1141	30	13	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31178	31183		10.1074/jbc.M605664200	http://dx.doi.org/10.1074/jbc.M605664200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16920720	Bronze			2022-12-27	WOS:000241235300002
J	Jantaro, S; Ali, Q; Lone, S; He, QF				Jantaro, Saowarath; Ali, Quaisar; Lone, Samea; He, Qingfang			Suppression of the lethality of high light to a quadruple HLI mutant by the inactivation of the regulatory protein PfsR in Synechocystis PCC 6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A/B-BINDING-PROTEINS; CAB-LIKE PROTEINS; SP. PCC 6803; HEME OXYGENASE; OXIDATIVE STRESS; IN-VIVO; INDUCIBLE POLYPEPTIDES; SUPEROXIDE-DISMUTASE; CRYSTAL-STRUCTURE; MAMMALIAN IRON	A regulatory gene, designated pfsR ( photosynthesis, Fe homeostasis and stress-response regulator), was discovered by a genetic screen in Synechocystis PCC 6803. Deletion of the gene from a high light-sensitive strain lacking four hli genes (4Xhli) restored viability to the parental strain under high light conditions. The quintuple mutant pfsR(-)/4Xhli retained photosystem-II and oxygen evolution capacity at levels similar to the wild-type levels under high light conditions. The transcripts of the two bfr genes ( encoding bacterioferritin) were found to be constitutively up-regulated, whereas the transcripts of ho1 gene ( encoding a heme oxygenase) were greatly down-regulated in high light upon deletion of pfsR. Under intermediate high intensity light, the pfsR deletion strains accumulated carotenoids and chlorophyll a to a significantly higher level than their corresponding parental strains. An exacerbated, transient increase in oxygen evolution during the early hours of high light acclimation and a somewhat increased steady-state level of photosystem-II-mediated oxygen evolution observed in the 4Xhli strain were brought back to the wild-type levels upon deletion of pfsR from the strain. The pfsR deletion mutants were found to be less sensitive to iron limitation under low light conditions and to suffer less lipid peroxidation following exposure to high light. Therefore, inactivation of PfsR resulted in tighter control of iron availability, which in turn reduced oxidative stress during photosynthesis in high light. These studies have revealed a critical role of PfsR in regulation of iron homeostasis and stress response.	Univ Arkansas, Dept Appl Sci, Little Rock, AR 72204 USA	University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock	He, QF (corresponding author), Univ Arkansas, Dept Appl Sci, ETAS 575,2801 S Univ Ave, Little Rock, AR 72204 USA.	qfhe@ualr.edu	He, Qingfang/I-4181-2013					Abdul-Tehrani H, 1999, J BACTERIOL, V181, P1415, DOI 10.1128/JB.181.5.1415-1428.1999; Asada K., 1994, Causes of photooxidative stress and amelioration of defense systems in plants., P77; Baranano DE, 2000, J BIOL CHEM, V275, P15166, DOI 10.1074/jbc.275.20.15166; Bhaya D, 2001, P NATL ACAD SCI USA, V98, P7540, DOI 10.1073/pnas.131201098; BOWLER C, 1994, CRIT REV PLANT SCI, V13, P199, DOI 10.1080/713608062; CHAMOVITZ D, 1993, J BIOL CHEM, V268, P17348; CHU HA, 1994, BIOCHEMISTRY-US, V33, P6137, DOI 10.1021/bi00186a013; Coleman ML, 2006, SCIENCE, V311, P1768, DOI 10.1126/science.1122050; Cornejo J, 1998, PLANT J, V15, P99, DOI 10.1046/j.1365-313X.1998.00186.x; COZZI A, 1990, FEBS LETT, V277, P119, DOI 10.1016/0014-5793(90)80823-2; DEMMIGADAMS B, 1992, ANNU REV PLANT PHYS, V43, P599, DOI 10.1146/annurev.pp.43.060192.003123; DemmigAdams B, 1996, TRENDS PLANT SCI, V1, P21, DOI 10.1016/S1360-1385(96)80019-7; DI MASCIO P, 1990, BIOCHEM SOC T, V18, P1054; DIMASCIO P, 1991, ADV EXP MED BIOL, V283, P71; Dolganov N, 1999, J BACTERIOL, V181, P610, DOI 10.1128/JB.181.2.610-617.1999; DOLGANOV NAM, 1995, P NATL ACAD SCI USA, V92, P636, DOI 10.1073/pnas.92.2.636; Durnford DG, 1997, PHOTOSYNTH RES, V53, P229, DOI 10.1023/A:1005815725371; Ferris CD, 1999, NAT CELL BIOL, V1, P152, DOI 10.1038/11072; Foyer C H, 2001, Biologist (London), V48, P115; Fryer MJ, 2003, PLANT J, V33, P691, DOI 10.1046/j.1365-313X.2003.01656.x; Funk C, 1999, BIOCHEMISTRY-US, V38, P9397, DOI 10.1021/bi990545+; Halliwell B., 1999, FREE RADICAL BIO MED, P1, DOI DOI 10.1093/ACPROF:OSO/9780198717478.001.0001; Havaux M, 2003, BBA-BIOENERGETICS, V1557, P21, DOI 10.1016/S0005-2728(02)00391-2; He QF, 1998, P NATL ACAD SCI USA, V95, P5830, DOI 10.1073/pnas.95.10.5830; He QF, 2001, J BIOL CHEM, V276, P306, DOI 10.1074/jbc.M008686200; Herranen M, 2001, PHYSIOL PLANTARUM, V112, P531, DOI 10.1034/j.1399-3054.2001.1120410.x; HERTWIG B, 1992, PLANT PHYSIOL, V100, P1547, DOI 10.1104/pp.100.3.1547; Horling F, 2003, PLANT PHYSIOL, V131, P317, DOI 10.1104/pp.010017; Hsiao HY, 2004, J BACTERIOL, V186, P3882, DOI 10.1128/JB.186.12.3882-3888.2004; JACOB J, 1993, PLANT CELL ENVIRON, V16, P785, DOI 10.1111/j.1365-3040.1993.tb00500.x; JURGENS UJ, 1986, J BACTERIOL, V168, P568; Kakhlon O, 2002, FREE RADICAL BIO MED, V33, P1037, DOI 10.1016/S0891-5849(02)01006-7; Keren N, 2004, PLANT PHYSIOL, V135, P1666, DOI 10.1104/pp.104.042770; LAULHERE JP, 1992, BIOCHEM J, V281, P785, DOI 10.1042/bj2810785; LEVY H, 1993, J BIOL CHEM, V268, P20892; LICHTENTHALER H K, 1981, Photosynthesis Research, V2, P115, DOI 10.1007/BF00028752; Meetam M, 1999, PLANT PHYSIOL, V121, P1267, DOI 10.1104/pp.121.4.1267; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; MOHAMED A, 1989, PLANT MOL BIOL, V13, P693, DOI 10.1007/BF00016024; MORAN R, 1982, PLANT PHYSIOL, V69, P1376, DOI 10.1104/pp.69.6.1376; Muramatsu M, 2003, PLANTA, V216, P446, DOI 10.1007/s00425-002-0859-5; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Ort DR, 2002, CURR OPIN PLANT BIOL, V5, P193, DOI 10.1016/S1369-5266(02)00259-5; PELTIER G, 1991, P NATL ACAD SCI USA, V88, P4791, DOI 10.1073/pnas.88.11.4791; PERLTREVES R, 1991, PLANT MOL BIOL, V17, P745, DOI 10.1007/BF00037058; PETER GF, 1991, J BIOL CHEM, V266, P16745; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10919, DOI 10.1073/pnas.94.20.10919; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; REDINBAUGH MG, 1990, P NATL ACAD SCI USA, V87, P6853, DOI 10.1073/pnas.87.17.6853; Sambrook J., 2001, MOL CLONING LAB MANU; St Johnston D, 2002, NAT REV GENET, V3, P176, DOI 10.1038/nrg751; Sugishima M, 2005, BIOCHEMISTRY-US, V44, P4257, DOI 10.1021/bi0480483; Sugishima M, 2004, EUR J BIOCHEM, V271, P4517, DOI 10.1111/j.1432-1033.2004.04411.x; TSANG EWT, 1991, PLANT CELL, V3, P783, DOI 10.1105/tpc.3.8.783; Wai SN, 1996, MOL MICROBIOL, V20, P1127, DOI 10.1111/j.1365-2958.1996.tb02633.x; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Xu H, 2004, J BIOL CHEM, V279, P27971, DOI 10.1074/jbc.M403307200; Xu H, 2002, PLANT MOL BIOL, V49, P149, DOI 10.1023/A:1014900806905; Yabuta Y, 2002, PLANT J, V32, P915, DOI 10.1046/j.1365-313X.2002.01476.x; Zhang XH, 2005, FEBS J, V272, P1012, DOI 10.1111/j.1742-4658.2004.04535.x; ZHONG HH, 1994, PLANT PHYSIOL, V104, P889, DOI 10.1104/pp.104.3.889	61	20	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30865	30874		10.1074/jbc.M606252200	http://dx.doi.org/10.1074/jbc.M606252200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16914546	hybrid			2022-12-27	WOS:000241075900062
J	Kashlan, OB; Maarouf, AB; Kussius, C; Denshaw, RM; Blumenthal, KM; Kleyman, TR				Kashlan, Ossama B.; Maarouf, Ahmad B.; Kussius, Cassandra; Denshaw, Robert M.; Blumenthal, Kenneth M.; Kleyman, Thomas R.			Distinct structural elements in the first membrane-spanning segment of the epithelial sodium channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECONDARY STRUCTURE PREDICTION; SUBUNIT STOICHIOMETRY; NA+ CHANNEL; ION PERMEATION; ALPHA-SUBUNIT; GAMMA-SUBUNIT; K+ CHANNEL; RESIDUES; SELECTIVITY; SERVER	Epithelial Na+ channels (ENaCs) comprise three subunits that have been proposed to be arranged in either an alpha(2)beta gamma or a higher ordered configuration. Each subunit has two putative membrane-spanning segments (M1 and M2), intracellular amino and carboxyl termini, and a large extracellular loop. We have used the TOXCAT assay (a reporter assay for transmembrane segment homodimerization) to identify residues within the transmembrane segments of ENaC that may participate in important structural interactions within ENaC, with which we identified a candidate site within alpha M1. We performed site-directed mutagenesis at this site and found that, although the mutants reduced channel activity, ENaC protein expression at the plasma membrane was unaffected. To deduce the role of alpha M1 in the pore structure of ENaC, we performed tryptophan-scanning mutagenesis throughout alpha M1( residues 110-130). We found that mutations within the amino-terminal part of alpha M1 had effects on activity and selectivity with a periodicity consistent with a helical structure but no effect on channel surface expression. We also observed that mutations within the carboxyl-terminal part of alpha M1 had effects on activity and selectivity but with no apparent periodicity. Additionally, these mutants reduced channel surface expression. Our data support a model in which the amino-terminal half of alpha M1 is alpha-helical and packs against structural element(s) that contribute to the ENaC pore. Furthermore, these data suggest that the carboxyl-terminal half of alpha M1 may be helical or assume a different conformation and may be involved in tertiary interactions essential to proper channel folding or assembly. Together, our data suggest that alpha M1 is divided into two distinct regions.	Univ Pittsburgh, Dept Med, Renal Electrolyte Div, Pittsburgh, PA 15261 USA; SUNY Buffalo, Dept Biochem, Buffalo, NY 14214 USA; Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kleyman, TR (corresponding author), Univ Pittsburgh, Dept Med, Renal Electrolyte Div, 3550 Terrace St, Pittsburgh, PA 15261 USA.	kleyman@pitt.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK066883, R01DK054354, T32DK061296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060582] Funding Source: NIH RePORTER; NIDDK NIH HHS [F32 DK066883, DK061296, DK066883, DK054354] Funding Source: Medline; NIGMS NIH HHS [GM060582] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahn YJ, 1999, AM J PHYSIOL-RENAL, V277, pF121, DOI 10.1152/ajprenal.1999.277.1.F121; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Carattino MD, 2003, J BIOL CHEM, V278, P36202, DOI 10.1074/jbc.M300312200; Chalfant ML, 1996, AM J PHYSIOL-RENAL, V271, pF861, DOI 10.1152/ajprenal.1996.271.4.F861; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; Cuff JA, 1998, BIOINFORMATICS, V14, P892, DOI 10.1093/bioinformatics/14.10.892; de la Rosa DA, 2000, ANNU REV PHYSIOL, V62, P573, DOI 10.1146/annurev.physiol.62.1.573; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Firsov D, 1998, EMBO J, V17, P344, DOI 10.1093/emboj/17.2.344; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Ishikawa T, 1998, J GEN PHYSIOL, V111, P825, DOI 10.1085/jgp.111.6.825; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Kellenberger S, 2005, J BIOL CHEM, V280, P7739, DOI 10.1074/jbc.M409955200; KNELLER DG, 1990, J MOL BIOL, V214, P171, DOI 10.1016/0022-2836(90)90154-E; Kosari F, 1998, J BIOL CHEM, V273, P13469, DOI 10.1074/jbc.273.22.13469; Labro AJ, 2003, J BIOL CHEM, V278, P50724, DOI 10.1074/jbc.M306097200; Langloh ALB, 2000, AM J PHYSIOL-CELL PH, V278, pC277, DOI 10.1152/ajpcell.2000.278.2.C277; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Pfister Y, 2006, J BIOL CHEM, V281, P11787, DOI 10.1074/jbc.M513692200; Poet M, 2001, EMBO J, V20, P5595, DOI 10.1093/emboj/20.20.5595; PUOTI A, 1995, AM J PHYSIOL-CELL PH, V269, pC188, DOI 10.1152/ajpcell.1995.269.1.C188; Russ WP, 1999, P NATL ACAD SCI USA, V96, P863, DOI 10.1073/pnas.96.3.863; Schild L, 1997, J GEN PHYSIOL, V109, P15, DOI 10.1085/jgp.109.1.15; Sen TZ, 2005, BIOINFORMATICS, V21, P2787, DOI 10.1093/bioinformatics/bti408; Sheng SH, 2005, J BIOL CHEM, V280, P8513, DOI 10.1074/jbc.M413880200; Sheng SH, 2002, J BIOL CHEM, V277, P50098, DOI 10.1074/jbc.M209975200; Sheng SH, 2001, J BIOL CHEM, V276, P44091, DOI 10.1074/jbc.M108522200; Sheng SH, 2001, J BIOL CHEM, V276, P1326, DOI 10.1074/jbc.M008117200; Snyder PM, 1998, J BIOL CHEM, V273, P681, DOI 10.1074/jbc.273.2.681; Staruschenko A, 2005, BIOPHYS J, V88, P3966, DOI 10.1529/biophysj.104.056804; Staruschenko A, 2004, J BIOL CHEM, V279, P27729, DOI 10.1074/jbc.M404169200; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhao Y, 2004, NEURON, V41, P859, DOI 10.1016/S0896-6273(04)00116-3	35	13	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30455	30462		10.1074/jbc.M604615200	http://dx.doi.org/10.1074/jbc.M604615200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16912051	hybrid			2022-12-27	WOS:000241075900020
J	Low, C; Macara, IG				Low, Claudia; Macara, Ian G.			Structural analysis of septin 2, 6, and 7 complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN SEPTIN; PROTEIN INTERACTIONS; YEAST SEPTINS; COILED COILS; ORGANIZATION; FILAMENTS; BINDING; CYTOKINESIS; MUTANT; ROLES	Mammalian septins comprise a family of 13 genes that encode GTP-binding proteins. Specific combinations of septins can hetero-oligomerize and form filaments in vivo and in vitro, by mechanisms that are not understood. Using fluorescence resonance energy transfer, size exclusion chromatography, and multi-angle light scattering techniques, we have characterized the conformation of a complex of filamentous human septins, Sept2, Sept6, and Sept7. We now show that Sept6 and Sept7 interact through a parallel coiled-coil, and that Sept2 interacts with Sept6 through their C-terminal domains. We have also been able to produce soluble, stable individual septins that behave as rod-like monomers and dimers. Taken together, these observations suggest that polymerized filaments could be comprised of laterally arranged septin core subunits.	Univ Virginia, HSC, Sch Med, Ctr Cell Signaling, Charlottesville, VA 22908 USA	University of Virginia	Low, C (corresponding author), Univ Virginia, HSC, Sch Med, Ctr Cell Signaling, Box 800577, Charlottesville, VA 22908 USA.	ccl3j@virginia.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066306] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM66306] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		An HB, 2004, MOL BIOL CELL, V15, P5551, DOI 10.1091/mbc.E04-07-0640; Beites CL, 2005, BIOCHEM J, V385, P347, DOI 10.1042/BJ20041090; Beites CL, 1999, NAT NEUROSCI, V2, P434, DOI 10.1038/8100; BYERS B, 1976, J CELL BIOL, V69, P717, DOI 10.1083/jcb.69.3.717; Cantor C. R., 1980, BIOPHYSICAL CHEM 2, P549; Faty M, 2002, CURR GENET, V41, P123, DOI 10.1007/s00294-002-0304-0; Field CM, 1996, J CELL BIOL, V133, P605, DOI 10.1083/jcb.133.3.605; Hanai N, 2004, FEBS LETT, V568, P83, DOI 10.1016/j.febslet.2004.05.030; Hsu SC, 1998, NEURON, V20, P1111, DOI 10.1016/S0896-6273(00)80493-6; Ihara M, 2005, DEV CELL, V8, P343, DOI 10.1016/j.devcel.2004.12.005; Kartmann B, 2001, J CELL SCI, V114, P839; Kinoshita M, 2002, DEV CELL, V3, P791, DOI 10.1016/S1534-5807(02)00366-0; Kinoshita M, 2001, CELL STRUCT FUNCT, V26, P667, DOI 10.1247/csf.26.667; Kinoshita M, 1997, GENE DEV, V11, P1535, DOI 10.1101/gad.11.12.1535; Kremer BE, 2005, MOL BIOL CELL, V16, P4648, DOI 10.1091/mbc.E05-03-0267; Longtine MS, 2003, TRENDS CELL BIOL, V13, P403, DOI 10.1016/S0962-8924(03)00151-X; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Macara IG, 2002, MOL BIOL CELL, V13, P4111, DOI 10.1091/mbc.E02-07-0438; Martinez C, 2004, BIOCHEM J, V382, P783, DOI 10.1042/BJ20040372; Mendoza M, 2002, CURR BIOL, V12, P1858, DOI 10.1016/S0960-9822(02)01258-7; Nagata K, 2004, J BIOL CHEM, V279, P55895, DOI 10.1074/jbc.M406153200; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Qi MY, 2005, BIOCHEM BIOPH RES CO, V336, P994, DOI 10.1016/j.bbrc.2005.06.212; Sheffield PJ, 2003, J BIOL CHEM, V278, P3483, DOI 10.1074/jbc.M209701200; Spiliotis ET, 2006, J CELL SCI, V119, P4, DOI 10.1242/jcs.02746; Spiliotis ET, 2005, SCIENCE, V307, P1781, DOI 10.1126/science.1106823; Stewart M, 1998, J MOL BIOL, V284, P1517, DOI 10.1006/jmbi.1998.2204; Surka MC, 2002, MOL BIOL CELL, V13, P3532, DOI 10.1091/mbc.E02-01-0042; Tsien RY, 2005, FEBS LETT, V579, P927, DOI 10.1016/j.febslet.2004.11.025; Versele M, 2005, TRENDS CELL BIOL, V15, P414, DOI 10.1016/j.tcb.2005.06.007; Versele M, 2004, MOL BIOL CELL, V15, P4568, DOI 10.1091/mbc.E04-04-0330; WITTINGHOFER F, 1991, ENVIRON HEALTH PERSP, V93, P11, DOI 10.2307/3431161; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606	33	50	59	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30697	30706		10.1074/jbc.M605179200	http://dx.doi.org/10.1074/jbc.M605179200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16914550	hybrid			2022-12-27	WOS:000241075900046
J	Zhu, YM; Marchal, CC; Casbon, AJ; Stull, N; von Lohneysen, K; Knaus, UG; Jesaitis, AJ; McCormick, S; Nauseef, WM; Dinauer, MC				Zhu, Yanmin; Marchal, Christophe C.; Casbon, Amy-Jo; Stull, Natalie; von Lohneysen, Katharina; Knaus, Ulla G.; Jesaitis, Algirdas J.; McCormick, Sally; Nauseef, William M.; Dinauer, Mary C.			Deletion mutagenesis of p22(phox) subunit of flavocytochrome b(558) - Identification of regions critical for gp91(phox) maturation and nadph oxidase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC GRANULOMATOUS-DISEASE; SRC HOMOLOGY-3 DOMAINS; CYTOCHROME-B; NEUTROPHIL CYTOCHROME-B558; CYTOPLASMIC DOMAIN; PLASMA-MEMBRANE; BINDING-SITE; ACTIVATION; SUPEROXIDE; HEME	The heterodimeric flavocytochrome b(558), comprised of the two integral membrane proteins p22(phox) and gp91(phox), mediates the transfer of electrons from NADPH to molecular oxygen in the phagocyte NADPH oxidase to generate the superoxide precursor of microbicidal oxidants. This study uses deletion mutagenesis to identify regions of p22(phox) required for maturation of gp91(phox) and for NADPH oxidase activity. N-terminal, C-terminal, or internal deletions of human p22(phox) were generated and expressed in Chinese hamster ovary cells with transgenes for gp91(phox) and two other NADPH oxidase subunits, p47(phox), and p67(phox). The results demonstrate that p22(phox)-dependent maturation of gp91(phox) carbohydrate, cell surface expression of gp91(phox), and the enzymatic function of flavocytochrome b(558) are closely correlated. Whereas the 5 N-terminal and 25 C-terminal amino acids are dispensable for these functions, the N-terminal 11 amino acids of p22(phox) are required, as is a hydrophilic region between amino acids 65 and 90. Upon deletion of 54 residues at the C terminus of p22(phox) (amino acids 142-195), maturation and cell surface expression of gp91(phox) was still preserved, although NADPH oxidase activity was absent, as expected, due to removal of a proline-rich domain between amino acids 151-160 that is required for recruitment of p47(phox). Antibody binding studies indicate that the extreme N terminus of p22(phox) is inaccessible in the absence of cell permeabilization, supporting a model in which both the N- and C-terminal domains of p22(phox) extend into the cytoplasm, anchored by two membrane-embedded regions.	James Whitcomb Riley Hosp Children, Herman B Wells Ctr Pediat Res, Dept Pediat Hematol Oncol, Indianapolis, IN 46202 USA; James Whitcomb Riley Hosp Children, Herman B Wells Ctr Pediat Res, Dept Microbiol Immunol, Indianapolis, IN 46202 USA; James Whitcomb Riley Hosp Children, Herman B Wells Ctr Pediat Res, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; USDA ARS, Tree Fruit Res Lab, Wenatchee, WA 98801 USA; Montana State Univ, Dept Microbiol, Bozeman, MT 59717 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Univ Iowa, Inflammat Program, Iowa City, IA 52241 USA; Univ Iowa, Dept Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52241 USA	James Whitcomb Riley Hospital Children; James Whitcomb Riley Hospital Children; James Whitcomb Riley Hospital Children; United States Department of Agriculture (USDA); Montana State University System; Montana State University Bozeman; Scripps Research Institute; University of Iowa; University of Iowa	Dinauer, MC (corresponding author), Indiana Univ, Sch Med, Canc Res Inst, 1044 W Walnut St,R4 402C, Indianapolis, IN 46202 USA.	mdinauer@iupui.edu		Jesaitis, Algirdas/0000-0001-9001-5617; Nauseef, William/0000-0003-4032-757X	NCI NIH HHS [P30 CA082709] Funding Source: Medline; NHLBI NIH HHS [HL 53592, R01 HL45635] Funding Source: Medline; NIAID NIH HHS [R01 AI34879, R01 AI26711, R01 AI24838] Funding Source: Medline; NIDDK NIH HHS [T32-DK007519] Funding Source: Medline; BLRD VA [I01 BX000513] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA082709] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053592, R01HL045635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024838, R01AI026711, R01AI034879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007519] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000513] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); BLRD VA; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)		Ambasta RK, 2004, J BIOL CHEM, V279, P45935, DOI 10.1074/jbc.M406486200; Biberstine-Kinkade KJ, 2002, J BIOL CHEM, V277, P30368, DOI 10.1074/jbc.M203993200; Biberstine-Kinkade KJ, 2001, J BIOL CHEM, V276, P31105, DOI 10.1074/jbc.M103327200; Burritt JB, 2001, J BIOL CHEM, V276, P2053, DOI 10.1074/jbc.M006236200; BURRITT JB, 1995, J BIOL CHEM, V270, P16974, DOI 10.1074/jbc.270.28.16974; CROSS AR, 1995, J BIOL CHEM, V270, P17075, DOI 10.1074/jbc.270.29.17075; Cross AR, 2000, BLOOD CELL MOL DIS, V26, P561, DOI 10.1006/bcmd.2000.0333; Dahan I, 2002, J BIOL CHEM, V277, P8421, DOI 10.1074/jbc.M109778200; Dahlgren C, 1999, J IMMUNOL METHODS, V232, P3, DOI 10.1016/S0022-1759(99)00146-5; Davis AR, 1998, J LEUKOCYTE BIOL, V64, P114, DOI 10.1002/jlb.64.1.114; DeLeo FR, 2000, J BIOL CHEM, V275, P13986, DOI 10.1074/jbc.275.18.13986; Dinauer M., 2003, NATHAN OSHIS HEMATOL, P923; DINAUER MC, 1991, P NATL ACAD SCI USA, V88, P11231, DOI 10.1073/pnas.88.24.11231; DOUSSIERE J, 1993, BIOCHEMISTRY-US, V32, P8880, DOI 10.1021/bi00085a020; Groemping Y, 2005, BIOCHEM J, V386, P401, DOI 10.1042/BJ20041835; Groemping Y, 2003, CELL, V113, P343, DOI 10.1016/S0092-8674(03)00314-3; HURST JK, 1991, J BIOL CHEM, V266, P1627; IMAJOHOHMI S, 1992, J BIOL CHEM, V267, P180; Inoue Y, 2000, VET IMMUNOL IMMUNOP, V76, P137, DOI 10.1016/S0165-2427(00)00207-5; Kawahara T, 2005, J BIOL CHEM, V280, P31859, DOI 10.1074/jbc.M501882200; LETO TL, 1994, P NATL ACAD SCI USA, V91, P10650, DOI 10.1073/pnas.91.22.10650; LEUSEN JHW, 1994, J EXP MED, V180, P2329, DOI 10.1084/jem.180.6.2329; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Nauseef WM, 2004, HISTOCHEM CELL BIOL, V122, P277, DOI 10.1007/s00418-004-0679-8; Nobuhisa I, 2006, BIOCHEM J, V396, P183, DOI 10.1042/BJ20051899; Ogura K, 2006, J BIOL CHEM, V281, P3660, DOI 10.1074/jbc.M505193200; PARKOS CA, 1987, J CLIN INVEST, V80, P732, DOI 10.1172/JCI113128; PARKOS CA, 1988, BIOCHIM BIOPHYS ACTA, V932, P71, DOI 10.1016/0005-2728(88)90140-5; Price MO, 2002, J BIOL CHEM, V277, P19220, DOI 10.1074/jbc.M200061200; QUINN MT, 1992, J BIOL CHEM, V267, P7303; ROTROSEN D, 1992, SCIENCE, V256, P1459, DOI 10.1126/science.1318579; ROTROSEN D, 1990, J BIOL CHEM, V265, P8745; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SEGAL AW, 1992, BIOCHEM J, V284, P781, DOI 10.1042/bj2840781; SUMIMOTO H, 1994, P NATL ACAD SCI USA, V91, P5345, DOI 10.1073/pnas.91.12.5345; Sumimoto H, 1996, J BIOL CHEM, V271, P22152, DOI 10.1074/jbc.271.36.22152; SUMIMOTO H, 1992, BIOCHEM BIOPH RES CO, V186, P1368, DOI 10.1016/S0006-291X(05)81557-8; Taylor RM, 2004, J IMMUNOL, V173, P7349, DOI 10.4049/jimmunol.173.12.7349; Ueno N, 2005, J BIOL CHEM, V280, P23328, DOI 10.1074/jbc.M414548200; Ueyama T, 2006, MOL CELL BIOL, V26, P2160, DOI 10.1128/MCB.26.6.2160-2174.2006; Yamauchi A, 2001, MICROBIOL IMMUNOL, V45, P249, DOI 10.1111/j.1348-0421.2001.tb02614.x; Yu LX, 1999, J BIOL CHEM, V274, P4364, DOI 10.1074/jbc.274.7.4364; Yu LX, 1997, J BIOL CHEM, V272, P27288, DOI 10.1074/jbc.272.43.27288; Yu LX, 1998, P NATL ACAD SCI USA, V95, P7993, DOI 10.1073/pnas.95.14.7993; ZHEN L, 1993, P NATL ACAD SCI USA, V90, P9832, DOI 10.1073/pnas.90.21.9832	45	61	61	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30336	30346		10.1074/jbc.M607191200	http://dx.doi.org/10.1074/jbc.M607191200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16895900	hybrid			2022-12-27	WOS:000241075900007
J	Lao, DH; Chandramouli, S; Yusoff, P; Fong, CW; Saw, TY; Tai, LP; Yu, CY; Leong, HF; Guy, GR				Lao, Dieu-Hung; Chandramouli, Sumana; Yusoff, Permeen; Fong, Chee Wai; Saw, Tzuen Yih; Tai, Lai Peng; Yu, Chye n Yu; Leong, Hwei Fen; Guy, Graeme R.			A Src homology 3-binding sequence on the C terminus of Sprouty2 is necessary for inhibition of the Ras/ERK pathway downstream of fibroblast growth factor receptor stimulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHORYLATION; KINASE; SHC; ACTIVATION; EXPRESSION; PROTEINS; BINDING	Because the Sprouty ( Spry) proteins were shown to be inhibitors of the mainstream Ras/ERK pathway, there has been considerable interest in ascertaining their mechanism of action especially since a possible role as tumor suppressors for these inhibitory proteins has been suggested. We compared the ability of the mammalian Spry isoforms to inhibit the Ras/ERK pathway in the context of fibroblast growth factor receptor ( FGFR) signaling. Spry2 is considerably more inhibitory than Spry1 or Spry4, and this correlates with the binding to Grb2 via a C-terminal proline-rich sequence that is found exclusively on Spry2. This PXXPXR motif binds directly to the N-terminal Src homology domain 3 of Grb2, and when added onto the C terminus of Spry4 the resultant chimera inhibits the Ras/ERK pathway. The ability to inhibit neurite outgrowth in PC-12 cells correlates with the propensity of Spry isoforms and engineered constructs to inhibit the phosphorylation of ERK1/2. The PXXPXR motif is cryptic in unstimulated cells, and it is postulated that Spry2 undergoes a conformational change following FGFR stimulation, enabling the subsequent interaction with Grb2. We present evidence that Spry2 can compete with the RasGEF ( guanine nucleotide exchange factor) SOS1 for binding to Grb2, resulting in the inhibition of phosphorylation of ERK1/2.	Inst Mol & Cell Biol, Signal Transduct Lab, Singapore 138673, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Guy, GR (corresponding author), Inst Mol & Cell Biol, Signal Transduct Lab, Rm 6-01A,61 Biopolis Dr, Singapore 138673, Singapore.	mcbgg@imcb.a-star.edu.sg		Chandramouli, Sumana/0000-0001-6994-506X				Casci T, 1999, CELL, V96, P655, DOI 10.1016/S0092-8674(00)80576-0; Chambers D, 2000, MECH DEVELOP, V91, P361, DOI 10.1016/S0925-4773(99)00288-9; Dans M, 2001, J BIOL CHEM, V276, P1494, DOI 10.1074/jbc.M008663200; de Maximy AA, 1999, MECH DEVELOP, V81, P213, DOI 10.1016/S0925-4773(98)00241-X; Fong CW, 2003, J BIOL CHEM, V278, P33456, DOI 10.1074/jbc.M301317200; Guy GR, 2003, J CELL SCI, V116, P3061, DOI 10.1242/jcs.00652; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Hall AB, 2003, CURR BIOL, V13, P308, DOI 10.1016/S0960-9822(03)00086-1; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Lim J, 2002, MOL CELL BIOL, V22, P7953, DOI 10.1128/MCB.22.22.7953-7966.2002; Mason JM, 2004, MOL BIOL CELL, V15, P2176, DOI 10.1091/mbc.E03-07-0503; Rubin C, 2003, CURR BIOL, V13, P297, DOI 10.1016/S0960-9822(03)00053-8; Sasaki A, 2003, NAT CELL BIOL, V5, P427, DOI 10.1038/ncb978; SIMON JA, 1995, CHEM BIOL, V2, P53, DOI 10.1016/1074-5521(95)90080-2; SKOLNIK EY, 1993, EMBO J, V12, P1929, DOI 10.1002/j.1460-2075.1993.tb05842.x; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; Tefft JD, 1999, CURR BIOL, V9, P219, DOI 10.1016/S0960-9822(99)80094-3; Wong ESM, 2002, EMBO J, V21, P4796, DOI 10.1093/emboj/cdf493; Yusoff P, 2002, J BIOL CHEM, V277, P3195, DOI 10.1074/jbc.M108368200	19	54	59	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					29993	30000		10.1074/jbc.M604044200	http://dx.doi.org/10.1074/jbc.M604044200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16893902	hybrid			2022-12-27	WOS:000240896300060
J	Oh, W; Yang, MR; Lee, EW; Park, KM; Pyo, S; Yang, JS; Lee, HW; Song, J				Oh, Wonkyung; Yang, Mi-Ran; Lee, Eun-Woo; Park, Ki-Moon; Pyo, Suhkneung; Yang, Joo-sung; Lee, Han-Woong; Song, Jaewhan			Jab1 mediates cytoplasmic localization and degradation of West Nile virus capsid protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COP9 SIGNALOSOME; JAB1/CSN5; COMPLEX; P27(KIP1); MECHANISM; INFECTION; RESPONSES; RECEPTOR; ALPHA; ENTRY	The clinical manifestations of West Nile virus (WNV), a member of the Flavivirus family, include febrile illness, sporadic encephalitis, and paralysis. The capsid (Cp) of WNV is thought to participate in these processes by inducing apoptosis through mitochondrial dysfunction and activation of caspase-9 and caspase-3. To further identify the molecular mechanism of the WNV capsid protein (WNVCp), yeast two-hybrid assays were employed using WNV-Cp as bait. Jab1, the fifth subunit of the COP9 signalosome, was subsequently identified as a molecule that interacts with WNVCp. Immunoprecipitation and glutathione S-transferase pulldown assays confirmed that direct interaction could occur between WNVCp and Jab1. Immunofluorescence microscopy demonstrated that the overexpressed WNVCp, which localized to the nucleolus, was translocated to the cytoplasm upon its co-expression with Jab1. When treated with leptomycin B, Jab1-facilitated nuclear exclusion of WNVCp was prevented, which indicated that the CRM1 complex is required for Jab1-facilitated nuclear export of WNVCp. Moreover, Jab1 promoted the degradation of WNVCp in a proteasome-dependent way. Consistent with this, WNVCp-mediated cell cycle arrest at the G2 phase in H1299 was prevented by exogenous Jab1. Finally, an analysis of WNVCp deletion mutants indicated that the first 15 amino acids were required for interaction with Jab1. Furthermore, the double-point mutant of the WNVCp, P5A/P8A, was incapable of binding to Jab1. These results indicate that Jab1 has a potential protective effect against pathogenic WNVCp and might provide a novel target site for the treatment of disease caused by WNV.	Sungkyunkwan Univ, Dept Food Sci & Biotechnol, Fac Life Sci & Engn, Suwon 440746, South Korea; Sungkyunkwan Univ, Dept Genet Engn, Suwon 440746, South Korea; Sungkyunkwan Univ, Coll Pharm, Suwon 440746, South Korea; Yonsei Univ, Dept Biochem, Seoul 120749, South Korea	Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Yonsei University	Song, J (corresponding author), Sungkyunkwan Univ, Dept Food Sci & Biotechnol, Fac Life Sci & Engn, Suwon 440746, South Korea.	jso678@skku.edu	Lee, Eun-Woo/AAP-9603-2020	Song, Jaewhan/0000-0001-8152-9210; Lee, Eun-Woo/0000-0002-5156-0003				Akamatsu E, 1998, J BIOL CHEM, V273, P16494, DOI 10.1074/jbc.273.26.16494; Bech-Otschir D, 2001, EMBO J, V20, P1630, DOI 10.1093/emboj/20.7.1630; Berse M, 2004, J MOL BIOL, V343, P361, DOI 10.1016/j.jmb.2004.08.043; Bimston D, 1998, EMBO J, V17, P6871, DOI 10.1093/emboj/17.23.6871; Callige M, 2005, MOL CELL BIOL, V25, P4349, DOI 10.1128/MCB.25.11.4349-4358.2005; CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245; Cheeran MCJ, 2005, J NEUROVIROL, V11, P512, DOI 10.1080/13550280500384982; Chu JJH, 2004, J VIROL, V78, P10543, DOI 10.1128/JVI.78.19.10543-10555.2004; Chu JJH, 2002, J MED VIROL, V67, P127, DOI 10.1002/jmv.2201; Chu JJH, 2003, J GEN VIROL, V84, P3305, DOI 10.1099/vir.0.19447-0; Claret FX, 1996, NATURE, V383, P453, DOI 10.1038/383453a0; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Diamond MS, 2003, VIRAL IMMUNOL, V16, P259, DOI 10.1089/088282403322396082; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Hiscox JA, 2001, J VIROL, V75, P506, DOI 10.1128/JVI.75.1.506-512.2001; Kim BC, 2004, MOL CELL BIOL, V24, P2251, DOI 10.1128/MCB.24.6.2251-2262.2004; Kwok SF, 1998, PLANT CELL, V10, P1779, DOI 10.1105/tpc.10.11.1779; Li SH, 2000, J BIOL CHEM, V275, P13386, DOI 10.1074/jbc.275.18.13386; Ning B, 2004, J VIROL, V78, P13653, DOI 10.1128/JVI.78.24.13653-13668.2004; Oh W, 2006, J BIOL CHEM, V281, P17457, DOI 10.1074/jbc.M601857200; Parquet MD, 2001, FEBS LETT, V500, P17, DOI 10.1016/S0014-5793(01)02573-X; Ramanathan MP, 2006, VIROLOGY, V345, P56, DOI 10.1016/j.virol.2005.08.043; Sampson BA, 2000, HUM PATHOL, V31, P527, DOI 10.1053/hp.2000.8047; SMITHBURN K. C, 1940, AMER JOUR TROP MED, V20, P471; Tomoda K, 1999, NATURE, V398, P160, DOI 10.1038/18230; Tomoda K, 2002, J BIOL CHEM, V277, P2302, DOI 10.1074/jbc.M104431200; Wan M, 2002, EMBO REP, V3, P171, DOI 10.1093/embo-reports/kvf024; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; WESTAWAY EG, 1985, INTERVIROLOGY, V24, P183, DOI 10.1159/000149642; Yang JS, 2002, EMERG INFECT DIS, V8, P1379, DOI 10.3201/eid0812.020224; Yun JS, 2004, J BIOL CHEM, V279, P31296, DOI 10.1074/jbc.M401411200	32	55	59	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					30166	30174		10.1074/jbc.M602651200	http://dx.doi.org/10.1074/jbc.M602651200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16882664	hybrid			2022-12-27	WOS:000240896300077
J	van den Born, J; Pisa, B; Bakker, MAH; Celie, JWAM; Straatman, C; Thomas, S; Viberti, GC; Kjellen, L; Berden, JHM				van den Born, Jacob; Pisa, Brenda; Bakker, Marinka A. H.; Celie, Johanna W. A. M.; Straatman, Carin; Thomas, Steven; Viberti, Gian C.; Kjellen, Lena; Berden, Jo H. M.			No change in glomerular heparan sulfate structure in early human and experimental diabetic nephropathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASEMENT-MEMBRANE; MONOCLONAL-ANTIBODY; SELECTIVE PROTEINURIA; ANIONIC SITES; MESSENGER-RNA; DEACETYLASE; EXPRESSION; PROTEOGLYCAN; MICROALBUMINURIA; SULFOTRANSFERASE	Heparan sulfate (HS) proteoglycans are major anionic glycoconjugates of the glomerular basement membrane and are thought to contribute to the permeability properties of the glomerular capillary wall. In this study we evaluated whether the development of ( micro) albuminuria in early human and experimental diabetic nephropathy is related to changes in glomerular HS expression or structure. Using a panel of recently characterized antibodies, glomerular HS expression was studied in kidney biopsies of type I diabetic patients with microalbuminuria or early albuminuria and in rat renal tissue after 5 months diabetes duration. Glomerular staining, however, revealed no differences between control and diabetic specimens. A significant (p < 0.05) similar to 60% increase was found in HS N-deacetylase activity, a key enzyme in HS sulfation reactions, in diabetic glomeruli. Structural analysis of glomerular HS after in vivo and in vitro radiolabeling techniques revealed no changes in HS N-sulfation or charge density. Also HS chain length, protein binding properties, as well as disaccharide composition did not differ between control and diabetic glomerular HS samples. These results indicate that in experimental and early human diabetic nephropathy, increased urinary albumin excretion is not caused by loss of glomerular HS expression or sulfation and suggest other mechanisms to be responsible for increased glomerular albumin permeability.	Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, NL-1007 MB Amsterdam, Netherlands; Radboud Univ Nijmegen, Med Ctr, Dept Nephrol, NL-6500 HB Nijmegen, Netherlands; Guys Hosp, Dept Diabet Endocrinol & Intenal Med, London SE1 9RT, England; Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden	Vrije Universiteit Amsterdam; Radboud University Nijmegen; Guy's & St Thomas' NHS Foundation Trust; Uppsala University	van den Born, J (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, POB 7057, NL-1007 MB Amsterdam, Netherlands.	j.vandenborn@vumc.nl	Berden, J.H.M./H-8009-2014; Kjellen, Lena/F-1362-2011					Baines LA, 2001, DIABETES, V50, P843; Branten AJW, 2001, KIDNEY INT, V59, P693, DOI 10.1046/j.1523-1755.2001.059002693.x; CHAKRABARTI S, 1989, DIABETOLOGIA, V32, P826; DANISHEF.V, 1965, BIOCHIM BIOPHYS ACTA, V101, P37; DECKERT T, 1989, DIABETOLOGIA, V32, P219, DOI 10.1007/BF00285287; DECKERT T, 1988, KIDNEY INT, V33, P100, DOI 10.1038/ki.1988.16; EDGE ASB, 1990, J BIOL CHEM, V265, P15874; Edge ASB, 2000, DIABETOLOGIA, V43, P1056, DOI 10.1007/s001250051489; Groffen AJ, 1998, J HISTOCHEM CYTOCHEM, V46, P19, DOI 10.1177/002215549804600104; KANWAR YS, 1980, J CELL BIOL, V86, P688, DOI 10.1083/jcb.86.2.688; KOFOEDENEVOLDSEN A, 1992, KIDNEY INT, V41, P763, DOI 10.1038/ki.1992.119; KOFOEDENEVOLDSEN A, 1993, DIABETOLOGIA, V36, P536, DOI 10.1007/BF02743270; KOFOEDENEVOLDSEN A, 1991, DIABETES, V40, P1449, DOI 10.2337/diabetes.40.11.1449; Liu JA, 1999, J BIOL CHEM, V274, P5185, DOI 10.1074/jbc.274.8.5185; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maccarana M, 1996, J BIOL CHEM, V271, P17804, DOI 10.1074/jbc.271.30.17804; MACCARANA M, 1993, GLYCOBIOLOGY, V3, P271, DOI 10.1093/glycob/3.3.271; Marshall SM, 2004, CLIN MED, V4, P277, DOI 10.7861/clinmedicine.4-3-277; Maxhimer JB, 2005, DIABETES, V54, P2172, DOI 10.2337/diabetes.54.7.2172; MOGENSEN CE, 1984, NEW ENGL J MED, V310, P356, DOI 10.1056/NEJM198402093100605; Mundel P, 2002, J AM SOC NEPHROL, V13, P3005, DOI 10.1097/01.ASN.0000039661.06947.FD; Oturai P, 1999, EXP CLIN ENDOCR DIAB, V107, P453, DOI 10.1055/s-0029-1212137; Parthasarathy N, 2000, MOL CELL BIOCHEM, V213, P1, DOI 10.1023/A:1007110700454; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; PEJLER G, 1987, J BIOL CHEM, V262, P5036; Raats CJI, 2000, KIDNEY INT, V57, P385, DOI 10.1046/j.1523-1755.2000.00858.x; Raats CJI, 1998, J BIOL CHEM, V273, P17832, DOI 10.1074/jbc.273.28.17832; RIESENFELD J, 1982, J BIOL CHEM, V257, P7050; SHAKLEE PN, 1984, BIOCHEM J, V217, P187, DOI 10.1042/bj2170187; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; TAMSMA JT, 1994, DIABETOLOGIA, V37, P313, DOI 10.1007/BF00398060; TEMPLETON DM, 1989, LAB INVEST, V61, P202; UNGER E, 1991, J BIOL CHEM, V266, P8671; van den Born J, 2005, J BIOL CHEM, V280, P20516, DOI 10.1074/jbc.M502065200; van den Born J, 2003, GLYCOBIOLOGY, V13, P1, DOI 10.1093/glycob/cwg011; vandenBorn J, 1995, J BIOL CHEM, V270, P31303, DOI 10.1074/jbc.270.52.31303; VANDENBORN J, 1992, KIDNEY INT, V41, P115, DOI 10.1038/ki.1992.15; VANDENBORN J, 1993, KIDNEY INT, V43, P454, DOI 10.1038/ki.1993.67; VANDENBORN J, 1995, NEPHROL DIAL TRANSPL, V10, P1277; VANDENBORN J, 1991, LAB INVEST, V65, P287; vandenBorn J, 1996, J BIOL CHEM, V271, P22802, DOI 10.1074/jbc.271.37.22802; VANDENBORN J, 1995, DIABETOLOGIA, V38, P1169, DOI 10.1007/BF00422365; VANDENBORN J, 1995, DIABETOLOGIA, V38, P161, DOI 10.1007/s001250050266; VANDENHEUVEL LPWJ, 1989, BIOCHEM J, V264, P457, DOI 10.1042/bj2640457; VERNIER RL, 1992, KIDNEY INT, V41, P1070, DOI 10.1038/ki.1992.163; VIBERTI GC, 1982, LANCET, V2, P611; Williams KJ, 2005, DIABETES, V54, P1116, DOI 10.2337/diabetes.54.4.1116; Wolf G, 2005, DIABETES, V54, P1626, DOI 10.2337/diabetes.54.6.1626; Wolf G, 2004, EUR J CLIN INVEST, V34, P785, DOI 10.1111/j.1365-2362.2004.01429.x; Yard B, 2002, NEPHROL DIAL TRANSPL, V17, P386, DOI 10.1093/ndt/17.3.386	50	41	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					29606	29613		10.1074/jbc.M601552200	http://dx.doi.org/10.1074/jbc.M601552200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16885165	hybrid, Green Published			2022-12-27	WOS:000240896300022
J	Viviani, B; Gardoni, F; Bartesaghi, S; Corsini, E; Facchi, A; Galli, CL; Di Luca, M; Marinovich, M				Viviani, Barbara; Gardoni, Fabrizio; Bartesaghi, Stefano; Corsini, Emanuela; Facchi, Alessandra; Galli, Corrado L.; Di Luca, Monica; Marinovich, Marina			Interleukin-1 beta released by gp120 drives neural death through tyrosine phosphorylation and trafficking of NMDA receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; COAT PROTEIN GP120; ACQUIRED-IMMUNODEFICIENCY-SYNDROME; D-ASPARTATE RECEPTOR; SRC FAMILY; POSTSYNAPTIC DENSITIES; ENVELOPE GLYCOPROTEIN; GLUTAMATE RECEPTORS; NEURONAL APOPTOSIS; ARACHIDONIC-ACID	Interleukin-1 beta is a proinflammatory cytokine implicated under pathological conditions involving NMDA receptor activation, including the AIDS dementia complex ( HAD). No information is available on the molecular mechanisms recruited by native interleukin-1 beta produced under this type of condition. Using a sandwich co-culture of primary hippocampal neurons and glia, we investigated whether native interleukin-1 beta released by HIV-gp120-activated glia (i) affects NMDAR functions and (ii) the relevance on neuronal spine density and survival, two specific traits of HAD. Increased phosphorylation of NR2B Tyr-1472 was observed after 24 h of exposure of neurons to 600 pM gp120. This effect occurred only when neurons were treated in the presence of glial cells and was abolished by the interleukin-1 receptor antagonist (IL-1ra). Gp120-induced phosphorylation of NR2B resulted in a sustained elevation of intracellular Ca2+ in neurons and in a significant increase of NR2B binding to PSD95. Increased intracellular Ca2+ was prevented by 10 mu M ifenprodil, that selectively inhibits receptors containing the NR2B, by interleukin-1ra and by Ca-pYEEIE, a Src family SH2 inhibitor peptide. These last two inhibitors, prevented also NR2B binding to PSD95. Finally, gp120 reduced by 35% of the total PSD95 positive spine density after 48 h of treatment and induced by 30% of the neuronal death. Again, both of these effects were blocked by Ca-pYEEIE. Altogether, our data show that gp120 releasing interleukin-1 beta from glia increases tyrosine phosphorylation of NMDAR. Thus, tyrosine phosphorylation may contribute to the sensitization of the receptor increasing its function and synaptic localization. Both of these effects are relevant for neurodegeneration.	Univ Milan, Dept Pharmacol Sci, Toxicol Lab, I-20133 Milan, Italy; Univ Milan, Ctr Excellence Neurodegenerat Dis, I-20133 Milan, Italy	University of Milan; University of Milan	Viviani, B (corresponding author), Univ Milan, Dept Pharmacol Sci, Toxicol Lab, Via Balzaretti 9, I-20133 Milan, Italy.	Barbara.Viviani@unimi.it	Corsini, Emanuela/B-5602-2011; Gardoni, Fabrizio/A-3135-2009; Viviani, Barbara/B-5663-2011; DiLuca, Monica/A-7632-2012; Bartesaghi, Stefano/G-1916-2015	Gardoni, Fabrizio/0000-0003-4598-5563; Viviani, Barbara/0000-0002-0935-0459; DiLuca, Monica/0000-0003-2298-615X; Bartesaghi, Stefano/0000-0002-2083-7807; Galli, Corrado Lodovico/0000-0003-0078-5488; Marinovich, Marina/0000-0003-0625-8101				Aarts MM, 2004, CURR MOL MED, V4, P137, DOI 10.2174/1566524043479202; Allan SM, 2001, NAT REV NEUROSCI, V2, P734, DOI 10.1038/35094583; Bagetta G, 1999, NEUROSCIENCE, V89, P1051, DOI 10.1016/S0306-4522(98)00363-7; Barak O, 2002, BRAIN RES, V933, P98, DOI 10.1016/S0006-8993(02)02280-1; BARBOUR B, 1989, NATURE, V342, P918, DOI 10.1038/342918a0; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Besshoh S, 2005, J NEUROCHEM, V93, P186, DOI 10.1111/j.1471-4159.2004.03009.x; Bilbo SD, 2005, J NEUROSCI, V25, P8000, DOI 10.1523/JNEUROSCI.1748-05.2005; BLATTEIS CM, 1990, YALE J BIOL MED, V63, P133; BREW BJ, 1995, ANN NEUROL, V38, P563, DOI 10.1002/ana.410380404; Cheung HH, 2000, J CEREBR BLOOD F MET, V20, P505, DOI 10.1097/00004647-200003000-00009; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; DAWSON VL, 1993, P NATL ACAD SCI USA, V90, P3256, DOI 10.1073/pnas.90.8.3256; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Dreyer EB, 1995, EUR J NEUROSCI, V7, P2502, DOI 10.1111/j.1460-9568.1995.tb01048.x; Dunah AW, 2004, MOL PHARMACOL, V65, P121, DOI 10.1124/mol.65.1.121; Ellis RJ, 1997, ARCH NEUROL-CHICAGO, V54, P416, DOI 10.1001/archneur.1997.00550160054016; GALLO P, 1989, J NEUROIMMUNOL, V23, P109, DOI 10.1016/0165-5728(89)90029-5; Gardoni F, 1998, J NEUROCHEM, V71, P1733; Gardoni F, 2003, J BIOL CHEM, V278, P44745, DOI 10.1074/jbc.M303576200; GIULIAN D, 1993, P NATL ACAD SCI USA, V90, P2769, DOI 10.1073/pnas.90.7.2769; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Haughey NJ, 2002, JAIDS-J ACQ IMM DEF, V31, pS55, DOI 10.1097/00126334-200210012-00005; Haughey NJ, 2001, J NEUROCHEM, V78, P457, DOI 10.1046/j.1471-4159.2001.00396.x; Ilyin SE, 1997, BIOCHEM BIOPH RES CO, V231, P514, DOI 10.1006/bbrc.1997.6131; Kalia LV, 2004, ONCOGENE, V23, P8007, DOI 10.1038/sj.onc.1208158; Kalia LV, 2003, NEUROPHARMACOLOGY, V45, P720, DOI 10.1016/S0028-3908(03)00313-7; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Kaul M, 1999, P NATL ACAD SCI USA, V96, P8212, DOI 10.1073/pnas.96.14.8212; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; Lavezzari G, 2003, NEUROPHARMACOLOGY, V45, P729, DOI 10.1016/S0028-3908(03)00308-3; Lipton JM, 1997, IMMUNOL TODAY, V18, P140, DOI 10.1016/S0167-5699(97)01009-8; LIPTON SA, 1995, NEW ENGL J MED, V332, P934, DOI 10.1056/NEJM199504063321407; Lynch DR, 2002, J PHARMACOL EXP THER, V300, P717, DOI 10.1124/jpet.300.3.717; Masliah E, 1997, ANN NEUROL, V42, P963, DOI 10.1002/ana.410420618; Masliah E, 1996, CRIT REV NEUROBIOL, V10, P57, DOI 10.1615/CritRevNeurobiol.v10.i1.30; Meucci O, 1996, J NEUROSCI, V16, P4080; Milligan ED, 2001, J NEUROSCI, V21, P2808, DOI 10.1523/JNEUROSCI.21-08-02808.2001; Nakazawa T, 2001, J BIOL CHEM, V276, P693, DOI 10.1074/jbc.M008085200; Niimura M, 2005, J NEUROCHEM, V92, P1377, DOI 10.1111/j.1471-4159.2005.02977.x; Osterhout DJ, 1999, J CELL BIOL, V145, P1209, DOI 10.1083/jcb.145.6.1209; Park SH, 2002, BIOORG MED CHEM LETT, V12, P2711, DOI 10.1016/S0960-894X(02)00523-1; PLATASALAMAN CR, 1991, NEUROSCI BIOBEHAV R, V15, P185, DOI 10.1016/S0149-7634(05)80001-6; Prybylowski K, 2005, NEURON, V47, P845, DOI 10.1016/j.neuron.2005.08.016; Pugh CR, 2001, NEUROSCI BIOBEHAV R, V25, P29, DOI 10.1016/S0149-7634(00)00048-8; Pugh CR, 2000, BRAIN RES, V861, P8, DOI 10.1016/S0006-8993(99)02445-2; Quan N, 1996, NEUROIMMUNOMODULAT, V3, P56, DOI 10.1159/000097227; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; Rong YQ, 2001, J NEUROCHEM, V79, P382, DOI 10.1046/j.1471-4159.2001.00565.x; Ross FM, 2003, J NEUROIMMUNOL, V144, P61, DOI 10.1016/j.jneuroim.2003.08.030; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Schneider H, 1998, P NATL ACAD SCI USA, V95, P7778, DOI 10.1073/pnas.95.13.7778; SEI Y, 1995, NEUROIMMUNOMODULAT, V2, P121, DOI 10.1159/000096881; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Song C, 2003, J BIOL CHEM, V278, P33364, DOI 10.1074/jbc.M304240200; Takagi N, 1997, J NEUROCHEM, V69, P1060; TAKAHASHI S, 1996, AM J PHYSIOL, V271, P101; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; TOGGAS SM, 1994, NATURE, V367, P188, DOI 10.1038/367188a0; TYOR WR, 1992, ANN NEUROL, V31, P349, DOI 10.1002/ana.410310402; Vesce S, 1997, FEBS LETT, V411, P107, DOI 10.1016/S0014-5793(97)00674-1; Vezzani A, 2000, P NATL ACAD SCI USA, V97, P11534, DOI 10.1073/pnas.190206797; Vissel B, 2001, NAT NEUROSCI, V4, P587, DOI 10.1038/88404; Vitkovic L, 2000, J NEUROCHEM, V74, P457, DOI 10.1046/j.1471-4159.2000.740457.x; Viviani B, 2003, J NEUROSCI, V23, P8692; Viviani B, 2001, NEUROSCIENCE, V107, P51, DOI 10.1016/S0306-4522(01)00332-3; Wang K, 2004, J BIOL CHEM, V279, P8779, DOI 10.1074/jbc.M309652200; Watkins LR, 2001, TRENDS NEUROSCI, V24, P450, DOI 10.1016/S0166-2236(00)01854-3; YAMASAKI Y, 1995, STROKE, V26, P676, DOI 10.1161/01.STR.26.4.676	70	96	99	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					30212	30222		10.1074/jbc.M602156200	http://dx.doi.org/10.1074/jbc.M602156200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16887807	Green Published, hybrid			2022-12-27	WOS:000240896300081
J	Kaadige, MR; Ayer, DE				Kaadige, Mohan R.; Ayer, Donald E.			The polybasic region that follows the plant homeodomain zinc finger 1 of Pf1 is necessary and sufficient for specific phosphoinositide binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHD FINGER; TRANSCRIPTIONAL REPRESSION; DEACETYLASE COMPLEX; HISTONE H3K4ME3; CELL-CYCLE; CHROMATIN; PROTEIN; DOMAIN; ING2; RECEPTOR	The plant homeodomain (PHD) zinc finger is one of 14 known zinc-binding domains. PHD domains have been found in more than 400 eukaryotic proteins and are characterized by a Cys(4)-His-Cys(3) zinc-binding motif that spans 50-80 residues. The precise function of PHD domains is currently unknown; however, the PHD domains of the ING1 and ING2 tumor suppressors have been shown recently to bind phosphoinositides (PIs). We have recently identified a novel PHD-containing protein, Pf1, as a binding partner for the abundant and ubiquitous transcriptional corepressor mSin3A. Pf1 contains two PHD zinc fingers, PHD1 and PHD2, and functions to bridge mSin3A to the TLE1 corepressor. Here, we show that PHD1, but not PHD2, binds several monophosporylated PIs but most strongly to PI(3) P. Surprisingly, a polybasic region that follows the PHD1 is necessary for PI(3) P binding. Furthermore, this polybasic region binds specifically to PI(3) P when fused to maltose-binding protein, PHD2, or as an isolated peptide, demonstrating that it is sufficient for specific PI binding. By exchanging the polybasic regions between different PHD fingers we show that this region is a strong determinant of PI binding specificity. These findings establish the Pf1 polybasic region as a phosphoinositide-binding module and suggest that the PHD domains function downstream of phosphoinositide signaling triggered by the interaction between polybasic regions and phosphoinositides.	Univ Utah, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT 84112 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Ayer, DE (corresponding author), Univ Utah, Huntsman Canc Inst, Dept Oncol Sci, 2000 Circle Hope,Rm 4365, Salt Lake City, UT 84112 USA.	don.ayer@hci.utah.edu		Ayer, Donald/0000-0002-5595-3269	NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055668] Funding Source: NIH RePORTER; NCI NIH HHS [2P30 CA42014] Funding Source: Medline; NIGMS NIH HHS [R01 GM055668] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; Ayer DE, 1999, TRENDS CELL BIOL, V9, P193, DOI 10.1016/S0962-8924(99)01536-6; Bienz M, 2006, TRENDS BIOCHEM SCI, V31, P35, DOI 10.1016/j.tibs.2005.11.001; Boronenkov IV, 1998, MOL BIOL CELL, V9, P3547, DOI 10.1091/mbc.9.12.3547; Clarke JH, 2001, BIOCHEM J, V357, P905, DOI 10.1042/0264-6021:3570905; Cocco L, 2004, EUR J HISTOCHEM, V48, P83; Eberharter A, 2004, EMBO J, V23, P4029, DOI 10.1038/sj.emboj.7600382; Gozani O, 2005, ADV ENZYME REGUL, V45, P171, DOI 10.1016/j.advenzreg.2005.02.010; Gozani O, 2003, CELL, V114, P99, DOI 10.1016/S0092-8674(03)00480-X; Irvine RF, 2003, NAT REV MOL CELL BIO, V4, P349, DOI 10.1038/nrm1100; Jones DR, 2004, CURR OPIN GENET DEV, V14, P196, DOI 10.1016/j.gde.2004.02.003; Knoepfler PS, 1999, CELL, V99, P447, DOI 10.1016/S0092-8674(00)81531-7; Kuzmichev A, 2002, MOL CELL BIOL, V22, P835, DOI 10.1128/MCB.22.3.835-848.2002; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Martelli AM, 2005, J CELL BIOCHEM, V96, P285, DOI 10.1002/jcb.20527; MCTIGUE MA, 1995, J MOL BIOL, V246, P21, DOI 10.1006/jmbi.1994.0061; Mochizuki Y, 2003, P NATL ACAD SCI USA, V100, P9768, DOI 10.1073/pnas.1333958100; Osborne SL, 2001, J CELL SCI, V114, P2501; Papayannopoulos V, 2005, MOL CELL, V17, P181, DOI 10.1016/j.molcel.2004.11.054; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Pendaries C, 2005, ADV ENZYME REGUL, V45, P201, DOI 10.1016/j.advenzreg.2005.02.006; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Sundaram M, 2004, BIOCHEM CELL BIOL, V82, P191, DOI 10.1139/o03-087; Wang JY, 2002, J BIOL CHEM, V277, P34401, DOI 10.1074/jbc.M203954200; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Yochum GS, 2002, MOL CELL BIOL, V22, P7868, DOI 10.1128/MCB.22.22.7868-7876.2002; Yochum GS, 2001, MOL CELL BIOL, V21, P4110, DOI 10.1128/MCB.21.13.4110-4118.2001; YORK JD, 1994, J BIOL CHEM, V269, P7847; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	30	65	78	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					28831	28836		10.1074/jbc.M605624200	http://dx.doi.org/10.1074/jbc.M605624200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16893883	hybrid			2022-12-27	WOS:000240680500037
J	Belfield, JL; Whittaker, C; Cader, MZ; Chawla, S				Belfield, Johanna L.; Whittaker, Chris; Cader, M. Zaeem; Chawla, Sangeeta			Differential effects of Ca2+ and cAMP on transcription mediated by MEF2D and cAMP-response element-binding protein in hippocampal neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBELLAR GRANULE NEURONS; MYOCYTE-ENHANCER FACTOR-2; LONG-TERM POTENTIATION; GENE-EXPRESSION; CALCIUM-CHANNELS; CELLULAR-LOCALIZATION; SYNAPTIC PLASTICITY; CORTICAL-NEURONS; NERVOUS-SYSTEM; CROSS-TALK	In neurons, the second messengers Ca2+ and cAMP are mediators of transcriptional responses that are important for the development and function of the nervous system. The pro-survival neuronal transcription factors cAMP-response elementbinding protein (CREB) and myocyte enhancer factor-2 (MEF2) both stimulate gene expression in response to activity-dependent increases in the concentration of intracellular Ca2+ ions. CREB is also activated by increases in intracellular cAMP. Here we have investigated whether the MEF2 family member MEF2D, similar to CREB, is also activated by cAMP in hippocampal neurons. We have shown that, unlike CREB, MEF2D is not activated by agents that increase intracellular cAMP. Moreover, increases in cAMP inhibit Ca2+-activated MEF2D-mediated gene expression. We have also shown that cAMP inhibits Ca2+-induced nuclear export of the MEF2 co-repressor HDAC5 and prevents Ca2+-stimulated nuclear import of the MEF2 co-activator NFAT3/c4. Our results suggest that cAMP interferes with MEF2D-mediated gene expression at multiple levels by antagonizing the derepression of MEF2D by HDAC5 and by inhibiting recruitment of the co-activator NFAT.	Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England	University of Cambridge	Chawla, S (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Ct Rd, Cambridge CB2 1PD, England.	sc10008@cam.ac.uk		Cader, Mohammed Zaeem/0000-0002-4121-748X	Biotechnology and Biological Sciences Research Council [JF20603] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; Benedito AB, 2005, J BIOL CHEM, V280, P2818, DOI 10.1074/jbc.M408741200; Blaeser F, 2000, J BIOL CHEM, V275, P197, DOI 10.1074/jbc.275.1.197; Chawla S, 2003, J NEUROCHEM, V85, P151, DOI 10.1046/j.1471-4159.2003.01648.x; Chow CW, 2000, MOL CELL BIOL, V20, P702, DOI 10.1128/MCB.20.2.702-712.2000; Cooper DMF, 2003, BIOCHEM SOC T, V31, P912; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Ferguson GD, 2004, PHYSIOLOGY, V19, P271, DOI 10.1152/physiol.00010.2004; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Fukuchi M, 2005, J PHARMACOL SCI, V98, P212, DOI 10.1254/jphs.FMJ05001X4; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; Hansen TVO, 2004, J NEUROCHEM, V89, P15, DOI 10.1046/j.1471-4159.2003.02252.x; Hanson MG, 1998, J NEUROSCI, V18, P7361; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 1999, NEURON, V22, P789, DOI 10.1016/S0896-6273(00)80737-0; HELL JW, 1995, EMBO J, V14, P3036, DOI 10.1002/j.1460-2075.1995.tb07306.x; IKESHIMA H, 1995, NEUROSCI LETT, V200, P117, DOI 10.1016/0304-3940(95)12092-I; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Li MT, 2001, J NEUROSCI, V21, P6544, DOI 10.1523/JNEUROSCI.21-17-06544.2001; Li MT, 2000, MOL CELL BIOL, V20, P9356, DOI 10.1128/MCB.20.24.9356-9363.2000; Lin SL, 2003, J NEUROCHEM, V87, P1076, DOI 10.1046/j.1471-4159.2003.02076.x; Lin X, 1996, MOL BRAIN RES, V42, P307, DOI 10.1016/S0169-328X(96)00135-0; Linseman DA, 2003, J BIOL CHEM, V278, P41472, DOI 10.1074/jbc.M307245200; Liu LD, 2003, P NATL ACAD SCI USA, V100, P8532, DOI 10.1073/pnas.1332804100; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Mao ZX, 1999, J BIOL CHEM, V274, P31102, DOI 10.1074/jbc.274.43.31102; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; Matsuo R, 1998, NEUROSCI LETT, V244, P173, DOI 10.1016/S0304-3940(98)00159-1; Mckenzie GJ, 2005, J NEUROCHEM, V93, P171, DOI 10.1111/j.1471-4159.2005.03010.x; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Nguyen PV, 2003, PROG NEUROBIOL, V71, P401, DOI 10.1016/j.pneurobio.2003.12.003; Poser S, 2003, J NEUROSCI, V23, P4420; Ramanan N, 2005, NAT NEUROSCI, V8, P759, DOI 10.1038/nn1462; Rogue PJ, 1998, P NATL ACAD SCI USA, V95, P9178, DOI 10.1073/pnas.95.16.9178; Schroeter S, 2000, J COMP NEUROL, V420, P211; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Shalizi A, 2003, J NEUROSCI, V23, P7326; Sheridan CM, 2002, J BIOL CHEM, V277, P48664, DOI 10.1074/jbc.M207029200; Soulsby MD, 2005, BIOCHEM J, V392, P493, DOI 10.1042/BJ20051325; VALDIVIA HH, 1995, SCIENCE, V267, P1997, DOI 10.1126/science.7701323; Wang XM, 2005, J BIOL CHEM, V280, P16705, DOI 10.1074/jbc.M501819200; Wayman GA, 1997, J BIOL CHEM, V272, P16073, DOI 10.1074/jbc.272.26.16073; Wu XY, 2001, J BIOL CHEM, V276, P24177, DOI 10.1074/jbc.M100412200; Yang TTC, 2002, MOL CELL BIOL, V22, P3892, DOI 10.1128/MCB.22.11.3892-3904.2002; YOSHIDA A, 1992, J NEUROSCI, V12, P1094; Youn HD, 2000, EMBO J, V19, P4323, DOI 10.1093/emboj/19.16.4323; Zhao M, 1999, MOL CELL BIOL, V19, P21; Zhou XB, 2000, P NATL ACAD SCI USA, V97, P14329, DOI 10.1073/pnas.250494697	53	53	53	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					27724	27732		10.1074/jbc.M601485200	http://dx.doi.org/10.1074/jbc.M601485200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16870618	hybrid			2022-12-27	WOS:000240534400008
J	Isaacs, AM; Senn, DB; Yuan, ML; Shine, JP; Yankner, BA				Isaacs, Adrian M.; Senn, David B.; Yuan, Menglan; Shine, James P.; Yankner, Bruce A.			Acceleration of amyloid beta-peptide aggregation by physiological concentrations of calcium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMER A-BETA; IN-VIVO; PROTEIN FIBRILLOGENESIS; CELL-DEATH; CONGO RED; NEURONS; DISEASE; BRAIN; CALBINDIN-D-28K; NEUROTOXICITY	Alzheimer disease is characterized by the accumulation of aggregated amyloid beta-peptide (A beta) in the brain. The physiological mechanisms and factors that predispose to A beta aggregation and deposition are not well understood. In this report, we show that calcium can predispose to A beta aggregation and fibril formation. Calcium increased the aggregation of early forming protofibrillar structures and markedly increased conversion of protofibrils to mature amyloid fibrils. This occurred at levels 20-fold below the calcium concentration in the extracellular space of the brain, the site at which amyloid plaque deposition occurs. In the absence of calcium, protofibrils can remain stable in vitro for several days. Using this approach, we directly compared the neurotoxicity of protofibrils and mature amyloid fibrils and demonstrate that both species are inherently toxic to neurons in culture. Thus, calcium may be an important predisposing factor for A beta aggregation and toxicity. The high extracellular concentration of calcium in the brain, together with impaired intraneuronal calcium regulation in the aging brain and Alzheimer disease, may play an important role in the onset of amyloid-related pathology.	Harvard Univ, Sch Med, Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Childrens Hosp, Div Neurosci, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Yankner, BA (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 77 Ave Louis Pasteur,MRB-858C, Boston, MA 02115 USA.	bruce_yankner@hms.harvard.edu	Senn, David B/E-7813-2010	Senn, David/0000-0002-4869-3550	NIA NIH HHS [R01 AG017573, AG17573] Funding Source: Medline; NINDS NIH HHS [NS030352, R01 NS030352] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG017573] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ARISPE N, 1993, P NATL ACAD SCI USA, V90, P567, DOI 10.1073/pnas.90.2.567; Atwood CS, 1998, J BIOL CHEM, V273, P12817, DOI 10.1074/jbc.273.21.12817; Biere AL, 1996, J BIOL CHEM, V271, P32916, DOI 10.1074/jbc.271.51.32916; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Bu J, 2003, EXP NEUROL, V182, P220, DOI 10.1016/S0014-4886(03)00094-3; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Dineley KT, 2001, J NEUROSCI, V21, P4125, DOI 10.1523/JNEUROSCI.21-12-04125.2001; Fahandejsaadi A, 2004, NEUROREPORT, V15, P443, DOI 10.1097/00001756-200403010-00012; Geula C, 1998, NAT MED, V4, P827, DOI 10.1038/nm0798-827; Harper JD, 1997, CHEM BIOL, V4, P119, DOI 10.1016/S1074-5521(97)90255-6; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Hayashi H, 2004, J NEUROSCI, V24, P4894, DOI 10.1523/JNEUROSCI.0861-04.2004; Huang XD, 2004, J BIOL INORG CHEM, V9, P954, DOI 10.1007/s00775-004-0602-8; Huang XD, 1997, J BIOL CHEM, V272, P26464, DOI 10.1074/jbc.272.42.26464; Klunk WE, 1999, ANAL BIOCHEM, V266, P66, DOI 10.1006/abio.1998.2933; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Leissring MA, 2000, J CELL BIOL, V149, P793, DOI 10.1083/jcb.149.4.793; LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; MARK RJ, 1995, J NEUROSCI, V15, P6239; McGowan E, 2005, NEURON, V47, P191, DOI 10.1016/j.neuron.2005.06.030; Naiki H, 1996, LAB INVEST, V74, P374; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Tariot PN, 2004, JAMA-J AM MED ASSOC, V291, P317, DOI 10.1001/jama.291.3.317; VILLA A, 1994, EUR J NEUROSCI, V6, P1491, DOI 10.1111/j.1460-9568.1994.tb01010.x; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wogulis M, 2005, J NEUROSCI, V25, P1071, DOI 10.1523/JNEUROSCI.2381-04.2005; Wu CK, 2003, NEUROSCIENCE, V120, P249, DOI 10.1016/S0306-4522(03)00248-3; Yoo AS, 2000, NEURON, V27, P561, DOI 10.1016/S0896-6273(00)00066-0	33	118	125	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					27916	27923		10.1074/jbc.M602061200	http://dx.doi.org/10.1074/jbc.M602061200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16870617	hybrid, Green Accepted			2022-12-27	WOS:000240534400027
J	Kim, SH; Pytlos, MJ; Rosche, WA; Sinden, RR				Kim, Seung-Hwan; Pytlos, Malgorzata J.; Rosche, William A.; Sinden, Richard R.			(CAG)center dot(CTG) repeats associated with neurodegenerative diseases are stable in the Escherichia coli chromosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOTONIC-DYSTROPHY TYPE-1; TRIPLET REPEATS; DNA-REPLICATION; TRINUCLEOTIDE REPEATS; CTG REPEATS; LAGGING STRANDS; IN-VIVO; INSTABILITY; EXPANSION; DELETION	(CAG)(n)(.)(CTG)(n) expansion is associated with many neurodegenerative diseases. Repeat instability has been extensively studied in bacterial plasmids, where repeats undergo deletion at high rates. We report an assay for (CAG)(n)(.)(CTG)(n) deletion from the chloramphenicol acetyltransferase gene integrated into the Escherichia coli chromosome. In strain AB1157, deletion rates for 25 - 60 (CAG)(.)( CTG) repeats integrated in the chromosome ranged from 6.88 x 10(-9) to 1.33 x 10(-10), or similar to 6,300 to 660,000-fold lower than in plasmid pBR325. In contrast to the situation in plasmids, deletions occur at a higher rate when (CTG)(43), rather than (CAG)(43), comprised the leading template strand, and complete rather than partial deletions were the predominant mutation observed. Repeats were also stable on long term growth following multiple passages through exponential and stationary phase. Mutations in priA and recG increased or decreased deletion rates, but repeats were still greatly stabilized in the chromosome. The remarkable stability of (CAG)(n)(.)(CTG)(n) repeats in the E. coli chromosome may result from the differences in the mechanisms for replication or the probability for recombination afforded by a high plasmid copy number. The integration of (CAG)(n)(.)(CTG) n repeats into the chromosome provides a model system in which the inherent stability of these repeats reflects that in the human genome more closely.	Texas A&M Univ Syst, Hlth Sci Ctr, Ctr Genome Res, Lab DNA Struct & Mutagenesis,Inst Biosci & Techno, Houston, TX 77030 USA; Univ Tulsa, Dept Biol Sci, Tulsa, OK 74104 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; University of Tulsa	Sinden, RR (corresponding author), Florida Inst Technol, Dept Biol Sci, Lab DNA Struct & Mutagenesis, 150 W Univ Blvd, Melbourne, FL 32901 USA.	Rsinden@fit.edu	Sinden, Richard/AAE-3086-2019	Kim, Seung-Hwan/0000-0002-9397-3324	NIEHS NIH HHS [ES05508] Funding Source: Medline	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BACKMAN K, 1978, COLD SPRING HARB SYM, V43, P69; Bhattacharyya S, 2002, GENETICS, V162, P579; Bowater RP, 1996, J MOL BIOL, V264, P82, DOI 10.1006/jmbi.1996.0625; Boyd D, 2000, J BACTERIOL, V182, P842, DOI 10.1128/JB.182.3.842-847.2000; Callahan JL, 2003, MOL CELL BIOL, V23, P7849, DOI 10.1128/MCB.23.21.7849-7860.2003; Cleary JD, 2003, CYTOGENET GENOME RES, V100, P25, DOI 10.1159/000072837; DRAKE JW, 1991, P NATL ACAD SCI USA, V88, P7160, DOI 10.1073/pnas.88.16.7160; Fijalkowska IJ, 1998, P NATL ACAD SCI USA, V95, P10020, DOI 10.1073/pnas.95.17.10020; Freudenreich CH, 1998, SCIENCE, V279, P853, DOI 10.1126/science.279.5352.853; Gawel D, 2002, MUTAT RES-FUND MOL M, V501, P129, DOI 10.1016/S0027-5107(02)00020-9; Gomes-Pereira M, 2004, NUCLEIC ACIDS RES, V32, P2865, DOI 10.1093/nar/gkh612; Gorbunova V, 2003, MOL CELL BIOL, V23, P4485, DOI 10.1128/MCB.23.13.4485-4493.2003; Gregg AV, 2002, MOL CELL, V9, P241, DOI 10.1016/S1097-2765(02)00455-0; Hashem VI, 2004, NUCLEIC ACIDS RES, V32, P6334, DOI 10.1093/nar/gkh976; Hashem VI, 2004, MUTAT RES-FUND MOL M, V554, P95, DOI 10.1016/j.mrfmmm.2004.03.012; Hashem VI, 2002, MUTAT RES-FUND MOL M, V502, P25, DOI 10.1016/S0027-5107(02)00026-X; Hashem VI, 2002, MUTAT RES-FUND MOL M, V508, P107, DOI 10.1016/S0027-5107(02)00190-2; Jakupciak JP, 1999, J BIOL CHEM, V274, P23468, DOI 10.1074/jbc.274.33.23468; JAWORSKI A, 1995, P NATL ACAD SCI USA, V92, P11019, DOI 10.1073/pnas.92.24.11019; KANG S, 1995, NAT GENET, V10, P213, DOI 10.1038/ng0695-213; Kennedy L, 2003, HUM MOL GENET, V12, P3359, DOI 10.1093/hmg/ddg352; Kornberg A., 1992, DNA REPLICATION; Krasilnikova MM, 2004, MOL CELL BIOL, V24, P2286, DOI 10.1128/MCB.24.6.2286-2295.2004; Maliszewska-Tkaczyk M, 2000, P NATL ACAD SCI USA, V97, P12678, DOI 10.1073/pnas.220424697; Martorell L, 2004, NEUROLOGY, V62, P269, DOI 10.1212/WNL.62.2.269; Napierala M, 2002, J BIOL CHEM, V277, P34087, DOI 10.1074/jbc.M202128200; Oussatcheva EA, 2001, J BIOL CHEM, V276, P30878, DOI 10.1074/jbc.M104697200; Pearson CE, 2002, NUCLEIC ACIDS RES, V30, P4534, DOI 10.1093/nar/gkf572; Pearson CE, 1996, BIOCHEMISTRY-US, V35, P5041, DOI 10.1021/bi9601013; Pelletier R, 2003, MOL CELL BIOL, V23, P1349, DOI 10.1128/MCB.23.4.1349-1357.2003; Pineiro E, 2003, NUCLEIC ACIDS RES, V31, P6733, DOI 10.1093/nar/gkg898; Rosche WA, 1996, J BACTERIOL, V178, P5042, DOI 10.1128/jb.178.16.5042-5044.1996; ROSCHE WA, 1995, J BACTERIOL, V177, P4385, DOI 10.1128/jb.177.15.4385-4391.1995; Samadashwily GM, 1997, NAT GENET, V17, P298, DOI 10.1038/ng1197-298; Saveson CJ, 1997, GENETICS, V146, P457; Sinden RR, 1999, AM J HUM GENET, V64, P346, DOI 10.1086/302271; VILETTE D, 1995, MOL MICROBIOL, V17, P493, DOI 10.1111/j.1365-2958.1995.mmi_17030493.x; WOHRLE D, 1993, NAT GENET, V4, P140, DOI 10.1038/ng0693-140; WONG LJC, 1995, AM J HUM GENET, V56, P114; Yang Z, 2003, AM J HUM GENET, V73, P1092, DOI 10.1086/379523; Zar J.H., 1999, BIOSTAT ANAL, V4th	41	5	6	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					27950	27955		10.1074/jbc.M601129200	http://dx.doi.org/10.1074/jbc.M601129200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16873366	hybrid			2022-12-27	WOS:000240534400031
J	Ernst, R; Koch, J; Horn, C; Tampe, R; Schmitt, L				Ernst, Robert; Koch, Joachim; Horn, Carsten; Tampe, Robert; Schmitt, Lutz			Engineering ATPase activity in the isolated ABC cassette of human TAP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING DOMAIN; RETRACTED ARTICLE. SEE; ESCHERICHIA-COLI; CATALYTIC CYCLE; GASTRIC H+,K+-ATPASE; CARBOXYLATE RESIDUES; MUTATIONAL ANALYSIS; HISTIDINE PERMEASE; DISTINCT FUNCTIONS; PROTEIN SECRETION	The human transporter associated with antigen processing ( TAP) translocates antigenic peptides from the cytosol into the endoplasmic reticulum lumen. The functional unit of TAP is a heterodimer composed of the TAP1 and TAP2 subunits, both of which are members of the ABC-transporter family. ABC-transporters are ATP-dependent pumps, channels, or receptors that are composed of four modules: two nucleotide-binding domains (NBDs) and two transmembrane domains (TMDs). Although the TMDs are rather divergent in sequence, the NBDs are conserved with respect to structure and function. Interestingly, the NBD of TAP1 contains mutations at amino acid positions that have been proposed to be essential for catalytic activity. Instead of a glutamate, proposed to act as a general base, TAP1 contains an aspartate and a glutamine instead of the conserved histidine, which has been suggested to act as the linchpin. We used this degeneration to evaluate the individual contribution of these two amino acids to the ATPase activity of the engineered TAP1-NBD mutants. Based on our results a catalytic hierarchy of these two fundamental amino acids in ATP hydrolysis of the mutated TAP1 motor domain was deduced.	Univ Dusseldorf, Inst Biochem, D-40225 Dusseldorf, Germany; Goethe Univ Frankfurt, Inst Biochem, Bioctr, D-60439 Frankfurt, Germany	Heinrich Heine University Dusseldorf; Goethe University Frankfurt	Schmitt, L (corresponding author), Univ Dusseldorf, Inst Biochem, Univ Str 1, D-40225 Dusseldorf, Germany.	lutz.schmitt@uni-duesseldorf.de	Ernst, Robert/AAW-2967-2020; Tampé, Robert/H-2953-2015; Ernst, Robert/H-9513-2013	Ernst, Robert/0000-0002-0283-3490; Tampé, Robert/0000-0002-0403-2160; 				Alberts P, 2001, CURR BIOL, V11, P242, DOI 10.1016/S0960-9822(01)00073-2; Aleksandrov L, 2002, J BIOL CHEM, V277, P15419, DOI 10.1074/jbc.M111713200; Arora S, 2001, P NATL ACAD SCI USA, V98, P7241, DOI 10.1073/pnas.131132198; BLIGHT MA, 1994, TRENDS BIOTECHNOL, V12, P450, DOI 10.1016/0167-7799(94)90020-5; Chang G, 2001, SCIENCE, V293, P1793, DOI 10.1126/science.293.5536.1793; Chang G, 2003, J MOL BIOL, V330, P419, DOI 10.1016/S0022-2836(03)00587-4; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Chen M, 2003, J BIOL CHEM, V278, P29686, DOI 10.1074/jbc.M302757200; Chen M, 2004, J BIOL CHEM, V279, P46073, DOI 10.1074/jbc.M404042200; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Daumke O, 2001, EUR J BIOCHEM, V268, P4776, DOI 10.1046/j.1432-1327.2001.02406.x; Davidson AL, 1997, J BACTERIOL, V179, P5458, DOI 10.1128/jb.179.17.5458-5464.1997; DELEPELAIRE P, 1994, J BIOL CHEM, V269, P27952; FALLER LD, 1990, BIOCHEMISTRY-US, V29, P3179, DOI 10.1021/bi00465a004; FALLER LD, 1989, BIOCHEMISTRY-US, V28, P6771, DOI 10.1021/bi00442a034; Fetsch EE, 2002, P NATL ACAD SCI USA, V99, P9685, DOI 10.1073/pnas.152204499; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Gao M, 2000, J BIOL CHEM, V275, P13098, DOI 10.1074/jbc.275.17.13098; Gaudet R, 2001, EMBO J, V20, P4964, DOI 10.1093/emboj/20.17.4964; Geourjon C, 2001, TRENDS BIOCHEM SCI, V26, P539, DOI 10.1016/S0968-0004(01)01907-7; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Holland IB, 2005, MOL MEMBR BIOL, V22, P29, DOI 10.1080/09687860500042013; Horn C, 2003, J MOL BIOL, V334, P403, DOI 10.1016/j.jmb.2003.09.079; Hou YX, 2000, J BIOL CHEM, V275, P20280, DOI 10.1074/jbc.M001109200; Hou YX, 2002, J BIOL CHEM, V277, P5110, DOI 10.1074/jbc.M107133200; Janas E, 2003, J BIOL CHEM, V278, P26862, DOI 10.1074/jbc.M301227200; Jones PM, 2004, CELL MOL LIFE SCI, V61, P682, DOI 10.1007/s00018-003-3336-9; Karttunen JT, 2001, P NATL ACAD SCI USA, V98, P7431, DOI 10.1073/pnas.121180198; Lapinski PE, 2001, J BIOL CHEM, V276, P7526, DOI 10.1074/jbc.M009448200; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Lubelski J, 2006, BIOCHEMISTRY-US, V45, P648, DOI 10.1021/bi051276s; Mildvan AS, 2004, BIOCHEMISTRY-US, V43, P14517, DOI 10.1021/bi048052e; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; Nikaido K, 1999, J BIOL CHEM, V274, P26727, DOI 10.1074/jbc.274.38.26727; Nikaido K, 1997, J BIOL CHEM, V272, P27745, DOI 10.1074/jbc.272.44.27745; Orelle C, 2003, J BIOL CHEM, V278, P47002, DOI 10.1074/jbc.M308268200; Oswald C, 2006, N-S ARCH PHARMACOL, V372, P385, DOI 10.1007/s00210-005-0031-4; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; Payen LF, 2003, J BIOL CHEM, V278, P38537, DOI 10.1074/jbc.M305786200; Ramaen O, 2003, BIOCHEM J, V376, P749, DOI 10.1042/BJ20030998; Ramaen O, 2006, J MOL BIOL, V359, P940, DOI 10.1016/j.jmb.2006.04.005; Reyes CL, 2005, SCIENCE, V308, P1028, DOI 10.1126/science.1107733; Sauna ZE, 2001, J BIOENERG BIOMEMBR, V33, P481, DOI 10.1023/A:1012875105006; Sauna ZE, 2002, BIOCHEMISTRY-US, V41, P13989, DOI 10.1021/bi026626e; Saveanu L, 2001, J BIOL CHEM, V276, P22107, DOI 10.1074/jbc.M011221200; Schmitt L, 2002, CURR OPIN STRUC BIOL, V12, P754, DOI 10.1016/S0959-440X(02)00399-8; Schmitt L, 2000, CHEMBIOCHEM, V1, P17; Schneider E, 1998, FEMS MICROBIOL REV, V22, P1; SCHWEINS T, 1995, NAT STRUCT BIOL, V2, P36, DOI 10.1038/nsb0195-36; SHYAMALA V, 1991, J BIOL CHEM, V266, P18714; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Tombline G, 2004, J BIOL CHEM, V279, P46518, DOI 10.1074/jbc.M408052200; Urbatsch IL, 2000, BIOCHEMISTRY-US, V39, P14138, DOI 10.1021/bi001128w; van der Does C, 2006, J BIOL CHEM, V281, P5694, DOI 10.1074/jbc.M511730200; VANENDERT PM, 1994, IMMUNITY, V1, P491, DOI 10.1016/1074-7613(94)90091-4; Verdon G, 2003, J MOL BIOL, V334, P255, DOI 10.1016/j.jmb.2003.08.065; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Yang J, 1997, P NATL ACAD SCI USA, V94, P1568, DOI 10.1073/pnas.94.4.1568; Ye JQ, 2004, BBA-BIOENERGETICS, V1659, P1, DOI 10.1016/j.bbabio.2004.06.003; York IA, 1996, ANNU REV IMMUNOL, V14, P369, DOI 10.1146/annurev.immunol.14.1.369; Zaitseva J, 2005, BIOCHEMISTRY-US, V44, P9680, DOI 10.1021/bi0506122; Zaitseva J, 2005, EMBO J, V24, P1901, DOI 10.1038/sj.emboj.7600657; Zaitseva J, 1996, PROTEIN SCI, V5, P1100	63	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2006	281	37					27471	27480		10.1074/jbc.M601131200	http://dx.doi.org/10.1074/jbc.M601131200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082PB	16864587	hybrid			2022-12-27	WOS:000240397700074
J	Rosenberg, E; Litus, I; Schwarzfuchs, N; Sinay, R; Schlesinger, P; Golenser, J; Baumeister, S; Lingelbach, K; Pollack, Y				Rosenberg, Elli; Litus, Ilena; Schwarzfuchs, Nurit; Sinay, Rosa; Schlesinger, Pnina; Golenser, Jacob; Baumeister, Stefan; Lingelbach, Klaus; Pollack, Yaakov			pfmdr2 confers heavy metal resistance to Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; TRANSPORT; MALARIA; GENE; TOXICITY	Heavy metals are required by all organisms for normal function, but high levels of heavy metals are toxic. Therefore, homeostasis of these metals is crucial. In the human malaria-causing agent Plasmodium falciparum, the mechanisms of heavy metal transport have yet to be characterized. We have developed a P. falciparum line resistant to heavy metals from a wild-type line sensitive to heavy metals. A molecular and biochemical analysis of the involvement of the P. falciparum multidrug resistance 2 (pfmdr2) gene, an ABC-type transporter, in heavy metal homeostasis was studied. Using a novel uptake assay applied on these two strains, it was demonstrated that, when exposed to heavy metals, the sensitive line accumulates metal, whereas no accumulation was observed in the resistant line. The accumulation occurs within the parasite itself and not in the cytoplasm of the red blood cell. This difference in the accumulation pattern is not a result of amplification of the pfmdr2 gene or of a change in the expression pattern of the gene in the two lines. Sequencing of the gene from both lines revealed a major difference; a stop codon is found in the sensitive line upstream of the normal termination, resulting in a truncated protein that lacks 188 amino acids that contain a portion of the essential cytoplasmatic transporter domain, thereby rendering it inactive. In contrast, the resistant line harbors a full-length, active protein. These findings strongly suggest that the PFMDR2 protein acts as an efflux pump of heavy metals.	Ben Gurion Univ Negev, Fac Hlth Sci, Dept Immunol & Microbiol, IL-84105 Beer Sheva, Israel; Hebrew Univ Jerusalem, Dept Parasitol, IL-91120 Jerusalem, Israel; Univ Marburg, Dept Biol Zool, D-35032 Marburg, Germany	Ben Gurion University; Hebrew University of Jerusalem; Philipps University Marburg	Pollack, Y (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Dept Immunol & Microbiol, POB 653, IL-84105 Beer Sheva, Israel.	polak@bgu.ac.il		Baumeister, Stefan/0000-0002-7784-3474				Agranoff DD, 1998, MOL MICROBIOL, V28, P403, DOI 10.1046/j.1365-2958.1998.00790.x; Ansorge I, 1996, BIOCHEM J, V315, P307, DOI 10.1042/bj3150307; BENTING J, 1994, BIOCHEM J, V300, P821, DOI 10.1042/bj3000821; Broeks A, 1996, EMBO J, V15, P6132, DOI 10.1002/j.1460-2075.1996.tb01001.x; Chrestensen CA, 2000, J BIOL CHEM, V275, P26556, DOI 10.1074/jbc.M004097200; Decottignies A, 1997, NAT GENET, V15, P137, DOI 10.1038/ng0297-137; Greenwood B, 2002, NATURE, V415, P670, DOI 10.1038/415670a; Hall JL, 2002, J EXP BOT, V53, P1, DOI 10.1093/jexbot/53.366.1; HUNT NH, 1990, BLOOD CELLS, V16, P499; Jin YH, 2003, NAT GENET, V34, P326, DOI 10.1038/ng1172; Jones PM, 2004, CELL MOL LIFE SCI, V61, P682, DOI 10.1007/s00018-003-3336-9; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Li ZS, 1996, J BIOL CHEM, V271, P6509, DOI 10.1074/jbc.271.11.6509; Li ZS, 1997, P NATL ACAD SCI USA, V94, P42, DOI 10.1073/pnas.94.1.42; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; ORTIZ DF, 1992, EMBO J, V11, P3491, DOI 10.1002/j.1460-2075.1992.tb05431.x; ORTIZ DF, 1995, J BIOL CHEM, V270, P4721, DOI 10.1074/jbc.270.9.4721; PAPADOPOULOU B, 1994, J BIOL CHEM, V269, P11980; Peel SA, 2001, DRUG RESIST UPDATE, V4, P66, DOI 10.1054/drup.2001.0183; POLLACK Y, 1990, PARASITOL RES, V76, P570, DOI 10.1007/BF00932563; POLLACK Y, 1982, NUCLEIC ACIDS RES, V10, P539, DOI 10.1093/nar/10.2.539; Rosen BP, 2002, COMP BIOCHEM PHYS A, V133, P689, DOI 10.1016/S1095-6433(02)00201-5; Rubio JP, 1996, PARASITOL TODAY, V12, P135, DOI 10.1016/0169-4758(96)10003-X; RUBIO JP, 1994, EXP PARASITOL, V79, P137, DOI 10.1006/expr.1994.1073; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; Silver S, 1996, ANNU REV MICROBIOL, V50, P753, DOI 10.1146/annurev.micro.50.1.753; STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H; SZCZYPKA MS, 1994, J BIOL CHEM, V269, P22853; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; WILSON CM, 1989, SCIENCE, V244, P1184, DOI 10.1126/science.2658061; ZALIS MG, 1993, MOL BIOCHEM PARASIT, V62, P83, DOI 10.1016/0166-6851(93)90180-6	32	28	28	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2006	281	37					27039	27045		10.1074/jbc.M601686200	http://dx.doi.org/10.1074/jbc.M601686200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082PB	16849328	hybrid			2022-12-27	WOS:000240397700030
J	Okano, K; Schnaper, HW; Bomsztyk, K; Hayashida, T				Okano, Kazuhiro; Schnaper, H. William; Bomsztyk, Karol; Hayashida, Tomoko			RACK1 binds to Smad3 to modulate transforming growth factor-beta 1-stimulated alpha 2(I) collagen transcription in renal tubular epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; SIGNAL-REGULATED KINASE; TGF-BETA; SCAFFOLD PROTEIN; MESANGIAL CELLS; I EXPRESSION; MAP KINASE; RECEPTOR; TGF-BETA-1; ACTIVATION	Although it is clear that transforming growth factor-beta 1 (TGF-beta 1) is critical for renal fibrogenesis, the complexity of the involved mechanisms is increasingly apparent. TGF-beta 1 stimulates phosphorylation of Smad2/3 and activates other signaling molecules as well. The molecular link between these other kinases and Smads is not known. We sought new binding partners for Smad3 in renal cells and identified receptor for activated protein kinase C1 (RACK1) as a novel binding partner of Smad3. The linker region of Smad3 and the tryptophan-aspartic acid repeat 6 and 7 of RACK1 are sufficient for the association. RACK1 also interacts with Smad3 in the human kidney epithelial cell line, HKC. Silencing RACK1 increases transcriptional activity of TGF-beta 1-responsive promoter sequences of the Smad binding element (SBE), p3TP-Lux, and alpha 2(I) collagen. Conversely, overexpressed RACK1 negatively modulates alpha 2(I) collagen transcriptional activity in TGF-beta 1-stimulated cells. RACK1 did not affect phosphorylation of Smad3 at the C terminus or in the linker region. However, RACK1 reduced direct binding of Smad3 to the SBE motif. Mutating a RACK1 tyrosine at residue 246, but not at 228, decreased the inhibitory effect of RACK1 on both alpha 2(I) collagen promoter activity and Smad binding to SBE induced by TGF-beta 1. These results suggest that RACK1 modulates transcription of alpha 2(I) collagen by TGF-beta 1 through interference with Smad3 binding to the gene promoter.	Northwestern Univ, Feinberg Sch Med, Dept Pediat, Chicago, IL 60611 USA; Univ Washington, Seattle, WA 98109 USA	Northwestern University; Feinberg School of Medicine; University of Washington; University of Washington Seattle	Schnaper, HW (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Pediat, 303 E Chicago Ave,Ward 12-120, Chicago, IL 60611 USA.	schnaper@northwestern.edu		Hayashida, Tomoko/0000-0002-4160-7859	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK049362, R01DK045978, R01DK049362, R37DK045978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045134] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK45978, R01 DK049362, DK49362] Funding Source: Medline; NIGMS NIH HHS [GM45134] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Attisano L, 1996, MOL CELL BIOL, V16, P1066; BASSING CH, 1994, SCIENCE, V263, P87, DOI 10.1126/science.8272871; Bottinger EP, 2002, J AM SOC NEPHROL, V13, P2600, DOI 10.1097/01.ASN.0000033611.79556.AE; Ceci M, 2003, NATURE, V426, P579, DOI 10.1038/nature02160; Chang BY, 1998, MOL CELL BIOL, V18, P3245, DOI 10.1128/MCB.18.6.3245; Chang BY, 2002, ONCOGENE, V21, P7619, DOI 10.1038/sj.onc.1206002; Chang BY, 2001, J BIOL CHEM, V276, P20346, DOI 10.1074/jbc.M101375200; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; de Caestecker MP, 2000, J BIOL CHEM, V275, P2115, DOI 10.1074/jbc.275.3.2115; Deng WG, 2003, ANAL BIOCHEM, V323, P12, DOI 10.1016/j.ab.2003.08.007; Dong CM, 2000, MOL CELL, V5, P27, DOI 10.1016/S1097-2765(00)80400-1; Ghosh AK, 2004, J BIOL CHEM, V279, P47455, DOI 10.1074/jbc.M403477200; HANSCH GM, 1995, J CELL PHYSIOL, V163, P451, DOI 10.1002/jcp.1041630304; Hayashida T, 1999, KIDNEY INT, V56, P1710, DOI 10.1046/j.1523-1755.1999.00733.x; Hayashida T, 2004, J AM SOC NEPHROL, V15, P2032, DOI 10.1097/01.ASN.0000133198.74973.60; Hayashida T, 2003, FASEB J, V17, P1576, DOI 10.1096/fj.03-0037fje; Isono M, 2000, J AM SOC NEPHROL, V11, P2222, DOI 10.1681/ASN.V11122222; Liliental J, 1998, J BIOL CHEM, V273, P2379, DOI 10.1074/jbc.273.4.2379; McCahill A, 2002, MOL PHARMACOL, V62, P1261, DOI 10.1124/mol.62.6.1261; MCKAY NG, 1993, EXP MOL PATHOL, V59, P211, DOI 10.1006/exmp.1993.1040; Miyajima A, 2000, KIDNEY INT, V58, P2301, DOI 10.1046/j.1523-1755.2000.00414.x; Nilsson J, 2004, EMBO REP, V5, P1137, DOI 10.1038/sj.embor.7400291; Patterson RL, 2004, P NATL ACAD SCI USA, V101, P2328, DOI 10.1073/pnas.0308567100; Poncelet AC, 1999, KIDNEY INT, V56, P1354, DOI 10.1046/j.1523-1755.1999.00680.x; Poncelet AC, 1998, AM J PHYSIOL-RENAL, V275, pF458; Poncelet AC, 2001, J BIOL CHEM, V276, P6983, DOI 10.1074/jbc.M006442200; Racusen LC, 1997, J LAB CLIN MED, V129, P318, DOI 10.1016/S0022-2143(97)90180-3; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; Runyan CE, 2004, J BIOL CHEM, V279, P2632, DOI 10.1074/jbc.M310412200; Runyan CE, 2003, AM J PHYSIOL-RENAL, V285, pF413, DOI 10.1152/ajprenal.00082.2003; Sang NL, 2001, J BIOL CHEM, V276, P27026, DOI 10.1074/jbc.M010346200; Sasaki A, 2001, J BIOL CHEM, V276, P17871, DOI 10.1074/jbc.M008422200; Schnaper HW, 2003, AM J PHYSIOL-RENAL, V284, pF243, DOI 10.1152/ajprenal.00300.2002; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yang JW, 2003, J AM SOC NEPHROL, V14, P3167, DOI 10.1097/01.ASN.0000099373.33259.B2; Yarwood SJ, 1999, J BIOL CHEM, V274, P14909, DOI 10.1074/jbc.274.21.14909; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1	38	17	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2006	281	36					26196	26204		10.1074/jbc.M606710200	http://dx.doi.org/10.1074/jbc.M606710200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	080LO	16849317	hybrid			2022-12-27	WOS:000240249500036
J	Yu, X; Egner, PA; Wakabayashi, J; Wakabayashi, N; Yamamoto, M; Kensler, TW				Yu, Xiang; Egner, Patricia A.; Wakabayashi, Junko; Wakabayashi, Nobunao; Yamamoto, Masayuki; Kensler, Thomas W.			Nrf2-mediated induction of cytoprotective enzymes by 15-deoxy-Delta(12,14)-prostaglandin J(2) is attenuated by alkenal/one oxidoreductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED RECEPTOR-GAMMA; TRANSCRIPTION FACTOR NRF2; SQUAMOUS CARCINOMA-CELLS; PPAR-GAMMA; CYCLOPENTENONE PROSTAGLANDINS; GENE-EXPRESSION; PROTEIN; KEAP1; UBIQUITINATION; INDUCERS	NADPH-dependent alkenal/one oxidoreductase (Aor) was discovered to be highly inducible in rat liver following treatment with the cancer chemopreventive agent 3H-1,2-dithiole-3-thione. Aor was further characterized as an Nrf2-regulated antioxidative enzyme that reduces carbon-carbon double bonds in a variety of alpha, beta-unsaturated aldehydes and ketones. 15-Deoxy-Delta(12,14)-prostaglandin J(2) (15d-PGJ(2)) is a reactive membrane lipid metabolite that activates multiple pathways, including Nrf2-mediated induction of cytoprotective enzymes. Physiologically, it is postulated that 15d-PGJ(2) alkylates key regulatory proteins via the electrophilic carbon centers found in two alpha,beta-unsaturated ketone moieties. This current study addresses the metabolism of 15d-PGJ(2) by rat Aor (rAor) and subsequent deactivation of the Nrf2 signaling pathway by both rat and human AOR. We demonstrate that induction of NADPH-dependent quinone oxidoreductase activity by 15d-PGJ(2) is markedly attenuated in mouse embryonic fibroblasts that overexpress rAor. Luciferase reporter assay and quantitative real-time PCR confirmed these findings. Concentrations required for doubling the NADPH-dependent quinone oxidoreductase response are increased from 1.8 mu m in wild-type to > 10 mu m in rat Aor transgenic fibroblasts. 15d-PGJ(2) is metabolized by recombinant rAor with a K-m of 9.6 mu m and k(cat) of 18.5 min(-1). The major product is 12,13-dihydro-15-deoxy-Delta(12,14)-prostaglandin J(2) (dihydro-15d-PGJ(2)). The reduction of C=C by Aor yielding dihydro-15d-PGJ(2) abolishes the inducibility in an antioxidant response element-driven luciferase assay. Collectively, these results demonstrate that 15d-PGJ(2) can be catabolized by Aor, thereby attenuating subsequent Nrf2 signaling and possibly inflammatory and apoptotic processes also influenced by 15d-PGJ(2).	Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Div Toxicol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Pharmacol & Mol Sci, John Hopkins Sch Med, Baltimore, MD 21205 USA; Univ Tsukuba, Ctr Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 3058577, Japan; Univ Tsukuba, Inst Basic Med Sci, Tsukuba, Ibaraki 3058577, Japan	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Tsukuba; University of Tsukuba	Kensler, TW (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Div Toxicol, 615 N Wolfe St, Baltimore, MD 21205 USA.	tkensler@jhsph.edu	Yamamoto, Masayuki/A-4873-2010; Kensler, Thomas W/D-8686-2014	Yamamoto, Masayuki/0000-0002-9073-9436; Kensler, Thomas W/0000-0002-6676-261X	NCI NIH HHS [CA39416] Funding Source: Medline; NIEHS NIH HHS [ES06052, ES03819] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA039416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES003819, P01ES006052] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Camp HS, 2000, DIABETES, V49, P539, DOI 10.2337/diabetes.49.4.539; Dick RA, 2001, J BIOL CHEM, V276, P40803, DOI 10.1074/jbc.M105487200; Dick RA, 2004, J BIOL CHEM, V279, P17269, DOI 10.1074/jbc.M400427200; Dinkova-Kostova AT, 2001, P NATL ACAD SCI USA, V98, P3404, DOI 10.1073/pnas.051632198; Fahey JW, 1997, P NATL ACAD SCI USA, V94, P10367, DOI 10.1073/pnas.94.19.10367; Fahey JW, 2004, METHOD ENZYMOL, V382, P243; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Hirai H, 2001, J EXP MED, V193, P255, DOI 10.1084/jem.193.2.255; Hong F, 2005, J BIOL CHEM, V280, P31768, DOI 10.1074/jbc.M503346200; Hori T, 2004, J BIOL CHEM, V279, P22615, DOI 10.1074/jbc.M312655200; IGARASHI K, 1994, NATURE, V367, P568, DOI 10.1038/367568a0; Ishii T, 2004, CIRC RES, V94, P609, DOI 10.1161/01.RES.0000119171.44657.45; Itoh K, 2004, MOL CELL BIOL, V24, P36, DOI 10.1128/MCB.24.1.36-45.2004; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; KANAI N, 1995, SCIENCE, V268, P866, DOI 10.1126/science.7754369; Katoh Y, 2005, ARCH BIOCHEM BIOPHYS, V433, P342, DOI 10.1016/j.abb.2004.10.012; Kensler TW, 1998, CANCER EPIDEM BIOMAR, V7, P127; Kim EH, 2004, ANN NY ACAD SCI, V1030, P493, DOI 10.1196/annals.1329.061; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; Knight LP, 1999, CARCINOGENESIS, V20, P1215, DOI 10.1093/carcin/20.7.1215; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Kobayashi M, 2005, ANTIOXID REDOX SIGN, V7, P385, DOI 10.1089/ars.2005.7.385; Kondo M, 2002, P NATL ACAD SCI USA, V99, P7367, DOI 10.1073/pnas.112212599; Kwak MK, 2003, J BIOL CHEM, V278, P8135, DOI 10.1074/jbc.M211898200; Levonen AL, 2004, BIOCHEM J, V378, P373, DOI 10.1042/BJ20031049; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; Moos PJ, 2003, J BIOL CHEM, V278, P745, DOI 10.1074/jbc.M211134200; Mullally JE, 2001, J BIOL CHEM, V276, P30366, DOI 10.1074/jbc.M102198200; Oliva JL, 2003, P NATL ACAD SCI USA, V100, P4772, DOI 10.1073/pnas.0735842100; Paumi CM, 2003, BIOCHEMISTRY-US, V42, P5429, DOI 10.1021/bi027347u; Perez-Sala D, 2003, J BIOL CHEM, V278, P51251, DOI 10.1074/jbc.M309409200; Primiano T, 1996, CARCINOGENESIS, V17, P2297, DOI 10.1093/carcin/17.11.2297; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Sanchez-Gomez FJ, 2004, MOL PHARMACOL, V66, P1349, DOI 10.1124/mol.104.002824; Sawyer N, 2002, BRIT J PHARMACOL, V137, P1163, DOI 10.1038/sj.bjp.0704973; Shibata T, 2002, J BIOL CHEM, V277, P10459, DOI 10.1074/jbc.M110314200; Siavash H, 2004, BRIT J CANCER, V91, P1074, DOI 10.1038/sj.bjc.6602055; Siavash H, 2004, CANCER LETT, V211, P97, DOI 10.1016/j.canlet.2004.02.003; Soares AF, 2005, BIOCHEM BIOPH RES CO, V337, P521, DOI 10.1016/j.bbrc.2005.09.085; Straus DS, 2000, P NATL ACAD SCI USA, V97, P4844, DOI 10.1073/pnas.97.9.4844; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Yang XY, 2000, J BIOL CHEM, V275, P4541, DOI 10.1074/jbc.275.7.4541; Yates MS, 2006, CANCER RES, V66, P2488, DOI 10.1158/0008-5472.CAN-05-3823; YOKOMIZO T, 1993, J BIOL CHEM, V268, P18128; Yu X, 2005, MUTAT RES-FUND MOL M, V591, P93, DOI 10.1016/j.mrfmmm.2005.04.017; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004	51	23	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2006	281	36					26245	26252		10.1074/jbc.M604620200	http://dx.doi.org/10.1074/jbc.M604620200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	080LO	16857669	hybrid			2022-12-27	WOS:000240249500041
J	Moulis, C; Joucla, G; Harrison, D; Fabre, E; Potocki-Veronese, G; Monsan, P; Remaud-Simeon, M				Moulis, Claire; Joucla, Gilles; Harrison, David; Fabre, Emeline; Potocki-Veronese, Gabrielle; Monsan, Pierre; Remaud-Simeon, Magali			Understanding the polymerization mechanism of glycoside-hydrolase family 70 glucansucrases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESENTEROIDES NRRL B-512F; NEISSERIA-POLYSACCHAREA AMYLOSUCRASE; ALPHA-AMYLASE FAMILY; AMINO-ACID-RESIDUES; LEUCONOSTOC-MESENTEROIDES; MOLECULAR CHARACTERIZATION; OLIGOSACCHARIDE SYNTHESIS; STREPTOCOCCUS-SOBRINUS; DEXTRANSUCRASE ACTION; SEQUENCE-ANALYSIS	Glucan formation catalyzed by two GH-family 70 enzymes, Leuconostoc mesenteroides NRRL B-512F dextransucrase and L. mesenteroides NRRL B-1355 alternansucrase, was investigated by combining biochemical and kinetic characterization of the recombinant enzymes and their respective products. Using HPAEC analysis, we showed that two molecules act as initiator of polymerization: sucrose itself and glucose produced by hydrolysis, the latter being preferred when produced in sufficient amounts. Then, elongation occurs by transfer of the glucosyl residue coming from sucrose to the non-reducing end of initially formed products. Dextransucrase preferentially produces an isomaltooligosaccharide series, whose concentration is always low because of the high ability of these products to be elongated and form high molecular weight dextran. Compared with dextransucrase, alternansucrase has a broader specificity. It produces a myriad of oligosaccharides with various alpha-1,3 and/or alpha-1,6 links in early reaction stages. Only some of them are further elongated. Overall alternan polymer is smaller in size than dextran. In dextransucrase, the A repeats often found in C-terminal domain of GH-family 70 were found to play a major role in efficient dextran elongation. Their truncation result in an enzyme much less efficient to catalyze high molecular weight polymer formation. It is thus proposed that, in dextransucrase, the A repeats define anchoring zones for the growing chains, favoring their elongation. Based on these results, a semi-processive mechanism involving only one active site and an elongation by the non-reducing end is proposed for the GH-family 70 glucansucrases.	CNRS, UMR 5504, Lab Biotechnol Bioproc, UMR 792,INRA,INSA, F-31077 Toulouse 4, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse	Remaud-Simeon, M (corresponding author), CNRS, UMR 5504, Lab Biotechnol Bioproc, UMR 792,INRA,INSA, 135 Ave Rangueil, F-31077 Toulouse 4, France.	remaud@insa-toulouse.fr	Veronese, Gabrielle/GTF-3473-2022	MOULIS, Claire/0000-0002-1937-9052; Joucla, Gilles/0000-0003-4192-9628				Albenne C, 2004, J BIOL CHEM, V279, P726, DOI 10.1074/jbc.M309891200; Arguello-Morales MA, 2000, FEMS MICROBIOL LETT, V182, P81, DOI 10.1016/S0378-1097(99)00572-8; BARIK S, 1995, MOL BIOTECHNOL, V3, P1, DOI 10.1007/BF02821329; Bozonnet S, 2002, J BACTERIOL, V184, P5753, DOI 10.1128/JB.184.20.5753-5761.2002; CHEETHAM NH, 1991, CARBOHYD POLYM, V16, P349; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; De Montalk GP, 1999, J BACTERIOL, V181, P375; Devulpalle KS, 1997, PROTEIN SCI, V6, P2489; DITSON SL, 1984, CARBOHYD RES, V126, P170, DOI 10.1016/0008-6215(84)85135-6; EBERT KH, 1968, ADV ENZYMOL RAMB, V30, P179; Funane K, 1998, BIOSCI BIOTECH BIOCH, V62, P123, DOI 10.1271/bbb.62.123; Funane K, 2005, FEBS LETT, V579, P4739, DOI 10.1016/j.febslet.2005.07.050; Jensen MH, 2004, BIOCHEMISTRY-US, V43, P3104, DOI 10.1021/bi0357762; Joucla G, 2006, FEBS LETT, V580, P763, DOI 10.1016/j.febslet.2006.01.001; KATO C, 1992, BIOCHEM BIOPH RES CO, V189, P1184, DOI 10.1016/0006-291X(92)92329-V; KOBAYASHI M, 1986, AGR BIOL CHEM TOKYO, V50, P2585, DOI 10.1080/00021369.1986.10867780; KOEPSELL HJ, 1953, J BIOL CHEM, V200, P793; Kralj S, 2002, APPL ENVIRON MICROB, V68, P4283, DOI 10.1128/AEM.68.9.4283-4291.2002; Kralj S, 2004, MICROBIOL-SGM, V150, P3681, DOI 10.1099/mic.0.27321-0; Kralj S, 2005, BIOCHEMISTRY-US, V44, P9206, DOI 10.1021/bi050447q; MACGREGOR EA, 1996, FEBS LETT, V378, P266; MILLER AW, 1986, ANAL BIOCHEM, V156, P357, DOI 10.1016/0003-2697(86)90266-6; Monchois V, 1997, APPL MICROBIOL BIOT, V48, P465, DOI 10.1007/s002530051081; Monchois V, 1998, APPL ENVIRON MICROB, V64, P1644; Monchois V, 1999, FEMS MICROBIOL REV, V23, P131, DOI 10.1016/S0168-6445(98)00041-2; Monsan P, 2001, INT DAIRY J, V11, P675, DOI 10.1016/S0958-6946(01)00113-3; MOOSER G, 1989, BIOCHEMISTRY-US, V28, P443, DOI 10.1021/bi00428a006; MOOSER G, 1991, J BIOL CHEM, V266, P8916; MOOSER G, 1992, ENZYMES, V20, P188; Moulis C, 2006, FEMS MICROBIOL LETT, V261, P203, DOI 10.1111/j.1574-6968.2006.00347.x; Pizzut-Serin S, 2005, FEBS LETT, V579, P1405, DOI 10.1016/j.febslet.2004.12.097; Remaud-Simeon M, 2000, J MOL CATAL B-ENZYM, V10, P117, DOI 10.1016/S1381-1177(00)00119-3; Richard GT, 2003, CARBOHYD RES, V338, P855, DOI 10.1016/S0008-6215(03)00070-3; ROBYT JF, 1974, ARCH BIOCHEM BIOPHYS, V165, P634, DOI 10.1016/0003-9861(74)90291-4; Robyt JF, 1995, ADV CARBOHYD CHEM BI, V51, P133, DOI 10.1016/S0065-2318(08)60193-6; ROBYT JF, 1983, CARBOHYD RES, V113, P301, DOI 10.1016/0008-6215(83)88245-7; ROBYT JF, 1978, CARBOHYD RES, V61, P433, DOI 10.1016/S0008-6215(00)84503-6; Sarcabal P, 2000, FEBS LETT, V474, P33, DOI 10.1016/S0014-5793(00)01567-2; Skov LK, 2002, J BIOL CHEM, V277, P47741, DOI 10.1074/jbc.M207860200; Skov LK, 2001, J BIOL CHEM, V276, P25273, DOI 10.1074/jbc.M010998200; STODOLA FH, 1952, J AM CHEM SOC, V74, P3202, DOI 10.1021/ja01132a540; SU DL, 1994, ARCH BIOCHEM BIOPHYS, V308, P471, DOI 10.1006/abbi.1994.1067; SUMNER JAMES B., 1935, JOUR BIOL CHEM, V108, P51; TSUCHIYA HM, 1953, J AM CHEM SOC, V75, P757, DOI 10.1021/ja01099a521; Uitdehaag JCM, 1999, NAT STRUCT BIOL, V6, P432, DOI 10.1038/8235	47	114	121	1	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31254	31267		10.1074/jbc.M604850200	http://dx.doi.org/10.1074/jbc.M604850200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16864576				2022-12-27	WOS:000241235300010
J	Robinson, JA; Chatterjee-Kishore, M; Yaworsky, PJ; Cullen, DM; Zhao, WG; Li, C; Kharode, Y; Sauter, L; Babij, P; Brown, EL; Hill, AA; Akhter, MP; Johnson, ML; Recker, RR; Komm, BS; Bex, FJ				Robinson, John A.; Chatterjee-Kishore, Moitreyee; Yaworsky, Paul J.; Cullen, Diane M.; Zhao, Weiguang; Li, Christine; Kharode, Yogendra; Sauter, Linda; Babij, Philip; Brown, Eugene L.; Hill, Andrew A.; Akhter, Mohammed P.; Johnson, Mark L.; Recker, Robert R.; Komm, Barry S.; Bex, Frederick J.			Wnt/beta-catenin signaling is a normal physiological response to mechanical loading in bone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; WNT; RECEPTOR; LRP5; GENE; MASS; INHIBITION; INCREASES; PROTEINS; PATHWAYS	A preliminary expression profiling analysis of osteoblasts derived from tibia explants of the high bone mass LRP5 G171V transgenic mice demonstrated increased expression of canonical Wnt pathway and Wnt/beta-catenin target genes compared with non-transgenic explant derived osteoblasts. Therefore, expression of Wnt/beta-catenin target genes were monitored after in vivo loading of the tibia of LRP5 G171V transgenic mice compared with non-transgenic mice. Loading resulted in the increased expression of Wnt pathway and Wnt/beta-catenin target genes including Wnt10B, SFRP1, cyclin D1, FzD2, WISP2, and connexin 43 in both genotypes; however, there was a further increased in transcriptional response with the LRP5 G171V transgenic mice. Similar increases in the expression of these genes (except cyclin D1) were observed when non- transgenic mice were pharmacologically treated with a canonical Wnt pathway activator, glycogen synthase kinase 3 beta inhibitor and then subjected to load. These in vivo results were further corroborated by in vitro mechanical loading experiments in which MC3T3-E1 osteoblastic cells were subjected to 3400 microstrain alone for 5 h, which increased the expression of Wnt10B, SFRP1, cyclin D1, FzD2, WISP2, and connexin 43. Furthermore, when MC3T3-E1 cells were treated with either glycogen synthase kinase 3 beta inhibitor or Wnt3A to activate Wnt signaling and then subjected to load, a synergistic up-regulation of these genes was observed compared with vehicle-treated cells. Collectively, the in vivo and in vitro mechanical loading results support that Wnt/beta-catenin signaling is a normal physiological response to load and that activation of the Wnt/beta-catenin pathway enhances the sensitivity of osteoblasts/osteocytes to mechanical loading.	Wyeth Res, Dept Womens Hlth & Musculoskeletal Biol, Collegeville, PA 19426 USA; Wyeth Ayerst Res, Cambridge, MA 02140 USA; Creighton Univ, Osteoporosis Res Ctr, Omaha, NE 68131 USA	Pfizer; Pfizer; Creighton University	Robinson, JA (corresponding author), Wyeth Res, Dept Womens Hlth & Musculoskeletal Biol, 500 Arcola Rd,RN3247, Collegeville, PA 19426 USA.	robinsj@wyeth.com						Aguirre J, 2001, AM J PATHOL, V158, P247, DOI 10.1016/S0002-9440(10)63963-6; Akhter MP, 1998, CALCIFIED TISSUE INT, V63, P442, DOI 10.1007/s002239900554; Akhter MP, 2004, BONE, V35, P162, DOI 10.1016/j.bone.2004.02.018; Babij P, 2003, J BONE MINER RES, V18, P960, DOI 10.1359/jbmr.2003.18.6.960; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Basso N, 2002, BONE, V30, P347, DOI 10.1016/S8756-3282(01)00678-0; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Bex F, 2003, J BONE MINER RES, V18, pS60; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Clement-Lacroix P, 2005, P NATL ACAD SCI USA, V102, P17406, DOI 10.1073/pnas.0505259102; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Cullen DM, 2002, J BONE MINER RES, V17, pS332; Danciu TE, 2003, FEBS LETT, V536, P193, DOI 10.1016/S0014-5793(03)00055-3; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Hens JR, 2005, J BONE MINER RES, V20, P1103, DOI 10.1359/JBMR.050210; Huelsken J, 2001, CURR OPIN GENET DEV, V11, P547, DOI 10.1016/S0959-437X(00)00231-8; Hughes-Fulford Millie, 2004, Sci STKE, V2004, pRE12; Itasaki N, 2003, DEVELOPMENT, V130, P4295, DOI 10.1242/dev.00674; Jochum W, 2000, NAT MED, V6, P980, DOI 10.1038/79676; Johnson M. L., 2004, Journal of Musculoskeletal & Neuronal Interactions, V4, P135; Johnson ML, 2002, ENDOCRINOLOGIST, V12, P445, DOI 10.1097/00019616-200209000-00012; Jones SE, 2002, BIOESSAYS, V24, P811, DOI 10.1002/bies.10136; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Lau KHW, 2006, J BIOL CHEM, V281, P9576, DOI 10.1074/jbc.M509205200; Lecanda F, 2000, J CELL BIOL, V151, P931, DOI 10.1083/jcb.151.4.931; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Mao BY, 2003, GENE, V302, P179, DOI 10.1016/S0378-1119(02)01106-X; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Nomura S, 2000, MATRIX BIOL, V19, P91, DOI 10.1016/S0945-053X(00)00050-0; Pavalko FM, 2003, J CELL PHYSIOL, V194, P194, DOI 10.1002/jcp.10221; Pilbeam Carol C., 1996, P715; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Pitsillides AA, 1995, FASEB J, V9, P1614, DOI 10.1096/fasebj.9.15.8529841; Pommerenke H, 2002, J BONE MINER RES, V17, P603, DOI 10.1359/jbmr.2002.17.4.603; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Sabatakos G, 2000, NAT MED, V6, P985, DOI 10.1038/79683; Sawakami K, 2006, J BIOL CHEM, V281, P23698, DOI 10.1074/jbc.M601000200; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tang LY, 1997, J BONE MINER RES, V12, P276, DOI 10.1359/jbmr.1997.12.2.276; van den Brink GR, 2004, NAT GENET, V36, P1038, DOI 10.1038/ng1004-1038; van Es JH, 2003, CURR OPIN GENET DEV, V13, P28, DOI 10.1016/S0959-437X(02)00012-6; Van Wesenbeeck L, 2003, AM J HUM GENET, V72, P763, DOI 10.1086/368277; van't Hof RJ, 2001, IMMUNOLOGY, V103, P255, DOI 10.1046/j.1365-2567.2001.01261.x; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Whyte MP, 2004, NEW ENGL J MED, V350, P2096; Willert Jennifer, 2002, BMC Dev Biol, V2, P8, DOI 10.1186/1471-213X-2-8; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Ziros PG, 2002, J BIOL CHEM, V277, P23934, DOI 10.1074/jbc.M109881200	56	418	445	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31720	31728		10.1074/jbc.M602308200	http://dx.doi.org/10.1074/jbc.M602308200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16908522				2022-12-27	WOS:000241235300058
J	Tomar, A; George, S; Kansal, P; Wang, YH; Khurana, S				Tomar, Alok; George, Sudeep; Kansal, Pallavi; Wang, Yaohong; Khurana, Seema			Interaction of phospholipase C-gamma(1) with villin regulates epithelial cell migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-BINDING PROTEINS; IN-VITRO; TYROSINE PHOSPHORYLATION; INTESTINAL EPITHELIUM; CYTOSKELETAL PROTEINS; PROXIMAL TUBULE; C ACTIVITY; GELSOLIN; 4,5-BISPHOSPHATE; IDENTIFICATION	Tyrosine-phosphorylated villin regulates actin dynamics, cell morphology, and cell migration. Previously, we identified four tyrosine phosphorylation sites in the amino-terminal domain of villin. In this study we report six new sites in the carboxyl-terminal region of the villin core. With this study we document all phosphorylatable tyrosine residues in villin and map them to functions of villin. In this study, we identify for the first time the functional relevance of the carboxyl-terminal domains of the villin core. Expression of the carboxyl-terminal phosphorylation site mutant, as well as the villin truncation mutant S1-S3, inhibited cell migration in HeLa and Madin-Darby canine kidney Tet-Off cells, confirming the role of the carboxyl-terminal phosphorylation sites in villin-induced cell migration. The carboxyl-terminal phosphorylation sites were found to be critical for the interaction of villin with its ligand phospholipase C-gamma(1) and for its localization to the developing lamellipodia in a motile cell. The results presented here elucidate the molecular basis for tyrosine-phosphorylated villin-induced changes in cell motility.	Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Khurana, S (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Nash 402,894 Union Ave, Memphis, TN 38163 USA.	skhurana@utmem.edu		Khurana, Seema/0000-0002-6884-810X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054755, R01DK065006] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-65006, DK-54755] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Albers TM, 1996, CELL BIOL INT, V20, P821, DOI 10.1006/cbir.1996.0105; Arora PD, 1996, J BIOL CHEM, V271, P20516, DOI 10.1074/jbc.271.34.20516; ARPIN M, 1988, J CELL BIOL, V107, P1759, DOI 10.1083/jcb.107.5.1759; Athman R, 2005, CELL MICROBIOL, V7, P1109, DOI 10.1111/j.1462-5822.2005.00535.x; Azuma T, 2000, J BIOL CHEM, V275, P3761, DOI 10.1074/jbc.275.6.3761; BACCHI CE, 1991, LAB INVEST, V64, P418; BARTHOD F, 1994, J CHIR-PARIS, V131, P221; Brown D, 1997, AM J PHYSIOL-RENAL, V273, pF1003, DOI 10.1152/ajprenal.1997.273.6.F1003; Burtnick LD, 2004, EMBO J, V23, P2713, DOI 10.1038/sj.emboj.7600280; Chang JS, 1997, CANCER RES, V57, P5465; CHEN P, 1994, J CELL BIOL, V127, P847, DOI 10.1083/jcb.127.3.847; Chou J, 2002, INT J BIOCHEM CELL B, V34, P776, DOI 10.1016/S1357-2725(01)00177-7; De Corte V, 1999, PROTEIN SCI, V8, P234; DeCorte V, 1997, FEBS LETT, V401, P191, DOI 10.1016/S0014-5793(96)01471-8; FINIDORI J, 1992, J CELL BIOL, V116, P1145, DOI 10.1083/jcb.116.5.1145; Finlay BB, 1997, SCIENCE, V276, P718, DOI 10.1126/science.276.5313.718; Folger PA, 1999, CANCER RES, V59, P5349; Friederich E, 1999, J BIOL CHEM, V274, P26751, DOI 10.1074/jbc.274.38.26751; GLENNEY JR, 1981, P NATL ACAD SCI-BIOL, V78, P2810, DOI 10.1073/pnas.78.5.2810; GOLENHOFEN N, 1995, KIDNEY INT, V48, P1837, DOI 10.1038/ki.1995.482; Gual P, 2000, ONCOGENE, V19, P1509, DOI 10.1038/sj.onc.1203514; JANMEY PA, 1988, J BIOL CHEM, V263, P16738; JIN S, 2006, IN PRESS AM J PHYSL; Khurana S, 1997, J BIOL CHEM, V272, P30115, DOI 10.1074/jbc.272.48.30115; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; Kumar N, 2004, J BIOL CHEM, V279, P45036, DOI 10.1074/jbc.M405424200; Kumar N, 2004, J BIOL CHEM, V279, P24915, DOI 10.1074/jbc.C400110200; Kumar N, 2004, J BIOL CHEM, V279, P3096, DOI 10.1074/jbc.M308878200; KWIATKOWSKI DJ, 1989, J CELL BIOL, V108, P1717, DOI 10.1083/jcb.108.5.1717; Lauwaet T, 2003, J BIOL CHEM, V278, P22650, DOI 10.1074/jbc.M300142200; Louvard RAD, 2003, MOL BIOL CELL, V14, P4641, DOI 10.1091/mbc.E03-02-0091; Lueck A, 1998, J CELL SCI, V111, P3633; MATSUDAIRA P, 1985, NATURE, V315, P248, DOI 10.1038/315248a0; Mouneimne G, 2004, J CELL BIOL, V166, P697, DOI 10.1083/jcb.200405156; NOMOTO K, 1995, MOL CARCINOGEN, V12, P146, DOI 10.1002/mc.2940120306; NORTHROP J, 1986, J BIOL CHEM, V261, P9274; NUSRAT A, 1992, J CLIN INVEST, V89, P1501, DOI 10.1172/JCI115741; Panebra A, 2001, AM J PHYSIOL-CELL PH, V281, pC1046, DOI 10.1152/ajpcell.2001.281.3.C1046; Papakonstanti EA, 2000, MOL MED, V6, P303, DOI 10.1007/BF03401939; PARK JG, 1994, CANCER RES, V54, P2240; Phillips MJ, 2003, LANCET, V362, P1112, DOI 10.1016/S0140-6736(03)14467-4; Piccolo E, 2002, ONCOGENE, V21, P6520, DOI 10.1038/sj.onc.1205821; Polk DB, 1998, GASTROENTEROLOGY, V114, P493, DOI 10.1016/S0016-5085(98)70532-3; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; Rieder G, 2005, J BIOL CHEM, V280, P4906, DOI 10.1074/jbc.M413399200; Rottner K, 1999, NAT CELL BIOL, V1, P321, DOI 10.1038/13040; Schafer DA, 1996, J CELL BIOL, V135, P169, DOI 10.1083/jcb.135.1.169; Smith MR, 1998, CARCINOGENESIS, V19, P177, DOI 10.1093/carcin/19.1.177; SODERQUIST AM, 1992, CANCER RES, V52, P4526; SUN HQ, 1994, J BIOL CHEM, V269, P9473; Tomar A, 2004, MOL BIOL CELL, V15, P4807, DOI 10.1091/mbc.E04-05-0431; Tsukamoto T, 2004, J CANCER RES CLIN, V130, P135, DOI 10.1007/s00432-003-0519-6; Wells A, 2000, ADV CANCER RES, V78, P31; White P, 2000, AM J PHYSIOL-RENAL, V278, pF886, DOI 10.1152/ajprenal.2000.278.6.F886; Yuan XL, 2003, J PROTEOME RES, V2, P476, DOI 10.1021/pr025589a; Zhai LW, 2002, BIOCHEMISTRY-US, V41, P11750, DOI 10.1021/bi0263762; Zhai LW, 2001, J BIOL CHEM, V276, P36163, DOI 10.1074/jbc.C100418200	57	21	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31972	31986		10.1074/jbc.M604323200	http://dx.doi.org/10.1074/jbc.M604323200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16921170	Bronze			2022-12-27	WOS:000241235300083
J	Djavaheri-Mergny, M; Amelotti, M; Mathieu, J; Besancon, F; Bauvy, C; Souquere, S; Pierron, G; Codogno, P				Djavaheri-Mergny, Mojgan; Amelotti, Manuela; Mathieu, Julie; Besancon, Francoise; Bauvy, Chantal; Souquere, Sylvie; Pierron, Gerard; Codogno, Patrice			NF-kappa B activation represses tumor necrosis factor-alpha-induced autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; TRANSCRIPTION FACTOR; INDUCED APOPTOSIS; OXIDATIVE STRESS; UP-REGULATION; CANCER; INDUCTION; SURVIVAL; LIFE; INHIBITION	Activation of NF-kappa B and autophagy are two processes involved in the regulation of cell death, but the possible crosstalk between these two signaling pathways is largely unknown. Here, we show that NF-kappa B activation mediates repression of autophagy in tumor necrosis factor-alpha (TNF alpha)-treated Ewing sarcoma cells. This repression is associated with an NF-kappa B-dependent activation of the autophagy inhibitor mTOR. In contrast, in cells lacking NF-kappa B activation, TNF alpha treatment up-regulates the expression of the autophagy-promoting protein Beclin 1 and subsequently induces the accumulation of autophagic vacuoles. Both of these responses are dependent on reactive oxygen species (ROS) production and can be mimicked in NF-kappa B-competent cells by the addition of H2O2. Small interfering RNA-mediated knockdown of beclin 1 and atg7 expression, two autophagy-related genes, reduced TNF alpha- and reactive oxygen species-induced apoptosis in cells lacking NF-kappa B activation and in NF-kappa B-competent cells, respectively. These findings demonstrate that autophagy may amplify apoptosis when associated with a death signaling pathway. They are also evidence that inhibition of autophagy is a novel mechanism of the antiapoptotic function of NF-kappa B activation. We suggest that stimulation of autophagy may be a potential way bypassing the resistance of cancer cells to anti-cancer agents that activate NF-kappa B.	Univ Paris Sud, Fac Pharm, INSERM, U756, F-92296 Chatenay Malabry, France; San Paolo Med Sch, Biochem & Mol Biol Lab, I-20142 Milan, Italy; Hop St Louis, INSERM, U685, Ctr Hayem, F-75475 Paris 10, France; CNRS, UPR 1983, Inst Andre Lwoff, Lab Replicat ADN & Ultrastruct Noyau, F-94801 Villejuif, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS)	Djavaheri-Mergny, M (corresponding author), Univ Paris Sud, Fac Pharm, INSERM, U756, 5 Rue Jean Baptiste Clement, F-92296 Chatenay Malabry, France.	mojgan.mergny@cep.u-psud.fr	Djavaheri-Mergny, Mojgan/N-6315-2017; Codogno, Patrice/G-1384-2013; Djavaheri-Mergny, Mojgan/L-3890-2019	Djavaheri-Mergny, Mojgan/0000-0003-4893-6505; Codogno, Patrice/0000-0002-5492-3180; Djavaheri-Mergny, Mojgan/0000-0003-4893-6505				Alva AS, 2004, CELL DEATH DIFFER, V11, P1046, DOI 10.1038/sj.cdd.4401445; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238; Bernard D, 2002, ONCOGENE, V21, P4392, DOI 10.1038/sj.onc.1205536; Bharti AC, 2002, BIOCHEM PHARMACOL, V64, P883, DOI 10.1016/S0006-2952(02)01154-1; BIEDERBICK A, 1995, EUR J CELL BIOL, V66, P3; BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320; BOURS V, 1994, BIOCHEM PHARMACOL, V47, P145, DOI 10.1016/0006-2952(94)90448-0; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Brouard S, 2002, J BIOL CHEM, V277, P17950, DOI 10.1074/jbc.M108317200; Chen CL, 2000, MOL CELL BIOL, V20, P2687, DOI 10.1128/MCB.20.8.2687-2695.2000; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195, DOI 10.1007/bf00174615; Djavaheri-Mergny M, 2004, FEBS LETT, V578, P111, DOI 10.1016/j.febslet.2004.10.082; Gomez-Santos C, 2003, J NEUROSCI RES, V73, P341, DOI 10.1002/jnr.10663; Iwanaga M, 1998, FREE RADICAL BIO MED, V24, P1256, DOI 10.1016/S0891-5849(97)00443-7; Jaattela M, 2004, ONCOGENE, V23, P2746, DOI 10.1038/sj.onc.1207513; Javelaud D, 2000, ONCOGENE, V19, P61, DOI 10.1038/sj.onc.1203246; Jia L, 1997, BRIT J HAEMATOL, V98, P673, DOI 10.1046/j.1365-2141.1997.2623081.x; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Kucharczak J, 2003, ONCOGENE, V22, P8961, DOI 10.1038/sj.onc.1207230; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lavieu G, 2006, J BIOL CHEM, V281, P8518, DOI 10.1074/jbc.M506182200; Lemasters JJ, 1998, BBA-BIOENERGETICS, V1366, P177, DOI 10.1016/S0005-2728(98)00112-1; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lockshin RA, 2004, ONCOGENE, V23, P2766, DOI 10.1038/sj.onc.1207514; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Luo JL, 2005, J CLIN INVEST, V115, P2625, DOI 10.1172/JCI26322; Martin DN, 2004, DEVELOPMENT, V131, P275, DOI 10.1242/dev.00933; Mathieu J, 2005, ONCOGENE, V24, P7145, DOI 10.1038/sj.onc.1208889; Mayo MW, 2000, BBA-REV CANCER, V1470, pM55, DOI 10.1016/S0304-419X(00)00002-0; Mills KR, 2004, P NATL ACAD SCI USA, V101, P3438, DOI 10.1073/pnas.0400443101; Nakanishi C, 2005, NAT REV CANCER, V5, P297, DOI 10.1038/nrc1588; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Ogier-Denis E, 2003, BBA-REV CANCER, V1603, P113, DOI 10.1016/S0304-419X(03)00004-0; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Ollinger K, 1997, J BIOL CHEM, V272, P23707, DOI 10.1074/jbc.272.38.23707; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pattingre S, 2004, METHOD ENZYMOL, V390, P17; Pham CG, 2004, CELL, V119, P529, DOI 10.1016/j.cell.2004.10.017; Pyo JO, 2005, J BIOL CHEM, V280, P20722, DOI 10.1074/jbc.M413934200; Saeki K, 2000, CELL DEATH DIFFER, V7, P1263, DOI 10.1038/sj.cdd.4400759; Sakon S, 2003, EMBO J, V22, P3898, DOI 10.1093/emboj/cdg379; SEGLEN PO, 1992, EXPERIENTIA, V48, P158, DOI 10.1007/BF01923509; THUMM M, 1994, FEBS LETT, V349, P275, DOI 10.1016/0014-5793(94)00672-5; Tomas-Zapico C, 2005, FASEB J, V19, P2066, DOI 10.1096/fj.04-3595fje; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Xu Y, 2006, J BIOL CHEM, V281, P19179, DOI 10.1074/jbc.M513377200; Xue L, 2001, CURR BIOL, V11, P361, DOI 10.1016/S0960-9822(01)00100-2; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Zheng L, 2006, NEUROSCI LETT, V394, P184, DOI 10.1016/j.neulet.2005.10.035; Zhou A, 2003, ONCOGENE, V22, P2054, DOI 10.1038/sj.onc.1206262	61	380	410	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30373	30382		10.1074/jbc.M602097200	http://dx.doi.org/10.1074/jbc.M602097200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16857678	Green Published, hybrid			2022-12-27	WOS:000241075900011
J	Meyn, MA; Wilson, MB; Abdi, FA; Fahey, N; Schiavone, AP; Wu, J; Hochrein, JM; Engen, JR; Smithgall, TE				Meyn, Malcolm A., III; Wilson, Matthew B.; Abdi, Fadi A.; Fahey, Nathalie; Schiavone, Anthony P.; Wu, Jiong; Hochrein, James M.; Engen, John R.; Smithgall, Thomas E.			Src family kinases phosphorylate the Bcr-Abl SH3-SH2 region and modulate Bcr-Abl transforming activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; NEF PROMOTES SURVIVAL; DNA-BINDING ACTIVITY; C-ABL; TYROSINE KINASE; ADAPTER PROTEIN; MYELOID CELLS; SH3 DOMAIN; ACTIVATION; RESISTANCE	Bcr-Abl is the oncogenic protein-tyrosine kinase responsible for chronic myelogenous leukemia. Recently, we observed that inhibition of myeloid Src family kinase activity ( e. g. Hck, Lyn, and Fyn) induces growth arrest and apoptosis in Bcr-Abl-transformed cells, suggesting that cell transformation by Bcr-Abl involves Src family kinases ( Wilson, M. B., Schreiner, S. J., Choi, H. J., Kamens, J., and Smithgall, T. E. ( 2002) Oncogene 21, 8075 8088). Here, we report the unexpected observation that Hck, Lyn, and Fyn strongly phosphorylate the SH3-SH2 region of Bcr- Abl. Seven phosphorylation sites were identified by matrix-assisted laser desorption ionization time-of-flight mass spectrometry: Tyr(89) and Tyr(134) in the Abl-derived SH3 domain; Tyr(147) in the SH3-SH2 connector; and Tyr(158), Tyr(191), Tyr(204), and Tyr(234) in the SH2 domain. SH3 domain Tyr(89), the most prominent phosphorylation site in vitro, was strongly phosphorylated in chronic myelogenous leukemia cells in a Src family kinase- dependent manner. Substitution of the SH3-SH2 tyrosine phosphorylation sites with phenylalanine substantially reduced Bcr-Abl-mediated transformation of TF-1 myeloid cells to cytokine independence. The positions of these tyrosines in the crystal structure of the c-Abl core and the transformation defect of the corresponding Bcr-Abl mutants together suggest that phosphorylation of the SH3-SH2 region by Src family kinases impacts Bcr- Abl protein conformation and signaling.	Univ Pittsburgh, Sch Med, Dept Mol Genet & Biochem, Pittsburgh, PA 15261 USA; Cell Signaling Technol, Beverly, MA 01915 USA; Univ New Mexico, Dept Chem, Albuquerque, NM 87131 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of New Mexico	Smithgall, TE (corresponding author), Univ Pittsburgh, Sch Med, Dept Mol Genet & Biochem, E1240 Biomed Sci Tower,200 Lothrop St, Pittsburgh, PA 15261 USA.	tsmithga@pitt.edu		Engen, John R./0000-0002-6918-9476	NATIONAL CANCER INSTITUTE [R01CA101828] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070590] Funding Source: NIH RePORTER; NCI NIH HHS [CA101828] Funding Source: Medline; NCRR NIH HHS [RR016480] Funding Source: Medline; NIGMS NIH HHS [R01 GM070590, GM70590] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; Brasher BB, 2000, J BIOL CHEM, V275, P35631, DOI 10.1074/jbc.M005401200; Briggs SD, 2001, J BIOL CHEM, V276, P25605, DOI 10.1074/jbc.M103244200; Calderwood DJ, 2002, BIOORG MED CHEM LETT, V12, P1683, DOI 10.1016/S0960-894X(02)00195-6; Carlesso N, 1996, J EXP MED, V183, P811, DOI 10.1084/jem.183.3.811; Choi HJ, 2004, J BIOL CHEM, V279, P51688, DOI 10.1074/jbc.M410068200; DALEY GQ, 1988, P NATL ACAD SCI USA, V85, P9312, DOI 10.1073/pnas.85.23.9312; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; DanhauserRiedl S, 1996, CANCER RES, V56, P3589; Donato NJ, 2003, BLOOD, V101, P690, DOI 10.1182/blood.V101.2.690; Dorey K, 2001, ONCOGENE, V20, P8075, DOI 10.1038/sj.onc.1205017; Furstoss O, 2002, EMBO J, V21, P514, DOI 10.1093/emboj/21.4.514; GISHIZKY ML, 1992, SCIENCE, V256, P836, DOI 10.1126/science.1375394; GOGA A, 1995, CELL, V82, P981, DOI 10.1016/0092-8674(95)90277-5; Hantschel O, 2004, NAT REV MOL CELL BIO, V5, P33, DOI 10.1038/nrm1280; Hantschel O, 2003, CELL, V112, P845, DOI 10.1016/S0092-8674(03)00191-0; Ilaria RL, 1996, J BIOL CHEM, V271, P31704, DOI 10.1074/jbc.271.49.31704; KITAMURA T, 1989, J CELL PHYSIOL, V140, P323, DOI 10.1002/jcp.1041400219; Lionberger JM, 2000, J BIOL CHEM, V275, P18581, DOI 10.1074/jbc.C000126200; Lionberger JM, 2000, CANCER RES, V60, P1097; Meyn MA, 2005, MOL PHARMACOL, V68, P1320, DOI 10.1124/mol.104.010231; Nagar B, 2002, CANCER RES, V62, P4236; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; NOWELL PC, 1960, JNCI-J NATL CANCER I, V25, P85; O'Hare T, 2006, CURR OPIN GENET DEV, V16, P92, DOI 10.1016/j.gde.2005.11.002; PENDERGAST AM, 1993, CELL, V75, P175, DOI 10.1016/S0092-8674(05)80094-7; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; PUIL L, 1994, EMBO J, V13, P764, DOI 10.1002/j.1460-2075.1994.tb06319.x; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Schreiner SJ, 2002, J BIOL CHEM, V277, P45680, DOI 10.1074/jbc.M204255200; Senechal K, 1996, J BIOL CHEM, V271, P23255, DOI 10.1074/jbc.271.38.23255; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Skorski T, 1997, EMBO J, V16, P6151, DOI 10.1093/emboj/16.20.6151; Smith KM, 2003, MOL CELL, V12, P27, DOI 10.1016/S1097-2765(03)00274-0; Tanis KQ, 2003, MOL CELL BIOL, V23, P3884, DOI 10.1128/MCB.23.11.3884-3896.2003; Van Etten RA, 2002, ONCOGENE, V21, P8643, DOI 10.1038/sj.onc.1206091; Warmuth M, 1997, J BIOL CHEM, V272, P33260, DOI 10.1074/jbc.272.52.33260; Wilson MB, 2002, ONCOGENE, V21, P8075, DOI 10.1038/sj.onc.1206008; Wong S, 2004, ANNU REV IMMUNOL, V22, P247, DOI 10.1146/annurev.immunol.22.012703.104753; Xie SH, 2001, ONCOGENE, V20, P6188, DOI 10.1038/sj.onc.1204834	43	96	99	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30907	30916		10.1074/jbc.M605902200	http://dx.doi.org/10.1074/jbc.M605902200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16912036	hybrid			2022-12-27	WOS:000241075900066
J	Ruf, F; Park, MJ; Hayot, F; Lin, G; Roysam, B; Ge, YC; Sealfon, SC				Ruf, Frederique; Park, Myung-June; Hayot, Fernand; Lin, Gang; Roysam, Badrinath; Ge, Yongchao; Sealfon, Stuart C.			Mixed analog/digital gonadotrope biosynthetic response to gonadotropin-releasing hormone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBUNIT GENE-TRANSCRIPTION; STEROIDOGENIC FACTOR-I; BETA-GENE; GNRH RECEPTOR; DIFFERENTIAL REGULATION; STOCHASTIC SIMULATION; SITU HYBRIDIZATION; SWITCH; SECRETION; PROTEIN-1	Mammalian reproduction requires gonadotropin-releasing hormone (GnRH)-mediated signaling from brain neurons to pituitary gonadotropes. Because the pulses of released GnRH vary greatly in amplitude, we studied the biosynthetic response of the gonadotrope to varying GnRH concentrations, focusing on extracellular-regulated kinase (ERK) phosphorylation and egr1 mRNA and protein production. The overall average level of ERK activation in populations of cells increased non-cooperatively with increasing GnRH and did not show evidence of either ultrasensitivity or bistability. However, automated image analysis of single-cell responses showed that whereas individual gonadotropes exhibited two response states, inactive and active, both the probability of activation and the average response in activated cells increased with increasing GnRH concentration. These data indicate a hybrid single-cell response having both digital (switch-like) and analog ( graded) features. Mathematical modeling suggests that the hybrid response can be explained by indirect thresholding of ERK activation resulting from the distributed structure of the GnRH-modulated network. The hybrid response mechanism improves the reliability of noisy reproductive signal transmission from the brain to the pituitary.	CUNY Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Ctr Translat Syst Biol, New York, NY 10029 USA; Rensselaer Polytech Inst, Dept Elect Comp & Syst Engn, Troy, NY 12180 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Rensselaer Polytechnic Institute	Sealfon, SC (corresponding author), Neurol Box 1137,1 Gustave L Levy Pl, New York, NY 10029 USA.	stuart.sealfon@mssm.edu	Zamojski, Frederique M Ruf/N-5718-2015; Park, Myung-June/D-6465-2013; Ge, Yongchao/AAG-9317-2021	Zamojski, Frederique M Ruf/0000-0002-2451-8598; Park, Myung-June/0000-0001-8779-9326; Ge, Yongchao/0000-0001-6448-5703; SEALFON, Stuart/0000-0001-5791-1217	NIDDK NIH HHS [DK46943] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046943, R56DK046943] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Broccardo CJ, 2004, TOXICOL SCI, V78, P287, DOI 10.1093/toxsci/kfh077; Burger LL, 2004, J MOL ENDOCRINOL, V33, P559, DOI 10.1677/jme.1.01600; Burger LL, 2002, ENDOCRINOLOGY, V143, P3243, DOI 10.1210/en.2002-220216; Caunt CJ, 2006, J BIOL CHEM, V281, P2701, DOI 10.1074/jbc.M507242200; Chan P, 2005, J COMP NEUROL, V482, P50, DOI 10.1002/cne.20377; Chan PM, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni162; Chawla MK, 2004, J NEUROSCI METH, V139, P13, DOI 10.1016/j.jneumeth.2004.04.017; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Clarke IJ, 2002, REPRODUCTION, P1; CLARKE IJ, 1995, J ENDOCRINOL, V145, P271, DOI 10.1677/joe.0.1450271; CLARKE IJ, 1982, ENDOCRINOLOGY, V111, P1737, DOI 10.1210/endo-111-5-1737; Clarke LJ, 2005, ANIM REPROD SCI, V88, P29, DOI 10.1016/j.anireprosci.2005.05.003; Cornish-Bowden A, 2001, EUR J BIOCHEM, V268, P6616, DOI 10.1046/j.0014-2956.2001.02616.x; Dorn C, 1999, J BIOL CHEM, V274, P13870, DOI 10.1074/jbc.274.20.13870; Duan WR, 2002, MOL ENDOCRINOL, V16, P221, DOI 10.1210/me.16.2.221; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; FINK MY, 2003, AM SOC CELL BIOL ANN; French CT, 2004, TOXICOL SCI, V78, P276, DOI 10.1093/toxsci/kfh105; GARCIANAVARRO S, 1991, ENDOCRINOLOGY, V129, P2780, DOI 10.1210/endo-129-5-2780; Gillespie DT, 2001, J CHEM PHYS, V115, P1716, DOI 10.1063/1.1378322; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Gunawardena J, 2005, P NATL ACAD SCI USA, V102, P14617, DOI 10.1073/pnas.0507322102; Haisenleder Daniel J., 1994, P1793; HAISENLEDER DJ, 1991, ENDOCRINOLOGY, V128, P509, DOI 10.1210/endo-128-1-509; Halvorson LM, 1999, MOL ENDOCRINOL, V13, P106, DOI 10.1210/me.13.1.106; Harding A, 2005, CURR BIOL, V15, P869, DOI 10.1016/j.cub.2005.04.020; Kaiser UB, 2000, MOL ENDOCRINOL, V14, P1235, DOI 10.1210/me.14.8.1235; Krakauer DC, 2002, J THEOR BIOL, V218, P457, DOI 10.1006/jtbi.2002.3092; Lee SL, 1996, SCIENCE, V273, P1219, DOI 10.1126/science.273.5279.1219; Lin G, 2005, CYTOM PART A, V66A, P9, DOI 10.1002/cyto.a.20149; Lin G, 2003, CYTOM PART A, V56A, P23, DOI 10.1002/cyto.a.10079; LIN G, 2004, CYTOMETRY, V63, P20; MacKeigan JP, 2005, MOL CELL BIOL, V25, P4676, DOI 10.1128/MCB.25.11.4676-4682.2005; MADDEN HH, 1978, ANAL CHEM, V50, P1383, DOI 10.1021/ac50031a048; Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060; Moenter SM, 2003, FRONT NEUROENDOCRIN, V24, P79, DOI 10.1016/S0091-3022(03)00013-X; MOENTER SM, 1991, ENDOCRINOLOGY, V129, P1175, DOI 10.1210/endo-129-3-1175; Nair VD, 2004, J BIOL CHEM, V279, P27494, DOI 10.1074/jbc.M312135200; Navratil AM, 2003, J BIOL CHEM, V278, P31593, DOI 10.1074/jbc.M304273200; Ortega F, 2002, P NATL ACAD SCI USA, V99, P1170, DOI 10.1073/pnas.022267399; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Padmanabhan V, 1997, ENDOCRINOLOGY, V138, P424, DOI 10.1210/en.138.1.424; Pawson AJ, 2005, ANIM REPROD SCI, V88, P75, DOI 10.1016/j.anireprosci.2005.05.010; Ruf F, 2004, TRENDS ENDOCRIN MET, V15, P331, DOI 10.1016/j.tem.2004.07.008; Ruf F, 2003, FRONT NEUROENDOCRIN, V24, P181, DOI 10.1016/S0091-3022(03)00027-X; Samoilov M, 2005, P NATL ACAD SCI USA, V102, P2310, DOI 10.1073/pnas.0406841102; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Sha W, 2003, P NATL ACAD SCI USA, V100, P975, DOI 10.1073/pnas.0235349100; Skinner DC, 1997, ENDOCRINOLOGY, V138, P4699, DOI 10.1210/en.138.11.4699; Tanaka Tomomi, 1997, Journal of Reproduction and Development, V43, P101, DOI 10.1262/jrd.43.101; Topilko P, 1997, J NEUROSCI RES, V50, P702, DOI 10.1002/(SICI)1097-4547(19971201)50:5<702::AID-JNR7>3.0.CO;2-L; Tremblay JJ, 1999, MOL CELL BIOL, V19, P2567; Whitehurst A, 2004, MOL CELL BIOL, V24, P10145, DOI 10.1128/MCB.24.23.10145-10150.2004; Wolfe MW, 1999, MOL ENDOCRINOL, V13, P752, DOI 10.1210/me.13.5.752; Wurmbach E, 2001, J BIOL CHEM, V276, P47195, DOI 10.1074/jbc.M108716200; Yuen T, 2002, MOL ENDOCRINOL, V16, P1145, DOI 10.1210/me.16.6.1145	57	37	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30967	30978		10.1074/jbc.M606486200	http://dx.doi.org/10.1074/jbc.M606486200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16916798	hybrid			2022-12-27	WOS:000241075900073
J	Rybakin, V; Gounko, NV; Spate, K; Honing, S; Majoul, IV; Duden, R; Noegel, AA				Rybakin, Vasily; Gounko, Natalia V.; Spaete, Kira; Hoening, Stefan; Majoul, Irina V.; Duden, Rainer; Noegel, Angelika A.			Crn7 interacts with AP-1 and is required for the maintenance of Golgi morphology and protein export from the Golgi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORONIN-LIKE PROTEIN; KINASE-D; CRYSTAL-STRUCTURE; PLASMA-MEMBRANE; CHOLERA-TOXIN; TRANSPORT; ACTIN; RECOGNITION; POD-1; CYTOSKELETON	Crn7 is a novel cytosolic mammalian WD-repeat protein of unknown function that associates with Golgi membranes. Here, we demonstrate that Crn7 knockdown by small interfering-RNA results in dramatic changes in the Golgi morphology and function. First, the Golgi ribbon is disorganized in Crn7 KD cells. Second, the Golgi export of several marker proteins including VSV envelope G glycoprotein is greatly reduced but not the retrograde protein import into the Golgi complex. We further establish that Crn7 co-precipitates with clathrin adaptor AP-1 but is not required for AP-1 targeting to Golgi membranes. We identify tyrosine 288-based motif as part of a canonical YXX Phi sorting signal and a major mu 1-adaptin binding site in vitro. This study provides the first insight into the function of mammalian Crn7 protein in the Golgi complex.	Univ Cologne, Fac Med, Inst Biochem 1, D-50931 Cologne, Germany; Univ Cologne, Fac Med, Ctr Mol Med, D-50931 Cologne, Germany; Univ Groningen, Med Ctr, Dept Cell Biol, Electron Microscopy Lab, NL-9713 AV Groningen, Netherlands; Univ London, Sch Biol Sci, Egham TW20 0EX, Surrey, England	University of Cologne; University of Cologne; University of Groningen; University of London; Royal Holloway University London	Rybakin, V (corresponding author), Univ Calif San Diego, Div Biol Sci, 9500 Gilman Dr,MC0634, La Jolla, CA 92093 USA.	vrybakin@ucsd.edu	Majoul, Irina V/K-5339-2013; Gounko, Natalia/N-4102-2019; Gounko, Natalia V/J-9085-2015; Duden, Rainer/C-8917-2011; Rybakin, Vasily/J-6310-2019	Gounko, Natalia/0000-0003-0791-9477; Rybakin, Vasily/0000-0002-5093-1757				Appleton BA, 2006, STRUCTURE, V14, P87, DOI 10.1016/j.str.2005.09.013; Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759; Boll W, 2002, TRAFFIC, V3, P590, DOI 10.1034/j.1600-0854.2002.30808.x; Bonifacino JS, 2004, NAT REV MOL CELL BIO, V5, P23, DOI 10.1038/nrm1279; Cai L, 2005, J BIOL CHEM, V280, P31913, DOI 10.1074/jbc.M504146200; de Hostos EL, 1999, TRENDS CELL BIOL, V9, P345, DOI 10.1016/S0962-8924(99)01620-7; GALLIONE CJ, 1985, J VIROL, V54, P374, DOI 10.1128/JVI.54.2.374-382.1985; Grass I, 2004, J BIOL CHEM, V279, P54872, DOI 10.1074/jbc.M409995200; Hasse A, 2005, EUR J NEUROSCI, V21, P1155, DOI 10.1111/j.1460-9568.2005.03917.x; Heldwein EE, 2004, P NATL ACAD SCI USA, V101, P14108, DOI 10.1073/pnas.0406102101; Hirschberg K, 1998, J CELL BIOL, V143, P1485, DOI 10.1083/jcb.143.6.1485; Honing S, 2005, MOL CELL, V18, P519, DOI 10.1016/j.molcel.2005.04.019; Lauvrak SU, 2004, J CELL SCI, V117, P2321, DOI 10.1242/jcs.01081; Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8; Maeda Y, 2001, EMBO J, V20, P5982, DOI 10.1093/emboj/20.21.5982; Majoul I, 1998, J CELL BIOL, V143, P601, DOI 10.1083/jcb.143.3.601; Majoul IV, 1996, J CELL BIOL, V133, P777, DOI 10.1083/jcb.133.4.777; Nakamura T, 1999, J BIOL CHEM, V274, P13322, DOI 10.1074/jbc.274.19.13322; Nal B, 2004, INT IMMUNOL, V16, P231, DOI 10.1093/intimm/dxh022; Neubrand VE, 2005, EMBO J, V24, P1122, DOI 10.1038/sj.emboj.7600600; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Polishchuk EV, 2003, MOL BIOL CELL, V14, P4470, DOI 10.1091/mbc.E03-01-0033; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Rappleye CA, 1999, GENE DEV, V13, P2838, DOI 10.1101/gad.13.21.2838; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Rothenberg ME, 2003, NEURON, V39, P779, DOI 10.1016/S0896-6273(03)00508-7; Rybakin V, 2005, BIOESSAYS, V27, P625, DOI 10.1002/bies.20235; Rybakin V, 2004, FEBS LETT, V573, P161, DOI 10.1016/j.febslet.2004.07.066; Shestakova A, 2006, TRAFFIC, V7, P191, DOI 10.1111/j.1600-0854.2005.00376.x; Spoerl Z, 2002, J BIOL CHEM, V277, P48858, DOI 10.1074/jbc.M205136200; Tikkanen R, 2000, TRAFFIC, V1, P631, DOI 10.1034/j.1600-0854.2000.010807.x; Yeaman C, 2004, NAT CELL BIOL, V6, P106, DOI 10.1038/ncb1090	32	27	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					31070	31078		10.1074/jbc.M604680200	http://dx.doi.org/10.1074/jbc.M604680200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16905771	Green Published, hybrid			2022-12-27	WOS:000241075900083
J	Yeong, SS; Zhu, Y; Smith, D; Verma, C; Lim, WG; Tan, BJ; Li, QT; Cheung, NS; Cai, M; Zhu, YZ; Zhou, SF; Tan, SL; Duan, W				Yeong, Sui Sum; Zhu, Yimin; Smith, Derek; Verma, Chandra; Lim, Wee Guan; Tan, Bee Jen; Li, Qiu Tian; Cheung, Nam Sang; Cai, Minnie; Zhu, Yi-Zhun; Zhou, Shu-Feng; Tan, Seng-Lai; Duan, Wei			The last 10 amino acid residues beyond the hydrophobic motif are critical for the catalytic competence and function of protein kinase C alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; PHOSPHOLIPASE D1; N1E-115 CELLS; PKC-ALPHA; IN-VIVO; PHOSPHORYLATION; ACTIVATION; EPSILON; MELATONIN; DYNAMICS	The segment C-terminal to the hydrophobic motif at the V5 domain of protein kinase C (PKC) is the least conserved both in length and in amino acid identity among all PKC isozymes. By generating serial truncation mutants followed by biochemical and functional analyses, we show here that the very C terminus of PKC alpha is critical in conferring the full catalytic competence to the kinase and for transducing signals in cells. Deletion of one C-terminal amino acid residue caused the loss of similar to 60% of the catalytic activity of the mutant PKC alpha, whereas deletion of 10 C-terminal amino acid residues abrogated the catalytic activity of PKC alpha in immune complex kinase assays. The PKC alpha C-terminal truncation mutants were found to lose their ability to activate mitogen-activated protein kinase, to rescue apoptosis induced by the inhibition of endogenous PKC in COS cells, and to augment melatonin-stimulated neurite outgrowth. Furthermore, molecular dynamics simulations revealed that the deletion of 1 or 10 C-terminal residues results in the deformation of the V5 domain and the ATP-binding pocket, respectively. Finally, PKC alpha immunoprecipitated using an antibody against its C terminus had only marginal catalytic activity compared with that of the PKC alpha immunoprecipitated by an antibody against its N terminus. Therefore, the very C-terminal tail of PKC alpha is a novel determinant of the catalytic activity of PKC and a promising target for selective modulation of PKC alpha function. Molecules that bind preferentially to the very C terminus of distinct PKC isozymes and suppress their catalytic activity may constitute a new class of selective inhibitors of PKC.	Natl Univ Singapore, Dept Biochem, Yong Loo Lin Sch Med, Singapore 117597, Singapore; Bioinformat Inst, Singapore 138671, Singapore; Natl Univ Singapore, Dept Biol Sci, Singapore 117546, Singapore; Temasek Life Sci Lab, Singapore 117604, Singapore; Fudan Univ, Sch Pharm, Dept Pharmacol, Shanghai 200032, Peoples R China; Natl Univ Singapore, Fac Sci, Dept Pharm, Singapore 117543, Singapore; Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA; Deakin Univ, Inst Biotechnol, Geelong, Vic 3216, Australia	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); National University of Singapore; Fudan University; National University of Singapore; Eli Lilly; Deakin University	Duan, W (corresponding author), Natl Univ Singapore, Dept Biochem, Yong Loo Lin Sch Med, 8 Med Dr, Singapore 117597, Singapore.	wduan@deakin.edu.au	Tan, Seng-Lai/AAQ-2585-2021; Zhu, Yi Zhun/ABG-8449-2021; Zhou, Shu-Feng/E-3166-2013; Duan, Wei/A-5181-2015	Zhu, Yi Zhun/0000-0001-7700-8041; Zhou, Shu-Feng/0000-0002-5542-6119; Duan, Wei/0000-0001-5782-9184				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Babwah AV, 2003, J BIOL CHEM, V278, P5419, DOI 10.1074/jbc.M211053200; Benitez-King G, 2001, NEUROCHEM INT, V39, P95; Benitez-King G, 2000, J PINEAL RES, V29, P8, DOI 10.1034/j.1600-079X.2000.290102.x; BENITEZKING G, 1990, J PINEAL RES, V9, P209, DOI 10.1111/j.1600-079X.1990.tb00709.x; Bordt SL, 2001, BBA-MOL CELL RES, V1499, P257, DOI 10.1016/S0167-4889(00)00127-0; Bornancin F, 1996, CURR BIOL, V6, P1114, DOI 10.1016/S0960-9822(02)70678-7; Bornancin F, 1997, J BIOL CHEM, V272, P3544, DOI 10.1074/jbc.272.6.3544; Braz JC, 2004, NAT MED, V10, P248, DOI 10.1038/nm1000; Breitenlechner C, 2004, BIOCHEMISTRY-US, V43, P7743, DOI 10.1021/bi0362525; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Cenni V, 2002, BIOCHEM J, V363, P537, DOI 10.1042/0264-6021:3630537; Chong YP, 2004, J BIOL CHEM, V279, P20752, DOI 10.1074/jbc.M309865200; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Duan W, 2000, GENE, V256, P113, DOI 10.1016/S0378-1119(00)00365-6; Dutil EM, 1998, CURR BIOL, V8, P1366, DOI 10.1016/S0960-9822(98)00017-7; Eckart MR, 1996, CURR OPIN BIOTECH, V7, P525, DOI 10.1016/S0958-1669(96)80056-5; ELDAR H, 1992, EXP CELL RES, V202, P259, DOI 10.1016/0014-4827(92)90073-H; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Gokmen-Polar Y, 1998, J BIOL CHEM, V273, P20261, DOI 10.1074/jbc.273.32.20261; Hansra G, 1999, BIOCHEM J, V342, P337, DOI 10.1042/0264-6021:3420337; Hu TH, 2005, BIOCHEM BIOPH RES CO, V333, P750, DOI 10.1016/j.bbrc.2005.05.184; Hu TH, 2003, J BIOL CHEM, V278, P2348, DOI 10.1074/jbc.M210093200; Jeon ES, 2005, CELL SIGNAL, V17, P777, DOI 10.1016/j.cellsig.2004.11.004; Johnson LN, 2001, E SCHERING RES FDN W, V34, P47; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Kim J, 2004, EXP MOL MED, V36, P103, DOI 10.1038/emm.2004.15; Kim Y, 1999, BIOCHEMISTRY-US, V38, P10344, DOI 10.1021/bi990579h; Kornitzer D, 2002, METHOD ENZYMOL, V351, P639; Kuklin V, 2005, CRIT CARE, V9, pR211, DOI 10.1186/cc3497; Leitges M, 2004, NEURON, V44, P585, DOI 10.1016/j.neuron.2004.10.024; LEVENTHAL PS, 1993, J BIOL CHEM, V268, P13906; Lim WG, 2005, CELL SIGNAL, V17, P1084, DOI 10.1016/j.cellsig.2004.12.003; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; Marais R, 1998, SCIENCE, V280, P109, DOI 10.1126/science.280.5360.109; Meller J, 2001, PROTEINS, V45, P241, DOI 10.1002/prot.1145; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Messerschmidt A, 2005, J MOL BIOL, V352, P918, DOI 10.1016/j.jmb.2005.07.060; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; ORR JW, 1994, J BIOL CHEM, V269, P8383; Papa FR, 2003, SCIENCE, V302, P1533, DOI 10.1126/science.1090031; Parekh D, 1999, J BIOL CHEM, V274, P34758, DOI 10.1074/jbc.274.49.34758; Parekh DB, 2000, EMBO J, V19, P496, DOI 10.1093/emboj/19.4.496; Parker PJ, 2004, J CELL SCI, V117, P131, DOI 10.1242/jcs.00982; Patrucco E, 2004, CELL, V118, P375, DOI 10.1016/j.cell.2004.07.017; ROACH PL, 1995, NATURE, V375, P700, DOI 10.1038/375700a0; Rybin VO, 2003, J BIOL CHEM, V278, P14555, DOI 10.1074/jbc.M212644200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schonwasser DC, 1998, MOL CELL BIOL, V18, P790, DOI 10.1128/MCB.18.2.790; SOUVIGNET C, 1990, CELL SIGNAL, V2, P171, DOI 10.1016/0898-6568(90)90020-B; Sowadski JM, 1999, PHARMACOL THERAPEUT, V82, P157, DOI 10.1016/S0163-7258(98)00054-0; Staudinger J, 1997, J BIOL CHEM, V272, P32019, DOI 10.1074/jbc.272.51.32019; SU LH, 1993, RECEPTOR CHANNEL, V1, P1; Sweatt JD, 1998, J NEUROCHEM, V71, P1075; Taylor SS, 1999, PHARMACOL THERAPEUT, V82, P133, DOI 10.1016/S0163-7258(99)00007-8; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toker A, 2005, EMBO REP, V6, P310, DOI 10.1038/sj.embor.7400378; VANGUNSTEREN WF, 1977, MOL PHYS, V34, P1311, DOI 10.1080/00268977700102571; Wang QMJ, 2004, MOL CANCER RES, V2, P129; Wang WL, 2003, J BIOL CHEM, V278, P37705, DOI 10.1074/jbc.M304619200; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Whelan RDH, 1998, ONCOGENE, V16, P1939, DOI 10.1038/sj.onc.1201725; Xu ZB, 2004, J BIOL CHEM, V279, P50401, DOI 10.1074/jbc.M409216200; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; Yu VPCC, 2005, MOL CELL, V17, P145, DOI 10.1016/j.molcel.2004.11.020	71	18	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30768	30781		10.1074/jbc.M511278200	http://dx.doi.org/10.1074/jbc.M511278200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16895917	hybrid			2022-12-27	WOS:000241075900053
J	Molle, V; Brown, AK; Besra, GS; Cozzone, AJ; Kremer, L				Molle, Virginie; Brown, Alistair K.; Besra, Gurdyal S.; Cozzone, Alain J.; Kremer, Laurent			The condensing activities of the Mycobacterium tuberculosis type II fatty acid synthase are differentially regulated by phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE/THREONINE PROTEIN-KINASE; KETOACYL-ACP SYNTHASE; BIOCHEMICAL-CHARACTERIZATION; SUBSTRATE-SPECIFICITY; ESCHERICHIA-COLI; TYROSINE KINASE; MYCOLIC ACIDS; FHA DOMAINS; PKNB; BIOSYNTHESIS	Phosphorylation of proteins by Ser/Thr protein kinases (STPKs) has recently become of major physiological importance because of its possible involvement in virulence of bacterial pathogens. Although Mycobacterium tuberculosis has eleven STPKs, the nature and function of the substrates of these enzymes remain largely unknown. In this work, we have identified for the first time STPK substrates in M. tuberculosis forming part of the type II fatty acid synthase (FAS-II) system involved in mycolic acid biosynthesis: the malonyl-CoA:: AcpM transacylase mtFabD, and the beta-ketoacyl AcpM synthases KasA and KasB. All three enzymes were phosphorylated in vitro by different kinases, suggesting a complex network of interactions between STPKs and these substrates. In addition, both KasA and KasB were efficiently phosphorylated in M. bovis BCG each at different sites and could be dephosphorylated by the M. tuberculosis Ser/Thr phosphatase PstP. Enzymatic studies revealed that, whereas phosphorylation decreases the activity of KasA in the elongation process of long chain fatty acids synthesis, this modification enhances that of KasB. Such a differential effect of phosphorylation may represent an unusual mechanism of FAS-II system regulation, allowing pathogenic mycobacteria to produce full-length mycolates, which are required for adaptation and intracellular survival in macrophages.	Univ Lyon 1, CNRS, IBCP,UMR 5086, IFR128 BioSci, F-69367 Lyon 07, France; Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; Univ Montpellier 2, CNRS, Lab Dynam Mol Interact Membranaires, UMR 5539, F-34095 Montpellier 05, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Birmingham; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Kremer, L (corresponding author), Univ Lyon 1, CNRS, IBCP,UMR 5086, IFR128 BioSci, 7 Passage Vercors, F-69367 Lyon 07, France.	laurent.kremer@univ-montp2.fr	MOLLE, Virginie/D-4050-2019; Kremer, Laurent/M-4935-2017	MOLLE, Virginie/0000-0002-6573-3411; Kremer, Laurent/0000-0002-6604-4458; Brown, Alistair/0000-0003-0479-8294; Besra, Gurdyal/0000-0002-5605-0395	Medical Research Council [G9901077] Funding Source: Medline; MRC [G9901077] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alderwick LJ, 2006, P NATL ACAD SCI USA, V103, P2558, DOI 10.1073/pnas.0507766103; Av-Gay Y, 1999, INFECT IMMUN, V67, P5676, DOI 10.1128/IAI.67.11.5676-5682.1999; Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0; Bendt AK, 2003, PROTEOMICS, V3, P1637, DOI 10.1002/pmic.200300494; Bhatt A, 2005, J BACTERIOL, V187, P7596, DOI 10.1128/JB.187.22.7596-7606.2005; Boitel B, 2003, MOL MICROBIOL, V49, P1493, DOI 10.1046/j.1365-2958.2003.03657.x; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Brown AK, 2005, J BIOL CHEM, V280, P32539, DOI 10.1074/jbc.M413216200; Chaba R, 2002, EUR J BIOCHEM, V269, P1078, DOI 10.1046/j.1432-1033.2002.02778.x; Choi KH, 2000, J BIOL CHEM, V275, P28201; Chopra P, 2003, BIOCHEM BIOPH RES CO, V311, P112, DOI 10.1016/j.bbrc.2003.09.173; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; DASGUPTA A, 2006, MICROBIOLOGY, V152, P43; Dubnau E, 2000, MOL MICROBIOL, V36, P630, DOI 10.1046/j.1365-2958.2000.01882.x; Duran R, 2005, BIOCHEM BIOPH RES CO, V333, P858, DOI 10.1016/j.bbrc.2005.05.173; Gao LY, 2003, MOL MICROBIOL, V49, P1547, DOI 10.1046/j.1365-2958.2003.03667.x; Gopalaswamy R, 2004, PROTEIN EXPRES PURIF, V36, P82, DOI 10.1016/j.pep.2004.03.011; Grangeasse C, 2003, J BIOL CHEM, V278, P39323, DOI 10.1074/jbc.M305134200; Grangeasse C, 1997, GENE, V204, P259, DOI 10.1016/S0378-1119(97)00554-4; Grundner C, 2005, PROTEIN SCI, V14, P1918, DOI 10.1110/ps.051413405; Jackson M, 2000, J BIOL CHEM, V275, P30092, DOI 10.1074/jbc.M004658200; Kang CM, 2005, GENE DEV, V19, P1692, DOI 10.1101/gad.1311105; Koul A, 2001, MICROBIOL-SGM, V147, P2307, DOI 10.1099/00221287-147-8-2307; Kremer L, 2002, MICROBIOL-SGM, V148, P3145, DOI 10.1099/00221287-148-10-3145; Kremer L, 2002, BIOCHEM J, V364, P423, DOI 10.1042/BJ20011628; Kremer L, 2001, J BIOL CHEM, V276, P27967, DOI 10.1074/jbc.M103687200; Kremer L, 2000, MOLECULAR GENETICS OF MYCOBACTERIA, P173; Mdluli K, 1998, SCIENCE, V280, P1607, DOI 10.1126/science.280.5369.1607; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Molle V, 2004, FEMS MICROBIOL LETT, V234, P215, DOI 10.1016/j.femsle.2004.03.033; Molle V, 2003, BIOCHEMISTRY-US, V42, P15300, DOI 10.1021/bi035150b; Molle V, 2003, BIOCHEM BIOPH RES CO, V308, P820, DOI 10.1016/S0006-291X(03)01476-1; Molle V, 2006, MOL MICROBIOL, V61, P826, DOI 10.1111/j.1365-2958.2006.05277.x; Ojha A, 2005, CELL, V123, P861, DOI 10.1016/j.cell.2005.09.012; Peirs P, 1997, EUR J BIOCHEM, V244, P604, DOI 10.1111/j.1432-1033.1997.00604.x; Schaeffer ML, 2001, J BIOL CHEM, V276, P47029, DOI 10.1074/jbc.M108903200; Senaratne RH, 1998, J BACTERIOL, V180, P3541, DOI 10.1128/JB.180.14.3541-3547.1998; Shawver LK, 2002, CANCER CELL, V1, P117, DOI 10.1016/S1535-6108(02)00039-9; Sinha I, 2003, FEMS MICROBIOL LETT, V227, P141, DOI 10.1016/S0378-1097(03)00664-5; Slayden RA, 2002, TUBERCULOSIS, V82, P149, DOI 10.1054/tube.2002.0333; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Veyron-Churlet R, 2004, MOL MICROBIOL, V54, P1161, DOI 10.1111/j.1365-2958.2004.04334.x; Villarino A, 2005, J MOL BIOL, V350, P953, DOI 10.1016/j.jmb.2005.05.049; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384; Young TA, 2003, NAT STRUCT BIOL, V10, P168, DOI 10.1038/nsb897	47	89	96	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					30094	30103		10.1074/jbc.M601691200	http://dx.doi.org/10.1074/jbc.M601691200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16873379	hybrid, Green Published			2022-12-27	WOS:000240896300070
J	Mundhenk, L; Alfalah, M; Elble, RC; Pauli, BU; Naim, HY; Gruber, AD				Mundhenk, Lars; Alfalah, Marwan; Elble, Randolph C.; Pauli, Bendicht U.; Naim, Hassan Y.; Gruber, Achim D.			Both cleavage products of the mCLCA3 protein are secreted soluble proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED CHLORIDE CHANNEL; LACTASE-PHLORHIZIN HYDROLASE; FUNCTIONAL-CHARACTERIZATION; MOLECULAR-CLONING; MEMBRANE-PROTEINS; SIGNAL PEPTIDES; FAMILY-MEMBERS; EXPRESSION; PREDICTION; GENE	Members of the chloride channels, calcium-activated ( CLCA) family of proteins and in particular the murine mCLCA3 ( alias gob-5) and its human ortholog hCLCA1 have been identified as clinically relevant molecules in diseases with secretory dysfunctions including asthma and cystic fibrosis. Initial studies have indicated that these proteins evoke a calcium-activated chloride conductance when transfected into human embryonic kidney cells 293 cells. However, it is not yet clear whether the CLCA proteins form chloride channels per se or function as mediators of other, yet unknown chloride channels. Here, we present a systematic biochemical analysis of the posttranslational processing and intracellular trafficking of the mCLCA3 protein. Pulse-chase experiments after metabolic protein labeling of mCLCA3-transfected COS-1 or human embryonic kidney 293 cells revealed cleavage of a primary 110-kDa mCLCA3 translation product in the endoplasmic reticulum into a 75-kDa amino-terminal and a 35-kDa carboxyl-terminal protein that were glycosylated and remained physically associated with each other. Confocal fluorescent analyses identified both cleavage products in vesicles of the secretory pathway. Neither cleavage product was associated with the cell membrane at any time. Instead, both subunits were fully secreted into the extracellular environment as a soluble complex of two glycoproteins. These results suggest that the two mCLCA3 cleavage products cannot form an anion channel on their own but may instead act as extracellular signaling molecules. Furthermore, our results point toward significant structural differences between mCLCA3 and its human ortholog, hCLCA1, which is thought to be a single, non-integral membrane protein.	Free Univ Berlin, Dept Vet Pathol, D-14163 Berlin, Germany; Univ Vet Med Hannover, Dept Physiol Chem, D-30559 Hannover, Germany; So Illinois Univ, Sch Med, Dept Pharmacol, Springfield, IL 62702 USA; So Illinois Univ, Sch Med, Simmons Cooper Canc Inst, Springfield, IL 62702 USA; Cornell Univ, Coll Vet Med, Dept Mol Med, Canc Biol Program, Ithaca, NY 14853 USA	Free University of Berlin; University of Veterinary Medicine Hannover, Foundation; Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; Cornell University	Gruber, AD (corresponding author), Free Univ Berlin, Dept Vet Pathol, Robert Ostertag Str 15, D-14163 Berlin, Germany.	gruber.achim@vetmed.fu-berlin.de	Al Falah, Dr. Marwan/C-6281-2011; Gruber, Achim D./ABA-4514-2021					Abdel-Ghany M, 2003, J BIOL CHEM, V278, P49406, DOI 10.1074/jbc.M309086200; Abdel-Ghany M, 2002, J BIOL CHEM, V277, P34391, DOI 10.1074/jbc.M205307200; Agnel M, 1999, FEBS LETT, V455, P295, DOI 10.1016/S0014-5793(99)00891-1; Anton F, 2005, J HISTOCHEM CYTOCHEM, V53, P1011, DOI 10.1369/jhc.4A6599.2005; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Brouillard F, 2005, MOL CELL PROTEOMICS, V4, P1762, DOI 10.1074/mcp.M500098-MCP200; CHINERY R, 1995, BRIT J PHARMACOL, V115, P77, DOI 10.1111/j.1476-5381.1995.tb16322.x; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; Cunningham SA, 1995, J BIOL CHEM, V270, P31016, DOI 10.1074/jbc.270.52.31016; Davies JR, 2002, NOVART FDN SYMP, V248, P76; Elble RC, 1997, J BIOL CHEM, V272, P27853, DOI 10.1074/jbc.272.44.27853; Elble RC, 2002, J BIOL CHEM, V277, P18586, DOI 10.1074/jbc.M200829200; Evans SR, 2004, J BIOL CHEM, V279, P41792, DOI 10.1074/jbc.M408354200; Gandhi R, 1998, J BIOL CHEM, V273, P32096, DOI 10.1074/jbc.273.48.32096; Gaspar KJ, 2000, PHYSIOL GENOMICS, V3, P101, DOI 10.1152/physiolgenomics.2000.3.2.101; Gibson A, 2005, J BIOL CHEM, V280, P27205, DOI 10.1074/jbc.M504654200; Greenwood IA, 2002, J BIOL CHEM, V277, P22119, DOI 10.1074/jbc.C200215200; Gruber AD, 1999, AM J PHYSIOL-CELL PH, V276, pC1261; Gruber AD, 2002, CURR TOP MEMBR, V53, P367; Gruber AD, 1998, GENOMICS, V54, P200, DOI 10.1006/geno.1998.5562; Gruber AD, 1999, BBA-GENE STRUCT EXPR, V1444, P418, DOI 10.1016/S0167-4781(99)00008-1; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hoffmann W, 2001, HISTOL HISTOPATHOL, V16, P319, DOI 10.14670/HH-16.319; Hofmann K., 1993, BIOL CHEM H-S, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Hoshino M, 2002, AM J RESP CRIT CARE, V165, P1132, DOI 10.1164/ajrccm.165.8.2107068; JACOB R, 2000, J BIOL CHEM, V275, P10650; Jeong SM, 2005, BIOCHEM BIOPH RES CO, V334, P569, DOI 10.1016/j.bbrc.2005.06.122; Komiya T, 1999, BIOCHEM BIOPH RES CO, V255, P347, DOI 10.1006/bbrc.1999.0168; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lee D, 1999, BIOCHEM BIOPH RES CO, V264, P933, DOI 10.1006/bbrc.1999.1583; Leverkoehne I, 2002, J HISTOCHEM CYTOCHEM, V50, P829, DOI 10.1177/002215540205000609; Leverkoehne I, 2000, CYTOGENET CELL GENET, V88, P208, DOI 10.1159/000015550; Leverkoehne I, 2006, HISTOCHEM CELL BIOL, V126, P239, DOI 10.1007/s00418-006-0164-7; Loewen ME, 2005, PHYSIOL REV, V85, P1061, DOI 10.1152/physrev.00016.2004; Loewen ME, 2002, BIOCHEM BIOPH RES CO, V298, P531, DOI 10.1016/S0006-291X(02)02498-1; Loewen ME, 2003, AM J PHYSIOL-CELL PH, V285, pC1314, DOI 10.1152/ajpcell.00210.2003; LOEWEN ME, 2004, AM J PHYSIOL-GASTR L, V287, P33; NAIM HY, 1987, BIOCHEM J, V241, P427, DOI 10.1042/bj2410427; NAIM HY, 1991, J BIOL CHEM, V266, P12313; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Nakanishi A, 2001, P NATL ACAD SCI USA, V98, P5175, DOI 10.1073/pnas.081510898; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; NIELSEN H, 1998, P 6 INT C INT SYST M, P122; Pawlowski K, 2006, PROTEINS, V63, P424, DOI 10.1002/prot.20887; RAN S, 1992, J BIOL CHEM, V267, P20630; RITZKA M, 2003, GENOME LETT, V2, P149; Rogers DF, 2003, INT J BIOCHEM CELL B, V35, P1, DOI 10.1016/S1357-2725(02)00083-3; Romio L, 1999, GENE, V228, P181, DOI 10.1016/S0378-1119(98)00620-9; Toda M, 2002, J ALLERGY CLIN IMMUN, V109, P246, DOI 10.1067/mai.2002.121555; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; Winpenny JP, 2002, J PHYSIOL-LONDON, V539, p2P; Zhou YH, 2002, NOVART FDN SYMP, V248, P150; ZHU DZ, 1993, INT J CANCER, V53, P628	54	51	56	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					30072	30080		10.1074/jbc.M606489200	http://dx.doi.org/10.1074/jbc.M606489200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16895902	hybrid			2022-12-27	WOS:000240896300068
J	Park, CS; Gong, R; Stuart, J; Tang, SJ				Park, Chang Sin; Gong, Ruomu; Stuart, Joshua; Tang, Shao-Jun			Molecular network and chromosomal clustering of genes involved in synaptic plasticity in the hippocampus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; IMMEDIATE-EARLY GENE; ELEMENT-BINDING PROTEIN; TISSUE TRANSGLUTAMINASE; MESSENGER-RNA; CROSS-LINKING; EXPRESSION; MEMORY; LTP; IDENTIFICATION	Gene transcription is required for establishing and maintaining the enduring form of long term potentiation (LTP). However, the transcriptome and its associated molecular programs that support LTP are not well understood. The purpose of this study was to identify activity-regulated genes (ARGs) and their molecular pathways that are modulated by LTP induction and to investigate the genomic mechanism for coordinating the transcription of ARGs. We performed time course DNA microarray analyses on the mouse dentate gyrus to determine the temporal genomic expression profiles of ARGs in response to LTP-inducing tetanic stimulation. Our studies uncovered ARGs that regulate various cellular processes, including the structure and function of the synapse, and offered an overview of the dynamic molecular programs that are probably important for LTP. Surprisingly, we found that ARGs are clustered on chromosomes, and ARG clusters are conserved during evolution. Although ARGs in the same cluster have apparently different molecular properties, they are functionally correlated by regulating LTP. In addition, ARGs in specific clusters are co-regulated by the cAMP-response element-binding protein. We propose that chromosomal clustering provides a genomic mechanism for coordinating the transcription of ARGs involved in LTP.	Univ Calif Irvine, Ctr Neurobiol Learning & Memory, Qureshey Res Lab 303, Dept Neurobiol & Behav, Irvine, CA 92697 USA; Dept Biomol Engn, Santa Cruz, CA 95064 USA	University of California System; University of California Irvine	Park, CS (corresponding author), Univ Calif Irvine, Ctr Neurobiol Learning & Memory, Qureshey Res Lab 303, Dept Neurobiol & Behav, Irvine, CA 92697 USA.	stang@uci.edu		Stuart, Joshua/0000-0002-2171-565X				Abraham WC, 2003, NEUROSCIENTIST, V9, P463, DOI 10.1177/1073858403259119; Altar CA, 2004, J NEUROSCI, V24, P2667, DOI 10.1523/JNEUROSCI.5377-03.2004; Avital A, 2003, HIPPOCAMPUS, V13, P826, DOI 10.1002/hipo.10135; BANKER G, 2002, CULTURING NERVE CELL; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Blumenthal T, 2003, NAT REV GENET, V4, P110, DOI 10.1038/nrg995; Boutanaev AM, 2002, NATURE, V420, P666, DOI 10.1038/nature01216; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Cavallaro S, 2002, P NATL ACAD SCI USA, V99, P16279, DOI 10.1073/pnas.242597199; Chen JY, 2006, J BIOL CHEM, V281, P11910, DOI 10.1074/jbc.M511920200; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; COLE AJ, 1989, NATURE, V340, P474, DOI 10.1038/340474a0; Comu S, 1997, J NEUROSCI, V17, P8702; Davis S, 2000, J NEUROSCI, V20, P4563, DOI 10.1523/JNEUROSCI.20-12-04563.2000; Dubrovsky B, 2003, BRAIN RES BULL, V59, P467, DOI 10.1016/S0361-9230(02)00961-9; Eckstein J., 1997, BIOCHIM BIOPHYS ACTA, V1332, P53; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; FACCHIANO F, 1993, TRENDS BIOCHEM SCI, V18, P327, DOI 10.1016/0968-0004(93)90066-V; Festoff BW, 2001, INT REV CYTOL, V211, P153, DOI 10.1016/S0074-7696(01)11018-1; French PJ, 2001, EUR J NEUROSCI, V14, P2037, DOI 10.1046/j.0953-816x.2001.01818.x; French PJ, 2001, EUR J NEUROSCI, V13, P968, DOI 10.1046/j.0953-816x.2001.01467.x; FRIEDRICH P, 1991, NEUROSCIENCE, V43, P331, DOI 10.1016/0306-4522(91)90297-2; Greenberg ME, 2001, SYNAPSES, P357; Grimwood PD, 2001, SYNAPSES, P519; Guzowski JF, 2002, HIPPOCAMPUS, V12, P86, DOI 10.1002/hipo.10010; Guzowski JF, 2000, J NEUROSCI, V20, P3993; HAND D, 1993, INT J DEV NEUROSCI, V11, P709, DOI 10.1016/0736-5748(93)90060-Q; Hevroni D, 1998, J MOL NEUROSCI, V10, P75, DOI 10.1007/BF02737120; Hong SJ, 2004, P NATL ACAD SCI USA, V101, P2145, DOI 10.1073/pnas.0305170101; Hung SP, 2002, J BIOL CHEM, V277, P40309, DOI 10.1074/jbc.M204044200; Ientile R, 2002, NEUROSCIENCE, V115, P723, DOI 10.1016/S0306-4522(02)00482-7; Igarashi S, 1998, NAT GENET, V18, P111, DOI 10.1038/ng0298-111; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; JACOB F, 1961, COLD SPRING HARB SYM, V26, P193, DOI 10.1101/SQB.1961.026.01.024; Jiang PH, 1999, J BIOL CHEM, V274, P559, DOI 10.1074/jbc.274.2.559; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Karpuj MV, 2002, NAT MED, V8, P143, DOI 10.1038/nm0202-143; Kosak ST, 2004, SCIENCE, V306, P644, DOI 10.1126/science.1103864; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; Lanahan A, 1998, NEUROBIOL LEARN MEM, V70, P37, DOI 10.1006/nlme.1998.3836; Lawrence JG, 2002, CELL, V110, P407, DOI 10.1016/S0092-8674(02)00900-5; Lee B, 2005, J NEUROSCI, V25, P1137, DOI 10.1523/JNEUROSCI.4288-04.2005; Lei G, 2002, EMBO J, V21, P2977, DOI 10.1093/emboj/cdf292; Leil TA, 2003, J NEUROSCI RES, V71, P763, DOI 10.1002/jnr.10541; Leil TA, 2002, J NEUROSCI RES, V68, P127, DOI 10.1002/jnr.10184; Levenson JM, 2004, J NEUROSCI, V24, P3933, DOI 10.1523/JNEUROSCI.5646-03.2004; Li HW, 2004, P NATL ACAD SCI USA, V101, P647, DOI 10.1073/pnas.0305145101; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; Lisman J, 2003, NAT REV NEUROSCI, V4, P926, DOI 10.1038/nrn1259; Lockhart DJ, 2000, NATURE, V405, P827, DOI 10.1038/35015701; Long AD, 2001, J BIOL CHEM, V276, P19937, DOI 10.1074/jbc.M010192200; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Lyon MA, 2002, NAT REV DRUG DISCOV, V1, P961, DOI 10.1038/nrd963; Malenka RC, 2003, NAT REV NEUROSCI, V4, P923, DOI 10.1038/nrn1258; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Matsuo R, 2000, J NEUROCHEM, V74, P2239, DOI 10.1046/j.1471-4159.2000.0742239.x; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; NEDIVI E, 1993, NATURE, V363, P718, DOI 10.1038/363718a0; O'Connor JJ, 1999, EXP PHYSIOL, V84, P601, DOI 10.1111/j.1469-445X.1999.01892.x; Oliver Brian, 2002, J Biol, V1, P4; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Oshima K, 2002, FEBS LETT, V519, P1, DOI 10.1016/S0014-5793(02)02703-5; PASTUSZKO A, 1986, J NEUROCHEM, V46, P499, DOI 10.1111/j.1471-4159.1986.tb12996.x; Peng HX, 2003, J NEUROSCI, V23, P6617; Petrone A, 2003, EMBO J, V22, P4121, DOI 10.1093/emboj/cdg399; QIAN Z, 1993, NATURE, V361, P453, DOI 10.1038/361453a0; Ross FM, 2003, J NEUROIMMUNOL, V144, P61, DOI 10.1016/j.jneuroim.2003.08.030; Roy PJ, 2002, NATURE, V418, P975, DOI 10.1038/nature01012; Sanes JR, 1999, NAT NEUROSCI, V2, P597, DOI 10.1038/10154; Sano S, 1997, FEBS LETT, V411, P327, DOI 10.1016/S0014-5793(97)00724-2; Spellman Paul T, 2002, J Biol, V1, P5, DOI 10.1186/1475-4924-1-5; Taubenfeld SM, 2002, J NEUROCHEM, V81, P1348, DOI 10.1046/j.1471-4159.2002.00936.x; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Tucholski J, 2003, J BIOL CHEM, V278, P26838, DOI 10.1074/jbc.M303683200; Vincent I, 2001, NEUROSCIENCE, V105, P639, DOI 10.1016/S0306-4522(01)00219-6; WAGNER JJ, 1993, NATURE, V363, P451, DOI 10.1038/363451a0; YANG YH, 2002, DNA MICROARRAYS, P513; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071	83	45	47	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					30195	30211		10.1074/jbc.M605876200	http://dx.doi.org/10.1074/jbc.M605876200			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16873368	hybrid			2022-12-27	WOS:000240896300080
J	Roberts, DS; Hu, YH; Lund, IV; Brooks-Kayal, AR; Russek, SJ				Roberts, Daniel S.; Hu, Yinghui; Lund, Ingrid V.; Brooks-Kayal, Amy R.; Russek, Shelley J.			Brain-derived neurotrophic factor (BDNF)-induced synthesis of early growth response factor 3 (Egr3) controls the levels of type A GABA receptor alpha 4 subunits in hippocampal neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TEMPORAL-LOBE EPILEPSY; GAMMA-AMINOBUTYRIC-ACID; MESSENGER-RNAS; TRANSCRIPTION FACTOR; DENTATE GRANULE; DOWN-REGULATION; CYCLOSPORINE-A; T-CELLS; EXPRESSION; ZINC	Altered function of gamma-aminobutyric acid type A receptors (GABA(A)Rs) in dentate granule cells of the hippocampus has been associated with temporal lobe epilepsy (TLE) in humans and in animal models of TLE. Such altered receptor function (including increased inhibition by zinc and lack of modulation by benzodiazepines) is related, in part, to changes in the mRNA levels of certain GABA(A)R subunits, including alpha 4, and may play a role in epileptogenesis. The majority of GABA(A)Rs that contain alpha 4 subunits are extra-synaptic due to lack of the gamma 2 subunit and presence of delta. However, it has been hypothesized that seizure activity may result in expression of synaptic receptors with altered properties driven by an increased pool of alpha 4 subunits. Results of our previous work suggests that signaling via protein kinase C (PKC) and early growth response factor 3 (Egr3) is the plasticity trigger for aberrant alpha 4 subunit gene (GABRA4) expression after status epilepticus. We now report that brain derived neurotrophic factor (BDNF) is the endogenous signal that induces Egr3 expression via a PKC/MAPK-dependent pathway. Taken together with the fact that blockade of tyrosine kinase (Trk) neurotrophin receptors reduces basal GABRA4 promoter activity by 50%, our findings support a role for BDNF as the mediator of Egr3-induced GABRA4 regulation in developing neurons and epilepsy and, moreover, suggest that BDNF may alter inhibitory processing in the brain by regulating the balance between phasic and tonic inhibition.	Boston Univ, Sch Med, Mol Neurobiol Lab, Dept Pharmacol, Boston, MA 02118 USA; Univ Penn, Neurosci Grad Grp, Philadelphia, PA 19104 USA; Univ Penn, Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19104 USA	Boston University; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Russek, SJ (corresponding author), Boston Univ, Sch Med, Mol Neurobiol Lab, Dept Pharmacol, 715 Albany St, Boston, MA 02118 USA.	srussek@bu.edu		Russek, Shelley/0000-0001-7547-3089	NINDS NIH HHS [NS050393] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050393] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Albert Y, 2005, J CELL BIOL, V169, P257, DOI 10.1083/jcb.200501156; Benke D, 1997, J NEUROCHEM, V69, P806; Bonnert TP, 1999, P NATL ACAD SCI USA, V96, P9891, DOI 10.1073/pnas.96.17.9891; Brooks-Kayal AR, 1998, NAT MED, V4, P1166, DOI 10.1038/2661; Brunig I, 2001, EUR J NEUROSCI, V13, P1320, DOI 10.1046/j.0953-816x.2001.01506.x; Buhl EH, 1996, SCIENCE, V271, P369, DOI 10.1126/science.271.5247.369; Christie SB, 2002, J NEUROSCI, V22, P684, DOI 10.1523/JNEUROSCI.22-03-00684.2002; Coulter DA, 2000, EPILEPSIA, V41, pS96, DOI 10.1111/j.1528-1157.2000.tb01565.x; Davies PA, 1997, NATURE, V385, P820, DOI 10.1038/385820a0; ERNFORS P, 1991, NEURON, V7, P165, DOI 10.1016/0896-6273(91)90084-D; Fisher JL, 1998, J NEUROSCI, V18, P2944; Gibbs JW, 1997, J NEUROPHYSIOL, V77, P1924, DOI 10.1152/jn.1997.77.4.1924; Honkaniemi J, 1999, EUR J NEUROSCI, V11, P10, DOI 10.1046/j.1460-9568.1999.00401.x; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Knoflach F, 1996, MOL PHARMACOL, V50, P1253; Koyama R, 2005, NEUROSCIENTIST, V11, P282, DOI 10.1177/1073858405278266; Koyama R, 2004, J NEUROSCI, V24, P7215, DOI 10.1523/JNEUROSCI.2045-04.2004; Mages HW, 1998, MOL CELL BIOL, V18, P7157, DOI 10.1128/MCB.18.12.7157; MAGES HW, 1993, INT IMMUNOL, V5, P63, DOI 10.1093/intimm/5.1.63; Murray KD, 2000, J COMP NEUROL, V418, P411, DOI 10.1002/(SICI)1096-9861(20000320)418:4<411::AID-CNE4>3.0.CO;2-F; O'Donovan KJ, 1999, MOL CELL BIOL, V19, P4711; Parsian A, 1999, AM J MED GENET, V88, P533, DOI 10.1002/(SICI)1096-8628(19991015)88:5<533::AID-AJMG18>3.0.CO;2-C; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Peng ZC, 2004, J NEUROSCI, V24, P8629, DOI 10.1523/JNEUROSCI.2877-04.2004; Poulsen FR, 2004, NEUROSCIENCE, V126, P665, DOI 10.1016/j.neuroscience.2004.04.008; Qiao XX, 2001, J NEUROSCI RES, V64, P268, DOI 10.1002/jnr.1075; RABOW LE, 1995, SYNAPSE, V21, P189, DOI 10.1002/syn.890210302; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Roberts DS, 2005, P NATL ACAD SCI USA, V102, P11894, DOI 10.1073/pnas.0501434102; Russek SJ, 2000, P NATL ACAD SCI USA, V97, P8600, DOI 10.1073/pnas.97.15.8600; RUSSEK SJ, 2003, NATURE ENCY HUMAN GE; Scharfman HE, 2002, EXP NEUROL, V174, P201, DOI 10.1006/exnr.2002.7869; Shetty AK, 2003, J NEUROCHEM, V87, P147, DOI 10.1046/j.1471-4159.2003.01979.x; Smith SS, 1998, NATURE, V392, P926, DOI 10.1038/31948; Steiger JL, 2004, PHARMACOL THERAPEUT, V101, P259, DOI 10.1016/j.pharmthera.2003.12.002; Sur C, 1999, MOL PHARMACOL, V56, P110, DOI 10.1124/mol.56.1.110; Takahashi M, 1999, BRAIN RES, V818, P579, DOI 10.1016/S0006-8993(98)01355-9; WHITE G, 1995, NEUROREPORT, V6, P461, DOI 10.1097/00001756-199502000-00014; Xia ZG, 1996, J NEUROSCI, V16, P5425; Yamagata K, 1994, Learn Mem, V1, P140; ZAFRA F, 1990, EMBO J, V9, P3545, DOI 10.1002/j.1460-2075.1990.tb07564.x; Zhang G, 2004, NEUROSCIENCE, V125, P299, DOI 10.1016/j.neuroscience.2004.01.040	42	99	100	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					29431	29435		10.1074/jbc.C600167200	http://dx.doi.org/10.1074/jbc.C600167200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16901909	hybrid			2022-12-27	WOS:000240896300004
J	Goda, E; Kamiyama, S; Uno, T; Yoshida, H; Ueyama, M; Kinoshita-Toyoda, A; Toyoda, H; Ueda, R; Nishihara, S				Goda, Emi; Kamiyama, Shin; Uno, Takaaki; Yoshida, Hideki; Ueyama, Morio; Kinoshita-Toyoda, Akiko; Toyoda, Hidenao; Ueda, Ryu; Nishihara, Shoko			Identification and characterization of a novel Drosophila 3 '-phosphoadenosine 5 '-phosphosulfate transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; NUCLEOTIDE-SUGAR TRANSPORTER; MOLECULAR-CLONING; TOUT-VELU; FRINGE CONNECTION; SALIVARY-GLAND; GENE; MELANOGASTER; EXPRESSION; GLYCOSAMINOGLYCANS	Sulfation of macromolecules requires the translocation of a high energy form of nucleotide sulfate, i.e. 3'-phosphoadenosine 5'-phosphosulfate ( PAPS), from the cytosol into the Golgi apparatus. In this study, we identified a novel Drosophila PAPS transporter gene dPAPST2 by conducting data base searches and screening the PAPS transport activity among the putative nucleotide sugar transporter genes in Drosophila. The amino acid sequence of dPAPST2 showed 50.5 and 21.5% homology to the human PAPST2 and SLALOM, respectively. The heterologous expression of dPAPST2 in yeast revealed that the dPAPST2 protein is a PAPS transporter with an apparent K-m value of 2.3 mu M. The RNA interference of dPAPST2 in cell line and flies showed that the dPAPST2 gene is essential for the sulfation of cellular proteins and the viability of the fly. In RNA interference flies, an analysis of the genetic interaction between dPAPST2 and genes that contribute to glycosaminoglycan synthesis suggested that dPAPST2 is involved in the glycosaminoglycan synthesis and the subsequent signaling. The dPAPST2 and sll genes showed a similar ubiquitous distribution. These results indicate that dPAPST2 may be involved in Hedgehog and Decapentaplegic signaling by controlling the sulfation of heparan sulfate.	Soka Univ, Cell Biol Lab, Dept Bioinformat, Hachioji, Tokyo 1928577, Japan; Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Saitama 3320012, Japan; Chiba Univ, Fac Pharmaceut Sci, Dept Analyt Chem, Chiba 2638522, Japan; Natl Inst Genet, Invertebrate Genet Lab, Shizuoka 4418540, Japan	Soka University; Japan Science & Technology Agency (JST); Chiba University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Nishihara, S (corresponding author), Soka Univ, Cell Biol Lab, Dept Bioinformat, 1-236 Tangi Cho, Hachioji, Tokyo 1928577, Japan.	shoko@t.soka.ac.jp		Ueyama, Morio/0000-0002-2950-7361; Nishihara, Shoko/0000-0002-1668-2603				Baeg GH, 2001, DEVELOPMENT, V128, P87; Bellaiche Y, 1998, NATURE, V394, P85, DOI 10.1038/27932; Brook WJ, 1996, ANNU REV CELL DEV BI, V12, P161, DOI 10.1146/annurev.cellbio.12.1.161; DENNIS RD, 1991, CELL TISSUE RES, V265, P589, DOI 10.1007/BF00340883; Fu WM, 2003, DEVELOPMENT, V130, P5229, DOI 10.1242/dev.00764; Goto S, 2001, NAT CELL BIOL, V3, P816, DOI 10.1038/ncb0901-816; HEBERLEIN U, 1993, CELL, V75, P913, DOI 10.1016/0092-8674(93)90535-X; Ichimiya T, 2004, J BIOL CHEM, V279, P42638, DOI 10.1074/jbc.M404900200; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jullien D, 1997, MECH DEVELOP, V68, P179, DOI 10.1016/S0925-4773(97)00136-6; Kamimura K, 2001, J BIOL CHEM, V276, P17014, DOI 10.1074/jbc.M011354200; Kamimura K, 2004, J CELL BIOL, V166, P1069, DOI 10.1083/jcb.200403077; Kamiyama S, 2006, J BIOL CHEM, V281, P10945, DOI 10.1074/jbc.M508991200; Kamiyama S, 2004, TRENDS GLYCOSCI GLYC, V16, P109, DOI 10.4052/tigg.16.109; Kamiyama S, 2003, J BIOL CHEM, V278, P25958, DOI 10.1074/jbc.M302439200; Kurima K, 1998, P NATL ACAD SCI USA, V95, P8681, DOI 10.1073/pnas.95.15.8681; LI H, 1995, J BIOL CHEM, V270, P29453, DOI 10.1074/jbc.270.49.29453; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Lin XH, 2000, MATRIX BIOL, V19, P303, DOI 10.1016/S0945-053X(00)00073-1; Lin XH, 1999, NATURE, V400, P281, DOI 10.1038/22343; Lin XH, 1999, DEVELOPMENT, V126, P3715; Luders F, 2003, EMBO J, V22, P3635, DOI 10.1093/emboj/cdg345; Muraoka M, 2001, FEBS LETT, V495, P87, DOI 10.1016/S0014-5793(01)02358-4; Nakamura Y, 2002, J BIOL CHEM, V277, P46280, DOI 10.1074/jbc.M203873200; OLWIN BB, 1992, J CELL BIOL, V118, P631, DOI 10.1083/jcb.118.3.631; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; Selleck SB, 2004, TRENDS GLYCOSCI GLYC, V16, P95, DOI 10.4052/tigg.16.95; Selva EM, 2001, NAT CELL BIOL, V3, P809, DOI 10.1038/ncb0901-809; Sen J, 1998, CELL, V95, P471, DOI 10.1016/S0092-8674(00)81615-3; Spradling AC, 1986, DROSOPHILA PRACTICAL, P175; Suda T, 2004, J BIOL CHEM, V279, P26469, DOI 10.1074/jbc.M311353200; Tabata T, 2004, DEVELOPMENT, V131, P703, DOI 10.1242/dev.01043; Takei Y, 2004, DEVELOPMENT, V131, P73, DOI 10.1242/dev.00913; Takemae H, 2003, J BIOL CHEM, V278, P15571, DOI 10.1074/jbc.M301123200; The I, 1999, MOL CELL, V4, P633, DOI 10.1016/S1097-2765(00)80214-2; Tiralongo J, 2006, GLYCOBIOLOGY, V16, P73, DOI 10.1093/glycob/cwj029; Toyoda H, 2000, J BIOL CHEM, V275, P2269, DOI 10.1074/jbc.275.4.2269; Tsuda M, 1999, NATURE, V400, P276, DOI 10.1038/22336; Wilson IBH, 2002, J BIOL CHEM, V277, P21207, DOI 10.1074/jbc.M201634200; Zhu XJ, 2005, DEVELOPMENT, V132, P3813, DOI 10.1242/dev.01962	40	18	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					28508	28517		10.1074/jbc.M605045200	http://dx.doi.org/10.1074/jbc.M605045200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16873373	hybrid			2022-12-27	WOS:000240680500004
J	Virkki, LV; Murer, H; Forster, IC				Virkki, Leila V.; Murer, Heini; Forster, Ian C.			Mapping conformational changes of a type IIb Na+/P-i cotransporter by voltage clamp fluorometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLED PHOSPHATE COTRANSPORTER; FUNCTIONALLY IMPORTANT SITES; SHAKER K+ CHANNEL; TRANSPORTER GAT1; NAPI-IIA; FLUORESCENCE; TRANSITIONS; DYNAMICS; BINDING; ATPASE	The fluorescence of a fluorophore depends on its environment, and if attached to a protein it may report on conformational changes. We have combined two-electrode voltage clamp with simultaneous fluorescence measurements to detect conformational changes in a type IIb Na+/P-i cotransporter expressed in Xenopus oocytes. Four novel Cys, labeled with a fluorescent probe, yielded voltage-and substrate-dependent changes in fluorescence (F). Neither Cys substitution nor labeling significantly altered the mutant electrogenic properties. Different F responses to voltage and substrate were recorded at the four sites. S155C, located in an intracellular re-entrant loop in the first half of the protein, and E451C, located in an extracellular re-entrant loop in the second half of the protein, both showed Na+, Li+, and P-i-dependent F signals. S226C and Q319C, located at opposite ends of a large extracellular loop in the middle of the protein, mainly responded to changes in Na+ and Li+. Hyperpolarization increased F for S155C and S226C but decreased F for Q319C and E451C. The labeling and F response of S155C, confirmed that the intracellular loop containing Ser155 is re-entrant as it is accessible from the extracellular milieu. The behavior of S155C and E451C indicates a strong involvement of the two re-entrant loops in conformational changes during the transport cycle. Moreover, the data for S226C and Q319C suggest that also the large extracellular loop is associated with transport function. Finally, the reciprocal voltage dependences of the S155C-E451C and S226C-Q319C pairs suggest reciprocal conformational changes during the transport cycle for their respective local environments.	Univ Zurich Irchel, Inst Physiol, CH-8057 Zurich, Switzerland; Univ Zurich Irchel, Ctr Integrat Human Physiol, CH-8057 Zurich, Switzerland	University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Virkki, LV (corresponding author), Univ Zurich Irchel, Inst Physiol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	leilav@physiol.unizh.ch		Forster, Ian/0000-0003-3087-9952				Bacconi A, 2005, P NATL ACAD SCI USA, V102, P12606, DOI 10.1073/pnas.0505882102; Cha A, 1998, J GEN PHYSIOL, V112, P391, DOI 10.1085/jgp.112.4.391; Cha A, 1997, NEURON, V19, P1127, DOI 10.1016/S0896-6273(00)80403-1; Ehnes C, 2004, J GEN PHYSIOL, V124, P489, DOI 10.1085/jgp.200409061; Forster I, 1998, J GEN PHYSIOL, V112, P1, DOI 10.1085/jgp.112.1.1; Forster IC, 1997, J MEMBRANE BIOL, V160, P9, DOI 10.1007/s002329900291; Forster IC, 2000, BIOPHYS J, V79, P215, DOI 10.1016/S0006-3495(00)76285-0; Forster IC, 2002, PROG BIOPHYS MOL BIO, V80, P69, DOI 10.1016/S0079-6107(02)00015-9; Geibel S, 2003, ANN NY ACAD SCI, V986, P31, DOI 10.1111/j.1749-6632.2003.tb07136.x; Geibel S, 2003, P NATL ACAD SCI USA, V100, P964, DOI 10.1073/pnas.0337336100; Kohler K, 2002, J GEN PHYSIOL, V120, P693, DOI 10.1085/jgp.20028645; Kohler K, 2002, AM J PHYSIOL-RENAL, V282, pF687, DOI 10.1152/ajprenal.00282.2001; Lambert G, 1999, J GEN PHYSIOL, V114, P637, DOI 10.1085/jgp.114.5.637; Lambert G, 2001, J GEN PHYSIOL, V117, P533, DOI 10.1085/jgp.117.6.533; Larsson HP, 2004, P NATL ACAD SCI USA, V101, P3951, DOI 10.1073/pnas.0306737101; Li M, 2002, BIOPHYS J, V83, P206, DOI 10.1016/S0006-3495(02)75162-X; Li M, 2000, J GEN PHYSIOL, V115, P491, DOI 10.1085/jgp.115.4.491; Loo DDF, 1998, P NATL ACAD SCI USA, V95, P7789, DOI 10.1073/pnas.95.13.7789; Mager S, 1996, J NEUROSCI, V16, P5405; Mager S, 1998, METHOD ENZYMOL, V296, P551; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; Meinild AK, 2002, BIOCHEMISTRY-US, V41, P1250, DOI 10.1021/bi011661r; Murer H, 2000, PHYSIOL REV, V80, P1373, DOI 10.1152/physrev.2000.80.4.1373; Virkki LV, 2006, J GEN PHYSIOL, V127, P539, DOI 10.1085/jgp.200609496; Virkki LV, 2005, AM J PHYSIOL-RENAL, V288, pF969, DOI 10.1152/ajprenal.00293.2004	25	23	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					28837	28849		10.1074/jbc.M603861200	http://dx.doi.org/10.1074/jbc.M603861200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16887801	hybrid, Green Published			2022-12-27	WOS:000240680500038
J	Dash, C; Fisher, TS; Prasad, VR; Le Grice, SFJ				Dash, Chandravanu; Fisher, Timothy S.; Prasad, Vinayaka R.; Le Grice, Stuart F. J.			Examining interactions of HIV-1 reverse transcriptase with single-stranded template nucleotides by nucleoside analog interference	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PRIMER GRIP REGION; SUBUNIT-SELECTIVE MUTAGENESIS; DIFFERENT SEQUENCE CONTEXTS; POLYMERASE ACTIVE-SITE; T7 DNA-POLYMERASE; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; TRANSLESION SYNTHESIS; FINGERS SUBDOMAIN	Crystallographic studies have implicated several residues of the p66 fingers subdomain of human immunodeficiency virus type-1 reverse transcriptase in contacting the single-stranded template overhang immediately ahead of the DNA polymerase catalytic center. This interaction presumably assists in inducing the appropriate geometry on the template base for efficient and accurate incorporation of the incoming dNTP. To investigate this, we introduced nucleoside analogs either individually or in tandem into the DNA template ahead of the catalytic center and investigated whether they induce pausing of the replication machinery before serving as the template base. Analogs included abasic tetrahydrofuran linkages, neutralizing methylphosphonate linkages, and conformationally locked nucleosides. In addition, several Phe-61 mutants were included in our analysis, based on previous data indicating that altering this residue affects both strand displacement synthesis and the fidelity of DNA synthesis. We demonstrate here that altering the topology of the template strand two nucleotides ahead of the catalytic center can interrupt DNA synthesis. Mutating Phe-61 to either Ala or Leu accentuates this defect, whereas replacement with an aromatic residue (Trp) allows the mutant enzyme to bypass the template analogs with relative ease.	NCI, Frederick Canc Res & Dev Ctr, Resistance Mechanisms Lab, HIV Drug Resistance Program,NIH, Frederick, MD 21702 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Yeshiva University; Albert Einstein College of Medicine	Le Grice, SFJ (corresponding author), NCI, Frederick Canc Res & Dev Ctr, Resistance Mechanisms Lab, HIV Drug Resistance Program,NIH, Frederick, MD 21702 USA.	slegrice@ncifcrf.gov	Fisher, Timothy S/D-8517-2011; Prasad, Vinayaka R./A-1029-2011	Fisher, Timothy S/0000-0002-8909-313X; Prasad, Vinayaka/0000-0002-9461-0189; Dash, Chandravanu/0000-0003-4466-8355	Intramural NIH HHS Funding Source: Medline; NIAID NIH HHS [R37 AI030861] Funding Source: Medline; NIDA NIH HHS [K99 DA024558, R00 DA024558] Funding Source: Medline; DIVISION OF BASIC SCIENCES - NCI [Z01BC010492] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI030861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R00DA024558] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); DIVISION OF BASIC SCIENCES - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Allawi HT, 2003, J MOL BIOL, V328, P537, DOI 10.1016/S0022-2836(03)00351-6; Bebenek K, 1997, NAT STRUCT BIOL, V4, P194, DOI 10.1038/nsb0397-194; Bibillo A, 2005, J BIOL CHEM, V280, P30282, DOI 10.1074/jbc.M502457200; BOOSALIS MS, 1989, J BIOL CHEM, V264, P11360; Boyer PL, 2002, J VIROL, V76, P3248, DOI 10.1128/JVI.76.7.3248-3256.2002; CAI H, 1993, J BIOL CHEM, V268, P23567; Cannistraro VJ, 2004, J BIOL CHEM, V279, P18288, DOI 10.1074/jbc.M400282200; Chary P, 1997, J BIOL CHEM, V272, P5805, DOI 10.1074/jbc.272.9.5805; Dash C, 2006, J BIOL CHEM, V281, P2773, DOI 10.1074/jbc.M510369200; Dash C, 2004, J BIOL CHEM, V279, P37095, DOI 10.1074/jbc.M403306200; DING J, 1995, STRUCTURE, V3, P365, DOI 10.1016/S0969-2126(01)00168-X; Ding JP, 1998, J MOL BIOL, V284, P1095, DOI 10.1006/jmbi.1998.2208; Fisher TS, 2003, J MOL BIOL, V325, P443, DOI 10.1016/S0022-2836(02)01225-1; Fisher TS, 2002, J BIOL CHEM, V277, P22345, DOI 10.1074/jbc.M200282200; Furge LL, 1998, BIOCHEMISTRY-US, V37, P3567, DOI 10.1021/bi9722094; Gao R, 2004, BIOCHEMISTRY-US, V43, P6167, DOI 10.1021/bi040005z; Ghosh M, 1997, BIOCHEMISTRY-US, V36, P5758, DOI 10.1021/bi963045e; Ghosh M, 1996, BIOCHEMISTRY-US, V35, P8553, DOI 10.1021/bi952773j; Goldschmidt V, 2002, J BIOL CHEM, V277, P43233, DOI 10.1074/jbc.M205295200; GOODMAN MF, 1994, ANN NY ACAD SCI, V726, P132, DOI 10.1111/j.1749-6632.1994.tb52804.x; Gutierrez-Rivas M, 2001, NUCLEIC ACIDS RES, V29, P4963, DOI 10.1093/nar/29.24.4963; Hoehn ST, 2001, NUCLEIC ACIDS RES, V29, P3413, DOI 10.1093/nar/29.16.3413; Hsiou Y, 1996, STRUCTURE, V4, P853, DOI 10.1016/S0969-2126(96)00091-3; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Huang XW, 2003, BIOCHEMISTRY-US, V42, P2456, DOI 10.1021/bi026912q; JACOBOMOLINA A, 1993, P NATL ACAD SCI USA, V90, P6320, DOI 10.1073/pnas.90.13.6320; KEW Y, 1994, J BIOL CHEM, V269, P15331; Klarmann GJ, 2000, J BIOL CHEM, V275, P359, DOI 10.1074/jbc.275.1.359; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; Lanchy JM, 1998, J BIOL CHEM, V273, P24425, DOI 10.1074/jbc.273.38.24425; Lanchy JM, 2000, J BIOL CHEM, V275, P12306, DOI 10.1074/jbc.275.16.12306; LATHAM GJ, 1994, J BIOL CHEM, V269, P28527; Latham GJ, 2000, J BIOL CHEM, V275, P15025, DOI 10.1074/jbc.M000279200; LeGrice SFJ, 1995, METHOD ENZYMOL, V262, P130, DOI 10.1016/0076-6879(95)62015-X; LEGRICE SFJ, 1991, EMBO J, V10, P3905, DOI 10.1002/j.1460-2075.1991.tb04960.x; Lener D, 2003, J BIOL CHEM, V278, P26526, DOI 10.1074/jbc.M302374200; Lhomme J, 1999, BIOPOLYMERS, V52, P65, DOI 10.1002/1097-0282(1999)52:2<65::AID-BIP1>3.0.CO;2-U; Ling H, 2004, MOL CELL, V13, P751, DOI 10.1016/S1097-2765(04)00101-7; Malins DC, 2000, P NATL ACAD SCI USA, V97, P12442, DOI 10.1073/pnas.230438797; Mbisa JL, 2005, J VIROL, V79, P419, DOI 10.1128/JVI.79.1.419-427.2005; Palaniappan C, 1997, J BIOL CHEM, V272, P11157, DOI 10.1074/jbc.272.17.11157; Peletskaya EN, 2001, J VIROL, V75, P9435, DOI 10.1128/JVI.75.19.9435-9445.2001; Petersen M, 2000, J MOL RECOGNIT, V13, P44, DOI 10.1002/(SICI)1099-1352(200001/02)13:1<44::AID-JMR486>3.0.CO;2-6; Powell MD, 1999, J BIOL CHEM, V274, P19885, DOI 10.1074/jbc.274.28.19885; PRASAD VR, 1991, P NATL ACAD SCI USA, V88, P11363, DOI 10.1073/pnas.88.24.11363; Rausch JW, 2003, P NATL ACAD SCI USA, V100, P11279, DOI 10.1073/pnas.1932546100; Rigourd M, 2000, J BIOL CHEM, V275, P26944; RODGERS DW, 1995, P NATL ACAD SCI USA, V92, P1222, DOI 10.1073/pnas.92.4.1222; Sarafianos SG, 2001, EMBO J, V20, P1449, DOI 10.1093/emboj/20.6.1449; Wisniewski M, 1999, J BIOL CHEM, V274, P28175, DOI 10.1074/jbc.274.40.28175; Wohrl BM, 1997, J BIOL CHEM, V272, P17581, DOI 10.1074/jbc.272.28.17581; WOHRL BM, 1995, BIOCHEMISTRY-US, V34, P5343; Yi-Brunozzi HY, 2005, J BIOL CHEM, V280, P20154, DOI 10.1074/jbc.M411228200; Yu Q, 1998, J VIROL, V72, P7676, DOI 10.1128/JVI.72.9.7676-7680.1998; Zhang WH, 2002, P NATL ACAD SCI USA, V99, P10090, DOI 10.1073/pnas.152186199; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	56	12	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					27873	27881		10.1074/jbc.M603970200	http://dx.doi.org/10.1074/jbc.M603970200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16867979	hybrid			2022-12-27	WOS:000240534400023
J	Schwenkert, S; Umate, P; Dal Bosco, C; Volz, S; Mlcochova, L; Zoryan, M; Eichacker, LA; Ohad, I; Herrmann, RG; Meurer, J				Schwenkert, Serena; Umate, Pavan; Dal Bosco, Cristina; Volz, Stefanie; Mlcochova, Lada; Zoryan, Mikael; Eichacker, Lutz A.; Ohad, Itzhak; Herrmann, Reinhold G.; Meurer, Joerg			PsbI affects the stability, function, and phosphorylation patterns of photosystem II assemblies in tobacco	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-MASS SUBUNITS; 3.2 ANGSTROM RESOLUTION; CHLOROPHYLL FLUORESCENCE; THERMO-LUMINESCENCE; CRYSTAL-STRUCTURE; CHARGE ACCUMULATION; PRIMARY ACCEPTOR; PROTEIN-KINASE; ELECTRON FLOW; GENE	Photosystem II ( PSII) core complexes consist of CP47, CP43, D1, D2 proteins and of several low molecular weight integral membrane polypeptides, such as the chloroplast-encoded PsbE, PsbF, and PsbI proteins. To elucidate the function of PsbI in the photosynthetic process as well as in the biogenesis of PSII in higher plants, we generated homoplastomic knock-out plants by replacing most of the tobacco psbI gene with a spectinomycin resistance cartridge. Mutant plants are photoautotrophically viable under green house conditions but sensitive to high light irradiation. Antenna proteins of PSII accumulate to normal amounts, but levels of the PSII core complex are reduced by 50%. Bioenergetic and fluorescence studies uncovered that PsbI is required for the stability but not for the assembly of dimeric PSII and supercomplexes consisting of PSII and the outer antenna (PSII-LHCII). Thermoluminescence emission bands indicate that the presence of PsbI is required for assembly of a fully functional Q(A) binding site. We show that phosphorylation of the reaction center proteins D1 and D2 is light and redoxregulated in the wild type, but phosphorylation is abolished in the mutant, presumably due to structural alterations of PSII when PsbI is deficient. Unlike wild type, phosphorylation of LHCII is strongly increased in the dark due to accumulation of reduced plastoquinone, whereas even upon state II light phosphorylation is decreased in Delta psbI. These data attest that phosphorylation of D1/D2, CP43, and LHCII is regulated differently.	Univ Munich, Dept Biol 1, D-80638 Munich, Germany; Hebrew Univ Jerusalem, Dept Biol Chem, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Minerva Ctr Photosynth Res, IL-91904 Jerusalem, Israel	University of Munich; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Meurer, J (corresponding author), Univ Munich, Dept Biol 1, Menzingerstr 67, D-80638 Munich, Germany.	joerg.meurer@lrz.uni-muenchen.de	Meurer, Jörg/F-8479-2010; Schwenkert, Serena/F-8564-2012	Meurer, Jörg/0000-0003-2973-9514; Dal Bosco, Cristina/0000-0002-0280-5369				Adir N, 2003, PHOTOSYNTH RES, V76, P343, DOI 10.1023/A:1024969518145; ALLEN JF, 1981, BIOCHIM BIOPHYS ACTA, V638, P290, DOI 10.1016/0005-2728(81)90239-5; Amann K, 2004, PLANT CELL, V16, P3084, DOI 10.1105/tpc.104.024935; Aro EM, 2005, J EXP BOT, V56, P347, DOI 10.1093/jxb/eri041; Bassi R, 1997, PHYSIOL PLANTARUM, V100, P769, DOI 10.1034/j.1399-3054.1997.1000404.x; Bellafiore S, 2005, NATURE, V433, P892, DOI 10.1038/nature03286; BENNETT J, 1977, NATURE, V269, P344, DOI 10.1038/269344a0; Biesiadka J, 2004, PHYS CHEM CHEM PHYS, V6, P4733, DOI 10.1039/b406989g; Bonardi V, 2005, NATURE, V437, P1179, DOI 10.1038/nature04016; Bondarava N, 2003, J BIOL CHEM, V278, P13554, DOI 10.1074/jbc.M212842200; BOWES JM, 1980, BIOCHIM BIOPHYS ACTA, V590, P373, DOI 10.1016/0005-2728(80)90208-X; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; DEMETER S, 1984, BIOCHIM BIOPHYS ACTA, V764, P24, DOI 10.1016/0005-2728(84)90136-1; Ducruet JM, 2003, J EXP BOT, V54, P2419, DOI 10.1093/jxb/erg268; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; GOVINDJEE, 1990, PHOTOSYNTH RES, V25, P151, DOI 10.1007/BF00033157; Granvogl B, 2006, PROTEOMICS, V6, P3681, DOI 10.1002/pmic.200500924; Haumann M, 2005, SCIENCE, V310, P1019, DOI 10.1126/science.1117551; IKEUCHI M, 1989, FEBS LETT, V251, P155, DOI 10.1016/0014-5793(89)81446-2; IKEUCHI M, 1988, FEBS LETT, V241, P99, DOI 10.1016/0014-5793(88)81039-1; Ikeuchi M, 1995, MOL GEN GENET, V249, P622, DOI 10.1007/BF00418031; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Kashino Y, 2002, BIOCHEMISTRY-US, V41, P8004, DOI 10.1021/bi026012+; Keren N, 1997, P NATL ACAD SCI USA, V94, P1579, DOI 10.1073/pnas.94.4.1579; Kern J, 2005, PHOTOSYNTH RES, V84, P153, DOI 10.1007/s11120-004-7077-x; KLUGHAMMER C, 1994, PLANTA, V192, P261, DOI 10.1007/BF01089043; KRAUSE GH, 1991, ANNU REV PLANT PHYS, V42, P313, DOI 10.1146/annurev.pp.42.060191.001525; KRIEGER A, 1995, BBA-BIOENERGETICS, V1229, P193, DOI 10.1016/0005-2728(95)00002-Z; Krieger-Liszkay A, 1998, BIOCHEMISTRY-US, V37, P17339, DOI 10.1021/bi9822628; KUNSTNER P, 1995, J BIOL CHEM, V270, P9651; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Meurer J, 1998, EMBO J, V17, P5286, DOI 10.1093/emboj/17.18.5286; Minagawa J, 2004, PHOTOSYNTH RES, V82, P241, DOI 10.1007/s11120-004-2079-2; Morais F, 2001, J BIOL CHEM, V276, P31986, DOI 10.1074/jbc.M103935200; Muller B, 1999, PLANT CELL, V11, P2365, DOI 10.1105/tpc.11.12.2365; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; MURATA N, 1988, FEBS LETT, V235, P283, DOI 10.1016/0014-5793(88)81280-8; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Ohad I, 2004, BIOCHEMISTRY-US, V43, P2297, DOI 10.1021/bi0348260; Ossenbuhl F, 2004, PLANT CELL, V16, P1790, DOI 10.1105/tpc.023226; PAKRASI HB, 1988, EMBO J, V7, P325, DOI 10.1002/j.1460-2075.1988.tb02816.x; PRASIL O, 1992, TOPICS PHOTOSYNTHESI, V2, P293; Regel RE, 2001, J BIOL CHEM, V276, P41473, DOI 10.1074/jbc.M102007200; Rokka A, 2005, BIOCHEM J, V388, P159, DOI 10.1042/BJ20042098; RUTHERFORD AW, 1984, P NATL ACAD SCI-BIOL, V81, P1107, DOI 10.1073/pnas.81.4.1107; RUTHERFORD AW, 1982, BIOCHIM BIOPHYS ACTA, V682, P457, DOI 10.1016/0005-2728(82)90061-5; Shen GZ, 2002, J BIOL CHEM, V277, P20343, DOI 10.1074/jbc.M201103200; Shi LX, 2004, BBA-BIOENERGETICS, V1608, P75, DOI 10.1016/j.bbabio.2003.12.004; SVAB Z, 1990, P NATL ACAD SCI USA, V87, P8526, DOI 10.1073/pnas.87.21.8526; Swiatek M, 2003, MOL GENET GENOMICS, V268, P699, DOI 10.1007/s00438-002-0791-1; Thornton LE, 2005, ADV PHOTO RESPIRAT, V22, P121; TOMO T, 1993, FEBS LETT, V323, P15, DOI 10.1016/0014-5793(93)81438-6; Vainonen JP, 2005, J BIOL CHEM, V280, P33679, DOI 10.1074/jbc.M505729200; VANKOOTEN O, 1990, PHOTOSYNTH RES, V25, P147, DOI 10.1007/BF00033156; Vasil'ev S, 2001, P NATL ACAD SCI USA, V98, P8602, DOI 10.1073/pnas.141239598; Vass I, 1996, PHOTOSYNTH RES, V48, P117, DOI 10.1007/BF00041002; VASS I, 1992, P NATL ACAD SCI USA, V89, P1408, DOI 10.1073/pnas.89.4.1408; Vass I., 1992, TOPICS PHOTOSYNTHESI, P259; WEBBER AN, 1989, FEBS LETT, V242, P259, DOI 10.1016/0014-5793(89)80481-8; WEIS E, 1985, PHOTOSYNTH RES, V6, P73, DOI 10.1007/BF00029047; Zer H, 2003, BIOCHEMISTRY-US, V42, P728, DOI 10.1021/bi020451r; Zheleva D, 1998, J BIOL CHEM, V273, P16122, DOI 10.1074/jbc.273.26.16122; ZILARD A, 2005, PHOTOSYNTH RES, V84, P15; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	65	55	58	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34227	34238		10.1074/jbc.M604888200	http://dx.doi.org/10.1074/jbc.M604888200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16920705	hybrid			2022-12-27	WOS:000241767600043
J	Fawcett, GL; Santi, CM; Butler, A; Harris, T; Covarrubias, M; Salkoff, L				Fawcett, Gloria L.; Santi, Celia M.; Butler, Alice; Harris, Thanawath; Covarrubias, Manuel; Salkoff, Lawrence			Mutant analysis of the Shal (Kv4) voltage-gated fast transient K+ channel in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLOSED-STATE INACTIVATION; POTASSIUM CHANNELS; ALPHA-SUBUNIT; C-ELEGANS; MUSCLE-CELLS; CURRENT DIVERSITY; SEX DETERMINATION; OUTWARD CURRENT; MOLECULAR-BASIS; GENE FAMILY	Shal (Kv4)alpha-subunits are the most conserved among the family of voltage-gated potassium channels. Previous work has shown that the Shal potassium channel subfamily underlies the predominant fast transient outward current in Drosophila neurons (Tsunoda, S., and Salkoff, L. ( 1995) J. Neurosci. 15, 1741 1754) and the fast transient outward current in mouse heart muscle (Guo, W., Jung, W. E., Marionneau, C., Aimond, F., Xu, H., Yamada, K. A., Schwarz, T. L., Demolombe, S., and Nerbonne, J. M. ( 2005) Circ. Res. 97, 1342 - 1350). We show that Shal channels also play a role as the predominant transient outward current in Caenorhabditis elegans muscle. Green fluorescent protein promoter experiments also revealed SHL-1 expression in a subset of neurons as well as in C. elegans body wall muscle and in male-specific diagonal muscles. The shl-1 (ok1168) null mutant removed all fast transient outward current from muscle cells. SHL-1 currents strongly resembled Shal currents in other species except that they were active in a more depolarized voltage range. We also determined that the remaining delayed-rectifier current in cultured myocytes was carried by the Shaker ortholog SHK-1. In shl-1 ( ok1168) mutants there was a significant compensatory increase in the SHK-1 current. Male shl-1 ( ok1168) animals exhibited reduced mating efficiency resulting from an apparent difficulty in locating the hermaphrodite vulva. SHL-1 channels are apparently important in fine-tuning complex behaviors, such as mating, that play a crucial role in the survival and propagation of the species.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Jefferson Med Coll, Philadelphia, PA 19107 USA	Washington University (WUSTL); Washington University (WUSTL); Jefferson University	Salkoff, L (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	salkoffl@pcg.wustl.edu		Covarrubias, Manuel/0000-0002-0881-4143	NCRR NIH HHS [R24 RR017342-01, R24 RR017342] Funding Source: Medline; NIAAA NIH HHS [T32 AA007463] Funding Source: Medline; NIGMS NIH HHS [R01 GM067154-01A1, R01 GM067154] Funding Source: Medline; NINDS NIH HHS [R01 NS032337-11, R01 NS032337-07, R01 NS032337-12, R01 NS032337-09A1, R01 NS032337-08, R01 NS032337-10, R01 NS032337, R01 NS032337-06] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR017342] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA007463] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Amberg GC, 2003, AM J PHYSIOL-CELL PH, V284, pC583, DOI 10.1152/ajpcell.00301.2002; Amberg GC, 2002, J PHYSIOL-LONDON, V544, P403, DOI 10.1113/jphysiol.2002.025163; Bahring R, 2001, J PHYSIOL-LONDON, V535, P65, DOI 10.1111/j.1469-7793.2001.00065.x; Baro DJ, 1996, J NEUROSCI, V16, P1689; Baro DJ, 2000, J NEUROSCI, V20, P6619, DOI 10.1523/JNEUROSCI.20-17-06619.2000; Barry DM, 1998, CIRC RES, V83, P560, DOI 10.1161/01.RES.83.5.560; Beck EJ, 2001, BIOPHYS J, V81, P867, DOI 10.1016/S0006-3495(01)75747-5; Bianchi L, 2003, J BIOL CHEM, V278, P12415, DOI 10.1074/jbc.M212788200; Birnbaum SG, 2004, PHYSIOL REV, V84, P803, DOI 10.1152/physrev.00039.2003; Cai X, 2004, NEURON, V44, P351, DOI 10.1016/j.neuron.2004.09.026; Christensen M, 2002, NEURON, V33, P503, DOI 10.1016/S0896-6273(02)00591-3; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; CONNOR JA, 1971, J PHYSIOL-LONDON, V213, P21, DOI 10.1113/jphysiol.1971.sp009365; CONNOR JA, 1971, J PHYSIOL-LONDON, V213, P31, DOI 10.1113/jphysiol.1971.sp009366; COVARRUBIAS M, 1991, NEURON, V7, P763, DOI 10.1016/0896-6273(91)90279-9; Crowder CM, 1996, ANESTHESIOLOGY, V85, P901, DOI 10.1097/00000542-199610000-00027; Dilks D, 1999, J NEUROPHYSIOL, V81, P1974, DOI 10.1152/jn.1999.81.4.1974; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Garcia LR, 2003, J NEUROSCI, V23, P2696; Garcia LR, 2001, CELL, V107, P777, DOI 10.1016/S0092-8674(01)00600-6; Guo WN, 2005, CIRC RES, V97, P1342, DOI 10.1161/01.RES.0000196559.63223.aa; Guo WN, 1999, J PHYSIOL-LONDON, V521, P587, DOI 10.1111/j.1469-7793.1999.00587.x; Guo WN, 2000, CIRC RES, V87, P73, DOI 10.1161/01.RES.87.1.73; HAGIWARA S, 1961, J PHYSIOL-LONDON, V155, P471; Hahn J, 2003, J NEUROSCI, V23, P10859; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HILLE B, 1992, IONIC CHANNELS EXCIT, P76; HODGKIN J, 1984, Journal of Embryology and Experimental Morphology, V83, P103; HODGKIN J, 1987, DEVELOPMENT, V101, P5; HODGKIN J, 1983, NATURE, V304, P267, DOI 10.1038/304267a0; Holmqvist MH, 2002, P NATL ACAD SCI USA, V99, P1035, DOI 10.1073/pnas.022509299; Jerng HH, 2004, MOL CELL NEUROSCI, V27, P343, DOI 10.1016/j.mcn.2004.06.011; JORGENSEN EM, 1995, NATURE, V378, P196, DOI 10.1038/378196a0; Jospin M, 2002, J PHYSIOL-LONDON, V544, P373, DOI 10.1113/jphysiol.2002.022293; KOVAC MP, 1982, J NEUROPHYSIOL, V47, P909, DOI 10.1152/jn.1982.47.5.909; LOER CM, 1993, J NEUROSCI, V13, P5407, DOI 10.1523/JNEUROSCI.13-12-05407.1993; MacLean JN, 2003, NEURON, V37, P109, DOI 10.1016/S0896-6273(02)01104-2; NEHER E, 1971, J GEN PHYSIOL, V58, P36, DOI 10.1085/jgp.58.1.36; Nerbonne JM, 2000, J PHYSIOL-LONDON, V525, P285, DOI 10.1111/j.1469-7793.2000.t01-1-00285.x; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; Ohya S, 1997, FEBS LETT, V420, P47, DOI 10.1016/S0014-5793(97)01483-X; OKKEMA PG, 1993, GENETICS, V135, P385; PAK MD, 1991, P NATL ACAD SCI USA, V88, P4386, DOI 10.1073/pnas.88.10.4386; Price MP, 2004, J BIOL CHEM, V279, P53886, DOI 10.1074/jbc.M407708200; Ramakers GMJ, 2002, P NATL ACAD SCI USA, V99, P10144, DOI 10.1073/pnas.152620399; Sah R, 2003, J PHYSIOL-LONDON, V546, P5, DOI 10.1113/jphysiol.2002.026468; Saifee O, 1998, MOL BIOL CELL, V9, P1235, DOI 10.1091/mbc.9.6.1235; Salkoff L, 2001, NEUROSCIENCE, V103, P853, DOI 10.1016/S0306-4522(01)00079-3; Santi CM, 2003, P NATL ACAD SCI USA, V100, P14391, DOI 10.1073/pnas.1935976100; Shibata R, 2000, J NEUROSCI, V20, P4145; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Takahashi E, 2004, NEUROSCI LETT, V359, P37, DOI 10.1016/j.neulet.2004.01.066; THOMPSON SH, 1977, J PHYSIOL-LONDON, V265, P465, DOI 10.1113/jphysiol.1977.sp011725; TSUNODA S, 1995, J NEUROSCI, V15, P1741, DOI 10.1523/JNEUROSCI.15-03-01741.1995; Waterston R., 1988, NEMATODE C ELEGANS, P281; WEI A, 1990, SCIENCE, V248, P599, DOI 10.1126/science.2333511; Wei A, 1996, NEUROPHARMACOLOGY, V35, P805, DOI 10.1016/0028-3908(96)00126-8; Xu HD, 1999, J PHYSIOL-LONDON, V519, P11, DOI 10.1111/j.1469-7793.1999.0011o.x; Yuan A, 2003, NEURON, V37, P765, DOI 10.1016/S0896-6273(03)00096-5; Yuan A, 2000, NAT NEUROSCI, V3, P771, DOI 10.1038/77670; Yuan LL, 2002, J NEUROSCI, V22, P4860, DOI 10.1523/JNEUROSCI.22-12-04860.2002; Yuan WL, 2005, J NEUROSCI, V25, P9185, DOI 10.1523/JNEUROSCI.2858-05.2005	62	24	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30725	30735		10.1074/jbc.M605814200	http://dx.doi.org/10.1074/jbc.M605814200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16899454	Green Accepted, hybrid			2022-12-27	WOS:000241075900049
J	Hirao, M; Tamai, N; Tsumaki, N; Yoshikawa, H; Myoui, A				Hirao, Makoto; Tamai, Noriyuki; Tsumaki, Noriyuki; Yoshikawa, Hideki; Myoui, Akira			Oxygen tension regulates chondrocyte differentiation and function during endochondral ossification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; BONE MORPHOGENETIC PROTEIN-2; MESENCHYMAL STEM-CELLS; COLLAGEN X PROMOTER; ARTICULAR-CARTILAGE; INDUCED APOPTOSIS; GENE-EXPRESSION; CHONDROGENESIS; C3H10T1/2; GROWTH	Cartilage functions at a lower oxygen tension than most other tissues. To determine the role of oxygen tension in chondrocyte differentiation and function, we investigated the influence of oxygen tension in the pluripotent mesenchymal cell line C3H10T1/2 and 14.5E mice embryo forelimb organ culture. 10T1/2 cells and embryo forelimbs were cultured under normoxia (20% O-2) or hypoxia (5% O-2) in the presence of recombinant human bone morphogenetic protein 2. To elucidate the mechanism by which oxygen tension influences chondrocyte differentiation, the Smad pathway was examined using Smad6 overexpression adenovirus and Smad6 transgenic mice embryo forelimbs. The p38 MAPK pathway was examined using dominant-negative MKK3 and FR167653, a specific p38 MAPK inhibitor. The transcriptional activities of Sox9 and Runx2 were also investigated. Hypoxia promoted bone morphogenetic protein 2-induced glycosaminoglycan production and suppressed alkaline phosphatase activity and mineralization of C3H10T1/2. Thus, hypoxia promoted chondrocytic commitment rather than osteoblastic differentiation. In the mice embryo forelimb organ culture, hypoxia increased cartilaginous matrix synthesis. These effects were primarily mediated by p38 MAPK activation, independent of Sox9. Hypoxia inhibited Col10a1 (type X collagen alpha 1) expression via down-regulation of Runx2 activity by Smad suppression and histone deacetylase 4 activation. In conclusion, hypoxia promotes chondrocytic differentiation and cartilage matrix synthesis and suppresses terminal chondrocyte differentiation. These hypoxia-induced phenomena may act on chondrocytes to enhance and preserve their phenotype and function during chondrocyte differentiation and endochondral ossification.	Osaka Univ Hosp, Med Ctr Translat Res, Suita, Osaka 5650871, Japan; Osaka Univ, Grad Sch Med, Dept Orthopaed, Suita, Osaka 5650871, Japan	Osaka University; Osaka University	Myoui, A (corresponding author), Osaka Univ Hosp, Med Ctr Translat Res, 2-15 Yamadaoka, Suita, Osaka 5650871, Japan.	myoi@hp-mctr.med.osaka-u.ac.jp	Myoui, Akira/E-8296-2010; Tamai, Noriyuki/AAO-4939-2021	Tsumaki, Noriyuki/0000-0002-0520-3654				AHRENS M, 1993, DNA CELL BIOL, V12, P871, DOI 10.1089/dna.1993.12.871; Asahina I, 1996, EXP CELL RES, V222, P38, DOI 10.1006/excr.1996.0005; Atkinson BL, 1997, J CELL BIOCHEM, V65, P325, DOI 10.1002/(SICI)1097-4644(19970601)65:3<325::AID-JCB3>3.0.CO;2-U; Beier F, 1999, BIOCHEM BIOPH RES CO, V262, P50, DOI 10.1006/bbrc.1999.1178; Beitner-Johnson D, 1998, BIOCHEM BIOPH RES CO, V242, P61, DOI 10.1006/bbrc.1997.7907; Bosnakovski D, 2004, EXP HEMATOL, V32, P502, DOI 10.1016/j.exphem.2004.02.009; BRIGHTON CT, 1984, ARTHRITIS RHEUM-US, V27, P1290, DOI 10.1002/art.1780271112; Chauchereau A, 2004, ONCOGENE, V23, P8777, DOI 10.1038/sj.onc.1208128; CONLON RA, 1993, METHOD ENZYMOL, V225, P373; Drissi MH, 2003, J CELL BIOCHEM, V90, P1287, DOI 10.1002/jcb.10677; FALCHUK KH, 1970, AM J MED, V49, P223, DOI 10.1016/S0002-9343(70)80078-X; FERRELL WR, 1992, J PHYSIOL-LONDON, V449, P607, DOI 10.1113/jphysiol.1992.sp019104; Ghatan S, 2000, J CELL BIOL, V150, P335, DOI 10.1083/jcb.150.2.335; GIBSON GJ, 1985, J CELL BIOL, V101, P277, DOI 10.1083/jcb.101.1.277; Haas AR, 2000, METH MOL B, V137, P383; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hiraki Y, 1997, J BIOL CHEM, V272, P32419, DOI 10.1074/jbc.272.51.32419; Horiki M, 2004, J CELL BIOL, V165, P433, DOI 10.1083/jcb.200311015; Huang CYC, 2004, ANAT REC PART A, V278A, P428, DOI 10.1002/ar.a.20010; Huang WD, 2000, MOL CELL BIOL, V20, P4149, DOI 10.1128/MCB.20.11.4149-4158.2000; Inada M, 1999, DEV DYNAM, V214, P279, DOI 10.1002/(SICI)1097-0177(199904)214:4<279::AID-AJA1>3.0.CO;2-W; Ito K, 2004, BIOCHEM BIOPH RES CO, V315, P240, DOI 10.1016/j.bbrc.2004.01.046; Iwasaki S, 1999, J BIOL CHEM, V274, P26503, DOI 10.1074/jbc.274.37.26503; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; Kamiya N, 2002, J BONE MINER RES, V17, P1832, DOI 10.1359/jbmr.2002.17.10.1832; KATAGIRI T, 1990, BIOCHEM BIOPH RES CO, V172, P295, DOI 10.1016/S0006-291X(05)80208-6; Kawasaki H, 1997, J BIOL CHEM, V272, P18518, DOI 10.1074/jbc.272.30.18518; KIAER T, 1988, CLIN ORTHOP RELAT R, V229, P149; Kim IS, 1999, MECH DEVELOP, V80, P159, DOI 10.1016/S0925-4773(98)00210-X; Kimura N, 2000, J BIOL CHEM, V275, P17647, DOI 10.1074/jbc.M908622199; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; Leboy PS, 2001, J BONE JOINT SURG AM, V83A, pS15; Lee JK, 2004, P NATL ACAD SCI USA, V101, P8815, DOI 10.1073/pnas.0402800101; LEE NH, 1974, CALC TISS RES, V16, P277, DOI 10.1007/BF02008235; Lee RB, 1997, BIOCHEM J, V321, P95, DOI 10.1042/bj3210095; Lefebvre V, 1996, MOL CELL BIOL, V16, P4512; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Lim YB, 2000, BIOCHEM BIOPH RES CO, V273, P609, DOI 10.1006/bbrc.2000.2987; Lim YB, 2003, J CELL BIOCHEM, V88, P713, DOI 10.1002/jcb.10389; MARTCUS RE, 1973, ARTHRITIS RHEUM, V16, P646; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Mengshol JA, 2001, NUCLEIC ACIDS RES, V29, P4361, DOI 10.1093/nar/29.21.4361; Minina E, 2002, DEV CELL, V3, P439, DOI 10.1016/S1534-5807(02)00261-7; OLESEN LL, 1970, ARTHRITIS RHEUM, V13, P769; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; OTTE P, 1991, Z RHEUMATOL, V50, P304; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Park JH, 2002, MOL CELL ENDOCRINOL, V192, P197, DOI 10.1016/S0303-7207(02)00036-9; Ratisoontorn C, 2005, BONE, V36, P627, DOI 10.1016/j.bone.2005.01.010; Robins JC, 2005, BONE, V37, P313, DOI 10.1016/j.bone.2005.04.040; Schipani E, 2001, GENE DEV, V15, P2865; SCHMID TM, 1983, J BIOL CHEM, V258, P9504; Sen A, 2001, J CELL BIOCHEM, V81, P312, DOI 10.1002/1097-4644(20010501)81:2<312::AID-JCB1046>3.0.CO;2-Q; Shukunami C, 1998, EXP CELL RES, V241, P1, DOI 10.1006/excr.1998.4045; SILVER IA, 1975, PHILOS T ROY SOC B, V271, P261, DOI 10.1098/rstb.1975.0050; Subbaramaiah K, 2000, J BIOL CHEM, V275, P14838, DOI 10.1074/jbc.275.20.14838; Takeda S, 2001, GENE DEV, V15, P467, DOI 10.1101/gad.845101; TREUHAFT PS, 1971, ARTHRITIS RHEUM, V14, P475, DOI 10.1002/art.1780140407; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; VORKAMP A, 1996, SCIENCE, V273, P613; WANG EA, 1993, GROWTH FACTORS, V9, P57, DOI 10.3109/08977199308991582; Watanabe H, 2001, J BIOL CHEM, V276, P14466, DOI 10.1074/jbc.M005724200; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704; Zehentner BK, 1999, J BONE MINER RES, V14, P1734, DOI 10.1359/jbmr.1999.14.10.1734; Zhen XC, 2001, J BIOL CHEM, V276, P4879, DOI 10.1074/jbc.M004990200; Zheng QP, 2003, J CELL BIOL, V162, P833, DOI 10.1083/jcb.200211089; Zhu YH, 2002, J BIOL CHEM, V277, P22909, DOI 10.1074/jbc.M200042200	71	140	145	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					31079	31092		10.1074/jbc.M602296200	http://dx.doi.org/10.1074/jbc.M602296200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16905540	hybrid			2022-12-27	WOS:000241075900084
J	Lopez-Contreras, AJ; Lopez-Garcia, C; Jimenez-Cervantes, C; Cremades, A; Penafiel, R				Lopez-Contreras, Andres J.; Lopez-Garcia, Carlos; Jimenez-Cervantes, Celia; Cremades, Asuncion; Penafiel, Rafael			Mouse ornithine decarboxylase-like gene encodes an antizyme inhibitor devoid of ornithine and arginine decarboxylating activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC IRREVERSIBLE INHIBITION; HYDROXY-L-ARGININE; TRANSGENIC MICE; RAT-LIVER; TRANSCRIPTIONAL TARGET; POLYAMINE TRANSPORT; CELL-GROWTH; DEGRADATION; AGMATINE; EXPRESSION	Ornithine decarboxylase (ODC), a key enzyme in the biosynthesis of polyamines, is a labile protein that is regulated by interacting with antizymes (AZs), a family of polyamine-induced proteins. Recently, a novel human gene highly homologous to ODC, termed ODC-like or ODC-paralogue (ODCp), was cloned, but the studies aimed to determine its function rendered contradictory results. We have cloned the mouse orthologue of human ODCp and studied its expression and possible function. mRNA of mouse Odcp was found in the brain and testes, showing a conserved expression pattern with regard to the human gene. Transfection of mouse Odcp in HEK 293T cells elicited an increase in ODC activity, but no signs of arginine decarboxylase activity were evident. On the other hand, whereas the ODCp protein was mainly localized in the mitochondrial/membrane fraction, ODC activity was found in the cytosolic fraction and was markedly decreased by small interfering RNA against human ODC. Co-transfection experiments with combinations of Odc, Az1, Az2, Az3, antizyme inhibitor (Azi), and Odcp genes showed that ODCp mimics the action of AZI, rescuing ODC from the effects of AZs and prevented ODC degradation by the proteasome. A direct interaction between ODCp and AZs was detected by immunoprecipitation experiments. We conclude that mouse ODCp has no intrinsic decarboxylase activity, but it acts as a novel antizyme inhibitory protein (AZI2).	Univ Murcia, Fac Med, Dept Pharmacol, E-30100 Murcia, Spain; Univ Murcia, Fac Med, Dept Biochem & Mol Biol & Immunol B, E-30100 Murcia, Spain	University of Murcia; University of Murcia	Penafiel, R (corresponding author), Univ Murcia, Fac Med, Dept Biochem & Mol Biol, Campus Espinardo, E-30100 Murcia, Spain.	rapegar@um.es	Lopez-Contreras, Andres J/AAA-1110-2020; Penafiel, Rafael/H-2660-2015; Jimenez-Cervantes, Celia/H-1953-2015	Penafiel, Rafael/0000-0002-5816-1056; Jimenez-Cervantes, Celia/0000-0002-5821-9510; Lopez-Contreras, Andres Joaquin/0000-0002-5517-7327; Lopez-Garcia, Carlos/0000-0001-9848-8216				Almrud JJ, 2000, J MOL BIOL, V295, P7, DOI 10.1006/jmbi.1999.3331; AUVINEN M, 1992, NATURE, V360, P355, DOI 10.1038/360355a0; BELLOFERNANDEZ C, 1993, P NATL ACAD SCI USA, V90, P7804, DOI 10.1073/pnas.90.16.7804; BIRECKA H, 1985, PLANT PHYSIOL, V79, P509, DOI 10.1104/pp.79.2.509; BITONTI AJ, 1987, BIOCHEM J, V242, P69, DOI 10.1042/bj2420069; BOUCHER JL, 1994, BIOCHEM BIOPH RES CO, V203, P1614, DOI 10.1006/bbrc.1994.2371; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Coffino P, 2001, NAT REV MOL CELL BIO, V2, P188, DOI 10.1038/35056508; Coffino P, 2001, BIOCHIMIE, V83, P319, DOI 10.1016/S0300-9084(01)01252-4; Cohen S.S., 1998, GUIDE POLYAMINES, V1st ed.; Coleman CS, 2004, BIOCHEM J, V379, P849, DOI 10.1042/BJ20040035; COLEMAN CS, 1993, J BIOL CHEM, V268, P24572; DAGHIGH F, 1994, BIOCHEM BIOPH RES CO, V202, P174, DOI 10.1006/bbrc.1994.1909; Feith DJ, 2001, CANCER RES, V61, P6073; Fong LYY, 2003, CANCER RES, V63, P3945; Gilad GM, 1996, NEUROSCI LETT, V216, P33; Gruendler C, 2001, J BIOL CHEM, V276, P46533, DOI 10.1074/jbc.M105500200; Hayashi S, 1996, TRENDS BIOCHEM SCI, V21, P27, DOI 10.1016/0968-0004(96)80882-6; HAYASHI S, 1989, ORNITHINE DECARBOXYL, P47; HEBY O, 1990, TRENDS BIOCHEM SCI, V15, P153, DOI 10.1016/0968-0004(90)90216-X; Horyn O, 2005, BIOCHEM J, V388, P419, DOI 10.1042/BJ20041260; Ivanov IP, 2000, P NATL ACAD SCI USA, V97, P4808, DOI 10.1073/pnas.070055897; Iyer RK, 2002, MOL GENET METAB, V75, P209, DOI 10.1006/mgme.2001.3277; Janne J, 2004, EUR J BIOCHEM, V271, P877, DOI 10.1111/j.1432-1033.2004.04009.x; Jung MH, 2000, GENOMICS, V69, P281, DOI 10.1006/geno.2000.6338; LI G, 1994, SCIENCE, V263, P966, DOI 10.1126/science.7906055; Li RS, 1999, EXP CELL RES, V247, P257, DOI 10.1006/excr.1998.4361; LI XQ, 1992, MOL CELL BIOL, V12, P3556, DOI 10.1128/MCB.12.8.3556; Lortie MJ, 1996, J CLIN INVEST, V97, P413, DOI 10.1172/JCI118430; LU L, 1991, BIOCHEM J, V277, P671, DOI 10.1042/bj2770671; Mangold U, 2005, IUBMB LIFE, V57, P671, DOI 10.1080/15216540500307031; Mangold U, 2005, BIOCHEM J, V385, P21, DOI 10.1042/BJ20040547; MATSUFUJI S, 1995, CELL, V80, P51, DOI 10.1016/0092-8674(95)90450-6; MEGOSH L, 1995, CANCER RES, V55, P4205; METCALF BW, 1978, J AM CHEM SOC, V100, P2551, DOI 10.1021/ja00476a050; Mistry SK, 2002, AM J PHYSIOL-GASTR L, V282, pG375, DOI 10.1152/ajpgi.00386.2001; MITCHELL JLA, 1994, BIOCHEM J, V299, P19, DOI 10.1042/bj2990019; MORRISSEY J, 1995, KIDNEY INT, V47, P1458, DOI 10.1038/ki.1995.204; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Murakami Y, 1996, BIOCHEM J, V317, P77, DOI 10.1042/bj3170077; Murakami Y, 1996, J BIOL CHEM, V271, P3340, DOI 10.1074/jbc.271.7.3340; Newman RM, 2004, J BIOL CHEM, V279, P41504, DOI 10.1074/jbc.M407349200; Nilsson J, 2000, BIOCHEM J, V346, P699, DOI 10.1042/0264-6021:3460699; OSTERMAN AL, 1995, J BIOL CHEM, V270, P11797, DOI 10.1074/jbc.270.20.11797; PEGG AE, 1986, BIOCHEM J, V234, P249, DOI 10.1042/bj2340249; Pegg AE, 2003, BIOCHEM SOC T, V31, P356, DOI 10.1042/BST0310356; Pegg AE, 2006, J BIOL CHEM, V281, P14529, DOI 10.1074/jbc.R500031200; Penafiel R, 1998, EUR COMMISS SCI RES, P79; Pitkanen LT, 2001, BIOCHEM BIOPH RES CO, V287, P1051, DOI 10.1006/bbrc.2001.5703; POULIN R, 1992, J BIOL CHEM, V267, P150; RAASCH W, 1995, LIFE SCI, V56, P2319, DOI 10.1016/0024-3205(95)00226-V; Reddy SG, 1996, J BIOL CHEM, V271, P24945, DOI 10.1074/jbc.271.40.24945; Regunathan S, 2000, J NEUROCHEM, V74, P2201, DOI 10.1046/j.1471-4159.2000.0742201.x; Regunathan S, 1996, J PHARMACOL EXP THER, V276, P1272; ROM E, 1994, P NATL ACAD SCI USA, V91, P3959, DOI 10.1073/pnas.91.9.3959; RUSSELL D, 1968, P NATL ACAD SCI USA, V60, P1420, DOI 10.1073/pnas.60.4.1420; Ruzafa C, 2003, J NUTR BIOCHEM, V14, P333, DOI 10.1016/S0955-2863(03)00055-X; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sastre M, 1996, J NEUROCHEM, V67, P1761; Sastre M, 1998, BIOCHEM J, V330, P1405, DOI 10.1042/bj3301405; Seiler N, 1996, INT J BIOCHEM CELL B, V28, P843, DOI 10.1016/1357-2725(96)00021-0; Seiler N, 2004, AMINO ACIDS, V26, P217, DOI 10.1007/s00726-004-0070-z; SEILER N, 1983, METHOD ENZYMOL, V94, P10; Shah R, 2004, J BIOL CHEM, V279, P35760, DOI 10.1074/jbc.M405366200; Shantz LM, 1999, INT J BIOCHEM CELL B, V31, P107, DOI 10.1016/S1357-2725(98)00135-6; SUZUKI T, 1994, P NATL ACAD SCI USA, V91, P8930, DOI 10.1073/pnas.91.19.8930; Szymanska G, 1997, ANAL BIOCHEM, V252, P96, DOI 10.1006/abio.1997.2319; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; TABOR CW, 1985, MICROBIOL REV, V49, P81, DOI 10.1128/MMBR.49.1.81-99.1985; Thomas T, 2001, CELL MOL LIFE SCI, V58, P244, DOI 10.1007/PL00000852; TOBIAS KE, 1993, BIOCHEMISTRY-US, V32, P5842, DOI 10.1021/bi00073a017; TOBIAS KE, 1993, EUR J BIOCHEM, V218, P245, DOI 10.1111/j.1432-1033.1993.tb18371.x; TSIRKA S, 1992, J BIOL CHEM, V267, P23057; Wallace HM, 2003, BIOCHEM J, V376, P1, DOI 10.1042/BJ20031327; Zhu C, 1999, J BIOL CHEM, V274, P26425, DOI 10.1074/jbc.274.37.26425; Zhu MY, 2004, BBA-GEN SUBJECTS, V1670, P156, DOI 10.1016/j.bbagen.2003.11.006	76	51	56	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30896	30906		10.1074/jbc.M602840200	http://dx.doi.org/10.1074/jbc.M602840200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16916800	hybrid			2022-12-27	WOS:000241075900065
J	Ryjenkov, DA; Simm, R; Romling, U; Gomelsky, M				Ryjenkov, Dmitri A.; Simm, Roger; Romling, Ute; Gomelsky, Mark			The PilZ domain is a receptor for the second messenger c-di-GMP - The PilZ domain protein YcgR controls motility in enterobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTERICA SEROVAR TYPHIMURIUM; CYCLIC DIGUANYLATE; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; ACETOBACTER-XYLINUM; CELLULOSE SYNTHESIS; SIGNALING MOLECULE; ALLOSTERIC CONTROL; BINDING-PROTEIN; EAL DOMAINS	The ubiquitous bacterial second messenger c-di-GMP controls exopolysaccharide synthesis, flagella-and pili-based motility, gene expression, and interactions of bacteria with eukaryotic hosts. With the exception of bacterial cellulose synthases, the identities of c-di-GMP receptors and end targets have remained unknown. Recently, Amikam and Galperin (Amikam, D., and Galperin, M. (2006) Bioinformatics 22, 3-6) hypothesized that the PilZ domains present in the BcsA subunits of bacterial cellulose synthases function in c-di-GMP binding. This hypothesis has been tested here using the Escherichia coli PilZ domain protein YcgR, its individual PilZ domain and the PilZ domain from Gluconacetobacter xylinus BcsA. YcgR was purified and found to bind c-di-GMP tightly and specifically, K-d 0.84 mu M. Individual PilZ domains from YcgR and BcsA also bound c-di-GMP, albeit with lesser affinity, indicating that PilZ is sufficient for binding. The site-directed mutagenesis performed on YcgR implicated the most conserved residues in the PilZ domain directly in c-di-GMP binding. It is suggested that c-di-GMP binding to PilZ brings about conformational changes in the protein that stabilize the bound ligand and initiate the downstream signal transduction cascade. While the identity of the downstream partner(s) of YcgR remains unknown, it is shown that YcgR regulates flagellum-based motility in a c-di-GMP-dependent manner. The inactivation of ycgR improves swimming and swarming motility of the poorly motile yhjH mutants of Salmonella enterica serovar Typhimurium UMR1. Therefore, biochemical and genetic evidence presented here establishes PilZ as a long sought after c-di-GMP-binding domain and YcgR as a c-di-GMP receptor affecting motility in enterobacteria.	Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA; Karolinska Inst, Dept Microbiol Tumor & Cell Biol, SE-17177 Stockholm, Sweden	University of Wyoming; Karolinska Institutet	Romling, U (corresponding author), Univ Wyoming, Dept Mol Biol, 1000 E Univ Ave,Dept 3944, Laramie, WY 82071 USA.	Ute.Romling@ki.se; Gomelsky@uwyo.edu	gomelsky, mark/F-6209-2010; Simm, Roger/AAN-8965-2020	Simm, Roger/0000-0001-5187-2456; Gomelsky, Mark/0000-0003-4077-3932; Romling, Ute/0000-0003-3812-6621				Alm RA, 1996, J BACTERIOL, V178, P46, DOI 10.1128/jb.178.1.46-53.1996; Amikam D, 2006, BIOINFORMATICS, V22, P3, DOI 10.1093/bioinformatics/bti739; Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101; Christen M, 2005, J BIOL CHEM, V280, P30829, DOI 10.1074/jbc.M504429200; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Frye J, 2006, J BACTERIOL, V188, P2233, DOI 10.1128/JB.188.6.2233-2243.2006; Gerstel U, 2003, MOL MICROBIOL, V49, P639, DOI 10.1046/j.1365-2958.2003.03594.x; Greer-Phillips SE, 2004, J BACTERIOL, V186, P6595, DOI 10.1128/JB.186.19.6595-6604.2004; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Ko M, 2000, J MOL BIOL, V303, P371, DOI 10.1006/jmbi.2000.4147; MAHARAJ R, 1993, GENE, V136, P267, DOI 10.1016/0378-1119(93)90477-K; MAYER R, 1991, P NATL ACAD SCI USA, V88, P5472, DOI 10.1073/pnas.88.12.5472; MUNOZDORADO J, 1991, CELL, V67, P995, DOI 10.1016/0092-8674(91)90372-6; Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Romling U, 1998, J BACTERIOL, V180, P722; Romling U, 2005, MOL MICROBIOL, V57, P629, DOI 10.1111/j.1365-2958.2005.04697.x; Romling U, 2005, CELL MOL LIFE SCI, V62, P1234, DOI 10.1007/s00018-005-4557-x; ROSS P, 1990, J BIOL CHEM, V265, P18933; Ryan RP, 2006, P NATL ACAD SCI USA, V103, P6712, DOI 10.1073/pnas.0600345103; Rychlik I, 2002, ARCH MICROBIOL, V178, P411, DOI 10.1007/s00203-002-0458-7; Ryjenkov DA, 2005, J BACTERIOL, V187, P1792, DOI 10.1128/JB.187.5.1792-1798.2005; Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005; SCHMIEGER H, 1972, MOL GEN GENET, V119, P75, DOI 10.1007/BF00270447; Schuster-Bockler B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-7; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Tamayo R, 2005, J BIOL CHEM, V280, P33324, DOI 10.1074/jbc.M506500200; Weinhouse H, 1997, FEBS LETT, V416, P207, DOI 10.1016/S0014-5793(97)01202-7; Zhang ZY, 2006, J AM CHEM SOC, V128, P7015, DOI 10.1021/ja0613714	30	367	394	3	60	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30310	30314		10.1074/jbc.C600179200	http://dx.doi.org/10.1074/jbc.C600179200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16920715	hybrid			2022-12-27	WOS:000241075900003
J	Yang, XC; Purdy, M; Marzluff, WF; Dominski, Z				Yang, Xiao-cui; Purdy, Matthew; Marzluff, William F.; Dominski, Zbigniew			Characterization of 3 ' hExo, a 3 ' exonuclease specifically interacting with the 3 ' end of histone mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; DNASE ACTIVITY; CELL-CYCLE; C-ELEGANS; 3' END; IDENTIFICATION	The 3' end of mammalian histone mRNAs consisting of a conserved stem-loop and a terminal ACCCA interacts with a recently identified human 3' exonuclease designated 3'hExo. The sequence-specific interaction suggests that 3'hExo may participate in the degradation of histone mRNAs. ERI-1, a Caenorhabditis elegans homologue of 3'hExo, has been implicated in degradation of small interfering RNAs. We introduced a number of mutations to 3'hExo to identify residues required for RNA binding and catalysis. To assure that the introduced mutations specifically target one of these two activities of 3'hExo rather than cause global structural defects, the mutant proteins were tested in parallel for the ability both to bind the stem-loop RNA and to degrade RNA substrates. Our analysis confirms that 3'hExo is a member of the DEDDh family of 3' exonucleases. Specific binding to the RNA requires the SAP domain and two lysines located immediately to its C terminus. 3'hExo binds with the highest affinity to the wild-type 3' end of histone mRNA, and any changes to this sequence reduce efficiency of binding. 3'hExo has only residual, if any, 3' exonuclease activity on DNA substrates and localizes mostly to the cytoplasm, suggesting that in vivo it performs exclusively RNA-specific functions. Efficient degradation of RNA substrates by 3'hExo requires 2' and 3' hydroxyl groups at the last nucleotide. 3'hExo removes 3' overhangs of small interfering RNAs, whereas the double-stranded region is resistant to the enzymatic activity.	Univ N Carolina, Program Mol Biol & Biotechnol, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Dominski, Z (corresponding author), Univ N Carolina, Program Mol Biol & Biotechnol, CB 3280, Chapel Hill, NC 27599 USA.	dominski@med.unc.edu			NIGMS NIH HHS [GM29832] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029832] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P112, DOI 10.1016/S0968-0004(99)01537-6; Buhler M, 2005, MOL CELL, V18, P307, DOI 10.1016/j.molcel.2005.03.030; Cheng Y, 2004, J MOL BIOL, V343, P305, DOI 10.1016/j.jmb.2004.08.055; Dominski Z, 1999, GENE, V239, P1, DOI 10.1016/S0378-1119(99)00367-4; Dominski Z, 2003, MOL CELL, V12, P295, DOI 10.1016/S1097-2765(03)00278-8; Duchaine TF, 2006, CELL, V124, P343, DOI [10.1016/j.cell.2005.11.036, 10.1016/j.cel.2005.11.036]; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Korner CG, 1997, J BIOL CHEM, V272, P10448; Marzluff WF, 2002, CURR OPIN CELL BIOL, V14, P692, DOI 10.1016/S0955-0674(02)00387-3; OSLEY MA, 1991, ANNU REV BIOCHEM, V60, P827, DOI 10.1146/annurev.biochem.60.1.827; PANDEY NB, 1987, MOL CELL BIOL, V7, P4557, DOI 10.1128/MCB.7.12.4557; Ren YG, 2002, J BIOL CHEM, V277, P5982, DOI 10.1074/jbc.M111515200; Sanchez R, 2002, MOL CELL BIOL, V22, P7093, DOI 10.1128/MCB.22.20.7093-7104.2002; Sollner-Webb B, 2001, METHOD ENZYMOL, V342, P378, DOI 10.1016/S0076-6879(01)42560-2; Viswanathan M, 1998, J BIOL CHEM, V273, P35126, DOI 10.1074/jbc.273.52.35126; Viswanathan M, 1999, GENETICS, V151, P929; Zuo YH, 1999, NUCLEIC ACIDS RES, V27, P4077, DOI 10.1093/nar/27.20.4077; Zuo YH, 2002, J BIOL CHEM, V277, P50155, DOI 10.1074/jbc.M207706200; Zuo YH, 2002, J BIOL CHEM, V277, P29654, DOI 10.1074/jbc.M204252200; Zuo YH, 2001, NUCLEIC ACIDS RES, V29, P1017, DOI 10.1093/nar/29.5.1017	20	47	49	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30447	30454		10.1074/jbc.M602947200	http://dx.doi.org/10.1074/jbc.M602947200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16912046	hybrid, Green Published			2022-12-27	WOS:000241075900019
J	Luo, C; Pan, H; Mines, M; Watson, K; Zhang, JW; Fan, GH				Luo, Cherry; Pan, Heng; Mines, Marjelo; Watson, Kurt; Zhang, Jingwu; Fan, Guo-Huang			CXCL12 induces tyrosine phosphorylation of cortactin, which plays a role in CXC chemokine receptor 4-mediated extracellular signal-regulated kinase activation and chemotaxis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOPOIETIC PROGENITOR CELLS; CLATHRIN-COATED PITS; ENDOTHELIAL-CELLS; BREAST-CANCER; MEDIATED ENDOCYTOSIS; BINDING-PROTEIN; DOWN-REGULATION; ARP2/3 COMPLEX; DYNAMIC ACTIN; C-SRC	CXC chemokine receptor 4 (CXCR4) plays a role in the development of immune and central nervous systems as well as in cancer growth and metastasis. CXCR4-initiated signaling cascades leading to cell proliferation and chemotaxis are critical for these functions. The present study demonstrated that stimulation of CXCR4 by its ligand, CXCL12, induced transient translocation of cortactin from endosomal compartments to the cell periphery where it colocalized with CXCR4 followed by internalization of CXCR4 together with cortactin into endosomes. Cortactin was co-immunoprecipitated with CXCR4 in response to CXCL12 treatment in a time-dependent manner. Ligand stimulation induced phosphorylation of cortact in at tyrosine 421, and the phosphorylation was both c-Src- and dynamin-dependent. Cortactin overexpression promoted CXCR4 internalization and recycling. However, overexpression of a cortactin mutant in which tyrosine 421 was replaced with alanine (cortactin-Y421A) or knockdown of cortactin with RNA interference (RNAi) reduced CXCR4 internalization in response to CXCL12. CXCR4-mediated activation of extracellular signal-regulated kinases 1 and 2 was significantly prolonged by overexpression of wild-type cortactin but not by the cortactin-Y421A mutant and was inhibited by cortactin knockdown with RNAi. Moreover, CXCL12-induced chemotaxis was enhanced by cortactin overexpression, reduced by overexpression of the cortactin-Y421A mutant, and blocked by cortactin knock-down with RNAi. These data provide strong evidence for an important role of cortactin in CXCR4 signaling and trafficking as well in the receptor-mediated cell migration.	Meharry Med Coll, Dept Vet Affairs, Nashville, TN 37208 USA; Meharry Med Coll, Dept Biomed Sci, Nashville, TN 37208 USA; Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai 200025, Peoples R China; Shanghai Jiao Tong Univ, Sch Med, Shanghai 200025, Peoples R China	Meharry Medical College; Meharry Medical College; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University	Fan, GH (corresponding author), Meharry Med Coll, Dept Vet Affairs, Nashville, TN 37208 USA.	gfan@mmc.edu			NCRR NIH HHS [RR03032-19] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Bagri A, 2002, DEVELOPMENT, V129, P4249; Bryce NS, 2005, CURR BIOL, V15, P1276, DOI 10.1016/j.cub.2005.06.043; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Cabioglu N, 2005, CANCER RES, V65, P6493, DOI 10.1158/0008-5472.CAN-04-1303; Campbell DH, 1999, CANCER RES, V59, P5376; Cantarelli VV, 2000, INFECT IMMUN, V68, P382, DOI 10.1128/IAI.68.1.382-386.2000; Cao H, 2003, MOL CELL BIOL, V23, P2162, DOI 10.1128/MCB.23.6.2162-2170.2003; Daaka Y, 1998, J BIOL CHEM, V273, P685, DOI 10.1074/jbc.273.2.685; Daly RJ, 2004, BIOCHEM J, V382, P13, DOI 10.1042/BJ20040737; de Parseval A, 2001, J VIROL, V75, P4528, DOI 10.1128/JVI.75.10.4528-4539.2001; Ding Y, 2006, MOL PHARMACOL, V69, P1269, DOI 10.1124/mol.105.020271; Fan GH, 2004, MOL BIOL CELL, V15, P2456, DOI 10.1091/mbc.E03-09-0706; Fan GH, 2002, J BIOL CHEM, V277, P6590, DOI 10.1074/jbc.M110588200; Fan GH, 2001, BIOCHEMISTRY-US, V40, P791, DOI 10.1021/bi001661b; Fan GH, 2003, BLOOD, V101, P2115, DOI 10.1182/blood-2002-07-1965; Ganju RK, 1998, J BIOL CHEM, V273, P23169, DOI 10.1074/jbc.273.36.23169; Goi T, 2000, EMBO J, V19, P623, DOI 10.1093/emboj/19.4.623; Gupta SK, 1998, J BIOL CHEM, V273, P4282, DOI 10.1074/jbc.273.7.4282; Helbig G, 2003, J BIOL CHEM, V278, P21631, DOI 10.1074/jbc.M300609200; Huang C, 1998, J BIOL CHEM, V273, P25770, DOI 10.1074/jbc.273.40.25770; Huang C, 1997, J BIOL CHEM, V272, P13911, DOI 10.1074/jbc.272.21.13911; Inngjerdingen M, 2002, BLOOD, V99, P4318, DOI 10.1182/blood.V99.12.4318; Kaksonen M, 2000, J CELL SCI, V113, P4421; KANNER SB, 1990, P NATL ACAD SCI USA, V87, P3328, DOI 10.1073/pnas.87.9.3328; Lu M, 2002, P NATL ACAD SCI USA, V99, P7090, DOI 10.1073/pnas.092013799; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Martinez-Quiles N, 2004, MOL CELL BIOL, V24, P5269, DOI 10.1128/MCB.24.12.5269-5280.2004; McNiven MA, 2000, J CELL BIOL, V151, P187, DOI 10.1083/jcb.151.1.187; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Muhlberg T, 1997, INVEST OPHTH VIS SCI, V38, P1018; Orth JD, 2003, CURR OPIN CELL BIOL, V15, P31, DOI 10.1016/S0955-0674(02)00010-8; Peng SB, 2005, MOL CANCER RES, V3, P227; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; SCHUURING E, 1992, CANCER RES, V52, P5229; Tilghman RW, 2002, FASEB J, V16, P1257, DOI 10.1096/fj.01-0969fje; Timpson P, 2005, CANCER RES, V65, P3273, DOI 10.1158/0008-5472.CAN-04-2118; Tran PB, 2003, NAT REV NEUROSCI, V4, P444, DOI 10.1038/nrn1116; Uchida D, 2003, EXP CELL RES, V290, P289, DOI 10.1016/S0014-4827(03)00344-6; Uruno T, 2001, NAT CELL BIOL, V3, P259, DOI 10.1038/35060051; Vila-Coro AJ, 1999, FASEB J, V13, P1699, DOI 10.1096/fasebj.13.13.1699; Wang JF, 2000, BLOOD, V95, P2505, DOI 10.1182/blood.V95.8.2505.008k24_2505_2513; Weaver AM, 2001, CURR BIOL, V11, P370, DOI 10.1016/S0960-9822(01)00098-7; Weed SA, 2001, ONCOGENE, V20, P6418, DOI 10.1038/sj.onc.1204783; Weed SA, 1998, J CELL SCI, V111, P2433; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; WU H, 1991, MOL CELL BIOL, V11, P5113, DOI 10.1128/MCB.11.10.5113; Yang W, 1999, J BIOL CHEM, V274, P11328, DOI 10.1074/jbc.274.16.11328; ZHAN X, 1993, J BIOL CHEM, V268, P24427; ZHAN X, 1994, J BIOL CHEM, V269, P20221; Zhang YY, 2004, STEM CELLS, V22, P1015, DOI 10.1634/stemcells.22-6-1015; Zhao M, 2006, MOL PHARMACOL, V69, P66, DOI 10.1124/mol.105.016923; Zhou Y, 2002, J BIOL CHEM, V277, P49481, DOI 10.1074/jbc.M206222200; Zitzer H, 1999, J BIOL CHEM, V274, P18153, DOI 10.1074/jbc.274.26.18153; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	58	34	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					30081	30093		10.1074/jbc.M605837200	http://dx.doi.org/10.1074/jbc.M605837200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16905744	hybrid			2022-12-27	WOS:000240896300069
J	Van Lanen, SG; Lin, SJ; Dorrestein, PC; Kelleher, NL; Shen, B				Van Lanen, Steven G.; Lin, Shuangjun; Dorrestein, Pieter C.; Kelleher, Neil L.; Shen, Ben			Substrate specificity of the adenylation enzyme SgcC1 involved in the biosynthesis of the enediyne antitumor antibiotic C-1027	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOCHEMICAL-CHARACTERIZATION; GENE-CLUSTER; SYNTHETASE; DOMAINS	C-1027 is an enediyne antitumor antibiotic composed of a chromophore with four distinct chemical moieties, including an (S)-3-chloro-4,5-dihydroxy-beta-phenylalanine moiety that is derived from L-alpha-tyrosine. SgcC4, a novel aminomutase requiring no added co-factor that catalyzes the formation of the first intermediate (S)-beta-tyrosine and subsequently SgcC1 homologous to adenylation domains of nonribosomal peptide synthetases, was identified as specific for the SgcC4 product and did not recognize any alpha-amino acids. To definitively establish the substrate for SgcC1, a full kinetic characterization of the enzyme was performed using amino acid-dependent ATP-[P-32]PPi exchange assay to monitor amino acid activation and electrospray ionization-Fourier transform mass spectroscopy to follow the loading of the activated alpha-amino acid substrate to the peptidyl carrier protein SgcC2. The data establish (S)-beta-tyrosine as the preferred substrate, although SgcC1 shows promiscuous activity toward aromatic alpha-amino acids such as beta-phenylalanine, 3-chloro-beta-tyrosine, and 3-hydroxy-beta-tyrosine, but all were < 50-fold efficient. A putative active site mutant P571A adjacent to the invariant aspartic acid residue of all alpha-amino acid-specific adenylation domains known to date was prepared as a preliminary attempt to probe the substrate specificity of SgcC1; however the mutation resulted in a loss of activity with all substrates except (S)-beta-tyrosine, which was 142-fold less efficient relative to the wild-type enzyme. In total, SgcC1 is now confirmed to catalyze the second step in the biosynthesis of the (S)-3-chloro-4,5-dihydroxy-beta-phenylalanine moiety of C-1027, presenting downstream enzymes with an (S)-beta-tyrosyl-S-SgcC2 thioester substrate, and represents the first alpha-amino acid-specific adenylation enzyme characterized biochemically.	Univ Wisconsin, Sch Pharm, Div Pharmaceut Sci, Madison, WI 53705 USA; Univ Wisconsin, Natl Cooperat Drug Discovery Grp, Madison, WI 53705 USA; Univ Wisconsin, Dept Chem, Madison, WI 53705 USA; Univ Illinois, Dept Chem, Urbana, IL 61801 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Illinois System; University of Illinois Urbana-Champaign	Shen, B (corresponding author), Univ Wisconsin, Sch Pharm, Div Pharmaceut Sci, 777 Highland Ave, Madison, WI 53705 USA.	bshen@pharmacy.wisc.edu	Dorrestein, Pieter/ABF-2930-2020; Dorrestein, Pieter/D-5012-2012		NCI NIH HHS [CA78747, CA1059845, F32 CA105984] Funding Source: Medline; NIAID NIH HHS [AI51687] Funding Source: Medline; NIGMS NIH HHS [GM067725, GM073323] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA078747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM073323, R01GM067725] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahlert J, 2002, SCIENCE, V297, P1173, DOI 10.1126/science.1072105; Belshaw PJ, 1999, SCIENCE, V284, P486, DOI 10.1126/science.284.5413.486; Challis GL, 2000, CHEM BIOL, V7, P211, DOI 10.1016/S1074-5521(00)00091-0; Chen HW, 2001, CHEM BIOL, V8, P301, DOI 10.1016/S1074-5521(01)00009-6; Christenson SD, 2003, BIOCHEMISTRY-US, V42, P12708, DOI 10.1021/bi035223r; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; Conti E, 1996, STRUCTURE, V4, P287, DOI 10.1016/S0969-2126(96)00033-0; ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405; Galm U, 2002, ARCH MICROBIOL, V178, P102, DOI 10.1007/s00203-002-0429-z; HU J, 1988, J ANTIBIOT, V41, P1575, DOI 10.7164/antibiotics.41.1575; Hua DH, 2004, J ORG CHEM, V69, P6065, DOI 10.1021/jo0491399; Liu W, 2005, CHEM BIOL, V12, P293, DOI 10.1016/j.chembiol.2004.12.013; Liu W, 2002, SCIENCE, V297, P1170, DOI 10.1126/science.1072110; MAY JJ, 2000, P NATL ACAD SCI USA, V97, P2509; Mootz HD, 1997, J BACTERIOL, V179, P6843, DOI 10.1128/jb.179.21.6843-6850.1997; Murrell JM, 2004, J NAT PROD, V67, P206, DOI 10.1021/np0340403; OTANI T, 1988, J ANTIBIOT, V41, P1580, DOI 10.7164/antibiotics.41.1580; POPPE L, 2001, CURR OPIN STRUC BIOL, V4, P902; Rausch C, 2005, NUCLEIC ACIDS RES, V33, P5799, DOI 10.1093/nar/gki885; Reiersen H, 2001, TRENDS BIOCHEM SCI, V26, P679, DOI 10.1016/S0968-0004(01)01957-0; Schwarzer D, 2003, NAT PROD REP, V20, P275, DOI 10.1039/b111145k; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; STACHELHAUS T, 1995, SCIENCE, V269, P69, DOI 10.1126/science.7604280; SUGIMOTO Y, 1990, J ANTIBIOT, V43, P417, DOI 10.7164/antibiotics.43.417; Tan CYK, 2002, TETRAHEDRON, V58, P7449, DOI 10.1016/S0040-4020(02)00824-4; Tillett D, 2000, CHEM BIOL, V7, P753, DOI 10.1016/S1074-5521(00)00021-1; Van Lanen SG, 2005, J AM CHEM SOC, V127, P11594, DOI 10.1021/ja052871k; van Wageningen AMA, 1998, CHEM BIOL, V5, P155, DOI 10.1016/S1074-5521(98)90060-6; Wang Xing-Wang, 1999, Drugs of the Future, V24, P847, DOI 10.1358/dof.1999.024.08.545524; ZHANG JY, 1992, BIOCHEM J, V283, P691, DOI 10.1042/bj2830691	30	29	29	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					29633	29640		10.1074/jbc.M605887200	http://dx.doi.org/10.1074/jbc.M605887200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16887797	hybrid			2022-12-27	WOS:000240896300025
J	Tian, Y; Jackson, P; Gunter, C; Wang, J; Rock, CO; Jackowski, S				Tian, Yong; Jackson, Pamela; Gunter, Christopher; Wang, Jina; Rock, Charles O.; Jackowski, Suzanne			Placental thrombosis and spontaneous fetal death in mice deficient in ethanolamine kinase 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-C; PHOSPHOLIPID BIOSYNTHESIS; CDP-ETHANOLAMINE; MAMMALIAN-CELLS; PHOSPHATIDYLETHANOLAMINE; GENE; PREGNANCY; MUTATION; LIVER; PHOSPHATIDYLSERINE	Ethanolamine kinase catalyzes the first step in the CDP-ethanolamine pathway for the formation of the major membrane phospholipid phosphatidylethanolamine (PtdEtn). In this work, the predicted Etnk2 cDNA was established as a soluble protein with ethanolamine-specific kinase activity that was most highly expressed in liver. Mice with an inactivated Etnk2 gene were derived, and its absence reduced the rate of PtdEtn synthesis from exogenous ethanolamine in hepatocytes. PtdEtn is a major precursor to phosphatidylcholine in liver; however, Etnk2(-/-) mice did not have reduced amounts of either PtdEtn or phosphatidylcholine or an altered phospholipid molecular species distribution. The knock-out animals were able to adapt to a choline-deficient diet. The Etnk2(-/-) mice exhibited a maternal-specific intrauterine growth retardation phenotype that resulted in a 33% reduction in litter size and frequent perinatal death. Histological analysis of pregnant Etnk2(-/-) females showed that fetal development failed at the late stage of pregnancy in a significant percentage of embryos because of the appearance of extensive placental thrombosis. These results illustrate a non-redundant role for EtnK2 expression in regulating placental hemostasis.	St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Jackowski, S (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale, Memphis, TN 38105 USA.	suzanne.jackowski@stjude.org	Jackowski, Suzanne/N-8168-2018	Jackowski, Suzanne/0000-0002-6855-1429	NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NCI NIH HHS [CA 21765] Funding Source: Medline; NIGMS NIH HHS [GM 45737] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aoyama C, 2004, PROG LIPID RES, V43, P266, DOI 10.1016/j.plipres.2003.12.001; ARTHUR G, 1991, BIOCHEM J, V273, P121, DOI 10.1042/bj2730121; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cheng T, 2003, NAT MED, V9, P338, DOI 10.1038/nm826; Emoto K, 2005, J BIOL CHEM, V280, P37901, DOI 10.1074/jbc.M504282200; Flury I, 2000, J BIOL CHEM, V275, P24458, DOI 10.1074/jbc.M003844200; Hurley TM, 2004, GENE EXPR PATTERNS, V4, P135, DOI 10.1016/j.modgep.2003.09.010; Isermann B, 2003, NAT MED, V9, P331, DOI 10.1038/nm825; JACKOWSKI S, 1981, J BACTERIOL, V148, P926, DOI 10.1128/JB.148.3.926-932.1981; Jacobs RL, 2004, J BIOL CHEM, V279, P47402, DOI 10.1074/jbc.M404027200; Kim KS, 1999, J BIOL CHEM, V274, P14857, DOI 10.1074/jbc.274.21.14857; Lay AJ, 2005, J CLIN INVEST, V115, P1552, DOI 10.1172/JCI24030; Lykidis A, 2001, J BIOL CHEM, V276, P2174, DOI 10.1074/jbc.M008794200; Nakagawa O, 1996, FEBS LETT, V392, P189, DOI 10.1016/0014-5793(96)00811-3; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Nyako M, 2001, BIOCHEM GENET, V39, P339, DOI 10.1023/A:1012209030803; Pascual A, 2005, DEV BIOL, V280, P177, DOI 10.1016/j.ydbio.2005.01.017; PAVLIDIS P, 1994, CELL, V79, P23, DOI 10.1016/0092-8674(94)90397-2; Peisach D, 2003, STRUCTURE, V11, P703, DOI 10.1016/S0969-2126(03)00094-7; PORTER TJ, 1990, J BIOL CHEM, V265, P414; Rand JH, 2003, ANNU REV MED, V54, P409, DOI 10.1146/annurev.med.54.101601.152412; Roberts D, 2002, NEW ENGL J MED, V347, P57, DOI 10.1056/NEJMe020061; Robertson SA, 2004, MOL HUM REPROD, V10, P409, DOI 10.1093/molehr/gah058; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; SMIRNOV MD, 1995, J CLIN INVEST, V95, P309, DOI 10.1172/JCI117657; SMIRNOV MD, 1994, J BIOL CHEM, V269, P816; Sugi T, 2004, J OBSTET GYNAECOL RE, V30, P326, DOI 10.1111/j.1447-0756.2004.00206.x; SUNDLER R, 1975, J BIOL CHEM, V250, P3359; Thumkeo D, 2003, MOL CELL BIOL, V23, P5043, DOI 10.1128/MCB.23.14.5043-5055.2003; Tong MH, 2005, NAT MED, V11, P153, DOI 10.1038/nm1184; Van Veldhoven PP, 2000, METHOD ENZYMOL, V311, P244; Vance JE, 2004, BIOCHEM CELL BIOL, V82, P113, DOI 10.1139/o03-073; VOELKER DR, 1984, P NATL ACAD SCI-BIOL, V81, P2669, DOI 10.1073/pnas.81.9.2669; Voelker DR, 2003, J LIPID RES, V44, P441, DOI 10.1194/jlr.R200020-JLR200; Waite KA, 2002, J NUTR, V132, P68, DOI 10.1093/jn/132.1.68; Walkey CJ, 1998, J BIOL CHEM, V273, P27043, DOI 10.1074/jbc.273.42.27043; Walkey CJ, 1997, P NATL ACAD SCI USA, V94, P12880, DOI 10.1073/pnas.94.24.12880; XU ZL, 1991, J BIOL CHEM, V266, P2143; Yasui Y, 1998, J CELL BIOL, V143, P1249, DOI 10.1083/jcb.143.5.1249; ZELINSKI TA, 1982, CAN J BIOCHEM CELL B, V60, P817, DOI 10.1139/o82-102; Zhang YM, 2002, J BIOL CHEM, V277, P15558, DOI 10.1074/jbc.M201399200	42	41	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					28438	28449		10.1074/jbc.M605861200	http://dx.doi.org/10.1074/jbc.M605861200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16861741	hybrid			2022-12-27	WOS:000240534400081
J	Lebreton, A; Saveanu, C; Decourty, L; Jacquier, A; Fromont-Racine, M				Lebreton, Alice; Saveanu, Cosmin; Decourty, Laurence; Jacquier, Alain; Fromont-Racine, Micheline			Nsa2 is an unstable, conserved factor required for the maturation of 27 SB pre-rRNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAIRY-CELL LEUKEMIA; SACCHAROMYCES-CEREVISIAE; PROTEIN COMPLEXES; YEAST; IDENTIFICATION; CYTOPLASM; DISRUPTION; NUCLEOLUS; DELETION; NUCLEUS	In Saccharomyces cerevisiae, a large variety of pre-ribosomal factors have been identified recently, a number of which are still of unknown function. The essential pre-ribosomal 30-kDa protein, Nsa2, was characterized as one of the most conserved proteins from yeast to human. We show here that the expression of the human orthologue TINP1 complements the repression of NSA2 in yeast. Nsa2 was co-purified in several pre-ribosomal complexes and found to be essential for the large ribosomal subunit biogenesis. Like several other factors of the pre-60 S particles, the absence of Nsa2 correlated with a decrease in the 25 S and 5.8 S ribosomal RNA levels, and with an accumulation of 27 SB pre-ribosomal RNA intermediates. We show that Nsa2 is a functional partner of the putative GTPase Nog1. In the absence of Nsa2, Nog1 was still able to associate with pre-ribosomal complexes blocked in maturation. In contrast, in the absence of Nog1, Nsa2 disappeared from pre-60 S complexes. Indeed, when ribosome biogenesis was blocked upstream of Nsa2, this short half-lived protein was largely depleted, suggesting that its cellular levels are tightly regulated.	Inst Pasteur, CNRS, Unite Genet Interact Macromol, URA2171, F-75724 Paris 15, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Fromont-Racine, M (corresponding author), Inst Pasteur, CNRS, Unite Genet Interact Macromol, URA2171, 25 Rue Dr Roux, F-75724 Paris 15, France.	mfromont@pasteur.fr	Saveanu, Cosmin/Q-1251-2019; Lebreton, Alice/M-8764-2015; Saveanu, Cosmin/K-6494-2015	Saveanu, Cosmin/0000-0002-1677-7936; Lebreton, Alice/0000-0002-6643-902X; Saveanu, Cosmin/0000-0002-1677-7936; JACQUIER, ALAIN/0000-0001-5707-9184; Fromont-Racine, Micheline/0000-0001-9906-0334				Bassler J, 2001, MOL CELL, V8, P517, DOI 10.1016/S1097-2765(01)00342-2; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; BaudinBaillieu A, 1997, YEAST, V13, P353, DOI 10.1002/(SICI)1097-0061(19970330)13:4<353::AID-YEA86>3.0.CO;2-P; Brachmann CB, 1998, YEAST, V14, P115; Davy A, 2001, EMBO REP, V2, P821, DOI 10.1093/embo-reports/kve184; Dundr M, 2001, BIOCHEM J, V356, P297, DOI 10.1042/0264-6021:3560297; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Harnpicharnchai P, 2001, MOL CELL, V8, P505, DOI 10.1016/S1097-2765(01)00344-6; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Kallstrom G, 2003, MOL CELL BIOL, V23, P4344, DOI 10.1128/MCB.23.12.4344-4355.2003; Krogan NJ, 2004, MOL CELL, V13, P225, DOI 10.1016/S1097-2765(04)00003-6; MUHLRAD D, 1992, YEAST, V8, P79, DOI 10.1002/yea.320080202; Nissan TA, 2002, EMBO J, V21, P5539, DOI 10.1093/emboj/cdf547; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Saveanu C, 2003, MOL CELL BIOL, V23, P4449, DOI 10.1128/MCB.23.13.4449-4460.2003; Saveanu C, 2001, EMBO J, V20, P6475, DOI 10.1093/emboj/20.22.6475; Shehata M, 2004, J CLIN INVEST, V113, P676, DOI 10.1172/JCI200419540; Stanchi F, 2001, YEAST, V18, P69, DOI 10.1002/1097-0061(200101)18:1<69::AID-YEA647>3.0.CO;2-H; Tschochner H, 2003, TRENDS CELL BIOL, V13, P255, DOI 10.1016/S0962-8924(03)00054-0; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Wu XS, 1999, GENOMICS, V60, P161, DOI 10.1006/geno.1999.5911	23	38	40	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2006	281	37					27099	27108		10.1074/jbc.M602199200	http://dx.doi.org/10.1074/jbc.M602199200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082PB	16861225	hybrid, Green Published			2022-12-27	WOS:000240397700037
J	Wagner, S; Weber, S; Kleinschmidt, MA; Nagata, K; Bauer, UM; Bauer, UM				Wagner, Sabine; Weber, Susanne; Kleinschmidt, Markus A.; Nagata, Kyosuke; Bauer, Uta-Maria; Bauer, Uta-Maria			SET-mediated promoter hypoacetylation is a prerequisite for coactivation of the estrogen-responsive pS2 gene by PRMT1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATING-FACTOR-I; RECEPTOR-ALPHA; ARGININE METHYLTRANSFERASE; TRANSCRIPTIONAL ACTIVATION; HISTONE H4; PROTEIN METHYLTRANSFERASE; DEACETYLASE INHIBITION; NEGATIVE REGULATION; METHYLATION; ACETYLATION	Induction of transcription requires an ordered recruitment of coregulators and specific combinations of histone modifications at the promoter. Occurrence of histone H4 arginine (Arg) 3 methylation by protein arginine methyltransferase 1 (PRMT1) represents an early promoter event in ER (estrogen receptor)regulated gene activation. However, its in vivo significance in ER signaling and the prerequisites for PRMT1 recruitment to promoters have not been established yet. We show here that endogenous PRMT1 is a crucial and non-redundant coactivator of ER-mediated pS2 gene induction in MCF7 cells. By investigating promoter requirements for PRMT1 recruitment we find that the patient SE translocation (SET) protein, which was reported to protect histone tails from acetylation, associates with the uninduced pS2 gene promoter and dissociates early upon estrogen treatment. Knockdown of SET or trichostatin A (TSA) treatment causes premature acetylation of H4 and abrogation of H4 Arg(3) methylation at the pS2 gene promoter resulting in diminished transcriptional induction. Thus, SET prevents promoter acetylation and is a prerequisite for the initial acetylation-sensitive steps of pS2 gene activation, namely PRMT1 function. Similar to pS2 we identify lactoferrin as a PRMT1-dependent and TSA-sensitive ER target gene. In contrast, we find that the C3 gene, another ER target, is activated in a PRMT1-independent manner and that SET is involved in C3 gene repression. These findings establish the existence of PRMT1-dependent and -independent ER target genes and show that proteins guarding promoter hypoacetylation, like SET, execute a key function in the coactivation process by PRMT1.	[Bauer, Uta-Maria; Bauer, Uta-Maria] Univ Marburg, Inst Mol Biol & Tumor Res, IMT, Emil Mannkopff Str 2, D-35032 Marburg, Germany; Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Infect Biol, Tsukuba, Ibaraki 3058575, Japan; Univ Tsukuba, Inst Basic Med Sci, Tsukuba, Ibaraki 3058575, Japan	Philipps University Marburg; University of Tsukuba; University of Tsukuba	Bauer, UM (corresponding author), Univ Marburg, Inst Mol Biol & Tumor Res, IMT, Emil Mannkopff Str 2, D-35032 Marburg, Germany.	bauer@imt.uni-marburg.de						An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; Balint BL, 2005, MOL CELL BIOL, V25, P5648, DOI 10.1128/MCB.25.13.5648-5663.2005; Bauer UM, 2002, EMBO REP, V3, P39, DOI 10.1093/embo-reports/kvf013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Cervoni N, 2002, J BIOL CHEM, V277, P25026, DOI 10.1074/jbc.M202256200; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Chen DG, 2000, J BIOL CHEM, V275, P40810, DOI 10.1074/jbc.M005459200; Chen SL, 2002, J BIOL CHEM, V277, P4324, DOI 10.1074/jbc.M109835200; Choi YB, 2004, J BIOL CHEM, V279, P50930, DOI 10.1074/jbc.M406831200; Covic M, 2005, EMBO J, V24, P85, DOI 10.1038/sj.emboj.7600500; Daujat S, 2002, CURR BIOL, V12, P2090, DOI 10.1016/S0960-9822(02)01387-8; Fabbrizio E, 2002, EMBO REP, V3, P641, DOI 10.1093/embo-reports/kvf136; Gamble MJ, 2005, MOL CELL BIOL, V25, P797, DOI 10.1128/MCB.25.2.797-807.2005; Huang SM, 2005, GENE DEV, V19, P1885, DOI 10.1101/gad.1333905; Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7; Klinge CM, 2004, J MOL ENDOCRINOL, V33, P387, DOI 10.1677/jme.1.01541; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; Koh SS, 2001, J BIOL CHEM, V276, P1089, DOI 10.1074/jbc.M004228200; Kutney SN, 2004, J BIOL CHEM, V279, P30850, DOI 10.1074/jbc.M404969200; Lee YH, 2002, MOL CELL BIOL, V22, P3621, DOI 10.1128/MCB.22.11.3621-3632.2002; Li JW, 2002, MOL CELL BIOL, V22, P5688, DOI 10.1128/MCB.22.16.5688-5697.2002; Loven MA, 2003, MOL ENDOCRINOL, V17, P67, DOI 10.1210/me.2002-0280; Macfarlan T, 2005, J BIOL CHEM, V280, P7346, DOI 10.1074/jbc.M411675200; Margueron R, 2004, J MOL ENDOCRINOL, V32, P583, DOI 10.1677/jme.0.0320583; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; MATSUMOTO K, 1993, J BIOL CHEM, V268, P10582; Mazumdar A, 2001, NAT CELL BIOL, V3, P30, DOI 10.1038/35050532; Metivier R, 2006, EMBO REP, V7, P161, DOI 10.1038/sj.embor.7400626; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Miyamoto S, 2003, MOL CELL BIOL, V23, P8528, DOI 10.1128/MCB.23.23.8528-8541.2003; Nagata K, 1998, EXP CELL RES, V240, P274, DOI 10.1006/excr.1997.3930; NAGATA K, 1995, P NATL ACAD SCI USA, V92, P4279, DOI 10.1073/pnas.92.10.4279; Nowak SJ, 2003, MOL CELL BIOL, V23, P6129, DOI 10.1128/MCB.23.17.6129-6138.2003; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reid G, 2005, ONCOGENE, V24, P4894, DOI 10.1038/sj.onc.1208662; Rezai-Zadeh N, 2003, GENE DEV, V17, P1019, DOI 10.1101/gad.1068003; Saitoh S, 2000, AM J HUM GENET, V66, P1958, DOI 10.1086/302917; Sanchez R, 2002, BIOESSAYS, V24, P244, DOI 10.1002/bies.10066; Schneider R, 2004, J BIOL CHEM, V279, P23859, DOI 10.1074/jbc.C400151200; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strahl BD, 2001, CURR BIOL, V11, P996, DOI 10.1016/S0960-9822(01)00294-9; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Telese F, 2005, EMBO REP, V6, P77, DOI 10.1038/sj.embor.7400309; TURNER BM, 1993, CELL, V75, P5, DOI 10.1016/S0092-8674(05)80078-9; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781	48	39	42	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2006	281	37					27242	27250		10.1074/jbc.M605172200	http://dx.doi.org/10.1074/jbc.M605172200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082PB	16861234	hybrid			2022-12-27	WOS:000240397700051
J	Severa, M; Coccia, EM; Fitzgerald, KA				Severa, Martina; Coccia, Eliana M.; Fitzgerald, Katherine A.			Toll-like receptor-dependent and -independent viperin gene expression and counter-regulation by PRDI-binding factor-1/BLIMP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; DOUBLE-STRANDED-RNA; HEPATITIS-C VIRUS; RIG-I; ADAPTER PROTEIN; DENDRITIC CELLS; TRANSCRIPTIONAL ACTIVATION; ANTIVIRAL RESPONSE; IKK-EPSILON; INTERFERON	Here we identify Viperin as a highly inducible gene in response to lipopolysaccharide (LPS), double-stranded RNA (poly(I-C)) or Sendai virus (SV). The only known function of Viperin relates to its ability to inhibit human Cytomegalovirus replication. Very little data are available on the regulation of this gene. In silico analysis of the promoter identified two interferon (IFN)-stimulated response elements (ISRE), which in other genes bind IRF3 or the IFN-stimulated gene factor-3 (ISGF3) complex. LPS and poly(I-C) induce very high levels of Viperin in wild type cells but not in cells deficient in TRIF, TBK1, IRF3, or the type I IFN alpha/beta R. SV-induced Viperin gene expression was mediated independently of Toll-like receptor (TLR) signaling by retinoic acid-inducible gene (RIG-I) and the downstream adapter, mitochondrial anti-viral signaling (MAVS). Virus-induced Viperin expression was not attenuated in macrophages deficient in either TBK1 or IKK epsilon alone. Moreover, IRF3-deficient, but not IFN alpha/beta R deficient, macrophages still induced Viperin in response to SV. Promoter reporter studies combined with DNA immunoprecipitation assays identified the ISGF3 complex as the key regulator of Viperin gene expression. Moreover, positive regulatory domain I-binding factor 1 (PRDI-BF1, also called BLIMP1) binds the ISRE sites and competes with ISGF3 binding in a virus inducible manner to inhibit Viperin transcription. Collectively, these studies identify Viperin as a tightly regulated ISGF3 target gene, which is counter-regulated by PRDI-BF1.	Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA; Ist Super Sanita, Dept Infect Parasit & Immunomediated Dis, I-00161 Rome, Italy	University of Massachusetts System; University of Massachusetts Worcester; Istituto Superiore di Sanita (ISS)	Fitzgerald, KA (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA.	kate.fitzgerald@umassmed.edu	SEVERA, MARTINA/J-8782-2016; Coccia, Eliana M/B-4752-2013; Fitzgerald, Katherine/ABE-6317-2020	SEVERA, MARTINA/0000-0002-0411-4545; Coccia, Eliana M/0000-0002-1606-2949; Fitzgerald, Kate/0000-0003-3175-609X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI067497, R01AI067497, R37AI067497] Funding Source: NIH RePORTER; NIAID NIH HHS [AI067497-01] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Bluyssen HAR, 1997, J BIOL CHEM, V272, P4600, DOI 10.1074/jbc.272.7.4600; Boudinot P, 2000, J GEN VIROL, V81, P2675, DOI 10.1099/0022-1317-81-11-2675; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chen GQ, 1999, GENE DEV, V13, P2218, DOI 10.1101/gad.13.17.2218; Chen JB, 2004, J INTERF CYTOK RES, V24, P687, DOI 10.1089/jir.2004.24.687; Chin KC, 2001, P NATL ACAD SCI USA, V98, P15125, DOI 10.1073/pnas.011593298; Coccia EM, 2004, EUR J IMMUNOL, V34, P796, DOI 10.1002/eji.200324610; Cui YZ, 2001, GENOMICS, V78, P129, DOI 10.1006/geno.2001.6661; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Doly J, 1998, CELL MOL LIFE SCI, V54, P1109, DOI 10.1007/s000180050240; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Gyory I, 2004, NAT IMMUNOL, V5, P299, DOI 10.1038/ni1046; Helbig KJ, 2005, HEPATOLOGY, V42, P702, DOI 10.1002/hep.20844; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Ihle J N, 1995, Semin Immunol, V7, P247, DOI 10.1006/smim.1995.0029; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Jefferies CA, 2005, TRENDS MOL MED, V11, P403, DOI 10.1016/j.molmed.2005.07.006; Johnson K, 2005, MOL IMMUNOL, V42, P749, DOI 10.1016/j.molimm.2004.06.039; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Khaiboullina SF, 2005, VIROLOGY, V342, P167, DOI 10.1016/j.virol.2005.07.035; Kunzi MS, 2003, AUTOIMMUNITY, V36, P457, DOI 10.1080/08916930310001605855; Lande R, 2003, J IMMUNOL, V170, P1174, DOI 10.4049/jimmunol.170.3.1174; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Menendez C, 1996, FEBS LETT, V391, P101, DOI 10.1016/0014-5793(96)00712-0; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; MOGENSEN KE, 1975, ACTA PATH MICRO IM B, V83, P443; Mogensen KE, 1999, J INTERF CYTOK RES, V19, P1069, DOI 10.1089/107999099313019; Paulson M, 1999, J BIOL CHEM, V274, P25343, DOI 10.1074/jbc.274.36.25343; Peters RT, 2000, MOL CELL, V5, P513, DOI 10.1016/S1097-2765(00)80445-1; Platanias LC, 2003, PHARMACOL THERAPEUT, V98, P129, DOI 10.1016/S0163-7258(03)00016-0; Qureshi SA, 1996, MOL CELL BIOL, V16, P288; Ren B, 1999, GENE DEV, V13, P125, DOI 10.1101/gad.13.1.125; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; Verma S, 2006, VIROLOGY, V345, P457, DOI 10.1016/j.virol.2005.10.012; Vogel Stefanie N, 2003, Mol Interv, V3, P466, DOI 10.1124/mi.3.8.466; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	44	99	107	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2006	281	36					26188	26195		10.1074/jbc.M604516200	http://dx.doi.org/10.1074/jbc.M604516200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	080LO	16849320	hybrid			2022-12-27	WOS:000240249500035
J	Archambaud, C; Nahori, MA; Pizarro-Cerda, J; Cossart, P; Dussurget, O				Archambaud, Cristel; Nahori, Marie-Anne; Pizarro-Cerda, Javier; Cossart, Pascale; Dussurget, Olivier			Control of Listeria superoxide dismutase by phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHAGOCYTE NADPH-OXIDASE; OXIDATIVE STRESS; MYCOBACTERIUM-TUBERCULOSIS; ESCHERICHIA-COLI; ACTIVATED MACROPHAGES; MONOCYTOGENES ACTA; REACTIVE OXYGEN; EXPRESSION; VIRULENCE; SALMONELLA	Superoxide dismutases (SODs) are enzymes that protect organisms against superoxides and reactive oxygen species (ROS) produced during their active metabolism. ROS are major mediators of phagocytes microbicidal activity. Here we show that the cytoplasmic Listeria monocytogenes MnSOD is phosphorylated on serine and threonine residues and less active when bacteria reach the stationary phase. We also provide evidence that the most active nonphosphorylated form of MnSOD can be secreted via the SecA2 pathway in culture supernatants and in infected cells, where it becomes phosphorylated. A Delta sod deletion mutant is impaired in survival within macrophages and is dramatically attenuated in mice. Together, our results demonstrate that the capacity to counteract ROS is an essential component of L. monocytogenes virulence. This is the first example of a bacterial SOD post-translationally controlled by phosphorylation, suggesting a possible new host innate mechanism to counteract a virulence factor.	Inst Pasteur, Unite Interact Bacteries Cellules, INSERM, U604,INRA,USC2020, F-75015 Paris, France	INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Cossart, P (corresponding author), Inst Pasteur, Unite Interact Bacteries Cellules, INSERM, U604,INRA,USC2020, 25 Rue Dr Roux, F-75015 Paris, France.	pcossart@pasteur.fr; odussur@pasteur.fr	Archambaud, Cristel/AAZ-8966-2021	Archambaud, Cristel/0000-0002-6237-0109; Marie-Anne, Nahori/0000-0002-4066-4528; Dussurget, Olivier/0000-0001-9924-0837				ADACHI T, 1991, BIOCHEM J, V279, P263, DOI 10.1042/bj2790263; Ahn BE, 2006, MOL MICROBIOL, V59, P1848, DOI 10.1111/j.1365-2958.2006.05065.x; ALFORD CE, 1991, J EXP MED, V174, P459, DOI 10.1084/jem.174.2.459; ARAI K, 1987, J BIOL CHEM, V262, P16969; Archambaud C, 2005, MOL MICROBIOL, V56, P383, DOI 10.1111/j.1365-2958.2005.04551.x; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Battistoni A, 2003, BIOCHEM SOC T, V31, P1326; Braunstein M, 2003, MOL MICROBIOL, V48, P453, DOI 10.1046/j.1365-2958.2003.03438.x; BREHM K, 1992, GENE, V118, P121, DOI 10.1016/0378-1119(92)90258-Q; Brown DR, 2005, FOLIA NEUROPATHOL, V43, P229; Chang TS, 2002, J BIOL CHEM, V277, P25370, DOI 10.1074/jbc.M110432200; Chatterjee SS, 2006, INFECT IMMUN, V74, P1323, DOI 10.1128/IAI.74.2.1323-1338.2006; COOPER HM, 1995, CURR PROTOCOL IMMUNO, P1; Cousens LP, 2000, IMMUNOL REV, V174, P150, DOI 10.1034/j.1600-0528.2002.017407.x; Csar XF, 2001, PROTEOMICS, V1, P435, DOI 10.1002/1615-9861(200103)1:3<435::AID-PROT435>3.3.CO;2-H; DeGroote MA, 1997, P NATL ACAD SCI USA, V94, P13997, DOI 10.1073/pnas.94.25.13997; Dramsi S, 2004, MOL MICROBIOL, V53, P639, DOI 10.1111/j.1365-2958.2004.04138.x; Edwards KM, 2001, AM J RESP CRIT CARE, V164, P2213, DOI 10.1164/ajrccm.164.12.2106093; Escuyer V, 1996, MICROB PATHOGENESIS, V20, P41, DOI 10.1006/mpat.1996.0004; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; FRANZON VL, 1990, INFECT IMMUN, V58, P529, DOI 10.1128/IAI.58.2.529-535.1990; Gee JM, 2005, INFECT IMMUN, V73, P2873, DOI 10.1128/IAI.73.5.2873-2880.2005; Glaser P, 2001, SCIENCE, V294, P849; GONZALEZFLECHA B, 1995, J BIOL CHEM, V270, P13681, DOI 10.1074/jbc.270.23.13681; GOUIN E, 1995, INFECT IMMUN, V63, P2729, DOI 10.1128/IAI.63.7.2729-2737.1995; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; Henry R, 2006, CELL MICROBIOL, V8, P107, DOI 10.1111/j.1462-5822.2005.00604.x; Heyworth PG, 2003, CURR OPIN IMMUNOL, V15, P578, DOI 10.1016/S0952-7915(03)00109-2; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Inaoka T, 1999, J BACTERIOL, V181, P1939, DOI 10.1128/JB.181.6.1939-1943.1999; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kang SK, 2006, PROTEIN EXPRES PURIF, V47, P52, DOI 10.1016/j.pep.2005.11.001; Knirsch L, 2001, BIOCHEMISTRY-US, V40, P7890, DOI 10.1021/bi010197n; Korshunov SS, 2002, MOL MICROBIOL, V43, P95, DOI 10.1046/j.1365-2958.2002.02719.x; Kubori T, 2003, CELL, V115, P333, DOI 10.1016/S0092-8674(03)00849-3; Lauer P, 2002, J BACTERIOL, V184, P4177, DOI 10.1128/JB.184.15.4177-4186.2002; Lenz LL, 2003, P NATL ACAD SCI USA, V100, P12432, DOI 10.1073/pnas.2133653100; Lenz LL, 2002, MOL MICROBIOL, V45, P1043, DOI 10.1046/j.1365-2958.2002.03072.x; Luu PT, 1997, INT J FOOD MICROBIOL, V35, P91, DOI 10.1016/S0168-1605(96)01205-6; Lynch M, 2000, MICROBES INFECT, V2, P1245, DOI 10.1016/S1286-4579(00)01278-8; MacMillanCrow LA, 1996, P NATL ACAD SCI USA, V93, P11853, DOI 10.1073/pnas.93.21.11853; Marques MAM, 1998, INFECT IMMUN, V66, P2625, DOI 10.1128/IAI.66.6.2625-2631.1998; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Miller RA, 1997, CLIN MICROBIOL REV, V10, P1; Myers JT, 2003, J IMMUNOL, V171, P5447, DOI 10.4049/jimmunol.171.10.5447; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Piddington DL, 2001, INFECT IMMUN, V69, P4980, DOI 10.1128/IAI.69.8.4980-4987.2001; Poussin MA, 2005, INFECT IMMUN, V73, P4410, DOI 10.1128/IAI.73.7.4410-4413.2005; Reeves EP, 2002, NATURE, V416, P291, DOI 10.1038/416291a; SAITO S, 1994, INFECT IMMUN, V62, P1551, DOI 10.1128/IAI.62.5.1551-1556.1994; Saveanu C, 2002, PROTEIN SCI, V11, P2551, DOI 10.1110/ps.0217502; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Steffen P, 2000, CELL MOTIL CYTOSKEL, V45, P58; Steinberg TH, 2003, PROTEOMICS, V3, P1128, DOI 10.1002/pmic.200300434; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; VASCONCELOS JAP, 1994, APPL ENVIRON MICROB, V60, P2360, DOI 10.1128/AEM.60.7.2360-2366.1994; Vazquez-Torres A, 2000, SCIENCE, V287, P1655, DOI 10.1126/science.287.5458.1655; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384; Yan H, 1997, BIOCHEM J, V328, P599, DOI 10.1042/bj3280599; Zelko IN, 2002, FREE RADICAL BIO MED, V33, P337, DOI 10.1016/S0891-5849(02)00905-X	64	101	107	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31812	31822		10.1074/jbc.M606249200	http://dx.doi.org/10.1074/jbc.M606249200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16905535	Bronze, Green Published			2022-12-27	WOS:000241235300068
J	Itoh, T; Fukuda, M				Itoh, Takashi; Fukuda, Mitsunori			Identification of EPI64 as a GTPase-activating protein specific for Rab27A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRISCELLI-SYNDROME; BINDING DOMAIN; MYOSIN-VA; MELANOSOME DISTRIBUTION; CRITICAL DETERMINANT; RAS SUPERFAMILY; PDZ DOMAIN; C2 DOMAINS; MELANOCYTES; FAMILY	Small GTPase Rab27A plays a pivotal role in melanosome transport in melanocytes and in secretion by various secreting cells. Because the GTP- or GDP-locked mutant of Rab27A causes perinuclear aggregation of melanosomes, appropriate GTP-GDP cycling of Rab27A is essential for melanosome transport, and certain guanine nucleotide exchange factors and GTPase-activating proteins (GAPs) of Rab27A must be present in melanocytes. However, no such regulators of Rab27A have ever been identified. In this study we developed novel methods of rapidly screening 40 different TBC (Tre2/Bub2/Cdc16) proteins, putative Rab-GAPs, for Rab27A-GAP by: (i) searching for TBC proteins that induce melanosome aggregation in melanocytes; (ii) trapping GTP-Rab27A with a Rab27A effector domain (i. e. the SHD of Slac2-a) in cultured cells that express both Rab27A and TBC proteins; and (iii) measuring in vitro Rab27AGAP activity. These methods allowed us to identify EPI64, previously characterized as an EBP50-binding protein that contains an orphan TBC domain, as a specific Rab27A-GAP. We further showed that mutations in the catalytic domain of EPI64 caused complete loss of its ability to induce melanosome aggregation. This is the first report of screening for Rab27A-GAP based on functional interactions, and our screening methods can be applied for other uncharacterized TBC proteins.	Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Lab Membrane Trafficking Mech,Aoba Ku, Sendai, Miyagi 9808578, Japan; RIKEN, Inst Phys & Chem Res, Fukuda Initiat Res Unit, Wako, Saitama 3510198, Japan	Tohoku University; RIKEN	Fukuda, M (corresponding author), Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Lab Membrane Trafficking Mech,Aoba Ku, Sendai, Miyagi 9808578, Japan.	nori@mail.tains.tohoku.ac.jp	Fukuda, MItsunori/I-1511-2015	Fukuda, MItsunori/0000-0002-8620-5853				Albert S, 1999, EMBO J, V18, P5216, DOI 10.1093/emboj/18.19.5216; Bahadoran P, 2003, J BIOL CHEM, V278, P11386, DOI 10.1074/jbc.M211996200; Bahadoran P, 2001, J CELL BIOL, V152, P843, DOI 10.1083/jcb.152.4.843; BENNETT DC, 1987, INT J CANCER, V39, P414, DOI 10.1002/ijc.2910390324; Bernards A, 2003, BBA-REV CANCER, V1603, P47, DOI 10.1016/S0304-419X(02)00082-3; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Cuif MH, 1999, EMBO J, V18, P1772, DOI 10.1093/emboj/18.7.1772; Du LL, 1998, J BIOL CHEM, V273, P3253, DOI 10.1074/jbc.273.6.3253; Fukuda M, 2004, J BIOL CHEM, V279, P13065, DOI 10.1074/jbc.M306812200; Fukuda M, 2003, J BIOL CHEM, V278, P15373, DOI 10.1074/jbc.M212341200; Fukuda M, 2005, J BIOCHEM, V137, P9, DOI 10.1093/jb/mvi002; Fukuda M, 2004, J BIOL CHEM, V279, P22314, DOI 10.1074/jbc.401791200; Fukuda M, 1999, J BIOL CHEM, V274, P31421, DOI 10.1074/jbc.274.44.31421; FUKUDA M, 1994, J BIOL CHEM, V269, P29206; FUKUDA M, 1995, J BIOL CHEM, V270, P26523, DOI 10.1074/jbc.270.44.26523; Fukuda M, 2002, J BIOL CHEM, V277, P29315, DOI 10.1074/jbc.M201697200; Fukuda M, 2002, J BIOL CHEM, V277, P40118, DOI 10.1074/jbc.M205765200; Fukuda M, 2002, J BIOL CHEM, V277, P12432, DOI 10.1074/jbc.C200005200; Fukui K, 1997, J BIOL CHEM, V272, P4655, DOI 10.1074/jbc.272.8.4655; Gao XD, 2003, J CELL BIOL, V162, P635, DOI 10.1083/jcb.200302038; Haas AK, 2005, NAT CELL BIOL, V7, P887, DOI 10.1038/ncb1290; Hume AN, 2001, J CELL BIOL, V152, P795, DOI 10.1083/jcb.152.4.795; IOTH T, 2006, GENES CELLS, V11, P1023; Kornau HC, 1997, CURR OPIN NEUROBIOL, V7, P368, DOI 10.1016/S0959-4388(97)80064-5; Kuroda TS, 2005, METHOD ENZYMOL, V403, P431, DOI 10.1016/S0076-6879(05)03038-7; Kuroda TS, 2004, NAT CELL BIOL, V6, P1195, DOI 10.1038/ncb1197; Kuroda TS, 2003, MOL CELL BIOL, V23, P5245, DOI 10.1128/MCB.23.15.5245-5255.2003; Kuroda TS, 2002, J BIOL CHEM, V277, P9212, DOI 10.1074/jbc.M112414200; Lanzetti L, 2000, NATURE, V408, P374, DOI 10.1038/35042605; Marks MS, 2001, NAT REV MOL CELL BIO, V2, P738, DOI 10.1038/35096009; Menasche G, 2000, NAT GENET, V25, P173, DOI 10.1038/76024; Menasche G, 2003, BLOOD, V101, P2736, DOI 10.1182/blood-2002-09-2789; Miinea CP, 2005, BIOCHEM J, V391, P87, DOI 10.1042/BJ20050887; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Otomo A, 2003, HUM MOL GENET, V12, P1671, DOI 10.1093/hmg/ddg184; Pei L, 2002, CANCER RES, V62, P5420; Pereira-Leal JB, 2001, J MOL BIOL, V313, P889, DOI 10.1006/jmbi.2001.5072; Raposo G, 2002, TRAFFIC, V3, P237, DOI 10.1034/j.1600-0854.2002.030401.x; Reczek D, 2001, J CELL BIOL, V153, P191, DOI 10.1083/jcb.153.1.191; Saras J, 1996, TRENDS BIOCHEM SCI, V21, P455, DOI 10.1016/S0968-0004(96)30044-3; Seabra MC, 2004, CURR OPIN CELL BIOL, V16, P451, DOI 10.1016/j.ceb.2004.06.014; STROM M, 1993, NATURE, V361, P736, DOI 10.1038/361736a0; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Wilson SM, 2000, P NATL ACAD SCI USA, V97, P7933, DOI 10.1073/pnas.140212797; Wu XF, 2001, J CELL SCI, V114, P1091; Wu XFS, 2002, NAT CELL BIOL, V4, P271, DOI 10.1038/ncb760; Yonekura H, 2001, ANN NY ACAD SCI, V947, P382; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang XM, 2005, BIOCHEM BIOPH RES CO, V335, P154, DOI 10.1016/j.bbrc.2005.07.070	50	74	78	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31823	31831		10.1074/jbc.M603808200	http://dx.doi.org/10.1074/jbc.M603808200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16923811				2022-12-27	WOS:000241235300069
J	Thomas, KE; Galligan, CL; Newman, RD; Fish, EN; Vogel, SN				Thomas, Karen E.; Galligan, Carole L.; Newman, Raj Deonarain; Fish, Eleanor N.; Vogel, Stefanie N.			Contribution of interferon-beta to the murine macrophage response to the toll-like receptor 4 agonist, lipopolysaccharide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEQUENCE-BINDING-PROTEIN; KINASE-C-DELTA; A-ASSOCIATED PROTEINS; REGULATORY FACTOR-I; GENE-EXPRESSION; IFN-GAMMA; ALPHA/BETA INTERFERON; MOUSE MACROPHAGES; INDUCIBLE GENES; ENDOTOXIN-SHOCK	Interferon-beta (IFN-beta) has been identified as the signature cytokine induced via the Toll-like receptor (TLR) 4, "MyD88-independent" signaling pathway in macrophages stimulated by Gram-negative bacterial lipopolysaccharide (LPS). In this study, we analyzed the responses of macrophages derived from wildtype (IFN-beta(+/+)) mice or mice with a targeted mutation in IFN-beta (IFN-beta(+/+)) to the prototype TLR4 agonist, Escherichia coli LPS. A comparison of basal and LPS-induced gene expression (by reverse transcription-PCR, real-time PCR, and Affymetrix microarray analyses) resulted in the identification of four distinct patterns of gene expression affected by IFN-beta deficiency. Analysis of a subset of each group of differentially regulated genes by computer-assisted promoter analysis revealed putative IFN-responsive elements in all genes examined. LPS-induced activation of intracellular signaling molecules, STAT1 Tyr-701, STAT1 Ser-727, and Akt, but not p38, JNK, and ERK MAPK proteins, was significantly diminished in IFN-beta(+/+) versus IFN-beta beta(+/+) macrophages. "Priming" of IFN-beta(-/-) macrophages with exogenous recombinant IFN-beta significantly increased levels of LPS-induced gene expression for induction of monocyte chemotactic protein 5, inducible nitric-oxide synthase, IP-10, and IL-12 p40 mRNA, whereas no increase or relatively small increases were observed for IL-1 beta, IL-6, monocyte chemotactic protein 1, and MyD88 mRNA. Finally, IFN-beta(+/+) mice challenged in vivo with LPS exhibited increased survival when compared with wild-type IFN-beta(+/+) controls, indicating that IFN-beta contributes to LPS-induced lethality; however, not to the extent that one observes in mice with more complete pathway deficiencies (e.g. TLR4(-/-) or TRIF-/- mice). Collectively, these findings reveal unanticipated regulatory roles for IFN-beta in response to LPS in vitro and in vivo.	Univ Maryland, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; Toronto Gen Res Inst, Toronto, ON M5G 2M9, Canada	University System of Maryland; University of Maryland Baltimore; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Vogel, SN (corresponding author), Univ Maryland, Dept Microbiol & Immunol, 660 W Redwood St,Rm 324, Baltimore, MD 21201 USA.	svogel@som.umaryland.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI018797, R37AI018797] Funding Source: NIH RePORTER; NIAID NIH HHS [AI18797] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; BARBER SA, 1995, INFECT IMMUN, V63, P601, DOI 10.1128/IAI.63.2.601-608.1995; Bjorkbacka H, 2004, PHYSIOL GENOMICS, V19, P319, DOI 10.1152/physiolgenomics.00128.2004; Bommhardt U, 2004, J IMMUNOL, V172, P7583, DOI 10.4049/jimmunol.172.12.7583; Brierley MM, 2006, FEBS J, V273, P1569, DOI 10.1111/j.1742-4658.2006.05176.x; Cuesta N, 2003, J IMMUNOL, V170, P5739, DOI 10.4049/jimmunol.170.11.5739; Deb DK, 2003, J IMMUNOL, V171, P267, DOI 10.4049/jimmunol.171.1.267; DEMAEYER E, 1971, ANN I PASTEUR PARIS, V120, P438; Deonarain R, 2000, J VIROL, V74, P3404, DOI 10.1128/JVI.74.7.3404-3409.2000; Deonarain R, 2004, CIRCULATION, V110, P3540, DOI 10.1161/01.CIR.0000136824.73458.20; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Doherty TM, 1996, J IMMUNOL, V156, P735; Durand V, 2004, IMMUNOL CELL BIOL, V82, P596, DOI 10.1111/j.0818-9641.2004.01285.x; Erlandsson L, 1998, CURR BIOL, V8, P223, DOI 10.1016/S0960-9822(98)70086-7; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; FULTZ MJ, 1989, J IMMUNOL, V143, P3001; FULTZ MJ, 1995, J ENDOTOXIN RES, V2, P77; GALABRU J, 1985, J GEN VIROL, V66, P711, DOI 10.1099/0022-1317-66-4-711; Gao JJ, 1998, J IMMUNOL, V161, P4803; Gao JJ, 2002, J LEUKOCYTE BIOL, V72, P1234; Gingras S, 2004, J BIOL CHEM, V279, P54702, DOI 10.1074/jbc.M411043200; Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002; Hirotani T, 2005, BIOCHEM BIOPH RES CO, V328, P383, DOI 10.1016/j.bbrc.2004.12.184; Hirschfeld M, 2001, INFECT IMMUN, V69, P1477, DOI 10.1128/IAI.69.3.1477-1482.2001; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; HOGAN MM, 1988, J IMMUNOL, V141, P4196; HOGAN MM, 1987, J IMMUNOL, V139, P3697; Ishida N, 2005, EXP HEMATOL, V33, P495, DOI 10.1016/j.exphem.2005.01.002; JOSHI VD, 2006, IN PRESS J INTERFERO; Karaghiosoff M, 2003, NAT IMMUNOL, V4, P471, DOI 10.1038/ni910; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kim KI, 2005, METHOD ENZYMOL, V398, P491, DOI 10.1016/S0076-6879(05)98040-3; Lentschat A, 2005, J IMMUNOL, V174, P4252, DOI 10.4049/jimmunol.174.7.4252; Lin RT, 2000, MOL CELL BIOL, V20, P6342, DOI 10.1128/MCB.20.17.6342-6353.2000; Liu JG, 2004, J BIOL CHEM, V279, P55609, DOI 10.1074/jbc.M406565200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MANTHEY CL, 1994, J IMMUNOL, V152, P825; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; MCINTIRE FC, 1967, BIOCHEMISTRY-US, V6, P2363, DOI 10.1021/bi00860a011; Medvedev AE, 2001, J IMMUNOL, V167, P2257, DOI 10.4049/jimmunol.167.4.2257; MOORE RN, 1990, J IMMUNOL, V144, P667; Nair JS, 2002, P NATL ACAD SCI USA, V99, P5971, DOI 10.1073/pnas.052159099; NAKAYAMA M, 1991, J BIOL CHEM, V266, P21404; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Rhee SH, 2003, J BIOL CHEM, V278, P22506, DOI 10.1074/jbc.M208633200; Sakaguchi S, 2003, BIOCHEM BIOPH RES CO, V306, P860, DOI 10.1016/S0006-291X(03)01049-0; SALKOWSKI CA, 1992, J IMMUNOL, V148, P2770; Salkowski CA, 2000, J IMMUNOL, V165, P3970, DOI 10.4049/jimmunol.165.7.3970; Salkowski CA, 1998, INFECT IMMUN, V66, P3569, DOI 10.1128/IAI.66.8.3569-3578.1998; SchartonKersten T, 1997, J EXP MED, V186, P1523, DOI 10.1084/jem.186.9.1523; Servant MJ, 2003, J BIOL CHEM, V278, P9441, DOI 10.1074/jbc.M209851200; Stockinger S, 2004, J IMMUNOL, V173, P7416, DOI 10.4049/jimmunol.173.12.7416; SVETIC A, 1991, J IMMUNOL, V147, P2391; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Toshchakov V, 2003, J ENDOTOXIN RES, V9, P169, DOI 10.1179/096805103125001577; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; Treschow AP, 2005, ARTHRITIS RHEUM-US, V52, P3739, DOI 10.1002/art.21496; Uddin S, 2002, J BIOL CHEM, V277, P14408, DOI 10.1074/jbc.M109671200; VOGEL SN, 1992, BACTERIAL ENDOTOXIC, P165; Vogel Stefanie N, 2003, Mol Interv, V3, P466, DOI 10.1124/mi.3.8.466; WYNN TA, 1993, J IMMUNOL, V151, P1430; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zhao KW, 2005, J BIOL CHEM, V280, P42707, DOI 10.1074/jbc.M506178200	64	126	128	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					31119	31130		10.1074/jbc.M604958200	http://dx.doi.org/10.1074/jbc.M604958200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16912041	hybrid			2022-12-27	WOS:000241075900087
J	Luster, TA; He, J; Huang, XM; Maiti, SN; Schroit, AJ; de Groot, PG; Thorpe, PE				Luster, Troy A.; He, Jin; Huang, Xianming; Maiti, Sourindra N.; Schroit, Alan J.; de Groot, Philip G.; Thorpe, Philip E.			Plasma protein beta-2-glycoprotein 1 mediates interaction between the anti-tumor monoclonal antibody 3G4 and anionic phospholipids on endothelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR BLOOD-VESSELS; BETA(2)-GLYCOPROTEIN I; 5TH DOMAIN; BINDING; PHOSPHATIDYLSERINE; AUTOANTIBODIES; COMPLEXES; SEQUENCE; DENSITY; SURFACE	A promising target on tumor vasculature is phosphatidylserine ( PS), an anionic phospholipid that resides exclusively on the inner leaflet of the plasma membrane of resting mammalian cells. We have shown previously that PS becomes exposed on the surface of endothelial cells (EC) in solid tumors. To target PS on tumor vasculature, the murine monoclonal antibody 3G4 was developed. 3G4 localizes to tumor vasculature, inhibits tumor growth, and enhances anti-tumor chemotherapies without toxicity in mice. A chimeric version of 3G4 is in clinical trials. In this study, we investigated the basis for the interaction between 3G4 and EC with surface-exposed PS. We demonstrate that antibody binding to PS is dependent on plasma protein beta-2-glycoprotein 1 (beta 2GP1). beta 2GP1 is a 50-kDa glycoprotein that binds weakly to anionic phospholipids under physiological conditions. We show that 3G4 enhances binding of beta 2GP1 to EC induced to expose PS. We also show that divalent 3G4-beta 2GP1 complexes are required for enhanced binding, since 3G4 Fab' fragments do not bind EC with exposed PS. Finally, we demonstrate that an artificial dimeric beta 2GP1 construct binds to EC with exposed PS in the absence of 3G4, confirming that antibody binding is mediated by dimerization of beta 2GP1. Together, these data indicate that 3G4 targets tumor EC by increasing the avidity of beta 2GP1 for anionic phospholipids through formation of multivalent 3G4-beta 2GP1 complexes.	Univ Texas, SW Med Ctr, Dept Pharmacol, Simmons Comprehens Canc Ctr,Hamon Ctr Therapeut O, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Radiat Oncol, Dallas, TX 75390 USA; Univ Texas, MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; Univ Med Ctr Utrecht, Dept Hematol, NL-3584 CX Utrecht, Netherlands	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; UTMD Anderson Cancer Center; Utrecht University; Utrecht University Medical Center	Thorpe, PE (corresponding author), Univ Texas, SW Med Ctr, Dept Pharmacol, Simmons Comprehens Canc Ctr,Hamon Ctr Therapeut O, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	philip.thorpe@utsouthwestern.edu						Beck AW, 2006, INT J CANCER, V118, P2639, DOI 10.1002/ijc.21684; Bevers EM, 2005, BIOCHEM J, V386, P271, DOI 10.1042/BJ20041167; Bevers EM, 2004, CLIN IMMUNOL, V112, P150, DOI 10.1016/j.clim.2004.02.009; BITBOL M, 1987, BIOCHIM BIOPHYS ACTA, V904, P268, DOI 10.1016/0005-2736(87)90376-2; Boyle EM, 1996, ANN THORAC SURG, V62, P1868, DOI 10.1016/S0003-4975(96)00950-2; Daleke DL, 2003, J LIPID RES, V44, P233, DOI 10.1194/jlr.R200019-JLR200; DEVAUX PF, 1992, ANNU REV BIOPH BIOM, V21, P417, DOI 10.1146/annurev.bb.21.060192.002221; Dillon SR, 2000, J IMMUNOL, V164, P1322, DOI 10.4049/jimmunol.164.3.1322; Galazka M, 1998, THROMB RES, V90, P131, DOI 10.1016/S0049-3848(98)00047-4; Gushiken FC, 2002, THROMB RES, V108, P175, DOI 10.1016/S0049-3848(02)00392-4; Huang XM, 2005, CANCER RES, V65, P4408, DOI 10.1158/0008-5472.CAN-05-0031; HUNT J, 1994, J IMMUNOL, V152, P653; HUNT JE, 1993, P NATL ACAD SCI USA, V90, P2141, DOI 10.1073/pnas.90.6.2141; Jankowski M, 2003, BLOOD, V101, P157, DOI 10.1182/blood-2002-05-1310; JENNEWEIN M, 2005, P AM ASSOC CANC RES, V46, P5261; Kogure K, 2003, CHEM PHYS LIPIDS, V126, P29, DOI 10.1016/S0009-3084(03)00091-4; Lutters BCH, 2001, J BIOL CHEM, V276, P3060, DOI 10.1074/jbc.M008224200; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Mehdi H, 2000, EUR J BIOCHEM, V267, P1770, DOI 10.1046/j.1432-1327.2000.01174.x; Orr FW, 2000, J PATHOL, V190, P310, DOI 10.1002/(SICI)1096-9896(200002)190:3<310::AID-PATH525>3.0.CO;2-P; POLZ E, 1980, INT J BIOCHEM, V11, P265, DOI 10.1016/0020-711X(80)90229-3; Ran S, 1998, CANCER RES, V58, P4646; Ran S, 2005, CLIN CANCER RES, V11, P1551, DOI 10.1158/1078-0432.CCR-04-1645; Ran S, 2003, NEOPLASIA, V5, P297, DOI 10.1016/S1476-5586(03)80023-4; Ran S, 2002, INT J RADIAT ONCOL, V54, P1479, DOI 10.1016/S0360-3016(02)03928-7; Ran S, 2002, CANCER RES, V62, P6132; ROUBEY RAS, 1995, J IMMUNOL, V154, P954; SHAUGHNESSY SG, 1989, AM J PATHOL, V134, P787; Sheng YH, 1996, J IMMUNOL, V157, P3744; SOARES FA, 1994, LAB INVEST, V71, P480; STEINKASSERER A, 1992, FEBS LETT, V313, P193, DOI 10.1016/0014-5793(92)81442-O; STEINKASSERER A, 1991, BIOCHEM J, V277, P387, DOI 10.1042/bj2770387; UTSUGI T, 1991, CANCER RES, V51, P3062; Willems GM, 1996, BIOCHEMISTRY-US, V35, P13833, DOI 10.1021/bi960657q; WURM H, 1984, INT J BIOCHEM, V16, P511, DOI 10.1016/0020-711X(84)90168-X; Zhou QS, 1997, J BIOL CHEM, V272, P18240, DOI 10.1074/jbc.272.29.18240; ZULUETA JJ, 1995, AM J RESP CELL MOL, V12, P41, DOI 10.1165/ajrcmb.12.1.7529030	37	59	70	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					29863	29871		10.1074/jbc.M605252200	http://dx.doi.org/10.1074/jbc.M605252200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16905548	hybrid			2022-12-27	WOS:000240896300048
J	Wilson, EM; Rotwein, P				Wilson, Elizabeth M.; Rotwein, Peter			Control of MyoD function during initiation of muscle differentiation by an autocrine signaling pathway activated by insulin-like growth factor-II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOXO TRANSCRIPTION FACTORS; ADULT SKELETAL-MUSCLE; PROTEIN-KINASE; GENE-TRANSCRIPTION; MYOCYTE MATURATION; CELL SURVIVAL; MYOGENIN GENE; MICE LACKING; HYPERTROPHY; EXPRESSION	The insulin-like growth factors (IGFs) play key roles in muscle development, maintenance, and repair, but their mechanisms of action are incompletely defined. We previously identified an autocrine pathway involving production of IGF-II and activation of the IGF-I receptor, phosphatidylinositol 3-kinase, and Akt in myoblast differentiation induced by MyoD in 10T1/2 mesenchymal stem cells and found that blocking this pathway prevented differentiation ( Wilson, E. M., Hsieh, M. M., and Rotwein, P. ( 2003) J. Biol. Chem. 278, 41109 - 41113). We now have analyzed regulation of MyoD function in this model system. Inhibition of IGF-II production impaired the transcriptional actions of MyoD, as seen by a 70-80% decline in activity of transfected reporter genes, including the myogenin and creatine kinase promoters, and by complete inhibition of transcription of the endogenous myogenin gene but had no effect on MyoD protein levels, post-translational modifications, or nuclear localization, and neither blocked the rapid disappearance of the inhibitory molecule Id1 nor altered the nuclear expression or abundance of the MyoD binding partner E12/E47. Impaired signaling through the IGF-I receptor also did not decrease the ability of MyoD or E12/E47 to bind to target DNA sites at the proximal myogenin promoter, as assessed by chromatin immunoprecipitation assay but, rather, blocked chromatin remodeling at this site, as indicated by reduced recruitment of co-activators p300 and P/CAF and diminished acetylation of histones H3 and H4. Taken together, these results show that IGF-II-initiated signaling through the insulin-like growth factor-I receptor targets transcriptional co-regulators that are essential co-factors for MyoD and suggests that the phosphatidylinositol 3-kinase-Akt pathway plays a key role in establishing an amplification cascade that is essential for sustaining the earliest events in muscle differentiation.	Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Oregon Health & Science University	Rotwein, P (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, 3181 SW Sam Jackson Rd, Portland, OR 97239 USA.	rotweinp@ohsu.edu	Rotwein, Peter/R-5783-2019	Rotwein, Peter/0000-0002-9505-1817	NIDDK NIH HHS [R01 DK42748, R01 DK042748] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042748] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Barton ER, 2002, J CELL BIOL, V157, P137, DOI 10.1083/jcb.200108071; Barton-Davis ER, 1998, P NATL ACAD SCI USA, V95, P15603, DOI 10.1073/pnas.95.26.15603; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Bergstrom DA, 2002, MOL CELL, V9, P587, DOI 10.1016/S1097-2765(02)00481-1; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Buckingham M, 2001, CURR OPIN GENET DEV, V11, P440, DOI 10.1016/S0959-437X(00)00215-X; Chan HM, 2001, J CELL SCI, V114, P2363; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen J, 2004, CELL MOL LIFE SCI, V61, P1675, DOI 10.1007/s00018-004-4103-9; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005; Eckner R, 1996, GENE DEV, V10, P2478, DOI 10.1101/gad.10.19.2478; Fujio Y, 1999, MOL CELL BIOL, V19, P5073; Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87; Gonzalez I, 2004, MOL CELL BIOL, V24, P3607, DOI 10.1128/MCB.24.9.3607-3622.2004; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Huang WC, 2005, MOL CELL BIOL, V25, P6592, DOI 10.1128/MCB.25.15.6592-6602.2005; Kaneko S, 2002, J BIOL CHEM, V277, P23230, DOI 10.1074/jbc.M201733200; Kitzmann M, 1999, MOL CELL BIOL, V19, P3167; KOU K, 1993, MOL ENDOCRINOL, V7, P291, DOI 10.1210/me.7.2.291; Lai KMV, 2004, MOL CELL BIOL, V24, P9295, DOI 10.1128/MCB.24.21.9295-9304.2004; Lawlor MA, 2000, MOL CELL BIOL, V20, P8983, DOI 10.1128/MCB.20.23.8983-8995.2000; Lawlor MA, 2000, J CELL BIOL, V151, P1131, DOI 10.1083/jcb.151.6.1131; Lee SJ, 1999, CURR OPIN GENET DEV, V9, P604, DOI 10.1016/S0959-437X(99)00004-0; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K; McKinnell LW, 2004, CELL, V119, P907, DOI 10.1016/j.cell.2004.12.007; McNally EM, 2004, NEW ENGL J MED, V350, P2642, DOI 10.1056/NEJMp048124; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Meinhart A, 2005, GENE DEV, V19, P1401, DOI 10.1101/gad.1318105; Miller BS, 2005, CANCER RES, V65, P10123, DOI 10.1158/0008-5472.CAN-05-2752; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; Nakae J, 2001, ENDOCR REV, V22, P818, DOI 10.1210/edrv.22.6.0452; Olson EN, 1996, CELL, V85, P1, DOI 10.1016/S0092-8674(00)81073-9; Paul AC, 2002, J CELL BIOL, V156, P751, DOI 10.1083/jcb.200105147; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Penn BH, 2004, GENE DEV, V18, P2348, DOI 10.1101/gad.1234304; Polesskaya A, 2000, J BIOL CHEM, V275, P34359, DOI 10.1074/jbc.M003815200; Polesskaya A, 2001, EMBO J, V20, P6816, DOI 10.1093/emboj/20.23.6816; Puri PL, 1997, EMBO J, V16, P369, DOI 10.1093/emboj/16.2.369; Puri PL, 1997, MOL CELL, V1, P35, DOI 10.1016/S1097-2765(00)80005-2; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Roth JF, 2003, EMBO J, V22, P5186, DOI 10.1093/emboj/cdg473; Rotwein P, 2003, GROWTH HORM IGF RES, V13, P303, DOI 10.1016/j.ghir.2003.09.001; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Sabourin LA, 1999, J CELL BIOL, V144, P631, DOI 10.1083/jcb.144.4.631; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sartorelli V, 1999, MOL CELL, V4, P725, DOI 10.1016/S1097-2765(00)80383-4; Sartorelli V, 1997, MOL CELL BIOL, V17, P1010, DOI 10.1128/MCB.17.2.1010; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Simone C, 2004, NAT GENET, V36, P738, DOI 10.1038/ng1378; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Tureckova J, 2001, J BIOL CHEM, V276, P39264, DOI 10.1074/jbc.M104991200; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Vandromme M, 2001, J BIOL CHEM, V276, P8173, DOI 10.1074/jbc.M005587200; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; WEINTRAUB H, 1990, P NATL ACAD SCI USA, V87, P5623, DOI 10.1073/pnas.87.15.5623; WEINTRAUB H, 1993, CELL, V75, P1241, DOI 10.1016/0092-8674(93)90610-3; Wilson EM, 2004, MOL BIOL CELL, V15, P497, DOI 10.1091/mbc.E03-05-0351; Wilson EM, 2003, J BIOL CHEM, V278, P41109, DOI 10.1074/jbc.C300299200; Woelfle J, 2003, J BIOL CHEM, V278, P51261, DOI 10.1074/jbc.M309486200	70	94	99	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					29962	29971		10.1074/jbc.M605445200	http://dx.doi.org/10.1074/jbc.M605445200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16901893	hybrid			2022-12-27	WOS:000240896300057
J	Falkevall, A; Alikhani, N; Bhushan, S; Pavlov, PF; Busch, K; Johnson, KA; Eneqvist, T; Tjernberg, L; Ankarcrona, M; Glaser, E				Falkevall, Annelie; Alikhani, Nyosha; Bhushan, Shashi; Pavlov, Pavel F.; Busch, Katrin; Johnson, Kenneth A.; Eneqvist, Therese; Tjernberg, Lars; Ankarcrona, Maria; Glaser, Elzbieta			Degradation of the amyloid beta-protein by the novel mitochondrial peptidasome, PreP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-DEGRADING ENZYME; ALZHEIMERS-DISEASE; A-BETA; IN-VIVO; DYSFUNCTION; CHLOROPLASTS; INSULYSIN; METALLOPEPTIDASE; PROTEOLYSIS; PROTEASES	Recently we have identified the novel mitochondrial peptidase responsible for degrading presequences and other short unstructured peptides in mitochondria, the presequence peptidase, which we named PreP peptidasome. In the present study we have identified and characterized the human PreP homologue, hPreP, in brain mitochondria, and we show its capacity to degrade the amyloid beta-protein (A beta). PreP belongs to the pitrilysin oligopeptidase family M16C containing an inverted zinc-binding motif. We show that hPreP is localized to the mitochondrial matrix. In situ immuno-inactivation studies in human brain mitochondria using anti-hPreP antibodies showed complete inhibition of proteolytic activity against A beta. We have cloned, overexpressed, and purified recombinant hPreP and its mutant with catalytic base Glu(78) in the inverted zinc-binding motif replaced by Gln. In vitro studies using recombinant hPreP and liquid chromatography nanospray tandem mass spectrometry revealed novel cleavage specificities against A beta-(1-42), A beta-(1-40), and A beta Arctic, a protein that causes increased protofibril formation an early onset familial variant of Alzheimer disease. In contrast to insulin degrading enzyme, which is a functional analogue of hPreP, hPreP does not degrade insulin but does degrade insulin B-chain. Molecular modeling of hPreP based on the crystal structure at 2.1 angstrom resolution of AtPreP allowed us to identify Cys(90) and Cys(527) that form disulfide bridges under oxidized conditions and might be involved in redox regulation of the enzyme. Degradation of the mitochondrial A beta by hPreP may potentially be of importance in the pathology of Alzheimer disease.	Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden; Karolinska Inst, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden; Neurotec, KASPAC, SE-14157 Huddinge, Sweden	Stockholm University; Karolinska Institutet	Glaser, E (corresponding author), Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden.	e_glaser@dbb.su.se		Bhushan, Shashi/0000-0002-8514-5959; Ankarcrona, Maria/0000-0002-7022-3694				Abagyan R, 1997, PROTEINS, P29; ABAGYAN R, 1994, PROTEINS, V19, P132, DOI 10.1002/prot.340190206; Aleardi AM, 2005, J BIOENERG BIOMEMBR, V37, P207, DOI 10.1007/s10863-005-6631-3; Anandatheerthavarada HK, 2003, J CELL BIOL, V161, P41, DOI 10.1083/jcb.200207030; Ankarcrona M, 2002, BIOCHEM BIOPH RES CO, V295, P766, DOI 10.1016/S0006-291X(02)00735-0; Arnold I, 2002, BBA-MOL CELL RES, V1592, P89, DOI 10.1016/S0167-4889(02)00267-7; BARROW CJ, 1992, J MOL BIOL, V225, P1075, DOI 10.1016/0022-2836(92)90106-T; BECKER AB, 1992, P NATL ACAD SCI USA, V89, P3835, DOI 10.1073/pnas.89.9.3835; Bertram L, 2000, SCIENCE, V290, P2302, DOI 10.1126/science.290.5500.2302; Bhushan S, 2003, EMBO REP, V4, P1073, DOI 10.1038/sj.embor.7400011; Cardoso SM, 2004, J NEUROCHEM, V89, P1417, DOI 10.1111/j.1471-4159.2004.02438.x; Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Glabe C, 2001, J MOL NEUROSCI, V17, P137, DOI 10.1385/JMN:17:2:137; Hansson CA, 2004, J BIOL CHEM, V279, P51654, DOI 10.1074/jbc.M404500200; Hashimoto M, 2003, NEUROMOL MED, V4, P21, DOI 10.1385/NMM:4:1-2:21; Higgins D G, 1994, Methods Mol Biol, V25, P307; Johnson KA, 2006, EMBO J, V25, P1977, DOI 10.1038/sj.emboj.7601080; Kambacheld M, 2005, J BIOL CHEM, V280, P20132, DOI 10.1074/jbc.M500398200; Kaser M, 2003, J BIOL CHEM, V278, P46414, DOI 10.1074/jbc.M305584200; Kurochkin IV, 2001, TRENDS BIOCHEM SCI, V26, P421, DOI 10.1016/S0968-0004(01)01876-X; KUROCHKIN IV, 1994, FEBS LETT, V345, P33, DOI 10.1016/0014-5793(94)00387-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAPIDUS RG, 1993, ARCH BIOCHEM BIOPHYS, V306, P246, DOI 10.1006/abbi.1993.1507; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Leissring MA, 2004, BIOCHEM J, V383, P439, DOI 10.1042/BJ20041081; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; Miller BC, 2003, P NATL ACAD SCI USA, V100, P6221, DOI 10.1073/pnas.1031520100; Moberg P, 2003, PLANT J, V36, P616, DOI 10.1046/j.1365-313X.2003.01904.x; Morelli L, 2003, J BIOL CHEM, V278, P23221, DOI 10.1074/jbc.M300276200; Mzhavia N, 1999, DNA CELL BIOL, V18, P369, DOI 10.1089/104454999315268; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Song ES, 2005, J MOL NEUROSCI, V25, P201, DOI 10.1385/JMN:25:3:201; Song ES, 2001, J BIOL CHEM, V276, P1152, DOI 10.1074/jbc.M008702200; Stahl A, 2005, J MOL BIOL, V349, P847, DOI 10.1016/j.jmb.2005.04.023; Stahl A, 2002, J BIOL CHEM, V277, P41931, DOI 10.1074/jbc.M205500200; Tanzi RE, 2004, NEURON, V43, P605, DOI 10.1016/j.neuron.2004.08.024; Yan SD, 2005, INT J EXP PATHOL, V86, P161, DOI 10.1111/j.0959-9673.2005.00427.x	42	162	169	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					29096	29104		10.1074/jbc.M602532200	http://dx.doi.org/10.1074/jbc.M602532200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16849325	hybrid			2022-12-27	WOS:000240680500064
J	Jiang, Q; Yan, Z; Feng, J				Jiang, Qian; Yan, Zhen; Feng, Jian			Neurotrophic factors stabilize microtubules and protect against rotenone toxicity on dopaminergic neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE BRAIN; SUBSTANTIA-NIGRA NEURONS; GDNF; INHIBITION; RECEPTORS; KINASE; CELLS	Parkinson disease is characterized by the selective degeneration of dopaminergic (DA) neurons in substantia nigra. Long term epidemiological studies have implicated exposure to agricultural pesticides as a significant risk factor. Systemic administration of rotenone, a widely used pesticide, causes selective degeneration of nigral DA neurons and Parkinson disease-like symptoms in rats. Our previous study has shown that the microtubule depolymerizing activity of rotenone plays a critical role in its selective toxicity on DA neurons. Rotenone toxicity is mimicked by the microtubule-depolymerizing drug colchicine and attenuated by the microtubule-stabilizing agent taxol. Here we show that nerve growth factor (NGF) significantly reduced rotenone toxicity on TH+ neurons in midbrain neuronal cultures. The protective effect of NGF was completely abolished by inhibiting the microtubule-associated protein kinase kinase (MEK) and partially reversed by blocking phosphatidylinositol 3-kinase. In addition, NGF decreased colchicine toxicity on TH+ neurons in a manner dependent on MEK but not phosphatidylinositol 3-kinase. The protective effect of NGF against rotenone toxicity was occluded by the microtubule-stabilizing drug taxol. In a MEK-dependent manner, NGF significantly attenuated rotenone- or colchicine-induced microtubule depolymerization and ensuing accumulation of vesicles in the soma and elevation in protein carbonyls. Moreover, other neurotrophic factors such as brain-derived neurotrophic factor and glia cell line-derived neurotrophic factor also reduced rotenone- or colchicine-induced microtubule depolymerization and death of TH+ through a MEK-dependent mechanism. Thus, our results suggest that neurotrophic factors activate the microtubule-associated protein kinase pathway to stabilize microtubules, and this action significantly attenuates rotenone toxicity on dopaminergic neurons.	SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Feng, J (corresponding author), SUNY Buffalo, Dept Physiol & Biophys, 124 Sherman Hall, Buffalo, NY 14214 USA.	jianfeng@buffalo.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041722] Funding Source: NIH RePORTER; NINDS NIH HHS [NS41722] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barker RA, 2006, LANCET NEUROL, V5, P285, DOI 10.1016/S1474-4422(06)70386-6; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; BOTHWELL M, 1995, ANNU REV NEUROSCI, V18, P223, DOI 10.1146/annurev.neuro.18.1.223; BRINKLEY BR, 1974, EXP CELL RES, V85, P41, DOI 10.1016/0014-4827(74)90210-9; Cassimeris L, 2001, INT REV CYTOL, V210, P163; CHANCE B, 1963, J BIOL CHEM, V238, P418; Chauhan NB, 2001, J CHEM NEUROANAT, V21, P277, DOI 10.1016/S0891-0618(01)00115-6; Di Monte DA, 2003, LANCET NEUROL, V2, P531, DOI 10.1016/S1474-4422(03)00501-5; Kirik D, 2004, NAT NEUROSCI, V7, P105, DOI 10.1038/nn1175; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Langston JW, 2002, NEUROTOXICOLOGY, V23, P443, DOI 10.1016/S0161-813X(02)00098-0; Markus A, 2002, CURR OPIN NEUROBIOL, V12, P523, DOI 10.1016/S0959-4388(02)00372-0; MARSHALL LE, 1978, BIOCHIM BIOPHYS ACTA, V543, P590, DOI 10.1016/0304-4165(78)90315-X; Nishio T, 1998, NEUROREPORT, V9, P2847, DOI 10.1097/00001756-199808240-00030; RAY LB, 1988, P NATL ACAD SCI USA, V85, P3753, DOI 10.1073/pnas.85.11.3753; Ren Y, 2005, J BIOL CHEM, V280, P34105, DOI 10.1074/jbc.M503483200; Sariola H, 2003, J CELL SCI, V116, P3855, DOI 10.1242/jcs.00786; Sherer TB, 2003, EXP NEUROL, V179, P9, DOI 10.1006/exnr.2002.8072; Siegel GJ, 2000, BRAIN RES REV, V33, P199, DOI 10.1016/S0165-0173(00)00030-8; STURGILL TW, 1986, BIOCHEM BIOPH RES CO, V134, P565, DOI 10.1016/S0006-291X(86)80457-0; TAKEMURA R, 1992, J CELL SCI, V103, P953; Tanner CM, 1999, JAMA-J AM MED ASSOC, V281, P341, DOI 10.1001/jama.281.4.341; Walker DG, 1998, BRAIN RES, V792, P207, DOI 10.1016/S0006-8993(98)00131-0; Yuen EY, 2005, J NEUROSCI, V25, P5488, DOI 10.1523/JNEUROSCI.1187-05.2005	24	46	48	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					29391	29400		10.1074/jbc.M602740200	http://dx.doi.org/10.1074/jbc.M602740200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16887804	hybrid			2022-12-27	WOS:000240680500094
J	Rost, M; Mann, S; Lambert, C; Doring, T; Thome, N; Prange, R				Rost, Martina; Mann, Sylvia; Lambert, Carsten; Doering, Tatjana; Thome, Nicole; Prange, Reinhild			gamma 2-adaptin, a novel ubiquitin-interacting adaptor, and Nedd4 ubiquitin ligase control hepatitis B virus maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE ENVELOPE PROTEIN; MURINE LEUKEMIA-VIRUS; VIRION FORMATION; SORTING PATHWAY; COATED VESICLES; SURFACE-ANTIGEN; GAMMA-ADAPTIN; LATE DOMAIN; HIV-1 GAG; TSG101	Hepatitis B virus (HBV) budding from infected cells is a tightly regulated process that requires both core and envelope structures. Here we report that HBV uses cellular gamma 2-adaptin and Nedd4, possibly in conjunction with ubiquitin, to coordinate its assembly and release. In search of interaction partners of the viral L envelope protein, we previously discovered gamma 2-adaptin, a putative endosomal sorting and trafficking adaptor of the adaptor protein complex family. We now demonstrate that the viral core interacts with the same gamma 2-adaptor and that disruption of the HBV/gamma 2-adaptin interactions inhibits virus production. Mutational analyses revealed a hitherto unknown ubiquitin-binding activity of gamma 2-adaptin, specified by a ubiquitin-interacting motif, which contributes to its interaction with core. For core, the lysine residue at position 96, a potential target for ubiquitination, was identified to be essential for both gamma 2-adaptin-recognition and virus production. The participation of the cellular ubiquitin system in HBV assembly was further suggested by our finding that core interacts with the endosomal ubiquitin ligase Nedd4, partly via its late domain-like PPAY sequence. Overexpression of a catalytically inactive Nedd4 mutant diminished HBV egress, indicating that protein ubiquitination is functionally involved in virus production. Additional evidence for a link of HBV assembly to the endosomal machinery was provided by immunolabeling studies that demonstrated colocalization of core and L with gamma 2-adaptin in compartments positive for the late endosomal marker CD63. Together, these data indicate that an enveloped DNA virus exploits a new ubiquitin receptor together with endosomal pathway functions for egress from hepatocytes.	Univ Mainz, Dept Med Microbiol & Hyg, D-55101 Mainz, Germany	Johannes Gutenberg University of Mainz	Prange, R (corresponding author), Univ Mainz, Dept Med Microbiol & Hyg, Augustuspl, D-55101 Mainz, Germany.	prange@mail.uni-mainz.de		Prange, Reinhild/0000-0001-8312-4970				Bieniasz PD, 2006, VIROLOGY, V344, P55, DOI 10.1016/j.virol.2005.09.044; Blot V, 2004, J CELL SCI, V117, P2357, DOI 10.1242/jcs.01095; Boehm M, 2001, MOL BIOL CELL, V12, P2907, DOI 10.1091/mbc.12.10.2907; Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0; Bouamr F, 2003, J VIROL, V77, P11882, DOI 10.1128/JVI.77.22.11882-11895.2003; Bruss V, 2004, VIRUS RES, V106, P199, DOI 10.1016/j.virusres.2004.08.016; Bruss V, 1997, J VIROL, V71, P9350, DOI 10.1128/JVI.71.12.9350-9357.1997; Chen CP, 2005, J BIOL CHEM, V280, P40474, DOI 10.1074/jbc.M509317200; Cooper A, 2003, BBA-BIOMEMBRANES, V1614, P89, DOI 10.1016/S0005-2736(03)00166-4; Dong XH, 2005, CELL, V120, P663, DOI 10.1016/j.cell.2004.12.023; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Hartmann-Stuhler C, 2001, J VIROL, V75, P5343, DOI 10.1128/JVI.75.11.5343-5351.2001; Hofmann K, 2001, TRENDS BIOCHEM SCI, V26, P347, DOI 10.1016/S0968-0004(01)01835-7; Hu JM, 2004, J VIROL, V78, P13122, DOI 10.1128/JVI.78.23.13122-13131.2004; HUOVILA APJ, 1992, J CELL BIOL, V118, P1305, DOI 10.1083/jcb.118.6.1305; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Lambert C, 2003, P NATL ACAD SCI USA, V100, P5199, DOI 10.1073/pnas.0930813100; Lambert C, 2001, J BIOL CHEM, V276, P22265, DOI 10.1074/jbc.M100956200; Lewin DA, 1998, FEBS LETT, V435, P263, DOI 10.1016/S0014-5793(98)01083-7; Loffler-Mary H, 2000, VIROLOGY, V270, P358, DOI 10.1006/viro.2000.0268; MAASSEN A, 1994, ARCH VIROL, V135, P131, DOI 10.1007/BF01309770; Martin-Serrano J, 2005, J CELL BIOL, V168, P89, DOI 10.1083/jcb.200408155; Martin-Serrano J, 2001, NAT MED, V7, P1313, DOI 10.1038/nm1201-1313; Medina G, 2005, TRAFFIC, V6, P880, DOI 10.1111/j.1600-0854.2005.00323.x; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Nassal M, 1999, INTERVIROLOGY, V42, P100, DOI 10.1159/000024970; Ott DE, 1998, J VIROL, V72, P2962, DOI 10.1128/JVI.72.4.2962-2968.1998; Ott DE, 2000, VIROLOGY, V278, P111, DOI 10.1006/viro.2000.0648; PATZER EJ, 1984, J VIROL, V51, P346, DOI 10.1128/JVI.51.2.346-353.1984; Pelchen-Matthews A, 2004, TRENDS MICROBIOL, V12, P310, DOI 10.1016/j.tim.2004.05.004; Pelchen-Matthews A, 2003, J CELL BIOL, V162, P443, DOI 10.1083/jcb.200304008; Perez OD, 2001, IMMUNITY, V15, P687, DOI 10.1016/S1074-7613(01)00238-2; Ponsel D, 2003, J VIROL, V77, P416, DOI 10.1128/JVI.77.1.416-422.2003; Puertollano R, 2004, NAT CELL BIOL, V6, P244, DOI 10.1038/ncb1106; Puffer BA, 1998, J VIROL, V72, P10218, DOI 10.1128/JVI.72.12.10218-10221.1998; Rabe B, 2003, P NATL ACAD SCI USA, V100, P9849, DOI 10.1073/pnas.1730940100; RADZIWILL G, 1990, J VIROL, V64, P613, DOI 10.1128/JVI.64.2.613-620.1990; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Roingeard P, 1998, HEPATOLOGY, V28, P1128, DOI 10.1002/hep.510280431; Schubert U, 2000, P NATL ACAD SCI USA, V97, P13057, DOI 10.1073/pnas.97.24.13057; Scott PM, 2004, NAT CELL BIOL, V6, P252, DOI 10.1038/ncb1107; Segura-Morales C, 2005, J BIOL CHEM, V280, P27004, DOI 10.1074/jbc.M413735200; Shih SC, 2002, NAT CELL BIOL, V4, P389, DOI 10.1038/ncb790; Takatsu H, 1998, J BIOL CHEM, V273, P24693, DOI 10.1074/jbc.273.38.24693; Vana ML, 2004, J VIROL, V78, P13943, DOI 10.1128/JVI.78.24.13943-13953.2004; Wang Margaret Q, 2003, J Biol, V3, P4, DOI 10.1186/1475-4924-3-4; ZAREMBA S, 1983, J CELL BIOL, V97, P1339, DOI 10.1083/jcb.97.5.1339; Zizioli D, 1999, J BIOL CHEM, V274, P5385, DOI 10.1074/jbc.274.9.5385	50	69	77	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					29297	29308		10.1074/jbc.M603517200	http://dx.doi.org/10.1074/jbc.M603517200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16867982	hybrid			2022-12-27	WOS:000240680500085
J	Targett-Adams, P; Schaller, T; Hope, G; Lanford, RE; Lemon, SM; Martin, A; McLauchlan, J				Targett-Adams, Paul; Schaller, Torsten; Hope, Graham; Lanford, Robert E.; Lemon, Stanley M.; Martin, Annette; McLauchlan, John			Signal peptide peptidase cleavage of GB virus B core protein is required for productive infection in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATITIS-C VIRUS; CATALYZED INTRAMEMBRANE PROTEOLYSIS; SURROGATE MODEL; LIPID DROPLETS; ALPHA-HELICES; HLA-E; VITRO; MEMBRANE; RESIDUES; CULTURE	Chronic infection by hepatitis C virus (HCV) is a leading cause of liver disease for which better therapies are urgently needed. Because a clearer understanding of the viral life cycle may suggest novel anti-viral approaches, we studied the role of host signal peptide peptidase (SPP) in viral infection. This intramembrane protease cleaves within a C-terminal signal sequence in the viral core protein, but the molecular determinants of cleavage and whether it is required for infection in vivo are unknown. To answer these questions, we studied SPP processing in GB virus B (GBV-B) infection. GBV-B is the closest phylogenetic relative of HCV and offers an accurate surrogate model for HCV infection. We demonstrate that SPP also processes GBV-B core protein and that a serine residue in the hydrophobic region of the signal sequence ( present also in HCV) is critical for efficient SPP cleavage. The small size of the serine side chain combined with its ability to form intra- and interhelical hydrogen bonds likely contributes to recognition of the signal sequence as a substrate for SPP. By introducing mutations with differing effects on SPP processing into an infectious GBV-B molecular clone, we demonstrate that SPP processing of the core protein is required for productive infection in primates. These results broaden our understanding of the mechanism and requirements for SPP cleavage and reveal a functional role in vivo for intramembrane proteolysis in host-pathogen interactions. Moreover, they identify SPP as a potential therapeutic target for reducing the impact of HCV infection.	MRC, Virol Unit, Glasgow G11 5JR, Lanark, Scotland; SW Fdn Biomed Res, Dept Virol & Immunol, San Antonio, TX USA; Univ Texas, Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; CNRS, Unite Genet Mol Virus Respiratoires, URA 1966, Inst Pasteur, F-75724 Paris, France	Texas Biomedical Research Institute; University of Texas System; University of Texas Medical Branch Galveston; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	McLauchlan, J (corresponding author), MRC, Virol Unit, Church St, Glasgow G11 5JR, Lanark, Scotland.	j.mclauchlan@mrcvu.gla.ac.uk	Schaller, Torsten/ABC-9153-2020; Martin, Annette/A-2425-2016	Schaller, Torsten/0000-0001-9597-4112; Martin, Annette/0000-0002-3054-3925; Targett-Adams, Paul/0000-0003-4967-1668	Medical Research Council [MC_U130184143, MC_UU_12014/1] Funding Source: Medline; NCRR NIH HHS [R24-RR15081] Funding Source: Medline; NIAID NIH HHS [R01-AI49574, U19-AI40035] Funding Source: Medline; MRC [MC_U130184143] Funding Source: UKRI; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR015081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI040035, R01AI049574] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ait-Goughoulte M, 2006, J GEN VIROL, V87, P855, DOI 10.1099/vir.0.81664-0; Ballesteros JA, 2000, BIOPHYS J, V79, P2754, DOI 10.1016/S0006-3495(00)76514-3; Beames B, 2001, ILAR J, V42, P152; Beames B, 2000, J VIROL, V74, P11764, DOI 10.1128/JVI.74.24.11764-11772.2000; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bland FA, 2003, J BIOL CHEM, V278, P33747, DOI 10.1074/jbc.M305593200; Bright H, 2004, J VIROL, V78, P2062, DOI 10.1128/JVI.78.4.2062-2071.2004; Bukh J, 1999, VIROLOGY, V262, P470, DOI 10.1006/viro.1999.9941; Bukh J, 2001, J MED VIROL, V65, P694, DOI 10.1002/jmv.2092; Casso DJ, 2005, GENETICS, V170, P139, DOI 10.1534/genetics.104.039933; Ghibaudo D, 2004, J BIOL CHEM, V279, P24965, DOI 10.1074/jbc.M401148200; GRAY TM, 1984, J MOL BIOL, V175, P75, DOI 10.1016/0022-2836(84)90446-7; Grigorenko AP, 2004, P NATL ACAD SCI USA, V101, P14955, DOI 10.1073/pnas.0406462101; Heimann M, 2006, J VIROL, V80, P1915, DOI 10.1128/JVI.80.4.1915-1921.2006; HIJIKATA M, 1991, P NATL ACAD SCI USA, V88, P5547, DOI 10.1073/pnas.88.13.5547; Hope RG, 2000, J GEN VIROL, V81, P1913, DOI 10.1099/0022-1317-81-8-1913; Hope RG, 2006, J GEN VIROL, V87, P623, DOI 10.1099/vir.0.81371-0; Hope RG, 2002, J BIOL CHEM, V277, P4261, DOI 10.1074/jbc.M108798200; Hussy P, 1996, VIROLOGY, V224, P93, DOI 10.1006/viro.1996.0510; Jacob JR, 2004, J GEN VIROL, V85, P2525, DOI 10.1099/vir.0.80036-0; Lanford RE, 2003, VIROLOGY, V311, P72, DOI 10.1016/S0042-6822(03)00193-4; Lemberg MK, 2004, FEBS LETT, V564, P213, DOI 10.1016/S0014-5793(04)00192-9; Lemberg MK, 2003, ANAL BIOCHEM, V319, P327, DOI 10.1016/S0003-2697(03)00298-7; Lemberg MK, 2002, MOL CELL, V10, P735, DOI 10.1016/S1097-2765(02)00655-X; Lemberg MK, 2001, J IMMUNOL, V167, P6441, DOI 10.4049/jimmunol.167.11.6441; LI SC, 1994, NAT STRUCT BIOL, V1, P368, DOI 10.1038/nsb0694-368; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Martin A, 2003, P NATL ACAD SCI USA, V100, P9962, DOI 10.1073/pnas.1731505100; Martoglio B, 2003, BIOCHEM SOC T, V31, P1243; Martoglio B, 2003, HUM MOL GENET, V12, pR201, DOI 10.1093/hmg/ddg303; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Nam JH, 2004, J VIROL, V78, P9389, DOI 10.1128/JVI.78.17.9389-9399.2004; Patel J, 1999, J GEN VIROL, V80, P1681, DOI 10.1099/0022-1317-80-7-1681; Rijnbrand R, 2005, HEPATOLOGY, V41, P986, DOI 10.1002/hep.20656; Sbardellati A, 2001, J GEN VIROL, V82, P2437, DOI 10.1099/0022-1317-82-10-2437; Senes A, 2001, P NATL ACAD SCI USA, V98, P9056, DOI 10.1073/pnas.161280798; Takikawa S, 2006, P NATL ACAD SCI USA, V103, P3345, DOI 10.1073/pnas.0511297103; Targett-Adams P, 2003, J BIOL CHEM, V278, P15998, DOI 10.1074/jbc.M211289200; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Weihofen A, 2000, J BIOL CHEM, V275, P30951, DOI 10.1074/jbc.M005980200; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Xia WM, 2003, J CELL SCI, V116, P2839, DOI 10.1242/jcs.00651; Yasui K, 1998, J VIROL, V72, P6048, DOI 10.1128/JVI.72.7.6048-6055.1998; Yi M, 2006, P NATL ACAD SCI USA, V103, P2310, DOI 10.1073/pnas.0510727103; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	45	37	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					29221	29227		10.1074/jbc.M605373200	http://dx.doi.org/10.1074/jbc.M605373200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16882659	hybrid			2022-12-27	WOS:000240680500077
J	Carkaci-Salli, N; Flanagan, JM; Martz, MK; Salli, U; Walther, DJ; Bader, M; Vrana, KE				Carkaci-Salli, Nurgul; Flanagan, John M.; Martz, Matthew K.; Salli, Ugur; Walther, Diego J.; Bader, Michael; Vrana, Kent E.			Functional domains of human tryptophan hydroxylase 2 (hTPH2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN PHENYLALANINE-HYDROXYLASE; AMINO-ACID HYDROXYLASES; TYROSINE-HYDROXYLASE; MAJOR DEPRESSION; BRAIN-SEROTONIN; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; TPH2 GENE; EXPRESSION; ENZYME	Tryptophan hydroxylase (TPH) is the rate-limiting enzyme in serotonin biosynthesis. A novel gene, termed TPH2, has recently been described. This gene is preferentially expressed in the central nervous system, while the original TPH1 is the peripheral gene. We have expressed human tryptophan hydroxylase 2 (hTPH2) and two deletion mutants (N Delta 150 and N Delta 150/C Delta 24) using isopropyl beta-D-thiogalactopyranoside-free autoinduction in Escherichia coli. This expression system produced active wild type TPH2 with relatively low solubility. The solubility was increased for mutants lacking the NH2-terminal regulatory domain. The solubility of hTPH2, N Delta 150, and N Delta 150/C Delta 24 are 6.9, 62, and 97.5%, respectively. Removal of the regulatory domain also produced a more than 6-fold increase in enzyme stability (t(1/2) at 37 degrees C). The wild type hTPH2, like other members of the aromatic amino acid hydroxylase superfamily, exists as a homotetramer ( 236 kDa on size exclusion chromatography). Similarly, N Delta 150 also migrates as a tetramer (168 kDa). In contrast, removal of the NH2-terminal domain and the COOH-terminal, putative leucine zipper tetramerization domain produces monomeric enzyme ( 39 kDa). Interestingly, removal of the NH2-terminal regulatory domain did not affect the Michaelis constants for either substrate but did increase V-max values. These data identify the NH2-terminal regulatory domain as the source of hTPH2 instability and reduced solubility.	Penn State Coll Med, Dept Pharmacol, Hershey, PA 17033 USA; Penn State Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; Max Planck Inst Mol Genet, Dept Human Genet, D-14195 Berlin, Germany; Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Max Planck Society; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Vrana, KE (corresponding author), Penn State Coll Med, Dept Pharmacol, 500 Univ Dr,H078, Hershey, PA 17033 USA.	kvrana@psu.edu	Bader, Michael/K-2124-2013	Vrana, Kent/0000-0003-4902-7733; Bader, Michael/0000-0003-4780-4164	NIGMS NIH HHS [GM 38981] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersen OA, 2002, J MOL BIOL, V320, P1095, DOI 10.1016/S0022-2836(02)00560-0; Cote F, 2003, P NATL ACAD SCI USA, V100, P13525, DOI 10.1073/pnas.2233056100; CRAIG DA, 1993, BRIT J PHARMACOL, V109, P609, DOI 10.1111/j.1476-5381.1993.tb13615.x; DSa CM, 1996, J NEUROCHEM, V67, P900; DSa CM, 1996, J NEUROCHEM, V67, P917; Fitzpatrick PF, 1999, ANNU REV BIOCHEM, V68, P355, DOI 10.1146/annurev.biochem.68.1.355; Goodwill KE, 1997, NAT STRUCT BIOL, V4, P578, DOI 10.1038/nsb0797-578; GRAHAMESMITH DG, 1964, BIOCHEM BIOPH RES CO, V16, P586, DOI 10.1016/0006-291X(64)90197-4; GRENETT HE, 1987, P NATL ACAD SCI USA, V84, P5530, DOI 10.1073/pnas.84.16.5530; GRIDER JR, 1996, AM J PHYSIOL, V270, P778; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HAKANSON R., 1967, LIFE SCI, V6, P2577, DOI 10.1016/0024-3205(67)90107-5; Harvey M, 2004, MOL PSYCHIATR, V9, P980, DOI 10.1038/sj.mp.4001557; JACOBS BL, 1992, PHYSIOL REV, V72, P165, DOI 10.1152/physrev.1992.72.1.165; JEQUIER E, 1967, MOL PHARMACOL, V3, P274; Jiang GCT, 2000, J MOL BIOL, V302, P1005, DOI 10.1006/jmbi.2000.4097; Knappskog PM, 1996, EUR J BIOCHEM, V242, P813, DOI 10.1111/j.1432-1033.1996.0813r.x; Kowlessur D, 1999, BBA-PROTEIN STRUCT M, V1434, P317, DOI 10.1016/S0167-4838(99)00184-3; Kumer SC, 1996, J NEUROCHEM, V67, P443; Matsuda M, 2004, DEV CELL, V6, P193, DOI 10.1016/S1534-5807(04)00022-X; McKinney J, 2005, J NEUROCHEM, V92, P311, DOI 10.1111/j.1471-4159.2004.02850.x; McKinney J, 2004, PROTEIN EXPRES PURIF, V33, P185, DOI 10.1016/j.pep.2003.09.014; McKinney J, 2001, BIOCHEMISTRY-US, V40, P15591, DOI 10.1021/bi015722x; Meller J, 2001, PROTEINS, V45, P241, DOI 10.1002/prot.1145; Mockus SM, 1998, J MOL NEUROSCI, V10, P163, DOI 10.1007/BF02761772; Mockus SM, 1997, J MOL NEUROSCI, V9, P35, DOI 10.1007/BF02789393; Patel PD, 2004, BIOL PSYCHIAT, V55, P428, DOI 10.1016/j.biopsych.2003.09.002; REED GE, 1995, BRAIN RES, V682, P1, DOI 10.1016/0006-8993(95)00284-W; REINHARD JF, 1986, LIFE SCI, V39, P2185, DOI 10.1016/0024-3205(86)90395-4; REITER RJ, 1991, ENDOCR REV, V12, P151, DOI 10.1210/edrv-12-2-151; Sakowski SA, 2006, J NEUROCHEM, V96, P758, DOI 10.1111/j.1471-4159.2005.03604.x; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Teodorescu O, 2004, PROTEINS, V54, P41, DOI 10.1002/prot.10474; Tinti C, 1997, J BIOL CHEM, V272, P19158, DOI 10.1074/jbc.272.31.19158; Tobi D, 2000, PROTEINS, V41, P40, DOI 10.1002/1097-0134(20001001)41:1<40::AID-PROT70>3.0.CO;2-U; VRANA KE, 1994, J NEUROCHEM, V63, P2014; VRANA SL, 1993, J NEUROSCI METH, V48, P123, DOI 10.1016/S0165-0270(05)80014-7; Walther DJ, 2003, BIOCHEM PHARMACOL, V66, P1673, DOI 10.1016/S0006-2952(03)00556-2; Walther DJ, 2003, CELL, V115, P851, DOI 10.1016/S0092-8674(03)01014-6; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Wang L, 2002, BIOCHEMISTRY-US, V41, P12569, DOI 10.1021/bi026561f; YOON SO, 1992, NEURON, V9, P55, DOI 10.1016/0896-6273(92)90220-8; Zhang XD, 2004, SCIENCE, V305, P217, DOI 10.1126/science.1097540; Zhang XD, 2005, NEURON, V45, P11, DOI 10.1016/j.neuron.2004.12.014; Zhou ZF, 2005, ARCH GEN PSYCHIAT, V62, P1109, DOI 10.1001/archpsyc.62.10.1109; Zill P, 2004, MOL PSYCHIATR, V9, P1030, DOI 10.1038/sj.mp.4001525	46	38	40	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					28105	28112		10.1074/jbc.M602817200	http://dx.doi.org/10.1074/jbc.M602817200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16864580	hybrid			2022-12-27	WOS:000240534400048
J	Li, XF; Chen, YS; Liu, YW; Gao, J; Gao, F; Bartlam, M; Wu, JY; Rao, ZH				Li, Xiaofeng; Chen, Yushu; Liu, Yiwei; Gao, Jia; Gao, Feng; Bartlam, Mark; Wu, Jane Y.; Rao, Zihe			Structural basis of robo proline-rich motif recognition by the srGAP1 Src homology 3 domain in the slit-robo signaling pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTORS; GTPASE-ACTIVATING PROTEINS; TERMINAL SH3 DOMAIN; AXON GUIDANCE; RHO-GTPASES; ROUNDABOUT RECEPTOR; NEURONAL MORPHOGENESIS; TYROSINE KINASE; CNS MIDLINE; BINDING	The Slit-Robo (sr) GTPase-activating protein (GAPs) are important components in the intracellular pathway mediating Slit-Robo signaling in axon guidance and cell migration. We report the first crystal structure of the srGAP1 SH3 domain at 1.8-angstrom resolution. The unusual side chain conformation of the conserved Phe-13 in the P1 pocket renders the ligand binding pocket shallow and narrow, which contributes toward the low binding affinity. Moreover, the opposing electrostatic charge and the hydrophobic properties of the P3 specificity pocket are consistent with the observed binding characteristics of the srGAP1 SH3 domain to its ligand. Surface plasmon resonance experiments indicate that the srGAP1 SH3 domain interacts with its natural ligand in a C to N orientation. The srGAP1 SH3 domain can bind to both the CC2 and CC3 motifs in vitro. The N-terminal two acidic residues in the CC3 motif recognition site are necessary for srGAP1 SH3 domain binding. A longer CC3 peptide (CC3-FL) binds with greater affinity than its shorter counterpart, suggesting that the residues surrounding the proline-rich core are important for protein-peptide interactions. Our study reveals previously unknown properties of the srGAP-Robo interaction. Our data provide a structural basis for the srGAP-Robo interaction, consistent with the role of the Robo intracellular domain in interacting with other downstream signaling molecules and mediating versatile and dynamic responses to axon guidance and cell migration cues.	Chinese Acad Sci, Inst Biophys, Natl lab Biomacromol, Beijing 100101, Peoples R China; Nankai Univ, Tianjin 300071, Peoples R China; Tsinghua Univ, Tsinghua Nankai IBP Joint Res Grp Struct Biol, Beijing 100084, Peoples R China; Northwestern Univ, Feinberg Sch Med, Lurie Canc Ctr, Dept Neurol, Chicago, IL 60611 USA	Chinese Academy of Sciences; Institute of Biophysics, CAS; Nankai University; Tsinghua University; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center	Wu, JY (corresponding author), Chinese Acad Sci, Inst Biophys, Natl lab Biomacromol, Beijing 100101, Peoples R China.	jane-wu@northwestern.edu	Rao, Zihe/HCH-6944-2022; Li, Xiaofeng/F-3735-2011	Bartlam, Mark/0000-0001-5173-5080	NATIONAL CANCER INSTITUTE [R01CA114197] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY014576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070967] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA114197-01A2, R01 CA114197] Funding Source: Medline; NEI NIH HHS [R01 EY014576-03, R01 EY014576] Funding Source: Medline; NIGMS NIH HHS [R01 GM070967-02, R01 GM070967] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADZHUBEI AA, 1993, J MOL BIOL, V229, P472, DOI 10.1006/jmbi.1993.1047; Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Bear JE, 2001, CURR OPIN CELL BIOL, V13, P158, DOI 10.1016/S0955-0674(00)00193-9; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHAN AWE, 1993, PROTEIN SCI, V2, P1574, DOI 10.1002/pro.5560021004; Dalgarno DC, 1997, BIOPOLYMERS, V43, P383; Dickson BJ, 2001, CURR OPIN NEUROBIOL, V11, P103, DOI 10.1016/S0959-4388(00)00180-X; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Fan XP, 2003, NEURON, V40, P113, DOI 10.1016/S0896-6273(03)00591-9; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; Feng SB, 1995, P NATL ACAD SCI USA, V92, P12408, DOI 10.1073/pnas.92.26.12408; Garbe DS, 2004, CRIT REV BIOCHEM MOL, V39, P319, DOI 10.1080/10409230490906797; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hsouna A, 2003, J NEUROBIOL, V57, P15, DOI 10.1002/neu.10232; Hu HL, 2005, P NATL ACAD SCI USA, V102, P4613, DOI 10.1073/pnas.0409325102; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; LAMARCHE N, 1994, TRENDS GENET, V10, P436, DOI 10.1016/0168-9525(94)90114-7; Larson SM, 2000, PROTEIN SCI, V9, P2170, DOI 10.1110/ps.9.11.2170; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li XF, 2006, BIOCHEM BIOPH RES CO, V339, P407, DOI 10.1016/j.bbrc.2005.10.212; LIM WA, 1994, NATURE, V372, P375, DOI 10.1038/372375a0; Lundstrom A, 2004, GENE DEV, V18, P2161, DOI 10.1101/gad.310204; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; Martinez JC, 1998, NAT STRUCT BIOL, V5, P721, DOI 10.1038/1418; Mayer BJ, 2001, J CELL SCI, V114, P1253; MERILAINEN J, 1993, J CELL SCI, V105, P647; Moon SY, 2003, TRENDS CELL BIOL, V13, P13, DOI 10.1016/S0962-8924(02)00004-1; MUSACCHIO A, 1994, NAT STRUCT BIOL, V1, P546, DOI 10.1038/nsb0894-546; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patel BN, 2002, CURR OPIN CELL BIOL, V14, P221, DOI 10.1016/S0955-0674(02)00308-3; Rao Y, 2002, GENE DEV, V16, P2973, DOI 10.1101/gad.1005802; Rotter B, 2005, BIOCHEM J, V388, P631, DOI 10.1042/BJ20041502; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Shin IJ, 1997, J AM CHEM SOC, V119, P12667, DOI 10.1021/ja972820q; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; WU XD, 1995, STRUCTURE, V3, P215, DOI 10.1016/S0969-2126(01)00151-4; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0; Yu TW, 2002, NAT NEUROSCI, V5, P1147, DOI 10.1038/nn956; Zallen JA, 1998, CELL, V92, P217, DOI 10.1016/S0092-8674(00)80916-2	44	28	29	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					28430	28437		10.1074/jbc.M604135200	http://dx.doi.org/10.1074/jbc.M604135200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16857672	hybrid, Green Accepted			2022-12-27	WOS:000240534400080
J	Yang, CD; McDonald, JG; Patel, A; Zhang, Y; Umetani, M; Xu, F; Westover, EJ; Covey, DF; Mangelsdorf, DJ; Cohen, JC; Hobbs, HH				Yang, Chendong; McDonald, Jeffrey G.; Patel, Amit; Zhang, Yuan; Umetani, Michihisa; Xu, Fang; Westover, Emily J.; Covey, Douglas F.; Mangelsdorf, David J.; Cohen, Jonathan C.; Hobbs, Helen H.			Sterol intermediates from cholesterol biosynthetic pathway as liver X receptor ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEIN-1C; FATTY-ACID SYNTHESIS; HAMSTER OVARY CELLS; LXR-ALPHA; NUCLEAR RECEPTOR; RESPONSE PATHWAY; GENE-EXPRESSION; PLANT STEROLS; MICE; ACTIVATION	The liver X receptors (LXRs) are ligand-activated transcription factors that regulate the expression of genes controlling lipid metabolism. Oxysterols bind LXRs with high affinity in vitro and are implicated as ligands for the receptor. We showed previously that accumulation of selected dietary sterols, in particular stigmasterol, is associated with activation of LXR in vivo. In the course of the defining of structural features of stigmasterol that confer LXR agonist activity, we determined that the presence of an unsaturated bond in the side chain of the sterol was necessary and sufficient for activity, with the C-24 unsaturated cholesterol precursor sterols desmosterol and zymosterol exerting the largest effects. Desmosterol failed to increase expression of the LXR target gene, ABCA1, in LXR alpha/beta-deficient mouse fibroblasts, but was fully active in cells lacking cholesterol 24-, 25-, and 27-hydroxylase; thus, the effect of desmosterol was LXR-dependent and did not require conversion to a side chain oxysterol. Desmosterol bound to purified LXR alpha and LXR beta in vitro and supported the recruitment of steroid receptor coactivator 1. Desmosterol also inhibited processing of the sterol response element-binding protein-2 and reduced expression of hydroxymethylglutaryl-CoA reductase. These observations are consistent with specific intermediates in the cholesterol biosynthetic pathway regulating lipid homeostasis through both the LXR and sterol response element-binding protein pathways.	Univ Texas, SW Med Ctr, Ctr Human Nutr, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Washington University (WUSTL)	Cohen, JC (corresponding author), Univ Texas, SW Med Ctr, Ctr Human Nutr, Dallas, TX 75390 USA.	jonathan.cohen@utsouthwestern.edu; jonathan.cohen@utsouthwestern.edu	Umetani, Michi/AAP-3964-2020	Umetani, Michi/0000-0001-8474-7088; Mangelsdorf, David/0000-0002-4355-0796	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL072304, R01HL072304, P01HL020948, T32HL007275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338, P01GM047969] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL72304, T32 HL07275, HL20948] Funding Source: Medline; NIDDK NIH HHS [R01 DK090066] Funding Source: Medline; NIGMS NIH HHS [GM069338, GM47969] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alberti S, 2000, GENE, V243, P93, DOI 10.1016/S0378-1119(99)00555-7; Berge KE, 2000, SCIENCE, V290, P1771, DOI 10.1126/science.290.5497.1771; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; Forman BM, 1997, P NATL ACAD SCI USA, V94, P10588, DOI 10.1073/pnas.94.20.10588; Fowler AJ, 2003, J INVEST DERMATOL, V120, P246, DOI 10.1046/j.1523-1747.2003.12033.x; Fu X, 2001, J BIOL CHEM, V276, P38378, DOI 10.1074/jbc.M105805200; HERZ J, 1990, J BIOL CHEM, V265, P21355; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Joseph SB, 2002, J BIOL CHEM, V277, P11019, DOI 10.1074/jbc.M111041200; Joseph SB, 2004, CELL, V119, P299, DOI 10.1016/j.cell.2004.09.032; Kennedy MA, 2001, J BIOL CHEM, V276, P39438, DOI 10.1074/jbc.M105863200; Laffitte BA, 2003, P NATL ACAD SCI USA, V100, P5419, DOI 10.1073/pnas.0830671100; Lange Y, 2004, P NATL ACAD SCI USA, V101, P11664, DOI 10.1073/pnas.0404766101; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; LISCUM L, 1983, J BIOL CHEM, V258, P8450; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Lund EG, 2003, J BIOL CHEM, V278, P22980, DOI 10.1074/jbc.M303415200; Ou JF, 2001, P NATL ACAD SCI USA, V98, P6027, DOI 10.1073/pnas.111138698; Pulfer MK, 2005, J PHARMACOL EXP THER, V312, P256, DOI 10.1124/jpet.104.073437; Rawson RB, 1999, J BIOL CHEM, V274, P28549, DOI 10.1074/jbc.274.40.28549; Rawson RB, 1998, J BIOL CHEM, V273, P28261, DOI 10.1074/jbc.273.43.28261; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Repa JJ, 2002, NAT MED, V8, P1243, DOI 10.1038/nm1102-1243; Repa JJ, 2002, J BIOL CHEM, V277, P18793, DOI 10.1074/jbc.M109927200; Rosen H, 1998, J BIOL CHEM, V273, P14805, DOI 10.1074/jbc.273.24.14805; Russell DW, 2000, BBA-MOL CELL BIOL L, V1529, P126, DOI 10.1016/S1388-1981(00)00142-6; Sakai J, 1998, MOL CELL, V2, P505, DOI 10.1016/S1097-2765(00)80150-1; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Sever N, 2004, J BIOL CHEM, V279, P43136, DOI 10.1074/jbc.M406406200; Sever N, 2003, MOL CELL, V11, P25, DOI 10.1016/S1097-2765(02)00822-5; Shimano H, 1997, J CLIN INVEST, V100, P2115, DOI 10.1172/JCI119746; Spencer TA, 2001, J MED CHEM, V44, P886, DOI 10.1021/jm0004749; Sun Y, 2003, J BIOL CHEM, V278, P5813, DOI 10.1074/jbc.M208687200; Svensson S, 2003, EMBO J, V22, P4625, DOI 10.1093/emboj/cdg456; Valledor AF, 2004, P NATL ACAD SCI USA, V101, P17813, DOI 10.1073/pnas.0407749101; Westover EJ, 2004, J MEMBRANE BIOL, V202, P61, DOI 10.1007/s00232-004-0714-7; Westover EJ, 2003, STEROIDS, V68, P159, DOI 10.1016/S0039-128X(02)00174-5; Wiebel FF, 1999, MOL ENDOCRINOL, V13, P1105, DOI 10.1210/me.13.7.1105; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; Wilund KR, 2004, ARTERIOSCL THROM VAS, V24, P2326, DOI 10.1161/01.ATV.0000149140.00499.92; Yang CD, 2004, J CLIN INVEST, V114, P813, DOI 10.1172/JCI200422186; Yang J, 2001, P NATL ACAD SCI USA, V98, P13607, DOI 10.1073/pnas.201524598; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Yoshikawa T, 2001, MOL CELL BIOL, V21, P2991, DOI 10.1128/MCB.21.9.2991-3000.2001; Yu LQ, 2004, J LIPID RES, V45, P301, DOI 10.1194/jlr.M300377-JLR200; Yu LQ, 2003, J BIOL CHEM, V278, P15565, DOI 10.1074/jbc.M301311200	50	200	210	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					27816	27826		10.1074/jbc.M603781200	http://dx.doi.org/10.1074/jbc.M603781200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16857673	hybrid			2022-12-27	WOS:000240534400017
J	Finkielstein, CV; Overduin, M; Capelluto, DGS				Finkielstein, Carla V.; Overduin, Michael; Capelluto, Daniel G. S.			Cell migration and signaling specificity is determined by the phosphatidylserine recognition motif of Rac1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROSS-CASCADE ACTIVATION; RHO-GTPASES; NUCLEAR-LOCALIZATION; PROTEIN INTERACTIONS; CRYSTAL-STRUCTURE; REGULATED KINASE; MEMBRANE-BINDING; POLYBASIC REGION; NADPH OXIDASE; RAF-1 KINASE	dThe Rho guanosine triphosphatases (GTPases) control cell shape and motility and are frequently overexpressed during malignant growth. These proteins act as molecular switches cycling between active GTP- and inactive GDP-bound forms. Despite being membrane anchored via their isoprenylated C-termini, Rho GTPases rapidly translocate between membrane and cytosolic compartments. Here, we show that the Rho GTPase Rac1 preferentially interacts with phosphatidylserine (PS)-containing bilayers through its polybasic motif (PBM). Rac1 isoprenylation contributes to membrane avidity but is not critical for PS recognition. The similar protein Cdc42 (cell division cycle 42), however, only associates with PS when prenylated. Conversely, other Rho GTPases such as Rac2, Rac3, and RhoA do not bind to PS even when they are prenylated. Cell stimulation with PS induces translocation of Rac1 toward the plasma membrane and stimulates GTP loading, membrane ruffling, and filopodia formation. This stimulation also promotes Cdc42 activation and phosphorylation of mitogen-activated protein kinase through Rac1/PS signaling. Consequently, the PBM specifically directs Rac1 to effect cytoskeletal rearrangement and cell migration by selective membrane phospholipid targeting.	Virginia Polytech Inst & State Univ, Dept Chem, Blacksburg, VA 24061 USA; Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA 24061 USA; Univ Birmingham, CR UK Inst Canc Studies, Sch Med, Birmingham B15 2TT, W Midlands, England	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; University of Birmingham	Capelluto, DGS (corresponding author), Virginia Polytech Inst & State Univ, Dept Chem, Blacksburg, VA 24061 USA.	capellut@vt.edu	Overduin, Michael/AAG-3632-2020	Overduin, Michael/0000-0002-3114-6585; finkielstein, carla/0000-0002-8417-4643	Biotechnology and Biological Sciences Research Council [BBS/B/10714] Funding Source: Medline; Cancer Research UK [A4592] Funding Source: Medline; Wellcome Trust [071684] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission)		Allan D, 1996, MOL MEMBR BIOL, V13, P81, DOI 10.3109/09687689609160580; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; BUSER CA, 1994, BIOCHEMISTRY-US, V33, P13093, DOI 10.1021/bi00248a019; Capelluto DGS, 2002, NATURE, V419, P726, DOI 10.1038/nature01056; Capelluto DGS, 2005, J BIOCHEM MOL BIOL, V38, P243; Casamayor A, 2003, MOL CELL BIOL, V23, P2762, DOI 10.1128/MCB.23.8.2762-2777.2003; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Coles LC, 2002, ONCOGENE, V21, P2236, DOI 10.1038/sj.onc.1205302; Del Pozo MA, 2002, NAT CELL BIOL, V4, P232, DOI 10.1038/ncb759; Eblen ST, 2002, MOL CELL BIOL, V22, P6023, DOI 10.1128/MCB.22.17.6023-6033.2002; Elliott JI, 2005, NAT CELL BIOL, V7, P808, DOI 10.1038/ncb1279; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Frost JA, 1997, EMBO J, V16, P6426, DOI 10.1093/emboj/16.21.6426; FUCHS A, 1994, EUR J BIOCHEM, V226, P587, DOI 10.1111/j.1432-1033.1994.tb20084.x; Gadella BM, 2002, BIOL REPROD, V67, P340, DOI 10.1095/biolreprod67.1.340; GHOSH SJ, 1994, J BIOL CHEM, V269, P10000; Gorzalczany Y, 2000, J BIOL CHEM, V275, P40073, DOI 10.1074/jbc.M006013200; Harding A, 2003, J BIOL CHEM, V278, P16747, DOI 10.1074/jbc.M301015200; Hirshberg M, 1997, NAT STRUCT BIOL, V4, P147, DOI 10.1038/nsb0297-147; Holt KH, 1996, MOL CELL BIOL, V16, P577; Lanning CC, 2004, J BIOL CHEM, V279, P44197, DOI 10.1074/jbc.M404977200; Ligeti E, 2004, J BIOL CHEM, V279, P5055, DOI 10.1074/jbc.C300547200; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Manser Edward J, 2002, Methods Mol Biol, V189, P3; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Missy K, 1998, J BIOL CHEM, V273, P30279, DOI 10.1074/jbc.273.46.30279; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; Nadkarni V, 1999, J BIOL CHEM, V274, P20185, DOI 10.1074/jbc.274.29.20185; Olofsson B, 1999, CELL SIGNAL, V11, P545, DOI 10.1016/S0898-6568(98)00063-1; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Ridley AJ, 2004, BREAST CANCER RES TR, V84, P13, DOI 10.1023/B:BREA.0000018423.47497.c6; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; SIGAL CT, 1994, P NATL ACAD SCI USA, V91, P12253, DOI 10.1073/pnas.91.25.12253; Thapar R, 2002, BIOCHEMISTRY-US, V41, P3875, DOI 10.1021/bi0120087; van Hennik PB, 2003, J BIOL CHEM, V278, P39166, DOI 10.1074/jbc.M307001200; Vance JE, 2005, PROG LIPID RES, V44, P207, DOI 10.1016/j.plipres.2005.05.001; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Williams CL, 2003, CELL SIGNAL, V15, P1071, DOI 10.1016/S0898-6568(03)00098-6; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Zhao RX, 2003, J BIOL CHEM, V278, P22609, DOI 10.1074/jbc.M301560200; Zwaal RFA, 1998, BBA-REV BIOMEMBRANES, V1376, P433, DOI 10.1016/S0304-4157(98)00018-5	42	45	45	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2006	281	37					27317	27326		10.1074/jbc.M605560200	http://dx.doi.org/10.1074/jbc.M605560200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082PB	16861229	hybrid			2022-12-27	WOS:000240397700058
J	Goswami, SC; Yoon, JH; Abramczyk, BM; Pfeifer, GP; Postel, EH				Goswami, Samridhi C.; Yoon, Jung-Hoon; Abramczyk, Bozena M.; Pfeifer, Gerd P.; Postel, Edith H.			Molecular and functional interactions between Escherichia coli nucleoside-diphosphate kinase and the uracil-DNA glycosylase UNG	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNTHETASE COMPLEX; SUPPRESSOR NM23-H1; TUMOR-METASTASIS; REPAIR NUCLEASE; PROTEIN; GENE; DROSOPHILA; CLEAVAGE; PROMOTER; SET	Escherichia coli nucleoside-diphosphate kinase (Ndk) catalyzes nucleoside triphosphate synthesis and maintains intracellular triphosphate pools. Mutants of E. coli lacking Ndk exhibit normal growth rates but show a mutator phenotype that cannot be entirely attributed to the absence of Ndk catalytic activity or to an imbalance in cellular triphosphates. It has been suggested previously that Ndk, similar to its human counterparts, possesses nuclease and DNA repair activities, including the excision of uracil from DNA, an activity normally associated with the Ung and Mug uracil-DNA glycosylases (UDGs) in E. coli. Here we have demonstrated that recombinant Ndk purified from wild-type E. coli contains significant UDG activity that is not intrinsic, but rather, is a consequence of a direct physical and functional interaction between Ung and Ndk, although a residual amount of intrinsic UDG activity exists as well. Co-purification of Ung and Ndk through multicolumn low pressure and nickel-nitrilotriacetic acid affinity chromatography suggests that the interaction occurs in a cellular context, as was also suggested by co-immunoprecipitation of endogenous Ung and Ndk from cellular extracts. Glutathione S-transferase pulldown and far Western analyses demonstrate that the interaction also occurs at the level of purified protein, suggesting that it is specific and direct. Moreover, significant augmentation of Ung catalytic activity by Ndk was observed, suggesting that the interaction between the two enzymes is functionally relevant. These findings represent the first example of Ung interacting with another E. coli protein and also lend support to the recently discovered role of nucleoside-diphosphate kinases as regulatory components of multiprotein complexes.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pediat, Biochem & Mol Biol Lab, New Brunswick, NJ 08903 USA; Beckman Res Inst City Hope, Div Biol, Duarte, CA 91010 USA; Princeton Univ, Dept Biol Mol, Princeton, NJ 08546 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; City of Hope; Beckman Research Institute of City of Hope; Princeton University	Postel, EH (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pediat, Biochem & Mol Biol Lab, 1 Robert Wood Johnson Pl,POB 19, New Brunswick, NJ 08903 USA.	posteleh@umdnj.edu			NATIONAL CANCER INSTITUTE [R01CA076496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES006070, R37ES006070] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA 076496] Funding Source: Medline; NIEHS NIH HHS [ES 06070] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ALMAULA N, 1995, J BACTERIOL, V177, P2524, DOI 10.1128/jb.177.9.2524-2529.1995; Bennett SE, 2004, P NATL ACAD SCI USA, V101, P6391, DOI 10.1073/pnas.0401031101; BERBERICH SJ, 1995, ONCOGENE, V10, P2343; Bernard MA, 2000, J BIOENERG BIOMEMBR, V32, P259, DOI 10.1023/A:1005537013120; Chowdhury D, 2006, MOL CELL, V23, P133, DOI 10.1016/j.molcel.2006.06.005; Cunningham RP, 1997, MUTAT RES-DNA REPAIR, V383, P189, DOI 10.1016/S0921-8777(97)00008-6; D'Angelo A, 2004, CANCER CELL, V5, P137, DOI 10.1016/S1535-6108(04)00021-2; Fan ZS, 2003, CELL, V112, P659, DOI 10.1016/S0092-8674(03)00150-8; Fournier HN, 2002, J BIOL CHEM, V277, P20895, DOI 10.1074/jbc.M200200200; Hartsough MT, 2000, J BIOENERG BIOMEMBR, V32, P301, DOI 10.1023/A:1005597231776; Janin J, 2000, J BIOENERG BIOMEMBR, V32, P215, DOI 10.1023/A:1005528811303; Jiang YL, 2001, J BIOL CHEM, V276, P42347, DOI 10.1074/jbc.M106594200; Kim J, 2005, J BIOL CHEM, V280, P28221, DOI 10.1074/jbc.M502201200; Kimura N, 2000, J BIOENERG BIOMEMBR, V32, P309, DOI 10.1023/A:1005549315846; Kumar P, 2004, DNA REPAIR, V3, P1483, DOI 10.1016/j.dnarep.2004.06.007; Lacombe ML, 2000, J BIOENERG BIOMEMBR, V32, P247, DOI 10.1023/A:1005584929050; Lascu I, 2000, J BIOENERG BIOMEMBR, V32, P227, DOI 10.1023/A:1005580828141; Levit MN, 2002, J BIOL CHEM, V277, P5163, DOI 10.1074/jbc.M111170200; Lombardi D, 2003, J BIOENERG BIOMEMBR, V35, P67, DOI 10.1023/A:1023445907439; LU Q, 1995, J MOL BIOL, V254, P337, DOI 10.1006/jmbi.1995.0620; Lutsenko E, 1999, J BIOL CHEM, V274, P31034, DOI 10.1074/jbc.274.43.31034; Ma DQ, 2004, J BIOL CHEM, V279, P18073, DOI 10.1074/jbc.M400185200; Ma DQ, 2002, J BIOL CHEM, V277, P1560, DOI 10.1074/jbc.M108359200; Miller JH, 2002, GENETICS, V162, P5; Parks R.E., 1973, ENZYMES, V8, P307, DOI [10.1016/S1874-6047(08)60069-4, DOI 10.1016/S1874-6047(08)60069-4]; Postel EH, 2003, P NATL ACAD SCI USA, V100, P13247, DOI 10.1073/pnas.2333230100; POSTEL EH, 1993, SCIENCE, V261, P478, DOI 10.1126/science.8392752; Postel EH, 1999, J BIOL CHEM, V274, P22821, DOI 10.1074/jbc.274.32.22821; POSTEL EH, 1994, J BIOL CHEM, V269, P8627; Postel EH, 2000, P NATL ACAD SCI USA, V97, P14194, DOI 10.1073/pnas.97.26.14194; Rochdi MD, 2004, J BIOL CHEM, V279, P18981, DOI 10.1074/jbc.M312621200; Roymans D, 2002, CLIN EXP METASTAS, V19, P465, DOI 10.1023/A:1020396722860; Shen RK, 2004, J BIOL CHEM, V279, P32225, DOI 10.1074/jbc.M402750200; Sung JS, 2001, J BIOL CHEM, V276, P2276, DOI 10.1074/jbc.M008147200; Timmons L, 1996, GENETICS, V144, P1589; Timmons L, 2000, J BIOENERG BIOMEMBR, V32, P293, DOI 10.1023/A:1005545214937; TYE BK, 1978, P NATL ACAD SCI USA, V75, P233, DOI 10.1073/pnas.75.1.233; Wheeler LJ, 1996, J BIOL CHEM, V271, P11156, DOI 10.1074/jbc.271.19.11156; Yoon JH, 2005, BIOCHEMISTRY-US, V44, P15774, DOI 10.1021/bi0515974	39	19	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32131	32139		10.1074/jbc.M604937200	http://dx.doi.org/10.1074/jbc.M604937200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16895920	hybrid			2022-12-27	WOS:000241414500010
J	Tsubotao, T; Tajima, R; Ode, K; Kubota, H; Fukuhara, N; Kawabata, T; Maki, S; Maki, H				Tsubotao, Toshiaki; Tajima, Rie; Ode, Kunitomo; Kubota, Hajime; Fukuhara, Naoshi; Kawabata, Takeshi; Maki, Satoko; Maki, Hisaji			Double-stranded DNA binding, an unusual property of DNA polymerase epsilon, promotes epigenetic silencing in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOSOME CORE PARTICLE; CELL NUCLEAR ANTIGEN; HISTONE-FOLD; PROTEIN STRUCTURES; S-PHASE; NF-Y; SUBUNIT; REPLICATION; CLONING; IDENTIFICATION	We have previously shown that DNA polymerase is an element of (Pol is an element of) of Saccharomyces cerevisiae binds stably to double-stranded DNA (dsDNA), a property not generally associated with DNA polymerases. Here, by reconstituting Pol is an element of activity from Pol2p-Dpb2p and Dpb3p-Dpb4p, its two component subassemblies, we report that Dpb3p-Dpb4p, a heterodimer of histone-fold motif-containing subunits, is responsible for the dsDNA binding. Substitution of specific lysine residues in Dpb3p, highlighted by homology modeling of Dpb3p-Dpb4p based on the structure of the histone H2A-H2B dimer, indicated that they play roles in binding of dsDNA by Dpb3p-Dpb4p, in a manner similar to the histone-DNA interaction. The lysine-substituted dpb3 mutants also displayed reduced telomeric silencing, whose degree paralleled that of the dsDNA-binding activity of Pol is an element of in the corresponding dpb3 mutants. Furthermore, additional amino acid substitutions to lysines in Dpb4p, to compensate for the loss of positive charges in the Dpb3p mutants, resulted in simultaneous restoration of dsDNA-binding activity by Pol is an element of and telomeric silencing. We conclude that the dsDNA-binding property of Pol is an element of is required for epigenetic silencing at telomeres.	Nara Inst Sci & Technol, Dept Mol Biol, Grad Sch Biol Sci, Nara 6300192, Japan; Nara Inst Sci & Technol, Grad Sch Informat Sci, Nara 6300192, Japan	Nara Institute of Science & Technology; Nara Institute of Science & Technology	Maki, S (corresponding author), Nara Inst Sci & Technol, Dept Mol Biol, Grad Sch Biol Sci, Nara 6300192, Japan.	smaki@bs.naist.jp						Amberg DC, 2005, METHODS YEAST GENETI, P199; ARAKI H, 1991, NUCLEIC ACIDS RES, V19, P4867, DOI 10.1093/nar/19.18.4867; ARAKI H, 1991, P NATL ACAD SCI USA, V88, P4601, DOI 10.1073/pnas.88.11.4601; ARENTS G, 1995, P NATL ACAD SCI USA, V92, P11170, DOI 10.1073/pnas.92.24.11170; Asturias FJ, 2006, NAT STRUCT MOL BIOL, V13, P35, DOI 10.1038/nsmb1040; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Caretti G, 1999, MOL CELL BIOL, V19, P8591; Chilkova O, 2003, J BIOL CHEM, V278, P14082, DOI 10.1074/jbc.M211818200; Corona DFV, 2000, EMBO J, V19, P3049, DOI 10.1093/emboj/19.12.3049; Feng WY, 2003, MOL BIOL CELL, V14, P3427, DOI 10.1091/mbc.E03-02-0088; Franco AA, 2004, COLD SPRING HARB SYM, V69, P201, DOI 10.1101/sqb.2004.69.201; Fuss J, 2002, J BIOL CHEM, V277, P8658, DOI 10.1074/jbc.M110615200; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; HAMATAKE RK, 1990, J BIOL CHEM, V265, P4072; Harp JM, 2000, ACTA CRYSTALLOGR D, V56, P1513, DOI 10.1107/S0907444900011847; Hartlepp KF, 2005, MOL CELL BIOL, V25, P9886, DOI 10.1128/MCB.25.22.9886-9896.2005; Iida T, 2004, MOL CELL BIOL, V24, P217, DOI 10.1128/MCB.24.1.217-227.2004; Jokela M, 1998, NUCLEIC ACIDS RES, V26, P730, DOI 10.1093/nar/26.3.730; Kawabata T, 2000, PROTEINS, V41, P108, DOI 10.1002/1097-0134(20001001)41:1<108::AID-PROT130>3.3.CO;2-J; KESTI T, 1993, J BIOL CHEM, V268, P10238; Kim IS, 1996, MOL CELL BIOL, V16, P4003; Krude T, 2001, CELL MOL LIFE SCI, V58, P665, DOI 10.1007/PL00000890; Kukimoto I, 2004, MOL CELL, V13, P265, DOI 10.1016/S1097-2765(03)00523-9; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Li Y, 1997, J BIOL CHEM, V272, P32337, DOI 10.1074/jbc.272.51.32337; Li Y, 2000, J BIOL CHEM, V275, P23247, DOI 10.1074/jbc.M002548200; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Maity SN, 1998, TRENDS BIOCHEM SCI, V23, P174, DOI 10.1016/S0968-0004(98)01201-8; Maki S, 1998, J BIOL CHEM, V273, P21332, DOI 10.1074/jbc.273.33.21332; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; Martin SG, 1999, CELL, V97, P621, DOI 10.1016/S0092-8674(00)80773-4; McAinsh AD, 1999, CURR BIOL, V9, P963, DOI 10.1016/S0960-9822(99)80424-2; Mills KD, 1999, CELL, V97, P609, DOI 10.1016/S0092-8674(00)80772-2; MORRISON A, 1990, CELL, V62, P1143, DOI 10.1016/0092-8674(90)90391-Q; Motta MC, 1999, J BIOL CHEM, V274, P1326, DOI 10.1074/jbc.274.3.1326; Ohya T, 2000, NUCLEIC ACIDS RES, V28, P3846, DOI 10.1093/nar/28.20.3846; Poot RA, 2000, EMBO J, V19, P3377, DOI 10.1093/emboj/19.13.3377; Romier C, 2003, J BIOL CHEM, V278, P1336, DOI 10.1074/jbc.M209635200; SALI A, 1990, J MOL BIOL, V212, P403, DOI 10.1016/0022-2836(90)90134-8; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; Spiga MG, 2004, NUCLEIC ACIDS RES, V32, P4945, DOI 10.1093/nar/gkh811; Tackett AJ, 2005, J CELL BIOL, V169, P35, DOI 10.1083/jcb.200502104; Tsubota T, 2003, GENES CELLS, V8, P873, DOI 10.1046/j.1365-2443.2003.00683.x; Zhang ZG, 2000, NATURE, V408, P221, DOI 10.1038/35041601	46	30	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32898	32908		10.1074/jbc.M606637200	http://dx.doi.org/10.1074/jbc.M606637200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16916794	hybrid			2022-12-27	WOS:000241414500088
J	Kirschner, KM; Wagner, N; Wagner, KD; Wellmann, S; Scholz, H				Kirschner, Karin M.; Wagner, Nicole; Wagner, Kay-Dietrich; Wellmann, Sven; Scholz, Holger			The Wilms tumor suppressor Wt1 promotes cell adhesion through transcriptional activation of the alpha 4integrin gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-4 INTEGRIN; PROTEIN WT1; MESENCHYMAL TRANSFORMATION; SUBNUCLEAR LOCALIZATION; KIDNEY DEVELOPMENT; BINDING-SITES; SMOOTH-MUSCLE; AVIAN HEART; EXPRESSION; PRODUCT	Cell-matrix interaction through specific adhesion molecules is a critical step during organ development. In addition, down-regulation of cell adhesion receptors may promote tumor invasion and metastasis. We show here that the Wilms tumor suppressor Wt1, which is necessary for normal development of the epicardium, coronary vessels, genitourinary system, and other tissues, activates transcription of the alpha 4integrin gene. Binding of the Wt1(-KTS) form, which is transcriptionally active, to the proximal alpha 4integrin promoter was demonstrated by electrophoretic mobility shift assay and chromatin immunoprecipitation. A reporter construct harboring similar to 1.9 kb of the human alpha 4integrin gene promoter was activated significantly by transient co-transfection of a Wt1(-KTS) expression plasmid. Introducing mutations in two identified Wt1(-KTS) binding motifs in the proximal promoter of the alpha 4integrin gene abrogated this stimulatory effect. Endogenous alpha 4integrin transcripts were increased more than 3-fold in human embryonic kidney 293 cells with stable expression of the Wt1(-KTS) protein. Wt1-overexpressing cells showed augmented adhesion to the alpha 4integrin ligand vascular cell adhesion molecule-1 that was abolished upon incubation with an inhibitory alpha 4integrin antibody. Double immunofluorescent staining revealed co-localization of Wt1 and alpha 4integrin in the developing epicardium of mouse embryos. Cardiac expression of alpha 4integrin was reduced significantly in embryos with a homozygous Wt1 defect (Wt1(-/-)). These findings demonstrate that Wt1 can support cell adhesion through enhanced expression of alpha 4integrin. This transcriptional activation of the alpha 4integrin gene by Wt1(-KTS) might contribute to normal formation of the epicardium and other tissues in the developing embryo.	Univ Med Berlin, Charite, Inst Vegetat Physiol, D-10117 Berlin, Germany; Fac Sci, Ctr Biochim, INSERM U636, F-06108 Nice, France; Univ Basel, Kinderspital Beider, CH-4058 Basel, Switzerland	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; University of Basel	Scholz, H (corresponding author), Univ Med Berlin, Charite, Inst Vegetat Physiol, Tucholskystr 2, D-10117 Berlin, Germany.	holger.scholz@charite.de	Wagner, Kay-Dietrich/E-6119-2016; Wellmann, Sven/A-2771-2017	Wagner, Kay-Dietrich/0000-0001-5483-7760; Wagner, Nicole/0000-0002-2746-0707; Kirschner, Karin/0000-0003-0226-8636				Alberta JA, 2003, BLOOD, V101, P2570, DOI 10.1182/blood-2002-06-1656; ARMSTRONG JF, 1993, MECH DEVELOP, V40, P85, DOI 10.1016/0925-4773(93)90090-K; Arroyo AG, 1996, CELL, V85, P997, DOI 10.1016/S0092-8674(00)81301-X; Baltensperger H, 1997, J BIOL CHEM, V272, P10151; BECKWITH J B, 1990, Pediatric Pathology, V10, P1; Bruening W, 1996, J BIOL CHEM, V271, P8646, DOI 10.1074/jbc.271.15.8646; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; Carmona R, 2001, CELL TISSUE RES, V303, P173, DOI 10.1007/s004410000307; Chen THP, 2002, DEV BIOL, V250, P198, DOI 10.1006/dbio.2002.0796; Cook DM, 1996, ONCOGENE, V13, P1789; Dame C, 2004, J BIOL CHEM, V279, P2955, DOI 10.1074/jbc.M310404200; Danen EHJ, 2003, J PATHOL, V201, P632, DOI 10.1002/path.1472; Davies RC, 1998, GENE DEV, V12, P3217, DOI 10.1101/gad.12.20.3217; Dettman RW, 1998, DEV BIOL, V193, P169, DOI 10.1006/dbio.1997.8801; Donovan MJ, 2000, DEVELOPMENT, V127, P4531; DRUMMOND IA, 1992, SCIENCE, V257, P674, DOI 10.1126/science.1323141; ELICES MJ, 1990, CELL, V60, P577, DOI 10.1016/0092-8674(90)90661-W; Englert C, 1997, CANCER RES, V57, P1429; Englert C, 1995, P NATL ACAD SCI USA, V92, P11960, DOI 10.1073/pnas.92.26.11960; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; GUAN JL, 1990, CELL, V60, P53, DOI 10.1016/0092-8674(90)90715-Q; HABER DA, 1991, P NATL ACAD SCI USA, V88, P9618, DOI 10.1073/pnas.88.21.9618; HASTIE ND, 1994, ANNU REV GENET, V28, P523; Herzer U, 1999, CURR BIOL, V9, P837, DOI 10.1016/S0960-9822(99)80369-8; Hosono S, 2000, J BIOL CHEM, V275, P10943, DOI 10.1074/jbc.275.15.10943; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Kennedy D, 1996, NAT GENET, V12, P329, DOI 10.1038/ng0396-329; Kim J, 1999, MOL CELL BIOL, V19, P2289; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; KWEE L, 1995, DEVELOPMENT, V121, P489; LARSSON SH, 1995, CELL, V81, P391, DOI 10.1016/0092-8674(95)90392-5; Lecuit T, 2005, TRENDS CELL BIOL, V15, P34, DOI 10.1016/j.tcb.2004.11.007; Lee SB, 2001, EXP CELL RES, V264, P74, DOI 10.1006/excr.2000.5131; Lee SB, 1999, CELL, V98, P663, DOI 10.1016/S0092-8674(00)80053-7; Manner J, 2001, CELLS TISSUES ORGANS, V169, P89, DOI 10.1159/000047867; Mannion BA, 1996, J IMMUNOL, V157, P2039; Moore AW, 1999, DEVELOPMENT, V126, P1845; Morabito CJ, 2001, DEV BIOL, V234, P204, DOI 10.1006/dbio.2001.0254; MORRISON AA, 2006, IN PRESS CANC LETT; NAKAGAMA H, 1995, MOL CELL BIOL, V15, P1489; NEEDHAM LA, 1994, CELL ADHES COMMUN, V2, P87, DOI 10.3109/15419069409004429; OSBORN L, 1989, CELL, V59, P1203, DOI 10.1016/0092-8674(89)90775-7; Peeters MPFMV, 1999, ANAT EMBRYOL, V199, P367, DOI 10.1007/s004290050235; PHELAN SA, 1994, CELL GROWTH DIFFER, V5, P677; Pinco KA, 2001, MECH DEVELOP, V100, P99, DOI 10.1016/S0925-4773(00)00503-7; Priestley GV, 2006, BLOOD, V107, P2959, DOI 10.1182/blood-2005-07-2670; RACKLEY RR, 1993, CELL GROWTH DIFFER, V4, P1023; RAUSCHER FJ, 1990, SCIENCE, V250, P1259, DOI 10.1126/science.2244209; Rivera MN, 2005, NAT REV CANCER, V5, P699, DOI 10.1038/nrc1696; ROSEN GD, 1994, J BIOL CHEM, V269, P15652; ROSEN GD, 1991, P NATL ACAD SCI USA, V88, P4094, DOI 10.1073/pnas.88.10.4094; RUPPRECHT HD, 1994, J BIOL CHEM, V269, P6198; RYAN G, 1995, DEVELOPMENT, V121, P867; Scharnhorst V, 1999, J BIOL CHEM, V274, P23456, DOI 10.1074/jbc.274.33.23456; Scharnhorst V, 2001, GENE, V273, P141, DOI 10.1016/S0378-1119(01)00593-5; Sengbusch JK, 2002, J CELL BIOL, V157, P873, DOI 10.1083/jcb.200203075; Seth A, 2005, EUR J CANCER, V41, P2462, DOI 10.1016/j.ejca.2005.08.013; SHARMA PM, 1994, GENE DEV, V8, P720, DOI 10.1101/gad.8.6.720; Wagner KD, 2003, FASEB J, V17, P1364, DOI 10.1096/fj.02-1065fje; Wagner KD, 2002, FASEB J, V16, P1117, DOI 10.1096/fj.01-0986fje; Wagner KD, 2001, J AM SOC NEPHROL, V12, P1188, DOI 10.1681/ASN.V1261188; Wagner KD, 2003, GENE, V305, P217, DOI 10.1016/S0378-1119(02)01231-3; Wagner KD, 2002, EMBO J, V21, P1398, DOI 10.1093/emboj/21.6.1398; Wagner N, 2005, DEVELOPMENT, V132, P1327, DOI 10.1242/dev.01682; Wagner N, 2005, GENE DEV, V19, P2631, DOI 10.1101/gad.346405; Wagner N, 2004, J AM SOC NEPHROL, V15, P3044, DOI 10.1097/01.ASN.0000146687.99058.25; WANG ZY, 1992, J BIOL CHEM, V267, P21999; WAYNER EA, 1989, J CELL BIOL, V109, P1321, DOI 10.1083/jcb.109.3.1321; YANG JT, 1995, DEVELOPMENT, V121, P549; Zaniolo K, 2004, INVEST OPHTH VIS SCI, V45, P1692, DOI 10.1167/iovs.03-0908	70	35	37	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31930	31939		10.1074/jbc.M602668200	http://dx.doi.org/10.1074/jbc.M602668200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16920711				2022-12-27	WOS:000241235300079
J	Olivera, BM				Olivera, Baldomero M.			Conus peptides: Biodiversity-based discovery and exogenomics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CALCIUM-CHANNEL BLOCKER; SNAIL VENOM; ION-CHANNEL; CONOTOXIN; SUPERFAMILY; ZICONOTIDE; ANALOGS; DEFINES; RATS; PAIN		Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Olivera, BM (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	olivera@biology.utah.edu			NIGMS NIH HHS [GM48677] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLEN JW, 2006, IN PRESS ANESTH ANAL; Buczek O, 2005, CELL MOL LIFE SCI, V62, P3067, DOI 10.1007/s00018-005-5283-0; Buczek O, 2005, FEBS J, V272, P4178, DOI 10.1111/j.1742-4658.2005.04830.x; Buczek O, 2004, BIOCHEMISTRY-US, V43, P1093, DOI 10.1021/bi0354233; Bulaj G, 2006, BIOCHEMISTRY-US, V45, P7404, DOI 10.1021/bi060159+; Bulaj G, 2003, P NATL ACAD SCI USA, V100, P14562, DOI 10.1073/pnas.2335845100; Conticello SG, 2001, MOL BIOL EVOL, V18, P120, DOI 10.1093/oxfordjournals.molbev.a003786; Corpuz GP, 2005, BIOCHEMISTRY-US, V44, P8176, DOI 10.1021/bi047541b; Ellison M, 2006, BIOCHEMISTRY-US, V45, P1511, DOI 10.1021/bi0520129; Ellison M, 2003, J BIOL CHEM, V278, P757, DOI 10.1074/jbc.M204565200; England LJ, 1998, SCIENCE, V281, P575, DOI 10.1126/science.281.5376.575; Hu LY, 1999, J MED CHEM, V42, P4239, DOI 10.1021/jm9902739; IMPERIAL JS, 2006, IN PRESS BIOCHEMISTR; IMPERIAL JS, 2006, IN PRESS P AM PHILOS; Lirazan MB, 2000, BIOCHEMISTRY-US, V39, P1583, DOI 10.1021/bi9923712; Lubbers NL, 2005, J CARDIOVASC PHARM, V46, P141, DOI 10.1097/01.fjc.0000167015.84715.27; Malmberg AB, 2003, PAIN, V101, P109, DOI 10.1016/S0304-3959(02)00303-2; McIntosh JM, 2000, EUR J PHARMACOL, V393, P205, DOI 10.1016/S0014-2999(99)00887-0; McIntosh JM, 2004, MOL PHARMACOL, V65, P944, DOI 10.1124/mol.65.4.944; McIntosh JM, 2000, J BIOL CHEM, V275, P32391, DOI 10.1074/jbc.M003619200; Miljanich GP, 2004, CURR MED CHEM, V11, P3029, DOI 10.2174/0929867043363884; Nielsen CK, 2005, PAIN, V118, P112, DOI 10.1016/j.pain.2005.08.002; Olivera Baldomero M., 2000, P74, DOI 10.1159/000062483; Olivera BM, 2002, ANNU REV ECOL SYST, V33, P25, DOI 10.1146/annurev.ecolsys.33.010802.150424; OLIVERA BM, 1985, SCIENCE, V230, P1338, DOI 10.1126/science.4071055; OLIVERA BM, 1990, SCIENCE, V249, P257, DOI 10.1126/science.2165278; Santos AD, 2004, J BIOL CHEM, V279, P17596, DOI 10.1074/jbc.M309654200; Satkunanathan N, 2005, BRAIN RES, V1059, P149, DOI 10.1016/j.brainres.2005.08.009; Sharpe IA, 2001, NAT NEUROSCI, V4, P902, DOI 10.1038/nn0901-902; Smith MT, 2002, PAIN, V96, P119, DOI 10.1016/S0304-3959(01)00436-5; SNUTCH TP, 2005, NEUROMED TECHNOLOG 1, V6, P1; Staats PS, 2004, JAMA-J AM MED ASSOC, V291, P63, DOI 10.1001/jama.291.1.63; Teichert RW, 2004, TOXICON, V44, P207, DOI 10.1016/j.toxicon.2004.05.026; Teichertt RW, 2005, BIOCHEMISTRY-US, V44, P7897, DOI 10.1021/bi047274+; Terlau H, 1996, NATURE, V381, P148, DOI 10.1038/381148a0; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Walker CS, 1999, J BIOL CHEM, V274, P30664, DOI 10.1074/jbc.274.43.30664; Zhang SJ, 2003, J CARDIOVASC PHARM, V42, P764, DOI 10.1097/00005344-200312000-00011	38	243	265	4	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31173	31177		10.1074/jbc.R600020200	http://dx.doi.org/10.1074/jbc.R600020200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16905531	Bronze			2022-12-27	WOS:000241235300001
J	Harant, H; Lettner, N; Hofer, L; Oberhauser, B; de Vries, JE; Lindley, IJD				Harant, Hanna; Lettner, Nicole; Hofer, Lotte; Oberhauser, Berndt; de Vries, Jan E.; Lindley, Ivan J. D.			The translocation inhibitor CAM741 interferes with vascular cell adhesion molecule 1 signal peptide insertion at the translocon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; PROTEIN-CONDUCTING CHANNEL; ER-MEMBRANE; RECOGNITION PARTICLE; SEQUENCE RECOGNITION; COTRANSLATIONAL TRANSLOCATION; NASCENT PREPROLACTIN; SECRETORY PROTEINS; CROSS-LINKING; COMPLEX	The cyclopeptolide CAM741 selectively inhibits cotranslational translocation of vascular cell adhesion molecule 1 (VCAM1), a process that is dependent on its signal peptide. In this study we identified the C-terminal (C-) region upstream of the cleavage site of the VCAM1 signal peptide as most critical for inhibition of translocation by CAM741, but full sensitivity to the compound also requires residues of the hydrophobic (h-) region and the first amino acid of the VCAM1 mature domain. The murine VCAM1 signal peptide, which is less susceptible to translocation inhibition by CAM741, can be converted into a fully sensitive signal peptide by two amino acid substitutions identified as critical for compound sensitivity of the human VCAM1 signal peptide. Using cysteine substitutions of non-critical residues in the human VCAM1 signal peptide and chemical cross-linking of targeted short nascent chains we show that, in the presence of CAM741, the N- and C-terminal segments of the VCAM1 signal peptide could be cross-linked to the cytoplasmic tail of Sec61 beta, indicating altered positioning of the VCAM1 signal peptide relative to this translocon component. Moreover, translocation of a tag fused N- terminal to the VCAM1 signal peptide is selectively inhibited by CAM741. Our data indicate that the compound inhibits translocation of VCAM1 by interfering with correct insertion of its signal peptide into the translocon.	Novartis Inst Biomed Res, A-1235 Vienna, Austria	Novartis	Harant, H (corresponding author), Novartis Inst Biomed Res, Brunner Str 59, A-1235 Vienna, Austria.	Hanna.Harant@novartis.com	Hanna, Harant/AAA-7120-2022	Hanna, Harant/0000-0003-3842-0249				Besemer J, 2005, NATURE, V436, P290, DOI 10.1038/nature03670; CROWLEY KS, 1993, CELL, V73, P1101, DOI 10.1016/0092-8674(93)90640-C; CROWLEY KS, 1994, CELL, V78, P461, DOI 10.1016/0092-8674(94)90424-3; Fons RD, 2003, J CELL BIOL, V160, P529, DOI 10.1083/jcb.200210095; Garrison JL, 2005, NATURE, V436, P285, DOI 10.1038/nature03821; GILMORE R, 1982, J CELL BIOL, V95, P463, DOI 10.1083/jcb.95.2.463; GILMORE R, 1982, J CELL BIOL, V95, P470, DOI 10.1083/jcb.95.2.470; Goder V, 2003, EMBO J, V22, P3645, DOI 10.1093/emboj/cdg361; GORLICH D, 1992, NATURE, V357, P47, DOI 10.1038/357047a0; GORLICH D, 1992, CELL, V71, P489, DOI 10.1016/0092-8674(92)90517-G; Hanein D, 1996, CELL, V87, P721, DOI 10.1016/S0092-8674(00)81391-4; Hegde RS, 1998, CELL, V92, P621, DOI 10.1016/S0092-8674(00)81130-7; Hegde RS, 1997, CELL, V91, P575, DOI 10.1016/S0092-8674(00)80445-6; Heinrich SU, 2000, CELL, V102, P233, DOI 10.1016/S0092-8674(00)00028-3; Heinrich SU, 2003, EMBO J, V22, P3654, DOI 10.1093/emboj/cdg346; HIGH S, 1993, J BIOL CHEM, V268, P26745; Ismail N, 2006, J CELL SCI, V119, P2826, DOI 10.1242/jcs.03018; Johnson AE, 1999, ANNU REV CELL DEV BI, V15, P799, DOI 10.1146/annurev.cellbio.15.1.799; JUNGNICKEL B, 1995, CELL, V82, P261, DOI 10.1016/0092-8674(95)90313-5; KALIES KU, 1994, J CELL BIOL, V126, P925, DOI 10.1083/jcb.126.4.925; Kim SJ, 2002, DEV CELL, V2, P207, DOI 10.1016/S1534-5807(01)00120-4; KRIEG UC, 1986, P NATL ACAD SCI USA, V83, P8604, DOI 10.1073/pnas.83.22.8604; KURZCHALIA TV, 1986, NATURE, V320, P634, DOI 10.1038/320634a0; Laird V, 1997, J BIOL CHEM, V272, P1983, DOI 10.1074/jbc.272.3.1983; MARTOGLIO B, 1995, CELL, V81, P207, DOI 10.1016/0092-8674(95)90330-5; Matlack KES, 1998, CELL, V92, P381, DOI 10.1016/S0092-8674(00)80930-7; Menetret JF, 2000, MOL CELL, V6, P1219, DOI 10.1016/S1097-2765(00)00118-0; Menetret JF, 2005, J MOL BIOL, V348, P445, DOI 10.1016/j.jmb.2005.02.053; MEYER DI, 1982, NATURE, V297, P647, DOI 10.1038/297647a0; Morgan DG, 2002, J MOL BIOL, V324, P871, DOI 10.1016/S0022-2836(02)01111-7; MOTHES W, 1994, EMBO J, V13, P3973, DOI 10.1002/j.1460-2075.1994.tb06713.x; Mothes W, 1998, J CELL BIOL, V142, P355, DOI 10.1083/jcb.142.2.355; NICCHITTA CV, 1995, J CELL BIOL, V129, P957, DOI 10.1083/jcb.129.4.957; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Nielsen H, 1999, PROTEIN ENG, V12, P3, DOI 10.1093/protein/12.1.3; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; Rapoport TA, 1996, ANNU REV BIOCHEM, V65, P271; Rutkowski DT, 2003, J BIOL CHEM, V278, P30365, DOI 10.1074/jbc.M302117200; Rutkowski DT, 2001, P NATL ACAD SCI USA, V98, P7823, DOI 10.1073/pnas.141125098; SIMON SM, 1991, CELL, V65, P371, DOI 10.1016/0092-8674(91)90455-8; Song WQ, 2000, CELL, V100, P333, DOI 10.1016/S0092-8674(00)80669-8; Stroud RM, 1999, CURR OPIN STRUC BIOL, V9, P754, DOI 10.1016/S0959-440X(99)00040-8; Voigt S, 1996, J CELL BIOL, V134, P25, DOI 10.1083/jcb.134.1.25	43	25	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30492	30502		10.1074/jbc.M607243200	http://dx.doi.org/10.1074/jbc.M607243200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16914554	hybrid			2022-12-27	WOS:000241075900025
J	Chuan, YC; Pang, ST; Cedazo-Minguez, A; Norstedt, G; Pousette, A; Flores-Morales, A				Chuan, Yin-Choy; Pang, See-Tong; Cedazo-Minguez, Angel; Norstedt, Gunnar; Pousette, Ake; Flores-Morales, Amilcar			Androgen induction of prostate cancer cell invasion is mediated by ezrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; PHOSPHATIDYLINOSITOL 3-KINASE/AKT PATHWAY; SIGNAL-TRANSDUCTION PATHWAYS; TUMOR CHARACTERISTICS; EPITHELIAL-CELLS; CONTROLLED-TRIAL; PLASMA-MEMBRANE; RECEPTOR GENE; EXPRESSION; ACTIVATION	Ezrin is a key signaling molecule that regulates cell survival, adhesion migration, and invasion. We have previously shown that ezrin is regulated by androgen in rat prostate and that its expression is increased in prostate cancer and in prostate intraepithelial neoplasia. We have used the androgen-sensitive cell line LNCaP-FGC to investigate the role of ezrin in androgen-induced cell invasion. We found that androgen treatment of LNCaP-FGC cells induces ezrin expression, an effect that is inhibited by the androgen receptor antagonist, bicalutamide. In addition, androgen treatment induces the phosphorylation of ezrin in Thr-567 and Tyr-353 in a sequential manner. This is mediated through protein kinase C alpha and Src tyrosine kinase, respectively. Androgen treatment induces the translocation of both protein kinase C alpha and ezrin to the cell membrane and their association. Inhibition of ezrin function using short interference RNA or the overexpression of T567A and Y353F-ezrin mutants significantly reduces androgen-induced Matrigel invasion but does not affect cell proliferation or cell adhesion. Matrigel invasion of the androgen-insensitive prostate cancer cell lines PC-3 and LNCaP-R is also dependent on ezrin. In summary, we have shown that androgens regulate ezrin at transcriptional and posttranscriptional levels. Hormonal regulation of ezrin phosphorylation is required for androgen-induced cell invasion.	Karolinska Inst, Dept Mol Med & Surg, S-17176 Stockholm, Sweden; Karolinska Inst, Neurotec, Sect Expt Geriatr, S-17176 Stockholm, Sweden; Karolinska Inst, Dept Med, Androl Ctr, S-17176 Stockholm, Sweden; Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Surg,Div Urol, Tao Yuan 333, Taiwan	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Chang Gung Memorial Hospital; Chang Gung University	Flores-Morales, A (corresponding author), Karolinska Hosp, Dept Mol Med & Surg, CMM L8-01, S-17176 Stockholm, Sweden.	Amilcar.Flores@cmm.ki.se	Cedazo-Minguez, Angel/C-6707-2012	Cedazo-Minguez, Angel/0000-0003-4626-4864				Akisawa N, 1999, BIOCHEM BIOPH RES CO, V258, P395, DOI 10.1006/bbrc.1999.0653; Bolla M, 2002, LANCET, V360, P103, DOI 10.1016/S0140-6736(02)09408-4; Bonaccorsi L, 2000, ENDOCRINOLOGY, V141, P3172, DOI 10.1210/en.141.9.3172; Bubendorf L, 2000, HUM PATHOL, V31, P578, DOI 10.1053/hp.2000.6698; Cheville JC, 2002, CANCER-AM CANCER SOC, V95, P1028, DOI 10.1002/cncr.10788; Crepaldi T, 1997, J CELL BIOL, V138, P423, DOI 10.1083/jcb.138.2.423; Curto M, 2004, CANCER CELL, V5, P113, DOI 10.1016/S1535-6108(04)00031-5; D'Amico AV, 2004, JAMA-J AM MED ASSOC, V292, P821, DOI 10.1001/jama.292.7.821; Draisma G, 2003, J NATL CANCER I, V95, P868, DOI 10.1093/jnci/95.12.868; Edwards J, 2005, BJU INT, V95, P1327, DOI 10.1111/j.1464-410X.2005.05527.x; Edwards J, 2005, BJU INT, V95, P1320, DOI 10.1111/j.1464-410X.2005.05526.x; Edwards J, 2003, BRIT J CANCER, V89, P552, DOI 10.1038/sj.bjc.6601127; Farla P, 2005, J CELL SCI, V118, P4187, DOI 10.1242/jcs.02546; Fievet BT, 2004, J CELL BIOL, V164, P653, DOI 10.1083/jcb.200307032; Furr BJA, 1996, UROLOGY, V47, P13, DOI 10.1016/S0090-4295(96)80003-3; Gautreau A, 1999, P NATL ACAD SCI USA, V96, P7300, DOI 10.1073/pnas.96.13.7300; Gautreau A, 2002, CURR OPIN CELL BIOL, V14, P104, DOI 10.1016/S0955-0674(01)00300-3; Gautreau A, 2000, J CELL BIOL, V150, P193, DOI 10.1083/jcb.150.1.193; HASENSON M, 1985, PROSTATE, V7, P183, DOI 10.1002/pros.2990070208; Heinlein CA, 2002, MOL ENDOCRINOL, V16, P2181, DOI 10.1210/me.2002-0070; Heiska L, 2005, J BIOL CHEM, V280, P10244, DOI 10.1074/jbc.M411353200; Kang HY, 2004, J BONE MINER RES, V19, P1181, DOI 10.1359/JBMR.040306; Khanna C, 2004, NAT MED, V10, P182, DOI 10.1038/nm982; KOBAYASHI E, 1989, BIOCHEM BIOPH RES CO, V159, P548, DOI 10.1016/0006-291X(89)90028-4; KRIEG J, 1992, J BIOL CHEM, V267, P19258; LIEBERHERR M, 1994, J BIOL CHEM, V269, P7217; Liu B, 1997, ADV EXP MED BIOL, V400, P707; Makinen T, 2003, CLIN CANCER RES, V9, P2435; Makitie T, 2001, INVEST OPHTH VIS SCI, V42, P2442; Martin TA, 2003, CRIT REV ONCOL HEMAT, V46, P165, DOI 10.1016/S1040-8428(02)00172-5; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Messing EM, 1999, NEW ENGL J MED, V341, P1781, DOI 10.1056/NEJM199912093412401; Migliaccio A, 2000, EMBO J, V19, P5406, DOI 10.1093/emboj/19.20.5406; Mitchell S, 2000, BJU INT, V85, P932, DOI 10.1046/j.1464-410x.2000.00606.x; Ng T, 2001, EMBO J, V20, P2723, DOI 10.1093/emboj/20.11.2723; Pang ST, 2006, PROSTATE, V66, P157, DOI 10.1002/pros.20328; Pang ST, 2004, ONCOL REP, V11, P1187; Pang ST, 2004, UROLOGY, V63, P609, DOI 10.1016/j.urology.2003.09.068; Pang ST, 2002, ENDOCRINOLOGY, V143, P4897, DOI 10.1210/en.2002-220327; Papakonstanti EA, 2003, MOL ENDOCRINOL, V17, P870, DOI 10.1210/me.2002-0253; Peterziel H, 1999, ONCOGENE, V18, P6322, DOI 10.1038/sj.onc.1203032; Pfitzenmaier J, 2003, J BONE MINER RES, V18, P1882, DOI 10.1359/jbmr.2003.18.10.1882; Pula G, 2005, J BIOL CHEM, V280, P7194, DOI 10.1074/jbc.M409212200; Quang CT, 2000, EMBO J, V19, P4565, DOI 10.1093/emboj/19.17.4565; SCHELLHAMMER P, 1995, UROLOGY, V45, P745, DOI 10.1016/S0090-4295(99)80077-6; Sonnenburg ED, 2001, J BIOL CHEM, V276, P45289, DOI 10.1074/jbc.M107416200; Srivastava J, 2005, MOL BIOL CELL, V16, P1481, DOI 10.1091/mbc.e04-08-0721; Sun M, 2003, J BIOL CHEM, V278, P42992, DOI 10.1074/jbc.M306295200; Taplin ME, 1999, CANCER RES, V59, P2511; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; Tyagi RK, 2000, MOL ENDOCRINOL, V14, P1162, DOI 10.1210/me.14.8.1162; Valdman A, 2005, EUR UROL, V48, P852, DOI 10.1016/j.eururo.2005.03.013; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; Yu YL, 2004, NAT MED, V10, P175, DOI 10.1038/nm966; Zhang M, 2004, ONCOGENE, V23, P3080, DOI 10.1038/sj.onc.1207435; Zhao X, 2001, UROLOGY, V57, P860, DOI 10.1016/S0090-4295(01)00946-3; Zhu P, 2006, CELL, V124, P615, DOI 10.1016/j.cell.2005.12.032	57	65	69	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					29938	29948		10.1074/jbc.M602237200	http://dx.doi.org/10.1074/jbc.M602237200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16873375	hybrid			2022-12-27	WOS:000240896300055
J	Ding, J; Rainey, JK; Xu, C; Sykes, BD; Fliegel, L				Ding, Jie; Rainey, Jan K.; Xu, Caroline; Sykes, Brian D.; Fliegel, Larry			Structural and functional characterization of transmembrane segment VII of the Na+/H+ exchanger isoform 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSERTION SCANNING MUTAGENESIS; PROTEIN SECONDARY STRUCTURE; HELIX-HELIX INTERACTIONS; CHEMICAL-SHIFT INDEX; MEMBRANE-PROTEIN; LACTOSE PERMEASE; AMINO-ACIDS; SYNTHETIC PEPTIDES; AMILORIDE; IDENTIFICATION	The Na+/ H+ exchanger isoform 1 is an integral membrane protein that regulates intracellular pH by exchanging one intracellular H+ for one extracellular Na+. It is composed of an N-terminal membrane domain of 12 transmembrane segments and an intracellular C-terminal regulatory domain. We characterized the structural and functional aspects of the critical transmembrane segment VII ( TM VII, residues 251 - 273) by using alanine scanning mutagenesis and high resolution NMR. Each residue of TM VII was mutated to alanine, the full-length protein expressed, and its activity characterized. TM VII was sensitive to mutation. Mutations at 13 of 22 residues resulted in severely reduced activity, whereas other mutants exhibited varying degrees of decreases in activity. The impaired activities sometimes resulted from low expression and/ or low surface targeting. Three of the alanine scanning mutant proteins displayed increased, and two displayed decreased resistance to the Na+/ H+ exchanger isoform 1 inhibitor EMD87580. The structure of a peptide of TM VII was determined by using high resolution NMR in dodecylphosphocholine micelles. TM VII is predominantly alpha- helical, with a break in the helix at the functionally critical residues Gly(261)-Glu(262). The relative positions and orientations of the N- and C- terminal helical segments are seen to vary about this extended segment in the ensemble of NMRstructures. Our results show thatTMVII is a critical transmembrane segment structured as an interrupted helix, with several residues that are essential to both protein function and sensitivity to inhibition.	Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; Univ Alberta, Prot Engn Network Ctr Excellence, Edmonton, AB T6G 2H7, Canada	University of Alberta; University of Alberta	Fliegel, L (corresponding author), Univ Alberta, Dept Biochem, 347 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	lfliegel@ualberta.ca	Rainey, Jan K/C-1927-2008	Rainey, Jan K/0000-0003-0793-5573; Jeffery, Caroline C./0000-0002-5536-4915				BONVIN AMJJ, 1995, J MOL BIOL, V250, P80, DOI 10.1006/jmbi.1995.0360; BONVIN AMJJ, 1994, J BIOMOL NMR, V4, P143, DOI 10.1007/BF00178343; Braun P, 1997, J BIOL CHEM, V272, P29566, DOI 10.1074/jbc.272.47.29566; BRUSCHWEILER R, 1991, Journal of Biomolecular NMR, V1, P3, DOI 10.1007/BF01874565; CAVANAGH J, 1990, J MAGN RESON, V87, P110, DOI 10.1016/0022-2364(90)90089-R; Cavanagh J., 1996, PROTEIN NMR SPECTROS; COUNILLON L, 1993, P NATL ACAD SCI USA, V90, P4508, DOI 10.1073/pnas.90.10.4508; Damberg P, 2001, METHOD ENZYMOL, V339, P271, DOI 10.1016/S0076-6879(01)39318-7; DAVIS JH, 1983, BIOCHEMISTRY-US, V22, P5298, DOI 10.1021/bi00292a008; De Beeck AO, 2000, J BIOL CHEM, V275, P31428, DOI 10.1074/jbc.M003003200; De Beeck AO, 2003, J VIROL, V77, P813, DOI 10.1128/JVI.77.2.813-820.2003; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Denker SP, 2002, J CELL BIOL, V159, P1087, DOI 10.1083/jcb.200208050; DUNTEN RL, 1993, BIOCHEMISTRY-US, V32, P12644, DOI 10.1021/bi00210a012; Eilers M, 2000, P NATL ACAD SCI USA, V97, P5796, DOI 10.1073/pnas.97.11.5796; Fleming KG, 2001, P NATL ACAD SCI USA, V98, P14340, DOI 10.1073/pnas.251367498; Fliegel L, 2001, BASIC RES CARDIOL, V96, P301, DOI 10.1007/s003950170036; Fraysse AS, 2005, J BIOL CHEM, V280, P21785, DOI 10.1074/jbc.M413091200; GRINSTEIN S, 1989, BIOCHIM BIOPHYS ACTA, V988, P73, DOI 10.1016/0304-4157(89)90004-X; Harris C, 1999, INT J MOL MED, V3, P315; HAWORTH RS, 1993, BIOCHEM J, V289, P637, DOI 10.1042/bj2890637; He MM, 1996, BIOCHEMISTRY-US, V35, P12909, DOI 10.1021/bi960876b; HENRY GD, 1994, METHOD ENZYMOL, V239, P515; Hunt JF, 1997, BIOCHEMISTRY-US, V36, P15156, DOI 10.1021/bi970146j; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; JONES DT, 1994, BIOCHEMISTRY-US, V33, P3038, DOI 10.1021/bi00176a037; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Karmazyn M., 2005, Current Drug Targets - Cardiovascular & Haematological Disorders, V5, P323, DOI 10.2174/1568006054553417; Karmazyn M, 2003, HYPERTENSION, V42, P1171, DOI 10.1161/01.HYP.0000102863.23854.0B; Katragadda M, 2001, BIOPHYS J, V81, P1029, DOI 10.1016/S0006-3495(01)75760-8; Katragadda M, 2001, J PEPT RES, V58, P79, DOI 10.1034/j.1399-3011.2001.00904.x; Khadilkar A, 2001, J BIOL CHEM, V276, P43792, DOI 10.1074/jbc.M106659200; KUNTZ ID, 1991, J AM CHEM SOC, V113, P1406, DOI 10.1021/ja00004a050; Lang HJ, 2003, SODIUM-HYDROGEN EXCHANGER: FROM MOLECULE TO ITS ROLE IN DISEASE, P239; Li XJ, 2004, BIOCHEMISTRY-US, V43, P16477, DOI 10.1021/bi048538v; Lindhout DA, 2003, PROTEIN SCI, V12, P1786, DOI 10.1110/ps.0376003; Liu H, 1998, J MOL CELL CARDIOL, V30, P685, DOI 10.1006/jmcc.1997.0636; Liu LP, 1998, J BIOL CHEM, V273, P23645, DOI 10.1074/jbc.273.37.23645; Lu ZL, 2001, J BIOL CHEM, V276, P34098, DOI 10.1074/jbc.M104217200; Mentzer RM, 2003, ANN THORAC SURG, V75, pS700, DOI 10.1016/S0003-4975(02)04700-8; MERUTKA G, 1995, J BIOMOL NMR, V5, P14, DOI 10.1007/BF00227466; Mingarro I, 1996, PROTEIN SCI, V5, P1339, DOI 10.1002/pro.5560050712; MURTAZINA BR, 2001, EUR J BIOCHEM, V268, P1; Naider F, 2005, BIOPOLYMERS, V80, P199, DOI 10.1002/bip.20183; Noel J, 2003, BIOCHEMISTRY-US, V42, P15361, DOI 10.1021/bi035296a; OBLATTMONTAL M, 1994, P NATL ACAD SCI USA, V91, P1495, DOI 10.1073/pnas.91.4.1495; Orlowski J, 1996, J BIOL CHEM, V271, P19922, DOI 10.1074/jbc.271.33.19922; Orlowski J, 1997, J BIOL CHEM, V272, P22373, DOI 10.1074/jbc.272.36.22373; Paradiso A, 2004, BREAST CANCER RES, V6, pR616, DOI 10.1186/bcr922; POUYSSEGUR J, 1984, P NATL ACAD SCI-BIOL, V81, P4833, DOI 10.1073/pnas.81.15.4833; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Slepkov ER, 2005, J BIOL CHEM, V280, P17863, DOI 10.1074/jbc.M409608200; Slepkov ER, 2004, BIOCHEM J, V379, P31, DOI 10.1042/BJ20030884; Vik SB, 1998, J BIOL CHEM, V273, P16229, DOI 10.1074/jbc.273.26.16229; Wakabayashi S, 2000, J BIOL CHEM, V275, P7942, DOI 10.1074/jbc.275.11.7942; WANG DH, 1995, AM J PHYSIOL-CELL PH, V269, pC392, DOI 10.1152/ajpcell.1995.269.2.C392; WANG JJ, 1995, J AM CHEM SOC, V117, P8627, DOI 10.1021/ja00138a019; Wigley WC, 1998, BIOCHEMISTRY-US, V37, P844, DOI 10.1021/bi972293n; WILLIAMSON MP, 1990, BIOPOLYMERS, V29, P1428; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Wuthrich K, 1986, NMR PROTEINS NUCL AC; ZHANG YP, 1995, BIOPHYS J, V68, P847, DOI 10.1016/S0006-3495(95)80261-4; [No title captured]	68	62	63	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					29817	29829		10.1074/jbc.M606152200	http://dx.doi.org/10.1074/jbc.M606152200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16861220	hybrid			2022-12-27	WOS:000240896300044
J	Herrmann, R; Heck, M; Henklein, P; Hofmann, KP; Ernst, OP				Herrmann, Rolf; Heck, Martin; Henklein, Peter; Hofmann, Klaus Peter; Ernst, Oliver P.			Signal transfer from GPCRs to G proteins - Role of the G alpha N-terminal region in rhodopsin-transducin coupling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-ACTIVATED RHODOPSIN; PHOTORECEPTOR G-PROTEIN; BETA-GAMMA; AMINO-TERMINUS; CONFORMATIONAL-CHANGES; CARBOXYL-TERMINUS; CRYSTAL-STRUCTURE; BINDING-SITES; SUBUNIT; RECEPTOR	Catalysis of nucleotide exchange in heterotrimeric G proteins (G alpha beta gamma) is a key step in cellular signal transduction mediated by G protein-coupled receptors. The G alpha N terminus with its helical stretch is thought to be crucial for G protein/activated receptor (R*) interaction. The N-terminal fatty acylation of G alpha is important for membrane targeting of G proteins. By applying biophysical techniques to the rhodopsin/transducin model system, we studied the effect of N-terminal truncations in G alpha. In G alpha beta gamma, lack of the fatty acid and G alpha truncations up to 33 amino acids had little effect on R* binding and R*-catalyzed nucleotide exchange, implying that this region is not mandatory for R*/G alpha beta gamma interaction. However, when the other hydrophobic modification of G alpha beta gamma, the G gamma C-terminal farnesyl moiety, is lacking, R* interaction requires the fatty acylated G alpha N terminus. This suggests that the two hydrophobic extensions can replace each other in the interaction of G alpha beta gamma with R*. We propose that in native G alpha beta gamma, these two terminal regions are functionally redundant and form a microdomain that serves both to anchor the G protein to the membrane and to establish an initial docking complex with R*. Accordingly, we find that the native fatty acylated G alpha is competent to interact with R* even in the absence of G beta gamma, whereas nonacylated G alpha requires G beta gamma for interaction. Experiments with N-terminally truncated G alpha subunits suggest that in the second step of the catalytic process, the receptor binds to the alpha N/beta 1-loop region of G alpha to reduce nucleotide affinity and to make the G alpha C terminus available for subsequent interaction with R*.	Charite Univ Med Berlin, Inst Med Phys & Biophys, D-10098 Berlin, Germany; Charite Univ Med Berlin, Inst Biochem, D-10098 Berlin, Germany; Humboldt Univ, Zentrum Biophys & Bioinformat, D-10015 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin	Ernst, OP (corresponding author), Charite Univ Med Berlin, Inst Med Phys & Biophys, Schumann Str 20-21, D-10098 Berlin, Germany.	oliver.ernst@charite.de						Abdulaev NG, 2005, J BIOL CHEM, V280, P38071, DOI 10.1074/jbc.M505259200; Anderson LL, 2005, J BIOL CHEM, V280, P31019, DOI 10.1074/jbc.M503690200; Bartl F, 2000, FEBS LETT, V473, P259, DOI 10.1016/S0014-5793(00)01544-1; Beck M, 1998, FEBS LETT, V436, P304, DOI 10.1016/S0014-5793(98)01156-9; BIGAY J, 1994, BIOCHEMISTRY-US, V33, P14081, DOI 10.1021/bi00251a017; Blahos J, 2001, J BIOL CHEM, V276, P3262, DOI 10.1074/jbc.M004880200; Bohm A, 1997, CURR OPIN BIOTECH, V8, P480, DOI 10.1016/S0958-1669(97)80072-9; Bourne HR, 1997, CURR OPIN CELL BIOL, V9, P134, DOI 10.1016/S0955-0674(97)80054-3; Cabrera-Vera TM, 2003, ENDOCR REV, V24, P765, DOI 10.1210/er.2000-0026; Chabre M, 2005, BIOCHEMISTRY-US, V44, P9395, DOI 10.1021/bi050720o; Cherfils J, 2003, TRENDS BIOCHEM SCI, V28, P13, DOI 10.1016/S0968-0004(02)00006-3; DENKER BM, 1992, J BIOL CHEM, V267, P6272; Ernst OP, 2000, METHOD ENZYMOL, V315, P471; Ernst OP, 2000, J BIOL CHEM, V275, P1937, DOI 10.1074/jbc.275.3.1937; Fanelli F, 2005, CHEM REV, V105, P3297, DOI 10.1021/cr000095n; Filipek S, 2004, PHOTOCH PHOTOBIO SCI, V3, P628, DOI 10.1039/b315661c; Filipek S, 2003, ANNU REV PHYSIOL, V65, P851, DOI 10.1146/annurev.physiol.65.092101.142611; Fritze O, 2003, P NATL ACAD SCI USA, V100, P2290, DOI 10.1073/pnas.0435715100; GRAF R, 1992, J BIOL CHEM, V267, P24307; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Hamm HE, 2001, P NATL ACAD SCI USA, V98, P4819, DOI 10.1073/pnas.011099798; Heck M, 2000, METHOD ENZYMOL, V315, P329; Heck M, 2001, J BIOL CHEM, V276, P10000, DOI 10.1074/jbc.M009475200; Herrmann R, 2004, J BIOL CHEM, V279, P24283, DOI 10.1074/jbc.M311166200; Hessel E, 2003, J BIOL CHEM, V278, P22853, DOI 10.1074/jbc.M302747200; Hessel E, 2001, J BIOL CHEM, V276, P2538, DOI 10.1074/jbc.M009061200; Iiri T, 1998, NATURE, V394, P35, DOI 10.1038/27831; Itoh Y, 2001, P NATL ACAD SCI USA, V98, P4883, DOI 10.1073/pnas.051632998; JOURNOT L, 1991, J BIOL CHEM, V266, P9009; KISSELEV O, 1995, P NATL ACAD SCI USA, V92, P9102, DOI 10.1073/pnas.92.20.9102; Kisselev OG, 2003, STRUCTURE, V11, P367, DOI 10.1016/S0969-2126(03)00045-5; Kisselev OG, 1998, P NATL ACAD SCI USA, V95, P4270, DOI 10.1073/pnas.95.8.4270; Kisselev OG, 1999, P NATL ACAD SCI USA, V96, P4898, DOI 10.1073/pnas.96.9.4898; Koenig BW, 2002, J MOL BIOL, V322, P441, DOI 10.1016/S0022-2836(02)00745-3; KOKAME K, 1992, NATURE, V359, P749, DOI 10.1038/359749a0; LAMBRIGHT DG, 1994, NATURE, V369, P621, DOI 10.1038/369621a0; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Lu ZL, 2002, TRENDS PHARMACOL SCI, V23, P140, DOI 10.1016/S0165-6147(00)01973-8; Marin EP, 2002, BIOCHEMISTRY-US, V41, P6988, DOI 10.1021/bi025514k; Medkova M, 2002, BIOCHEMISTRY-US, V41, P9962, DOI 10.1021/bi0255726; Muradov KG, 2000, BIOCHEMISTRY-US, V39, P3937, DOI 10.1021/bi992156l; Nanoff C, 2006, MOL PHARMACOL, V69, P397, DOI 10.1124/mol.105.016725; Natochin M, 1998, J BIOL CHEM, V273, P21808, DOI 10.1074/jbc.273.34.21808; Natochin M, 1999, J BIOL CHEM, V274, P7865, DOI 10.1074/jbc.274.12.7865; Natochin M, 2001, J NEUROCHEM, V77, P202, DOI 10.1046/j.1471-4159.2001.00221.x; NAVON SE, 1987, J BIOL CHEM, V262, P15746; NEUBERT TA, 1992, J BIOL CHEM, V267, P18274; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Okada T, 2001, TRENDS BIOCHEM SCI, V26, P318, DOI 10.1016/S0968-0004(01)01799-6; OLDHAM W, 2006, IN PRESS NAT STRUCT; Onrust R, 1997, SCIENCE, V275, P381, DOI 10.1126/science.275.5298.381; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pereira R, 2005, J BIOL CHEM, V280, P35696, DOI 10.1074/jbc.M504935200; Preininger AM, 2003, BIOCHEMISTRY-US, V42, P7931, DOI 10.1021/bi0345438; Ridge KD, 2006, J BIOL CHEM, V281, P7635, DOI 10.1074/jbc.M509851200; Rondard P, 2001, P NATL ACAD SCI USA, V98, P6150, DOI 10.1073/pnas.101136198; Sachs K, 2000, J BIOL CHEM, V275, P6189, DOI 10.1074/jbc.275.9.6189; Seitz HR, 1999, BIOCHEMISTRY-US, V38, P7950, DOI 10.1021/bi990298+; SHICHIDA Y, 2006, IN PRESS PHOTOCHEM P; Skiba NP, 1996, J BIOL CHEM, V271, P413, DOI 10.1074/jbc.271.1.413; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; TAYLOR JM, 1994, J BIOL CHEM, V269, P27618; VOSS T, 1993, J BIOL CHEM, V268, P4637; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Yang CS, 1999, J BIOL CHEM, V274, P2379, DOI 10.1074/jbc.274.4.2379; Yeagle PL, 2003, BIOCHEMISTRY-US, V42, P1365, DOI 10.1021/bi0270539; Zhang ZX, 2004, J BIOL CHEM, V279, P33937, DOI 10.1074/jbc.M403404200	70	42	44	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					30234	30241		10.1074/jbc.M600797200	http://dx.doi.org/10.1074/jbc.M600797200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16847064	hybrid			2022-12-27	WOS:000240896300083
J	Suzuki, H; Takahashi, S; Watanabe, R; Fukushima, Y; Fujita, N; Noguchi, A; Yokoyama, R; Nishitani, K; Nishino, T; Nakayama, T				Suzuki, Hirokazu; Takahashi, Seiji; Watanabe, Ryoko; Fukushima, Yusuke; Fujita, Naoki; Noguchi, Akio; Yokoyama, Ryusuke; Nishitani, Kazuhiko; Nishino, Tokuzo; Nakayama, Toru			An isoflavone conjugate-hydrolyzing beta-glucosidase from the roots of soybean (Glycine max) seedlings - Purification, gene cloning, phylogenetics, and cellular localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; MOLECULAR CHARACTERIZATION; AGLYCONE SPECIFICITY; GLYCOSYL HYDROLASES; CDNA CLONING; EXPRESSION; PLANTS; CLASSIFICATION; BIOSYNTHESIS; SUBSTRATE	Soybeans ( Glycine max ( L.) Merr.) and certain other legumes excrete isoflavones from their roots, which participate in plantmicrobe interactions such as symbiosis and as a defense against infections by pathogens. In G. max, the release of free isoflavones from their conjugates, the latent forms, is mediated by an isoflavone conjugate-hydrolyzing beta-glucosidase. Here we report on the purification and cDNA cloning of this important beta-glucosidase from the roots of G. max seedlings as well as related phylogenetic and cellular localization studies. The purified enzyme, isoflavone conjugate-hydrolyzing beta-glucosidase from roots of G. max seedling (GmICHG), is a homodimeric glycoprotein with a subunit molecular mass of 58 kDa and is capable of directly hydrolyzing genistein 7-O-(6"-O-malonyl-beta-D-glucoside) to produce free genistein (k(cat), 98 s(-1); Km, 25 mu m at 30 degrees C, pH 7.0). GmICHG cDNA was isolated based on the amino acid sequence of the purified enzyme. GmICHG cDNA was abundantly expressed in the roots of G. max seedlings but only negligibly in the hypocotyl and cotyledon. An immunocytochemical analysis using anti-GmICHG antibodies, along with green fluorescent protein imaging analyses of Arabidopsis cultured cells transformed by the GmICHG: GFP fusion gene, revealed that the enzyme is exclusively localized in the cell wall and intercellular space of seedling roots, particularly in the cell wall of root hairs. A phylogenetic analysis revealed that GmICHG is a member of glycoside hydrolase family 1 and can be co-clustered with many other leguminous beta-glucosidases, the majority of which may also be involved in flavonoid-mediated interactions of legumes with microbes.	Tohoku Univ, Grad Sch Engn, Dept Biomol Engn, Sendai, Miyagi 9808579, Japan; Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Sendai, Miyagi 9808578, Japan	Tohoku University; Tohoku University	Nakayama, T (corresponding author), Tohoku Univ, Grad Sch Engn, Dept Biomol Engn, Aoba Yama 6-6-11, Sendai, Miyagi 9808579, Japan.	nakayama@seika.che.tohoku.ac.jp	Takahashi, Seiji/AAE-1509-2019; Suzuki, Hirokazu/AAG-2285-2020	Takahashi, Seiji/0000-0002-2288-4340; Suzuki, Hirokazu/0000-0002-9507-6467; Nishitani, Kazuhiko/0000-0002-0073-9564; Yokoyama, Ryusuke/0000-0003-0326-0433				Ahn YO, 2004, J BIOL CHEM, V279, P23405, DOI 10.1074/jbc.M311379200; Akashi T, 1999, PLANT PHYSIOL, V121, P821, DOI 10.1104/pp.121.3.821; AXELOS M, 1992, PLANT PHYSIOL BIOCH, V30, P123; BARZ W, 1992, RECENT ADV PHYTOCHEM, V26, P139; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUCHANAN B, 2002, BIOCH MOL BIOL PLANT, P796; Chiu WL, 1996, CURR BIOL, V6, P325, DOI 10.1016/S0960-9822(02)00483-9; CLARKE JT, 1964, ANN NY ACAD SCI, V121, P428, DOI 10.1111/j.1749-6632.1964.tb14214.x; Conn E. E., 1979, Herbivores: their interaction with secondary plant metabolites, P387; Czjzek M, 2000, P NATL ACAD SCI USA, V97, P13555, DOI 10.1073/pnas.97.25.13555; Dakora FD, 1996, PHYSIOL MOL PLANT P, V49, P1, DOI 10.1006/pmpp.1996.0035; DHARMAWARDHANA DP, 1995, PLANT PHYSIOL, V107, P331, DOI 10.1104/pp.107.2.331; FALK A, 1995, PLANT PHYSIOL, V108, P1369, DOI 10.1104/pp.108.4.1369; Fujiwara H, 1998, PLANT J, V16, P421, DOI 10.1046/j.1365-313x.1998.00312.x; GRAHAM TL, 1991, PLANT PHYSIOL, V95, P594, DOI 10.1104/pp.95.2.594; Graham TL, 2000, PLANT MIC I, V5, P181; Graham TL, 1996, PLANT PHYSIOL, V110, P1123, DOI 10.1104/pp.110.4.1123; Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; HOSEL W, 1975, EUR J BIOCHEM, V57, P607, DOI 10.1111/j.1432-1033.1975.tb02336.x; Hsieh MC, 2001, PHYTOCHEMISTRY, V58, P995, DOI 10.1016/S0031-9422(01)00380-6; Hungria M, 1997, SOIL BIOL BIOCHEM, V29, P819, DOI 10.1016/S0038-0717(96)00239-8; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEAH R, 1995, J BIOL CHEM, V270, P15789, DOI 10.1074/jbc.270.26.15789; LEATHERBARROW RJ, 1990, TRENDS BIOCHEM SCI, V15, P455, DOI 10.1016/0968-0004(90)90295-M; Mitsuhara I, 1996, PLANT CELL PHYSIOL, V37, P49, DOI 10.1093/oxfordjournals.pcp.a028913; Nakayama T, 2000, SCIENCE, V290, P1163, DOI 10.1126/science.290.5494.1163; OXTOBY E, 1991, PLANT MOL BIOL, V17, P209, DOI 10.1007/BF00039495; PHILLIPS DA, 1992, RECENT ADV PHYTOCHEM, V26, P201; Rask L, 2000, PLANT MOL BIOL, V42, P93, DOI 10.1023/A:1006380021658; RIVERAVARGAS LI, 1993, PHYTOCHEMISTRY, V32, P851, DOI 10.1016/0031-9422(93)85219-H; Steele CL, 1999, ARCH BIOCHEM BIOPHYS, V367, P146, DOI 10.1006/abbi.1999.1238; Suzuki H, 2002, PLANT PHYSIOL, V130, P2142, DOI 10.1104/pp.010447; Svasti J, 1999, PHYTOCHEMISTRY, V50, P739, DOI 10.1016/S0031-9422(98)00552-4; Verdoucq L, 2004, J BIOL CHEM, V279, P31796, DOI 10.1074/jbc.M402918200; Zhou JM, 2002, PLANT PHYSIOL, V129, P1252, DOI 10.1104/pp.010863	36	131	136	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					30251	30259		10.1074/jbc.M605726200	http://dx.doi.org/10.1074/jbc.M605726200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16891302	hybrid			2022-12-27	WOS:000240896300085
J	Doi, H; Iso, T; Sato, H; Yamazaki, M; Matsui, H; Tanaka, T; Manabe, I; Arai, M; Nagai, R; Kurabayashi, M				Doi, Hiroshi; Iso, Tatsuya; Sato, Hiroko; Yamazaki, Miki; Matsui, Hiroki; Tanaka, Toru; Manabe, Ichiro; Arai, Masashi; Nagai, Ryozo; Kurabayashi, Masahiko			Jagged1-selective notch signaling induces smooth muscle differentiation via a RBP-J kappa-dependent pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; OSTEOBLASTIC CELL-DIFFERENTIATION; DEVELOPING MAMMALIAN HEART; GENE-EXPRESSION; INTRACELLULAR DOMAIN; ENDOTHELIAL-CELLS; PRIMARY TARGET; MYOCARDIN; ACTIVATION; JAGGED1	The Notch signaling pathway plays a crucial role in specifying cellular fates by interaction between cellular neighbors; however, the molecular mechanism underlying smooth muscle cell (SMC) differentiation by Notch signaling has not been well characterized. Here we demonstrate that Jagged1-Notch signaling promotes SMC differentiation from mesenchymal cells. Overexpression of the Notch intracellular domain, an activated form of Notch, up-regulates the expression of multiple SMC marker genes including SMC-myosin heavy chain (Sm-mhc) in mesenchymal 10T1/2 cells, but not in non-mesenchymal cells. Physiological Notch stimulation by its ligand Jagged1, but not Dll4, directly induces Sm-mhc expression in 10T1/2 cells without de novo protein synthesis, indicative of a ligand-selective effect. Jagged1-induced expression of SM-MHC was blocked by gamma-secretase inhibitor, N-(N-(3,5-difluorophenyl)-L-alanyl)-S-phenylglycine t-butyl ester, which impedes Notch signaling. Using Rbp-j kappa-deficient cells and site-specific mutagenesis of the SM-MHC gene, weshow that such an induction is independent of the myocardin-serum response factor-CArG complex, but absolutely dependent on RBP-J kappa, a major mediator of Notch signaling, and its cognate binding sequence. Of importance, Notch signaling and myocardin synergistically activate SM-MHC gene expression. Taken together, these data suggest that the Jagged1-Notch pathway constitutes an instructive signal for SMC differentiation through an RBP-J kappa-dependent mechanism and augments gene expression mediated by the myocardin-SRF-CArG complex. Given that Notch pathway components are expressed in vascular SMC during normal development and disease, Notch signaling is likely to play a pivotal role in such situations to modulate the vascular smooth muscle cell phenotype.	Gunma Univ, Grad Sch Med, Dept Med & Biol Sci, Maebashi, Gumma 3718511, Japan; Gunma Univ, Grad Sch Med, Educ & Res Ctr, Maebashi, Gumma 3718511, Japan; Gunma Univ, Grad Sch Med, Sci Labs, Maebashi, Gumma 3718511, Japan; Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, Tokyo 1130033, Japan	Gunma University; Gunma University; Gunma University; University of Tokyo	Kurabayashi, M (corresponding author), Gunma Univ, Grad Sch Med, Dept Med & Biol Sci, 3-39-15 Showa Machi, Maebashi, Gumma 3718511, Japan.	mkuraba@med.gunma-u.ac.jp	Manabe, Ichiro/AAE-5105-2021; Matsui, Hiroki/P-4033-2019; Manabe, Ichiro/E-1529-2014	Matsui, Hiroki/0000-0003-3243-333X; Iso, Tatsuya/0000-0001-5045-1676				Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Anthony TE, 2005, GENE DEV, V19, P1028, DOI 10.1101/gad.1302105; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Cao DS, 2005, MOL CELL BIOL, V25, P364, DOI 10.1128/MCB.25.1.364-376.2005; Chen JY, 2002, J MOL CELL CARDIOL, V34, P1345, DOI 10.1006/jmcc.2002.2086; Chin MT, 2000, J BIOL CHEM, V275, P6381, DOI 10.1074/jbc.275.9.6381; CHUNG CN, 1994, NUCLEIC ACIDS RES, V22, P2938, DOI 10.1093/nar/22.15.2938; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Deregowski V, 2006, J BIOL CHEM, V281, P6203, DOI 10.1074/jbc.M508370200; Doi H, 2005, ARTERIOSCL THROM VAS, V25, P2328, DOI 10.1161/01.ATV.0000185829.47163.32; Domenga V, 2004, GENE DEV, V18, P2730, DOI 10.1101/gad.308904; Du KL, 2003, MOL CELL BIOL, V23, P2425, DOI 10.1128/MCB.23.7.2425-2437.2003; Elagib KE, 2004, MOL CELL BIOL, V24, P7779, DOI 10.1128/MCB.24.17.7779-7794.2004; Garces C, 1997, J BIOL CHEM, V272, P29729, DOI 10.1074/jbc.272.47.29729; GAZIT D, 1993, MOL ENDOCRINOL, V7, P189, DOI 10.1210/me.7.2.189; Geling A, 2002, EMBO REP, V3, P688, DOI 10.1093/embo-reports/kvf124; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; Iso T, 2006, BIOCHEM BIOPH RES CO, V341, P708, DOI 10.1016/j.bbrc.2006.01.020; Iso T, 2003, ARTERIOSCL THROM VAS, V23, P543, DOI 10.1161/01.ATV.0000060892.81529.8F; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Iso T, 2002, J BIOL CHEM, V277, P6598, DOI 10.1074/jbc.M110495200; Iso T, 2001, MOL CELL BIOL, V21, P6071, DOI 10.1128/MCB.21.17.6071-6079.2001; Itoh F, 2004, EMBO J, V23, P541, DOI 10.1038/sj.emboj.7600065; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Kato H, 1997, DEVELOPMENT, V124, P4133; Kawai-Kowase K, 2004, ARTERIOSCL THROM VAS, V24, P1384, DOI 10.1161/01.ATV.0000136548.17816.07; Kumar MS, 2003, ARTERIOSCL THROM VAS, V23, P737, DOI 10.1161/01.ATV.0000065197.07635.BA; Lardelli M, 1996, MECH DEVELOP, V59, P177, DOI 10.1016/0925-4773(96)00589-8; Li L, 1996, CIRC RES, V78, P188, DOI 10.1161/01.RES.78.2.188; Li SJ, 2003, P NATL ACAD SCI USA, V100, P9366, DOI 10.1073/pnas.1233635100; Loomes KM, 1999, HUM MOL GENET, V8, P2443, DOI 10.1093/hmg/8.13.2443; Loomes KM, 2002, AM J MED GENET, V112, P181, DOI 10.1002/ajmg.10592; LU Y, 1992, BIOCHEM CELL BIOL, V70, P1249, DOI 10.1139/o92-171; Merika M, 2001, CURR OPIN GENET DEV, V11, P205, DOI 10.1016/S0959-437X(00)00180-5; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; Morrow D, 2005, AM J PHYSIOL-CELL PH, V289, pC1188, DOI 10.1152/ajpcell.00198.2005; Nofziger D, 1999, DEVELOPMENT, V126, P1689; Noseda M, 2004, CIRC RES, V94, P910, DOI 10.1161/01.RES.0000124300.76171.C9; Noseda M, 2006, CIRC RES, V98, P1468, DOI 10.1161/01.RES.0000229683.81357.26; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; Oswald F, 2001, MOL CELL BIOL, V21, P7761, DOI 10.1128/MCB.21.22.7761-7774.2001; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Proweller A, 2005, J BIOL CHEM, V280, P8994, DOI 10.1074/jbc.M413316200; REAUME AG, 1992, DEV BIOL, V154, P377, DOI 10.1016/0012-1606(92)90076-S; Ross DA, 2004, MOL CELL BIOL, V24, P3505, DOI 10.1128/MCB.24.8.3505-3513.2004; Rutz S, 2005, EUR J IMMUNOL, V35, P2443, DOI 10.1002/eji.200526294; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Sciaudone M, 2003, ENDOCRINOLOGY, V144, P5631, DOI 10.1210/en.2003-0463; Shimizu K, 2001, J BIOL CHEM, V276, P25753, DOI 10.1074/jbc.M103473200; Shimizu K, 2000, BIOCHEM BIOPH RES CO, V276, P385, DOI 10.1006/bbrc.2000.3469; Tezuka K, 2002, J BONE MINER RES, V17, P231, DOI 10.1359/jbmr.2002.17.2.231; Ueyama T, 2003, MOL CELL BIOL, V23, P9222, DOI 10.1128/MCB.23.24.9222-9232.2003; Villa N, 2001, MECH DEVELOP, V108, P161, DOI 10.1016/S0925-4773(01)00469-5; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Yang LT, 2005, MOL BIOL CELL, V16, P927, DOI 10.1091/mbc.e04-07-0614; Yoshida T, 2004, ARTERIOSCL THROM VAS, V24, P1596, DOI 10.1161/01.ATV.0000137190.63214.c5; Yoshida T, 2003, CIRC RES, V92, P856, DOI 10.1161/01.RES.0000068405.49081.09; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069	61	117	123	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					28555	28564		10.1074/jbc.M602749200	http://dx.doi.org/10.1074/jbc.M602749200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16867989	hybrid			2022-12-27	WOS:000240680500009
J	Dunlap, JC				Dunlap, Jay C.			Proteins in the Neurospora circadian clockworks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CASEIN KINASE-II; WHITE COLLAR-1; BLUE-LIGHT; GENE-FREQUENCY; FEEDBACK LOOPS; TEMPERATURE COMPENSATION; TRANSCRIPTION FACTORS; MOLECULAR-MECHANISM; PERIOD LENGTH; CRASSA		Dartmouth Coll Sch Med, Dept Genet, Hanover, NH 03755 USA	Dartmouth College	Dunlap, JC (corresponding author), Dartmouth Coll Sch Med, Dept Genet, 7400 Remsen, Hanover, NH 03755 USA.	jay.c.dunlap@dartmouth.edu	Dunlap, Jay/L-6232-2013	Dunlap, Jay/0000-0003-1577-0457	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM068087, R01GM034985] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM034985, P01 GM068087] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARONSON BD, 1994, P NATL ACAD SCI USA, V91, P7683, DOI 10.1073/pnas.91.16.7683; ARONSON BD, 1994, SCIENCE, V263, P1578, DOI 10.1126/science.8128244; Arpaia G, 1999, MOL GEN GENET, V262, P314, DOI 10.1007/s004380051089; Ballario P, 1998, MOL MICROBIOL, V29, P719, DOI 10.1046/j.1365-2958.1998.00955.x; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Cheng P, 2005, GENE DEV, V19, P234, DOI 10.1101/gad.1266805; Cheng P, 2003, J BIOL CHEM, V278, P3801, DOI 10.1074/jbc.M209592200; Cheng P, 2002, MOL CELL BIOL, V22, P517, DOI 10.1128/MCB.22.2.517-524.2002; Cheng P, 2001, P NATL ACAD SCI USA, V98, P7408, DOI 10.1073/pnas.121170298; Cheng P, 2001, EMBO J, V20, P101, DOI 10.1093/emboj/20.1.101; Christensen MK, 2004, J BIOL RHYTHM, V19, P280, DOI 10.1177/0748730404265532; Collett MA, 2002, GENETICS, V160, P149; Collett MA, 2001, MOL CELL BIOL, V21, P2619, DOI 10.1128/MCB.21.8.2619-2628.2001; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Colot HV, 2005, MOL BIOL CELL, V16, P5563, DOI 10.1091/mbc.E05-08-0756; CROSTHWAITE SK, 1995, CELL, V81, P1003, DOI 10.1016/S0092-8674(05)80005-4; Crosthwaite SK, 1997, SCIENCE, V276, P763, DOI 10.1126/science.276.5313.763; de Paula RM, 2006, J BIOL RHYTHM, V21, P159, DOI 10.1177/0748730406288338; Denault DL, 2001, EMBO J, V20, P109, DOI 10.1093/emboj/20.1.109; Diernfellner ACR, 2005, GENE DEV, V19, P1968, DOI 10.1101/gad.345905; Dunlap J, 1998, SCIENCE, V280, P1548, DOI 10.1126/science.280.5369.1548; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; DUNLAP JC, 1988, P NATL ACAD SCI USA, V85, P1096, DOI 10.1073/pnas.85.4.1096; Dunlap JC, 2004, J BIOL RHYTHM, V19, P414, DOI 10.1177/0748730404269116; DUNLAP JC, 2004, CHRONOBIOLOGY BIOL T, P212; FELDMAN J F, 1973, Genetics, V75, P605; Froehlich AC, 2003, P NATL ACAD SCI USA, V100, P5914, DOI 10.1073/pnas.1030057100; Froehlich AC, 2002, SCIENCE, V297, P815, DOI 10.1126/science.1073681; Garceau NY, 1997, CELL, V89, P469, DOI 10.1016/S0092-8674(00)80227-5; Gorl M, 2001, EMBO J, V20, P7074, DOI 10.1093/emboj/20.24.7074; He Q, 2005, GENE DEV, V19, P1518, DOI 10.1101/gad.1322205; He Q, 2003, EMBO J, V22, P4421, DOI 10.1093/emboj/cdg425; HE Q, 2006, IN PRESS GENES DEV; He QY, 2005, GENE DEV, V19, P2888, DOI 10.1101/gad.1369605; He QY, 2005, J BIOL CHEM, V280, P17526, DOI 10.1074/jbc.M414010200; He QY, 2002, SCIENCE, V297, P840, DOI 10.1126/science.1072795; HEINTZEN C, 2006, IN PRESS ADV GENET; Hirayama J, 2005, CURR OPIN GENET DEV, V15, P548, DOI 10.1016/j.gde.2005.07.003; Kaldi K, 2006, EMBO REP, V7, P199, DOI 10.1038/sj.embor.7400595; Ko HW, 2002, NATURE, V420, P673, DOI 10.1038/nature01272; Kramer C, 2003, NATURE, V421, P948, DOI 10.1038/nature01427; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Lakin-Thomas PL, 2006, P NATL ACAD SCI USA, V103, P4469, DOI 10.1073/pnas.0510404103; Lakin-Thomas PL, 2000, TRENDS GENET, V16, P135, DOI 10.1016/S0168-9525(99)01945-9; Lee K, 2000, SCIENCE, V289, P107, DOI 10.1126/science.289.5476.107; Lewis ZA, 2002, MOL MICROBIOL, V45, P917, DOI 10.1046/j.1365-2958.2002.03074.x; Linden H, 1999, ADV GENET, V41, P35, DOI 10.1016/S0065-2660(08)60150-9; Liu Y, 2000, P NATL ACAD SCI USA, V97, P234, DOI 10.1073/pnas.97.1.234; Liu Y, 1998, SCIENCE, V281, P825, DOI 10.1126/science.281.5378.825; Liu Y, 1997, CELL, V89, P477, DOI 10.1016/S0092-8674(00)80228-7; Loros J J, 1986, J Biol Rhythms, V1, P187, DOI 10.1177/074873048600100302; Luo CH, 1998, EMBO J, V17, P1228, DOI 10.1093/emboj/17.5.1228; Merrow M, 1999, NATURE, V399, P584, DOI 10.1038/21190; Merrow M, 2001, EMBO J, V20, P307, DOI 10.1093/emboj/20.3.307; Mitchell P, 2003, MOL CELL, V11, P1405, DOI 10.1016/S1097-2765(03)00190-4; Pregueiro AM, 2006, SCIENCE, V313, P644, DOI 10.1126/science.1121716; Ruoff P, 2005, P NATL ACAD SCI USA, V102, P17681, DOI 10.1073/pnas.0505137102; Schafmeier T, 2006, GENE DEV, V20, P297, DOI 10.1101/gad.360906; Schafmeier T, 2005, CELL, V122, P235, DOI 10.1016/j.cell.2005.05.032; Schwerdtfeger C, 2000, EUR J BIOCHEM, V267, P414, DOI 10.1046/j.1432-1327.2000.01016.x; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; Yang YH, 2004, GENE DEV, V18, P255, DOI 10.1101/gad.1152604; Yang YH, 2003, MOL CELL BIOL, V23, P6221, DOI 10.1128/MCB.23.17.6221-6228.2003; Yang YH, 2002, GENE DEV, V16, P994, DOI 10.1101/gad.965102; Yang YH, 2001, J BIOL CHEM, V276, P41064, DOI 10.1074/jbc.M106905200; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576	66	54	54	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					28489	28493		10.1074/jbc.R600018200	http://dx.doi.org/10.1074/jbc.R600018200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16905532	hybrid			2022-12-27	WOS:000240680500001
J	Hasegawa, M; Yang, KK; Hashimoto, M; Park, JH; Kim, YG; Fujimoto, Y; Nunez, G; Fukase, K; Inohara, N				Hasegawa, Mizuho; Yang, Kangkang; Hashimoto, Masahito; Park, Jong-Hwan; Kim, Yun-Gi; Fujimoto, Yukari; Nunez, Gabriel; Fukase, Koichi; Inohara, Naohiro			Differential release and distribution of Nod1 and Nod2 immunostimulatory molecules among bacterial species and environments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; MURAMYL DIPEPTIDE; HOST RECOGNITION; LIPID-A; PEPTIDOGLYCAN; ASSOCIATION; RECEPTOR; SUSCEPTIBILITY; POLYMORPHISMS; INNATE	Nod1 and Nod2 are intracellular proteins that are involved in recognition of bacterial molecules and their genetic variations have been linked to several inflammatory diseases that are strongly affected by environmental factors. However, the distribution of Nod1- and Nod2-stimulatory molecules in different bacterial species and environments is unknown. Here we established a quantitative bioassay to screen and characterize Nod1 and Nod2-stimulatory activities in different environmental sites and bacterial species. Using this system, we found that common environments including foods and soils contain high levels of Nod1- and Nod2-stimulatory activities. Several Bacillus species were identified to possess the highest Nod1- stimulatory activity among soil bacteria. Unlike other immunostimulatory molecules, the higher level of Nod1- stimulatory activity was found in the culture supernatant and not in extracts from whole cell bacteria. Nod1- stimulatory molecules were highly stable at extreme pH and boiling conditions and were synthesized in an amidase- and sltY-independent manner. These results suggest a novel mechanism by which bacteria present in the environment stimulate the host immune system through Nod1.	Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Comprehens Canc Ctr, Ann Arbor, MI 48109 USA; Kagoshima Univ, Dept Nanostruct & Adv Mat, Kagoshima 8900065, Japan; Osaka Univ, Grad Sch Sci, Dept Chem, Toyonaka, Osaka 5600043, Japan	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Kagoshima University; Osaka University	Inohara, N (corresponding author), 1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	ino@umich.edu	Nuñez, Gabriel/A-7160-2014; Fujimoto, Yukari/M-7282-2014	Fujimoto, Yukari/0000-0001-5320-3192				Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Backhed F, 2003, MICROBES INFECT, V5, P1057, DOI 10.1016/S1286-4579(03)00207-7; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Chin AI, 2002, NATURE, V416, P190, DOI 10.1038/416190a; Foley-Comer AJ, 2002, J CELL SCI, V115, P1383; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2003, J BIOL CHEM, V278, P41702, DOI 10.1074/jbc.M307198200; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; GOTO T, 1987, IMMUNOSTIMULANTS NOW, P99; Granum PE, 1997, FEMS MICROBIOL LETT, V157, P223, DOI 10.1016/S0378-1097(97)00438-2; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; Hashimoto M, 2002, EUR J BIOCHEM, V269, P3715, DOI 10.1046/j.1432-1033.2002.03062.x; Heidrich C, 2001, MOL MICROBIOL, V41, P167, DOI 10.1046/j.1365-2958.2001.02499.x; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; Hosoi T, 2003, INT J FOOD MICROBIOL, V82, P255, DOI 10.1016/S0168-1605(02)00311-2; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hysi P, 2005, HUM MOL GENET, V14, P935, DOI 10.1093/hmg/ddi087; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; Inohara N, 2001, J BIOL CHEM, V276, P2551, DOI 10.1074/jbc.M009728200; JACOBS C, 1994, EMBO J, V13, P4684, DOI 10.1002/j.1460-2075.1994.tb06792.x; Kabesch M, 2003, J ALLERGY CLIN IMMUN, V111, P813, DOI 10.1067/mai.2003.1336; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Li J, 2004, HUM MOL GENET, V13, P1715, DOI 10.1093/hmg/ddh182; Lin J, 2004, CURR OPIN MOL THER, V6, P629; Mack DR, 2004, CURR OPIN GASTROEN, V20, P22, DOI 10.1097/00001574-200401000-00006; Masumoto J, 2006, J EXP MED, V203, P203, DOI 10.1084/jem.20051229; McGovern DPB, 2005, HUM MOL GENET, V14, P1245, DOI 10.1093/hmg/ddi135; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; PROCTOR RA, 1985, INFECT IMMUN, V49, P286, DOI 10.1128/IAI.49.2.286-290.1985; Rastall RA, 2004, J NUTR, V134, p2022S, DOI 10.1093/jn/134.8.2022S; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Tada H, 2005, INFECT IMMUN, V73, P7967, DOI 10.1128/IAI.73.12.7967-7976.2005; TANAMOTO K, 1984, INFECT IMMUN, V44, P421, DOI 10.1128/IAI.44.2.421-426.1984; Trujillo C, 2003, INT J MED MICROBIOL, V293, P123, DOI 10.1078/1438-4221-00257; van Heel DA, 2005, LANCET, V365, P1794, DOI 10.1016/S0140-6736(05)66582-8; Vavricka SR, 2004, GASTROENTEROLOGY, V127, P1401, DOI 10.1053/j.gastro.2004.07.024; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Wang DH, 2002, NAT IMMUNOL, V3, P830, DOI 10.1038/ni824; WARD PA, 1972, P SOC EXP BIOL MED, V141, P898, DOI 10.3181/00379727-141-36897; Weidinger S, 2005, J ALLERGY CLIN IMMUN, V116, P177, DOI 10.1016/j.jaci.2005.02.034; Weidinger S, 2005, CLIN EXP ALLERGY, V35, P866, DOI 10.1111/j.1365-2222.2005.02269.x; Wills-Karp M, 2001, NAT REV IMMUNOL, V1, P69, DOI 10.1038/35095579; YIN ET, 1972, BIOCHIM BIOPHYS ACTA, V261, P284	47	134	135	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					29054	29063		10.1074/jbc.M602638200	http://dx.doi.org/10.1074/jbc.M602638200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16870615	hybrid			2022-12-27	WOS:000240680500060
J	Kim, SY; Nguyen, AD; Gao, JL; Murphy, PM; Mansfield, BC; Chou, JY				Kim, So Youn; Nguyen, Andrew D.; Gao, Ji-Liang; Murphy, Philip M.; Mansfield, Brian C.; Chou, Janice Yang			Bone marrow-derived cells require a functional glucose 6-phosphate transporter for normal myeloid functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE TYPE 1B; 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; PHOSPHOHISTIDINE-ENZYME INTERMEDIATE; LIVER-TRANSPLANTATION; HEXOSE-6-PHOSPHATE DEHYDROGENASE; NEUTROPHIL RECRUITMENT; MICE LACKING; CATALYSIS; IB	Glycogen storage disease type Ib (GSD-Ib) is caused by a deficiency in the ubiquitously expressed glucose 6-phosphate transporter (Glc-6-PT). Glc-6-PT activity has been shown to be critical in the liver and kidney where a deficiency disrupts glucose homeostasis. GSD-Ib patients also have defects in the neutrophil respiratory burst, chemotaxis, and calcium flux. They also manifest neutropenia, but whether Glc-6-PT deficiency in the bone marrow underlies myeloid dysfunctions in GSD-Ib remains controversial. To address this, we transferred bone marrow from Glc-6-PT-deficient (Glc-6-PT-/-) mice to wild-type mice to generate chimeric mice (BM-Glc-6-PT-/-). As a control, we also transferred bone marrow between wild-type mice (BM-Glc-6-PT+/+). While BM-Glc-6-PT+/+ mice have normal myeloid functions, BM-Glc-6-PT-/- mice manifest myeloid abnormalities characteristic of Glc-6-PT-/- mice. Both have impairments in their neutrophil respiratory burst, chemotaxis response, and calcium flux activities and exhibit neutropenia. In the bone marrow of BM-Glc-6-PT-/- and Glc-6-PT-/- mice, the numbers of myeloid progenitor cells are increased, while in the serum there is an increase in granulocyte colony-stimulating factor and chemokine KC levels. Moreover, in an experimental model of peritoneal inflammation, local production of KC and the related chemokine macrophage inflammatory protein-2 is decreased in both BM-Glc-6-PT-/- and Glc-6-PT-/- mice along with depressed peritoneal neutrophil accumulation. The neutrophil recruitment defect was less severe in BM-Glc-6-PT-/- mice than in Glc-6-PT-/- mice. These findings demonstrate that Glc-6-PT expression in bone marrow and neutrophils is required for normal myeloid functions and that non-marrow Glc-6-PT activity also influences some myeloid functions.	NICHD, Sect Cellular Differentiat, Heritable Disorders Branch, NIH, Bethesda, MD 20892 USA; NIAID, Lab Mol Immunol, Mol Signaling Sect, NIH, Bethesda, MD 20892 USA; Correlog Syst Inc, Rockville, MD 20850 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Chou, JY (corresponding author), NICHD, Sect Cellular Differentiat, Heritable Disorders Branch, NIH, Bldg 10,Rm 9D42, Bethesda, MD 20892 USA.	chouja@mail.nih.gov	Gao, Ji-Liang/Y-4397-2019	Nguyen, Andrew/0000-0002-9492-9472; Mansfield, Brian/0000-0002-8533-2789	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000912] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000912] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000615, Z01AI000615] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Adachi M, 2004, EUR J PEDIATR, V163, P202, DOI 10.1007/s00431-004-1405-1; BARON EJ, 1982, J IMMUNOL METHODS, V49, P305, DOI 10.1016/0022-1759(82)90130-2; Call DR, 2001, AM J PATHOL, V158, P715, DOI 10.1016/S0002-9440(10)64014-X; Chen LY, 2003, HUM MOL GENET, V12, P2547, DOI 10.1093/hmg/ddg263; Chou Janice Yang, 2002, Current Molecular Medicine (Hilversum), V2, P121, DOI 10.2174/1566524024605798; CHOU JY, 2003, MEMBRANE TRANSPORTER, P191; Gao JL, 1999, J EXP MED, V189, P657, DOI 10.1084/jem.189.4.657; Garcia-Ramallo E, 2002, J IMMUNOL, V169, P6467, DOI 10.4049/jimmunol.169.11.6467; Garty BZ, 1996, ISRAEL J MED SCI, V32, P1276; Ghosh A, 2002, J BIOL CHEM, V277, P32837, DOI 10.1074/jbc.M201853200; Ghosh A, 2004, J BIOL CHEM, V279, P12479, DOI 10.1074/jbc.M313271200; GITZELMANN R, 1993, EUR J PEDIATR, V152, P33; Guionie O, 2003, FEBS LETT, V551, P159, DOI 10.1016/S0014-5793(03)00903-7; Hewitt KN, 2005, ENDOCRINOLOGY, V146, P2539, DOI 10.1210/en.2005-0117; LACHAUX A, 1993, J PEDIATR-US, V123, P1005, DOI 10.1016/S0022-3476(05)80403-2; Lavery GG, 2006, J BIOL CHEM, V281, P6546, DOI 10.1074/jbc.M512635200; Lin BC, 1998, J BIOL CHEM, V273, P31656, DOI 10.1074/jbc.273.48.31656; Martinez-Olmos MA, 2001, CLIN NUTR, V20, P375, DOI 10.1054/clnu.2001.0432; Matern D, 1999, EUR J PEDIATR, V158, pS43, DOI 10.1007/PL00014320; Mizgerd JP, 2002, SEMIN IMMUNOL, V14, P123, DOI 10.1006/smim.2001.0349; NORDLIE RC, 1985, ENZYMES BIOL MEMBR, P349; Pan CJ, 1998, ARCH BIOCHEM BIOPHYS, V358, P17, DOI 10.1006/abbi.1998.0849; Reutershan J, 2004, CRIT CARE, V8, P453, DOI 10.1186/cc2881; Scriver C.R., 2001, METABOLIC MOL BASIS, VEighth; Shieh JJ, 2003, J BIOL CHEM, V278, P47098, DOI 10.1074/jbc.M309472200; SIEFF CA, 1998, HEMATOLOGY INFANCY C, V1, P161; Tomlinson JW, 2004, ENDOCR REV, V25, P831, DOI 10.1210/er.2003-0031	27	27	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					28794	28801		10.1074/jbc.M604964200	http://dx.doi.org/10.1074/jbc.M604964200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16891306	hybrid			2022-12-27	WOS:000240680500033
J	Wang, WZ; Chu, XP; Li, MH; Seeds, J; Simon, RP; Xiong, ZG				Wang, Wei-Zhen; Chu, Xiang-Ping; Li, Ming-Hua; Seeds, Joshua; Simon, Roger P.; Xiong, Zhi-Gang			Modulation of acid-sensing ion channel currents, acid-induced increase of intracellular Ca2+, and acidosis-mediated neuronal injury by intracellular pH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPREADING DEPRESSION; HIPPOCAMPAL-NEURONS; CEREBRAL-ISCHEMIA; SENSORY NEURONS; NERVOUS-SYSTEM; CONTRIBUTES; RECEPTOR; CALCIUM; EXCITABILITY; DIVALENT	Acid-sensing ion channels (ASICs), activated by lowering extracellular pH (pH(o)), play an important role in normal synaptic transmission in brain and in the pathology of brain ischemia. Like pHo, intracellular pH (pH(i)) changes dramatically in both physiological and pathological conditions. Although it is known that a drop in pHo activates the ASICs, it is not clear whether alterations of pHi have an effect on these channels. Here we demonstrate that the overall activities of ASICs, including channel activation, inactivation, and recovery from desensitization, are tightly regulated by pHi. In cultured mouse cortical neurons, bath perfusion of the intracellular alkalizing agent quinine increased the amplitude of the ASIC current by similar to 50%. In contrast, intracellular acidification by withdrawal of NH4Cl or perfusion of propionate inhibited the current. Increasing pH buffering capacity in the pipette solution with 40 mM HEPES attenuated the effects of quinine and NH4Cl. The effects of intracellular alkalizing/ acidifying agents were mimicked by using intracellular solutions with pH directly buffered at high/low values. Increasing pHi induced a shift in H+ dose-response curve toward less acidic pH but a shift in the steady state inactivation curve toward more acidic pH. In addition, alkalizing pHi induced an increase in the recovery rate of ASICs from desensitization. Consistent with its effect on the ASIC current, changing pHi has a significant influence on the acid-induced increase of intracellular Ca2+, membrane depolarization, and acidosis-mediated neuronal injury. Our findings suggest that changes in pHi may play an important role in determining the overall function of ASICs in both physiological and pathological conditions.	Legacy Clin Res Ctr, Robert S Dow Neurobiol Labs, Portland, OR 97232 USA		Xiong, ZG (corresponding author), Legacy Clin Res Ctr, Robert S Dow Neurobiol Labs, 1225 NE 2nd Ave, Portland, OR 97232 USA.	zxiong@Downeurobiology.org		Chu, Xiang-Ping/0000-0002-6781-0468				Allen NJ, 2002, J PHYSIOL-LONDON, V543, P521, DOI 10.1113/jphysiol.2002.020297; Askwith CC, 2000, NEURON, V26, P133, DOI 10.1016/S0896-6273(00)81144-7; Askwith CC, 2004, J BIOL CHEM, V279, P18296, DOI 10.1074/jbc.M312145200; Babini E, 2002, J BIOL CHEM, V277, P41597, DOI 10.1074/jbc.M205877200; Back T, 2000, ANN NEUROL, V47, P485, DOI 10.1002/1531-8249(200004)47:4<485::AID-ANA12>3.3.CO;2-#; Bonnet U, 2000, NEUROPHARMACOLOGY, V39, P2067, DOI 10.1016/S0028-3908(00)00033-2; BORON WF, 1976, J GEN PHYSIOL, V67, P91, DOI 10.1085/jgp.67.1.91; CHESLER M, 1990, PROG NEUROBIOL, V34, P401, DOI 10.1016/0301-0082(90)90034-E; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Chu XP, 2004, J NEUROSCI, V24, P8678, DOI 10.1523/JNEUROSCI.2844-04.2004; Chu XP, 2003, J PHYSIOL-LONDON, V550, P385, DOI 10.1113/jphysiol.2003.043091; DEITMER JW, 1980, J PHYSIOL-LONDON, V304, P471, DOI 10.1113/jphysiol.1980.sp013337; Deval E, 2003, NEUROPHARMACOLOGY, V44, P662, DOI 10.1016/S0028-3908(03)00047-9; Dixon DB, 1996, VISION RES, V36, P3925, DOI 10.1016/S0042-6989(96)00129-0; FIEVET B, 1988, RESP PHYSIOL, V74, P99, DOI 10.1016/0034-5687(88)90144-2; Gao J, 2005, NEURON, V48, P635, DOI 10.1016/j.neuron.2005.10.011; GAULT LM, 1994, BRAIN RES, V641, P176, DOI 10.1016/0006-8993(94)91835-X; Gorji A, 2001, BRAIN RES REV, V38, P33, DOI 10.1016/S0165-0173(01)00081-9; HILLE B, 1968, J GEN PHYSIOL, V51, P221, DOI 10.1085/jgp.51.2.221; Immke DC, 2001, NAT NEUROSCI, V4, P869, DOI 10.1038/nn0901-869; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; KRISHTAL OA, 1981, NEUROSCIENCE, V6, P2599, DOI 10.1016/0306-4522(81)90105-6; Mamet J, 2002, J NEUROSCI, V22, P10662; MUTCH WAC, 1984, J CEREBR BLOOD F MET, V4, P17, DOI 10.1038/jcbfm.1984.3; NEDERGAARD M, 1991, AM J PHYSIOL, V260, P581; Obeidat AS, 1998, EUR J NEUROSCI, V10, P3451, DOI 10.1046/j.1460-9568.1998.00358.x; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; REHNCRONA S, 1985, ANN EMERG MED, V14, P770, DOI 10.1016/S0196-0644(85)80055-X; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; Schubert R, 1996, J VASC RES, V33, P86, DOI 10.1159/000159136; SHARP AP, 1981, J PHYSIOL-LONDON, V312, P71, DOI 10.1113/jphysiol.1981.sp013616; Ugawa S, 2003, J NEUROSCI, V23, P3616; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2004, P NATL ACAD SCI USA, V101, P3621, DOI 10.1073/pnas.0308753101; Wemmie JA, 2003, J NEUROSCI, V23, P5496; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P6752, DOI 10.1073/pnas.0308636100	39	50	53	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					29369	29378		10.1074/jbc.M605122200	http://dx.doi.org/10.1074/jbc.M605122200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16882660	hybrid			2022-12-27	WOS:000240680500092
J	Akhtar, MS; Krishnan, MY; Bhakuni, V				Akhtar, Md. Sohail; Krishnan, Manju Yasoda; Bhakuni, Vinod			Insights into the mechanism of action of hyaluronate lyase - Role of C-terminal domain and Ca2+ in the functional regulation of enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOCOCCUS; DEGRADATION; GENE; PURIFICATION; EXPRESSION; BINDING; HYALURONIDASES; SEQUENCE; CLONING; COMPLEX	Hyaluronate lyases (HLs) cleave hyaluronan and certain other chondroitin/chondroitin sulfates. Although native HL from Streptococcus agalactiae is composed of four domains, it finally stabilizes after autocatalytic conversion as a 92-kDa enzyme composed of the N-terminal spacer, middle alpha-, and C-terminal domains. These three domains are independent folding/unfolding units of the enzyme. Comparative structural and functional studies using the enzyme and its various fragments/domains suggest a relatively insignificant role of the N-terminal spacer domain in the 92-kDa enzyme. Functional studies demonstrate that the alpha-domain is the catalytic domain. However, independently it has a maximum of only about 10% of the activity of the 92-kDa enzyme, whereas its complex with the C-terminal domain in vitro shows a significant enhancement (about 6-fold) in the activity. It has been previously proposed that the C-terminal domain modulates the enzymatic activity of HLs. In addition, one of the possible roles for calcium ions was suggested to induce conformational changes in the enzyme loops, making HL more suitable for catalysis. However, we observed that calcium ions do not interact with the enzyme, and its role actually is in modulating the hyaluronan conformation and not in the functional regulation of enzyme.	Cent Drug Res Inst, Div Mol & Struct Biol, Lucknow 226001, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Bhakuni, V (corresponding author), Cent Drug Res Inst, Div Mol & Struct Biol, Lucknow 226001, Uttar Pradesh, India.	bhakuniv@rediffmail.com	Akhtar, Sohail/A-2300-2010; Krishnan, Manju Y/B-7195-2009					Akhtar MS, 2003, J BIOL CHEM, V278, P25509, DOI 10.1074/jbc.M301894200; Akhtar MS, 2002, BIOCHEMISTRY-US, V41, P3819, DOI 10.1021/bi0116700; Baker JR, 1997, BIOCHEM J, V327, P65, DOI 10.1042/bj3270065; BERRY AM, 1994, INFECT IMMUN, V62, P1101, DOI 10.1128/IAI.62.3.1101-1108.1994; CHEN YH, 1972, BIOCHEMISTRY-US, V11, P4120, DOI 10.1021/bi00772a015; DILLON HC, 1987, J PEDIATR-US, V110, P31, DOI 10.1016/S0022-3476(87)80283-4; Fethiere J, 1999, J MOL BIOL, V288, P635, DOI 10.1006/jmbi.1999.2698; Gase K, 1998, BBA-GENE STRUCT EXPR, V1398, P86, DOI 10.1016/S0167-4781(98)00045-1; Hynes WL, 2000, FEMS MICROBIOL LETT, V183, P201, DOI 10.1111/j.1574-6968.2000.tb08958.x; Jedrzejas MJ, 2000, CRIT REV BIOCHEM MOL, V35, P221, DOI 10.1080/10409230091169195; Jedrzejas MJ, 1998, PROTEIN EXPRES PURIF, V13, P83, DOI 10.1006/prep.1997.0864; Jedrzejas MJ, 2000, ACTA CRYSTALLOGR D, V56, P460, DOI 10.1107/S0907444900000706; Jedrzejas MJ, 2002, J BIOL CHEM, V277, P28287, DOI 10.1074/jbc.M112009200; Jedrzejas MJ, 2001, MICROBIOL MOL BIOL R, V65, P187, DOI 10.1128/MMBR.65.2.187-207.2001; Kelly SJ, 2001, GLYCOBIOLOGY, V11, P297, DOI 10.1093/glycob/11.4.297; KREIL G, 1995, PROTEIN SCI, V4, P1666, DOI 10.1002/pro.5560040902; Li SL, 2000, EMBO J, V19, P1228, DOI 10.1093/emboj/19.6.1228; Li SL, 2001, J BIOL CHEM, V276, P41407, DOI 10.1074/jbc.M106634200; LIN B, 1994, J BIOL CHEM, V269, P30113; Mello LV, 2002, J BIOL CHEM, V277, P36678, DOI 10.1074/jbc.M205140200; PATON JC, 1986, INFECT IMMUN, V54, P50, DOI 10.1128/IAI.54.1.50-55.1986; Ponnuraj K, 2000, J MOL BIOL, V299, P885, DOI 10.1006/jmbi.2000.3817; Pritchard DG, 2000, PROTEINS, V40, P126; PRITCHARD DG, 1994, ARCH BIOCHEM BIOPHYS, V315, P431, DOI 10.1006/abbi.1994.1521; QUI GN, 1996, CHEM PHARM BULL, V44, P1017; Rigden DJ, 2003, PROTEINS, V52, P203, DOI 10.1002/prot.10405; Scott JE, 1999, P NATL ACAD SCI USA, V96, P4850, DOI 10.1073/pnas.96.9.4850; Spellerberg B, 2000, MICROBES INFECT, V2, P1733, DOI 10.1016/S1286-4579(00)01328-9; WINTER WT, 1977, J MOL BIOL, V117, P761, DOI 10.1016/0022-2836(77)90068-7; YAMAGATA T, 1968, J BIOL CHEM, V243, P1523; Yildirim AO, 2002, RES VET SCI, V73, P131, DOI 10.1016/S0034-5288(02)00029-2	31	10	11	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					28336	28344		10.1074/jbc.M601165200	http://dx.doi.org/10.1074/jbc.M601165200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16854993	hybrid			2022-12-27	WOS:000240534400071
J	Paschinger, K; Hackl, M; Gutternigg, M; Kretschmer-Lubich, D; Stemmer, U; Jantsch, V; Lochnit, G; Wilson, IBH				Paschinger, Katharina; Hackl, Matthias; Gutternigg, Martin; Kretschmer-Lubich, Dorothea; Stemmer, Ute; Jantsch, Verena; Lochnit, Guenter; Wilson, Iain B. H.			A deletion in the Golgi alpha-mannosidase II gene of Caenorhabditis elegans results in unexpected non-wild-type N-glycan structures*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARAGINE-LINKED OLIGOSACCHARIDES; DROSOPHILA-MELANOGASTER; INSECT CELLS; GLYCOPROTEIN-SYNTHESIS; MOLECULAR-CLONING; IN-VITRO; IDENTIFICATION; COMPLEX; CDNA; PHOSPHORYLCHOLINE	The processing of N-linked oligosaccharides by alpha-mannosidases in the endoplasmic reticulum and Golgi is a process conserved in plants and animals. After the transfer of a GlcNAc residue to Asn- bound Man(5)GlcNAc(2) by N-acetylglucosaminyl-transferase I, an alpha-mannosidase (EC 3.2.1.114) removes one alpha 1,3- linked and one alpha 1,6- linked mannose residue. In this study, we have identified the relevant alpha-mannosidase II gene (aman- 2; F58H1.1) from Caenorhabditis elegans and have detected its activity in both native and recombinant forms. For comparative studies, the two other cDNAs encoding class II mannosidases aman-1 (F55D10.1) and aman- 3 (F48C1.1) were cloned; the corresponding enzymes are, respectively, a putative lysosomal alpha-mannosidase and a Co(II)-activated alpha-mannosidase. The analysis of the N-glycan structures of an aman- 2 mutant strain demonstrates that the absence of alpha-mannosidase II activity results in a shift to structures not seen in wild-type worms (e. g. N-glycans with the composition Hex(5-7)HexNAc(2-3)Fuc(2)Me) and an accumulation of hybrid oligosaccharides. Paucimannosidic glycans are almost absent from aman-2 worms, indicative also of a general lack of alpha-mannosidase III activity. We hypothesize that there is a tremendous flexibility in the glycosylation pathway of C. elegans that does not impinge, under standard laboratory conditions, on the viability of worms with glycotypes very unlike the wild-type pattern.	Univ Bodenkultur Wien, Dept Chem, A-1190 Vienna, Austria; Vienna Bioctr 2, Abt Chromosomenbiol, A-1030 Vienna, Austria; Univ Giessen, Inst Biochem, D-35292 Giessen, Germany	University of Natural Resources & Life Sciences, Vienna; Vienna Biocenter (VBC); Justus Liebig University Giessen	Wilson, IBH (corresponding author), Univ Bodenkultur Wien, Dept Chem, A-1190 Vienna, Austria.	iain.wilson@boku.ac.at	Wilson, Iain/B-3326-2009; Jantsch, Verena/A-3910-2017	Wilson, Iain/0000-0001-8996-1518; Jantsch, Verena/0000-0002-1978-682X; Paschinger, Katharina/0000-0002-3594-7136; Hackl, Matthias/0000-0002-4136-7293	Austrian Science Fund FWF [P 18447] Funding Source: Medline	Austrian Science Fund FWF(Austrian Science Fund (FWF))		Akama TO, 2006, P NATL ACAD SCI USA, V103, P8983, DOI 10.1073/pnas.0603248103; ALLEN SD, 1984, J BIOL CHEM, V259, P6984; ALTMANN F, 1995, J BIOL CHEM, V270, P17344, DOI 10.1074/jbc.270.29.17344; Altmann F, 2001, BIOCHIMIE, V83, P703, DOI 10.1016/S0300-9084(01)01297-4; ALTMANN F, 1995, GLYCOCONJUGATE J, V12, P150, DOI 10.1007/BF00731359; Berg T, 1997, BIOCHEM J, V328, P863, DOI 10.1042/bj3280863; BISCHOFF J, 1990, J BIOL CHEM, V265, P17110; BOLANOWSKI MA, 1983, MECH AGEING DEV, V21, P295, DOI 10.1016/0047-6374(83)90048-9; Chui D, 1997, CELL, V90, P157, DOI 10.1016/S0092-8674(00)80322-0; Chui D, 2001, P NATL ACAD SCI USA, V98, P1142, DOI 10.1073/pnas.98.3.1142; Cipollo JF, 2005, J BIOL CHEM, V280, P26063, DOI 10.1074/jbc.M503828200; Cipollo JF, 2004, J BIOL CHEM, V279, P52893, DOI 10.1074/jbc.M409557200; Cipollo JF, 2004, P NATL ACAD SCI USA, V101, P3404, DOI 10.1073/pnas.0400384101; DEWALD B, 1973, J BIOL CHEM, V248, P7223; DIXON M, 1953, BIOCHEM J, V55, P161, DOI 10.1042/bj0550161; Fabini G, 2001, J BIOL CHEM, V276, P28058, DOI 10.1074/jbc.M100573200; FOSTER JM, 1995, GENE, V154, P183, DOI 10.1016/0378-1119(94)00867-R; Gerdt S, 1999, EUR J BIOCHEM, V266, P952, DOI 10.1046/j.1432-1327.1999.00937.x; Gonzalez DS, 1999, J BIOL CHEM, V274, P21375, DOI 10.1074/jbc.274.30.21375; Hanneman AJ, 2006, GLYCOBIOLOGY, V16, P874, DOI 10.1093/glycob/cwl011; HASE S, 1984, J BIOCHEM-TOKYO, V95, P197, DOI 10.1093/oxfordjournals.jbchem.a134585; Haslam SM, 2003, BIOCHIMIE, V85, P25, DOI 10.1016/S0300-9084(03)00041-5; Haslam SM, 2002, BIOCHEM SOC SYMP, V69, P117; Haslam SM, 1997, MOL BIOCHEM PARASIT, V85, P53, DOI 10.1016/S0166-6851(96)02807-1; Heikinheimo P, 2003, J MOL BIOL, V327, P631, DOI 10.1016/S0022-2836(03)00172-4; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; Herscovics A, 2001, BIOCHIMIE, V83, P757, DOI 10.1016/S0300-9084(01)01319-0; Hirabayashi J, 2002, J BIOCHEM, V132, P103, DOI 10.1093/oxfordjournals.jbchem.a003186; Houston KM, 1997, J BIOL CHEM, V272, P1527, DOI 10.1074/jbc.272.3.1527; Howard S, 1998, J BIOL CHEM, V273, P2067, DOI 10.1074/jbc.273.4.2067; IOFFE E, 1994, P NATL ACAD SCI USA, V91, P728, DOI 10.1073/pnas.91.2.728; Kaji H, 2003, NAT BIOTECHNOL, V21, P667, DOI 10.1038/nbt829; Kawar Z, 2001, J BIOL CHEM, V276, P16335, DOI 10.1074/jbc.M100119200; Landis G, 2001, GENETICS, V158, P1167; LEON MA, 1971, BIOCHEMISTRY-US, V10, P1424, DOI 10.1021/bi00784a024; Liao YF, 1996, J BIOL CHEM, V271, P28348, DOI 10.1074/jbc.271.45.28348; Lukacsovich T, 2001, GENETICS, V157, P727; McIlvaine TC, 1921, J BIOL CHEM, V49, P183; METZLER M, 1994, EMBO J, V13, P2056, DOI 10.1002/j.1460-2075.1994.tb06480.x; MISAGO M, 1995, P NATL ACAD SCI USA, V92, P11766, DOI 10.1073/pnas.92.25.11766; MONIS E, 1987, EUR J BIOCHEM, V168, P287, DOI 10.1111/j.1432-1033.1987.tb13419.x; MOREMEN KW, 1991, J CELL BIOL, V115, P1521, DOI 10.1083/jcb.115.6.1521; MOREMEN KW, 1994, GLYCOBIOLOGY, V4, P113, DOI 10.1093/glycob/4.2.113; Natsuka S, 2002, J BIOCHEM, V131, P807, DOI 10.1093/oxfordjournals.jbchem.a003169; Nilssen O, 1997, HUM MOL GENET, V6, P717, DOI 10.1093/hmg/6.5.717; NOVIKOFF PM, 1983, P NATL ACAD SCI-BIOL, V80, P4364, DOI 10.1073/pnas.80.14.4364; Numao S, 2000, FEBS LETT, V484, P175, DOI 10.1016/S0014-5793(00)02148-7; Park C, 2005, J BIOL CHEM, V280, P37204, DOI 10.1074/jbc.M508930200; Paschinger K, 2004, J BIOL CHEM, V279, P49588, DOI 10.1074/jbc.M408978200; Paschinger K, 2005, GLYCOBIOLOGY, V15, P463, DOI 10.1093/glycob/cwi028; Praitis V, 2001, GENETICS, V157, P1217; Rabouille C, 1999, J CELL SCI, V112, P3319; Rendic D, 2006, J BIOL CHEM, V281, P3343, DOI 10.1074/jbc.M508334200; Rolls MM, 2002, MOL BIOL CELL, V13, P1778, DOI 10.1091/mbc.01-10-0514; SCHACHTER H, 1986, BIOCHEM CELL BIOL, V64, P163, DOI 10.1139/o86-026; Schachter H, 2005, GLYCOBIOLOGY, V15, P1191; Strasser R, 2006, PLANT J, V45, P789, DOI 10.1111/j.1365-313X.2005.02648.x; Strasser R, 2005, BIOCHEM J, V387, P385, DOI 10.1042/BJ20041686; SUZUKI T, 2006, IN PRESS BIOCH J; TABAS I, 1978, J BIOL CHEM, V253, P7779; Tollersrud OK, 1997, EUR J BIOCHEM, V246, P410, DOI 10.1111/j.1432-1033.1997.00410.x; Tremblay LO, 2000, J BIOL CHEM, V275, P31655, DOI 10.1074/jbc.M004935200; Treusch S, 2004, P NATL ACAD SCI USA, V101, P4483, DOI 10.1073/pnas.0400709101; TULSIANI DRP, 1982, J BIOL CHEM, V257, P3660; TULSIANI DRP, 1977, J BIOL CHEM, V252, P3227; van den Elsen JMH, 2001, EMBO J, V20, P3008, DOI 10.1093/emboj/20.12.3008; van Die I, 1999, FEBS LETT, V463, P189, DOI 10.1016/S0014-5793(99)01508-2; VONSCHAEWEN A, 1993, PLANT PHYSIOL, V102, P1109, DOI 10.1104/pp.102.4.1109; Weiser JN, 1997, INFECT IMMUN, V65, P943, DOI 10.1128/IAI.65.3.943-950.1997; Wilson IBH, 1998, GLYCOCONJUGATE J, V15, P1055, DOI 10.1023/A:1006960401562; Zhang WL, 2003, BIOCHEM J, V372, P53, DOI 10.1042/BJ20021931; Zhu SX, 2004, BIOCHEM J, V382, P995, DOI 10.1042/BJ20040793	72	35	38	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					28265	28277		10.1074/jbc.M602878200	http://dx.doi.org/10.1074/jbc.M602878200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16864579	Green Accepted, hybrid			2022-12-27	WOS:000240534400064
J	Wang, J; Sun, F; Zhang, DW; Ma, YM; Xu, F; Belani, JD; Cohen, JC; Hobbs, HH; Xie, XS				Wang, Jin; Sun, Fang; Zhang, Da-wei; Ma, Yongming; Xu, Fang; Belani, Jitendra D.; Cohen, Jonathan C.; Hobbs, Helen H.; Xie, Xiao-Song			Sterol transfer by ABCG5 and ABCG8 - In vitro assay and reconstitution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIGEN-PROCESSING TAP; MULTIDRUG-RESISTANCE TRANSPORTER; BILIARY CHOLESTEROL SECRETION; GLYCOPROTEIN ATPASE ACTIVITY; NUCLEOTIDE-BINDING DOMAINS; MYOSIN MOTOR DOMAIN; P-GLYCOPROTEIN; DIETARY-CHOLESTEROL; MEMBRANE-VESICLES; RAT-LIVER	ATP-binding cassette transporters G5 and G8 are half-transporters expressed on the apical membranes of enterocytes and hepatocytes that limit intestinal uptake and promote secretion of neutral sterols. Genetic defects that inactivate either half-transporter cause accumulation of cholesterol and plant sterols, resulting in premature coronary atherosclerosis. These observations suggest that G5 and G8 promote the translocation of sterols across membranes, but the primary transport substrate of the G5G8 complex has not been directly determined. Here we report the development of a sterol transfer assay using "insideout" membrane vesicles from Sf9 cells expressing recombinant mouse G5 and G8. Radiolabeled cholesterol or sitosterol was transferred from donor liposomes to G5- and G8-containing membrane vesicles in an ATP-dependent and vanadate-sensitive manner; net transfer of cholesterol was associated with an increase in vesicular cholesterol mass. CTP, GTP, and UTP, as well as ATP, supported transfer but with lesser efficiency (ATP >> CTP > GTP > UTP). Transfer was specific for sterols and was stereoselective; minimal ATP-dependent and vanadate-sensitive transfer of cholesteryl oleate, phosphatidylcholine, or enantiomeric cholesterol was observed. These studies indicate that G5 and G8 are sufficient for reconstitution of sterol transfer activity in vitro and provide the first demonstration that sterols are direct transport substrates of the G5 and G8 heterodimer.	Univ Texas, SW Med Ctr, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Ctr Human Nutr, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA; Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of California System; University of California Irvine	Xie, XS (corresponding author), Univ Texas, SW Med Ctr, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA.	xiao-song.xie@UTSouthwestern.edu	Belani, Jitendra/W-5561-2019; Zhang, Dawei/ABD-8990-2022	Zhang, Dawei/0000-0001-8279-8041	NHLBI NIH HHS [R37 HL072304, HL72304, HL20948, P01 HL020948, R01 HL072304] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948, R01HL072304, R37HL072304] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Albrecht C, 2002, BBA-BIOMEMBRANES, V1567, P133, DOI 10.1016/S0005-2736(02)00608-9; Berge KE, 2000, SCIENCE, V290, P1771, DOI 10.1126/science.290.5497.1771; Biswas EE, 2001, BIOCHEMISTRY-US, V40, P8181, DOI 10.1021/bi0106686; Burg D, 2002, MOL PHARMACOL, V62, P1160, DOI 10.1124/mol.62.5.1160; Cai J, 2002, BIOCHEMISTRY-US, V41, P8058, DOI 10.1021/bi012082p; Chen M, 2003, J BIOL CHEM, V278, P29686, DOI 10.1074/jbc.M302757200; Chen M, 2004, J BIOL CHEM, V279, P46073, DOI 10.1074/jbc.M404042200; Dean M, 2001, J LIPID RES, V42, P1007; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; FISHER AJ, 1995, BIOCHEMISTRY-US, V34, P8960, DOI 10.1021/bi00028a004; Gerloff T, 1998, J BIOL CHEM, V273, P10046, DOI 10.1074/jbc.273.16.10046; Graf GA, 2004, J BIOL CHEM, V279, P24881, DOI 10.1074/jbc.M402634200; Graf GA, 2003, J BIOL CHEM, V278, P48275, DOI 10.1074/jbc.M310223200; Graf GA, 2002, J CLIN INVEST, V110, P659, DOI 10.1172/JCI200216000; Henriksen U, 2005, J CELL SCI, V118, P1417, DOI 10.1242/jcs.01729; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; INOUE M, 1983, J BIOL CHEM, V258, P5183; Janvilisri T, 2003, J BIOL CHEM, V278, P20645, DOI 10.1074/jbc.M301358200; Jones PM, 2004, CELL MOL LIFE SCI, V61, P682, DOI 10.1007/s00018-003-3336-9; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; Kipp H, 2000, J BIOL CHEM, V275, P15917, DOI 10.1074/jbc.M909875199; Koch J, 2004, J BIOL CHEM, V279, P10142, DOI 10.1074/jbc.M312816200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lange Y, 2004, P NATL ACAD SCI USA, V101, P11664, DOI 10.1073/pnas.0404766101; Lapinski PE, 2001, J BIOL CHEM, V276, P7526, DOI 10.1074/jbc.M009448200; Lee MH, 2001, NAT GENET, V27, P79, DOI 10.1038/83799; LELONG IH, 1992, FEBS LETT, V304, P256, DOI 10.1016/0014-5793(92)80632-Q; Melin P, 2004, BIOCHEM PHARMACOL, V67, P2187, DOI 10.1016/j.bcp.2004.02.022; MULLER KM, 1994, J BIOL CHEM, V269, P14032; Ozvegy C, 2002, J BIOL CHEM, V277, P47980, DOI 10.1074/jbc.M207857200; Powe AC, 2002, J PHYSIOL-LONDON, V539, P333, DOI 10.1113/jphysiol.2001.013162; RYCHNOVSKY SD, 1992, J ORG CHEM, V57, P2732, DOI 10.1021/jo00035a036; Sankaran B, 1997, BIOCHEMISTRY-US, V36, P6847, DOI 10.1021/bi970034s; Sankaran B, 1997, ARCH BIOCHEM BIOPHYS, V341, P160, DOI 10.1006/abbi.1997.9944; Small DM, 2003, P NATL ACAD SCI USA, V100, P4, DOI 10.1073/pnas.0237205100; Smith CA, 1996, BIOCHEMISTRY-US, V35, P5404, DOI 10.1021/bi952633+; Takahashi K, 2006, J BIOL CHEM, V281, P10760, DOI 10.1074/jbc.M513783200; Tam SP, 2006, AM J PHYSIOL-CELL PH, V291, pC490, DOI 10.1152/ajpcell.00055.2006; Urbatsch IL, 2003, J BIOL CHEM, V278, P23171, DOI 10.1074/jbc.M301957200; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; Wang N, 2004, P NATL ACAD SCI USA, V101, P9774, DOI 10.1073/pnas.0403506101; Wang N, 2001, J BIOL CHEM, V276, P23742, DOI 10.1074/jbc.M102348200; Wang ZL, 2006, BIOCHEMISTRY-US, V45, P9929, DOI 10.1021/bi0608055; XIE XS, 1986, J BIOL CHEM, V261, P2492; XIE XS, 1983, J BIOL CHEM, V258, P4834; XIE XS, 1989, J BIOL CHEM, V264, P1710; Yu LQ, 2002, P NATL ACAD SCI USA, V99, P16237, DOI 10.1073/pnas.252582399; Yu LQ, 2004, J LIPID RES, V45, P301, DOI 10.1194/jlr.M300377-JLR200; Yu LQ, 2002, J CLIN INVEST, V110, P671, DOI [10.1172/JCI200216001, 10.1172/JCI0216001]; Zelcer N, 2003, BIOCHEM J, V371, P361, DOI 10.1042/BJ20021886; Zhang DW, 2006, J BIOL CHEM, V281, P4507, DOI 10.1074/jbc.M512277200	52	67	71	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					27894	27904		10.1074/jbc.M605603200	http://dx.doi.org/10.1074/jbc.M605603200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16867993	Green Accepted, hybrid			2022-12-27	WOS:000240534400025
J	Heyes, DJ; Heathcote, P; Rigby, SEJ; Palacios, MA; van Grondelle, R; Hunter, CN				Heyes, Derren J.; Heathcote, Peter; Rigby, Stephen E. J.; Palacios, Miguel A.; van Grondelle, Rienk; Hunter, C. Neil			The first catalytic step of the light-driven enzyme protochlorophyllide oxidoreductase proceeds via a charge transfer complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STARK SPECTROSCOPY; PHOTOSYSTEM-I; RHODOBACTER-SPHAEROIDES; SUBSTRATE-SPECIFICITY; ENDOR SPECTROSCOPY; REDUCTASE; NADPH; PHOTOREDUCTION; RADICALS; IDENTIFICATION	In chlorophyll biosynthesis protochlorophyllide reductase (POR) catalyzes the light-driven reduction of protochlorophyllide (Pchlide) to chlorophyllide, providing a rare opportunity to trap and characterize catalytic intermediates at low temperatures. Moreover, the presence of a chlorophyll-like molecule allows the use of EPR, electron nuclear double resonance, and Stark spectroscopies, previously used for the analysis of photosynthetic systems, to follow catalytic events in the active site of POR. Different models involving the formation of either radical species or charge transfer complexes have been proposed for the initial photochemical step, which forms a nonfluorescent intermediate absorbing at 696nm(A(696)). Our EPR data show that the concentration of the radical species formed in the initial photochemical step is not stoichiometric with conversion of substrate. Instead, a large Stark effect, indicative of charge transfer character, is associated with A(696). Two components were required to fit the Stark data, providing clear evidence that charge transfer complexes are formed during the initial photochemistry. The temperature dependences of both A(696) formation and NADPH oxidation are identical, and we propose that formation of the A(696) state involves hydride transfer from NADPH to form a charge transfer complex. A catalytic mechanism of POR is suggested in which Pchlide absorbs a photon, creating a transient charge separation across the C-17-C-18 double bond, which promotes ultrafast hydride transfer from the pro-S face of NADPH to the C-17 of Pchlide. The resulting A(696) charge transfer intermediate facilitates transfer of a proton to the C-18 of Pchlide during the subsequent first "dark" reaction.	Univ Sheffield, Dept Mol Biol & Biotechnol, Robert Hill Inst Photosynth, Sheffield S10 2TN, S Yorkshire, England; Univ Sheffield, Dept Mol Biol & Biotechnol, Krebs Inst Biomolec Res, Sheffield S10 2TN, S Yorkshire, England; Univ London Queen Mary Coll, Sch Biol Sci, London E1 4NS, England; Vrije Univ Amsterdam, Dept Exact Sci, NL-1081 HV Amsterdam, Netherlands	University of Sheffield; University of Sheffield; University of London; Queen Mary University London; Vrije Universiteit Amsterdam	Heyes, DJ (corresponding author), Univ Manchester, Manchester Interdisciplinary Bioctr, 131 Princess St, Manchester M1 7ND, Lancs, England.	derren.heyes@manchester.ac.uk	Heathcote, Peter/B-3749-2011	Heyes, Derren/0000-0002-7453-1571				BAKER ME, 1994, BIOCHEM J, V300, P605; Beekman LMP, 1997, J PHYS CHEM B, V101, P7284, DOI 10.1021/jp963445b; BEGLEY TP, 1989, J AM CHEM SOC, V111, P3095, DOI 10.1021/ja00190a071; BELYAEVA OB, 1988, PHOTOSYNTH RES, V15, P247, DOI 10.1007/BF00047356; Bublitz GU, 1997, ANNU REV PHYS CHEM, V48, P213, DOI 10.1146/annurev.physchem.48.1.213; Frese R, 1997, PHOTOSYNTH RES, V54, P115, DOI 10.1023/A:1005903613179; Frese RN, 2002, BBA-BIOENERGETICS, V1554, P180, DOI 10.1016/S0005-2728(02)00242-6; GRIFFITHS WT, 1980, BIOCHEM J, V186, P267, DOI 10.1042/bj1860267; HAMMES SL, 1990, P NATL ACAD SCI USA, V87, P5682, DOI 10.1073/pnas.87.15.5682; Heyes DJ, 2005, TRENDS BIOCHEM SCI, V30, P642, DOI 10.1016/j.tibs.2005.09.001; Heyes DJ, 2004, BIOCHEMISTRY-US, V43, P8265, DOI 10.1021/bi049576h; Heyes DJ, 2003, NAT STRUCT BIOL, V10, P491, DOI 10.1038/nsb929; Heyes DJ, 2003, BIOCHEMISTRY-US, V42, P523, DOI 10.1021/bi0268448; Heyes DJ, 2002, P NATL ACAD SCI USA, V99, P11145, DOI 10.1073/pnas.182274199; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Klement H, 1999, EUR J BIOCHEM, V265, P862, DOI 10.1046/j.1432-1327.1999.00627.x; KURRECK H, 1988, ELECT NUCL DOUBLE RE; Lebedev N, 1999, P NATL ACAD SCI USA, V96, P9954, DOI 10.1073/pnas.96.17.9954; LOCKHART DJ, 1988, P NATL ACAD SCI USA, V85, P107, DOI 10.1073/pnas.85.1.107; Lubitz W, 2002, ACCOUNTS CHEM RES, V35, P313, DOI 10.1021/ar000084g; Palacios MA, 2004, BBA-BIOENERGETICS, V1656, P177, DOI 10.1016/j.bbabio.2004.04.002; Palacios MA, 2003, BBA-BIOENERGETICS, V1605, P83, DOI 10.1016/S0005-2728(03)00080-X; Raskin VI, 2002, PHOTOSYNTH RES, V74, P181, DOI 10.1023/A:1020955526882; Rigby SEJ, 2001, BBA-BIOENERGETICS, V1507, P247, DOI 10.1016/S0005-2728(01)00211-0; SCHEER H, 1977, J AM CHEM SOC, V99, P1372, DOI 10.1021/ja00447a015; Scheer H., 1991, CHLOROPHYLLS; Townley HE, 1998, FEBS LETT, V422, P19, DOI 10.1016/S0014-5793(97)01589-5; Townley HE, 2001, PROTEINS, V44, P329, DOI 10.1002/prot.1098; Un S, 2001, APPL MAGN RESON, V21, P341, DOI 10.1007/BF03162413; VALERA V, 1987, BIOCHEM BIOPH RES CO, V148, P515, DOI 10.1016/0006-291X(87)91141-7; WILKS HM, 1995, P NATL ACAD SCI USA, V92, P724, DOI 10.1073/pnas.92.3.724; WILLIAMSSMITH DL, 1978, BIOCHEM J, V170, P365, DOI 10.1042/bj1700365	32	46	49	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2006	281	37					26847	26853		10.1074/jbc.M602943200	http://dx.doi.org/10.1074/jbc.M602943200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082PB	16867988	Green Published, hybrid			2022-12-27	WOS:000240397700011
J	Mangmool, S; Haga, T; Kobayashi, H; Kim, KM; Nakata, H; Nishida, M; Kurose, H				Mangmool, Supachoke; Haga, Tatsuya; Kobayashi, Hiroyuki; Kim, Kyeong-Man; Nakata, Hiroyasu; Nishida, Motohiro; Kurose, Hitoshi			Clathrin required for phosphorylation and internalization of beta(2)-adrenergic receptor by G protein-coupled receptor kinase 2 (GRK2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ARRESTIN; ARRESTIN/CLATHRIN INTERACTION; TERMINAL DOMAIN; BINDING; ENDOCYTOSIS; KINASES; LOCALIZATION; DESENSITIZATION; SEQUESTRATION; TRAFFICKING	Clathrin is a major component of clathrin-coated pits and serves as a binding scaffold for endocytic machinery through the binding of a specific sequence known as the clathrin-binding motif. This motif is also found in cellular signaling proteins other than endocytic components, including G protein-coupled receptor kinase 2 (GRK2), which phosphorylates G protein-coupled receptors and promotes uncoupling of receptor-G protein interaction. However, the functions of clathrin in the regulation of GRK2 are unknown. Here we demonstrated that overexpression of GRK2 mutated at the clathrin-binding motif with alanine (GRK2-5A) results in inhibition of phosphorylation and internalization of the beta(2)-adrenergic receptor (beta(2)AR). However, the interaction of beta(2)AR with GRK2-5A is the same as that of wild type GRK2 as determined by bioluminescence resonance energy transfer. Furthermore, GRK2-5A phosphorylates rhodopsin essentially to the same extent as wild type GRK2 in vitro. Depletion of the clathrin heavy chain using small interference RNA inhibits agonist-induced phosphorylation and internalization of beta(2)AR. Thus, clathrin works as a regulator of GRK2 in cells. These results indicate that clathrin is a novel player in cellular functions in addition to being a component of endocytosis.	Kyushu Univ, Dept Pharmacol & Toxicol, Grad Sch Pharmaceut Sci, Higashi Ku, Fukuoka 8128582, Japan; Gakushuin Univ, Fac Sci, Inst Biomol Sci, Tokyo 1718588, Japan; Chonnam Natl Univ, Coll Pharm, Dept Pharmacol, Kwangju 500757, South Korea; Tokyo Metropolitan Inst Neurosci, Dept Mol Cell Signaling, Tokyo 1838526, Japan	Kyushu University; Gakushuin University; Chonnam National University; Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science	Kurose, H (corresponding author), Kyushu Univ, Dept Pharmacol & Toxicol, Grad Sch Pharmaceut Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	kurose@phar.kyushu-u.ac.jp	Kim, Kyeong-Man/AAA-9847-2020; Kobayashi, Hiroyuki/F-6386-2013	Kobayashi, Hiroyuki/0000-0003-4965-0883; Nishida, Motohiro/0000-0002-2587-5458				Akbarzadeh S, 2002, J BIOL CHEM, V277, P36280, DOI 10.1074/jbc.M204626200; BENOVIC JL, 1986, P NATL ACAD SCI USA, V83, P2797, DOI 10.1073/pnas.83.9.2797; Dell'Angelica EC, 2001, TRENDS CELL BIOL, V11, P315, DOI 10.1016/S0962-8924(01)02043-8; Dell'Angelica EC, 1998, SCIENCE, V280, P431, DOI 10.1126/science.280.5362.431; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Gaidarov I, 2001, MOL CELL, V7, P443, DOI 10.1016/S1097-2765(01)00191-5; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Goodman OB, 1997, J BIOL CHEM, V272, P15017, DOI 10.1074/jbc.272.23.15017; HAGA K, 1992, J BIOL CHEM, V267, P2222; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Johnson LR, 2004, MOL CELL BIOL, V24, P10169, DOI 10.1128/MCB.24.23.10169-10179.2004; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; Koenig JA, 1997, TRENDS PHARMACOL SCI, V18, P276, DOI 10.1016/S0165-6147(97)01091-2; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Krupnick JG, 1997, J BIOL CHEM, V272, P15011, DOI 10.1074/jbc.272.23.15011; KUROSE H, 1994, J BIOL CHEM, V269, P10093; Lafer EM, 2002, TRAFFIC, V3, P513, DOI 10.1034/j.1600-0854.2002.30801.x; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; Penela P, 2003, CELL SIGNAL, V15, P973, DOI 10.1016/S0898-6568(03)00099-8; Penn RB, 2000, TRENDS CARDIOVAS MED, V10, P81, DOI 10.1016/S1050-1738(00)00053-0; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; PIPPIG S, 1995, MOL PHARMACOL, V47, P666; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Royle SJ, 2005, NATURE, V434, P1152, DOI 10.1038/nature03502; RuizGomez A, 1997, J BIOL CHEM, V272, P9601; Sato Y, 1996, EUR J PHARMACOL, V315, P363, DOI 10.1016/S0014-2999(96)00648-6; Schulz R, 2002, MOL PHARMACOL, V61, P1444, DOI 10.1124/mol.61.6.1444; Shih W, 1995, J BIOL CHEM, V270, P31083, DOI 10.1074/jbc.270.52.31083; Shiina T, 2000, J BIOL CHEM, V275, P29082, DOI 10.1074/jbc.M909757199; Shiina T, 2001, J BIOL CHEM, V276, P33019, DOI 10.1074/jbc.M100140200; Smith CJ, 1999, TRENDS CELL BIOL, V9, P335, DOI 10.1016/S0962-8924(99)01631-1; Teo M, 2001, J BIOL CHEM, V276, P18392, DOI 10.1074/jbc.M008795200; ter Haar E, 2000, P NATL ACAD SCI USA, V97, P1096, DOI 10.1073/pnas.97.3.1096; ter Haar E, 1998, CELL, V95, P563, DOI 10.1016/S0092-8674(00)81623-2; Wettey FR, 2002, SCIENCE, V297, P1521, DOI 10.1126/science.1074222; Wheeler M, 2006, J CELL PHYSIOL, V206, P586, DOI 10.1002/jcp.20507; Yang WN, 2001, J BIOL CHEM, V276, P17468, DOI 10.1074/jbc.M010893200; Yoshioka K, 2002, FEBS LETT, V523, P147, DOI 10.1016/S0014-5793(02)02965-4	39	29	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31940	31949		10.1074/jbc.M602832200	http://dx.doi.org/10.1074/jbc.M602832200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16920721	Bronze			2022-12-27	WOS:000241235300080
J	Natarajan, A; Ghose, R; Hill, JM				Natarajan, Aswin; Ghose, Ranajeet; Hill, Justine M.			Structure and dynamics of ASC2, a pyrin domain-only protein that regulates inflammatory signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MODEL-FREE APPROACH; DEATH-EFFECTOR DOMAIN; NMR RELAXATION DATA; ORIENTED MACROMOLECULES; CRYSTAL-STRUCTURE; DIRECT REFINEMENT; N-15 RELAXATION; KAPPA-B; APOPTOSIS; INSIGHTS	Pyrin domain (PYD)-containing proteins are key components of pathways that regulate inflammation, apoptosis, and cytokine processing. Their importance is further evidenced by the consequences of mutations in these proteins that give rise to autoimmune and hyperinflammatory syndromes. PYDs, like other members of the death domain ( DD) superfamily, are postulated to mediate homotypic interactions that assemble and regulate the activity of signaling complexes. However, PYDs are presently the least well characterized of all four DD subfamilies. Here we report the three-dimensional structure and dynamic properties of ASC2, a PYD-only protein that functions as a modulator of multidomain PYD-containing proteins involved in NF-KB and caspase-1 activation. ASC2 adopts a six-helix bundle structure with a prominent loop, comprising 13 amino acid residues, between helices two and three. This loop represents a divergent feature of PYDs from other domains with the DD fold. Detailed analysis of backbone N-15 NMR relaxation data using both the Lipari-Szabo model-free and reduced spectral density function formalisms revealed no evidence of contiguous stretches of polypeptide chain with dramatically increased internal motion, except at the extreme N and C termini. Some mobility in the fast, picosecond to nanosecond timescale, was seen in helix 3 and the preceding alpha 2-alpha 3 loop, in stark contrast to the complete disorder seen in the corresponding region of the NALP1 PYD. Our results suggest that extensive conformational flexibility in helix 3 and the alpha 2-alpha 3 loop is not a general feature of pyrin domains. Further, a transition from complete disorder to order of the alpha 2-alpha 3 loop upon binding, as suggested for NALP1, is unlikely to be a common attribute of pyrin domain interactions.	Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; CUNY City Coll, Dept Chem, New York, NY 10031 USA; CUNY, Grad Ctr, New York, NY 10016 USA	University of Queensland; City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System	Hill, JM (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	j.hill@imb.uq.edu.au	Hill, Justine M/C-5781-2009		NCRR NIH HHS [5G12 RR03060] Funding Source: Medline; NIGMS NIH HHS [P41 GM-66354] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM066354] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Andrec M, 1999, J MAGN RESON, V139, P408, DOI 10.1006/jmre.1999.1839; BOGGS PT, 1989, ACM T MATH SOFTWARE, V15, P348, DOI 10.1145/76909.76913; Burns K, 2003, CURR OPIN IMMUNOL, V15, P26, DOI 10.1016/S0952-7915(02)00017-1; Carrington PE, 2006, MOL CELL, V22, P599, DOI 10.1016/j.molcel.2006.04.018; Chou JJ, 1998, CELL, V94, P171, DOI 10.1016/S0092-8674(00)81417-8; Christodoulou C, 2006, CLIN EXP MED, V6, P13, DOI 10.1007/s10238-006-0088-5; Clore GM, 1998, J MAGN RESON, V133, P216, DOI 10.1006/jmre.1998.1419; Clore GM, 1998, J MAGN RESON, V131, P159, DOI 10.1006/jmre.1997.1345; CLORE GM, 1990, J AM CHEM SOC, V112, P4989, DOI 10.1021/ja00168a070; Cordier F, 1999, J BIOMOL NMR, V13, P175, DOI 10.1023/A:1008301415843; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Druilhe A, 2001, CELL DEATH DIFFER, V8, P649, DOI 10.1038/sj.cdd.4400881; Dutta K, 2004, BIOCHEMISTRY-US, V43, P8094, DOI 10.1021/bi030268d; Eberstadt M, 1998, NATURE, V392, P941, DOI 10.1038/31972; Eberstadt M, 1997, NAT STRUCT BIOL, V4, P983, DOI 10.1038/nsb1297-983; Eliezer D, 2003, STRUCTURE, V11, P1190, DOI 10.1016/j.str.2003.09.008; Espejo F, 2006, BIOCHEM BIOPH RES CO, V340, P860, DOI 10.1016/j.bbrc.2005.12.087; Espejo F, 2002, J BIOMOL NMR, V23, P151, DOI 10.1023/A:1016398403157; Fairbrother WJ, 2001, PROTEIN SCI, V10, P1911, DOI 10.1110/ps.13801; FARROW NA, 1995, J BIOMOL NMR, V6, P153, DOI 10.1007/BF00211779; Fesik SW, 2000, CELL, V103, P273, DOI 10.1016/S0092-8674(00)00119-7; Fushman D, 1997, J MOL BIOL, V266, P173, DOI 10.1006/jmbi.1996.0771; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; GARRETT DS, 1994, J MAGN RESON SER B, V104, P99, DOI 10.1006/jmrb.1994.1061; Ghose R, 2001, J MAGN RESON, V149, P204, DOI 10.1006/jmre.2001.2295; Hill JM, 2004, J BIOL CHEM, V279, P1474, DOI 10.1074/jbc.M304996200; Hill JM, 2002, EMBO J, V21, P6494, DOI 10.1093/emboj/cdf641; Hiller S, 2003, STRUCTURE, V11, P1199, DOI 10.1016/j.str.2003.08.009; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hull KM, 2003, CURR OPIN RHEUMATOL, V15, P61, DOI 10.1097/00002281-200301000-00011; Humke EW, 2000, CELL, V103, P99, DOI 10.1016/S0092-8674(00)00108-2; Koradi R, 1996, J MOL GRAPHICS, V14, P29; KUSZEWSKI J, 1995, J MAGN RESON SER B, V106, P92, DOI 10.1006/jmrb.1995.1017; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee SH, 2001, J BIOL CHEM, V276, P34495, DOI 10.1074/jbc.M101415200; Li FY, 2006, J BIOL CHEM, V281, P2960, DOI 10.1074/jbc.M511074200; Liepinsh E, 2003, J MOL BIOL, V332, P1155, DOI 10.1016/j.jmb.2003.07.007; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Liu T, 2003, PROTEIN SCI, V12, P1872, DOI 10.1110/ps.0359603; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; Moriya M, 2005, BIOCHEMISTRY-US, V44, P575, DOI 10.1021/bi048374i; Nabuurs SB, 2006, PLOS COMPUT BIOL, V2, P71, DOI 10.1371/journal.pcbi.0020009; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; NILGES M, 1993, PROTEINS, V17, P297, DOI 10.1002/prot.340170307; Palmer AG, 2001, ANNU REV BIOPH BIOM, V30, P129, DOI 10.1146/annurev.biophys.30.1.129; Pawlowski K, 2001, TRENDS BIOCHEM SCI, V26, P85, DOI 10.1016/S0968-0004(00)01729-1; Petrilli V, 2005, CURR BIOL, V15, pR581, DOI 10.1016/j.cub.2005.07.049; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; Richards N, 2001, J BIOL CHEM, V276, P39320, DOI 10.1074/jbc.M104730200; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Stehlik C, 2003, BIOCHEM J, V373, P101, DOI 10.1042/BJ20030304; Thome M, 2001, NAT REV IMMUNOL, V1, P50, DOI 10.1038/35095508; Ting JPY, 2006, NAT REV IMMUNOL, V6, P183, DOI 10.1038/nri1788; Tjandra N, 1997, NAT STRUCT BIOL, V4, P732, DOI 10.1038/nsb0997-732; Vuister G. W., 1999, BIOL MAGNETIC RESONA, V16, P195; Xiao T, 1999, CELL, V99, P545, DOI 10.1016/S0092-8674(00)81542-1; Yang JK, 2005, MOL CELL, V20, P939, DOI 10.1016/j.molcel.2005.10.023; Yu JW, 2006, CELL DEATH DIFFER, V13, P236, DOI 10.1038/sj.cdd.4401734	65	44	46	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31863	31875		10.1074/jbc.M605458200	http://dx.doi.org/10.1074/jbc.M605458200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16905547				2022-12-27	WOS:000241235300073
J	Barker, M; de Vries, R; Nield, J; Komenda, J; Nixon, PJ				Barker, Myles; de Vries, Remco; Nield, Jon; Komenda, Josef; Nixon, Peter J.			The Deg proteases protect Synechocystis sp PCC 6803 during heat and light stresses but are not essential for removal of damaged D1 protein during the photosystem two repair cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAY; ESCHERICHIA-COLI; CHLOROPLAST MEMBRANES; PERIPLASMIC PROTEINS; QUALITY-CONTROL; HTRA FAMILY; II COMPLEX; PCC 6803; MOTILITY; GENE	Members of the DegP/HtrA (or Deg) family of proteases are found widely in nature and play an important role in the proteolysis of misfolded and damaged proteins. As yet, their physiological role in oxygenic photosynthetic organisms is unclear, although it has been widely speculated that they participate in the degradation of the photodamaged D1 subunit in the photosystem two complex (PSII) repair cycle, which is needed to maintain PSII activity in both cyanobacteria and chloroplasts. We have examined the role of the three Deg proteases found in the cyanobacterium Synechocystis sp. PCC 6803 through analysis of double and triple insertion mutants. We have discovered that these proteases show overlap in function and are involved in a number of key physiological responses ranging from protection against light and heat stresses to phototaxis. In previous work, we concluded that the Deg proteases played either a direct or an indirect role in PSII repair in a glucose-tolerant version of Synechocystis 6803 (Silva, P., Choi, Y. J., Hassan, H. A., and Nixon, P. J. (2002) Philos. Trans. R. Soc. Lond. B Biol. Sci. 357, 1461-1467). In this work, we have now been able to demonstrate unambiguously, using a triple deg mutant created in the wild type strain of Synechocystis 6803, that the Deg proteases are not obligatory for PSII repair and D1 degradation. We therefore conclude that although the Deg proteases are needed for photo-protection of Synechocystis sp. PCC 6803, they do not play an essential role in D1 turnover and PSII repair in vivo.	Univ London Imperial Coll Sci Technol & Med, Div Biol, Fac Nat Sci, London SW7 2AZ, England; Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, Fac Nat Sci, London SW7 2AZ, England; Acad Sci Czech Republ, Inst Microbiol, Trebon 37981, Czech Republic	Imperial College London; Imperial College London; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Nixon, PJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Biol, Fac Nat Sci, S Kensington Campus,Wolfson Biochem Bldg, London SW7 2AZ, England.	p.nixon@imperial.ac.uk	Komenda, Josef/H-4083-2014; Nield, Jon/C-5892-2013	Komenda, Josef/0000-0003-4588-0382; Nield, Jon/0000-0001-9983-0239; Nixon, Peter/0000-0003-1952-6937				Adir N, 2003, PHOTOSYNTH RES, V76, P343, DOI 10.1023/A:1024969518145; Alba BM, 2001, MOL MICROBIOL, V40, P1323, DOI 10.1046/j.1365-2958.2001.02475.x; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; Bhaya D, 2000, MOL MICROBIOL, V37, P941, DOI 10.1046/j.1365-2958.2000.02068.x; Bhaya D, 1999, P NATL ACAD SCI USA, V96, P3188, DOI 10.1073/pnas.96.6.3188; Bhaya D, 2001, P NATL ACAD SCI USA, V98, P7540, DOI 10.1073/pnas.131201098; Boucher JC, 1996, J BACTERIOL, V178, P511, DOI 10.1128/jb.178.2.511-523.1996; Choi JS, 1999, PHOTOCHEM PHOTOBIOL, V70, P95; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; DANESE PN, 1995, GENE DEV, V9, P387, DOI 10.1101/gad.9.4.387; Finn PF, 2005, J BIOL CHEM, V280, P25864, DOI 10.1074/jbc.M502456200; Fulda S, 2000, EUR J BIOCHEM, V267, P5900, DOI 10.1046/j.1432-1327.2000.01642.x; FUNK C, 2001, P 12 INT C PHOT BRIS; Harris Jr, 1999, METH MOL B, V117, P13; Haussuhl K, 2001, EMBO J, V20, P713, DOI 10.1093/emboj/20.4.713; Huang F, 2004, MOL CELL PROTEOMICS, V3, P586, DOI 10.1074/mcp.M300137-MCP200; Huesgen PF, 2005, PHYSIOL PLANTARUM, V123, P413, DOI 10.1111/j.1399-3054.2005.00458.x; Jansen T, 2005, PHOTOSYNTH RES, V84, P57, DOI 10.1007/s11120-005-0475-x; Kanervo E, 2003, BBA-BIOENERGETICS, V1607, P131, DOI 10.1016/j.bbabio.2003.09.007; Kanesaki Y, 2002, BIOCHEM BIOPH RES CO, V290, P339, DOI 10.1006/bbrc.2001.6201; Keren N, 2005, J BIOL CHEM, V280, P6548, DOI 10.1074/jbc.M410218200; Kieselbach T, 2003, PHYSIOL PLANTARUM, V119, P337, DOI 10.1034/j.1399-3054.2003.00199.x; Kolmar H, 1996, J BACTERIOL, V178, P5925, DOI 10.1128/jb.178.20.5925-5929.1996; Komenda J, 2006, J BIOL CHEM, V281, P1145, DOI 10.1074/jbc.M503852200; KOMENDA J, 1995, BIOCHEMISTRY-US, V34, P9625, DOI 10.1021/bi00029a040; Komenda J, 2002, EUR J BIOCHEM, V269, P610, DOI 10.1046/j.0014-2956.2001.02693.x; KYLE DJ, 1984, P NATL ACAD SCI-BIOL, V81, P4070, DOI 10.1073/pnas.81.13.4070; Lindahl M, 2000, PLANT CELL, V12, P419, DOI 10.1105/tpc.12.3.419; Lupinkova L, 2004, PHOTOCHEM PHOTOBIOL, V79, P152, DOI 10.1562/0031-8655(2004)079<0152:OMOTPI>2.0.CO;2; Nixon P. J., 1990, CURRENT RES PHOTOSYN, VI, P471; Nixon PJ, 2005, J EXP BOT, V56, P357, DOI 10.1093/jxb/eri021; NIXON PJ, 1995, J BIOL CHEM, V270, P14919, DOI 10.1074/jbc.270.25.14919; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Noone D, 2001, J BACTERIOL, V183, P654, DOI 10.1128/JB.183.2.654-663.2001; OHAD I, 1984, J CELL BIOL, V99, P481, DOI 10.1083/jcb.99.2.481; Okamoto S, 2002, PLANT CELL PHYSIOL, V43, P1127, DOI 10.1093/pcp/pcf128; Raffa RG, 2002, MOL MICROBIOL, V45, P1599, DOI 10.1046/j.1365-2958.2002.03112.x; Silva P, 2003, PLANT CELL, V15, P2152, DOI 10.1105/tpc.012609; Silva P, 2002, PHILOS T R SOC B, V357, P1461, DOI 10.1098/rstb.2002.1146; Skorko-Glonek J, 1999, MOL GEN GENET, V262, P342, DOI 10.1007/s004380051092; SMITH D, 1993, FEMS MICROBIOL LETT, V110, P341, DOI 10.1016/0378-1097(93)90126-M; Sokolenko A, 2002, CURR GENET, V41, P291, DOI 10.1007/s00294-002-0309-8; Spiess C, 1999, CELL, V97, P339, DOI 10.1016/S0092-8674(00)80743-6; STRAUCH KL, 1988, P NATL ACAD SCI USA, V85, P1576, DOI 10.1073/pnas.85.5.1576; Tichy M, 2003, BBA-BIOENERGETICS, V1605, P55, DOI 10.1016/S0005-2728(03)00064-1; Waller PRH, 1996, J BACTERIOL, V178, P1146, DOI 10.1128/jb.178.4.1146-1153.1996; WILLIAMS JGK, 1988, METHOD ENZYMOL, V167, P766; Yamamoto Y, 2001, PLANT CELL PHYSIOL, V42, P121, DOI 10.1093/pcp/pce022; YOKOYAMA E, 1991, PLANT CELL PHYSIOL, V32, P827; Yoshihara S, 2001, PLANT CELL PHYSIOL, V42, P63, DOI 10.1093/pcp/pce007; Zak E, 2001, P NATL ACAD SCI USA, V98, P13443, DOI 10.1073/pnas.241503898	52	52	59	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30347	30355		10.1074/jbc.M601064200	http://dx.doi.org/10.1074/jbc.M601064200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16912048	hybrid			2022-12-27	WOS:000241075900008
J	Godoi, PHC; Galhardo, RS; Luche, DD; Van Sluys, MA; Menck, CFM; Oliva, G				Godoi, Paulo H. C.; Galhardo, Rodrigo S.; Luche, Douglas D.; Van Sluys, Marie-Anne; Menck, Carlos F. M.; Oliva, Glaucius			Structure of the thiazole biosynthetic enzyme THI1 from Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIAMIN BIOSYNTHESIS; SACCHAROMYCES-CEREVISIAE; CRASSA CYPBP37; PROTEIN; YEAST; GENE; ORIGIN; MOIETY; SEQUENCE; FAMILY	Thiamin pyrophosphate is an essential coenzyme in all organisms that depend on fermentation, respiration or photosynthesis to produce ATP. It is synthesized through two independent biosynthetic routes: one for the synthesis of 2-methyl-4-amino5-hydroxymethylpyrimidine pyrophosphate (pyrimidine moiety) and another for the synthesis of 4-methyl-5-(beta-hydroxyethyl) thiazole phosphate ( thiazole moiety). Herein, we will describe the three-dimensional structure of THI1 protein from Arabidopsis thaliana determined by single wavelength anomalous diffraction to 1.6 angstrom resolution. The protein was produced using heterologous expression in bacteria, unexpectedly bound to 2-carboxylate-4-methyl-5-beta-(ethyladenosine 5'-diphosphate) thiazole, a potential intermediate of the thiazole biosynthesis in Eukaryotes. THI1 has a topology similar to dinucleotide binding domains and although details concerning its function are unknown, this work provides new clues about the thiazole biosynthesis in Eukaryotes.	Univ Sao Paulo, Inst Fis Sao Carlos, Dept Fis & Informat, BR-13560970 Sao Carlos, SP, Brazil; Univ Sao Paulo, Inst Quim Sao Carlos, Dept Quim Fis, BR-13560970 Sao Carlos, SP, Brazil; Univ Sao Paulo, Inst Biociencias, Dept Bot, BR-05508900 Sao Paulo, Brazil; Univ Sao Paulo, Dept Microbiol, Inst Ciencias Biomed, BR-05508900 Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Oliva, G (corresponding author), Univ Sao Paulo, Inst Fis Sao Carlos, Dept Fis & Informat, CP 369, BR-13560970 Sao Carlos, SP, Brazil.	oliva@if.sc.usp.br	Menck, Carlos FM/G-6321-2011; Godoi, Paulo HC/B-9847-2012; Galhardo, Rodrigo/L-2238-2016; Van Sluys, Marie-Anne/A-8483-2012; Oliva, Glaucius/B-9059-2012	Menck, Carlos FM/0000-0003-1941-0694; Godoi, Paulo HC/0000-0003-1859-3513; Galhardo, Rodrigo/0000-0002-5686-9704; Van Sluys, Marie-Anne/0000-0002-6506-2734; Oliva, Glaucius/0000-0003-2719-0302				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carugo O, 1997, PROTEINS, V28, P10, DOI 10.1002/(SICI)1097-0134(199705)28:1<10::AID-PROT2>3.3.CO;2-R; Chatterjee A, 2006, J AM CHEM SOC, V128, P7158, DOI 10.1021/ja061413o; Denessiouk KA, 2001, PROTEINS, V44, P282, DOI 10.1002/prot.1093; DUGAS H, 1996, BIOORG CHEM, P560; Dym O, 2001, PROTEIN SCI, V10, P1712, DOI 10.1110/ps.12801; Faou P, 2004, J MOL BIOL, V344, P1147, DOI 10.1016/j.jmb.2004.09.097; Faou P, 2003, J MOL BIOL, V333, P831, DOI 10.1016/j.jmb.2003.09.003; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JULLIARD JH, 1991, P NATL ACAD SCI USA, V88, P2042, DOI 10.1073/pnas.88.6.2042; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P525, DOI 10.1016/S0076-6879(97)77029-0; Lamzin V. S., 2001, INT TABLES CRYSTALLO, VF, P720; Lawhorn BG, 2004, ORG BIOMOL CHEM, V2, P2538, DOI 10.1039/b405429f; Machado CR, 1997, J MOL BIOL, V273, P114, DOI 10.1006/jmbi.1997.1302; Machado CR, 1996, PLANT MOL BIOL, V31, P585, DOI 10.1007/BF00042231; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Medina-Silva R, 2006, RES MICROBIOL, V157, P275, DOI 10.1016/j.resmic.2005.07.004; Morett E, 2003, NAT BIOTECHNOL, V21, P790, DOI 10.1038/nbt834; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; OGUR M, 1957, SCIENCE, V125, P928, DOI 10.1126/science.125.3254.928; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papini-Terzi FS, 2003, PLANT CELL PHYSIOL, V44, P856, DOI 10.1093/pcp/pcg104; Park JH, 2003, BIOCHEMISTRY-US, V42, P12430, DOI 10.1021/bi034902z; Pearl F, 2005, NUCLEIC ACIDS RES, V33, pD247, DOI 10.1093/nar/gki024; PRAEKELT UM, 1994, YEAST, V10, P481, DOI 10.1002/yea.320100407; SCHENA M, 1991, METHOD ENZYMOL, V194, P389; Settembre EC, 2003, BIOCHEMISTRY-US, V42, P2971, DOI 10.1021/bi026916v; Settembre EC, 2004, BIOCHEMISTRY-US, V43, P11647, DOI 10.1021/bi0488911; Singleton Charles K., 2001, Current Molecular Medicine (Hilversum), V1, P197, DOI 10.2174/1566524013363870; TAZUYA K, 1987, BIOCHIM BIOPHYS ACTA, V924, P210, DOI 10.1016/0304-4165(87)90089-4; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tong L, 1997, METHOD ENZYMOL, V276, P594, DOI 10.1016/S0076-6879(97)76080-4; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; WHITE RL, 1979, BIOCHEM J, V179, P315, DOI 10.1042/bj1790315; WHITE RL, 1982, J AM CHEM SOC, V104, P4934, DOI 10.1021/ja00382a033; Wightman R, 2003, MICROBIOL-SGM, V149, P1447, DOI 10.1099/mic.0.26194-0; Wilkinson A, 2001, MOL MICROBIOL, V40, P1241, DOI 10.1046/j.1365-2958.2001.02479.x; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Xi J, 2001, P NATL ACAD SCI USA, V98, P8513, DOI 10.1073/pnas.141226698	44	44	52	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30957	30966		10.1074/jbc.M604469200	http://dx.doi.org/10.1074/jbc.M604469200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16912043	hybrid			2022-12-27	WOS:000241075900072
J	Mackenzie, J; Pedersen, L; Arent, S; Henriksen, A				Mackenzie, Jenny; Pedersen, Lise; Arent, Susan; Henriksen, Anette			Controlling electron transfer in acyl-CoA oxidases and dehydrogenases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIUM-CHAIN; CRYSTAL-STRUCTURES; BETA-OXIDATION; 3-DIMENSIONAL STRUCTURE; LIVER MITOCHONDRIA; RAT-LIVER; SUBSTRATE; ENZYME; PURIFICATION; MECHANISM	Plants produce a unique peroxisomal short chain-specific acyl-CoA oxidase (ACX4) for beta-oxidation of lipids. The short chain-specific oxidase has little resemblance to other peroxisomal acyl-CoA oxidases but has an similar to 30% sequence identity to mitochondrial acyl-CoA dehydrogenases. Two biochemical features have been linked to structural properties by comparing the structures of short chain-specific Arabidopsis thaliana ACX4 with and without a substrate analogue bound in the active site to known acyl-CoA oxidases and dehydrogenase structures: (i) a solvent-accessible acyl binding pocket is not required for oxygen reactivity, and (ii) the oligomeric state plays a role in substrate pocket architecture but is not linked to oxygen reactivity. The structures indicate that the acyl-CoA oxidases may encapsulate the electrons for transfer to molecular oxygen by blocking the dehydrogenase substrate interaction site with structural extensions. A small binding pocket observed adjoining the flavin adenine dinucleotide N5 and C4a atoms could increase the number of productive encounters between flavin adenine dinucleotide and O-2.	Carlsberg Lab, Biostruct Grp, DK-2500 Copenhagen, Denmark		Henriksen, A (corresponding author), Carlsberg Lab, Biostruct Grp, G Carlsberg Vej 10, DK-2500 Copenhagen, Denmark.	anette@crc.dk		Henriksen, Anette/0000-0003-4051-5079; Pedersen, Lise/0000-0002-0057-208X				Adams PD, 1997, P NATL ACAD SCI USA, V94, P5018, DOI 10.1073/pnas.94.10.5018; Adham AR, 2005, PLANT J, V41, P859, DOI 10.1111/j.1365-313X.2005.02343.x; Andreeva A, 2004, NUCLEIC ACIDS RES, V32, pD226, DOI 10.1093/nar/gkh039; AOYAMA T, 1994, J BIOL CHEM, V269, P19088; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bansal M, 2000, J BIOMOL STRUCT DYN, V17, P811, DOI 10.1080/07391102.2000.10506570; Battaile KP, 2004, J BIOL CHEM, V279, P16526, DOI 10.1074/jbc.M400034200; Battaile KP, 2002, J BIOL CHEM, V277, P12200, DOI 10.1074/jbc.M111296200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Castillo MC, 2004, PLANT PHYSIOL, V135, P85, DOI 10.1104/pp.104.039925; Cuff JA, 1998, BIOINFORMATICS, V14, P892, DOI 10.1093/bioinformatics/14.10.892; De Bellis L, 2000, PLANT PHYSIOL, V123, P327, DOI 10.1104/pp.123.1.327; DJORDJEVIC S, 1995, BIOCHEMISTRY-US, V34, P2163, DOI 10.1021/bi00007a009; Eastmond PJ, 2000, BIOCHEM SOC T, V28, P755, DOI 10.1042/BST0280755; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Enroth C, 2000, P NATL ACAD SCI USA, V97, P10723, DOI 10.1073/pnas.97.20.10723; Fu ZJ, 2004, BIOCHEMISTRY-US, V43, P9674, DOI 10.1021/bi049290c; Ghisla S, 2004, EUR J BIOCHEM, V271, P494, DOI 10.1046/j.1432-1033.2003.03946.x; GHISLA S, 1989, EUR J BIOCHEM, V181, P1, DOI 10.1111/j.1432-1033.1989.tb14688.x; Graham IA, 2002, PROG LIPID RES, V41, P156, DOI 10.1016/S0163-7827(01)00022-4; Hayashi H, 1999, J BIOL CHEM, V274, P12715, DOI 10.1074/jbc.274.18.12715; Hoard-Fruchey HM, 2004, J BIOL CHEM, V279, P13786, DOI 10.1074/jbc.M313914200; Hooks MA, 1999, PLANT J, V20, P1, DOI 10.1046/j.1365-313X.1999.00559.x; IKEDA Y, 1985, J BIOL CHEM, V260, P1326; IZAI K, 1992, J BIOL CHEM, V267, P1027; JIANG ZY, 1983, BIOCHEMISTRY-US, V22, P3752, DOI 10.1021/bi00285a006; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; KIM JJP, 1993, P NATL ACAD SCI USA, V90, P7523, DOI 10.1073/pnas.90.16.7523; KLEYWEGT GJ, 2001, INT TABLES CRYSTALLO, VF; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LASKOWSKI RA, 1995, J MOL GRAPHICS, V13, P323, DOI 10.1016/0263-7855(95)00073-9; Lee HJ, 1996, BIOCHEMISTRY-US, V35, P12412, DOI 10.1021/bi9607867; LESLIE A, 1999, MOSFLM; Li CY, 2005, PLANT CELL, V17, P971, DOI 10.1105/tpc.104.029108; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakajima Y, 2002, J BIOCHEM, V131, P365, DOI 10.1093/oxfordjournals.jbchem.a003111; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Pearson WR, 1996, METHOD ENZYMOL, V266, P227; Pedersen L, 2005, J MOL BIOL, V345, P487, DOI 10.1016/j.jmb.2004.10.062; Pedersen L, 2004, ACTA CRYSTALLOGR D, V60, P1125, DOI 10.1107/S0907444904007577; PEDERSEN L, 2004, THESIS U COPENHAGEN; Satoh A, 2003, J BIOCHEM, V134, P297, DOI 10.1093/jb/mvg143; Souri M, 1998, J BIOL CHEM, V273, P4227, DOI 10.1074/jbc.273.7.4227; Souri M, 1998, FEBS LETT, V426, P187, DOI 10.1016/S0014-5793(98)00343-3; Tiffany KA, 1997, BIOCHEMISTRY-US, V36, P8455, DOI 10.1021/bi970422u; Toogood HS, 2004, J BIOL CHEM, V279, P32904, DOI 10.1074/jbc.M404884200; Umhau S, 2000, P NATL ACAD SCI USA, V97, P12463, DOI 10.1073/pnas.97.23.12463; Vagin AA, 2001, ACTA CRYSTALLOGR D, V57, P1451, DOI 10.1107/S0907444901012409; WANG R, 1991, BIOCHEMISTRY-US, V30, P7895, DOI 10.1021/bi00246a004; WANG R, 1991, ARCH BIOCHEM BIOPHYS, V286, P504, DOI 10.1016/0003-9861(91)90072-Q; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	54	17	18	4	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					31012	31020		10.1074/jbc.M603405200	http://dx.doi.org/10.1074/jbc.M603405200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16887802	hybrid			2022-12-27	WOS:000241075900077
J	Ronnebaum, SM; Ilkayeva, O; Burgess, SC; Joseph, JW; Lu, D; Stevens, RD; Becker, TC; Sherry, AD; Newgard, CB; Jensen, MV				Ronnebaum, Sarah M.; Ilkayeva, Olga; Burgess, Shawn C.; Joseph, Jamie W.; Lu, Danhong; Stevens, Robert D.; Becker, Thomas C.; Sherry, A. Dean; Newgard, Christopher B.; Jensen, Mette V.			A pyruvate cycling pathway involving cytosolic NADP-dependent isocitrate dehydrogenase regulates glucose-stimulated insulin secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; METABOLIC COUPLING FACTORS; NMR ISOTOPOMER ANALYSIS; MALONYL-COA; PENTOSE CYCLE; ISLETS; ANAPLEROSIS; SHUTTLE; MITOCHONDRIA; SUPPRESSION	Glucose-stimulated insulin secretion (GSIS) from pancreatic islet beta-cells is central to control of mammalian fuel homeostasis. Glucose metabolism mediates GSIS in part via ATP-regulated K+ (K-ATP) channels, but multiple lines of evidence suggest participation of other signals. Here we investigated the role of cytosolic NADP-dependent isocitrate dehydrogenase (ICDc) in control of GSIS in beta-cells. Delivery of small interfering RNAs specific for ICDc caused impairment of GSIS in two independent robustly glucose-responsive rat insulinoma (INS-1-derived) cell lines and in primary rat islets. Suppression of ICDc also attenuated the glucose-induced increments in pyruvate cycling activity and in NADPH levels, a predicted by-product of pyruvate cycling pathways, as well as the total cellular NADP( H) content. Metabolic profiling of eight organic acids in cell extracts revealed that suppression of ICDc caused increases in lactate production in both INS-1-derived cell lines and primary islets, consistent with the attenuation of pyruvate cycling, with no significant changes in other intermediates. Based on these studies, we propose that a pyruvate cycling pathway involving ICDc plays an important role in control of GSIS.	Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27704 USA; Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27704 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27704 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27704 USA; Univ Texas, SW Med Ctr, Ralph & Mary Nell Rogers NMR Ctr, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Adv Imaging Res Ctr, Dept Radiol, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75235 USA	Duke University; Duke University; Duke University; Duke University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Newgard, CB (corresponding author), Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Independence Pk Facil,4321 Med Pk Dr,Ste 200, Durham, NC 27704 USA.	newga002@mc.duke.edu	; Sherry, Dean/P-2348-2018	Ronnebaum, Sarah/0000-0003-4787-754X; Sherry, Dean/0000-0001-7150-8301	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK058398] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK42583, DK58398] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Amin R, 2002, J PHARMACOL EXP THER, V303, P82, DOI 10.1124/jpet.102.036160; Antinozzi PA, 1998, J BIOL CHEM, V273, P16146, DOI 10.1074/jbc.273.26.16146; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; ASHCROFT F M, 1991, Current Opinion in Cell Biology, V3, P671, DOI 10.1016/0955-0674(91)90040-6; ASHCROFT SJ, 1972, BIOCHEM J, V126, P525, DOI 10.1042/bj1260525; Bain JR, 2004, DIABETES, V53, P2190, DOI 10.2337/diabetes.53.9.2190; Boucher A, 2004, J BIOL CHEM, V279, P27263, DOI 10.1074/jbc.M401167200; Brun T, 1996, DIABETES, V45, P190, DOI 10.2337/diabetes.45.2.190; Chouinard SW, 2000, RECEPTOR CHANNEL, V7, P237; Cline GW, 2004, J BIOL CHEM, V279, P44370, DOI 10.1074/jbc.M311842200; CORKEY BE, 1989, J BIOL CHEM, V264, P21608; Corkey BE, 2000, J NUTR, V130, p299S, DOI 10.1093/jn/130.2.299S; Eto K, 1999, SCIENCE, V283, P981, DOI 10.1126/science.283.5404.981; Farfari S, 2000, DIABETES, V49, P718, DOI 10.2337/diabetes.49.5.718; Henquin JC, 2004, DIABETES, V53, pS48, DOI 10.2337/diabetes.53.suppl_3.S48; Herrero L, 2005, DIABETES, V54, P462, DOI 10.2337/diabetes.54.2.462; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; HUGHES SD, 1993, J BIOL CHEM, V268, P15205; Ivarsson R, 2005, DIABETES, V54, P2132, DOI 10.2337/diabetes.54.7.2132; Jensen MV, 2006, J BIOL CHEM, V281, P22342, DOI 10.1074/jbc.M604350200; Khan A, 1996, J BIOL CHEM, V271, P2539, DOI 10.1074/jbc.271.5.2539; Kim JY, 2002, AM J PHYSIOL-ENDOC M, V282, pE1014, DOI 10.1152/ajpendo.00233.2001; Lee SH, 2004, INT J RADIAT BIOL, V80, P635, DOI 10.1080/09553000400007680; Lee SM, 2002, FREE RADICAL BIO MED, V32, P1185, DOI 10.1016/S0891-5849(02)00815-8; Liu YQ, 2002, J BIOL CHEM, V277, P39163, DOI 10.1074/jbc.M207157200; Lu DH, 2002, P NATL ACAD SCI USA, V99, P2708, DOI 10.1073/pnas.052005699; MacDonald MJ, 2000, J BIOL CHEM, V275, P34025, DOI 10.1074/jbc.C000411200; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; MACDONALD MJ, 1992, HORM METAB RES, V24, P158, DOI 10.1055/s-2007-1003284; MACDONALD MJ, 1993, ARCH BIOCHEM BIOPHYS, V305, P205, DOI 10.1006/abbi.1993.1413; MacDonald MJ, 2003, METABOLISM, V52, P993, DOI 10.1016/S0026-0495(03)00149-5; MacDonald MJ, 2003, BBA-GEN SUBJECTS, V1619, P77, DOI 10.1016/S0304-4165(02)00443-9; MacDonald MJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE302, DOI 10.1152/ajpendo.00041.2002; MacDonald PE, 2003, DIABETOLOGIA, V46, P1046, DOI 10.1007/s00125-003-1159-8; MacDonald PE, 2003, J PHYSIOL-LONDON, V546, P647, DOI 10.1113/jphysiol.2002.035709; Maechler P, 1999, NATURE, V402, P685, DOI 10.1038/45280; MILBURN JL, 1995, J BIOL CHEM, V270, P1295, DOI 10.1074/jbc.270.3.1295; Minich T, 2003, J NEUROCHEM, V86, P605, DOI 10.1046/j.1471-4159.2003.01871.x; Mulder H, 2001, J BIOL CHEM, V276, P6479, DOI 10.1074/jbc.M010364200; NABER SP, 1980, DIABETOLOGIA, V19, P439, DOI 10.1007/BF00281823; Newgard CB, 2002, DIABETES, V51, pS389, DOI 10.2337/diabetes.51.2007.S389; NEWGARD CB, 1995, ANNU REV BIOCHEM, V64, P689, DOI 10.1146/annurev.biochem.64.1.689; Passonneau J.V., 1993, ENZYMATIC ANAL PRACT; PRENTKI M, 1992, J BIOL CHEM, V267, P5802; Rabaglia ME, 2005, AM J PHYSIOL-ENDOC M, V289, pE218, DOI 10.1152/ajpendo.00573.2004; Ramanadham S, 2002, BBA-MOL CELL BIOL L, V1580, P40, DOI 10.1016/S1388-1981(01)00189-5; Schisler JC, 2005, P NATL ACAD SCI USA, V102, P7297, DOI 10.1073/pnas.0502168102; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; SNYDER PJ, 1970, AM J PHYSIOL, V219, P876, DOI 10.1152/ajplegacy.1970.219.4.876; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329; WATKINS DT, 1977, ENDOCRINOLOGY, V100, P1461, DOI 10.1210/endo-100-5-1461	52	179	181	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30593	30602		10.1074/jbc.M511908200	http://dx.doi.org/10.1074/jbc.M511908200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16912049	hybrid			2022-12-27	WOS:000241075900035
J	Shulga, N; Pastorino, JG				Shulga, Nataly; Pastorino, John G.			Acyl coenzyme A-binding protein augments Bid-induced mitochondrial damage and cell death by activating mu-calpain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; INDUCED APOPTOSIS; BCL-2 FAMILY; PERMEABILITY TRANSITION; BAX; CLEAVAGE; ISCHEMIA/REPERFUSION; RETICULUM; RECEPTORS; PATHWAYS	Activation of calpain has been shown to occur in some contexts of cell injury and to be essential for loss of cell viability. Part of this may be mediated at the mitochondrial level. It has been demonstrated that calpain activity is necessary for the complete discharge of apoptosis-inducing factor from the mitochondrial intermembrane space and can cause the cleavage of full-length Bid to a more potent truncated form (Polster, B. M., Basanez, G., Etxebarria, A., Hardwick, J. M., and Nicholls, D. G. ( 2005) J. Biol. Chem. 280, 6447 - 6454). In this study, we identify acyl-CoA-binding protein ( ACBP) as playing a critical role in the activation of calpain upon exposure of mitochondria to both full-length Bid and truncated Bid (t-Bid). Suppression of ACBP levels by small interfering RNA inhibited the t-Bid-induced activation of mitochondrial mu-calpain and release of apoptosis-inducing factor from the mitochondrial intermembrane space and the cleavage of full-length Bid to t-Bid. Moreover, ACBP required the presence of the peripheral benzodiazepine receptor ( for which ACBP is a ligand) to be retained at the mitochondria, to activate mu-calpain, and to amplify Bid-induced mitochondrial damage.	Thomas Jefferson Univ, Dept Pathol, Philadelphia, PA 19107 USA	Jefferson University	Pastorino, JG (corresponding author), Thomas Jefferson Univ, Dept Pathol, Jefferson Alumni Hall,Rm 272,1020 Locust St, Philadelphia, PA 19107 USA.	John.Pastorino@jefferson.edu			NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K01AA000330, R01AA012897] Funding Source: NIH RePORTER; NIAAA NIH HHS [1R01 AA012897-05, 5K01 AA000330-05] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Beurdeley-Thomas A, 2000, J NEURO-ONCOL, V46, P45, DOI 10.1023/A:1006456715525; Cartron PF, 2003, MOL CELL BIOL, V23, P4701, DOI 10.1128/MCB.23.13.4701-4712.2003; Chen M, 2001, J BIOL CHEM, V276, P30724, DOI 10.1074/jbc.M103701200; Chen M, 2002, J BIOL CHEM, V277, P29181, DOI 10.1074/jbc.M204951200; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Fulceri R, 1997, BIOCHEM J, V325, P423, DOI 10.1042/bj3250423; Garcia M, 2005, BIOCHEM BIOPH RES CO, V338, P1241, DOI 10.1016/j.bbrc.2005.10.081; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; KNUDSEN J, 1993, MOL CELL BIOCHEM, V123, P129, DOI 10.1007/BF01076484; Korsmeyer SJ, 2000, CELL DEATH DIFFER, V7, P1166, DOI 10.1038/sj.cdd.4400783; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Lorenzo HK, 1999, CELL DEATH DIFFER, V6, P516, DOI 10.1038/sj.cdd.4400527; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Lutter M, 2001, BMC CELL BIOL, V2, DOI 10.1186/1471-2121-2-22; Mandic A, 2002, MOL CELL BIOL, V22, P3003, DOI 10.1128/MCB.22.9.3003-3013.2002; Melloni E, 2000, J BIOL CHEM, V275, P82, DOI 10.1074/jbc.275.1.82; Neess D, 2006, MOL CELL BIOCHEM, V284, P149, DOI 10.1007/s11010-005-9039-9; Papadopoulos V, 1997, STEROIDS, V62, P21, DOI 10.1016/S0039-128X(96)00154-7; Petrescu AD, 2003, J BIOL CHEM, V278, P51813, DOI 10.1074/jbc.M303858200; Polster BM, 2005, J BIOL CHEM, V280, P6447, DOI 10.1074/jbc.M413269200; Reed JC, 1998, BBA-BIOENERGETICS, V1366, P127, DOI 10.1016/S0005-2728(98)00108-X; Rostovtseva TK, 2004, J BIOL CHEM, V279, P13575, DOI 10.1074/jbc.M310593200; ROUCOU X, 2000, BIOCHEM J, V368, P915; Tafani M, 2002, J BIOL CHEM, V277, P10073, DOI 10.1074/jbc.M111350200; Takano J, 2005, J BIOL CHEM, V280, P16175, DOI 10.1074/jbc.M414552200; Tan YF, 2006, J BIOL CHEM, V281, P16016, DOI 10.1074/jbc.M601299200; Tan Y, 2006, J BIOL CHEM, V281, P17689, DOI 10.1074/jbc.M601978200; Tsujimoto Y, 2000, FEBS LETT, V466, P6, DOI 10.1016/S0014-5793(99)01761-5; Van Loo G, 2002, CELL DEATH DIFFER, V9, P301, DOI 10.1038/sj.cdd.4400966; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Waterhouse NJ, 1998, CELL DEATH DIFFER, V5, P1051, DOI 10.1038/sj.cdd.4400425; Wood DE, 1998, ONCOGENE, V17, P1069, DOI 10.1038/sj.onc.1202034; Yin XM, 2006, GENE, V369, P7, DOI 10.1016/j.gene.2005.10.038; Zamzami N, 2000, ONCOGENE, V19, P6342, DOI 10.1038/sj.onc.1204030	34	28	28	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30824	30833		10.1074/jbc.M602503200	http://dx.doi.org/10.1074/jbc.M602503200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16908521	hybrid			2022-12-27	WOS:000241075900058
J	Wang, W; Kirsch, T				Wang, Wei; Kirsch, Thorsten			Annexin V/beta 5 integrin interactions regulate apoptosis of growth plate chondrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; HORMONE-RELATED PEPTIDE; PROGRAMMED CELL-DEATH; ANNEXIN-V; ARTICULAR-CARTILAGE; ENDOCHONDRAL OSSIFICATION; TERMINAL DIFFERENTIATION; OSTEOARTHRITIC CARTILAGE; MATRIX VESICLES; PKC-ALPHA	Apoptosis of terminally differentiated chondrocytes allows the replacement of growth plate cartilage by bone. Despite its importance, little is known about the regulation of chondrocyte apoptosis. We show that overexpression of annexin V, which binds to the cytoplasmic domain of beta 5 integrin and protein kinase C alpha(PKC alpha), stimulates apoptotic events in hypertrophic growth plate chondrocytes. To determine whether the balance between the interactions of annexin V/beta 5 integrin and annexin V/active PKC alpha play a role in the regulation of terminally differentiated growth plate chondrocyte apoptosis, a peptide mimic of annexin V ( Penetratin (Pen)-VVISYSMPD) that binds to beta 5 integrin but not to PKC alpha was used. This peptide stimulated apoptotic events in growth plate chondrocytes. Suppression of annexin V expression using small interfering ribonucleic acid decreased caspase-3 activity and increased cell viability in Pen-VVISYSMPD-treated growth plate chondrocytes. An activator of PKC resulted in a further decrease of cell viability and further increase of caspase-3 activity in Pen-VVISYSMPD-treated growth plate chondrocytes, whereas inhibitors of PKC alpha led to an increase of cell viability and decrease of caspase-3 activity of Pen-VVISYSMPD-treated cells. These findings suggest that binding of annexin V to active PKC alpha stimulates apoptotic events in growth plate chondrocytes and that binding of annexin V to beta 5 integrin controls these interactions and ultimately apoptosis.	Univ Maryland, Dept Orthoped, Sch Med, Musculoskeletal Res Labs, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Kirsch, T (corresponding author), Univ Maryland, Dept Orthoped, Sch Med, Musculoskeletal Res Labs, 20 Penn St HSFII S003D, Baltimore, MD 21201 USA.	tkirsch@umoa.umm.edu	Kirsch, Thorsten/GQP-1157-2022		NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049074, R01AR046245] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR049074, AR046245] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Amizuka N, 1996, ENDOCRINOLOGY, V137, P5055, DOI 10.1210/en.137.11.5055; Amling M, 1997, J CELL BIOL, V136, P205, DOI 10.1083/jcb.136.1.205; ANNEFELD M, 1992, PATHOL RES PRACT, V188, P649, DOI 10.1016/S0344-0338(11)80073-7; Blanco FJ, 1998, ARTHRITIS RHEUM, V41, P284, DOI 10.1002/1529-0131(199802)41:2<284::AID-ART12>3.0.CO;2-T; Cardo-Vila M, 2003, MOL CELL, V11, P1151, DOI 10.1016/S1097-2765(03)00138-2; Chen CT, 2001, J ORTHOPAED RES, V19, P703, DOI 10.1016/S0736-0266(00)00066-8; Chrysis D, 2003, J ENDOCRINOL, V176, P331, DOI 10.1677/joe.0.1760331; de Thonel A, 2001, BLOOD, V98, P3770, DOI 10.1182/blood.V98.13.3770; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; DiazMeco MT, 1996, CELL, V86, P777, DOI 10.1016/S0092-8674(00)80152-X; Dubois T, 1998, BIOCHEM J, V330, P1277, DOI 10.1042/bj3301277; Gibson G, 1998, MICROSC RES TECHNIQ, V43, P191, DOI 10.1002/(SICI)1097-0029(19981015)43:2<191::AID-JEMT10>3.0.CO;2-T; GIBSON GJ, 1995, DEV DYNAM, V203, P468, DOI 10.1002/aja.1002030409; Hashimoto S, 1998, ARTHRITIS RHEUM-US, V41, P1266, DOI 10.1002/1529-0131(199807)41:7<1266::AID-ART18>3.0.CO;2-Y; HATORI M, 1995, J BONE MINER RES, V10, P1960, DOI 10.1002/jbmr.5650101216; Hausler G, 2002, CALCIFIED TISSUE INT, V71, P212, DOI 10.1007/s00223-001-2083-x; Herr C, 2001, MOL CELL BIOL, V21, P4119, DOI 10.1128/MCB.21.13.4119-4128.2001; Horton WE, 1998, MATRIX BIOL, V17, P107, DOI 10.1016/S0945-053X(98)90024-5; Huang XZ, 2000, MOL CELL BIOL, V20, P755, DOI 10.1128/MCB.20.3.755-759.2000; HUGHES S, 1984, VIROLOGY, V136, P89, DOI 10.1016/0042-6822(84)90250-2; Jao HC, 2001, SHOCK, V15, P130, DOI 10.1097/00024382-200115020-00009; Johnson KA, 2005, J BIOL CHEM, V280, P15004, DOI 10.1074/jbc.M500962200; Kim SJ, 2002, J BIOL CHEM, V277, P30375, DOI 10.1074/jbc.M205193200; Kirsch T, 2000, OSTEOARTHR CARTILAGE, V8, P294, DOI 10.1053/joca.1999.0304; Kirsch T, 1997, J CELL BIOL, V137, P1149, DOI 10.1083/jcb.137.5.1149; Kirsch T, 2003, J BONE MINER RES, V18, P1872, DOI 10.1359/jbmr.2003.18.10.1872; Le Gat L, 2001, CELL COMMUN ADHES, V8, P99; Legeai-Mallet L, 1998, J BIOL CHEM, V273, P13007, DOI 10.1074/jbc.273.21.13007; Mollenhauer J, 1999, J HISTOCHEM CYTOCHEM, V47, P209, DOI 10.1177/002215549904700209; Nakashima S, 2002, J BIOCHEM, V132, P669, DOI 10.1093/oxfordjournals.jbchem.a003272; Ostergaard K, 1998, ANN RHEUM DIS, V57, P303, DOI 10.1136/ard.57.5.303; ROTHHUT B, 1995, EUR J BIOCHEM, V232, P865; SCHLAEPFER DD, 1992, BIOCHEMISTRY-US, V31, P1886, DOI 10.1021/bi00121a043; Spitaler M, 1999, ANTICANCER RES, V19, P3969; Srivastava M, 1999, P NATL ACAD SCI USA, V96, P13783, DOI 10.1073/pnas.96.24.13783; Tchetina EV, 2005, J RHEUMATOL, V32, P876; Wang W, 2003, J BIOL CHEM, V278, P3762, DOI 10.1074/jbc.M208868200; Wang W, 2002, J CELL BIOL, V157, P1061, DOI 10.1083/jcb.200203014; Wang W, 2005, EXP CELL RES, V305, P156, DOI 10.1016/j.yexcr.2004.12.022	39	31	35	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30848	30856		10.1074/jbc.M605937200	http://dx.doi.org/10.1074/jbc.M605937200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16914549	hybrid			2022-12-27	WOS:000241075900060
J	Franco, R; Cidlowski, JA				Franco, Rodrigo; Cidlowski, John A.			SLCO/OATP-like transport of glutathione in FasL-induced apoptosis - Glutathione efflux is coupled to an organic anion exchange and is necessary for the progression of the execution phase of apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; REDUCED GLUTATHIONE; INTRACELLULAR GLUTATHIONE; CELL-DEATH; MEMBRANE-TRANSPORT; REDOX-REGULATION; MEDIATED APOPTOSIS; VOLUME DECREASE; LEUKEMIA-CELLS; GSH EXTRUSION	Apoptosis is characterized by the activation of specific biochemical pathways that lead to the organized demise of cells. Intracellular GSH depletion has been observed during apoptosis; however, neither the mechanisms involved in the reduction of the intracellular GSH concentration, [ GSH] i, nor its link to the progression of apoptosis have been elucidated. We have studied this issue using Fas ligand ( FasL)- induced apoptosis in Jurkat cells where changes in [GSH](i) can be analyzed biochemically and at the single cell level by flow cytometry. A reduction in the total [ GSH](i) in response to FasL occurs in two distinct stages prior to the loss of membrane integrity. Jurkat cells express several members of the multidrug resistance protein ( ABCC/ MRP), and the organic anion- transporting polypeptide protein ( SLCO/ OATP) families of GSH efflux pumps at the mRNAlevel. Glutathione loss and its accumulation in the extracellular medium, induced by FasL, was trans- stimulated by the organic substrates MK571, probenecid, taurocholic acid, estrone sulfate, and bromosulfophthalein and inhibited by high concentrations of extracellular GSH. Single cell analysis demonstrated that intracellular GSH loss was paralleled by the activation of an organic anion uptake process, supporting the role of an anion exchange mechanism ( SLCO/ OATP- like transport) in GSH efflux induced by FasL. Additionally, high extracellular GSH inhibited the activation of the execution caspases, the cleavage of their substrates poly(ADP-ribose) polymerase ( PARP) and alpha-fodrin, and DNA degradation. In contrast, the trans- stimulation of GSH efflux by MK571 increased the cleavage of the execution caspases and their substrates. Together these results suggest that GSH efflux during FasL- induced apoptosis is mediated by a SLCO/ OATP- like transport mechanism that modulates the progression of the execution phase of apoptosis.	NIEHS, Lab Signal Transduct, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Cidlowski, JA (corresponding author), NIEHS, Lab Signal Transduct, NIH, POB 12233,111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	cidlows1@mail.nih.gov	Cidlowski, John A/G-2548-2019; Franco, Rodrigo/D-9470-2013	Cidlowski, John A/0000-0003-1420-0516; Franco, Rodrigo/0000-0003-3241-8615	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES090079, Z01ES090079, Z01ES090057, ZIAES090057] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Adachi H, 2003, AM J PHYSIOL-RENAL, V285, pF1188, DOI 10.1152/ajprenal.00402.2002; Armstrong JS, 2002, FASEB J, V16, P1263, DOI 10.1096/fj.02-0097fje; Ballatori N, 2005, TOXICOL APPL PHARM, V204, P238, DOI 10.1016/j.taap.2004.09.008; Benlloch M, 2005, J BIOL CHEM, V280, P6950, DOI 10.1074/jbc.M408531200; Bortner CD, 2004, PFLUG ARCH EUR J PHY, V448, P313, DOI 10.1007/s00424-004-1266-5; Bortner CD, 2002, CELL DEATH DIFFER, V9, P1307, DOI 10.1038/sj.cdd.4401126; Chiba T, 1996, EUR J IMMUNOL, V26, P1164, DOI 10.1002/eji.1830260530; Cihlar T, 2000, ANAL BIOCHEM, V283, P49, DOI 10.1006/abio.2000.4633; Clarke G, 2001, HUM MOL GENET, V10, P2269, DOI 10.1093/hmg/10.20.2269; Coppola S, 2000, BIOCHEM SOC T, V28, P56, DOI 10.1042/bst0280056; Curtin JF, 2003, CELL SIGNAL, V15, P983, DOI 10.1016/S0898-6568(03)00093-7; Davis W, 2001, J PHARMACOL EXP THER, V296, P1; Echevarria-Lima J, 2005, IMMUNOLOGY, V114, P468, DOI 10.1111/j.1365-2567.2005.02116.x; FERNANDEZ A, 1995, J IMMUNOL, V155, P5133; Franklin CC, 2002, AM J PATHOL, V160, P1887, DOI 10.1016/S0002-9440(10)61135-2; Friesen C, 2004, CELL DEATH DIFFER, V11, pS73, DOI 10.1038/sj.cdd.4401431; GARCIARUIZ C, 1992, J BIOL CHEM, V267, P22256; Ghibelli L, 1998, FASEB J, V12, P479, DOI 10.1096/fasebj.12.6.479; Green DR, 2003, IMMUNOL REV, V193, P5, DOI 10.1034/j.1600-065X.2003.00045.x; Hagenbuch B, 2004, PFLUG ARCH EUR J PHY, V447, P653, DOI 10.1007/s00424-003-1168-y; Hall AG, 1999, ADV EXP MED BIOL, V457, P199; Hammond CL, 2004, TOXICOL APPL PHARM, V195, P12, DOI 10.1016/j.taap.2003.10.008; Hammond CL, 2001, J HEPATOL, V34, P946, DOI 10.1016/S0168-8278(01)00037-X; Haouzi D, 2001, HEPATOLOGY, V33, P1181, DOI 10.1053/jhep.2001.24235; He YY, 2003, J BIOL CHEM, V278, P8058, DOI 10.1074/jbc.M207781200; HEDLEY DW, 1994, CYTOMETRY, V15, P349, DOI 10.1002/cyto.990150411; Hentze H, 2003, TOXICOL LETT, V139, P111, DOI 10.1016/S0378-4274(02)00425-3; Hentze H, 2002, J BIOL CHEM, V277, P5588, DOI 10.1074/jbc.M110766200; Homolya L, 2003, BIOFACTORS, V17, P103, DOI 10.1002/biof.5520170111; Keppler D, 1999, FREE RADICAL BIO MED, V27, P985, DOI 10.1016/S0891-5849(99)00171-9; Kern JC, 2005, FRONT BIOSCI-LANDMRK, V10, P1727, DOI 10.2741/1656; Kohno T, 1996, J IMMUNOL, V156, P4722; Lee TK, 2001, TOXICOL APPL PHARM, V174, P207, DOI 10.1006/taap.2001.9208; Li LQ, 2000, MOL PHARMACOL, V58, P335, DOI 10.1124/mol.58.2.335; Li LQ, 1998, J BIOL CHEM, V273, P16184, DOI 10.1074/jbc.273.26.16184; Macho A, 1997, J IMMUNOL, V158, P4612; Marchetti P, 1997, EUR J IMMUNOL, V27, P289, DOI 10.1002/eji.1830270142; Martel J, 1997, LEUKEMIA RES, V21, P1077, DOI 10.1016/S0145-2126(97)00063-5; Miller DS, 1996, AM J PHYSIOL-RENAL, V271, pF508, DOI 10.1152/ajprenal.1996.271.3.F508; Perl A, 2002, ANTIOXID REDOX SIGN, V4, P427, DOI 10.1089/15230860260196227; Pompella A, 2003, BIOCHEM PHARMACOL, V66, P1499, DOI 10.1016/S0006-2952(03)00504-5; Raaijmakers HGP, 2002, CYTOMETRY, V49, P135, DOI 10.1002/cyto.10157; Rius M, 2003, HEPATOLOGY, V38, P374, DOI 10.1053/jhep.2003.50331; Russel FGM, 2002, ANNU REV PHYSIOL, V64, P563, DOI 10.1146/annurev.physiol.64.081501.155913; Salerno M, 2004, BIOCHEM PHARMACOL, V68, P2159, DOI 10.1016/j.bcp.2004.08.010; Sebastia J, 2003, CYTOM PART A, V51A, P16, DOI 10.1002/cyto.a.10003; SOMMER F, 1994, J IMMUNOL, V153, P3523; Sykes D, 2004, AM J PHYSIOL-RENAL, V286, pF972, DOI 10.1152/ajprenal.00356.2003; SZE G, 1993, AM J PHYSIOL, V265, pG1128, DOI 10.1152/ajpgi.1993.265.6.G1128; Ueda S, 1998, J IMMUNOL, V161, P6689; vandenDobbelsteen DJ, 1996, J BIOL CHEM, V271, P15420, DOI 10.1074/jbc.271.26.15420; Varghese J, 2003, APOPTOSIS, V8, P363, DOI 10.1023/A:1024121017841; William R, 1997, BLOOD, V89, P4175, DOI 10.1182/blood.V89.11.4175; Zamek-Gliszczynski MJ, 2003, J PHARMACOL EXP THER, V304, P801, DOI 10.1124/jpet.102.044107	54	92	93	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					29542	29557		10.1074/jbc.M602500200	http://dx.doi.org/10.1074/jbc.M602500200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16857677	hybrid			2022-12-27	WOS:000240896300016
J	Graille, M; Baltaze, JP; Leulliot, N; Liger, D; Quevillon-Cheruel, S; van Tilbeurgh, H				Graille, Marc; Baltaze, Jean-Pierre; Leulliot, Nicolas; Liger, Dominique; Quevillon-Cheruel, Sophie; van Tilbeurgh, Herman			Structure-based functional annotation - Yeast YMR099c codes for a D-hexose-6-phosphate mutarotase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNTHASE-COMPLEMENTING PROTEIN; HUMAN GALACTOSE METABOLISM; X-RAY STRUCTURE; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; GLUCOSE-6-PHOSPHATE 1-EPIMERASE; ANOMERIC SPECIFICITY; ANGSTROM RESOLUTION; LACTOCOCCUS-LACTIS	Despite the generation of a large amount of sequence information over the last decade, more than 40% of well characterized enzymatic functions still lack associated protein sequences. Assigning protein sequences to documented biochemical functions is an interesting challenge. We illustrate here that structural genomics may be a reasonable approach in addressing these questions. We present the crystal structure of the Saccharomyces cerevisiae YMR099cp, a protein of unknown function. YMR099cp adopts the same fold as galactose mutarotase and shares the same catalytic machinery necessary for the interconversion of the alpha and beta anomers of galactose. The structure revealed the presence in the active site of a sulfate ion attached by an arginine clamp made by the side chain from two strictly conserved arginine residues. This sulfate is ideally positioned to mimic the phosphate group of hexose 6-phosphate. We have subsequently successfully demonstrated that YMR099cp is a hexose-6-phosphate mutarotase with broad substrate specificity. We solved high resolution structures of some substrate enzyme complexes, further confirming our functional hypothesis. The metabolic role of a hexose-6-phosphate mutarotase is discussed. This work illustrates that structural information has been crucial to assign YMR099cp to the orphan EC activity: hexose-phosphate mutarotase.	Univ Paris 11, Inst Biochim & Biophys Mol & Cellulaire, CNRS, UMR 8619,IFR115, F-91405 Orsay, France; Univ Paris 11, Inst Chim Mol & Mat, CNRS, UMR 8182, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay	van Tilbeurgh, H (corresponding author), Univ Paris 11, Inst Biochim & Biophys Mol & Cellulaire, CNRS, UMR 8619,IFR115, F-91405 Orsay, France.	Herman.Van-Tilbeurgh@ibbmc.u-psud.fr	Leulliot, Nicolas/AAA-7160-2019; GRAILLE, Marc/D-3242-2014	Leulliot, Nicolas/0000-0003-0283-4298; GRAILLE, Marc/0000-0002-7853-5852				Assairi L, 2004, PROTEIN SCI, V13, P1295, DOI 10.1110/ps.03566004; CHANCE EM, 1975, EUR J BIOCHEM, V50, P419, DOI 10.1111/j.1432-1033.1975.tb09818.x; Chen Y, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-12; de la Sierra IL, 2001, J MOL BIOL, V311, P87, DOI 10.1006/jmbi.2001.4843; de La Sierra-Gallay IL, 2004, PROTEINS, V54, P776, DOI 10.1002/prot.10596; Egloff MP, 2001, STRUCTURE, V9, P689, DOI 10.1016/S0969-2126(01)00626-8; Frey PA, 1996, FASEB J, V10, P461, DOI 10.1096/fasebj.10.4.8647345; Hazbun TR, 2003, MOL CELL, V12, P1353, DOI 10.1016/S1097-2765(03)00476-3; Holden HM, 2003, J BIOL CHEM, V278, P43885, DOI 10.1074/jbc.R300025200; HOWARD SM, 1965, ARCH BIOCHEM BIOPHYS, V110, P395, DOI 10.1016/0003-9861(65)90140-2; JACOBSON RH, 1994, NATURE, V369, P761, DOI 10.1038/369761a0; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Karp PD, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-401; Kuhn P, 2002, PROTEINS, V49, P142, DOI 10.1002/prot.10202; Lespinet O, 2005, SCIENCE, V307, P42; LIVINGSTONE G, 1977, J SOLUTION CHEM, V6, P203, DOI 10.1007/BF00646739; Majumdar S, 2004, EUR J BIOCHEM, V271, P753, DOI 10.1111/j.1432-1033.2003.03974.x; Mathews II, 2003, STRUCTURE, V11, P677, DOI 10.1016/S0969-2126(03)00097-2; Meyer B, 2003, ANGEW CHEM INT EDIT, V42, P864, DOI 10.1002/anie.200390233; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NOGAE I, 1990, GENE, V96, P161, DOI 10.1016/0378-1119(90)90248-P; Novelli G, 2000, MOL GENET METAB, V71, P62, DOI 10.1006/mgme.2000.3073; PAULY HE, 1975, H-S Z PHYSIOL CHEM, V356, P1613, DOI 10.1515/bchm2.1975.356.2.1613; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Petry KG, 1998, TRENDS GENET, V14, P98, DOI 10.1016/S0168-9525(97)01379-6; Quevillon-Cheruel S, 2004, BIOCHIMIE, V86, P617, DOI 10.1016/j.biochi.2004.09.013; Roberts RJ, 2004, PLOS BIOL, V2, P293, DOI 10.1371/journal.pbio.0020042; ROSE IA, 1973, J BIOL CHEM, V248, P2232; Ryu KS, 2005, J MOL BIOL, V349, P153, DOI 10.1016/j.jmb.2005.03.047; Ryu KS, 2004, J AM CHEM SOC, V126, P9180, DOI 10.1021/ja047911j; Ryu KS, 2004, J BIOL CHEM, V279, P25544, DOI 10.1074/jbc.M402016200; SALAS M, 1965, J BIOL CHEM, V240, P561; Schuldiner O, 1998, CURR GENET, V33, P16, DOI 10.1007/s002940050303; Takaku H, 2003, NUCLEIC ACIDS RES, V31, P2272, DOI 10.1093/nar/gkg337; Thoden JB, 2005, J BIOL CHEM, V280, P21900, DOI 10.1074/jbc.M502411200; Thoden JB, 2004, J BIOL CHEM, V279, P23431, DOI 10.1074/jbc.M402347200; Thoden JB, 2003, PROTEIN SCI, V12, P1051, DOI 10.1110/ps.0243203; Thoden JB, 2002, J BIOL CHEM, V277, P20854, DOI 10.1074/jbc.M201415200; Thoden JB, 2002, J BIOL CHEM, V277, P45458, DOI 10.1074/jbc.M208395200; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; WURSTER B, 1972, FEBS LETT, V23, P341, DOI 10.1016/0014-5793(72)80311-9; WURSTER B, 1974, H-S Z PHYSIOL CHEM, V355, P255, DOI 10.1515/bchm2.1974.355.1.255; Wurster B, 1975, Methods Enzymol, V41, P488	43	21	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					30175	30185		10.1074/jbc.M604443200	http://dx.doi.org/10.1074/jbc.M604443200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16857670	Green Published, hybrid			2022-12-27	WOS:000240896300078
J	Yegutkin, GG; Samburski, SS; Jalkanen, S; Novak, I				Yegutkin, Gennady G.; Samburski, Sergei S.; Jalkanen, Sirpa; Novak, Ivana			ATP-consuming and ATP-generating enzymes secreted by pancreas	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOSIDE DIPHOSPHOKINASE; PHOSPHOTRANSFER REACTIONS; CONFOCAL MICROSCOPY; ENDOTHELIAL-CELLS; EXOCRINE PANCREAS; ADENYLATE KINASE; AIRWAY SURFACES; RAT PANCREAS; DIPHOSPHOHYDROLASE; IDENTIFICATION	Pancreatic acini release ATP in response to various stimuli, including cholecystokinin octapeptide (CCK-8), as we show in the present study. There were indications that pancreatic juice also contains enzymes that could hydrolyze ATP during its passage through the ductal system. The aim of this study was to determine which ATP-degrading and possibly ATP-generating enzymes were present in pancreatic secretion. For this purpose, pancreatic juice was collected from anesthetized rats stimulated with infusion of CCK-8. Purine-converting activities in juice samples were assayed by TLC using either [gamma-P-32] ATP or C-14/H-3-labeled and unlabeled nucleotides as appropriate substrates. Data show that the juice contains the enzyme ecto-nucleoside triphosphate diphosphohydrolase that can hydrolyze both [C-14]ATP and [H-3]ADP about equally well, i.e. CD39. Reverse-phase high-performance liquid chromatography analysis additionally shows that this enzyme has broad substrate specificity toward other nucleotides, UTP, UDP, ITP, and IDP. In addition, secretion contains ecto-5'-nucleotidase, CD73, further converting [H-3]AMP to adenosine. Along with highly active hydrolytic enzymes, there were also ATP-generating enzymes in pancreatic juice, adenylate kinase, and NDP kinase, capable of sequentially phosphorylating AMP via ADP to ATP. Activities of nonspecific phosphatases, nucleotide pyrophosphatase/phosphodiesterases, and adenosine deaminase were negligible. Taken together, CCK-8 stimulation of pancreas causes release of both ATP-consuming and ATP-generating enzymes into pancreatic juice. This newly discovered richness of secreted enzymes underscores the importance of purine signaling between acini and pancreatic ducts lumen and implies regulation of the purine-converting enzymes release.	Univ Copenhagen, Inst Mol Biol & Physiol, DK-2100 Copenhagen 0, Denmark; Turku Univ, MediCity Res Lab, FIN-2050 Turku, Finland; Turku Univ, Dept Med Microbiol, FIN-2050 Turku, Finland; Natl Publ Hlth Inst, FIN-2050 Turku, Finland	University of Copenhagen; University of Turku; University of Turku; Finland National Institute for Health & Welfare	Novak, I (corresponding author), Univ Copenhagen, Inst Mol Biol & Physiol, August Krogh Bldg,Universitetsparken 13, DK-2100 Copenhagen 0, Denmark.	inovak@aki.ku.dk	Yegutkin, Gennady G./K-3815-2014; Novak, Ivana/M-2791-2014	Yegutkin, Gennady G./0000-0001-6684-7982; Novak, Ivana/0000-0002-8917-8010				Airas L, 1997, J CELL BIOL, V136, P421, DOI 10.1083/jcb.136.2.421; Bigonnesse F, 2004, BIOCHEMISTRY-US, V43, P5511, DOI 10.1021/bi0362222; Braun N, 2000, BIOCHEM J, V351, P639, DOI 10.1042/0264-6021:3510639; Donaldson SH, 2002, AM J RESP CELL MOL, V26, P209, DOI 10.1165/ajrcmb.26.2.4650; Dorsam RT, 2004, J CLIN INVEST, V113, P340, DOI 10.1172/JCI200420986; Goding JW, 2003, BBA-MOL BASIS DIS, V1638, P1, DOI 10.1016/S0925-4439(03)00058-9; HAMLYN JM, 1983, BIOCHEM J, V214, P59, DOI 10.1042/bj2140059; HARPER F, 1978, CAN J BIOCHEM CELL B, V56, P565, DOI 10.1139/o78-086; Hede SE, 1999, J BIOL CHEM, V274, P31784, DOI 10.1074/jbc.274.45.31784; Henttinen T, 2003, J BIOL CHEM, V278, P24888, DOI 10.1074/jbc.M300779200; Hugel B, 2005, PHYSIOLOGY, V20, P22, DOI 10.1152/physiol.00029.2004; JANSEN JWCM, 1980, BIOCHIM BIOPHYS ACTA, V599, P315, DOI 10.1016/0005-2736(80)90077-2; Kaczmarek E, 1996, J BIOL CHEM, V271, P33116, DOI 10.1074/jbc.271.51.33116; Kittel A, 2004, J HISTOCHEM CYTOCHEM, V52, P861, DOI 10.1369/jhc.3A6167.2004; Kittel A, 2002, J HISTOCHEM CYTOCHEM, V50, P549, DOI 10.1177/002215540205000412; Kordas KS, 2004, PANCREAS, V29, P53, DOI 10.1097/00006676-200407000-00056; Kukulski F, 2005, Purinergic Signal, V1, P193, DOI 10.1007/s11302-005-6217-x; LALIBERTE JF, 1982, J BIOL CHEM, V257, P3869; Lazarowski ER, 2000, J BIOL CHEM, V275, P31061, DOI 10.1074/jbc.M003255200; LEBEL D, 1986, BIOCHEM CELL BIOL, V64, P13, DOI 10.1139/o86-003; MARTEAU C, 1993, DIGEST DIS SCI, V38, P2090, DOI 10.1007/BF01297090; Novak I, 2002, CELL PHYSIOL BIOCHEM, V12, P83, DOI 10.1159/000063784; Novak I, 2003, NEWS PHYSIOL SCI, V18, P12, DOI 10.1152/nips.01409.2002; Picher M, 2003, J BIOL CHEM, V278, P11256, DOI 10.1074/jbc.M208071200; Picher M, 2003, J BIOL CHEM, V278, P13468, DOI 10.1074/jbc.M300569200; SEVIGNY J, 1995, BIOCHEM J, V312, P351, DOI 10.1042/bj3120351; Sevigny J, 1998, AM J PHYSIOL-GASTR L, V275, pG473, DOI 10.1152/ajpgi.1998.275.3.G473; Sorensen CE, 2003, J PHYSIOL-LONDON, V551, P881, DOI 10.1113/jphysiol.2003.049411; Sorensen CE, 2001, J BIOL CHEM, V276, P32925, DOI 10.1074/jbc.M103313200; UCHIYAMA Y, 1983, CELL TISSUE RES, V230, P411; Wang TF, 1996, J BIOL CHEM, V271, P9898, DOI 10.1074/jbc.271.17.9898; Yegutkin GG, 2001, FASEB J, V15, P251, DOI 10.1096/fj.00-0268com; Yegutkin GG, 2002, BIOCHEM J, V367, P121, DOI 10.1042/BJ20020439; Yegutkin GG, 2003, FASEB J, V17, P1328, DOI 10.1096/fj.02-1136fje; Zimmermann H, 2000, N-S ARCH PHARMACOL, V362, P299, DOI 10.1007/s002100000309	35	42	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					29441	29447		10.1074/jbc.M602480200	http://dx.doi.org/10.1074/jbc.M602480200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16885159	hybrid			2022-12-27	WOS:000240896300006
J	Joe, YS; Jeong, JH; Yang, S; Kang, H; Motoyama, N; Pandolfi, PP; Chung, JH; Kim, MK				Joe, YeonSoo; Jeong, Jae-Hoon; Yang, Shutong; Kang, Hyeog; Motoyama, Noburu; Pandolfi, Pier Paolo; Chung, Jay H.; Kim, Myung K.			ATR, PML, and CHK2 play a role in arsenic trioxide-induced apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; DEPENDENT PROTEIN-KINASE; DNA-DAMAGE CHECKPOINT; ATAXIA-TELANGIECTASIA; HISTONE H2AX; CELL-LINES; ACTIVATION; PHOSPHORYLATION; PATHWAY; P53	Arsenic trioxide (ATO) is a potent anti-leukemic chemotherapeutic agent for acute promyelocytic leukemia (APL) that results from a t (15, 17) chromosomal translocation that produces PML-RAR alpha, a fusion protein between a tumor suppressor PML and the retinoic acid receptor RAR alpha. APL patients are initially treated with retinoic acid, but most develop resistance and relapse. In contrast, ATO induces prolonged remissions even in the relapsed cases. However, the molecular mechanisms by which ATO kills the leukemic cells are not fully understood. We find that ATO induces apoptosis, at least in part, by activating proapoptotic kinase Chk2. ATO does this by stimulating ATR (ataxia telangiectasia mutated and Rad3-related) kinase, a Chk2-activating kinase. In conjunction, ATO degrades PML-RAR alpha, resulting in the restoration of PML, which is required for autophosphorylation and full activation of Chk2. As a result, the p53-dependent apoptosis pathway is activated. Based on this, we propose that a pathway composed of ATR, PML, Chk2, and p53 plays a role in ATO-mediated apoptosis, a notion that is consistent with the observation that Chk2 is genetically intact and mutations in the p53 gene are extremely rare in APL.	Natl Inst Hlth, NHLBI, Lab Biochem Genet, Bethesda, MD 20892 USA; Natl Inst Longev Sci, Dept Geriatr Res, Obu, Aichi 4748522, Japan; Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Chung, JH (corresponding author), Natl Inst Hlth, NHLBI, Lab Biochem Genet, Bldg 10,Rm 7D14,10 Ctr Dr, Bethesda, MD 20892 USA.	ChungJ@nhlbi.nih.gov; KimM@nhlbi.nih.gov		kang, hyeog/0000-0001-8935-1103	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL002243, Z01HL002243] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Blunt T, 1996, P NATL ACAD SCI USA, V93, P10285, DOI 10.1073/pnas.93.19.10285; Brown AL, 1999, P NATL ACAD SCI USA, V96, P3745, DOI 10.1073/pnas.96.7.3745; Brown EJ, 2000, GENE DEV, V14, P397; Chaturvedi P, 1999, ONCOGENE, V18, P4047, DOI 10.1038/sj.onc.1202925; Chen GQ, 1997, BLOOD, V89, P3345; Davison K, 2004, BLOOD, V103, P3496, DOI 10.1182/blood-2003-05-1412; de Stanchina E, 2004, MOL CELL, V13, P523, DOI 10.1016/S1097-2765(04)00062-0; Fojo T, 2002, CELL CYCLE, V1, P183, DOI 10.4161/cc.1.3.123; Guo A, 2000, NAT CELL BIOL, V2, P730, DOI 10.1038/35036365; Guo ZJ, 2000, GENE DEV, V14, P2745, DOI 10.1101/gad.842500; Gurrieri C, 2004, BLOOD, V103, P2358, DOI 10.1182/blood-2003-07-2200; Gurrieri C, 2004, JNCI-J NATL CANCER I, V96, P269, DOI 10.1093/jnci/djh043; Hayakawa F, 2004, CANCER CELL, V5, P389, DOI 10.1016/S1535-6108(04)00082-0; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Jing YK, 1999, BLOOD, V94, P2102, DOI 10.1182/blood.V94.6.2102; Kang H, 2004, MOL CELL BIOL, V24, P1188, DOI 10.1128/MCB.24.3.1188-1199.2004; Lallemand-Breitenbach V, 1999, J EXP MED, V189, P1043, DOI 10.1084/jem.189.7.1043; Li J, 2005, J BIOL CHEM, V280, P12041, DOI 10.1074/jbc.M412445200; Liu QH, 2000, GENE DEV, V14, P1448; LONGO L, 1993, LEUKEMIA LYMPHOMA, V11, P405, DOI 10.3109/10428199309067933; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rojewski MT, 2002, BRIT J HAEMATOL, V116, P555, DOI 10.1046/j.0007-1048.2001.03298.x; Salomoni P, 2002, CELL, V108, P165, DOI 10.1016/S0092-8674(02)00626-8; Shao WL, 1998, J NATL CANCER I, V90, P124, DOI 10.1093/jnci/90.2.124; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Takai H, 2002, EMBO J, V21, P5195, DOI 10.1093/emboj/cdf506; Verma A, 2002, J BIOL CHEM, V277, P44988, DOI 10.1074/jbc.M207176200; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Wang ZG, 1998, BLOOD, V92, P1497, DOI 10.1182/blood.V92.5.1497.417k41_1497_1504; Wang ZG, 1998, NAT GENET, V20, P266, DOI 10.1038/3073; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Ward IM, 2004, J BIOL CHEM, V279, P9677, DOI 10.1074/jbc.C300554200; YANG S, 2006, J BIOL CHEM; Yang ST, 2002, NAT CELL BIOL, V4, P865, DOI 10.1038/ncb869; Zhang TD, 2001, ONCOGENE, V20, P7146, DOI 10.1038/sj.onc.1204762; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001	38	36	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					28764	28771		10.1074/jbc.M604392200	http://dx.doi.org/10.1074/jbc.M604392200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16891316	hybrid			2022-12-27	WOS:000240680500030
J	Koivunen, P; Hirsila, M; Kivirikko, KI; Myllyharju, J				Koivunen, Peppi; Hirsila, Maija; Kivirikko, Kari I.; Myllyharju, Johanna			The length of peptide substrates has a marked effect on hydroxylation by the hypoxia-inducible factor prolyl 4-hydroxylases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGEN SENSING PATHWAY; PROLINE HYDROXYLATION; HIF-ALPHA; HYDROXYPROLINE; HIF-1-ALPHA; FAMILY; RECOGNITION; DESTRUCTION; SUBUNIT; DOMAINS	Three hypoxia-inducible factor prolyl 4-hydroxylases (HIF-P4Hs) regulate the HIFs by hydroxylating prolines at two separate sites in the oxygen-dependent degradation domain (ODDD) of their alpha subunits. We compared in vitro hydroxylation by purified recombinant human HIF-P4Hs of 19-20- and 35-residue peptides corresponding to the two sites in HIF-alpha s and purified recombinant HIF-1 alpha and HIF-2 alpha ODDDs of 248 and 215 residues. The increase in the length of peptides representing the C-terminal site from 19 to 20 to 35 residues reduced the K-m values to 90-800 nM, i.e. to 0.7-11% of those for the shorter peptides, whereas those representing the N-terminal site were 10-470 mu M, i.e. 10-135%. The K-m values of HIF-P4H-1 for the recombinant HIF-alpha ODDDs were 10-20 nM, whereas those of HIF-P4H-2 and -3 were 60-140 nM, identical values being found for the wild-type HIF-1 alpha ODDD and its N site mutant. The K-m values for the C site mutant were about 5-10 times higher but only 0.2-3% of those for the 35-residue N site peptides, and this marked difference suggested that the HIF-P4Hs may become bound first to the C-terminal site of an ODDD and that this binding may enhance subsequent binding to the N-terminal site. The K-m values of HIF-P4H-2 for oxygen determined with the HIF-1 alpha ODDD and both its mutants as substrates were all about 100 mu M, being 40% of those reported for the three HIF-P4Hs with a 19-residue peptide. Even this value is high compared with tissue O-2 levels, indicating that HIF-P4Hs are effective oxygen sensors.	Univ Oulu, Collagen Res Unit, Bioctr Oulu, FIN-90014 Oulu, Finland; Univ Oulu, Dept Med Biochem & Mol Biol, FIN-90014 Oulu, Finland	University of Oulu; University of Oulu	Myllyharju, J (corresponding author), Univ Oulu, Collagen Res Unit, Bioctr Oulu, POB 5000, FIN-90014 Oulu, Finland.	johanna.myllyharju@oulu.fi						ACKER H, 2003, OXYGEN SENSING RESPO, P507; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Chan DA, 2005, MOL CELL BIOL, V25, P6415, DOI 10.1128/MCB.25.15.6415-6426.2005; DEJONG L, 1984, BIOCHIM BIOPHYS ACTA, V787, P105; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Hewitson KS, 2002, J BIOL CHEM, V277, P26351, DOI 10.1074/jbc.C200273200; Hirsila M, 2005, FASEB J, V19, P1308, DOI 10.1096/fj.04-3399fje; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Hon WC, 2002, NATURE, V417, P975, DOI 10.1038/nature00767; Huang JH, 2002, J BIOL CHEM, V277, P39792, DOI 10.1074/jbc.M206955200; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; JUVA K, 1966, ANAL BIOCHEM, V15, P77, DOI 10.1016/0003-2697(66)90249-1; Kaelin WG, 2005, ANNU REV BIOCHEM, V74, P115, DOI 10.1146/annurev.biochem.74.082803.133142; Kageyama Y, 2004, FASEB J, V18, P1028, DOI 10.1096/fj.03-1233fje; Kivirikko KI, 1998, ADV ENZYMOL RAMB, V72, P325; Koivunen P, 2004, J BIOL CHEM, V279, P9899, DOI 10.1074/jbc.M312254200; Kukkola L, 2004, J BIOL CHEM, V279, P18656, DOI 10.1074/jbc.M401514200; Kukkola L, 2003, J BIOL CHEM, V278, P47685, DOI 10.1074/jbc.M306806200; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Li DX, 2004, J BIOL CHEM, V279, P55051, DOI 10.1074/jbc.M410287200; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; Myllyharju J, 2003, MATRIX BIOL, V22, P15, DOI 10.1016/S0945-053X(03)00006-4; Sanchez-Puig N, 2005, MOL CELL, V17, P11, DOI 10.1016/j.molcel.2004.11.019; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Tuckerman JR, 2004, FEBS LETT, V576, P145, DOI 10.1016/j.febslet.2004.09.005; Van den Diepstraten C, 2003, CIRCULATION, V108, P508, DOI 10.1161/01.CIR.0000080883.53863.5C; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498	34	111	113	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					28712	28720		10.1074/jbc.M604628200	http://dx.doi.org/10.1074/jbc.M604628200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16885164	hybrid			2022-12-27	WOS:000240680500024
J	Kulikov, R; Winter, M; Blattner, C				Kulikov, Roman; Winter, Markus; Blattner, Christine			Binding of p53 to the central domain of Mdm2 is regulated by phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN LIGASE ACTIVITY; ACIDIC DOMAIN; EMBRYONIC LETHALITY; MDM2-DEFICIENT MICE; DEGRADATION; PROTEIN; OLIGOMERIZATION; PROMOTES; PATHWAY; RESCUE	The Mdm2 protein is the major regulator of the tumor suppressor protein p53. We show that the p53 protein associates both with the N-terminal and with the central domain of Mdm2. The central p53-binding site of Mdm2 encompasses amino acids 235-300. Binding of p53 to the central domain is significantly enhanced after phosphorylation of the central domain of Mdm2. The N-terminal and central domains of Mdm2 act synergistically in binding to p53. p53 mutants that have mutations in the tetramerization domain and that fail to oligomerize do not show such an enhancement of binding in the presence of the other binding site.	Forschungszentrum Karlsruhe, Inst Toxicol & Genet, D-76021 Karlsruhe, Germany	Helmholtz Association; Karlsruhe Institute of Technology	Blattner, C (corresponding author), Forschungszentrum Karlsruhe, Inst Toxicol & Genet, POB 3640, D-76021 Karlsruhe, Germany.	christine.blattner@itg.fzk.de	Blattner, Christine/H-2105-2013; Blattner, Christine/ABI-2152-2020	Blattner, Christine/0000-0002-7250-5273; Blattner, Christine/0000-0002-7250-5273				Argentini M, 2001, ONCOGENE, V20, P1267, DOI 10.1038/sj.onc.1204241; Blattner C, 2002, MOL CELL BIOL, V22, P6170, DOI 10.1128/MCB.22.17.6170-6182.2002; Blattner C, 1999, ONCOGENE, V18, P1723, DOI 10.1038/sj.onc.1202480; Burch LR, 2000, FEBS LETT, V472, P93, DOI 10.1016/S0014-5793(00)01427-7; Chene P, 2001, ONCOGENE, V20, P2611, DOI 10.1038/sj.onc.1204373; Freedman DA, 1998, MOL CELL BIOL, V18, P7288, DOI 10.1128/MCB.18.12.7288; FRIEDMAN PN, 1993, P NATL ACAD SCI USA, V90, P3319, DOI 10.1073/pnas.90.8.3319; Grossman SR, 2003, SCIENCE, V300, P342, DOI 10.1126/science.1080386; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Honda R, 1999, EMBO J, V18, P22, DOI 10.1093/emboj/18.1.22; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Iwakuma T, 2003, MOL CANCER RES, V1, P993; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Kawai H, 2003, MOL CELL BIOL, V23, P4939, DOI 10.1128/MCB.23.14.4939-4947.2003; Kohn KW, 2005, BIOCHEM BIOPH RES CO, V331, P816, DOI 10.1016/j.bbrc.2005.03.186; Kubbutat MHG, 1998, MOL CELL BIOL, V18, P5690, DOI 10.1128/MCB.18.10.5690; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Lohrum MAE, 2000, NAT CELL BIOL, V2, P179, DOI 10.1038/35004057; Lomax ME, 1998, ONCOGENE, V17, P643, DOI 10.1038/sj.onc.1201974; LUNA RMD, 1995, NATURE, V378, P203; Maki CG, 1999, J BIOL CHEM, V274, P16531, DOI 10.1074/jbc.274.23.16531; Meulmeester E, 2003, MOL CELL BIOL, V23, P4929, DOI 10.1128/MCB.23.14.4929-4938.2003; Nicholls CD, 2002, J BIOL CHEM, V277, P12937, DOI 10.1074/jbc.M108815200; Roth J, 1998, EMBO J, V17, P554, DOI 10.1093/emboj/17.2.554; Shimizu H, 2002, J BIOL CHEM, V277, P28446, DOI 10.1074/jbc.M202296200; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Winter M, 2004, BIOCHEMISTRY-US, V43, P16356, DOI 10.1021/bi0489255; Yu GW, 2006, P NATL ACAD SCI USA, V103, P1227, DOI 10.1073/pnas.0510343103; Zhu QZ, 2001, J BIOL CHEM, V276, P29695, DOI 10.1074/jbc.M102634200	30	55	56	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					28575	28583		10.1074/jbc.M513311200	http://dx.doi.org/10.1074/jbc.M513311200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16870621	hybrid			2022-12-27	WOS:000240680500011
J	Smid, O; Horakova, E; Vilimova, V; Hrdy, I; Cammack, R; Horvath, A; Lukes, J; Tachezy, J				Smid, Ondrej; Horakova, Eva; Vilimova, Vanda; Hrdy, Ivan; Cammack, Richard; Horvath, Anton; Lukes, Julius; Tachezy, Jan			Knock-downs of iron-sulfur cluster assembly proteins IscS and IscU down-regulate the active mitochondrion of procyclic Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FE-S CLUSTER; RNA INTERFERENCE; TRICHOMONAS-VAGINALIS; SCAFFOLD PROTEIN; GENE-EXPRESSION; BIOGENESIS; EUKARYOTES; MATURATION; GENOME; HYDROGENOSOMES	Transformation of the metabolically down-regulated mitochondrion of the mammalian bloodstream stage of Trypanosoma brucei to the ATP-producing mitochondrion of the insect procyclic stage is accompanied by the de novo synthesis of citric acid cycle enzymes and components of the respiratory chain. Because these metabolic pathways contain multiple iron-sulfur (FeS) proteins, their synthesis, including the formation of FeS clusters, is required. However, nothing is known about FeS cluster biogenesis in trypanosomes, organisms that are evolutionarily distant from yeast and humans. Here we demonstrate that two mitochondrial proteins, the cysteine desulfurase TbiscS and the metallochaperone TbiscU, are functionally conserved in trypanosomes and essential for this parasite. Knock-downs of TbiscS and TbiscU in the procyclic stage by means of RNA interference resulted in reduced activity of the marker FeS enzyme aconitase in both the mitochondrion and cytosol because of the lack of FeS clusters. Moreover, down-regulation of TbiscS and TbiscU affected the metabolism of procyclic T. brucei so that their mitochondria resembled the organelle of the bloodstream stage; mitochondrial ATP production was impaired, the activity of the respiratory chain protein complex ubiquinol-cytochrome-c reductase was reduced, and the production of pyruvate as an end product of glucose metabolism was enhanced. These results indicate that mitochondrial FeS cluster assembly is indispensable for completion of the T. brucei life cycle.	Charles Univ Prague, Dept Parasitol, Fac Sci, CR-12844 Prague 2, Czech Republic; Univ S Bohemia, Fac Biol, Ceske Budejovice 35007, Czech Republic; Acad Sci Czech Republ, Inst Parasitol, Ceske Budejovice 35007, Czech Republic; Comenius Univ, Fac Nat Sci, Bratislava 84215, Slovakia; Kings Coll London, Dept Life Sci, London WC2R 2LS, England	Charles University Prague; University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Comenius University Bratislava; University of London; King's College London	Tachezy, J (corresponding author), Charles Univ Prague, Dept Parasitol, Fac Sci, Vinicna 7, CR-12844 Prague 2, Czech Republic.	tachezy@natur.cuni.cz	Horakova, Eva/G-9322-2014; Janštová, Vanda/AAD-5465-2022; Horvath, Anton/I-3626-2014; Cammack, Richard/B-7841-2008; Horvath, Anton/V-1097-2018; Lukes, Julius/H-6760-2012; Horáková, Eva/AAD-9124-2021; Hrdý, Ivan/K-8931-2017; Janštová, Vanda/H-7107-2017	Janštová, Vanda/0000-0002-5950-5738; Horvath, Anton/0000-0003-0785-4204; Lukes, Julius/0000-0002-0578-6618; Horáková, Eva/0000-0002-3730-8979; Hrdý, Ivan/0000-0002-5595-9177; Janštová, Vanda/0000-0002-5950-5738				ACKRELL BAC, 1984, J BIOL CHEM, V259, P4015; Balk J, 2005, TRENDS PLANT SCI, V10, P324, DOI 10.1016/j.tplants.2005.05.002; BEINERT H, 1983, P NATL ACAD SCI-BIOL, V80, P393, DOI 10.1073/pnas.80.2.393; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Besteiro S, 2005, TRENDS PARASITOL, V21, P185, DOI 10.1016/j.pt.2005.02.008; Bochud-Allemann N, 2002, J BIOL CHEM, V277, P32849, DOI 10.1074/jbc.M205776200; CALLENS M, 1992, MOL BIOCHEM PARASIT, V50, P235, DOI 10.1016/0166-6851(92)90220-E; Cavalier-Smith T, 2004, P ROY SOC B-BIOL SCI, V271, P1251, DOI 10.1098/rspb.2004.2705; Chaudhuri M, 1998, MOL BIOCHEM PARASIT, V95, P53, DOI 10.1016/S0166-6851(98)00091-7; Clayton CE, 1996, PARASITOL TODAY, V12, P465, DOI 10.1016/S0169-4758(96)10073-9; Dolezal P, 2005, P NATL ACAD SCI USA, V102, P10924, DOI 10.1073/pnas.0500349102; Embley TM, 2006, NATURE, V440, P623, DOI 10.1038/nature04546; FLINT DH, 1993, J BIOL CHEM, V268, P22369; Foldynova-Trantirkova S, 2005, INT J PARASITOL, V35, P359, DOI 10.1016/j.ijpara.2004.12.012; Gerber J, 2003, EMBO REP, V4, P906, DOI 10.1038/sj.embor.embor918; Heise N, 1999, MOL BIOCHEM PARASIT, V99, P21, DOI 10.1016/S0166-6851(98)00176-5; Hendriks E, 2000, BIOCHEM SOC T, V28, P531, DOI 10.1042/bst0280531; Horvath A, 2005, MOL MICROBIOL, V58, P116, DOI 10.1111/j.1365-2958.2005.04813.x; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; Kispal G, 2005, EMBO J, V24, P589, DOI 10.1038/sj.emboj.7600541; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; LaGier MJ, 2003, MICROBIOL-SGM, V149, P3519, DOI 10.1099/mic.0.26365-0; Land T, 1998, MOL CELL, V2, P807, DOI 10.1016/S1097-2765(00)80295-6; Lauhon CT, 2004, J BIOL CHEM, V279, P19551, DOI 10.1074/jbc.M401261200; Li KY, 2006, J BIOL CHEM, V281, P12344, DOI 10.1074/jbc.M600582200; Lill R, 2000, TRENDS BIOCHEM SCI, V25, P352, DOI 10.1016/S0968-0004(00)01589-9; Lill R, 2005, TRENDS BIOCHEM SCI, V30, P133, DOI 10.1016/j.tibs.2005.01.006; Lukes J, 2005, CURR GENET, V48, P277, DOI 10.1007/s00294-005-0027-0; Michels PAM, 2005, MOL MEMBR BIOL, V22, P133, DOI 10.1080/09687860400024186; Motyka SA, 2004, CURR OPIN MICROBIOL, V7, P362, DOI 10.1016/j.mib.2004.06.004; Moyersoen J, 2003, EUR J BIOCHEM, V270, P2059, DOI 10.1046/j.1432-1033.2003.03582.x; Panigrahi AK, 2001, MOL CELL BIOL, V21, P6833, DOI 10.1128/MCB.21.20.6833-6840.2001; Regoes A, 2005, J BIOL CHEM, V280, P30557, DOI 10.1074/jbc.M500787200; Saas J, 2000, J BIOL CHEM, V275, P2745, DOI 10.1074/jbc.275.4.2745; Simpson AGB, 2004, CURR BIOL, V14, pR693, DOI 10.1016/j.cub.2004.08.038; Sutak R, 2004, P NATL ACAD SCI USA, V101, P10368, DOI 10.1073/pnas.0401319101; Tachezy J, 2001, MOL BIOL EVOL, V18, P1919, DOI 10.1093/oxfordjournals.molbev.a003732; Tielens AGM, 1998, BBA-BIOENERGETICS, V1365, P71, DOI 10.1016/S0005-2728(98)00045-0; Tong WH, 2000, EMBO J, V19, P5692, DOI 10.1093/emboj/19.21.5692; Tong WH, 2003, P NATL ACAD SCI USA, V100, P9762, DOI 10.1073/pnas.1732541100; Tovar J, 2003, NATURE, V426, P172, DOI 10.1038/nature01945; TRUMPOWER BL, 1979, J BIOL CHEM, V254, P8697; Urbina HD, 2001, J BIOL CHEM, V276, P44521, DOI 10.1074/jbc.M106907200; Van Hellemond JJ, 1998, P NATL ACAD SCI USA, V95, P3036, DOI 10.1073/pnas.95.6.3036; van Weelden SWH, 2005, J BIOL CHEM, V280, P12451, DOI 10.1074/jbc.M412447200; Vanacova S, 2001, MICROBIOL-UK, V147, P53; Vondruskova E, 2005, J BIOL CHEM, V280, P2429, DOI 10.1074/jbc.M405933200; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Wickstead B, 2002, MOL BIOCHEM PARASIT, V125, P211, DOI 10.1016/S0166-6851(02)00238-4; WIRTZ E, 1995, SCIENCE, V268, P1179, DOI 10.1126/science.7761835; Yarunin A, 2005, EMBO J, V24, P580, DOI 10.1038/sj.emboj.7600540	52	57	59	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					28679	28686		10.1074/jbc.M513781200	http://dx.doi.org/10.1074/jbc.M513781200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16882667	hybrid			2022-12-27	WOS:000240680500021
J	Ubeda, M; Rukstalis, JM; Habener, JF				Ubeda, Mariano; Rukstalis, J. Michael; Habener, Joel F.			Inhibition of cyclin-dependent kinase 5 activity protects pancreatic beta cells from glucotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN GENE-TRANSCRIPTION; OXIDATIVE STRESS; GLUCOSE-CONCENTRATION; BINDING; EXPRESSION; CDK5; REDUCTION; MECHANISM; RIPE3B1	Type 2 diabetes (T2D) and Alzheimer disease are degenerative diseases that may share common pathophysiologic mechanisms. Neuronal dysfunction in Alzheimer patients has been linked to overactivity of the cyclin-dependent kinase 5 (CDK5) and its activator p35. Both of these proteins are expressed in the insulin-producing beta cells of the pancreas. Further, glucose enhances p35 gene expression, promoting the formation of active p35/CDK5 complexes that regulate the expression of the insulin gene. In T2D, chronic elevations of glucose, glucotoxicity, impair beta cell function. We therefore postulated that CDK5 and p35 may be responsible for this beta cell impairment and that inhibition of CDK5 might have a beneficial effect. To test this hypothesis, the pancreatic cell line INS-1 was selected as a known in vitro model of glucotoxicity, and roscovitine (10 mu M) was used as a CDK5 inhibitor. Chronic exposure of INS-1 cells to high glucose (20-30 mM) reduced both insulin mRNA levels and the activity of an insulin promoter reporter gene. Inhibition of CDK5 prevented this decrease of insulin gene expression. We used DNA binding (gel shift) assays and Western immunoblots to demonstrate that cellular levels of the transcription factor PDX-1, normally decreased by glucotoxicity, were preserved with CDK5 inhibition, as was the binding of PDX-1 to the insulin promoter. Analyses of nuclear and cytoplasmic PDX-1 protein levels revealed that CDK5 inhibition restores nuclear PDX-1, without affecting its cytoplasmic concentration, suggesting that CDK5 regulates the nuclear/cytoplasm partitioning of PDX-1. Using a Myc-tagged PDX-1 construct, we showed that the translocation of PDX-1 from the nucleus to the cytoplasm during glucotoxic conditions was prevented when CDK5 was inhibited. These studies indicate that CDK5 plays a role in the loss of beta cell function under glucotoxic conditions and that CDK5 inhibitors could have therapeutic value for T2D.	Harvard Univ, Sch Med, Massachusetts Gen Hosp, Mol Endocrinol Lab, Boston, MA 02114 USA; Howard Hughes Med Inst, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Howard Hughes Medical Institute	Ubeda, M (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Mol Endocrinol Lab, THEIR 320,55 Fruit St, Boston, MA 02114 USA.	jhabener@partners.org	Ubeda, Mariano/ABB-2691-2021		NIDDK NIH HHS [DK057521-06, DK55365] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055365, P30DK057521] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Cruz JC, 2004, TRENDS MOL MED, V10, P452, DOI 10.1016/j.molmed.2004.07.001; Habener JF, 2002, DRUG NEWS PERSPECT, V15, P491, DOI 10.1358/dnp.2002.15.8.740224; Harmon JS, 2005, J BIOL CHEM, V280, P11107, DOI 10.1074/jbc.M410345200; Harmon JS, 1998, DIABETES, V47, P900, DOI 10.2337/diabetes.47.6.900; Kaiser N, 2003, J PEDIATR ENDOCR MET, V16, P5, DOI 10.1515/JPEM.2003.16.1.5; Kajimoto Y, 2004, ANN NY ACAD SCI, V1011, P168, DOI 10.1196/annals.1293.017; Kawamori D, 2003, DIABETES, V52, P2896, DOI 10.2337/diabetes.52.12.2896; LEAHY JL, 1986, J CLIN INVEST, V77, P908, DOI 10.1172/JCI112389; Lim ACB, 2003, J ALZHEIMERS DIS, V5, P329, DOI 10.3233/JAD-2003-5409; Lu M, 1997, J BIOL CHEM, V272, P28349, DOI 10.1074/jbc.272.45.28349; Nguyen MD, 2003, NEUROSIGNALS, V12, P215, DOI 10.1159/000074623; OLSON LK, 1995, P NATL ACAD SCI USA, V92, P9127, DOI 10.1073/pnas.92.20.9127; Olson LK, 1998, MOL ENDOCRINOL, V12, P207, DOI 10.1210/me.12.2.207; Otth C, 2003, NEUROREPORT, V14, P2403, DOI 10.1097/00001756-200312190-00023; PARK BH, 1995, BIOCHEM BIOPH RES CO, V210, P1, DOI 10.1006/bbrc.1995.1619; Poitout V, 1996, J CLIN INVEST, V97, P1041, DOI 10.1172/JCI118496; Seufert J, 1998, J CLIN INVEST, V101, P2528, DOI 10.1172/JCI2401; SHARMA A, 1995, MOL ENDOCRINOL, V9, P1127, DOI 10.1210/me.9.9.1127; Srinivasan S, 2002, AM J PHYSIOL-ENDOC M, V283, pE784, DOI 10.1152/ajpendo.00177.2002; Strocchi P, 2003, J CELL BIOCHEM, V88, P758, DOI 10.1002/jcb.10391; TOKUYAMA Y, 1995, DIABETES, V44, P1447, DOI 10.2337/diabetes.44.12.1447; Tsai LH, 2004, BBA-PROTEINS PROTEOM, V1697, P137, DOI 10.1016/j.bbapap.2003.11.019; Ubeda M, 1996, MOL CELL BIOL, V16, P1479; Ubeda M, 2004, ENDOCRINOLOGY, V145, P3023, DOI 10.1210/en.2003-1522; Zangen DH, 1997, DIABETES, V46, P258, DOI 10.2337/diabetes.46.2.258	25	102	143	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					28858	28864		10.1074/jbc.M604690200	http://dx.doi.org/10.1074/jbc.M604690200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16887799	hybrid			2022-12-27	WOS:000240680500040
J	Choudhury, B; Leoff, C; Saile, E; Wilkins, P; Quinn, CP; Kannenberg, EL; Carlson, RW				Choudhury, Biswa; Leoff, Christine; Saile, Elke; Wilkins, Patricia; Quinn, Conrad P.; Kannenberg, Elmar L.; Carlson, Russell W.			The structure of the major cell wall polysaccharide of Bacillus anthracis is species-specific	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTRAL POLYSACCHARIDE; CEREUS AHU-1356; IDENTIFICATION; GLYCOPROTEINS; SUBTILIS; SEQUENCE; ACID	In this report we describe the structure of the polysaccharide released from Bacillus anthracis vegetative cell walls by aqueous hydrogen fluoride (HF). This HF-released polysaccharide (HF-PS) was isolated and structurally characterized from the Ames, Sterne, and Pasteur strains of B. anthracis. The HF-PSs were also isolated from the closely related Bacillus cereus ATCC 10987 strain, and from the B. cereus ATCC 14579 type strain and compared with those of B. anthracis. The structure of the B. anthracis HF-PS was determined by glycosyl composition and linkage analyses, matrix-assisted laser desorption-time of flight mass spectrometry, and one- and two-dimensional nuclear magnetic resonance spectroscopy. The HF-PSs from all of the B. anthracis isolates had an identical structure consisting of an amino sugar backbone of -> 6)-alpha-GlcNAc-(1 -> 4)-beta-ManNAc-(1 -> 4)-beta-GlcNAc-(1 ->, in which the alpha-GlcNAc residue is sub-stituted with alpha-Gal and beta-Gal at O-3 and O-4, respectively, and the beta-GlcNAc substituted with alpha-Gal at O-3. There is some variability in the presence of two of these three Gal substitutions. Comparison with the HF-PSs from B. cereus ATCC 10987 and B. cereus ATCC 14579 showed that the B. anthracis structure was clearly different from each of these HF-PSs and, furthermore, that the B. cereus ATCC 10987 HF-PS structure was different from that of B. cereus ATCC 14579. The presence of a B. anthra-cis-specific polysaccharide structure in its vegetative cell wall is discussed with regard to its relationship to those of other Bacillus species.	Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; Univ Tubingen, Dept Microbiol, D-72076 Tubingen, Germany; Univ Tubingen, Dept Biotechnol, D-72076 Tubingen, Germany	University System of Georgia; University of Georgia; Centers for Disease Control & Prevention - USA; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Carlson, RW (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA.	rcarlson@ccrc.uga.edu			NIAID NIH HHS [R21 AI059577] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AMANO K, 1977, EUR J BIOCHEM, V75, P513, DOI 10.1111/j.1432-1033.1977.tb11552.x; Brechtel E, 1999, J BACTERIOL, V181, P5017, DOI 10.1128/JB.181.16.5017-5023.1999; BROWN WC, 1973, APPL MICROBIOL, V25, P295, DOI 10.1128/AEM.25.2.295-300.1973; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; EKWUNIFE FS, 1991, FEMS MICROBIOL LETT, V82, P257; Fox A, 2003, J MICROBIOL METH, V54, P143, DOI 10.1016/S0167-7012(03)00095-2; FOX A, 1993, J CLIN MICROBIOL, V31, P887, DOI 10.1128/JCM.31.4.887-894.1993; Han CS, 2006, J BACTERIOL, V188, P3382, DOI 10.1128/JB.188.9.3382-3390.2006; Hoffmaster AR, 2004, P NATL ACAD SCI USA, V101, P8449, DOI 10.1073/pnas.0402414101; IWASAKI H, 1989, EUR J BIOCHEM, V178, P635, DOI 10.1111/j.1432-1033.1989.tb14492.x; KATSUKI H, 1971, ANAL BIOCHEM, V43, P349, DOI 10.1016/0003-2697(71)90263-6; KOJIMA N, 1985, EUR J BIOCHEM, V148, P479, DOI 10.1111/j.1432-1033.1985.tb08864.x; KOJIMA N, 1988, EUR J BIOCHEM, V174, P255, DOI 10.1111/j.1432-1033.1988.tb14091.x; Mayer-Scholl A, 2005, PLOS PATHOG, V1, P179, DOI 10.1371/journal.ppat.0010023; Mesnage S, 2000, EMBO J, V19, P4473, DOI 10.1093/emboj/19.17.4473; Messner P, 1997, GLYCOCONJUGATE J, V14, P3, DOI 10.1023/A:1018551228663; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; MOLNAR J, 1971, ACTA MICROBIOL HUNG, V18, P105; MURAZUMI N, 1986, EUR J BIOCHEM, V161, P51, DOI 10.1111/j.1432-1033.1986.tb10123.x; Priest FG, 2004, J BACTERIOL, V186, P7959, DOI 10.1128/JB.186.23.7959-7970.2004; Rasko DA, 2004, NUCLEIC ACIDS RES, V32, P977, DOI 10.1093/nar/gkh258; Wang W, 2004, J IMMUNOL, V173, P515, DOI 10.4049/jimmunol.173.1.515; YORK WS, 1986, METHOD ENZYMOL, V118, P3	23	78	84	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					27932	27941		10.1074/jbc.M605768200	http://dx.doi.org/10.1074/jbc.M605768200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16870610	hybrid			2022-12-27	WOS:000240534400029
J	Tang, HP; Kambris, Z; Lemaitre, B; Hashimoto, C				Tang, Huaping; Kambris, Zakaria; Lemaitre, Bruno; Hashimoto, Carl			Two proteases defining a melanization cascade in the immune system of Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOLOTRICHIA-DIOMPHALIA LARVAE; SERINE-PROTEASE; COLEOPTERAN INSECT; TOLL ACTIVATION; HOST-DEFENSE; SERPIN; PROPHENOLOXIDASE; INFECTION; ADULTS; RESPONSES	The melanization reaction is used as an immune mechanism in arthropods to encapsulate and kill microbial pathogens. In Drosophila, the serpin Spn27A regulates melanization apparently by inhibiting the protease that activates phenoloxidase, the key enzyme in melanin synthesis. Here, we have described the genetic characterization of two immune inducible serine proteases, MP1 and MP2, which act in a melanization cascade regulated by Spn27A. MP1 is required to activate melanization in response to both bacterial and fungal infection, whereas MP2 is mainly involved during fungal infection. Pathogenic bacteria and fungi may therefore trigger two different melanization cascades that use MP1 as a common downstream protease to activate phenoloxidase. We have also shown that the melanization reaction activated by MP1 and MP2 plays an important role in augmenting the effectiveness of other immune reactions, thereby promoting resistance of Drosophila to microbial infection.	Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; CNRS, Ctr Genet Mol, F-91198 Gif Sur Yvette, France	Yale University; Yale University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Hashimoto, C (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, 333 Cedar St, New Haven, CT 06520 USA.	carl.hashimoto@yale.edu	Lemaitre, Bruno/T-8146-2019	Lemaitre, Bruno/0000-0001-7970-1667	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049370] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM49370] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Castillejo-Lopez C, 2005, BIOCHEM BIOPH RES CO, V338, P1075, DOI 10.1016/j.bbrc.2005.10.042; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; CHASAN R, 1989, CELL, V56, P391, DOI 10.1016/0092-8674(89)90242-0; Christensen BM, 2005, TRENDS PARASITOL, V21, P192, DOI 10.1016/j.pt.2005.02.007; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; De Gregorio E, 2002, DEV CELL, V3, P581, DOI 10.1016/S1534-5807(02)00267-8; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Gobert V, 2003, SCIENCE, V302, P2126, DOI 10.1126/science.1085432; Hashimoto C, 2003, DEV CELL, V5, P945, DOI 10.1016/S1534-5807(03)00338-1; Hedengren M, 1999, MOL CELL, V4, P827, DOI 10.1016/S1097-2765(00)80392-5; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Kambris Z, 2006, CURR BIOL, V16, P808, DOI 10.1016/j.cub.2006.03.020; Kanost Michael R, 2004, Immunol Rev, V198, P97, DOI 10.1111/j.0105-2896.2004.0121.x; Krem MM, 2002, TRENDS BIOCHEM SCI, V27, P67, DOI 10.1016/S0968-0004(01)02007-2; Kwon TH, 2000, EUR J BIOCHEM, V267, P6188, DOI 10.1046/j.1432-1327.2000.01695.x; Leclerc V, 2006, EMBO REP, V7, P231, DOI 10.1038/sj.embor.7400592; Lee SY, 1998, EUR J BIOCHEM, V257, P615, DOI 10.1046/j.1432-1327.1998.2570615.x; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; LEMAITRE B, 1995, P NATL ACAD SCI USA, V92, P9465, DOI 10.1073/pnas.92.21.9465; Leulier F, 2002, CURR BIOL, V12, P996, DOI 10.1016/S0960-9822(02)00873-4; Levashina EA, 1999, SCIENCE, V285, P1917, DOI 10.1126/science.285.5435.1917; Ligoxygakis P, 2003, CURR BIOL, V13, P2097, DOI 10.1016/j.cub.2003.10.062; Ligoxygakis P, 2002, EMBO J, V21, P6330, DOI 10.1093/emboj/cdf661; Ligoxygakis P, 2002, SCIENCE, V297, P114, DOI 10.1126/science.1072391; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Nappi AJ, 2005, INSECT BIOCHEM MOLEC, V35, P443, DOI 10.1016/j.ibmb.2005.01.014; Pili-Floury S, 2004, J BIOL CHEM, V279, P12848, DOI 10.1074/jbc.M313324200; PYE AE, 1974, NATURE, V251, P610, DOI 10.1038/251610a0; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Satoh D, 1999, J BIOL CHEM, V274, P7441, DOI 10.1074/jbc.274.11.7441; Takehana A, 2004, EMBO J, V23, P4690, DOI 10.1038/sj.emboj.7600466; Tzou P, 2002, METHOD MICROBIOL, V31, P507, DOI 10.1016/S0580-9517(02)31028-6	34	152	162	5	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					28097	28104		10.1074/jbc.M601642200	http://dx.doi.org/10.1074/jbc.M601642200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16861233	Green Published, hybrid			2022-12-27	WOS:000240534400047
J	Chavez, C; Bowman, EJ; Reidling, JC; Haw, KH; Bowman, BJ				Chavez, Christopher; Bowman, Emma Jean; Reidling, Jack C.; Haw, Kimberly H.; Bowman, Barry J.			Analysis of strains with mutations in six genes encoding subunits of the V-ATPase - Eukaryotes differ in the composition of the V-0 sector of the enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLAR H+-ATPASE; PROTON-TRANSLOCATING ATPASE; NEUROSPORA-CRASSA; SACCHAROMYCES-CEREVISIAE; PROTEOLIPID SUBUNIT; ELECTRON-MICROSCOPY; PUMP; SYNTHASE; POLYPEPTIDE; SEQUENCE	To address questions about the structure of the vacuolar ATPase, we have generated mutant strains of Neurospora crassa defective in six subunits, C, H, a, c, c', and c". Except for strains lacking subunit c', the mutant strains were indistinguishable from each other in most phenotypic characteristics. They did not accumulate arginine in the vacuoles, grew poorly at pH 5.8 with altered morphology, and failed to grow at alkaline pH. Consistent with findings from Saccharomyces cerevisiae, the data indicate that subunits C and H are essential for generation of a functional enzyme. Unlike S. cerevisiae, N. crassa has a single isoform of the a subunit. Analysis of other fungal genomes indicates that only the budding yeasts have a two-gene family for subunit a. It has been unclear whether subunit c', a small proteolipid, is a component of all V-ATPases. Our data suggest that this subunit is present in all fungi, but not in other organisms. Mutation or deletion of the N. crassa gene encoding subunit c' did not completely eliminate V-ATPase function. Unlike other V-ATPase null strains, they grew, although slowly, at alkaline pH, were able to form conidia (asexual spores), and were inhibited by concanamycin, a specific inhibitor of the V-ATPase. The phenotypic character in which strains differed was the ability to go through the sexual cycle to generate mature spores and viable mutant progeny. Strains lacking the integral membrane subunits a, c, c', and c" had more severe defects than strains lacking subunits C or H.	Univ Calif Santa Cruz, Dept Mol Cellular & Dev Biol, Sinsheimer Labs, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Bowman, BJ (corresponding author), Univ Calif Santa Cruz, Dept Mol Cellular & Dev Biol, Sinsheimer Labs, Santa Cruz, CA 95064 USA.	bowman@biology.ucsc.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028703, R25GM058903] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM28703, GM58903] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allan AK, 2005, PHYSIOL GENOMICS, V22, P128, DOI 10.1152/physiolgenomics.00233.2004; BAUERLE C, 1993, J BIOL CHEM, V268, P12749; BELTRAN C, 1992, J BIOL CHEM, V267, P774; BOWMAN BJ, 1988, J BIOL CHEM, V263, P14002; BOWMAN BJ, 1992, J BIOENERG BIOMEMBR, V24, P361, DOI 10.1007/BF00762529; Bowman EJ, 2000, J BIOL CHEM, V275, P167, DOI 10.1074/jbc.275.1.167; Bowman EJ, 2004, J BIOL CHEM, V279, P33131, DOI 10.1074/jbc.M404638200; BOWMAN EJ, 1988, J BIOL CHEM, V263, P13994; Bowman EJ, 1997, J BIOL CHEM, V272, P14776, DOI 10.1074/jbc.272.23.14776; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Curtis KK, 2002, J BIOL CHEM, V277, P2716, DOI 10.1074/jbc.M107777200; DAVIS RH, 1986, MICROBIOL REV, V50, P280, DOI 10.1128/MMBR.50.3.280-313.1986; DSCHIDA WJ, 1992, J BIOL CHEM, V267, P18783; Farina C, 2002, CURR PHARM DESIGN, V8, P2033, DOI 10.2174/1381612023393369; FAVIS RH, 2000, NEUROSPORA CONTRIBUT, P283; Fillingame RH, 2002, BBA-BIOENERGETICS, V1555, P29, DOI 10.1016/S0005-2728(02)00250-5; Futai M, 2000, BBA-BIOENERGETICS, V1458, P276, DOI 10.1016/S0005-2728(00)00080-3; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Gluck SL, 1998, ACTA PHYSIOL SCAND, V163, P203; GOGARTEN JP, 1989, P NATL ACAD SCI USA, V86, P6661, DOI 10.1073/pnas.86.17.6661; Hirata R, 1997, J BIOL CHEM, V272, P4795, DOI 10.1074/jbc.272.8.4795; HO MN, 1993, J BIOL CHEM, V268, P18286; Hunt IE, 1997, J BIOENERG BIOMEMBR, V29, P533, DOI 10.1023/A:1022474816665; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; Inoue H, 1999, BBA-BIOENERGETICS, V1413, P130, DOI 10.1016/S0005-2728(99)00096-1; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P47411, DOI 10.1074/jbc.M108310200; Kluge C, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-29; Lu XB, 1998, IMMUNITY, V8, P647, DOI 10.1016/S1074-7613(00)80569-5; MacLeod KJ, 1998, J BIOL CHEM, V273, P150, DOI 10.1074/jbc.273.1.150; Malkus P, 2004, MOL BIOL CELL, V15, P5075, DOI 10.1091/mbc.E04-06-0514; Manolson MF, 2003, J BIOL CHEM, V278, P49271, DOI 10.1074/jbc.M309914200; MANOLSON MF, 1992, J BIOL CHEM, V267, P14294; MANOLSON MF, 1994, J BIOL CHEM, V269, P14064; Margolin B.S., 1997, FUNGAL GENET REP, V44, P34, DOI [10.4148/1941-4765.1281, DOI 10.4148/1941-4765.1281, DOI 10.1128/EC.00244-07]; Margolles-Clark E, 1999, J BIOENERG BIOMEMBR, V31, P29, DOI 10.1023/A:1005440412633; MELNIK VI, 1996, J BIOL CHEM, V273, P22570; Ninomiya Y, 2004, P NATL ACAD SCI USA, V101, P12248, DOI 10.1073/pnas.0402780101; Nishi T, 2000, J BIOL CHEM, V275, P6824, DOI 10.1074/jbc.275.10.6824; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Nishi T, 2003, J BIOL CHEM, V278, P5821, DOI 10.1074/jbc.M209875200; Oka T, 2000, J BIOL CHEM, V275, P29556, DOI 10.1074/jbc.M002756200; Pall ML, 1993, FUNGAL GENET NEWSL, V40, P58; Parra KJ, 2000, J BIOL CHEM, V275, P21761, DOI 10.1074/jbc.M002305200; PUOPOLO K, 1992, J BIOL CHEM, V267, P5171; SELKER EU, 1990, ANNU REV GENET, V24, P579, DOI 10.1146/annurev.ge.24.120190.003051; SELKER EU, 1988, P NATL ACAD SCI USA, V85, P6870, DOI 10.1073/pnas.85.18.6870; SENIOR AE, 1990, ANNU REV BIOPHYS BIO, V19, P7; SISTA H, 1994, MOL GEN GENET, V243, P82, DOI 10.1007/BF00283879; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Sun-Wada GH, 2004, BBA-BIOENERGETICS, V1658, P106, DOI 10.1016/j.bbabio.2004.04.013; Sze H, 2002, TRENDS PLANT SCI, V7, P157, DOI 10.1016/S1360-1385(02)02240-9; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ueno H, 2005, P NATL ACAD SCI USA, V102, P1333, DOI 10.1073/pnas.0407857102; UMEMOTO N, 1991, J BIOL CHEM, V266, P24526; VOGEL HJ, 1964, AM NAT, V98, P435, DOI 10.1086/282338; Wagner CA, 2004, PHYSIOL REV, V84, P1263, DOI 10.1152/physrev.00045.2003; Whyteside G, 2005, FEBS LETT, V579, P2981, DOI 10.1016/j.febslet.2005.04.049; Wilkens S, 1999, J BIOL CHEM, V274, P31804, DOI 10.1074/jbc.274.45.31804; XIE XS, 1994, J BIOL CHEM, V269, P25809; Zhong XT, 2000, J BIOL CHEM, V275, P35592, DOI 10.1074/jbc.M006932200; Zhou ZM, 1998, J BIOL CHEM, V273, P5878, DOI 10.1074/jbc.273.10.5878	62	15	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2006	281	37					27052	27062		10.1074/jbc.M603883200	http://dx.doi.org/10.1074/jbc.M603883200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082PB	16857684	hybrid			2022-12-27	WOS:000240397700032
J	Akimova, OA; Grygorczyk, A; Bundey, RA; Bourcier, N; Gekle, M; Insel, PA; Orlov, SN				Akimova, Olga A.; Grygorczyk, Alexandra; Bundey, Richard A.; Bourcier, Nathalie; Gekle, Michael; Insel, Paul A.; Orlov, Sergei N.			Transient activation and delayed inhibition of Na+, K+, Cl- cotransport in ATP-treated C11-MDCK cells involve distinct P2Y receptor subtypes and signaling mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR SMOOTH-MUSCLE; CATION-CHLORIDE COTRANSPORTERS; ALANINE-RICH KINASE; CANINE KIDNEY-CELLS; NA+-K+-2CL(-) COTRANSPORTER; EPITHELIAL-CELLS; C7-MDCK CELLS; EXPRESSION; CLONING; RAT	In C11-MDCK cells, which resemble intercalated cells from collecting ducts of the canine kidney, P2Y agonists promote transient activation of the Na+, K+, Cl- cotransporter (NKCC), followed by its sustained inhibition. We designed this study to identify P2Y receptor subtypes involved in dual regulation of this carrier. Real time polymerase chain reaction analysis demonstrated that C11-MDCK cells express abundant P2Y(1) and P2Y(2) mRNA compared with that of other P2Y receptor subtypes. The rank order of potency of agents (ATP similar to UTP >> 2-(methylthio)-ATP (2MeSATP); adenosine 5' -[beta-thio]diphosphate (ADP beta S) inactive) indicated that P2Y(2) rather than P2Y(1) receptors mediate a 3-4-fold activation of NKCC within the first 5-10 min of nucleotide addition. NKCC activation in ATP-treated cells was abolished by the intracellular calcium chelator 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid, calmodulin (CaM) antagonists trifluoroperazine and W-7, and KN-62, an inhibitor of Ca2+/CaM-dependent protein kinase II. By contrast with the transient activation, 30-min incubation with nucleotides produced up to 4-5-fold inhibition of NKCC, and this inhibition exhibited a rank order of potency (2MeSATP > ADP beta S > ATP >> UTP) typical of P2Y(1) receptors. Unlike the early response, delayed inhibition of NKCC occurred in 1,2-bis(2-aminophenoxy)ethane-N, N, N', N'-tetraacetic acid-loaded cells and was completely abolished by the P2Y(1) antagonists MRS2179 and MRS2500. Transient activation and delayed inhibition of NKCC in C11 cell monolayers were observed after the addition of ATP to mucosal and serosal solutions, respectively. NKCC inhibition triggered by basolateral application of ADP beta S was abolished by MRS2500. Our results thus show that transient activation and delayed inhibition of NKCC in ATP-treated C11-MDCK cells is mediated by Ca2+/CaM-dependent protein kinase II- and Ca2+-independent signaling triggered by apical P2Y(2) and basolateral P2Y(1) receptors, respectively.	CHUM, Ctr Rech, Montreal, PQ H1W 4A4, Canada; Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Wurzburg, Dept Physiol, D-97070 Wurzburg, Germany	Universite de Montreal; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Wurzburg	Orlov, SN (corresponding author), CHUM, Ctr Rech, 2901 Rachel Es Rm 313, Montreal, PQ H1W 4A4, Canada.	sergei.n.orlov@umontreal.ca	ORLOV, SERGEI/I-4071-2013; Akimova, Olga/I-2669-2014	Grygorczyk, Alexandra/0000-0001-9416-6316	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066232] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM66232] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akar F, 2001, AM J PHYSIOL-CELL PH, V281, pC579, DOI 10.1152/ajpcell.2001.281.2.C579; Akimova AO, 2005, J PHYSIOL-LONDON, V568, P789, DOI 10.1113/jphysiol.2005.094375; Anfinogenova YJ, 2004, PFLUG ARCH EUR J PHY, V449, P42, DOI 10.1007/s00424-004-1316-z; Anfinogenova YJ, 2001, CELL PHYSIOL BIOCHEM, V11, P295, DOI 10.1159/000047816; Bailey MA, 2000, KIDNEY INT, V58, P1893, DOI 10.1111/j.1523-1755.2000.00361.x; Bailey MA, 2000, J AUTONOM NERV SYST, V81, P264, DOI 10.1016/S0165-1838(00)00125-9; Berra-Romani R, 2004, J VASC RES, V41, P166, DOI 10.1159/000077146; Bourcier N, 2002, J MEMBRANE BIOL, V186, P131, DOI 10.1007/s00232-001-0141-y; BREYER MD, 1994, ANNU REV PHYSIOL, V56, P711, DOI 10.1146/annurev.ph.56.030194.003431; Brindikova TA, 2003, AM J PHYSIOL-CELL PH, V285, pC1445, DOI 10.1152/ajpcell.00386.2002; Burnstock G, 2004, INT REV CYTOL, V240, P31, DOI 10.1016/S0074-7696(04)40002-3; Cattaneo M, 2004, BIOCHEM PHARMACOL, V68, P1995, DOI 10.1016/j.bcp.2004.06.026; Chan CM, 1998, EXP NEPHROL, V6, P200; DELLES C, 1995, J PHYSIOL-LONDON, V486, P557, DOI 10.1113/jphysiol.1995.sp020834; DELPIRE E, 1994, J BIOL CHEM, V269, P25677; Delpire E, 2000, NEWS PHYSIOL SCI, V15, P309, DOI 10.1152/physiologyonline.2000.15.6.309; Drakulich DA, 2004, EUR J PHARMACOL, V485, P137, DOI 10.1016/j.ejphar.2003.11.056; FREDHOLM BB, 1994, PHARMACOL REV, V46, P143; Gagnon F, 1998, BBA-BIOMEMBRANES, V1369, P233, DOI 10.1016/S0005-2736(97)00225-3; Gagnon F, 1999, J MEMBRANE BIOL, V167, P193, DOI 10.1007/s002329900483; Gagnon KBE, 2006, MOL CELL BIOL, V26, P689, DOI 10.1128/MCB.26.2.689-698.2006; Gagnon KBE, 2006, AM J PHYSIOL-CELL PH, V290, pC134, DOI 10.1152/ajpcell.00037.2005; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Gamba G., 2004, AM J PHYSIOL, V288, pF245; GEKLE M, 1994, PFLUG ARCH EUR J PHY, V428, P157, DOI 10.1007/BF00374853; Greger R, 2000, AM J MED SCI, V319, P51, DOI 10.1097/00000441-200001000-00005; Haas M, 2000, ANNU REV PHYSIOL, V62, P515, DOI 10.1146/annurev.physiol.62.1.515; HANSON PI, 1992, ANNU REV BIOCHEM, V61, P559, DOI 10.1146/annurev.bi.61.070192.003015; Joseph SM, 2003, J BIOL CHEM, V278, P23331, DOI 10.1074/jbc.M302680200; Kunapuli SP, 1998, BIOCHEM J, V336, P513, DOI 10.1042/bj3360513; Lazarowski ER, 2001, NEWS PHYSIOL SCI, V16, P1; Mount DB, 1998, J EXP BIOL, V201, P2091; Orlov SN, 1996, J MEMBRANE BIOL, V153, P125, DOI 10.1007/s002329900116; Orlov SN, 1996, AM J PHYSIOL-CELL PH, V270, pC1388, DOI 10.1152/ajpcell.1996.270.5.C1388; Orlov SN, 1999, J MEMBRANE BIOL, V172, P225, DOI 10.1007/s002329900599; Ostrom RS, 2000, J BIOL CHEM, V275, P11735, DOI 10.1074/jbc.275.16.11735; PAULMICHL M, 1991, J CELL PHYSIOL, V147, P68, DOI 10.1002/jcp.1041470110; Piechotta K, 2002, J BIOL CHEM, V277, P50812, DOI 10.1074/jbc.M208108200; Qi AD, 2005, J BIOL CHEM, V280, P29169, DOI 10.1074/jbc.M501301200; RICE WR, 1995, AM J RESP CELL MOL, V12, P27, DOI 10.1165/ajrcmb.12.1.7811468; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; Schwiebert EM, 2002, AM J PHYSIOL-RENAL, V282, pF763, DOI 10.1152/ajprenal.0337.2000; Schwiebert EM, 2003, BBA-BIOMEMBRANES, V1615, P7, DOI 10.1016/S0005-2736(03)00210-4; Takeda M, 1998, BIOCHEM MOL BIOL INT, V44, P657; Taurin S, 2002, J PHYSIOL-LONDON, V543, P835, DOI 10.1113/jphysiol.2002.023259; TOKUYAMA Y, 1995, BIOCHEM BIOPH RES CO, V211, P211, DOI 10.1006/bbrc.1995.1798; Vassort G, 2001, PHYSIOL REV, V81, P767, DOI 10.1152/physrev.2001.81.2.767; von Kugelgen I, 2006, PHARMACOL THERAPEUT, V110, P415, DOI 10.1016/j.pharmthera.2005.08.014; Williams M, 2000, BIOCHEM PHARMACOL, V59, P1173, DOI 10.1016/S0006-2952(99)00341-X; Wolff SC, 2005, AM J PHYSIOL-CELL PH, V288, pC624, DOI 10.1152/ajpcell.00338.2004; Zambon AC, 2000, AM J PHYSIOL-RENAL, V279, pF1045, DOI 10.1152/ajprenal.2000.279.6.F1045	51	23	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31317	31325		10.1074/jbc.M602117200	http://dx.doi.org/10.1074/jbc.M602117200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16916802	Bronze			2022-12-27	WOS:000241235300016
J	Choudhury, P; Srivastava, S; Li, Z; Ko, K; Albaqumi, M; Narayan, K; Coetzee, WA; Lemmon, MA; Skolnik, EY				Choudhury, Papiya; Srivastava, Shekhar; Li, Zhai; Ko, Kyung; Albaqumi, Mamdouh; Narayan, Kartik; Coetzee, William A.; Lemmon, Mark A.; Skolnik, Edward Y.			Specificity of the myotubularin family of phosphatidylinositol-3-phosphatase is determined by the PH/GRAM domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAINS; CA2+-ACTIVATED K+ CHANNEL; PHOSPHOINOSITIDE PHOSPHATASES; CAENORHABDITIS-ELEGANS; BINDING DOMAIN; GRAM DOMAIN; IN-VIVO; MYOPATHY; 3-PHOSPHATE; DISEASE	Myotubularins (MTM) are a large subfamily of lipid phosphatases that specifically dephosphorylate at the D3 position of phosphatidylinositol 3-phosphate (PI(3)P) in PI(3)P and PI(3,5)P-2. We recently found that MTMR6 specifically inhibits the Ca2+-activated K+ channel, KCa3.1, by dephosphorylating PI(3)P. We now show that inhibition is specific for MTMR6 and other MTMs do not inhibit KCa3.1. By replacing either or both of the coiled-coil (CC) and pleckstrin homology/GRAM (PH/G) domains of MTMs that failed to inhibit KCa3.1 with the CC and PH/ G domains of MTMR6, we found that chimeric MTMs containing both the MTMR6 CC and PH/G domains functioned like MTMR6 to inhibit KCa3.1 channel activity, whereas chimeric MTMs containing either domain alone did not. Immunofluorescent microscopy demonstrated that both the MTMR6 CC and PH/G domains are required to co-localize MTMR6 to the plasma membrane with KCa3.1. These findings support a model in which two specific low affinity interactions are required to co-localize MTMR6 with KCa3.1: 1) between the CC domains on MTMR6 and KCa3.1 and (2) between the PH/G domain and a component of the plasma membrane. Our inability to detect significant interaction of the MTMR6 G/PH domain with phosphoinositides suggests that this domain may bind a protein. Identifying the specific binding partners of the CC and PH/G domains on other MTMs will provide important clues to the specific functions regulated by other MTMs as well as the mechanism(s) whereby loss of some MTMs lead to disease.	NYU, Sch Med, Skirball Inst, Dept Med, New York, NY 10016 USA; NYU, Sch Med, Dept Pediat Cardiol, New York, NY 10016 USA; NYU, Sch Med, Dept Nephrol, New York, NY 10016 USA; Univ Penn, Med Ctr, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	New York University; New York University; New York University; University of Pennsylvania	Skolnik, EY (corresponding author), NYU, Sch Med, Skirball Inst, Dept Med, 550 1St Ave, New York, NY 10016 USA.	Skolnik@saturn.med.nyu.edu		Coetzee, William/0000-0003-1522-8326; Lemmon, Mark/0000-0002-3379-5319; Srivastava, Shekhar/0000-0001-5165-7385				Begley MJ, 2006, P NATL ACAD SCI USA, V103, P927, DOI 10.1073/pnas.0510006103; Begley MJ, 2005, CURR OPIN STRUC BIOL, V15, P614, DOI 10.1016/j.sbi.2005.10.016; Begley MJ, 2003, MOL CELL, V12, P1391, DOI 10.1016/S1097-2765(03)00486-6; Berger P, 2003, P NATL ACAD SCI USA, V100, P12177, DOI 10.1073/pnas.2132732100; Bolino A, 2000, NAT GENET, V25, P17, DOI 10.1038/75542; Clague MJ, 2005, TRAFFIC, V6, P1063, DOI 10.1111/j.1600-0854.2005.00338.x; Dang H, 2004, MOL BIOL CELL, V15, P189, DOI 10.1091/mbc.E03-08-0605; Doerks T, 2000, TRENDS BIOCHEM SCI, V25, P483, DOI 10.1016/S0968-0004(00)01664-9; Fournier E, 2003, CURR BIOL, V13, P1858, DOI 10.1016/j.cub.2003.09.034; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; Isakoff SJ, 1998, EMBO J, V17, P5374, DOI 10.1093/emboj/17.18.5374; Isakoff SJ, 1996, J BIOL CHEM, V271, P3959; Kim SA, 2003, P NATL ACAD SCI USA, V100, P4492, DOI 10.1073/pnas.0431052100; Kim SA, 2002, J BIOL CHEM, V277, P4526, DOI 10.1074/jbc.M111087200; Laporte J, 2003, HUM MOL GENET, V12, pR285, DOI 10.1093/hmg/ddg273; Laporte J, 1996, NAT GENET, V13, P175, DOI 10.1038/ng0696-175; Lemmon MA, 2004, BIOCHEM SOC T, V32, P707, DOI 10.1042/BST0320707; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; Lorenzo O, 2005, J CELL SCI, V118, P2005, DOI 10.1242/jcs.02325; Mochizuki Y, 2003, P NATL ACAD SCI USA, V100, P9768, DOI 10.1073/pnas.1333958100; Nandurkar HH, 2003, P NATL ACAD SCI USA, V100, P8660, DOI 10.1073/pnas.1033097100; Schaletzky J, 2003, CURR BIOL, V13, P504, DOI 10.1016/S0960-9822(03)00132-5; Senderek J, 2003, HUM MOL GENET, V12, P349, DOI 10.1093/hmg/ddg030; Srivastava S, 2005, MOL CELL BIOL, V25, P3630, DOI 10.1128/MCB.25.9.3630-3638.2005; Srivastava S, 2006, MOL BIOL CELL, V17, P146, DOI 10.1091/mbc.e05-08-0763; Srivastava S, 2006, MOL CELL BIOL, V26, P5595, DOI 10.1128/MCB.00352-06; Syme CA, 2003, J BIOL CHEM, V278, P8476, DOI 10.1074/jbc.M210072200; Taylor GS, 2000, P NATL ACAD SCI USA, V97, P8910, DOI 10.1073/pnas.160255697; Taylor GS, 2003, METHOD ENZYMOL, V366, P43; Tsujita K, 2004, J BIOL CHEM, V279, P13817, DOI 10.1074/jbc.M312294200; Wishart MJ, 2001, CURR OPIN CELL BIOL, V13, P172, DOI 10.1016/S0955-0674(00)00195-2; Xue YZ, 2003, J BIOL CHEM, V278, P34380, DOI 10.1074/jbc.M303259200; Yu JW, 2004, MOL CELL, V13, P677, DOI 10.1016/S1097-2765(04)00083-8	33	32	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31762	31769		10.1074/jbc.M606344200	http://dx.doi.org/10.1074/jbc.M606344200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16914545	Bronze			2022-12-27	WOS:000241235300063
J	Mercante, J; Suzuki, K; Cheng, XD; Babitzke, P; Romeo, T				Mercante, Jeffrey; Suzuki, Kazushi; Cheng, Xiaodong; Babitzke, Paul; Romeo, Tony			Comprehensive alanine-scanning mutagenesis of Escherichia coli CsrA defines two subdomains of critical functional importance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTERICA SEROVAR TYPHIMURIUM; BINDING ATTENUATION PROTEIN; GLOBAL REGULATOR CSRA; RNA-BINDING; STRUCTURAL BASIS; GENE-EXPRESSION; CRYSTAL-STRUCTURE; EXTRACELLULAR ENZYMES; GLYCOGEN BIOSYNTHESIS; RECEPTOR INTERACTIONS	The RNA-binding protein CsrA (carbon storage regulator) of Escherichia coli is a global regulator of gene expression and is representative of the CsrA/RsmA family of bacterial proteins. These proteins act by regulating mRNA translation and stability and are antagonized by binding to small noncoding RNAs. Although the RNA target sequence and structure for CsrA binding have been well defined, little information exists concerning the protein requirements for RNA recognition. The three-dimensional structures of three CsrA/RsmA proteins were recently solved, revealing a novel protein fold consisting of two interdigitated monomers. Here, we performed comprehensive alanine- scanning mutagenesis on csrA of E. coli and tested the 58 resulting mutants for regulation of glycogen accumulation, motility, and biofilm formation. Quantitative effects of these mutations on expression of glgCA'-'lacZ, flhDC'-'lacZ, and pgaA'-'lacZ translational fusions were also examined, and eight of the mutant proteins were purified and tested for RNA binding. These studies identified two regions of the amino acid sequence that were critical for regulation and RNA binding, located within the first (beta(1), residues 2-7) and containing the last (beta(5), residues 40-47) beta-strands of CsrA. The beta(1) and beta(5) strands of opposite monomers lie adjacent and parallel to each other in the three-dimensional structure of this protein. Given the symmetry of the CsrA dimer, these findings imply that two distinct RNA binding surfaces or functional subdomains lie on opposite sides of the protein.	Emory Univ, Sch Med, Dept Immunol & Microbiol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Emory University; Emory University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Romeo, T (corresponding author), Emory Univ, Sch Med, Dept Immunol & Microbiol, 3105 Rollins Res Ctr,1510 Clifton Rd NE, Atlanta, GA 30322 USA.	romeo@microbio.emory.edu	Suzuki, Kazushi/I-4509-2016; Babitzke, Paul/AAL-3048-2020	Babitzke, Paul/0000-0003-2481-1062; Mercante, Jeffrey/0000-0003-2553-1230	NIGMS NIH HHS [R01 GM059969] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059969] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAM SA, 1986, MOL CELL BIOL, V6, P2932, DOI 10.1128/MCB.6.8.2932; Allain FHT, 1997, EMBO J, V16, P5764, DOI 10.1093/emboj/16.18.5764; Altier C, 2000, MOL MICROBIOL, V35, P635, DOI 10.1046/j.1365-2958.2000.01734.x; Altier C, 2000, INFECT IMMUN, V68, P6790, DOI 10.1128/IAI.68.12.6790-6797.2000; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Antson AA, 1999, NATURE, V401, P235, DOI 10.1038/45730; BAASE WA, 1992, FARADAY DISCUSS, V93, P173, DOI 10.1039/fd9929300173; Baker CS, 2002, MOL MICROBIOL, V44, P1599, DOI 10.1046/j.1365-2958.2002.02982.x; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BIOU V, 1994, SCIENCE, V263, P1404, DOI 10.1126/science.8128220; Boyd D, 2000, J BACTERIOL, V182, P842, DOI 10.1128/JB.182.3.842-847.2000; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; CUI Y, 1995, J BACTERIOL, V177, P5108, DOI 10.1128/jb.177.17.5108-5115.1995; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; De Guzman RN, 1998, BIOPOLYMERS, V48, P181, DOI 10.1002/(SICI)1097-0282(1998)48:2<181::AID-BIP7>3.0.CO;2-L; DeLano W.L, PYMOL MOL GRAPHICS S; Deo RC, 1999, CELL, V98, P835, DOI 10.1016/S0092-8674(00)81517-2; Dubey AK, 2005, RNA, V11, P1579, DOI 10.1261/rna.2990205; Dubey AK, 2003, J BACTERIOL, V185, P4450, DOI 10.1128/JB.185.15.4450-4460.2003; Eiler S, 1999, EMBO J, V18, P6532, DOI 10.1093/emboj/18.22.6532; Fortune DR, 2006, INFECT IMMUN, V74, P331, DOI 10.1128/IAI.74.1.331-339.2006; Gollnick P, 2005, ANNU REV GENET, V39, P47, DOI 10.1146/annurev.genet.39.073003.093745; Griffith KL, 2002, BIOCHEM BIOPH RES CO, V290, P397, DOI 10.1006/bbrc.2001.6152; Gutierrez P, 2005, J BACTERIOL, V187, P3496, DOI 10.1128/JB.187.10.3496-3501.2005; Handa N, 1999, NATURE, V398, P579, DOI 10.1038/19242; Heeb S, 2006, J MOL BIOL, V355, P1026, DOI 10.1016/j.jmb.2005.11.045; Heurlier K, 2004, J BACTERIOL, V186, P2936, DOI 10.1128/JB.186.10.2936-2945.2004; Jackson DW, 2002, J BACTERIOL, V184, P290, DOI 10.1128/JB.184.1.290-301.2002; Jovine L, 1996, STRUCTURE, V4, P621, DOI 10.1016/S0969-2126(96)00066-4; KELLY PA, 1994, HORM RES, V42, P133, DOI 10.1159/000184185; KIMURA M, 1979, SCI AM, V241, P98, DOI 10.1038/scientificamerican1179-98; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lenz DH, 2005, MOL MICROBIOL, V58, P1186, DOI 10.1111/j.1365-2958.2005.04902.x; Lewis HA, 2000, CELL, V100, P323, DOI 10.1016/S0092-8674(00)80668-6; Liu MY, 1997, J BACTERIOL, V179, P4639, DOI 10.1128/jb.179.14.4639-4642.1997; Liu MY, 1997, J BIOL CHEM, V272, P17502, DOI 10.1074/jbc.272.28.17502; Liu Y, 1998, MOL MICROBIOL, V29, P219, DOI 10.1046/j.1365-2958.1998.00924.x; LIVINGSTONE CD, 1993, COMPUT APPL BIOSCI, V9, P745; MacLennan DH, 1998, ACTA PHYSIOL SCAND, V163, P55; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Messias AC, 2004, ACCOUNTS CHEM RES, V37, P279, DOI 10.1021/ar030034m; Molofsky AB, 2003, MOL MICROBIOL, V50, P445, DOI 10.1046/j.1365-2958.2003.03706.x; Norton RS, 2004, CURR MED CHEM, V11, P3041, DOI 10.2174/0929867043363947; OUBRIDGE C, 1994, NATURE, V372, P432, DOI 10.1038/372432a0; Rife C, 2005, PROTEINS, V61, P449, DOI 10.1002/prot.20502; ROMEO T, 1993, J BACTERIOL, V175, P4744, DOI 10.1128/JB.175.15.4744-4755.1993; SABNIS NA, 1995, J BIOL CHEM, V270, P29096, DOI 10.1074/jbc.270.49.29096; Sasaki N, 1998, ADV BIOPHYS, V35, P1; Siomi H, 1997, CURR OPIN GENET DEV, V7, P345, DOI 10.1016/S0959-437X(97)80148-7; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Stefl R, 2005, EMBO REP, V6, P33, DOI 10.1038/sj.embor.7400325; Symmons MF, 2000, STRUCTURE, V8, P1215, DOI 10.1016/S0969-2126(00)00521-9; Theobald DL, 2003, ANNU REV BIOPH BIOM, V32, P115, DOI 10.1146/annurev.biophys.32.110601.142506; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Valverde C, 2004, J BIOL CHEM, V279, P25066, DOI 10.1074/jbc.M401870200; van den Worm SHE, 1998, NUCLEIC ACIDS RES, V26, P1345, DOI 10.1093/nar/26.5.1345; Varani G, 1998, ANNU REV BIOPH BIOM, V27, P407, DOI 10.1146/annurev.biophys.27.1.407; Wang X, 2005, MOL MICROBIOL, V56, P1648, DOI 10.1111/j.1365-2958.2005.04648.x; Wei BDL, 2001, MOL MICROBIOL, V40, P245, DOI 10.1046/j.1365-2958.2001.02380.x; Weilbacher T, 2003, MOL MICROBIOL, V48, P657, DOI 10.1046/j.1365-2958.2003.03459.x; WELLS JA, 1993, RECENT PROG HORM RES, V48, P253; Wiesmann C, 2001, CELL MOL LIFE SCI, V58, P748, DOI 10.1007/PL00000898; Wilusz CJ, 2005, NAT STRUCT MOL BIOL, V12, P1031, DOI 10.1038/nsmb1037; Yakhnin AV, 2000, J BIOL CHEM, V275, P4519, DOI 10.1074/jbc.275.6.4519	65	87	91	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31832	31842		10.1074/jbc.M606057200	http://dx.doi.org/10.1074/jbc.M606057200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16923806				2022-12-27	WOS:000241235300070
J	Briz, O; Romero, MR; Martinez-Becerra, P; Macias, RIR; Perez, MJ; Jimenez, F; San Martin, FG; Marin, JJG				Briz, Oscar; Romero, Marta R.; Martinez-Becerra, Pablo; Macias, Rocio I. R.; Perez, Maria J.; Jimenez, Felipe; San Martin, Francisco G.; Marin, Jose J. G.			OATP8/1B3-mediated cotransport of bile acids and glutathione - An export pathway for organic anions from hepatocytes?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOBILIARY TRANSPORTER EXPRESSION; REDUCED GLUTATHIONE; FUNCTIONAL-CHARACTERIZATION; INTRACELLULAR GLUTATHIONE; INTRAHEPATIC CHOLESTASIS; SUBSTRATE-SPECIFICITY; HUMAN LIVER; OATP-B; POLYPEPTIDE; MEMBRANE	In cholestasis, the accumulation of organic anions in hepato-cytes is reduced by transporters (multidrug resistance-associated proteins and OST alpha-OST beta) able to extrude them across the basolateral membrane. Here we investigated whether organic anion-transporting polypeptides (OATPs) may contribute to this function. Xenopus laevis oocytes expressing human carboxylesterase-1 efficiently loaded cholic acid (CA) methyl ester, which was cleaved to CA and exported. Expression of OATP8/1B3 enhanced CA efflux, which was trans-activated by taurocholate but trans-inhibited by reduced (GSH) and oxidized (GSSG) glutathione. Moreover, taurocholate and estradiol 17 beta-D-glucuronide, but not bicarbonate and glutamate, cis-inhibited OATP8/1B3-mediated bile acid transport, whereas glutathione cis-stimulated this process, which involved the transport of glutathione itself with a stoichiometry of 2:1 (GSH/bile acid). No cis-activation by glutathione of OATP-C/1B1 was found. Using real time quantitative reverse transcription-PCR, the absolute abundance of OATP-A/1A2, OATP-C/1B1, and OATP8/1B3 mRNA in human liver biopsies was measured. In healthy liver, expression levels of OATP-C/1B1 were similar to 5-fold those of OATP8/1B3 and > 100-fold those of OATP-A/1A2. This situation was not substantially modified in several cholestatic liver diseases studied here. In conclusion, although both OATP-C/1B1 and OATP8/1B3 are highly expressed, and able to transport bile acids, their mechanisms of action are different. OATP-C/1B1 may be involved in uptake processes, whereas OATP8/1B3 may mediate the extrusion of organic anions by symporting with glutathione as a normal route of exporting metabolites produced by hepatocytes or preventing their intracellular accumulation when their vectorial traffic toward the bile is impaired.	Univ Hosp Salamanca, Res Unit, Salamanca, Spain; Univ Salamanca, Lab Expt Hepatol & Drug Targeting, Salamanca 37007, Spain; Univ Salamanca Hosp, Div Gastroenterol, Salamanca 37007, Spain	University of Salamanca; University of Salamanca	Marin, JJG (corresponding author), Dept Physiol & Pharmacol, Campus Miguel Unamuno,ED S-09, Salamanca 37007, Spain.	jjgmarin@usal.es	Macias, Rocio/ABG-8938-2020; Macias, Rocio I.R./A-9617-2017; Perez, Maria Jose/A-9830-2017; Marin, Jose J. G./D-5017-2011; Romero, Marta Rodriguez/B-1596-2017; Briz Sanchez, Oscar/A-9634-2017	Macias, Rocio/0000-0002-4748-0326; Macias, Rocio I.R./0000-0002-4748-0326; Perez, Maria Jose/0000-0003-4917-6413; Marin, Jose J. G./0000-0003-1186-6849; Romero, Marta Rodriguez/0000-0001-6729-0215; Briz Sanchez, Oscar/0000-0001-6891-1554				Ballatori N, 2005, TOXICOL APPL PHARM, V204, P238, DOI 10.1016/j.taap.2004.09.008; Ballatori N, 1998, SEMIN LIVER DIS, V18, P377, DOI 10.1055/s-2007-1007171; Ballatori N, 1996, AM J PHYSIOL-REG I, V270, pR1156, DOI 10.1152/ajpregu.1996.270.5.R1156; Boyer JL, 2006, AM J PHYSIOL-GASTR L, V290, pG1124, DOI 10.1152/ajpgi.00539.2005; Briz O, 2003, BIOCHEM J, V371, P897, DOI 10.1042/BJ20030034; Briz O, 2002, MOL PHARMACOL, V61, P853, DOI 10.1124/mol.61.4.853; Chignard N, 2001, HEPATOLOGY, V33, P496, DOI 10.1053/jhep.2001.22345; Hagenbuch B, 2003, BBA-BIOMEMBRANES, V1609, P1, DOI 10.1016/S0005-2736(02)00633-8; Hagenbuch B, 2004, PFLUG ARCH EUR J PHY, V447, P653, DOI 10.1007/s00424-003-1168-y; HAGENBUCH B, 1991, P NATL ACAD SCI USA, V88, P10629, DOI 10.1073/pnas.88.23.10629; Keitel V, 2005, HEPATOLOGY, V41, P1160, DOI 10.1002/hep.20682; Koepsell H, 2004, PFLUG ARCH EUR J PHY, V447, P666, DOI 10.1007/s00424-003-1089-9; Konig J, 2000, J BIOL CHEM, V275, P23161, DOI 10.1074/jbc.M001448200; Konig J, 2000, AM J PHYSIOL-GASTR L, V278, pG156, DOI 10.1152/ajpgi.2000.278.1.G156; Kullak-Ublick GA, 2004, GASTROENTEROLOGY, V126, P322, DOI 10.1053/j.gastro.2003.06.005; Kullak-Ublick GA, 2001, GASTROENTEROLOGY, V120, P525, DOI 10.1053/gast.2001.21176; KULLAKUBLICK GA, 1995, GASTROENTEROLOGY, V109, P1274, DOI 10.1016/0016-5085(95)90588-X; Lee TK, 2001, TOXICOL APPL PHARM, V174, P207, DOI 10.1006/taap.2001.9208; Letschert K, 2004, PHARMACOGENETICS, V14, P441, DOI 10.1097/01.fpc.0000114744.08559.92; Li LQ, 2000, MOL PHARMACOL, V58, P335, DOI 10.1124/mol.58.2.335; Li LQ, 1998, J BIOL CHEM, V273, P16184, DOI 10.1074/jbc.273.26.16184; Marin JJG, 2003, BBA-BIOMEMBRANES, V1611, P249, DOI 10.1016/S0005-2736(03)00080-4; MARIN JJG, 2005, MED HYPOTHESES RES, V2, P425; Noe B, 1997, P NATL ACAD SCI USA, V94, P10346, DOI 10.1073/pnas.94.19.10346; Nozawa T, 2004, J PHARMACOL EXP THER, V308, P438, DOI 10.1124/jpet.103.060194; Oswald M, 2001, LIVER, V21, P247, DOI 10.1034/j.1600-0676.2001.021004247.x; Rius M, 2006, AM J PHYSIOL-GASTR L, V290, pG640, DOI 10.1152/ajpgi.00354.2005; Satlin LM, 1997, J BIOL CHEM, V272, P26340, DOI 10.1074/jbc.272.42.26340; SHI XY, 1995, J BIOL CHEM, V270, P25591, DOI 10.1074/jbc.270.43.25591; SORSCHER S, 1992, BIOCHEM BIOPH RES CO, V186, P1455, DOI 10.1016/S0006-291X(05)81570-0; Suzuki H, 2000, SEMIN LIVER DIS, V20, P251, DOI 10.1055/s-2000-8408; Tamai I, 2000, BIOCHEM BIOPH RES CO, V273, P251, DOI 10.1006/bbrc.2000.2922; Vallejo M, 2006, J HEPATOL, V44, P1150, DOI 10.1016/j.jhep.2005.09.017; Zollner G, 2003, J HEPATOL, V38, P717, DOI 10.1016/S0168-8278(03)00096-5; Zollner G, 2001, HEPATOLOGY, V33, P633, DOI 10.1053/jhep.2001.22646	35	64	67	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30326	30335		10.1074/jbc.M602048200	http://dx.doi.org/10.1074/jbc.M602048200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16877380	hybrid			2022-12-27	WOS:000241075900006
J	Demarest, SJ; Hopp, J; Chung, J; Hathaway, K; Mertsching, E; Cao, X; George, J; Miatkowski, K; LaBarre, MJ; Shields, M; Kehry, MR				Demarest, Stephen J.; Hopp, Jennifer; Chung, Julie; Hathaway, Karen; Mertsching, Elisabeth; Cao, Xianjun; George, Judy; Miatkowski, Konrad; LaBarre, Michael J.; Shields, Michael; Kehry, Marilyn R.			An intermediate pH unfolding transition abrogates the ability of IgE to interact with its high affinity receptor Fc epsilon RI alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIAL SCANNING CALORIMETRY; HUMAN-IMMUNOGLOBULIN E; MAST-CELLS; PROTEIN INTERACTIONS; CYTOKINE PRODUCTION; CRYSTAL-STRUCTURE; ANTIBODY; DOMAIN; BINDING; SURVIVAL	The interaction between IgE-Fc (Fc epsilon) and its high affinity receptor Fc epsilon RI on the surface of mast cells and basophils is a key event in allergen-induced allergic inflammation. Recently, several therapeutic strategies have been developed based on this interaction, and some include Fc epsilon-containing moieties. Unlike well characterized IgG therapeutics, the stability and folding properties of IgE are not well understood. Here, we present comparative biophysical analyses of the pH stability and thermostability of Fc epsilon and IgG1-Fc (Fc gamma). Fc gamma was found to be significantly less stable than Fc gamma under all pH and NaCl conditions tested. Additionally, the C epsilon 3C epsilon 4 domains of Fc epsilon were shown to become intrinsically unfolded at pH values below 5.0. The interaction between Fc epsilon and an Fc gamma-Fc epsilon RI alpha fusion protein was studied between pH 4.5 and 7.4 using circular dichroism and a combination of differential scanning calorimetry and isothermal titration calorimetry. Under neutral pH conditions, the apparent affinity of Fc epsilon for the dimeric fusion protein was extremely high compared with published values for the monomeric receptor (K-D < 10(-12) M). Titration to pH 6.0 did not significantly change the binding affinity, and titration to pH 5.5 only modestly attenuated affinity. At pH values below 5.0, the receptor binding domains of Fc epsilon unfolded, and interaction of Fc epsilon with the Fc gamma-Fc epsilon RI alpha fusion protein was abrogated. The unusual pH sensitivity of Fc epsilon may play a role in antigen-dependent regulation of receptor-bound, non-circulating IgE.	Biogen Idec Inc, Dept Prot Chem, San Diego, CA 92122 USA	Biogen	Demarest, SJ (corresponding author), Biogen Idec Inc, Dept Prot Chem, 5200 Res Pl, San Diego, CA 92122 USA.	stephen.demarest@biogenidec.com						Belostotsky R, 2004, CLIN IMMUNOL, V110, P89, DOI 10.1016/j.clim.2003.08.014; BONNEFOY JY, 1995, CURR OPIN IMMUNOL, V7, P355, DOI 10.1016/0952-7915(95)80110-3; Borkowski TA, 2001, J IMMUNOL, V167, P1290, DOI 10.4049/jimmunol.167.3.1290; BRANDTS JF, 1990, BIOCHEMISTRY-US, V29, P6927, DOI 10.1021/bi00481a024; Brezinsky SCG, 2003, J IMMUNOL METHODS, V277, P141, DOI 10.1016/S0022-1759(03)00108-X; Demarest SJ, 2004, J MOL BIOL, V335, P41, DOI 10.1016/j.jmb.2003.10.040; FURUICHI K, 1986, J IMMUNOL, V136, P1015; Garman SC, 2000, NATURE, V406, P259, DOI 10.1038/35018500; Glaser SM, 2005, J BIOL CHEM, V280, P41494, DOI 10.1074/jbc.M508739200; Gould HJ, 2003, ANNU REV IMMUNOL, V21, P579, DOI 10.1146/annurev.immunol.21.120601.141103; Helm BA, 1996, J BIOL CHEM, V271, P7494, DOI 10.1074/jbc.271.13.7494; Henry AJ, 1997, BIOCHEMISTRY-US, V36, P15568, DOI 10.1021/bi971299+; Henry AJ, 2000, BIOCHEMISTRY-US, V39, P7406, DOI 10.1021/bi9928391; Hunt J, 2005, J BIOL CHEM, V280, P16808, DOI 10.1074/jbc.M500965200; Kabat EA, 1991, SEQUENCES PROTEINS I; Kalesnikoff J, 2001, IMMUNITY, V14, P801, DOI 10.1016/S1074-7613(01)00159-5; Kawakami T, 2005, J IMMUNOL, V175, P4167, DOI 10.4049/jimmunol.175.7.4167; Keown MB, 1998, BIOCHEMISTRY-US, V37, P8863, DOI 10.1021/bi972354h; Kinet JP, 1999, ANNU REV IMMUNOL, V17, P931, DOI 10.1146/annurev.immunol.17.1.931; Kitaura J, 2004, J IMMUNOL, V173, P4317, DOI 10.4049/jimmunol.173.7.4317; Kubo S, 2003, J IMMUNOL, V170, P775, DOI 10.4049/jimmunol.170.2.775; MacGlashan D, 1998, BLOOD, V91, P1633, DOI 10.1182/blood.V91.5.1633.1633_1633_1643; MacGlashan D, 2005, CLIN REV ALLERG IMMU, V29, P49, DOI 10.1385/CRIAI:29:1:049; McDonnell JM, 2001, NAT STRUCT BIOL, V8, P437, DOI 10.1038/87603; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Nakamura T, 2000, INT J IMMUNOPHARMACO, V22, P131, DOI 10.1016/S0192-0561(99)00068-5; Pierce MM, 1999, METHODS, V19, P213, DOI 10.1006/meth.1999.0852; Price NE, 2005, J BIOL CHEM, V280, P2324, DOI 10.1074/jbc.M409458200; RAGHAVAN M, 1995, BIOCHEMISTRY-US, V34, P14649, DOI 10.1021/bi00045a005; SANCHEZRUIZ JM, 1988, BIOCHEMISTRY-US, V27, P1648, DOI 10.1021/bi00405a039; Sechi S, 1996, J BIOL CHEM, V271, P19256, DOI 10.1074/jbc.271.32.19256; Sondermann P, 2000, NATURE, V406, P267, DOI 10.1038/35018508; Sondermann P, 2002, IMMUNOL LETT, V82, P51, DOI 10.1016/S0165-2478(02)00018-4; URLAUB G, 1985, SOMAT CELL MOLEC GEN, V11, P71, DOI 10.1007/BF01534736; Vermeer AWP, 2000, BIOPHYS J, V78, P394, DOI 10.1016/S0006-3495(00)76602-1; Wan T, 2002, NAT IMMUNOL, V3, P681, DOI 10.1038/ni811; Wurzburg BA, 2000, IMMUNITY, V13, P375, DOI 10.1016/S1074-7613(00)00037-6; Wurzburg BA, 2002, MOL IMMUNOL, V38, P1063, DOI 10.1016/S0161-5890(02)00035-4; Xu K, 1998, J CELL SCI, V111, P2385; Zhu DC, 2005, NAT MED, V11, P446, DOI 10.1038/nm1219; Zhu DC, 2002, NAT MED, V8, P518, DOI 10.1038/nm0502-518	41	17	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30755	30767		10.1074/jbc.M605190200	http://dx.doi.org/10.1074/jbc.M605190200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16905745	hybrid			2022-12-27	WOS:000241075900052
J	Devgan, V; Nguyen, BC; Oh, H; Dotto, GP				Devgan, Vikram; Nguyen, Bach-Cuc; Oh, Heysun; Dotto, G. Paolo			p21(WAF1/Cip1) suppresses keratinocyte differentiation independently of the cell cycle through transcriptional up-regulation of the IGF-I gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUSTAINED ACTIVATION; GROWTH; EXPRESSION; P21(CIP1/WAF1); RECEPTOR; INHIBITOR; APOPTOSIS; P21; RESISTANCE; PROTEINS	p21 plays a dual role in keratinocyte growth and differentiation control. It restricts the number of keratinocyte stem cell populations while inhibiting the later stages of differentiation independently of the cell cycle. The molecular/biochemical mechanism for the differentiation suppressive function of p21 is unknown. Here we show that elevated p21 expression leads to activation of MAPK family members in a keratinocyte-specific and cell cycle-independent manner, and up-regulation of MAPK activity can explain the inhibitory effects of p21 on differentiation. p21 induces transcription of several genes with MAPK activation potential. Although several of these genes are induced by p21 in a MAPK-dependent manner, expression of IGF-I is induced upstream of MAPK activation. IGF-I stimulation is by itself sufficient to cause MAPK activation and inhibit differentiation and suppression of IGF-I signaling by knock down of the cognate receptor (IGF-R1), diminishing the ability of p21 to activate MAPK and suppress differentiation. Thus, in keratinocytes, the ability of p21 to suppress differentiation can be explained by cell type-specific activation of the MAPK cascade by transcriptional up-regulation of the IGF-I gene.	Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA	University of Lausanne; Harvard University; Massachusetts General Hospital; Harvard University	Dotto, GP (corresponding author), Univ Lausanne, Dept Biochem, Chem Bovaresses 155, CH-1066 Epalinges, Switzerland.	Gian-Paolo.Dotto@unil.ch			NATIONAL CANCER INSTITUTE [P01CA016038, R01CA073796] Funding Source: NIH RePORTER; NCI NIH HHS [CA73796, CA16038] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adamo ML., 1995, DIABETES REV, V3, P2; Aoki M, 2004, J BIOL CHEM, V279, P32643, DOI 10.1074/jbc.M313247200; Asada M, 1999, EMBO J, V18, P1223, DOI 10.1093/emboj/18.5.1223; Bellosta P, 2003, J BONE MINER RES, V18, P818, DOI 10.1359/jbmr.2003.18.5.818; Casini T, 1999, ONCOGENE, V18, P3235, DOI 10.1038/sj.onc.1202630; Celil AB, 2005, J BIOL CHEM, V280, P31353, DOI 10.1074/jbc.M503845200; Chang BD, 2000, P NATL ACAD SCI USA, V97, P4291, DOI 10.1073/pnas.97.8.4291; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Coqueret O, 2000, J BIOL CHEM, V275, P18794, DOI 10.1074/jbc.M001601200; Devgan V, 2005, GENE DEV, V19, P1485, DOI 10.1101/gad.341405; Di Cunto F, 1998, SCIENCE, V280, P1069, DOI 10.1126/science.280.5366.1069; DOTTO GP, 1989, J CELL BIOL, V109, P3115, DOI 10.1083/jcb.109.6.3115; DOTTO GP, 2000, BIOCHIM BIOPHYS ACTA, V1471, P43; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fritah A, 2005, MOL CELL BIOL, V25, P2419, DOI 10.1128/MCB.25.6.2419-2430.2005; Fuhler GM, 2005, J LEUKOCYTE BIOL, V77, P257, DOI 10.1189/jlb.0504306; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Haase I, 2001, J CLIN INVEST, V108, P527, DOI 10.1172/JCI200112153; HARPER JW, 1993, CELL, V75, P805; HEALY E, 1995, J INVEST DERMATOL, V105, P274, DOI 10.1111/1523-1747.ep12318430; Huang S, 2003, MOL CELL, V11, P1491, DOI 10.1016/S1097-2765(03)00180-1; Kelley KM, 1996, INT J BIOCHEM CELL B, V28, P619, DOI 10.1016/1357-2725(96)00005-2; KIKUCHI K, 1992, J BIOL CHEM, V267, P21505; Lee SW, 2000, P NATL ACAD SCI USA, V97, P8302, DOI 10.1073/pnas.150024397; Missero C, 1996, GENE DEV, V10, P3065, DOI 10.1101/gad.10.23.3065; Ng IOL, 1999, ORAL ONCOL, V35, P63, DOI 10.1016/S1368-8375(98)00083-9; Nguyen BC, 2006, GENE DEV, V20, P1028, DOI 10.1101/gad.1406006; NODA A, 1994, EXP CELL RES, V211, P90, DOI 10.1006/excr.1994.1063; Oh H, 2002, P NATL ACAD SCI USA, V99, P5430, DOI 10.1073/pnas.082123999; RISTOW HJ, 1993, GROWTH REGULAT, V3, P129; Rudman SM, 1997, J INVEST DERMATOL, V109, P770, DOI 10.1111/1523-1747.ep12340934; Sadagurski M, 2006, MOL CELL BIOL, V26, P2675, DOI 10.1128/MCB.26.7.2675-2687.2006; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shim J, 1996, NATURE, V381, P804, DOI 10.1038/381804a0; Suzuki A, 1998, ONCOGENE, V17, P931, DOI 10.1038/sj.onc.1202021; TAVAKKOL A, 1992, J INVEST DERMATOL, V99, P343, DOI 10.1111/1523-1747.ep12616668; Topley GI, 1999, P NATL ACAD SCI USA, V96, P9089, DOI 10.1073/pnas.96.16.9089; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; Wang J, 2005, J BIOL CHEM, V280, P37725, DOI 10.1074/jbc.M507976200; Weger N, 2005, J INVEST DERMATOL, V125, P873, DOI 10.1111/j.0022-202X.2005.23946.x; Xu SQ, 2000, BIOCHEM BIOPH RES CO, V269, P179, DOI 10.1006/bbrc.2000.2247; ZENDEGUI J G, 1988, Journal of Cellular Physiology, V136, P257, DOI 10.1002/jcp.1041360207; Zhang PM, 1999, GENE DEV, V13, P213, DOI 10.1101/gad.13.2.213	43	29	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30463	30470		10.1074/jbc.M604684200	http://dx.doi.org/10.1074/jbc.M604684200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16912042	hybrid			2022-12-27	WOS:000241075900021
J	Kanekura, K; Nishimoto, I; Aiso, S; Matsuoka, M				Kanekura, Kohsuke; Nishimoto, Ikuo; Aiso, Sadakazu; Matsuoka, Masaaki			Characterization of amyotrophic lateral sclerosis-linked P56S mutation of vesicle-associated membrane protein-associated protein B (VAPB/ALS8)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; MOTOR-NEURON DEGENERATION; OXYSTEROL-BINDING PROTEIN; ENDOPLASMIC-RETICULUM; INO1 EXPRESSION; ALS2 GENE; MUTANT; PRODUCT; DEATH; ACTIVATION	The P56S mutation in VAPB (vesicle-associated membrane protein-associated protein B) causes autosomal dominant motoneuronal diseases. Although it was reported that the P56S mutation induces localization shift of VAPB from endoplasmic reticulum ( ER) to non-ER compartments, it remains unclear what the physiological function of VAPB is and how the P56S mutation in VAPB causes motoneuronal diseases. Here we demonstrate that overexpression of wild type VAPB (wt-VAPB) promotes unfolded protein response (UPR), which is an ER reaction to suppress accumulation of misfolded proteins, and that small interfering RNA for VAPB attenuates UPR to chemically induced ER stresses, indicating that VAPB is physiologically involved in UPR. The P56S mutation nullifies the function of VAPB to mediate UPR by inhibiting folding of VAPB that results in insolubility and aggregate formation of VAPB in non-ER fractions. Furthermore, we have found that expression of P56S-VAPB inhibits UPR, mediated by endogenous wt-VAPB, by inducing aggregate formation and mislocalization into non-ER fractions of wt-VAPB. Consequently, the P56S mutation in a single allele of the VAPB gene may diminish the activity of VAPB to mediate UPR to less than half the normal level. We thus speculate that the malfunction of VAPB to mediate UPR, caused by the P56S mutation, may contribute to the development of motoneuronal degeneration linked to VAPB/ALS8.	Keio Univ, Sch Med, Dept Pharmacol, Shinjuku Ku, Tokyo 1608582, Japan	Keio University	Matsuoka, M (corresponding author), Keio Univ, Sch Med, Dept Pharmacol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	sakimatu@sc.itc.keio.ac.jp						Amarilio R, 2005, J BIOL CHEM, V280, P5934, DOI 10.1074/jbc.M409566200; Bates G, 2003, LANCET, V361, P1642, DOI 10.1016/S0140-6736(03)13304-1; Berg S, 2005, J BIOL CHEM, V280, P5651, DOI 10.1074/jbc.M411418200; Brickner JH, 2004, PLOS BIOL, V2, P1843, DOI 10.1371/journal.pbio.0020342; Brown B, 2001, J LAW MED ETHICS, V29, P166; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chamberlain LH, 2002, J BIOL CHEM, V277, P49750, DOI 10.1074/jbc.M206936200; Chen YZ, 2004, AM J HUM GENET, V74, P1128, DOI 10.1086/421054; Chiba T, 2004, J NEUROSCI RES, V78, P542, DOI 10.1002/jnr.20305; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Ghadge GD, 1997, J NEUROSCI, V17, P8756; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hadano S, 2006, HUM MOL GENET, V15, P233, DOI 10.1093/hmg/ddi440; Hamamoto I, 2005, J VIROL, V79, P13473, DOI 10.1128/JVI.79.21.13473-13482.2005; Iwawaki T, 2004, NAT MED, V10, P98, DOI 10.1038/nm970; Kagiwada S, 2003, J BIOCHEM, V133, P515, DOI 10.1093/jb/mvg068; Kagiwada S, 1998, J BACTERIOL, V180, P1700, DOI 10.1128/JB.180.7.1700-1708.1998; Kaiser SE, 2005, STRUCTURE, V13, P1035, DOI 10.1016/j.str.2005.04.010; Kanekura K, 2004, J BIOL CHEM, V279, P19247, DOI 10.1074/jbc.M313236200; Kanekura K, 2005, J BIOL CHEM, V280, P4532, DOI 10.1074/jbc.M410508200; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Lehto M, 2005, EXP CELL RES, V310, P445, DOI 10.1016/j.yexcr.2005.08.003; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; NIKAWA J, 1995, J BIOCHEM, V118, P39, DOI 10.1093/oxfordjournals.jbchem.a124889; Nikawa J, 1996, NUCLEIC ACIDS RES, V24, P4222, DOI 10.1093/nar/24.21.4222; NIKAWA JI, 1992, MOL MICROBIOL, V6, P1441, DOI 10.1111/j.1365-2958.1992.tb00864.x; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Nishimura AL, 2005, HUM GENET, V118, P499, DOI 10.1007/s00439-005-0031-y; Nishimura Y, 1999, BIOCHEM BIOPH RES CO, V254, P21, DOI 10.1006/bbrc.1998.9876; Obata Y, 2005, J NEUROSCI RES, V81, P720, DOI 10.1002/jnr.20594; Otomo A, 2003, HUM MOL GENET, V12, P1671, DOI 10.1093/hmg/ddg184; Perry RJ, 2006, MOL BIOL CELL, V17, P2604, DOI 10.1091/mbc.E06-01-0060; Schofield CM, 2004, BIOCHEMISTRY-US, V43, P10058, DOI 10.1021/bi036159g; Shults CW, 2006, P NATL ACAD SCI USA, V103, P1661, DOI 10.1073/pnas.0509567103; SKEHEL PA, 1995, SCIENCE, V269, P1580, DOI 10.1126/science.7667638; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Urushitani M, 2002, J NEUROCHEM, V83, P1030, DOI 10.1046/j.1471-4159.2002.01211.x; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Wyles JP, 2002, J BIOL CHEM, V277, P29908, DOI 10.1074/jbc.M201191200; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160	43	157	163	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					30223	30233		10.1074/jbc.M605049200	http://dx.doi.org/10.1074/jbc.M605049200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16891305	hybrid			2022-12-27	WOS:000240896300082
J	Lundgren, TK; Scott, RP; Smith, M; Pawson, T; Ernfors, P				Lundgren, T. Kalle; Scott, Rizaldy P.; Smith, Matthew; Pawson, Tony; Ernfors, Patrik			Engineering the recruitment of phosphotyrosine binding domain-containing adaptor proteins reveals distinct roles for RET receptor-mediated cell survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; ENTERIC NERVOUS-SYSTEM; TYROSINE KINASE; INSULIN-RECEPTOR; SH2 DOMAIN; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNALING PATHWAY; PTB DOMAINS; PROTOONCOGENE; ACTIVATION	The RET receptor tyrosine kinase is important for several different biological functions during development. The recruitment at the phosphorylated Tyr1062 site in RET of a number of different phosphotyrosine binding ( PTB) domain-containing adaptor proteins, including Shc and Frs2, plays a dominant role for the multiple different biological functions of the RET receptor during development, including stimulation of cell survival. Here, we demonstrate that a competitive recruitment of Shc as opposed to Frs2 mediates the survival signaling arising from RET activation. Based on results from a peptide array, we have genetically engineered the PTB domain binding site of RET to rewire its recruitment of the PTB proteins Shc and Frs2. An engineered RET that has a competitive interaction with Shc at the expense of Frs2, but not a RET receptor that only recruits Frs2, activates cell survival signaling pathways and is protective from cell death in neuronal SK- N- MC cells. Thus, cell type- specific functions involve a competitive recruitment of different PTB adaptor molecules by RET that activate selective signaling pathways.	Karolinska Inst, Dept Med Biochem & Biophys, Mol Neurobiol Unit, S-17177 Stockholm, Sweden; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada	Karolinska Institutet; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Ernfors, P (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Mol Neurobiol Unit, S-17177 Stockholm, Sweden.	Patrik.Ernfors@ki.se	Smith, Matthew J/AAI-8060-2020; Scott, Rizaldy/AAC-5264-2020; Lundgren, Kalle/E-9056-2015; Scott, Rizaldy/Y-7584-2019; Pawson, Tony J/E-4578-2013	Smith, Matthew J/0000-0003-2896-9350; Lundgren, Kalle/0000-0001-6781-762X; Scott, Rizaldy/0000-0002-0288-8862; Ernfors, Patrik/0000-0002-1140-3986				Arighi E, 1997, ONCOGENE, V14, P773, DOI 10.1038/sj.onc.1200896; Asai N, 1996, J BIOL CHEM, V271, P17644, DOI 10.1074/jbc.271.30.17644; ASAI N, 1995, MOL CELL BIOL, V15, P1613; Barlow A, 2003, NEURON, V40, P905, DOI 10.1016/S0896-6273(03)00730-X; Besset V, 2000, J BIOL CHEM, V275, P39159, DOI 10.1074/jbc.M006908200; BLAIKIE P, 1994, J BIOL CHEM, V269, P32031; Borrello MG, 1996, MOL CELL BIOL, V16, P2151; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; de Graaff E, 2001, GENE DEV, V15, P2433, DOI 10.1101/gad.205001; Durick K, 1996, J BIOL CHEM, V271, P12691, DOI 10.1074/jbc.271.22.12691; Encinas M, 2004, J BIOL CHEM, V279, P18262, DOI 10.1074/jbc.M400505200; Eng C, 1999, J CLIN ONCOL, V17, P380, DOI 10.1200/JCO.1999.17.1.380; Enomoto H, 2001, DEVELOPMENT, V128, P3963; FRANK R, 1992, TETRAHEDRON, V48, P9217, DOI 10.1016/S0040-4020(01)85612-X; Fukuda T, 2002, J BIOL CHEM, V277, P19114, DOI 10.1074/jbc.M200643200; Gianino S, 2003, DEVELOPMENT, V130, P2187, DOI 10.1242/dev.00433; Grimm J, 2001, J CELL BIOL, V154, P345, DOI 10.1083/jcb.200102032; GUSTAFSON TA, 1995, MOL CELL BIOL, V15, P2500; Hayashi H, 2000, ONCOGENE, V19, P4469, DOI 10.1038/sj.onc.1203799; He WM, 1998, J BIOL CHEM, V273, P6860, DOI 10.1074/jbc.273.12.6860; Heuckeroth RO, 1999, NEURON, V22, P253, DOI 10.1016/S0896-6273(00)81087-9; HUTCHINSON EG, 1994, PROTEIN SCI, V3, P2207, DOI 10.1002/pro.5560031206; Jain S, 2006, GENE DEV, V20, P321, DOI 10.1101/gad.1387206; Jhiang SM, 2000, ONCOGENE, V19, P5590, DOI 10.1038/sj.onc.1203857; Jijiwa M, 2004, MOL CELL BIOL, V24, P8026, DOI 10.1128/MCB.24.18.8026-8036.2004; Kane LP, 1999, CURR BIOL, V9, P601, DOI 10.1016/S0960-9822(99)80265-6; KAVANAUGH WM, 1995, SCIENCE, V268, P1177, DOI 10.1126/science.7539155; Kurokawa K, 2001, ONCOGENE, V20, P1929, DOI 10.1038/sj.onc.1204290; KUROKAWA K, 1996, J INTERN MED, V3, P627; Laminet AA, 1996, J BIOL CHEM, V271, P264, DOI 10.1074/jbc.271.1.264; Lorenzo MJ, 1997, ONCOGENE, V14, P763, DOI 10.1038/sj.onc.1200894; Marone R, 2004, NAT CELL BIOL, V6, P515, DOI 10.1038/ncb1134; Meakin SO, 1999, J BIOL CHEM, V274, P9861, DOI 10.1074/jbc.274.14.9861; Melillo RM, 2001, MOL CELL BIOL, V21, P4177, DOI 10.1128/MCB.21.13.4177-4187.2001; Melillo RM, 2001, ONCOGENE, V20, P209, DOI 10.1038/sj.onc.1204049; Murakami H, 2002, J BIOL CHEM, V277, P32781, DOI 10.1074/jbc.M202336200; Natarajan D, 2002, DEVELOPMENT, V129, P5151; Ong SH, 2000, MOL CELL BIOL, V20, P979, DOI 10.1128/MCB.20.3.979-989.2000; SANTORO M, 1995, SCIENCE, V267, P381, DOI 10.1126/science.7824936; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Scott RP, 2005, J BIOL CHEM, V280, P13442, DOI 10.1074/jbc.M500507200; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Takahashi M, 2001, CYTOKINE GROWTH F R, V12, P361, DOI 10.1016/S1359-6101(01)00012-0; TAKAHASHI M, 1989, ONCOGENE, V4, P805; TAKAHASHI M, 1988, ONCOGENE, V3, P571; Taraviras S, 1999, DEVELOPMENT, V126, P2785; van der Geer P, 1999, ONCOGENE, V18, P3071, DOI 10.1038/sj.onc.1202879; vanderGeer P, 1996, P NATL ACAD SCI USA, V93, P963, DOI 10.1073/pnas.93.3.963; VANDERGEER P, 1995, CURR BIOL, V5, P404, DOI 10.1016/S0960-9822(95)00081-9; vanWeering DHJ, 1995, ONCOGENE, V11, P2207; WOLF G, 1995, J BIOL CHEM, V270, P27407, DOI 10.1074/jbc.270.46.27407; Worby CA, 1996, J BIOL CHEM, V271, P23619, DOI 10.1074/jbc.271.39.23619; Worley DS, 2000, DEVELOPMENT, V127, P4383; Xu H, 1998, J BIOL CHEM, V273, P17987, DOI 10.1074/jbc.273.29.17987; Young HM, 2001, DEV BIOL, V229, P503, DOI 10.1006/dbio.2000.0100; ZHOU MM, 1995, NATURE, V378, P584, DOI 10.1038/378584a0	57	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					29886	29896		10.1074/jbc.M600473200	http://dx.doi.org/10.1074/jbc.M600473200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16847065	hybrid			2022-12-27	WOS:000240896300050
J	Muller, MR; Zheng, F; Werner, S; Alzheimer, C				Mueller, Mischa Roland; Zheng, Fang; Werner, Sabine; Alzheimer, Christian			Transgenic mice expressing dominant-negative activin receptor IB in forebrain neurons reveal novel functions of activin at glutamatergic synapses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; BRAIN-INJURY; BETA; INDUCTION; ISOFORMS; REPAIR; SIGNAL	The transforming growth factor beta family member activin is an important regulator of development and tissue repair. It is strongly up-regulated after acute injury to the adult brain, and application of exogenous activin protects neurons in several lesion models. To explore the role of endogenous activin in the normal and acutely damaged brain, we generated transgenic mice expressing a dominant-negative activin receptor IB (dnActRIB) mutant in forebrain neurons. The functionality of the transgene was verified in vivo. Hippocampal neurons from dnActRIB mice were significantly more vulnerable to intracerebroventricular injection of the excitotoxin kainic acid than those from control littermates, indicating a crucial role of endogenous activin in the rescue of neurons from excitotoxic insult. Because dnActRIB is only expressed in neurons, but not in glial cells, activin affords protection at least in part through a direct action on endangered neurons. Unexpectedly, the transgenic mice also revealed a prominent novel role of activin in glutamatergic neurotransmission in the intact adult brain. Electrophysiologic examination of excitatory synapses onto CA1 pyramidal cells in hippocampal slices of dnActRIB mice showed a reduced NMDA current response, which was associated with impaired long term potentiation. This is the first demonstration that activin receptor signaling is essential to optimize the performance of neuronal circuits in the mature brain under physiological conditions.	Swiss Fed Inst Technol, Inst Cell Biol, CH-8093 Zurich, Switzerland; Univ Kiel, Inst Physiol, D-24098 Kiel, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Kiel	Werner, S (corresponding author), Swiss Fed Inst Technol, Inst Cell Biol, HPM D42, CH-8093 Zurich, Switzerland.	sabine.werner@cell.biol.ethz.ch; c.alzheimer@physiologie.uni-kiel.de		Zheng, Fang/0000-0002-5699-8063; Werner, Sabine/0000-0001-7397-8710				Alzheimer C, 2002, ADV EXP MED BIOL, V513, P335; ANDREASSON K, 1995, NEUROSCIENCE, V69, P781, DOI 10.1016/0306-4522(95)00245-E; [Anonymous], CYTOKINE HDB; Attisano L, 1996, MOL CELL BIOL, V16, P1066; Bamberger C, 2005, AM J PATHOL, V167, P733, DOI 10.1016/S0002-9440(10)62047-0; Bao YL, 2005, J ENDOCRINOL, V184, P493, DOI 10.1677/joe.1.05978; Dow AL, 2005, J NEUROSCI, V25, P4908, DOI 10.1523/JNEUROSCI.5155-04.2005; Gamer LW, 2005, DEV BIOL, V285, P156, DOI 10.1016/j.ydbio.2005.06.012; Hughes PE, 1999, NEUROSCIENCE, V92, P197, DOI 10.1016/S0306-4522(98)00724-6; Inokuchi K, 1996, FEBS LETT, V382, P48, DOI 10.1016/0014-5793(96)00135-4; Iwahori Y, 1997, BRAIN RES, V760, P52, DOI 10.1016/S0006-8993(97)00275-8; KRIEGLSTEIN K, 1995, EMBO J, V14, P736, DOI 10.1002/j.1460-2075.1995.tb07052.x; Lai M, 1997, NEUROREPORT, V8, P2691, DOI 10.1097/00001756-199708180-00011; Mansuy IM, 1998, NEURON, V21, P257, DOI 10.1016/S0896-6273(00)80533-4; MATHEWS LS, 1993, RECEPTOR, V3, P173; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Soderstrom S, 1996, CELL TISSUE RES, V286, P269, DOI 10.1007/s004410050697; ten Dijke P, 2000, TRENDS BIOCHEM SCI, V25, P64, DOI 10.1016/S0968-0004(99)01519-4; Tretter YP, 2000, NAT MED, V6, P812, DOI 10.1038/77548; Tretter YP, 1996, NEUROREPORT, V7, P1819, DOI 10.1097/00001756-199607290-00026; Tsuchida K, 2004, MOL CELL ENDOCRINOL, V220, P59, DOI 10.1016/j.mce.2004.03.009; Werner S, 2006, CYTOKINE GROWTH F R, V17, P157, DOI 10.1016/j.cytogfr.2006.01.001; Wu DD, 1999, BRAIN RES, V835, P369, DOI 10.1016/S0006-8993(99)01638-8; Yang H, 1999, J HISTOCHEM CYTOCHEM, V47, P431, DOI 10.1177/002215549904700402; Zhou YL, 2000, MOL ENDOCRINOL, V14, P2066, DOI 10.1210/me.14.12.2066	27	42	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					29076	29084		10.1074/jbc.M604959200	http://dx.doi.org/10.1074/jbc.M604959200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16885157	hybrid			2022-12-27	WOS:000240680500062
J	Macdonald, PR; Progias, P; Ciani, B; Patel, S; Mayer, U; Steinmetz, MO; Kammerer, RA				Macdonald, Philip R.; Progias, Pavlos; Ciani, Barbara; Patel, Sanjai; Mayer, Ulrike; Steinmetz, Michel O.; Kammerer, Richard A.			Structure of the extracellular domain of tie receptor tyrosine kinases and localization of the angiopoietin-binding epitope	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-CELLS; CRYSTAL-STRUCTURES; NIDOGEN BINDING; ANGIOGENESIS; EXPRESSION; LIGAND; MICE; GENE; HEMANGIOMA; COMPLEXES	Angiogenesis is essential for tissue repair and regeneration during wound healing but also plays important roles in many pathological processes including tumor growth and metastasis. The receptor protein tyrosine kinase Tie2 and its ligands, the angiopoietins, have important functions in the regulation of angiogenesis. Here, we report a detailed structural and functional characterization of the extracellular region of Tie2. Sequence analysis of the extracellular domain revealed an additional immunoglobulin-like domain resulting in a tandem repeat of immunoglobulin-like domains at the N terminus of the protein. The same domain organization was also found for the Tie1 receptor that shares a high degree of homology with Tie2. Based on structural similarities to other receptor tyrosine kinases and cell adhesion molecules, we demonstrate that the N-terminal two immunoglobulin-like domains of Tie2 harbor the angiopoietin-binding site. Using transmission electron microscopy we furthermore show that the extracellular domain of Tie receptors consists of a globular head domain and a short rod-like stalk that probably forms a spacer between the cell surface and the angiopoietin-binding site. Mutational analysis demonstrated that the head domain consists of the three immunoglobulin-like domains and the three epidermal growth factor-like modules and that the stalk is formed by the three fibronectin type III repeats. These findings might be of particular interest for drug development because Tie receptors are potential targets for treatment of angiogenesis-associated diseases.	Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; Univ E Anglia, Sch Biol Sci, Biomed Res Ctr, Norwich NR4 7TJ, Norfolk, England; Paul Scherrer Inst, Biomol Res Struct Biol, CH-5232 Villigen, Switzerland	University of Manchester; University of East Anglia; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Kammerer, RA (corresponding author), Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	richard.kammerer@manchester.ac.uk	Steinmetz, Michel O/AAA-3349-2022; Ciani, Barbara/A-1679-2012	Steinmetz, Michel O/0000-0001-6157-3687; Ciani, Barbara/0000-0001-7223-4154; Mayer, Ulrike/0000-0003-2328-0052; Kammerer, Richard/0000-0003-4570-5197				Aguilar HC, 2006, J VIROL, V80, P4878, DOI 10.1128/JVI.80.10.4878-4889.2006; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Barton WA, 2006, NAT STRUCT MOL BIOL, V13, P524, DOI 10.1038/nsmb1101; Calvert JT, 1999, HUM MOL GENET, V8, P1279, DOI 10.1093/hmg/8.7.1279; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Cho CH, 2004, P NATL ACAD SCI USA, V101, P5547, DOI 10.1073/pnas.0307574101; CO MS, 1993, MOL IMMUNOL, V30, P1361; Cuff JA, 1998, BIOINFORMATICS, V14, P892, DOI 10.1093/bioinformatics/14.10.892; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; Du Lingling, 2003, New England Journal of Medicine, V348, P500, DOI 10.1056/NEJMoa021650; DUMONT DJ, 1992, ONCOGENE, V7, P1471; Eklund L, 2006, EXP CELL RES, V312, P630, DOI 10.1016/j.yexcr.2005.09.002; Fiedler U, 2003, J BIOL CHEM, V278, P1721, DOI 10.1074/jbc.M208550200; FOWLER WE, 1983, J ULTRA MOL STRUCT R, V83, P319, DOI 10.1016/S0022-5320(83)90139-9; Frank S, 2002, J BIOL CHEM, V277, P19071, DOI 10.1074/jbc.M202146200; Gale NW, 2002, DEV CELL, V3, P411, DOI 10.1016/S1534-5807(02)00217-4; Hafizi S, 2006, CYTOKINE GROWTH F R, V17, P295, DOI 10.1016/j.cytogfr.2006.04.004; Heiring C, 2004, J BIOL CHEM, V279, P6952, DOI 10.1074/jbc.M311750200; Holden PH, 1997, NAT BIOTECHNOL, V15, P668, DOI 10.1038/nbt0797-668; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Kim I, 2000, ONCOGENE, V19, P4549, DOI 10.1038/sj.onc.1203800; Kontos CD, 2002, MOL CELL BIOL, V22, P1704, DOI 10.1128/MCB.22.6.1704-1713.2002; Kuroda K, 2001, J INVEST DERMATOL, V116, P713, DOI 10.1046/j.1523-1747.2001.01316.x; Lee HJ, 2004, FASEB J, V18, P1200, DOI 10.1096/fj.03-1466com; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Marron MB, 2000, ADV EXP MED BIOL, V476, P35; Marron MB, 2000, J BIOL CHEM, V275, P39741, DOI 10.1074/jbc.M007189200; MARTIN S, 1993, ANTIMICROB AGENTS CH, V37, P1278, DOI 10.1128/AAC.37.6.1278; PARTANEN J, 1992, MOL CELL BIOL, V12, P1698, DOI 10.1128/MCB.12.4.1698; Plotnikov AN, 2000, CELL, V101, P413, DOI 10.1016/S0092-8674(00)80851-X; POSCHL E, 1994, EMBO J, V13, P3741, DOI 10.1002/j.1460-2075.1994.tb06683.x; Puri MC, 2003, P NATL ACAD SCI USA, V100, P12753, DOI 10.1073/pnas.2133552100; Saharinen P, 2005, J CELL BIOL, V169, P239, DOI 10.1083/jcb.200411105; Sasaki T, 2006, EMBO J, V25, P80, DOI 10.1038/sj.emboj.7600912; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sharma A, 1999, EMBO J, V18, P1468, DOI 10.1093/emboj/18.6.1468; Shewchuk LM, 2000, STRUCTURE, V8, P1105, DOI 10.1016/S0969-2126(00)00516-5; Springer TA, 1998, J MOL BIOL, V283, P837, DOI 10.1006/jmbi.1998.2115; Stetefeld J, 1996, J MOL BIOL, V257, P644, DOI 10.1006/jmbi.1996.0191; Sullivan CC, 2003, P NATL ACAD SCI USA, V100, P12331, DOI 10.1073/pnas.1933740100; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Suri C, 1998, SCIENCE, V282, P468, DOI 10.1126/science.282.5388.468; Tait CR, 2004, J PATHOL, V204, P1, DOI 10.1002/path.1618; Tate CG, 2003, BBA-BIOMEMBRANES, V1610, P141, DOI 10.1016/S0005-2736(02)00719-8; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thurston G, 2003, CELL TISSUE RES, V314, P61, DOI 10.1007/s00441-003-0749-6; Valenzuela DM, 1999, P NATL ACAD SCI USA, V96, P1904, DOI 10.1073/pnas.96.5.1904; Vikkula M, 1996, CELL, V87, P1181, DOI 10.1016/S0092-8674(00)81814-0; Voskas D, 2005, AM J PATHOL, V166, P843, DOI 10.1016/S0002-9440(10)62305-X; Wang H, 2004, ONCOGENE, V23, P8700, DOI 10.1038/sj.onc.1208006; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Yu Y, 2001, AM J PATHOL, V159, P2271, DOI 10.1016/S0002-9440(10)63077-5	53	26	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					28408	28414		10.1074/jbc.M605219200	http://dx.doi.org/10.1074/jbc.M605219200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16849318	Green Published, hybrid			2022-12-27	WOS:000240534400078
J	Raffa, GD; Wohlschlegel, J; Yates, JR; Boddy, MN				Raffa, Grazia D.; Wohlschlegel, James; Yates, John R., III; Boddy, Michael N.			SUMO-binding motifs mediate the Rad60-dependent response to replicative stress and self-association	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHECKPOINT KINASE CDS1; FISSION YEAST; FHA DOMAIN; PROTEINS; IDENTIFICATION; RECOMBINATION; TOLERANCE; COMPLEXES; FAMILY; MUS81	In fission yeast, the replication checkpoint is enforced by the kinase Cds1 ( human Chk2), which regulates both cell cycle progression and DNA repair factors to ensure that the genome is faithfully duplicated prior to mitosis. Cds1 contains a forkhead-associated domain that mediates its interaction with phosphorylated residues in target proteins. One target of Cds1 is the essential nuclear protein Rad60, which contains the unique structural feature of tandem SUMO homology domains at its C terminus. Hypomorphic mutants of Rad60 cause profound defects in DNA repair and replication stress tolerance. To explore the physiological significance of the Cds1-Rad60 interaction, we have examined the phosphorylation of Rad60 by Cds1 in vitro and the in vivo phosphorylation of Rad60 in response to replication blocks. We find that the N terminus but not the SUMO-like domain of Rad60 is phosphorylated in both conditions. Three important Rad60 phosphorylation sites were identified: Thr(72), Ser(32), and Ser(34). Rad(60) Thr(72) mediates the Cds1-Rad60 interaction and is required for the Cds1-dependent phosphorylation of Rad60 in response to replication arrest. Phosphorylation of Rad60 Ser32 and Ser34 in a putative SUMO-binding motif is critical for the survival of replication stress. In addition, mutation of Rad60 Ser32 and Ser34 to alanine is lethal in cells deleted for the RecQ DNA helicase Rqh1. Finally, we find that Rad60 self-associates via its C-terminal SUMO-like domain and putative SUMO-binding motifs.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Boddy, MN (corresponding author), Scripps Res Inst, Dept Mol Biol, MB107,10550 N Torrey Pines Rd,MB-3, La Jolla, CA 92037 USA.	nboddy@scripps.edu	Boddy, Michael/A-7214-2009	raffa, grazia daniela/0000-0002-5072-5240	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068608] Funding Source: NIH RePORTER; NCRR NIH HHS [RR11823-08] Funding Source: Medline; NIGMS NIH HHS [GM068608] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahn JS, 2005, EMBO J, V24, P2011, DOI 10.1038/sj.emboj.7600670; Boddy MN, 2000, MOL CELL BIOL, V20, P8758, DOI 10.1128/MCB.20.23.8758-8766.2000; Boddy MN, 2003, MOL CELL BIOL, V23, P5939, DOI 10.1128/MCB.23.16.5939-5946.2003; Branzei D, 2005, CURR OPIN CELL BIOL, V17, P568, DOI 10.1016/j.ceb.2005.09.003; Durocher D, 1999, MOL CELL, V4, P387, DOI 10.1016/S1097-2765(00)80340-8; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Hartmann-Petersen R, 2004, SEMIN CELL DEV BIOL, V15, P247, DOI 10.1016/j.semcdb.2003.12.006; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Kai M, 2005, GENE DEV, V19, P919, DOI 10.1101/gad.1304305; Kai M, 2003, MUTAT RES-FUND MOL M, V532, P59, DOI 10.1016/j.mrfmmm.2003.08.010; MacCoss MJ, 2002, P NATL ACAD SCI USA, V99, P7900, DOI 10.1073/pnas.122231399; Matunis MJ, 1998, J CELL BIOL, V140, P499, DOI 10.1083/jcb.140.3.499; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; McCormack AL, 1997, ANAL CHEM, V69, P767, DOI 10.1021/ac960799q; Meister P, 2005, J CELL BIOL, V168, P537, DOI 10.1083/jcb.200410006; Minty A, 2000, J BIOL CHEM, V275, P36316, DOI 10.1074/jbc.M004293200; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Morishita T, 2002, MOL CELL BIOL, V22, P3537, DOI 10.1128/MCB.22.10.3537-3548.2002; Novatchkova M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-22; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Shiozaki K, 1997, METHOD ENZYMOL, V283, P506; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Upadhya SC, 2003, TRENDS BIOCHEM SCI, V28, P280, DOI 10.1016/S0968-0004(03)00092-6	25	26	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					27973	27981		10.1074/jbc.M601943200	http://dx.doi.org/10.1074/jbc.M601943200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16880212	hybrid			2022-12-27	WOS:000240534400034
J	Tamura, S; Yasutake, S; Matsumoto, N; Fujiki, Y				Tamura, Shigehiko; Yasutake, Shinobu; Matsumoto, Naomi; Fujiki, Yukio			Dynamic and functional assembly of the AAA peroxins, Pex1p and Pex6p, and their membrane receptor Pex26p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE FUSION PROTEIN; CHO-CELL MUTANT; BIOGENESIS DISORDERS; COMPLEMENTATION GROUP; ZELLWEGER-SYNDROME; TERMINAL DOMAIN; PTS1 RECEPTOR; CDNA CLONING; ATPASE; INTERACTS	Two AAA peroxins, Pex1p and Pex6p, are encoded by PEX1 and PEX6, the causal genes for peroxisome biogenesis disorders of complementation group 1 (CG1) and CG4, respectively. PEX26 responsible for peroxisome biogenesis disorders of CG8 encodes Pex26p, the recruiter of Pex1p (.) Pex6p complexes to peroxisomes. We herein assigned the binding regions between human Pex1p and Pex6p and elucidated pivotal roles of the AAA cassettes, called D1 and D2 domains, in Pex1p - Pex6p interaction and peroxisome biogenesis. ATP binding in both AAA cassettes but not ATP hydrolysis in D2 of both Pex1p and Pex6p was prerequisite for Pex1p - Pex6p interaction and their peroxisomal localization. The AAA cassettes, D1 and D2, were essential for peroxisome-restoring activity of Pex1p and Pex6p. In HEK293 cells, endogenous Pex1p was partly localized likely as a homo-oligomer in the cytoplasm, while Pex6p and Pex26p were predominantly localized on peroxisomes. Interaction of Pex1p with Pex6p conferred a conformational change and dissociation of the Pex1p oligomer. These results suggested that Pex1p possesses two distinct oligomeric forms, a homo-oligomer in the cytosol and a hetero-oligomer on peroxisome membranes, possibly playing distinct functions in peroxisome biogenesis.	Kyushu Univ, Dept Biol, Fac Sci, Grad Sch,Higashi Ku, Fukuoka 8128581, Japan; SORST, Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan	Kyushu University; Japan Science & Technology Agency (JST)	Fujiki, Y (corresponding author), Kyushu Univ, Dept Biol, Fac Sci, Grad Sch,Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	yfujiscb@mbox.nc.kyushu-u.ac.jp	Matsumoto, Naomi/AFL-4833-2022; Matsumoto, Naomi/AAD-3468-2022					Beyer A, 1997, PROTEIN SCI, V6, P2043; Birschmann I, 2005, FEBS J, V272, P47, DOI 10.1111/j.1432-1033.2004.04393.x; Birschmann I, 2003, MOL BIOL CELL, V14, P2226, DOI 10.1091/mbc.E02-11-0752; Dekker PJT, 1997, EMBO J, V16, P5408, DOI 10.1093/emboj/16.17.5408; Eckert JH, 2003, REV PHYSIOL BIOCH P, V147, P75, DOI 10.1007/s10254-003-0007-z; Faber KN, 1998, MOL CELL BIOL, V18, P936, DOI 10.1128/MCB.18.2.936; Furuki S, 2006, J BIOL CHEM, V281, P1317, DOI 10.1074/jbc.M510044200; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; Imamura A, 1998, HUM MOL GENET, V7, P2089, DOI 10.1093/hmg/7.13.2089; Lupas AN, 2002, CURR OPIN STRUC BIOL, V12, P746, DOI 10.1016/S0959-440X(02)00388-3; Matsumoto N, 2003, NAT CELL BIOL, V5, P454, DOI 10.1038/ncb982; Matsumoto N, 2001, J HUM GENET, V46, P273, DOI 10.1007/s100380170078; May AP, 2001, J BIOL CHEM, V276, P21991, DOI 10.1074/jbc.R100013200; May AP, 1999, NAT CELL BIOL, V1, P175, DOI 10.1038/11097; Miyata N, 2005, MOL CELL BIOL, V25, P10822, DOI 10.1128/MCB.25.24.10822-10832.2005; Neuwald AF, 1999, GENOME RES, V9, P27; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Okumoto K, 2000, J BIOL CHEM, V275, P25700, DOI 10.1074/jbc.M003303200; Okumoto K, 1998, MOL CELL BIOL, V18, P4324, DOI 10.1128/MCB.18.7.4324; Otera H, 2000, J BIOL CHEM, V275, P21703, DOI 10.1074/jbc.M000720200; Otera H, 1998, MOL CELL BIOL, V18, P388, DOI 10.1128/MCB.18.1.388; Otera H, 2002, MOL CELL BIOL, V22, P1639, DOI 10.1128/MCB.22.6.1639-1655.2002; Platta HW, 2005, NAT CELL BIOL, V7, P817, DOI 10.1038/ncb1281; Purdue PE, 2001, ANNU REV CELL DEV BI, V17, P701, DOI 10.1146/annurev.cellbio.17.1.701; Shimizu N, 1999, J BIOL CHEM, V274, P12593, DOI 10.1074/jbc.274.18.12593; Shimozawa N, 2004, HUM MUTAT, V23, P552, DOI 10.1002/humu.20032; Shiozawa K, 2004, J BIOL CHEM, V279, P50060, DOI 10.1074/jbc.M407837200; TAGAYA M, 1993, J BIOL CHEM, V268, P2662; Tamura S, 1998, BIOCHEM BIOPH RES CO, V245, P883, DOI 10.1006/bbrc.1998.8522; Tamura S, 1998, P NATL ACAD SCI USA, V95, P4350, DOI 10.1073/pnas.95.8.4350; Tamura S, 2001, BIOCHEM J, V357, P417, DOI 10.1042/0264-6021:3570417; Titorenko VI, 2000, J CELL BIOL, V150, P881, DOI 10.1083/jcb.150.4.881; TSUKAMOTO T, 1990, J CELL BIOL, V110, P651, DOI 10.1083/jcb.110.3.651; Vale RD, 2000, J CELL BIOL, V150, pF13, DOI 10.1083/jcb.150.1.F13; Weller S, 2005, AM J HUM GENET, V76, P987, DOI 10.1086/430637; Weller S, 2003, ANNU REV GENOM HUM G, V4, P165, DOI 10.1146/annurev.genom.4.070802.110424; WHITEHEART SW, 1994, J CELL BIOL, V126, P945, DOI 10.1083/jcb.126.4.945; Whiteheart SW, 2004, J STRUCT BIOL, V146, P32, DOI 10.1016/j.jsb.2003.09.015; Yan MD, 2005, CURR OPIN CELL BIOL, V17, P376, DOI 10.1016/j.ceb.2005.06.003	40	47	47	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					27693	27704		10.1074/jbc.M605159200	http://dx.doi.org/10.1074/jbc.M605159200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16854980	hybrid			2022-12-27	WOS:000240534400005
J	Herrick-Davis, K; Weaver, BA; Grinde, E; Mazurkiewicz, JE				Herrick-Davis, Katharine; Weaver, Barbara A.; Grinde, Ellinor; Mazurkiewicz, Joseph E.			Serotonin 5-HT2C receptor homodimer biogenesis in the endoplasmic reticulum - Real-time visualization with confocal fluorescence resonance energy transfer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; LIGAND-INDEPENDENT DIMERIZATION; LIVING CELLS; HORMONE RECEPTOR; SURFACE; HETERODIMERIZATION; TRAFFICKING; OLIGOMERIZATION; INHIBITION; INTERFACE	Dimerization is a common property of G-protein-coupled receptors (GPCR). While the formation of GPCR dimers/oligomers has been reported to play important roles in regulating receptor expression, ligand binding, and second messenger activation, less is known about how and where GPCR dimerization occurs. The present study was performed to identify the precise cellular compartment in which class A GPCR dimer/oligomer biogenesis occurs. We addressed this issue using confocal microscopy and fluorescence resonance energy transfer (FRET) to monitor GPCR proximity within discrete intracellular compartments of intact living cells. Time-lapse confocal imaging was used to follow CFP- and YFP-tagged serotonin 5-HT2C receptors during biosynthesis in the endoplasmic reticulum (ER), trafficking through the Golgi apparatus and subsequent expression on the plasma membrane. Real-time monitoring of FRET between CFP- and YFP-tagged 5-HT2C receptors was performed by acceptor photobleaching within discrete regions of the ER, Golgi, and plasma membrane. The FRET signal was dependent on the ratio of CFP- to YFP-tagged 5-HT2C receptors expressed in each region and was independent of receptor expression level, as predicted for proteins in a non-random, clustered distribution. FRET efficiencies measured in the ER, Golgi, and plasma membrane were similar. These experiments provide direct evidence for homodimerization/oligomerization of class A GPCR in the ER and Golgi of intact living cells, and suggest that dimer/oligomer formation is a naturally occurring step in 5-HT2C receptor maturation and processing.	Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA	Albany Medical College	Herrick-Davis, K (corresponding author), Albany Med Coll, Ctr Neuropharmacol & Neurosci, MC-136,47 New Scotland Ave, Albany, NY 12208 USA.	daviskh@mail.amc.edu			NCRR NIH HHS [RR017926] Funding Source: Medline; NIMH NIH HHS [MH057019] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017926] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057019] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; Angers S, 2002, ANNU REV PHARMACOL, V42, P409, DOI 10.1146/annurev.pharmtox.42.091701.082314; Ayoub MA, 2002, J BIOL CHEM, V277, P21522, DOI 10.1074/jbc.M200729200; Babcock GJ, 2003, J BIOL CHEM, V278, P3378, DOI 10.1074/jbc.M210140200; Baneres JL, 2003, J MOL BIOL, V329, P815, DOI 10.1016/S0022-2836(03)00439-X; Bastiaens PIH, 1996, EMBO J, V15, P4246, DOI 10.1002/j.1460-2075.1996.tb00799.x; Benkirane M, 1997, J BIOL CHEM, V272, P30603, DOI 10.1074/jbc.272.49.30603; Cornea A, 2001, J BIOL CHEM, V276, P2153, DOI 10.1074/jbc.M007850200; Dinger MC, 2003, J BIOL CHEM, V278, P10562, DOI 10.1074/jbc.M205747200; Fotiadis D, 2004, FEBS LETT, V564, P281, DOI 10.1016/S0014-5793(04)00194-2; George SR, 2002, NAT REV DRUG DISCOV, V1, P808, DOI 10.1038/nrd913; Goudet C, 2005, J BIOL CHEM, V280, P24380, DOI 10.1074/jbc.M502642200; Guo W, 2005, P NATL ACAD SCI USA, V102, P17495, DOI 10.1073/pnas.0508950102; Guo W, 2003, J BIOL CHEM, V278, P4385, DOI 10.1074/jbc.C200679200; Hamm HE, 2001, P NATL ACAD SCI USA, V98, P4819, DOI 10.1073/pnas.011099798; Herrick-Davis K, 2005, J BIOL CHEM, V280, P40144, DOI 10.1074/jbc.M507396200; Herrick-Davis K, 1999, J NEUROCHEM, V73, P1711, DOI 10.1046/j.1471-4159.1999.731711.x; Herrick-Davis K, 2004, BIOCHEMISTRY-US, V43, P13963, DOI 10.1021/bi048398p; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Karpa KD, 2000, MOL PHARMACOL, V58, P677, DOI 10.1124/mol.58.4.677; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; Kong MMC, 2005, CONTEMPORARY CLIN NE, P287; Kroeger KM, 2001, J BIOL CHEM, V276, P12736, DOI 10.1074/jbc.M011311200; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Lee SP, 2004, J BIOL CHEM, V279, P35671, DOI 10.1074/jbc.M401923200; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; McVey M, 2001, J BIOL CHEM, V276, P14092, DOI 10.1074/jbc.M008902200; O'Dowd BF, 2005, J BIOL CHEM, V280, P37225, DOI 10.1074/jbc.M504562200; Overton MC, 2000, CURR BIOL, V10, P341, DOI 10.1016/S0960-9822(00)00386-9; Rocheville M, 2000, J BIOL CHEM, V275, P7862, DOI 10.1074/jbc.275.11.7862; Salahpour A, 2004, J BIOL CHEM, V279, P33390, DOI 10.1074/jbc.M403363200; SANDERSBUSH E, 1990, J PHARMACOL EXP THER, V252, P984; Shioda T, 2001, J VIROL, V75, P3462, DOI 10.1128/JVI.75.7.3462-3468.2001; Terrillon S, 2004, EMBO REP, V5, P30, DOI 10.1038/sj.embor.7400052; Terrillon S, 2003, MOL ENDOCRINOL, V17, P677, DOI 10.1210/me.2002-0222; Uberti MA, 2005, J PHARMACOL EXP THER, V313, P16, DOI 10.1124/jpet.104.079541; Villemure JF, 2005, BIOCHEM J, V388, P47, DOI 10.1042/BJ20041435; Wallrabe H, 2003, BIOPHYS J, V85, P559, DOI 10.1016/S0006-3495(03)74500-7; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Zhu XY, 1998, BIOCHEMISTRY-US, V37, P15773, DOI 10.1021/bi981162z	42	95	96	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2006	281	37					27109	27116		10.1074/jbc.M604390200	http://dx.doi.org/10.1074/jbc.M604390200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082PB	16857671	hybrid			2022-12-27	WOS:000240397700038
J	Slominska, EM; Carrey, EA; Foks, H; Orlewska, C; Wieczerzak, E; Sowinski, P; Yacoub, MH; Marinaki, AM; Simmonds, HA; Smolenski, RT				Slominska, Ewa M.; Carrey, Elizabeth A.; Foks, Henryk; Orlewska, Czeslawa; Wieczerzak, Ewa; Sowinski, Pawel; Yacoub, Magdi H.; Marinaki, Anthony M.; Simmonds, H. Anne; Smolenski, Ryszard T.			A novel nucleotide found in human erythrocytes, 4-pyridone-3-carboxamide-1-beta-D-ribonucleoside triphosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DE-NOVO SYNTHESIS; RENAL-FAILURE; POSITIVE CORRELATION; HEALTHY HUMANS; NICOTINIC-ACID; T-LYMPHOCYTES; HUMAN PLASMA; PSEUDOURIDINE; NUCLEOSIDE	We report the identification of a hitherto unknown nucleotide that is present in micromolar concentrations in the erythrocytes of healthy subjects and accumulates at levels comparable with the ATP concentration in erythrocytes of patients with chronic renal failure. The unknown nucleotide was isolated and identified by liquid chromatography with UV and tandem mass detection, H-1 nuclear magnetic resonance and infrared spectroscopy as 4-pyridone-3-carboxamide-1-beta-D-ribonucleoside triphosphate (4PYTP), a structure indicating association with metabolism of the oxidized nicotinamide compounds. Subsequently, we demonstrated formation of 4PYTP in intact human erythrocytes during incubation with the chemically synthesized nucleoside precursor 4-pyridone-3-carboxamide-1-beta-D-ribonucleoside (4PYR). We noted preferential accumulation of monophosphate of 4PYR (4PYMP) over 4PYTP as well as a decrease in erythrocyte ATP concentration during incubation with 4PYR. Both the 4PYR phosphorylation and ATP depletion were blocked by an inhibitor of adenosine kinase. Plasma concentration of 4PYR was detectable but very low (0.013 +/- 0.006 mu M) in contrast with the high daily urine excretion of this compound (26.7 +/- 18.2 mu mol/24 h) in healthy subjects, indicating much greater renal clearance than other nicotinamide metabolites, nucleosides, or creatinine. We also noted a 40-fold increase in 4PYR plasma concentration in patients with chronic renal failure (0.563 +/- 0.321 mu M). We suggest that 4PYTP formation in the erythrocytes is a hitherto unknown process aimed at sequestering potentially toxic 4PYR in a form that could be safely transported and subsequently released and excreted during passage of erythrocytes through the kidney.	Imperial Coll London, Heart Sci Ctr, Harefield UB9 6JH, Middx, England; Med Univ Gdansk, Dept Biochem, PL-80211 Gdansk, Poland; Guys Hosp, Purine Res Unit, London SE9 RT, England; UCL, Inst Child Hlth, London WC1N EH, England; Med Acad Gdansk, Dept Organ Chem, PL-80416 Gdansk, Poland; Univ Gdansk, Dept Organ Chem, PL-80952 Gdansk, Poland; Univ Gdansk, Fac Chem, Lab NMR Spect, PL-80952 Gdansk, Poland	Imperial College London; Fahrenheit Universities; Medical University Gdansk; Guy's & St Thomas' NHS Foundation Trust; University of London; University College London; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; University of Gdansk	Smolenski, RT (corresponding author), Imperial Coll London, Heart Sci Ctr, Harefield UB9 6JH, Middx, England.	r.smolenski@ic.ac.uk	Wieczerzak, Ewa/AAA-9432-2021; Orlewska, Czeslawa/T-5986-2018; Smolenski, Ryszard T/B-9713-2013	Wieczerzak, Ewa/0000-0003-2539-5160; Orlewska, Czeslawa/0000-0003-3495-696X; Smolenski, Ryszard/0000-0002-0190-9414; Slominska, Ewa/0000-0002-3037-1844				ABELSON D, 1963, NATURE, V197, P460, DOI 10.1038/197460a0; ABELSON D, 1963, J BIOL CHEM, V238, P717; BERMAN PA, 1988, J CLIN INVEST, V82, P980, DOI 10.1172/JCI113707; BERMAN PAM, 1990, J BIOL CHEM, V265, P6562; BERNOFSKY C, 1979, ANAL BIOCHEM, V96, P189, DOI 10.1016/0003-2697(79)90572-4; Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7; Carrey EA, 2004, NUCLEOS NUCLEOT NUCL, V23, P1135, DOI 10.1081/NCN-200027391; Carrey EA, 2003, CLIN CHIM ACTA, V335, P117, DOI 10.1016/S0009-8981(03)00294-8; CHANG MLW, 1959, J BIOL CHEM, V234, P1817; CHHEDA GB, 1995, NUCLEOS NUCLEOT, V14, P1519, DOI 10.1080/15257779508009489; DUTTA SP, 1979, LIFE SCI, V24, P1381, DOI 10.1016/0024-3205(79)90008-0; FAIRBANKS LD, 1995, J BIOL CHEM, V270, P29682; Intrieri M, 1996, J INFECT DIS, V174, P199, DOI 10.1093/infdis/174.1.199; Jenner A, 1998, BIOCHEM J, V331, P365, DOI 10.1042/bj3310365; Knip M, 2000, DIABETOLOGIA, V43, P1337, DOI 10.1007/s001250051536; Maiese K, 2003, TRENDS PHARMACOL SCI, V24, P228, DOI 10.1016/S0165-6147(03)00078-6; Marlewski M, 2000, NEPHRON, V86, P281, DOI 10.1159/000045782; MEYER H, 1928, CHEM BER, V61, P2202; MIEGH JP, 2001, J CHEM SOC T, P2012; Moriwaki Y, 1997, HISTOL HISTOPATHOL, V12, P513; MOTYL T, 1993, EUR J CLIN CHEM CLIN, V31, P765; MROCHEK JE, 1976, CLIN CHEM, V22, P1821; Murray MF, 2003, CLIN INFECT DIS, V36, P453, DOI 10.1086/367544; Ruckemann K, 1998, J BIOL CHEM, V273, P21682, DOI 10.1074/jbc.273.34.21682; Schram KH, 1998, MASS SPECTROM REV, V17, P131, DOI 10.1002/(SICI)1098-2787(1998)17:3<131::AID-MAS1>3.0.CO;2-O; Simmonds H., 1991, TECHNIQUES DIAGNOSTI, P397; Simmonds HA, 1997, J INHERIT METAB DIS, V20, P214, DOI 10.1023/A:1005308923168; Slominska E, 2004, MOL CELL BIOCHEM, V267, P25, DOI 10.1023/B:MCBI.0000049359.66669.29; Smolenski R.T., 1996, PURINES MYOCARDIAL P, P56; Takahashi Y, 2004, KIDNEY INT, V65, P1099, DOI 10.1111/j.1523-1755.2004.00482.x; TALIK T, 1961, ROCZ CHEM, V35, P463; VORBRUGGEN H, 1981, CHEM BER-RECL, V114, P1234, DOI 10.1002/cber.19811140404	32	28	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32057	32064		10.1074/jbc.M607514200	http://dx.doi.org/10.1074/jbc.M607514200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16920716	hybrid			2022-12-27	WOS:000241414500002
J	Ukropec, J; Anunciado, RP; Ravussin, Y; Hulver, MW; Kozak, LP				Ukropec, Jozef; Anunciado, Rea P.; Ravussin, Yann; Hulver, Matthew W.; Kozak, Leslie P.			UCP1-independent thermogenesis in white adipose tissue of cold-acclimated Ucp1(-/-) mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC SARCOPLASMIC-RETICULUM; DEPENDENT PROTEIN-KINASE; FATTY-ACID OXIDATION; DIET-INDUCED OBESITY; UCP1-DEFICIENT MICE; BROWN ADIPOCYTES; PHOSPHOLAMBAN PHOSPHORYLATION; NONSHIVERING THERMOGENESIS; CELLULAR PLASTICITY; CA2+-ATPASE	Apart from UCP1-based nonshivering thermogenesis in brown adipocytes, the identity of thermogenic mechanisms that can be activated to reduce a positive energy balance is largely unknown. To identify potentially useful mechanisms, we have analyzed physiological and molecular mechanisms that enable mice, genetically deficient in UCP1 and sensitive to acute exposure to the cold at 4 C, to adapt to long term exposure at 4 C. UCP1-deficient mice that can adapt to the cold have increased oxygen consumption and show increased oxidation of both fat and glucose as indicated from serum metabolite levels and liver glycogen content. Enhanced energy metabolism in inguinal fat was also indicated by increased oxygen consumption and fat oxidation in tissue suspensions and increased AMP kinase activity in dissected tissues. Analysis of gene expression in skeletal muscle showed surprisingly little change between cold-adapted Ucp1(+/+) and Ucp1(+/+) mice, whereas in inguinal fat a robust induction occurred for type 2 deiodinase, sarcoendoplasmic reticulum Ca2+-ATPase, mitochondrial glycerol 3-phosphate dehydrogenase, PGC1 alpha, CoxII, and mitochondrial DNA content. Western blot analysis showed an induction of total phospholamban and its phosphorylated form in inguinal fat and other white fat depots, but no induction was apparent in muscle. We conclude that alternative thermogenic mechanisms, based in part upon the enhanced capacity for ion and substrate cycling associated with brown adipocytes in white fat depots, are induced in UCP1-deficient mice by gradual cold adaptation.	Louisiana State Univ, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Kozak, LP (corresponding author), Louisiana State Univ, Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	kozaklp@pbrc.edu	Ravussin, Yann/ABE-8061-2021; Ukropec, Jozef/D-5960-2018; Ukropec, Jozef/AAI-5590-2020; Ravussin, Yann/AAE-1440-2020	Ravussin, Yann/0000-0002-6699-3944; Ukropec, Jozef/0000-0001-8401-6621; 	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD008431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD08431] Funding Source: Medline; NIDDK NIH HHS [P30 DK072476] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; BLOCK BA, 1994, J CELL BIOL, V127, P1275, DOI 10.1083/jcb.127.5.1275; BLOCK BA, 1994, ANNU REV PHYSIOL, V56, P535; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; CAREY FG, 1982, SCIENCE, V216, P1327, DOI 10.1126/science.7079766; Cinti S, 2002, J HISTOCHEM CYTOCHEM, V50, P21, DOI 10.1177/002215540205000103; Collins S, 1997, ENDOCRINOLOGY, V138, P405, DOI 10.1210/en.138.1.405; Commins SP, 2001, AM J PHYSIOL-ENDOC M, V280, pE372; COUSIN B, 1992, J CELL SCI, V103, P931; Crosson SM, 2003, J CLIN INVEST, V111, P1423, DOI 10.1172/JCI200317975; De Meis L, 1998, AM J PHYSIOL-CELL PH, V274, pC1738, DOI 10.1152/ajpcell.1998.274.6.C1738; de Meis L, 2005, BIOSCIENCE REP, V25, P181, DOI 10.1007/s10540-005-2884-7; de Meis L, 2003, J BIOL CHEM, V278, P41856, DOI 10.1074/jbc.M308280200; de Meis L, 2006, J BIOL CHEM, V281, P16384, DOI 10.1074/jbc.M600678200; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Golozoubova V, 2001, FASEB J, V15, P2048, DOI 10.1096/fj.00-0536fje; Gordon CJ, 1993, TEMPERATURE REGULATI, DOI 10.1017/CBO9780511565595; Granneman JG, 2005, AM J PHYSIOL-ENDOC M, V289, pE608, DOI 10.1152/ajpendo.00009.2005; Granneman JG, 2003, AM J PHYSIOL-ENDOC M, V285, pE1230, DOI 10.1152/ajpendo.00197.2003; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Guerra C, 1998, J CLIN INVEST, V102, P1724, DOI 10.1172/JCI4532; HAWKINS C, 1995, MOL CELL BIOCHEM, V142, P131, DOI 10.1007/BF00928934; Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857; Himms-Hagen J, 2000, AM J PHYSIOL-CELL PH, V279, pC670, DOI 10.1152/ajpcell.2000.279.3.C670; Himms-Hagen J, 2004, CNS NEUROL DISORD-DR, V3, P389, DOI 10.2174/1568007043337076; HIMMSHAGEN J, 1994, AM J PHYSIOL, V266, pR1371, DOI 10.1152/ajpregu.1994.266.4.R1371; Hofmann WE, 2001, J BIOL CHEM, V276, P12460, DOI 10.1074/jbc.M100466200; Hulver MW, 2005, CELL METAB, V2, P251, DOI 10.1016/j.cmet.2005.09.002; Hulver MW, 2003, AM J PHYSIOL-ENDOC M, V284, pE741, DOI 10.1152/ajpendo.00514.2002; Inokuma K, 2005, DIABETES, V54, P1385, DOI 10.2337/diabetes.54.5.1385; INUI M, 1986, J BIOL CHEM, V261, P1794; Isoda T, 2003, FASEB J, V17, P144, DOI 10.1096/fj.01-0981com; LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7; Landeira-Fernandez AM, 2004, AM J PHYSIOL-REG I, V286, pR398, DOI 10.1152/ajpregu.00392.2003; Li JH, 2003, BIOCHEMISTRY-US, V42, P10674, DOI 10.1021/bi034708c; Li PP, 2005, AM J PHYSIOL-ENDOC M, V289, pE617, DOI 10.1152/ajpendo.00010.2005; Liu XT, 2003, J CLIN INVEST, V111, P399, DOI 10.1172/JCI200315737; Liu YW, 1997, AM J PHYSIOL-CELL PH, V273, pC1915, DOI 10.1152/ajpcell.1997.273.6.C1915; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Matejkova O, 2004, FEBS LETT, V569, P245, DOI 10.1016/j.febslet.2004.06.002; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Ojamaa K, 2000, ENDOCRINOLOGY, V141, P2139, DOI 10.1210/en.141.6.2139; SHOLTE HR, 1997, MOL CELL BIOCHEM, V174, P61; Solinas G, 2004, FEBS LETT, V577, P539, DOI 10.1016/j.febslet.2004.10.066; SUZUKI T, 1986, J BIOL CHEM, V261, P7018; TADA M, 1982, MOL CELL BIOCHEM, V46, P73; TADA M, 1982, ANNU REV PHYSIOL, V44, P401, DOI 10.1146/annurev.ph.44.030182.002153; Thomas SA, 1997, NATURE, V387, P94, DOI 10.1038/387094a0; Ukropec J, 2006, ENDOCRINOLOGY, V147, P2468, DOI 10.1210/en.2005-1216; Wang YX, 2006, PFLUG ARCH EUR J PHY, V452, P363, DOI 10.1007/s00424-005-0036-3; YOUNG P, 1984, FEBS LETT, V167, P10, DOI 10.1016/0014-5793(84)80822-4	51	204	205	3	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31894	31908		10.1074/jbc.M606114200	http://dx.doi.org/10.1074/jbc.M606114200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16914547				2022-12-27	WOS:000241235300076
J	Baran, K; Ciccone, A; Peters, C; Yagita, H; Bird, PI; Villadangos, JA; Trapani, JA				Baran, Katherine; Ciccone, Annette; Peters, Christoph; Yagita, Hideo; Bird, Phillip I.; Villadangos, Jose A.; Trapani, Joseph A.			Cytotoxic T lymphocytes from cathepsin B-deficient mice survive normally in vitro and in vivo after encountering and killing target cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFORIN-MEDIATED LYSIS; PORE-FORMING PROTEIN; GRANZYME-B; CYTOLYTIC LYMPHOCYTES; CASPASE ACTIVATION; TOXIC GRANULES; KILLER-CELLS; C2 DOMAIN; BINDING; RESISTANCE	The lysosomal protease cathepsin B has been proposed to protect cytotoxic T lymphocytes from the membrane-disruptive effects of perforin secreted during the execution phase of target cell death. Accordingly, cathepsin B that translocates to the lymphocyte surface upon degranulation has been postulated to cleave and inactivate perforin molecules that diffuse back to the killer cell. We have found that recombinant perforin is cleaved inefficiently by cathepsin B and shows no significant reduction in its lytic activity following co-incubation. Furthermore, purified CD8+ cytotoxic T lymphocytes of cathepsin B-null gene-targeted mice were able to induce normal death of target cells both in vitro and in vivo and to survive the encounter with target cells as efficiently as cathepsin B-expressing killer cells. We conclude that cathepsin B is not essential for protection of cytotoxic lymphocytes from the toxic effects of their secreted perforin.	Peter MacCallum Canc Ctr, Canc Immunol Program, Melbourne, Vic 3002, Australia; Walter & Eliza Hall Inst Med Res, Div Immunol, Parkville, Vic 3052, Australia; Univ Freiburg, Inst Mol Med & Cell Res, D-79104 Freiburg, Germany; Juntendo Univ, Sch Med, Dept Immunol, Tokyo 1138421, Japan; Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3600, Australia	Peter Maccallum Cancer Center; Walter & Eliza Hall Institute; University of Freiburg; Juntendo University; Monash University	Trapani, JA (corresponding author), Peter MacCallum Canc Ctr, Locked Bag 1,ABeckett St, Melbourne, Vic 8006, Australia.	joe.trapani@petermac.org	Villadangos, Jose A/AAU-1404-2020	Villadangos, Jose A/0000-0001-6771-8891; Trapani, Joseph/0000-0003-0983-1532; Bird, Phillip/0000-0002-6695-606X				ANTIA R, 1992, IMMUNOL LETT, V32, P153, DOI 10.1016/0165-2478(92)90108-Z; Balaji KN, 2002, J EXP MED, V196, P493, DOI 10.1084/jem.20011836; BARRETT AJ, 1982, BIOCHEM J, V201, P189, DOI 10.1042/bj2010189; Coles RM, 2002, J IMMUNOL, V168, P834, DOI 10.4049/jimmunol.168.2.834; Deussing J, 1998, P NATL ACAD SCI USA, V95, P4516, DOI 10.1073/pnas.95.8.4516; Halangk W, 2000, J CLIN INVEST, V106, P773, DOI 10.1172/JCI9411; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; ISAAZ S, 1995, EUR J IMMUNOL, V25, P1071, DOI 10.1002/eji.1830250432; JENNE DE, 1988, IMMUNOL REV, V103, P53, DOI 10.1111/j.1600-065X.1988.tb00749.x; JIANG S, 1990, J IMMUNOL, V144, P998; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; KAWASAKI A, 1990, INT IMMUNOL, V2, P677, DOI 10.1093/intimm/2.7.677; Keefe D, 2005, IMMUNITY, V23, P249, DOI 10.1016/j.immuni.2005.08.001; Linnevers C, 1997, FEBS LETT, V405, P253, DOI 10.1016/S0014-5793(97)00118-X; MARTZ E, 1976, TRANSPLANTATION, V21, P5, DOI 10.1097/00007890-197601000-00002; MULLER C, 1994, J IMMUNOL, V153, P2470; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; NAGLERANDERSON C, 1988, J IMMUNOL, V141, P3299; OJCIUS DM, 1991, MOL IMMUNOL, V28, P1011, DOI 10.1016/0161-5890(91)90187-O; OJCIUS DM, 1991, P NATL ACAD SCI USA, V88, P4621, DOI 10.1073/pnas.88.11.4621; Ondr JK, 2004, J BIOL CHEM, V279, P27525, DOI 10.1074/jbc.M400304200; PERSECHINI PM, 1990, J CELL BIOL, V110, P2109, DOI 10.1083/jcb.110.6.2109; Rochel N, 1996, CHEM BIOL, V3, P31, DOI 10.1016/S1074-5521(96)90081-2; Smyth MJ, 2000, J EXP MED, V192, P755, DOI 10.1084/jem.192.5.755; Sutton VR, 2000, J EXP MED, V192, P1403, DOI 10.1084/jem.192.10.1403; Sutton VR, 2006, TRANSPLANTATION, V81, P146, DOI 10.1097/01.tp.0000191939.68451.d9; Sutton VR, 2003, IMMUNITY, V18, P319, DOI 10.1016/S1074-7613(03)00050-5; Trapani JA, 1998, INT REV CYTOL, V182, P111, DOI 10.1016/S0074-7696(08)62169-5; Trapani JA, 2002, NAT REV IMMUNOL, V2, P735, DOI 10.1038/nri911; Turk B, 2000, BBA-PROTEIN STRUCT M, V1477, P98, DOI 10.1016/S0167-4838(99)00263-0; Uellner R, 1997, EMBO J, V16, P7287, DOI 10.1093/emboj/16.24.7287; VERRET CR, 1987, J EXP MED, V166, P1536, DOI 10.1084/jem.166.5.1536; Voskoboinik I, 2005, J BIOL CHEM, V280, P8426, DOI 10.1074/jbc.M413303200; Voskoboinik I, 2004, J EXP MED, V200, P811, DOI 10.1084/jem.20040776; Waterhouse NJ, 2005, J BIOL CHEM, V280, P4476, DOI 10.1074/jbc.M410985200; Yamamoto A, 1997, J BIOCHEM-TOKYO, V121, P974	36	40	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30485	30491		10.1074/jbc.M602007200	http://dx.doi.org/10.1074/jbc.M602007200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16914553	hybrid			2022-12-27	WOS:000241075900024
J	Bhattacharya, N; Ghosh, S; Sept, D; Cooper, JA				Bhattacharya, Nandini; Ghosh, Shatadal; Sept, David; Cooper, John A.			Binding of myotrophin/V-1 to actin-capping protein - Implications for how capping protein binds to the filament barbed end	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPRESSION; V-1	The heterodimeric actin-capping protein (CP) regulates actin assembly and cell motility by binding tightly to the barbed end of the actin filament. Here we demonstrate that myotrophin/V-1 binds directly to CP in a 1: 1 molar ratio with a K-d of 10-50 nM. V-1 binding inhibited the ability of CP to cap the barbed ends of actin filaments. The actin-binding COOH-terminal region, the "tentacle," of the CP beta subunit was important for binding V-1, with lesser contributions from the alpha subunit COOH- terminal region and the body of the protein. V-1 appears to be unable to bind to CP that is on the barbed end, based on the observations that V-1 had no activity in an uncapping assay and that the V-1(.)CP complex had no capping activity. Two loops of V-1, which extend out from the alpha-helical backbone of this ankyrin repeat protein, were necessary for V-1 to bind CP. Parallel computational studies determined a bound conformation of the beta tentacle with V-1 that is consistent with these findings, and they offered insight into experimentally observed differences between the alpha 1 and alpha 2 isoforms as well as the mutant lacking the alpha tentacle. These results support and extend our "wobble" model for CP binding to the actin filament, in which the two COOH- terminal regions of CP bind independently to the actin filament, and bound CP is able to wobble when attached only via its mobile beta-subunit tentacle. This model is also supported by molecular dynamics simulations of CP reported here. The existence of the wobble state may be important for actin dynamics in cells.	Washington Univ, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; Washington Univ, Dept Biomed Engn, St Louis, MO 63110 USA; Washington Univ, Ctr Computat Biol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Cooper, JA (corresponding author), Campus Box 8228,660 S Euclid Ave, St Louis, MO 63110 USA.	jcooper@wustl.edu	Sept, David/F-6497-2011; Bhattacharya, Nandini/HGU-4374-2022; Cooper, John/E-9389-2012; Cooper, John/D-4448-2014	Sept, David/0000-0003-3719-2483; Cooper, John/0000-0002-0933-4571	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038542, R01GM067246] Funding Source: NIH RePORTER; NHLBI NIH HHS [T32 HL007873] Funding Source: Medline; NIGMS NIH HHS [GM067246, R01 GM038542, R01 GM038542-18, GM38542, R01 GM067246-04, R01 GM067246] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson KM, 1999, J MOL CELL CARDIOL, V31, P705, DOI 10.1006/jmcc.1998.0903; Braun P, 2002, P NATL ACAD SCI USA, V99, P2654, DOI 10.1073/pnas.042684199; Canton DA, 2005, MOL CELL BIOL, V25, P3519, DOI 10.1128/MCB.25.9.3519-3534.2005; Carlsson AE, 2004, BIOPHYS J, V86, P1074, DOI 10.1016/S0006-3495(04)74182-X; Furukawa Y, 2003, NEUROMUSCULAR DISORD, V13, P32, DOI 10.1016/S0960-8966(02)00185-2; Ghosh J, 2004, MOL MICROBIOL, V51, P203, DOI 10.1046/j.1365-2958.2003.03816.x; Hart MC, 1997, CELL MOTIL CYTOSKEL, V38, P120, DOI 10.1002/(SICI)1097-0169(1997)38:2<120::AID-CM2>3.0.CO;2-B; Hart MC, 1999, J CELL BIOL, V147, P1287, DOI 10.1083/jcb.147.6.1287; HUANG CY, 1982, METHOD ENZYMOL, V87, P509; HUG C, 1995, CELL, V81, P591, DOI 10.1016/0092-8674(95)90080-2; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Mosavi LK, 2002, P NATL ACAD SCI USA, V99, P16029, DOI 10.1073/pnas.252537899; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Palmgren S, 2001, J CELL BIOL, V155, P251, DOI 10.1083/jcb.200106157; PENNICA D, 1995, GENE, V158, P305, DOI 10.1016/0378-1119(95)00131-O; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rosenfeld RJ, 2003, J COMPUT AID MOL DES, V17, P525, DOI 10.1023/B:JCAM.0000004604.87558.02; Sarkar S, 2004, J BIOL CHEM, V279, P20422, DOI 10.1074/jbc.M308488200; Schafer DA, 1996, J CELL BIOL, V135, P169, DOI 10.1083/jcb.135.1.169; SCHAIBLE UE, 1994, CELL ADHES COMMUN, V2, P465, DOI 10.3109/15419069409014211; SEN S, 1990, J BIOL CHEM, V265, P16635; SIL P, 1995, CIRC RES, V76, P1020, DOI 10.1161/01.RES.76.6.1020; SIL P, 1993, CIRC RES, V73, P98, DOI 10.1161/01.RES.73.1.98; Song SY, 1996, ENDOCRINOLOGY, V137, P1423, DOI 10.1210/en.137.4.1423; TAOKA M, 1994, J BIOL CHEM, V269, P9946; Taoka M, 2003, J BIOL CHEM, V278, P5864, DOI 10.1074/jbc.M211509200; URUNO T, 2006, J BIOL CHEM; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wear MA, 2003, CURR BIOL, V13, P1531, DOI 10.1016/S0960-9822(03)00559-1; Wear MA, 2004, TRENDS BIOCHEM SCI, V29, P418, DOI 10.1016/j.tibs.2004.06.003; Wear MA, 2004, J BIOL CHEM, V279, P14382, DOI 10.1074/jbc.M313412200; Yamakuni T, 1998, J BIOL CHEM, V273, P27051, DOI 10.1074/jbc.273.42.27051; Yamashita A, 2003, EMBO J, V22, P1529, DOI 10.1093/emboj/cdg167; Yang CS, 2005, DEV CELL, V9, P209, DOI 10.1016/j.devcel.2005.06.008; Yang YW, 1998, STRUCTURE, V6, P619, DOI 10.1016/S0969-2126(98)00063-X; Yang YW, 1997, PROTEIN SCI, V6, P1347, DOI 10.1002/pro.5560060625	40	38	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					31021	31030		10.1074/jbc.M606278200	http://dx.doi.org/10.1074/jbc.M606278200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16895918	hybrid, Green Accepted			2022-12-27	WOS:000241075900078
J	Bouchard, R; Bailly, A; Blakeslee, JJ; Oehring, SC; Vincenzetti, V; Lee, OR; Paponov, I; Palme, K; Mancuso, S; Murphy, AS; Schulz, B; Geisler, M				Bouchard, Rodolphe; Bailly, Aurelien; Blakeslee, Joshua J.; Oehring, Sophie C.; Vincenzetti, Vincent; Lee, Ok Ran; Paponov, Ivan; Palme, Klaus; Mancuso, Stefano; Murphy, Angus S.; Schulz, Burkhard; Geisler, Markus			Immunophilin-like TWISTED DWARF1 modulates auxin efflux activities of Arabidopsis P-glycoproteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; FK506-BINDING PROTEIN; PROLYL ISOMERASE; POLAR TRANSPORT; ABC TRANSPORTER; LATERAL ROOT; PLANT; GENE; GROWTH; INHIBITION	The immunophilin-like protein TWISTED DWARF1 (TWD1/FKBP42) has been shown to physically interact with the multidrug resistance/P-glycoprotein (PGP) ATP-binding cassette transporters PGP1 and PGP19 (MDR1). Overlapping phenotypes of pgp1/pgp19 and twd1 mutant plants suggested a positive regulatory role of TWD1 in PGP-mediated export of the plant hormone auxin, which controls plant development. Here, we provide evidence at the cellular and plant levels that TWD1 controls PGP-mediated auxin transport. twd1 and pgp1/pgp19 cells showed greatly reduced export of the native auxin indole-3-acetic acid (IAA). Constitutive overexpression of PGP1 and PGP19, but not TWD1, enhanced auxin export. Coexpression of TWD1 and PGP1 in yeast and mammalian cells verified the specificity of the regulatory effect. Employing an IAA-specific microelectrode demonstrated that IAA influx in the root elongation zone was perturbed and apically shifted in pgp1/pgp19 and twd1 roots. Mature roots of pgp1/pgp19 and twd1 plants revealed elevated levels of free IAA, which seemed to account for agravitropic root behavior. Our data suggest a novel mode of PGP regulation via FK506-binding protein-like immunophilins, implicating possible alternative strategies to overcome multidrug resistance.	Univ Zurich, Inst Plant Biol, Zurich Basel Plant Sci Ctr, CH-8008 Zurich, Switzerland; Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA; Univ Freiburg, Inst Biol 2, D-79104 Freiburg, Germany; Univ Florence, Dept Hort, I-50019 Sesto Fiorentino, Italy	University of Zurich; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Freiburg; University of Florence	Geisler, M (corresponding author), Univ Zurich, Inst Plant Biol, Zurich Basel Plant Sci Ctr, Zollikerstr 107, CH-8008 Zurich, Switzerland.	markus.geisler@botinst.unizh.ch	Palme, Klaus/A-9524-2013; Mancuso, Stefano/G-6515-2012; Geisler, Markus M/B-3921-2012; Paponov, Ivan A./H-9680-2016; Blakeslee, Joshua/G-4420-2011	Palme, Klaus/0000-0002-2728-3835; Mancuso, Stefano/0000-0003-1752-3986; Geisler, Markus M/0000-0002-6641-5810; Paponov, Ivan A./0000-0002-2138-0722; 				Aghdasi B, 2001, P NATL ACAD SCI USA, V98, P2425, DOI 10.1073/pnas.041614198; Ambudkar SV, 2003, ONCOGENE, V22, P7468, DOI 10.1038/sj.onc.1206948; Arndt C, 1999, MICROBIOL-SGM, V145, P1989, DOI 10.1099/13500872-145-8-1989; Baluska F, 2003, TRENDS CELL BIOL, V13, P282, DOI 10.1016/S0962-8924(03)00084-9; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Blakeslee JJ, 2005, CURR OPIN PLANT BIOL, V8, P494, DOI 10.1016/j.pbi.2005.07.014; Blakeslee JJ, 2004, PLANT PHYSIOL, V134, P28, DOI 10.1104/pp.103.031690; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; CAMERON AM, 1995, CELL, V83, P463, DOI 10.1016/0092-8674(95)90124-8; Castro AF, 1999, BIOCHEM PHARMACOL, V58, P1723, DOI 10.1016/S0006-2952(99)00288-9; Cruz MC, 1999, MOL CELL BIOL, V19, P4101; Dunnwald M, 1999, MOL BIOL CELL, V10, P329, DOI 10.1091/mbc.10.2.329; Faure JD, 1998, DEVELOPMENT, V125, P909; Folkes LK, 2003, CANCER RES, V63, P776; Friml J, 2003, CURR OPIN PLANT BIOL, V6, P7, DOI 10.1016/S1369526602000031; Friml J, 2005, ANNU PLANT REV, V16, P1; Geisler M, 2006, FEBS LETT, V580, P1094, DOI 10.1016/j.febslet.2005.11.054; Geisler M, 2005, PLANT J, V44, P179, DOI 10.1111/j.1365-313X.2005.02519.x; Geisler M, 2004, MOL BIOL CELL, V15, P3393, DOI 10.1091/mbc.E03-11-0831; Geisler M, 2003, MOL BIOL CELL, V14, P4238, DOI 10.1091/mbc.E02-10-0698; Geisler M, 2000, PLANT PHYSIOL, V124, P1814, DOI 10.1104/pp.124.4.1814; GOLDSMITH MHM, 1977, ANNU REV PLANT PHYS, V28, P439, DOI 10.1146/annurev.pp.28.060177.002255; Harrar Y, 2001, TRENDS PLANT SCI, V6, P426, DOI 10.1016/S1360-1385(01)02044-1; Hemenway CS, 1996, J BIOL CHEM, V271, P18527, DOI 10.1074/jbc.271.31.18527; Hrycyna CA, 1998, METHOD ENZYMOL, V292, P456; Jasinski M, 2003, PLANT PHYSIOL, V131, P1169, DOI 10.1104/pp.102.014720; Kamphausen T, 2002, PLANT J, V32, P263, DOI 10.1046/j.1365-313X.2002.01420.x; Krishna Rajesh, 2001, Current Medicinal Chemistry - Anti-Cancer Agents, V1, P163, DOI 10.2174/1568011013354705; Kurek I, 2002, PLANTA, V215, P119, DOI 10.1007/s00425-001-0722-0; Lariguet P, 2004, PLANT J, V40, P826, DOI 10.1111/j.1365-313X.2004.02256.x; Li JS, 2005, SCIENCE, V310, P121, DOI 10.1126/science.1115711; Lin RC, 2005, PLANT PHYSIOL, V138, P949, DOI 10.1104/pp.105.061572; LOMAX TL, 1985, P NATL ACAD SCI USA, V82, P6541, DOI 10.1073/pnas.82.19.6541; Luschnig C, 1998, GENE DEV, V12, P2175, DOI 10.1101/gad.12.14.2175; Mancuso S, 2005, ANAL BIOCHEM, V341, P344, DOI 10.1016/j.ab.2005.03.054; Mancuso S, 2006, PLANT CELL PHYSIOL, V47, P401, DOI 10.1093/pcp/pcj007; Martinoia E, 2002, PLANTA, V214, P345, DOI 10.1007/s004250100661; Mealey KL, 1999, CANCER CHEMOTH PHARM, V44, P152, DOI 10.1007/s002800050960; Muday GK, 2001, TRENDS PLANT SCI, V6, P535, DOI 10.1016/S1360-1385(01)02101-X; Multani DS, 2003, SCIENCE, V302, P81, DOI 10.1126/science.1086072; Murphy AS, 2002, PLANT PHYSIOL, V128, P935, DOI 10.1104/pp.010519; Noh B, 2003, NATURE, V423, P999, DOI 10.1038/nature01716; Noh B, 2001, PLANT CELL, V13, P2441, DOI 10.1105/tpc.13.11.2441; Nuhse TS, 2004, PLANT CELL, V16, P2394, DOI 10.1105/tpc.104.023150; Ottenschlager I, 2003, P NATL ACAD SCI USA, V100, P2987, DOI 10.1073/pnas.0437936100; Peer WA, 2004, PLANT CELL, V16, P1898, DOI 10.1105/tpc.021501; Perez-Perez JM, 2004, PLANT PHYSIOL, V134, P101, DOI 10.1104/pp.103.032524; Petrasek J, 2006, SCIENCE, V312, P914, DOI 10.1126/science.1123542; Prusty R, 2004, P NATL ACAD SCI USA, V101, P4153, DOI 10.1073/pnas.0400659101; Ramaen O, 2005, BIOCHEM J, V391, P481, DOI 10.1042/BJ20050897; Romano P, 2005, NEW PHYTOL, V166, P753, DOI 10.1111/j.1469-8137.2005.01373.x; Santelia D, 2005, FEBS LETT, V579, P5399, DOI 10.1016/j.febslet.2005.08.061; Schiene C, 2000, CURR OPIN STRUC BIOL, V10, P40, DOI 10.1016/S0959-440X(99)00046-9; Schlicht M, 2006, PLANT SIGNAL BEHAV, V1, P122, DOI 10.4161/psb.1.3.2759; Sidler M, 1998, PLANT CELL, V10, P1623, DOI 10.1105/tpc.10.10.1623; STAMNES MA, 1991, CELL, V65, P219, DOI 10.1016/0092-8674(91)90156-S; Terasaka K, 2005, PLANT CELL, V17, P2922, DOI 10.1105/tpc.105.035816; TIMERMAN AP, 1995, J BIOL CHEM, V270, P2451, DOI 10.1074/jbc.270.6.2451; Ueda M, 2004, DEVELOPMENT, V131, P2101, DOI 10.1242/dev.01096; Vespa L, 2004, PLANT PHYSIOL, V134, P1283, DOI 10.1104/pp.103.028050; Vittorioso P, 1998, MOL CELL BIOL, V18, P3034, DOI 10.1128/MCB.18.5.3034; Vucich VA, 1996, MOL GEN GENET, V252, P510, DOI 10.1007/BF02172397; Weiergraber OH, 2006, FEBS LETT, V580, P251, DOI 10.1016/j.febslet.2005.12.007	63	156	162	1	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30603	30612		10.1074/jbc.M604604200	http://dx.doi.org/10.1074/jbc.M604604200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16887800	Green Published, hybrid			2022-12-27	WOS:000241075900036
J	Franzke, CW; Has, C; Schulte, C; Huilaja, L; Tasanen, K; Aumailley, M; Bruckner-Tuderman, L				Franzke, Claus-Werner; Has, Cristina; Schulte, Carsten; Huilaja, Laura; Tasanen, Kaisa; Aumailley, Monique; Bruckner-Tuderman, Leena			C-terminal truncation impairs glycosylation of transmembrane collagen XVII and leads to intracellular accumulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BENIGN EPIDERMOLYSIS-BULLOSA; PEMPHIGOID ANTIGEN BPAG2; GLYCINE SUBSTITUTION; CELL-ADHESION; MUTATIONS; PROTEIN; COL17A1; GENE; ECTODOMAIN; LAMININ-5	Collagen XVII, a type II transmembrane protein in hemidesmosomes, is involved in the anchorage of stratified epithelia to the underlying mesenchyme. Its functions are regulated by ectodomain shedding, and its genetic defects lead to epidermal detachment in junctional epidermolysis bullosa ( JEB), a heritable skin fragility syndrome, but the molecular disease mechanisms remain elusive. Here we used a spontaneously occurring homozygous COL17A1 deletion mutant in JEB to discern glycosylation of collagen XVII. The mutation truncated the distal ectodomain and positioned the only N-glycosylation site 34 amino acids from the newly formed C terminus, which impaired efficient N-glycosylation. Immunofluorescence staining of authentic JEB keratinocytes and of COS-7 cells transfected with the mutant indicated intracellular accumulation of collagen XVII precursor molecules. Cell surface biotinylation and quantification of ectodomain shedding demonstrated that only about 15% of the truncated collagen XVII reached the cell surface. The cell surface-associated molecules were N-glycosylated in a normal manner, in contrast to the molecules retained within the cells, indicating that N-glycosylation of the ectodomain is required for targeting of collagen XVII to the plasma membrane and that reduced accessibility of the N-glycosylation site negatively regulates this process. Functional consequences of the strong reduction of collagen XVII on the cell surface included scattered deposition of cell adhesion molecule laminin 5 into the extracellular environment and, as a consequence of faulty collagen XVII-laminin ligand interactions, aberrant motility of the mutant cells.	Univ Freiburg, Med Ctr, Dept Dermatol, D-79104 Freiburg, Germany; Univ Cologne, Fac Med, Dept Biochem, D-50923 Cologne, Germany; Univ Oulu, Dept Dermatol, Oulu 90014, Finland; Oulu Univ Hosp, Clin Res Ctr, Oulu 90014, Finland; Univ Cologne, Ctr Mol Med Cologne, D-50923 Cologne, Germany	University of Freiburg; University of Cologne; University of Oulu; University of Oulu; University of Cologne	Bruckner-Tuderman, L (corresponding author), Univ Freiburg, Med Ctr, Dept Dermatol, Hauptstr 7, D-79104 Freiburg, Germany.	bruckner_tuderman@haut.ukl.uni-freiburg.de	Has, Cristina/B-3310-2017; Schulte, Carsten/R-2370-2016; Has, Cristina/AGF-7185-2022; Has, Cristina/V-2132-2019	Has, Cristina/0000-0001-6066-507X; Schulte, Carsten/0000-0002-7554-5342; Has, Cristina/0000-0001-6066-507X; Has, Cristina/0000-0001-6066-507X; Tasanen, Kaisa/0000-0001-8056-5949				Conti LR, 2002, J BIOL CHEM, V277, P25416, DOI 10.1074/jbc.M203109200; DUKSIN D, 1982, J BIOL CHEM, V257, P3105; Esapa CT, 2005, HUM MOL GENET, V14, P295, DOI 10.1093/hmg/ddi026; FINE JD, 1988, ARCH DERMATOL, V124, P713, DOI 10.1001/archderm.124.5.713; Floeth M, 1998, J INVEST DERMATOL, V111, P528, DOI 10.1046/j.1523-1747.1998.00325.x; Franzke CW, 2002, EMBO J, V21, P5026, DOI 10.1093/emboj/cdf532; Franzke CW, 2004, J BIOL CHEM, V279, P24521, DOI 10.1074/jbc.M308835200; Franzke CW, 2005, J BIOL CHEM, V280, P4005, DOI 10.1074/jbc.R400034200; Gagnoux-Palacios L, 2001, J CELL BIOL, V153, P835, DOI 10.1083/jcb.153.4.835; Gatalica B, 1997, AM J HUM GENET, V60, P352; Goldfinger LE, 1998, J CELL BIOL, V141, P255, DOI 10.1083/jcb.141.1.255; GORLICH D, 1992, CELL, V71, P489, DOI 10.1016/0092-8674(92)90517-G; JONKMAN MF, 1995, J CLIN INVEST, V95, P1345, DOI 10.1172/JCI117785; KONIG A, 1992, J CELL BIOL, V117, P679, DOI 10.1083/jcb.117.3.679; MAHONEY WC, 1979, J BIOL CHEM, V254, P6572; McGrath JA, 1996, J INVEST DERMATOL, V106, P771, DOI 10.1111/1523-1747.ep12345821; MCGRATH JA, 1995, NAT GENET, V11, P83, DOI 10.1038/ng0995-83; Nilsson I, 2000, J BIOL CHEM, V275, P17338, DOI 10.1074/jbc.M002317200; Pulkkinen L, 1998, EXP DERMATOL, V7, P46, DOI 10.1111/j.1600-0625.1998.tb00304.x; Pulkkinen L, 1999, MATRIX BIOL, V18, P29, DOI 10.1016/S0945-053X(98)00005-5; Sabbagh Y, 2001, HUM MOL GENET, V10, P1539, DOI 10.1093/hmg/10.15.1539; Schacke H, 1998, J BIOL CHEM, V273, P25937, DOI 10.1074/jbc.273.40.25937; Schumann H, 1997, AM J HUM GENET, V60, P1344, DOI 10.1086/515463; Schumann H, 2000, AM J PATHOL, V156, P685, DOI 10.1016/S0002-9440(10)64772-4; Silberstein S, 1996, FASEB J, V10, P849, DOI 10.1096/fasebj.10.8.8666161; Tasanen K, 2004, AM J PATHOL, V164, P2027, DOI 10.1016/S0002-9440(10)63762-5; Tasanen K, 2000, J BIOL CHEM, V275, P3093, DOI 10.1074/jbc.275.5.3093; Tasanen K, 2000, J INVEST DERMATOL, V115, P207, DOI 10.1046/j.1523-1747.2000.00049.x; Tunggal L, 2002, AM J PATHOL, V160, P459, DOI 10.1016/S0002-9440(10)64865-1; Vaisanen L, 2005, J INVEST DERMATOL, V125, P1112, DOI 10.1111/j.0022-202X.2005.23943.x; Walmsley AR, 2003, BIOCHEM J, V370, P351, DOI 10.1042/BJ20021303; White JK, 2004, BIOCHEM J, V382, P811, DOI 10.1042/BJ20040808; Whitley P, 1996, J BIOL CHEM, V271, P6241, DOI 10.1074/jbc.271.11.6241	33	18	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					30260	30268		10.1074/jbc.M604464200	http://dx.doi.org/10.1074/jbc.M604464200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16899459	hybrid			2022-12-27	WOS:000240896300086
J	Paquet, M; Asay, MJ; Fam, SR; Inuzuka, H; Castleberry, AM; Oller, H; Smith, Y; Yun, CC; Traynelis, SF; Hall, RA				Paquet, Maryse; Asay, Matthew J.; Fam, Sami R.; Inuzuka, Hiroyuki; Castleberry, Amanda M.; Oller, Heide; Smith, Yoland; Yun, C. Chris; Traynelis, Stephen F.; Hall, Randy A.			The PDZ scaffold NHERF-2 interacts with mGluR5 and regulates receptor activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; BORDER NA+/H+ EXCHANGER; GROUP-I; UP-REGULATION; HIPPOCAMPAL ASTROCYTES; SHANK FAMILY; SPINAL-CORD; PROTEIN; EXPRESSION; ASSOCIATION	The two members of the group I metabotropic glutamate receptor family, mGluR1 and mGluR5, both couple to G(q) to mediate rises in intracellular calcium. The alternatively spliced C termini (CT) of mGluRs 1 & 5 are known to be critical for regulating receptor activity and to terminate in motifs suggestive of potential interactions with PDZ domains. We therefore screened the CTs of both mGluR1a and mGluR5 against a PDZ domain proteomic array. Out of 96 PDZ domains examined, the domain that bound most strongly to mGluR5-CT was the second PDZ domain of the Na+/H+ exchanger regulatory factor 2 (NHERF-2). This interaction was confirmed by reverse overlay, and a single point mutation to the mGluR5-CT was found to completely disrupt the interaction. Full-length mGluR5 robustly associated with full-length NHERF-2 in cells, as assessed by co-immunoprecipitation and confocal microscopy experiments. In contrast, mGluR1a was found to bind NHERF-2 in vitro with a weaker affinity than mGluR5, and furthermore mGluR1a did not detectably associate with NHERF-2 in a cellular context. Immunohistochemical experiments revealed that NHERF-2 and mGluR5 exhibit overlapping patterns of expression in mouse brain, being found most abundantly in astrocytic processes and postsynaptic neuronal elements. In functional experiments, the interaction of NHERF-2 with mGluR5 in cells was found to prolong mGluR5-mediated calcium mobilization and to also potentiate mGluR5-mediated cell death, whereas co-expression of mGluR1a with NHERF-2 had no evident effects on mGluR1a functional activity. These observations reveal that NHERF-2 can selectively modulate mGluR5 signaling, which may contribute to cell-specific regulation of mGluR5 activity.	Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Div Digest Dis, Dept Med, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Emory University	Hall, RA (corresponding author), Emory Univ, Sch Med, Dept Pharmacol, 5113 Rollins Res Ctr,1510 Clifton Rd, Atlanta, GA 30322 USA.	rhall@pharm.emory.edu		Hall, Randy/0000-0002-8318-8728	NIDDK NIH HHS [R01 DK061418-03, R01 DK061418-02, R01 DK061418-04, R01 DK061418] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061418] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Albasanz JL, 2002, MOL BRAIN RES, V99, P54; Ango F, 2001, NATURE, V411, P962, DOI 10.1038/35082096; Aronica E, 2001, NEUROSCIENCE, V105, P509, DOI 10.1016/S0306-4522(01)00181-6; Aronica E, 2003, EPILEPSIA, V44, P785, DOI 10.1046/j.1528-1157.2003.54802.x; Aronica E, 2000, EUR J NEUROSCI, V12, P2333, DOI 10.1046/j.1460-9568.2000.00131.x; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Cai ZH, 2000, GLIA, V29, P70, DOI 10.1002/(SICI)1098-1136(20000101)29:1<70::AID-GLIA7>3.0.CO;2-V; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Dev KK, 2004, NAT REV DRUG DISCOV, V3, P1047, DOI 10.1038/nrd1578; Fagni L, 2004, SEMIN CELL DEV BIOL, V15, P289, DOI 10.1016/j.semcdb.2003.12.018; Fam SR, 2005, P NATL ACAD SCI USA, V102, P8042, DOI 10.1073/pnas.0408818102; Ferraguti F, 2001, EXP BRAIN RES, V137, P1, DOI 10.1007/s002210000633; Fouassier L, 2000, J BIOL CHEM, V275, P25039, DOI 10.1074/jbc.C000092200; Geurts JJG, 2003, BRAIN, V126, P1755, DOI 10.1093/brain/awg179; Gwak YS, 2005, EXP NEUROL, V195, P236, DOI 10.1016/j.expneurol.2005.05.012; He JQ, 2006, J BIOL CHEM, V281, P2820, DOI 10.1074/jbc.M509503200; Hermans E, 2001, BIOCHEM J, V359, P465, DOI 10.1042/0264-6021:3590465; Hubert GW, 2004, J COMP NEUROL, V475, P95, DOI 10.1002/cne.20163; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Hwang JI, 2000, J BIOL CHEM, V275, P16632, DOI 10.1074/jbc.M001410200; Hwang JI, 2005, J BIOL CHEM, V280, P12467, DOI 10.1074/jbc.M410740200; JOLY C, 1995, J NEUROSCI, V15, P3970; Kawabata S, 1996, NATURE, V383, P89, DOI 10.1038/383089a0; Kew JNC, 2004, PHARMACOL THERAPEUT, V104, P233, DOI 10.1016/j.pharmthera.2004.08.010; Kitano J, 2002, J NEUROSCI, V22, P1280, DOI 10.1523/JNEUROSCI.22-04-01280.2002; Lau AG, 2001, BIOCHEMISTRY-US, V40, P8572, DOI 10.1021/bi0103516; Lee-Kwon W, 2005, AM J PHYSIOL-CELL PH, V288, pC942, DOI 10.1152/ajpcell.00417.2004; Lee-Kwon W, 2003, AM J PHYSIOL-CELL PH, V285, pC1527, DOI 10.1152/ajpcell.00017.2003; Martin M, 1998, BBA-LIPID LIPID MET, V1393, P186, DOI 10.1016/S0005-2760(98)00036-8; Maudsley S, 2000, MOL CELL BIOL, V20, P8352, DOI 10.1128/MCB.20.22.8352-8363.2000; Moghaddam B, 2004, PSYCHOPHARMACOLOGY, V174, P39, DOI 10.1007/s00213-004-1792-z; Nguyen R, 2001, J BIOL CHEM, V276, P7621, DOI 10.1074/jbc.M006708200; Pagano A, 2000, J BIOL CHEM, V275, P33750, DOI 10.1074/jbc.M006230200; Paquet M, 2006, J COMP NEUROL, V494, P752, DOI 10.1002/cne.20854; Rochdi MD, 2003, J BIOL CHEM, V278, P17827, DOI 10.1074/jbc.M210319200; Rong R, 2003, NAT NEUROSCI, V6, P1153, DOI 10.1038/nn1134; Sala C, 2005, J NEUROSCI, V25, P4587, DOI 10.1523/JNEUROSCI.4822-04.2005; Schools GP, 1999, J NEUROSCI RES, V58, P533, DOI 10.1002/(SICI)1097-4547(19991115)58:4<533::AID-JNR6>3.0.CO;2-G; Sheng M, 2000, J CELL SCI, V113, P1851; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Shenolikar S, 2001, FEBS LETT, V489, P233, DOI 10.1016/S0014-5793(01)02109-3; Smith Y, 2001, J CHEM NEUROANAT, V22, P13, DOI 10.1016/S0891-0618(01)00098-9; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Ulas J, 2000, GLIA, V30, P352, DOI 10.1002/(SICI)1098-1136(200006)30:4<352::AID-GLIA40>3.0.CO;2-6; Valenti O, 2002, J CELL PHYSIOL, V191, P125, DOI 10.1002/jcp.10081; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7; Yun CHC, 1997, P NATL ACAD SCI USA, V94, P3010, DOI 10.1073/pnas.94.7.3010; Yun CHC, 1998, J BIOL CHEM, V273, P25856, DOI 10.1074/jbc.273.40.25856	49	48	49	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					29949	29961		10.1074/jbc.M602262200	http://dx.doi.org/10.1074/jbc.M602262200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16891310	Green Accepted, hybrid			2022-12-27	WOS:000240896300056
J	Sonobe, H; Ohira, T; Ieki, K; Maeda, S; Ito, Y; Ajimura, M; Mita, K; Matsumoto, H; Wilder, MN				Sonobe, Haruyuki; Ohira, Tsuyoshi; Ieki, Katsunori; Maeda, Sayaka; Ito, Yoichi; Ajimura, Masahiro; Mita, Kazuei; Matsumoto, Hitoshi; Wilder, Marcy N.			Purification, kinetic characterization, and molecular cloning of a novel enzyme, ecdysteroid 22-kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EARLY EMBRYONIC-DEVELOPMENT; BOMBYX-MORI; DIAPAUSE EGGS; CYTOCHROME-P450 ENZYME; CRYSTAL-STRUCTURE; NONDIAPAUSE EGGS; PHOSPHORIC ESTER; FOLLICLE CELLS; P450 ENZYMES; SILKWORM	This is the first report succeeding in the isolation and characterization of an enzyme and its gene involved in the phosphorylation of a steroid hormone. It has been demonstrated that ecdysteroid 22-phosphates in insect ovaries, which are physiologically inactive, serve as a "reservoir" that supplies active free ecdysteroids during early embryonic development and that their dephosphorylation is catalyzed by a specific enzyme, ecdysteroid-phosphate phosphatase (Yamada, R., and Sonobe, H. (2003), J. Biol. Chem. 278, 26365-26373). In this study, ecdysteroid 22-kinase (EcKinase) was purified from the cytosol of the silkworm Bombyx mori ovaries to about 1,800-fold homogeneity in six steps of column chromatography and biochemically characterized. Results obtained indicated that the reciprocal conversion of free ecdysteroids and ecdysteroid 22-phosphates by two enzymes, EcKinase and ecdysteroid-phosphate phosphatase, plays an important role in ecdysteroid economy of the ovary-egg system of B. mori. On the basis of the partial amino acid sequence obtained from purified EcKinase, the nucleotide sequence of the cDNA encoding EcKinase was determined. The full-length cDNA of EcKinase was composed of 1,850 bp with an open reading frame encoding a protein of 386 amino acid residues. The cloned cDNA was confirmed to encode the functional EcKinase using the transformant harboring the open reading frame of EcKinase. A data base search showed that EcKinase has an amino acid sequence characteristic of phosphotransferases, in that it harbors Brenner's motif and putative ATP binding sites, but there are no functional proteins that share high identity with the amino acid sequence of EcKinase.	Konan Univ, Fac Sci & Engn, Dept Biol, Kobe, Hyogo 6588501, Japan; Japan Int Res Ctr Agr Sci, Tsukuba, Ibaraki 3058686, Japan; Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058634, Japan	Konan University; Japan International Research Center for Agricultural Sciences; National Institute of Agrobiological Sciences - Japan	Sonobe, H (corresponding author), Konan Univ, Fac Sci & Engn, Dept Biol, Kobe, Hyogo 6588501, Japan.	sonobe@konan-u.ac.jp	WILDER, MARCY/CAH-4807-2022					Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; Aoyama C, 2000, J LIPID RES, V41, P452; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENNER S, 1987, NATURE, V329, P21, DOI 10.1038/329021a0; BULLIERE D, 1979, ROUX ARCH DEV BIOL, V186, P103, DOI 10.1007/BF00848172; Chavez VM, 2000, DEVELOPMENT, V127, P4115; Coughtrie MWH, 1998, CHEM-BIOL INTERACT, V109, P3, DOI 10.1016/S0009-2797(97)00117-8; Fukuda S., 1951, Proceedings of the Japan Academy, V27, P672; GHARIB B, 1981, J INSECT PHYSIOL, V27, P711, DOI 10.1016/0022-1910(81)90008-1; GHARIB B, 1981, EXPERIENTIA, V37, P1107, DOI 10.1007/BF02085039; Gilbert LI, 2004, MOL CELL ENDOCRINOL, V215, P1, DOI 10.1016/j.mce.2003.11.003; Hagedorn H.H., 1985, P205; Hochberg RB, 1998, ENDOCR REV, V19, P331, DOI 10.1210/er.19.3.331; Hoffmann J.A., 1985, P435; Horike N, 1999, ARCH INSECT BIOCHEM, V41, P9, DOI 10.1002/(SICI)1520-6327(1999)41:1&lt;9::AID-ARCH3&gt;3.0.CO;2-G; Horike N, 2000, EUR J BIOCHEM, V267, P6914, DOI 10.1046/j.1432-1033.2000.01796.x; KABBOUH M, 1991, INSECT BIOCHEM, V21, P57, DOI 10.1016/0020-1790(91)90064-L; Kamba M, 2000, NAT PROD LETT, V14, P349, DOI 10.1080/10575630008043767; KAMBA M, 1994, INSECT BIOCHEM MOLEC, V24, P395, DOI 10.1016/0965-1748(94)90032-9; Kamba M, 2000, NAT PROD LETT, V14, P469, DOI 10.1080/10575630008043787; Kamba Mari, 1995, Journal of Sericultural Science of Japan, V64, P333; KAPPLER C, 1986, INT J INVER REP DEV, V9, P17, DOI 10.1080/01688170.1986.10510177; KOOLMAN J, 1990, ZOOL SCI, V7, P563; Kozlova T, 2003, SCIENCE, V301, P1911, DOI 10.1126/science.1087419; Lafont R., 1984, P196; Lafont R., 2005, COMPREHENSIVE MOL IN, V3, P125, DOI DOI 10.1016/B0-44-451924-6/00035-1; LAFONT R, 2002, ECOYSONE HDB; LAGUEUX M, 1979, J INSECT PHYSIOL, V25, P709, DOI 10.1016/0022-1910(79)90123-9; Lanot R., 1989, P262; Lee DC, 2003, J BIOL CHEM, V278, P31412, DOI 10.1074/jbc.M213154200; Makka T, 2000, ZOOL SCI, V17, P89, DOI 10.2108/zsj.17.89; Makka T, 2002, ARCH INSECT BIOCHEM, V51, P111, DOI 10.1002/arch.10055; MAMIYA Y, 1995, EXPERIENTIA, V51, P363, DOI 10.1007/BF01928896; Matsumoto E, 2003, BIOSCI BIOTECH BIOCH, V67, P1780, DOI 10.1271/bbb.67.1780; Nakatsuji T, 2004, GEN COMP ENDOCR, V135, P358, DOI 10.1016/j.ygcen.2003.11.001; Niwa R, 2004, J BIOL CHEM, V279, P35942, DOI 10.1074/jbc.M404514200; OHNISHI E, 1981, INSECT BIOCHEM, V11, P155, DOI 10.1016/0020-1790(81)90090-1; OHNISHI E, 1989, INSECT BIOCHEM, V19, P95, DOI 10.1016/0020-1790(89)90014-0; OSTANIN K, 1992, J BIOL CHEM, V267, P22830; Peisach D, 2003, STRUCTURE, V11, P703, DOI 10.1016/S0969-2126(03)00094-7; Petryk A, 2003, P NATL ACAD SCI USA, V100, P13773, DOI 10.1073/pnas.2336088100; Raftogianis R, 2000, J Natl Cancer Inst Monogr, P113; Rees H.H., 1984, P181; REES HH, 1995, EUR J ENTOMOL, V92, P9; REES HH, 1984, COMPREHENSIVE MOL IN, P181; RYBCZYNSKI R, 2005, COMPREHENSIVE MOL IN, V3, P61; SCALIA S, 1987, INSECT BIOCHEM, V17, P227, DOI 10.1016/0020-1790(87)90164-8; Sieglaff DH, 2005, INSECT BIOCHEM MOLEC, V35, P471, DOI 10.1016/j.ibmb.2005.01.011; SONOBE H, 1991, EXPERIENTIA, V47, P948, DOI 10.1007/BF01929889; Sonobe H, 1999, ZOOL SCI, V16, P935, DOI 10.2108/zsj.16.935; SONOBE H, 1986, J INSECT PHYSIOL, V32, P215, DOI 10.1016/0022-1910(86)90061-2; SONOBE H, 1970, DEV GROWTH DIFFER, V12, P41; Sonobe H, 2004, ZOOL SCI, V21, P503, DOI 10.2108/zsj.21.503; TAKAHASHI SY, 1992, ZOOL SCI, V9, P169; Tawfik AI, 1999, ARCH INSECT BIOCHEM, V41, P134, DOI 10.1002/(SICI)1520-6327(1999)41:3&lt;134::AID-ARCH4&gt;3.0.CO;2-6; VANETTEN RL, 1991, J BIOL CHEM, V266, P2313; VANETTEN RL, 1982, ANN NY ACAD SCI, V390, P27; VINCENT JB, 1992, TRENDS BIOCHEM SCI, V17, P105, DOI 10.1016/0968-0004(92)90246-6; Wang YL, 2004, J BIOL CHEM, V279, P39132, DOI 10.1074/jbc.M405982200; WARREN JT, 1986, J LIQ CHROMATOGR, V9, P1759, DOI 10.1080/01483918608076716; Warren JT, 2004, INSECT BIOCHEM MOLEC, V34, P991, DOI 10.1016/j.ibmb.2004.06.009; Warren JT, 2002, P NATL ACAD SCI USA, V99, P11043, DOI 10.1073/pnas.162375799; WATANABE K, 1984, ZOOL SCI, V1, P114; Weinshilboum RM, 1997, FASEB J, V11, P3, DOI 10.1096/fasebj.11.1.9034160; Yamada R, 2002, PROCEEDINGS OF THE 21ST CONFERENCE OF EUROPEAN COMPARATIVE ENDOCRINOLOGISTS, P179; Yamada R, 2003, J BIOL CHEM, V278, P26365, DOI 10.1074/jbc.M304158200; Yamada R, 2005, ZOOL SCI, V22, P187, DOI 10.2108/zsj.22.187	67	20	22	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					29513	29524		10.1074/jbc.M604035200	http://dx.doi.org/10.1074/jbc.M604035200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16899460	hybrid			2022-12-27	WOS:000240896300013
J	Zong, Y; Zhou, S; Fatima, S; Sorrentino, BP				Zong, Yang; Zhou, Sheng; Fatima, Soghra; Sorrentino, Brian P.			Expression of mouse Abcg2 mRNA during hematopoiesis is regulated by alternative use of multiple leader Exons and promoters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELLS; GENE; RESISTANCE; TRANSCRIPTION; TRANSPORTER; SEQUENCE; REGION; ELEMENT; EFFLUX	ABCG2 encodes a transmembrane transporter associated with multidrug resistance in various cancer cells. ABCG2 is also highly expressed in hematopoietic stem cells (HSCs) and is down- regulated in most committed progenitors, whereas expression is sharply up- regulated during erythroid differentiation. The mechanisms for regulation of ABCG2 expression in hematopoietic cells are poorly understood. We have recently identified three novel leader exons ( termed E1A, E1B, and E1C) located in the 5 alpha-untranslated region of mouse Abcg2 mRNA by data base searches and reverse transcription-PCR. In a mouse erythroid cell line, reverse transcription- PCR analysis showed that the transcript containing E1B exon was the only isoform detected. Consistently, the E1B- containing transcript was the predominant isoform of Abcg2 mRNA in primary Ter119+ erythroid cells from mouse bone marrow as well as in mouse fetal liver cells. In contrast, the E1A- containing transcript was highly expressed inc-Kit+, Sca-1+, Lin-( KSL) bone marrow cells, especially in CD34- KSL fraction, which is highly enriched for repopulating HSCs. The differential expression pattern of Abcg2 mRNA isoforms in mouse HSCs and erythroid cells was confirmed by 5'- rapid amplification of cDNA ends, indicating that at least two different promoters control mouse Abcg2 transcription during hematopoiesis. Promoter functional assays using EGFP as reporter gene demonstrated that the E1A5'-flanking region had promoter activity, which contains multiple putative hematopoietic transcription factor binding sites. In summary, our data show that the expression of Abcg2 during hematopoiesis is transcriptionally regulated by alternative use of multiple leader exons and promoters in a developmental stage- specific manner.	St Jude Childrens Hosp, Dept Hematol Oncol, Div Expt Hematol, Memphis, TN 38105 USA; Univ Tennessee, Ctr Hlth Sci, Coll Grad Hlth Sci, Interdisciplinary Program, Memphis, TN 38163 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	Zong, Y (corresponding author), St Jude Childrens Hosp, Dept Hematol Oncol, Div Expt Hematol, 332 N Lauderdale St, Memphis, TN 38105 USA.	yang.zong@stjude.org; brian.sorrentino@stjude.org	Zong, Yang/F-4272-2010	Zhou, Sheng/0000-0001-5902-5868	NHLBI NIH HHS [R01 HL67366] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067366] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Allen JD, 1999, CANCER RES, V59, P4237; Ayoubi TAY, 1996, FASEB J, V10, P453, DOI 10.1096/fasebj.10.4.8647344; Bailey-Dell KJ, 2001, BBA-GENE STRUCT EXPR, V1520, P234, DOI 10.1016/S0167-4781(01)00270-6; Bunting KD, 2002, STEM CELLS, V20, P11, DOI 10.1002/stem.200011; Chan Y, 2004, J BIOL CHEM, V279, P35087, DOI 10.1074/jbc.M405063200; Doyle LA, 2003, ONCOGENE, V22, P7340, DOI 10.1038/sj.onc.1206938; Ee PLR, 2004, CANCER RES, V64, P1247, DOI 10.1158/0008-5472.CAN-03-3583; Ghozi MC, 1996, P NATL ACAD SCI USA, V93, P1935, DOI 10.1073/pnas.93.5.1935; Hanawa H, 2005, J VIROL, V79, P8410, DOI 10.1128/JVI.79.13.8410-8421.2005; Huff LM, 2005, CANCER RES, V65, P11694; ITO E, 1993, NATURE, V362, P466, DOI 10.1038/362466a0; Jonker JW, 2002, P NATL ACAD SCI USA, V99, P15649, DOI 10.1073/pnas.202607599; Kina T, 2000, BRIT J HAEMATOL, V109, P280, DOI 10.1046/j.1365-2141.2000.02037.x; Krishnamurthy P, 2004, J BIOL CHEM, V279, P24218, DOI 10.1074/jbc.M313599200; Minegishi N, 1998, J BIOL CHEM, V273, P3625, DOI 10.1074/jbc.273.6.3625; MORI N, 1990, NEURON, V4, P583, DOI 10.1016/0896-6273(90)90116-W; Nakamura K, 2004, J BIOL CHEM, V279, P45980, DOI 10.1074/jbc.M408652200; Nakanishi T, 2006, CANCER RES, V66, P5007, DOI 10.1158/0008-5472.CAN-05-4572; OKADA S, 1992, BLOOD, V80, P3044; Pozner A, 2000, MOL CELL BIOL, V20, P2297, DOI 10.1128/MCB.20.7.2297-2307.2000; PRESTRIDGE DS, 1995, J MOL BIOL, V249, P923, DOI 10.1006/jmbi.1995.0349; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Scharenberg CW, 2002, BLOOD, V99, P507, DOI 10.1182/blood.V99.2.507; Schug J., 1997, CBILTR19971001V00 U; Shivdasani RA, 1996, BLOOD, V87, P4025, DOI 10.1182/blood.V87.10.4025.bloodjournal87104025; Shmelkov SV, 2004, BLOOD, V103, P2055, DOI 10.1182/blood-2003-06-1881; SPANOPOULOU E, 1991, MOL CELL BIOL, V11, P2216, DOI 10.1128/MCB.11.4.2216; UEDA K, 1987, J BIOL CHEM, V262, P17432; WENGER RH, 1993, J BIOL CHEM, V268, P23345; WHITELAW E, 1989, MOL CELL BIOL, V9, P241, DOI 10.1128/MCB.9.1.241; Zhou S, 2005, BLOOD, V105, P2571, DOI 10.1182/blood-2004-04-1566; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028; ZHU QC, 1994, CANCER RES, V54, P4488	33	29	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					29625	29632		10.1074/jbc.M606314200	http://dx.doi.org/10.1074/jbc.M606314200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16885162	hybrid			2022-12-27	WOS:000240896300024
J	Chen, YW; Dokholyan, NV				Chen, Yiwen; Dokholyan, Nikolay V.			Insights into allosteric control of vinculin function from its large scale conformational dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLING MEMBRANE PROTRUSION; LOCAL-STRUCTURE MODEL; MOLECULAR-DYNAMICS; CELL-ADHESION; BINDING-SITE; INTRAMOLECULAR ASSOCIATION; UNFOLDING TRANSITION; ACIDIC PHOSPHOLIPIDS; GLOBULAR-PROTEINS; STRUCTURAL BASIS	Vinculin is an important constituent of both cell-cell and cell-matrix junctions, where it plays crucial roles in the regulation of cell adhesion and migration. When activated, it mediates the linkage between cadherins (cell-cell) or integrins (cell-matrix) and the actin cytoskeleton through interactions with various proteins. The activation of vinculin requires structural conversions from an autoinhibited conformation to the "open" conformations in which the occluded binding sites of its different ligands become exposed, while the structural dynamics underlying the vinculin activation remains largely unknown. Here we report the first computational study of large scale conformational dynamics of full-length vinculin. We find that the "holding" and "releasing" motions between vinculin tail and pincer-like structure formed by first three domains of vinculin are the dominant motions near the native state of vinculin, indicating that an inherent flexibility of vinculin has a large influence on its allostery. We also find a cooperative dissociation between the head and tail domains of vinculin with increasing temperature in both thermodynamic and kinetic simulations, implying that vinculin may function as an allosteric switch in response to external signals. We show that the kinetics of vinculin unfolding exhibits specific sequential patterns, suggesting that a sophisticated interplay between domains may synergistically contribute to vinculin activation. We further find that the interaction between vinculin-binding site peptide from talin and vinculin significantly destabilizes the intramolecular head-tail interactions, suggesting a direct role of talin binding in vinculin activation.	Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Phys & Astron, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Dokholyan, NV (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	dokh@med.unc.edu	Dokholyan, Nikolay/D-8081-2018; Dokholyan, Nikolay/B-2238-2009	Dokholyan, Nikolay/0000-0002-8225-4025; Dokholyan, Nikolay/0000-0002-8225-4025				ABE H, 1981, BIOPOLYMERS, V20, P1013, DOI 10.1002/bip.1981.360200512; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Bakolitsa C, 1999, CELL, V99, P603, DOI 10.1016/S0092-8674(00)81549-4; Bakolitsa C, 2004, NATURE, V430, P583, DOI 10.1038/nature02610; Bass MD, 1999, BIOCHEM J, V341, P257, DOI 10.1042/0264-6021:3410257; Berendsen HJC, 2000, CURR OPIN STRUC BIOL, V10, P165, DOI 10.1016/S0959-440X(00)00061-0; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bois PRJ, 2006, J BIOL CHEM, V281, P7228, DOI 10.1074/jbc.M510397200; Cohen DM, 2005, J BIOL CHEM, V280, P17109, DOI 10.1074/jbc.M414704200; Critchley DR, 2000, CURR OPIN CELL BIOL, V12, P133, DOI 10.1016/S0955-0674(99)00067-8; DeMali KA, 2004, TRENDS BIOCHEM SCI, V29, P565, DOI 10.1016/j.tibs.2004.09.001; DeMali KA, 2003, J CELL SCI, V116, P2389, DOI 10.1242/jcs.00605; DeMali KA, 2002, J CELL BIOL, V159, P881, DOI 10.1083/jcb.200206043; Ding F, 2006, STRUCTURE, V14, P5, DOI 10.1016/j.str.2005.09.008; Ding F, 2002, J MOL BIOL, V324, P851, DOI 10.1016/S0022-2836(02)01112-9; Ding F, 2002, BIOPHYS J, V83, P3525, DOI 10.1016/S0006-3495(02)75352-6; Dokholyan NV, 1998, FOLD DES, V3, P577, DOI 10.1016/S1359-0278(98)00072-8; FERNANDEZ JLR, 1992, J CELL BIOL, V119, P427, DOI 10.1083/jcb.119.2.427; FERNANDEZ JLR, 1993, J CELL BIOL, V122, P1285, DOI 10.1083/jcb.122.6.1285; Gilmore AP, 1996, NATURE, V381, P531, DOI 10.1038/381531a0; GO N, 1981, BIOPOLYMERS, V20, P991, DOI 10.1002/bip.1981.360200511; ICHIYE T, 1991, PROTEINS, V11, P205, DOI 10.1002/prot.340110305; Izard T, 2004, J BIOL CHEM, V279, P27667, DOI 10.1074/jbc.M403076200; Izard T, 2004, NATURE, V427, P171, DOI 10.1038/nature02281; JOHNSON RP, 1995, NATURE, V373, P261, DOI 10.1038/373261a0; JOHNSON RP, 1995, BIOCHEM BIOPH RES CO, V210, P159, DOI 10.1006/bbrc.1995.1641; Onuchic JN, 2000, ADV PROTEIN CHEM, V53, P87; Papagrigoriou E, 2004, EMBO J, V23, P2942, DOI 10.1038/sj.emboj.7600285; Pokutta S, 2002, CURR OPIN STRUC BIOL, V12, P255, DOI 10.1016/S0959-440X(02)00318-4; RAPAPORT DC, 2004, ART MOL DYNAMICS STI, P391; Sanchez R, 1997, CURR OPIN STRUC BIOL, V7, P206, DOI 10.1016/S0959-440X(97)80027-9; Smith SW, 1997, J COMPUT PHYS, V134, P16, DOI 10.1006/jcph.1996.5510; Subauste MC, 2004, J CELL BIOL, V165, P371, DOI 10.1083/jcb.200308011; Tobi D, 2005, P NATL ACAD SCI USA, V102, P18908, DOI 10.1073/pnas.0507603102; VOLBERG T, 1995, J CELL SCI, V108, P2253; Weekes J, 1996, BIOCHEM J, V314, P827, DOI 10.1042/bj3140827; Xu WM, 1998, DEVELOPMENT, V125, P327; Zamir E, 2001, J CELL SCI, V114, P3583	38	30	30	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					29148	29154		10.1074/jbc.M605512200	http://dx.doi.org/10.1074/jbc.M605512200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16891659	hybrid, Green Published			2022-12-27	WOS:000240680500069
J	Dulebohn, DP; Cho, HJ; Karzai, AW				Dulebohn, Daniel P.; Cho, Hye Jin; Karzai, A. Wali			Role of conserved surface amino acids in binding of SmpB protein to SsrA RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-MESSENGER RNA; ELONGATION-FACTOR TU; TRANS-TRANSLATION; THERMUS-THERMOPHILUS; RIBOSOME RESCUE; TMRNA; SYSTEM; DEGRADATION; PROTEOLYSIS; DOMAIN	Bacteria possess a unique salvage mechanism for rescuing ribosomes stalled on aberrant mRNAs. A complex of SmpB protein and SsrA RNA orchestrates this salvage process. The specific and direct binding of SmpB facilitates recognition and delivery of SsrA RNA to stalled ribosomes. The SmpB protein is conserved throughout the bacterial kingdom and contains several conserved amino acid sequence motifs. We present evidence to demonstrate that amino acid residues Glu-31, Leu-91, and Lys-124, which are highly conserved and clustered along an exposed surface of the protein, play a crucial role in the SsrA-mediated peptide tagging process. Our analysis suggests that the peptide-tagging defect exhibited by these SmpB variants is due to their inability to facilitate the delivery of SsrA RNA to stalled ribosomes. Moreover, we present evidence to demonstrate that the ribosome association defect of these variants is due to their reduced SsrA binding affinity. Consistent with these findings, we present biochemical evidence to demonstrate that residues Glu-31, Leu-91, and Lys-124 are essential for the SsrA binding activity of SmpB protein. Furthermore, we have investigated the interactions of SmpB . SsrA orthologues from the thermophilic bacterium Thermoanaerobacter tengcongensis. Our investigations demonstrate an analogous role for the equivalent T. tengcongensis residues in SmpB.SsrA interactions, hence further validating our findings for the Escherichia coli SmpB.SsrA system. These results demonstrate the functional significance of this cluster of conserved residues in SmpB binding to SsrA RNA, suggesting they might represent a core contact surface for recognition of SsrA RNA.	SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; SUNY Stony Brook, Ctr Infect Dis, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Karzai, AW (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	akarzai@ms.cc.sunysb.edu						Barends S, 2001, J MOL BIOL, V314, P9, DOI 10.1006/jmbi.2001.5114; Berggrun A, 2000, J MOL BIOL, V301, P959, DOI 10.1006/jmbi.2000.4007; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dong G, 2002, EMBO J, V21, P1845, DOI 10.1093/emboj/21.7.1845; Felden B, 1998, EMBO J, V17, P3188, DOI 10.1093/emboj/17.11.3188; Gillet R, 2001, MOL MICROBIOL, V42, P879, DOI 10.1046/j.1365-2958.2001.02701.x; Grzymski EC, 2003, NAT STRUCT BIOL, V10, P321, DOI 10.1038/nsb0503-321; Gutmann S, 2003, NATURE, V424, P699, DOI 10.1038/nature01831; Hanawa-Suetsugu K, 2002, NUCLEIC ACIDS RES, V30, P1620, DOI 10.1093/nar/30.7.1620; Huang CH, 2000, EMBO J, V19, P1098, DOI 10.1093/emboj/19.5.1098; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Karzai AW, 2000, NAT STRUCT BIOL, V7, P449; Karzai AW, 1999, EMBO J, V18, P3793, DOI 10.1093/emboj/18.13.3793; Keiler KC, 2000, P NATL ACAD SCI USA, V97, P7778, DOI 10.1073/pnas.97.14.7778; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Okan Nihal A., 2006, PLoS Pathogens, V2, P50; Rudinger-Thirion J, 1999, RNA, V5, P989, DOI 10.1017/S135583829999101X; Someya T, 2003, FEBS LETT, V535, P94, DOI 10.1016/S0014-5793(02)03880-2; Stepanov VG, 2003, EUR J BIOCHEM, V270, P463, DOI 10.1046/j.1432-1033.2003.03401.x; Sundermeier TR, 2005, P NATL ACAD SCI USA, V102, P2316, DOI 10.1073/pnas.0409694102; Withey JH, 2003, ANNU REV MICROBIOL, V57, P101, DOI 10.1146/annurev.micro.57.030502.090945; Zvereva ME, 2000, MOL BIOL+, V34, P927, DOI 10.1023/A:1026692229336; Zwieb C, 2001, BIOCHEMISTRY-US, V40, P9587, DOI 10.1021/bi010443v	23	14	16	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					28536	28545		10.1074/jbc.M605137200	http://dx.doi.org/10.1074/jbc.M605137200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16867994	hybrid			2022-12-27	WOS:000240680500007
J	Lee, JF; Zeng, Q; Ozaki, H; Wang, LC; Hand, AR; Hla, T; Wang, E; Lee, MJ				Lee, Jen-Fu; Zeng, Qun; Ozaki, Harunobu; Wang, Lichun; Hand, Arthur R.; Hla, Timothy; Wang, Eugenia; Lee, Menq-Jer			Dual roles of tight junction-associated protein, Zonula Occludens-1, in sphingosine 1-phosphate-mediated endothelial chemotaxis and barrier integrity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLED RECEPTOR EDG-1; BLOOD-BRAIN-BARRIER/; ARP2/3 COMPLEX; MULTIPLE-SCLEROSIS; CELL-ADHESION; IN-VITRO; ZO-1; CORTACTIN; ACTIN; SPHINGOSINE-1-PHOSPHATE	In this report, sphingosine-1-phosphate (S1P), a serum-borne bioactive lipid, is shown to activate tight-junction-associated protein Zonula Occludens-1 (ZO-1), which in turn plays a critical role in regulating endothelial chemotaxis and barrier integrity. After S1P stimulation, ZO-1 was redistributed to the lamellipodia and cell-cell junctions via the S1P1/G(i)/Akt/Rac pathway. Similarly, both endothelial barrier integrity and cell motility were significantly enhanced in S1P-treated cells through the G(i)/Akt/Rac pathway. Importantly, S1P-enhanced barrier integrity and cell migration were abrogated in ZO-1 knockdown cells, indicating ZO-1 is functionally indispensable for these processes. To investigate the underlying mechanisms, we demonstrated that cortactin plays a critical role in S1P-induced ZO-1 redistribution to the lamellipodia. In addition, S1P significantly induced the formation of endothelial tight junctions. ZO-1 and alpha-catenin polypeptides were colocalized in S1P-induced junctional structures; whereas, cortactin was not observed in these regions. Together, these results suggest that S1P induces the formation of two distinct ZO-1 complexes to regulate two different endothelial functions: ZO-1/cortactin complexes to regulate chemotactic response and ZO-1/alpha-catenin complexes to regulate endothelial barrier integrity. The concerted operation of these two ZO-1 complexes may coordinate two important S1P-mediated functions, i.e. migration and barrier integrity, in vascular endothelial cells.	Univ Louisville, Hlth Sci Ctr, Dept Biochem & Mol Biol, Louisville, KY 40202 USA; Univ Louisville, Hlth Sci Ctr, Dept Microbiol & Immunol, Louisville, KY 40202 USA; Univ Louisville, Hlth Sci Ctr, Gheens Ctr Aging, Louisville, KY 40202 USA; Keihanna Hosp, Dept Cardiol, Hirakata, Osaka 5730153, Japan; Univ Connecticut, Hlth Ctr, Dept Physiol, Ctr Vasc Biol, Farmington, CT 06030 USA; Univ Connecticut, Hlth Ctr, Dept Pediat Dent, Farmington, CT 06030 USA	University of Louisville; University of Louisville; University of Louisville; University of Connecticut; University of Connecticut	Lee, MJ (corresponding author), Univ Louisville, Hlth Sci Ctr, Dept Biochem & Mol Biol, 580 S Preston St, Louisville, KY 40202 USA.	menqjer.lee@louisville.edu	wang, lichun/D-3969-2013; Hla, Timothy/G-5873-2012; LEE, JEN-FU/GRO-3670-2022	Hla, Timothy/0000-0001-8355-4065; 	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067330, R01HL071071] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01HL067330, R01HL071071] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDERSON JM, 1988, J CELL BIOL, V106, P1141, DOI 10.1083/jcb.106.4.1141; Andersson LM, 2001, J NEUROVIROL, V7, P542, DOI 10.1080/135502801753248123; Bussolino F, 2001, INT J BIOCHEM CELL B, V33, P371, DOI 10.1016/S1357-2725(01)00024-3; Dudek SM, 2004, J BIOL CHEM, V279, P24692, DOI 10.1074/jbc.M313969200; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; FENSTERMACHER JD, 2000, BLOOD BRAIN BARRIER; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Giepmans BNG, 1998, CURR BIOL, V8, P931, DOI 10.1016/S0960-9822(07)00375-2; Gumbleton M, 2001, J PHARM SCI-US, V90, P1681, DOI 10.1002/jps.1119; Huber JD, 2001, TRENDS NEUROSCI, V24, P719, DOI 10.1016/S0166-2236(00)02004-X; Hunter AW, 2005, MOL BIOL CELL, V16, P5686, DOI 10.1091/mbc.E05-08-0737; Itoh M, 1997, J CELL BIOL, V138, P181, DOI 10.1083/jcb.138.1.181; Kalaria RN, 2002, CEREBROVASC DIS, V13, P48, DOI 10.1159/000049150; Kalman D, 1999, MOL BIOL CELL, V10, P1665, DOI 10.1091/mbc.10.5.1665; Katsube T, 1998, J BIOL CHEM, V273, P29672, DOI 10.1074/jbc.273.45.29672; Keese CR, 2004, P NATL ACAD SCI USA, V101, P1554, DOI 10.1073/pnas.0307588100; KRUMPKONVALINKO.V, 2005, ARTERIOSCLER THROMB, V25, P1; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Lee MJ, 1999, CELL, V99, P301, DOI 10.1016/S0092-8674(00)81661-X; Lee MJ, 2001, MOL CELL, V8, P693, DOI 10.1016/S1097-2765(01)00324-0; Lee SH, 2006, INTERMETALLICS, V14, P1, DOI 10.1016/j.intermet.2005.02.010; Li YS, 2004, EXP CELL RES, V298, P107, DOI 10.1016/j.yexcr.2004.03.023; Miyakawa T, 2002, ANN NY ACAD SCI, V977, P303, DOI 10.1111/j.1749-6632.2002.tb04830.x; Muller SL, 2005, J BIOL CHEM, V280, P3747, DOI 10.1074/jbc.M411365200; Plumb J, 2002, BRAIN PATHOL, V12, P154; Rosenberg GA, 2002, NEUROSCIENTIST, V8, P586, DOI 10.1177/1073858402238517; Smalley KSM, 2005, AM J PATHOL, V166, P1541, DOI 10.1016/S0002-9440(10)62370-X; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Uruno T, 2001, NAT CELL BIOL, V3, P259, DOI 10.1038/35060051; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; YATOMI Y, 1995, BLOOD, V86, P193, DOI 10.1182/blood.V86.1.193.bloodjournal861193; Yokoyama S, 2001, MOL BIOL CELL, V12, P1595, DOI 10.1091/mbc.12.6.1595; Zhu C, 2005, MICROSC MICROANAL, V11, P244, DOI 10.1017/S143192760505049X	33	135	139	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					29190	29200		10.1074/jbc.M604310200	http://dx.doi.org/10.1074/jbc.M604310200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16891661	hybrid			2022-12-27	WOS:000240680500074
J	Ma, L; Robinson, LN; Towle, HC				Ma, Lin; Robinson, Luke N.; Towle, Howard C.			ChREBP center dot Mlx is the principal mediator of glucose-induced gene expression in the liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE RESPONSE ELEMENT; TRIGLYCERIDE TRANSFER PROTEIN; STIMULATED INSULIN-SECRETION; LIPOGENIC ENZYME GENES; PYRUVATE-KINASE GENE; FATTY-ACID SYNTHESIS; IN-VIVO SECRETION; BINDING PROTEIN; TRANSCRIPTION FACTORS; APOLIPOPROTEIN-B	In mammals, glucose-regulated gene expression has been best characterized in the liver, where increased glucose metabolism induces transcription of genes encoding enzymes involved in de novo lipogenesis. ChREBP and Mlx dimerize and function together as a glucose-responsive transcription factor to regulate target genes, such as liver-type pyruvate kinase, acetyl-CoA carboxylase 1, and fatty acid synthase. To identify additional glucose-responsive genes in the liver, we used microarray analysis to compare gene expression patterns in low and high glucose conditions in hepatocytes. Target genes of ChREBP center dot Mlx were simultaneously identified by gene profiling in the presence or absence of a dominant negative Mlx. Of 224 genes that are induced by glucose, 139 genes (62%) were also inhibited by the dominant negative Mlx. Lipogenic enzyme genes involved in the entire pathway of de novo lipogenesis were found to be glucose-responsive target genes of ChREBP center dot Mlx. Genes encoding enzymes in other metabolic pathways and numerous regulators of metabolism were also identified. To determine if any of these genes are direct targets of ChREBP center dot Mlx, we searched for ChoRE-like sequences in the 5'-flanking regions of several genes that responded rapidly to glucose. ChoRE sequences that bound to ChREBP center dot Mlx and supported a glucose response were identified in two additional genes. Combining all of the known ChoRE sequences, we generated a modified ChoRE consensus sequence, CAYGNGN(5)CNCRTG. In summary, ChREBP center dot Mlx is the principal transcription factor regulating glucose-responsive genes in the liver and coordinately regulates a family of genes required for glucose utilization and energy storage.	Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Towle, HC (corresponding author), 6-155 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	towle@mail.ahc.umn.edu						Argaud D, 1997, J BIOL CHEM, V272, P12854, DOI 10.1074/jbc.272.19.12854; Bartels ED, 2002, DIABETES, V51, P1233, DOI 10.2337/diabetes.51.4.1233; Billin AN, 1999, J BIOL CHEM, V274, P36344, DOI 10.1074/jbc.274.51.36344; Billin AN, 2000, MOL CELL BIOL, V20, P8845, DOI 10.1128/MCB.20.23.8845-8854.2000; Bodnar JS, 2002, NAT GENET, V30, P110, DOI 10.1038/ng811; Boucher A, 2004, J BIOL CHEM, V279, P27263, DOI 10.1074/jbc.M401167200; Brown LJ, 2002, J BIOL CHEM, V277, P32899, DOI 10.1074/jbc.M202409200; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Corpe CP, 1996, AM J PHYSIOL-GASTR L, V271, pG211, DOI 10.1152/ajpgi.1996.271.1.G211; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dentin R, 2004, J BIOL CHEM, V279, P20314, DOI 10.1074/jbc.M312475200; Donnelly KL, 2004, J NUTR, V134, P1475, DOI 10.1093/jn/134.6.1475; Dvorak CMT, 2005, VET IMMUNOL IMMUNOP, V105, P301, DOI 10.1016/j.vetimm.2005.02.006; Girard J, 1997, ANNU REV NUTR, V17, P325, DOI 10.1146/annurev.nutr.17.1.325; Gordon DA, 2000, BBA-MOL CELL BIOL L, V1486, P72, DOI 10.1016/S1388-1981(00)00049-4; HILLGARTNER F, 1995, PHYSIOL REV, V75, P47, DOI 10.1152/physrev.1995.75.1.47; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ishii S, 2004, P NATL ACAD SCI USA, V101, P15597, DOI 10.1073/pnas.0405238101; IYNEDJIAN PB, 1989, J BIOL CHEM, V264, P21824; Kawaguchi T, 2001, P NATL ACAD SCI USA, V98, P13710, DOI 10.1073/pnas.231370798; Kaytor EN, 1997, J BIOL CHEM, V272, P7525, DOI 10.1074/jbc.272.11.7525; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; KUROKAWA R, 1995, NATURE, V377, P451, DOI 10.1038/377451a0; Liao W, 1999, BIOCHEMISTRY-US, V38, P7532, DOI 10.1021/bi9904196; LIU ML, 1992, J BIOL CHEM, V267, P11673; Lu DH, 2002, P NATL ACAD SCI USA, V99, P2708, DOI 10.1073/pnas.052005699; Ma L, 2005, J BIOL CHEM, V280, P12019, DOI 10.1074/jbc.M413063200; MARIE S, 1993, J BIOL CHEM, V268, P23881; Massillon D, 1996, J BIOL CHEM, V271, P9871, DOI 10.1074/jbc.271.17.9871; Melloul D, 2002, DIABETOLOGIA, V45, P309, DOI 10.1007/s00125-001-0728-y; Meroni G, 2000, ONCOGENE, V19, P3266, DOI 10.1038/sj.onc.1203634; Minn AH, 2005, ENDOCRINOLOGY, V146, P2397, DOI 10.1210/en.2004-1378; MOORHEAD G, 1995, FEBS LETT, V362, P101, DOI 10.1016/0014-5793(95)00197-H; Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1; O'Callaghan BL, 2001, J BIOL CHEM, V276, P16033, DOI 10.1074/jbc.M101557200; Olson DP, 1998, J BIOL CHEM, V273, P3375, DOI 10.1074/jbc.273.6.3375; Osborne TF, 2000, J BIOL CHEM, V275, P32379, DOI 10.1074/jbc.R000017200; Raabe M, 1999, J CLIN INVEST, V103, P1287, DOI 10.1172/JCI6576; Rencurel F, 1996, BIOCHEM J, V314, P903, DOI 10.1042/bj3140903; Rumberger JM, 2003, J BIOL CHEM, V278, P28547, DOI 10.1074/jbc.M302793200; Shalev A, 2002, ENDOCRINOLOGY, V143, P3695, DOI 10.1210/en.2002-220564; SHIH HM, 1994, J BIOL CHEM, V269, P9380; Shimano H, 1999, J BIOL CHEM, V274, P35832, DOI 10.1074/jbc.274.50.35832; Stoeckman AK, 2004, J BIOL CHEM, V279, P15662, DOI 10.1074/jbc.M311301200; Swierczynski J, 2003, MOL CELL BIOCHEM, V254, P55, DOI 10.1023/A:1027332523114; Tietge UJF, 1999, J LIPID RES, V40, P2134; Towle HC, 2005, TRENDS ENDOCRIN MET, V16, P489, DOI 10.1016/j.tem.2005.10.003; VANSCHAFTINGEN E, 1994, DIABETOLOG, V37, P43; WAEBER G, 1994, J BIOL CHEM, V269, P26912; Wang HY, 2002, J BIOL CHEM, V277, P32746, DOI 10.1074/jbc.M201635200; Webb GC, 2000, P NATL ACAD SCI USA, V97, P5773, DOI 10.1073/pnas.100126597; Wetterau JR, 1998, SCIENCE, V282, P751, DOI 10.1126/science.282.5389.751; Yamashita H, 2001, P NATL ACAD SCI USA, V98, P9116, DOI 10.1073/pnas.161284298	56	286	300	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					28721	28730		10.1074/jbc.M601576200	http://dx.doi.org/10.1074/jbc.M601576200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16885160	hybrid			2022-12-27	WOS:000240680500025
J	Ramm, G; Larance, M; Guilhaus, M; James, DE				Ramm, Georg; Larance, Mark; Guilhaus, Michael; James, David E.			A role for 14-3-3 in insulin-stimulated GLUT4 translocation through its interaction with the RabGAP AS160	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING-PROTEIN; SIGNALING PROTEINS; TUMOR-SUPPRESSOR; GENE-PRODUCT; PHOSPHORYLATION; TRAFFICKING; REGULATOR; TUBERIN; BINDING; TSC2	Translocation of the insulin-regulated glucose transporter GLUT4 to the cell surface is dependent on the phosphatidylinositol 3-kinase/Akt pathway. The RabGAP (Rab GTPase-activating protein) AS160 (Akt substrate of 160 kDa) is a direct substrate of Akt and plays an essential role in the regulation of GLUT4 trafficking. We have used liquid chromatography tandem mass spectrometry to identify several 14-3-3 isoforms as AS160-interacting proteins. 14-3-3 proteins interact with AS160 in an insulin- and Akt-dependent manner via an Akt phosphorylation site, Thr-642. This correlates with the dominant negative effect of both the AS160(T642A) and the AS160(4P) mutants on insulin- stimulated GLUT4 translocation. Introduction of a constitutive 14-3-3 binding site into AS160(4P) restored 14-3-3 binding without disrupting AS160- IRAP (insulin- responsive amino peptidase) interaction and reversed the inhibitory effect of AS160(4P) on GLUT4 translocation. These data show that the insulin- dependent association of 14-3-3 with AS160 plays an important role in GLUT4 trafficking in adipocytes.	Garvan Inst Med Res, Diabet & Obes Program, Darlinghurst, NSW 2010, Australia; Univ New S Wales, Bioanalyt Mass Spectrometry Facil, Sydney, NSW 2052, Australia	Garvan Institute of Medical Research; University of New South Wales Sydney	Ramm, G (corresponding author), Garvan Inst Med Res, Diabet & Obes Program, 384 Victoria St, Darlinghurst, NSW 2010, Australia.	g.ramm@garvan.org.au; d.james@garvan.org.au	Larance, Mark/AAG-8613-2019	James, David/0000-0001-5946-5257; Ramm, Georg/0000-0003-3596-2288; Larance, Mark/0000-0002-8579-2267				Beguin P, 2005, J CELL SCI, V118, P1923, DOI 10.1242/jcs.02321; Benzing T, 2000, J BIOL CHEM, V275, P28167; Benzing T, 2002, J BIOL CHEM, V277, P32954, DOI 10.1074/jbc.M200859200; Bernards A, 2005, GROWTH FACTORS, V23, P143, DOI 10.1080/08977190500130480; Bernards A, 2004, TRENDS CELL BIOL, V14, P377, DOI 10.1016/j.tcb.2004.05.003; Bernards A, 2003, BBA-REV CANCER, V1603, P47, DOI 10.1016/S0304-419X(02)00082-3; BRIDGES D, 2005, SCI STKE, pRE10, DOI DOI 10.1126/STKE.2962005RE10; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Cai SL, 2006, J CELL BIOL, V173, P279, DOI 10.1083/jcb.200507119; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Eguez L, 2005, CELL METAB, V2, P263, DOI 10.1016/j.cmet.2005.09.005; Feng LP, 2004, FEBS LETT, V557, P275, DOI 10.1016/S0014-5793(03)01507-2; Hekman M, 2004, J BIOL CHEM, V279, P14074, DOI 10.1074/jbc.M309620200; Kane S, 2002, J BIOL CHEM, V277, P22115, DOI 10.1074/jbc.C200198200; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; Li Y, 2003, J BIOL CHEM, V278, P13663, DOI 10.1074/jbc.M300862200; Li Y, 2002, J BIOL CHEM, V277, P44593, DOI 10.1074/jbc.C200510200; Liu J, 2003, J BIOL CHEM, V278, P36754, DOI 10.1074/jbc.M300664200; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; Manning BD, 2003, TRENDS BIOCHEM SCI, V28, P573, DOI 10.1016/j.tibs.2003.09.003; Miinea CP, 2005, BIOCHEM J, V391, P87, DOI 10.1042/BJ20050887; Nellist M, 2002, J BIOL CHEM, V277, P39417, DOI 10.1074/jbc.M204802200; Ramm G, 2005, CELL METAB, V2, P150, DOI 10.1016/j.cmet.2005.08.008; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Scheffzek K, 2005, CELL MOL LIFE SCI, V62, P3014, DOI 10.1007/s00018-005-5136-x; Shewan AM, 2003, MOL BIOL CELL, V14, P973, DOI 10.1091/mbc.E02-06-0315; Shumway SD, 2003, J BIOL CHEM, V278, P2089, DOI 10.1074/jbc.C200499200; Wang BC, 1999, BIOCHEMISTRY-US, V38, P12499, DOI 10.1021/bi991353h; Ward RJ, 2005, MOL PHARMACOL, V68, P1821, DOI 10.1124/moi.105.015073; Watson RT, 2004, ENDOCR REV, V25, P177, DOI 10.1210/er.2003-0011; Welsh GL, 2005, BIOCHEM SOC T, V33, P346, DOI 10.1042/BST0330346; Wilker E, 2004, J MOL CELL CARDIOL, V37, P633, DOI 10.1016/j.yjmcc.2004.04.015; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Zeigerer A, 2004, MOL BIOL CELL, V15, P4406, DOI 10.1091/mbc.e04-04-0333	34	164	167	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					29174	29180		10.1074/jbc.M603274200	http://dx.doi.org/10.1074/jbc.M603274200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16880201	hybrid			2022-12-27	WOS:000240680500072
J	Sun, JP; Zhuang, FF; Mullersman, JE; Chen, H; Robertson, EJ; Warburton, D; Liu, YH; Shi, W				Sun, Jianping; Zhuang, Feng-Feng; Mullersman, Jerald E.; Chen, Hui; Robertson, Elizabeth J.; Warburton, David; Liu, Yi-Hsin; Shi, Wei			BMP4 activation and secretion are negatively regulated by an intracellular gremlin-BMP4 interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEINS; TGF-BETA; ANTAGONIST; GENE; SCLEROSTIN; EXPRESSION; XENOPUS; INHIBITION; CERBERUS; SIGNALS	Bone morphogenetic protein 4 (BMP4) is a potent growth factor that is involved in many important biological processes. Regulation of the level of secreted mature BMP4 determines the biological effects of BMP4 on cells in the local microenvironment. Previous studies suggested that Gremlin, a member of DAN family proteins, antagonizes BMP4 activity by sequestering extracellular BMP4. Herein, we report a novel intracellular regulatory mechanism by which Gremlin interacts with BMP4 precursor, prevents secretion of mature BMP4, and therefore inhibits BMP4 activity more efficiently. Furthermore, we also defined a 30-amino acid peptide sequence within the Gremlin DAN domain that is essential for BMP4 interaction. This novel Gremlin-mediated BMP4 posttranslational regulatory mechanism implies that the level of BMP4 mRNA expression does not truly reflect BMP4 activity when Gremlin and BMP4 are coexpressed within the same cell. Similar regulatory mechanisms may be utilized by other DAN family proteins.	Childrens Hosp Los Angeles, Dept Surg, Dev Biol Program, Saban Res Inst, Los Angeles, CA 90027 USA; Univ So Calif, Ctr Craniofacial Mol Biol, Los Angeles, CA 90033 USA; E Tennessee State Univ, Dept Pathol, Johnson City, TN 37614 USA; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England	Children's Hospital Los Angeles; University of Southern California; East Tennessee State University; University of Oxford; Wellcome Centre for Human Genetics	Shi, W (corresponding author), Childrens Hosp Los Angeles, Dept Surg, Dev Biol Program, Saban Res Inst, 4650 Sunset Blvd,MS 35, Los Angeles, CA 90027 USA.	wshi@chla.usc.edu	zhuang, Fengfeng/A-5822-2018; Warburton, David/AAD-5709-2020	zhuang, Fengfeng/0000-0001-7888-0827; 	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068597, R01HL061286] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL68597, R01 HL068597-05A1, R01 HL068597, HL61286] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abdolzade-Bavil A, 2004, PROTEOMICS, V4, P1397, DOI 10.1002/pmic.200300710; Avsian-Kretchmer O, 2004, MOL ENDOCRINOL, V18, P1, DOI 10.1210/me.2003-0227; Balemans W, 2002, DEV BIOL, V250, P231, DOI 10.1006/dbio.2002.0779; Bell E, 2003, DEVELOPMENT, V130, P1381, DOI 10.1242/dev.00344; Constam DB, 1999, J CELL BIOL, V144, P139, DOI 10.1083/jcb.144.1.139; Cui YZ, 1998, EMBO J, V17, P4735, DOI 10.1093/emboj/17.16.4735; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; Ghosh RN, 1998, J CELL BIOL, V142, P923, DOI 10.1083/jcb.142.4.923; Groppe J, 2002, NATURE, V420, P636, DOI 10.1038/nature01245; HAMMONDS RG, 1991, MOL ENDOCRINOL, V5, P149, DOI 10.1210/mend-5-1-149; Hogan BLM, 1996, CURR OPIN GENET DEV, V6, P432, DOI 10.1016/S0959-437X(96)80064-5; Hsu DR, 1998, MOL CELL, V1, P673, DOI 10.1016/S1097-2765(00)80067-2; Khokha MK, 2003, NAT GENET, V34, P303, DOI 10.1038/ng1178; Kishigami S, 2005, CYTOKINE GROWTH F R, V16, P265, DOI 10.1016/j.cytogfr.2005.04.002; Kusu N, 2003, J BIOL CHEM, V278, P24113, DOI 10.1074/jbc.M301716200; Michos O, 2004, DEVELOPMENT, V131, P3401, DOI 10.1242/dev.01251; Minabe-Saegusa C, 1998, DEV GROWTH DIFFER, V40, P343; Nickel J, 2001, J BONE JOINT SURG AM, V83A, pS7; OZAKI T, 1993, P NATL ACAD SCI USA, V90, P2593, DOI 10.1073/pnas.90.7.2593; Pearce JJH, 1999, DEV BIOL, V209, P98, DOI 10.1006/dbio.1999.9240; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shi W, 2003, DEV BIOL, V261, P371, DOI 10.1016/S0012-1606(03)00315-4; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Simmons DG, 2002, BIOL REPROD, V67, P1638, DOI 10.1095/biolreprod.102.006858; Topol LZ, 1997, MOL CELL BIOL, V17, P4801, DOI 10.1128/MCB.17.8.4801; van Bezooijen RL, 2004, J EXP MED, V199, P805, DOI 10.1084/jem.20031454; Wilkinson L, 2003, J BIOL CHEM, V278, P34181, DOI 10.1074/jbc.M301247200; Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599; WU H, 1994, STRUCTURE, V2, P545, DOI 10.1016/S0969-2126(00)00054-X; Yanagita M, 2005, CYTOKINE GROWTH F R, V16, P309, DOI 10.1016/j.cytogfr.2005.02.007	32	65	70	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					29349	29356		10.1074/jbc.M603833200	http://dx.doi.org/10.1074/jbc.M603833200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16880207	hybrid, Green Published			2022-12-27	WOS:000240680500090
J	Takahara, T; Hara, K; Yonezawa, K; Sorimachi, H; Maeda, T				Takahara, Terunao; Hara, Kenta; Yonezawa, Kazuyoshi; Sorimachi, Hiroyuki; Maeda, Tatsuya			Nutrient-dependent multimerization of the mammalian target of rapamycin through the N-terminal HEAT repeat region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P70 S6 KINASE; CELL-GROWTH; BINDING PARTNER; AMINO-ACIDS; EIF-4E BP1; MTOR; TOR; ACTIVATION; PROTEIN; RAPTOR	The mammalian target of rapamycin ( mTOR) plays a pivotal role in the regulation of cell growth in response to a variety of signals such as nutrients and growth factors. mTOR forms two distinct complexes in vivo. mTORC1(mTOR complex 1) is rapamycin-sensitive and regulates the rate of protein synthesis in part by phosphorylating two well established effectors, S6K1 (p70 ribosomal S6 kinase 1) and 4E-BP1 (eukaryotic initiation factor 4E-binding protein 1). mTORC2 is rapamycin-insensitive and likely regulates actin organization and activates Akt/protein kinase B. Here, we show that mTOR forms a multimer via its N-terminal HEAT repeat region in mammalian cells. mTOR multimerization is promoted by amino acid sufficiency, although the state of multimerization does not directly correlate with the phosphorylation state of S6K1. mTOR multimerization was insensitive to rapamycin treatment but hindered by butanol treatment, which inhibits phosphatidic acid production by phospholipase D. We also found that mTOR forms a multimer in both mTORC1 and mTORC2. In addition, Saccharomyces cerevisiae TOR proteins Tor1p and Tor2p also exist as homo-multimers. These results suggest that TOR multimerization is a conserved mechanism for TOR functioning.	Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; Kobe Univ, Sch Med, Dept Geriatr Med, Kobe, Hyogo 6500017, Japan; Kobe Univ, Biosignal Res Ctr, Kobe, Hyogo 6578501, Japan; Tokyo Metropolitan Inst Med Sci, Dept Enzymat Regulat Cell Funct, Tokyo 1138613, Japan	University of Tokyo; Kobe University; Kobe University; Tokyo Metropolitan Institute of Medical Science	Maeda, T (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	maeda@iam.u-tokyo.ac.jp	Maeda, Tatsuya/L-5540-2019; Sorimachi, Hiroyuki/C-6448-2009	Sorimachi, Hiroyuki/0000-0001-9509-6727				ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bosotti R, 2000, TRENDS BIOCHEM SCI, V25, P225, DOI 10.1016/S0968-0004(00)01563-2; Byfield MP, 2005, J BIOL CHEM, V280, P33076, DOI 10.1074/jbc.M507201200; Choi JH, 2002, EMBO REP, V3, P988, DOI 10.1093/embo-reports/kvf197; Crespo JL, 2002, MICROBIOL MOL BIOL R, V66, P579, DOI 10.1128/MMBR.66.4.579-591.2002; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Farrar MA, 2000, METHOD ENZYMOL, V327, P421, DOI 10.1016/S0076-6879(00)27293-5; Farrar MA, 1996, NATURE, V383, P178, DOI 10.1038/383178a0; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Hara K, 1997, J BIOL CHEM, V272, P26457, DOI 10.1074/jbc.272.42.26457; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Harris Thurl E, 2003, Sci STKE, V2003, pre15; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Long XM, 2005, J BIOL CHEM, V280, P23433, DOI 10.1074/jbc.C500169200; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Martin DE, 2005, CURR OPIN CELL BIOL, V17, P158, DOI 10.1016/j.ceb.2005.02.008; Nagase T, 2000, DNA RES, V7, P65, DOI 10.1093/dnares/7.1.65; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Oshiro N, 2004, GENES CELLS, V9, P359, DOI 10.1111/j.1356-9597.2004.00727.x; Perry J, 2003, CELL, V112, P151, DOI 10.1016/S0092-8674(03)00033-3; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; Reinke A, 2004, J BIOL CHEM, V279, P14752, DOI 10.1074/jbc.M313062200; Sabatini DM, 1999, SCIENCE, V284, P1161, DOI 10.1126/science.284.5417.1161; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Smith EM, 2005, J BIOL CHEM, V280, P18717, DOI 10.1074/jbc.M414499200; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Wang XM, 1998, BIOCHEM J, V334, P261, DOI 10.1042/bj3340261; Wedaman KP, 2003, MOL BIOL CELL, V14, P1204, DOI 10.1091/mbc.E02-09-0609; Wu SL, 2002, BBA-MOL CELL RES, V1542, P41, DOI 10.1016/S0167-4889(01)00164-1; Wullschleger S, 2005, J BIOL CHEM, V280, P30697, DOI 10.1074/jbc.M505553200; Zhang Y, 2006, GENETICS, V172, P355, DOI 10.1534/genetics.105.051979	43	60	60	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					28605	28614		10.1074/jbc.M606087200	http://dx.doi.org/10.1074/jbc.M606087200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16870609	hybrid			2022-12-27	WOS:000240680500014
J	Khan, MA; Miyoshi, H; Ray, S; Natsuaki, T; Suehiro, N; Goss, DJ				Khan, Mateen A.; Miyoshi, Hiroshi; Ray, Sibnath; Natsuaki, Tomohide; Suehiro, Noriko; Goss, Dixie J.			Interaction of genome-linked protein (VPg) of turnip mosaic virus with wheat germ translation initiation factors eIFiso4E and eIFiso4F	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOBACCO ETCH VIRUS; YEAST 2-HYBRID SYSTEM; CAP-BINDING-PROTEINS; MESSENGER-RNA; RESISTANCE-BREAKING; ISOZYME FORM; FACTOR 4F; POTYVIRUS; COMPLEX; IDENTIFICATION	The interaction between VPg of turnip mosaic virus and wheat germ eukaryotic translation initiation factors eIFiso4E and eIFiso4F ( the complex of eIFiso4E and eIFiso4G) were measured and compared. The fluorescence quenching data showed the presence of one binding site on eIFiso4E for VPg. Scatchard analysis revealed the binding affinity (K-a) and average binding sites (n) for VPg were (8.51 +/- 0.21) x 10(6) M-1 and 1.0, respectively. The addition of eIFiso4G to the eIFiso4E increased the binding affinity 1.5-fold for VPg as compared with eIFiso4E alone. However, eIFiso4G alone did not bind with VPg. The van't Hoff analyses showed that VPg binding is enthalpy-driven and entropy-favorable with a large negative Delta H degrees (-29.32 +/- 0.13 kJmol(-1)) and positive Delta S degrees (36.88 +/- 0.25 Jmol(-1) K-1). A Lineweaver-Burk plot indicates mixed-type competitive ligand binding between VPg and anthraniloyl-7- methylguanosine triphosphate for eIFiso4E. Fluorescence stopped-flow studies of eIFiso4E and eIFiso4F with VPg show rapid binding, suggesting kinetic competition between VPg and m(7)G cap. The VPg protein binds much faster than cap analogs. The activation energies for binding of eIFiso4E and eIFiso4F with VPg were 50.70 +/- 1.27 and 75.37 +/- 2.95 kJmol(-1) respectively. Enhancement of eIFiso4F-VPg binding with the addition of a structured RNA derived from tobacco etch virus suggests that translation initiation involving VPg occurs at internal ribosomal entry sites. Furthermore, the formation of a protein-RNA complex containing VPg suggests the possibility of direct participation of VPg in the translation of the viral genome.	CUNY Hunter Coll, Dept Chem, New York, NY 10021 USA; CUNY, Grad Ctr, New York, NY 10021 USA; St Marianna Univ, Sch Med, Dept Microbiol, Kawasaki, Kanagawa 2168511, Japan; Utsunomiya Univ, Genome Res Inst, Utsunomiya, Tochigi 3218505, Japan	City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; Saint Marianna University; Utsunomiya University	Goss, DJ (corresponding author), CUNY Hunter Coll, Dept Chem, New York, NY 10021 USA.	dgoss@hunter.cuny.edu	NATSUAKI, Tomohide/AAG-1963-2020; Ray, Sibnath/C-7369-2008	Ray, Sibnath/0000-0002-6313-3930; Khan, Mateen A./0000-0002-2300-4595; Natsuaki, Tomohide/0000-0003-1823-7308; Miyoshi, Hiroshi/0000-0002-0489-9848	NCRR NIH HHS [RR-03037] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ABRAMSON RD, 1988, J BIOL CHEM, V263, P5462; BALASTA ML, 1993, J BIOL CHEM, V268, P18599; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWNING KS, 1987, J BIOL CHEM, V262, P11228; BROWNING KS, 1992, J BIOL CHEM, V267, P10096; CARRINGTON JC, 1990, J VIROL, V64, P1590, DOI 10.1128/JVI.64.4.1590-1597.1990; Daughenbaugh KF, 2003, EMBO J, V22, P2852, DOI 10.1093/emboj/cdg251; Fellers J, 1998, J GEN VIROL, V79, P2043, DOI 10.1099/0022-1317-79-8-2043; Gale M, 2000, MICROBIOL MOL BIOL R, V64, P239, DOI 10.1128/MMBR.64.2.239-280.2000; GARLAND DL, 1978, BIOCHEMISTRY-US, V17, P4266, DOI 10.1021/bi00613a024; Goodfellow I, 2005, EMBO REP, V6, P968, DOI 10.1038/sj.embor.7400510; Haghighat A, 1996, J VIROL, V70, P8444, DOI 10.1128/JVI.70.12.8444-8450.1996; Herbert TP, 1997, J GEN VIROL, V78, P1033, DOI 10.1099/0022-1317-78-5-1033; HONG YL, 1995, VIROLOGY, V214, P159, DOI 10.1006/viro.1995.9944; Keller KE, 1998, MOL PLANT MICROBE IN, V11, P124, DOI 10.1094/MPMI.1998.11.2.124; Khan MA, 2005, BIOCHEMISTRY-US, V44, P4510, DOI 10.1021/bi047298g; Khan MA, 2004, BIOCHEMISTRY-US, V43, P9092, DOI 10.1021/bi049602b; Khan MA, 2002, INT J BIOL MACROMOL, V30, P243, DOI 10.1016/S0141-8130(02)00038-7; LAX S, 1985, P NATL ACAD SCI USA, V82, P330, DOI 10.1073/pnas.82.2.330; Le H, 1997, J BIOL CHEM, V272, P16247, DOI 10.1074/jbc.272.26.16247; Leonard S, 2000, J VIROL, V74, P7730, DOI 10.1128/JVI.74.17.7730-7737.2000; LEVINE RL, 1977, CLIN CHEM, V23, P2292; Li XH, 1997, J VIROL, V71, P1598, DOI 10.1128/JVI.71.2.1598-1607.1997; Masuta C, 1999, PHYTOPATHOLOGY, V89, P118, DOI 10.1094/PHYTO.1999.89.2.118; Michon T, 2006, FEBS J, V273, P1312, DOI 10.1111/j.1742-4658.2006.05156.x; Miyoshi H, 2006, BIOCHIMIE, V88, P329, DOI 10.1016/j.biochi.2005.09.002; MURPHY JF, 1990, VIROLOGY, V178, P285, DOI 10.1016/0042-6822(90)90405-G; Nicolas O, 1996, ARCH VIROL, V141, P1535, DOI 10.1007/BF01718253; Nicolas O, 1997, VIROLOGY, V237, P452, DOI 10.1006/viro.1997.8780; Noueiry AO, 2000, P NATL ACAD SCI USA, V97, P12985, DOI 10.1073/pnas.240460897; OLSEN K, 1993, BIOCHEMISTRY-US, V32, P9686, DOI 10.1021/bi00088a021; Ren JH, 1996, NUCLEIC ACIDS RES, V24, P3629, DOI 10.1093/nar/24.18.3629; RIECHMANN JL, 1992, J GEN VIROL, V73, P1, DOI 10.1099/0022-1317-73-1-1; RIECHMANN JL, 1989, J GEN VIROL, V70, P2785, DOI 10.1099/0022-1317-70-10-2785; Rodriguez CM, 1998, PLANT J, V13, P465, DOI 10.1046/j.1365-313X.1998.00047.x; Schaad MC, 1997, J VIROL, V71, P8624, DOI 10.1128/JVI.71.11.8624-8631.1997; Schaad MC, 2000, VIROLOGY, V273, P300, DOI 10.1006/viro.2000.0416; SIAW MFE, 1985, VIROLOGY, V142, P134, DOI 10.1016/0042-6822(85)90428-3; Suehiro N, 2004, J GEN VIROL, V85, P2087, DOI 10.1099/vir.0.79825-0; Thompson SR, 2000, CURR OPIN MICROBIOL, V3, P366, DOI 10.1016/S1369-5274(00)00106-5; VANHEERDEN A, 1994, J BIOL CHEM, V269, P17454; Wei CC, 1998, BIOCHEMISTRY-US, V37, P1910, DOI 10.1021/bi9724570; Wittmann S, 1997, VIROLOGY, V234, P84, DOI 10.1006/viro.1997.8634; Zeenko V, 2005, J BIOL CHEM, V280, P26813, DOI 10.1074/jbc.M503576200	44	54	59	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					28002	28010		10.1074/jbc.M605479200	http://dx.doi.org/10.1074/jbc.M605479200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16880203	hybrid			2022-12-27	WOS:000240534400037
J	Kuroda, K; Ito, M; Shikano, T; Awaji, T; Yoda, A; Takeuchi, H; Kinoshita, K; Miyazaki, S				Kuroda, Keiji; Ito, Masahiko; Shikano, Tomohide; Awaji, Takeo; Yoda, Ayako; Takeuchi, Hiroyuki; Kinoshita, Katsuyuki; Miyazaki, Shunichi			The role of X/Y linker region and N-terminal EF-hand domain in nuclear translocation and Ca2+ oscillation-inducing activities of phospholipase C zeta, a mammalian egg-activating factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE OOCYTES; INOSITOL 1,4,5-TRISPHOSPHATE; FLUORESCENT PROTEIN; SPERM; PLC; FERTILIZATION; EMBRYOS; SITE; TRANSIENTS; CONTAINS	Sperm-specific phospholipase C-zeta (PLC zeta) causes intracellular Ca2+ oscillations and thereby egg activation and is accumulated into the formed pronucleus (PN) when expressed in mouse eggs by injection of cRNA encoding PLC zeta, which consists of four EF-hand domains (EF1-EF4) in the N terminus, X and Y catalytic domains, and C-terminal C2 domain. Those activities were analyzed by expressing PLC zeta mutants tagged with fluorescent protein Venus by injection of cRNA into unfertilized eggs or 1-cell embryos after fertilization. Nuclear localization signal (NLS) existed at 374 - 381 in the X/Y linker region. Nuclear translocation was lost by replacement of Arg(376), Lys(377), Arg(378), Lys(379), or Lys(381) with glutamate, whereas Ca2+ oscillations were conserved. Nuclear targeting was also absent for point mutation of Lys(299) and/or Lys(301) in the C terminus of X domain, or Trp(13), Phe(14), or Val(18) in the N terminus of EF1. Ca2+ oscillation-inducing activity was lost by the former mutation and was remarkably inhibited by the latter. Ashort sequence 374 - 383 fused with Venus showed active translocation into the nucleus of COS-7 cells, but 296 - 309 or 1 - 19 did not. Despite the presence of these special regions, both activities were deprived by deletion of not only EF1 but also EF2 - 4 or C2 domain. Thus, PLC zeta is driven into the nucleus primarily by the aid of NLS and putative regulatory sites, but coordinated three-dimensional structure, possibly formed by a folding in the X/Y linker and close EF/C2 contact as in PLC delta 1, seems to be required not only for enzymatic activity but also for nuclear translocation ability.	Tokyo Womens Med Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 1628666, Japan; Juntendo Univ, Sch Med, Dept Obstet & Gynecol, Bunkyo Ku, Tokyo 1138241, Japan	Tokyo Women's Medical University; Juntendo University	Ito, M (corresponding author), Tokyo Womens Med Univ, Sch Med, Dept Physiol, Shinjuku Ku, 8-1 Kawado Cho, Tokyo 1628666, Japan.	mito@research.twmu.ac.jp						Aida T, 2001, MOL HUM REPROD, V7, P1039, DOI 10.1093/molehr/7.11.1039; Ali H, 1999, J BIOL CHEM, V274, P6027, DOI 10.1074/jbc.274.10.6027; Ananthanarayanan B, 2002, J BIOL CHEM, V277, P3568, DOI 10.1074/jbc.M109705200; Avazeri N, 2000, MOL BIOL CELL, V11, P4369, DOI 10.1091/mbc.11.12.4369; Awaji T, 2001, BIOCHEM BIOPH RES CO, V289, P457, DOI 10.1006/bbrc.2001.6004; Birbach A, 2004, J CELL SCI, V117, P3615, DOI 10.1242/jcs.01224; Brind S, 2000, DEV BIOL, V223, P251, DOI 10.1006/dbio.2000.9728; Chen MH, 2005, J BIOL CHEM, V280, P10599, DOI 10.1074/jbc.M413194200; Corpet F, 2000, NUCLEIC ACIDS RES, V28, P267, DOI 10.1093/nar/28.1.267; Deguchi R, 2000, DEV BIOL, V218, P299, DOI 10.1006/dbio.1999.9573; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Ellis MV, 1998, J BIOL CHEM, V273, P11650, DOI 10.1074/jbc.273.19.11650; Essen LO, 1996, NATURE, V380, P595, DOI 10.1038/380595a0; GARCIABUSTOS J, 1991, BIOCHIM BIOPHYS ACTA, V1071, P83, DOI 10.1016/0304-4157(91)90013-M; GOSS VL, 1994, J BIOL CHEM, V269, P19074; Irvine RF, 2003, NAT REV MOL CELL BIO, V4, P349, DOI 10.1038/nrm1100; Jellerette T, 2000, DEV BIOL, V223, P238, DOI 10.1006/dbio.2000.9675; JONES KT, 1995, DEVELOPMENT, V121, P3259; Jones KT, 1998, INT J DEV BIOL, V42, P1; Jones KT, 2000, DEV BIOL, V225, P1, DOI 10.1006/dbio.2000.9826; Knott JG, 2005, BIOL REPROD, V72, P992, DOI 10.1095/biolreprod.104.036244; Kono T, 1996, J CELL BIOL, V132, P915, DOI 10.1083/jcb.132.5.915; KONO T, 1995, DEVELOPMENT, V121, P1123; Kouchi Z, 2005, J BIOL CHEM, V280, P21015, DOI 10.1074/jbc.M412123200; Kouchi Z, 2004, J BIOL CHEM, V279, P10408, DOI 10.1074/jbc.M313801200; Kumakiri J, 2003, DEV BIOL, V260, P522, DOI 10.1016/S0012-1606(03)00273-2; Kurokawa M, 2005, DEV BIOL, V285, P376, DOI 10.1016/j.ydbio.2005.06.029; Larman MG, 2004, J CELL SCI, V117, P2513, DOI 10.1242/jcs.01109; Marangos P, 2003, DEVELOPMENT, V130, P1461, DOI 10.1242/dev.00340; MIYAZAKI S, 1993, DEV BIOL, V158, P62, DOI 10.1006/dbio.1993.1168; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nomikos M, 2005, J BIOL CHEM, V280, P31011, DOI 10.1074/jbc.M500629200; Oda S, 1999, DEV BIOL, V209, P172, DOI 10.1006/dbio.1999.9233; Okada M, 2002, GENES CELLS, V7, P985, DOI 10.1046/j.1365-2443.2002.00577.x; Saunders CM, 2002, DEVELOPMENT, V129, P3533; Shirakawa H, 2004, BIOPHYS J, V86, P1739, DOI 10.1016/S0006-3495(04)74242-3; Sone Y, 2005, BIOCHEM BIOPH RES CO, V330, P690, DOI 10.1016/j.bbrc.2005.03.032; Swann K, 2004, REPRODUCTION, V127, P431, DOI 10.1530/rep.1.00169; Swann K, 1996, Rev Reprod, V1, P33, DOI 10.1530/ror.0.0010033; Williams RL, 1999, BBA-MOL CELL BIOL L, V1441, P255, DOI 10.1016/S1388-1981(99)00150-X; Yamaga M, 1999, J BIOL CHEM, V274, P28537, DOI 10.1074/jbc.274.40.28537; Yoda A, 2004, DEV BIOL, V268, P245, DOI 10.1016/j.ydbio.2003.12.028	42	45	48	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					27794	27805		10.1074/jbc.M603473200	http://dx.doi.org/10.1074/jbc.M603473200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16854985	hybrid			2022-12-27	WOS:000240534400015
J	Pietri, M; Caprini, A; Mouillet-Richard, S; Pradines, E; Ermonval, M; Grassi, J; Kellermann, O; Schneider, B				Pietri, Mathea; Caprini, Andrea; Mouillet-Richard, Sophie; Pradines, Elodie; Ermonval, Myriam; Grassi, Jacques; Kellermann, Odile; Schneider, Benoit			Overstimulation of PrPC signaling pathways by prion peptide 106-126 causes oxidative injury of bioaminergic neuronal cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SH-SY5Y NEUROBLASTOMA-CELLS; AMYLOID-BETA PEPTIDE; PROTEIN-FRAGMENT; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; NADPH-OXIDASE; ACTIVATION; SCRAPIE; NEUROTOXICITY; KINASE	Transmissible spongiform encephalopathies, also called prion diseases, are characterized by neuronal loss linked to the accumulation of PrPSc, a pathologic variant of the cellular prion protein ( PrPC). Although the molecular and cellular bases of PrPSc-induced neuropathogenesis are not yet fully understood, increasing evidence supports the view that PrPSc accumulation interferes with PrPC normal function(s) in neurons. In the present work, we exploit the properties of PrP(106-126), a synthetic peptide encompassing residues 106 126 of PrP, to investigate into the mechanisms sustaining prion-associated neuronal damage. This peptide shares many physicochemical properties with PrPSc and is neurotoxic in vitro and in vivo. We examined the impact of PrP-(106-126) exposure on 1C11 neuroepithelial cells, their neuronal progenies, and GT1-7 hypothalamic cells. This peptide triggers reactive oxygen species overflow, mitogen-activated protein kinase (ERK1/2), and SAPK (p38 and JNK1/2) sustained activation, and apoptotic signals in 1C11-derived serotonergic and noradrenergic neuronal cells, while having no effect on 1C11 precursor and GT1-7 cells. The neurotoxic action of PrP-(106-126) relies on cell surface expression of PrPC, recruitment of a PrPC-Caveolin-Fyn signaling platform, and overstimulation of NADPH- oxidase activity. Altogether, these findings provide actual evidence that PrP-(106-126)induced neuronal injury is caused by an amplification of PrPC-associated signaling responses, which notably promotes oxidative stress conditions. Distorsion of PrPC signaling in neuronal cells could hence represent a causal event in transmissible spongiform encephalopathy pathogenesis.	CNRS, FRE 2937, Differenciat Cellulaire & Prions, Inst Andre Lwoff, F-94801 Villejuif, France; Inst Pasteur, Dept Biol Cellulaire & Infect, F-75724 Paris 15, France; CEA Saclay, Serv Pharmacol & Immunol, Commissariat Energie Atom, F-91191 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay	Kellermann, O (corresponding author), CNRS, FRE 2937, Differenciat Cellulaire & Prions, Inst Andre Lwoff, 7 Rue Guy Moquet, F-94801 Villejuif, France.	okellerm@vjf.cnrs.fr	Mouillet, Sophie/E-4960-2017; Schneider, Benoit/AAF-3850-2019	Mouillet, Sophie/0000-0002-8950-1949; Ermonval, Myriam/0000-0002-9685-9826; PIETRI, Mathea/0000-0002-1819-2878; Schneider, Benoit/0000-0002-1377-2670				Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Belichenko PV, 2000, NEUROPATH APPL NEURO, V26, P143, DOI 10.1046/j.1365-2990.2000.026002143.x; Brown DR, 1996, NATURE, V380, P345, DOI 10.1038/380345a0; BROWN DR, 1994, NEUROREPORT, V5, P2057, DOI 10.1097/00001756-199410270-00017; Budka H, 2003, BRIT MED BULL, V66, P121, DOI 10.1093/bmb/66.1.121; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Carimalo J, 2005, EUR J NEUROSCI, V21, P2311, DOI 10.1111/j.1460-9568.2005.04080.x; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Chiesa R, 2003, J VIROL, V77, P7611, DOI 10.1128/JVI.77.13.7611-7622.2003; Chiesa R, 2000, P NATL ACAD SCI USA, V97, P5574, DOI 10.1073/pnas.97.10.5574; Contestabile Antonio, 2001, Current Topics in Medicinal Chemistry, V1, P553, DOI 10.2174/1568026013394723; Cooper AJL, 1997, BIOL CHEM, V378, P793; Corsaro A, 2003, ANN NY ACAD SCI, V1010, P610, DOI 10.1196/annals.1299.114; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Della-Bianca V, 2001, J BIOL CHEM, V276, P38929, DOI 10.1074/jbc.M107454200; Dupiereux I, 2005, BIOCHEM BIOPH RES CO, V331, P894, DOI 10.1016/j.bbrc.2005.04.012; Ettaiche M, 2000, J BIOL CHEM, V275, P36487, DOI 10.1074/jbc.C000579200; Fabrizi C, 2001, J BIOL CHEM, V276, P25692, DOI 10.1074/jbc.M100133200; Fioriti L, 2005, MOL CELL NEUROSCI, V28, P165, DOI 10.1016/j.mcn.2004.09.006; Florio T, 2003, J NEUROCHEM, V85, P62, DOI 10.1046/j.1471-4159.2003.01664.x; FORLONI G, 1993, NATURE, V362, P543, DOI 10.1038/362543a0; Gavin R, 2005, FEBS LETT, V579, P4099, DOI 10.1016/j.febslet.2005.06.037; Gu YP, 2002, J BIOL CHEM, V277, P2275, DOI 10.1074/jbc.M104345200; Hetz C, 2003, TRENDS MOL MED, V9, P237, DOI 10.1016/S1471-4914(03)00069-8; Hugel B, 2004, CELL MOL LIFE SCI, V61, P2998, DOI 10.1007/s00018-004-4318-2; Ishikura N, 2005, P NATL ACAD SCI USA, V102, P886, DOI 10.1073/pnas.0408612101; Jamieson E, 2001, NEUROREPORT, V12, P3567, DOI 10.1097/00001756-200111160-00039; Jeffrey M, 2001, J COMP PATHOL, V124, P20, DOI 10.1053/jcpa.2000.0423; Jellinger KA, 2003, J NEURAL TRANSM-SUPP, P101; Kourie JI, 2001, CHEM-BIOL INTERACT, V138, P1, DOI 10.1016/S0009-2797(01)00228-9; Kovacs GG, 2001, NEUROBIOL DIS, V8, P881, DOI 10.1006/nbdi.2001.0418; Kulich SM, 2001, J NEUROCHEM, V77, P1058, DOI 10.1046/j.1471-4159.2001.00304.x; Lee HP, 2005, J NEUROCHEM, V95, P584, DOI 10.1111/j.1471-4159.2005.03429.x; Mallucci G, 2004, CURR OPIN NEUROL, V17, P641, DOI 10.1097/00019052-200412000-00002; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Marcus DL, 1998, EXP NEUROL, V150, P40, DOI 10.1006/exnr.1997.6750; Milhavet O, 2002, BRAIN RES REV, V38, P328, DOI 10.1016/S0165-0173(01)00150-3; Monnet C, 2004, FEBS LETT, V576, P114, DOI 10.1016/j.febslet.2004.08.076; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Mouillet-Richard S, 1999, MICROBES INFECT, V1, P969, DOI 10.1016/S1286-4579(99)80514-0; Mouillet-Richard S, 2000, J BIOL CHEM, V275, P9186, DOI 10.1074/jbc.275.13.9186; MULLER WEG, 1993, EUR J PHARM-MOLEC PH, V246, P261, DOI 10.1016/0922-4106(93)90040-G; Nixon RR, 2005, J BIOL CHEM, V280, P2455, DOI 10.1074/jbc.M410883200; O'Donovan CN, 2001, J BIOL CHEM, V276, P43516, DOI 10.1074/jbc.M103894200; Pearce RKB, 1997, J NEURAL TRANSM, V104, P661, DOI 10.1007/BF01291884; Perez M, 2003, BIOCHEM J, V372, P129, DOI 10.1042/BJ20021596; PERRY TL, 1982, NEUROSCI LETT, V33, P305, DOI 10.1016/0304-3940(82)90390-1; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rodolfo K, 1999, NEUROREPORT, V10, P3639, DOI 10.1097/00001756-199911260-00032; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Salmona M, 1997, NEUROBIOL DIS, V4, P47, DOI 10.1006/nbdi.1997.0133; Schneider B, 2003, P NATL ACAD SCI USA, V100, P13326, DOI 10.1073/pnas.2235648100; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Stanciu M, 2002, J BIOL CHEM, V277, P4010, DOI 10.1074/jbc.M104479200; Stuermer CAO, 2004, FASEB J, V18, P1731, DOI 10.1096/fj.04-2150fje; Thellung S, 2002, NEUROBIOL DIS, V9, P69, DOI 10.1006/nbdi.2001.0461; White AR, 2001, NEUROBIOL DIS, V8, P299, DOI 10.1006/nbdi.2001.0386; White AR, 2001, J NEUROCHEM, V76, P1509, DOI 10.1046/j.1471-4159.2001.00178.x	59	63	66	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					28470	28479		10.1074/jbc.M602774200	http://dx.doi.org/10.1074/jbc.M602774200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16864581	hybrid			2022-12-27	WOS:000240534400084
J	Devin, A; Dejean, L; Beauvoit, B; Chevtzoff, C; Averet, N; Bunoust, O; Rigoulet, M				Devin, Anne; Dejean, Laurent; Beauvoit, Bertrand; Chevtzoff, Cyrille; Averet, Nicole; Bunoust, Odile; Rigoulet, Michel			Growth yield homeostasis in respiring yeast is due to a strict mitochondrial content adjustment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOLATED RAT HEPATOCYTES; COLI AEROBIC GROWTH; SACCHAROMYCES-CEREVISIAE; RESPIRATORY-CHAIN; HEAT-PRODUCTION; ENERGY BALANCES; SUCCINIC ACID; METABOLISM; CELLS; EFFICIENCY	In living cells, growth is the result of coupling between substrate catabolism and multiple metabolic processes taking place during net biomass formation and cell property maintenance. A crucial parameter for growth description is its yield, i.e. the efficiency of the transformation from substrate consumption to biomass formation. Using numerous yeast strains growing on different respiratory media, we have shown that the growth yield is identical regardless of the strain, growth phase, and respiratory substrate used. This homeostasis is the consequence of a strict linear relationship between growth and respiratory rates. Moreover, in all conditions tested, the oxygen consumption rate was strictly controlled by the cellular content of respiratory chain compounds in such a way that, in vivo, the steady state of oxidative phosphorylation was kept constant. Thus, the growth yield homeostasis depends on the tight adjustment of the cellular content of respiratory chain compounds to the growth rate. Any process leading to a defect in this adjustment allows an energy waste and consequently an energy yield decrease.	Univ Bordeaux 2, IBGC, Bioenerget Lab, CNRS,UMR 5095, F-33077 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Rigoulet, M (corresponding author), Univ Bordeaux 2, IBGC, Bioenerget Lab, CNRS,UMR 5095, 1 Rue Camille St Saens, F-33077 Bordeaux, France.	michel.rigoulet@ibgc.u-bordeaux2.fr		Beauvoit, Bertrand/0000-0002-7666-6429				Aguilaniu H, 2001, J BIOL CHEM, V276, P35396, DOI 10.1074/jbc.M101796200; Boumans H, 1998, J BIOL CHEM, V273, P4872, DOI 10.1074/jbc.273.9.4872; Boumans H, 1998, BIOCHEM J, V331, P877, DOI 10.1042/bj3310877; Bunoust O, 2005, J BIOL CHEM, V280, P3407, DOI 10.1074/jbc.M407746200; CLARK DG, 1979, BIOCHEM J, V184, P501, DOI 10.1042/bj1840501; Dejean L, 2000, BBA-BIOENERGETICS, V1457, P45, DOI 10.1016/S0005-2728(00)00053-0; Dejean L, 2002, BBA-BIOENERGETICS, V1554, P159, DOI 10.1016/S0005-2728(02)00240-2; Dejean L, 2002, BIOCHEM BIOPH RES CO, V293, P1383, DOI 10.1016/S0006-291X(02)00391-1; Dejean L, 2001, BBA-BIOENERGETICS, V1503, P329, DOI 10.1016/S0005-2728(00)00210-3; DERMOUN Z, 1979, J BACTERIOL, V140, P377, DOI 10.1128/JB.140.2.377-380.1979; DERMOUN Z, 1980, J BACTERIOL, V143, P742, DOI 10.1128/JB.143.2.742-746.1980; Duvezin-Caubet S, 2003, P NATL ACAD SCI USA, V100, P13235, DOI 10.1073/pnas.2135169100; GNAIGER E, 1990, BIOCHIM BIOPHYS ACTA, V1016, P328, DOI 10.1016/0005-2728(90)90164-Y; Guan Y., 1996, BIOTHERMOKINETICS LI, P387; GUSTAFSSON L, 1991, THERMOCHIM ACTA, V193, P145, DOI 10.1016/0040-6031(91)80181-H; HOFFNER SES, 1985, CYTOBIOS, V42, P71; HOOGERHEIDE JC, 1975, RADIAT ENVIRON BIOPH, V12, P281, DOI 10.1007/BF01323416; JARRETT IG, 1979, BIOCHEM J, V180, P631, DOI 10.1042/bj1800631; KATAOKA T, 1984, CELL, V37, P437, DOI 10.1016/0092-8674(84)90374-X; Kemp R.B., 1996, BIOTHERMOKINETICS LI, P398; KEMP RB, 1989, ENERGY TRANSFORMATIO, P91; LARSSON C, 1991, BIOTECHNOL BIOENG, V38, P447, DOI 10.1002/bit.260380503; SAMUELSSON MO, 1988, APPL ENVIRON MICROB, V54, P2220, DOI 10.1128/AEM.54.9.2220-2225.1988; Schagger H, 2002, BBA-BIOENERGETICS, V1555, P154, DOI 10.1016/S0005-2728(02)00271-2; vanKleeff BHA, 1996, BIOTECHNOL PROGR, V12, P510, DOI 10.1021/bp960033b; VANURK H, 1988, YEAST, V4, P283, DOI 10.1002/yea.320040406; VONSTOCKAR U, 1993, BIOCHIM BIOPHYS ACTA, V1183, P221, DOI 10.1016/0005-2728(93)90225-5; VONSTOCKAR U, 1989, BIOTECHNOL BIOENG, V34, P86, DOI 10.1002/bit.260340112; WESTERHOFF HV, 1983, P NATL ACAD SCI-BIOL, V80, P305, DOI 10.1073/pnas.80.1.305	29	20	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2006	281	37					26779	26784		10.1074/jbc.M604800200	http://dx.doi.org/10.1074/jbc.M604800200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082PB	16849319	hybrid			2022-12-27	WOS:000240397700004
J	Theocharis, AD; Seidel, C; Borset, M; Dobra, K; Baykov, V; Labropoulou, V; Kanakis, I; Dalas, E; Karamanos, NK; Sundan, A; Hjerpe, A				Theocharis, Achilleas D.; Seidel, Carina; Borset, Magne; Dobra, Katalin; Baykov, Vadim; Labropoulou, Vassiliki; Kanakis, Ioannis; Dalas, Evangelos; Karamanos, Nikos K.; Sundan, Anders; Hjerpe, Anders			Serglycin constitutively secreted by myeloma plasma cells is a potent inhibitor of bone mineralization in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROITIN SULFATE PROTEOGLYCAN; HYDROXYAPATITE CRYSTAL-GROWTH; HEMATOPOIETIC-CELLS; MOLECULAR-CLONING; MULTIPLE-MYELOMA; BINDING; GRANULE; SURFACE; MATRIX-METALLOPROTEINASE-9; SYNDECAN-1	Although the biological significance of proteoglycans (PGs) has previously been highlighted in multiple myeloma (MM), little is known about serglycin, which is a hematopoietic cell granule PG. In this study, we describe the expression and highly constitutive secretion of serglycin in several MM cell lines. Serglycin messenger RNA was detected in six MM cell lines. PGs were purified from conditioned medium of four MM cell lines, and serglycin substituted with 4-sulfated chondroitin sulfate was identified as the predominant PG. Flow cytometry and confocal microscopy showed that serglycin was also present intracellularly and on the cell surface, and attachment to the cell surface was at least in part dependent on intact glycosaminoglycan side chains. Immunohistochemical staining of bone marrow biopsies showed the presence of serglycin both in benign and malignant plasma cells. Immunoblotting in bone marrow aspirates from a limited number of patients with newly diagnosed MM revealed highly increased levels of serglycin in 30% of the cases. Serglycin isolated from myeloma plasma cells was found to influence the bone mineralization process through inhibition of the crystal growth rate of hydroxyapatite. This rate reduction was attributed to adsorption and further blocking of the active growth sites on the crystal surface. The apparent order of the crystallization reaction was found to be n = 2, suggesting a surface diffusion-controlled spiral growth mechanism. Our findings suggest that serglycin release is a constitutive process, which may be of fundamental biological importance in the study of MM.	Univ Patras, Dept Chem, Biochem Lab, Patras 26500, Greece; F46 Huddinge Univ Hosp, Dept Lab Med, Div Pathol, Karolinska Inst, SE-14186 Stockholm, Sweden; Norwegian Univ Sci & Technol, Inst Canc Res & Mol Med, N-7489 Trondheim, Norway; Univ Hosp Patras, Dept Internal Med, Patras 26500, Greece; Univ Patras, Chem Phys Lab, Dept Chem, Patras 26500, Greece	University of Patras; Karolinska Institutet; Norwegian University of Science & Technology (NTNU); University of Patras; University of Patras	Seidel, C (corresponding author), Univ Patras, Dept Chem, Biochem Lab, Patras 26500, Greece.	atheoch@upatras.gr; Carina.Seidel@dll.se	Kanakis, Ioannis/E-3206-2018; Karamanos, Nikos/A-3616-2008; Borset, Magne/AAY-1713-2021; theocharis, achilleas/F-6903-2010; Kanakis, Ioannis/N-7874-2019	Kanakis, Ioannis/0000-0001-6410-1482; Karamanos, Nikos/0000-0003-3618-0288; Kanakis, Ioannis/0000-0001-6410-1482; Theocharis, Achilleas/0000-0001-8611-2297; Borset, Magne/0000-0001-5179-2835				Abecassis I, 2003, EXP CELL RES, V291, P363, DOI 10.1016/j.yexcr.2003.08.006; Abrink M, 2004, J BIOL CHEM, V279, P40897, DOI 10.1074/jbc.M405856200; AVRAHAM S, 1989, P NATL ACAD SCI USA, V86, P3763, DOI 10.1073/pnas.86.10.3763; Biederbick A, 2003, EUR J CELL BIOL, V82, P19, DOI 10.1078/0171-9335-00287; BORSET M, 1994, EUR J HAEMATOL, V53, P31; BOURDON MA, 1985, P NATL ACAD SCI USA, V82, P1321, DOI 10.1073/pnas.82.5.1321; Bourguignon LYW, 1998, J CELL PHYSIOL, V176, P206, DOI 10.1002/(SICI)1097-4652(199807)176:1<206::AID-JCP22>3.0.CO;2-3; Brenne AT, 2002, BLOOD, V99, P3756, DOI 10.1182/blood.V99.10.3756; Cowland JB, 1999, J LEUKOCYTE BIOL, V66, P989, DOI 10.1002/jlb.66.6.989; Derksen PWB, 2002, BLOOD, V99, P1405, DOI 10.1182/blood.V99.4.1405; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Grujic M, 2005, J BIOL CHEM, V280, P33411, DOI 10.1074/jbc.M501708200; Heider U, 2005, BIOCHEM BIOPH RES CO, V338, P687, DOI 10.1016/j.bbrc.2005.09.146; Ho HCK, 2001, BIOL REPROD, V64, P1667, DOI 10.1095/biolreprod64.6.1667; Humphries DE, 1999, NATURE, V400, P769, DOI 10.1038/23481; Jiang HD, 2005, J BIOL CHEM, V280, P42061, DOI 10.1074/jbc.M412280200; Karamanos N K, 2001, Methods Mol Biol, V171, P181; Kolset SO, 1996, J LEUKOCYTE BIOL, V59, P545, DOI 10.1002/jlb.59.4.545; KOLSET SO, 1990, BIOCHIM BIOPHYS ACTA, V1032, P191, DOI 10.1016/0304-419X(90)90004-K; Koutsopoulos S, 2000, LANGMUIR, V16, P6745, DOI 10.1021/la000070j; KOUTSOUKOS P, 1980, J AM CHEM SOC, V102, P1553, DOI 10.1021/ja00525a015; LEVITT D, 1989, CELL IMMUNOL, V98, P78; Manes S, 1999, J BIOL CHEM, V274, P6935, DOI 10.1074/jbc.274.11.6935; Nancollas GH., 1989, BIOMINERALISATION, P156; OLDBERG A, 1981, J BIOL CHEM, V256, P847; Olson MW, 1998, J BIOL CHEM, V273, P10672, DOI 10.1074/jbc.273.17.10672; Oshima T, 2005, BLOOD, V106, P3160, DOI 10.1182/blood-2004-12-4940; PASCHALAKIS P, 1993, BIOCHIM BIOPHYS ACTA, V1158, P129, DOI 10.1016/0304-4165(93)90006-T; Raja SM, 2005, J BIOL CHEM, V280, P20752, DOI 10.1074/jbc.M501181200; Rees SG, 2002, BIOCHEM BIOPH RES CO, V292, P727, DOI 10.1006/bbrc.2002.6699; RIDLEY RC, 1993, BLOOD, V81, P767; SALI A, 1993, J BIOL CHEM, V268, P9023; SANDERSON RD, 1992, J IMMUNOL, V148, P3902; SCHICK BP, 1995, J CELL PHYSIOL, V165, P96, DOI 10.1002/jcp.1041650113; Schick BP, 2003, BBA-MOL CELL RES, V1593, P259, DOI 10.1016/S0167-4889(02)00396-8; SCHICK BP, 1988, J BIOL CHEM, V263, P1052; SCHICK BP, 1992, BIOCHEM J, V282, P651, DOI 10.1042/bj2820651; Schick BP, 2001, BLOOD, V97, P449, DOI 10.1182/blood.V97.2.449; Schick BP, 1997, J CELL PHYSIOL, V172, P87, DOI 10.1002/(SICI)1097-4652(199707)172:1<87::AID-JCP10>3.0.CO;2-L; Seidel C, 2000, BLOOD, V96, P3139, DOI 10.1182/blood.V96.9.3139.h8003139_3139_3146; Standal T, 2002, BLOOD, V100, P3002, DOI 10.1182/blood-2002-04-1190; Tanaka Y, 1993, Curr Top Microbiol Immunol, V184, P99; Theocharis AD, 2002, BBA-MOL BASIS DIS, V1588, P165, DOI 10.1016/S0925-4439(02)00161-8; ToyamaSorimachi N, 1997, J BIOL CHEM, V272, P26714, DOI 10.1074/jbc.272.42.26714; TOYAMASORIMACHI N, 1995, J BIOL CHEM, V270, P7437, DOI 10.1074/jbc.270.13.7437; Wijdenes J, 1996, BRIT J HAEMATOL, V94, P318, DOI 10.1046/j.1365-2141.1996.d01-1811.x; Winberg JO, 2000, J MOL BIOL, V304, P669, DOI 10.1006/jmbi.2000.4235; Yang Y, 2003, J BIOL CHEM, V278, P12888, DOI 10.1074/jbc.M209440200; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; Yu Q, 1999, GENE DEV, V13, P35, DOI 10.1101/gad.13.1.35	50	75	78	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					35116	35128		10.1074/jbc.M601061200	http://dx.doi.org/10.1074/jbc.M601061200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16870619	hybrid			2022-12-27	WOS:000241933700045
J	Lee, WC; Ohshiro, T; Matsubara, T; Izumi, Y; Tanokura, M				Lee, Woo Cheol; Ohshiro, Takashi; Matsubara, Toshiyuki; Izumi, Yoshikazu; Tanokura, Masaru			Crystal structure and desulfurization mechanism of 2 '-hydroxybiphenyl-2-sulfinic acid desulfinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROBIAL DESULFURIZATION; DIBENZOTHIOPHENE; PROGRAM; SEQUENCE; HYDRODESULFURIZATION; CRYSTALLOGRAPHY; CATALYSIS; MOLSCRIPT; ENZYME; DSZB	The desulfurization of dibenzothiophene in Rhodococcus erythropolis is catalyzed by two monooxygenases, DszA and DszC, and a desulfinase, DszB. In the last step of this pathway, DszB hydrolyzes 2'-hydroxybiphenyl-2-sulfinic acid into 2-hydroxybiphenyl and sulfite. We report on the crystal structures of DszB and an inactive mutant of DszB in complex with substrates at resolutions of 1.8 angstrom or better. The overall fold of DszB is similar to those of periplasmic substrate-binding proteins. In the substrate complexes, biphenyl rings of substrates are recognized by extensive hydrophobic interactions with the active site residues. Binding of substrates accompanies structural changes of the active site loops and recruits His(60) to the active site. The sulfinate group of bound substrates forms hydrogen bonds with side chains of Ser(27), His(60), and Arg(70), each of which is shown by site-directed mutagenesis to be essential for the activity. In our proposed reaction mechanism, Cys(27) functions as a nucleophile and seems to be activated by the sulfinate group of substrates, whereas His(60) and Arg(70) orient the syn orbital of sulfinate oxygen to the sulfhydryl hydrogen of Cys(27) and stabilize the negatively charged reaction intermediate. Cys, His, and Arg residues are conserved in putative proteins homologous to DszB, which are presumed to constitute a new family of desulfinases.	Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan; Tottori Univ, Dept Biotechnol, Tottori 6808552, Japan	University of Tokyo; Tottori University	Tanokura, M (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, 1-1-1Yayoi, Tokyo 1138657, Japan.	amtanok@mail.ecc.u-tokyo.ac.jp		Tanokura, Masaru/0000-0001-5072-2480				Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Campobasso N, 1998, BIOCHEMISTRY-US, V37, P15981, DOI 10.1021/bi981673l; *COLL COMP PROJ 4, 1995, ACTA CRYSTALLOGR D, V50, P760; Dall'Acqua W, 2000, PROTEIN SCI, V9, P1; DENOME SA, 1994, J BACTERIOL, V176, P6707, DOI 10.1128/JB.176.21.6707-6716.1994; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; FUJIHARA H, 1990, CHEM SULFINIC ACIDS, P275; GALLAGHER JR, 1993, FEMS MICROBIOL LETT, V107, P31, DOI 10.1111/j.1574-6968.1993.tb05999.x; GANDOUR RD, 1981, BIOORG CHEM, V10, P169, DOI 10.1016/0045-2068(81)90020-1; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Graber R, 1999, J BIOL CHEM, V274, P31203, DOI 10.1074/jbc.274.44.31203; Gray KA, 2003, CURR OPIN MICROBIOL, V6, P229, DOI 10.1016/S1369-5274(03)00065-1; Gray KA, 1996, NAT BIOTECHNOL, V14, P1705, DOI 10.1038/nbt1296-1705; HANSON G, 1981, J ORG CHEM, V46, P5441, DOI 10.1021/jo00339a048; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; HOUALLA M, 1980, J CATAL, V61, P523, DOI 10.1016/0021-9517(80)90400-5; IZUMI Y, 1994, APPL ENVIRON MICROB, V60, P223, DOI 10.1128/AEM.60.1.223-226.1994; Kabe T, 1997, IND ENG CHEM RES, V36, P5146, DOI 10.1021/ie970297i; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kahnert A, 2000, J BIOL CHEM, V275, P31661, DOI 10.1074/jbc.M005820200; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee WC, 2004, ACTA CRYSTALLOGR D, V60, P1636, DOI 10.1107/S0907444904017627; LOUIE GV, 1992, NATURE, V359, P33, DOI 10.1038/359033a0; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; MIZOBATA T, 1992, J BIOL CHEM, V267, P17773; MONTICELLO DJ, 1985, ANNU REV MICROBIOL, V39, P371, DOI 10.1146/annurev.mi.39.100185.002103; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nakayama N, 2002, BBA-PROTEINS PROTEOM, V1598, P122, DOI 10.1016/S0167-4838(02)00365-5; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; PIDDINGTON CS, 1995, APPL ENVIRON MICROB, V61, P468, DOI 10.1128/AEM.61.2.468-475.1995; POLGAR L, 1974, FEBS LETT, V47, P15, DOI 10.1016/0014-5793(74)80415-1; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SODA K, 1987, METHOD ENZYMOL, V143, P453; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Van Hamme JD, 2003, MICROBIOL MOL BIOL R, V67, P503, DOI 10.1128/MMBR.67.4.503-549.2003; [No title captured]	42	31	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32534	32539		10.1074/jbc.M602974200	http://dx.doi.org/10.1074/jbc.M602974200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16891315	hybrid			2022-12-27	WOS:000241414500051
J	Yamaguchi, Y; Shirai, Y; Matsubara, T; Sanse, K; Kuriyama, M; Oshiro, N; Yoshino, KI; Yonezawa, K; Ono, Y; Saito, N				Yamaguchi, Yasuto; Shirai, Yasuhito; Matsubara, Takehiro; Sanse, Koichi; Kuriyama, Masamitsu; Oshiro, Noriko; Yoshino, Ken-ichi; Yonezawa, Kazuyoshi; Ono, Yoshitaka; Saito, Naoaki			Phosphorylation and up-regulation of diacylglycerol kinase gamma via its interaction with protein kinase C gamma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR HETEROGENEITY; NUCLEAR-LOCALIZATION; MEDIATED ACTIVATION; SPATIAL REGULATION; PLASMA-MEMBRANE; PKC-GAMMA; ALPHA; ZETA; TRANSLOCATION; DOMAIN	Diacylglycerol (DAG) acts as an allosteric activator of protein kinase C (PKC) and is converted to phosphatidic acid by DAG kinase (DGK). Therefore, DGK is thought to be a negative regulator of PKC activation. Here we show molecular mechanisms of functional coupling of the two kinases. gamma PKC directly associated with DGK gamma through its accessory domain (AD), depending on Ca2+ as well as phosphatidylserine/diolein in vitro. Mass spectrometric analysis and mutation studies revealed that gamma PKC phosphorylated Ser-776 and Ser-779 in the AD of DGK gamma. The phosphorylation by gamma KC resulted in activation of DGK gamma because a DGK gamma mutant in which Ser-776 and Ser-779 were substituted with glutamic acid to mimic phosphorylation exhibited significantly higher activity compared with wild typeDGK gamma and an unphosphorylatable DGK gamma mutant. Importantly, the interaction of the two kinases and the phosphorylation of DGK gamma by gamma PKC could be confirmed in vivo, and overexpression of the AD of DGK gamma inhibited re-translocation of gamma PKC. These results demonstrate that localization and activation of the functionally correlated kinases, gamma PKC and DGK gamma, are spatio-temporally orchestrated by their direct association and phosphorylation, contributing to subtype-specific regulation of DGK gamma and DAG signaling.	Kobe Univ, Biosignal Res Ctr, Nada Ku, Kobe, Hyogo 6578501, Japan	Kobe University	Saito, N (corresponding author), Kobe Univ, Biosignal Res Ctr, Nada Ku, Rokkodai Cho 1-1, Kobe, Hyogo 6578501, Japan.	naosaito@kobe-u.ac.jp	Shirai, Yasuhito/O-3255-2018					Adachi N, 2005, MOL BRAIN RES, V139, P288, DOI 10.1016/j.molbrainres.2005.06.007; Aragones J, 2001, J BIOL CHEM, V276, P10548, DOI 10.1074/jbc.M006180200; Baldanzi G, 2004, ONCOGENE, V23, P4828, DOI 10.1038/sj.onc.1207633; Brose N, 2002, J CELL SCI, V115, P4399, DOI 10.1242/jcs.00122; Caricasole A, 2002, J BIOL CHEM, V277, P4790, DOI 10.1074/jbc.M110249200; Chen DH, 2003, AM J HUM GENET, V72, P839, DOI 10.1086/373883; Cho W, 2001, J BIOL CHEM, V276, P32407, DOI 10.1074/jbc.R100007200; Cipres A, 2003, J BIOL CHEM, V278, P35629, DOI 10.1074/jbc.M305635200; Cutrupi S, 2000, EMBO J, V19, P4614, DOI 10.1093/emboj/19.17.4614; Davidson L, 2004, J BIOL CHEM, V279, P11906, DOI 10.1074/jbc.M310784200; DEKKER LV, 1994, TRENDS BIOCHEM SCI, V19, P73, DOI 10.1016/0968-0004(94)90038-8; Eto M, 2002, NEURON, V36, P1145, DOI 10.1016/S0896-6273(02)01107-8; Goto K, 1999, CHEM PHYS LIPIDS, V98, P109, DOI 10.1016/S0009-3084(99)00023-7; Hogan A, 2001, J BIOL CHEM, V276, P26526, DOI 10.1074/jbc.M104156200; Houssa B, 1999, J BIOL CHEM, V274, P6820, DOI 10.1074/jbc.274.11.6820; Imai S, 2005, J BIOL CHEM, V280, P39870, DOI 10.1074/jbc.M500669200; Imai S, 2004, BIOCHEM J, V382, P957, DOI 10.1042/BJ20040681; Imai S, 2002, J BIOL CHEM, V277, P35323, DOI 10.1074/jbc.M202035200; Ito M, 2002, NAT REV NEUROSCI, V3, P896, DOI 10.1038/nrn962; Jiang Y, 2000, J BIOL CHEM, V275, P34092, DOI 10.1074/jbc.M004914200; Kanoh H, 2002, J BIOCHEM, V131, P629, DOI 10.1093/oxfordjournals.jbchem.a003144; Kashiwagi K, 2002, J BIOL CHEM, V277, P18037, DOI 10.1074/jbc.M111761200; Kazanietz MG, 2002, MOL PHARMACOL, V61, P759, DOI 10.1124/mol.61.4.759; Luo B, 2003, J CELL BIOL, V160, P929, DOI 10.1083/jcb.200208120; Luo B, 2003, J BIOL CHEM, V278, P39542, DOI 10.1074/jbc.M307153200; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; Pettitt TR, 1999, J BIOL CHEM, V274, P36181, DOI 10.1074/jbc.274.51.36181; PREISS J, 1986, J BIOL CHEM, V261, P8597; Ron D, 1999, FASEB J, V13, P1658, DOI 10.1096/fasebj.13.13.1658; Saito N, 2002, J BIOCHEM, V132, P683, DOI 10.1093/oxfordjournals.jbchem.a003274; Sakai N, 1997, J CELL BIOL, V139, P1465, DOI 10.1083/jcb.139.6.1465; Shindo M, 2003, J BIOL CHEM, V278, P18448, DOI 10.1074/jbc.M300400200; Shindo M, 2001, BIOCHEM BIOPH RES CO, V289, P451, DOI 10.1006/bbrc.2001.5935; Shirai Y, 2000, J BIOL CHEM, V275, P24760, DOI 10.1074/jbc.M003151200; TANAKA C, 1994, ANNU REV NEUROSCI, V17, P551, DOI 10.1146/annurev.ne.17.030194.003003; Teixeira C, 2003, BLOOD, V102, P1414, DOI 10.1182/blood-2002-11-3621; Tognon CE, 1998, MOL CELL BIOL, V18, P6995, DOI 10.1128/MCB.18.12.6995; Topham MK, 1999, J BIOL CHEM, V274, P11447, DOI 10.1074/jbc.274.17.11447; Topham MK, 1998, NATURE, V394, P697, DOI 10.1038/29337; Topham MK, 2001, J CELL BIOL, V152, P1135, DOI 10.1083/jcb.152.6.1135; van Baal J, 2005, J BIOL CHEM, V280, P9870, DOI 10.1074/jbc.M409301200; van Blitterswijk WJ, 2000, CELL SIGNAL, V12, P595, DOI 10.1016/S0898-6568(00)00113-3; Yamada K, 1997, BIOCHEM J, V321, P59, DOI 10.1042/bj3210059	46	33	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31627	31637		10.1074/jbc.M606992200	http://dx.doi.org/10.1074/jbc.M606992200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16905533				2022-12-27	WOS:000241235300048
J	Choi, SJ; Chung, SS; Rho, EJ; Lee, HW; Lee, MH; Choi, HS; Seol, JH; Baek, SH; Bang, OS; Chung, CH				Choi, Soo Joon; Chung, Sung Soo; Rho, Eun Jung; Lee, Hyung Woo; Lee, Moon Hee; Choi, Hueng-Sik; Seol, Jae Hong; Baek, Sung Hee; Bang, Ok Sun; Chung, Chin Ha			Negative modulation of RXR alpha transcriptional activity by small ubiquitin-related modifier (SUMO) modification and its reversal by SUMO-specific protease SUSP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; E3 LIGASE; DEPENDENT TRANSCRIPTION; GLUCOCORTICOID RECEPTOR; ANDROGEN RECEPTOR; NUCLEAR-PORE; X-RECEPTOR; SUMOYLATION; BINDING; REPRESSION	Retinoid X receptor alpha(RXR alpha) belongs to a family of ligand-activated transcription factors that regulate many aspects of metazoan life. Here we demonstrate that RXR alpha is a target substrate of a small ubiquitin-related modifier ( SUMO)-specific protease, SUSP1, which is capable of controlling the transcriptional activity of RXR alpha. RXR alpha was modified by SUMO-1 in vivo as well as in vitro, and the Lys-108 residue within the IKPP sequence of RXR alpha AF-1 domain was identified as the major SUMO-1 acceptor site. Prevention of SUMO modification by Lys-to-Arg mutation led to an increase not only in the transcriptional activity of RXR alpha but also in the activity of its heterodimeric complex with retinoic acid receptor-alpha or peroxisome proliferator-activated receptor-gamma ( PPAR gamma). SUSP1 co-localized with RXR alpha in the nucleus and removed SUMO-1 from RXR alpha but not from androgen receptor or PPAR gamma. Moreover, overexpression of SUSP1 caused an increase in the transcriptional activity of RXR alpha, whereas small hairpin RNA-mediated knockdown of endogenous SUSP1 led to a decrease in RXR alpha activity. These results suggest that SUSP1 plays an important role in the control of the transcriptional activity of RXR alpha and thus in the RXR alpha-mediated cellular processes.	Seoul Natl Univ, Sch Biol Sci, Natl Res Lab Prot Biochem, Seoul 151742, South Korea; Chonnam Natl Univ, Hormone Res Ctr, Sch Biol Sci & Technol, Kwangju 500757, South Korea	Seoul National University (SNU); Chonnam National University	Bang, OS (corresponding author), Seoul Natl Univ, Sch Biol Sci, Natl Res Lab Prot Biochem, Seoul 151742, South Korea.	osbang@snu.ac.kr; chchung@snu.ac.kr	Lee, Hyungwoo/AAX-4011-2020					Abdel-Hafiz H, 2002, J BIOL CHEM, V277, P33950, DOI 10.1074/jbc.M204573200; Bailey D, 2004, J BIOL CHEM, V279, P692, DOI 10.1074/jbc.M306195200; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; Best JL, 2002, MOL CELL, V10, P843, DOI 10.1016/S1097-2765(02)00699-8; Bies J, 2002, J BIOL CHEM, V277, P8999, DOI 10.1074/jbc.M110453200; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Chang CC, 2005, J BIOL CHEM, V280, P10164, DOI 10.1074/jbc.M409161200; Cheng JK, 2005, J BIOL CHEM, V280, P14492, DOI 10.1074/jbc.M412185200; Cheng JK, 2004, MOL CELL BIOL, V24, P6021, DOI 10.1128/MCB.24.13.6021-6028.2004; Desterro JMP, 2005, MOL BIOL CELL, V16, P5115, DOI 10.1091/mbc.E05-06-0536; Dohmen RJ, 2004, BBA-MOL CELL RES, V1695, P113, DOI 10.1016/j.bbamcr.2004.09.021; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; Hang J, 2002, J BIOL CHEM, V277, P19961, DOI 10.1074/jbc.M201799200; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Kahyo T, 2001, MOL CELL, V8, P713, DOI 10.1016/S1097-2765(01)00349-5; Kim J, 2002, J BIOL CHEM, V277, P38037, DOI 10.1074/jbc.M207235200; Kim KI, 2000, J BIOL CHEM, V275, P14102, DOI 10.1074/jbc.275.19.14102; Kim KI, 2002, J CELL PHYSIOL, V191, P257, DOI 10.1002/jcp.10100; Kirsh O, 2002, EMBO J, V21, P2682, DOI 10.1093/emboj/21.11.2682; Le Drean Y, 2002, ENDOCRINOLOGY, V143, P3482, DOI 10.1210/en.2002-220135; Lin X, 2003, MOL CELL, V11, P1389, DOI 10.1016/S1097-2765(03)00175-8; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; Muller S, 2004, ONCOGENE, V23, P1998, DOI 10.1038/sj.onc.1207415; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; Nishida T, 2000, EUR J BIOCHEM, V267, P6423, DOI 10.1046/j.1432-1327.2000.01729.x; Nishida T, 2001, J BIOL CHEM, V276, P39060, DOI 10.1074/jbc.M103955200; Ohshima T, 2004, J BIOL CHEM, V279, P29551, DOI 10.1074/jbc.M403866200; Pichler A, 2004, NAT STRUCT MOL BIOL, V11, P984, DOI 10.1038/nsmb834; Poukka H, 2000, P NATL ACAD SCI USA, V97, P14145, DOI 10.1073/pnas.97.26.14145; Rastinejad F, 2001, CURR OPIN STRUC BIOL, V11, P33, DOI 10.1016/S0959-440X(00)00165-2; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Rui HL, 2002, J BIOL CHEM, V277, P42981, DOI 10.1074/jbc.M208099200; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Salinas S, 2004, J CELL BIOL, V165, P767, DOI 10.1083/jcb.200310136; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Sapetschnig A, 2002, EMBO J, V21, P5206, DOI 10.1093/emboj/cdf510; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Szanto A, 2004, MOL CELL BIOL, V24, P8154, DOI 10.1128/MCB.24.18.8154-8166.2004; Tian S, 2002, BIOCHEM J, V367, P907, DOI 10.1042/BJ20021085; Yang SH, 2004, MOL CELL, V13, P611, DOI 10.1016/S1097-2765(04)00060-7; Yang SH, 2003, CELL CYCLE, V2, P528, DOI 10.4161/cc.2.6.597; Yeh ETH, 2000, GENE, V248, P1, DOI 10.1016/S0378-1119(00)00139-6; Zhang H, 2002, MOL CELL BIOL, V22, P6498, DOI 10.1128/MCB.22.18.6498-6508.2002	47	59	66	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30669	30677		10.1074/jbc.M604033200	http://dx.doi.org/10.1074/jbc.M604033200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16912044	hybrid			2022-12-27	WOS:000241075900043
J	Domercq, M; Brambilla, L; Pilati, E; Marchaland, J; Volterra, A; Bezzi, P				Domercq, Maria; Brambilla, Liliana; Pilati, Ethel; Marchaland, Julie; Volterra, Andrea; Bezzi, Paola			P2Y1 receptor-evoked glutamate exocytosis from astrocytes - Control by tumor necrosis factor-alpha and prostaglandins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSOLIC CALCIUM OSCILLATIONS; DORSAL SPINAL-CORD; GLIAL-CELLS; P2X RECEPTORS; SYNAPTIC-TRANSMISSION; REGULATED EXOCYTOSIS; MOLECULAR PHYSIOLOGY; NEURONAL-ACTIVITY; ATP RELEASE; P2Y(1)	ATP, released by both neurons and glia, is an important mediator of brain intercellular communication. We find that selective activation of purinergic P2Y1 receptors (P2Y1R) in cultured astrocytes triggers glutamate release. By total internal fluorescence reflection imaging of fluorescence-labeled glutamatergic vesicles, we document that such release occurs by regulated exocytosis. The stimulus-secretion coupling mechanism involves Ca2+ release from internal stores and is controlled by additional transductive events mediated by tumor necrosis factor-alpha (TNF alpha) and prostaglandins (PG). P2Y1R activation induces release of both TNF alpha and PGE2 and blocking either one significantly reduces glutamate release. Accordingly, astrocytes from TNF alpha-deficient (TNF-/-) or TNF type 1 receptor-deficient (TNFR1(-/-)) mice display altered P2Y1R-dependent Ca2+ signaling and deficient glutamate release. In mixed hippocampal cultures, the P2Y1R-evoked process occurs in astrocytes but not in neurons or microglia. P2Y1R stimulation induces Ca2+-dependent glutamate release also from acute hippocampal slices. The process in situ displays characteristics resembling those in cultured astrocytes and is distinctly different from synaptic glutamate release evoked by high K+ stimulation as follows: (a) it is sensitive to cyclooxygenase inhibitors; (b) it is deficient in preparations from TNF-/- and TNFR1(-/-) mice; and (c) it is inhibited by the exocytosis blocker bafilomycin A1 with a different time course. No glutamate release is evoked by P2Y1R-dependent stimulation of hippocampal synaptosomes. Taken together, our data identify the coupling of purinergic P2Y1R to glutamate exocytosis and its peculiar TNF alpha- and PG-dependent control, and we strongly suggest that this cascade operates selectively in astrocytes. The identified pathway may play physiological roles in glial-glial and glial-neuronal communication.	Univ Lausanne, Dept Morfol & Biol Celular, CH-1005 Lausanne, Switzerland; Univ Milan, Dept Pharmacol Sci, Ctr Excellence Neurodegenerat Dis, I-20133 Milan, Italy	University of Lausanne; University of Milan	Bezzi, P (corresponding author), Univ Lausanne, Dept Morfol & Biol Celular, Rue Bugnon 9, CH-1005 Lausanne, Switzerland.	Paola.Bezzi@unil.ch	Brambilla, Liliana/AAA-3303-2021; Domercq, Maria/Z-2274-2019; Bezzi, Paola/AAP-2440-2020	Brambilla, Liliana/0000-0001-5714-3625; Domercq, Maria/0000-0002-4918-9276; Volterra, Andrea/0000-0003-1069-1602				Angulo MC, 2004, J NEUROSCI, V24, P6920, DOI 10.1523/JNEUROSCI.0473-04.2004; Araque A, 2000, J NEUROSCI, V20, P666, DOI 10.1523/JNEUROSCI.20-02-00666.2000; Araque A, 1998, J NEUROSCI, V18, P6822; Arcuino G, 2002, P NATL ACAD SCI USA, V99, P9840, DOI 10.1073/pnas.152588599; Auld DS, 2003, NEURON, V40, P389, DOI 10.1016/S0896-6273(03)00607-X; Avery J, 2000, J CELL BIOL, V148, P317, DOI 10.1083/jcb.148.2.317; Baker DA, 2002, J NEUROSCI, V22, P9134; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Bernardinelli Y, 2004, P NATL ACAD SCI USA, V101, P14937, DOI 10.1073/pnas.0405315101; Bezzi P, 2004, NAT NEUROSCI, V7, P613, DOI 10.1038/nn1246; Bezzi P, 2001, NAT NEUROSCI, V4, P702, DOI 10.1038/89490; Bezzi P, 1998, NATURE, V391, P281, DOI 10.1038/34651; Bowser DN, 2004, J NEUROSCI, V24, P8606, DOI 10.1523/JNEUROSCI.2660-04.2004; Boyer JL, 1996, MOL PHARMACOL, V50, P1323; Chen XK, 2005, J NEUROSCI, V25, P9236, DOI 10.1523/JNEUROSCI.1640-05.2005; Cheviet S, 2006, J CELL SCI, V119, P2912, DOI 10.1242/jcs.03037; Coco S, 2003, J BIOL CHEM, V278, P1354, DOI 10.1074/jbc.M209454200; Cotrina ML, 1998, P NATL ACAD SCI USA, V95, P15735, DOI 10.1073/pnas.95.26.15735; Crippa D, 2006, J PHYSIOL-LONDON, V570, P567, DOI 10.1113/jphysiol.2005.094052; D'Arcangelo G, 2000, EUR J NEUROSCI, V12, P1241, DOI 10.1046/j.1460-9568.2000.00011.x; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Duan SM, 2003, J NEUROSCI, V23, P1320, DOI 10.1523/JNEUROSCI.23-04-01320.2003; Fam SR, 2003, J NEUROSCI, V23, P4437; Fam SR, 2000, J NEUROSCI, V20, P2800; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Fellin T, 2006, PHYSIOLOGY, V21, P208, DOI 10.1152/physiol.00161.2005; Fiacco TA, 2004, J NEUROSCI, V24, P722, DOI 10.1523/JNEUROSCI.2859-03.2004; Fields RD, 2006, NAT REV NEUROSCI, V7, P423, DOI 10.1038/nrn1928; Franks KM, 2003, J NEUROSCI, V23, P3186; Glavinovic MI, 1999, PFLUG ARCH EUR J PHY, V437, P462, DOI 10.1007/s004240050802; Goddard DR, 2001, GLIA, V34, P267, DOI 10.1002/glia.1060; Gordon GRJ, 2005, NAT NEUROSCI, V8, P1078, DOI 10.1038/nn1498; Gundersen V, 1998, J NEUROSCI, V18, P6059; HO C, 1995, BRIT J PHARMACOL, V116, P2909, DOI 10.1111/j.1476-5381.1995.tb15944.x; Jeremic A, 2001, J NEUROCHEM, V77, P664, DOI 10.1046/j.1471-4159.2001.00272.x; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Kang N, 2004, J NEUROPHYSIOL, V92, P873, DOI 10.1152/jn.01231.2003; Kawamura M, 2004, J NEUROSCI, V24, P10835, DOI 10.1523/JNEUROSCI.3028-04.2004; Khakh BS, 2001, NAT REV NEUROSCI, V2, P165, DOI 10.1038/35058521; KIMELBERG HK, 1990, J NEUROSCI, V10, P1583; Kreft M, 2004, GLIA, V46, P437, DOI 10.1002/glia.20018; Liu QS, 2004, P NATL ACAD SCI USA, V101, P3172, DOI 10.1073/pnas.0306731101; Metea MR, 2006, J NEUROSCI, V26, P2862, DOI 10.1523/JNEUROSCI.4048-05.2006; Montana V, 2004, J NEUROSCI, V24, P2633, DOI 10.1523/JNEUROSCI.3770-03.2004; Moran-Jimenez MJ, 2000, MOL BRAIN RES, V78, P50, DOI 10.1016/S0169-328X(00)00067-X; Mori M, 2001, J PHYSIOL-LONDON, V535, P115, DOI 10.1111/j.1469-7793.2001.t01-1-00115.x; Mothet JP, 2005, P NATL ACAD SCI USA, V102, P5606, DOI 10.1073/pnas.0408483102; Mulligan SJ, 2004, NATURE, V431, P195, DOI 10.1038/nature02827; Newman EA, 2003, J NEUROSCI, V23, P1659, DOI 10.1523/jneurosci.23-05-01659.2003; Newman EA, 2001, J NEUROSCI, V21, P2215, DOI 10.1523/JNEUROSCI.21-07-02215.2001; Newman EA, 1998, J NEUROSCI, V18, P4022; Newman EA, 2003, TRENDS NEUROSCI, V26, P536, DOI 10.1016/S0166-2236(03)00237-6; North RA, 2000, ANNU REV PHARMACOL, V40, P563, DOI 10.1146/annurev.pharmtox.40.1.563; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; Pankratov Y, 1998, EUR J NEUROSCI, V10, P3898, DOI 10.1046/j.1460-9568.1998.00419.x; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Parri HR, 2001, NAT NEUROSCI, V4, P803, DOI 10.1038/90507; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; Pasti L, 2001, J NEUROSCI, V21, P477, DOI 10.1523/JNEUROSCI.21-02-00477.2001; Perea G, 2005, J NEUROSCI, V25, P2192, DOI 10.1523/JNEUROSCI.3965-04.2005; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Ralevic V, 1998, PHARMACOL REV, V50, P413; Rodrigues RJ, 2005, J NEUROSCI, V25, P6286, DOI 10.1523/JNEUROSCI.0628-05.2005; Rossi DJ, 2000, NATURE, V403, P316, DOI 10.1038/35002090; Rouach N, 2000, J CELL BIOL, V149, P1513, DOI 10.1083/jcb.149.7.1513; Sanzgiri RP, 1999, J NEUROBIOL, V41, P221, DOI 10.1002/(SICI)1097-4695(19991105)41:2<221::AID-NEU5>3.3.CO;2-1; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Schipke CG, 2001, FASEB J, V15, P255, DOI 10.1096/fj.01-0514fje; Serrano A, 2006, J NEUROSCI, V26, P5370, DOI 10.1523/JNEUROSCI.5255-05.2006; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Steyer JA, 1997, NATURE, V388, P474, DOI 10.1038/41329; Steyer JA, 2001, NAT REV MOL CELL BIO, V2, P268, DOI 10.1038/35067069; Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200; Suadicani SO, 2006, J NEUROSCI, V26, P1378, DOI 10.1523/JNEUROSCI.3902-05.2006; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Takano T, 2005, P NATL ACAD SCI USA, V102, P16466, DOI 10.1073/pnas.0506382102; Tian GF, 2005, NAT MED, V11, P973, DOI 10.1038/nm1277; Tsuboi T, 2000, CURR BIOL, V10, P1307, DOI 10.1016/S0960-9822(00)00756-9; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; VOLTERRA A, 2002, TRIPATITE SYNAPSE GL; Wang XH, 2004, NAT MED, V10, P821, DOI 10.1038/nm1082; Yang YL, 2003, P NATL ACAD SCI USA, V100, P15194, DOI 10.1073/pnas.2431073100; Ye ZC, 2003, J NEUROSCI, V23, P3588, DOI 10.1523/jneurosci.23-09-03588.2003; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500; Zhang JM, 2003, NEURON, V40, P971, DOI 10.1016/S0896-6273(03)00717-7; Zhang Q, 2004, J BIOL CHEM, V279, P12724, DOI 10.1074/jbc.M312845200; Zhang Q, 2004, P NATL ACAD SCI USA, V101, P9441, DOI 10.1073/pnas.0401960101; Zhou Q, 2000, J PHYSIOL-LONDON, V525, P195, DOI 10.1111/j.1469-7793.2000.t01-1-00195.x; Zonta M, 2003, J PHYSIOL-LONDON, V553, P407, DOI 10.1113/jphysiol.2003.046706; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	93	166	171	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30684	30696		10.1074/jbc.M606429200	http://dx.doi.org/10.1074/jbc.M606429200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16882655	hybrid			2022-12-27	WOS:000241075900045
J	Singh, RD; Liu, YD; Wheatley, CL; Holicky, EL; Makino, A; Marks, DL; Kobayashi, T; Subramaniam, G; Bittman, R; Pagano, RE				Singh, Raman Deep; Liu, Yidong; Wheatley, Christine L.; Holicky, Eileen L.; Makino, Asami; Marks, David L.; Kobayashi, Toshihide; Subramaniam, Gopal; Bittman, Robert; Pagano, Richard E.			Caveolar endocytosis and microdomain association of a glycosphingolipid analog is dependent on its sphingosine stereochemistry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; CHOLERA-TOXIN; SPECTRAL PROPERTIES; GOLGI-APPARATUS; LIPID RAFTS; INTERNALIZATION; TRANSPORT; SPHINGOLIPIDS; SPHINGOMYELIN; VESICLES	We have previously shown that glycosphingolipid analogs are internalized primarily via caveolae in various cell types. This selective internalization was not dependent on particular carbohydrate headgroups or sphingosine chain length. Here, we examine the role of sphingosine structure in the endocytosis of BODIPY (TM)-tagged lactosylceramide ( LacCer) analogs via caveolae. We found that whereas the LacCer analog with the natural (D-erythro) sphingosine stereochemistry is internalized mainly via caveolae, the non-natural (L-threo) LacCer analog is taken up via clathrin-, RhoA-, and Cdc42-dependent mechanisms and largely excluded from uptake via caveolae. Unlike the D-erythro-LacCer analog, the L-threo analog did not cluster in membrane microdomains when added at higher concentrations (5-20 mu M). In vitro studies using small unilamellar vesicles and giant unilamellar vesicles demonstrated that L-threo-LacCer did not undergo a concentration-dependent excimer shift in fluorescence emission such as that seen with BODIPY (TM)-sphingolipids with natural stereochemistry. Molecular modeling studies suggest that in D-erythro-LacCer, the disaccharide moiety extends above and in the same plane as the sphingosine hydrocarbon chain, while in L-threo-LacCer the carbohydrate group is nearly perpendicular to the hydrocarbon chain. Together, these results suggest that the altered stereochemistry of the sphingosine group in L-threo-LacCer results in a perturbed structure, which is unable to pack closely with natural membrane lipids, leading to a reduced inclusion in plasma membrane microdomains and decreased uptake by caveolar endocytosis. These findings demonstrate the importance of the sphingolipid stereochemistry in the formation of membrane microdomains.	Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; CUNY Queens Coll, Dept Chem & Biochem, Flushing, NY 11367 USA; RIKEN Frontier Res Syst, Wako, Saitama 3510198, Japan	Mayo Clinic; City University of New York (CUNY) System; Queens College NY (CUNY); RIKEN	Pagano, RE (corresponding author), Mayo Clin, Coll Med, Dept Biochem & Mol Biol, 200 1st St,SW, Rochester, MN 55905 USA.	pagano.richard@mayo.edu	KOBAYASHI, TOSHIHIDE/S-8313-2019; Takhter, Ramandeep/AAG-8977-2019; Kobayashi, Toshihide/B-6298-2015	KOBAYASHI, TOSHIHIDE/0000-0002-4811-7270; Kobayashi, Toshihide/0000-0002-4811-7270; Takhter, Ramandeep/0000-0002-1441-2722	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R24HL083187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022942, R37GM022942] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-083187] Funding Source: Medline; NIGMS NIH HHS [GM-22942] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aktories K, 2000, BIOL CHEM, V381, P421, DOI 10.1515/BC.2000.054; ALLINGER NL, 1977, J AM CHEM SOC, V99, P8127, DOI 10.1021/ja00467a001; AMVAMZOLLO PH, 1986, CARBOHYD RES, V150, P199, DOI 10.1016/0008-6215(86)80016-7; BITTMAN R, 1994, BIOCHEMISTRY-US, V33, P11776, DOI 10.1021/bi00205a013; Chen CS, 1997, BIOPHYS J, V72, P37, DOI 10.1016/S0006-3495(97)78645-4; Cheng ZJ, 2006, MOL BIOL CELL, V17, P3197, DOI 10.1091/mbc.E05-12-1101; Cheng ZJ, 2006, MOL MEMBR BIOL, V23, P101, DOI 10.1080/09687860500460041; He LL, 1999, J ORG CHEM, V64, P6049, DOI 10.1021/jo9906375; HEHRE W, 2003, GUIDE MOL MECH QUANT, P343; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Ishitsuka R, 2004, BIOPHYS J, V86, P296, DOI 10.1016/S0006-3495(04)74105-3; Kirkham M, 2005, J CELL BIOL, V168, P465, DOI 10.1083/jcb.200407078; KOVAL M, 1989, J CELL BIOL, V108, P2169, DOI 10.1083/jcb.108.6.2169; KREMER JMH, 1977, BIOCHEMISTRY-US, V16, P3932, DOI 10.1021/bi00636a033; Lencer WI, 1999, BBA-MOL CELL RES, V1450, P177, DOI 10.1016/S0167-4889(99)00070-1; Liu YD, 2006, CHEM PHYS LIPIDS, V142, P58, DOI 10.1016/j.chemphyslip.2006.03.001; London E, 2005, BBA-MOL CELL RES, V1746, P203, DOI 10.1016/j.bbamcr.2005.09.002; MARTIN OC, 1994, J CELL BIOL, V125, P769, DOI 10.1083/jcb.125.4.769; Masserini M, 2001, BBA-MOL CELL BIOL L, V1532, P149, DOI 10.1016/S1388-1981(01)00128-7; Mineo C, 2001, HISTOCHEM CELL BIOL, V116, P109; Nichols BJ, 2003, CURR BIOL, V13, P686, DOI 10.1016/S0960-9822(03)00209-4; Norkin LC, 1999, IMMUNOL REV, V168, P13, DOI 10.1111/j.1600-065X.1999.tb01279.x; Oh P, 1998, J CELL BIOL, V141, P101, DOI 10.1083/jcb.141.1.101; Orlandi PA, 1998, J CELL BIOL, V141, P905, DOI 10.1083/jcb.141.4.905; PAGANO RE, 1991, J CELL BIOL, V113, P1267, DOI 10.1083/jcb.113.6.1267; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Pelkmans L, 2002, TRAFFIC, V3, P311, DOI 10.1034/j.1600-0854.2002.30501.x; PIETRO WJ, 1982, J AM CHEM SOC, V104, P5039, DOI 10.1021/ja00383a007; PULAY P, 1982, J COMPUT CHEM, V3, P556, DOI 10.1002/jcc.540030413; Puri V, 2001, J CELL BIOL, V154, P535, DOI 10.1083/jcb.200102084; Rajendran L, 2005, J CELL SCI, V118, P1099, DOI 10.1242/jcs.01681; Rietveld A, 1998, BBA-REV BIOMEMBRANES, V1376, P467, DOI 10.1016/S0304-4157(98)00019-7; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; SCHNITZER JE, 1994, J CELL BIOL, V127, P1217, DOI 10.1083/jcb.127.5.1217; Sharma DK, 2005, CANCER RES, V65, P8233, DOI 10.1158/0008-5472.CAN-05-0803; Sharma DK, 2003, J BIOL CHEM, V278, P7564, DOI 10.1074/jbc.M210457200; Sharma DK, 2004, MOL BIOL CELL, V15, P3114, DOI 10.1091/mbc.E04-03-0189; Singh RD, 2003, MOL BIOL CELL, V14, P3254, DOI 10.1091/mbc.E02-12-0809; Torgersen ML, 2001, J CELL SCI, V114, P3737; Wang TY, 2000, BIOPHYS J, V79, P1478, DOI 10.1016/S0006-3495(00)76399-5	41	45	46	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30660	30668		10.1074/jbc.M606194200	http://dx.doi.org/10.1074/jbc.M606194200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16893900	hybrid			2022-12-27	WOS:000241075900042
J	Schoeber, JP; Topala, CN; Wang, XH; Diepens, RJ; Lambers, TT; Hoenderop, JG; Bindels, RJ				Schoeber, Joost P.; Topala, Catalin N.; Wang, Xinhua; Diepens, Robin J.; Lambers, Tim T.; Hoenderop, Joost G.; Bindels, Rene J.			RGS2 inhibits the epithelial Ca2+ channel TRPV6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3RD-INTRACELLULAR LOOP; CALCIUM-ABSORPTION; INTRACELLULAR LOOP; PLASMA-MEMBRANE; ANKYRIN REPEAT; G-PROTEINS; EXPRESSION; ARCHITECTURE; FAMILY; KIDNEY	The epithelial Ca2+ channels TRPV5 and TRPV6 constitute the apical Ca2+ entry pathway in the process of active Ca2+ (re)absorption. By yeast two-hybrid and glutathione S-transferase pulldown analysis we identified RGS2 as a novel TRPV6-associated protein. RGS proteins determine the inactivation kinetics of heterotrimeric G-protein-coupled receptor (GPCR) signaling by regulating the GTPase activity of G(alpha) subunits. Here we demonstrate that TRPV6 interacts with the NH2-terminal domain of RGS2 in a Ca2+-independent fashion and that overexpression of RGS2 reduces the Na+ and Ca2+ current of TRPV6 but not that of TRPV5-transfected human embryonic kidney 293 (HEK293) cells. In contrast, overexpression of the deletion mutant Delta N-RGS2, lacking the NH2-terminal domain of RGS2, in TRPV6-expressing HEK293 cells did not show this inhibition. Furthermore, cell surface biotinylation indicated that the inhibitory effect of RGS2 on TRPV6 activity is not mediated by differences in trafficking or retrieval of TRPV6 from the plasma membrane. This effect probably results from the direct interaction between RGS2 and TRPV6, affecting the gating properties of the channel. Finally, the scaffolding protein spinophilin, shown to recruit RGS2 and regulate GPCR-signaling via G(alpha), did not affect RGS2 binding and electrophysiological properties of TRPV6, indicating a GPCR-independent mechanism of TRPV6 regulation by RGS2.	Radboud Univ Nijmegen, Med Ctr, Dept Physiol, Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands; Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA	Radboud University Nijmegen; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Bindels, RJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Physiol, Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands.	R.Bindels@ncmls.ru.nl	Bindels, René JM/B-9824-2013; Hoenderop, Joost G.J./H-8047-2014	Bindels, René JM/0000-0003-1167-1339; Hoenderop, Joost G.J./0000-0002-1816-8544				Abramow-Newerly M, 2006, CELL SIGNAL, V18, P579, DOI 10.1016/j.cellsig.2005.08.010; Bernstein LS, 2004, J BIOL CHEM, V279, P21248, DOI 10.1074/jbc.M312407200; Birnbaumer L, 2003, CELL CALCIUM, V33, P419, DOI 10.1016/S0143-4160(03)00068-X; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; den Dekker E, 2003, CELL CALCIUM, V33, P497, DOI 10.1016/S0143-4160(03)00065-4; Erler I, 2004, J BIOL CHEM, V279, P34456, DOI 10.1074/jbc.M404778200; Hague C, 2005, J BIOL CHEM, V280, P27289, DOI 10.1074/jbc.M502365200; Heximer SP, 2001, J BIOL CHEM, V276, P14195, DOI 10.1074/jbc.M009942200; Hoenderop JGJ, 2005, PHYSIOL REV, V85, P373, DOI 10.1152/physrev.00003.2004; Hoenderop JGJ, 2001, J PHYSIOL-LONDON, V537, P747; Kehrl JH, 2002, INT J BIOCHEM CELL B, V34, P432, DOI 10.1016/S1357-2725(01)00141-8; Lambers TT, 2004, J BIOL CHEM, V279, P28855, DOI 10.1074/jbc.M313637200; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Montell C, 2003, CELL CALCIUM, V33, P409, DOI 10.1016/S0143-4160(03)00053-8; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Nijenhuis T, 2003, J AM SOC NEPHROL, V14, P2731, DOI 10.1097/01.ASN.0000094081.78893.E8; Nilius B, 2002, J BIOL CHEM, V277, P30852, DOI 10.1074/jbc.M202418200; Pedersen SF, 2005, CELL CALCIUM, V38, P233, DOI 10.1016/j.ceca.2005.06.028; Peng JB, 1999, J BIOL CHEM, V274, P22739, DOI 10.1074/jbc.274.32.22739; Putney JW, 2003, CELL CALCIUM, V34, P339, DOI 10.1016/S0143-4160(03)00143-X; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Roy AA, 2003, MOL PHARMACOL, V64, P587, DOI 10.1124/mol.64.3.587; Van Abel M, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000022423.34922.2A; van de Graaf SFJ, 2006, MOL CELL BIOL, V26, P303, DOI 10.1128/MCB.26.1.303-312.2006; Van de Graaf SFJ, 2003, EMBO J, V22, P1478, DOI 10.1093/emboj/cdg162; van de Graaf SFJ, 2006, PFLUG ARCH EUR J PHY, V452, P407, DOI 10.1007/s00424-006-0051-z; Vennekens R, 2000, J BIOL CHEM, V275, P3963, DOI 10.1074/jbc.275.6.3963; Voets T, 2004, J BIOL CHEM, V279, P15223, DOI 10.1074/jbc.M312076200; Voets T, 2003, J GEN PHYSIOL, V121, P245, DOI 10.1085/jgp.20028752; Wang XH, 2005, NAT CELL BIOL, V7, P405, DOI 10.1038/ncb1237; Wissenbach U, 2001, J BIOL CHEM, V276, P19461, DOI 10.1074/jbc.M009895200	33	36	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					29669	29674		10.1074/jbc.M606233200	http://dx.doi.org/10.1074/jbc.M606233200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16895908	Green Published, hybrid			2022-12-27	WOS:000240896300028
J	Yan, ZY; Lei-Butters, DCM; Liu, XM; Zhang, YL; Zhang, L; Luo, MH; Zak, R; Engelhardt, JF				Yan, Ziying; Lei-Butters, Diana C. M.; Liu, Xiaoming; Zhang, Yulong; Zhang, Liang; Luo, Meihui; Zak, Roman; Engelhardt, John F.			Unique biologic properties of recombinant AAV1 transduction in polarized human airway epithelia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOASSOCIATED VIRUS TYPE-2; PROTEASOME-MODULATING AGENTS; CYSTIC-FIBROSIS; GENE-TRANSFER; INTRACELLULAR TRAFFICKING; EFFICIENT TRANSDUCTION; MURINE FIBROBLASTS; MAXILLARY SINUS; APICAL SURFACES; VIRAL VECTORS	The choice of adeno- associated virus serotypes for clinical applications is influenced by the animal model and model system used to evaluate various serotypes. In the present study, we sought to compare the biologic properties of rAAV2/ 1, rAAV2/ 2, and rAAV2/ 5 transduction in polarized human airway epithelia using viruses purified by a newly developed common column chromatography method. Results demonstrated that apical transduction of human airway epithelia with rAAV2/ 1 was 100- fold more efficient than rAAV2/ 2 and rAAV2/ 5. This transduction profile in human airway epithelia ( rAAV2/ 1 >> rAAV2/ 2 = rAAV2/ 5) was significantly different from that seen following nasal administration of these vectors to mouse lung ( rAAV2/ 5 > rAAV2/ 1 >> rAAV2/ 2), emphasizing differences in transduction of these serotypes between these two species. In stark contrast to rAAV2/ 2 and rAAV2/ 5, rAAV2/ 1 transduced both the apical and basolateral membraneofhumanairway epithelia with similar efficiency. However, the overall level of transduction across serotypes did not correlate with vector internalization. We hypothesized that differences in post-entry processing of these serotypes might influence the efficiency of apical transduction. To this end, we tested the effectiveness of proteasome inhibitors to augment nuclear translocation and gene expression from the three serotypes. Augmentation of rAAV2/ 1 apical transduction of human polarized airway epithelia was 10- fold lower than that for rAAV2/ 2 and rAAV2/ 5. Cellular fractionation studies demonstrated that proteasome inhibitors more significantly enhanced rAAV2/ 2 and rAAV2/ 5 translocation to the nucleus than rAAV2/ 1. These results demonstrate that AAV1 transduction biology in human airway epithelia differs from that ofAAV2andAAV5by virtue of altered ubiquitin/ proteasome sensitivities that influence nuclear translocation.	Univ Iowa, Coll Med, Dept Anat & Cell Biol, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Ctr Gene Therapy Cyst Fibrosis & Other Genet Dis, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa	Engelhardt, JF (corresponding author), Univ Iowa, Coll Med, Dept Anat & Cell Biol, Rm 1 111 BSB,51 Newton Rd, Iowa City, IA 52242 USA.	john-engelhardt@uiowa.edu		LIU, XIAOMING/0000-0002-3902-9105; ZHANG, Liang/0000-0003-3100-8593; Yan, Ziying/0000-0001-8210-5567; Engelhardt, John/0000-0003-2389-9277	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL058340, R01 HL58340] Funding Source: Medline; NIDDK NIH HHS [P30 DK054759, DK54759] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aitken ML, 2001, HUM GENE THER, V12, P1907, DOI 10.1089/104303401753153956; Auricchio A, 2002, J CLIN INVEST, V110, P499, DOI 10.1172/JCI200215780; BERNS KI, 1996, CURRENT TOPICS MICRO, V218; BLACKLOW N R, 1988, P165; Ding W, 2006, MOL THER, V13, P671, DOI 10.1016/j.ymthe.2005.12.002; Ding W, 2003, J VIROL, V77, P7361, DOI 10.1128/JVI.77.13.7361-7366.2003; Ding W, 2005, GENE THER, V12, P873, DOI 10.1038/sj.gt.3302527; Douar AM, 2001, J VIROL, V75, P1824, DOI 10.1128/JVI.75.4.1824-1833.2001; Duan DS, 2000, J CLIN INVEST, V105, P1573, DOI 10.1172/JCI8317; Duan DS, 1998, HUM GENE THER, V9, P2761, DOI 10.1089/hum.1998.9.18-2761; Flotte TR, 2005, CURR GENE THER, V5, P361, DOI 10.2174/1566523054064986; Gao GP, 2005, CURR GENE THER, V5, P285, DOI 10.2174/1566523054065057; Grimm D., 2003, Current Gene Therapy, V3, P281, DOI 10.2174/1566523034578285; Halbert CL, 2001, J VIROL, V75, P6615, DOI 10.1128/JVI.75.14.6615-6624.2001; Hansen J, 2000, J VIROL, V74, P992, DOI 10.1128/JVI.74.2.992-996.2000; Hansen J, 2001, J VIROL, V75, P4080, DOI 10.1128/JVI.75.9.4080-4090.2001; Karp Philip H, 2002, Methods Mol Biol, V188, P115; Liu XM, 2006, AM J RESP CELL MOL, V34, P56, DOI 10.1165/rcmb.2005-0189OC; Louboutin JP, 2005, J GENE MED, V7, P442, DOI 10.1002/jgm.686; Mori S, 2004, VIROLOGY, V330, P375, DOI 10.1016/j.virol.2004.10.012; Qing K, 1999, NAT MED, V5, P71, DOI 10.1038/4758; Romano G, 2005, DRUG NEWS PERSPECT, V18, P311, DOI 10.1358/dnp.2005.18.5.917326; Srivastava A, 2002, J CELL BIOCHEM, P39, DOI 10.1002/jcb.10053; Summerford C, 1999, NAT MED, V5, P78, DOI 10.1038/4768; Summerford C, 1998, J VIROL, V72, P1438, DOI 10.1128/JVI.72.2.1438-1445.1998; Thomas CE, 2004, J VIROL, V78, P3110, DOI 10.1128/JVI.78.6.3110-3122.2004; Virella-Lowell I, 2005, J GENE MED, V7, P842, DOI 10.1002/jgm.759; Wagner JA, 2002, HUM GENE THER, V13, P1349, DOI 10.1089/104303402760128577; Wagner JA, 1998, HUM GENE THER, V9, P889, DOI 10.1089/hum.1998.9.6-889; Wagner JA, 1999, LARYNGOSCOPE, V109, P266, DOI 10.1097/00005537-199902000-00017; Walters RW, 2001, J BIOL CHEM, V276, P20610, DOI 10.1074/jbc.M101559200; Xiao W, 2002, J VIROL, V76, P11505, DOI 10.1128/JVI.76.22.11505-11517.2002; Yan ZY, 2002, J VIROL, V76, P2043, DOI 10.1128/JVI.76.5.2043-2053.2002; Yan ZY, 2004, J VIROL, V78, P2863, DOI 10.1128/JVI.78.6.2863-2874.2004; Zabner J, 2000, J VIROL, V74, P3852, DOI 10.1128/JVI.74.8.3852-3858.2000; Zhang LN, 2004, MOL THER, V10, P990, DOI 10.1016/j.ymthe.2004.08.009; Zhong L, 2004, HUM GENE THER, V15, P1207, DOI 10.1089/hum.2004.15.1207; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938	38	37	52	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					29684	29692		10.1074/jbc.M604099200	http://dx.doi.org/10.1074/jbc.M604099200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16899463	Green Accepted, hybrid			2022-12-27	WOS:000240896300030
J	Dorfman, T; Moore, MJ; Guth, AC; Choe, H; Farzan, M				Dorfman, Tatyana; Moore, Michael J.; Guth, Alexander C.; Choe, Hyeryun; Farzan, Michael			A tyrosine-sulfated peptide derived from the heavy-chain CDR3 region of an HIV-1-neutralizing antibody binds gp120 and inhibits HIV-1 infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; AMINO-TERMINAL DOMAIN; CHEMOKINE RECEPTORS; ENVELOPE GLYCOPROTEIN; CORECEPTOR USAGE; DISTINCT CCR5; N-TERMINUS; ENTRY; MACROPHAGE; RESIDUES	Sulfated tyrosines at the amino terminus of the principal HIV-1 coreceptor CCR5 play a critical role in its ability to bind the HIV-1 envelope glycoprotein gp120 and mediate HIV-1 entry. Human antibodies that recognize the CCR5-binding region of gp120 are also modified by tyrosine sulfation, which is necessary for their ability to neutralize HIV-1. Here we demonstrate that a sulfated peptide derived from the CDR3 region of one of these antibodies, E51, can efficiently bind gp120. Association of this peptide, pE51, with gp120 requires tyrosine sulfation and is enhanced by, but not dependent on, CD4. Alteration of any of four pE51 tyrosines, or alteration of gp120 residues 420, 421, or 422, critical for association with CCR5, prevents gp120 association with pE51. pE51 neutralizes HIV-1 more effectively than peptides based on the CCR5 amino terminus and may be useful as a fusion partner with other protein inhibitors of HIV-1 entry. Our data provide further insight into the association of the CCR5 amino terminus with gp120, show that a conserved, sulfate-binding region of gp120 is accessible to inhibitors in the absence of CD4, and suggest that soluble mimetics of CCR5 can be more effective than previously appreciated.	Harvard Univ, New England Reg Primate Res Ctr, Sch Med, Dept Microbiol & Mol Genet, Southborough, MA 01772 USA; Harvard Univ, Sch Med, Childrens Hosp, Div Pulm, Boston, MA 02115 USA	Harvard University; Harvard University; Boston Children's Hospital; Harvard Medical School	Farzan, M (corresponding author), Harvard Univ, New England Reg Primate Res Ctr, Sch Med, Dept Microbiol & Mol Genet, 1 Pine Hill Dr, Southborough, MA 01772 USA.	farzan@hms.harvard.edu		Farzan, Michael/0000-0002-2990-5319	NIAID NIH HHS [R01 AI043891] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043891] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Atchison RE, 1996, SCIENCE, V274, P1924, DOI 10.1126/science.274.5294.1924; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Berger EA, 1998, NATURE, V391, P240, DOI 10.1038/34571; Blanpain C, 1999, J BIOL CHEM, V274, P34719, DOI 10.1074/jbc.274.49.34719; Bleul CC, 1997, P NATL ACAD SCI USA, V94, P1925, DOI 10.1073/pnas.94.5.1925; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Choe H, 2003, CELL, V114, P161, DOI 10.1016/S0092-8674(03)00508-7; COLLMAN R, 1992, J VIROL, V66, P7517, DOI 10.1128/JVI.66.12.7517-7521.1992; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; Cormier EG, 2000, P NATL ACAD SCI USA, V97, P5762, DOI 10.1073/pnas.97.11.5762; Cormier EG, 2001, J VIROL, V75, P5541, DOI 10.1128/JVI.75.12.5541-5549.2001; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8; Doranz BJ, 1997, J VIROL, V71, P6305, DOI 10.1128/JVI.71.9.6305-6314.1997; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Dragic T, 1998, J VIROL, V72, P279, DOI 10.1128/JVI.72.1.279-285.1998; EARL PL, 1990, P NATL ACAD SCI USA, V87, P648, DOI 10.1073/pnas.87.2.648; Farzan M, 2000, J BIOL CHEM, V275, P33516, DOI 10.1074/jbc.M007228200; Farzan M, 1999, CELL, V96, P667, DOI 10.1016/S0092-8674(00)80577-2; Farzan M, 2002, J BIOL CHEM, V277, P29484, DOI 10.1074/jbc.M203361200; Farzan M, 2002, J BIOL CHEM, V277, P40397, DOI 10.1074/jbc.M206784200; Farzan M, 1997, J BIOL CHEM, V272, P6854, DOI 10.1074/jbc.272.11.6854; Farzan M, 2001, J EXP MED, V193, P1059, DOI 10.1084/jem.193.9.1059; Farzan M, 1998, J VIROL, V72, P1160, DOI 10.1128/JVI.72.2.1160-1164.1998; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Huang CC, 2004, P NATL ACAD SCI USA, V101, P2706, DOI 10.1073/pnas.0308527100; Lu ZH, 1997, P NATL ACAD SCI USA, V94, P6426, DOI 10.1073/pnas.94.12.6426; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Picard L, 1997, VIROLOGY, V231, P105, DOI 10.1006/viro.1997.8506; Poignard P, 2001, ANNU REV IMMUNOL, V19, P253, DOI 10.1146/annurev.immunol.19.1.253; Rabut GEE, 1998, J VIROL, V72, P3464, DOI 10.1128/JVI.72.4.3464-3468.1998; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; ROBEN P, 1994, J VIROL, V68, P4821, DOI 10.1128/JVI.68.8.4821-4828.1994; Ross TM, 1998, J VIROL, V72, P1918, DOI 10.1128/JVI.72.3.1918-1924.1998; Rucker J, 1996, CELL, V87, P437, DOI 10.1016/S0092-8674(00)81364-1; Sullivan N, 1998, J VIROL, V72, P4694, DOI 10.1128/JVI.72.6.4694-4703.1998; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	42	54	62	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					28529	28535		10.1074/jbc.M602732200	http://dx.doi.org/10.1074/jbc.M602732200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16849323	hybrid			2022-12-27	WOS:000240680500006
J	HuangFu, WC; Omori, E; Akira, S; Matsumoto, K; Ninomiya-Tsuji, J				HuangFu, Wei-Chun; Omori, Emily; Akira, Shizuo; Matsumoto, Kunihiro; Ninomiya-Tsuji, Jun			Osmotic stress activates the TAK1-JNK pathway while blocking TAK1-mediated NF-kappa B activation - TAO2 regulates TAK1 pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAP KINASE PATHWAYS; PROTEIN-KINASE; SIGNAL-TRANSDUCTION; JNK; COMPLEX; TAB1; APOPTOSIS; ASK1; CASPASE-2; NECROSIS	Osmotic stress activates MAPKs, including JNK and p38, which play important roles in cellular stress responses. Transforming growth factor-beta-activated kinase 1 (TAK1) is a member of the MAPK kinase kinase ( MAPKKK) family and can activate JNK and p38. TAK1 can also activate I kappa B kinase (IKK) that leads to degradation of I kappa B and subsequent NF-kappa B activation. We found that TAK1 is essential for osmotic stress-induced activation of JNK but is not an exclusive mediator of p38 activation. Furthermore, we found that although TAK1 was highly activated upon osmotic stress, it could not induce degradation of I kappa B or activation of NF-kappa B. These results suggest that TAK1 activity is somehow modulated to function specifically in osmotic stress signaling, leading to the activation of JNK but not of IKK. To elucidate the mechanism underlying this modulation, we screened for potential TAK1-binding proteins. We found that TAO2 (thousand-and-one amino acid kinase 2) associates with TAK1 and can inhibit TAK1-mediated activation of NF-kappa B but not of JNK. We observed that TAO2 can interfere with the interaction between TAK1 and IKK and thus may regulate TAK1 function. TAK1 is activated by many distinct stimuli, including cytokines and stresses, and regulation by TAO2 may be important to activate specific intracellular signaling pathways that are unique to osmotic stress.	N Carolina State Univ, Dept Environm & Mol Toxicol, Raleigh, NC 27695 USA; Nagoya Univ, Grad Sch Sci, Dept Biol Mol, Nagoya, Aichi 4648602, Japan; Osaka Univ, Res Inst Microbial Dis, Dept Host Def, Osaka 5650871, Japan; Japan Sci & Technol Agcy, Kawaguchi 3320012, Japan	University of North Carolina; North Carolina State University; Nagoya University; Osaka University; Japan Science & Technology Agency (JST)	Ninomiya-Tsuji, J (corresponding author), N Carolina State Univ, Dept Environm & Mol Toxicol, Campus Box 7633, Raleigh, NC 27695 USA.	Jun_Tsuji@ncsu.edu	Akira, Shizuo/C-3134-2009	Ninomiya-Tsuji, Jun/0000-0002-5584-0176	NIAMS NIH HHS [R21 AR050972, AR050972] Funding Source: Medline; NIGMS NIH HHS [R01 GM068812, GM068812] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR050972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068812] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chen W, 2002, J BIOL CHEM, V277, P49105, DOI 10.1074/jbc.M204934200; Chen Z, 2003, J BIOL CHEM, V278, P22278, DOI 10.1074/jbc.M301173200; Chen Z, 2001, J BIOL CHEM, V276, P16070, DOI 10.1074/jbc.M100681200; Chen Z, 1999, J BIOL CHEM, V274, P28803, DOI 10.1074/jbc.274.40.28803; Cheung PCF, 2003, EMBO J, V22, P5793, DOI 10.1093/emboj/cdg552; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hutchison M, 1998, J BIOL CHEM, V273, P28625, DOI 10.1074/jbc.273.44.28625; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Janssens S, 2005, CELL, V123, P1079, DOI 10.1016/j.cell.2005.09.036; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kishida S, 2005, GENES CELLS, V10, P447, DOI 10.1111/j.1365-2443.2005.00852.x; Kishimoto K, 2000, J BIOL CHEM, V275, P7359, DOI 10.1074/jbc.275.10.7359; Mochida Y, 2000, J BIOL CHEM, V275, P32747, DOI 10.1074/jbc.M003042200; Moore TM, 2000, J BIOL CHEM, V275, P4311, DOI 10.1074/jbc.275.6.4311; Nakano H, 2006, CELL DEATH DIFFER, V13, P730, DOI 10.1038/sj.cdd.4401830; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Omori E, 2006, J BIOL CHEM, V281, P19610, DOI 10.1074/jbc.M603384200; Ono K, 2001, J BIOL CHEM, V276, P24396, DOI 10.1074/jbc.M102631200; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Read SH, 2002, J CELL BIOL, V159, P739, DOI 10.1083/jcb.200209004; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Sheikh-Hamad D, 2004, AM J PHYSIOL-RENAL, V287, pF1102, DOI 10.1152/ajprenal.00225.2004; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Shirakabe K, 1997, J BIOL CHEM, V272, P8141, DOI 10.1074/jbc.272.13.8141; Singhirunnusorn P, 2005, J BIOL CHEM, V280, P7359, DOI 10.1074/jbc.M407537200; Takaesu G, 2003, J MOL BIOL, V326, P105, DOI 10.1016/S0022-2836(02)01404-3; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Takaesu G, 2001, MOL CELL BIOL, V21, P2475, DOI 10.1128/MCB.21.7.2475-2484.2001; Tinel A, 2004, SCIENCE, V304, P843, DOI 10.1126/science.1095432; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Uemura N, 2006, J BIOL CHEM, V281, P7863, DOI 10.1074/jbc.M509834200; Varfolomeev EE, 2004, CELL, V116, P491, DOI 10.1016/S0092-8674(04)00166-7; Ventura JJ, 2004, GENE DEV, V18, P2905, DOI 10.1101/gad.1223004; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556	39	49	54	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					28802	28810		10.1074/jbc.M603627200	http://dx.doi.org/10.1074/jbc.M603627200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16893890	hybrid, Green Accepted			2022-12-27	WOS:000240680500034
J	Shenton, D; Smirnova, JB; Selley, JN; Carroll, K; Hubbard, SJ; Pavitt, GD; Ashe, MP; Grant, CM				Shenton, Daniel; Smirnova, Julia B.; Selley, Julian N.; Carroll, Kathleen; Hubbard, Simon J.; Pavitt, Graham D.; Ashe, Mark P.; Grant, Chris M.			Global translational responses to oxidative stress impact upon multiple levels of protein synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA TRANSLATION; GENE-EXPRESSION; YEAST-CELLS; ACID; GLUTATHIONE; ELONGATION; INITIATION; HYDROPEROXIDE; RESISTANCE; EIF2	Global inhibition of protein synthesis is a common response to stress conditions. We have analyzed the regulation of protein synthesis in response to oxidative stress induced by exposure to H2O2 in the yeast Saccharomyces cerevisiae. Our data show that H2O2 causes an inhibition of translation initiation dependent on the Gcn2 protein kinase, which phosphorylates the alpha-subunit of eukaryotic initiation factor-2. Additionally, our data indicate that translation is regulated in a Gcn2-independent manner because protein synthesis was still inhibited in response to H2O2 in a gcn2 mutant. Polysome analysis indicated that H2O2 causes a slower rate of ribosomal runoff, consistent with an inhibitory effect on translation elongation or termination. Furthermore, analysis of ribosomal transit times indicated that oxidative stress increases the average mRNA transit time, confirming a post-initiation inhibition of translation. Using microarray analysis of polysome- and monosome-associated mRNA pools, we demonstrate that certain mRNAs, including mRNAs encoding stress protective molecules, increase in association with ribosomes following H2O2 stress. For some candidate mRNAs, we show that a low concentration of H2O2 results in increased protein production. In contrast, a high concentration of H2O2 promotes polyribosome association but does not necessarily lead to increased protein production. We suggest that these mRNAs may represent an mRNA store that could become rapidly activated following relief of the stress condition. In summary, oxidative stress elicits complex translational reprogramming that is fundamental for adaptation to the stress.	Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Grant, CM (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	chris.grant@manchester.ac.uk	Pavitt, Graham D/A-1363-2010; Hubbard, Simon J/B-9006-2009	Pavitt, Graham D/0000-0002-8593-2418; Cain, Kathleen/0000-0002-1446-5170; Grant, Chris/0000-0002-0616-6576; Selley, Julian/0000-0003-4618-6691; Hubbard, Simon/0000-0002-8601-9524	Biotechnology and Biological Sciences Research Council [C20436] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Ashe MP, 2000, MOL BIOL CELL, V11, P833, DOI 10.1091/mbc.11.3.833; Avery AM, 2001, J BIOL CHEM, V276, P33730, DOI 10.1074/jbc.M105672200; Ayala A, 1996, J BIOL CHEM, V271, P23105, DOI 10.1074/jbc.271.38.23105; Beilharz Traude H., 2004, Briefings in Functional Genomics & Proteomics, V3, P103, DOI 10.1093/bfgp/3.2.103; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Cherkasova VA, 2003, GENE DEV, V17, P859, DOI 10.1101/gad.1069003; Clemens MJ, 2001, PROG MOLEC, V27, P57; Decottignies A, 1997, NAT GENET, V15, P137, DOI 10.1038/ng0297-137; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Ding QX, 2005, J NEUROSCI, V25, P9171, DOI 10.1523/JNEUROSCI.3040-05.2005; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gasch Audrey P, 2002, Funct Integr Genomics, V2, P181, DOI 10.1007/s10142-002-0058-2; Grant CM, 1996, CURR GENET, V29, P511, DOI 10.1007/BF02426954; Grant CM, 1997, FEBS LETT, V410, P219, DOI 10.1016/S0014-5793(97)00592-9; GUTTERIDGE JMC, 1993, FREE RADICAL RES COM, V19, P141, DOI 10.3109/10715769309111598; HALLIWELL B, 1991, AM J MED S3C, V91, P14, DOI DOI 10.1016/0002-9343(91)90279-7; Halliwell B, 1989, FREE RADICALS BIOL M, VUK; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; HINNEBUSCH AG, 1994, TRENDS BIOCHEM SCI, V19, P409, DOI 10.1016/0968-0004(94)90089-2; Holmes LEA, 2004, MOL CELL BIOL, V24, P2998, DOI 10.1128/MCB.24.7.2998-3010.2004; Honda K, 2005, J BIOL CHEM, V280, P20978, DOI 10.1074/jbc.M500526200; Izawa S, 1996, BIOCHEM J, V320, P61, DOI 10.1042/bj3200061; Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; LUCCHINI G, 1984, MOL CELL BIOL, V4, P1326, DOI 10.1128/MCB.4.7.1326; MATHEWS MB, 2000, MONOGRAPH, V39, P1; Narasimhan J, 2004, J BIOL CHEM, V279, P22820, DOI 10.1074/jbc.M402228200; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; NIELSEN PJ, 1980, J CELL PHYSIOL, V104, P269, DOI 10.1002/jcp.1041040302; Patel J, 2002, EUR J BIOCHEM, V269, P3076, DOI 10.1046/j.1432-1033.2002.02992.x; Pavitt GD, 1998, GENE DEV, V12, P514, DOI 10.1101/gad.12.4.514; Pohl A, 2005, BBA-MOL CELL BIOL L, V1733, P29, DOI 10.1016/j.bbalip.2004.12.007; Poljak A, 2003, REDOX REP, V8, P371, DOI 10.1179/135100003225003401; Preiss T, 2003, NAT STRUCT BIOL, V10, P1039, DOI 10.1038/nsb1015; Proud C, 2000, COLD SPRING HARBOR M, V39, P719; Proud CG, 2005, SEMIN CELL DEV BIOL, V16, P3, DOI 10.1016/j.semcdb.2004.11.004; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; ROPER MD, 1978, P NATL ACAD SCI USA, V75, P140, DOI 10.1073/pnas.75.1.140; Rudra D, 2004, GENE DEV, V18, P2431, DOI 10.1101/gad.1256704; Rutherford JC, 2003, J BIOL CHEM, V278, P27636, DOI 10.1074/jbc.M300076200; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Shenton D, 2003, BIOCHEM J, V374, P513, DOI 10.1042/BJ20030414; Sherman F., 1974, METHODS YEAST GENETI; Smirnova JB, 2005, MOL CELL BIOL, V25, P9340, DOI 10.1128/MCB.25.21.9340-9349.2005; Srinivasan C, 2000, J BIOL CHEM, V275, P29187, DOI 10.1074/jbc.M004239200; Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2; TAKAHASHI R, 1990, ARCH BIOCHEM BIOPHYS, V277, P228, DOI 10.1016/0003-9861(90)90573-H; Tanaka T, 2005, J BIOL CHEM, V280, P42078, DOI 10.1074/jbc.M508622200; Temple MD, 2005, TRENDS CELL BIOL, V15, P319, DOI 10.1016/j.tcb.2005.04.003; Tuite MF, 1998, METHOD MICROBIOL, V26, P351; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; YamaguchiIwai Y, 1996, EMBO J, V15, P3377, DOI 10.1002/j.1460-2075.1996.tb00703.x	58	298	301	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					29011	29021		10.1074/jbc.M601545200	http://dx.doi.org/10.1074/jbc.M601545200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16849329	hybrid			2022-12-27	WOS:000240680500056
J	Erdogan, E; Lamark, T; Stallings-Mann, M; Jamieson, L; Pellechia, M; Thompson, EA; Johansen, T; Fields, AP				Erdogan, Eda; Lamark, Trond; Stallings-Mann, Melody; Jamieson, Lee; Pellechia, Mauricio; Thompson, E. Aubrey; Johansen, Terje; Fields, Alan P.			Aurothiomalate inhibits transformed growth by targeting the PB1 domain of protein kinase C iota	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CELL-POLARITY; ATYPICAL PKC; PAR6; ZETA; LINKS; ACTIVATION; COMPLEX; DNA; OVEREXPRESSION	We recently identified the gold compound aurothiomalate (ATM) as a potent inhibitor of the Phox and Bem1p (PB1)-PB1 domain interaction between protein kinase C (PKC) iota and the adaptor molecule Par6. ATM also blocks oncogenic PKC iota signaling and the transformed growth of human lung cancer cells. Here we demonstrate that ATM is a highly selective inhibitor of PB1-PB1 domain interactions between PKC iota and the two adaptors Par6 and p62. ATM has no appreciable inhibitory effect on other PB1-PB1 domain interactions, including p62-p62, p62-NBR1, and MEKK3-MEK5 interactions. ATM can form thio-gold adducts with cysteine residues on target proteins. Interestingly, PKC iota (and PKC zeta) contains a unique cysteine residue, Cys-69, within its PB1 domain that is not present in other PB1 domain containing proteins. Cys-69 resides within the OPR, PC, and AID motif of PKC iota at the binding interface between PKC iota and Par6 where it interacts with Arg-28 on Par6. Molecular modeling predicts formation of a cysteinyl-aurothiomalate adduct at Cys-69 that protrudes into the binding cleft normally occupied by Par6, providing a plausible structural explanation for ATM inhibition. Mutation of Cys-69 of PKC iota to isoleucine or valine, residues frequently found at this position in other PB1 domains, has little or no effect on the affinity of PKC iota for Par6 but confers resistance to ATM-mediated inhibition of Par6 binding. Expression of the PKC iota C69I mutant in human non-small cell lung cancer cells confers resistance to the inhibitory effects of ATM on transformed growth. We conclude that ATM inhibits cellular transformation by selectively targeting Cys-69 within the PB1 domain of PKC iota.	Mayo Clin, Coll Med, Dept Canc Biol, Jacksonville, FL 32224 USA; Univ Tromso, Inst Med Biol, Dept Biochem, N-9037 Tromso, Norway; Burnham Inst, La Jolla, CA 92037 USA	Mayo Clinic; UiT The Arctic University of Tromso; Sanford Burnham Prebys Medical Discovery Institute	Fields, AP (corresponding author), Mayo Clin, Coll Med, Dept Canc Biol, 4500 San Pablo Rd,Griffin Canc Res Bldg,312, Jacksonville, FL 32224 USA.	fields.alan@mayo.edu	Johansen, Terje/N-2971-2015; Johansen, Terje/AAY-1753-2021	Johansen, Terje/0000-0003-1451-9578; Johansen, Terje/0000-0003-1451-9578; Stallings-Mann, Melody/0000-0003-3227-6063; Lamark, Trond/0000-0001-6338-3342				Balsara BR, 1997, CANCER RES, V57, P2116; Brass N, 1997, CANCER RES, V57, P2290; Bratt J, 2000, CLIN EXP IMMUNOL, V120, P79, DOI 10.1046/j.1365-2249.2000.01190.x; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Dong LQ, 1999, J BIOL CHEM, V274, P8117, DOI 10.1074/jbc.274.12.8117; Eder AM, 2005, P NATL ACAD SCI USA, V102, P12519, DOI 10.1073/pnas.0505641102; Erdogan E, 2005, MOL BIOTECHNOL, V30, P21, DOI 10.1385/MB:30:1:021; Etienne-Manneville S, 2003, CURR OPIN CELL BIOL, V15, P67, DOI 10.1016/S0955-0674(02)00005-4; Grunicke HH, 2003, ADV ENZYME REGUL, V43, P213, DOI 10.1016/S0065-2571(02)00032-8; Hirano Y, 2005, J BIOL CHEM, V280, P9653, DOI 10.1074/jbc.M409823200; Jamieson L, 1999, J BIOL CHEM, V274, P3927, DOI 10.1074/jbc.274.7.3927; Jeon KI, 2000, J IMMUNOL, V164, P5981, DOI 10.4049/jimmunol.164.11.5981; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Martasek P, 1996, BIOCHEM BIOPH RES CO, V219, P359, DOI 10.1006/bbrc.1996.0238; Moscat J, 2000, EMBO REP, V1, P399, DOI 10.1093/embo-reports/kvd098; Moscat J, 2001, ADV ENZYME REGUL, V41, P99, DOI 10.1016/S0065-2571(00)00009-1; Murray NR, 1997, J BIOL CHEM, V272, P27521, DOI 10.1074/jbc.272.44.27521; Murray NR, 2004, J CELL BIOL, V164, P797, DOI 10.1083/jcb.200311011; NAKANISHI H, 1993, J BIOL CHEM, V268, P13; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; Noda Y, 2001, GENES CELLS, V6, P107, DOI 10.1046/j.1365-2443.2001.00404.x; ONO Y, 1989, P NATL ACAD SCI USA, V86, P3099, DOI 10.1073/pnas.86.9.3099; Puls A, 1997, P NATL ACAD SCI USA, V94, P6191, DOI 10.1073/pnas.94.12.6191; Qiu RG, 2000, CURR BIOL, V10, P697, DOI 10.1016/S0960-9822(00)00535-2; Regala RP, 2005, CANCER RES, V65, P8905, DOI 10.1158/0008-5472.CAN-05-2372; Regala RP, 2005, J BIOL CHEM, V280, P31109, DOI 10.1074/jbc.M505402200; Rigobello MP, 2004, J INORG BIOCHEM, V98, P1634, DOI 10.1016/j.jinorgbio.2004.04.020; Sakurai A, 2004, J CELL PHYSIOL, V198, P22, DOI 10.1002/jcp.10377; Sanchez P, 1998, MOL CELL BIOL, V18, P3069, DOI 10.1128/MCB.18.5.3069; Sanz L, 1999, EMBO J, V18, P3044, DOI 10.1093/emboj/18.11.3044; Smith AD, 1999, J NUTR, V129, P194, DOI 10.1093/jn/129.1.194; Stallings-Mann M, 2006, CANCER RES, V66, P1767, DOI 10.1158/0008-5472.CAN-05-3405; Suzuki A, 2003, J BIOCHEM, V133, P9, DOI 10.1093/jb/mvg018; Suzuki A, 2001, J CELL BIOL, V152, P1183, DOI 10.1083/jcb.152.6.1183; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Wilson MI, 2003, MOL CELL, V12, P39, DOI 10.1016/S1097-2765(03)00246-6; Wooten MW, 2001, J BIOL CHEM, V276, P7709, DOI 10.1074/jbc.C000869200; Yamashita M, 2003, J PHARM PHARMACOL, V55, P245, DOI 10.1211/002235702513; YANG JP, 1995, FEBS LETT, V361, P89, DOI 10.1016/0014-5793(95)00157-5; Zhang L, 2006, CANCER RES, V66, P4627, DOI 10.1158/0008-5472.CAN-05-4527	43	88	93	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					28450	28459		10.1074/jbc.M606054200	http://dx.doi.org/10.1074/jbc.M606054200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16861740	hybrid			2022-12-27	WOS:000240534400082
J	Wessels, E; Notebaart, RA; Duijsings, D; Lanke, K; Vergeer, B; Melchers, WJG; van Kuppeveld, FJM				Wessels, Els; Notebaart, Richard A.; Duijsings, Daniel; Lanke, Kjerstin; Vergeer, Bart; Melchers, Willem J. G.; van Kuppeveld, Frank J. M.			Structure-function analysis of the coxsackievirus protein 3A - Identification of residues important for dimerization, viral RNA replication, and transport inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE 3D(POL); HYDROPHOBIC DOMAIN; POLIOVIRUS; SECRETION; 2B; STIMULATION; DISSECTION; BINDING; GENOME	The coxsackievirus B3 3A protein forms homodimers and plays important roles in both viral RNA (vRNA) replication and the viral inhibition of intracellular protein transport. The molecular determinants that are required for each of these functions are yet poorly understood. Based on the NMR structure of the closely related poliovirus 3A protein, a molecular model of the coxsackievirus B3 3A protein was constructed. Using this structural model, specific mutants were designed to study the structure-function relationship of 3A. The mutants were tested for their capacity to dimerize, support vRNA replication, and block protein transport. A hydrophobic interaction between the monomers and an intermolecular salt bridge were identified as major determinants required for dimerization. We show that dimerization is important for both efficient vRNA replication and inhibition of protein transport. In addition, determinants were identified that were not required for dimerization but that were essential for either one of the biological functions of 3A. The combination of the in silico and in vivo results obtained in this study provides important insights in both the structural and functional aspects of 3A.	Univ Nijmegen, Radboud Med Ctr, Dept Med Microbiol, NL-6500 HB Nijmegen, Netherlands; Univ Nijmegen, Ctr Mol & Biomol Informat, NL-6500 GL Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	van Kuppeveld, FJM (corresponding author), Univ Nijmegen, Radboud Med Ctr, Dept Med Microbiol, POB 9101, NL-6500 HB Nijmegen, Netherlands.	f.vankuppeveld@ncmls.ru.nl	Melchers, Willem/C-8819-2015; Notebaart, Richard/A-1459-2014	Melchers, Willem/0000-0002-5446-2230; van Kuppeveld, Frank/0000-0001-5800-749X; Duijsings, Daniel/0000-0001-5434-9038				BERNSTEIN HD, 1986, J VIROL, V60, P1040, DOI 10.1128/JVI.60.3.1040-1049.1986; CHINEA G, 1995, PROTEINS, V23, P415, DOI 10.1002/prot.340230315; Choe SS, 2005, VIROLOGY, V337, P18, DOI 10.1016/j.virol.2005.03.036; de Jong AS, 2002, J GEN VIROL, V83, P783, DOI 10.1099/0022-1317-83-4-783; Deitz SB, 2000, P NATL ACAD SCI USA, V97, P13790, DOI 10.1073/pnas.250483097; Dodd DA, 2001, J VIROL, V75, P8158, DOI 10.1128/JVI.75.17.8158-8165.2001; Doedens JR, 1997, J VIROL, V71, P9054, DOI 10.1128/JVI.71.12.9054-9064.1997; DOEDENS JR, 1995, EMBO J, V14, P894, DOI 10.1002/j.1460-2075.1995.tb07071.x; GIACHETTI C, 1992, J VIROL, V66, P6045, DOI 10.1128/JVI.66.10.6045-6057.1992; HARRIS KS, 1994, J BIOL CHEM, V269, P27004; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Hope DA, 1997, J VIROL, V71, P9490, DOI 10.1128/JVI.71.12.9490-9498.1997; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; LAMA J, 1994, J BIOL CHEM, V269, P66; Lyle JM, 2002, SCIENCE, V296, P2218, DOI 10.1126/science.1070585; MOLLA A, 1994, J BIOL CHEM, V269, P27015; Neznanov N, 2001, J VIROL, V75, P10409, DOI 10.1128/JVI.75.21.10409-10420.2001; Paul AV, 1998, NATURE, V393, P280, DOI 10.1038/30529; PAUL AV, 1994, J BIOL CHEM, V269, P29173; PORTER AG, 1993, J VIROL, V67, P6917, DOI 10.1128/JVI.67.12.6917-6921.1993; Strauss DM, 2003, J MOL BIOL, V330, P225, DOI 10.1016/S0022-2836(03)00577-1; Towner JS, 1996, J BIOL CHEM, V271, P26810, DOI 10.1074/jbc.271.43.26810; van Ooij MJM, 2006, J GEN VIROL, V87, P103, DOI 10.1099/vir.0.81297-0; van Ooij MJM, 2006, J GEN VIROL, V87, P689, DOI 10.1099/vir.0.81558-0; VANKUPPEVELD FJM, 1995, J VIROL, V69, P7782, DOI 10.1128/JVI.69.12.7782-7790.1995; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wessels E, 2005, J VIROL, V79, P5163, DOI 10.1128/JVI.79.8.5163-5173.2005; WIMMER E, 1993, ANNU REV GENET, V27, P353, DOI 10.1146/annurev.ge.27.120193.002033; Xiang WK, 1995, RNA, V1, P892	29	29	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					28232	28243		10.1074/jbc.M601122200	http://dx.doi.org/10.1074/jbc.M601122200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16867984	hybrid, Green Published			2022-12-27	WOS:000240534400061
J	Pizzo, E; Buonanno, P; Di Maro, A; Ponticelli, S; De Falco, S; Quarto, N; Cubellis, MV; D'Alessio, G				Pizzo, Elio; Buonanno, Pasquale; Di Maro, Antimo; Ponticelli, Salvatore; De Falco, Sandro; Quarto, Natalina; Cubellis, Maria Vittoria; D'Alessio, Giuseppe			Ribonucleases and angiogenins from fish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-CELLS; A SUPERFAMILY; INHIBITOR; RECOGNITION; PROTEINS; SEQUENCE; EMBRYO	For the first time fish RNases have been isolated and characterized. Their functional and structural properties indicate that they belong to the RNase A superfamily (or tetrapod RNase superfamily), now more appropriately described as the vertebrate RNase superfamily. Our findings suggest why previously repeated efforts to isolate RNases from fish tissues have met with no success; fish RNases have a very low ribonucleolytic activity, and their genes have a low sequence identity with those of mammalian RNases. The investigated RNases are from the bony fish Danio rerio ( or zebrafish). Their cDNAs have been cloned and expressed, and the three recombinant proteins have been purified to homogeneity. Their characterization has revealed that they have indeed a very low RNA-degrading activity, when compared with that of RNase A, the superfamily prototype, but comparable with that of mammalian angiogenins; that two of them have angiogenic activity that is inhibited by the cytosolic RNase inhibitor. These data and a phylogenetic analysis indicate that angiogenic fish RNases are the earliest diverging members of the vertebrate superfamily, suggesting that ribonucleases with angiogenic activity were the ancestors of all ribonucleases in the superfamily. They later evolved into both mammalian angiogenins and, through a successful phylogenesis, RNases endowed with digestive features or with diverse bioactivities.	Univ Naples Federico II, Dept Struct & Funct Biol, I-80126 Naples, Italy; Univ Naples 2, Dept Life Sci, I-81100 Caserta, Italy; CNR, Inst Genet & Biophys A Buzzati Traverso, I-80131 Naples, Italy	University of Naples Federico II; Universita della Campania Vanvitelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR)	D'Alessio, G (corresponding author), Univ Naples Federico II, Dept Struct & Funct Biol, Complesso MS Angelo,Via Cintia, I-80126 Naples, Italy.	dalessio@unina.it	De Falco, Sandro/P-6724-2015; Pizzo, Elio/Q-4722-2017	Pizzo, Elio/0000-0002-3652-8865; Di Maro, Antimo/0000-0002-9595-9665; cubellis, maria vittoria/0000-0001-6147-6553; De Falco, Sandro/0000-0002-6501-1697; Buonanno, Pasquale/0000-0001-7933-6209				Adams S A, 1999, Angiogenesis, V3, P189, DOI 10.1023/A:1009015512200; Beintema J.J., 1997, RIBONUCLEASES STRUCT, P245; Beintema JJ, 1998, CELL MOL LIFE SCI, V54, P825, DOI 10.1007/s000180050211; BLANK A, 1982, ANAL BIOCHEM, V120, P267, DOI 10.1016/0003-2697(82)90347-5; Childs S, 2002, DEVELOPMENT, V129, P973; Cho S, 2005, GENOMICS, V85, P208, DOI 10.1016/j.ygeno.2004.10.008; Cubellis MV, 2005, PROTEINS, V58, P880, DOI 10.1002/prot.20327; D'Alessio G., 1997, RIBONUCLEASES STRUCT, P383; D'Alessio Giuseppe, 1993, Trends in Cell Biology, V3, P106, DOI 10.1016/0962-8924(93)90166-X; Dickson KA, 2005, PROG NUCLEIC ACID RE, V80, P349, DOI 10.1016/S0079-6603(05)80009-1; Hofsteenge J., 1997, RIBONUCLEASES STRUCT, P621, DOI [10.1016/b978-012588945-2/50020-0, DOI 10.1016/B978-012588945-2/50020-0]; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; Hu GF, 1997, P NATL ACAD SCI USA, V94, P2204, DOI 10.1073/pnas.94.6.2204; KANZAWA S, 1993, ANN PLAS SURG, V30, P244, DOI 10.1097/00000637-199303000-00008; Kelemen BR, 1999, NUCLEIC ACIDS RES, V27, P3696, DOI 10.1093/nar/27.18.3696; KNIGHTON D, 1977, BRIT J CANCER, V35, P347, DOI 10.1038/bjc.1977.49; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; LAEMMLI UK, 1973, J MOL BIOL, V80, P575, DOI 10.1016/0022-2836(73)90198-8; LAWLEY TJ, 1989, J INVEST DERMATOL, V93, pS59, DOI 10.1111/1523-1747.ep12581070; LEE FS, 1993, PROG NUCLEIC ACID RE, V44, P1, DOI 10.1016/S0079-6603(08)60215-9; MELO F, 1997, P INT C INTELL SYST, V5, P187; MOROIANU J, 1994, BIOCHEMISTRY-US, V33, P12535, DOI 10.1021/bi00208a001; Papageorgiou AC, 1997, EMBO J, V16, P5162, DOI 10.1093/emboj/16.17.5162; RIORDAN JF, 1997, RIBONUCLEASES STRUCT, P446; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Serbedzija G N, 1999, Angiogenesis, V3, P353, DOI 10.1023/A:1026598300052; SHAPIRO R, 1987, P NATL ACAD SCI USA, V86, P1573; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Staton CA, 2004, INT J EXP PATHOL, V85, P233, DOI 10.1111/j.0959-9673.2004.00396.x; Strydom DJ, 1998, CELL MOL LIFE SCI, V54, P811, DOI 10.1007/s000180050210; WU YN, 1995, J BIOL CHEM, V270, P17476, DOI 10.1074/jbc.270.29.17476; Xu ZP, 2003, BIOCHEMISTRY-US, V42, P121, DOI 10.1021/bi020465x	32	34	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2006	281	37					27454	27460		10.1074/jbc.M605505200	http://dx.doi.org/10.1074/jbc.M605505200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082PB	16861230	hybrid			2022-12-27	WOS:000240397700072
J	Poulalhon, N; Farge, D; Roos, N; Tacheau, C; Neuzillet, C; Michel, L; Mauviel, A; Verrecchia, F				Poulalhon, Nicolas; Farge, Dominique; Roos, Nina; Tacheau, Charlotte; Neuzillet, Cindy; Michel, Laurence; Mauviel, Alain; Verrecchia, Franck			Modulation of collagen and MMP-1 gene expression in fibroblasts by the immunosuppressive drug rapamycin - A direct role as an antifibrotic agent?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; DIFFERENTIAL REGULATION; AMINO-ACID; TRANSCRIPTION; DISTINCT; ALPHA; FIBRONECTIN; ACTIVATION; INDUCTION; SIROLIMUS	We have examined whether rapamycin, an immunosuppressive drug, may exert part of its antifibrotic activity by directly targeting fibroblast extracellular matrix deposition. Incubation of human lung fibroblast (WI-26) cultures with rapamycin led to dose-and time-dependent reduction in the expression of types I and III collagens, both at the protein and mRNA levels. Rapamycin had no effect on collagen promoter activity but accelerated mRNA decay, indicating post-transcriptional control of collagen gene expression. In contrast, rapamycin significantly enhanced the expression of interstitial collagenase (MMP-1) at the protein and mRNA levels and transcriptionally. We determined that rapamycin efficiently activates AP-1-driven transcription by rapidly inducing c-jun/AP-1 phosphorylation with activation of the c-Jun N-terminal kinase (JNK) cascade, resulting in enhanced binding of AP-1(.)DNA complex formation and AP-1-dependent gene transactivation. Conversely, the JNK inhibitor SP600125 inhibited rapamycin-induced MMP-1 gene transactivation and AP-1/DNA interactions. A c-jun antisense expression vector efficiently prevented rapamycin-induced MMP-1 gene transcription. Pharmacological inhibition of either ERK or p38 MAPK pathways was without effect on rapamycin-induced MMP-1 gene expression. It thus appears that rapamycin may exert direct antifibrotic activities independent from its immunosuppressive action.	Hop St Louis, INSERM, U697, F-75010 Paris, France; Hop St Louis, Serv Med Interne, F-75010 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Verrecchia, F (corresponding author), Hop St Louis, INSERM, U697, Pavillon Bazin,1 Ave Claude Vellefaux, F-75010 Paris, France.	franck.verrecchia@stlouis.inserm.fr	MAUVIEL, Alain/F-6251-2013; Verrecchia, Franck/G-5535-2018; Michel, Laurence/E-8605-2017; NEUZILLET, Cindy/K-1378-2017	Verrecchia, Franck/0000-0003-4920-2554; Mauviel, Alain/0000-0002-0438-2793; NEUZILLET, Cindy/0000-0001-7037-7477				ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Asano Y, 2005, ARTHRITIS RHEUM-US, V52, P1237, DOI 10.1002/art.20934; Biecker E, 2004, LIVER INT, V24, P345, DOI 10.1111/j.1478-3231.2004.0933.x; BOAST S, 1990, J BIOL CHEM, V265, P13351; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Cardenas M E, 1995, Curr Opin Nephrol Hypertens, V4, P472, DOI 10.1097/00041552-199511000-00002; Chen SJ, 1998, GENE, V215, P101, DOI 10.1016/S0378-1119(98)00268-6; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; Eckes B, 1996, BIOCHEM J, V315, P549, DOI 10.1042/bj3150549; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Huang S, 2003, MOL CELL, V11, P1491, DOI 10.1016/S1097-2765(03)00180-1; Jaeschke A, 2003, CURR TOP MICROBIOL, V279, P283; Kahan BD, 1998, TRANSPLANTATION, V66, P1040, DOI 10.1097/00007890-199810270-00013; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; KRUPSKY M, 1994, BBA-GENE STRUCT EXPR, V1219, P335, DOI 10.1016/0167-4781(94)90057-4; Krupsky M, 1997, J BIOL CHEM, V272, P13864, DOI 10.1074/jbc.272.21.13864; MAUVIEL A, 1993, CURR BIOL, V3, P822, DOI 10.1016/0960-9822(93)90216-B; Mauviel A, 1996, J BIOL CHEM, V271, P10917, DOI 10.1074/jbc.271.18.10917; MAUVIEL A, 1993, J CELL BIOCHEM, V53, P288, DOI 10.1002/jcb.240530404; Minden A., 1997, BIOCHIM BIOPHYS ACTA, V1333, P85, DOI DOI 10.1016/S0304-419X(97)00018-8; MUDRYJ M, 1988, NUCLEIC ACIDS RES, V16, P7513, DOI 10.1093/nar/16.15.7513; Peng T, 2002, MOL CELL BIOL, V22, P5575, DOI 10.1128/MCB.22.15.5575-5584.2002; Pridohl O, 2001, TRANSPLANT P, V33, P3229, DOI 10.1016/S0041-1345(01)02373-9; SCHORPP M, 1995, BIOCHEM J, V308, P211, DOI 10.1042/bj3080211; Schuck S, 2003, BMC MOL BIOL, V4, DOI 10.1186/1471-2199-4-6; Sehgal S N, 1995, Curr Opin Nephrol Hypertens, V4, P482, DOI 10.1097/00041552-199511000-00004; Shegogue D, 2004, J BIOL CHEM, V279, P23166, DOI 10.1074/jbc.M401238200; Simler NR, 2002, EUR RESPIR J, V19, P1124, DOI 10.1183/09031936.02.00281602; Uitto J, 2000, J DERMATOL SCI, V24, pS60, DOI 10.1016/S0923-1811(00)00143-2; VARGA J, 1987, BIOCHEM BIOPH RES CO, V147, P1282, DOI 10.1016/S0006-291X(87)80209-7; Verrecchia F, 2000, J BIOL CHEM, V275, P30226, DOI 10.1074/jbc.M005310200; Verrecchia F, 2004, CELL SIGNAL, V16, P873, DOI 10.1016/j.cellsig.2004.02.007; Verrecchia F, 2003, J BIOL CHEM, V278, P1585, DOI 10.1074/jbc.M206927200; Verrecchia F, 2002, EMBO REP, V3, P1069, DOI 10.1093/embo-reports/kvf219; Verrecchia F, 2002, J INVEST DERMATOL, V118, P211, DOI 10.1046/j.1523-1747.2002.01641.x; Verrecchia Franck, 2002, Curr Rheumatol Rep, V4, P143, DOI 10.1007/s11926-002-0010-4; Webster AC, 2006, TRANSPLANTATION, V81, P1234, DOI 10.1097/01.tp.0000219703.39149.85; Wendling J, 2003, MOL PHARMACOL, V64, P707, DOI 10.1124/mol.64.3.707; Zhu JL, 1999, GASTROENTEROLOGY, V117, P1198, DOI 10.1016/S0016-5085(99)70406-3	39	68	73	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33045	33052		10.1074/jbc.M606366200	http://dx.doi.org/10.1074/jbc.M606366200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16914544	hybrid			2022-12-27	WOS:000241621400013
J	Lu, HL; Krementsova, EB; Trybus, KM				Lu, Hailong; Krementsova, Elena B.; Trybus, Kathleen M.			Regulation of myosin V processivity by calcium at the single molecule level	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNCONVENTIONAL MYOSIN; CALMODULIN; DOMAIN; ACTIN; MOTOR	Calcium can affect myosin V (myoV) function in at least two ways. The full-length molecule, which adopts a folded inhibited conformation in EGTA, becomes extended and active in the presence of calcium. Calcium also dissociates one or more calmodulin molecules from the extended neck. Here we investigated at the single molecule level how calcium regulates the processive run length of full-length myosin V (dFull) and a truncated dimeric construct (dHMM), which cannot adopt the folded conformation. The processivity of dFull and dHMM is tightly controlled by the calcium and calmodulin concentration, with shorter runs occurring at higher calcium concentration. The data indicate that a calcium-dependent dissociation of calmodulin from the neck region of myoV terminates its processive run. dFull showed unexpected processive movement in EGTA, suggesting that a small population of extended, active molecules are in equilibrium with the inhibited, folded form. Single turnover assays showed that the ATPase activity of the folded full-length molecule is inhibited by more than 50-fold compared with the extended molecule. The results imply that activation and termination of the processive runs of myoV can be accomplished by multiple mechanisms.	Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA	University of Vermont	Trybus, KM (corresponding author), Univ Vermont, Dept Mol Physiol & Biophys, 149 Beaumont Ave, Burlington, VT 05405 USA.	trybus@uvm.edu	lu, hailong/C-7754-2009		NHLBI NIH HHS [HL38113] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038113, R29HL038113] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baker JE, 2004, P NATL ACAD SCI USA, V101, P5542, DOI 10.1073/pnas.0307247101; BURGER D, 1983, J BIOL CHEM, V258, P4733; CHENEY RE, 1993, CELL, V75, P13, DOI 10.1016/0092-8674(93)90675-G; COX JA, 1988, BIOCHEM J, V249, P621, DOI 10.1042/bj2490621; Forkey JN, 2003, NATURE, V422, P399, DOI 10.1038/nature01529; Krementsov DN, 2004, J CELL BIOL, V164, P877, DOI 10.1083/jcb.200310065; Krementsova EB, 2006, J BIOL CHEM, V281, P6079, DOI 10.1074/jbc.M510041200; Li XD, 2004, BIOCHEM BIOPH RES CO, V315, P538, DOI 10.1016/j.bbrc.2004.01.084; Liu J, 2006, NATURE, V442, P208, DOI 10.1038/nature04719; Martin SR, 2004, FEBS LETT, V567, P166, DOI 10.1016/j.febslet.2004.04.053; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Nascimento AAC, 1996, J BIOL CHEM, V271, P17561, DOI 10.1074/jbc.271.29.17561; Nguyen H, 2005, NAT STRUCT MOL BIOL, V12, P127, DOI 10.1038/nsmb894; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Sakamoto T, 2000, BIOCHEM BIOPH RES CO, V272, P586, DOI 10.1006/bbrc.2000.2819; Trybus KM, 2005, NAT CELL BIOL, V7, P854, DOI 10.1038/ncb0905-854; Trybus KM, 1999, J BIOL CHEM, V274, P27448, DOI 10.1074/jbc.274.39.27448; Wang F, 2004, J BIOL CHEM, V279, P2333, DOI 10.1074/jbc.C300488200; Watanabe M, 2005, MOL BIOL CELL, V16, P4519, DOI 10.1091/mbc.E05-03-0252; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	21	41	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31987	31994		10.1074/jbc.M605181200	http://dx.doi.org/10.1074/jbc.M605181200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16920704	Bronze			2022-12-27	WOS:000241235300084
J	Chen, Q; Yang, YY; Li, L; Zhang, JT				Chen, Qun; Yang, Youyun; Li, Lang; Zhang, Jian-Ting			The amino terminus of the human multidrug resistance transporter ABCC1 has a U-shaped folding with a gating function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE TOPOLOGY; LEUKOTRIENE C-4; PROTEIN MRP1; GLYCOSYLATION; REGIONS; BINDING; DOMAINS; CANCER	Multidrug resistance is a serious problem in successful cancer chemotherapy. Studies using model cell lines have demonstrated that overexpression of some members of the ATP-binding cassette (ABC) transporter superfamily, such as ABCC1, causes enhanced efflux and, thus, decreased accumulation of multiple anticancer drugs, which leads to increased cell survival. Unlike most other ABC transporters, ABCC1 has an additional membrane-spanning domain (MSD0) with a putative extracellular amino terminus of 32 amino acids. However, the function of MSD0 and the role of the extracellular amino terminus are largely unknown. In this study, we examined the structural folding and the function of the amino terminus. We found that it has a U-shaped folding with the bottom of the U-structure facing cytoplasm and both ends in extracellular space. We also found that this U-shaped amino terminus probably functions as a gate to regulate the drug transport activity of human ABCC1.	Indiana Univ, Sch Med, IUCC, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Div Biostat, Dept Med, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Walther Oncol Ctr, Walther Canc Inst, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Walther Cancer Institute	Zhang, JT (corresponding author), Indiana Univ, Sch Med, IUCC, Dept Pharmacol & Toxicol, 1044 W Walnut St,R4-166, Indianapolis, IN 46202 USA.	jianzhan@iupui.edu	Zhang, Jian-Ting/L-8334-2015		NATIONAL CANCER INSTITUTE [R01CA094961, R01CA120221] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007910] Funding Source: NIH RePORTER; NCI NIH HHS [CA94961, CA120221] Funding Source: Medline; NHLBI NIH HHS [T32 HL07910] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bakos E, 1996, J BIOL CHEM, V271, P12322, DOI 10.1074/jbc.271.21.12322; Bakos E, 2000, J CELL SCI, V113, P4451; Bakos E, 1998, J BIOL CHEM, V273, P32167, DOI 10.1074/jbc.273.48.32167; Chen Q, 2002, BIOCHEMISTRY-US, V41, P9052, DOI 10.1021/bi025634s; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; CHOU PY, 1979, BIOPHYS J, V26, P367, DOI 10.1016/S0006-3495(79)85259-5; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Dean M, 2005, ANNU REV GENOM HUM G, V6, P123, DOI 10.1146/annurev.genom.6.080604.162122; Gao M, 1998, J BIOL CHEM, V273, P10733, DOI 10.1074/jbc.273.17.10733; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Han B., 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P31, DOI 10.2174/1568011043482205; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Hipfner DR, 1997, J BIOL CHEM, V272, P23623, DOI 10.1074/jbc.272.38.23623; Karwatsky J, 2003, BIOCHEMISTRY-US, V42, P3286, DOI 10.1021/bi0268807; Kast C, 1997, J BIOL CHEM, V272, P26479, DOI 10.1074/jbc.272.42.26479; Krishnamurthy P, 2006, ANNU REV PHARMACOL, V46, P381, DOI 10.1146/annurev.pharmtox.46.120604.141238; Kruh GD, 2003, ONCOGENE, V22, P7537, DOI 10.1038/sj.onc.1206953; Lee SH, 2003, BIOCHEM J, V370, P357, DOI 10.1042/BJ20021452; Leslie EM, 2005, TOXICOL APPL PHARM, V204, P216, DOI 10.1016/j.taap.2004.10.012; LING V, 1997, CANC CHEMOTHER PHA S, V40, P3; Muller M, 2002, BIOCHEMISTRY-US, V41, P10123, DOI 10.1021/bi026075s; Westlake CJ, 2005, MOL BIOL CELL, V16, P2483, DOI 10.1091/mbc.E04-12-1113; Yang YY, 2002, J BIOL CHEM, V277, P44268, DOI 10.1074/jbc.M207003200; Zhang JT, 2000, BIOCHEM J, V348, P597, DOI 10.1042/0264-6021:3480597	24	20	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					31152	31163		10.1074/jbc.M603529200	http://dx.doi.org/10.1074/jbc.M603529200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16914551	hybrid			2022-12-27	WOS:000241075900090
J	Hu, YL; Fay, AW; Schmid, B; Makar, B; Ribbe, MW				Hu, Yilin; Fay, Aaron W.; Schmid, Benedikt; Makar, Beshoie; Ribbe, Markus W.			Molecular insights into nitrogenase FeMoco insertion - TRP-444 of MoFe protein alpha-subunit locks FeMoco in its binding site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-MOLYBDENUM COFACTOR; STRUCTURAL BASIS; BIOSYNTHESIS; MECHANISM; CLUSTERS; MUTANT	Biosynthesis of the FeMo cofactor (FeMoco) of nitrogenase MoFe protein is arguably one of the most complex processes in metalloprotein biochemistry. Here we investigate the role of a MoFe protein residue (Trp-alpha 444) in the final step of FeMoco assembly, which involves the insertion of FeMoco into its binding site. Mutations of this aromatic residue to small uncharged ones result in significantly decreased levels of FeMoco insertion/retention and drastically reduced activities of MoFe proteins, suggesting that Trp-alpha 444 may lock the FeMoco tightly in its binding site through the sterically restricting effect of its bulky, aromatic side chain. Additionally, these mutations cause partial conversion of the P-cluster to a more open conformation, indicating a potential connection between FeMoco insertion and P-cluster assembly. Our results provide some of the initial molecular insights into the FeMoco insertion process and, moreover, have useful implications for the overall scheme of nitrogenase assembly.	Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; Univ Erlangen Nurnberg, Dept Biotechnol, D-91052 Erlangen, Germany	University of California System; University of California Irvine; University of Erlangen Nuremberg	Ribbe, MW (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA.	mribbe@uci.edu			NIGMS NIH HHS [GM-67626] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067626] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Blanchard CZ, 1996, BIOCHEMISTRY-US, V35, P472, DOI 10.1021/bi951429j; Burgess BK, 1996, CHEM REV, V96, P2983, DOI 10.1021/cr950055x; BURGESS BK, 1980, BIOCHIM BIOPHYS ACTA, V614, P196, DOI 10.1016/0005-2744(80)90180-1; Bursey EH, 1998, J BIOL CHEM, V273, P16927, DOI 10.1074/jbc.273.27.16927; Bursey EH, 1998, J BIOL CHEM, V273, P29678, DOI 10.1074/jbc.273.45.29678; Christiansen J, 2001, ANNU REV PLANT PHYS, V52, P269, DOI 10.1146/annurev.arplant.52.1.269; Christiansen J, 1998, BIOCHEMISTRY-US, V37, P12611, DOI 10.1021/bi981165b; CLARK LJ, 1955, ANAL CHEM, V27, P2000, DOI 10.1021/ac60108a046; Corbett MC, 2006, P NATL ACAD SCI USA, V103, P1238, DOI 10.1073/pnas.0507853103; Corbett MC, 2004, J BIOL CHEM, V279, P28276, DOI 10.1074/jbc.M403156200; CORBIN JL, 1984, APPL ENVIRON MICROB, V47, P1027, DOI 10.1128/AEM.47.5.1027-1030.1984; Curatti L, 2006, P NATL ACAD SCI USA, V103, P5297, DOI 10.1073/pnas.0601115103; Dos Santos PC, 2004, CHEM REV, V104, P1159, DOI 10.1021/cr020608l; Einsle O, 2002, SCIENCE, V297, P1696, DOI 10.1126/science.1073877; GAVINI N, 1992, J BIOL CHEM, V267, P21179; Howard JB, 1996, CHEM REV, V96, P2965, DOI 10.1021/cr9500545; HU Y, 2006, IN PRESS P NATL ACAD; Hu YL, 2004, J BIOL CHEM, V279, P54963, DOI 10.1074/jbc.M408983200; Hu YL, 2005, P NATL ACAD SCI USA, V102, P13825, DOI 10.1073/pnas.0506967102; Hu YL, 2005, P NATL ACAD SCI USA, V102, P3236, DOI 10.1073/pnas.0409201102; Igarashi RY, 2003, CRIT REV BIOCHEM MOL, V38, P351, DOI 10.1080/10409230390242380; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; PAGE WJ, 1979, J BACTERIOL, V139, P1058, DOI 10.1128/JB.139.3.1058-1061.1979; Peters JW, 2006, CURR OPIN CHEM BIOL, V10, P101, DOI 10.1016/j.cbpa.2006.02.019; Peters JW, 1997, BIOCHEMISTRY-US, V36, P1181, DOI 10.1021/bi9626665; Rees DC, 2005, PHILOS T R SOC A, V363, P971, DOI 10.1098/rsta.2004.1539; Rees DC, 2002, ANNU REV BIOCHEM, V71, P221, DOI 10.1146/annurev.biochem.71.110601.135406; Rees DC, 2003, SCIENCE, V300, P929, DOI 10.1126/science.1083075; Ribbe MW, 2002, J BIOL CHEM, V277, P23469, DOI 10.1074/jbc.M202061200; Rubio LM, 2005, J BACTERIOL, V187, P405, DOI 10.1128/JB.187.2.405-414.2005; Schmid B, 2002, SCIENCE, V296, P352, DOI 10.1126/science.1070010; Schwarz G, 2006, ANNU REV PLANT BIOL, V57, P623, DOI 10.1146/annurev.arplant.57.032905.105437; Seefeldt LC, 2004, BIOCHEMISTRY-US, V43, P1401, DOI 10.1021/bi036038g; Smith BE, 1999, ADV INORG CHEM, V47, P159, DOI 10.1016/S0898-8838(08)60078-1; Stiebritz MT, 2006, ACTA CRYSTALLOGR D, V62, P648, DOI 10.1107/S0907444906013333; SURERUS KK, 1992, J AM CHEM SOC, V114, P8579, DOI 10.1021/ja00048a034; VANDEBOGART M, 1967, ANAL BIOCHEM, V20, P325, DOI 10.1016/0003-2697(67)90038-3	39	23	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30534	30541		10.1074/jbc.M605527200	http://dx.doi.org/10.1074/jbc.M605527200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16893897	hybrid			2022-12-27	WOS:000241075900029
J	Ma, L; Wang, HY				Ma, Li; Wang, Hsien-yu			Suppression of cyclic GMP-dependent protein kinase is essential to the Wnt/cGMP/Ca2+ pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F9 TERATOCARCINOMA CELLS; ADP-RIBOSYLATION; XENOPUS EMBRYOS; WNT; RAT; ACTIVATION; DROSOPHILA; RECEPTOR; FAMILY; CA2+	Novel downstream effectors sensing changes in intracellular concentrations of Ca2+ and cyclic GMP in response to activation of the Wnt/Frizzled-2 pathway were sought. Activation of Frizzled-2 suppressed protein kinase G activity while activating NF-AT-dependent transcription. Each of these responses was abolished by pertussis toxin and by knock-down of the expression of either G alpha(t2) or G alpha(o). Activation of NF-AT-dependent transcription in response to Wnt5a stimulation was suppressed by activation of protein kinase G and by buffering intracellular Ca2+. Elevation of intracellular cyclic GMP either by inhibition of cyclic GMP phosphodiesterase or by addition of 8-bromocyclic GMP was shown to activate protein kinase G, to block Ca2+ mobilization, as well as to markedly attenuate activation of NF-AT-dependent transcription in response to Wnt5a stimulation. Chemical inhibition of protein kinase G by Rp-8-pCPT-cGMP, conversely, was shown to provoke increased NF-AT gene transcription and Ca2+ mobilization in the absence of Wnt stimulation. Protein kinase G is shown to be a critical downstream effector of the noncanonical Wnt-Frizzled-2/cGMP/Ca2+ pathway.	SUNY Stony Brook, Sch Med, Diabet & Metab Dis Res Ctr, Dept Physiol & Biophys, Stony Brook, NY 11794 USA; SUNY Stony Brook, Sch Med, Diabet & Metab Dis Res Ctr, Dept Pharmacol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Wang, HY (corresponding author), SUNY Stony Brook, Sch Med, Diabet & Metab Dis Res Ctr, Dept Physiol & Biophys, Stony Brook, NY 11794 USA.	wangh@pharm.stonybrook.edu	Ma, Li/AAG-4109-2020	Ma, Li/0000-0001-8470-0378	NIGMS NIH HHS [GM 069375] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069375] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahumada A, 2002, SCIENCE, V298, P2006, DOI 10.1126/science.1073776; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; DeCostanzo AJ, 2002, N-S ARCH PHARMACOL, V365, P341, DOI 10.1007/s00210-002-0540-3; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Ishitani T, 2003, MOL CELL BIOL, V23, P131, DOI 10.1128/MCB.23.1.131-139.2003; Katanaev VL, 2005, CELL, V120, P111, DOI 10.1016/j.cell.2004.11.014; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; Kuhl M, 2000, J BIOL CHEM, V275, P12701, DOI 10.1074/jbc.275.17.12701; Liu T, 1999, J BIOL CHEM, V274, P33539, DOI 10.1074/jbc.274.47.33539; Liu XX, 1999, P NATL ACAD SCI USA, V96, P14383, DOI 10.1073/pnas.96.25.14383; LUGNIER C, 1986, BIOCHEM PHARMACOL, V35, P1743, DOI 10.1016/0006-2952(86)90333-3; MANNING DR, 1984, J BIOL CHEM, V259, P749; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; MURAYAMA T, 1984, J BIOL CHEM, V259, P761; NORDSTROM O, 1981, BRAIN RES, V213, P467, DOI 10.1016/0006-8993(81)90255-9; OUEDRAOGO S, 1994, BRIT J PHARMACOL, V112, P867, DOI 10.1111/j.1476-5381.1994.tb13160.x; Quaiser T, 2006, BIOESSAYS, V28, P339, DOI 10.1002/bies.20386; Saneyoshi T, 2002, NATURE, V417, P295, DOI 10.1038/417295a; Sheldahl LC, 2003, J CELL BIOL, V161, P769, DOI 10.1083/jcb.200211094; Slusarski DC, 1997, NATURE, V390, P410, DOI 10.1038/37138; Slusarski DC, 1997, DEV BIOL, V182, P114, DOI 10.1006/dbio.1996.8463; VANDOP C, 1984, J BIOL CHEM, V259, P23; Wang H, 2004, BIOCHEM SOC T, V32, P792, DOI 10.1042/BST0320792; Wang HY, 1997, J BIOL CHEM, V272, P1817, DOI 10.1074/jbc.272.3.1817; Wang HY, 2003, SCIENCE, V300, P1529, DOI 10.1126/science.1085259; Wang YS, 1996, J BIOL CHEM, V271, P4468; WENSEL T G, 1986, Proteins Structure Function and Genetics, V1, P90, DOI 10.1002/prot.340010114; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; WOLFE L, 1987, J BIOL CHEM, V262, P16906	30	49	53	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30990	31001		10.1074/jbc.M603603200	http://dx.doi.org/10.1074/jbc.M603603200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16920709	hybrid			2022-12-27	WOS:000241075900075
J	Triantafilou, M; Gamper, FGJ; Haston, RM; Mouratis, MA; Morath, S; Hartung, T; Triantafilou, K				Triantafilou, Martha; Gamper, Frederick G. J.; Haston, Rowenna M.; Mouratis, Marios Angelos; Morath, Siegfried; Hartung, Thomas; Triantafilou, Kathy			Membrane sorting of toll-like receptor (TLR)-2/6 and TLR2/1 heterodimers at the cell surface determines heterotypic associations with CD36 and intracellular targeting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; INNATE IMMUNE-SYSTEM; LIPOTEICHOIC ACID; BACTERIAL LIPOPOLYSACCHARIDE; GOLGI-APPARATUS; PLASMA-MEMBRANE; CUTTING EDGE; STRANDED-RNA; LIPID RAFTS; RECOGNITION	Toll-like receptors (TLRs) are receptors of the innate immune system responsible for recognizing pathogen-associated molecular patterns. TLR2 seems to be the most promiscuous TLR receptor able to recognize the most diverse set of pathogen-associated patterns. Its promiscuity has been attributed to its unique ability to heterodimerize with TLRs 1 and 6 and, most recently, to its association with CD36 in response to diacylated lipoproteins. Thus, it seems that TLR2 forms receptor clusters in response to different microbial ligands. In this study we investigated TLR2 cell surface heterotypic interactions in response to different ligands as well as internalization and intracellular trafficking. Our data show that TLR2 forms heterodimers with TLR1 and TLR6 and that these heterodimer pre-exist and are not induced by the ligand. Upon stimulation by the specific ligand, these heterodimers are recruited within lipid rafts. In contrast, heterotypic associations of TLR2/6 with CD36 are not preformed and are ligand-induced. All TLR2 receptor clusters accumulate in lipid rafts and are targeted to the Golgi apparatus. This localization and targeting is ligand-specific. Activation occurs at the cell surface, and the observed trafficking is independent of signaling.	Univ Sussex, Sch Life Sci, Infect & Immun Grp, Brighton BN1 9QG, E Sussex, England; Univ Konstanz, Dept Biochem Pharmacol, D-78457 Constance, Germany	University of Sussex; University of Konstanz	Triantafilou, K (corresponding author), Univ Sussex, Sch Life Sci, Infect & Immun Grp, JMS Bldg, Brighton BN1 9QG, E Sussex, England.	K.Triantafilou@sussex.ac.uk			Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Akira S, 2001, ADV IMMUNOL, V78, P1, DOI 10.1016/S0065-2776(01)78001-7; Alexopoulou L, 2002, NAT MED, V8, P878, DOI 10.1038/nm732; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Anderson HA, 1996, MOL BIOL CELL, V7, P1825, DOI 10.1091/mbc.7.11.1825; Buwitt-Beckmann U, 2005, EUR J IMMUNOL, V35, P282, DOI 10.1002/eji.200424955; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Heine H, 2003, INT ARCH ALLERGY IMM, V130, P180, DOI 10.1159/000069517; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Keller P, 1998, J CELL BIOL, V140, P1357, DOI 10.1083/jcb.140.6.1357; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; Kenworthy AK, 1999, METH MOL B, V116, P37; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Means TK, 1999, J IMMUNOL, V163, P6748; Morath S, 2002, INFECT IMMUN, V70, P938, DOI 10.1128/IAI.70.2.938-944.2002; Morr M, 2002, EUR J IMMUNOL, V32, P3337, DOI 10.1002/1521-4141(2002012)32:12<3337::AID-IMMU3337>3.0.CO;2-I; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Stuart LM, 2005, J CELL BIOL, V170, P477, DOI 10.1083/jcb.200501113; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Thieblemont N, 1999, J EXP MED, V190, P523, DOI 10.1084/jem.190.4.523; Triantafilou M, 2004, J BIOL CHEM, V279, P40882, DOI 10.1074/jbc.M400466200; Triantafilou M, 2004, BIOCHEM J, V381, P527, DOI 10.1042/BJ20040172; Triantafilou M, 2004, J CELL SCI, V117, P4007, DOI 10.1242/jcs.01270; Triantafilou M, 2003, J ENDOTOXIN RES, V9, P331, DOI 10.1179/096805103225002557; Triantafilou M, 2002, J CELL SCI, V115, P2603; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Wang PY, 1996, J INFLAMM, V47, P126; Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045; Werts C, 2001, NAT IMMUNOL, V2, P346, DOI 10.1038/86354; Yoshimura A, 1999, J IMMUNOL, V163, P1	38	343	353	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					31002	31011		10.1074/jbc.M602794200	http://dx.doi.org/10.1074/jbc.M602794200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16880211	hybrid			2022-12-27	WOS:000241075900076
J	Fleishman, SJ; Sabag, AD; Ophir, E; Avraham, KB; Ben-Tal, N				Fleishman, Sarel J.; Sabag, Adi D.; Ophir, Eran; Avraham, Karen B.; Ben-Tal, Nir			The structural context of disease-causing mutations in gap junctions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE PROTEIN STRUCTURES; GATING PROPERTIES; SALT BRIDGES; CONNEXIN-26; PREDICTION; TOPOLOGY; CHANNELS; MUTANTS; MODEL; SITE	Gap junctions form intercellular channels that mediate metabolic and electrical signaling between neighboring cells in a tissue. Lack of an atomic resolution structure of the gap junction has made it difficult to identify interactions that stabilize its transmembrane domain. Using a recently computed model of this domain, which specifies the locations of each amino acid, we postulated the existence of several interactions and tested them experimentally. We introduced mutations within the transmembrane domain of the gap junction-forming protein connexin that were previously implicated in genetic diseases and that apparently destabilized the gap junction, as evidenced here by the absence of the protein from the sites of cell-cell apposition. The model structure helped identify positions on adjacent helices where second-site mutations restored membrane localization, revealing possible interactions between residue pairs. We thus identified two putative salt bridges and one pair involved in packing interactions in which one disease-causing mutation suppressed the effects of another. These results seem to reveal some of the physical forces that underlie the structural stability of the gap junction transmembrane domain and suggest that abrogation of such interactions bring about some of the effects of disease-causing mutations.	Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, IL-69978 Tel Aviv, Israel; Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine	Ben-Tal, N (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, IL-69978 Tel Aviv, Israel.	nirb@tauex.tau.ac.il		Avraham, Karen B/0000-0002-4913-251X; Fleishman, Sarel/0000-0003-3177-7560; Ben-Tal, Nir/0000-0001-6901-832X	NIDCD NIH HHS [R01 DC005641] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005641] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Aasen T, 2003, ONCOGENE, V22, P7969, DOI 10.1038/sj.onc.1206709; BERGOFFEN J, 1993, SCIENCE, V262, P2039, DOI 10.1126/science.8266101; CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; CASCIO M, 1995, J BIOL CHEM, V270, P18643, DOI 10.1074/jbc.270.31.18643; Dall'Acqua W, 1998, BIOCHEMISTRY-US, V37, P7981, DOI 10.1021/bi980148j; Das Sarma J, 2001, J CELL SCI, V114, P4013; Evans WH, 2002, MOL MEMBR BIOL, V19, P121, DOI 10.1080/09687680210139839; Fleishman SJ, 2006, CURR OPIN STRUC BIOL, V16, P496, DOI 10.1016/j.sbi.2006.06.003; Fleishman SJ, 2006, TRENDS BIOCHEM SCI, V31, P106, DOI 10.1016/j.tibs.2005.12.005; Fleishman SJ, 2004, BIOPHYS J, V87, P3448, DOI 10.1529/biophysj.104.046417; Fleishman SJ, 2004, MOL CELL, V15, P879, DOI 10.1016/j.molcel.2004.08.016; Fleishman SJ, 2004, J MOL BIOL, V340, P307, DOI 10.1016/j.jmb.2004.04.064; Gottfried I, 2002, HUM MOL GENET, V11, P1311, DOI 10.1093/hmg/11.11.1311; Harris AL, 2001, Q REV BIOPHYS, V34, P325, DOI 10.1017/S0033583501003705; HENDSCH ZS, 1994, PROTEIN SCI, V3, P211; HOROVITZ A, 1993, J MOL BIOL, V231, P58, DOI 10.1006/jmbi.1993.1256; HOROVITZ A, 1994, J MOL BIOL, V238, P133, DOI 10.1006/jmbi.1994.1275; HOROVITZ A, 1990, J MOL BIOL, V216, P1031, DOI 10.1016/S0022-2836(99)80018-7; Hu XG, 1999, FEBS LETT, V451, P113, DOI 10.1016/S0014-5793(99)00558-X; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; Kenna MA, 2001, ARCH OTOLARYNGOL, V127, P1037, DOI 10.1001/archotol.127.9.1037; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kronengold J, 2003, J GEN PHYSIOL, V122, P389, DOI 10.1085/jgp.200308861; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; Marlin S, 2001, ARCH OTOLARYNGOL, V127, P927, DOI 10.1001/archotol.127.8.927; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Mese G, 2004, HUM GENET, V115, P191, DOI 10.1007/s00439-004-1142-6; MILKS LC, 1988, EMBO J, V7, P2967, DOI 10.1002/j.1460-2075.1988.tb03159.x; Nikolova PV, 2000, EMBO J, V19, P370, DOI 10.1093/emboj/19.3.370; Numakura C, 2002, HUM MUTAT, V20, P392, DOI 10.1002/humu.10134; Pitts JD, 1998, BIOESSAYS, V20, P1047, DOI 10.1002/(SICI)1521-1878(199812)20:12<1047::AID-BIES11>3.0.CO;2-0; Ressot C, 1996, HUM GENET, V98, P172, DOI 10.1007/s004390050183; Roisman LC, 2001, P NATL ACAD SCI USA, V98, P13231, DOI 10.1073/pnas.221290398; Skerrett IM, 2002, J CELL BIOL, V159, P349, DOI 10.1083/jcb.200207060; Trexler EB, 2000, BIOPHYS J, V79, P3036, DOI 10.1016/S0006-3495(00)76539-8; Unger VM, 1999, SCIENCE, V283, P1176, DOI 10.1126/science.283.5405.1176; Vanslyke JK, 2000, MOL BIOL CELL, V11, P1933, DOI 10.1091/mbc.11.6.1933; Willecke K, 2002, BIOL CHEM, V383, P725, DOI 10.1515/BC.2002.076; YEAGER M, 1992, J MOL BIOL, V223, P929, DOI 10.1016/0022-2836(92)90253-G	39	11	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					28958	28963		10.1074/jbc.M605764200	http://dx.doi.org/10.1074/jbc.M605764200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16864573	hybrid			2022-12-27	WOS:000240680500050
J	Goswami, T; Andrews, NC				Goswami, Tapasree; Andrews, Nancy C.			Hereditary hemochromatosis protein, HFE, interaction with transferrin receptor 2 suggests a molecular mechanism for mammalian iron sensing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFERRIC TRANSFERRIN; RECEPTOR; EXPRESSION; HEPCIDIN; BINDING; ANEMIA	HFE and transferrin receptor 2 (TFR2) are membrane proteins integral to mammalian iron homeostasis and associated with human hereditary hemochromatosis. Here we demonstrate that HFE and TFR2 interact in cells, that this interaction is not abrogated by disease-associated mutations of HFE and TFR2, and that TFR2 competes with TFR1 for binding to HFE. We propose a new model for the mechanism of iron status sensing that results in the regulation of iron homeostasis.	Harvard Univ, Sch Med, Childrens Hosp Boston, Karp Family Res Labs,Div Hematol Oncol, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Andrews, NC (corresponding author), Harvard Univ, Sch Med, Childrens Hosp Boston, Karp Family Res Labs,Div Hematol Oncol, Rm 8-125,1,Blackfan Circle, Boston, MA 02115 USA.	nancy_andrews@hms.harvard.edu		Andrews, Nancy/0000-0003-0243-4462	NIDDK NIH HHS [R01 DK53813, R01 DK053813-10, R01 DK053813] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053813] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ausubel FM, CURRENT PROTOCOLS MO; Bennett MJ, 2000, NATURE, V403, P46, DOI 10.1038/47417; Griffiths WJH, 2003, J HISTOCHEM CYTOCHEM, V51, P613, DOI 10.1177/002215540305100507; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; HUBERT N, 1993, J HEPATOL, V18, P301, DOI 10.1016/S0168-8278(05)80274-0; Johnson MB, 2004, BLOOD, V104, P4287, DOI 10.1182/blood-2004-06-2477; Kawabata H, 1999, J BIOL CHEM, V274, P20826, DOI 10.1074/jbc.274.30.20826; Le Gac G, 2005, EUR J HUM GENET, V13, P1172, DOI 10.1038/sj.ejhg.5201490; Levy JE, 1999, BLOOD, V94, P9, DOI 10.1182/blood.V94.1.9.413a43_9_11; MCGRAW TE, 1987, J CELL BIOL, V105, P207, DOI 10.1083/jcb.105.1.207; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Robb A, 2004, BLOOD, V104, P4294, DOI 10.1182/blood-2004-06-2481; Roetto A, 2002, BLOOD CELL MOL DIS, V29, P465, DOI 10.1006/bcmd.2002.0585; Sidis Y, 2006, ENDOCRINOLOGY, V147, P3586, DOI 10.1210/en.2006-0089; Weinstein DA, 2002, BLOOD, V100, P3776, DOI 10.1182/blood-2002-04-1260; West AP, 2001, J MOL BIOL, V313, P385, DOI 10.1006/jmbi.2001.5048; West AP, 2000, J BIOL CHEM, V275, P38135, DOI 10.1074/jbc.C000664200; Wilkins SJ, 2006, BLOOD, V107, P1659, DOI 10.1182/blood-2005-07-2614; WU JC, 1994, P NATL ACAD SCI USA, V91, P674, DOI 10.1073/pnas.91.2.674	20	260	270	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					28494	28498		10.1074/jbc.C600197200	http://dx.doi.org/10.1074/jbc.C600197200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16893896	hybrid			2022-12-27	WOS:000240680500002
J	Jang, LT; Buu, LM; Lee, FJS				Jang, Li-Ting; Buu, Leh-Miauh; Lee, Fang-Jen S.			Determinants of Rbp1p localization in specific cytoplasmic mRNA-processing foci, P-bodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN STRESS GRANULES; SACCHAROMYCES-CEREVISIAE; BINDING PROTEINS; YEAST; MECHANISMS; TURNOVER; TRANSLATION; STABILITY; COMPLEXES; CELLS	Rbp1p, a yeast RNA-binding protein, decreases the level of mitochondrial porin mRNA by enhancing its degradation, but the intracellular location of the Rbp1p-mediated degradation complex remains unknown. We show here that Rbp1p in xrn1 Delta mutant yeast localizes in specific cytoplasmic foci that are known as P-bodies. The N-terminal and RNA recognition motif (RRM) 1 domains of Rbp1p are necessary but not sufficient for its localization in P bodies. Rbp1p forms oligomers through its C-terminal domain in vivo; N-terminal-delete, or RRM1-mutated Rbp1p can be more efficiently recruited to P-bodies in an xrn1 Delta strain, expressing a full-length Rbp1p. Although POR1 mRNA is localized to P bodies in an xrn1 Delta strain, this localization does not depend on Rbp1p. Decapping activator Dhh1p directly interacts with Rbp1p. However, the recruitment of Rbp1p to P-bodies does not require Dhh1p or Ccr4p. In wildtype cells, Rbp1p can localize to P-bodies under glucose deprivation or treatment with KCl. In addition, Rbp1p-mediated porin mRNA decay is elicited by Xrn1p, a 5' to 3' exonuclease. These results provide new insight into the mechanism of Rbp1p function.	Natl Taiwan Univ Hosp, Dept Med Res, Taipei, Taiwan; Natl Taiwan Univ, Sch Med, Inst Mol Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University	Lee, FJS (corresponding author), Natl Taiwan Univ Hosp, Dept Med Res, 7 Chung Shan S Rd, Taipei, Taiwan.	fangjen@ha.mc.ntu.edu.tw		LEE, FANG-JEN/0000-0002-2167-2426				Beck ARP, 1998, P NATL ACAD SCI USA, V95, P2331, DOI 10.1073/pnas.95.5.2331; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Buu LM, 2004, J BIOL CHEM, V279, P453, DOI 10.1074/jbc.M309278200; Caponigro G, 1996, MICROBIOL REV, V60, P233, DOI 10.1128/MMBR.60.1.233-249.1996; Coller J, 2004, ANNU REV BIOCHEM, V73, P861, DOI 10.1146/annurev.biochem.73.011303.074032; Coller JM, 2001, RNA, V7, P1717, DOI 10.1017/S135583820101994X; Deutschbauer AM, 2002, P NATL ACAD SCI USA, V99, P15530, DOI 10.1073/pnas.202604399; Fischer N, 2002, EMBO J, V21, P2788, DOI 10.1093/emboj/21.11.2788; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; HEYER WD, 1995, MOL CELL BIOL, V15, P2728; Hilleren P, 1999, ANNU REV GENET, V33, P229, DOI 10.1146/annurev.genet.33.1.229; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jacobson A, 1996, ANNU REV BIOCHEM, V65, P693, DOI 10.1146/annurev.bi.65.070196.003401; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha N, 2002, BIOCHEM SOC T, V30, P963, DOI 10.1042/BST0300963; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; LEE FJS, 1994, J BIOL CHEM, V269, P20931; Lee FJS, 1997, J BIOL CHEM, V272, P30998, DOI 10.1074/jbc.272.49.30998; LEE FJS, 1993, J BIOL CHEM, V268, P15080; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; MITCHELL DA, 1993, YEAST, V9, P715, DOI 10.1002/yea.320090705; MUHLRAD D, 1995, MOL CELL BIOL, V15, P2145; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sherman F., 1986, METHODS YEAST GENETI; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Siomi H, 1997, CURR OPIN GENET DEV, V7, P345, DOI 10.1016/S0959-437X(97)80148-7; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Tharun S, 2001, MOL CELL, V8, P1075, DOI 10.1016/S1097-2765(01)00395-1; Tseng-Rogenski SSI, 2003, NUCLEIC ACIDS RES, V31, P4995, DOI 10.1093/nar/gkg712; Tucker M, 2000, ANNU REV BIOCHEM, V69, P571, DOI 10.1146/annurev.biochem.69.1.571; VERENT T, 1987, GENE, V52, P225; Wickens M, 2003, SCIENCE, V300, P753, DOI 10.1126/science.1084512; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025	34	11	12	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					29379	29390		10.1074/jbc.M601573200	http://dx.doi.org/10.1074/jbc.M601573200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16885161	hybrid			2022-12-27	WOS:000240680500093
J	Bang, IS; Liu, LM; Vazquez-Torres, A; Crouch, ML; Stamler, JS; Fang, FC				Bang, Iel-Soo; Liu, Limin; Vazquez-Torres, Andres; Crouch, Marie-Laure; Stamler, Jonathan S.; Fang, Ferric C.			Maintenance of nitric oxide and redox homeostasis by the Salmonella flavohemoglobin Hmp	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI FLAVOHAEMOGLOBIN HMP; ENTERICA SEROVAR TYPHIMURIUM; HEMOGLOBIN-LIKE PROTEIN; ESCHERICHIA-COLI; NITROSATIVE STRESS; OXIDATIVE STRESS; GENE-EXPRESSION; BACTERIAL HEMOGLOBINS; MYCOBACTERIUM-BOVIS; REACTIVE OXYGEN	Intracellular pathogens must resist the antimicrobial actions of nitric oxide (NO.) produced by host cells. To this end pathogens possess several NO.-metabolizing enzymes. Here we show that the flavohemoglobin Hmp is the principal enzyme responsible for aerobic NO. metabolism by Salmonella enterica serovar typhimurium. We further show that Hmp is required for Salmonella virulence in mice, in contrast to S-nitrosoglutathione reductase, flavorubredoxin, or cytochrome c nitrite reductase. Abrogation of murine-inducible NO. synthase restores virulence to hmp mutant bacteria. In the presence of nitrosative stress, Hmp-deficient Salmonella exhibits reduced NO. consumption, impaired growth, increased protein S-nitrosylation, and filamentous morphology. However, under aerobic conditions in the absence of nitrosative stress, elevated hmp expression increases S. typhimurium susceptibility to hydrogen peroxide. Both the heme binding and flavoreductase domains are required for resistance to NO., whereas the flavoreductase domain is responsible for iron-dependent susceptibility to oxidative stress. This provides a rationale for the regulation of hmp expression by the transcriptional repressor NsrR in response to both nitrosative stress and intracellular free iron concentration. The Hmp flavohemoglobin plays a central role in the response of Salmonella to nitrosative stress but requires precise regulation to avoid the exacerbation of oxidative stress that can result if electrons are shuttled to extraneous iron.	Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Lab Med, Seattle, WA 98195 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; Univ Colorado, Hlth Sci Ctr, Dept Microbiol, Aurora, CO 80010 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Duke University; Duke University; University of Colorado System; University of Colorado Anschutz Medical Campus	Fang, FC (corresponding author), Univ Washington, Sch Med, Dept Microbiol, 1959 Pacific St NE,Box 357242, Seattle, WA 98195 USA.	fcfang@u.washington.edu		Stamler, Jonathan/0000-0002-6866-1572; Fang, Ferric/0000-0002-3243-110X	NIAID NIH HHS [AI54959, AI39557, AI50660] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039557, R01AI054959, R21AI039557, R56AI054959, R01AI050660] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDREWS SC, 1992, FEBS LETT, V302, P247, DOI 10.1016/0014-5793(92)80452-M; Bang IS, 2000, J BACTERIOL, V182, P2245, DOI 10.1128/JB.182.8.2245-2252.2000; Bang IS, 2005, MOL MICROBIOL, V56, P811, DOI 10.1111/j.1365-2958.2005.04580.x; BENJAMIN N, 1999, NITRIC OXIDE INFECT, P215; Bjarnason J, 2003, J BACTERIOL, V185, P4973, DOI 10.1128/JB.185.16.4973-4982.2003; Bodenmiller DM, 2006, J BACTERIOL, V188, P874, DOI 10.1128/JB.188.3.874-881.2006; Crawford MJ, 2006, J BIOL CHEM, V281, P3752; Crawford MJ, 1998, J BIOL CHEM, V273, P34028, DOI 10.1074/jbc.273.51.34028; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de Jesus-Berrios M, 2003, CURR BIOL, V13, P1963, DOI 10.1016/j.cub.2003.10.029; DEGROOTE MA, 1995, P NATL ACAD SCI USA, V92, P6399, DOI 10.1073/pnas.92.14.6399; DeGroote MA, 1997, P NATL ACAD SCI USA, V94, P13997, DOI 10.1073/pnas.94.25.13997; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; Ermler U, 1995, EMBO J, V14, P6067, DOI 10.1002/j.1460-2075.1995.tb00297.x; ESCHENBRENNER M, 1994, BIOCHEM BIOPH RES CO, V198, P127, DOI 10.1006/bbrc.1994.1018; Eu JP, 2000, BIOCHEMISTRY-US, V39, P1040, DOI 10.1021/bi992046e; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; Fang FC, 1999, P NATL ACAD SCI USA, V96, P7502, DOI 10.1073/pnas.96.13.7502; Freitas TAK, 2004, P NATL ACAD SCI USA, V101, P6675, DOI 10.1073/pnas.0308657101; Frey AD, 2002, APPL ENVIRON MICROB, V68, P4835, DOI 10.1128/AEM.68.10.4835-4840.2002; Frey AD, 2003, FEMS MICROBIOL REV, V27, P525, DOI 10.1016/S0168-6445(03)00056-1; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Gardner AM, 2002, J BIOL CHEM, V277, P8172, DOI 10.1074/jbc.M110471200; Gomes CM, 2002, J BIOL CHEM, V277, P25273, DOI 10.1074/jbc.M203886200; Hausladen A, 2001, P NATL ACAD SCI USA, V98, P10108, DOI 10.1073/pnas.181199698; Hausladen A, 1998, P NATL ACAD SCI USA, V95, P14100, DOI 10.1073/pnas.95.24.14100; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; Hernandez-Urzua E, 2003, J BIOL CHEM, V278, P34975, DOI 10.1074/jbc.M303629200; Ilari A, 2002, J BIOL CHEM, V277, P23725, DOI 10.1074/jbc.M202228200; IOANNIDIS N, 1992, BIOCHEM J, V288, P649, DOI 10.1042/bj2880649; Justino MC, 2005, J BIOL CHEM, V280, P2636, DOI 10.1074/jbc.M411070200; Kim SO, 1999, FEBS LETT, V445, P389, DOI 10.1016/S0014-5793(99)00157-X; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; Makarova O, 2000, BIOTECHNIQUES, V29, P970, DOI 10.2144/00295bm08; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Membrillo-Hernandez J, 1998, MOL MICROBIOL, V29, P1101, DOI 10.1046/j.1365-2958.1998.01000.x; MembrilloHernandez J, 1996, FEBS LETT, V382, P141, DOI 10.1016/0014-5793(96)00154-8; Mills CE, 2001, BIOCHEM J, V353, P207, DOI 10.1042/0264-6021:3530207; Monack DM, 2004, J EXP MED, V199, P231, DOI 10.1084/jem.20031319; MOORE WM, 1994, J MED CHEM, V37, P3886, DOI 10.1021/jm00049a007; MORLEY D, 1993, J CARDIOVASC PHARM, V21, P670, DOI 10.1097/00005344-199304000-00023; Mukhopadhyay P, 2004, P NATL ACAD SCI USA, V101, P745, DOI 10.1073/pnas.0307741100; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Ouellett H, 2002, P NATL ACAD SCI USA, V99, P5902, DOI 10.1073/pnas.092017799; Poock SR, 2002, J BIOL CHEM, V277, P23664, DOI 10.1074/jbc.M200731200; Poole RK, 1996, J BACTERIOL, V178, P5487, DOI 10.1128/jb.178.18.5487-5492.1996; Poole RK, 2005, BIOCHEM SOC T, V33, P176, DOI 10.1042/BST0330176; Poole RK, 1997, MICROBIOL-SGM, V143, P1557, DOI 10.1099/00221287-143-5-1557; POOLE RK, 1994, P ROY SOC B-BIOL SCI, V255, P251, DOI 10.1098/rspb.1994.0036; Rodionov DA, 2005, PLOS COMPUT BIOL, V1, P415, DOI 10.1371/journal.pcbi.0010055; SALE FO, 1984, ANAL BIOCHEM, V142, P347, DOI 10.1016/0003-2697(84)90475-5; Sambrook J., 2001, MOL CLONING LAB MANU; Schapiro JM, 2003, P NATL ACAD SCI USA, V100, P8496, DOI 10.1073/pnas.1033133100; Seyler RW, 2001, INFECT IMMUN, V69, P4034, DOI 10.1128/IAI.69.6.4034-4040.2001; Simon J, 2002, FEMS MICROBIOL REV, V26, P285, DOI 10.1111/j.1574-6976.2002.tb00616.x; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P7674, DOI 10.1073/pnas.89.16.7674; Stevanin TM, 2002, INFECT IMMUN, V70, P4399, DOI 10.1128/IAI.70.8.4399-4405.2002; Stevanin TM, 2000, J BIOL CHEM, V275, P35868, DOI 10.1074/jbc.M002471200; VASUDEVAN SG, 1995, FEMS MICROBIOL LETT, V125, P219, DOI 10.1016/0378-1097(94)00501-H; Vazquez-Torres A, 2000, J EXP MED, V192, P227, DOI 10.1084/jem.192.2.227; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; WILSON TM, 1995, MOL MICROBIOL, V15, P1009, DOI 10.1111/j.1365-2958.1995.tb02276.x; Woodmansee AN, 2002, J BIOL CHEM, V277, P34055, DOI 10.1074/jbc.M203977200	63	156	161	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					28039	28047		10.1074/jbc.M605174200	http://dx.doi.org/10.1074/jbc.M605174200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16873371	hybrid			2022-12-27	WOS:000240534400041
J	Coustou, V; Biran, M; Besteiro, S; Riviere, L; Baltz, T; Franconi, JM; Bringaud, F				Coustou, Virginie; Biran, Marc; Besteiro, Sebastien; Riviere, Loic; Baltz, Theo; Franconi, Jean-Michel; Bringaud, Frederic			Fumarate is an essential intermediary metabolite produced by the procyclic Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCIBLE EXPRESSION SYSTEM; SUCCINATE COA-TRANSFERASE; RNA INTERFERENCE RNAI; BLOOD-STREAM FORM; MOLECULAR CHARACTERIZATION; ESCHERICHIA-COLI; DIHYDROOROTATE DEHYDROGENASE; SACCHAROMYCES-CEREVISIAE; CARBOHYDRATE-METABOLISM; ENERGY GENERATION	The procyclic stage of Trypanosoma brucei, a parasitic protist responsible for sleeping sickness in humans, converts most of the consumed glucose into excreted succinate, by succinic fermentation. Succinate is produced by the glycosomal and mitochondrial NADH-dependent fumarate reductases, which are not essential for parasite viability. To further explore the role of the succinic fermentation pathways, we studied the trypanosome fumarases, the enzymes providing fumarate to fumarate reductases. The T. brucei genome contains two class I fumarase genes encoding cytosolic (FHc) and mitochondrial (FHm) enzymes, which account for total cellular fumarase activity as shown by RNA interference. The growth arrest of a double RNA interference mutant cell line showing no fumarase activity indicates that fumarases are essential for the parasite. Interestingly, addition of fumarate to the medium rescues the growth phenotype, indicating that fumarate is an essential intermediary metabolite of the insect stage trypanosomes. We propose that trypanosomes use fumarate as an essential electron acceptor, as exemplified by the fumarate dependence previously reported for an enzyme of the essential de novo pyrimidine synthesis.	Univ Bordeaux 2, Lab Genom Fonct Trypanosomatides, CNRS, UMR 5162, F-33076 Bordeaux, France; Univ Bordeaux 2, CNRS, UMR 5536, F-33076 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Bringaud, F (corresponding author), Univ Bordeaux 2, Lab Genom Fonct Trypanosomatides, CNRS, UMR 5162, 146 Rue Leo Saignat, F-33076 Bordeaux, France.	bringaud@u-bordeaux2.fr	Besteiro, Sébastien/F-3622-2014	Besteiro, Sébastien/0000-0003-1853-1494				Annoura T, 2005, J MOL EVOL, V60, P113, DOI 10.1007/s00239-004-0078-8; Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; Bastin P, 1996, MOL BIOCHEM PARASIT, V77, P235, DOI 10.1016/0166-6851(96)02598-4; Berens Randolph L., 1995, P89, DOI 10.1016/B978-012473345-9/50007-6; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Besteiro S, 2005, TRENDS PARASITOL, V21, P185, DOI 10.1016/j.pt.2005.02.008; Besteiro S, 2002, J BIOL CHEM, V277, P38001, DOI 10.1074/jbc.M201759200; Bringaud F, 1995, MOL BIOCHEM PARASIT, V74, P119, DOI 10.1016/0166-6851(95)02486-7; Bringaud F, 2000, MOL BIOCHEM PARASIT, V111, P283, DOI 10.1016/S0166-6851(00)00319-4; Bringaud F, 1998, P NATL ACAD SCI USA, V95, P7963, DOI 10.1073/pnas.95.14.7963; BRUN R, 1979, ACTA TROP, V36, P289; CAZZULO JJ, 1992, FASEB J, V6, P3153, DOI 10.1096/fasebj.6.13.1397837; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Colasante C, 2006, PROTEOMICS, V6, P3275, DOI 10.1002/pmic.200500668; Coustou V, 2005, J BIOL CHEM, V280, P16559, DOI 10.1074/jbc.M500343200; Coustou V, 2003, J BIOL CHEM, V278, P49625, DOI 10.1074/jbc.M307872200; CZOK R, 1974, METHOD ENZYMAT AN, P1600; DaRocha WD, 2004, MOL BIOCHEM PARASIT, V133, P175, DOI 10.1016/j.molbiopara.2003.10.005; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Fairlamb A. H., 1986, Carbohydrate metabolism in cultured cells., P183; Fang J, 2002, BIOCHEMISTRY-US, V41, P3065, DOI 10.1021/bi015989w; Fang J, 2001, EUR J BIOCHEM, V268, P3075, DOI 10.1046/j.1432-1327.2001.02205.x; Gao GH, 1999, J MOL BIOL, V285, P149, DOI 10.1006/jmbi.1998.2293; GEST H, 1980, FEMS MICROBIOL LETT, V7, P73, DOI 10.1111/j.1574-6941.1980.tb01579.x; GUEST JR, 1985, J GEN MICROBIOL, V131, P2971; Hannaert Veronique, 2003, Kinetoplastid Biology and Disease, V2, pUnpaginated; Harlow E., 1988, ANTIBODIES LAB MANUA; HUNTER FRISSELL R., 1960, EXPTL PARASITOL, V9, P271, DOI 10.1016/0014-4894(60)90035-7; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Lamour N, 2005, J BIOL CHEM, V280, P11902, DOI 10.1074/jbc.M414274200; LANHAM SM, 1970, EXP PARASITOL, V28, P521, DOI 10.1016/0014-4894(70)90120-7; Michels PAM, 2000, PARASITOL TODAY, V16, P482, DOI 10.1016/S0169-4758(00)01810-X; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; Nast G, 1996, PLANT PHYSIOL, V112, P1219, DOI 10.1104/pp.112.3.1219; Ngo H, 1998, P NATL ACAD SCI USA, V95, P14687, DOI 10.1073/pnas.95.25.14687; OPPERDOES FR, 1977, EUR J BIOCHEM, V76, P21, DOI 10.1111/j.1432-1033.1977.tb11566.x; OPPERDOES FR, 1987, ANNU REV MICROBIOL, V41, P127, DOI 10.1146/annurev.mi.41.100187.001015; Pines O, 1996, APPL MICROBIOL BIOT, V46, P393, DOI 10.1007/s002530050835; Riviere L, 2004, J BIOL CHEM, V279, P45337, DOI 10.1074/jbc.M407513200; Robinson KA, 2003, MOL BIOCHEM PARASIT, V128, P217, DOI 10.1016/S0166-6851(03)00079-3; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SUZUKI T, 1989, J BIOL CHEM, V264, P2581; Takashima E, 2002, MOL BIOCHEM PARASIT, V122, P189, DOI 10.1016/S0166-6851(02)00100-7; Tetaud E, 2001, MOL BIOCHEM PARASIT, V116, P171, DOI 10.1016/S0166-6851(01)00320-6; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tielens AGM, 1998, PARASITOL TODAY, V14, P265, DOI 10.1016/S0169-4758(98)01263-0; TONER JJ, 1972, BIOCHEM BIOPH RES CO, V46, P652, DOI 10.1016/S0006-291X(72)80190-6; Turner MA, 1997, P NATL ACAD SCI USA, V94, P9063, DOI 10.1073/pnas.94.17.9063; Van Hellemond JJ, 1998, P NATL ACAD SCI USA, V95, P3036, DOI 10.1073/pnas.95.6.3036; van Weelden SWH, 2005, J BIOL CHEM, V280, P12451, DOI 10.1074/jbc.M412447200; van Weelden SWH, 2003, J BIOL CHEM, V278, P12854, DOI 10.1074/jbc.M213190200; WEAVER TM, 1995, NAT STRUCT BIOL, V2, P654, DOI 10.1038/nsb0895-654; Wickstead B, 2002, MOL BIOCHEM PARASIT, V125, P211, DOI 10.1016/S0166-6851(02)00238-4; WILLIAMS SE, 1992, BIOCHEMISTRY-US, V31, P9768, DOI 10.1021/bi00155a033; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; WOODS SA, 1988, BIOCHIM BIOPHYS ACTA, V954, P14, DOI 10.1016/0167-4838(88)90050-7; WU M, 1987, J BIOL CHEM, V262, P12275	57	43	44	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2006	281	37					26832	26846		10.1074/jbc.M601377200	http://dx.doi.org/10.1074/jbc.M601377200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082PB	16857679	hybrid			2022-12-27	WOS:000240397700010
J	Gibbard, RJ; Morley, PJ; Gay, NJ				Gibbard, Rebecca J.; Morley, Peter J.; Gay, Nicholas J.			Conserved features in the extracellular domain of human toll-like receptor 8 are essential for pH-dependent signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTOR-3; BACTERIAL-DNA; CPG-DNA; RECOGNITION; BINDING; CELLS; TLR9; RESPONSIVENESS; ACTIVATION; IMIQUIMOD	Toll-like receptor (TLR) 8 has an important role in initiating immune responses to viral single-stranded RNA and the antiviral compound resiquimod. Together with TLR3, -7, and -9, it forms a subgroup of the TLRs that are localized intracellularly and signal in response to pathogen-derived nucleic acids. In this work, we have used site-directed mutagenesis to identify regions of the TLR8 extracellular domain that are required for stimulus-induced signal transduction. We have shown that a cysteine-rich sequence predicted to form a loop projecting from the sole-noidal ectodomain structure at leucine-rich repeat 8 is essential for signaling in response to both single-stranded RNA and resiquimod. A second region, centered on an aspartic acid residue in leucine-rich repeat 17, is also required for TLR8 function. The corresponding residue in TLR9 is known to be important for pH-dependent binding and signaling in response to unmethylated CpG DNA, suggesting that the TLR7/8/9 subgroups share a common signaling mechanism. We have also shown that TLR8 is localized predominantly in the endoplasmic reticulum but that signaling is completely abolished by an inhibitor of vesicle-type H+ ATPases. This indicates that TLR8 is present at low levels in an acidified compartment and that a lowered pH is required for receptor function. We propose that pH-dependent changes in the ligand facilitate activation of the receptor. The protonated form of resiquimod, a cell-permeable weak base, is likely to concentrate significantly (similar to 100x) in acidified compartments, and this may potentiate low affinity interactions with either the receptor or a specific binding protein.	Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; GlaxoSmithKline Med Res Ctr, Stevenage SG1 2NY, Herts, England	University of Cambridge; GlaxoSmithKline	Gay, NJ (corresponding author), Univ Cambridge, Dept Biochem, 80 Tennis Court Rd, Cambridge CB2 1GA, England.	njg11@mole.bio.cam.ac.uk			MRC [G0400007] Funding Source: UKRI; Medical Research Council [G1000133, G0400007] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Bauer S, 2001, P NATL ACAD SCI USA, V98, P9237, DOI 10.1073/pnas.161293498; Beignon AS, 2005, J CLIN INVEST, V115, P3265, DOI 10.1172/JCI26032; Bell JK, 2003, TRENDS IMMUNOL, V24, P528, DOI 10.1016/S1471-4906(03)00242-4; Bell JK, 2005, P NATL ACAD SCI USA, V102, P10976, DOI 10.1073/pnas.0505077102; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; Chollet JL, 1999, PHARM DEV TECHNOL, V4, P35, DOI 10.1081/PDT-100101337; de Bouteiller O, 2005, J BIOL CHEM, V280, P38133, DOI 10.1074/jbc.M507163200; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Gangloff M, 2004, TRENDS BIOCHEM SCI, V29, P294, DOI 10.1016/j.tibs.2004.04.008; Gorden KB, 2005, J IMMUNOL, V174, P1259, DOI 10.4049/jimmunol.174.3.1259; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Jurk M, 2002, NAT IMMUNOL, V3, P499, DOI 10.1038/ni0602-499; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Lee J, 2003, P NATL ACAD SCI USA, V100, P6646, DOI 10.1073/pnas.0631696100; Levy O, 2004, J IMMUNOL, V173, P4627, DOI 10.4049/jimmunol.173.7.4627; Mizel SB, 2003, J BIOL CHEM, V278, P23624, DOI 10.1074/jbc.M303481200; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; Rutz M, 2004, EUR J IMMUNOL, V34, P2541, DOI 10.1002/eji.200425218; Weber ANR, 2005, J BIOL CHEM, V280, P22793, DOI 10.1074/jbc.M502074200; Weber ANR, 2003, NAT IMMUNOL, V4, P794, DOI 10.1038/ni955; Wu MM, 2000, CHEM BIOL, V7, P197, DOI 10.1016/S1074-5521(00)00088-0; Yasuda K, 2006, EUR J IMMUNOL, V36, P431, DOI 10.1002/eji.200535210; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707	29	71	74	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2006	281	37					27503	27511		10.1074/jbc.M605003200	http://dx.doi.org/10.1074/jbc.M605003200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082PB	16857668	hybrid			2022-12-27	WOS:000240397700077
J	Xu, H; Wickner, W				Xu, Hao; Wickner, William			Bem1p is a positive regulator of the homotypic fusion of yeast vacuoles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR MEMBRANE-FUSION; NSF ATTACHMENT PROTEINS; VERTEX RING DOMAIN; SACCHAROMYCES-CEREVISIAE; PX DOMAIN; NUCLEOTIDE EXCHANGE; KINASE CASCADE; ALPHA-SNAP; DOCKING; COMPLEX	Docked vacuoles are believed to undergo rapid lipid mixing during hemifusion and then a slow, rate-limiting completion of fusion and mixing of lumenal contents. Previous genomic analysis has suggested that Bem1p, a scaffold protein critical for cell polarity, may support vacuole fusion. We now report that bem1 Delta strains have fragmented vacuoles (vps class B and C). During in vitro fusion reactions, vacuoles from bem1 Delta strains showed a strong reduction in the rate of lipid mixing when compared with vacuoles from the BEM1 parent. The reduction in the overall rate of fusion with bem1 Delta vacuoles was modest, consistent with lipid mixing as a non-rate-limiting step in the pathway. Although the fusion of either BEM1 (wild-type) or bem1 Delta vacuoles is stimulated by recombinant Bem1p, the lipid mixing of docked bem1 Delta vacuoles is highly dependent on rBem1p under certain reaction conditions. Bem1p-stimulated lipid mixing is blocked by well characterized fusion inhibitors including lipid ligands and antibodies to Ypt7p, Vps33p, and Vam3p. Although full-length Bem1p is required for maximal stimulation, a truncation mutant comprising the SH3 domains and the Phox homology (PX) domain retains modest stimulatory activity. In contrast to an earlier report (Han, B. K., Bogomolnaya, L. M., Totten, J. M., Blank, H. M., Dangott, L. J., and Polymenis, M. (2005) Genes Dev. 19, 2606-2618), we did not find phosphorylation of Bem1p at Ser-72 to be required for Bem1p-stimulated fusion. Taken together, Bem1p is a positive regulator of lipid mixing during vacuole hemifusion and fusion.	Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA	Dartmouth College	Wickner, W (corresponding author), Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Biochem, 7200 Vail Bldg, Hanover, NH 03755 USA.	Bill.Wickner@Dartmouth.edu	Xu, Hao/B-3194-2011	Xu, Hao/0000-0002-5776-0276				Ago T, 2001, BIOCHEM BIOPH RES CO, V287, P733, DOI 10.1006/bbrc.2001.5629; Andrews NW, 2005, TRENDS CELL BIOL, V15, P626, DOI 10.1016/j.tcb.2005.09.001; Bose I, 2001, J BIOL CHEM, V276, P7176, DOI 10.1074/jbc.M010546200; Brachmann CB, 1998, YEAST, V14, P115; Burgoyne RD, 2003, BBA-MOL CELL RES, V1641, P137, DOI 10.1016/S0167-4889(03)00089-2; Butty AC, 2002, EMBO J, V21, P1565, DOI 10.1093/emboj/21.7.1565; Chapman ER, 2002, NAT REV MOL CELL BIO, V3, P498, DOI 10.1038/nrm855; Eitzen G, 2003, BBA-MOL CELL RES, V1641, P175, DOI 10.1016/S0167-4889(03)00087-9; Eitzen G, 2002, J CELL BIOL, V158, P669, DOI 10.1083/jcb.200204089; Eitzen G, 2001, EMBO J, V20, P5650, DOI 10.1093/emboj/20.20.5650; Fratti RA, 2004, J CELL BIOL, V167, P1087, DOI 10.1083/jcb.200409068; Gaits F, 1999, MOL BIOL CELL, V10, P2647, DOI 10.1091/mbc.10.8.2647; Gerst JE, 2003, BBA-MOL CELL RES, V1641, P99, DOI 10.1016/S0167-4889(03)00096-X; Giraudo CG, 2005, J CELL BIOL, V170, P249, DOI 10.1083/jcb.200501093; GUELMAN R, 2002, BONE, V30, P23; Haas A, 1996, EMBO J, V15, P3296, DOI 10.1002/j.1460-2075.1996.tb00694.x; Haas Albert, 1995, Methods in Cell Science, V17, P283, DOI 10.1007/BF00986234; Han BK, 2005, GENE DEV, V19, P2606, DOI 10.1101/gad.1361505; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; Hiesinger PR, 2005, CELL, V121, P607, DOI 10.1016/j.cell.2005.03.012; Hiroaki H, 2001, NAT STRUCT BIOL, V8, P526, DOI 10.1038/88591; Huynh H, 2004, NAT CELL BIOL, V6, P831, DOI 10.1038/ncb1164; Ito T, 2001, EMBO J, V20, P3938, DOI 10.1093/emboj/20.15.3938; Jahn R, 2000, NEURON, V27, P201, DOI 10.1016/S0896-6273(00)00029-5; Karathanassis D, 2002, EMBO J, V21, P5057, DOI 10.1093/emboj/cdf519; LEEUW T, 1995, SCIENCE, V270, P1210, DOI 10.1126/science.270.5239.1210; Lu XB, 2005, J BIOL CHEM, V280, P30538, DOI 10.1074/jbc.M506862200; Lyons DM, 1996, MOL CELL BIOL, V16, P4095; Mayer A, 2002, ANNU REV CELL DEV BI, V18, P289, DOI 10.1146/annurev.cellbio.18.032202.114809; Mayer A, 1996, CELL, V85, P83, DOI 10.1016/S0092-8674(00)81084-3; Muller O, 2001, EMBO J, V20, P5657, DOI 10.1093/emboj/20.20.5657; NAGIEC EE, 1995, J BIOL CHEM, V270, P29182, DOI 10.1074/jbc.270.49.29182; Nichols BJ, 1997, NATURE, V387, P199, DOI 10.1038/387199a0; Peters C, 1999, SCIENCE, V285, P1084, DOI 10.1126/science.285.5430.1084; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Roth MG, 1997, CURR OPIN CELL BIOL, V9, P519, DOI 10.1016/S0955-0674(97)80028-2; SAMBROOK J, 1989, MOL CLONING LAB MANU, pA1; Sato TK, 2000, MOL CELL, V6, P661, DOI 10.1016/S1097-2765(00)00064-2; Seals DF, 2000, P NATL ACAD SCI USA, V97, P9402, DOI 10.1073/pnas.97.17.9402; Seeley ES, 2002, MOL BIOL CELL, V13, P782, DOI 10.1091/mbc.01-10-0512; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Simonsen A, 2001, CURR OPIN CELL BIOL, V13, P485, DOI 10.1016/S0955-0674(00)00240-4; Steel GJ, 1998, FEBS LETT, V423, P113, DOI 10.1016/S0014-5793(98)00072-6; Stroupe C, 2006, EMBO J, V25, P1579, DOI 10.1038/sj.emboj.7601051; Thorngren N, 2004, EMBO J, V23, P2765, DOI 10.1038/sj.emboj.7600286; Ungermann C, 2005, J CELL SCI, V118, P3819, DOI 10.1242/jcs.02561; Vollert CS, 2004, MOL CELL PROTEOMICS, V3, P1053, DOI 10.1074/mcp.M400081-MCP200; WADA Y, 1992, J BIOL CHEM, V267, P18671; Wang L, 2003, J CELL BIOL, V160, P365, DOI 10.1083/jcb.200209095; Wang L, 2002, CELL, V108, P357, DOI 10.1016/S0092-8674(02)00632-3; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Weixel KM, 2005, J BIOL CHEM, V280, P10501, DOI 10.1074/jbc.M414304200; WHITEHEART SW, 1993, NATURE, V362, P353, DOI 10.1038/362353a0; Wickner W, 2002, EMBO J, V21, P1241, DOI 10.1093/emboj/21.6.1241; Wurmser AE, 2000, J CELL BIOL, V151, P551, DOI 10.1083/jcb.151.3.551; Xu YB, 2005, NAT STRUCT MOL BIOL, V12, P417, DOI 10.1038/nsmb921; Yu JW, 2001, J BIOL CHEM, V276, P44179, DOI 10.1074/jbc.M108811200; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	58	15	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2006	281	37					27158	27166		10.1074/jbc.M605592200	http://dx.doi.org/10.1074/jbc.M605592200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082PB	16854988	hybrid			2022-12-27	WOS:000240397700043
J	Kumar, RS; Brannigan, JA; Prabhune, AA; Pundle, AV; Dodson, GG; Dodson, EJ; Suresh, CG				Kumar, R. Suresh; Brannigan, James A.; Prabhune, Asmita A.; Pundle, Archana V.; Dodson, Guy G.; Dodson, Eleanor J.; Suresh, C. G.			Structural and functional analysis of a conjugated bile salt hydrolase from Bifidobacterium longum reveals an evolutionary relationship with penicillin V acylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LACTIC-ACID BACTERIA; QUANTITATIVE-DETERMINATION; LACTOBACILLUS-PLANTARUM; PURIFICATION; CHOLESTEROL; CLONING; DECONJUGATION; EXPRESSION; GENE	Bile salt hydrolase (BSH) is an enzyme produced by the intestinal microflora that catalyzes the deconjugation of glycine- or taurine-linked bile salts. The crystal structure of BSH reported here from Bifidobacterium longum reveals that it is a member of N-terminal nucleophil hydrolase structural superfamily possessing the characteristic alpha beta beta alpha tetra-lamellar tertiary structure arrangement. Site-directed mutagenesis of the catalytic nucleophil residue, however, shows that it has no role in zymogen processing into its corresponding active form. Substrate specificity was studied using Michaelis-Menten and inhibition kinetics and fluorescence spectroscopy. These data were compared with the specificity profile of BSH from Clostridium perfrigens and pencillin V acylase from Bacillus sphaericus, for both of which the three-dimensional structures are available. Comparative analysis shows a gradation in activity toward common substrates, throwing light on a possible common route toward the evolution of pencillin V acylase and BSH.	Natl Chem Lab, Div Chem Sci, Pune 410008, Maharashtra, India; Univ York, Dept Chem, Struct Biol Lab, York YO10 5YW, N Yorkshire, England	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL); University of York - UK	Brannigan, JA (corresponding author), Natl Chem Lab, Div Chem Sci, Pune 410008, Maharashtra, India.	jab@ysbl.york.ac.uk; cg.suresh@ncl.res.in	Ramasamy, Sureshkumar/C-1744-2017	Ramasamy, Sureshkumar/0000-0002-2088-8065; prabhune, Asmita/0000-0003-1839-2105	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bahar RJ, 1999, GASTROENTEROL CLIN N, V28, P27, DOI 10.1016/S0889-8553(05)70042-X; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BATTA AK, 1990, J BIOL CHEM, V265, P10925; BATTA AK, 1984, J BIOL CHEM, V259, P5035; BRANNIGAN JA, 1995, NATURE, V378, P416, DOI 10.1038/378416a0; Chandra PM, 2005, ACTA CRYSTALLOGR F, V61, P124, DOI 10.1107/S1744309104031227; CHIKAI T, 1987, LIPIDS, V22, P669, DOI 10.1007/BF02533948; CHRISTIAENS H, 1992, APPL ENVIRON MICROB, V58, P3792, DOI 10.1128/AEM.58.12.3792-3798.1992; COLEMAN JP, 1995, APPL ENVIRON MICROB, V61, P2514, DOI 10.1128/AEM.61.7.2514-2520.1995; Colloc'h N, 2000, PROTEINS, V39, P142, DOI 10.1002/(SICI)1097-0134(20000501)39:2<142::AID-PROT4>3.0.CO;2-X; Dambekodi PC, 1998, J DAIRY SCI, V81, P1818, DOI 10.3168/jds.S0022-0302(98)75751-0; De Boever P, 1999, J APPL MICROBIOL, V87, P345, DOI 10.1046/j.1365-2672.1999.00019.x; De Smet I, 1998, BRIT J NUTR, V79, P185, DOI 10.1079/BJN19980030; Dussurget O, 2002, MOL MICROBIOL, V45, P1095, DOI 10.1046/j.1365-2958.2002.03080.x; EFTINK MR, 1976, BIOCHEMISTRY-US, V15, P672, DOI 10.1021/bi00648a035; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GRILL JP, 1995, APPL ENVIRON MICROB, V61, P2577, DOI 10.1128/AEM.61.7.2577-2582.1995; Hofmann AF, 1999, NEWS PHYSIOL SCI, V14, P24, DOI 10.1152/physiologyonline.1999.14.1.24; HOFMANN AF, 1984, J LIPID RES, V25, P1477; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Jones ML, 2004, J BIOMED BIOTECHNOL, P61, DOI 10.1155/S1110724304307011; Kaufmann P, 1997, APPL ENVIRON MICROB, V63, P1268, DOI 10.1128/AEM.63.4.1268-1273.1997; Knarreborg A, 2002, APPL ENVIRON MICROB, V68, P6425, DOI 10.1128/AEM.68.12.6425-6428.2002; Kumar RS, 2004, ACTA CRYSTALLOGR D, V60, P1665, DOI 10.1107/S0907444904017561; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE YP, 1966, ANAL BIOCHEM, V14, P71, DOI 10.1016/0003-2697(66)90057-1; LEHRER SS, 1971, BIOCHEMISTRY-US, V10, P3254, DOI 10.1021/bi00793a015; Lim Hyeong-Jun, 2004, J Vet Sci, V5, P391; Lisy JM, 1998, COMPUT CHEM, V22, P509, DOI 10.1016/S0097-8485(98)00014-X; MARTEAU P, 1993, FEMS MICROBIOL REV, V12, P207, DOI [10.1016/0168-6445(93)90064-G, 10.1111/j.1574-6976.1993.tb00019.x]; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oinonen C, 2000, PROTEIN SCI, V9, P2329, DOI 10.1110/ps.9.12.2329; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; Rossocha M, 2005, BIOCHEMISTRY-US, V44, P5739, DOI 10.1021/bi0473206; STELLWAG EJ, 1976, BIOCHIM BIOPHYS ACTA, V452, P165, DOI 10.1016/0005-2744(76)90068-1; Suresh CG, 1999, NAT STRUCT BIOL, V6, P414, DOI 10.1038/8213; Tanaka H, 1999, J DAIRY SCI, V82, P2530, DOI 10.3168/jds.S0022-0302(99)75506-2; Tanaka H, 2000, APPL ENVIRON MICROB, V66, P2502, DOI 10.1128/AEM.66.6.2502-2512.2000; TANNOCK GW, 1989, APPL ENVIRON MICROB, V55, P1848, DOI 10.1128/AEM.55.7.1848-1851.1989; Thomas LA, 2000, GASTROENTEROLOGY, V119, P806, DOI 10.1053/gast.2000.16495; Torchia EC, 2001, BMC BIOCHEM, V2, DOI 10.1186/1471-2091-2-11; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780	43	109	115	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32516	32525		10.1074/jbc.M604172200	http://dx.doi.org/10.1074/jbc.M604172200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16905539	hybrid			2022-12-27	WOS:000241414500049
J	Bowman, BJ; McCall, ME; Baertsch, R; Bowman, EJ				Bowman, Barry J.; McCall, Mary E.; Baertsch, Robert; Bowman, Emma Jean			A model for the proteolipid ring and bafilomycin/concanamycin-binding site in the vacuolar ATPase of Neurospora crassa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST V-ATPASE; H+-ATPASE; SUBUNIT-C; SACCHAROMYCES-CEREVISIAE; PROTON PUMP; ENTEROCOCCUS-HIRAE; MEMBRANE DOMAIN; CONCANAMYCIN-A; NA+-ATPASE; PROTEIN	The vacuolar ATPase has been implicated in a variety of physiological processes in eukaryotic cells. Bafilomycin and concanamycin, highly potent and specific inhibitors of the vacuolar ATPase, have been widely used to investigate the enzyme. Derivatives have been developed as possible therapeutic drugs. We have used random mutagenesis and site-directed mutagenesis to identify 23 residues in the c subunit involved in binding these drugs. We generated a model for the structure of the ring of c subunits in Neurospora crassa by using data from the crystal structure of the homologous subunits of the bacterium Enterococcus hirae (Murata, T., Yamato, I., Kakinuma, Y., Leslie, A. G., and Walker, J.E. (2005) Science 308, 654-659). In the model 10 of the 11 mutation sites that confer the highest degree of resistance are closely clustered. They form a putative drug-binding pocket at the interface between helices 1 and 2 on one c subunit and helix 4 of the adjacent c subunit. The excellent fit of the N. crassa sequence to the E. hirae structure and the degree to which the structural model predicts the clustering of these residues suggest that the folding of the bacterial and eukaryotic polypeptides is very similar.	Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Bowman, EJ (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA.	bowman@biology.ucsc.edu		Baertsch, Robert/0000-0002-4733-2649	NIGMS NIH HHS [GM058903] Funding Source: Medline; PHS HHS [22XS013A] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM058903] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARAI H, 1988, J BIOL CHEM, V263, P8796; BAKER GH, 1987, TETRAHEDRON LETT, V28, P5565, DOI 10.1016/S0040-4039(00)96783-2; Beutler JA, 2003, CURR MED CHEM, V10, P787, DOI 10.2174/0929867033457827; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; BLAIR HC, 1989, SCIENCE, V245, P855, DOI 10.1126/science.2528207; Bowman BJ, 2002, J BIOL CHEM, V277, P3965, DOI 10.1074/jbc.M109756200; Bowman EJ, 2000, J BIOL CHEM, V275, P167, DOI 10.1074/jbc.275.1.167; Bowman EJ, 2004, J BIOL CHEM, V279, P33131, DOI 10.1074/jbc.M404638200; Bowman EJ, 2003, J BIOL CHEM, V278, P44147, DOI 10.1074/jbc.M306595200; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; BOWMAN EJ, 1997, BIOMEMBRANE, P861; Boyd MR, 2001, J PHARMACOL EXP THER, V297, P114; Chavez C, 2006, J BIOL CHEM, V281, P27052, DOI 10.1074/jbc.M603883200; DAVIS RH, 2000, NEUROSPORA CONTRIBUT, P273; DROSE S, 1993, BIOCHEMISTRY-US, V32, P3902, DOI 10.1021/bi00066a008; Drose S, 1997, J EXP BIOL, V200, P1; Farina C, 2001, FARMACO, V56, P113, DOI 10.1016/S0014-827X(01)01013-8; Farina C, 2002, CURR PHARM DESIGN, V8, P2033, DOI 10.2174/1381612023393369; FOSTER DL, 1982, J BIOL CHEM, V257, P2009; Girvin ME, 1998, BIOCHEMISTRY-US, V37, P8817, DOI 10.1021/bi980511m; Harrison M, 2003, J BIOENERG BIOMEMBR, V35, P337, DOI 10.1023/A:1025728915565; Harrison M, 2000, BIOCHEMISTRY-US, V39, P7531, DOI 10.1021/bi000159o; Harrison MA, 1999, J BIOL CHEM, V274, P25461, DOI 10.1074/jbc.274.36.25461; Hirata R, 1997, J BIOL CHEM, V272, P4795, DOI 10.1074/jbc.272.8.4795; Hirata T, 2003, J BIOL CHEM, V278, P23714, DOI 10.1074/jbc.M302756200; Huss M, 2002, J BIOL CHEM, V277, P40544, DOI 10.1074/jbc.M207345200; Imamura H, 2003, P NATL ACAD SCI USA, V100, P2312, DOI 10.1073/pnas.0436796100; Iwata M, 2004, P NATL ACAD SCI USA, V101, P59, DOI 10.1073/pnas.0305165101; Izumi H, 2003, CANCER TREAT REV, V29, P541, DOI 10.1016/S0305-7372(03)00106-3; JOHN UP, 1986, FEBS LETT, V207, P79, DOI 10.1016/0014-5793(86)80016-3; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Karet FE, 1999, NAT GENET, V21, P84, DOI 10.1038/5022; Kawasaki-Nishi S, 2003, J BIOL CHEM, V278, P41908, DOI 10.1074/jbc.M308026200; Kawasaki-Nishi S, 2001, P NATL ACAD SCI USA, V98, P12397, DOI 10.1073/pnas.221291798; MANDEL M, 1988, P NATL ACAD SCI USA, V85, P5521, DOI 10.1073/pnas.85.15.5521; Margolin B.S., 1997, FUNGAL GENET REP, V44, P34, DOI [10.4148/1941-4765.1281, DOI 10.4148/1941-4765.1281, DOI 10.1128/EC.00244-07]; MCLACHLAN AD, 1982, ACTA CRYSTALLOGR A, V38, P871, DOI 10.1107/S0567739482001806; Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199; Melnik VI, 1996, BBA-BIOENERGETICS, V1273, P77, DOI 10.1016/0005-2728(95)00144-1; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; Murata T, 2003, J BIOL CHEM, V278, P21162, DOI 10.1074/jbc.M301620200; NAKAI H, 1992, ACTA CRYSTALLOGR C, V48, P1519, DOI 10.1107/S0108270191014749; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Sachs MS, 1997, NUCLEIC ACIDS RES, V25, P2389, DOI 10.1093/nar/25.12.2389; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; SEBALD W, 1979, EUR J BIOCHEM, V93, P587, DOI 10.1111/j.1432-1033.1979.tb12859.x; Sennoune SR, 2004, AM J PHYSIOL-CELL PH, V286, pC1443, DOI 10.1152/ajpcell.00407.2003; SIGRISTNELSON K, 1978, EUR J BIOCHEM, V92, P9, DOI 10.1111/j.1432-1033.1978.tb12717.x; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Sun-Wada GH, 2004, BBA-BIOENERGETICS, V1658, P106, DOI 10.1016/j.bbabio.2004.04.013; Venzke D, 2005, J MOL BIOL, V349, P659, DOI 10.1016/j.jmb.2005.04.033; VOGEL HJ, 1964, AM NAT, V98, P435, DOI 10.1086/282338; Wang YR, 2005, J BIOL CHEM, V280, P40481, DOI 10.1074/jbc.M509106200; Whyteside G, 2005, BIOCHEMISTRY-US, V44, P15024, DOI 10.1021/bi051529h; Wilkens S, 2001, J BIOL CHEM, V276, P44064, DOI 10.1074/jbc.M106579200; Yokoyama K, 2005, J BIOENERG BIOMEMBR, V37, P405, DOI 10.1007/s10863-005-9480-1	57	59	61	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31885	31893		10.1074/jbc.M605532200	http://dx.doi.org/10.1074/jbc.M605532200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16912037	Bronze			2022-12-27	WOS:000241235300075
J	Clarke, EE; Churcher, I; Ellis, S; Wrigley, JDJ; Lewis, HD; Harrison, T; Shearman, MS; Beher, D				Clarke, Earl E.; Churcher, Ian; Ellis, Semantha; Wrigley, Jonathan D. J.; Lewis, Huw D.; Harrison, Timothy; Shearman, Mark S.; Beher, Dirk			Intra- or intercomplex binding to the gamma-secretase enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL ALZHEIMERS-DISEASE; AMYLOID PRECURSOR PROTEIN; SIGNAL PEPTIDE PEPTIDASE; ACTIVE-SITE; MISSENSE MUTATIONS; INHIBITOR BINDING; BETA-APP; PRESENILIN; COMPLEX; NICASTRIN	gamma-Secretase is one of the critical enzymes required for the generation of amyloid-beta peptides from the beta-amyloid precursor protein. Because amyloid-beta peptides are generally accepted to play a key role in Alzheimer disease, gamma-secretase inhibition holds the promise for a disease-modifying therapy for this neurodegenerative condition. Although recent progress has enhanced the understanding of the biology and composition of the gamma-secretase enzyme complex, less information is available on the actual interaction of various inhibitor classes with the enzyme. Here we show that the two principal classes of inhibitor described in the scientific and patent literature, aspartyl protease transition state analogue and small molecule non-transition state inhibitors, display fundamental differences in the way they interact with the enzyme. Taking advantage of a gamma-secretase enzyme overexpressing cellular system and different radiolabeled gamma-secretase inhibitors, we observed that the maximal binding of nontransition state gamma-secretase inhibitors accounts only for half the number of catalytic sites of the recombinant enzyme complex. This characteristic stoichiometry can be best accommodated with a model whereby the non-transition state inhibitors bind to a unique site at the interface of a dimeric enzyme. Subsequent competition studies confirm that this site appears to be targeted by the main classes of small molecule gamma-secretase inhibitor. In contrast, the non-steroidal anti-inflammatory drug gamma-secretase modulator sulindac sulfide displayed noncompetitive antagonism for all types of inhibitor. This finding suggests that non-steroidal anti-inflammatory drug-type gamma-secretase modulators target an alternative site on the enzyme, thereby changing the conformation of the binding sites for gamma-secretase inhibitors.	Merck Sharp & Dohme Res Labs, Neurosci Res Ctr, Dept Mol & Cellular Neurosci, Harlow CM20 2QR, Essex, England; Merck Sharp & Dohme Res Labs, Neurosci Res Ctr, Dept Med Chem, Harlow CM20 2QR, Essex, England	Merck & Company; GlaxoSmithKline; Merck & Company	Beher, D (corresponding author), Amgen Inc, Dept Neurosci, 1 Amgen Ctr Dr, Thousand Oaks, CA 91320 USA.	dbeher@amgen.com		Beher, Dirk/0000-0001-8005-5359				Barten DM, 2005, J PHARMACOL EXP THER, V312, P635, DOI 10.1124/jpet.104.075408; Beher D, 2004, J BIOL CHEM, V279, P43419, DOI 10.1074/jbc.M404937200; Beher D, 2003, BIOCHEMISTRY-US, V42, P8133, DOI 10.1021/bi034045z; Beher D, 2001, J BIOL CHEM, V276, P45394, DOI 10.1074/jbc.M103075200; Capell A, 1998, J BIOL CHEM, V273, P3205, DOI 10.1074/jbc.273.6.3205; Churcher I, 2003, J MED CHEM, V46, P2275, DOI 10.1021/jm034058a; Churcher I, 2003, BIOORG MED CHEM LETT, V13, P179, DOI 10.1016/S0960-894X(02)00909-5; Edbauer D, 2002, P NATL ACAD SCI USA, V99, P8666, DOI 10.1073/pnas.132277899; Esler WP, 2002, P NATL ACAD SCI USA, V99, P2720, DOI 10.1073/pnas.052436599; Esler WP, 2000, NAT CELL BIOL, V2, P428, DOI 10.1038/35017062; Farmery MR, 2003, J BIOL CHEM, V278, P24277, DOI 10.1074/jbc.M211992200; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Goutte C, 2002, P NATL ACAD SCI USA, V99, P775, DOI 10.1073/pnas.022523499; Guo W, 2005, P NATL ACAD SCI USA, V102, P17495, DOI 10.1073/pnas.0508950102; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harrison T, 2004, CURR OPIN DRUG DISC, V7, P709; Hebert SS, 2004, NEUROBIOL DIS, V17, P260, DOI 10.1016/j.nbd.2004.08.002; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; LEVYLAHAD E, 1995, SCIENCE, V269, P970, DOI 10.1126/science.7638621; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Lewis SJ, 2005, BIOORG MED CHEM LETT, V15, P373, DOI 10.1016/j.bmcl.2004.10.062; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Milano J, 2004, TOXICOL SCI, V82, P341, DOI 10.1093/toxsci/kfh254; Nyborg AC, 2004, J BIOL CHEM, V279, P15153, DOI 10.1074/jbc.M309305200; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Scheer JM, 2006, P NATL ACAD SCI USA, V103, P7595, DOI 10.1073/pnas.0602571103; Schroeter EH, 2003, P NATL ACAD SCI USA, V100, P13075, DOI 10.1073/pnas.1735338100; Searfoss GH, 2003, J BIOL CHEM, V278, P46107, DOI 10.1074/jbc.M307757200; Seiffert D, 2000, J BIOL CHEM, V275, P34086, DOI 10.1074/jbc.M005430200; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Shearman MS, 2000, BIOCHEMISTRY-US, V39, P8698, DOI 10.1021/bi0005456; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Shirotani K, 2004, J BIOL CHEM, V279, P41340, DOI 10.1074/jbc.M405768200; Siemers E, 2005, CLIN NEUROPHARMACOL, V28, P126, DOI 10.1097/01.wnf.0000167360.27670.29; SMITH DW, 2005, Patent No. 6967196; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Teall M, 2005, BIOORG MED CHEM LETT, V15, P2685, DOI 10.1016/j.bmcl.2004.12.017; Tian GC, 2003, J BIOL CHEM, V278, P28968, DOI 10.1074/jbc.M300905200; Tian GC, 2002, J BIOL CHEM, V277, P31499, DOI 10.1074/jbc.M112328200; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wang J, 2006, J NEUROCHEM, V96, P218, DOI 10.1111/j.1471-4159.2005.03548.x; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Weihofen A, 2003, J BIOL CHEM, V278, P16528, DOI 10.1074/jbc.M301372200; Wolfe MS, 1998, J MED CHEM, V41, P6, DOI 10.1021/jm970621b; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wong GT, 2004, J BIOL CHEM, V279, P12876, DOI 10.1074/jbc.M311652200; Wrigley JDJ, 2005, J BIOL CHEM, V280, P12523, DOI 10.1074/jbc.M413086200; Wrigley JDJ, 2004, J NEUROCHEM, V90, P1312, DOI 10.1111/j.1471-4159.2004.02596.x; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009; Yu G, 1998, J BIOL CHEM, V273, P16470, DOI 10.1074/jbc.273.26.16470	51	41	46	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31279	31289		10.1074/jbc.M605051200	http://dx.doi.org/10.1074/jbc.M605051200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16899457	Bronze			2022-12-27	WOS:000241235300012
J	Durkin, SS; Ward, MD; Fryrear, KA; Semmes, OJ				Durkin, Sarah S.; Ward, Michael D.; Fryrear, Kimberly A.; Semmes, O. John			Site-specific phosphorylation differentiates active from inactive forms of the human T-cell leukemia virus type 1 Tax oncoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HTLV-I TAX; NF-KAPPA-B; TANDEM MASS-SPECTROMETRY; DNA-BINDING; ACTIVATION; PROTEINS; TRANSCRIPTION; DOMAIN; UBIQUITINATION; TRANSFORMATION	The human T-cell leukemia virus type 1 oncoprotein Tax is a phosphoprotein with a predominately nuclear subcellular localization that accomplishes multiple functions via protein-protein interactions. It has been proposed that regulation of this protein's pleiotropic functions may be accomplished through phosphorylation of specific amino acid residues. We have conducted a phosphoryl mapping of mammalian-expressed Tax protein using a combination of affinity purification, liquid chromatography tandem mass spectrometry, and site-directed substitution mutational analysis. We achieved physical coverage of 77% of the Tax sequence and identified four novel sites of phosphorylation at Thr-48, Thr-184, Thr-215, and Ser-336. Previously identified potential serine phosphorylation sites at Ser-10, Ser-77, and Ser-274 could not be confirmed by mass spectrometry. The functional significance of these novel phosphorylation events was evaluated by mutational analysis and subsequent evaluation for activity via both CREB and NF-kappa B-responsive promoters. Our results demonstrate that phosphorylation at Thr-215 is associated with loss of both Tax functions, phosphorylation at Thr-48 was specifically deficient for activation via NF-kappa B, and phosphorylation at Thr-184 and Ser-336 had no effect on these Tax functions. Semiquantitation of phosphopeptides revealed that the majority of Tax was phosphorylated at Thr-48, Thr-184, Thr-215, and Ser-336, whereas only a minor population of Tax was phosphorylated at either Ser-300 or Ser-301. These results suggest that both positive and negative phosphorylation signals result in the maintenance of a subfraction of Tax as "active" protein.	Eastern Virginia Med Sch, Ctr Biomed Proteom, Dept Microbiol & Mol Cell Biol, Norfolk, VA 23507 USA	Eastern Virginia Medical School	Semmes, OJ (corresponding author), Eastern Virginia Med Sch, Ctr Biomed Proteom, Dept Microbiol & Mol Cell Biol, 700 W Olney Rd, Norfolk, VA 23507 USA.	semmesoj@evms.edu	Semmes, Oliver/GQA-5179-2022		NCI NIH HHS [R01 CA076595] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA076595] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alefantis T, 2003, J BIOL CHEM, V278, P21814, DOI 10.1074/jbc.M211576200; Arnott David, 2003, J Biomol Tech, V14, P205; Basbous J, 2003, J VIROL, V77, P13028, DOI 10.1128/JVI.77.24.13028-13035.2003; Bex F, 1999, J VIROL, V73, P738, DOI 10.1128/JVI.73.1.738-745.1999; Boehm AK, 1999, J BIOMED SCI, V6, P206, DOI 10.1007/BF02255904; Burton M, 2000, J VIROL, V74, P2351, DOI 10.1128/JVI.74.5.2351-2364.2000; Chiari E, 2004, J VIROL, V78, P11823, DOI 10.1128/JVI.78.21.11823-11832.2004; FONTES JD, 1993, J VIROL, V67, P4436, DOI 10.1128/JVI.67.7.4436-4441.1993; Gachon F, 1998, J VIROL, V72, P8332, DOI 10.1128/JVI.72.10.8332-8337.1998; Gachon F, 2000, MOL CELL BIOL, V20, P3470, DOI 10.1128/MCB.20.10.3470-3481.2000; GESSAIN A, 1985, LANCET, V2, P407; Grassmann R, 2005, ONCOGENE, V24, P5976, DOI 10.1038/sj.onc.1208978; Haoudi A, 2003, J BIOL CHEM, V278, P37736, DOI 10.1074/jbc.M301649200; Haoudi A, 2003, VIROLOGY, V305, P229, DOI 10.1006/viro.2002.1642; Harrod R, 1998, MOL CELL BIOL, V18, P5052, DOI 10.1128/MCB.18.9.5052; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; Jaffe H, 1998, BIOCHEMISTRY-US, V37, P16211, DOI 10.1021/bi981264p; JEANG KT, 1988, MECHANISMS CONTROL G, P181; Jin DY, 1997, NUCLEIC ACIDS RES, V25, P379, DOI 10.1093/nar/25.2.379; KIM JS, 1993, PROTEIN SCI, V2, P348; Kimzey AL, 1999, J BIOL CHEM, V274, P34226, DOI 10.1074/jbc.274.48.34226; Lamsoul I, 2005, MOL CELL BIOL, V25, P10391, DOI 10.1128/MCB.25.23.10391-10406.2005; Loyet KM, 2005, MOL CELL PROTEOMICS, V4, P235, DOI 10.1074/mcp.R400011-MCP200; Majone F, 2000, J BIOL CHEM, V275, P32906, DOI 10.1074/jbc.C000538200; Majone F, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-45; Marriott SJ, 2005, ONCOGENE, V24, P5986, DOI 10.1038/sj.onc.1208976; Matsuoka M, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-27; McLachlin DT, 2001, CURR OPIN CHEM BIOL, V5, P591, DOI 10.1016/S1367-5931(00)00250-7; Nasr R, 2006, BLOOD, V107, P4021, DOI 10.1182/blood-2005-09-3572; Neubauer G, 1999, ANAL CHEM, V71, P235, DOI 10.1021/ac9804902; OSAME M, 1986, LANCET, V1, P1031; Peloponese JM, 2004, J VIROL, V78, P11686, DOI 10.1128/JVI.78.21.11686-11695.2004; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; RADONOVICH M, 1989, J VIROL, V63, P2987, DOI 10.1128/JVI.63.7.2987-2994.1989; Rousset R, 1998, ONCOGENE, V16, P643, DOI 10.1038/sj.onc.1201567; Sakamoto Y, 1997, ONCOGENE, V15, P2001, DOI 10.1038/sj.onc.1201391; SEMMES OJ, 1995, J VIROL, V69, P1827, DOI 10.1128/JVI.69.3.1827-1833.1995; SEMMES OJ, 1992, J VIROL, V66, P7183, DOI 10.1128/JVI.66.12.7183-7192.1992; SEMMES OJ, 1992, VIROLOGY, V188, P754, DOI 10.1016/0042-6822(92)90530-3; SMITH MR, 1990, GENE DEV, V4, P1875, DOI 10.1101/gad.4.11.1875; Sun SC, 2005, ONCOGENE, V24, P5952, DOI 10.1038/sj.onc.1208969; TAYLOR WE, 1990, P NATL ACAD SCI USA, V87, P4098, DOI 10.1073/pnas.87.11.4098; Tie F, 1996, J VIROL, V70, P8368, DOI 10.1128/JVI.70.12.8368-8374.1996; Tootle TL, 2005, BIOESSAYS, V27, P285, DOI 10.1002/bies.20198; Whitmarsh AJ, 2000, CELL MOL LIFE SCI, V57, P1172, DOI 10.1007/PL00000757; Xiao GT, 2000, J BIOL CHEM, V275, P34060, DOI 10.1074/jbc.M002970200; Yamaoka S, 1996, EMBO J, V15, P873, DOI 10.1002/j.1460-2075.1996.tb00422.x; YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031; Yoshida M, 2001, ANNU REV IMMUNOL, V19, P475, DOI 10.1146/annurev.immunol.19.1.475	49	37	40	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31705	31712		10.1074/jbc.M607011200	http://dx.doi.org/10.1074/jbc.M607011200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16923801	Bronze			2022-12-27	WOS:000241235300056
J	Noguera-Mazon, V; Lemoine, J; Walker, O; Rouhier, N; Salvador, A; Jacquot, JP; Lancelin, JM; Krimm, I				Noguera-Mazon, Valerie; Lemoine, Jerome; Walker, Olivier; Rouhier, Nicolas; Salvador, Arnaud; Jacquot, Jean-Pierre; Lancelin, Jean-Marc; Krimm, Isabelle			Glutathionylation induces the dissociation of 1-Cys D-peroxiredoxin non-covalent homodimer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; 2-CYS PEROXIREDOXIN; THIOL PEROXIDASE; MYCOBACTERIUM-TUBERCULOSIS; HYDROPEROXIDE REDUCTASE; ANGSTROM RESOLUTION; II PEROXIREDOXIN; PROTEIN FUNCTION; SULFINIC ACID; GLUTAREDOXIN	1-Cys peroxiredoxins (1-Cys Prxs) are antioxidant enzymes that catalyze the reduction of hydroperoxides into alcohols using a strictly conserved cysteine. 1-Cys B-Prxs, homologous to human PrxVI, were recently shown to be reactivated by glutathione S-transferase (GST) pi via the formation of a GST-Prx heterodimer and Prx glutathionylation. In contrast, 1-Cys D-Prxs, homologous to human PrxV, are reactivated by the glutaredoxin-glutathione system through an unknown mechanism. To investigate the mechanistic events that mediate the 1-Cys D-Prx regeneration, interaction of the Prx with glutathione was studied by mass spectrometry and NMR. This work reveals that the Prx can be glutathionylated on its active site cysteine. Evidences are reported that the glutathionylation of 1-Cys D-Prx induces the dissociation of the Prx non-covalent homodimer, which can be recovered by reduction with dithiothreitol. This work demonstrates for the first time the existence of a redox-dependent dimer-monomer switch in the Prx family, similar to the decamer-dimer switch for the 2-Cys Prxs.	Univ Lyon 1, RMN Biomol, ESPCE Lyon, CNRS,Unite Mixte Rech 5180 Sci Analyt, F-69622 Villeurbanne, France; Univ Nancy 1, INRA, Unite Mixte Rech 1136, IFR110 Genom Ecophysiol & Ecol Fonct, F-54506 Vandoeuvre Les Nancy, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; INRAE; Universite de Lorraine	Krimm, I (corresponding author), Univ Lyon 1, RMN Biomol, ESPCE Lyon, CNRS,Unite Mixte Rech 5180 Sci Analyt, Domaine Sci Doua, F-69622 Villeurbanne, France.	isabelle@hikari.cpe.fr	WALKER, Olivier/B-2580-2016; Lancelin, Jean-marc/AAC-5686-2019; Jacquot, Jean-Pierre/A-1571-2012; lemoine, jerome/C-4272-2014; Krimm, Isabelle/O-4972-2014; Salvador, Arnaud/R-7846-2017	WALKER, Olivier/0000-0001-7284-2555; Jacquot, Jean-Pierre/0000-0003-4975-8587; lemoine, jerome/0000-0002-5497-6880; Krimm, Isabelle/0000-0002-5981-109X; Rouhier, Nicolas/0000-0002-2036-7884; Salvador, Arnaud/0000-0002-5981-3028				Alphey MS, 2000, J MOL BIOL, V300, P903, DOI 10.1006/jmbi.2000.3881; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Bouillac S, 2004, J BIOMOL NMR, V30, P105, DOI 10.1023/B:JNMR.0000042965.46172.1b; Brehelin C, 2003, PLANT PHYSIOL, V132, P2045, DOI 10.1104/pp.103.022533; Cha MK, 2004, J BIOL CHEM, V279, P11035, DOI 10.1074/jbc.M312657200; Chang TS, 2004, J BIOL CHEM, V279, P50994, DOI 10.1074/jbc.M409482200; Choi HJ, 1998, NAT STRUCT BIOL, V5, P400, DOI 10.1038/nsb0598-400; Choi J, 2005, PROTEINS, V61, P1146, DOI 10.1002/prot.20704; Choi JK, 2003, J BIOL CHEM, V278, P49478, DOI 10.1074/jbc.M309015200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Echalier A, 2005, BIOCHEMISTRY-US, V44, P1755, DOI 10.1021/bi048226s; Ellis HR, 1997, BIOCHEMISTRY-US, V36, P15013, DOI 10.1021/bi972191x; Fratelli M, 2002, P NATL ACAD SCI USA, V99, P3505, DOI 10.1073/pnas.052592699; Fratelli M, 2003, PROTEOMICS, V3, P1154, DOI 10.1002/pmic.200300436; Ghezzi P, 2005, FREE RADICAL RES, V39, P573, DOI 10.1080/10715760500072172; Giustarini D, 2004, J CELL MOL MED, V8, P201, DOI 10.1111/j.1582-4934.2004.tb00275.x; Guimaraes BG, 2005, J BIOL CHEM, V280, P25735, DOI 10.1074/jbc.M503076200; Hirotsu S, 1999, P NATL ACAD SCI USA, V96, P12333, DOI 10.1073/pnas.96.22.12333; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kim SJ, 2003, J BIOL CHEM, V278, P10790, DOI 10.1074/jbc.M209553200; Klatt P, 2000, EUR J BIOCHEM, V267, P4928, DOI 10.1046/j.1432-1327.2000.01601.x; Krishnan VV, 1998, J BIOMOL NMR, V12, P177, DOI 10.1023/A:1008226330666; Li S, 2005, J MOL BIOL, V346, P1035, DOI 10.1016/j.jmb.2004.12.046; Manevich Y, 2004, P NATL ACAD SCI USA, V101, P3780, DOI 10.1073/pnas.0400181101; Michelet L, 2005, P NATL ACAD SCI USA, V102, P16478, DOI 10.1073/pnas.0507498102; Mizohata E, 2005, J MOL BIOL, V354, P317, DOI 10.1016/j.jmb.2005.09.006; Parsonage D, 2005, BIOCHEMISTRY-US, V44, P10583, DOI 10.1021/bi050448i; Pauwels F, 2003, J BIOL CHEM, V278, P16658, DOI 10.1074/jbc.M300157200; Ralat LA, 2006, BIOCHEMISTRY-US, V45, P360, DOI 10.1021/bi0520737; Rouhier N, 2006, BIOCHEM BIOPH RES CO, V341, P1300, DOI 10.1016/j.bbrc.2006.01.099; Rouhier N, 2003, FEBS LETT, V554, P149, DOI 10.1016/S0014-5793(03)01156-6; Rouhier N, 2002, J BIOL CHEM, V277, P13609, DOI 10.1074/jbc.M111489200; Rouhier N, 2001, PLANT PHYSIOL, V127, P1299, DOI 10.1104/pp.010586; Sarma GN, 2005, J MOL BIOL, V346, P1021, DOI 10.1016/j.jmb.2004.12.022; Schroder E, 2000, STRUCTURE, V8, P605, DOI 10.1016/S0969-2126(00)00147-7; Sullivan DM, 2000, BIOCHEMISTRY-US, V39, P11121, DOI 10.1021/bi0007674; Trivelli X, 2003, BIOCHEMISTRY-US, V42, P14139, DOI 10.1021/bi035551r; Vergauwen B, 2001, J BIOL CHEM, V276, P20890, DOI 10.1074/jbc.M102026200; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Woo HA, 2005, J BIOL CHEM, V280, P3125, DOI 10.1074/jbc.C400496200; Wood ZA, 2002, BIOCHEMISTRY-US, V41, P5493, DOI 10.1021/bi012173m; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8	43	56	59	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31736	31742		10.1074/jbc.M602188200	http://dx.doi.org/10.1074/jbc.M602188200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16916801	Green Published, Bronze			2022-12-27	WOS:000241235300060
J	Coppe, JP; Kauser, K; Campisi, J; Beausejour, CM				Coppe, Jean-Philippe; Kauser, Katalin; Campisi, Judith; Beausejour, Christian M.			Secretion of vascular endothelial growth factor by primary human fibroblasts at senescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATIVE LIFE-SPAN; CELLULAR SENESCENCE; HUMAN-CELLS; IN-VIVO; EXPRESSION; CANCER; P53; ANGIOGENESIS; SENSITIVITY; VPF/VEGF	Cellular senescence prevents the proliferation of cells at risk for neoplastic transformation. Nonetheless, the senescence response is thought to be antagonistically pleiotropic and thus contribute to aging phenotypes, including, ironically, late life cancers. The cancer- promoting activity of senescent cells is likely due to secreted molecules, the identity of which remains largely unknown. Here, we have shown that senescent fibroblasts, much more than presenescent fibroblasts, stimulate tumor vascularization in mice. Weakly malignant epithelial cells co- injected with senescent fibroblasts had larger and greater numbers of blood vessels compared with controls. Accordingly, increased vascular endothelial growth factor ( VEGF) expression was a frequent characteristic of senescent human and mouse fibroblasts in culture. Importantly, conditioned medium from senescent fibroblasts, more than medium from presenescent cells, stimulates cultured human umbilical vein endothelial cells to invade a basement membrane, a hallmark of angiogenesis. Increased VEGF expression was specific to the senescent phenotype and increased whether senescence was induced by replicative exhaustion, overexpression of p16(Ink4a), or overexpression of oncogenic RAS. The senescence-dependent increase in VEGF production was accompanied by very little increase in hypoxic- inducible ( transcription) factor 1 alpha protein levels, and hypoxia further inducedVEGFin senescent cells. This result suggests the rise in VEGF expression at senescence is not a hypoxic response. Our findings may in part explain why senescent cells stimulate tumorigenesis in vivo and support the idea that senescent cells may facilitate age- associated cancer development by secreting factors that promote malignant progression.	Univ Montreal, Ctr Hosp Univ Ste Justine, Montreal, PQ H3T 1C5, Canada; Univ Montreal, Dept Pharmacol, Montreal, PQ H3T 1C5, Canada; Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; Berlex Biosci, Richmond, CA 94804 USA; Buck Inst Age Res, Novato, CA 94945 USA	Universite de Montreal; Universite de Montreal; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Buck Institute for Research on Aging	Beausejour, CM (corresponding author), Univ Montreal, Ctr Hosp Univ Ste Justine, 3175 Chemin Cote Ste Catherine, Montreal, PQ H3T 1C5, Canada.	christian.beausejour@recherche-ste-justine.qc.ca			NIA NIH HHS [AG09909] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R37AG009909, R01AG009909, R56AG009909] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Barcellos-Hoff MH, 2000, CANCER RES, V60, P1254; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Ben-Porath I, 2004, J CLIN INVEST, V113, P8, DOI 10.1172/JCI200420663; Budde A, 2005, ONCOGENE, V24, P1802, DOI 10.1038/sj.onc.1208369; Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)02151-1; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Choi J, 2000, UROLOGY, V56, P160, DOI 10.1016/S0090-4295(00)00538-0; Collins CJ, 2003, AGING CELL, V2, P145, DOI 10.1046/j.1474-9728.2003.00048.x; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; Dimri GP, 2000, MOL CELL BIOL, V20, P273, DOI 10.1128/MCB.20.1.273-285.2000; Dimri GP, 2005, CANCER CELL, V7, P505, DOI 10.1016/j.ccr.2005.05.025; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Drayton S, 2003, CANCER CELL, V4, P301, DOI 10.1016/S1535-6108(03)00242-3; Giaccia AJ, 2004, GENE DEV, V18, P2183, DOI 10.1101/gad.1243304; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hara E, 1996, DEV GENET, V18, P161; Itahana K, 2001, EUR J BIOCHEM, V268, P2784, DOI 10.1046/j.1432-1327.2001.02228.x; Itahana K, 2002, J BIOL CHEM, V277, P18206, DOI 10.1074/jbc.M201028200; Itahana K, 2003, MOL CELL BIOL, V23, P389, DOI 10.1128/MCB.23.1.389-401.2003; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Leavitt AD, 1996, J VIROL, V70, P721, DOI 10.1128/JVI.70.2.721-728.1996; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Mukhopadhyay D, 2004, SEMIN CANCER BIOL, V14, P123, DOI 10.1016/j.semcancer.2003.09.019; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Neri D, 2005, NAT REV CANCER, V5, P436, DOI 10.1038/nrc1627; Ohuchida K, 2004, CANCER RES, V64, P3215, DOI 10.1158/0008-5472.CAN-03-2464; Olumi AF, 1999, CANCER RES, V59, P5002; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Parrinello S, 2005, J CELL SCI, V118, P485, DOI 10.1242/jcs.01635; Roninson IB, 2002, CANCER LETT, V179, P1, DOI 10.1016/S0304-3835(01)00847-3; Sasaki M, 2005, J PATHOL, V205, P451, DOI 10.1002/path.1729; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Serrano M, 2001, CURR OPIN CELL BIOL, V13, P748, DOI 10.1016/S0955-0674(00)00278-7; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Tonini T, 2003, ONCOGENE, V22, P6549, DOI 10.1038/sj.onc.1206816; Vasile E, 2001, FASEB J, V15, P458, DOI 10.1096/fj.00-0051com	38	374	382	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					29568	29574		10.1074/jbc.M603307200	http://dx.doi.org/10.1074/jbc.M603307200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16880208	hybrid			2022-12-27	WOS:000240896300018
J	Gautam, JK; Ashish; Comeau, LD; Krueger, JK; Smith, MF				Gautam, Jitendra K.; Ashish; Comeau, Laurey D.; Krueger, Joanna K.; Smith, Michael F., Jr.			Structural and functional evidence for the role of the TLR2 DD loop in TLR1/TLR2 heterodimerization and signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; NF-KAPPA-B; ARG753GLN POLYMORPHISM; INNATE IMMUNITY; TIR DOMAIN; GENE; RECOGNITION; DISEASE; ACTIVATION; MYD88	The Toll/Interleukin-1 receptor (TIR) domain of the Toll-like receptors (TLRs) plays an important role in innate host defense signaling. The TIR-TIR platform formed by the dimerization of two TLRs promotes homotypic protein-protein interactions with additional cytoplasmic adapter molecules to form an active signaling complex resulting in the expression of pro- and anti-inflammatory cytokine genes. To generate a better understanding of the functional domains of TLR2 we performed a random mutagenesis analysis of the human TLR2 TIR domain and screened for TLR2/1 signaling-deficient mutants. Based upon the random mutagenesis results, we performed an alanine scanning mutagenesis of the TLR2 DD loop and part of the alpha D region. This resulted in the identification of four residues crucial for TLR2/1 signaling: Arg-748, Phe-749, Leu-752, and Arg-753. Computer-assisted energy minimization and docking studies indicated three regions of interaction in the TLR2/1 TIR-docked heterodimer. In Region I, residues Arg-748 and Phe-749 in TLR2 DD loop were involved in close contacts with Gly-676 in the TLR1 BB loop. Because this model suggested that steric hindrance would significantly alter the binding interactions between DD loop of TLR2 and BB loop of TLR1, Gly-676 in TLR1 was rationally mutated to Ala and Leu. As expected, in vitro functional studies involving TLR1 G676A and TLR1 G676L resulted in reduced PAM(3)CSK(4) mediated NF-kappa B activation lending support to the computerized predictions. Additionally, mutation of an amino acid residue ( TLR2 Asp-730) in Region II also resulted in decreased activity in agreement with our model, providing new insights into the structure-function relationship of TLR2/1 TIR domains.	Univ Virginia, Hlth Syst, Dept Med, Digest Hlth Ctr Excellence, Charlottesville, VA 22908 USA; Univ Virginia, Hlth Syst, Dept Microbiol, Charlottesville, VA 22908 USA; Univ N Carolina, Dept Chem, Charlotte, NC 28223 USA	University of Virginia; University of Virginia; University of North Carolina; University of North Carolina Charlotte	Smith, MF (corresponding author), Univ Virginia, Hlth Syst, Dept Med, Digest Hlth Ctr Excellence, POB 800708, Charlottesville, VA 22908 USA.	mfs3k@virginia.edu	Krueger, Joanna/A-3110-2011		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034358] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI034358, R01 AI034358-10, R01-AI34358] Funding Source: Medline; NIDDK NIH HHS [DK 56703] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahmad-Nejad P, 2004, J ALLERGY CLIN IMMUN, V113, P565, DOI 10.1016/j.jaci.2003.12.583; Ashish, 2002, BIOORGAN MED CHEM, V10, P4083, DOI 10.1016/S0968-0896(02)00301-2; Bartfai T, 2003, P NATL ACAD SCI USA, V100, P7971, DOI 10.1073/pnas.0932746100; Berdeli A, 2005, J MOL MED, V83, P535, DOI 10.1007/s00109-005-0677-x; Brown V, 2006, EUR J IMMUNOL, V36, P742, DOI 10.1002/eji.200535158; Carl VS, 2002, J BIOL CHEM, V277, P17448, DOI 10.1074/jbc.M111847200; Cook DN, 2004, NAT IMMUNOL, V5, P975, DOI 10.1038/ni1116; David L, 2001, J COMPUT AID MOL DES, V15, P157, DOI 10.1023/A:1008128723048; Dunne A, 2003, J BIOL CHEM, V278, P41443, DOI 10.1074/jbc.M301742200; Hajjar AM, 2001, J IMMUNOL, V166, P15, DOI 10.4049/jimmunol.166.1.15; Hodsdon ME, 1996, J MOL BIOL, V264, P585, DOI 10.1006/jmbi.1996.0663; KATCHALSKIKATZIR E, 1992, P NATL ACAD SCI USA, V89, P2195, DOI 10.1073/pnas.89.6.2195; Loiarro M, 2005, J BIOL CHEM, V280, P15809, DOI 10.1074/jbc.C400613200; Lorenz E, 2000, INFECT IMMUN, V68, P6398, DOI 10.1128/IAI.68.11.6398-6401.2000; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Meng GX, 2003, J BIOL CHEM, V278, P39822, DOI 10.1074/jbc.M304766200; O'Neill LAJ, 2003, TRENDS IMMUNOL, V24, P287, DOI 10.1016/S1471-4906(03)00115-7; O'Neill LAJ, 2006, CURR OPIN IMMUNOL, V18, P3, DOI 10.1016/j.coi.2005.11.012; Ogus AC, 2004, EUR RESPIR J, V23, P219, DOI 10.1183/09031936.03.00061703; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Ren PY, 2003, J PHYS CHEM B, V107, P5933, DOI 10.1021/jp027815+; Ronni T, 2003, MOL CELL BIOL, V23, P2543, DOI 10.1128/MCB.23.7.2543-2555.2003; Sandor F, 2003, J CELL BIOL, V162, P1099, DOI 10.1083/jcb.200304093; Schroder NWJ, 2005, J IMMUNOL, V175, P2534, DOI 10.4049/jimmunol.175.4.2534; Slack JL, 2000, J BIOL CHEM, V275, P4670, DOI 10.1074/jbc.275.7.4670; Tao X, 2002, BIOCHEM BIOPH RES CO, V299, P216, DOI 10.1016/S0006-291X(02)02581-0; Vakser IA, 1999, P NATL ACAD SCI USA, V96, P8477, DOI 10.1073/pnas.96.15.8477; Vogel Stefanie N, 2003, Mol Interv, V3, P466, DOI 10.1124/mi.3.8.466; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600	30	91	94	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					30132	30142		10.1074/jbc.M602057200	http://dx.doi.org/10.1074/jbc.M602057200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16893894	hybrid, Green Accepted			2022-12-27	WOS:000240896300074
J	Hamacher-Brady, A; Brady, NR; Gottlieb, RA				Hamacher-Brady, Anne; Brady, Nathan R.; Gottlieb, Roberta A.			Enhancing macroautophagy protects against ischemia/reperfusion injury in cardiac myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOLATED RAT HEPATOCYTES; AUTOPHAGIC CELL-DEATH; 3-KINASE INHIBITORS; HL-1 CELLS; APOPTOSIS; MITOCHONDRIA; PROTEINS; YEAST; RAB7; DEGRADATION	Cardiac myocytes undergo programmed cell death as a result of ischemia/ reperfusion (I/ R). One feature of I/ R injury is the increased presence of autophagosomes. However, to date it is not known whether macroautophagy functions as a protective pathway, contributes to programmed cell death, or is an irrelevant event during cardiac I/ R injury. We employed simulated I/ R of cardiac HL-1 cells as an in vitro model of I/ R injury to the heart. To assess macroautophagy, we quantified autophagosome generation and degradation ( autophagic flux), as determined by steady- state levels of autophagosomes in relation to lysosomal inhibitor- mediated accumulation of autophagosomes. We found that I/ R impaired both formation and downstream lysosomal degradation of autophagosomes. Overexpression of Beclin1 enhanced autophagic flux following I/ R and significantly reduced activation of pro- apoptotic Bax, whereas RNA interference knockdown of Beclin1 increased Bax activation. Bcl-2 and Bcl-x(L) were protective against I/ R injury, and expression of a Beclin1 Bcl-2/-x(L) binding domain mutant resulted in decreased autophagic flux and did not protect against I/ R injury. Overexpression of Atg5, a component of the autophagosomal machinery downstream of Beclin1, did not affect cellular injury, whereas expression of a dominant negative mutant of Atg5 increased cellular injury. These results demonstrate that autophagic flux is impaired at the level of both induction and degradation and that enhancing autophagy constitutes a powerful and previously uncharacterized protective mechanism against I/ R injury to the heart cell.	Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Scripps Research Institute	Gottlieb, RA (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10550 N Torrey Pines Rd,MEM-220, La Jolla, CA 92037 USA.	robbieg@scripps.edu	Brady, Nathan/H-2452-2013; Hamacher-Brady, Anne/G-4268-2013	Hamacher-Brady, Anne/0000-0001-5042-1338; Brady, Nathan/0000-0002-1901-5996	NHLBI NIH HHS [R01-HL60590] Funding Source: Medline; PHS HHS [R01-AJ21568] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060590] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Amarzguioui M, 2005, FEBS LETT, V579, P5974, DOI 10.1016/j.febslet.2005.08.070; ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320; Brady NR, 2006, BBA-BIOENERGETICS, V1757, P667, DOI 10.1016/j.bbabio.2006.04.011; Brocheriou V, 2000, J GENE MED, V2, P326, DOI 10.1002/1521-2254(200009/10)2:5<326::AID-JGM133>3.0.CO;2-1; Brunk UT, 2002, EUR J BIOCHEM, V269, P1996, DOI 10.1046/j.1432-1033.2002.02869.x; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; CARO LHP, 1988, EUR J BIOCHEM, V175, P325, DOI 10.1111/j.1432-1033.1988.tb14200.x; CHIESI M, 1990, MOL CELL BIOCHEM, V97, P129; Cirman T, 2004, J BIOL CHEM, V279, P3578, DOI 10.1074/jbc.M308347200; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Cuervo AM, 2004, MOL CELL BIOCHEM, V263, P55, DOI 10.1023/B:MCBI.0000041848.57020.57; DECKER RS, 1980, AM J PATHOL, V98, P425; Depre C, 2004, CIRC RES, V95, P433, DOI 10.1161/01.RES.0000138301.42713.18; Finn PF, 2005, J BIOL CHEM, V280, P25864, DOI 10.1074/jbc.M502456200; Foyouzi-Youssefi R, 2000, P NATL ACAD SCI USA, V97, P5723, DOI 10.1073/pnas.97.11.5723; GORDON PB, 1993, J BIOL CHEM, V268, P26107; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Gutierrez MG, 2004, J CELL SCI, V117, P2687, DOI 10.1242/jcs.01114; HAMACHERBRADY A, 2006, IN PRESS CELL DEATH; Huang JH, 2005, CIRCULATION, V112, P76, DOI 10.1161/CIRCULATIONAHA.105.535740; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Imahashi K, 2004, CIRC RES, V95, P734, DOI 10.1161/01.RES.0000143898.67182.4c; Ishii T, 2005, BIOCHEMISTRY-US, V44, P13893, DOI 10.1021/bi051336u; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Karwatowska-Prokopczuk E, 1998, CIRC RES, V82, P1139, DOI 10.1161/01.RES.82.11.1139; Kiffin R, 2004, MOL BIOL CELL, V15, P4829, DOI 10.1091/mbc.E04-06-0477; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kochl R, 2006, TRAFFIC, V7, P129, DOI 10.1111/j.1600-0854.2005.00368.x; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lamparska-Przybysz M, 2005, J Physiol Pharmacol, V56 Suppl 3, P159; Larsen KE, 2002, HISTOL HISTOPATHOL, V17, P897, DOI 10.14670/HH-17.897; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liu CL, 2005, NEUROSCIENCE, V134, P1273, DOI 10.1016/j.neuroscience.2005.05.015; Liu JB, 2006, FASEB J, V20, P362, DOI 10.1096/fj.05-4869fje; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Obara K, 2006, MOL BIOL CELL, V17, P1527, DOI 10.1091/mbc.E05-09-0841; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Powell SR, 2005, ANTIOXID REDOX SIGN, V7, P538, DOI 10.1089/ars.2005.7.538; Priault M, 2005, CELL DEATH DIFFER, V12, P1613, DOI 10.1038/sj.cdd.4401697; Pyo JO, 2005, J BIOL CHEM, V280, P20722, DOI 10.1074/jbc.M413934200; Ravikumar B, 2006, HUM MOL GENET, V15, P1209, DOI 10.1093/hmg/ddl036; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Row PE, 2001, BIOCHEM J, V353, P655, DOI 10.1042/0264-6021:3530655; Saeki K, 2000, CELL DEATH DIFFER, V7, P1263, DOI 10.1038/sj.cdd.4400759; Saftig P, 2001, TRENDS MOL MED, V7, P37, DOI 10.1016/S1471-4914(00)01868-2; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; SEGLEN PO, 1992, EXPERIENTIA, V48, P158, DOI 10.1007/BF01923509; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shibata M, 2006, J BIOL CHEM, V281, P14474, DOI 10.1074/jbc.M600364200; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Stein MP, 2003, TRAFFIC, V4, P754, DOI 10.1034/j.1600-0854.2003.00133.x; Stoka V, 2001, J BIOL CHEM, V276, P3149, DOI 10.1074/jbc.M008944200; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Uchiyama Y, 2001, ARCH HISTOL CYTOL, V64, P233, DOI 10.1679/aohc.64.233; Waters MG, 1999, CURR OPIN CELL BIOL, V11, P453, DOI 10.1016/S0955-0674(99)80065-9; Webb JL, 2004, INT J BIOCHEM CELL B, V36, P2541, DOI 10.1016/j.biocel.2004.02.003; White SM, 2004, AM J PHYSIOL-HEART C, V286, pH823, DOI 10.1152/ajpheart.00986.2003; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Xue L, 2001, CURR BIOL, V11, P361, DOI 10.1016/S0960-9822(01)00100-2; Xue LZ, 1999, MOL CELL NEUROSCI, V14, P180, DOI 10.1006/mcne.1999.0780; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yan L, 2005, P NATL ACAD SCI USA, V102, P13807, DOI 10.1073/pnas.0506843102; Yanagisawa H, 2003, CELL DEATH DIFFER, V10, P798, DOI 10.1038/sj.cdd.4401246	75	461	484	2	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					29776	29787		10.1074/jbc.M603783200	http://dx.doi.org/10.1074/jbc.M603783200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16882669	hybrid			2022-12-27	WOS:000240896300040
J	Zhang, F; Hamanaka, RB; Bobrovnikova-Marjon, E; Gordan, JD; Dai, MS; Lu, H; Simon, MC; Diehl, JA				Zhang, Fang; Hamanaka, Robert B.; Bobrovnikova-Marjon, Ekaterina; Gordan, John D.; Dai, Mu-Shui; Lu, Hua; Simon, M. Celeste; Diehl, J. Alan			Ribosomal stress couples the unfolded protein response to p53-dependent cell cycle arrest	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; TRANSLATIONAL CONTROL; ER STRESS; P53; PERK; INHIBITION; KINASE; HDM2; MDM2; RNA	Protein misfolding in the endoplasmic reticulum (ER) triggers a signaling pathway termed the unfolded protein response pathway (UPR). UPR signaling is transduced through the transmembrane ER effectors PKR-like ER kinase (PERK), inositol requiring kinase-1 (IRE-1), and activating transcription factor 6 (ATF6). PERK activation triggers phosphorylation of eIF2 alpha leading to repression of protein synthesis, thereby relieving ER protein load and directly inhibiting cyclin D1 translation thereby contributing to cell cycle arrest. However, PERK-/- murine embryonic fibroblasts have an attenuated G(1)/S arrest that is not attributable to cyclin D1 loss, suggesting a cyclin D1-independent mechanism. Here we show that the UPR triggers p53 accumulation and activation. UPR induction promotes enhanced interaction between the ribosome proteins (rpL5, rpL11, and rpL23) and Hdm2 in a PERK-dependent manner. Interaction with ribosomal proteins results in inhibition of Hdm2-mediated ubiquitination and degradation of p53. Our data demonstrate that ribosomal subunit: Hdm2 association couples the unfolded protein response to p53-dependent cell cycle arrest.	Leonard & Madlyn Abramson Family Canc Res Inst, Dept Canc Biol, Philadelphia, PA 19104 USA; Univ Penn, Ctr Canc, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; Oregon Hlth & Sci Univ, Sch Med, Dept Biochem & Mol Biol, Portland, OR 97201 USA	University of Pennsylvania; Pennsylvania Medicine; Howard Hughes Medical Institute; University of Pennsylvania; Oregon Health & Science University	Diehl, JA (corresponding author), Leonard & Madlyn Abramson Family Canc Res Inst, Dept Canc Biol, 454 BRB 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	adiehl@mail.med.upenn.edu	Simon, Celeste/AAG-3941-2021		NCI NIH HHS [P01 CA104838, CA093614, CA095441] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA104838, R01CA093614, R01CA095441] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bhat KP, 2004, EMBO J, V23, P2402, DOI 10.1038/sj.emboj.7600247; Brewer JW, 2000, P NATL ACAD SCI USA, V97, P12625, DOI 10.1073/pnas.220247197; Brewer JW, 1999, P NATL ACAD SCI USA, V96, P8505, DOI 10.1073/pnas.96.15.8505; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; Cullinan SB, 2004, J BIOL CHEM, V279, P20108, DOI 10.1074/jbc.M314219200; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Li JZ, 2006, J BIOL CHEM, V281, P7260, DOI 10.1074/jbc.M509868200; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; Pestov DG, 2001, MOL CELL BIOL, V21, P4246, DOI 10.1128/MCB.21.13.4246-4255.2001; Pluquet O, 2005, MOL CELL BIOL, V25, P9392, DOI 10.1128/MCB.25.21.9392-9405.2005; Qu LK, 2004, GENE DEV, V18, P261, DOI 10.1101/gad.1165804; Rosorius O, 2000, J BIOL CHEM, V275, P12061, DOI 10.1074/jbc.275.16.12061; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; Strezoska Z, 2002, J BIOL CHEM, V277, P29617, DOI 10.1074/jbc.M204381200; Sugimoto M, 2003, MOL CELL, V11, P415, DOI 10.1016/S1097-2765(03)00057-1; Tao WK, 1999, P NATL ACAD SCI USA, V96, P6937, DOI 10.1073/pnas.96.12.6937; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; WALDMAN T, 1995, CANCER RES, V55, P5187; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; WONG WL, 1993, BIOCHEM J, V289, P71, DOI 10.1042/bj2890071; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2003, DEV CELL, V4, P265, DOI 10.1016/S1534-5807(03)00022-4; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003	41	90	90	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					30036	30045		10.1074/jbc.M604674200	http://dx.doi.org/10.1074/jbc.M604674200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16893887	hybrid			2022-12-27	WOS:000240896300064
J	Ibrahim, M; Kerby, RL; Puranik, M; Wasbotten, IH; Youn, H; Roberts, GP; Spiro, TG				Ibrahim, Mohammed; Kerby, Robert L.; Puranik, Mrinalini; Wasbotten, Ingar H.; Youn, Hwan; Roberts, Gary P.; Spiro, Thomas G.			Heme displacement mechanism of CooA activation - Mutational and Raman spectroscopic evidence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSING TRANSCRIPTIONAL ACTIVATOR; DNA-BINDING; REGULATOR COOA; AXIAL LIGAND; HISTIDINE 77; C-HELIX; PROTEIN; RESOLUTION; POCKET; SENSOR	The heme-containing protein CooA of Rhodospirillum rubrum regulates the expression of genes involved in CO oxidation. CooA binds its target DNA sequence in response to CO binding to its heme. Activity measurements and resonance Raman (RR) spectra are reported for CooA variants that bind DNA even in the absence of CO, those in which the wild-type residues at the 121-126 positions, TSCMRT, are replaced by the residues AYLLRL or RYLLRL, and also for variants that bind DNA poorly in the presence of CO, such as L120S and L120F. The Fe-C and C-O stretching resonance Raman ( RR) frequencies of all CooAs examined deviate from the expected back-bonding correlation in a manner indicating weakening of the Fe-His-77 proximal ligand bond, and the extent of weakening correlates positively with DNA binding activity. The (A/R) YLLRL variants have detectable populations of a 5-coordinate heme resulting from partial dissociation of the endogenous distal ligand, Pro-2. Selective excitation of this population reveals downshifted Fe-His-77-stretching RR bands, confirming the proximal bond weakening. These results support our previous hypothesis that the conformational change required for DNA binding is initiated by displacement of the heme into an adjacent hydrophobic cavity once CO displaces the Pro-2 ligand. Examination of the crystal structure reveals a physical basis for these results, and a mechanism is proposed to link heme displacement to conformational change.	Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	Princeton University; University of Wisconsin System; University of Wisconsin Madison	Spiro, TG (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.	spiro@princeton.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053228, R01GM033576] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM033576-40, R01 GM033576, GM33576, R01 GM053228, R01 GM053228-13, GM53228] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akiyama S, 2004, J MOL BIOL, V341, P651, DOI 10.1016/j.jmb.2004.06.040; Aono S, 1998, J BIOL CHEM, V273, P25757, DOI 10.1074/jbc.273.40.25757; Aono S, 2003, ACCOUNTS CHEM RES, V36, P825, DOI 10.1021/ar020097p; Clark RW, 2006, P NATL ACAD SCI USA, V103, P891, DOI 10.1073/pnas.0505919103; Coyle CM, 2003, J BIOL CHEM, V278, P35384, DOI 10.1074/jbc.M301000200; Franzen S, 2001, J AM CHEM SOC, V123, P12578, DOI 10.1021/ja0108988; Gilles-Gonzalez MA, 2005, J INORG BIOCHEM, V99, P1, DOI 10.1016/j.jinorgbio.2004.11.006; Kerby RL, 2003, J MOL BIOL, V325, P809, DOI 10.1016/S0022-2836(02)01203-2; Kitagawa T, 1988, BIOL APPL RAMAN SPEC, V3, P97; Kubo M, 2006, J BIOL CHEM, V281, P11271, DOI 10.1074/jbc.M513261200; Lanzilotta WN, 2000, NAT STRUCT BIOL, V7, P876; Marti MA, 2003, J BIOL INORG CHEM, V8, P595, DOI 10.1007/s00775-003-0452-9; Parkinson G, 1996, J MOL BIOL, V260, P395, DOI 10.1006/jmbi.1996.0409; Passner JM, 2000, J MOL BIOL, V304, P847, DOI 10.1006/jmbi.2000.4231; Puranik M, 2004, J BIOL CHEM, V279, P21096, DOI 10.1074/jbc.M400613200; Reynolds MF, 2000, BIOCHEMISTRY-US, V39, P388, DOI 10.1021/bi991378g; Roberts GP, 2005, J INORG BIOCHEM, V99, P280, DOI 10.1016/j.jinorgbio.2004.10.032; Rubtsov IV, 2001, J AM CHEM SOC, V123, P10056, DOI 10.1021/ja011023w; Shelver D, 1999, BIOCHEMISTRY-US, V38, P2669, DOI 10.1021/bi982658j; SMULEVICH G, 1988, BIOCHEMISTRY-US, V27, P5477, DOI 10.1021/bi00415a014; Spiro TG, 2005, J INORG BIOCHEM, V99, P34, DOI 10.1016/j.jinorgbio.2004.09.026; Spiro TG, 1988, BIOL APPL RAMAN SPEC, V3, P1; Thorsteinsson MV, 2000, BIOCHEMISTRY-US, V39, P8284, DOI 10.1021/bi000327c; Thorsteinsson MV, 2001, J BIOL CHEM, V276, P26807, DOI 10.1074/jbc.M102758200; Thorsteinsson MV, 2000, J BIOL CHEM, V275, P39332, DOI 10.1074/jbc.M007691200; Uchida T, 1998, J BIOL CHEM, V273, P19988, DOI 10.1074/jbc.273.32.19988; Uchida T, 2000, BIOCHEMISTRY-US, V39, P12747, DOI 10.1021/bi0011476; Uchida T, 2005, ACCOUNTS CHEM RES, V38, P662, DOI 10.1021/ar030267d; Uchida T, 2005, J BIOL CHEM, V280, P21358, DOI 10.1074/jbc.M412350200; WEBER IT, 1987, J MOL BIOL, V198, P311, DOI 10.1016/0022-2836(87)90315-9; Yamamoto K, 2001, J BIOL CHEM, V276, P11473, DOI 10.1074/jbc.C100047200; Yamashita T, 2004, J BIOL CHEM, V279, P47320, DOI 10.1074/jbc.M407766200; Youn H, 2005, J BACTERIOL, V187, P2573, DOI 10.1128/JB.187.8.2573-2581.2005; Youn H, 2004, J BACTERIOL, V186, P1320, DOI 10.1128/JB.186.5.1320-1329.2004; Youn H, 2003, J BIOL CHEM, V278, P2333, DOI 10.1074/jbc.M210825200; Youn H, 2002, J BIOL CHEM, V277, P33616, DOI 10.1074/jbc.M203684200; Youn H, 2001, J BIOL CHEM, V276, P41603, DOI 10.1074/jbc.M106165200	37	17	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					29165	29173		10.1074/jbc.M605568200	http://dx.doi.org/10.1074/jbc.M605568200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16873369	hybrid, Green Accepted			2022-12-27	WOS:000240680500071
J	Monroe, DG; Secreto, FJ; Hawse, JR; Subramaniam, M; Khosla, S; Spelsberg, TC				Monroe, David G.; Secreto, Frank J.; Hawse, John R.; Subramaniam, Malayannan; Khosla, Sundeep; Spelsberg, Thomas C.			Estrogen receptor isoform-specific regulation of the retinoblastoma-binding protein 1 (RBBP1) gene - Roles of AF1 and enhancer elements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; ACTIVATION FUNCTION 1; ER-ALPHA; TRANSCRIPTIONAL ACTIVATION; MCF-7 CELLS; TRANSACTIVATION DOMAINS; OSTEOSARCOMA CELLS; STEROID-RECEPTORS; BINDING PROTEIN; TARGET GENES	Estrogen (E2) is involved in mediating many important functions relevant to osteoblast biology through the actions of the estrogen receptors (ER) alpha and beta. To further understand the mechanisms of ER-specific regulation, we used microarray and reverse transcription-PCR analyses of E2-treated U2OS-ER alpha or -ER beta cells and identified retinoblastoma-binding protein 1 (RBBP1) as a major E2-regulated gene. RBBP1 is a retinoblastoma cofactor involved in the control of osteoblastic proliferation. Although RBBP1 mRNA levels rapidly increased after 2 h of E2 treatment in both U2OS-ER-expressing lines, a sustained induction was only observed in U2OS-ER alpha cells. Examination of the RBBP1 genomic sequence revealed an ER response element and a Sp1 site located within the first intron. Chromatin immunoprecipitation analyses demonstrated that E2-dependent ER alpha binding to the intron 1 enhancer region was constitutive, whereas ER beta binding was transient, consistent with the mRNA time course. Interestingly, transient transfection and receptor mutational studies revealed that RBBP1 induction by ER alpha only requires the Sp1 site, whereas ER beta utilizes both the Sp1 and estrogen response elements binding sites for maximal E2-dependent activation. Stable U2OS transfectants containing a deletion of the ER alpha activation function 1 (AF1) resulted in a temporal mRNA induction profile similar to that of wild type ER beta. Further, overexpression and chromatin immunoprecipitation analyses also demonstrated that E2-dependent RBBP1 induction is SRC2-dependent for both ER isoforms. These results describe an E2-dependent, ER isoform-specific transcriptional activation of the RBBP1 gene, which in part, is explained by the differential activity of ER AF1 and enhancer element binding.	Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; Mayo Clin, Coll Med, Endocrine Res Unit, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Monroe, DG (corresponding author), Mayo Clin, Coll Med, Dept Biochem & Mol Biol, 1601C Guggenheim,200 1st St SW, Rochester, MN 55905 USA.	Monroe.David@mayo.edu	Khosla, Sundeep/AAE-6170-2020	Khosla, Sundeep/0000-0002-2936-4372	NIA NIH HHS [P01-AG04875-21] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG004875] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Benecke A, 2000, EMBO REP, V1, P151, DOI 10.1093/embo-reports/kvd028; Binda O, 2006, MOL CELL BIOL, V26, P1917, DOI 10.1128/MCB.26.5.1917-1931.2006; Delaunay F, 2000, MOL PHARMACOL, V58, P584, DOI 10.1124/mol.58.3.584; Denger S, 2001, MOL ENDOCRINOL, V15, P2064, DOI 10.1210/me.15.12.2064; Dutertre M, 2003, MOL ENDOCRINOL, V17, P1296, DOI 10.1210/me.2001-0316; Endoh H, 1999, MOL CELL BIOL, V19, P5363; Flototto T, 2004, J STEROID BIOCHEM, V88, P131, DOI 10.1016/j.jsbmb.2003.11.004; Flouriot G, 2000, EMBO J, V19, P4688, DOI 10.1093/emboj/19.17.4688; HARRIS RD, 2000, PRINCIPLES BONE BIOL, P655; Jakacka M, 2001, J BIOL CHEM, V276, P13615, DOI 10.1074/jbc.M008384200; KADONAGA JT, 1986, P NATL ACAD SCI USA, V83, P5889, DOI 10.1073/pnas.83.16.5889; Kawashima H, 2003, BIOCHEM J, V369, P163, DOI 10.1042/BJ20020743; Khan S, 2003, ENDOCRINOLOGY, V144, P2325, DOI 10.1210/en.2002-0149; Kim K, 2005, MOL ENDOCRINOL, V19, P843, DOI 10.1210/me.2004-0326; Kim K, 2003, MOL ENDOCRINOL, V17, P804, DOI 10.1210/me.2002-0406; KLEINHITPASS L, 1986, CELL, V46, P1053, DOI 10.1016/0092-8674(86)90705-1; Kobayashi Y, 2000, J BIOL CHEM, V275, P15645, DOI 10.1074/jbc.M000042200; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; Lai A, 1999, ONCOGENE, V18, P2091, DOI 10.1038/sj.onc.1202520; Laj A, 1999, MOL CELL BIOL, V19, P6632; Lambert Jr, 2001, METH MOL B, V176, P273; Lanz RB, 1999, CELL, V97, P17, DOI 10.1016/S0092-8674(00)80711-4; LEES JA, 1989, NUCLEIC ACIDS RES, V17, P5477, DOI 10.1093/nar/17.14.5477; LEES JA, 1989, J STEROID BIOCHEM, V34, P33, DOI 10.1016/0022-4731(89)90063-0; Lonard DM, 2006, CELL, V125, P411, DOI 10.1016/j.cell.2006.04.021; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Merot Y, 2004, J BIOL CHEM, V279, P26184, DOI 10.1074/jbc.M402148200; Monroe DG, 2003, J ENDOCRINOL, V176, P349, DOI 10.1677/joe.0.1760349; Monroe DG, 2004, ADV MOL CEL, V34, P39, DOI 10.1016/S1569-2558(03)34003-2; Monroe DG, 2005, MOL ENDOCRINOL, V19, P1555, DOI 10.1210/me.2004-0381; Monroe DG, 2003, J CELL BIOCHEM, V90, P315, DOI 10.1002/jcb.10633; MONROE DG, 2004, PRIMER METABOLIC BON, P32; Mosselman S, 1996, FEBS LETT, V392, P49, DOI 10.1016/0014-5793(96)00782-X; Onate SA, 1998, J BIOL CHEM, V273, P12101, DOI 10.1074/jbc.273.20.12101; ONATE SA, 1995, SCIENCE, V270, P1354; Penot G, 2005, ENDOCRINOLOGY, V146, P5474, DOI 10.1210/en.2005-0866; Porter W, 1997, MOL ENDOCRINOL, V11, P1569, DOI 10.1210/me.11.11.1569; Qin CH, 1999, ENDOCRINOLOGY, V140, P2501, DOI 10.1210/en.140.6.2501; Qin CH, 2004, MOL CARCINOGEN, V40, P160, DOI 10.1002/mc.20030; Salvatori L, 2003, ONCOGENE, V22, P4875, DOI 10.1038/sj.onc.1206784; Samudio I, 2001, ENDOCRINOLOGY, V142, P1000, DOI 10.1210/en.142.3.1000; Saville B, 2000, J BIOL CHEM, V275, P5379, DOI 10.1074/jbc.275.8.5379; Saville B, 2002, J BIOL CHEM, V277, P2485, DOI 10.1074/jbc.M109021200; Smith CL, 2004, ENDOCR REV, V25, P45, DOI 10.1210/er.2003-0023; Stoner M, 2004, ONCOGENE, V23, P1052, DOI 10.1038/sj.onc.1207201; Stossi F, 2004, ENDOCRINOLOGY, V145, P3473, DOI 10.1210/en.2003-1682; Sun GL, 1998, MOL ENDOCRINOL, V12, P882, DOI 10.1210/me.12.6.882; Tee MK, 2004, MOL BIOL CELL, V15, P1262, DOI 10.1091/mbc.E03-06-0360; Thomas DM, 2001, MOL CELL, V8, P303, DOI 10.1016/S1097-2765(01)00327-6; TORA L, 1989, CELL, V59, P477, DOI 10.1016/0092-8674(89)90031-7; Tremblay GB, 1997, MOL ENDOCRINOL, V11, P353, DOI 10.1210/me.11.3.353; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; Wang WL, 1999, MOL ENDOCRINOL, V13, P1373, DOI 10.1210/me.13.8.1373; Watanabe M, 2001, EMBO J, V20, P1341, DOI 10.1093/emboj/20.6.1341; Webb P, 1998, MOL ENDOCRINOL, V12, P1605, DOI 10.1210/me.12.10.1605; Wu XY, 2001, J BIOL CHEM, V276, P23962, DOI 10.1074/jbc.M101041200; Xie W, 1999, ENDOCRINOLOGY, V140, P219, DOI 10.1210/en.140.1.219	57	21	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					28596	28604		10.1074/jbc.M605226200	http://dx.doi.org/10.1074/jbc.M605226200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16873370	hybrid			2022-12-27	WOS:000240680500013
J	Shi, L; Adkins, JN; Coleman, JR; Schepmoes, AA; Dohnkova, A; Mottaz, HM; Norbeck, AD; Purvine, SO; Manes, NP; Smallwood, HS; Wang, HX; Forbes, J; Gros, P; Uzzau, S; Rodland, KD; Heffron, F; Smith, RD; Squier, TC				Shi, Liang; Adkins, Joshua N.; Coleman, James R.; Schepmoes, Athena A.; Dohnkova, Alice; Mottaz, Heather M.; Norbeck, Angela D.; Purvine, Samuel O.; Manes, Nathan P.; Smallwood, Heather S.; Wang, Haixing; Forbes, John; Gros, Philippe; Uzzau, Sergio; Rodland, Karin D.; Heffron, Fred; Smith, Richard D.; Squier, Thomas C.			Proteomic analysis of Salmonella enterica serovar Typhimurium isolated from RAW 264.7 macrophages - Identification of a novel protein that contributes to the replication of serovar Typhimurium inside macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRATION HOST FACTOR; ANTIMICROBIAL PEPTIDES; CHROMOSOMAL GENES; ESCHERICHIA-COLI; ACCURATE MASS; EXPRESSION; VIRULENCE; PEPTIDOGLYCAN; RESISTANCE; TRANSPORT	To evade host resistance mechanisms, Salmonella enterica serovar Typhimurium (STM), a facultative intracellular pathogen, must alter its proteome following macrophage infection. To identify new colonization and virulence factors that mediate STM pathogenesis, we have isolated STM cells from RAW 264.7 macrophages at various time points following infection and used a liquid chromatography-mass spectrometry-based proteomic approach to detect the changes in STM protein abundance. Because host resistance to STM infection is strongly modulated by the expression of a functional host-resistant regulator, i.e. natural resistance-associated macrophage protein 1 (Nramp1, also called Slc11a1), we have also examined the effects of Nramp1 activity on the changes of STM protein abundances. A total of 315 STM proteins have been identified from isolated STM cells, which are largely housekeeping proteins whose abundances remain relatively constant during the time course of infection. However, 39 STM proteins are strongly induced after infection, suggesting their involvement in modulating colonization and infection. Of the 39 induced proteins, 6 proteins are specifically modulated by Nramp1 activity, including STM3117, as well as STM3118-3119 whose time-dependent abundance changes were confirmed using Western blot analysis. Deletion of the gene encoding STM3117 resulted in a dramatic reduction in the ability of STM to colonize wild-type RAW 264.7 macrophages, demonstrating a critical involvement of STM3117 in promoting the replication of STM inside macrophages. The predicted function common for STM3117-3119 is biosynthesis and modification of the peptidoglycan layer of the STM cell wall.	Pacific NW Natl Lab, Microbiol Grp, Richland, WA 99354 USA; Univ Sassari, I-07100 Sassari, Italy; McGill Univ, Montreal, PQ H3G 1Y6, Canada; Univ Sassari, I-07100 Sassari, Italy; Oregon Hlth & Sci Univ, Portland, OR 97201 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; University of Sassari; McGill University; University of Sassari; Oregon Health & Science University	Shi, L (corresponding author), Pacific NW Natl Lab, Microbiol Grp, 902 Battelle Blvd,POB 999, Richland, WA 99354 USA.	liang.shi@pnl.gov	Purvine, Samuel O/O-3358-2017; Adkins, Joshua/B-9881-2013; Uzzau, Sergio/F-3233-2015; Rodland, Karin/R-6186-2019; Manes, Nathan P/E-2817-2012; Smith, Richard D/J-3664-2012	Purvine, Samuel O/0000-0002-2257-2400; Adkins, Joshua/0000-0003-0399-0700; Uzzau, Sergio/0000-0001-6246-2794; Manes, Nathan P/0000-0001-6701-3314; Smith, Richard D/0000-0002-2381-2349; Smallwood, Heather/0000-0001-5711-5771	NIAID NIH HHS [Y1-AI-4894-01] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adkins JN, 2006, MOL CELL PROTEOMICS, V5, P1450, DOI 10.1074/mcp.M600139-MCP200; ANAKIRAMAN A, 2000, MOL MICROBIOL, V35, P1146; Bader MW, 2005, CELL, V122, P461, DOI 10.1016/j.cell.2005.05.030; Becker D, 2006, NATURE, V440, P303, DOI 10.1038/nature04616; Blanc-Potard AB, 1999, J BACTERIOL, V181, P998, DOI 10.1128/JB.181.3.998-1004.1999; Boneca IG, 2005, CURR OPIN MICROBIOL, V8, P46, DOI 10.1016/j.mib.2004.12.008; BUCHMEIER NA, 1990, SCIENCE, V248, P730, DOI 10.1126/science.1970672; Chakravortty D, 2005, EMBO J, V24, P2043, DOI 10.1038/sj.emboj.7600676; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Coldham NG, 2004, J PROTEOME RES, V3, P595, DOI 10.1021/pr034129u; Cuellar-Mata P, 2002, J BIOL CHEM, V277, P2258, DOI 10.1074/jbc.M105508200; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Elias DA, 2005, PROTEOMICS, V5, P3120, DOI 10.1002/pmic.200401140; Encheva V, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-42; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; Forbes JR, 2001, TRENDS MICROBIOL, V9, P397, DOI 10.1016/S0966-842X(01)02098-4; FOSTER JW, 1995, ANNU REV MICROBIOL, V49, P145, DOI 10.1146/annurev.micro.49.1.145; Garmendia J, 2003, MICROBIOL-SGM, V149, P2385, DOI 10.1099/mic.0.26397-0; Govoni G, 1999, INFECT IMMUN, V67, P2225, DOI 10.1128/IAI.67.5.2225-2232.1999; Guignot J, 2004, J CELL SCI, V117, P1033, DOI 10.1242/jcs.00949; Hashim S, 2000, J BIOL CHEM, V275, P16281, DOI 10.1074/jbc.275.21.16281; Hensel M, 2000, MOL MICROBIOL, V36, P1015, DOI 10.1046/j.1365-2958.2000.01935.x; Holden DW, 2002, TRAFFIC, V3, P161, DOI 10.1034/j.1600-0854.2002.030301.x; Jones BD, 1996, ANNU REV IMMUNOL, V14, P533, DOI 10.1146/annurev.immunol.14.1.533; Kehres DG, 2002, J BACTERIOL, V184, P3159, DOI 10.1128/JB.184.12.3159-3166.2002; Kim I, 2004, J BACTERIOL, V186, P7229, DOI 10.1128/JB.186.21.7229-7235.2004; Knodler LA, 2003, TRAFFIC, V4, P587, DOI 10.1034/j.1600-0854.2003.00118.x; Lam-Yuk-Tseung S, 2003, CELL MICROBIOL, V5, P299, DOI 10.1046/j.1462-5822.2003.00276.x; Mangan MW, 2006, MOL MICROBIOL, V59, P1831, DOI 10.1111/j.1365-2958.2006.05062.x; Marshall DG, 1999, MOL MICROBIOL, V34, P134, DOI 10.1046/j.1365-2958.1999.01587.x; MARTINUSSEN J, 1995, J BACTERIOL, V177, P271, DOI 10.1128/jb.177.1.271-274.1995; MILLER SI, 1989, P NATL ACAD SCI USA, V86, P5054, DOI 10.1073/pnas.86.13.5054; Mouslim C, 2002, MOL MICROBIOL, V45, P1019, DOI 10.1046/j.1365-2958.2002.03070.x; Navarre WW, 2005, MOL MICROBIOL, V56, P492, DOI 10.1111/j.1365-2958.2005.04553.x; Pasa-Tolic L, 2004, BIOTECHNIQUES, V37, P621, DOI 10.2144/04374RV01; Peters-Wendisch P, 2005, APPL ENVIRON MICROB, V71, P7139, DOI 10.1128/AEM.71.11.7139-7144.2005; Pucciarelli MG, 2003, MOL MICROBIOL, V48, P573, DOI 10.1046/j.1365-2958.2003.03469.x; Qi SY, 1996, J BACTERIOL, V178, P5032, DOI 10.1128/jb.178.16.5032-5038.1996; Quintela JC, 1997, MOL MICROBIOL, V23, P693, DOI 10.1046/j.1365-2958.1997.2561621.x; RichterDahlfors A, 1997, J EXP MED, V186, P569, DOI 10.1084/jem.186.4.569; Rosenberger CM, 2004, P NATL ACAD SCI USA, V101, P2422, DOI 10.1073/pnas.0304455101; Rosenberger CM, 2002, J BIOL CHEM, V277, P18753, DOI 10.1074/jbc.M110649200; Salcedo SP, 2001, CELL MICROBIOL, V3, P587, DOI 10.1046/j.1462-5822.2001.00137.x; Smith RD, 2002, PROTEOMICS, V2, P513, DOI 10.1002/1615-9861(200205)2:5<513::AID-PROT513>3.0.CO;2-W; SNAVELY MD, 1991, J BIOL CHEM, V266, P815; Strittmatter EF, 2004, J PROTEOME RES, V3, P760, DOI 10.1021/pr049965y; Takaya A, 2004, INFECT IMMUN, V72, P1364, DOI 10.1128/IAI.72.3.1364-1373.2004; Uzzau S, 2002, MOL MICROBIOL, V46, P147, DOI 10.1046/j.1365-2958.2002.03145.x; Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198; van Heijenoort J, 1998, CELL MOL LIFE SCI, V54, P300, DOI 10.1007/s000180050155; Vazquez-Torres A, 2001, MICROBES INFECT, V3, P1313, DOI 10.1016/S1286-4579(01)01492-7; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wijburg OLC, 2000, EUR J IMMUNOL, V30, P944, DOI 10.1002/1521-4141(200003)30:3<944::AID-IMMU944>3.3.CO;2-T; Yoon H, 2003, FEMS MICROBIOL LETT, V226, P391, DOI 10.1016/S0378-1097(03)00641-4; Zaharik ML, 2002, P NATL ACAD SCI USA, V99, P15705, DOI 10.1073/pnas.252415599	57	121	122	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					29131	29140		10.1074/jbc.M604640200	http://dx.doi.org/10.1074/jbc.M604640200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16893888	hybrid			2022-12-27	WOS:000240680500067
J	Soksawatmaekhin, W; Uemura, T; Fukiwake, N; Kashiwagi, K; Igarashi, K				Soksawatmaekhin, Waraporn; Uemura, Takeshi; Fukiwake, Natsuko; Kashiwagi, Keiko; Igarashi, Kazuei			Identification of the cadaverine recognition site on the cadaverine-lysine antiporter CadB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PREFERENTIAL UPTAKE SYSTEM; PROTON MOTIVE FORCE; ESCHERICHIA-COLI; POLYAMINE TRANSPORT; CRYSTAL-STRUCTURE; LACTOSE PERMEASE; PUTRESCINE; OPERON; RECEPTOR; PROTEIN	Amino acid residues involved in cadaverine uptake and cadaverine-lysine antiporter activity were identified by site-directed mutagenesis of the CadB protein. It was found that Tyr(73), Tyr(89), Tyr(90), Glu(204), Tyr(235), Asp(303), and Tyr(423) were strongly involved in both uptake and excretion and that Tyr(55), Glu(76), Tyr(246), Tyr(310), Cys(370), and Glu(377) were moderately involved in both activities. Mutations of Trp(43), Tyr(57), Tyr(107), Tyr(366), and Tyr(368) mainly affected uptake activity, and Trp(41), Tyr(174), Asp(185), and Glu(408) had weak effects on uptake. The decrease in the activities of the mutants was reflected by an increase in the K-m value. Mutation of Arg(299) mainly affected excretion, suggesting that Arg(299) is involved in the recognition of the carboxyl group of lysine. These results indicate that amino acid residues involved in both uptake and excretion, or solely in excretion, are located in the cytoplasmic loops and the cytoplasmic side of transmembrane segments, whereas residues involved in uptake were located in the periplasmic loops and the transmembrane segments. The SH group of Cys(370) seemed to be important for uptake and excretion, because both were inhibited by the existence of Cys(125), Cys(389), or Cys(394) together with Cys(370). The relative topology of 12 transmembrane segments was determined by inserting cysteine residues at various sites and measuring the degree of inhibition of transport through crosslinking with Cys(370). The results suggest that a hydrophilic cavity is formed by the transmembrane segments II, III, IV, VI, VII, X, XI, and XII.	Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, Chiba 2608675, Japan; Chiba Inst Sci, Fac Pharmaceut Sci, Chiba 2880025, Japan	Chiba University	Igarashi, K (corresponding author), Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, 1-8-1 Inohana, Chiba 2608675, Japan.	iga16077@p.chiba-u.ac.jp		Igarashi, Kazuei/0000-0003-3751-3187				Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Cohen S A, 1998, Guttmacher Rep Public Policy, V1, P1; Gong S, 2003, J BACTERIOL, V185, P4402, DOI 10.1128/JB.185.15.4402-4409.2003; Hirai T, 2003, J BACTERIOL, V185, P1712, DOI 10.1128/JB.185.5.1712-1718.2003; HOUNG HS, 1986, J BACTERIOL, V168, P1040, DOI 10.1128/jb.168.2.1040-1044.1986; IGARASHI K, 1986, J BACTERIOL, V166, P128, DOI 10.1128/jb.166.1.128-134.1986; Igarashi K, 2001, RES MICROBIOL, V152, P271, DOI 10.1016/S0923-2508(01)01198-6; Igarashi K, 1999, BIOCHEM J, V344, P633, DOI 10.1042/0264-6021:3440633; Igarashi K, 2000, BIOCHEM BIOPH RES CO, V271, P559, DOI 10.1006/bbrc.2000.2601; Kashiwagi K, 2000, J BIOL CHEM, V275, P36007, DOI 10.1074/jbc.M006083200; KASHIWAGI K, 1991, J BIOL CHEM, V266, P20922; KASHIWAGI K, 1992, P NATL ACAD SCI USA, V89, P4529, DOI 10.1073/pnas.89.10.4529; Kashiwagi K, 1996, J BIOL CHEM, V271, P12205, DOI 10.1074/jbc.271.21.12205; KASHIWAGI K, 1986, J BACTERIOL, V165, P972, DOI 10.1128/jb.165.3.972-977.1986; KASHIWAGI K, 1988, J BACTERIOL, V170, P3131, DOI 10.1128/jb.170.7.3131-3135.1988; Kashiwagi K, 2002, J BIOL CHEM, V277, P24212, DOI 10.1074/jbc.M202849200; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MENG SY, 1992, J BACTERIOL, V174, P2659, DOI 10.1128/jb.174.8.2659-2669.1992; MOLENAAR D, 1993, J BACTERIOL, V175, P2864, DOI 10.1128/JB.175.10.2864-2870.1993; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Neely MN, 1996, J BACTERIOL, V178, P5522, DOI 10.1128/jb.178.18.5522-5528.1996; NIELSEN PJ, 1982, J BIOL CHEM, V257, P2316; PEGG AE, 1988, CANCER RES, V48, P759; POSNETT DN, 1988, J BIOL CHEM, V263, P1719; Sahin-Toth M, 2002, BIOCHEMISTRY-US, V41, P13039, DOI 10.1021/bi0203076; SAMBROOK J, MOL CLONING LAB MANU; Soksawatmaekhin W, 2004, MOL MICROBIOL, V51, P1401, DOI 10.1046/j.1365-2958.2003.03913.x; Sugiyama S, 1996, J BIOL CHEM, V271, P9519, DOI 10.1074/jbc.271.16.9519; TAKAYAMA M, 1994, MOL MICROBIOL, V11, P913, DOI 10.1111/j.1365-2958.1994.tb00370.x; Vassylyev DG, 1998, J BIOL CHEM, V273, P17604, DOI 10.1074/jbc.273.28.17604; Wallace HM, 2003, BIOCHEM J, V376, P1, DOI 10.1042/BJ20031327; WATSON N, 1992, J BACTERIOL, V174, P530, DOI 10.1128/jb.174.2.530-540.1992	33	39	42	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					29213	29220		10.1074/jbc.M600754200	http://dx.doi.org/10.1074/jbc.M600754200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16877381	hybrid			2022-12-27	WOS:000240680500076
J	Waheed, AA; Ablan, SD; Mankowski, MK; Cummins, JE; Ptak, RG; Schaffner, CP; Freed, EO				Waheed, Abdul A.; Ablan, Sherimay D.; Mankowski, Marie K.; Cummins, James E.; Ptak, Roger G.; Schaffner, Carl P.; Freed, Eric O.			Inhibition of HIV-1 replication by amphotericin B methyl ester - Selection for resistant variants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; VIRION-ASSOCIATED CHOLESTEROL; GP41 CYTOPLASMIC TAIL; CELL-SURFACE EXPRESSION; TYROSINE-BASED SIGNAL; ENVELOPE GLYCOPROTEIN; LIPID RAFTS; ANTIRETROVIRAL THERAPY; MEMBRANE CHOLESTEROL; CLATHRIN ADAPTER	Membrane cholesterol plays an important role in human immunodeficiency virus type 1 (HIV-1) particle production and infectivity. Here, we have investigated the target and mechanism of action of a cholesterol-binding compound, the polyene antifungal antibiotic amphotericin B methyl ester (AME). We found that AME potently inhibited the replication of a highly divergent panel of HIV-1 isolates in various T-cell lines and primary cells irrespective of clade or target cell tropism. The defects in HIV-1 replication caused by AME were due to profoundly impaired viral infectivity as well as a defect in viral particle production. To elucidate further the mechanism of action of AME, we selected for and characterized AME-resistant HIV-1 variants. Mutations responsible for AME resistance mapped to a highly conserved and functionally important endocytosis motif in the cytoplasmic tail of the transmembrane glycoprotein gp41. Interestingly, truncation of the gp41 cytoplasmic tail in the context of either HIV-1 or rhesus macaque simian immunodeficiency virus also conferred resistance to AME. The infectivity of HIV-1 virions bearing murine leukemia virus or vesicular stomatitis virus glycoproteins was unaffected by AME. Our data define the target and mechanism of action of AME and provide support for the concept that cholesterol-binding compounds should be pursued as antiretroviral drugs to disrupt HIV-1 replication.	NCI, Virus Cell Interact Sect, HIV Drug Resistance Program, NIH, Frederick, MD 21702 USA; So Res Inst, Infect Dis Res Dept, Frederick, MD 21701 USA; Rutgers State Univ, Waksman Inst, Dept Microbiol & Biochem, New Brunswick, NJ 08903 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Rutgers State University New Brunswick	Freed, EO (corresponding author), NCI, Virus Cell Interact Sect, HIV Drug Resistance Program, NIH, Bldg 535,Rm 108, Frederick, MD 21702 USA.	efreed@mail.nih.gov			Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; ALOIA RC, 1993, P NATL ACAD SCI USA, V90, P5181, DOI 10.1073/pnas.90.11.5181; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Berlioz-Torrent C, 1999, J VIROL, V73, P1350, DOI 10.1128/JVI.73.2.1350-1361.1999; Boge M, 1998, J BIOL CHEM, V273, P15773, DOI 10.1074/jbc.273.25.15773; Bowers K, 2000, TRAFFIC, V1, P661, DOI 10.1034/j.1600-0854.2000.010810.x; Brajtburg J, 1996, CLIN MICROBIOL REV, V9, P512, DOI 10.1128/CMR.9.4.512; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; Campbell S, 2004, J VIROL, V78, P10556, DOI 10.1128/JVI.78.19.10556-10565.2004; Campbell SM, 2002, AIDS, V16, P2253, DOI 10.1097/00002030-200211220-00004; Campbell SM, 2001, J CLIN VIROL, V22, P217, DOI 10.1016/S1386-6532(01)00193-7; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; del Real G, 2004, J EXP MED, V200, P541, DOI 10.1084/jem.20040061; Deschambeault J, 1999, J VIROL, V73, P5010, DOI 10.1128/JVI.73.6.5010-5017.1999; Ding LM, 2003, J VIROL, V77, P1916, DOI 10.1128/JVI.77.3.1916-1926.2003; Doms RW, 2000, VIROLOGY, V276, P229, DOI 10.1006/viro.2000.0612; Dumonceaux J, 1998, J VIROL, V72, P512, DOI 10.1128/JVI.72.1.512-519.1998; Edwards TG, 2002, J VIROL, V76, P2683, DOI 10.1128/JVI.76.6.2683-2691.2002; FREED EO, 1995, J VIROL, V69, P1984, DOI 10.1128/JVI.69.3.1984-1989.1995; FREED EO, 1989, J VIROL, V63, P4670, DOI 10.1128/JVI.63.11.4670-4675.1989; Freed EO, 1996, J VIROL, V70, P341, DOI 10.1128/JVI.70.1.341-351.1996; FREED EO, 1994, J VIROL, V68, P2503, DOI 10.1128/JVI.68.4.2503-2512.1994; FREED EO, 1995, J VIROL, V69, P3949, DOI 10.1128/JVI.69.6.3949-3954.1995; Fultz PN, 2001, J VIROL, V75, P278, DOI 10.1128/JVI.75.1.278-291.2001; Graham DRM, 2003, J VIROL, V77, P8237, DOI 10.1128/JVI.77.15.8237-8248.2003; Guyader M, 2002, J VIROL, V76, P10356, DOI 10.1128/JVI.76.20.10356-10364.2002; Halwani R, 2003, J VIROL, V77, P3973, DOI 10.1128/JVI.77.7.3973-3984.2003; HANSEN JES, 1990, ANTIVIR RES, V14, P149, DOI 10.1016/0166-3542(90)90031-2; HANSEN JES, 1992, SCAND J INFECT DIS, V24, P35, DOI 10.3109/00365549209048398; Hartsell TL, 1996, J PHARMACOL EXP THER, V277, P1158; Holm K, 2003, J VIROL, V77, P4805, DOI 10.1128/JVI.77.8.4805-4817.2003; HUANG MJ, 1995, J VIROL, V69, P6810, DOI 10.1128/JVI.69.11.6810-6818.1995; Hug P, 2000, J VIROL, V74, P6377, DOI 10.1128/JVI.74.14.6377-6385.2000; JOLY V, 1992, J INFECT DIS, V165, P337, DOI 10.1093/infdis/165.2.337; Kalia V, 2005, J VIROL, V79, P2097, DOI 10.1128/JVI.79.4.2097-2107.2005; Khanna KV, 2002, J CLIN INVEST, V109, P205; Kiernan RE, 1998, J VIROL, V72, P4116, DOI 10.1128/JVI.72.5.4116-4126.1998; Kilby JM, 1998, NAT MED, V4, P1302, DOI 10.1038/3293; LABRANCHE CC, 1995, J VIROL, V69, P5217, DOI 10.1128/JVI.69.9.5217-5227.1995; LANDAU NR, 1991, J VIROL, V65, P162, DOI 10.1128/JVI.65.1.162-169.1991; Liao ZH, 2001, AIDS RES HUM RETROV, V17, P1009, DOI 10.1089/088922201300343690; Liao ZH, 2003, AIDS RES HUM RETROV, V19, P675, DOI 10.1089/088922203322280900; Lindwasser OW, 2001, J VIROL, V75, P7913, DOI 10.1128/JVI.75.17.7913-7924.2001; Lodge R, 1997, EMBO J, V16, P695, DOI 10.1093/emboj/16.4.695; MAEBA R, 1994, BBA-LIPID LIPID MET, V1215, P79, DOI 10.1016/0005-2760(94)90094-9; Moncunill G, 2005, AIDS, V19, P1697, DOI 10.1097/01.aids.0000183517.60384.db; MOORE JP, 1990, SCIENCE, V250, P1139, DOI 10.1126/science.2251501; Murakami T, 2004, J VIROL, V78, P1026, DOI 10.1128/JVI.78.2.1026-1031.2004; Murakami T, 2000, P NATL ACAD SCI USA, V97, P343, DOI 10.1073/pnas.97.1.343; Negredo E, 2006, AIDS, V20, P619, DOI 10.1097/01.aids.0000210617.90954.0e; Nguyen DH, 2000, J VIROL, V74, P3264, DOI 10.1128/JVI.74.7.3264-3272.2000; Ohno H, 1997, VIROLOGY, V238, P305, DOI 10.1006/viro.1997.8839; Ono A, 2005, ADV VIRUS RES, V64, P311, DOI 10.1016/S0065-3527(05)64010-9; Ono A, 2001, P NATL ACAD SCI USA, V98, P13925, DOI 10.1073/pnas.241320298; Palmer S, 1999, AIDS, V13, P661, DOI 10.1097/00002030-199904160-00006; Pickl WF, 2001, J VIROL, V75, P7175, DOI 10.1128/JVI.75.15.7175-7183.2001; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; PLESCIA OJ, 1989, PROTECTION LYMPHOCYT, P485; Pleskoff O, 1996, J VIROL, V70, P8247, DOI 10.1128/JVI.70.11.8247-8251.1996; PLESKOFF O, 1995, J VIROL, V69, P570, DOI 10.1128/JVI.69.1.570-574.1995; Pontani D, 1990, ANTIVIR CHEM CHEMOTH, V1, P67, DOI 10.1177/095632029000100111; REGIER DA, 1990, AIDS RES HUM RETROV, V6, P1221, DOI 10.1089/aid.1990.6.1221; Rousso I, 2000, P NATL ACAD SCI USA, V97, P13523, DOI 10.1073/pnas.240459697; Sauter MM, 1996, J CELL BIOL, V132, P795, DOI 10.1083/jcb.132.5.795; SCHAFFNER CP, 1986, BIOCHEM PHARMACOL, V35, P4110, DOI 10.1016/0006-2952(86)90037-7; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Sklar PA, 2005, AIDS, V19, P1109, DOI 10.1097/01.aids.0000174461.31794.50; SMITH DH, 1987, SCIENCE, V238, P1704, DOI 10.1126/science.3500514; Vzorov AN, 2005, VIROLOGY, V332, P89, DOI 10.1016/j.virol.2004.10.044; Wyma DJ, 2004, J VIROL, V78, P3429, DOI 10.1128/JVI.78.7.3429-3435.2004; Wyss S, 2005, J VIROL, V79, P12231, DOI 10.1128/JVI.79.19.12231-12241.2005; Ye L, 2004, J VIROL, V78, P13409, DOI 10.1128/JVI.78.24.13409-13419.2004; YEE JK, 1994, METHOD CELL BIOL, V43, P99	73	47	49	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					28699	28711		10.1074/jbc.M603609200	http://dx.doi.org/10.1074/jbc.M603609200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16882663	hybrid			2022-12-27	WOS:000240680500023
J	Sbodio, JI; Hicks, SW; Simon, D; Machamer, CE				Sbodio, Juan I.; Hicks, Stuart W.; Simon, Dan; Machamer, Carolyn E.			GCP60 preferentially interacts with a caspase-generated golgin-160 fragment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-ASSOCIATED PROTEIN; SECRETORY PATHWAY; MEDIATED CLEAVAGE; APOPTOSIS; COMPLEX; APPARATUS; PAP7; STEROIDOGENESIS; IDENTIFICATION; AUTOANTIGENS	Golgin-160, a ubiquitous protein in vertebrates, localizes to the cytoplasmic face of the Golgi complex. Golgin-160 has a large coiled-coil C-terminal domain and a non-coiled-coil N-terminal ("head") domain. The head domain contains important motifs, including a nuclear localization signal, a Golgi targeting domain, and three aspartates that are recognized by caspases during apoptosis. Some of the caspase cleavage products accumulate in the nucleus when overexpressed. Expression of a non-cleavable form of golgin-160 impairs apoptosis induced by some pro-apoptotic stimuli; thus cleavage of golgin-160 appears to play a role in apoptotic signaling. We used a yeast two-hybrid assay to screen for interactors of the golgin-160 head and identified GCP60 (Golgi complex-associated protein of 60 kDa). Further analysis demonstrated that GCP60 interacts preferentially with one of the golgin-160 caspase cleavage fragments (residues 140 - 311). This strong interaction prevented the golgin-160 fragment from accumulating in the nucleus when this fragment and GCP60 were overexpressed. In addition, cells overexpressing GCP60 were more sensitive to apoptosis induced by staurosporine, suggesting that nuclear-localized golgin-160-(140 - 311) might promote cell survival. Our results suggest a potential mechanism for regulating the nuclear translocation and potential functions of golgin-160 fragments.	Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Johns Hopkins University	Machamer, CE (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, 725 Wolfe St, Baltimore, MD 21205 USA.	machamer@jhmi.edu	Hicks, Stuart/R-9815-2019	Simon, Dan/0000-0001-7041-4450	NIGMS NIH HHS [GM42522] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anantharaman V, 2002, GENOME BIOL, V3; Barr FA, 2003, CURR OPIN CELL BIOL, V15, P405, DOI 10.1016/S0955-0674(03)00054-1; Chiu R, 2002, J CELL BIOL, V159, P637, DOI 10.1083/jcb.200208013; Farquhar MG, 1998, TRENDS CELL BIOL, V8, P2, DOI 10.1016/S0962-8924(97)01187-2; Hicks SW, 2005, BBA-MOL CELL RES, V1744, P406, DOI 10.1016/j.bbamcr.2005.03.002; Hicks SW, 2005, J BIOL CHEM, V280, P28944, DOI 10.1074/jbc.M504937200; Hicks SW, 2002, J BIOL CHEM, V277, P35833, DOI 10.1074/jbc.M206280200; Lane JD, 2002, J CELL BIOL, V156, P495, DOI 10.1083/jcb.200110007; Li H, 2001, MOL ENDOCRINOL, V15, P2211, DOI 10.1210/me.15.12.2211; Liu J, 2003, J STEROID BIOCHEM, V85, P275, DOI 10.1016/S0960-0760(03)00213-9; Liu J, 2003, GENE, V308, P1, DOI 10.1016/S0378-1119(03)00453-0; Lowe M, 2004, J CELL SCI, V117, P1139, DOI 10.1242/jcs.00950; Maag RS, 2005, MOL BIOL CELL, V16, P3019, DOI 10.1091/mbc.E04-11-0971; Maag RS, 2003, CURR OPIN CELL BIOL, V15, P456, DOI 10.1016/S0955-0674(03)00075-9; Mancini M, 2000, J CELL BIOL, V149, P603, DOI 10.1083/jcb.149.3.603; Marsh BJ, 2002, NAT REV MOL CELL BIO, V3, P789, DOI 10.1038/nrm933; Misumi Y, 1997, J BIOL CHEM, V272, P23851, DOI 10.1074/jbc.272.38.23851; Nozawa K, 2005, AUTOIMMUN REV, V4, P35, DOI 10.1016/j.autrev.2004.06.002; Nozawa K, 2002, ARTHRITIS RES, V4, DOI 10.1186/ar422; Short B, 2005, BBA-MOL CELL RES, V1744, P383, DOI 10.1016/j.bbamcr.2005.02.001; Sohda M, 2001, J BIOL CHEM, V276, P45298, DOI 10.1074/jbc.M108961200	21	37	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					27924	27931		10.1074/jbc.M603276200	http://dx.doi.org/10.1074/jbc.M603276200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16870622	hybrid			2022-12-27	WOS:000240534400028
J	Daryadel, A; Grifone, RF; Simon, HU; Yousefi, S				Daryadel, Arezoo; Grifone, Remo Filippo; Simon, Hans-Uwe; Yousefi, Shida			Apoptotic neutrophils release macrophage migration inhibitory factor upon stimulation with tumor necrosis factor-alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEATH PATHWAY; CELL-DEATH; FACTOR MIF; INFLAMMATION; HYPERSENSITIVITY; PHAGOCYTOSIS; TRANSPORTER; ACTIVATION; SECRETION; CYTOKINE	Macrophage migration inhibitory factor (MIF) is an important cytokine involved in the regulation of innate immunity and present at increased levels during inflammatory responses. Here we demonstrate that mature blood and tissue neutrophils constitutively express MIF as a cytosolic protein not associated with azurophil granules. Functionally active MIF, but not proteases stored in azurophil granules, was released from apoptotic neutrophils following short term tumor necrosis factor (TNF)-alpha stimulation in a caspase-dependent manner and prior to any detectable phagocytosis by monocyte-derived macrophages. Moreover, TNF-alpha-mediated MIF release was blocked by glyburide and propenicide, both inhibitors of ATP-binding cassette-type transporters, suggesting that this transporter system is activated during neutrophil apoptosis. Taken together, apoptotic mature neutrophils release MIF upon short term TNF-alpha stimulation. Therefore, apoptosis may not always occur without the induction of pro-inflammatory mechanisms.	Univ Bern, Dept Pharmacol, CH-3010 Bern, Switzerland	University of Bern	Yousefi, S (corresponding author), Univ Bern, Dept Pharmacol, Friedbuhlstr 49, CH-3010 Bern, Switzerland.	shida.yousefi@pki.unibe.ch	Simon, Hans-Uwe/AAU-5079-2020; Simon, Hans-Uwe/AAU-7410-2020; Yousefi, Shida/AAU-7986-2020; Yousefi, Shida/L-9689-2016	Simon, Hans-Uwe/0000-0002-9404-7736; Yousefi, Shida/0000-0002-9855-4305; Yousefi, Shida/0000-0002-9855-4305				Altznauer F, 2004, J BIOL CHEM, V279, P5947, DOI 10.1074/jbc.M308576200; Altznauer F, 2004, J EXP MED, V199, P1343, DOI 10.1084/jem.20032033; Baumann R, 2003, FASEB J, V17, P2221, DOI 10.1096/fj.03-0110com; Baumann R, 2004, EUR J IMMUNOL, V34, P2268, DOI 10.1002/eji.200424863; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; BLOOM BR, 1966, SCIENCE, V153, P80, DOI 10.1126/science.153.3731.80; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; Bruno A, 2005, J IMMUNOL, V174, P8090, DOI 10.4049/jimmunol.174.12.8090; CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Calandra T, 2000, NAT MED, V6, P164, DOI 10.1038/72262; Chen WJ, 2001, IMMUNITY, V14, P715, DOI 10.1016/S1074-7613(01)00147-9; Cowburn AS, 2005, BLOOD, V105, P2970, DOI 10.1182/blood-2004-07-2870; DAVID JR, 1966, P NATL ACAD SCI USA, V56, P72, DOI 10.1073/pnas.56.1.72; Flieger O, 2003, FEBS LETT, V551, P78, DOI 10.1016/S0014-5793(03)00900-1; Gando S, 2001, INTENS CARE MED, V27, P1187, DOI 10.1007/s001340000818; Gao YK, 1998, J EXP MED, V188, P887, DOI 10.1084/jem.188.5.887; Godson C, 2000, J IMMUNOL, V164, P1663, DOI 10.4049/jimmunol.164.4.1663; Hamon Y, 1997, BLOOD, V90, P2911, DOI 10.1182/blood.V90.8.2911; Koebernick H, 2002, P NATL ACAD SCI USA, V99, P13681, DOI 10.1073/pnas.212488699; Lehmann LE, 2001, INTENS CARE MED, V27, P1412, DOI 10.1007/s001340101022; Liu CY, 2003, BLOOD, V101, P295, DOI 10.1182/blood-2001-12-0266; Maianski NA, 2003, BLOOD, V101, P1987, DOI 10.1182/blood-2002-02-0522; Martinelli S, 2004, J BIOL CHEM, V279, P44123, DOI 10.1074/jbc.M405883200; Miwa K, 1998, NAT MED, V4, P1287, DOI 10.1038/3276; Riedemann NC, 2004, J IMMUNOL, V173, P1355, DOI 10.4049/jimmunol.173.2.1355; Rossi AG, 1998, J CLIN INVEST, V101, P2869, DOI 10.1172/JCI1524; SAVILL JS, 1989, J CLIN INVEST, V83, P865, DOI 10.1172/JCI113970; SIMON HU, 1994, J IMMUNOL, V153, P364; Simon HU, 2003, IMMUNOL REV, V193, P101, DOI 10.1034/j.1600-065X.2003.00038.x; van den Berg JM, 2001, J LEUKOCYTE BIOL, V69, P467; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; von Gunten S, 2005, BLOOD, V106, P1423, DOI 10.1182/blood-2004-10-4112; WEISER WY, 1989, P NATL ACAD SCI USA, V86, P7522, DOI 10.1073/pnas.86.19.7522	34	32	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2006	281	37					27653	27661		10.1074/jbc.M604051200	http://dx.doi.org/10.1074/jbc.M604051200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082PB	16861224	hybrid			2022-12-27	WOS:000240397700090
J	Marquez, JA; Reinelt, S; Koch, B; Engelmann, R; Hengstenberg, W; Scheffzek, K				Marquez, Jose A.; Reinelt, Stefan; Koch, Brigitte; Engelmann, Roswitha; Hengstenberg, Wolfgang; Scheffzek, Klaus			Structure of the full-length enzyme I of the phosphoenolpyruvate-dependent sugar phosphotransferase system.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL DOMAIN; PYRUVATE PHOSPHATE DIKINASE; BACTERIAL PHOSPHOENOLPYRUVATE; SALMONELLA-TYPHIMURIUM; PHOSPHORYL TRANSFER; CRYSTAL-STRUCTURE; PROTEIN-PHOSPHORYLATION; CARBON METABOLISM; TRANSPORT; DIMERIZATION	Enzyme I (EI) is the phosphoenolpyruvate (PEP)-protein phosphotransferase at the entry point of the PEP-dependent sugar phosphotransferase system, which catalyzes carbohydrate uptake into bacterial cells. In the first step of this pathway EI phosphorylates the heat-stable phospho carrier protein at His-15 using PEP as a phosphoryl donor in a reaction that requires EI dimerization and autophosphorylation at His-190. The structure of the full-length protein from Staphylococcus carnosus at 2.5 angstrom reveals an extensive interaction surface between two molecules in adjacent asymmetric units. Structural comparison with related domains indicates that this surface represents the biochemically relevant contact area of dimeric EI. Each monomer has an extended configuration with the phosphohistidine and heat-stable phospho carrier protein-binding domains clearly separated from the C-terminal dimerization and PEP-binding region. The large distance of more than 35 angstrom between the active site His-190 and the PEP binding site suggests that large conformational changes must occur during the process of autophosphorylation, as has been proposed for the structurally related enzyme pyruvate phosphate dikinase. Our structure for the first time offers a framework to analyze a large amount of research in the context of the full-length model.	European Mol Biol Lab, Struct & Computat Biol Programme, D-69117 Heidelberg, Germany; European Mol Biol Lab, F-38042 Grenoble 9, France; Ruhr Univ Bochum, AG Physiol Microorganisms, D-44780 Bochum, Germany	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Ruhr University Bochum	Scheffzek, K (corresponding author), European Mol Biol Lab, Struct & Computat Biol Programme, Meyerhofstr 1, D-69117 Heidelberg, Germany.	scheffzek@embl.de	Marquez, Jose/C-5826-2015					Brokx SJ, 2000, BIOCHEMISTRY-US, V39, P3624, DOI 10.1021/bi991250z; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHAUVIN F, 1994, J BIOL CHEM, V269, P20263; Chauvin F, 1996, RES MICROBIOL, V147, P471, DOI 10.1016/0923-2508(96)84001-0; CHAUVIN F, 1992, BIOPHYS CHEM, V44, P163, DOI 10.1016/0301-4622(92)80049-B; COPLEY RR, 1994, J MOL BIOL, V242, P321; Dimitrova MN, 2002, BIOCHEMISTRY-US, V41, P906, DOI 10.1021/bi011801x; Garcia-Alles LF, 2003, BIOCHEMISTRY-US, V42, P4744, DOI 10.1021/bi034007f; Garcia-Alles LF, 2002, J BIOL CHEM, V277, P6934, DOI 10.1074/jbc.M110067200; Garrett DS, 1999, NAT STRUCT BIOL, V6, P166; Garrett DS, 1997, BIOCHEMISTRY-US, V36, P2517, DOI 10.1021/bi962924y; Ginsburg A, 2002, ARCH BIOCHEM BIOPHYS, V397, P273, DOI 10.1006/abbi.2001.2603; Girard E, 2003, ACTA CRYSTALLOGR D, V59, P118, DOI 10.1107/S0907444902020176; Herzberg O, 1996, P NATL ACAD SCI USA, V93, P2652, DOI 10.1073/pnas.93.7.2652; Herzberg O, 2002, BIOCHEMISTRY-US, V41, P780, DOI 10.1021/bi011799+; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KOHLBRECHER D, 1992, J BACTERIOL, V174, P2208, DOI 10.1128/JB.174.7.2208-2214.1992; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KUKURUZINSKA MA, 1984, J BIOL CHEM, V259, P1679; KUNDIG W, 1964, P NATL ACAD SCI USA, V52, P1067, DOI 10.1073/pnas.52.4.1067; LEE BR, 1994, ARCH BIOCHEM BIOPHYS, V312, P121, DOI 10.1006/abbi.1994.1289; Liao DI, 1996, STRUCTURE, V4, P861, DOI 10.1016/S0969-2126(96)00092-5; LICALSI C, 1991, J BIOL CHEM, V266, P19519; MEADOW ND, 1990, ANNU REV BIOCHEM, V59, P497, DOI 10.1146/annurev.biochem.59.1.497; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MISSET O, 1980, BIOCHEMISTRY-US, V19, P883, DOI 10.1021/bi00546a009; Nakanishi T, 2005, BIOCHEMISTRY-US, V44, P1136, DOI 10.1021/bi0484522; Oberholzer AE, 2005, J MOL BIOL, V346, P521, DOI 10.1016/j.jmb.2004.11.077; Patel HV, 2006, J BIOL CHEM, V281, P17579, DOI 10.1074/jbc.M508966200; Patel HV, 2006, J BIOL CHEM, V281, P17570, DOI 10.1074/jbc.M508965200; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; REIZER J, 1992, PROTEIN SCI, V1, P722, DOI 10.1002/pro.5560010604; REIZER J, 1993, PROTEIN SCI, V2, P506; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; SAIER MH, 1980, J BIOL CHEM, V255, P8579; SAIER MH, 1994, MOL MICROBIOL, V13, P755; SAIER MH, 1995, TRENDS BIOCHEM SCI, V20, P267, DOI 10.1016/S0968-0004(00)89041-6; Seok YJ, 1996, P NATL ACAD SCI USA, V93, P347, DOI 10.1073/pnas.93.1.347; Seok YJ, 1998, BIOCHEM BIOPH RES CO, V250, P381, DOI 10.1006/bbrc.1998.9323; Sicheri F, 1997, CURR OPIN STRUC BIOL, V7, P777, DOI 10.1016/S0959-440X(97)80146-7; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Warner JB, 2003, MICROBIOL MOL BIOL R, V67, P475, DOI 10.1128/MMBR.67.4.475-490.2003; WEIGEL N, 1982, J BIOL CHEM, V257, P4477; Zhu PP, 1999, BIOCHEMISTRY-US, V38, P15470, DOI 10.1021/bi991680p	45	25	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32508	32515		10.1074/jbc.M513721200	http://dx.doi.org/10.1074/jbc.M513721200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16867985	hybrid			2022-12-27	WOS:000241414500048
J	Korbas, M; Vogt, S; Meyer-Klaucke, W; Bill, E; Lyon, EJ; Thauer, RK; Shima, S				Korbas, Malgorzata; Vogt, Sonja; Meyer-Klaucke, Wolfram; Bill, Eckhard; Lyon, Erica J.; Thauer, Rudolf K.; Shima, Seigo			The iron-sulfur cluster-free hydrogenase (Hmd) is a metalloenzyme with a novel iron binding motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FE-ONLY HYDROGENASE; H-2-FORMING METHYLENETETRAHYDROMETHANOPTERIN DEHYDROGENASE; METAL-FREE HYDROGENASE; ACTIVE-SITE; METHANOBACTERIUM-THERMOAUTOTROPHICUM; CRYSTAL-STRUCTURE; N5,N10-METHYLENETETRAHYDROMETHANOPTERIN DEHYDROGENASE; DESULFOVIBRIO-DESULFURICANS; METHANOGENIC ARCHAEA; CATALYTIC MECHANISM	The iron-sulfur cluster-free hydrogenase (Hmd) from methanogenic archaea harbors an iron-containing cofactor of yet unknown structure. X-ray absorption spectroscopy of the active, as isolated enzyme from Methanothermobacter marburgensis (mHmd) and of the active, reconstituted enzyme from Methanocaldococcus jannaschii (jHmd) revealed the presence of mononuclear iron with two CO, one sulfur and one or two N/O in coordination distance. In jHmd, the single sulfur ligand is most probably provided by Cys(176), as deduced from a comparison of the activity and of the x-ray absorption and Mossbauer spectra of the enzyme mutated in any of the three conserved cysteines. In the isolated Hmd cofactor, two CO, one sulfur, and two nitrogen/oxygen atoms coordinate the iron, the sulfur ligand being most probably provided by mercaptoethanol, which is absolutely required for the extraction of the iron-containing cofactor from the holoenzyme and for the stabilization of the extracted cofactor. In active mHmd holoenzyme, the number of iron ligands increased by one when one of the Hmd inhibitors ( CO or KCN)were present, indicating that in active Hmd, the iron contains an open coordination site, which is proposed to be the site of H-2 interaction.	Deutsch Elektronen Synchrotron DESY, Outstn Hamburg, EMBL, D-22603 Hamburg, Germany; Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany; Max Planck Inst Bioinorgan Chem, D-45470 Mulheim, Germany	European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Max Planck Society; Max Planck Society	Meyer-Klaucke, W (corresponding author), Deutsch Elektronen Synchrotron DESY, Outstn Hamburg, EMBL, Notkestr 85, D-22603 Hamburg, Germany.	Wolfram@embl-hamburg.de; shima@mpi-marburg.mpg.de	Meyer-Klaucke, Wolfram/G-1148-2010; Korbas, Malgorzata/B-4024-2009	Korbas, Malgorzata/0000-0003-3064-0132; Oduaran, Erica/0000-0001-9298-5721				Afting C, 1998, ARCH MICROBIOL, V169, P206, DOI 10.1007/s002030050562; Armstrong FA, 2004, CURR OPIN CHEM BIOL, V8, P133, DOI 10.1016/j.cbpa.2004.02.004; Bennett B, 2000, BIOCHEMISTRY-US, V39, P7455, DOI 10.1021/bi992583z; Berkessel A, 2001, CURR OPIN CHEM BIOL, V5, P486, DOI 10.1016/S1367-5931(00)00245-3; BINSTED N, 1992, BIOCHEMISTRY-US, V31, P12117, DOI 10.1021/bi00163a021; Buurman G, 2000, FEBS LETT, V485, P200, DOI 10.1016/S0014-5793(00)02225-0; Chen CH, 2004, DALTON T, P137, DOI 10.1039/b311059a; DeBord JRD, 1997, ACTA CRYSTALLOGR C, V53, P45, DOI 10.1107/S0108270196011584; Frey M, 2002, CHEMBIOCHEM, V3, P153, DOI 10.1002/1439-7633(20020301)3:2/3<153::AID-CBIC153>3.0.CO;2-B; Hartmann GC, 1996, J BIOL INORG CHEM, V1, P446, DOI 10.1007/s007750050077; Huyett JE, 1997, J AM CHEM SOC, V119, P9291, DOI 10.1021/ja9700919; Liu ZP, 2002, J AM CHEM SOC, V124, P5175, DOI 10.1021/ja0118690; Loscher S, 2005, FEBS LETT, V579, P4287, DOI 10.1016/j.febslet.2005.06.063; Lyon EJ, 2004, EUR J BIOCHEM, V271, P195, DOI 10.1046/j.1432-1033.2003.03920.x; Lyon EJ, 2004, J AM CHEM SOC, V126, P14239, DOI 10.1021/ja046818s; Mijovilovich A, 2003, J SYNCHROTRON RADIAT, V10, P64, DOI 10.1107/S0909049502017296; MOORE JT, 1993, PROTEIN EXPRES PURIF, V4, P160, DOI 10.1006/prep.1993.1022; Nicolet Y, 2002, J INORG BIOCHEM, V91, P1, DOI 10.1016/S0162-0134(02)00392-6; Nicolet Y, 1999, STRUCTURE, V7, P13, DOI 10.1016/S0969-2126(99)80005-7; Nicolet Y, 2001, J AM CHEM SOC, V123, P1596, DOI 10.1021/ja0020963; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; PETTIFER RF, 1985, J APPL CRYSTALLOGR, V18, P404, DOI 10.1107/S0021889885010627; Pilak O, 2006, J MOL BIOL, V358, P798, DOI 10.1016/j.jmb.2006.02.035; SCHWORER B, 1993, EUR J BIOCHEM, V212, P255, DOI 10.1111/j.1432-1033.1993.tb17657.x; Shima S, 2005, J AM CHEM SOC, V127, P10430, DOI 10.1021/ja051895o; Shima S, 2004, ANGEW CHEM INT EDIT, V43, P2547, DOI 10.1002/anie.200353763; Shima S, 2001, METHOD ENZYMOL, V331, P317; Shokes JE, 2005, FEBS LETT, V579, P1741, DOI 10.1016/j.febslet.2005.02.034; STERN EA, 1993, PHYS REV B, V48, P9825, DOI 10.1103/PhysRevB.48.9825; Strub MP, 2003, STRUCTURE, V11, P1359, DOI 10.1016/j.str.2003.09.014; Thauer RK, 1996, CHEM REV, V96, P3031, DOI 10.1021/cr9500601; Vignais PM, 2001, FEMS MICROBIOL REV, V25, P455, DOI 10.1111/j.1574-6976.2001.tb00587.x; Volbeda A, 2005, J BIOL INORG CHEM, V10, P239, DOI 10.1007/s00775-005-0632-x; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0; Zhou TJ, 2004, INORG CHEM, V43, P923, DOI 10.1021/ic0342301; ZIRNGIBL C, 1990, FEBS LETT, V261, P112, DOI 10.1016/0014-5793(90)80649-4	36	114	118	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30804	30813		10.1074/jbc.M605306200	http://dx.doi.org/10.1074/jbc.M605306200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16887798	hybrid			2022-12-27	WOS:000241075900056
J	Du, WL; McMahon, TJ; Zhang, ZS; Stiber, JA; Meissner, G; Eu, JP				Du, Wanglei; McMahon, Timothy J.; Zhang, Zhu-Shan; Stiber, Jonathan A.; Meissner, Gerhard; Eu, Jerry P.			Excitation-contraction coupling in airway smooth muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RYANODINE RECEPTOR SUBTYPES; CA2+ RELEASE CHANNELS; CALCIUM-CHANNELS; PULMONARY-ARTERY; HYPOXIC VASOCONSTRICTION; SKELETAL-MUSCLE; CELLS; STORES; ACETYLCHOLINE; BRONCHOCONSTRICTION	Excitation-contraction (EC) coupling in striated muscles is mediated by the cardiac or skeletal muscle isoform of voltage-dependent L-type Ca2+ channel (Ca(v)1.2 and Ca(v)1.1, respectively) that senses a depolarization of the cell membrane, and in response, activates its corresponding isoform of intracellular Ca2+ release channel/ryanodine receptor (RyR) to release stored Ca2+, thereby initiating muscle contraction. Specifically, in cardiac muscle following cell membrane depolarization, Cav1.2 activates cardiac RyR (RyR2) through an influx of extracellular Ca2+. In contrast, in skeletal muscle, Cav1.1 activates skeletal muscle RyR (RyR1) through a direct physical coupling that negates the need for extracellular Ca2+. Since airway smooth muscle (ASM) expresses Ca(v)1.2 and all three RyR isoforms, we examined whether a cardiac muscle type of EC coupling also mediates contraction in this tissue. We found that the sustained contractions of rat ASM preparations induced by depolarization with KCl were indeed partially reversed (similar to 40%) by 200 mu M ryanodine, thus indicating a functional coupling of L-type channels and RyRs in ASM. However, KCl still caused transient ASM contractions and stored Ca2+ release in cultured ASM cells without extracellular Ca2+. Further analyses of rat ASM indicated that this tissue expresses as many as four L-type channel isoforms, including Cav1.1. Moreover, Cav1.1 and RyR1 in rat ASM cells have a similar distribution near the cell membrane in rat ASM cells and thus may be directly coupled as in skeletal muscle. Collectively, our data implicate that EC-coupling mechanisms in striated muscles may also broadly transduce diverse smooth muscle functions.	Duke Univ, Med Ctr, Div Pulm Allergy & Crit Care Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Div Cardiol, Durham, NC 27710 USA; Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill	Eu, JP (corresponding author), Duke Univ, Med Ctr, Div Pulm Allergy & Crit Care Med, MSRB 241,Res Dr, Durham, NC 27710 USA.	eu000001@duke.edu	McMahon, Tim/K-3986-2012	McMahon, Tim/0000-0002-3404-3223	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR018687, R01AR018687] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR18687] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bergner A, 2002, J GEN PHYSIOL, V119, P187, DOI 10.1085/jgp.119.2.187; BOURREAU JP, 1991, AM J PHYSIOL, V261, pC497, DOI 10.1152/ajpcell.1991.261.3.C497; BOURREAU JP, 1993, AM J PHYSIOL, V265, pC28, DOI 10.1152/ajpcell.1993.265.1.C28; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Chavis P, 1996, NATURE, V382, P719, DOI 10.1038/382719a0; Coussin F, 2000, J BIOL CHEM, V275, P9596, DOI 10.1074/jbc.275.13.9596; Deshpande DA, 2005, AM J PHYSIOL-LUNG C, V288, pL773, DOI 10.1152/ajplung.00217.2004; Du WL, 2005, J BIOL CHEM, V280, P26287, DOI 10.1074/jbc.M502905200; FANTA CH, 1982, AM REV RESPIR DIS, V125, P61; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; FLEISCHMANN BK, 1994, P NATL ACAD SCI USA, V91, P11914, DOI 10.1073/pnas.91.25.11914; FranziniArmstrong C, 1997, PHYSIOL REV, V77, P699, DOI 10.1152/physrev.1997.77.3.699; Fritz N, 2005, J CELL SCI, V118, P2261, DOI 10.1242/jcs.02344; Gelband CH, 1997, CIRCULATION, V96, P3647; HELL JW, 1993, J CELL BIOL, V123, P949, DOI 10.1083/jcb.123.4.949; Jabr RI, 1997, BRIT J PHARMACOL, V122, P21, DOI 10.1038/sj.bjp.0701326; Janssen LJ, 2002, AM J PHYSIOL-LUNG C, V282, pL1161, DOI 10.1152/ajplung.00452.2001; JANSSEN LJ, 2004, AM J PHYSIOL, V287, pL8528; Koschak A, 2001, J BIOL CHEM, V276, P22100, DOI 10.1074/jbc.M101469200; Kovac JR, 2005, AM J PHYSIOL-GASTR L, V289, pG998, DOI 10.1152/ajpgi.00529.2004; Meissner G, 2004, CELL CALCIUM, V35, P621, DOI 10.1016/j.ceca.2004.01.015; MEISSNER G, 1994, ANNU REV PHYSIOL, V56, P485, DOI 10.1146/annurev.ph.56.030194.002413; Moosmang S, 2003, EMBO J, V22, P6027, DOI 10.1093/emboj/cdg583; Morio Y, 2002, J APPL PHYSIOL, V92, P527, DOI 10.1152/jappl.2002.92.2.527; MORTON ME, 1987, J BIOL CHEM, V262, P11904; Nakai J, 1996, NATURE, V380, P72, DOI 10.1038/380072a0; Nakai J, 1998, J BIOL CHEM, V273, P13403, DOI 10.1074/jbc.273.22.13403; Protasi F, 2000, BIOPHYS J, V79, P2494, DOI 10.1016/S0006-3495(00)76491-5; Rosenberg P, 2004, P NATL ACAD SCI USA, V101, P9387, DOI 10.1073/pnas.0308179101; Sutko JL, 1996, PHYSIOL REV, V76, P1027, DOI 10.1152/physrev.1996.76.4.1027; TANABE T, 1990, NATURE, V346, P567, DOI 10.1038/346567a0; TANABE T, 1988, NATURE, V336, P134, DOI 10.1038/336134a0; TOMASIC M, 1992, AM J PHYSIOL, V263, pC106, DOI 10.1152/ajpcell.1992.263.1.C106; Wang YX, 2004, AM J PHYSIOL-CELL PH, V286, pC538, DOI 10.1152/ajpcell.00106.2003; Weir EK, 2005, NEW ENGL J MED, V353, P2042, DOI 10.1056/NEJMra050002; Xu WF, 2001, J NEUROSCI, V21, P5944, DOI 10.1523/JNEUROSCI.21-16-05944.2001; Yang XR, 2005, AM J PHYSIOL-LUNG C, V289, pL338, DOI 10.1152/ajplung.00328.2004; Zhang Z, 2005, CIRCULATION, V112, P1936, DOI 10.1161/CIRCULATIONAHA.105.540070; Zheng YM, 2005, J GEN PHYSIOL, V125, P427, DOI 10.1085/jgp.200409232	40	32	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					30143	30151		10.1074/jbc.M606541200	http://dx.doi.org/10.1074/jbc.M606541200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16891657	hybrid, Green Published			2022-12-27	WOS:000240896300075
J	Anders, A; Lilie, H; Franke, K; Kapp, L; Stelling, J; Gilles, ED; Breunig, KD				Anders, Alexander; Lilie, Hauke; Franke, Kathlen; Kapp, Lutz; Stelling, Joerg; Gilles, Ernst D.; Breunig, Karin D.			The galactose switch in Kluyveromyces lactis depends on nuclear competition between Gal4 and Gal1 for Gal80 binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSE-FRUCTOSE OXIDOREDUCTASE; NEGATIVE REGULATORY PROTEIN; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL ACTIVATION; GAL4P-ACTIVATED GENES; FUNCTIONAL HOMOLOGY; TERMINAL FRAGMENT; ESCHERICHIA-COLI; AMINO-ACIDS; YEAST	The Gal4 protein represents a universally functional transcription activator, which in yeast is regulated by protein-protein interaction of its transcription activation domain with the inhibitor Gal80. Gal80 inhibition is relieved via galactose-mediated Gal80-Gal1-Gal3 interaction. The Gal4-Gal80-Gal1/3 regulatory module is conserved between Saccharomyces cerevisiae and Kluyveromyces lactis. Here we demonstrate that K. lactis Gal80 (KlGal80) is a nuclear protein independent of the Gal4 activity status, whereas KlGal1 is detected throughout the entire cell, which implies that KlGal80 and KlGal1 interact in the nucleus. Consistently KlGal1 accumulates in the nucleus upon KlGAL80 overexpression. Furthermore, we show that the KlGal80-KlGal1 interaction blocks the galactokinase activity of KlGal1 and is incompatible with KlGal80-KlGal4-AD interaction. Thus, we propose that dissociation of KlGal80 from the AD forms the basis of KlGal4 activation in K. lactis. Quantitation of the dissociation constants for the KlGal80 complexes gives a much lower affinity for KlGal1 as compared with Gal4. Mathematical modeling shows that with these affinities a switch based on competition between Gal1 and Gal4 for Gal80 binding is nevertheless efficient provided two monomeric Gal1 molecules interact with dimeric Gal80. Consistent with such a mechanism, analysis of the sedimentation behavior by analytical ultracentrifugation demonstrates the formation of a heterotetrameric KlGal80-KlGal1 complex of 2:2 stoichiometry.	Univ Halle Wittenberg, Genet Inst, D-06099 Halle, Germany; Univ Halle Wittenberg, Inst Biotechnol, D-06099 Halle, Germany; Max Planck Inst Dynam Komplexer Tech Syst, D-39106 Magdeburg, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; Max Planck Society	Breunig, KD (corresponding author), Univ Halle Wittenberg, Genet Inst, D-06099 Halle, Germany.	karin.breunig@genetik.uni-halle.de	Stelling, Joerg/F-7499-2010	Stelling, Joerg/0000-0002-1145-891X; Anders, Alexander/0000-0002-9845-3491				ALI JA, 1993, BIOCHEMISTRY-US, V32, P2717, DOI 10.1021/bi00061a033; Ansari AZ, 1998, P NATL ACAD SCI USA, V95, P13543, DOI 10.1073/pnas.95.23.13543; Behlke J, 1997, BIOCHEMISTRY-US, V36, P5149, DOI 10.1021/bi962755h; BHAT PJ, 1992, MOL CELL BIOL, V12, P2701, DOI 10.1128/MCB.12.6.2701; Bhaumik SR, 2004, GENE DEV, V18, P333, DOI 10.1101/gad.1148404; Blank TE, 1997, MOL CELL BIOL, V17, P2566, DOI 10.1128/MCB.17.5.2566; BREUNIG KD, 1987, MOL CELL BIOL, V7, P4400, DOI 10.1128/MCB.7.12.4400; BROACH JR, 1979, J MOL BIOL, V131, P41, DOI 10.1016/0022-2836(79)90300-0; CAREY M, 1989, J MOL BIOL, V209, P423, DOI 10.1016/0022-2836(89)90007-7; Carrozza MJ, 2002, J BIOL CHEM, V277, P24648, DOI 10.1074/jbc.M201965200; DAS S, 1985, EMBO J, V4, P793, DOI 10.1002/j.1460-2075.1985.tb03699.x; DICKSON RC, 1983, J BACTERIOL, V154, P1245, DOI 10.1128/JB.154.3.1245-1251.1983; ENGELS R, 1999, THESIS HEINRICHHEINE; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; JOHNSTON M, 1987, MICROBIOL REV, V51, P458, DOI 10.1128/MMBR.51.4.458-476.1987; JOHNSTON M, 1992, MOL CELLULAR BIOL YE, V2, P195; JOHNSTON SA, 1987, CELL, V50, P143, DOI 10.1016/0092-8674(87)90671-4; Kingston RL, 1996, STRUCTURE, V4, P1413, DOI 10.1016/S0969-2126(96)00149-9; KODADEK TJ, 1994, TRANSCRIPTION MECH R, P505; LACY LR, 1981, MOL CELL BIOL, V1, P629, DOI 10.1128/MCB.1.7.629; LEUTHER KK, 1993, CELL, V72, P575, DOI 10.1016/0092-8674(93)90076-3; LODI T, 1991, J GEN MICROBIOL, V137, P1039, DOI 10.1099/00221287-137-5-1039; Lott JS, 2000, J MOL BIOL, V304, P575, DOI 10.1006/jmbi.2000.4245; LUE NF, 1987, MOL CELL BIOL, V7, P3446, DOI 10.1128/MCB.7.10.3446; MA J, 1987, CELL, V50, P137, DOI 10.1016/0092-8674(87)90670-2; Maru Y, 1996, J BIOL CHEM, V271, P15353, DOI 10.1074/jbc.271.26.15353; Melcher K, 2005, GENETICS, V171, P469, DOI 10.1534/genetics.105.045237; Melcher K, 2001, EMBO J, V20, P841, DOI 10.1093/emboj/20.4.841; Menezes RA, 2003, J MOL BIOL, V333, P479, DOI 10.1016/j.jmb.2003.08.034; MEYER J, 1991, MOL CELL BIOL, V11, P5454, DOI 10.1128/MCB.11.11.5454; NOGI Y, 1989, MOL CELL BIOL, V9, P3009, DOI 10.1128/MCB.9.7.3009; Peng G, 2000, MOL CELL BIOL, V20, P5140, DOI 10.1128/MCB.20.14.5140-5148.2000; Peng G, 2002, P NATL ACAD SCI USA, V99, P8548, DOI 10.1073/pnas.142100099; Pilauri V, 2005, GENETICS, V169, P1903, DOI 10.1534/genetics.104.036723; Platt A, 2000, P NATL ACAD SCI USA, V97, P3154, DOI 10.1073/pnas.97.7.3154; Platt A, 1998, EMBO J, V17, P4086, DOI 10.1093/emboj/17.14.4086; Reece RJ, 1997, BIOESSAYS, V19, P1001, DOI 10.1002/bies.950191110; REECE RJ, 1993, GENE, V126, P105, DOI 10.1016/0378-1119(93)90596-U; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; RILEY MI, 1987, MOL CELL BIOL, V7, P780, DOI 10.1128/MCB.7.2.780; SALMERON JM, 1990, GENETICS, V125, P21; SALMERON JM, 1986, NUCLEIC ACIDS RES, V14, P7767, DOI 10.1093/nar/14.19.7767; SALMERON JM, 1989, MOL CELL BIOL, V9, P2950, DOI 10.1128/MCB.9.7.2950; SCHULZ WA, 1993, BIOL CHEM H-S, V374, P313, DOI 10.1515/bchm3.1993.374.1-6.313; SELLECK SB, 1987, MOL CELL BIOL, V7, P3260, DOI 10.1128/MCB.7.9.3260; Sherman F, 1986, LAB COURSE MANUAL ME, P3; Sil AK, 1999, MOL CELL BIOL, V19, P7828; SuzukiFujimoto T, 1996, MOL CELL BIOL, V16, P2504; Thoden JB, 2005, J BIOL CHEM, V280, P36905, DOI 10.1074/jbc.M508446200; Timson DJ, 2002, BIOCHEM J, V363, P515, DOI 10.1042/0264-6021:3630515; Timson DJ, 2002, BIOCHIMIE, V84, P265, DOI 10.1016/S0300-9084(02)01399-8; Verma M, 2004, EUR J BIOCHEM, V271, P4064, DOI 10.1111/j.1432-1033.2004.04344.x; Verma M, 2003, J BIOL CHEM, V278, P48764, DOI 10.1074/jbc.M303526200; Winey M, 1997, MOL BIOL CELL, V8, P2119, DOI 10.1091/mbc.8.11.2119; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Wu YB, 1996, EMBO J, V15, P3951, DOI 10.1002/j.1460-2075.1996.tb00769.x; Yano KI, 1997, P NATL ACAD SCI USA, V94, P1721, DOI 10.1073/pnas.94.5.1721; ZACHARIAE W, 1993, MOL CELL BIOL, V13, P3058, DOI 10.1128/MCB.13.5.3058; ZACHARIAE W, 1994, THESIS HEINRICHHEINE; ZENKE FT, 1993, MOL CELL BIOL, V13, P7566, DOI 10.1128/MCB.13.12.7566; Zenke FT, 1999, BIOL CHEM, V380, P419, DOI 10.1515/BC.1999.056; Zenke FT, 1996, SCIENCE, V272, P1662, DOI 10.1126/science.272.5268.1662	62	28	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					29337	29348		10.1074/jbc.M604271200	http://dx.doi.org/10.1074/jbc.M604271200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16867978	hybrid			2022-12-27	WOS:000240680500089
J	Kinghorn, KJ; Crowther, DC; Sharp, LK; Nerelius, C; Davis, RL; Chang, HT; Green, C; Gubb, DC; Johansson, J; Lomas, DA				Kinghorn, Kerri J.; Crowther, Damian C.; Sharp, Lynda K.; Nerelius, Charlotte; Davis, Richard L.; Chang, Howard T.; Green, Clare; Gubb, David C.; Johansson, Jan; Lomas, David A.			Neuroserpin binds A beta and is a neuroprotective component of amyloid plaques in Alzheimer disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLID-STATE NMR; TISSUE-PLASMINOGEN ACTIVATOR; NUCLEAR-MAGNETIC-RESONANCE; SERINE-PROTEASE INHIBITOR; LONG-TERM POTENTIATION; APOLIPOPROTEIN-E; FORMS POLYMERS; IN-VITRO; FAMILIAL ENCEPHALOPATHY; ELECTRON-MICROSCOPY	Alzheimer disease is characterized by extracellular plaques composed of A beta peptides. We show here that these plaques also contain the serine protease inhibitor neuroserpin and that neuroserpin forms a 1:1 binary complex with the N-terminal or middle parts of the A beta(1-42) peptide. This complex inactivates neuroserpin as an inhibitor of tissue plasminogen activator and blocks the loop-sheet polymerization process that is characteristic of members of the serpin superfamily. In contrast neuroserpin accelerates the aggregation of A beta(1-42) with the resulting species having an appearance that is distinct from the mature amyloid fibril. Neuroserpin reduces the cytotoxicity of A beta(1-42) when assessed using standard cell assays, and the interaction has been confirmed in vivo in novel Drosophila models of disease. Taken together, these data show that neuroserpin interacts with A beta(1-42) to form off-pathway non-toxic oligomers and so protects neurons in Alzheimer disease.	Univ Cambridge, Dept Med, Inst Med Res, Cambridge CB2 2XY, England; Swedish Univ Agr Sci, Dept Mol Biosci Med Biochem, Biomed Ctr, S-75123 Uppsala, Sweden; SUNY Upstate Med Univ, Dept Pathol, Syracuse, NY 13210 USA; Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; Ctr Invest Cooperat Biogune, Derio 48160, Spain	University of Cambridge; Swedish University of Agricultural Sciences; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University of Cambridge	Crowther, DC (corresponding author), Univ Cambridge, Dept Med, Inst Med Res, Wellcome Trust Med Res Council Bldg,Hills Rd, Cambridge CB2 2XY, England.	dcc26@cam.ac.uk		Skipper, Lynda/0000-0002-1463-5811; Johansson, Jan/0000-0002-8719-4703; Kinghorn, Kerri J/0000-0003-2048-4332	MRC [G0500306] Funding Source: UKRI; Medical Research Council [G0500306] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		ABRAHAM CR, 1988, CELL, V52, P487, DOI 10.1016/0092-8674(88)90462-X; Antzutkin ON, 2000, P NATL ACAD SCI USA, V97, P13045, DOI 10.1073/pnas.230315097; Antzutkin ON, 2003, BIOPHYS J, V84, P3326, DOI 10.1016/S0006-3495(03)70057-5; Antzutkin ON, 2002, BIOCHEMISTRY-US, V41, P15436, DOI 10.1021/bi0204185; Asante EA, 2002, EMBO J, V21, P6358, DOI 10.1093/emboj/cdf653; Balbach JJ, 2002, BIOPHYS J, V83, P1205, DOI 10.1016/S0006-3495(02)75244-2; Belorgey D, 2004, EUR J BIOCHEM, V271, P3360, DOI 10.1111/j.1432-1033.2004.04270.x; Belorgey D, 2002, J BIOL CHEM, V277, P17367, DOI 10.1074/jbc.M200680200; Centonze D, 2002, EUR J NEUROSCI, V16, P713, DOI 10.1046/j.1460-9568.2002.02106.x; Cinelli P, 2001, MOL CELL NEUROSCI, V18, P443, DOI 10.1006/mcne.2001.1028; Collinge J, 2005, J NEUROL NEUROSUR PS, V76, P906, DOI 10.1136/jnnp.2004.048660; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Costa DA, 2004, J ALZHEIMERS DIS, V6, P509; Crowther DC, 2005, NEUROSCIENCE, V132, P123, DOI 10.1016/j.neuroscience.2004.12.025; Dafforn TR, 1999, J BIOL CHEM, V274, P9548, DOI 10.1074/jbc.274.14.9548; Davis RL, 1999, NATURE, V401, P376, DOI 10.1038/43897; Davis RL, 2002, LANCET, V359, P2242, DOI 10.1016/S0140-6736(02)09293-0; De Gregorio E, 2002, DEV CELL, V3, P581, DOI 10.1016/S1534-5807(02)00267-8; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Dolev I, 2004, P NATL ACAD SCI USA, V101, P13909, DOI 10.1073/pnas.0404458101; Elliott PR, 1996, NAT STRUCT BIOL, V3, P676, DOI 10.1038/nsb0896-676; ERIKSSON S, 1995, P NATL ACAD SCI USA, V92, P2313, DOI 10.1073/pnas.92.6.2313; Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514; FRASER PE, 1993, J NEUROCHEM, V61, P298, DOI 10.1111/j.1471-4159.1993.tb03568.x; Hastings GA, 1997, J BIOL CHEM, V272, P33062, DOI 10.1074/jbc.272.52.33062; Huang THJ, 2000, J MOL BIOL, V297, P73, DOI 10.1006/jmbi.2000.3559; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lashuel HA, 2003, J MOL BIOL, V332, P795, DOI 10.1016/S0022-2836(03)00927-6; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; Miranda E, 2004, J BIOL CHEM, V279, P28283, DOI 10.1074/jbc.M313166200; NAMBA Y, 1991, BRAIN RES, V541, P163, DOI 10.1016/0006-8993(91)91092-F; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; Onda M, 2005, J BIOL CHEM, V280, P13735, DOI 10.1074/jbc.M413282200; Osterwalder T, 1996, EMBO J, V15, P2944, DOI 10.1002/j.1460-2075.1996.tb00657.x; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Renatus M, 1997, J BIOL CHEM, V272, P21713, DOI 10.1074/jbc.272.35.21713; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; SCHULZE AJ, 1990, EUR J BIOCHEM, V194, P51, DOI 10.1111/j.1432-1033.1990.tb19425.x; Selkoe DJ, 2000, ANN NY ACAD SCI, V924, P17; SERPELL LC, 1995, J MOL BIOL, V254, P113, DOI 10.1006/jmbi.1995.0604; Skinner R, 1998, J MOL BIOL, V283, P9, DOI 10.1006/jmbi.1998.2083; Sunde M, 1997, ADV PROTEIN CHEM, V50, P123, DOI 10.1016/S0065-3233(08)60320-4; TSAI MS, 1994, AM J HUM GENET, V54, P643; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang XY, 2002, NEUROBIOL AGING, V23, P377, DOI 10.1016/S0197-4580(01)00322-0; WILCOCK GK, 1982, J NEUROL SCI, V56, P343, DOI 10.1016/0022-510X(82)90155-1; Wilkins A, 2001, GLIA, V36, P48, DOI 10.1002/glia.1094; Williams AD, 2004, J MOL BIOL, V335, P833, DOI 10.1016/j.jmb.2003.11.008; Xue YF, 1998, STRUCT FOLD DES, V6, P627, DOI 10.1016/S0969-2126(98)00064-1; Yepes M, 2002, J CLIN INVEST, V109, P1571, DOI 10.1172/JCI200214308; Yepes M, 2000, BLOOD, V96, P569	56	66	67	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					29268	29277		10.1074/jbc.M600690200	http://dx.doi.org/10.1074/jbc.M600690200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16849336	hybrid			2022-12-27	WOS:000240680500082
J	Bell, CJ; Bright, NA; Rutter, GA; Griffiths, EJ				Bell, Christopher J.; Bright, Nicholas A.; Rutter, Guy A.; Griffiths, Elinor J.			Atp regulation in adult rat cardiomyocytes time-resolved decoding of rapid mitochondrial calcium spiking imaged with targeted photoproteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RABBIT CARDIAC MYOCYTES; TO-BEAT OSCILLATIONS; NA-CA EXCHANGE; VENTRICULAR MYOCYTES; HEART-MITOCHONDRIA; OXIDATIVE-PHOSPHORYLATION; METABOLIC INHIBITION; RYANODINE RECEPTOR; INSULIN-SECRETION; CYTOSOLIC CALCIUM	The mechanisms that enable the heart to rapidly increase ATP supply in line with increased demand have not been fully elucidated. Here we used an adenoviral system to express the photoproteins luciferase and aequorin, targeted to the mitochondria or cytosol of adult cardiomyocytes, to investigate the interrelationship between ATP and Ca2+ in these compartments. In neither compartment were changes in free [ATP] observed upon increased workload (addition of isoproterenol) in myocytes that were already beating. However, when myocytes were stimulated to beat rapidly from rest, in the presence of isoproterenol, a significant but transient drop in mitochondrial [ATP] ([ATP](m)) occurred ( on average to 10% of the initial signal). Corresponding changes in cytosolic [ATP] ([ATP](C)) were much smaller (< 5%), indicating that [ATP](C) was effectively buffered in this compartment. Although mitochondrial [Ca2+] ([Ca2+](m)) is an important regulator of respiratory chain activity and ATP production in other cells, the kinetics of mitochondrial Ca2+ transport are controversial. Parallel experiments in cells expressing mitochondrial aequorin showed that the drop in [ATP](m) occurred over the same time scale as average [Ca2+](m) was increasing. Conversely, in the absence or presence of isoproterenol, clear beat-to-beat peaks in [Ca2+](m) were observed at 0.9 or 1.3 mu M, respectively, concentrations similar to those observed in the cytosol. These results suggest that mitochondrial Ca2+ transients occur during the contractile cycle and are translated into a time-averaged increase in mitochondrial ATP production that keeps pace with increased cytosolic demand.	Univ Bristol, Sch Med Sci, Dept Biochem, Bristol BS8 1TD, Avon, England; Univ Bristol, Bristol Heart Inst, Bristol BS8 1TD, Avon, England; Univ Bristol, Henry Wellcome Labs Integrated Cell Signalling, Bristol BS8 1TD, Avon, England; Univ London Imperial Coll Sci Technol & Med, Dept Cell Biol, Div Med, London SW7 2AZ, England; Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge CB2 2XY, England	University of Bristol; University of Bristol; University of Bristol; Imperial College London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Griffiths, EJ (corresponding author), Univ Bristol, Sch Med Sci, Dept Biochem, Bristol BS8 1TD, Avon, England.	Elinor.Griffiths@bristol.ac.uk		Rutter, Guy/0000-0001-6360-0343	Medical Research Council [G9721484] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G9721484] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ainscow EK, 2001, BIOCHEM J, V353, P175, DOI 10.1042/0264-6021:3530175; Balaban RS, 2002, J MOL CELL CARDIOL, V34, P1259, DOI 10.1006/jmcc.2002.2082; Bers DM, 1996, ANN NY ACAD SCI, V779, P430, DOI 10.1111/j.1749-6632.1996.tb44818.x; Beutner G, 2001, J BIOL CHEM, V276, P21482, DOI 10.1074/jbc.M101486200; Beutner G, 2005, BBA-BIOMEMBRANES, V1717, P1, DOI 10.1016/j.bbamem.2005.09.016; BOWERS KC, 1992, J MOL CELL CARDIOL, V24, P213, DOI 10.1016/0022-2828(92)93159-H; Brandes R, 2002, BIOPHYS J, V83, P587, DOI 10.1016/S0006-3495(02)75194-1; Brandes R, 1997, CIRC RES, V80, P82, DOI 10.1161/01.RES.80.1.82; Brandes R, 1996, BIOPHYS J, V71, P1024, DOI 10.1016/S0006-3495(96)79303-7; BROWN GC, 1992, BIOCHEM J, V284, P1; Buntinas L, 2001, BBA-BIOENERGETICS, V1504, P248, DOI 10.1016/S0005-2728(00)00254-1; Chacon E, 1996, FEBS LETT, V382, P31, DOI 10.1016/0014-5793(96)00138-X; CHANCE B, 1956, J BIOL CHEM, V221, P477; COX DA, 1993, J CARDIOVASC PHARM, V21, P595, DOI 10.1097/00005344-199304000-00013; Csordas G, 2001, TRENDS CARDIOVAS MED, V11, P269, DOI 10.1016/S1050-1738(01)00123-2; DAS AM, 1990, CARDIOVASC RES, V24, P411, DOI 10.1093/cvr/24.5.411; DILISA F, 1995, J PHYSIOL-LONDON, V486, P1; ENG J, 1989, BIOPHYS J, V55, P621, DOI 10.1016/S0006-3495(89)82859-0; Filippin L, 2005, CELL CALCIUM, V37, P129, DOI 10.1016/j.ceca.2004.08.002; Filippin L, 2003, J BIOL CHEM, V278, P39224, DOI 10.1074/jbc.M302301200; Griffiths EJ, 1999, FEBS LETT, V453, P400, DOI 10.1016/S0014-5793(99)00726-7; Griffiths EJ, 1997, AM J PHYSIOL-CELL PH, V273, pC37, DOI 10.1152/ajpcell.1997.273.1.C37; Griffiths EJ, 1997, CELL CALCIUM, V21, P321, DOI 10.1016/S0143-4160(97)90120-2; GUNTER TE, 1990, AM J PHYSIOL, V258, P755; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; HEINEMAN FW, 1993, AM J PHYSIOL, V264, pH433, DOI 10.1152/ajpheart.1993.264.2.H433; Huser J, 2000, J BIOENERG BIOMEMBR, V32, P27, DOI 10.1023/A:1005556227425; Ingwall JS, 2004, J MOL CELL CARDIOL, V37, P613, DOI 10.1016/j.yjmcc.2004.05.020; Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807; KATZ LA, 1989, AM J PHYSIOL, V256, pH265, DOI 10.1152/ajpheart.1989.256.1.H265; KATZ LA, 1987, FEBS LETT, V221, P270, DOI 10.1016/0014-5793(87)80939-0; Kennedy HJ, 1999, J BIOL CHEM, V274, P13281, DOI 10.1074/jbc.274.19.13281; MATLIB MA, 1985, BIOCHEM BIOPH RES CO, V128, P290, DOI 10.1016/0006-291X(85)91677-8; MATLIB MA, 1983, LIFE SCI, V32, P2837, DOI 10.1016/0024-3205(83)90319-3; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; Mitcheson JS, 1998, CARDIOVASC RES, V39, P280, DOI 10.1016/S0008-6363(98)00128-X; MIYATA H, 1991, AM J PHYSIOL, V261, pH1123, DOI 10.1152/ajpheart.1991.261.4.H1123; NICHOLLS DG, 1980, FEBS LETT, V111, P261, DOI 10.1016/0014-5793(80)80806-4; PRALONG WF, 1994, J BIOL CHEM, V269, P27310; Ravier MA, 2005, DIABETES, V54, P1789, DOI 10.2337/diabetes.54.6.1789; RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0; Robert V, 2001, EMBO J, V20, P4998, DOI 10.1093/emboj/20.17.4998; Rutter GA, 2000, TRENDS BIOCHEM SCI, V25, P215, DOI 10.1016/S0968-0004(00)01585-1; RUTTER GA, 1993, J BIOL CHEM, V268, P22385; Rutter GA, 1996, P NATL ACAD SCI USA, V93, P5489, DOI 10.1073/pnas.93.11.5489; Saghir AN, 2001, BIOCHEM J, V356, P557, DOI 10.1042/0264-6021:3560557; SCHOLZ TD, 1995, AM J PHYSIOL-HEART C, V268, pH82, DOI 10.1152/ajpheart.1995.268.1.H82; Searle S, 1998, J CELL SCI, V111, P2855; Sharma VK, 2000, J BIOENERG BIOMEMBR, V32, P97, DOI 10.1023/A:1005520714221; SHEU SS, 1994, J BIOENERG BIOMEMBR, V26, P487, DOI 10.1007/BF00762733; SPARAGNA GC, 1995, J BIOL CHEM, V270, P27510, DOI 10.1074/jbc.270.46.27510; Territo PR, 2000, AM J PHYSIOL-CELL PH, V278, pC423, DOI 10.1152/ajpcell.2000.278.2.C423; Trollinger DR, 1997, BIOCHEM BIOPH RES CO, V236, P738, DOI 10.1006/bbrc.1997.7042; White RL, 1995, BIOPHYS J, V69, P2790, DOI 10.1016/S0006-3495(95)80152-9; WHITE RL, 1993, BIOPHYS J, V65, P196, DOI 10.1016/S0006-3495(93)81058-0; Zhou Z, 1998, J PHYSIOL-LONDON, V507, P379, DOI 10.1111/j.1469-7793.1998.379bt.x	57	76	75	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					28058	28067		10.1074/jbc.M604540200	http://dx.doi.org/10.1074/jbc.M604540200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16882672	hybrid			2022-12-27	WOS:000240534400043
J	Oloo, EO; Fung, EY; Tieleman, DP				Oloo, Eliud O.; Fung, Eric Y.; Tieleman, D. Peter			The dynamics of the MgATP-driven closure of MalK, the energy-transducing subunit of the maltose ABC transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-CASSETTE TRANSPORTER; PARTICLE MESH EWALD; ATP-BINDING; ESCHERICHIA-COLI; MOLECULAR-DYNAMICS; NUCLEOTIDE-BINDING; INDUCER EXCLUSION; PHOSPHOTRANSFERASE SYSTEM; MEMBRANE-PROTEINS; STRUCTURAL MODEL	The nucleotide binding domains (NBDs) are the energy supplying subunits of ATP-binding cassette (ABC) proteins. They power transport by binding and hydrolyzing ATP. Tracing the pathway between different conformational states of the NBDs during ATP binding, hydrolysis, and release has, however, proven difficult. We have used molecular dynamics simulations to study the ATP-driven association of the NBDs of the maltose ABC transporter, MalK, based on the crystal structures of its open and semiopen dimers. When MgATP was introduced into the binding pockets, the semiopen dimer transitioned to a closed conformation, whereas the open dimer evolved to a semiopen state. In the absence of docked MgATP, however, the twin NBDs of both the open and semiopen starting configurations drifted further apart. Both the presence of MgATP and direct cross-interface protein-protein hydrogen bonds, primarily involving the D-loop, quite likely play a key role in initiating closure. The simulations of the MgATP-docked semiopen form indicate that completion of closure is driven mainly by cross-interface contacts between the gamma-phosphate of ATP and residues in the signature motif. Our simulations also give insight into possible interactions of MalK with the regulatory proteins MalT and enzyme IIA(glc).	Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	University of Calgary	Tieleman, DP (corresponding author), Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada.	tieleman@ucalgary.ca	Tieleman, D. Peter/A-4790-2011	Tieleman, D. Peter/0000-0001-5507-0688				Antes I, 2003, BIOPHYS J, V85, P695, DOI 10.1016/S0006-3495(03)74513-5; Ash WL, 2004, BBA-BIOMEMBRANES, V1666, P158, DOI 10.1016/j.bbamem.2004.04.012; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bohm A, 2002, J BIOL CHEM, V277, P3708, DOI 10.1074/jbc.M107905200; Boos W, 1998, MICROBIOL MOL BIOL R, V62, P204, DOI 10.1128/MMBR.62.1.204-229.1998; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; Campbell JD, 2005, FEBS LETT, V579, P4193, DOI 10.1016/j.febslet.2005.06.027; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Chen J, 2001, P NATL ACAD SCI USA, V98, P1525, DOI 10.1073/pnas.041542498; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626; DEAN DA, 1990, J BIOL CHEM, V265, P21005; Dean M, 2001, J LIPID RES, V42, P1007; DeLano W.L, PYMOL MOL GRAPHICS S; Ehrmann M, 1998, MOL MICROBIOL, V29, P685, DOI 10.1046/j.1365-2958.1998.00915.x; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Feenstra KA, 1999, J COMPUT CHEM, V20, P786, DOI 10.1002/(SICI)1096-987X(199906)20:8<786::AID-JCC5>3.0.CO;2-B; Feese MD, 1997, BIOCHEMISTRY-US, V36, P16087, DOI 10.1021/bi971999e; Hansson T, 2002, CURR OPIN STRUC BIOL, V12, P190, DOI 10.1016/S0959-440X(02)00308-1; HERMANS J, 1984, BIOPOLYMERS, V23, P1513, DOI 10.1002/bip.360230807; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HIGGINS CF, 1986, NATURE, V323, P448, DOI 10.1038/323448a0; Hubbard S. J., 1993, NACCESS; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; Hunke S, 2000, J BIOL CHEM, V275, P15526, DOI 10.1074/jbc.275.20.15526; HURLEY JH, 1993, SCIENCE, V259, P673, DOI 10.1126/science.8430315; HYDE SC, 1990, NATURE, V346, P362, DOI 10.1038/346362a0; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; KUHNAU S, 1991, J BACTERIOL, V173, P2180; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Liao JC, 2004, EUR BIOPHYS J BIOPHY, V33, P29, DOI 10.1007/s00249-003-0339-2; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Liu RH, 1996, BIOCHEMISTRY-US, V35, P11865, DOI 10.1021/bi960823u; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Lu G, 2005, P NATL ACAD SCI USA, V102, P17969, DOI 10.1073/pnas.0506039102; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; Mourez M, 1997, EMBO J, V16, P3066, DOI 10.1093/emboj/16.11.3066; Oloo EO, 2004, J BIOL CHEM, V279, P45013, DOI 10.1074/jbc.M405084200; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; Reyes CL, 2005, SCIENCE, V308, P1028, DOI 10.1126/science.1107733; Samanta S, 2003, J BIOL CHEM, V278, P35265, DOI 10.1074/jbc.M301171200; Scheffel F, 2005, FEBS LETT, V579, P2953, DOI 10.1016/j.febslet.2005.04.017; Scott WRP, 1999, J PHYS CHEM A, V103, P3596, DOI 10.1021/jp984217f; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Sondej M, 2000, BIOCHEMISTRY-US, V39, P2931, DOI 10.1021/bi9919596; Stein A, 2002, EUR J BIOCHEM, V269, P4074, DOI 10.1046/j.1432-1033.2002.03099.x; Valdar WSJ, 2001, J MOL BIOL, V313, P399, DOI 10.1006/jmbi.2001.5034; Verdon G, 2003, J MOL BIOL, V330, P343, DOI 10.1016/S0022-2836(03)00575-8; WORTHYLAKE D, 1991, P NATL ACAD SCI USA, V88, P10382, DOI 10.1073/pnas.88.23.10382; Zaitseva J, 2005, EMBO J, V24, P1901, DOI 10.1038/sj.emboj.7600657	53	53	53	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					28397	28407		10.1074/jbc.M513614200	http://dx.doi.org/10.1074/jbc.M513614200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16877382	hybrid			2022-12-27	WOS:000240534400077
J	Semba, S; Han, SY; Qin, HR; McCorkell, KA; Iliopoulos, D; Pekarsky, Y; Druck, T; Trapasso, F; Croce, CM; Huebner, K				Semba, Shuho; Han, Shuang-Yin; Qin, Haiyan R.; McCorkell, Kelly A.; Iliopoulos, Dimitrios; Pekarsky, Yuri; Druck, Teresa; Trapasso, Francesco; Croce, Carlo M.; Huebner, Kay			Biological functions of mammalian NIT1, the counterpart of the invertebrate NitFhit Rosetta Stone protein, a possible tumor suppressor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPRESSION INDUCES APOPTOSIS; FHIT GENE; CANCER-CELLS; LUNG; TUMORIGENICITY; NITRILASE; RESTORATION; CARCINOMA; BREAST; 3P14.2	The "Rosetta Stone" hypothesis proposes that the existence of a fusion protein in some organisms predicts that the separate polypeptides function in the same biochemical pathway in other organisms and may physically interact. In Drosophila melanogaster and Caenorhabditis elegans, NitFhit protein is composed of two domains, a fragile histidine triad homolog and a bacterial and plant nitrilase homolog. Weassessed the biological effects of mammalian Nit1 expression in comparison with Fhit and observed that: 1) Nit1 expression was observed in most normal tissues and overlapped partially with Fhit expression; 2) Nit1-deficient mouse kidney cells exhibited accelerated proliferation, resistance to DNA damagestress, and increased cyclin D1 expression; 3) cyclin D1 was up-regulated in Nit1 null mammary gland and skin; 4) Nit1 overexpression induced caspase-dependent apoptosis in vitro; and 5) Nit1 allele deficiency led to increased incidence of N-nitrosomethylbenzylamine-induced murine forestomach tumors. Thus, the biological effects of Nit1 expression are similar to Fhit effects. Adenoviruses carrying recombinant NIT1 and FHIT induced apoptosis in Fhit- and Nit1-deficient cells, respectively, suggesting that Nit1-Fhit interaction is not essential for function of either protein. The results suggest that Nit1 and Fhit share tumor suppressor signaling pathways, while localization of the NIT1 gene at a stable, rather than fragile, chromosome site explains the paucity of gene alterations and infrequent loss of expression of the NIT1 gene inhuman malignancies.	Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; Stanford Univ, Med Ctr, Stanford, CA 94305 USA; Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA; Magna Graecia Univ Catanzaro, Med Sch Catanzaro, Dept Expt & Clin Med, I-88100 Catanzaro, Italy	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Stanford University; Jefferson University; Magna Graecia University of Catanzaro	Huebner, K (corresponding author), Ohio State Univ, Ctr Comprehens Canc, 455C Wiseman Hall,410 W 12th Ave, Columbus, OH 43210 USA.	kay.huebner@osumc.edu	Iliopoulos, Dimitrios/AAE-9106-2019; Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647	NCI NIH HHS [P01 CA77738, P01 CA78890] Funding Source: Medline; NHLBI NIH HHS [T32-HL07780] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA077738, P01CA078890] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007780] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Barnes LD, 1996, BIOCHEMISTRY-US, V35, P11529, DOI 10.1021/bi961415t; Casimiro I, 2001, PLANT CELL, V13, P843, DOI 10.1105/tpc.13.4.843; Croce CM, 1999, J CLIN ONCOL, V17, P1618, DOI 10.1200/JCO.1999.17.5.1618; Cutler SR, 2005, BMC PLANT BIOL, V5, DOI 10.1186/1471-2229-5-4; Deans AJ, 2004, ONCOGENE, V23, P6136, DOI 10.1038/sj.onc.1207805; Dumon KR, 2001, CANCER RES, V61, P4827; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; Enright AJ, 2001, GENOME BIOL, V2; Fong LYY, 2000, P NATL ACAD SCI USA, V97, P4742, DOI 10.1073/pnas.080063497; Fujishita T, 2004, BRIT J CANCER, V91, P1571, DOI 10.1038/sj.bjc.6602182; Garrison PN, 2005, BIOCHEMISTRY-US, V44, P6286, DOI 10.1021/bi047670s; Grsic-Rausch S, 2000, PLANT PHYSIOL, V122, P369, DOI 10.1104/pp.122.2.369; Hu BC, 2005, J CELL PHYSIOL, V202, P518, DOI 10.1002/jcp.20139; Huebner K, 2003, BRIT J CANCER, V88, P1501, DOI 10.1038/sj.bjc.6600937; Huebner K, 1998, ANNU REV GENET, V32, P7, DOI 10.1146/annurev.genet.32.1.7; Iliopoulos D, 2005, ONCOGENE, V24, P1625, DOI 10.1038/sj.onc.1208398; Ishii H, 2001, CANCER RES, V61, P1578; Ji L, 1999, CANCER RES, V59, P3333; Junttila TT, 2003, CLIN CANCER RES, V9, P5346; Kuroki T, 2003, CANCER RES, V63, P3724; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Normanly J, 1997, PLANT CELL, V9, P1781, DOI 10.1105/tpc.9.10.1781; Ohta M, 1996, CELL, V84, P587, DOI 10.1016/S0092-8674(00)81034-X; Ottey M, 2004, BRIT J CANCER, V91, P1669, DOI 10.1038/sj.bjc.6602058; Pace HC, 1998, P NATL ACAD SCI USA, V95, P5484, DOI 10.1073/pnas.95.10.5484; Pace HC, 2000, CURR BIOL, V10, P907, DOI 10.1016/S0960-9822(00)00621-7; Pace HC, 2001, GENOME BIOL, V2; Pekarsky Y, 2004, P NATL ACAD SCI USA, V101, P3775, DOI 10.1073/pnas.0400481101; Pekarsky Y, 1998, P NATL ACAD SCI USA, V95, P8744, DOI 10.1073/pnas.95.15.8744; Qi C, 2004, J BIOL CHEM, V279, P33696, DOI 10.1074/jbc.M401266200; Reinhardt D, 2000, PLANT CELL, V12, P507, DOI 10.1105/tpc.12.4.507; Roz L, 2002, P NATL ACAD SCI USA, V99, P3615, DOI 10.1073/pnas.062030799; Semba S, 2006, ONCOGENE, V25, P2860, DOI 10.1038/sj.onc.1209323; Sevignani C, 2003, CANCER RES, V63, P1183; Sozzi G, 1996, CELL, V85, P17, DOI 10.1016/S0092-8674(00)81078-8; Trapasso F, 2003, P NATL ACAD SCI USA, V100, P1592, DOI 10.1073/pnas.0437915100; Veitia RA, 2002, GENOME BIOL, V3; Zanesi N, 2001, P NATL ACAD SCI USA, V98, P10250, DOI 10.1073/pnas.191345898; ZANESI N, 1995, CANCER RES, V65, P6576	39	36	39	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					28244	28253		10.1074/jbc.M603590200	http://dx.doi.org/10.1074/jbc.M603590200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16864578	hybrid			2022-12-27	WOS:000240534400062
J	Garg, RP; Gonzalez, JM; Parry, RJ				Garg, Ram P.; Gonzalez, Jose M.; Parry, Ronald J.			Biochemical characterization of VlmL, a seryl-tRNA synthetase encoded by the valanimycin biosynthetic gene cluster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOMYCES-VIRIDIFACIENS MG456-HF10; ISOBUTYLAMINE N-HYDROXYLASE; ELAIOMYCIN; PRODUCER; OVEREXPRESSION; ANTIBIOTICS; CLONING	Previous studies have shown that the valanimycin producer Streptomyces viridifaciens contains two genes encoding proteins that are similar to seryl- tRNA synthetases (SerRSs). One of these proteins (SvsR) is presumed to function in protein biosynthesis, because it exhibits a high degree of similarity to the single SerRS of Streptomyces coelicolor. The second protein (VlmL), which exhibits a low similarity to the S. coelicolor SerRS, is hypothesized to play a role in valanimycin biosynthesis, because the vlmL gene resides within the valanimycin biosynthetic gene cluster. To investigate the role of VlmL in valanimycin biosynthesis, VlmL and SvsR have been overproduced in soluble form in Escherichia coli, and the biochemical properties of both proteins have been analyzed and compared. Both proteins were found to catalyze a serine- dependent exchange of P-32-labeled pyrophosphate into ATP and to aminoacylate total E. coli tRNA with L-serine. Kinetic parameters for the two enzymes show that SvsR is catalytically more efficient than VlmL. The results of these experiments suggest that the role of VlmL in valanimycin biosynthesis is to produce seryl-tRNA, which is then utilized for a subsequent step in the biosynthetic pathway. Orthologs of VlmL were identified in two other actinomycetes species that also contain orthologs of the S. coelicolor SerRS. The significance of these findings is herein discussed.	Rice Univ, Dept Chem, Houston, TX 77005 USA; Univ La Laguna, Fac Farm, Dept Microbiol & Biol Celular, E-38206 San Cristobal la Laguna, Tenerife, Spain	Rice University; Universidad de la Laguna	Parry, RJ (corresponding author), Rice Univ, Dept Chem, Houston, TX 77005 USA.	parry@rice.edu	Gonzalez, Jose M./C-3333-2013	Gonzalez, Jose M./0000-0002-9926-3323	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053818] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM053818] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BIOU V, 1994, SCIENCE, V263, P1404, DOI 10.1126/science.8128220; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Couch R, 2002, BIOTECHNIQUES, V32, P1230, DOI 10.2144/02326bm03; CUSACK S, 1990, NATURE, V347, P249, DOI 10.1038/347249a0; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Francklyn C, 2002, RNA, V8, P1363, DOI 10.1017/S1355838202021180; FUJIU M, 1994, J ANTIBIOT, V47, P833, DOI 10.7164/antibiotics.47.833; Garg RP, 2002, MOL MICROBIOL, V46, P505, DOI 10.1046/j.1365-2958.2002.03169.x; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; IMAMURA N, 1989, J ANTIBIOT, V42, P156, DOI 10.7164/antibiotics.42.156; JAHN D, 1992, TRENDS BIOCHEM SCI, V17, P215, DOI 10.1016/0968-0004(92)90380-R; LANGLEY BW, 1951, CHEM IND-LONDON, P75; LYTHGOE B, 1949, J CHEM SOC, P2716, DOI 10.1039/jr9490002716; Ma YQ, 2000, MICROBIOL-UK, V146, P345, DOI 10.1099/00221287-146-2-345; Martinis SA, 1999, BIOCHIMIE, V81, P683, DOI 10.1016/S0300-9084(99)80126-6; Parry RJ, 1997, J BACTERIOL, V179, P409, DOI 10.1128/jb.179.2.409-416.1997; PARRY RJ, 1992, J AM CHEM SOC, V114, P10062, DOI 10.1021/ja00051a049; Parry RJ, 1997, ARCH BIOCHEM BIOPHYS, V339, P47, DOI 10.1006/abbi.1996.9857; Parry RJ, 1997, J BIOL CHEM, V272, P23303, DOI 10.1074/jbc.272.37.23303; RIGGS NV, 1956, CHEM IND-LONDON, P926; Schimmel P, 2000, TRENDS BIOCHEM SCI, V25, P207, DOI 10.1016/S0968-0004(00)01553-X; STEVENS CL, 1958, J AM CHEM SOC, V80, P6088, DOI 10.1021/ja01555a048; STEVENS CL, 1959, J AM CHEM SOC, V81, P1435, DOI 10.1021/ja01515a037; STEVENS CL, 1956, J AM CHEM SOC, V78, P3229, DOI 10.1021/ja01594a078; TAKAHASHI Y, 1989, J ANTIBIOT, V42, P1541, DOI 10.7164/antibiotics.42.1541; Tao T, 2003, ORG LETT, V5, P1213, DOI 10.1021/ol0340989; VARSHNEY U, 1991, J BIOL CHEM, V266, P24712; YAMATO M, 1986, J ANTIBIOT, V39, P184	29	31	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2006	281	37					26785	26791		10.1074/jbc.M603675200	http://dx.doi.org/10.1074/jbc.M603675200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082PB	16857674	hybrid			2022-12-27	WOS:000240397700005
J	Liu, FL; Yoo, BC; Lee, JY; Pan, W; Harmon, AC				Liu, Fenglong; Yoo, Byung-Chun; Lee, Jung-Youn; Pan, Wei; Harmon, Alice C.			Calcium-regulated phosphorylation of soybean serine acetyltransferase in response to oxidative stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-GLUTAMYLCYSTEINE SYNTHETASE; O-ACETYLSERINE SULFHYDRYLASE; CYSTEINE BIOSYNTHESIS; PROTEIN-KINASE; ARABIDOPSIS-THALIANA; MOLECULAR-CLONING; ESCHERICHIA-COLI; GLUTATHIONE METABOLISM; SULFUR ASSIMILATION; EXPRESSION ANALYSIS	Glycinemaxserine acetyltransferase 2;1 (GmSerat2;1) is a member of a family of enzymes that catalyze the first reaction in the biosynthesis of cysteine from serine. It was identified by interaction cloning as a protein that binds to calcium-dependent protein kinase. In vitro phosphorylation assays showed that GmSerat2; 1, but not GmSerat2;1 mutants (S378A or S378D), were phosphorylated by soybean calcium-dependent protein kinase isoforms. Recombinant GmSerat2;1 was also phosphorylated by soybean cell extract in a Ca2+-dependent manner. Phosphorylation of recombinant GmSerat2;1 had no effect on its catalytic activity but rendered the enzyme in sensitive to the feedback inhibition by cysteine. In transient expression analyses, fluorescently tagged GmSerat2;1 localized in the cytoplasm and with plastids. Phosphorylation state-specific antibodies showed that an increase in GmSerat2;1 phosphorylation occurred in vivo within 5 min of treatment of soybean cells with 0.5 mM hydrogen peroxide, whereas GmSerat2;1 protein synthesis was not significantly induced until 1 h after oxidant challenge. Internal Ca2+ was required in the induction of both GmSerat2;1 phosphorylation and synthesis. Treatment of cells with calcium antagonists showed that externally derived Ca2+ was important for retaining GmSerat2;1 at a basal level of phosphorylation but was not necessary for its hydrogen peroxide-induced synthesis. Protein phosphatase type 1, but not type 2A or alkaline phosphatase, dephosphorylated native GmSerat2;1 in vitro. These results support the hypothesis that GmSerat2;1 is regulated by calcium-dependent protein kinase phosphorylation in vivo and suggest that increased GmSerat2;1 synthesis and phosphorylation in response to active oxygen species could play a role in anti-oxidative stress response.	Univ Florida, Program Plant Mol & Cellular Biol, Gainesville, FL 32611 USA; Univ Florida, Dept Bot, Gainesville, FL 32611 USA; Univ Delaware, Dept Plant & Soil Sci, Newark, DE 19711 USA; Univ Delaware, Delaware Biotechnol Inst, Newark, DE 19711 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Delaware; University of Delaware	Harmon, AC (corresponding author), Univ Florida, Canc Genet Complex,POB 103610, Gainesville, FL 32610 USA.	harmon@ufl.edu	Pan, Wei/G-7547-2015	Pan, Wei/0000-0002-8827-8650; Lee, Jinkee/0000-0001-5590-0549; Lee, Jung-Youn/0000-0003-4604-7974	NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015588] Funding Source: NIH RePORTER; NCRR NIH HHS [P20 RR-15588] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Bachmann M, 1996, PLANT CELL, V8, P505, DOI 10.1105/tpc.8.3.505; BLANAR MA, 1992, SCIENCE, V256, P1014, DOI 10.1126/science.1589769; Blume B, 2000, PLANT CELL, V12, P1425, DOI 10.1105/tpc.12.8.1425; Bonner ER, 2005, J BIOL CHEM, V280, P38803, DOI 10.1074/jbc.M505313200; BUWALDA F, 1993, J PLANT PHYSIOL, V142, P281, DOI 10.1016/S0176-1617(11)80423-2; Cessna SG, 2001, PLANTA, V214, P126, DOI 10.1007/s004250100596; Chronis D, 2004, PLANTA, V218, P417, DOI 10.1007/s00425-003-1123-3; Dammann C, 2003, PLANT PHYSIOL, V132, P1840, DOI 10.1104/pp.103.020008; DEKOK LJ, 1986, PHYSIOL PLANTARUM, V68, P477; DENK D, 1987, J GEN MICROBIOL, V133, P515; DHINDSA RS, 1991, PLANT PHYSIOL, V95, P648, DOI 10.1104/pp.95.2.648; Droux M, 2003, PLANT PHYSIOL BIOCH, V41, P619, DOI 10.1016/S0981-9428(03)00083-4; Droux M, 1998, EUR J BIOCHEM, V255, P235, DOI 10.1046/j.1432-1327.1998.2550235.x; FARAGO S, 1994, J PLANT PHYSIOL, V144, P433, DOI 10.1016/S0176-1617(11)82119-X; HARMON AC, 1994, BIOCHEMISTRY-US, V33, P7278, DOI 10.1021/bi00189a032; Harmon AC, 2000, TRENDS PLANT SCI, V5, P154, DOI 10.1016/S1360-1385(00)01577-6; Harper JF, 2005, NAT REV MOL CELL BIO, V6, P555, DOI 10.1038/nrm1679; He JX, 2002, P NATL ACAD SCI USA, V99, P10185, DOI 10.1073/pnas.152342599; Herschbach C, 2000, PLANT PHYSIOL, V124, P461, DOI 10.1104/pp.124.1.461; Howarth JR, 2003, PLANT MOL BIOL, V51, P589, DOI 10.1023/A:1022349623951; Huang B, 2005, J BACTERIOL, V187, P3201, DOI 10.1128/JB.187.9.3201-3205.2005; Inoue K, 1999, EUR J BIOCHEM, V266, P220, DOI 10.1046/j.1432-1327.1999.00847.x; JONES DH, 1991, BIOTECHNIQUES, V10, P62; JONESMOR.MC, 1968, BIOCHEM J, V110, P597, DOI 10.1042/bj1100597; Kawano T, 2000, PLANT CELL PHYSIOL, V41, P1251, DOI 10.1093/pcp/pcd052; Kawashima CG, 2005, PLANT PHYSIOL, V137, P220, DOI 10.1104/pp.104.045377; Knight H, 1996, PLANT CELL, V8, P489, DOI 10.1105/tpc.8.3.489; Knight H, 1997, PLANT J, V12, P1067, DOI 10.1046/j.1365-313X.1997.12051067.x; Kocsy G, 1996, PLANTA, V198, P365, DOI 10.1007/BF00620052; Kocsy G, 2001, PLANT PHYSIOL, V127, P1147, DOI 10.1104/pp.010107; Kopriva S, 2006, ANN BOT-LONDON, V97, P479, DOI 10.1093/aob/mcl006; KREDICH NM, 1966, J BIOL CHEM, V241, P4955; Lecourieux D, 2002, PLANT CELL, V14, P2627, DOI 10.1105/tpc.005579; Lee JY, 2005, PLANT CELL, V17, P2817, DOI 10.1105/tpc.105.034330; Lee JY, 1998, BIOCHEMISTRY-US, V37, P6801, DOI 10.1021/bi980062q; Li JX, 2002, NATURE, V418, P793, DOI 10.1038/nature00936; Liszewska F, 2001, ACTA BIOCHIM POL, V48, P647; MacKintosh C, 2001, CELL MOL LIFE SCI, V58, P205, DOI 10.1007/PL00000848; May MJ, 1996, PLANT PHYSIOL, V110, P1367, DOI 10.1104/pp.110.4.1367; McManus MT, 2005, PHYTOCHEMISTRY, V66, P1407, DOI 10.1016/j.phytochem.2005.04.034; Murillo M, 1995, CELL MOL BIOL RES, V41, P425; NAKAMURA K, 1987, PLANT CELL PHYSIOL, V28, P885, DOI 10.1093/oxfordjournals.pcp.a077370; Noctor G, 2002, J EXP BOT, V53, P1283, DOI 10.1093/jexbot/53.372.1283; Noctor G, 1996, PLANT PHYSIOL, V112, P1071, DOI 10.1104/pp.112.3.1071; Noji M, 1998, J BIOL CHEM, V273, P32739, DOI 10.1074/jbc.273.49.32739; Noji M, 2002, AMINO ACIDS, V22, P231, DOI 10.1007/s007260200011; Noji M, 2001, PLANT CELL PHYSIOL, V42, P627, DOI 10.1093/pcp/pce078; Olsen LR, 2004, BIOCHEMISTRY-US, V43, P6013, DOI 10.1021/bi0358521; PRICE AH, 1994, PLANT CELL, V6, P1301, DOI 10.1105/tpc.6.9.1301; Rentel MC, 2004, PLANT PHYSIOL, V135, P1471, DOI 10.1104/pp.104.042663; SAITO K, 1995, J BIOL CHEM, V270, P16321, DOI 10.1074/jbc.270.27.16321; SAITO K, 1994, PLANT PHYSIOL, V106, P887, DOI 10.1104/pp.106.3.887; Saito K, 2000, CURR OPIN PLANT BIOL, V3, P188, DOI 10.1016/S1369-5266(00)00063-7; Sirko A, 2004, J EXP BOT, V55, P1881, DOI 10.1093/jxb/erh151; SMITH IK, 1969, BIOCHEM BIOPH RES CO, V35, P939, DOI 10.1016/0006-291X(69)90715-3; STONE JM, 1994, SCIENCE, V266, P793, DOI 10.1126/science.7973632; Urano Y, 2000, GENE, V257, P269, DOI 10.1016/S0378-1119(00)00399-1; Wirtz M, 2003, AMINO ACIDS, V24, P195, DOI 10.1007/s00726-002-0313-9	58	37	46	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2006	281	37					27405	27415		10.1074/jbc.M604548200	http://dx.doi.org/10.1074/jbc.M604548200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082PB	16854983	hybrid			2022-12-27	WOS:000240397700067
J	Bentle, MS; Reinicke, KE; Bey, EA; Spitz, DR; Boothman, DA				Bentle, Melissa S.; Reinicke, Kathryn E.; Bey, Erik A.; Spitz, Douglas R.; Boothman, David A.			Calcium-dependent modulation of poly(ADP-ribose) polymerase-1 alters cellular metabolism and DNA repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; NAD(P)H-QUINONE OXIDOREDUCTASE-1; OXIDATIVE STRESS; GLUCOSE DEPRIVATION; PANCREATIC-CANCER; ACTIVATION; TUMOR; INHIBITION; SYNTHETASE; APOPTOSIS	After genotoxic stress poly(ADP-ribose) polymerase-1 (PARP-1) can be hyperactivated, causing (ADP-ribosyl) ation of nuclear proteins ( including itself), resulting in NAD+ and ATP depletion and cell death. Mechanisms of PARP-1-mediated cell death and downstream proteolysis remain enigmatic. beta-lapachone (beta-lap) is the first chemotherapeutic agent to elicit a Ca2+-mediated cell death by PARP-1 hyperactivation at clinically relevent doses in cancer cells expressing elevated NAD(P)H: quinone oxidoreductase 1 (NQO1) levels. beta-lap induces the generation of NQO1-dependent reactive oxygen species (ROS), DNA breaks, and triggers Ca2+-dependent gamma-H2AX formation and PARP-1 hyperactivation. Subsequent NAD(+) and ATP losses suppress DNA repair and cause cell death. Reduction of PARP-1 activity or Ca2+ chelation protects cells. Interestingly, Ca2+ chelation abrogates hydrogen peroxide ( H2O2), but not N-Methyl-N'-nitro-N-nitrosoguanidine (MNNG)-induced PARP-1 hyperactivation and cell death. Thus, Ca2+ appears to be an important co-factor in PARP-1 hyperactivation after ROS-induced DNA damage, which alters cellular metabolism and DNA repair.	Univ Texas, SW Med Ctr, Lab Mol Stress Responses, Dept Pharmacol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; Univ Iowa, Holden Comprehens Canc Ctr, Dept Radiat Oncol, Free Rad & Radiat Biol Program, Iowa City, IA 52242 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Case Western Reserve University; Case Western Reserve University; University of Iowa	Boothman, DA (corresponding author), Univ Texas, SW Med Ctr, Lab Mol Stress Responses, Dept Pharmacol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	David.Boothman@UTSouthwestern.edu	Boothman, David/Q-7776-2019	Spitz, Douglas/0000-0002-1254-8765; Srougi, Melissa/0000-0003-2183-0233	NATIONAL CANCER INSTITUTE [R01CA100045, P30CA142543, P30CA043703, R01CA102792] Funding Source: NIH RePORTER; NCI NIH HHS [P30CA43703, 1R01CA10279201, P30CA43703-12, 1R01CA100045, P30 CA142543, R01 CA102792] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Barbouti A, 2001, FREE RADICAL BIO MED, V31, P490, DOI 10.1016/S0891-5849(01)00608-6; Beigi RD, 2000, J IMMUNOL, V165, P7189, DOI 10.4049/jimmunol.165.12.7189; Blackburn RV, 1999, FREE RADICAL BIO MED, V26, P419, DOI 10.1016/S0891-5849(98)00217-2; BOOTHMAN DA, 1989, P NATL ACAD SCI USA, V86, P4963, DOI 10.1073/pnas.86.13.4963; BOOTHMAN DA, 1992, INT J RADIAT ONCOL, V24, P939, DOI 10.1016/0360-3016(92)90478-Z; BOOTHMAN DA, 1993, P NATL ACAD SCI USA, V90, P7200, DOI 10.1073/pnas.90.15.7200; Britigan BE, 1998, BIOCHEM PHARMACOL, V55, P287, DOI 10.1016/S0006-2952(97)00463-2; Calabrese CR, 2004, J NATL CANCER I, V96, P56, DOI 10.1093/jnci/djh005; Chowdhury D, 2005, MOL CELL, V20, P801, DOI 10.1016/j.molcel.2005.10.003; Cipriani G, 2005, J BIOL CHEM, V280, P17227, DOI 10.1074/jbc.M414526200; Cullen JJ, 2003, CANCER RES, V63, P5513; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; DAWSON TL, 1993, AM J PHYSIOL, V264, pC961, DOI 10.1152/ajpcell.1993.264.4.C961; Fitzsimmons SA, 1996, J NATL CANCER I, V88, P259, DOI 10.1093/jnci/88.5.259; Fonfria E, 2004, BRIT J PHARMACOL, V143, P186, DOI 10.1038/sj.bjp.0705914; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; HOLLANDER PM, 1975, ARCH BIOCHEM BIOPHYS, V169, P560, DOI 10.1016/0003-9861(75)90200-3; HORNBURG S, 2000, J CELL BIOL, V150, P293; Jacobson EL, 1997, METHOD ENZYMOL, V280, P221; Jacobson MD, 1996, J CELL BIOL, V133, P1041, DOI 10.1083/jcb.133.5.1041; Jagtap P, 2005, NAT REV DRUG DISCOV, V4, P421, DOI 10.1038/nrd1718; Jornot L, 1998, BIOCHEM J, V335, P85, DOI 10.1042/bj3350085; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kun E, 2004, BIOCHEMISTRY-US, V43, P210, DOI 10.1021/bi0301791; Lee YJ, 1998, J BIOL CHEM, V273, P5294, DOI 10.1074/jbc.273.9.5294; Lewis A, 2004, CLIN CANCER RES, V10, P4550, DOI 10.1158/1078-0432.CCR-03-0667; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Manna SK, 1999, BIOCHEM PHARMACOL, V57, P763, DOI 10.1016/S0006-2952(98)00354-2; MCLICK J, 1987, BIOCHIM BIOPHYS ACTA, V909, P71, DOI 10.1016/0167-4781(87)90047-9; Nieminen AL, 1997, AM J PHYSIOL-CELL PH, V272, pC1286; OGATA N, 1981, J BIOL CHEM, V256, P4135; OLIVE PL, 1990, RADIAT RES, V122, P86, DOI 10.2307/3577587; Pardee AB, 2002, CURR CANCER DRUG TAR, V2, P227, DOI 10.2174/1568009023333854; Pieper AA, 1999, TRENDS PHARMACOL SCI, V20, P171, DOI 10.1016/S0165-6147(99)01292-4; Pink JJ, 2000, EXP CELL RES, V255, P144, DOI 10.1006/excr.1999.4790; Polster BM, 2005, J BIOL CHEM, V280, P6447, DOI 10.1074/jbc.M413269200; RASBAND W, 2005, IMAGE J INT; Reinicke KE, 2005, CLIN CANCER RES, V11, P3055, DOI 10.1158/1078-0432.CCR-04-2185; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Ross D, 2000, CHEM-BIOL INTERACT, V129, P77, DOI 10.1016/S0009-2797(00)00199-X; Siegel D, 1998, CLIN CANCER RES, V4, P2065; Siegel D, 2004, MOL PHARMACOL, V65, P1238, DOI 10.1124/mol.65.5.1238; Southan GJ, 2003, CURR MED CHEM, V10, P321, DOI 10.2174/0929867033368376; Szabo C, 1998, TRENDS PHARMACOL SCI, V19, P287, DOI 10.1016/S0165-6147(98)01193-6; Tagliarino C, 2001, J BIOL CHEM, V276, P19150, DOI 10.1074/jbc.M100730200; Tagliarino C, 2003, CANCER BIOL THER, V2, P141, DOI 10.4161/cbt.2.2.237; Takano J, 2005, J BIOL CHEM, V280, P16175, DOI 10.1074/jbc.M414552200; TANUMA SI, 1986, J BIOL CHEM, V261, P965; Virag L, 1999, MOL PHARMACOL, V56, P824; Wuerzberger SM, 1998, CANCER RES, V58, P1876; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zong WX, 2004, GENE DEV, V18, P1272, DOI 10.1101/gad.1199904	53	97	99	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33684	33696		10.1074/jbc.M603678200	http://dx.doi.org/10.1074/jbc.M603678200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16920718	hybrid			2022-12-27	WOS:000241621400076
J	Hitchens, TK; Zhan, YP; Richardson, LV; Richardson, JP; Rule, GS				Hitchens, T. Kevin; Zhan, Yiping; Richardson, Lislott V.; Richardson, John P.; Rule, Gordon S.			Sequence-specific interactions in the RNA-binding domain of Escherichia coli transcription termination factor Rho	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLIGONUCLEOTIDE COFACTORS; DEPENDENT TERMINATION; MESSENGER-RNA; PROTEIN; RECOGNITION; ACTIVATION; RESONANCE; HELICASE; SITES	Rho factor is an essential protein that causes termination of transcription in a wide variety of bacteria by an RNA-dependent helicase activity. Rho is activated by transcripts that contain a high proportion of cytidine residues. The interaction between Rho and two adjacent cytidine residues within the bound RNA has been identified by previous crystallographic studies (Skordalakes, E., and Berger, J.M. (2003) Cell 114, 135-146). In this study, NMR methods were used to investigate the sequence dependence of the binding of oligonucleotides to the RNA-binding domain of Rho protein (rho130). A comparison of the NMR spectra obtained for rho130 bound to single-stranded oligonucleotides ACTTCCA or ATTTCCA showed that the 5'-cytidine residue interacts with Rho at a site that is distinct from the CC binding site identified by crystallographic studies. Two amino acid residues within this new cytidine binding site, Arg(88) and Phe(89), were altered to Glu and Ser, respectively. These mutant forms of Rho were defective in transcriptional termination, suggesting that those residues play an important role in the activation of Rho by bound RNA.	Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; Indiana Univ, Dept Chem, Bloomington, IN 47405 USA	Carnegie Mellon University; Indiana University System; Indiana University Bloomington	Rule, GS (corresponding author), Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA.	rule@andrew.cmu.edu	Rule, Gordon S/Q-2422-2015	Rule, Gordon S/0000-0002-4396-3363	NIGMS NIH HHS [GM 56095] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS SP, 1983, J AM CHEM SOC, V105, P661, DOI 10.1021/ja00341a078; Allison TJ, 1998, NAT STRUCT BIOL, V5, P352, DOI 10.1038/nsb0598-352; Bogden CE, 1999, MOL CELL, V3, P487, DOI 10.1016/S1097-2765(00)80476-1; Briercheck DM, 1996, J BIOMOL NMR, V8, P429; Burgess BR, 2001, J BIOL CHEM, V276, P4182, DOI 10.1074/jbc.M007066200; Burgess BR, 2001, J BIOL CHEM, V276, P17106, DOI 10.1074/jbc.M101856200; Chen X, 2004, J BIOL CHEM, V279, P16301, DOI 10.1074/jbc.M313640200; FAUS I, 1989, BIOCHEMISTRY-US, V28, P3510, DOI 10.1021/bi00434a054; GALLUPPI GR, 1980, J MOL BIOL, V138, P513, DOI 10.1016/S0022-2836(80)80016-7; Graham JE, 1998, J BIOL CHEM, V273, P20764, DOI 10.1074/jbc.273.33.20764; GRZESIEK S, 1992, J MAGN RESON, V99, P201, DOI 10.1016/0022-2364(92)90169-8; Kim DE, 2001, J BIOL CHEM, V276, P13902, DOI 10.1074/jbc.M011043200; Lian L. Y., 1993, NMR MACROMOLECULES P, P153; Martinez A, 1996, J MOL BIOL, V257, P909, DOI 10.1006/jmbi.1996.0211; MCCONNELL HM, 1958, J CHEM PHYS, V28, P430, DOI 10.1063/1.1744152; MCSWIGGEN JA, 1988, J MOL BIOL, V199, P609, DOI 10.1016/0022-2836(88)90305-1; MODRAK D, 1994, BIOCHEMISTRY-US, V33, P8292, DOI 10.1021/bi00193a016; Nowatzke W, 1996, METHOD ENZYMOL, V274, P353; Nudler E, 2002, GENES CELLS, V7, P755, DOI 10.1046/j.1365-2443.2002.00563.x; OPPERMAN T, 1994, J BACTERIOL, V176, P5033, DOI 10.1128/jb.176.16.5033-5043.1994; RICHARDSON JP, 1982, J BIOL CHEM, V257, P5760; Richardson JP, 2002, BBA-GENE STRUCT EXPR, V1577, P251, DOI 10.1016/S0167-4781(02)00456-6; RICHARDSON LV, 1992, GENE, V118, P103, DOI 10.1016/0378-1119(92)90255-N; Richardson LV, 1996, J BIOL CHEM, V271, P21597, DOI 10.1074/jbc.271.35.21597; Skordalakes E, 2003, CELL, V114, P135, DOI 10.1016/S0092-8674(03)00512-9; TABOR S, 1991, CURRENT PROTOCOLS MO; WANG Y, 1993, J BIOL CHEM, V268, P13940; WANG Y, 1993, J BIOL CHEM, V268, P13947; Wei RR, 2001, J BIOL CHEM, V276, P28380, DOI 10.1074/jbc.M102444200; WITHERELL GW, 1989, BIOCHEMISTRY-US, V28, P71, DOI 10.1021/bi00427a011	30	8	8	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33697	33703		10.1074/jbc.M605312200	http://dx.doi.org/10.1074/jbc.M605312200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16908525	hybrid			2022-12-27	WOS:000241621400077
J	Galander, M; Uppsten, M; Uhlin, U; Lendzian, F				Galander, Marcus; Uppsten, Malin; Uhlin, Ulla; Lendzian, Friedhelm			Orientation of the tyrosyl radical in Salmonella typhimurium class Ib ribonucleotide reductase determined by high field EPR of R2F single crystals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-PARAMAGNETIC-RESONANCE; ESCHERICHIA-COLI; MYCOBACTERIUM-TUBERCULOSIS; PEPTIDE INHIBITORS; ACTIVE FORM; AMINO-ACID; PROTEIN; MECHANISM; COFACTOR; SUBUNIT	The R2 protein of class I ribonucleotide reductase (RNR) generates and stores a tyrosyl radical, located next to a diferric iron center, which is essential for ribonucleotide reduction and thus DNA synthesis. X-ray structures of class Ia and Ib proteins from various organisms served as bases for detailed mechanistic suggestions. The active site tyrosine in R2F of class Ib RNR of Salmonella typhimurium is located at larger distance to the diiron site, and shows a different side chain orientation, as compared with the tyrosine in R2 of class Ia RNR from Escherichia coli. No structural information has been available for the active tyrosyl radical in R2F. Here we report on high field EPR experiments of single crystals of R2F from S. typhimurium, containing the radical Tyr-105(.). Full rotational pattern of the spectra were recorded, and the orientation of the g-tensor axes were determined, which directly reflect the orientation of the radical Tyr-105 (.) in the crystal frame. Comparison with the orientation of the reduced tyrosine Tyr-105-OH from the x-ray structure reveals a rotation of the tyrosyl side chain, which reduces the distance between the tyrosyl radical and the nearest iron ligands toward similar values as observed earlier for Tyr-122 (.) in E. coli R2. Presence of the substrate binding subunit R1E did not change the EPR spectra of Tyr-105(.), indicating that binding of R2E alone induces no structural change of the diiron site. The present study demonstrates that structural and functional information about active radical states can be obtained by combining x-ray and high-field-EPR crystallography.	Swedish Univ Agr Sci, Uppsala Biomed Ctr, Dept Biol Mol, S-75007 Uppsala, Sweden; Tech Univ Berlin, Max Volmer Lab Biophys Chem, D-10623 Berlin, Germany	Swedish University of Agricultural Sciences; Technical University of Berlin	Uhlin, U (corresponding author), Swedish Univ Agr Sci, Uppsala Biomed Ctr, Dept Biol Mol, Box 590, S-75007 Uppsala, Sweden.	uhlin@molbio.lu; f.lendzian@tu-berlin.de						Allard P, 1996, J AM CHEM SOC, V118, P895, DOI 10.1021/ja9529192; Atherton N. M, 1993, PRINCIPLES ELECT SPI; Bar G, 2001, J AM CHEM SOC, V123, P3569, DOI 10.1021/ja003108n; Bennati M, 2005, J AM CHEM SOC, V127, P15014, DOI 10.1021/ja054991y; Bennati M, 2005, BIOL CHEM, V386, P1007, DOI 10.1515/BC.2005.117; Bleifuss G, 2001, BIOCHEMISTRY-US, V40, P15362, DOI 10.1021/bi010707d; BOLLINGER JM, 1991, SCIENCE, V253, P292, DOI 10.1126/science.1650033; BOLLINGER JM, 1994, J AM CHEM SOC, V116, P8024, DOI 10.1021/ja00097a009; Duboc-Toia C, 2003, J AM CHEM SOC, V125, P38, DOI 10.1021/ja026690j; EATON JW, 1998, OCTAVE COMPUTER PROG; Eklund H, 2001, PROG BIOPHYS MOL BIO, V77, P177, DOI 10.1016/S0079-6107(01)00014-1; Eliasson R, 1996, J BIOL CHEM, V271, P26582, DOI 10.1074/jbc.271.43.26582; Engstrom M, 2000, J PHYS CHEM A, V104, P5149, DOI 10.1021/jp0006633; Eriksson M, 1998, BIOCHEMISTRY-US, V37, P13359, DOI 10.1021/bi981380s; Fontecave M, 2002, PROG NUCLEIC ACID RE, V72, P95, DOI 10.1016/S0079-6603(02)72068-0; Ge J, 2003, BIOCHEMISTRY-US, V42, P10071, DOI 10.1021/bi034374r; Gerfen GJ, 1996, J AM CHEM SOC, V118, P8192, DOI 10.1021/ja960363s; HELLER C, 1960, J CHEM PHYS, V32, P1535, DOI 10.1063/1.1730955; Himo F, 1997, BIOPHYS J, V72, P1556, DOI 10.1016/S0006-3495(97)78803-9; Hofbauer W, 2001, P NATL ACAD SCI USA, V98, P6623, DOI 10.1073/pnas.101127598; Hoganson CW, 1996, J AM CHEM SOC, V118, P4672, DOI 10.1021/ja953979a; Hogbom M, 2003, P NATL ACAD SCI USA, V100, P3209, DOI 10.1073/pnas.0536684100; Hogbom M, 2002, BIOCHEMISTRY-US, V41, P1381, DOI 10.1021/bi011429l; Huque Y, 2000, J BIOL CHEM, V275, P25365, DOI 10.1074/jbc.M002751200; Ivancich A, 2001, BIOCHEMISTRY-US, V40, P6860, DOI 10.1021/bi002826j; Jordan A, 1996, J BIOL CHEM, V271, P8779, DOI 10.1074/jbc.271.15.8779; JORDAN A, 1994, J BACTERIOL, V176, P3420, DOI 10.1128/jb.176.11.3420-3427.1994; JORDAN A, 1994, P NATL ACAD SCI USA, V91, P12892, DOI 10.1073/pnas.91.26.12892; Jordan A, 1996, MOL MICROBIOL, V19, P777, DOI 10.1046/j.1365-2958.1996.424950.x; Jordan A, 1995, GENE, V167, P75, DOI 10.1016/0378-1119(95)00656-7; Kolberg M, 2004, BBA-PROTEINS PROTEOM, V1699, P1, DOI 10.1016/j.bbapap.2004.02.007; Lendzian F, 1996, J AM CHEM SOC, V118, P8111, DOI 10.1021/ja960917r; Lendzian F, 2005, BBA-BIOENERGETICS, V1707, P67, DOI 10.1016/j.bbabio.2004.02.011; Licht S, 1996, SCIENCE, V271, P477, DOI 10.1126/science.271.5248.477; Liu A, 1998, BIOCHEMISTRY-US, V37, P16369, DOI 10.1021/bi981471p; Liu A, 1998, BIOCHEM BIOPH RES CO, V246, P740, DOI 10.1006/bbrc.1998.8701; Liu AM, 2000, J AM CHEM SOC, V122, P1974, DOI 10.1021/ja990123n; Logan DT, 1999, SCIENCE, V283, P1499, DOI 10.1126/science.283.5407.1499; LYCKSELL PO, 1994, BIOCHEMISTRY-US, V33, P2838, DOI 10.1021/bi00176a013; MAO SS, 1992, BIOCHEMISTRY-US, V31, P9733, DOI 10.1021/bi00155a029; Mezzetti A, 1999, J PHYS CHEM A, V103, P9636, DOI 10.1021/jp9903763; Ollagnier S, 1996, J BIOL CHEM, V271, P9410, DOI 10.1074/jbc.271.16.9410; Pellegrini M, 2000, BIOCHEMISTRY-US, V39, P12210, DOI 10.1021/bi001323a; Pender BA, 2001, J MED CHEM, V44, P36, DOI 10.1021/jm000335r; Press WH., 2002, NUMERICAL RECIPES C, V2; SAHLIN M, 1990, BIOCHEM BIOPH RES CO, V167, P813, DOI 10.1016/0006-291X(90)92098-K; Schmidt PP, 1996, J BIOL CHEM, V271, P23615, DOI 10.1074/jbc.271.39.23615; Schunemann V, 2004, J BIOL CHEM, V279, P10919, DOI 10.1074/jbc.M307884200; Scotti C, 1996, MICROBIOL-SGM, V142, P2995, DOI 10.1099/13500872-142-11-2995; Seyedsayamdost MR, 2006, J AM CHEM SOC, V128, P1562, DOI 10.1021/ja055927j; Siegbahn PEM, 1998, J PHYS CHEM B, V102, P10622, DOI 10.1021/jp9827835; Siegbahn PEM, 1998, J AM CHEM SOC, V120, P8417, DOI 10.1021/ja9736065; Sintchak MD, 2002, NAT STRUCT BIOL, V9, P293, DOI 10.1038/nsb774; Sjoberg BM, 1997, STRUCT BOND, V88, P139; SJOBERG BM, 1983, J BIOL CHEM, V258, P8060; SJOBERG BM, 1994, STRUCTURE, V2, P793, DOI 10.1016/S0969-2126(94)00080-8; Sjoberg BM, 2002, METHOD ENZYMOL, V348, P1; STESMANS A, 1989, REV SCI INSTRUM, V60, P2949, DOI 10.1063/1.1140633; Stubbe J, 2003, CHEM REV, V103, P2167, DOI 10.1021/cr020421u; Stubbe J, 1998, TRENDS BIOCHEM SCI, V23, P438, DOI 10.1016/S0968-0004(98)01296-1; Stubbe J, 1998, CHEM REV, V98, P705, DOI 10.1021/cr9400875; Sun XY, 1996, J BIOL CHEM, V271, P6827, DOI 10.1074/jbc.271.12.6827; THELANDER L, 1976, J BIOL CHEM, V251, P1398; Torrents E, 2005, P NATL ACAD SCI USA, V102, P17946, DOI 10.1073/pnas.0506410102; UHLIN U, 1994, NATURE, V370, P533, DOI 10.1038/370533a0; UHLIN U, 1993, FEBS LETT, V336, P148, DOI 10.1016/0014-5793(93)81629-E; Un S, 2001, J AM CHEM SOC, V123, P3048, DOI 10.1021/ja003650b; Uppsten M, 2004, FEBS LETT, V569, P117, DOI 10.1016/j.febslet.2004.05.059; Uppsten M, 2003, ACTA CRYSTALLOGR D, V59, P1081, DOI 10.1107/S0907444903006942; Uppsten M, 2006, J MOL BIOL, V359, P365, DOI 10.1016/j.jmb.2006.03.035; van Dam PJ, 1998, J AM CHEM SOC, V120, P5080, DOI 10.1021/ja9737127; van der Donk WA, 1998, BIOCHEMISTRY-US, V37, P6419, DOI 10.1021/bi9729357; YANG FD, 1994, J BACTERIOL, V176, P6738, DOI 10.1128/JB.176.21.6738-6743.1994	73	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31743	31752		10.1074/jbc.M605089200	http://dx.doi.org/10.1074/jbc.M605089200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16854982	Bronze			2022-12-27	WOS:000241235300061
J	Nakamura, S; Oda, M; Kataoka, S; Ueda, S; Uchiyama, S; Yoshida, T; Kobayashi, Y; Ohkubo, T				Nakamura, Shota; Oda, Masayuki; Kataoka, Sachiyo; Ueda, Shigeru; Uchiyama, Susumu; Yoshida, Takuya; Kobayashi, Yuji; Ohkubo, Tadayasu			Apo- and holo-structures of 3 alpha-hydroxysteroid dehydrogenase from Pseudomonas sp B-0831 - Loop-helix transition induced by coenzyme binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; CHAIN; PROGRAM; REFINEMENT; REDUCTASES; PATTERN	Bacterial 3 alpha-hydroxysteroid dehydrogenase, which belongs to a short-chain dehydrogenase/reductase family and forms a dimer composed of two 26-kDa subunits, catalyzes the oxidoreduction of hydroxysteroids in a coenzyme-dependent manner. This enzyme also catalyzes the oxidoreduction of nonsteroid compounds that play an important role in xenobiotic metabolism of bacteria. We performed an x-ray analysis on the crystal of Ps3 alpha HSD, the enzyme from Pseudomonas sp. B-0831 complexed with NADH. The resulting crystal structure at 1.8 angstrom resolution showed that Ps3 alpha HSD exists as a structural heterodimer composed of apo- and holo-subunits. A distinct structural difference between them was found in the 185-207-amino acid region, where the structure in the apo- subunit is disordered whereas that in the holo-subunit consists of two alpha-helices. This fact proved that the NADH binding allows the helical structures to form the substrate binding pocket even in the absence of the substrate, although the region corresponds to the so-called "substrate-binding loop." The induction of alpha-helices in solution by the coenzyme binding was also confirmed by the CD experiment. In addition, the CD experiment revealed that the helix-inducing ability of NADH is stronger than that of NAD. We discuss the negative cooperativity for the coenzyme binding, which is caused by the effect of the structural change transferred between the subunits of the heterodimer.	Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan; Kyoto Prefectural Univ, Grad Sch Agr, Sakyo Ku, Kyoto 6068522, Japan; Asahi Kasei Pharma Corp, Diagnost Dept, Shizuoka 4102321, Japan; Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; Osaka Univ Pharmaceut Sci, Takatsuki, Osaka 5691094, Japan	Osaka University; Kyoto Prefectural University; Asahi Kasei Pharma Corporation; Osaka University; Osaka University of Pharmaceutical Sciences	Ohkubo, T (corresponding author), Osaka Univ, Grad Sch Pharmaceut Sci, 1-6 Yamadaoka, Suita, Osaka 5650871, Japan.	ohkubo@protein.osaka-u.ac.jp	UCHIYAMA, Susumu/F-9590-2017; Nakamura, Shota/E-3033-2010	UCHIYAMA, Susumu/0000-0002-5181-179X; Nakamura, Shota/0000-0003-2058-5942; Oda, Masayuki/0000-0002-8568-4223; Yoshida, Takuya/0000-0002-3491-9344; Ueda, Shigeru/0000-0001-9328-4943				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; GHOSH D, 1991, P NATL ACAD SCI USA, V88, P10064, DOI 10.1073/pnas.88.22.10064; Grimm C, 2000, J BIOL CHEM, V275, P41333, DOI 10.1074/jbc.M007559200; Hill AV, 1910, J PHYSIOL-LONDON, V40, P190; INANO H, 1977, J STEROID BIOCHEM, V8, P41, DOI 10.1016/0022-4731(77)90215-1; Ito K, 2006, J MOL BIOL, V355, P722, DOI 10.1016/j.jmb.2005.10.072; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kataoka S, 2006, ACTA CRYSTALLOGR F, V62, P569, DOI 10.1107/S1744309106016861; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MASER E, 1995, BIOCHEM PHARMACOL, V49, P421, DOI 10.1016/0006-2952(94)00330-O; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Michael G., 1975, ENZYMES, V11, P61, DOI 10.1016/S1874-6047(08)60210-3; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Nakanishi M, 1997, J BIOL CHEM, V272, P2218, DOI 10.1074/jbc.272.4.2218; Oppermann U, 2003, CHEM-BIOL INTERACT, V143, P247, DOI 10.1016/S0009-2797(02)00164-3; Oppermann UCT, 2000, TOXICOLOGY, V144, P71, DOI 10.1016/S0300-483X(99)00192-4; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PENNING TM, 1986, STEROIDS, V47, P221; PENNING TM, 1993, CHEM-BIOL INTERACT, V89, P1, DOI 10.1016/0009-2797(93)03203-7; ROSSMANN MG, 1973, J MOL BIOL, V76, P533, DOI 10.1016/0022-2836(73)90491-9; Shi R, 2004, J BIOL CHEM, V279, P16778, DOI 10.1074/jbc.M313156200; Shigeyuki I, 2004, J BIOL MACROMOL, V4, P23; Tanaka N, 1996, BIOCHEMISTRY-US, V35, P7715, DOI 10.1021/bi951904d; TAUROG JD, 1975, BIOCHEMISTRY-US, V14, P810, DOI 10.1021/bi00675a026; Ueda S, 2004, EUR J BIOCHEM, V271, P1774, DOI 10.1111/j.1432-1033.2004.04089.x; Ueda S, 2004, J BIOL MACROMOL, V4, P29; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Valencia E, 2004, J MOL BIOL, V341, P1049, DOI 10.1016/j.jmb.2004.06.037; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wilson DR, 1997, PROTEIN ENG, V10, P519, DOI 10.1093/protein/10.5.519; WIMPENNY JW, 1972, J BACTERIOL, V11, P24, DOI 10.1128/JB.111.1.24-32.1972	34	16	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31876	31884		10.1074/jbc.M604226200	http://dx.doi.org/10.1074/jbc.M604226200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16905772	Bronze			2022-12-27	WOS:000241235300074
J	Kondo, H; Shirakawa, R; Higashi, T; Kawato, M; Fukuda, M; Kita, T; Horiuchi, H				Kondo, Hirokazu; Shirakawa, Ryutaro; Higashi, Tomohito; Kawato, Mitsunori; Fukuda, Mitsunori; Kita, Toru; Horiuchi, Hisanori			Constitutive GDP/GTP exchange and secretion-dependent GTP hydrolysis activity for Rab27 in platelets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORE GRANULE SECRETION; CA2+-INDUCED ALPHA-GRANULE; EPIDERMAL-GROWTH-FACTOR; MEMBRANE-FUSION; MYOSIN-VA; ACTIVATION; PROTEINS; CELLS; IDENTIFICATION; EFFECTOR	We have previously demonstrated that Rab27 regulates dense granule secretion in platelets. Here, we analyzed the activation status of Rab27 using the thin layer chromatography method analyzing nucleotides bound to immunoprecipitated Rab27 and the pull-down method quantifying Rab27 bound to the GTP-Rab27-binding domain (synaptotagmin-like protein (Slp)-homology domain) of its specific effector, Slac2-b. We found that Rab27 was predominantly present in the GTP-bound form in unstimulated platelets due to constitutive GDP/GTP exchange activity. The GTP-bound Rab27 level drastically decreased due to enhanced GTP hydrolysis activity upon granule secretion. In permeabilized platelets, increase of Ca2+ concentration induced dense granule secretion with concomitant decrease of GTP-Rab27, whereas in non-hydrolyzable GTP analogue GppNHp (beta-gamma-imidoguanosine 5'-triphosphate)-loaded permeabilized platelets, the GTP (GppNHp)-Rab27 level did not decrease upon the Ca2+-induced secretion. These data suggested that GTP hydrolysis of Rab27 was not necessary for inducing the secretion. Taken together, Rab27 is maintained in the active status in unstimulated platelets, which could function to keep dense granules in a preparative status for secretion.	Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto 6068507, Japan; RIKEN, Fukuda Initiat Res Unit, Wako, Saitama 3510198, Japan; Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Lab Membrane Trafficking Mechanisms,Aoba Ku, Sendai, Miyagi 9808578, Japan	Kyoto University; RIKEN; Tohoku University	Horiuchi, H (corresponding author), Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto 6068507, Japan.	horiuchi@kuhp.kyoto-u.ac.jp	Higashi, Tomohito/AHE-7942-2022; Fukuda, MItsunori/I-1511-2015	Fukuda, MItsunori/0000-0002-8620-5853; Higashi, Tomohito/0000-0001-5616-1477				Barbieri MA, 2000, J CELL BIOL, V151, P539, DOI 10.1083/jcb.151.3.539; Barral DC, 2002, J CLIN INVEST, V110, P247, DOI 10.1172/JCI200215058; BHAKDI S, 1993, MED MICROBIOL IMMUN, V182, P167; Bodie SL, 2001, BIOCHEM BIOPH RES CO, V287, P71, DOI 10.1006/bbrc.2001.5547; BOURNE HR, 1988, CELL, V53, P669, DOI 10.1016/0092-8674(88)90081-5; BRASS LF, 2005, HEMATOLOGY MOL BASIS, P1889; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Chen D, 1997, BIOCHEM MOL MED, V60, P27, DOI 10.1006/bmme.1996.2559; Chen XQ, 2003, J BIOL CHEM, V278, P50053, DOI 10.1074/jbc.M309910200; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Choi W, 2006, BLOOD, V107, P3145, DOI 10.1182/blood-2005-09-3563; COORSSEN JR, 1993, FEBS LETT, V316, P170, DOI 10.1016/0014-5793(93)81209-I; DiracSvejstrup AB, 1997, EMBO J, V16, P465, DOI 10.1093/emboj/16.3.465; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; Franke B, 1997, EMBO J, V16, P252, DOI 10.1093/emboj/16.2.252; Fukuda M, 2005, J BIOCHEM, V137, P9, DOI 10.1093/jb/mvi002; Fukuda M, 2002, J BIOL CHEM, V277, P12432, DOI 10.1074/jbc.C200005200; Goishi K, 2004, BIOCHEM BIOPH RES CO, V324, P294, DOI 10.1016/j.bbrc.2004.09.050; Haddad EK, 2001, J CELL BIOL, V152, P835, DOI 10.1083/jcb.152.4.835; HORIUCHI H, 1995, J BIOL CHEM, V270, P11257, DOI 10.1074/jbc.270.19.11257; Horiuchi H, 2006, ANN MED, V38, P162, DOI 10.1080/07853890600640657; Hume AN, 2001, J CELL BIOL, V152, P795, DOI 10.1083/jcb.152.4.795; Imai A, 2004, J CELL SCI, V117, P1945, DOI 10.1242/jcs.01048; Jordens I, 2005, TRAFFIC, V6, P1070, DOI 10.1111/j.1600-0854.2005.00336.x; KNIGHT DE, 1982, NATURE, V296, P256, DOI 10.1038/296256a0; Kuroda TS, 2002, J BIOL CHEM, V277, P9212, DOI 10.1074/jbc.M112414200; Nagashima K, 2002, FEBS LETT, V517, P233, DOI 10.1016/S0014-5793(02)02634-0; NAGATA K, 1990, FEBS LETT, V275, P29, DOI 10.1016/0014-5793(90)81431-M; Neeft M, 2005, MOL BIOL CELL, V16, P731, DOI 10.1091/mbc.E04-10-0923; Polgar J, 1999, BLOOD, V94, P1313, DOI 10.1182/blood.V94.4.1313.416k27_1313_1318; Rybin V, 1996, NATURE, V383, P266, DOI 10.1038/383266a0; SATOH T, 1990, P NATL ACAD SCI USA, V87, P7926, DOI 10.1073/pnas.87.20.7926; Shirakawa R, 2000, J BIOL CHEM, V275, P33844, DOI 10.1074/jbc.M002834200; Shirakawa R, 2005, METHOD ENZYMOL, V403, P778, DOI 10.1016/S0076-6879(05)03067-3; Shirakawa R, 2004, J BIOL CHEM, V279, P10730, DOI 10.1074/jbc.M309426200; SOLDATI T, 1994, NATURE, V369, P76, DOI 10.1038/369076a0; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Stinchcombe JC, 2001, J CELL BIOL, V152, P825, DOI 10.1083/jcb.152.4.825; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; ULLRICH O, 1994, NATURE, V368, P157, DOI 10.1038/368157a0; Wolthuis RMF, 1998, MOL CELL BIOL, V18, P2486, DOI 10.1128/MCB.18.5.2486; Wu XFS, 2002, NAT CELL BIOL, V4, P271, DOI 10.1038/ncb760; Yi Z, 2002, MOL CELL BIOL, V22, P1858, DOI 10.1128/MCB.22.6.1858-1867.2002; Yoshioka A, 2001, ANN NY ACAD SCI, V947, P403; Yoshioka A, 2001, J BIOL CHEM, V276, P39379, DOI 10.1074/jbc.M102933200; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	46	38	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					28657	28665		10.1074/jbc.M603227200	http://dx.doi.org/10.1074/jbc.M603227200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16880209	hybrid, Green Submitted			2022-12-27	WOS:000240680500019
J	Hua, QX; Mayer, JP; Jia, WH; Zhang, JW; Weiss, MA				Hua, Qing-xin; Mayer, John P.; Jia, Wenhua; Zhang, Jingwen; Weiss, Michael A.			The folding nucleus of the insulin superfamily - A flexible peptide model foreshadows the native state	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-I; SOLID-PHASE SYNTHESIS; IGF-I; STRUCTURAL INFORMATION; TRANSITION-STATE; DISULFIDE BONDS; KINETIC ROLE; PROTEIN; BINDING; GENE	Oxidative folding of insulin-like growth factor I (IGF-I) and single-chain insulin analogs proceeds via one- and two- disulfide intermediates. A predominant one- disulfide intermediate in each case contains the canonical A20 - B19 disulfide bridge (cystines 18 - 61 in IGF-I and 19 - 85 in human proinsulin). Here, we describe a disulfide-linked peptide model of this on-pathway intermediate. One peptide fragment ( 19 amino acids) spans IGF-I residues 7 - 25 ( canonical positions B8-B26 in the insulin superfamily); the other ( 18 amino acids) spans IGF-I residues 53 - 70 ( positions A12-A21 and D1-D8). Containing only half of the IGF-I sequence, the disulfide-linked polypeptide ( designated IGF-p) is not well ordered. Nascent helical elements corresponding to native alpha-helices are nonetheless observed at 4 degrees C. Furthermore, C-13-edited nuclear Overhauser effects establish transient formation of a native-like partial core; no non-native nuclear Overhauser effects are observed. Together, these observations suggest that early events in the folding of insulin-related polypeptides are nucleated by a native-like molten subdomain containing Cys(A20) and Cys(B19). We propose that nascent interactions within this subdomain orient the A20 and B19 thiolates for disulfide bond formation and stabilize the one- disulfide intermediate once formed. Substitutions in the corresponding region of insulin are associated with inefficient chain combination and impaired biosynthetic expression. The intrinsic conformational propensities of a flexible disulfide-linked peptide thus define a folding nucleus, foreshadowing the structure of the native state.	Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA; Amgen Inc, Thousand Oaks, CA 91320 USA	Case Western Reserve University; Eli Lilly; Amgen	Weiss, MA (corresponding author), 10900 Euclid Ave, Cleveland, OH 44106 USA.	maw21@case.edu			NIDDK NIH HHS [DK0697674] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adams TE, 2000, CELL MOL LIFE SCI, V57, P1050, DOI 10.1007/PL00000744; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Atherton E., 1990, SOLID PHASE PEPTIDE; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; BALDWIN RL, 1995, J BIOMOL NMR, V5, P103; BALDWIN TO, 1993, J BIOL CHEM, V268, P10766; Bathgate RAD, 2002, J BIOL CHEM, V277, P1148, DOI 10.1074/jbc.M107882200; Bernado P, 2005, P NATL ACAD SCI USA, V102, P17002, DOI 10.1073/pnas.0506202102; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Brzozowski AM, 2002, BIOCHEMISTRY-US, V41, P9389, DOI 10.1021/bi020084j; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; BURKHARDT E, 1994, HUM GENET, V94, P91, DOI 10.1007/BF02272850; CHASSIN D, 1995, GENOMICS, V29, P465, DOI 10.1006/geno.1995.9980; Chen Y, 2004, BIOCHEMISTRY-US, V43, P9225, DOI 10.1021/bi049710y; Conklin D, 1999, GENOMICS, V60, P50, DOI 10.1006/geno.1999.5899; COOKE RM, 1991, BIOCHEMISTRY-US, V30, P5484, DOI 10.1021/bi00236a022; CREIGHTON T, 1995, PHILOS T ROY SOC B, V348, P5, DOI 10.1098/rstb.1995.0039; Creighton T.E., 1997, PROTEIN STRUCTURE PR; Creighton TE, 1997, BIOL CHEM, V378, P731; Creighton TE, 1996, FASEB J, V10, P110, DOI 10.1096/fasebj.10.1.8566531; CREIGHTON TE, 1984, J MOL BIOL, V179, P497, DOI 10.1016/0022-2836(84)90077-9; CREIGHTON TE, 1990, BIOCHEM J, V270, P1; CREIGHTON TE, 1992, BIOESSAYS, V14, P195, DOI 10.1002/bies.950140310; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; DULL TJ, 1984, NATURE, V310, P777, DOI 10.1038/310777a0; Dyson HJ, 1996, ANNU REV PHYS CHEM, V47, P369, DOI 10.1146/annurev.physchem.47.1.369; Guo ZY, 2001, BIOL CHEM, V382, P443, DOI 10.1515/BC.2001.054; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Harding HP, 2002, DIABETES, V51, pS455, DOI 10.2337/diabetes.51.2007.S455; HOBER S, 1992, BIOCHEMISTRY-US, V31, P1749, DOI 10.1021/bi00121a024; Hsu SY, 1999, MOL ENDOCRINOL, V13, P2163, DOI 10.1210/me.13.12.2163; Hua QX, 2004, PROG BIOCHEM BIOPHYS, V31, P1; Hua QX, 1996, J MOL BIOL, V259, P297, DOI 10.1006/jmbi.1996.0320; HUA QX, 1995, NAT STRUCT BIOL, V2, P129, DOI 10.1038/nsb0295-129; Hua QX, 2002, BIOCHEMISTRY-US, V41, P14700, DOI 10.1021/bi0202981; Hua QX, 2002, J BIOL CHEM, V277, P43443, DOI 10.1074/jbc.M206107200; Hua QX, 1996, J MOL BIOL, V264, P390, DOI 10.1006/jmbi.1996.0648; HUA QX, 1991, NATURE, V354, P238, DOI 10.1038/354238a0; Hua QX, 2001, BIOCHEMISTRY-US, V40, P12299, DOI 10.1021/bi011021o; HUA QX, 1993, J MOL BIOL, V230, P387, DOI 10.1006/jmbi.1993.1156; Huang K, 2004, J MOL BIOL, V341, P529, DOI 10.1016/j.jmb.2004.05.023; HUDSON P, 1984, EMBO J, V3, P2333, DOI 10.1002/j.1460-2075.1984.tb02135.x; HUDSON P, 1983, NATURE, V301, P628, DOI 10.1038/301628a0; Jacoby E, 1996, J MOL BIOL, V258, P136, DOI 10.1006/jmbi.1996.0239; Jansson M, 1998, J BIOL CHEM, V273, P24701, DOI 10.1074/jbc.273.38.24701; Jha AK, 2005, P NATL ACAD SCI USA, V102, P13099, DOI 10.1073/pnas.0506078102; Katugampola S, 2003, TRENDS PHARMACOL SCI, V24, P30, DOI 10.1016/S0165-6147(02)00007-X; Krishna MMG, 2004, METHODS, V34, P51, DOI 10.1016/j.ymeth.2004.03.005; Lazaridis T, 1997, SCIENCE, V278, P1928, DOI 10.1126/science.278.5345.1928; Liu M, 2005, J BIOL CHEM, V280, P13209, DOI 10.1074/jbc.C400475200; MARKUSSEN J, 1985, INT J PEPT PROT RES, V25, P431; Matagne A, 1997, J MOL BIOL, V267, P1068, DOI 10.1006/jmbi.1997.0963; MATSUEDA GR, 1981, PEPTIDES, V2, P45, DOI 10.1016/S0196-9781(81)80010-1; MERRIFIELD RB, 1982, BIOCHEMISTRY-US, V21, P5020, DOI 10.1021/bi00263a028; MILLER JA, 1993, BIOCHEMISTRY-US, V32, P5203, DOI 10.1021/bi00070a032; Milner SJ, 1999, BIOTECHNOL BIOENG, V62, P693; NARHI LO, 1993, BIOCHEMISTRY-US, V32, P5214, DOI 10.1021/bi00070a033; OAS TG, 1988, NATURE, V336, P42, DOI 10.1038/336042a0; Ohnishi S, 2004, BIOCHEMISTRY-US, V43, P4064, DOI 10.1021/bi049879b; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; PTITSYN OB, 1991, FEBS LETT, V285, P176, DOI 10.1016/0014-5793(91)80799-9; Qiao ZS, 2001, BIOCHEMISTRY-US, V40, P2662, DOI 10.1021/bi001613r; Raleigh DP, 2005, PROTEIN PEPTIDE LETT, V12, P117, DOI 10.2174/0929866053005809; ROTWEIN P, 1986, J BIOL CHEM, V261, P4828; Rumbley J, 2001, P NATL ACAD SCI USA, V98, P105, DOI 10.1073/pnas.98.1.105; SALI A, 1994, NATURE, V369, P248, DOI 10.1038/369248a0; SARIN VK, 1981, ANAL BIOCHEM, V117, P147, DOI 10.1016/0003-2697(81)90704-1; SATO A, 1993, INT J PEPT PROT RES, V41, P433; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; STALEY JP, 1992, P NATL ACAD SCI USA, V89, P1519, DOI 10.1073/pnas.89.5.1519; TANG JG, 1990, BIOCHEM J, V268, P429, DOI 10.1042/bj2680429; Vajdos FF, 2001, BIOCHEMISTRY-US, V40, P11022, DOI 10.1021/bi0109111; WANG CC, 1991, TRENDS BIOCHEM SCI, V16, P279, DOI 10.1016/0968-0004(91)90114-B; WANG SS, 1973, J AM CHEM SOC, V95, P1328, DOI 10.1021/ja00785a602; Weiss MA, 2002, BIOCHEMISTRY-US, V41, P809, DOI 10.1021/bi011839+; Weiss MA, 2000, BIOCHEMISTRY-US, V39, P15429, DOI 10.1021/bi001905s; WEISSMAN JS, 1992, P NATL ACAD SCI USA, V89, P9900, DOI 10.1073/pnas.89.20.9900; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yan H, 2003, PROTEIN SCI, V12, P768, DOI 10.1110/ps.0237203; Yokota A, 2000, J MOL BIOL, V295, P1275, DOI 10.1006/jmbi.1999.3442; Zhang YS, 1996, SCI CHINA SER C, V39, P225; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	84	41	45	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					28131	28142		10.1074/jbc.M602616200	http://dx.doi.org/10.1074/jbc.M602616200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16864583	hybrid			2022-12-27	WOS:000240534400051
J	Kerssen, D; Hambruch, E; Klaas, W; Platta, HW; de Kruijff, B; Erdmann, R; Kunau, WH; Schliebs, W				Kerssen, Daniela; Hambruch, Eva; Klaas, Wibke; Platta, Harald W.; de Kruijff, Ben; Erdmann, Ralf; Kunau, Wolf-H.; Schliebs, Wolfgang			Membrane association of the cycling peroxisome import receptor Pex5p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARGETING SIGNAL RECEPTOR; MATRIX PROTEIN IMPORT; SACCHAROMYCES-CEREVISIAE; PTS1 RECEPTOR; BINDING-SITES; RAT-LIVER; ALCOHOL OXIDASE; IDENTIFICATION; MACHINERY; DOCKING	Peroxisomal proteins carrying a peroxisome targeting signal type 1 (PTS1) are recognized in the cytosol by the cycling import receptor Pex5p. The receptor-cargo complex docks at the peroxisomal membrane where it associates with multimeric protein complexes, referred to as the docking and RING finger complexes. Here we have identified regions within the Saccharomyces cerevisiae Pex5p sequence that interconnect the receptor-cargo complex with the docking complex. Site-directed mutagenesis of the conserved tryptophan residue within a reverse WXXXF motif abolished two-hybrid binding with the N-terminal half of Pex14p. In combination with an additional mutation introduced into the Pex13p-binding site, we generated a Pex5p mutant defective in a stable association not only with the docking complex but also with the RING finger peroxins at the membrane. Surprisingly, PTS1 proteins are still imported into peroxisomes in these mutant cells. Because these mutations had no significant effect on the membrane binding properties of Pex5p, we examined yeast and human Pex5p for intrinsic lipid binding activity. In vitro analyses demonstrated that both proteins have the potential to insert spontaneously into phospholipid membranes. Altogether, these data strongly suggest that a translocation-competent state of the PTS1 receptor enters the membrane via protein-lipid interactions before it tightly associates with other peroxins.	Ruhr Univ Bochum, Inst Physiol Chem, Abt Syst Biol, D-44780 Bochum, Germany; Univ Utrecht, Ctr Biomembranes & Lipid Enzymol, Dept Biochem Membranes, NL-3584 CH Utrecht, Netherlands	Ruhr University Bochum; Utrecht University	Schliebs, W (corresponding author), Ruhr Univ Bochum, Inst Physiol Chem, Abt Syst Biol, D-44780 Bochum, Germany.	wolfgang.schliebs@rub.de	Platta, Harald Wolfgang/G-7423-2014	Platta, Harald Wolfgang/0000-0001-8968-7280; Schliebs, Wolfgang/0000-0003-2762-3403				Agne B, 2003, MOL CELL, V11, P635, DOI 10.1016/S1097-2765(03)00062-5; Albertini M, 1997, CELL, V89, P83, DOI 10.1016/S0092-8674(00)80185-3; Barnett P, 2000, EMBO J, V19, P6382, DOI 10.1093/emboj/19.23.6382; BREUKINK E, 1992, BIOCHEMISTRY-US, V31, P1119, DOI 10.1021/bi00119a021; CHEVRAY PM, 1992, P NATL ACAD SCI USA, V89, P5789, DOI 10.1073/pnas.89.13.5789; Choe J, 2003, BIOCHEMISTRY-US, V42, P10915, DOI 10.1021/bi034248n; Dammai V, 2001, CELL, V105, P187, DOI 10.1016/S0092-8674(01)00310-5; Demel R A, 1994, Subcell Biochem, V23, P83; Dodt G, 1996, J CELL BIOL, V135, P1763, DOI 10.1083/jcb.135.6.1763; Eckert JH, 2003, REV PHYSIOL BIOCH P, V147, P75, DOI 10.1007/s10254-003-0007-z; Elgersma Y, 1996, J CELL BIOL, V135, P97, DOI 10.1083/jcb.135.1.97; ELGERSMA Y, 1996, J BIOL CHEM, V271, P185; Erdmann R, 1996, J CELL BIOL, V135, P111, DOI 10.1083/jcb.135.1.111; ERDMANN R, 1989, P NATL ACAD SCI USA, V86, P2432; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Fransen M, 1998, P NATL ACAD SCI USA, V95, P8087, DOI 10.1073/pnas.95.14.8087; FRANSEN M, 1995, J BIOL CHEM, V270, P7731, DOI 10.1074/jbc.270.13.7731; Gatto GJ, 2000, NAT STRUCT BIOL, V7, P1091; Girzalsky W, 1999, J CELL BIOL, V144, P1151, DOI 10.1083/jcb.144.6.1151; Gouveia AM, 2003, J BIOL CHEM, V278, P4389, DOI 10.1074/jbc.C200650200; Gouveia AMM, 2000, J BIOL CHEM, V275, P32444, DOI 10.1074/jbc.M004366200; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Gunkel K, 2004, MOL BIOL CELL, V15, P1347, DOI 10.1091/mbc.E03-04-0258; HARDEMAN D, 1990, INT J BIOCHEM, V22, P1413, DOI 10.1016/0020-711X(90)90231-Q; Hazra PP, 2002, TRAFFIC, V3, P560, DOI 10.1034/j.1600-0854.2002.30806.x; Hettema EH, 2000, EMBO J, V19, P223, DOI 10.1093/emboj/19.2.223; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Huhse B, 1998, J CELL BIOL, V140, P49, DOI 10.1083/jcb.140.1.49; Kal AJ, 1999, MOL BIOL CELL, V10, P1859, DOI 10.1091/mbc.10.6.1859; Kikuchi M, 2004, J BIOL CHEM, V279, P421, DOI 10.1074/jbc.M305623200; Klein ATJ, 2002, J BIOL CHEM, V277, P25011, DOI 10.1074/jbc.M203254200; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; KRAGLER F, 1993, J CELL BIOL, V120, P665, DOI 10.1083/jcb.120.3.665; LAMB JR, 1994, EMBO J, V13, P4321, DOI 10.1002/j.1460-2075.1994.tb06752.x; Lazarow PB, 2003, CURR OPIN CELL BIOL, V15, P489, DOI 10.1016/S0955-0674(03)00082-6; MCCOLLUM D, 1993, J CELL BIOL, V121, P761, DOI 10.1083/jcb.121.4.761; Nair DM, 2004, J CELL BIOL, V167, P599, DOI 10.1083/jcb.200407119; Niederhoff K, 2005, J BIOL CHEM, V280, P35571, DOI 10.1074/jbc.M502460200; Nito K, 2002, PLANT CELL PHYSIOL, V43, P355, DOI 10.1093/pcp/pcf057; Oliveira MEM, 2002, BBA-BIOMEMBRANES, V1567, P13, DOI 10.1016/S0005-2736(02)00635-1; Otera H, 2002, MOL CELL BIOL, V22, P1639, DOI 10.1128/MCB.22.6.1639-1655.2002; Parkes JA, 2003, MOL MEMBR BIOL, V20, P61, DOI 10.1080/0968768031000047859; Platta HW, 2005, NAT CELL BIOL, V7, P817, DOI 10.1038/ncb1281; Rehling P, 2000, J BIOL CHEM, V275, P3593, DOI 10.1074/jbc.275.5.3593; Rehling P, 1996, EMBO J, V15, P2901, DOI 10.1002/j.1460-2075.1996.tb00653.x; ROUSER G, 1970, LIPIDS, V5, P496; Saidowsky J, 2001, J BIOL CHEM, V276, P34524, DOI 10.1074/jbc.M104647200; Salomons FA, 2000, J BIOL CHEM, V275, P12603, DOI 10.1074/jbc.275.17.12603; Schafer A, 2004, MOL CELL BIOL, V24, P8895, DOI 10.1128/MCB.24.20.8895-8906.2004; Schell-Steven A, 2005, MOL CELL BIOL, V25, P3007, DOI 10.1128/MCB.25.8.3007-3018.2005; Schliebs W, 1999, J BIOL CHEM, V274, P5666, DOI 10.1074/jbc.274.9.5666; Schnell DJ, 2003, CELL, V112, P491, DOI 10.1016/S0092-8674(03)00110-7; Sparkes IA, 2002, MOL MEMBR BIOL, V19, P171, DOI 10.1080/09687680210159422; Stein K, 2002, MOL CELL BIOL, V22, P6056, DOI 10.1128/MCB.22.17.6056-6069.2002; TERLECKY SR, 1995, EMBO J, V14, P3627, DOI 10.1002/j.1460-2075.1995.tb00032.x; van der Klei IJ, 2002, CURR OPIN CELL BIOL, V14, P500, DOI 10.1016/S0955-0674(02)00354-X; vanRaalte ALJ, 1996, EUR J BIOCHEM, V235, P207; WIEMER EAC, 1995, J CELL BIOL, V130, P51, DOI 10.1083/jcb.130.1.51; Williams C, 2005, FEBS LETT, V579, P3416, DOI 10.1016/j.febslet.2005.05.011	59	85	85	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2006	281	37					27003	27015		10.1074/jbc.M509257200	http://dx.doi.org/10.1074/jbc.M509257200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082PB	16849337	hybrid			2022-12-27	WOS:000240397700027
J	Kang, YJ; Seit-Nebi, A; Davis, RJ; Han, JH				Kang, Young Jun; Seit-Nebi, Alim; Davis, Roger J.; Han, Jiahuai			Multiple activation mechanisms of p38 alpha mitogen-activated protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETRACTED ARTICLE. SEE; INDEPENDENT ACTIVATION; SIGNAL-TRANSDUCTION; MAP KINASES; JNK; AUTOPHOSPHORYLATION; ORGANIZATION; PATHWAYS; TYROSINE; TAK1	The p38 alpha MAPK participates in a variety of biological processes. Activation of p38 alpha is mediated by phosphorylation on specific regulatory tyrosine and threonine sites, and the three dual kinases, MAPK kinase 3 (MKK3), MKK4, and MKK6, are known to be the upstream activators of p38 alpha. In addition to activation by upstream kinases, p38 alpha can autoactivate when interacting with transforming growth factor-beta-activated protein kinase 1-binding protein 1 (TAB1). Here we used MKK3 and MKK6 double knock-out (MKK3/6 DKO) and MKK4/7 DKO mouse embryonic fibroblast (MEF) cells to examine activation mechanisms of p38 alpha. We confirmed that the MKK3/6 pathway is a primary mechanism for p38 alpha phosphorylation in MEF cells, and we also showed the presence of other p38 alpha activation pathways. We show that TAB1-mediated p38 alpha phosphorylation in MEF cells did not need MKK3/4/6, and it accounted for a small portion of the total p38 alpha phosphorylation that was induced by hyperosmolarity and anisomycin. We observed that a portion of peroxynitrite-induced phospho-p38 alpha is associated with an similar to 85-kDa disulfide complex in wild-type MEF cells. Peroxynitrite-induced phosphorylation of p38 alpha in the similar to 85-kDa complex is independent from MKK3/6 because only phospho-p38 alpha not associated with the disulfide complex was diminished in MKK3/6DKO cells. In addition, our data suggest interference among different pathways because TAB1 had an inhibitory effect on p38 alpha phosphorylation in the peroxynitrite-induced similar to 85-kDa complex. Mutagenesis analysis of the cysteines in p38 alpha revealed that no disulfide bond forms between p38 alpha and other proteins in the similar to 85-kDa complex, suggesting it is a p38 alpha binding partner(s) that forms disulfide bonds, which enable it to bind to p38 alpha. Therefore, multiple mechanisms of p38 alpha activation exist that can influence each other, be simultaneously activated by a given stimulus, and/or be selectively used by different stimuli in a cell type-specific manner.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Mol Med, Worcester, MA 01605 USA	Scripps Research Institute; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Han, JH (corresponding author), Scripps Res Inst, Dept Immunol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jhan@scripps.edu	Han, J/G-4671-2010	Kang, Young Jun/0000-0001-9778-1963	NIAID NIH HHS [AI054796, AI041637] Funding Source: Medline; NIGMS NIH HHS [GM067101, GM037696] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041637, R01AI054796] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067101, P01GM037696] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abe Y, 2000, J BIOL CHEM, V275, P21525, DOI 10.1074/jbc.M909629199; Brancho D, 2003, GENE DEV, V17, P1969, DOI 10.1101/gad.1107303; Chang CI, 2002, MOL CELL, V9, P1241, DOI 10.1016/S1097-2765(02)00525-7; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Cheung PCF, 2003, EMBO J, V22, P5793, DOI 10.1093/emboj/cdg552; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Garrington TP, 1999, CURR OPIN CELL BIOL, V11, P211, DOI 10.1016/S0955-0674(99)80028-3; Ge BX, 2002, SCIENCE, V295, P1291, DOI 10.1126/science.1067289; Ge BX, 2003, J BIOL CHEM, V278, P2286, DOI 10.1074/jbc.M210918200; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Han JH, 1996, J BIOL CHEM, V271, P2886, DOI 10.1074/jbc.271.6.2886; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kim L, 2005, J IMMUNOL, V174, P4178, DOI 10.4049/jimmunol.174.7.4178; Matsuyama W, 2003, J IMMUNOL, V171, P3520, DOI 10.4049/jimmunol.171.7.3520; Nebreda AR, 2000, TRENDS BIOCHEM SCI, V25, P257, DOI 10.1016/S0968-0004(00)01595-4; Ohkusu-Tsukada K, 2004, MOL CELL BIOL, V24, P6957, DOI 10.1128/MCB.24.16.6957-6966.2004; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Salvador JM, 2005, NAT IMMUNOL, V6, P390, DOI 10.1038/ni1177; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Tanno M, 2003, CIRC RES, V93, P254, DOI 10.1161/01.RES.0000083490.43943.85; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Veal EA, 2004, MOL CELL, V15, P129, DOI 10.1016/j.molcel.2004.06.021; Whitmarsh AJ, 1998, TRENDS BIOCHEM SCI, V23, P481, DOI 10.1016/S0968-0004(98)01309-7; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257	29	73	76	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2006	281	36					26225	26234		10.1074/jbc.M606800200	http://dx.doi.org/10.1074/jbc.M606800200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	080LO	16849316	hybrid			2022-12-27	WOS:000240249500039
J	Wade, M; Wong, ET; Tang, M; Stommel, JM; Wahl, GM				Wade, Mark; Wong, Ee Tsin; Tang, Mengjia; Stommel, Jayne M.; Wahl, Geoffrey M.			Hdmx modulates the outcome of P53 activation in human tumor cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE ANTAGONISTS; DNA-DAMAGE; IN-VIVO; EMBRYONIC LETHALITY; DEPENDENT DEGRADATION; MDM2-DEFICIENT MICE; P53-BINDING PROTEIN; NEGATIVE REGULATOR; PROVIDES INSIGHT; MDM2 ONCOPROTEIN	Tumors that express wild-type P53 provide a target for therapies designed to reactivate P53 function. This is supported by the potent activation of P53 in tumor cells by Nutlin, a cis-imidazoline that inhibits the Hdm2-P53 interaction. The efficacy of Hdm2(.)P53 antagonists could be compromised if they do not antagonize Hdmx, an Hdm2 homolog that inhibits P53 transactivation. We evaluated the role of Hdmx expression in sensitivity to Nutlin in a range of cancer cell lines. Nutlin reduced Hdmx levels in normal cells and some cancer cell lines, whereas other cancer cells were refractory to such down-regulation. Strikingly, Nutlin did not disrupt Hdmx(.)P53 complexes, and in cell lines where no Hdmx degradation occurred, Nutlin failed to induce apoptosis. shRNA-mediated reduction of Hdmx sensitized cells to apoptosis, but caspase-3 was neither required nor sufficient for Hdmx degradation or apoptosis. Our data imply that Hdmx is an important determinant of the outcome of P53 activation. Thus, targeting Hdmx may be a therapeutic strategy that complements drugs such as Nutlin.	Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; Univ Calif San Diego, Grad Program, Div Biol Sci, La Jolla, CA 92037 USA	Salk Institute; University of California System; University of California San Diego	Wahl, GM (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wahl@salk.edu	Wade, Mark/B-6719-2009; Stommel, Jayne M/M-3439-2017	Wade, Mark/0000-0002-2688-5965; Wade, Mark/0000-0002-8355-9680	NATIONAL CANCER INSTITUTE [R01CA061449] Funding Source: NIH RePORTER; NCI NIH HHS [CA61449] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Bottger V, 1999, ONCOGENE, V18, P189, DOI 10.1038/sj.onc.1202281; Brummelkamp TR, 2006, NAT CHEM BIOL, V2, P202, DOI 10.1038/nchembio774; Buolamwini JK, 2005, CURR CANCER DRUG TAR, V5, P57, DOI 10.2174/1568009053332672; Chen LH, 2005, EMBO J, V24, P3411, DOI 10.1038/sj.emboj.7600812; Coll-Mulet L, 2006, BLOOD, V107, P4109, DOI 10.1182/blood-2005-08-3273; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; de Toledo SM, 2000, ONCOGENE, V19, P6185, DOI 10.1038/sj.onc.1204020; Finch RA, 2002, CANCER RES, V62, P3221; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; Francoz S, 2006, P NATL ACAD SCI USA, V103, P3232, DOI 10.1073/pnas.0508476103; Gentiletti F, 2002, ONCOGENE, V21, P867, DOI 10.1038/sj.onc.1205137; Gu JJ, 2002, J BIOL CHEM, V277, P19251, DOI 10.1074/jbc.C200150200; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hoh J, 2002, P NATL ACAD SCI USA, V99, P8467, DOI 10.1073/pnas.132268899; ICHIKAWA A, 1993, LEUKEMIA LYMPHOMA, V11, P21, DOI 10.3109/10428199309054727; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Jin YT, 2006, EMBO J, V25, P1207, DOI 10.1038/sj.emboj.7601010; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Kawai H, 2003, J BIOL CHEM, V278, P45946, DOI 10.1074/jbc.M308295200; Khosravi R, 1999, P NATL ACAD SCI USA, V96, P14973, DOI 10.1073/pnas.96.26.14973; Kmet LM, 2003, CANCER, V97, P389, DOI 10.1002/cncr.11064; Kojima K, 2005, BLOOD, V106, P3150, DOI 10.1182/blood-2005-02-0553; Krummel KA, 2005, P NATL ACAD SCI USA, V102, P10188, DOI 10.1073/pnas.0503068102; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lavin MF, 2005, MUTAT RES-FUND MOL M, V569, P123, DOI 10.1016/j.mrfmmm.2004.04.020; LeBron C, 2006, EMBO J, V25, P1196, DOI 10.1038/sj.emboj.7601032; Legube G, 2002, EMBO J, V21, P1704, DOI 10.1093/emboj/21.7.1704; LUNA RMD, 1995, NATURE, V378, P203; Marine JC, 2005, BIOCHEM BIOPH RES CO, V331, P750, DOI 10.1016/j.bbrc.2005.03.151; Meulmeester E, 2005, MOL CELL, V18, P565, DOI 10.1016/j.molcel.2005.04.024; Migliorini D, 2002, MOL CELL BIOL, V22, P5527, DOI 10.1128/MCB.22.15.5527-5538.2002; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Okamoto K, 2005, MOL CELL BIOL, V25, P9608, DOI 10.1128/MCB.25.21.9608-9620.2005; Parant J, 2001, NAT GENET, V29, P92, DOI 10.1038/ng714; Patton JT, 2006, CANCER RES, V66, P3169, DOI 10.1158/0008-5472.CAN-05-3832; Pereg Y, 2005, P NATL ACAD SCI USA, V102, P5056, DOI 10.1073/pnas.0408595102; Secchiero P, 2006, BLOOD, V107, P4122, DOI 10.1182/blood-2005-11-4465; Sharp DA, 1999, J BIOL CHEM, V274, P38189, DOI 10.1074/jbc.274.53.38189; SHCWARTZBERG L, 2006, J SUPPORT ONCOL S1, V42, P3; Shvarts A, 1996, EMBO J, V15, P5349, DOI 10.1002/j.1460-2075.1996.tb00919.x; Shvarts A, 1997, GENOMICS, V43, P34, DOI 10.1006/geno.1997.4775; Smith ND, 2003, J UROLOGY, V169, P1219, DOI 10.1097/01.ju.0000056085.58221.80; Stad R, 2000, J BIOL CHEM, V275, P28039; Stommel JM, 2004, EMBO J, V23, P1547, DOI 10.1038/sj.emboj.7600145; Stuhmer T, 2005, BLOOD, V106, P3609, DOI 10.1182/blood-2005-04-1489; Thompson T, 2004, J BIOL CHEM, V279, P53015, DOI 10.1074/jbc.M410233200; TIAN LF, 2006, BIOCHEM BIOPH RES CO, V2, P2; Toledo F, 2006, CANCER CELL, V9, P273, DOI 10.1016/j.ccr.2006.03.014; Tovar C, 2006, P NATL ACAD SCI USA, V103, P1888, DOI 10.1073/pnas.0507493103; Uchida CH, 2005, EMBO J, V24, P160, DOI 10.1038/sj.emboj.7600486; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vega-Stromberg Teri, 2003, J Infus Nurs, V26, P353, DOI 10.1097/00129804-200311000-00004; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wahl GM, 2006, CELL DEATH DIFFER, V13, P973, DOI 10.1038/sj.cdd.4401911; Wahl GM, 2005, 25 YEARS OF P53 RESEARCH, P73, DOI 10.1007/1-4020-2922-5_4; Wendt J, 2006, ONCOGENE, V25, P972, DOI 10.1038/sj.onc.1209031; Xiong SB, 2006, P NATL ACAD SCI USA, V103, P3226, DOI 10.1073/pnas.0508500103; Zhang Z, 2004, J BIOL CHEM, V279, P16000, DOI 10.1074/jbc.M312264200	59	131	134	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33036	33044		10.1074/jbc.M605405200	http://dx.doi.org/10.1074/jbc.M605405200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16905769	hybrid			2022-12-27	WOS:000241621400012
J	Anthonisen, AN; Clausen, JD; Andersen, JP				Anthonisen, Anne Nyholm; Clausen, Johannes D.; Andersen, Jens Peter			Mutational analysis of the conserved TGES loop of sarcoplasmic reticulum Ca2+-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-PUMP; FUNCTIONAL CONSEQUENCES; PHOSPHOENZYME INTERMEDIATE; CRYSTAL-STRUCTURE; AMINO-ACIDS; DOMAIN-A; CA-2+-ATPASE; DEPHOSPHORYLATION; ION; PHOSPHORYLATION	Crystal structures have shown that the conserved TGES loop of the Ca2+-ATPase is isolated in the Ca(2)E1 state but becomes inserted in the catalytic site in E2 states. Here, we have examined the kinetics of the partial reaction steps of the transport cycle and the binding of the phosphoryl analogs BeF, AlF, MgF, and vanadate in mutants with alterations to the TGES residues. The mutations encompassed variation of size, polarity, and charge of the side chains. Differential effects on the Ca(2)E1P -> E2P, E2P -> E2, and E2 -> Ca(2)E1 reactions and the binding of the phosphoryl analogs were observed. In the E183D mutant, the E2P -> E2 dephosphorylation reaction proceeded at a rate as high as one-third that of the wild type, whereas it was very slow in the other Glu(183) mutants, including E183Q, thus demonstrating the need for a negatively charged carboxylate group to catalyze dephosphorylation. By contrast, the Ca(2)E1P -> E2P transition was accomplished at a reasonable rate with glutamine in place of Glu(183), but not with aspartate, indicating that the length of the Glu(183) side chain, in addition to its hydrogen bonding potential, is critical for Ca2E1P -> E2P. This transition was also slowed in mutants with alteration to other TGES residues. The data provide functional evidence in support of the proposed role of Glu(183) in activating the water molecule involved in the E2P -> E2 dephosphorylation and suggest a direct participation of the side chains of the TGES loop in the control and facilitation of the insertion of the loop in the catalytic site. The interactions of the TGES loop furthermore seem to facilitate its disengagement from the catalytic site during the E2 -> Ca(2)E1 transition.	Univ Aarhus, Dept Physiol, Inst Physiol & Biophys, DK-8000 Aarhus C, Denmark	Aarhus University	Andersen, JP (corresponding author), Univ Aarhus, Dept Physiol, Inst Physiol & Biophys, Ole Worms Alle 1160, DK-8000 Aarhus C, Denmark.	jpa@fi.au.dk		Andersen, Jens Peter/0000-0003-0654-4300				Andersen JP, 1995, BIOSCIENCE REP, V15, P243, DOI 10.1007/BF01788358; ANDERSEN JP, 1989, J BIOL CHEM, V264, P21018; BAGINSKI ES, 1967, CLIN CHEM, V13, P326; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CLARKE DM, 1989, NATURE, V339, P476, DOI 10.1038/339476a0; CLARKE DM, 1990, J BIOL CHEM, V265, P14088; Clausen JD, 2006, J BIOL CHEM, V281, P9471, DOI 10.1074/jbc.M512371200; Clausen JD, 2004, P NATL ACAD SCI USA, V101, P2776, DOI 10.1073/pnas.0400122101; Clausen JD, 2003, BIOCHEMISTRY-US, V42, P2585, DOI 10.1021/bi0271897; Clausen JD, 2001, J BIOL CHEM, V276, P35741, DOI 10.1074/jbc.M105434200; Danko S, 2004, J BIOL CHEM, V279, P14991, DOI 10.1074/jbc.M313363200; DEMEIS L, 1980, BIOCHEMISTRY-US, V19, P4252, DOI 10.1021/bi00559a017; DEMEIS L, 1979, ANNU REV BIOCHEM, V48, P275; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; HASSELBACH W, 1963, BIOCHEM Z, V339, P94; KAUFMAN RJ, 1989, MOL CELL BIOL, V9, P946, DOI 10.1128/MCB.9.3.946; Lenoir G, 2004, J BIOL CHEM, V279, P9156, DOI 10.1074/jbc.M311411200; MACLENNAN DH, 1985, NATURE, V316, P696, DOI 10.1038/316696a0; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; PEDERSEN PL, 1987, TRENDS BIOCHEM SCI, V12, P146, DOI 10.1016/0968-0004(87)90071-5; Sorensen T, 1997, J BIOL CHEM, V272, P30244, DOI 10.1074/jbc.272.48.30244; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Sorensen TLM, 2004, J BIOL CHEM, V279, P46355, DOI 10.1074/jbc.C400414200; Sorensen TLM, 2000, J BIOL CHEM, V275, P5400, DOI 10.1074/jbc.275.8.5400; Toustrup-Jensen M, 2003, J BIOL CHEM, V278, P11402, DOI 10.1074/jbc.M212136200; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; VILSEN B, 1991, J BIOL CHEM, V266, P16157; VILSEN B, 1989, J BIOL CHEM, V264, P21024; Wang GL, 2005, J BIOL CHEM, V280, P26508, DOI 10.1074/jbc.M503789200; WEBER K, 1969, J BIOL CHEM, V244, P4406; Yamasaki K, 2004, J BIOL CHEM, V279, P2202, DOI 10.1074/jbc.M309398200	37	34	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31572	31582		10.1074/jbc.M605194200	http://dx.doi.org/10.1074/jbc.M605194200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16893884				2022-12-27	WOS:000241235300043
J	Gautier-Stein, A; Zitoun, C; Lalli, E; Mithieux, G; Rajas, F				Gautier-Stein, Amandine; Zitoun, Carine; Lalli, Enzo; Mithieux, Gilles; Rajas, Fabienne			Transcriptional regulation of the glucose-6-phosphatase gene by cAMP/vasoactive intestinal peptide in the intestine - Role of HNF4 alpha, CREM, HNF1 alpha, and C/EBP alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE NUCLEAR FACTOR-4-ALPHA; RAT SMALL-INTESTINE; DEPENDENT DIABETES-MELLITUS; PORTAL GLUCOSE-INFUSION; CAMP RESPONSE-ELEMENT; CATALYTIC SUBUNIT; BINDING-PROTEIN; CYCLIC-AMP; ACETYLTRANSFERASE ACTIVITY; ADENYLATE-CYCLASE	Gluconeogenesis is induced in both the liver and intestine by increased cAMP levels. However, hepatic and intestinal glucose production can have opposite effects on glucose homeostasis. Glucose release into the portal vein by the intestine increases glucose uptake and reduces food intake. In contrast, glucose production by the liver contributes to hyperglycemia in type II diabetes. Glucose-6-phosphatase (Glc6Pase) is the key enzyme of gluconeogenesis in both the liver and intestine. Here we specify the cAMP/protein kinase A regulation of the Glc6Pase gene in the intestine compared with the liver. Similarly to the liver, the molecular mechanism of cAMP/protein kinase A regulation involves cAMP-response element-binding protein, HNF4 alpha, CAAT/enhancer-binding protein, and HNF1. In contrast to the situation in the liver, we find that different isoforms of CAAT/enhancer-binding protein and HNF1 contribute to the specific regulation of the Glc6Pase gene in the intestine. Moreover, we show that cAMP-response element binding modulator specifically contributes to the regulation of the Glc6Pase gene in the intestine but not in the liver. These results allow us to identify intestine-specific regulators of the Glc6Pase gene and to improve the understanding of the differences in the regulation of gluconeogenesis in the intestine compared with the liver.	INSERM, Fac Med Laennec, U449, F-69372 Lyon 08, France; INRA, U1235, F-69372 Lyon, France; Univ Lyon 1, F-69372 Lyon, France; Inst Fed Rech Laennec 62, F-69372 Lyon, France; CNRS, UMR 6097, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France	Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Gautier-Stein, A (corresponding author), INSERM, Fac Med Laennec, U449, Rue Guillaume Paradin, F-69372 Lyon 08, France.	Amandine.Gautier@univ-lyon1.fr	RAJAS, Fabienne/P-4091-2016; Lalli, Enzo/F-7052-2013	RAJAS, Fabienne/0000-0002-9233-7633; Lalli, Enzo/0000-0002-0584-5681; Gilles, Mithieux/0000-0003-3579-8529; Gautier-Stein, Amandine/0000-0002-6003-1891				AMIRANOFF B, 1978, BIOCHIM BIOPHYS ACTA, V544, P474, DOI 10.1016/0304-4165(78)90321-5; Antes TJ, 2001, DNA CELL BIOL, V20, P67, DOI 10.1089/104454901750070265; BARZILAI N, 1993, J BIOL CHEM, V268, P25019; Boudreau F, 2002, J BIOL CHEM, V277, P31909, DOI 10.1074/jbc.M204622200; Boudreau F, 2001, J BIOL CHEM, V276, P32122, DOI 10.1074/jbc.M102002200; Boustead JN, 2003, BIOCHEM J, V369, P17, DOI 10.1042/BJ20021382; Burcelin R, 2000, DIABETES, V49, P1635, DOI 10.2337/diabetes.49.10.1635; Cardin S, 1999, J APPL PHYSIOL, V87, P1470, DOI 10.1152/jappl.1999.87.4.1470; Carriere V, 2005, J BIOL CHEM, V280, P20094, DOI 10.1074/jbc.M502192200; Chakravarti D, 1999, CELL, V96, P393, DOI 10.1016/S0092-8674(00)80552-8; Chatelain F, 1998, DIABETES, V47, P882, DOI 10.2337/diabetes.47.6.882; Clore JN, 2000, DIABETES, V49, P969, DOI 10.2337/diabetes.49.6.969; Croset M, 2001, DIABETES, V50, P740, DOI 10.2337/diabetes.50.4.740; DEFRONZO RA, 1992, DIABETOLOGIA, V35, P389, DOI 10.1007/BF00401208; Dell H, 1999, J BIOL CHEM, V274, P9013, DOI 10.1074/jbc.274.13.9013; Duong DT, 2002, J BIOL CHEM, V277, P32234, DOI 10.1074/jbc.M204873200; Erickson RH, 2000, BIOCHEM BIOPH RES CO, V270, P235, DOI 10.1006/bbrc.2000.2420; Fimia GM, 2001, J CELL SCI, V114, P1971; FOULKES NS, 1992, NATURE, V355, P80, DOI 10.1038/355080a0; GARDEMANN A, 1986, FEBS LETT, V202, P255, DOI 10.1016/0014-5793(86)80697-4; Gautier-Stein A, 2005, MOL ENDOCRINOL, V19, P163, DOI 10.1210/me.2004-0105; Gautier-Stein A, 2003, NUCLEIC ACIDS RES, V31, P5238, DOI 10.1093/nar/gkg747; GERICH JE, 1991, DIABETOLOGIA, V34, P607, DOI 10.1007/BF00400282; Gevrey JC, 2004, DIABETOLOGIA, V47, P926, DOI 10.1007/s00125-004-1380-0; Gevrey JC, 2002, J BIOL CHEM, V277, P22407, DOI 10.1074/jbc.M201624200; Gresh L, 2004, EMBO J, V23, P1657, DOI 10.1038/sj.emboj.7600160; Hornbuckle LA, 2004, AM J PHYSIOL-ENDOC M, V286, pE795, DOI 10.1152/ajpendo.00455.2003; Kimmins S, 2004, REPRODUCTION, V128, P5, DOI 10.1530/rep.1.00170; LABURTHE M, 1987, J BIOL CHEM, V262, P10180; LALLI E, 1994, J BIOL CHEM, V269, P17359; LEFF T, 1989, J BIOL CHEM, V264, P16132; Lin BC, 1997, BIOCHEMISTRY-US, V36, P14096, DOI 10.1021/bi9703249; Lin BC, 1998, DNA CELL BIOL, V17, P967, DOI 10.1089/dna.1998.17.967; LIU JS, 1991, J BIOL CHEM, V266, P19095; Manna PR, 2002, MOL ENDOCRINOL, V16, P184, DOI 10.1210/me.16.1.184; Massillon D, 2001, J BIOL CHEM, V276, P4055, DOI 10.1074/jbc.M007939200; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Minassian C, 1996, MOL CELL BIOCHEM, V155, P37, DOI 10.1007/BF00714331; Mithieux G, 1996, DIABETES, V45, P891, DOI 10.2337/diabetes.45.7.891; Mithieux G, 2004, AM J PHYSIOL-ENDOC M, V286, pE370, DOI 10.1152/ajpendo.00299.2003; Mithieux G, 2004, J BIOL CHEM, V279, P44231, DOI 10.1074/jbc.R400011200; Mithieux G, 2005, CELL METAB, V2, P321, DOI 10.1016/j.cmet.2005.09.010; Montminy M, 2004, ANN ENDOCRINOL-PARIS, V65, P73, DOI 10.1016/S0003-4266(04)95634-X; Nantel F, 1996, NATURE, V380, P159, DOI 10.1038/380159a0; Olsen L, 2005, AM J PHYSIOL-GASTR L, V289, pG220, DOI 10.1152/ajpgi.00449.2004; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; OWEN OE, 1969, J CLIN INVEST, V48, P574, DOI 10.1172/JCI106016; PINTO M, 1983, BIOL CELL, V47, P323; PRIETO JC, 1979, EUR J BIOCHEM, V96, P229, DOI 10.1111/j.1432-1033.1979.tb13033.x; Rajas F, 1999, GASTROENTEROLOGY, V117, P132, DOI 10.1016/S0016-5085(99)70559-7; Rajas F, 2000, DIABETES, V49, P1165, DOI 10.2337/diabetes.49.7.1165; Rajas F, 2002, J BIOL CHEM, V277, P15736, DOI 10.1074/jbc.M200971200; Rowley CW, 2006, AM J PHYSIOL-GASTR L, V290, pG466, DOI 10.1152/ajpgi.00431.2005; Sauvaget D, 2002, J BIOL CHEM, V277, P34540, DOI 10.1074/jbc.M206074200; Schmoll D, 1999, BIOCHEM J, V338, P457, DOI 10.1042/0264-6021:3380457; Seoane J, 1997, J BIOL CHEM, V272, P26972, DOI 10.1074/jbc.272.43.26972; Servillo G, 2002, EXP CELL RES, V275, P143, DOI 10.1006/excr.2002.5491; Shih DQ, 2001, DIABETES, V50, P2472, DOI 10.2337/diabetes.50.11.2472; Sindelar DK, 1997, AM J PHYSIOL-ENDOC M, V273, pE972, DOI 10.1152/ajpendo.1997.273.5.E972; Soutoglou E, 2000, MOL CELL, V5, P745, DOI 10.1016/S1097-2765(00)80253-1; Soutoglou E, 2001, EMBO J, V20, P1984, DOI 10.1093/emboj/20.8.1984; Streeper RS, 2000, J BIOL CHEM, V275, P12108, DOI 10.1074/jbc.275.16.12108; Streeper RS, 2001, J BIOL CHEM, V276, P19111, DOI 10.1074/jbc.M101442200; Swenson ES, 1999, AM J PHYSIOL-GASTR L, V276, pG728, DOI 10.1152/ajpgi.1999.276.3.G728; Traber PG, 1996, ANNU REV PHYSIOL, V58, P275, DOI 10.1146/annurev.physiol.58.1.275; Trinh KY, 1998, J BIOL CHEM, V273, P31615, DOI 10.1074/jbc.273.47.31615; Van Schaftingen E, 2002, BIOCHEM J, V362, P513, DOI 10.1042/0264-6021:3620513; Vander Kooi BT, 2003, J BIOL CHEM, V278, P11782, DOI 10.1074/jbc.M212570200; Vander Kooi CW, 2006, BIOCHEMISTRY-US, V45, P121, DOI 10.1021/bi051787e; Viollet B, 1997, MOL CELL BIOL, V17, P4208, DOI 10.1128/MCB.17.8.4208; Wang D, 2006, ENDOCRINOLOGY, V147, P350, DOI 10.1210/en.2005-1014; Yang JQ, 2005, J BIOL CHEM, V280, P38689, DOI 10.1074/jbc.M503486200	72	42	45	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31268	31278		10.1074/jbc.M603258200	http://dx.doi.org/10.1074/jbc.M603258200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16893891	Green Published, Bronze			2022-12-27	WOS:000241235300011
J	Mueller, S; Kleinau, G; Jaeschke, H; Neumann, S; Krause, G; Paschke, R				Mueller, Sandra; Kleinau, Gunnar; Jaeschke, Holger; Neumann, Susanne; Krause, Gerd; Paschke, Ralf			Significance of ectodomain cysteine boxes 2 and 3 for the activation mechanism of the thyroid-stimulating hormone receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROTROPIN TSH RECEPTOR; EXTRACELLULAR DOMAIN; CONSTITUTIVE ACTIVITY; TRANSMEMBRANE DOMAIN; INVERSE AGONIST; MUTATIONS; IDENTIFICATION; PHYSIOLOGY; RESIDUES; PORTION	Recently, we identified constitutively activating mutations at positions Asp-403, Glu-404, and Asn-406 in the third extracellular cysteine box (C-b3) of the thyroid-stimulating hormone receptor. We hypothesized that this region could act as a molecular interface between the extracellular and serpentine domain. In this study we present a model for properties of potential interaction partners for this region. Moreover, we show that Pro-400 and Pro-407 adjacent to this epitope are also important for stabilizing the partially active, basal conformation of the wild-type (WT) thyroid-stimulating hormone receptor. Furthermore, the mutation K291A in the second extracellular cysteine box (C-b2) was identified as a new constitutively activating mutation that releases the basal conformation of the WT receptor like the known tryptic cleavage in its close vicinity. Taken together, we provide an activation scenario at the C-b2/C-b3 unit. Three anchor fragments (anchors I-III) most likely constrain the basal conformation. The three anchor fragments are tightly packed. A disulfide bridge holds the C-b2/C-b3 portions in close positions. Independent of the type of conformational interference such as side chain modifications, tryptic cleavage, or hormone stimulation that act on the constrained C-b2/C-b3 WT conformation, it will always release one of the anchor fragments. Subsequently, this results in a conformational displacement of the C-b2/C-b3 portions relative to each other, inducing receptor activation.	Univ Leipzig, Dept Med 3, D-04103 Leipzig, Germany; Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany; NIDDK, NIH, Clin Endocrinol Branch, Bethesda, MD 20892 USA	Leipzig University; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Paschke, R (corresponding author), Univ Leipzig, Dept Med 3, Str 27, D-04103 Leipzig, Germany.	pasr@medizin.uni-leipzig.de	Neumann, Susanne/GPK-6035-2022; Kleinau, Gunnar/GPX-6330-2022		Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bozon W, 2002, PROTEIN EXPRES PURIF, V25, P114, DOI 10.1006/prep.2002.1617; Chen CR, 2003, ENDOCRINOLOGY, V144, P3821, DOI 10.1210/en.2003-0430; Claus M, 2005, ENDOCRINOLOGY, V146, P5197, DOI 10.1210/en.2005-0713; deRoux N, 1996, J CLIN ENDOCR METAB, V81, P4229, DOI 10.1210/jc.81.12.4229; Duprez L, 1997, FEBS LETT, V409, P469, DOI 10.1016/S0014-5793(97)00532-2; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; Gruters A, 1998, J CLIN ENDOCR METAB, V83, P1431, DOI 10.1210/jc.83.5.1431; GUDERMANN T, 1995, J MOL MED, V73, P51, DOI 10.1007/BF00270578; Hjorth SA, 1998, MOL ENDOCRINOL, V12, P78, DOI 10.1210/mend.12.1.0045; Ho SC, 2005, MOL CELL ENDOCRINOL, V245, P158, DOI 10.1016/j.mce.2005.11.008; Ho SC, 2001, ENDOCRINOLOGY, V142, P2760, DOI 10.1210/en.142.7.2760; Jaeschke H, 2006, ENDOCRINOLOGY, V147, P1753, DOI 10.1210/en.2005-1138; Karges B, 2005, MOL ENDOCRINOL, V19, P2086, DOI 10.1210/me.2004-0378; Kleinau G, 2004, J BIOL CHEM, V279, P51590, DOI 10.1074/jbc.M404748200; Kopp P, 1997, J CLIN INVEST, V100, P1634, DOI 10.1172/JCI119687; LIBERT F, 1989, BIOCHEM BIOPH RES CO, V165, P1250, DOI 10.1016/0006-291X(89)92736-8; NAGAYAMA Y, 1992, MOL ENDOCRINOL, V6, P145, DOI 10.1210/me.6.2.145; Nakabayashi K, 2003, MOL CELL ENDOCRINOL, V202, P139, DOI 10.1016/S0303-7207(03)00075-3; Neumann S, 2005, EUR J ENDOCRINOL, V152, P625, DOI 10.1530/eje.1.01891; Nishi S, 2002, J BIOL CHEM, V277, P3958, DOI 10.1074/jbc.M109617200; PARMA J, 1995, MOL ENDOCRINOL, V9, P725, DOI 10.1210/me.9.6.725; Rapoport B, 1998, ENDOCR REV, V19, P673, DOI 10.1210/er.19.6.673; SEGALOFF DL, 1993, ENDOCR REV, V14, P324, DOI 10.1210/er.14.3.324; Simoni M, 1997, ENDOCR REV, V18, P739, DOI 10.1210/er.18.6.739; Smits G, 2002, MOL ENDOCRINOL, V16, P722, DOI 10.1210/me.16.4.722; Stavrou SS, 1998, J CLIN ENDOCR METAB, V83, P2091, DOI 10.1210/jc.83.6.2091; Szkudlinski MW, 2002, PHYSIOL REV, V82, P473, DOI 10.1152/physrev.00031.2001; Themmen APN, 2000, ENDOCR REV, V21, P551, DOI 10.1210/er.21.5.551; VanSande J, 1996, MOL CELL ENDOCRINOL, V119, P161, DOI 10.1016/0303-7207(96)03804-X; Vlaeminck-Guillem V, 2002, MOL ENDOCRINOL, V16, P736, DOI 10.1210/me.16.4.736; Wonerow P, 1998, J BIOL CHEM, V273, P7900, DOI 10.1074/jbc.273.14.7900; Wonerow P, 2001, J MOL MED, V79, P707, DOI 10.1007/s001090100279; Zhang M, 2000, ENDOCRINOLOGY, V141, P3514, DOI 10.1210/en.141.9.3514; ZHANG ML, 1995, BIOCHEM BIOPH RES CO, V211, P205, DOI 10.1006/bbrc.1995.1797; Zhang R, 1996, J BIOL CHEM, V271, P5755, DOI 10.1074/jbc.271.10.5755	35	31	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31638	31646		10.1074/jbc.M604770200	http://dx.doi.org/10.1074/jbc.M604770200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16899458	Bronze			2022-12-27	WOS:000241235300049
J	Stuart, JR; Gonzalez, FH; Kawai, H; Yuan, ZM				Stuart, Jeremy R.; Gonzalez, Francis H.; Kawai, Hidehiko; Yuan, Zhi-Min			c-Abl interacts with the WAVE2 signaling complex to induce membrane ruffling and cell spreading	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WISKOTT-ALDRICH-SYNDROME; TYROSINE KINASE-ACTIVITY; SYNDROME PROTEIN; ACTIN CYTOSKELETON; ARP2/3 COMPLEX; N-WASP; RAC; PHOSPHORYLATION; ACTIVATION; REORGANIZATION	The Wiskott-Aldrich syndrome-related protein WAVE2 promotes Arp2/3-dependent actin polymerization downstream of Rho-GTPase activation. The Abelson-interacting protein-1 (Abi-1) forms the core of the WAVE2 complex and is necessary for proper stimulation of WAVE2 activity. Here we have shown that the Abl-tyrosine kinase interacts with the WAVE2 complex and that Abl kinase activity facilitates interaction between Abl and WAVE2 complex members. We have characterized various interactions between Abl and members of the WAVE2 complex and revealed that Abi-1 promotes interaction between Abl and WAVE2 members. We have demonstrated that Abl-dependent phosphorylation of WAVE2 is necessary for its activation in vivo, which is highlighted by the findings that RNA interference of WAVE2 expression in Abl/Arg(-/-) cells has no additive effect on the amount of membrane ruffling. Furthermore, Abl phosphorylates WAVE2 on tyrosine 150, and WAVE2-deficient cells rescued with a Y150F mutant fail to regain their ability to ruffle and form microspikes, unlike cells rescued with wild-type WAVE2. Together, these data show that c-Abl activates WAVE2 via tyrosine phosphorylation to promote actin remodeling in vivo and that Abi-1 forms the crucial link between these two factors.	Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Yuan, ZM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, 665 Huntington Ave,HSPH-1,Rm 508, Boston, MA 02115 USA.	zyuan@hsph.harvard.edu		Kawai, Hidehiko/0000-0003-2213-7166	NCI NIH HHS [R29 CA85679] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA085679] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aspenstrom P, 2004, BIOCHEM J, V377, P327, DOI 10.1042/BJ20031041; Aspenstrom P, 1996, CURR BIOL, V6, P70, DOI 10.1016/S0960-9822(02)00423-2; Borm B, 2005, EXP CELL RES, V302, P83, DOI 10.1016/j.yexcr.2004.08.034; Cestra G, 2005, P NATL ACAD SCI USA, V102, P1731, DOI 10.1073/pnas.0409376102; Echarri A, 2004, MOL CELL BIOL, V24, P4979, DOI 10.1128/MCB.24.11.4979-4993.2004; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Gautreau A, 2004, P NATL ACAD SCI USA, V101, P4379, DOI 10.1073/pnas.0400628101; Gu JJ, 2000, MOL CELL BIOL, V20, P1243, DOI 10.1128/MCB.20.4.1243-1253.2000; Hantschel O, 2005, MOL CELL, V19, P461, DOI 10.1016/j.molcel.2005.06.030; Hantschel O, 2003, CELL, V112, P845, DOI 10.1016/S0092-8674(03)00191-0; Innocenti M, 2005, NAT CELL BIOL, V7, P969, DOI 10.1038/ncb1304; Innocenti M, 2004, NAT CELL BIOL, V6, P319, DOI 10.1038/ncb1105; Kawai H, 2002, MOL CELL BIOL, V22, P6079, DOI 10.1128/MCB.22.17.6079-6088.2002; Koleske AJ, 1998, NEURON, V21, P1259, DOI 10.1016/S0896-6273(00)80646-7; Leng Y, 2005, P NATL ACAD SCI USA, V102, P1098, DOI 10.1073/pnas.0409120102; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; Miki H, 1998, EMBO J, V17, P6932, DOI 10.1093/emboj/17.23.6932; Miki H, 1996, EMBO J, V15, P5326, DOI 10.1002/j.1460-2075.1996.tb00917.x; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; Schulte RJ, 2003, BIOCHEMISTRY-US, V42, P9424, DOI 10.1021/bi034519u; She HY, 1997, MOL BIOL CELL, V8, P1709, DOI 10.1091/mbc.8.9.1709; Sini P, 2004, NAT CELL BIOL, V6, P268, DOI 10.1038/ncb1096; Suetsugu S, 1999, BIOCHEM BIOPH RES CO, V260, P296, DOI 10.1006/bbrc.1999.0894; Tani K, 2003, J BIOL CHEM, V278, P21685, DOI 10.1074/jbc.M301447200; Westphal RS, 2000, EMBO J, V19, P4589, DOI 10.1093/emboj/19.17.4589; Woodring PJ, 2002, J CELL BIOL, V156, P879, DOI 10.1083/jcb.200110014; Woodring PJ, 2001, J BIOL CHEM, V276, P27104, DOI 10.1074/jbc.M100559200; Yamazaki D, 2003, NATURE, V424, P452, DOI 10.1038/nature01770; Yan C, 2003, EMBO J, V22, P3602, DOI 10.1093/emboj/cdg350; Zhu JY, 1996, MOL CELL BIOL, V16, P7054	31	64	69	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31290	31297		10.1074/jbc.M602389200	http://dx.doi.org/10.1074/jbc.M602389200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16899465	Bronze			2022-12-27	WOS:000241235300013
J	Lager, I; Looger, LL; Hilpert, M; Lalonde, S; Frommer, WB				Lager, Ida; Looger, Loren L.; Hilpert, Melanie; Lalonde, Sylvie; Frommer, Wolf B.			Conversion of a putative agrobacterium sugar-binding protein into a FRET sensor with high selectivity for sucrose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENT NANOSENSORS; SINORHIZOBIUM-MELILOTI; COS-7 CELLS; TRANSPORT; TREHALOSE; MALTOSE; ARABIDOPSIS; CYTOSOL; PHLOEM	Glucose is the main sugar transport form in animals, whereas plants use sucrose to supply non-photosynthetic organs with carbon skeletons and energy. Many aspects of sucrose transport, metabolism, and signaling are not well understood, including the route of sucrose efflux from leaf mesophyll cells and transport across vacuolar membranes. Tools that can detect sucrose with high spatial and temporal resolution in intact organs may help elucidate the players involved. Here, FRET sensors were generated by fusing putative sucrose-binding proteins to green fluorescent protein variants. Plant-associated bacteria such as Rhizobium and Agrobacterium can use sucrose as a nutrient source; sugar-binding proteins were, thus, used as scaffolds for developing sucrose nanosensors. Among a set of putative sucrose-binding protein genes cloned in between eCFP and eYFP and tested for sugar-dependent FRET changes, an Agrobacterium sugar-binding protein bound sucrose with 4 mu M affinity. This FLIPsuc-4 mu protein also recognized other sugars including maltose, trehalose, and turanose and, with lower efficiency, glucose and palatinose. Homology modeling enabled the prediction of binding pocket mutations to modulate the relative affinity of FLIPsuc-4 mu for sucrose, maltose, and glucose. Mutant nanosensors showed up to 50- and 11-fold increases in specificity for sucrose over maltose and glucose, respectively, and the sucrose binding affinity was simultaneously decreased to allow detection in the physiological range. In addition, the signal-to-noise ratio of the sucrose nanosensor was improved by linker engineering. This novel reagent complements FLIPs for glucose, maltose, ribose, glutamate, and phosphate and will be used for analysis of sucrose-derived carbon flux in bacterial, fungal, plant, and animal cells.	Carnegie Inst, Dept Plant Biol, Stanford, CA 94305 USA	Carnegie Institution for Science	Frommer, WB (corresponding author), Carnegie Inst, Dept Plant Biol, 260 Panama St, Stanford, CA 94305 USA.	wfrommer@stanford.edu	Frommer, Wolf B/A-8256-2008; Frommer, Wolf B/K-5042-2017	Frommer, Wolf B/0000-0001-6465-0115; Frommer, Wolf B/0000-0001-6465-0115				Barra L, 2003, FEMS MICROBIOL LETT, V229, P183, DOI 10.1016/S0378-1097(03)00819-X; Carpaneto A, 2005, J BIOL CHEM, V280, P21437, DOI 10.1074/jbc.M501785200; Deuschle K, 2005, PROTEIN SCI, V14, P2304, DOI 10.1110/ps.051508105; DEUSCHLE K, 2006, IN PRESS PLANT CELL; Diez J, 2001, J MOL BIOL, V305, P905, DOI 10.1006/jmbi.2000.4203; Endler A, 2006, PLANT PHYSIOL, V141, P196, DOI 10.1104/pp.106.079533; Farre EM, 2001, PLANT PHYSIOL, V127, P685, DOI 10.1104/pp.127.2.685; Fehr M, 2005, MOL CELL BIOL, V25, P11102, DOI 10.1128/MCB.25.24.11102-11112.2005; Fehr M, 2005, BIOCHEM SOC T, V33, P287, DOI 10.1042/BST0330287; Fehr M, 2004, J FLUORESC, V14, P603, DOI 10.1023/B:JOFL.0000039347.94943.99; Fehr M, 2003, J BIOL CHEM, V278, P19127, DOI 10.1074/jbc.M301333200; Fehr M, 2002, P NATL ACAD SCI USA, V99, P9846, DOI 10.1073/pnas.142089199; Gage DJ, 1998, J BACTERIOL, V180, P5739, DOI 10.1128/JB.180.21.5739-5748.1998; Gerrits N, 2001, PLANT PHYSIOL, V125, P926, DOI 10.1104/pp.125.2.926; Guntas G, 2005, P NATL ACAD SCI USA, V102, P11224, DOI 10.1073/pnas.0502673102; HEINEKE D, 1994, PLANTA, V194, P29, DOI 10.1007/BF00201031; Jensen JB, 2002, J BACTERIOL, V184, P2978, DOI 10.1128/JB.184.11.2978-2986.2002; Kuhn C, 2003, PLANT PHYSIOL, V131, P102, DOI 10.1104/pp.011676; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Lager I, 2003, FEBS LETT, V553, P85, DOI 10.1016/S0014-5793(03)00976-1; Lalonde S, 2004, ANNU REV PLANT BIOL, V55, P341, DOI 10.1146/annurev.arplant.55.031903.141758; Magnusson U, 2002, J BIOL CHEM, V277, P14077, DOI 10.1074/jbc.M200514200; Marvin JS, 2001, NAT STRUCT BIOL, V8, P795, DOI 10.1038/nsb0901-795; Muller J, 2001, PLANT PHYSIOL, V125, P1086, DOI 10.1104/pp.125.2.1086; Nagai T, 2004, BIOCHEM BIOPH RES CO, V319, P72, DOI 10.1016/j.bbrc.2004.04.147; TAM R, 1993, MICROBIOL REV, V57, P320, DOI 10.1128/MMBR.57.2.320-346.1993; Weise SE, 2005, PLANT PHYSIOL, V137, P756, DOI 10.1104/pp.104.055996; Willis LB, 1999, J BACTERIOL, V181, P4176, DOI 10.1128/JB.181.14.4176-4184.1999	28	77	83	3	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30875	30883		10.1074/jbc.M605257200	http://dx.doi.org/10.1074/jbc.M605257200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16912038	hybrid			2022-12-27	WOS:000241075900063
J	Liao, JH; Planchon, SM; Wolfman, JC; Wolfman, A				Liao, Jinhui; Planchon, Sarah M.; Wolfman, Janice C.; Wolfman, Alan			Growth factor-dependent AKT activation and cell migration requires the function of c-K(B)-Ras versus other cellular Ras isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-N-RAS; PHOSPHATIDYLINOSITOL 3-KINASE; K-RAS; FAMILY GTPASES; HA-RAS; CALMODULIN; MOTILITY; ASSOCIATION; SUPPRESSOR; EXPRESSION	K-Ras-negative fibroblasts are defective in their steady- state expression of MMP-2. This occurs through c- K( B)- Ras dependent regulation of basal levels of AKT activity. In this report, we have extended those studies to demonstrate that in the absence of K- Ras expression, PDGF- BB fails to induce significant AKT activation, although this was not the case in N- Ras- negative cells. This phenotype was directly linked to PDGF- dependent cell migration. All of the independently immortalized K-Ras-negative cells failed to migrate upon the addition of PDGF. Only ectopic expression of c- K( B)- Ras, not c- K( A)- Ras nor oncogenic N- Ras, could restore both PDGF- dependentAKTactivation and cell migration. Since most Ras binding partners can interact with all Ras isoforms, the specificity of PDGF- dependent activation of AKT and enhanced cell migration suggests that these outcomes are likely to be regulated through a c- K( B)- Ras- specific binding partner. Others have published that of the four Ras isoforms, only K( B)- Ras can form a stable complex with calmodulin ( CaM). Along those lines, we provide evidence that 1) PDGF addition results in increased levels of a complex between c- K( B)Ras and CaM and 2) the biological outcomes that are strictly dependent on c- K( B)- Ras ( AKT activation and cell migration) are blocked by CaM antagonists. The PDGF- dependent activation of ERK is unaffected by the absence of K( B)- Ras and presence of CaM antagonists. This is the first example of a linkage between a specific biological outcome, cell migration, and the activity of a single Ras isoform, c- K( B)- Ras.	Case Western Reserve Univ, Cleveland Clin Fdn, Dept Cell Biol, Lerner Coll Med, Cleveland, OH 44195 USA	Case Western Reserve University; Cleveland Clinic Foundation	Wolfman, A (corresponding author), Case Western Reserve Univ, Cleveland Clin Fdn, Dept Cell Biol, Lerner Coll Med, 9500 Euclid Ave,NC 10, Cleveland, OH 44195 USA.	wolfmaa@ccf.org	Planchon, Sarah/A-5731-2009		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM065719, R01GM062644] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM62644, GM065719] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arozarena I, 2004, MOL CELL BIOL, V24, P1516, DOI 10.1128/MCB.24.4.1516-1530.2004; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BARBACID M, 1990, EUR J CLIN INVEST, V20, P225, DOI 10.1111/j.1365-2362.1990.tb01848.x; Bivona TG, 2003, CURR OPIN CELL BIOL, V15, P136, DOI 10.1016/S0955-0674(03)00016-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caloca MJ, 2003, J BIOL CHEM, V278, P33465, DOI 10.1074/jbc.M302807200; Choi YA, 2004, J BIOL CHEM, V279, P36579, DOI 10.1074/jbc.M314235200; COX AD, 1995, METHOD ENZYMOL, V255, P195; de Hoog CL, 2000, MOL CELL BIOL, V20, P2727, DOI 10.1128/MCB.20.8.2727-2733.2000; Del Prete A, 2004, EMBO J, V23, P3505, DOI 10.1038/sj.emboj.7600361; Fischer R, 1998, FEBS LETT, V425, P175, DOI 10.1016/S0014-5793(98)00225-7; FOX PL, 1994, ONCOGENE, V9, P3519; Franz CM, 2002, DEV CELL, V2, P153, DOI 10.1016/S1534-5807(02)00120-X; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Hamilton M, 1998, ONCOGENE, V16, P1417, DOI 10.1038/sj.onc.1201653; Hamilton M, 2001, J BIOL CHEM, V276, P29079, DOI 10.1074/jbc.M102001200; Hamilton M, 1998, J BIOL CHEM, V273, P28155, DOI 10.1074/jbc.273.43.28155; Higuchi M, 2001, CURR BIOL, V11, P1958, DOI 10.1016/S0960-9822(01)00599-1; Horwitz R, 2003, CURR BIOL, V13, pR756, DOI 10.1016/j.cub.2003.09.014; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Jiang K, 2004, MOL CELL BIOL, V24, P5565, DOI 10.1128/MCB.24.12.5565-5576.2004; Joyal JL, 1997, J BIOL CHEM, V272, P28183, DOI 10.1074/jbc.272.45.28183; Kranenburg O, 2001, CURR BIOL, V11, P1880, DOI 10.1016/S0960-9822(01)00582-6; KUMAR R, 1990, SCIENCE, V248, P1101, DOI 10.1126/science.2188364; Lafitte D, 1999, EUR J BIOCHEM, V261, P337, DOI 10.1046/j.1432-1327.1999.00284.x; Liao JH, 2003, J BIOL CHEM, V278, P31871, DOI 10.1074/jbc.M301931200; Marcoux N, 2003, ONCOGENE, V22, P6100, DOI 10.1038/sj.onc.1206712; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; Pollock CB, 2005, CANCER RES, V65, P1244, DOI 10.1158/0008-5472.CAN-04-1911; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Qian Y, 2004, AM J PHYSIOL-CELL PH, V286, pC153, DOI 10.1152/ajpcell.00142.2003; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rodriguez-Viciana P, 2004, MOL CELL BIOL, V24, P4943, DOI 10.1128/MCB.24.11.4943-4954.2004; Rodriguez-Viciana P, 2001, METHOD ENZYMOL, V333, P37; Sasaki AT, 2004, J CELL BIOL, V167, P505, DOI 10.1083/jcb.200406177; Storz P, 2002, FRONT BIOSCI-LANDMRK, V7, pD886, DOI 10.2741/storz; Villalonga P, 2002, J BIOL CHEM, V277, P37929, DOI 10.1074/jbc.M202245200; Villalonga P, 2001, MOL CELL BIOL, V21, P7345, DOI 10.1128/MCB.21.21.7345-7354.2001; Walker SA, 2004, J CELL SCI, V117, P2879, DOI 10.1242/jcs.01285; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Wolfman JC, 2000, J BIOL CHEM, V275, P19315, DOI 10.1074/jbc.M000250200; Zhou GL, 2003, MOL CELL BIOL, V23, P8058, DOI 10.1128/MCB.23.22.8058-8069.2003; Zippel R, 2000, EXP CELL RES, V258, P403, DOI 10.1006/excr.2000.4937	44	37	42	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					29730	29738		10.1074/jbc.M600668200	http://dx.doi.org/10.1074/jbc.M600668200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16908523	hybrid			2022-12-27	WOS:000240896300035
J	Metcalf, CE; Wassarman, DA				Metcalf, Chad E.; Wassarman, David A.			DNA binding properties of TAF1 isoforms with two AT-hooks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORE PROMOTER ELEMENTS; GROUP PROTEIN I; TRANSCRIPTION; GENE; SELECTIVITY; COMPLEX; DOWNSTREAM; RECOGNIZES; REPRESSION; EXPRESSION	TATA-binding protein-associated factor 1 (TAF1) is an essential component of the general transcription factor IID ( TFIID), which nucleates assembly of the preinitiation complex for transcription by RNA polymerase II. TATA-binding protein and TAF1 (,) TAF2 heterodimers are the only components of TFIID shown to bind specific DNA sequences ( the TATA box and initiator, respectively), raising the question of how TFIID localizes to gene promoters that lack binding sites for these proteins. Here we demonstrate that Drosophila TAF1 protein isoforms TAF1-2 and TAF1-4 directly bind DNA independently of TAF2. DNA binding by TAF1 isoforms is mediated by cooperative interactions of two identical AT-hook motifs, one of which is encoded by an alternatively spliced exon. Electrophoretic mobility shift assays revealed that TAF1-2 bound the minor groove of adenine-thymine-rich DNA with a preference for the sequence AAT. Alanine-scanning mutagenesis of the alternatively spliced AT-hook indicated that Lys and Arg residues made essential DNA contacts, whereas Gly and Pro residues within the Arg-Gly-Arg-Pro core sequence were less important for DNA binding, suggesting that AT-hooks are more divergent than previously predicted. TAF1-2 bound with variable affinity to the transcription start site of several Drosophila genes, and binding to the hsp70 promoter was reduced by mutation of a single base pair at the transcription start site. Collectively, these data indicate that AT-hooks serve to anchor TAF1 isoforms to the minor groove of adenine-thymine-rich Drosophila gene promoters and suggest a model in which regulated expression of TAF1 isoforms by alternative splicing contributes to gene-specific transcription.	Univ Wisconsin, Sch Med & Publ Hlth, Dept Pharmacol, Madison, WI 53706 USA; Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Wassarman, DA (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Pharmacol, Madison, WI 53706 USA.	dawassarman@wisc.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066204] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM066204] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aerts S, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-34; Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4413, DOI 10.1093/nar/26.19.4413; Banks GC, 1999, J BIOL CHEM, V274, P16536, DOI 10.1074/jbc.274.23.16536; Bell B, 2001, MOL CELL, V8, P591, DOI 10.1016/S1097-2765(01)00325-2; Blumer N, 2002, MECH DEVELOP, V110, P97, DOI 10.1016/S0925-4773(01)00577-9; Caiafa P, 2005, J CELL BIOCHEM, V94, P257, DOI 10.1002/jcb.20325; Cairns BR, 1999, MOL CELL, V4, P715, DOI 10.1016/S1097-2765(00)80382-2; Chalkley GE, 1999, EMBO J, V18, P4835, DOI 10.1093/emboj/18.17.4835; Chen BS, 2002, CURR BIOL, V12, pR620, DOI 10.1016/S0960-9822(02)01134-X; Christiansen H, 1996, PLANT MOL BIOL, V32, P809, DOI 10.1007/BF00020479; Chuang RY, 1999, P NATL ACAD SCI USA, V96, P2656, DOI 10.1073/pnas.96.6.2656; CLAUS P, 1994, J BIOL CHEM, V269, P33042; Dehm SM, 2004, MOL CELL BIOL, V24, P2296, DOI 10.1128/MCB.24.6.2296-2307.2004; Dragan AI, 2003, J MOL BIOL, V327, P393, DOI 10.1016/S0022-2836(03)00050-0; Falender AE, 2005, GENE DEV, V19, P794, DOI 10.1101/gad.1290105; Falvo JV, 1995, CELL, V83, P1101, DOI 10.1016/0092-8674(95)90137-X; Frank O, 1998, J BIOL CHEM, V273, P20015, DOI 10.1074/jbc.273.32.20015; Freiman RN, 2001, SCIENCE, V293, P2084, DOI 10.1126/science.1061935; Hiller M, 2004, DEVELOPMENT, V131, P5297, DOI 10.1242/dev.01314; Hiller MA, 2001, GENE DEV, V15, P1021, DOI 10.1101/gad.869101; Hochheimer A, 2003, GENE DEV, V17, P1309, DOI 10.1101/gad.1099903; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Huth JR, 1997, NAT STRUCT BIOL, V4, P657, DOI 10.1038/nsb0897-657; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Koonin EV, 2000, CELL, V101, P573, DOI 10.1016/S0092-8674(00)80867-3; KORFHAGE U, 1994, PLANT CELL, V6, P695, DOI 10.1105/tpc.6.5.695; Lee DH, 2005, MOL CELL BIOL, V25, P9674, DOI 10.1128/MCB.25.21.9674-9686.2005; Lours C, 2003, NUCLEIC ACIDS RES, V31, P5389, DOI 10.1093/nar/gkg724; Maher JF, 1996, P NATL ACAD SCI USA, V93, P6716, DOI 10.1073/pnas.93.13.6716; Matangkasombut O, 2004, ADV PROTEIN CHEM, V67, P67; Maxam A M, 1980, Methods Enzymol, V65, P499; Muller F, 2004, EMBO J, V23, P2, DOI 10.1038/sj.emboj.7600027; Nurminsky DI, 1998, NATURE, V396, P572, DOI 10.1038/25126; Ohler U., 2002, GENOME BIOL, V3, pRESEARCH0087, DOI [10.1186/gb-2002-3-12-research0087, DOI 10.1186/GB-2002-3-12-RESEARCH0087]; Pointud JC, 2003, J CELL SCI, V116, P1847, DOI 10.1242/jcs.00391; Reeves R, 2001, GENE, V277, P63, DOI 10.1016/S0378-1119(01)00689-8; Santel A, 2000, NUCLEIC ACIDS RES, V28, P1439, DOI 10.1093/nar/28.6.1439; Schawaroch V, 2002, BIOL J LINN SOC, V76, P21, DOI 10.1111/j.1095-8312.2002.tb01711.x; Schwanbeck R, 2000, J BIOL CHEM, V275, P1793, DOI 10.1074/jbc.275.3.1793; Schwanbeck R, 2000, BIOCHEMISTRY-US, V39, P14419, DOI 10.1021/bi0011274; Shen WC, 1997, CELL, V90, P615, DOI 10.1016/S0092-8674(00)80523-1; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; SOLOMON MJ, 1986, P NATL ACAD SCI USA, V83, P1276, DOI 10.1073/pnas.83.5.1276; Turlure F, 2006, NUCLEIC ACIDS RES, V34, P1653, DOI 10.1093/nar/gkl052; VERRIJZER CP, 1994, SCIENCE, V264, P933, DOI 10.1126/science.8178153; VERRIJZER CP, 1995, CELL, V81, P1115, DOI 10.1016/S0092-8674(05)80016-9; WANG EH, 1994, SCIENCE, V263, P811, DOI 10.1126/science.8303298; Wu CH, 2001, MOL CELL BIOL, V21, P1593, DOI 10.1128/MCB.21.5.1593-1602.2001; Yie JM, 1997, MOL CELL BIOL, V17, P3649, DOI 10.1128/MCB.17.7.3649	49	25	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					30015	30023		10.1074/jbc.M606289200	http://dx.doi.org/10.1074/jbc.M606289200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16893881	hybrid			2022-12-27	WOS:000240896300062
J	Ng, CJ; Bourquard, N; Grijalva, V; Hama, S; Shih, DM; Navab, M; Fogelman, AM; Lusis, AJ; Young, S; Reddy, ST				Ng, Carey J.; Bourquard, Noam; Grijalva, Victor; Hama, Susan; Shih, Diana M.; Navab, Mohamad; Fogelman, Alan M.; Lusis, Aldons J.; Young, Stephen; Reddy, Srinivasa T.			Paraoxonase-2 deficiency aggravates atherosclerosis in mice despite lower apolipoprotein-B-containing lipoproteins - Anti-atherogenic role for paraoxonase-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; CORONARY-HEART-DISEASE; REVERSE CHOLESTEROL TRANSPORT; SERUM PARAOXONASE; OXIDIZED PHOSPHOLIPIDS; OXIDATIVE MODIFICATION; INSERTIONAL MUTATIONS; TRANSGENIC MICE; ARTERY-DISEASE; GENE	Paraoxonases (PONs) are a family of proteins that may play a significant role in providing relief from both toxic environmental chemicals as well as physiological oxidative stress. Although the physiological roles of the PON family of proteins, PON1, PON2, and PON3, remain unknown, epidemiological, biochemical, and mouse genetic studies of PON1 suggest an anti-atherogenic function for paraoxonases. To determine whether PON2 plays a role in the development of atherosclerosis in vivo, we generated PON2-deficient mice. When challenged with a high fat, high cholesterol diet for 15 weeks, serum levels of high density lipoprotein cholesterol, triglycerides, and glucose were not significantly different between wild-type and PON2-deficient mice. In contrast, serum levels of very low density lipoprotein (VLDL)/low density lipoprotein (LDL) cholesterol were significantly lower (-32%) in PON2-deficient mice compared with wild-type mice. However, despite lower levels of VLDL/LDL cholesterol, mice deficient in PON2 developed significantly larger (2.7-fold) atherosclerotic lesions compared with their wild-type counterparts. Enhanced inflammatory properties of LDL, attenuated anti-atherogenic capacity of high density lipoprotein, and a heightened state of oxidative stress coupled with an exacerbated inflammatory response from PON2-deficient macrophages appear to be the main mechanisms behind the larger atherosclerotic lesions in PON2-deficient mice. These results demonstrate that PON2 plays a protective role in atherosclerosis.	Univ Calif Los Angeles, Dept Med, Div Cardiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Reddy, ST (corresponding author), Univ Calif Los Angeles, Dept Med, Div Cardiol, 10833 Le Conte Ave, Los Angeles, CA 90095 USA.	sreddy@mednet.ucla.edu			NHLBI NIH HHS [R01 HL071776, 1R01 HL-71776, HL-30568] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071776, P01HL030568] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ansell BJ, 2003, CIRCULATION, V108, P2751, DOI 10.1161/01.CIR.0000103624.14436.4B; AUERBACH BJ, 1992, ANAL BIOCHEM, V201, P375, DOI 10.1016/0003-2697(92)90354-A; Aviram M, 1999, FREE RADICAL BIO MED, V26, P892, DOI 10.1016/S0891-5849(98)00272-X; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Castellani LW, 1997, J CLIN INVEST, V100, P464, DOI 10.1172/JCI119554; Chen Q, 2003, AM J HUM GENET, V72, P13, DOI 10.1086/345312; Draganov DI, 2000, J BIOL CHEM, V275, P33435, DOI 10.1074/jbc.M004543200; Draganov DI, 2005, J LIPID RES, V46, P1239, DOI 10.1194/jlr.M400511-JLR200; FIELDING CJ, 1995, J LIPID RES, V36, P211; Fisher EA, 2001, J BIOL CHEM, V276, P27855, DOI 10.1074/jbc.M008885200; Forte TM, 2002, J LIPID RES, V43, P477; Janka Z, 2002, MOL PSYCHIATR, V7, P110, DOI 10.1038/sj/mp/4000916; Jarvik GP, 2000, ARTERIOSCL THROM VAS, V20, P2441, DOI 10.1161/01.ATV.20.11.2441; Li BL, 2003, J BIOL CHEM, V278, P43276, DOI 10.1074/jbc.M306361200; Mackness B, 2003, CIRCULATION, V107, P2775, DOI 10.1161/01.CIR.0000070954.00271.13; Mackness B, 2001, ARTERIOSCL THROM VAS, V21, P1451, DOI 10.1161/hq0901.094247; MACKNESS MI, 1993, ATHEROSCLEROSIS, V104, P129, DOI 10.1016/0021-9150(93)90183-U; Millar JS, 2005, J LIPID RES, V46, P2023, DOI 10.1194/jlr.D500019-JLR200; Navab M, 2002, CURR OPIN LIPIDOL, V13, P363, DOI 10.1097/00041433-200208000-00003; Navab M, 2001, ARTERIOSCL THROM VAS, V21, P481, DOI 10.1161/01.ATV.21.4.481; Nayernia K, 2003, J BIOL CHEM, V278, P48377, DOI 10.1074/jbc.M309583200; Ng CJ, 2005, FREE RADICAL BIO MED, V38, P153, DOI 10.1016/j.freeradbiomed.2004.09.035; Ng CJ, 2001, J BIOL CHEM, V276, P44444, DOI 10.1074/jbc.M105660200; Ozer EA, 2005, FEMS MICROBIOL LETT, V253, P29, DOI 10.1016/j.femsle.2005.09.023; Pan Ju-Pin, 2002, Zhonghua Yi Xue Za Zhi (Taipei), V65, P415; Pan MH, 2004, J CLIN INVEST, V113, P1277, DOI 10.1172/JCI200419197; PEARSON JP, 1994, P NATL ACAD SCI USA, V91, P197, DOI 10.1073/pnas.91.1.197; PrimoParmo SL, 1996, GENOMICS, V33, P498, DOI 10.1006/geno.1996.0225; Reardon CA, 2004, J LIPID RES, V45, P1347, DOI 10.1194/jlr.M400075-JLR200; Reddy ST, 2001, ARTERIOSCL THROM VAS, V21, P542, DOI 10.1161/01.ATV.21.4.542; Rosenblat M, 2003, ARTERIOSCL THROM VAS, V23, P468, DOI 10.1161/01.ATV.0000059385.95664.4D; Roshon M, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-2; Sanghera DK, 1998, AM J HUM GENET, V62, P36, DOI 10.1086/301669; Shih DM, 1998, NATURE, V394, P284, DOI 10.1038/28406; Shih DM, 2000, J BIOL CHEM, V275, P17527, DOI 10.1074/jbc.M910376199; Stryke D, 2003, NUCLEIC ACIDS RES, V31, P278, DOI 10.1093/nar/gkg064; Townley DJ, 1997, GENOME RES, V7, P293, DOI 10.1101/gr.7.3.293; Tsimikas S, 2005, NEW ENGL J MED, V353, P46, DOI 10.1056/NEJMoa043175; Tward A, 2002, CIRCULATION, V106, P484, DOI 10.1161/01.CIR.0000023623.87083.4F; von Eckardstein A, 2001, ARTERIOSCL THROM VAS, V21, P13, DOI 10.1161/01.ATV.21.1.13; [王丽琼 Wang LiQiong], 2003, [应用化学, Chinese Journal of Applied Chemistry], V20, P219; Yang F, 2005, FEBS LETT, V579, P3713, DOI 10.1016/j.febslet.2005.05.060; YOUNG SG, 1986, ARTERIOSCLEROSIS, V6, P178, DOI 10.1161/01.ATV.6.2.178	43	127	134	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					29491	29500		10.1074/jbc.M605379200	http://dx.doi.org/10.1074/jbc.M605379200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16891303	hybrid			2022-12-27	WOS:000240896300011
J	Pashov, AD; Plaxco, J; Kaveri, SV; Monzavi-Karbassi, B; Harn, D; Kieber-Emmons, T				Pashov, Anastas D.; Plaxco, Jason; Kaveri, Srinivas V.; Monzavi-Karbassi, Behjatolah; Harn, Donald; Kieber-Emmons, Thomas			Multiple antigenic mimotopes of HIV carbohydrate antigens - Relating structure and antigenicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SUPERANTIGEN-BINDING SITE; CONCANAVALIN-A; PEPTIDE MIMOTOPES; NEUTRALIZING ANTIBODIES; LINKED OLIGOSACCHARIDES; MAACKIA-AMURENSIS; LECTIN; GP120; INFECTION	Carbohydrate mimetic peptides are designable, and they can carry T-cell epitopes and circumvent tolerance. A mimic- based human immunodeficiency virus (HIV) vaccine can be a viable alternative to carbohydrate- based antigens if the diversity of epitopes found on gp120 can be recapitulated. To improve existing mimics, an attempt was made to study the structural correlates of the observed polyspecificity of carbohydrate mimetic peptides based on the Y( P/ R) Y motif in more detail. A carbohydrate mimetic peptide, D002 ( RGGLCYCRYRYCVCVGR), bound a number of lectins with different specificities. Although this peptide reacted strongly with both lotus and concanavalinA ( ConA) lectins, it bound to lotus stronger than ConA. By varying the central motif RYRY, five versions were produced in multiple antigen peptide format, and their avidity for lotus and ConA lectins was tested by surface plasmon resonance. Although the kinetic parameters were similar, the version based on the sequence YPYRY had an optimal affinity for both lectins as well as improved avidity for wheat germ agglutinin and phytohemagglutinin. Thus, as far as lectin specificity is concerned, YPYRY had improved multiple antigenic properties. Both RYRY and YPYRY precipitated antibodies from human IgG for intravenous use that bound to gp120 in vitro and immunoprecipitated gp120 from transfected CHO- PI cells. Thus, Y( P/ R) Y motifs mimic multiple carbohydrate epitopes, many of which are found on HIV, and preimmune human IgG antibodies that bind to HIV carbohydrates cross- react to a comparable extent with both RYRY and YPYRY carbohydrate mimetic peptides.	Univ Arkansas Med Sci, Dept Pathol, Little Rock, AR 72205 USA; INSERM, U681, Inst Biomed Cordeliers, F-75006 Paris, France; Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	University of Arkansas System; University of Arkansas Medical Sciences; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Harvard University; Harvard T.H. Chan School of Public Health	Kieber-Emmons, T (corresponding author), Univ Arkansas Med Sci, Dept Pathol, 4301 W Markham St, Little Rock, AR 72205 USA.	tke@uams.edu	Pashov, Anastas/AAE-7997-2019	Pashov, Anastas/0000-0002-6033-3566	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI049092, R01AI049092] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-49092] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agadjanyan M, 1997, NAT BIOTECHNOL, V15, P547, DOI 10.1038/nbt0697-547; BAENZIGER JU, 1979, J BIOL CHEM, V254, P2400; Balzarini J, 2005, MOL PHARMACOL, V67, P1556, DOI 10.1124/mol.104.005082; Balzarini O, 2005, LANCET INFECT DIS, V5, P726, DOI 10.1016/S1473-3099(05)70271-1; Basu A, 2003, ANGEW CHEM INT EDIT, V42, P2504, DOI 10.1002/anie.200250859; Baumgarth N, 2000, J EXP MED, V192, P271, DOI 10.1084/jem.192.2.271; BHAVANANDAN VP, 1979, J BIOL CHEM, V254, P4000; Bouvet JP, 2001, J AUTOIMMUN, V16, P163, DOI 10.1006/jaut.2000.0472; Cunto-Amesty G, 2003, INT J PARASITOL, V33, P597, DOI 10.1016/S0020-7519(03)00054-7; Cunto-Amesty G, 2001, J BIOL CHEM, V276, P30490, DOI 10.1074/jbc.M103257200; Dacheux L, 2004, J VIROL, V78, P12625, DOI 10.1128/JVI.78.22.12625-12637.2004; Dam TK, 2000, J BIOL CHEM, V275, P14223, DOI 10.1074/jbc.275.19.14223; Dudkin VY, 2004, J AM CHEM SOC, V126, P9560, DOI 10.1021/ja047720g; DUK M, 1994, GLYCOCONJUGATE J, V11, P371, DOI 10.1007/BF00731211; EZEKOWITZ RAB, 1989, J EXP MED, V169, P185, DOI 10.1084/jem.169.1.185; Ferrantelli F, 2003, AIDS, V17, P301, DOI 10.1097/00002030-200302140-00003; GATTEGNO L, 1992, AIDS RES HUM RETROV, V8, P27, DOI 10.1089/aid.1992.8.27; Geng XD, 2004, ANGEW CHEM INT EDIT, V43, P2562, DOI 10.1002/anie.200353626; GEYER H, 1988, J BIOL CHEM, V263, P11760; GOLDSTEIN IJ, 1981, J BIOL CHEM, V256, P3890; HAMMAR L, 1995, AIDS RES HUM RETROV, V11, P87, DOI 10.1089/aid.1995.11.87; HANSEN JES, 1991, J VIROL, V65, P6461, DOI 10.1128/JVI.65.12.6461-6467.1991; HANSEN JES, 1989, AIDS, V3, P635, DOI 10.1097/00002030-198910000-00003; Harris SL, 1997, P NATL ACAD SCI USA, V94, P2454, DOI 10.1073/pnas.94.6.2454; Harrison BA, 1998, J IMMUNOL METHODS, V212, P29, DOI 10.1016/S0022-1759(98)00012-X; HORTIN GL, 1990, ANAL BIOCHEM, V191, P262, DOI 10.1016/0003-2697(90)90217-W; Hutchins WA, 1996, MOL IMMUNOL, V33, P503, DOI 10.1016/0161-5890(96)00012-0; Jain D, 2000, BIOCHEM BIOPH RES CO, V272, P843, DOI 10.1006/bbrc.2000.2871; Jain D, 2000, J BIOL CHEM, V275, P16098, DOI 10.1074/jbc.275.21.16098; KALININ NL, 1995, ANAL BIOCHEM, V228, P238, DOI 10.1006/abio.1995.1345; Karray S, 1997, P NATL ACAD SCI USA, V94, P1356, DOI 10.1073/pnas.94.4.1356; Karray S, 1998, J IMMUNOL, V161, P6681; KNIBBS RN, 1991, J BIOL CHEM, V266, P83; Lee RT, 2000, GLYCOCONJUGATE J, V17, P543, DOI 10.1023/A:1011070425430; LIFSON J, 1986, J EXP MED, V164, P2101, DOI 10.1084/jem.164.6.2101; Llorente M, 1999, SCAND J IMMUNOL, V50, P270; MacKenzie CR, 1996, J BIOL CHEM, V271, P1527, DOI 10.1074/jbc.271.3.1527; MacKenzie CR, 1997, J BIOL CHEM, V272, P5533, DOI 10.1074/jbc.272.9.5533; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; Mandal M, 2004, ANGEW CHEM INT EDIT, V43, P2557, DOI 10.1002/anie.200353625; MIZUOCHI T, 1990, J BIOL CHEM, V265, P8519; Mizuochi T, 1988, Biomed Chromatogr, V2, P260; Monzavi-Karbassi B, 2003, VACCINE, V21, P753, DOI 10.1016/S0264-410X(02)00703-X; Monzavi-Karbassi B, 2001, BIOLOGICALS, V29, P249, DOI 10.1006/biol.2001.0307; MULLER WEG, 1991, J ACQ IMMUN DEF SYND, V4, P694; MULLER WEG, 1990, AIDS, V4, P159, DOI 10.1097/00002030-199002000-00010; Murali R, 1997, J MOL RECOGNIT, V10, P269, DOI 10.1002/(SICI)1099-1352(199711/12)10:6<269::AID-JMR370>3.0.CO;2-9; OLDENBURG KR, 1992, P NATL ACAD SCI USA, V89, P5393, DOI 10.1073/pnas.89.12.5393; Pashov A, 2005, VACCINE, V23, P2168, DOI 10.1016/j.vaccine.2005.01.045; Pashov A, 2005, J BIOL CHEM, V280, P28959, DOI 10.1074/jbc.M502964200; Pashov A, 2002, INT IMMUNOL, V14, P453, DOI 10.1093/intimm/14.5.453; Quan CP, 2001, J AUTOIMMUN, V17, P81, DOI 10.1006/jaut.2001.0529; ROBINSON WE, 1987, AIDS RES HUM RETROV, V3, P265, DOI 10.1089/aid.1987.3.265; Scanlan CN, 2003, ADV EXP MED BIOL, V535, P205; SCOTT JK, 1992, P NATL ACAD SCI USA, V89, P5398, DOI 10.1073/pnas.89.12.5398; Sharon N, 2002, J AGR FOOD CHEM, V50, P6586, DOI 10.1021/jf020190s; Sharon N, 2001, ADV EXP MED BIOL, V491, P1; Shin JS, 2002, J IMMUNOL, V168, P6273, DOI 10.4049/jimmunol.168.12.6273; Shinohara Y, 1997, GLYCOBIOLOGY, V7, P1201, DOI 10.1093/glycob/7.8.1201; TOMIYAMA T, 1991, BIOCHEM BIOPH RES CO, V177, P279, DOI 10.1016/0006-291X(91)91979-M; Wang LX, 2006, CURR OPIN DRUG DISC, V9, P194; WANG WC, 1988, J BIOL CHEM, V263, P4576; WEISS CD, 1993, J VIROL, V67, P7060, DOI 10.1128/JVI.67.12.7060-7066.1993; WESTERINK MAJ, 1995, P NATL ACAD SCI USA, V92, P4021, DOI 10.1073/pnas.92.9.4021; YAMAMOTO K, 1981, BIOCHEMISTRY-US, V20, P5894, DOI 10.1021/bi00523a037; Yan LY, 1997, GLYCOCONJUGATE J, V14, P45, DOI 10.1023/A:1018508914551	66	19	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					29675	29683		10.1074/jbc.M604137200	http://dx.doi.org/10.1074/jbc.M604137200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16899462	hybrid			2022-12-27	WOS:000240896300029
J	Sitailo, LA; Tibudan, SS; Denning, MF				Sitailo, Leonid A.; Tibudan, Shalini S.; Denning, Mitchell F.			The protein kinase C delta catalytic fragment targets Mcl-1 for degradation to trigger apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RADIATION-INDUCED APOPTOSIS; UVB-INDUCED APOPTOSIS; BCL-2 FAMILY-MEMBER; PKC-DELTA; HUMAN KERATINOCYTES; DNA-DAMAGE; PHOSPHOLIPID SCRAMBLASE-3; MITOCHONDRIAL APOPTOSIS; INDUCED PHOSPHORYLATION; PROTEOLYTIC ACTIVATION	Proteolytic cleavage and subsequent activation of protein kinaseC( PKC) delta is required for apoptosis induced by a variety of genotoxic agent, including UV radiation. In addition, overexpression of the constitutively active PKC delta catalytic fragment (PKC delta-cat) is sufficient to trigger Bax activation, cytochrome c release, and apoptosis. While PKC delta is a key apoptotic effector, the downstream target( s) responsible for the mitochondrial apoptotic cascade are not known. We found that expression of the active PKC delta- cat in HaCaT cells triggers a reduction in the antiapoptotic protein Mcl-1, similar to UV radiation. The downregulation of Mcl-1 induced by PKC delta- cat was not at the mRNA level but was due to decreased protein half- life. Overexpression of Mcl-1 protected HaCaT cells from both UV and PKC delta- catinduced apoptosis and blocked the release of cytochrome c from the mitochondria, indicating that Mcl-1 down- regulation was required for apoptosis signaling. Indeed, down- regulation of Mcl-1 with siRNA slightly increased the basal apoptotic rate of HaCaT cells and dramatically sensitized them to UV or PKC delta cat- induced apoptosis. HaCaT cells with down- regulated Mcl-1 had higher activated Bax protein, as measured by Bax cross-linking, indicating that Mcl-1 down- regulation is sufficient for Bax activation. Finally, recombinant PKC delta could phosphorylate Mcl-1 in vitro, identifying Mcl-1 as a direct target for PKC delta. Overall our results identify Mcl-1 as an important target for PKC delta-cat that can mediate its pro- apoptotic effects on mitochondria to amplify the apoptotic signaling induced by a wide range of apoptotic stimuli.	Loyola Univ, Med Ctr, Cardinal Bernardin Canc Ctr, Dept Pathol, Maywood, IL 60153 USA; Loyola Univ, Med Ctr, Inst Oncol, Maywood, IL 60153 USA	Loyola University Chicago; Loyola University Chicago	Denning, MF (corresponding author), Loyola Univ, Med Ctr, Cardinal Bernardin Canc Ctr, Dept Pathol, Rm 304,2160 S 1st Ave, Maywood, IL 60153 USA.	mdennin@lumc.edu			NATIONAL CANCER INSTITUTE [R01CA083784] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA083784, R01 CA083784-06A2, CA83784] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bae J, 2000, J BIOL CHEM, V275, P25255, DOI 10.1074/jbc.M909826199; Bharti A, 1998, MOL CELL BIOL, V18, P6719, DOI 10.1128/MCB.18.11.6719; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Bowen AR, 2003, J INVEST DERMATOL, V120, P48, DOI 10.1046/j.1523-1747.2003.12010.x; Chaturvedi V, 1999, J BIOL CHEM, V274, P23358, DOI 10.1074/jbc.274.33.23358; Cross T, 2000, ONCOGENE, V19, P2331, DOI 10.1038/sj.onc.1203555; Croxton R, 2002, ONCOGENE, V21, P1359, DOI 10.1038/sj.onc.1205157; Croxton R, 2002, ONCOGENE, V21, P1563, DOI 10.1038/sj.onc.1205232; Cuconati A, 2003, GENE DEV, V17, P2922, DOI 10.1101/gad.1156903; D'Costa AM, 2005, CELL DEATH DIFFER, V12, P224, DOI 10.1038/sj.cdd.4401558; Denning MF, 1998, J BIOL CHEM, V273, P29995, DOI 10.1074/jbc.273.45.29995; Denning MF, 2002, CELL DEATH DIFFER, V9, P40, DOI 10.1038/sj.cdd.4400929; Derouet M, 2004, J BIOL CHEM, V279, P26915, DOI 10.1074/jbc.M313875200; DeVries TA, 2002, EMBO J, V21, P6050, DOI 10.1093/emboj/cdf606; Domina AM, 2000, J BIOL CHEM, V275, P21688, DOI 10.1074/jbc.M000915200; Domina AM, 2004, ONCOGENE, V23, P5301, DOI 10.1038/sj.onc.1207692; Efimova T, 2004, MOL CELL BIOL, V24, P8167, DOI 10.1128/MCB.24.18.8167-8183.2004; Emoto Y, 1995, EMBO J, V14, P6148, DOI 10.1002/j.1460-2075.1995.tb00305.x; Fujii T, 2000, J BIOL CHEM, V275, P7574, DOI 10.1074/jbc.275.11.7574; Fujise K, 2000, J BIOL CHEM, V275, P39458, DOI 10.1074/jbc.M006626200; Ghayur T, 1996, J EXP MED, V184, P2399, DOI 10.1084/jem.184.6.2399; Grossman D, 2001, J CLIN INVEST, V108, P991, DOI 10.1172/JCI200113345; Han J, 2005, J BIOL CHEM, V280, P16383, DOI 10.1074/jbc.M411377200; Han J, 2004, J BIOL CHEM, V279, P22020, DOI 10.1074/jbc.M313234200; He YW, 2005, CANCER RES, V65, P10016, DOI 10.1158/0008-5472.CAN-05-1688; Iglesias-Serret D, 2003, ARCH BIOCHEM BIOPHYS, V417, P141, DOI 10.1016/S0003-9861(03)00345-X; Inoshita S, 2002, J BIOL CHEM, V277, P43730, DOI 10.1074/jbc.M207951200; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; LEHMAN TA, 1993, CARCINOGENESIS, V14, P833, DOI 10.1093/carcin/14.5.833; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Liu JH, 2003, CANCER RES, V63, P1153; Ma YH, 2003, MOL CANCER THER, V2, P73; Matassa AA, 2001, J BIOL CHEM, V276, P29719, DOI 10.1074/jbc.M100273200; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Michels J, 2005, INT J BIOCHEM CELL B, V37, P267, DOI 10.1016/j.biocel.2004.04.007; Mizuno K, 1997, EUR J BIOCHEM, V250, P7, DOI 10.1111/j.1432-1033.1997.00007.x; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Opferman JT, 2005, SCIENCE, V307, P1101, DOI 10.1126/science.1106114; Qin JZ, 2004, J CELL PHYSIOL, V200, P155, DOI 10.1002/jcp.20017; Rahmani M, 2005, J BIOL CHEM, V280, P35217, DOI 10.1074/jbc.M506551200; Ren J, 2002, J BIOL CHEM, V277, P33758, DOI 10.1074/jbc.M110667200; Rinkenberger JL, 2000, GENE DEV, V14, P23; Sitailo LA, 2004, J INVEST DERMATOL, V123, P434, DOI 10.1111/j.0022-202X.2004.23403.x; Sitailo LA, 2002, J BIOL CHEM, V277, P19346, DOI 10.1074/jbc.M200401200; Takasawa R, 2003, APOPTOSIS, V8, P291, DOI 10.1023/A:1023629023696; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Yoshida K, 2003, EMBO J, V22, P1431, DOI 10.1093/emboj/cdg134; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009; Zhou P, 1997, BLOOD, V89, P630, DOI 10.1182/blood.V89.2.630	50	49	52	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					29703	29710		10.1074/jbc.M607351200	http://dx.doi.org/10.1074/jbc.M607351200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16901898	hybrid, Green Accepted			2022-12-27	WOS:000240896300032
J	Thompson, A; Rolfe, MD; Lucchini, S; Schwerk, P; Hinton, JCD; Tedin, K				Thompson, Arthur; Rolfe, Matthew D.; Lucchini, Sacha; Schwerk, Peter; Hinton, Jay C. D.; Tedin, Karsten			The bacterial signal molecule, ppGpp, mediates the environmental regulation of both the invasion and intracellular virulence gene programs of Salmonella	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTERICA SEROVAR TYPHIMURIUM; III SECRETION SYSTEM; PATHOGENICITY ISLAND 2; ESCHERICHIA-COLI; STATIONARY-PHASE; HILA EXPRESSION; SSRA-SSRB; RELA; INFECTION; HOST	During infection of mammalian hosts, facultative intracellular pathogens have to adjust rapidly to different environmental conditions encountered during passage through the gastrointestinal tract and following uptake into epithelial cells and macrophages. Successful establishment within the host therefore requires the coordinated expression of a large number of virulence genes necessary for the adaptation between the extracellular and intracellular phases of infection. In this study we show that the bacterial signal molecule, ppGpp, plays a major role in mediating the environmental signals involved in the regulation of both the extracellular and intracellular virulence gene programs. Under oxygen limiting conditions, we observed a strong ppGpp dependence for invasion gene expression, the result of severe reductions in expression of the Salmonella pathogenicity island (SPI) 1 transcriptional regulator genes hilA, C, and D and invF. Overexpression of the non-SPI1-encoded regulator RtsA restored hilA expression in the absence of ppGpp. SPI2-encoded genes, required for intracellular proliferation in macrophages, were activated in the wild type strain under aerobic, late log phase growth conditions. The expression of SPI2 genes was also shown to be ppGpp-dependent under these conditions. The results from this study suggest a mechanism for the alternate regulation of the opposing extracellular and intracellular virulence gene programs and indicate a remarkable specificity for ppGpp in the regulation of genes involved in virulence compared with the rest of the genome. This is the first demonstration that this highly conserved regulatory system is involved in bacterial virulence gene expression on a global scale.	Food Res Inst, Mol Microbiol Grp, Norwich NR4 7UA, Norfolk, England; Free Univ Berlin, Inst Mikrobiol & Tierseuchen, D-10115 Berlin, Germany	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; Free University of Berlin	Thompson, A (corresponding author), Food Res Inst, Mol Microbiol Grp, Norwich Res Pk, Norwich NR4 7UA, Norfolk, England.	Arthur.Thompson@bbsrc.ac.uk	Hinton, Jay C. D./B-2142-2008	Hinton, Jay C. D./0000-0003-2671-6026; Tedin, Karsten/0000-0003-2109-0730				Adak GK, 2002, GUT, V51, P832, DOI 10.1136/gut.51.6.832; Arricau N, 1998, MOL MICROBIOL, V29, P835, DOI 10.1046/j.1365-2958.1998.00976.x; Bajaj V, 1996, MOL MICROBIOL, V22, P703, DOI 10.1046/j.1365-2958.1996.d01-1718.x; BELDEN WJ, 1994, INFECT IMMUN, V62, P5095, DOI 10.1128/IAI.62.11.5095-5101.1994; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beuzon CR, 1999, MOL MICROBIOL, V33, P806, DOI 10.1046/j.1365-2958.1999.01527.x; BlancPotard AB, 1997, EMBO J, V16, P5376, DOI 10.1093/emboj/16.17.5376; Brown NF, 2005, PLOS PATHOG, V1, P252, DOI 10.1371/journal.ppat.0010032; Brumell JH, 2004, CURR OPIN MICROBIOL, V7, P78, DOI 10.1016/j.mib.2003.12.005; Cashel M., 1996, ESCHERICHIA COLI SAL, P1458; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Cirillo DM, 1998, MOL MICROBIOL, V30, P175, DOI 10.1046/j.1365-2958.1998.01048.x; Clements MO, 2002, P NATL ACAD SCI USA, V99, P8784, DOI 10.1073/pnas.132047099; DaCosta XJ, 1997, J BACTERIOL, V179, P5211, DOI 10.1128/jb.179.16.5211-5217.1997; Deiwick J, 1999, MOL MICROBIOL, V31, P1759, DOI 10.1046/j.1365-2958.1999.01312.x; Dennis PP, 2004, MICROBIOL MOL BIOL R, V68, P639, DOI 10.1128/MMBR.68.4.639-668.2004; Drecktrah D, 2006, TRAFFIC, V7, P39, DOI 10.1111/j.1600-0854.2005.00360.x; Ellermeier CD, 2005, MOL MICROBIOL, V57, P691, DOI 10.1111/j.1365-2958.2005.04737.x; Ellermeier CD, 2003, J BACTERIOL, V185, P5096, DOI 10.1128/JB.185.17.5096-5108.2003; Erickson DL, 2004, INFECT IMMUN, V72, P5638, DOI 10.1128/IAI.72.10.5638-5645.2004; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; Garmendia J, 2003, MICROBIOL-SGM, V149, P2385, DOI 10.1099/mic.0.26397-0; GULIG PA, 1993, MOL MICROBIOL, V7, P825, DOI 10.1111/j.1365-2958.1993.tb01172.x; Hammer BK, 1999, MOL MICROBIOL, V33, P721, DOI 10.1046/j.1365-2958.1999.01519.x; Hansen-Wester I, 2004, INFECT IMMUN, V72, P2879, DOI 10.1128/IAI.72.5.2879-2888.2004; Haralalka S, 2003, J BACTERIOL, V185, P4672, DOI 10.1128/JB.185.16.4672-4682.2003; Hensel M, 2004, INT J MED MICROBIOL, V294, P95, DOI 10.1016/j.ijmm.2004.06.025; Hensel M, 1997, MOL MICROBIOL, V24, P155, DOI 10.1046/j.1365-2958.1997.3271699.x; Hensel M, 1998, MOL MICROBIOL, V30, P163, DOI 10.1046/j.1365-2958.1998.01047.x; Herikstad H, 2002, EPIDEMIOL INFECT, V129, P1, DOI 10.1017/S0950268802006842; HERNANDEZ VJ, 1991, J BIOL CHEM, V266, P5991; Hinton JCD, 2004, CURR OPIN MICROBIOL, V7, P277, DOI 10.1016/j.mib.2004.04.009; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Johnston C, 1996, MOL MICROBIOL, V22, P715, DOI 10.1046/j.1365-2958.1996.d01-1719.x; Kelly A, 2004, MICROBIOL-SGM, V150, P2037, DOI 10.1099/mic.0.27209-0; Knodler LA, 2005, J BIOL CHEM, V280, P9058, DOI 10.1074/jbc.M412588200; Lee AK, 2000, J BACTERIOL, V182, P771, DOI 10.1128/JB.182.3.771-781.2000; LENNOX ES, 1955, VIROLOGY, V1, P190, DOI 10.1016/0042-6822(55)90016-7; Linehan SA, 2005, INFECT IMMUN, V73, P4354, DOI 10.1128/IAI.73.7.4354-4362.2005; Lucas RL, 2000, MOL MICROBIOL, V36, P1024, DOI 10.1046/j.1365-2958.2000.01961.x; Lucas RL, 2001, J BACTERIOL, V183, P2733, DOI 10.1128/JB.183.9.2733-2745.2001; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Mittenhuber G, 2001, J MOL MICROB BIOTECH, V3, P585; Morgan E, 2004, MOL MICROBIOL, V54, P994, DOI 10.1111/j.1365-2958.2004.04323.x; Murray RA, 2000, INFECT IMMUN, V68, P5050, DOI 10.1128/IAI.68.9.5050-5055.2000; Na HS, 2006, VACCINE, V24, P2027, DOI 10.1016/j.vaccine.2005.11.031; Paul BJ, 2005, P NATL ACAD SCI USA, V102, P7823, DOI 10.1073/pnas.0501170102; Paul BJ, 2004, CELL, V118, P311, DOI 10.1016/j.cell.2004.07.009; Pizarro-Cerda J, 2004, MOL MICROBIOL, V52, P1827, DOI 10.1111/j.1365-2958.2004.04122.x; Primm TP, 2000, J BACTERIOL, V182, P4889, DOI 10.1128/JB.182.17.4889-4898.2000; Rhen M, 2005, INT J MED MICROBIOL, V294, P487, DOI 10.1016/j.ijmm.2004.11.004; Schechter LM, 1999, MOL MICROBIOL, V32, P629, DOI 10.1046/j.1365-2958.1999.01381.x; Schmidt H, 2004, CLIN MICROBIOL REV, V17, P14, DOI 10.1128/CMR.17.1.14-56.2004; Song MY, 2004, J BIOL CHEM, V279, P34183, DOI 10.1074/jbc.M313491200; Taylor CA, 2002, J BACTERIOL, V184, P621, DOI 10.1128/JB.184.3.621-628.2002; Tedin K, 2001, J BACTERIOL, V183, P6184, DOI 10.1128/JB.183.21.6184-6196.2001; Thompson A, 2006, CURR OPIN MICROBIOL, V9, P109, DOI 10.1016/j.mib.2005.12.010; Vazquez-Torres A, 1999, NATURE, V401, P804, DOI 10.1038/44593; Waterman SR, 2003, CELL MICROBIOL, V5, P501, DOI 10.1046/j.1462-5822.2003.00294.x; XIAO H, 1991, J BIOL CHEM, V266, P5980; Yang YH, 2002, NAT REV GENET, V3, P579, DOI 10.1038/nrg863; Zaharik ML, 2002, P NATL ACAD SCI USA, V99, P15705, DOI 10.1073/pnas.252415599; Zusman T, 2002, J BACTERIOL, V184, P67, DOI 10.1128/JB.184.1.67-75.2002	64	56	68	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					30112	30121		10.1074/jbc.M605616200	http://dx.doi.org/10.1074/jbc.M605616200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16905537	hybrid			2022-12-27	WOS:000240896300072
J	Alvarado, D; Evans, TA; Sharma, R; Lemmon, MA; Duffy, JB				Alvarado, Diego; Evans, Timothy A.; Sharma, Raghav; Lemmon, Mark A.; Duffy, Joseph B.			Argos mutants define an affinity threshold for Spitz inhibition in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; DROSOPHILA EGF RECEPTOR; FEEDBACK LOOP; CELL FATE; VENTRAL ECTODERM; SIGNALING GENES; CHORDIN; EYE; EXPRESSION; OOGENESIS	Argos, a secreted antagonist of Drosophila epidermal growth factor receptor (dEGFR) signaling, acts by sequestering the activating ligand Spitz. To understand how different domains in Argos contribute to efficient Spitz sequestration, we performed a genetic screen aimed at uncovering modifiers of an Argos misexpression phenotype in the developing eye. We identified a series of suppressors mapping to the Argos transgene that affect its activity in multiple developmental contexts. These point mutations map to both the N- and C- terminal cysteine-rich regions, implicating both domains in Argos function. We show by surface plasmon resonance that these Argos mutants are deficient in their ability to bind Spitz in vitro. Our data indicate that a mere similar to 2-fold decrease in K-D is sufficient to compromise Argos activity in vivo. This effect could be recapitulated in a cell-based assay, where a higher molar concentration of mutant Argos was needed to inhibit Spitz-dependent dEGFR phosphorylation. In contrast, a similar to 37-fold decrease in the binding constant nearly abolishes Argos activity in vivo and in cellular assays. In agreement with previously reported computational studies, our results define an affinity threshold for optimal Argos inhibition of dEGFR signaling during development.	Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	University of Pennsylvania; Indiana University System; Indiana University Bloomington	Alvarado, D (corresponding author), Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA.	dalvarad@mail.med.upenn.edu; jduffy@wpi.edu	Garzon-Alvarado, Diego/AAD-6607-2019	Lemmon, Mark/0000-0002-3379-5319; Evans, Timothy/0000-0002-2756-8064	NATIONAL CANCER INSTITUTE [R01CA079992] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA079992, R01-CA079992] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abreu JG, 2002, GENE, V287, P39, DOI 10.1016/S0378-1119(01)00827-7; Alvarado D, 2004, GENETICS, V167, P187, DOI 10.1534/genetics.167.1.187; Arteaga CL, 2003, EXP CELL RES, V284, P122, DOI 10.1016/S0014-4827(02)00104-0; Ashburner M., 1989, DROSOPHILA LAB HDB; Ben-Shlomo Izhar, 2003, Sci STKE, V2003, pRE9, DOI 10.1126/stke.2003.187.re9; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brodu V, 2004, DEV CELL, V7, P885, DOI 10.1016/j.devcel.2004.10.016; Casci T, 1999, CELL, V96, P655, DOI 10.1016/S0092-8674(00)80576-0; Chang J, 2003, MOL CELLS, V15, P186; Chang J, 2001, INT J DEV BIOL, V45, P715; Clemmons DR, 2001, ENDOCR REV, V22, P800, DOI 10.1210/er.22.6.800; Cohen MH, 2004, CLIN CANCER RES, V10, P1212, DOI 10.1158/1078-0432.CCR-03-0564; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; FRANCOIS V, 1995, CELL, V80, P19, DOI 10.1016/0092-8674(95)90446-8; FREEMAN M, 1994, DEVELOPMENT, V120, P2297; Freeman M, 1997, DEVELOPMENT, V124, P261; FREEMAN M, 1992, CELL, V69, P963, DOI 10.1016/0092-8674(92)90615-J; Gazdar AF, 2004, TRENDS MOL MED, V10, P481, DOI 10.1016/j.molmed.2004.08.008; Ghiglione C, 1999, CELL, V96, P847, DOI 10.1016/S0092-8674(00)80594-2; Golembo M, 1999, GENE DEV, V13, P158, DOI 10.1101/gad.13.2.158; Golembo M, 1996, DEVELOPMENT, V122, P3363; Golembo M, 1996, DEVELOPMENT, V122, P223; Gonzalez-Reyes A, 1998, DEVELOPMENT, V125, P2837; Graham J, 2004, NAT REV DRUG DISCOV, V3, P549, DOI 10.1038/nrd1445; Guichard A, 1999, DEVELOPMENT, V126, P2663; Gur G, 2004, EMBO J, V23, P3270, DOI 10.1038/sj.emboj.7600342; Holbro T, 2003, EXP CELL RES, V284, P99, DOI 10.1016/S0014-4827(02)00099-X; Howes R, 1998, J BIOL CHEM, V273, P4275, DOI 10.1074/jbc.273.7.4275; Klein DE, 2004, NATURE, V430, P1040, DOI 10.1038/nature02840; MacLaren CM, 2004, DEV GENES EVOL, V214, P360, DOI 10.1007/s00427-004-0414-4; Martin-Blanco E, 1999, DEVELOPMENT, V126, P5739; Nilson LA, 1999, CURR TOP DEV BIOL, V44, P203; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Piccolo S, 1997, CELL, V91, P407, DOI 10.1016/S0092-8674(00)80424-9; Reeves GT, 2005, DEV BIOL, V284, P523, DOI 10.1016/j.ydbio.2005.05.013; Reich A, 2002, EMBO J, V21, P4287, DOI 10.1093/emboj/cdf439; SASAI Y, 1995, NATURE, V376, P333, DOI 10.1038/376333a0; SCHWEITZER R, 1995, NATURE, V376, P699, DOI 10.1038/376699a0; Shilo BZ, 2005, DEVELOPMENT, V132, P4017, DOI 10.1242/dev.02006; Simcox A, 1997, MECH DEVELOP, V62, P41, DOI 10.1016/S0925-4773(96)00643-0; Simcox AA, 1996, DEV BIOL, V177, P475, DOI 10.1006/dbio.1996.0179; Siwanowicz I, 2005, STRUCTURE, V13, P155, DOI 10.1016/j.str.2004.11.009; Stein RA, 2000, J MOL EVOL, V50, P397, DOI 10.1007/s002390010043; Taguchi A, 2000, GENETICS, V154, P1639; Tio M, 1997, DEVELOPMENT, V124, P343; TIO M, 1994, MECH DEVELOP, V48, P13, DOI 10.1016/0925-4773(94)90002-7; Wasserman JD, 1998, CELL, V95, P355, DOI 10.1016/S0092-8674(00)81767-5; Wessells RJ, 1999, DEV BIOL, V216, P243, DOI 10.1006/dbio.1999.9459	48	3	4	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					28993	29001		10.1074/jbc.M603782200	http://dx.doi.org/10.1074/jbc.M603782200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16870613	hybrid			2022-12-27	WOS:000240680500054
J	Feller, A; Hernandez, JM; Grotewold, E				Feller, Antje; Hernandez, J. Marcela; Grotewold, Erich			An ACT-like domain participates in the dimerization of several plant basic-helix-loop-helix transcription factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE-S-TRANSFERASE; EPIDERMAL-CELL FATE; DNA-BINDING; PHOSPHOGLYCERATE DEHYDROGENASE; ENDOPLASMIC-RETICULUM; ARABIDOPSIS-THALIANA; NUCLEAR-LOCALIZATION; ESCHERICHIA-COLI; FUSION PROTEINS; BHLH PROTEINS	The maize basic-helix-loop-helix ( bHLH) factor R belongs to a group of proteins with important functions in the regulation of metabolism and development through the cooperation with R2R3-MYB transcription factors. Here we show that in addition to the bHLH and the R2R3-MYB-interacting domains, R contains a dimerization region located C-terminal to the bHLH motif. This protein-protein interaction domain is important for the regulation of anthocyanin pigment biosynthesis by contributing to the recruitment of the C1 R2R3-MYB factor to the C1 binding sites present in the promoters of flavonoid biosynthetic genes. The R dimerization region bares structural similarity to the ACT domain present in several metabolic enzymes. Protein fold recognition analyses resulted in the identification of similar ACT-like domains in several other plant bHLH proteins. We show that at least one of these related motifs is capable of mediating homodimer formation. These findings underscore the function of R as a docking site for multiple protein-protein interactions and provide evidence for the presence of a novel dimerization domain in multiple plant bHLH proteins.	Ohio State Univ, Dept Plant Cellular & Mol Biol, Columbus, OH 43210 USA; Ohio State Univ, Mol Cellular & Dev Biol Program, Columbus, OH 43210 USA; Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Grotewold, E (corresponding author), Ohio State Univ, Dept Plant Cellular & Mol Biol, 206 Rightmire Hall,1060 Carmack Rd, Columbus, OH 43210 USA.	grotewold.1@osu.edu	Feller, Antje C/B-8188-2011	Grotewold, Erich/0000-0002-4720-7290				Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Atchley WR, 2000, MOL BIOL EVOL, V17, P164, DOI 10.1093/oxfordjournals.molbev.a026229; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Baudry A, 2004, PLANT J, V39, P366, DOI 10.1111/j.1365-313X.2004.02138.x; Bell JK, 2004, BIOCHEMISTRY-US, V43, P3450, DOI 10.1021/bi035462e; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Bernhardt C, 2005, DEVELOPMENT, V132, P291, DOI 10.1242/dev.01565; Bernhardt C, 2003, DEVELOPMENT, V130, P6431, DOI 10.1242/dev.00880; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; BODEAU JP, 1992, MOL GEN GENET, V233, P379, DOI 10.1007/BF00265434; Buck MJ, 2003, J MOL EVOL, V56, P742, DOI 10.1007/s00239-002-2449-3; Chipman DM, 2001, CURR OPIN STRUC BIOL, V11, P694, DOI 10.1016/S0959-440X(01)00272-X; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; GOFF SA, 1991, GENE DEV, V5, P298, DOI 10.1101/gad.5.2.298; GOFF SA, 1992, GENE DEV, V6, P864, DOI 10.1101/gad.6.5.864; GORDONKAMM WJ, 1999, MOL IMPROVEMENT CERE, P189; Grotewold E, 2000, P NATL ACAD SCI USA, V97, P13579, DOI 10.1073/pnas.250379897; Grotewold E, 1998, PLANT CELL, V10, P721, DOI 10.1105/tpc.10.5.721; GROTEWOLD E, 1994, CELL, V76, P543, DOI 10.1016/0092-8674(94)90117-1; Grotewold E, 2006, ANNU REV PLANT BIOL, V57, P761, DOI 10.1146/annurev.arplant.57.032905.105248; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Heil G, 2002, MICROBIOL-SGM, V148, P2203, DOI 10.1099/00221287-148-7-2203; Heim MA, 2003, MOL BIOL EVOL, V20, P735, DOI 10.1093/molbev/msg088; Herman E, 2004, PLANT PHYSIOL, V136, P3440, DOI 10.1104/pp.104.051722; Hernandez JM, 2004, J BIOL CHEM, V279, P48205, DOI 10.1074/jbc.M407845200; Herold S, 2002, MOL CELL, V10, P509, DOI 10.1016/S1097-2765(02)00633-0; James P, 1996, GENETICS, V144, P1425; Khanna R, 2004, PLANT CELL, V16, P3033, DOI 10.1105/tpc.104.025643; Kobe B, 1999, NAT STRUCT BIOL, V6, P442, DOI 10.1038/8247; Lesnick ML, 1998, PLANT PHYSIOL, V117, P437, DOI 10.1104/pp.117.2.437; Liberles JS, 2005, AMINO ACIDS, V28, P1, DOI 10.1007/s00726-004-0152-y; Liu YH, 1996, P NATL ACAD SCI USA, V93, P7816, DOI 10.1073/pnas.93.15.7816; LLOYD AM, 1994, SCIENCE, V266, P436, DOI 10.1126/science.7939683; LUDWIG SR, 1990, CELL, V62, P849, DOI 10.1016/0092-8674(90)90259-H; Mas-Droux C, 2006, PLANT CELL, V18, P1681, DOI 10.1105/tpc.105.040451; Matsushima R, 2004, PLANT CELL, V16, P1536, DOI 10.1105/tpc.021154; Morgenstern B, 1999, MOL BIOL EVOL, V16, P1654, DOI 10.1093/oxfordjournals.molbev.a026079; Moriguchi K, 2005, PLANT CELL, V17, P389, DOI 10.1105/tpc.104.028456; Mount R C, 1996, Methods Mol Biol, V53, P239; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; MURRE C, 1992, TRANSCRIPTIONAL REGU; Nesi N, 2000, PLANT CELL, V12, P1863, DOI 10.1105/tpc.12.10.1863; Payne CT, 2000, GENETICS, V156, P1349; Pollastri G, 2002, PROTEINS, V47, P228, DOI 10.1002/prot.10082; Pooma W, 2002, GENETICS, V161, P793; Quattrocchio F., 2006, SCI FLAVONOIDS, P97, DOI [10.1007/978-0-387-28822-2_4, DOI 10.1007/978-0-387-28822-2_4]; Sainz MB, 1997, MOL CELL BIOL, V17, P115, DOI 10.1128/MCB.17.1.115; Sainz MB, 1997, PLANT CELL, V9, P611, DOI 10.1105/tpc.9.4.611; SCHUDSON M, 1995, FORBES MEDIA CRITIC, V2, P76; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; SHIEH MW, 1993, PLANT PHYSIOL, V101, P353, DOI 10.1104/pp.101.2.353; Thompson JR, 2005, BIOCHEMISTRY-US, V44, P5763, DOI 10.1021/bi047944b; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Williams CE, 1997, J BIOL CHEM, V272, P563, DOI 10.1074/jbc.272.1.563; Zhang F, 2003, DEVELOPMENT, V130, P4859, DOI 10.1242/dev.00681; Zimmermann IM, 2004, PLANT J, V40, P22, DOI 10.1111/j.1365-313X.2004.02183.x	57	95	99	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					28964	28974		10.1074/jbc.M603262200	http://dx.doi.org/10.1074/jbc.M603262200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16867983	hybrid			2022-12-27	WOS:000240680500051
J	Suzuki, Y; Zhang, H; Saito, N; Kojima, I; Urano, T; Mogami, H				Suzuki, Yuko; Zhang, Hui; Saito, Naoaki; Kojima, Itaru; Urano, Tetsumei; Mogami, Hideo			Glucagon-like peptide 1 activates protein kinase C through Ca2+-dependent activation of phospholipase C in insulin-secreting cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; K-ATP CHANNELS; INTRACELLULAR DELIVERY; SELECTIVE-INHIBITION; CA2+ RELEASE; TRANSLOCATION; CALCIUM; PHOSPHORYLATION; EXOCYTOSIS; RECEPTOR	Although the stimulatory effect of glucagon-like peptide 1(GLP1), a cAMP-generating agonist, on Ca2+ signal and insulin secretion is well established, the underlying mechanisms remain to be fully elucidated. We recently discovered that Ca2+ influx alone can activate conventional protein kinase C (PKC) as well as novel PKC in insulin-secreting (INS-1) cells. Building on this earlier finding, here we examined whether GLP-1-evoked Ca2+ signaling can activate PKC alpha and PKC epsilon at a substimulatory concentration of glucose (3 mM) in INS-1 cells. We first showed that GLP-1 translocated endogenous PKC alpha and PKC epsilon from the cytosol to the plasma membrane. Next, we assessed the phosphorylation state of the PKC substrate, myristoylated alanine-rich C kinase substrate ( MARCKS), by using MARCKS-GFP. GLP-1 translocated MARCKS-GFP to the cytosol in a Ca2+-dependent manner, and the GLP-1-evoked translocation of MARCKS-GFP was blocked by PKC inhibitors, either a broad PKC inhibitor, bisindolylmaleimide I, or a PKC epsilon inhibitor peptide, antennapedia peptide-fused pseudosubstrate PKC epsilon-(149-164) (antp-PKC epsilon) and a conventional PKC inhibitor, Go-6976. Furthermore, forskolin-induced translocation of MARCKS-GFP was almost completely inhibited by U73122, a putative inhibitor of phospholipase C. These observations were verified in two different ways by demonstrating 1) forskolin-induced translocation of the GFP-tagged C1 domain of PKC gamma and 2) translocation of PKC alpha-DsRed and PKC alpha-GFP. In addition, PKC inhibitors reduced forskolin-induced insulin secretion in both INS-1 cells and rat islets. Thus, GLP-1 can activate PKC alpha and PKC epsilon, and these GLP-1-activated PKCs may contribute considerably to insulin secretion at a substimulatory concentration of glucose.	Hamamatsu Univ Sch Med, Dept Physiol, Hamamatsu, Shizuoka 4313192, Japan; Gunma Univ, Inst Mol & Cellular Regulat, Maebashi, Gumma 3718512, Japan; Kobe Univ, Biosignal Res Ctr, Mol Pharmacol Lab, Nada Ku, Kobe, Hyogo 6578501, Japan	Hamamatsu University School of Medicine; Gunma University; Kobe University	Mogami, H (corresponding author), Hamamatsu Univ Sch Med, Dept Physiol, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	hmogami@hama-med.ac.jp						Almholt K, 1999, BIOCHEM J, V337, P211, DOI 10.1042/0264-6021:3370211; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Baukrowitz T, 1998, SCIENCE, V282, P1141, DOI 10.1126/science.282.5391.1141; BLACKSHEAR PJ, 1993, J BIOL CHEM, V268, P1501; BLEASDALE JE, 1990, J PHARMACOL EXP THER, V255, P756; Derossi D, 1998, TRENDS CELL BIOL, V8, P84, DOI 10.1016/S0962-8924(97)01214-2; DILLON JS, 1993, ENDOCRINOLOGY, V133, P1907, DOI 10.1210/en.133.4.1907; Fischer PM, 2000, J PEPT RES, V55, P163, DOI 10.1034/j.1399-3011.2000.00163.x; GROMADA J, 1995, DIABETES, V44, P767, DOI 10.2337/diabetes.44.7.767; Gromada J, 1998, PFLUG ARCH EUR J PHY, V435, P583, DOI 10.1007/s004240050558; Hanoune J, 2001, ANNU REV PHARMACOL, V41, P145, DOI 10.1146/annurev.pharmtox.41.1.145; Harris TE, 1999, MOL CELL ENDOCRINOL, V155, P61, DOI 10.1016/S0303-7207(99)00114-8; Holz GG, 2004, DIABETES, V53, P5, DOI 10.2337/diabetes.53.1.5; HOLZ GG, 1993, NATURE, V361, P362, DOI 10.1038/361362a0; HOLZ GG, 1995, J BIOL CHEM, V270, P17749, DOI 10.1074/jbc.270.30.17749; Kang GX, 2003, J BIOL CHEM, V278, P8279, DOI 10.1074/jbc.M211682200; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; MacDonald PE, 2002, DIABETES, V51, pS434, DOI 10.2337/diabetes.51.2007.S434; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; Mashima H, 1996, J CLIN INVEST, V97, P1647, DOI 10.1172/JCI118591; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Mendez CF, 2003, J BIOL CHEM, V278, P44753, DOI 10.1074/jbc.M308664200; Mogami H, 2003, J BIOL CHEM, V278, P9896, DOI 10.1074/jbc.M210653200; Mogami H, 1997, CELL, V88, P49, DOI 10.1016/S0092-8674(00)81857-7; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; Ohmori S, 2000, J BIOL CHEM, V275, P26449, DOI 10.1074/jbc.M003588200; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Schmidt M, 2001, NAT CELL BIOL, V3, P1020, DOI 10.1038/ncb1101-1020; Shirai Y, 1998, J CELL BIOL, V143, P511, DOI 10.1083/jcb.143.2.511; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; Suga S, 1997, DIABETES, V46, P1755, DOI 10.2337/diabetes.46.11.1755; Tian YM, 1996, MOL CELL ENDOCRINOL, V119, P185, DOI 10.1016/0303-7207(96)03811-7; Toft-Nielsen M, 1998, DIABETOLOGIA, V41, P1180, DOI 10.1007/s001250051049; Toker A., 1998, FRONT BIOSCI-LANDMRK, V3, P1134, DOI 10.2741/A350; Tsuboi T, 2003, BIOCHEM J, V369, P287, DOI 10.1042/BJ20021288; Uchino M, 2004, J BIOL CHEM, V279, P2254, DOI 10.1074/jbc.M309894200; WOLLHEIM CB, 1988, EMBO J, V7, P2443, DOI 10.1002/j.1460-2075.1988.tb03090.x; Yamada S, 2002, ENDOCRINOLOGY, V143, P4203, DOI 10.1210/en.2002-220368; Yedovitzky M, 1997, J BIOL CHEM, V272, P1417, DOI 10.1074/jbc.272.3.1417; Zhang H, 2004, J PHYSIOL-LONDON, V561, P133, DOI 10.1113/jphysiol.2004.071241; ZOUKHRI D, 1997, AM J PHYSIOL, V272, P263	43	45	45	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					28499	28507		10.1074/jbc.M604291200	http://dx.doi.org/10.1074/jbc.M604291200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16870611	hybrid			2022-12-27	WOS:000240680500003
J	Bennasser, Y; Yeung, ML; Jeang, KT				Bennasser, Yamina; Yeung, Man Lung; Jeang, Kuan-Teh			HIV-1 TAR RNA subverts RNA interference in transfected cells through sequestration of TAR RNA-binding protein, TRBP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HEPATITIS-C VIRUS; MICRORNA EXPRESSION; VIRAL SUPPRESSOR; KINASE; DICER; RECOGNITION; ARGONAUTE2; INHIBITOR; STRATEGY	TAR RNA-binding protein, TRBP, was recently discovered to be an essential partner for Dicer and a crucial component of the RNA-induced silencing complex ( RISC), a critical element of the RNA interference (RNAi) of the cell apparatus. Human TRBP was originally characterized and cloned 15 years ago based on its high affinity for binding the HIV-1 encoded leader RNA, TAR. RNAi is used, in part, by cells to defend against infection by viruses. Here, we report that transfected TAR RNA can attenuate the RNAi machinery in human cells. Our data suggest that TAR RNA sequesters TRBP rendering it unavailable for downstream Dicer-RISC complexes. TAR-induced inhibition of Dicer-RISC activity in transfected cells was partially relieved by exogenous expression of TRBP.	NIAID, Mol Virol Sect, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Jeang, KT (corresponding author), NIAID, Mol Virol Sect, Mol Microbiol Lab, NIH, Bldg 4,Rm 306,Rockville Pike, Bethesda, MD 20892 USA.	kj7e@nih.gov	Jeang, Kuan-Teh/A-2424-2008; Bennasser, Yamina/M-4833-2017; Yeung, Man Lung/E-9903-2010	Yeung, Man Lung/0000-0002-6117-7884	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000547, Z01AI000547] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andersson MG, 2005, J VIROL, V79, P9556, DOI 10.1128/JVI.79.15.9556-9565.2005; Bennasser Y, 2005, IMMUNITY, V22, P607, DOI 10.1016/j.immuni.2005.03.010; Bennasser Y, 2006, CURR OPIN HIV AIDS, V1, P208, DOI 10.1097/01.COH.0000221593.49412.56; BERKHOUT B, 1991, NUCLEIC ACIDS RES, V19, P6169, DOI 10.1093/nar/19.22.6169; Brady J, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-69; Brand SR, 1997, J BIOL CHEM, V272, P8388, DOI 10.1074/jbc.272.13.8388; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Das AT, 2004, J VIROL, V78, P2601, DOI 10.1128/JVI.78.5.2601-2605.2004; DAVIES MV, 1993, J VIROL, V67, P1688, DOI 10.1128/JVI.67.3.1688-1692.1993; FOLKS TM, 1989, P NATL ACAD SCI USA, V86, P2365, DOI 10.1073/pnas.86.7.2365; FOSTERMANN K, 2005, PLOS BIOL, V3, pE236; Gatignol A, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-65; GATIGNOL A, 1991, SCIENCE, V251, P1597, DOI 10.1126/science.2011739; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; He YP, 2002, VIRAL IMMUNOL, V15, P95, DOI 10.1089/088282402317340260; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; Kasschau KD, 1998, CELL, V95, P461, DOI 10.1016/S0092-8674(00)81614-1; Le Page C, 2000, Rev Immunogenet, V2, P374; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942; Lichner Z, 2003, J GEN VIROL, V84, P975, DOI 10.1099/vir.0.18987-0; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Lu SH, 2004, J VIROL, V78, P12868, DOI 10.1128/JVI.78.23.12868-12876.2004; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; PARK HS, 1994, P NATL ACAD SCI USA, V91, P4713, DOI 10.1073/pnas.91.11.4713; Provost P, 2002, EMBO J, V21, P5864, DOI 10.1093/emboj/cdf578; Rana TM, 1999, ARCH BIOCHEM BIOPHYS, V365, P175, DOI 10.1006/abbi.1999.1206; Rossi JJ, 2005, EMBO REP, V6, P927, DOI 10.1038/sj.embor.7400531; Saumet A, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-3; Sen GL, 2005, NAT CELL BIOL, V7, P633, DOI 10.1038/ncb1265; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; Voinnet O, 1999, P NATL ACAD SCI USA, V96, P14147, DOI 10.1073/pnas.96.24.14147; Voinnet O, 2005, NAT REV GENET, V6, P206, DOI 10.1038/nrg1555; Westerhout EM, 2005, NUCLEIC ACIDS RES, V33, P796, DOI 10.1093/nar/gki220; Ye KQ, 2003, NATURE, V426, P874, DOI 10.1038/nature02213; Yeung ML, 2005, CELL RES, V15, P935, DOI 10.1038/sj.cr.7290371; Yeung ML, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-81	42	92	103	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					27674	27678		10.1074/jbc.C600072200	http://dx.doi.org/10.1074/jbc.C600072200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16887810	hybrid			2022-12-27	WOS:000240534400003
J	Martin, E; Berka, V; Bogatenkova, E; Murad, F; Tsai, AL				Martin, Emil; Berka, Vladimir; Bogatenkova, Elena; Murad, Ferid; Tsai, Ah-Lim			Ligand selectivity of soluble guanylyl cyclase - Effect of the hydrogen-bonding tyrosine in the distal heme pocket on binding of oxygen, nitric oxide, and carbon monoxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-BASIS; BOVINE LUNG; NO; ACTIVATION; DISSOCIATION; PROTEINS; DOMAIN; SENSOR; IDENTIFICATION; HEMOGLOBIN	Although soluble guanylyl cyclase(sGC) functions in an environment in which O-2, NO, and CO are potential ligands for its heme moiety, the enzyme displays a high affinity for only its physiological ligand, NO, but has a limited affinity for CO and no affinity for O-2. Recent studies of a truncated version of the sGC beta(1)-subunit containing the heme-binding domain (Boon, E. M., Huang, S H., and Marletta, M.A. (2005) Nat. Chem. Biol., 1, 53 - 59) showed that introduction of the hydrogen-bonding tyrosine into the distal heme pocket changes the ligand specificity of the heme moiety and results in an oxygen-binding sGC. The hypothesis that the absence of hydrogen-bonding residues in the distal heme pocket is sufficient to provide oxygen discrimination by sGC was put forward. We tested this hypothesis in a context of a complete sGC heterodimer containing both the intact alpha(1)- and beta(1)-subunits. We found that the I145Y substitution in the full-length beta-subunit of the sGC heterodimer did not produce an oxygen-binding enzyme. However, this substitution impeded the association of NO and destabilized the NO (.) heme complex. The tyrosine in the distal heme pocket also impeded both the binding and dissociation of the CO ligand. We propose that the mechanism of oxygen exclusion by sGC not only involves the lack of hydrogen bonding in the distal heme pocket, but also depends on structural elements from other domains of sGC.	Univ Texas, Hlth Sci Ctr, Brown Fdn Inst Mol Med, Houston, TX 77030 USA; Univ Texas, Sch Med, Div Hematol, Dept Internal Med, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System	Martin, E (corresponding author), Univ Texas, Hlth Sci Ctr, Brown Fdn Inst Mol Med, Houston, TX 77030 USA.	emil.martin@uth.tmc.edu; ferid.murad@uth.tmc.edu; ah-lim.tsai@uth.tmc.edu		Martin, Emil/0000-0002-9094-4165	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056818, R01GM061731] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL64221] Funding Source: Medline; NIDDK NIH HHS [DK065153-17] Funding Source: Medline; NIGMS NIH HHS [GM61731, GM56818] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Berka V, 1996, J BIOL CHEM, V271, P33293, DOI 10.1074/jbc.271.52.33293; Boon EM, 2006, J BIOL CHEM, V281, P21892, DOI 10.1074/jbc.M600557200; Boon EM, 2005, J INORG BIOCHEM, V99, P892, DOI 10.1016/j.jinorgbio.2004.12.016; Boon EM, 2005, NAT CHEM BIOL, V1, P53, DOI 10.1038/nchembio704; Boon EM, 2005, CURR OPIN CHEM BIOL, V9, P441, DOI 10.1016/j.cbpa.2005.08.015; Cary SPL, 2006, TRENDS BIOCHEM SCI, V31, P231, DOI 10.1016/j.tibs.2006.02.003; Cary SPL, 2005, P NATL ACAD SCI USA, V102, P13064, DOI 10.1073/pnas.0506289102; Condorelli P, 2001, BIOPHYS J, V80, P2110, DOI 10.1016/S0006-3495(01)76184-X; Deinum G, 1996, BIOCHEMISTRY-US, V35, P1540; Draghi F, 2002, J BIOL CHEM, V277, P7509, DOI 10.1074/jbc.M109206200; Foerster J, 1996, EUR J BIOCHEM, V240, P380, DOI 10.1111/j.1432-1033.1996.0380h.x; Friebe A, 1996, EMBO J, V15, P6863, DOI 10.1002/j.1460-2075.1996.tb01078.x; GERZER R, 1981, FEBS LETT, V132, P71, DOI 10.1016/0014-5793(81)80429-2; Hoenicka M, 1999, J MOL MED-JMM, V77, P14, DOI 10.1007/s001090050292; IGNARRO LJ, 1982, P NATL ACAD SCI-BIOL, V79, P2870, DOI 10.1073/pnas.79.9.2870; Karow DS, 2004, BIOCHEMISTRY-US, V43, P10203, DOI 10.1021/bi049374l; Kharitonov VG, 1997, BIOCHEMISTRY-US, V36, P6814, DOI 10.1021/bi970201o; Kharitonov VG, 1997, BIOCHEM BIOPH RES CO, V239, P284, DOI 10.1006/bbrc.1997.7470; Lee YC, 2000, P NATL ACAD SCI USA, V97, P10763, DOI 10.1073/pnas.190333697; Lucas KA, 2000, PHARMACOL REV, V52, P375; Makino R, 1999, J BIOL CHEM, V274, P7714, DOI 10.1074/jbc.274.12.7714; Martin E, 2005, METHOD ENZYMOL, V396, P478, DOI 10.1016/S0076-6879(05)96040-0; Martin E, 2003, P NATL ACAD SCI USA, V100, P9208, DOI 10.1073/pnas.1633590100; MARTIN E, 2005, NITRIC OXIDE CELL SI, P167; McCleverty JA, 2004, CHEM REV, V104, P403, DOI 10.1021/cr020623q; MOMENTEAU M, 1994, CHEM REV, V94, P659, DOI 10.1021/cr00027a006; Nioche P, 2004, SCIENCE, V306, P1550, DOI 10.1126/science.1103596; OERTLING WA, 1990, INORG CHEM, V29, P2633, DOI 10.1021/ic00339a021; Pellicena P, 2004, P NATL ACAD SCI USA, V101, P12854, DOI 10.1073/pnas.0405188101; Pesce A, 2004, J BIOL CHEM, V279, P33662, DOI 10.1074/jbc.M403597200; Pesce A, 2001, J MOL BIOL, V309, P1153, DOI 10.1006/jmbi.2001.4731; ROSE EJ, 1983, J AM CHEM SOC, V105, P2866, DOI 10.1021/ja00347a056; Russwurm M, 2004, EMBO J, V23, P4443, DOI 10.1038/sj.emboj.7600422; Schelvis JPM, 1998, BIOCHEMISTRY-US, V37, P16289, DOI 10.1021/bi981547h; Schmidt PM, 2005, EUR J PHARMACOL, V513, P67, DOI 10.1016/j.ejphar.2005.02.046; Schmidt PM, 2004, J BIOL CHEM, V279, P3025, DOI 10.1074/jbc.M310141200; Stasch JP, 2001, NATURE, V410, P212, DOI 10.1038/35065611; STONE JR, 1994, BIOCHEMISTRY-US, V33, P5636, DOI 10.1021/bi00184a036; TRAYLOR TG, 1992, BIOCHEMISTRY-US, V31, P2847, DOI 10.1021/bi00126a001; TSAI AL, 1995, J BIOL CHEM, V270, P10503, DOI 10.1074/jbc.270.18.10503; TSAI AL, 1994, FEBS LETT, V341, P141, DOI 10.1016/0014-5793(94)80445-1; Zhao Y, 1999, P NATL ACAD SCI USA, V96, P14753, DOI 10.1073/pnas.96.26.14753; Zhao Y, 1998, BIOCHEMISTRY-US, V37, P4502, DOI 10.1021/bi972686m	43	78	81	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					27836	27845		10.1074/jbc.M601078200	http://dx.doi.org/10.1074/jbc.M601078200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16864588	hybrid			2022-12-27	WOS:000240534400019
J	Rosental, N; Bendahan, A; Kanner, BI				Rosental, Noa; Bendahan, Annie; Kanner, Baruch I.			Multiple consequences of mutating two conserved beta-bridge forming residues in the translocation cycle of a neuronal glutamate transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOBUTYRIC-ACID TRANSPORTER; RAT-BRAIN; MEMBRANE-VESICLES; CHLORIDE CHANNEL; REENTRANT LOOP; GLT-1; SUBSTRATE; EXPRESSION; BINDING; FLUXES	Glutamate transporters remove this neurotransmitter from the synapse in an electrogenic process. After sodium-coupled glutamate translocation, the cycle is completed by obligatory outward translocation of potassium. In the crystal structure of an archaeal homologue, two conserved residues form a beta-bridge, which points away from the binding pocket. In the neuronal glutamate transporter EAAC1, the equivalent residues are asparagine 366 and aspartate 368. Substitution mutants N366Q and D368E, but not N366D and D368N, show glutamate-induced inwardly rectifying steady-state currents, but their apparent substrate affinity is dramatically decreased. Such currents, which reflect electrogenic net uptake of substrate are not observed with the reciprocal double mutant N366D/D368N. Remarkably, the double mutant exhibits slow substrate-induced voltage-dependent capacitative transient currents. These currents apparently reflect the reversible sodium-coupled glutamate translocation step, because the interaction of the double mutant with potassium is largely impaired. Moreover, when the analogous double mutant in the glutamate transporter GLT-1 is reconstituted into liposomes, a slow exchange of radioactive and unlabeled acidic amino acids is observed. Our results suggest that it is the interaction of asparagine 366 and aspartate 368 that is important during the glutamate translocation step. On the other hand, the side chains of these residues themselves are required for the subsequent potassium relocation step.	Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Kanner, BI (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem, POB 12272, IL-91120 Jerusalem, Israel.	kannerb@cc.huji.ac.il			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS016708, R01NS016708] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 16708] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arriza JL, 1997, P NATL ACAD SCI USA, V94, P4155, DOI 10.1073/pnas.94.8.4155; Bendahan A, 2000, J BIOL CHEM, V275, P37436, DOI 10.1074/jbc.M006536200; Bennett ER, 2000, J BIOL CHEM, V275, P34106, DOI 10.1074/jbc.M004229200; Borre L, 2004, J BIOL CHEM, V279, P2513, DOI 10.1074/jbc.M311446200; Borre L, 2002, J BIOL CHEM, V277, P13501, DOI 10.1074/jbc.M110861200; Borre L, 2001, J BIOL CHEM, V276, P40396, DOI 10.1074/jbc.M104926200; BREW H, 1987, NATURE, V327, P707, DOI 10.1038/327707a0; Brocke L, 2002, J BIOL CHEM, V277, P3985, DOI 10.1074/jbc.M107735200; DANBOLT NC, 1992, NEUROSCIENCE, V51, P295, DOI 10.1016/0306-4522(92)90316-T; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Grunewald M, 1998, NEURON, V21, P623, DOI 10.1016/S0896-6273(00)80572-3; Grunewald M, 2000, J BIOL CHEM, V275, P9684, DOI 10.1074/jbc.275.13.9684; Holmseth S, 2005, NEUROSCIENCE, V136, P649, DOI 10.1016/j.neuroscience.2005.07.022; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; KANNER BI, 1978, BIOCHEMISTRY-US, V17, P3949, DOI 10.1021/bi00612a011; KANNER BI, 1982, BIOCHEMISTRY-US, V21, P6327, DOI 10.1021/bi00267a044; Kavanaugh MP, 1997, J BIOL CHEM, V272, P1703, DOI 10.1074/jbc.272.3.1703; KEYNAN S, 1992, BIOCHEMISTRY-US, V31, P1974, DOI 10.1021/bi00122a011; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ogawa H, 2002, P NATL ACAD SCI USA, V99, P15977, DOI 10.1073/pnas.202622299; PINES G, 1995, J BIOL CHEM, V270, P17093, DOI 10.1074/jbc.270.29.17093; PINES G, 1990, BIOCHEMISTRY-US, V29, P11209, DOI 10.1021/bi00503a008; PINES G, 1992, NATURE, V360, P464, DOI 10.1038/360464a0; Ryan RM, 2004, J BIOL CHEM, V279, P20742, DOI 10.1074/jbc.M304433200; Ryan RM, 2002, J BIOL CHEM, V277, P13494, DOI 10.1074/jbc.M109970200; Seal RP, 2001, P NATL ACAD SCI USA, V98, P15324, DOI 10.1073/pnas.011400198; Slotboom DJ, 1999, P NATL ACAD SCI USA, V96, P14282, DOI 10.1073/pnas.96.25.14282; STORCK T, 1992, P NATL ACAD SCI USA, V89, P10955, DOI 10.1073/pnas.89.22.10955; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Tao Z, 2006, J BIOL CHEM, V281, P10263, DOI 10.1074/jbc.M510739200; WADICHE JI, 1995, NEURON, V14, P1019, DOI 10.1016/0896-6273(95)90340-2; Wadiche JI, 1998, J NEUROSCI, V18, P7650; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zarbiv R, 1998, J BIOL CHEM, V273, P14231, DOI 10.1074/jbc.273.23.14231; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zhang YM, 1999, P NATL ACAD SCI USA, V96, P1710, DOI 10.1073/pnas.96.4.1710; Zhang YM, 1998, P NATL ACAD SCI USA, V95, P751, DOI 10.1073/pnas.95.2.751	41	32	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					27905	27915		10.1074/jbc.M600331200	http://dx.doi.org/10.1074/jbc.M600331200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16870620	hybrid			2022-12-27	WOS:000240534400026
J	van den Hemel, D; Brige, A; Savvides, SN; Van Beeumen, J				van den Hemel, Debbie; Brige, Ann; Savvides, Savvas N.; Van Beeumen, Jozef			Ligand-induced conformational changes in the capping subdomain of a bacterial old yellow enzyme homologue and conserved sequence fingerprints provide new insights into substrate binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PENTAERYTHRITOL TETRANITRATE REDUCTASE; GLYCEROL TRINITRATE REDUCTASE; OXIDATIVE STRESS-RESPONSE; ENTEROBACTER-CLOACAE PB2; ACTIVE-SITE RESIDUES; MORPHINONE REDUCTASE; SHEWANELLA-ONEIDENSIS; CRYSTAL-STRUCTURE; LIPID-PEROXIDATION; FLAVIN REACTIVITY	We have recently reported that Shewanella oneidensis, a Gram-negative gamma-proteobacterium with a rich arsenal of redox proteins, possesses four old yellow enzyme (OYE) homologues. Here, we report a series of high resolution crystal structures for one of these OYEs, Shewanella yellow enzyme 1 (SYE1), in its oxidized form at 1.4 angstrom resolution, which binds a molecule of PEG 400 in the active site, and in its NADH-reduced and p-hydroxybenzaldehyde and p-hydroxyacetophenone-bound forms at 1.7 angstrom resolution. Although the overall structure of SYE1 reveals a monomeric enzyme based on the alpha(8)beta(8) barrel scaffold observed for other OYEs, the active site exhibits a unique combination of features: a strongly butterfly-bent FMN cofactor both in the oxidized and NADH-reduced forms, a collapsed and narrow active site tunnel, and a novel combination of conserved residues involved in the binding of phenolic ligands. Furthermore, we identify a second p-hydroxybenzaldehyde- binding site in a hydrophobic cleft next to the entry of the active site tunnel in the capping subdomain, formed by a restructuring of Loop 3 to an "open" conformation. This constitutes the first evidence to date for the entire family of OYEs that Loop 3 may indeed play a dynamic role in ligand binding and thus provides insights into the elusive NADH complex and into substrate binding in general. Structure-based sequence alignments indicate that the novelties we observe in SYE1 are supported by conserved residues in a number of structurally uncharacterized OYEs from the beta- and gamma-proteobacteria, suggesting that SYE1 represents a new subfamily of bacterial OYEs.	Univ Ghent, Dept Biochem Physiol & Microbiol, Lab Prot Biochem & Prot Engn, B-9000 Ghent, Belgium	Ghent University	Savvides, SN (corresponding author), Univ Ghent, Dept Biochem Physiol & Microbiol, Lab Prot Biochem & Prot Engn, KL Ledeganckstr 35, B-9000 Ghent, Belgium.	savvas.savvides@ugent.be; jozef.vanbeeumen@ugent.be	Savvides, Savvas/E-1938-2011	Savvides, Savvas/0000-0003-3420-5947				Abboud R, 2005, APPL ENVIRON MICROB, V71, P811, DOI 10.1128/AEM.71.2.811-816.2005; ABRAMOVITZ AS, 1976, J BIOL CHEM, V251, P5327; Barna T, 2002, J BIOL CHEM, V277, P30976, DOI 10.1074/jbc.M202846200; Barna TM, 2001, J MOL BIOL, V310, P433, DOI 10.1006/jmbi.2001.4779; Blehert DS, 1997, J BACTERIOL, V179, P6912, DOI 10.1128/jb.179.22.6912-6920.1997; Blehert DS, 1999, J BACTERIOL, V181, P6254, DOI 10.1128/JB.181.20.6254-6263.1999; Bowman JP, 1997, INT J SYST BACTERIOL, V47, P1040, DOI 10.1099/00207713-47-4-1040; Breithaupt C, 2001, STRUCTURE, V9, P419, DOI 10.1016/S0969-2126(01)00602-5; Brige A, 2006, BIOCHEM J, V394, P335, DOI 10.1042/BJ20050979; Brown BJ, 1998, J BIOL CHEM, V273, P32753, DOI 10.1074/jbc.273.49.32753; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bruns CM, 1999, J MOL BIOL, V288, P427, DOI 10.1006/jmbi.1999.2697; Craig DH, 2001, BIOCHEM J, V359, P315, DOI 10.1042/0264-6021:3590315; CROFT KPC, 1993, PLANT PHYSIOL, V101, P13, DOI 10.1104/pp.101.1.13; Duax WL, 2003, PROTEINS, V53, P931, DOI 10.1002/prot.10512; Fitzpatrick TB, 2003, J BIOL CHEM, V278, P19891, DOI 10.1074/jbc.M211778200; FOX KM, 1994, STRUCTURE, V2, P1089, DOI 10.1016/S0969-2126(94)00111-1; FRENCH CE, 1994, BIOCHEM J, V301, P97, DOI 10.1042/bj3010097; French CE, 1998, APPL ENVIRON MICROB, V64, P2864; French CE, 1996, J BACTERIOL, V178, P6623, DOI 10.1128/jb.178.22.6623-6627.1996; Haarer BK, 2004, MOL BIOL CELL, V15, P4522, DOI 10.1091/mbc.E04-06-0445; Haynes CA, 2002, J BIOL CHEM, V277, P11513, DOI 10.1074/jbc.M111334200; Heidelberg JF, 2002, NAT BIOTECHNOL, V20, P1118, DOI 10.1038/nbt749; Khan H, 2002, J BIOL CHEM, V277, P21906, DOI 10.1074/jbc.M200637200; Kitzing K, 2005, J BIOL CHEM, V280, P27904, DOI 10.1074/jbc.M502587200; Koder RL, 2002, BIOCHEMISTRY-US, V41, P14197, DOI 10.1021/bi025805t; Kohli RM, 1998, J BIOL CHEM, V273, P32763, DOI 10.1074/jbc.273.49.32763; Komduur JA, 2002, CURR GENET, V41, P401, DOI 10.1007/s00294-002-0321-z; Kubata BK, 2002, J EXP MED, V196, P1241, DOI 10.1084/jem.20020885; Kubo I, 2004, J APPL MICROBIOL, V96, P693, DOI 10.1111/j.1365-2672.2003.02175.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee J, 1999, J BIOL CHEM, V274, P16040, DOI 10.1074/jbc.274.23.16040; Marshall SJ, 2004, J BACTERIOL, V186, P1802, DOI 10.1128/JB.186.6.1802-1810.2004; Meah Y, 2000, P NATL ACAD SCI USA, V97, P10733, DOI 10.1073/pnas.190345597; Meah Y, 2001, P NATL ACAD SCI USA, V98, P8560, DOI 10.1073/pnas.151249098; Messiha HL, 2005, J BIOL CHEM, V280, P27103, DOI 10.1074/jbc.M502293200; MIRANDA M, 1995, YEAST, V11, P459, DOI 10.1002/yea.320110509; NIINO YS, 1995, J BIOL CHEM, V270, P1983, DOI 10.1074/jbc.270.5.1983; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pak JW, 2000, APPL ENVIRON MICROB, V66, P4742, DOI 10.1128/AEM.66.11.4742-4750.2000; Reekmans R, 2005, FEMS YEAST RES, V5, P711, DOI 10.1016/j.femsyr.2004.12.010; Schaller F, 1997, J BIOL CHEM, V272, P28066, DOI 10.1074/jbc.272.44.28066; Snape JR, 1997, J BACTERIOL, V179, P7796, DOI 10.1128/jb.179.24.7796-7802.1997; STEWART RC, 1985, J BIOL CHEM, V260, P3639; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; STOTT K, 1993, J BIOL CHEM, V268, P6097; Strassner J, 1999, J BIOL CHEM, V274, P35067, DOI 10.1074/jbc.274.49.35067; VAZ ADN, 1995, BIOCHEMISTRY-US, V34, P4246, DOI 10.1021/bi00013a014; Wada M, 2003, APPL ENVIRON MICROB, V69, P933, DOI 10.1128/AEM.69.2.933-937.2003; Williams RE, 2002, MICROBIOL-SGM, V148, P1607, DOI 10.1099/00221287-148-6-1607; Williams RE, 2004, APPL ENVIRON MICROB, V70, P3566, DOI 10.1128/AEM.70.6.3566-3574.2004; Xu D, 1999, P NATL ACAD SCI USA, V96, P3556, DOI 10.1073/pnas.96.7.3556	52	28	30	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					28152	28161		10.1074/jbc.M603946200	http://dx.doi.org/10.1074/jbc.M603946200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16857682	hybrid			2022-12-27	WOS:000240534400053
J	Wilkes, MC; Leof, EB				Wilkes, Mark C.; Leof, Edward B.			Transforming growth factor beta activation of c-Abl is independent of receptor internalization and regulated by phosphatidylinositol 3-kinase and PAK2 in mesenchymal cultures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; TYROSINE KINASE; EARLY ENDOSOMES; FAMILY KINASES; SMAD; DIFFERENTIATION; TRANSCRIPTION; SPECIFICITY; MECHANISMS; INHIBITION	Transforming growth factor beta(TGF-beta) modulates a number of cellular phenotypes as divergent as growth stimulation and growth inhibition. Although the Smad pathway is critical for many of these responses, recent evidence indicates that Smad-independent pathways may also have a critical role. One such protein previously shown to regulate TGF-beta action independent of the Smad proteins is the c-Abl nonreceptor tyrosine kinase. In the current study we determined that TGF-beta receptor signaling activates c-Abl kinase activity in a subset of fibroblast but not epithelial cultures. This cell type-specific response occurs in a membrane-proximal locale independent of receptor internalization and upstream of dynamin action. Although c-Abl activation by TGF-beta is independent of Smad2 or Smad3, it is prevented by inhibitors of phosphatidylinositol 3-kinase or PAK2. Thus, c-Abl represents a target downstream of phosphatidylinositol 3-kinase-activated PAK2, which differentiates TGF-beta signaling in fibroblasts and epithelial cell lines and integrates serine/threonine receptor kinases with tyrosine kinase pathways.	Mayo Clin & Mayo Fdn, Coll Med, Dept Biochem & Mol Biol, Thorac Dis Res Unit, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Coll Med, Ctr Canc, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Leof, EB (corresponding author), Mayo Clin & Mayo Fdn, Coll Med, Dept Biochem & Mol Biol, Thorac Dis Res Unit, 200 1st St SW,Stabile 8-58, Rochester, MN 55905 USA.	leof.edward@mayo.edu		Wilkes, Mark/0000-0002-9600-6831	NIGMS NIH HHS [R01 GM54200, R01 GM55816] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055816, R01GM054200] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anders RA, 1998, J BIOL CHEM, V273, P23118, DOI 10.1074/jbc.273.36.23118; Anders RA, 1996, J BIOL CHEM, V271, P21758, DOI 10.1074/jbc.271.36.21758; Chen YG, 1998, GENE DEV, V12, P2144, DOI 10.1101/gad.12.14.2144; Cogan JG, 2002, J BIOL CHEM, V277, P36433, DOI 10.1074/jbc.M203232200; Daniels CE, 2004, J CLIN INVEST, V114, P1308, DOI 10.1175/JCI200419603; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Elliott RL, 2005, J CLIN ONCOL, V23, P2078, DOI 10.1200/JCO.2005.02.047; Engel ME, 1999, J BIOL CHEM, V274, P37413, DOI 10.1074/jbc.274.52.37413; Feng XH, 1997, EMBO J, V16, P3912, DOI 10.1093/emboj/16.13.3912; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Flanders KC, 2004, INT J EXP PATHOL, V85, P47, DOI 10.1111/j.0959-9673.2004.00377.x; GROFFEN J, 1984, CELL, V36, P93, DOI 10.1016/0092-8674(84)90077-1; Hayes S, 2002, J CELL BIOL, V158, P1239, DOI 10.1083/jcb.200204088; Hernandez SE, 2004, TRENDS CELL BIOL, V14, P36, DOI 10.1016/j.tcb.2003.11.003; Hocevar BA, 1999, EMBO J, V18, P1345, DOI 10.1093/emboj/18.5.1345; Javelaud D, 2005, ONCOGENE, V24, P5742, DOI 10.1038/sj.onc.1208928; LEOF EB, 1986, J CELL PHYSIOL, V127, P83, DOI 10.1002/jcp.1041270111; Levy L, 2005, MOL CELL BIOL, V25, P8108, DOI 10.1128/MCB.25.18.8108-8125.2005; Lu ZX, 2002, J BIOL CHEM, V277, P29363, DOI 10.1074/jbc.M203495200; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Moses HL, 1996, CURR OPIN GENET DEV, V6, P581, DOI 10.1016/S0959-437X(96)80087-6; MOSES HL, 1990, CELL, V63, P245, DOI 10.1016/0092-8674(90)90155-8; MOSES HL, 1981, CANCER RES, V41, P2842; MOSES HL, 1985, CANCER CELL, V3, P65; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Pendergast AM, 2002, ADV CANCER RES, V85, P51, DOI 10.1016/S0065-230X(02)85003-5; Penheiter SG, 2002, MOL CELL BIOL, V22, P4750, DOI 10.1128/MCB.22.13.4750-4759.2002; Piek E, 2001, J BIOL CHEM, V276, P19945, DOI 10.1074/jbc.M102382200; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; ROBERTS AB, 1992, MOL REPROD DEV, V32, P91, DOI 10.1002/mrd.1080320203; ROBERTS AB, 1982, NATURE, V295, P417, DOI 10.1038/295417a0; ROBERTS AB, 1981, P NATL ACAD SCI-BIOL, V78, P5339, DOI 10.1073/pnas.78.9.5339; Roig J, 2000, J BIOL CHEM, V275, P16933, DOI 10.1074/jbc.M001627200; Runyan CE, 2005, J BIOL CHEM, V280, P8300, DOI 10.1074/jbc.M407939200; Sharma DK, 2003, J BIOL CHEM, V278, P7564, DOI 10.1074/jbc.M210457200; Smith JM, 2002, FRONT BIOSCI, V7, pD31; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Van Etten RA, 1999, TRENDS CELL BIOL, V9, P179, DOI 10.1016/S0962-8924(99)01549-4; WANG JYJ, 1984, CELL, V36, P349; Wang SN, 2005, FASEB J, V19, P1, DOI 10.1096/fj.04-2370com; Wang YX, 2001, P NATL ACAD SCI USA, V98, P14865, DOI 10.1073/pnas.251249298; Wilkes MC, 2005, CANCER RES, V65, P10431, DOI 10.1158/0008-5472.CAN-05-1522; Wilkes MC, 2003, MOL CELL BIOL, V23, P8878, DOI 10.1128/MCB.23.23.8878-8889.2003; Woodring PJ, 2003, J CELL SCI, V116, P2613, DOI 10.1242/jcs.00622; Woodring PJ, 2002, J CELL BIOL, V156, P879, DOI 10.1083/jcb.200110014; Woodring PJ, 2001, J BIOL CHEM, V276, P27104, DOI 10.1074/jbc.M100559200; Yue JB, 2001, PHARMACOL THERAPEUT, V91, P1, DOI 10.1016/S0163-7258(01)00143-7; Zhu JY, 2004, CURR TOP DEV BIOL, V59, P165, DOI 10.1016/S0070-2153(04)59007-5	49	60	62	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					27846	27854		10.1074/jbc.M603721200	http://dx.doi.org/10.1074/jbc.M603721200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16867995	hybrid			2022-12-27	WOS:000240534400020
J	Panizzi, P; Boxrud, PD; Verhamme, IM; Bock, PE				Panizzi, Peter; Boxrud, Paul D.; Verhamme, Ingrid M.; Bock, Paul E.			Binding of the COOH-terminal lysine residue of streptokinase to plasmin(ogen) kringles enhances formation of the streptokinase center dot plasmin(ogen) catalytic complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN ACTIVATOR COMPLEX; CONFORMATIONAL ACTIVATION; DOMAIN INTERACTIONS; KINETIC MECHANISM; ALPHA-DOMAIN; SITE; FIBRINOLYSIS; GENERATION; PROTEASES; SEQUENCE	Streptokinase (SK) activates human fibrinolysis by inducing non-proteolytic activation of the serine proteinase zymogen, plasminogen (Pg), in the SK center dot Pg* catalytic complex. SK center dot Pg* proteolytically activates Pg to plasmin (Pm). SK-induced Pg activation is enhanced by lysine-binding site (LBS) interactions with kringles on Pg and Pm, as evidenced by inhibition of the reactions by the lysine analogue, 6- aminohexanoic acid. Equilibrium binding analysis and [Lys] Pg activation kinetics with wild-type SK, carboxypeptidase B-treated SK, and a COOH-terminal Lys(414) deletion mutant (SK Delta K414) demonstrated a critical role for Lys414 in the enhancement of [Lys] Pg and [Lys] Pm binding and conformational [Lys] Pg activation. The LBS-independent affinity ofSKfor [Glu] Pg was unaffected by deletion of Lys(414). By contrast, removal of SK Lys414 caused 19- and 14-fold decreases in SK affinity for [Lys] Pg and [ Lys] Pm binding in the catalytic mode, respectively. In kinetic studies of the coupled conformational and proteolytic activation of [Lys] Pg, SK Delta K-414 exhibited a corresponding 17-fold affinity decrease for formation of the SK Delta K-414[Lys]Pg* complex. SK Delta K414 binding to [Lys] Pg and [Lys] Pm and conformational [Lys] Pg activation were LBS-independent, whereas [Lys] Pg substrate binding and proteolytic [Lys] Pm generation remained LBS-dependent. We conclude that binding of SK Lys414 to [Lys] Pg and [Lys] Pm kringles enhances SK[Lys] Pg* and SK[Lys] Pm catalytic complex formation. This interaction is distinct structurally and functionally from LBS-dependent Pg substrate recognition by these complexes.	Vanderbilt Univ, Sch Med, Dept Pathol, Med Ctr N, Nashville, TN 37232 USA	Vanderbilt University	Bock, PE (corresponding author), Vanderbilt Univ, Sch Med, Dept Pathol, Med Ctr N, C3321A, Nashville, TN 37232 USA.	paul.bock@vanderbilt.edu	Panizzi, Peter/A-6072-2019	Panizzi, Peter/0000-0003-0141-8807	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056181, R00HL094533] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL056181-12, R01 HL056181, R00 HL094533, HL056181] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bean RR, 2005, J BIOL CHEM, V280, P7504, DOI 10.1074/jbc.M411637200; Bock PE, 1996, J BIOL CHEM, V271, P1072, DOI 10.1074/jbc.271.2.1072; BOK RA, 1985, BIOCHEMISTRY-US, V24, P3279, DOI 10.1021/bi00334a031; Boxrud PD, 2000, J BIOL CHEM, V275, P14579, DOI 10.1074/jbc.275.19.14579; Boxrud PD, 2000, BIOCHEMISTRY-US, V39, P13974, DOI 10.1021/bi000594i; Boxrud PD, 2004, J BIOL CHEM, V279, P36633, DOI 10.1074/jbc.M405264200; Boxrud PD, 2004, J BIOL CHEM, V279, P36642, DOI 10.1074/jbc.M405265200; Boxrud PD, 2001, J BIOL CHEM, V276, P26084, DOI 10.1074/jbc.M101966200; Castellino FJ, 1997, CIBA F SYMP, V212, P46; Chaudhary A, 1999, PROTEIN SCI, V8, P2791; CLEMMENSEN I, 1986, EUR J BIOCHEM, V156, P327, DOI 10.1111/j.1432-1033.1986.tb09586.x; COLLEN D, 1991, BLOOD, V78, P3114; Conejero-Lara F, 1998, PROTEIN SCI, V7, P2190, DOI 10.1002/pro.5560071017; Dhar J, 2002, J BIOL CHEM, V277, P13257, DOI 10.1074/jbc.M108422200; GONZALEZGRONOW M, 1978, J BIOL CHEM, V253, P1090; HORTIN GL, 1988, BIOCHEM BIOPH RES CO, V155, P591, DOI 10.1016/S0006-291X(88)80535-7; JACKSON KW, 1982, BIOCHEMISTRY-US, V21, P6620, DOI 10.1021/bi00269a001; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; LIJNEN HR, 1980, J BIOL CHEM, V255, P214; Lin LF, 2000, BIOCHEMISTRY-US, V39, P4740, DOI 10.1021/bi992028x; Loy JA, 2001, BIOCHEMISTRY-US, V40, P14686, DOI 10.1021/bi011309d; LUCAS MA, 1983, J BIOL CHEM, V258, P4249; MARSHALL JM, 1994, BIOCHEMISTRY-US, V33, P3599, DOI 10.1021/bi00178a017; MCCANCE SG, 1995, BIOCHEMISTRY-US, V34, P9581, DOI 10.1021/bi00029a035; MCCLINTOCK DK, 1971, BIOCHEM BIOPH RES CO, V43, P694, DOI 10.1016/0006-291X(71)90670-X; PONTING CP, 1992, BIOCHIM BIOPHYS ACTA, V1159, P155, DOI 10.1016/0167-4838(92)90020-E; PONTING CP, 1992, BLOOD COAGUL FIBRIN, V3, P605, DOI 10.1097/00001721-199210000-00012; REDDY KNN, 1972, J BIOL CHEM, V247, P1683; Sazonova IY, 2004, J BIOL CHEM, V279, P24994, DOI 10.1074/jbc.M400253200; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCHICK LA, 1974, BIOCHEM BIOPH RES CO, V57, P47, DOI 10.1016/S0006-291X(74)80355-4; VIOLAND BN, 1978, J BIOL CHEM, V253, P5395; Wang XQ, 1998, SCIENCE, V281, P1662, DOI 10.1126/science.281.5383.1662; WIMAN B, 1978, NATURE, V272, P549, DOI 10.1038/272549a0; WIMAN B, 1978, EUR J BIOCHEM, V84, P573, DOI 10.1111/j.1432-1033.1978.tb12200.x; WOHL RC, 1980, J BIOL CHEM, V255, P2005	36	23	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2006	281	37					26774	26778		10.1074/jbc.C600171200	http://dx.doi.org/10.1074/jbc.C600171200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082PB	16857686	Green Accepted, hybrid			2022-12-27	WOS:000240397700003
J	White, D; Musse, AA; Wang, J; London, E; Merrill, AR				White, Dawn; Musse, Abdiwahab A.; Wang, Jie; London, Erwin; Merrill, A. Rod			Toward elucidating the membrane topology of helix two of the colicin E1 channel domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORE-FORMING COLICINS; BCL-2 FAMILY PROTEINS; E1 CHANNEL; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; LIPID-BILAYERS; ION-CHANNEL; ANGSTROM RESOLUTION; DIPHTHERIA-TOXIN; MOLECULAR-BASIS	The membrane-bound closed state of the colicin E1 channel domain was investigated by site-directed fluorescence labeling using a bimane fluorophore attached to each single cysteine residue within helix 2 of each mutant protein. The fluorescence properties of the bimane fluorophore were measured for the membrane-associated form of the closed channel and included fluorescence emission maximum, fluorescence anisotropy, apparent polarity, surface accessibility, and membrane bilayer penetration depth. The fluorescence data show that helix 2 is an amphipathic alpha-helix that is situated parallel to the membrane surface, but it is less deeply embedded within the bilayer interfacial region than is helix 1 in the closed channel. A least squares fit of the various data sets to a harmonic wave function indicated that the periodicity and angular frequency for helix 2 in the membrane-bound state are typical for an amphipathic alpha-helix (3.8 +/- 0.1 residues per turn and 94 +/- 4 degrees, respectively) that is located at an interfacial region of a membrane bilayer. Dual quencher analysis also revealed that helix 2 is peripherally membrane associated, with one face of the helix dipping into the interfacial region of the lipid bilayer and the other face projecting outwardly into the aqueous solvent. Finally, our data show that helices 1 and 2 remain independent helices upon membrane association with a short connector link (Tyr(363)-Gly(364)) and that short amphipathic alpha-helices participate in the formation of a lipid-dependent, toroidal pore for this colicin.	Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	University of Guelph; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Merrill, AR (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	rmerrill@uoguelph.ca	Merrill, Rod/M-8313-2014		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031986] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 31986] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAMS CK, 1991, J GEN PHYSIOL, V98, P77, DOI 10.1085/jgp.98.1.77; Alvarez C, 2003, CHEM PHYS LIPIDS, V122, P97, DOI 10.1016/S0009-3084(02)00181-0; Anderluh G, 2003, J BIOL CHEM, V278, P45216, DOI 10.1074/jbc.M305916200; Basanez G, 2002, J BIOL CHEM, V277, P49360, DOI 10.1074/jbc.M206069200; Berne S, 2005, BIOCHEMISTRY-US, V44, P11137, DOI 10.1021/bi051013y; BRUNDEN KR, 1984, J BIOL CHEM, V259, P190; Caputo GA, 2003, BIOCHEMISTRY-US, V42, P3265, DOI 10.1021/bi026696l; COOPER PC, 1984, J GEN MICROBIOL, V130, P209; CORNETTE JL, 1987, J MOL BIOL, V195, P659, DOI 10.1016/0022-2836(87)90189-6; CRAMER WA, 1995, ANNU REV BIOPH BIOM, V24, P611, DOI 10.1146/annurev.biophys.24.1.611; DANKERT JR, 1982, J BIOL CHEM, V257, P3857; Dempsey CE, 2003, BIOCHEMISTRY-US, V42, P402, DOI 10.1021/bi026328h; Elkins P, 1997, STRUCTURE, V5, P443, DOI 10.1016/S0969-2126(97)00200-1; Eraso JM, 1996, J BACTERIOL, V178, P1928, DOI 10.1128/jb.178.7.1928-1935.1996; Eun SY, 2006, MOL CELLS, V21, P229; Filloux A, 2002, BIOCHIMIE, V84, P489, DOI 10.1016/S0300-9084(02)01412-8; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; Garcia-Saez AJ, 2004, BIOCHEMISTRY-US, V43, P10930, DOI 10.1021/bi036044c; Gouaux E, 1997, STRUCTURE, V5, P313, DOI 10.1016/S0969-2126(97)00188-3; GOULD JM, 1977, J BIOL CHEM, V252, P5491; HARKNESS RE, 1989, J BIOL CHEM, V264, P6177; Hayashibara M, 2005, BIOCHEMISTRY-US, V44, P2183, DOI 10.1021/bi0482093; Hilsenbeck JL, 2004, MOL MICROBIOL, V51, P711, DOI 10.1111/j.1365-2958.2003.03884.x; Jakes KS, 1999, Q REV BIOPHYS, V32, P189, DOI 10.1017/S0033583599003492; Kim Y, 1998, PROTEIN SCI, V7, P342; Ladokhin AS, 2002, BIOCHEMISTRY-US, V41, P13617, DOI 10.1021/bi0264418; Lakey JH, 2001, CURR TOP MICROBIOL, V257, P131; Lazdunski CJ, 1998, J BACTERIOL, V180, P4993, DOI 10.1128/JB.180.19.4993-5002.1998; Lindeberg M, 2000, J MOL BIOL, V295, P679, DOI 10.1006/jmbi.1999.3396; Malenbaum SE, 1998, J NAT TOXINS, V7, P269; Masaki H, 2002, BIOCHIMIE, V84, P433, DOI 10.1016/S0300-9084(02)01425-6; McDonnell JM, 1999, CELL, V96, P625, DOI 10.1016/S0092-8674(00)80573-5; MERRILL AR, 1990, BIOCHEMISTRY-US, V29, P8529, DOI 10.1021/bi00489a004; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Musse AA, 2003, J BIOL CHEM, V278, P24491, DOI 10.1074/jbc.M302371200; Musse AA, 2006, J BIOL CHEM, V281, P885, DOI 10.1074/jbc.M511140200; PALMER LR, 1994, J BIOL CHEM, V269, P4187; PARKER MW, 1992, J MOL BIOL, V224, P639, DOI 10.1016/0022-2836(92)90550-4; Petros AM, 2000, PROTEIN SCI, V9, P2528, DOI 10.1017/S096183680000331X; RICHMOND TJ, 1978, J MOL BIOL, V119, P537, DOI 10.1016/0022-2836(78)90201-2; Salwinski L, 1999, PROTEIN SCI, V8, P562; Schendel SL, 1998, CELL DEATH DIFFER, V5, P372, DOI 10.1038/sj.cdd.4400365; Schendel SL, 2000, METHOD ENZYMOL, V322, P274; SHIN YK, 1993, SCIENCE, V259, P960, DOI 10.1126/science.8382373; Slatin SL, 2004, J MEMBRANE BIOL, V202, P73, DOI 10.1007/s00232-004-0720-9; Sobko AA, 2004, FEBS LETT, V576, P205, DOI 10.1016/j.febslet.2004.09.016; Sobko AA, 2006, J BIOL CHEM, V281, P14408, DOI 10.1074/jbc.M513634200; SONG HY, 1991, J BACTERIOL, V173, P2935, DOI 10.1128/JB.173.9.2935-2943.1991; STEER BA, 1995, BIOCHEMISTRY-US, V34, P7225, DOI 10.1021/bi00021a038; Stroud RM, 1998, CURR OPIN STRUC BIOL, V8, P525, DOI 10.1016/S0959-440X(98)80132-2; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Taylor R, 1998, J BIOL CHEM, V273, P31113, DOI 10.1074/jbc.273.47.31113; Tory MC, 2002, BBA-BIOMEMBRANES, V1564, P435, DOI 10.1016/S0005-2736(02)00493-5; Tory MC, 1999, J BIOL CHEM, V274, P24539, DOI 10.1074/jbc.274.35.24539; Vetter IR, 1998, STRUCTURE, V6, P863, DOI 10.1016/S0969-2126(98)00088-4; Wiener M, 1997, NATURE, V385, P461, DOI 10.1038/385461a0; Yan L, 2003, FEBS LETT, V555, P545, DOI 10.1016/s0014-5793(03)01346-2; Zakharov SD, 1999, BIOCHEMISTRY-US, V38, P11325, DOI 10.1021/bi9903087; Zakharov SD, 1998, P NATL ACAD SCI USA, V95, P4282, DOI 10.1073/pnas.95.8.4282; Zakharov SD, 2004, BBA-BIOMEMBRANES, V1666, P239, DOI 10.1016/j.bbamem.2004.07.001; Zakharov SD, 2004, FRONT BIOSCI-LANDMRK, V9, P1311, DOI 10.2741/1334; Zakharov SD, 2002, BBA-BIOMEMBRANES, V1565, P333, DOI 10.1016/S0005-2736(02)00579-5; Zakharov SD, 2002, BIOCHIMIE, V84, P465, DOI 10.1016/S0300-9084(02)01453-0; ZHANG YL, 1992, PROTEIN SCI, V1, P1666, DOI 10.1002/pro.5560011215; Zhao G, 2005, BIOCHEMISTRY-US, V44, P4488, DOI 10.1021/bi047705o	65	10	10	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32375	32384		10.1074/jbc.M605880200	http://dx.doi.org/10.1074/jbc.M605880200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16854987	hybrid			2022-12-27	WOS:000241414500035
J	Liu, XS; Shi, Y; Birnbaum, MJ; Ye, KQ; De Jong, R; Oltersdorf, T; Giranda, VL; Luo, Y				Liu, Xuesong; Shi, Yan; Birnbaum, Morris J.; Ye, Keqiang; De Jong, Ron; Oltersdorf, Tillman; Giranda, Vincent L.; Luo, Yan			Quantitative analysis of anti-apoptotic function of Akt in Akt1 and Akt2 double knock-out mouse embryonic fibroblast cells under normal and stressed conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE B; MOLECULAR-CLONING; CRITICAL ROLES; CANCER CELLS; MICE LACKING; GROWTH; PHOSPHORYLATION; IDENTIFICATION; RESISTANCE; ONCOGENE	The serine/threonine kinases Akt1/PKB alpha, Akt2/PKB beta, and Akt3/PKB gamma have been implicated in preventing cells from undergoing apoptosis. Although several small molecule inhibitors of Akt have been reported to induce apoptosis in cancer cells, these inhibitors may have additional targets. In the current study, we used an Akt3 small interfering RNA (Akt3 siRNA) to analyze apoptosis induction in Akt1 and Akt2 double knock-out mouse embryonic fibroblast cells (MEF-Akt1,2-DKO). Our data indicated that Akt3 siRNA inhibited Akt3 protein expression in a dose-dependent manner. As a result, phosphorylation of Akt and its downstream targets, including FKHRL1 and GSK3 alpha/beta, were reduced accordingly. The treatment also induced apoptosis in MEF-Akt1,2-DKO cells. However, apoptosis induction is significant only when more than 80% of Akt3 protein was depleted. Reintroducing Akt3 totally rescued Akt3-siRNA-induced apoptosis in MEF-Akt1,2-DKO cells. In addition, reintroducing Akt1 also inhibited apoptosis induced by Akt3 siRNA. Moreover, Akt3 siRNA potentiated different stress-induced apoptosis in MEF-Akt1,2-DKO cells at a lower dose when compared with what is required for apoptosis induction by itself. Our study suggests that only a small portion of Akt is active in wild-type MEF cells and a threshold of Akt inhibition is required to induce apoptosis by pure Akt inhibitors. In addition, our data indicate that cells under stress require more Akt for its survival.	Abbott Labs, Dept Canc Res R47S, Abbott Pk, IL 60064 USA; Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; Idun Pharmaceut, San Diego, CA 92121 USA	Abbott Laboratories; University of Pennsylvania; Emory University	Luo, Y (corresponding author), Abbott Labs, Dept Canc Res R47S, 100 Abbott Pk Rd, Abbott Pk, IL 60064 USA.	Yan.luo@abbott.com		Birnbaum, Morris/0000-0001-9972-8680				Ahn JY, 2004, EMBO J, V23, P3995, DOI 10.1038/sj.emboj.7600392; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Balendran A, 1999, CURR BIOL, V9, P393, DOI 10.1016/S0960-9822(99)80186-9; BELLACOSA A, 1991, SCIENCE, V254, P274, DOI 10.1126/science.1833819; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; CHENG JQ, 1992, P NATL ACAD SCI USA, V89, P9267, DOI 10.1073/pnas.89.19.9267; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Clark AS, 2002, MOL CANCER THER, V1, P707; COFFER PJ, 1991, EUR J BIOCHEM, V201, P475, DOI 10.1111/j.1432-1033.1991.tb16305.x; Czauderna F, 2003, NUCLEIC ACIDS RES, V31, P670, DOI 10.1093/nar/gkg141; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; JONES PF, 1991, P NATL ACAD SCI USA, V88, P4171, DOI 10.1073/pnas.88.10.4171; Liu X, 2005, J NEUROCHEM, V93, P892, DOI 10.1111/j.1471-4159.2005.03064.x; Liu XS, 2004, ANTICANCER RES, V24, P2697; Luo Y, 2005, MOL CANCER THER, V4, P977, DOI 10.1158/1535-7163.MCT-05-0005; Mandal M, 2005, BRIT J CANCER, V92, P1899, DOI 10.1038/sj.bjc.6602595; Martelli AM, 2003, LEUKEMIA, V17, P1794, DOI 10.1038/sj.leu.2403044; Masure S, 1999, EUR J BIOCHEM, V265, P353, DOI 10.1046/j.1432-1327.1999.00774.x; Nakatani K, 1999, BIOCHEM BIOPH RES CO, V257, P906, DOI 10.1006/bbrc.1999.0559; Persad S, 2001, J BIOL CHEM, V276, P27462, DOI 10.1074/jbc.M102940200; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; STAAL SP, 1987, P NATL ACAD SCI USA, V84, P5034, DOI 10.1073/pnas.84.14.5034; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Sugatani T, 2005, J BIOL CHEM, V280, P3583, DOI 10.1074/jbc.M410480200; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Toker A, 2000, J BIOL CHEM, V275, P8271, DOI 10.1074/jbc.275.12.8271	32	31	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31380	31388		10.1074/jbc.M606603200	http://dx.doi.org/10.1074/jbc.M606603200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16923802				2022-12-27	WOS:000241235300022
J	Mellody, KT; Freeman, LJ; Baldock, C; Jowitt, TA; Siegler, V; Raynal, BDE; Cain, SA; Wess, TJ; Shuttleworth, CA; Kielty, CM				Mellody, Kieran T.; Freeman, Lyle J.; Baldock, Clair; Jowitt, Thomas A.; Siegler, Veronique; Raynal, Bertrand D. E.; Cain, Stuart A.; Wess, Tim J.; Shuttleworth, C. Adrian; Kielty, Cay M.			Marfan syndrome-causing mutations in fibrillin-1 result in gross morphological alterations and highlight the structural importance of the second hybrid domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-ANGLE SCATTERING; CALCIUM-BINDING PROPERTIES; LOW-RESOLUTION STRUCTURE; RAY SOLUTION SCATTERING; EGF-LIKE DOMAINS; MICROFIBRIL ORGANIZATION; RICH MICROFIBRILS; CODING SEQUENCE; ELASTIC FIBERS; PAIR	Mutations in fibrillin-1 result in Marfan syndrome, which affects the cardiovascular, skeletal and ocular systems. The multiorgan involvement and wide spectrum of associated phenotypes highlights the complex pathogenesis underlying Marfan syndrome. To elucidate the genotype to phenotype correlations, we engineered four Marfan syndrome causing mutations into a fibrillin-1 fragment encoded by exons 18-25, a region known to interact with tropoelastin. Biophysical and biochemical approaches, including small angle x-ray scattering, analytical ultracentrifugation, and circular dichroism, were used to study the impact of these mutations upon the structure and function of the protein. Mutations G880S, C862R, and C908R, situated within the second hybrid domain, disrupted the ratio of alpha-helix to beta-sheet leading to a more compact conformation. These data clearly demonstrate the importance of the previously uncharacterized hybrid domain in fibrillin-1 structure. In contrast, mutation K1023N situated within the linker region between the third eight cysteine motif and cbEGF 11 markedly extended the length of the fragment. However, none of the mutations affected tropoelastin binding. The profound effects of all four mutations on fragment conformation suggest that they contribute to the pathogenesis of Marfan syndrome by disrupting protein folding and its assembly into fibrillin-rich microfibrils.	Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; Cardiff Univ, Sch Optometry & Vis Sci, Cardiff CF10 3NB, Wales	University of Manchester; Cardiff University	Kielty, CM (corresponding author), Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England.	cay.kielty@manchester.ac.uk	Cain, Stuart A/G-2836-2017	Cain, Stuart/0000-0001-8417-1058; Mellody, Kieran/0000-0002-8164-9148; raynal, Bertrand/0000-0001-5634-0408; Baldock, Clair/0000-0003-3497-1959; Jowitt, Thomas/0000-0002-4045-0933	MRC [G0300379] Funding Source: UKRI; Medical Research Council [G0300379] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ashworth JL, 2000, BRIT J OPHTHALMOL, V84, P1312, DOI 10.1136/bjo.84.11.1312; Baldock C, 2001, J CELL BIOL, V152, P1045, DOI 10.1083/jcb.152.5.1045; Baldock C, 2006, P NATL ACAD SCI USA, V103, P11922, DOI 10.1073/pnas.0601609103; Bernocco S, 2003, J BIOL CHEM, V278, P7199, DOI 10.1074/jbc.M210857200; Cardy CM, 1998, J MOL BIOL, V276, P855, DOI 10.1006/jmbi.1997.1593; Chatterjee S, 2004, CLIN EXP RHEUMATOL, V22, P617; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; Dietz HC, 2000, MATRIX BIOL, V19, P481, DOI 10.1016/S0945-053X(00)00101-3; Downing AK, 1996, CELL, V85, P597, DOI 10.1016/S0092-8674(00)81259-3; HANDFORD P, 1995, J BIOL CHEM, V270, P6751, DOI 10.1074/jbc.270.12.6751; HANDFORD PA, 1991, NATURE, V351, P164, DOI 10.1038/351164a0; Hayward C, 1997, HUM MUTAT, V10, P415, DOI 10.1002/(SICI)1098-1004(1997)10:6<415::AID-HUMU1>3.3.CO;2-2; Jensen SA, 2001, J BIOL CHEM, V276, P39661, DOI 10.1074/jbc.M104533200; KAINULAINEN K, 1994, NAT GENET, V6, P64, DOI 10.1038/ng0194-64; Katzke S, 2002, HUM MUTAT, V20, P197, DOI 10.1002/humu.10112; Kielty CM, 2005, ADV PROTEIN CHEM, V70, P405, DOI 10.1016/S0065-3233(04)70012-1; KIELTY CM, 1995, J CELL SCI, V108, P1317; Kielty CM, 2002, J CELL SCI, V115, P2817; Knott V, 1996, J MOL BIOL, V255, P22, DOI 10.1006/jmbi.1996.0003; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lee SSJ, 2004, STRUCTURE, V12, P717, DOI 10.1016/j.str.2004.02.023; Loeys BL, 2003, ACTA CLIN BELG, V58, P3, DOI 10.1179/acb.2003.58.1.001; Lu YH, 2005, J MOL BIOL, V349, P73, DOI 10.1016/j.jmb.2005.03.066; Marquez JA, 2003, EMBO J, V22, P4616, DOI 10.1093/emboj/cdg448; MAYHEW M, 1992, PROTEIN ENG, V5, P489, DOI 10.1093/protein/5.6.489; McGettrick AJ, 2000, HUM MOL GENET, V9, P1987, DOI 10.1093/hmg/9.13.1987; Ng CM, 2004, J CLIN INVEST, V114, P1586, DOI 10.1172/JCI22715; Pereira L, 1997, NAT GENET, V17, P218, DOI 10.1038/ng1097-218; Pereira L, 1999, P NATL ACAD SCI USA, V96, P3819, DOI 10.1073/pnas.96.7.3819; Qian RQ, 1997, BIOCHEMISTRY-US, V36, P15841, DOI 10.1021/bi971036f; RAO Z, 1995, CELL, V82, P131, DOI 10.1016/0092-8674(95)90059-4; Reinhardt DP, 1997, J BIOL CHEM, V272, P7368, DOI 10.1074/jbc.272.11.7368; Robinson PN, 2001, CELL MOL LIFE SCI, V58, P1698, DOI 10.1007/PL00000807; ROBINSON PN, 2006, IN PRESS J MED GENET; Rock MJ, 2004, J BIOL CHEM, V279, P23748, DOI 10.1074/jbc.M400212200; Rommel Kathrin, 2002, Hum Mutat, V20, P406, DOI 10.1002/humu.9075; Sakamoto H, 1996, J BIOL CHEM, V271, P4916; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Scott DJ, 2002, J MOL BIOL, V315, P1179, DOI 10.1006/jmbi.2001.5306; SELANDERSUNNERHAGEN M, 1992, J BIOL CHEM, V267, P19642; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Sherratt MJ, 2001, MICRON, V32, P185, DOI 10.1016/S0968-4328(99)00082-7; Smallridge RS, 2003, J BIOL CHEM, V278, P12199, DOI 10.1074/jbc.M208266200; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; SVEDBERG T, 1940, ULTRACENTRIFUGE, P296; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; TANFORD C, 1961, PHYSICAL CHEM MACROM, P306; Tiecke F, 2001, EUR J HUM GENET, V9, P13, DOI 10.1038/sj.ejhg.5200582; TYNAN K, 1993, HUM MOL GENET, V2, P1813, DOI 10.1093/hmg/2.11.1813; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Vollbrandt T, 2004, J BIOL CHEM, V279, P32924, DOI 10.1074/jbc.M405239200; Whiteman P, 1998, PROTEIN ENG, V11, P957, DOI 10.1093/protein/11.11.957; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Yuan XM, 2002, J MOL BIOL, V316, P113, DOI 10.1006/jmbi.2001.5329	56	20	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31854	31862		10.1074/jbc.M602743200	http://dx.doi.org/10.1074/jbc.M602743200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16905551	Bronze			2022-12-27	WOS:000241235300072
J	Benjannet, S; Rhainds, D; Hamelin, JE; Seidah, NG; Seidah, NG				Benjannet, Suzanne; Rhainds, David; Hamelin, Josee; Nassoury, Nasha; Seidah, Nabil G.			The proprotein convertase (PC) PCSK9 is inactivated by furin and/or PC5/6A-Functional consequences of natural mutations and post-translational modifications	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOSOMAL-DOMINANT HYPERCHOLESTEROLEMIA; DENSITY-LIPOPROTEIN RECEPTOR; SECRETORY PATHWAY; LDL RECEPTOR; TARGET GENES; MOUSE-LIVER; IN-VITRO; PROTEIN; CHOLESTEROL; PRECURSOR	PCSK9 is the ninth member of the proprotein convertase ( PC) family. Some of its natural mutations have been genetically associated with the development of a dominant form of familial hyper- or hypocholesterolemia. The exact mechanism of action of PCSK9 is not clear, although it is known to enhance the intracellular degradation of the low density lipoprotein (LDL) receptor in acidic compartments, likely the endosomes/lysosomes. We analyzed the post-translational modifications of PCSK9 and show that it is sulfated within its prosegment at Tyr(38). We also examined the susceptibility of PCSK9 to proteolytic cleavage by the other members of the PC family. The data show that the natural gain-of-function mutations R218S, F216L, and D374Y associated with hypercholesterolemia result in total or partial loss of furin/PC5/6A processing at the motif RFHR218 down arrow. In contrast, the loss-of-function mutations A443T and C679X lead either to the lack of trans-Golgi network/recycling endosome localization and an enhanced susceptibility to furin cleavage (A443T) or to the inability of PCSK9 to exit the endoplasmic reticulum (C679X). Furthermore, we report the presence of both native and furin-like cleaved forms of PCSK9 in circulating human plasma. Thus, we propose that PCSK9 levels are finely regulated by the basic amino acid convertases furin and PC5/6A. The latter may reduce the lifetime of this proteinase and its ability to degrade the cell-surface LDL receptor, thereby regulating the levels of circulating LDL cholesterol.	[Benjannet, Suzanne; Rhainds, David; Hamelin, Josee; Nassoury, Nasha; Seidah, Nabil G.] Clin Res Inst Montreal, Lab Biochem Neuroendocrinol, 110 Pine Ave W, Montreal, PQ H2W 1R7, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Seidah, NG (corresponding author), Clin Res Inst Montreal, Lab Biochem Neuroendocrinol, 110 Pine Ave W, Montreal, PQ H2W 1R7, Canada.	seidahn@ircm.qc.ca	Seidah, Nabil/I-3596-2013	Seidah, Nabil/0000-0001-6503-9342				Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Allard Delphine, 2005, Hum Mutat, V26, P497, DOI 10.1002/humu.9383; ANDERSON ED, 1993, J BIOL CHEM, V268, P24887; Attie AD, 2005, CELL METAB, V1, P290, DOI 10.1016/j.cmet.2005.04.006; Attie AD, 2004, ARTERIOSCL THROM VAS, V24, P1337, DOI 10.1161/01.ATV.0000137288.82390.04; Bedard K, 2005, INT REV CYTOL, V245, P91, DOI 10.1016/S0074-7696(05)45004-4; Benjannet S, 2004, BIOCHEM BIOPH RES CO, V325, P235, DOI 10.1016/j.bbrc.2004.10.019; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Benjannet S, 1997, J BIOL CHEM, V272, P26210, DOI 10.1074/jbc.272.42.26210; Benjannet S, 2001, J BIOL CHEM, V276, P10879, DOI 10.1074/jbc.M009899200; BENJANNET S, 1992, J BIOL CHEM, V267, P11417; Berge KE, 2006, ARTERIOSCL THROM VAS, V26, P1094, DOI 10.1161/01.ATV.0000204337.81286.1c; Bergeron E, 2005, BIOCHEM BIOPH RES CO, V326, P554, DOI 10.1016/j.bbrc.2004.11.063; Brennan SO, 1995, J CLIN INVEST, V96, P2854, DOI 10.1172/JCI118356; Cameron J, 2006, HUM MOL GENET, V15, P1551, DOI 10.1093/hmg/ddl077; Chalhoub N, 2003, NAT MED, V9, P399, DOI 10.1038/nm842; Cheng D, 1999, J BIOL CHEM, V274, P22805, DOI 10.1074/jbc.274.32.22805; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; Decroly E, 1997, FEBS LETT, V405, P68, DOI 10.1016/S0014-5793(97)00156-7; Dubuc G, 2004, ARTERIOSCL THROM VAS, V24, P1454, DOI 10.1161/01.ATV.0000134621.14315.43; Essalmani R, 2006, MOL CELL BIOL, V26, P354, DOI 10.1128/MCB.26.1.354-361.2006; Henrich S, 2003, NAT STRUCT BIOL, V10, P520, DOI 10.1038/nsb941; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Jin WJ, 2005, J BIOL CHEM, V280, P36551, DOI 10.1074/jbc.M502264200; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Lalanne F, 2005, J LIPID RES, V46, P1312, DOI 10.1194/jlr.M400396-JLR200; Lange PF, 2006, NATURE, V440, P220, DOI 10.1038/nature04535; Lazure C, 1998, J BIOL CHEM, V273, P8572, DOI 10.1074/jbc.273.15.8572; Leren TP, 2004, CLIN GENET, V65, P419, DOI 10.1111/j.0009-9163.2004.0238.x; Lonnqvist L, 1998, HUM MOL GENET, V7, P2039, DOI 10.1093/hmg/7.13.2039; Maxwell KN, 2005, P NATL ACAD SCI USA, V102, P2069, DOI 10.1073/pnas.0409736102; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; Maxwell KN, 2003, J LIPID RES, V44, P2109, DOI 10.1194/jlr.M300203-JLR200; Mbikay M, 2001, BIOCHEM J, V357, P329, DOI 10.1042/0264-6021:3570329; Naoumova RP, 2005, ARTERIOSCL THROM VAS, V25, P2654, DOI 10.1161/01.ATV.0000190668.94752.ab; Naureckiene S, 2003, ARCH BIOCHEM BIOPHYS, V420, P55, DOI 10.1016/j.abb.2003.09.011; Nour N, 2005, MOL BIOL CELL, V16, P5215, DOI 10.1091/mbc.E05-06-0504; PAQUET L, 1994, J BIOL CHEM, V269, P19279; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Pisciotta L, 2006, ATHEROSCLEROSIS, V188, P398, DOI 10.1016/j.atherosclerosis.2005.11.016; Pisciotta L, 2006, ATHEROSCLEROSIS, V186, P433, DOI 10.1016/j.atherosclerosis.2005.08.015; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; Roebroek AJM, 2004, J BIOL CHEM, V279, P53442, DOI 10.1074/jbc.M407152200; Seidah NG, 2006, BIOL CHEM, V387, P871, DOI 10.1515/BC.2006.110; Seidah NG, 2002, ESSAYS BIOCHEM, V38, P79, DOI 10.1042/bse0380079; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Seidah NG, 1999, P NATL ACAD SCI USA, V96, P1321, DOI 10.1073/pnas.96.4.1321; Seidah NG, 1996, P NATL ACAD SCI USA, V93, P3388, DOI 10.1073/pnas.93.8.3388; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Timms KM, 2004, HUM GENET, V114, P349, DOI 10.1007/s00439-003-1071-9; Tsuji A, 2006, BIOCHEM J, V396, P51, DOI 10.1042/BJ20051524; Xiang Y, 2000, MOL BIOL CELL, V11, P1257, DOI 10.1091/mbc.11.4.1257; YOSHIMASA Y, 1988, SCIENCE, V240, P784, DOI 10.1126/science.3283938; YOSHIMURA A, 1987, J BIOL CHEM, V262, P13299; Zhong M, 1999, J BIOL CHEM, V274, P33913, DOI 10.1074/jbc.274.48.33913	58	215	264	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30561	30572		10.1074/jbc.M606495200	http://dx.doi.org/10.1074/jbc.M606495200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16912035	hybrid			2022-12-27	WOS:000241075900032
J	Covian, R; Trumpower, BL				Covian, Raul; Trumpower, Bernard L.			Regulatory interactions between ubiquinol oxidation and ubiquinone reduction sites in the dimeric cytochrome bc(1) complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR PROTEIN; BOVINE HEART-MITOCHONDRIA; ELECTRON-TRANSFER; DOMAIN MOVEMENT; C REDUCTASE; SACCHAROMYCES-CEREVISIAE; RESPIRATORY-CHAIN; CRYSTAL-STRUCTURE; Q(O) SITE; QI SITE	We have obtained evidence for conformational communication between ubiquinol oxidation ( center P) and ubiquinone reduction (center N) sites of the yeast bc(1) complex dimer by analyzing antimycin binding and heme b(H) reduction at center N in the presence of different center P inhibitors. When stigmatellin was occupying center P, concentration-dependent binding of antimycin occurred only to half of the center N sites. The remaining half of the bc(1) complex bound antimycin with a slower rate that was independent of inhibitor concentration, indicating that a slow conformational change needed to occur before half of the enzyme could bind antimycin. In contrast, under conditions where the Rieske protein was not fixed proximal to heme b(L) at center P, all center N sites bound antimycin with fast and concentration-dependent kinetics. Additionally, the extent of fast cytochrome b reduction by menaquinol through center N in the presence of stigmatellin was approximately half of that observed when myxothiazol was bound at center P. The reduction kinetics of the b(H) heme by decylubiquinol in the presence of stigmatellin or myxothiazol were also consistent with a model in which fixation of the Rieske protein close to heme b(L) in both monomers allows rapid binding of ligands only to one center N. Decylubiquinol at high concentrations was able to abolish the biphasic binding of antimycin in the presence of stigmatellin but did not slow down antimycin binding rates. These results are discussed in terms of half-of-the-sites activity of the dimeric bc(1) complex.	Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA	Dartmouth College	Trumpower, BL (corresponding author), Dartmouth Med Sch, Dept Biochem, 7200 Vail, Hanover, NH 03755 USA.	Trumpower@Dartmouth.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020379, R37GM020379] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 20379] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BERDEN JA, 1970, BIOCHIM BIOPHYS ACTA, V216, P237, DOI 10.1016/0005-2728(70)90215-X; Berry EA, 2004, PHOTOSYNTH RES, V81, P251, DOI 10.1023/B:PRES.0000036888.18223.0e; Cooley JW, 2005, BIOCHEMISTRY-US, V44, P10520, DOI 10.1021/bi050571+; Covian R, 2005, J BIOL CHEM, V280, P22732, DOI 10.1074/jbc.M413592200; Covian R, 2004, J BIOL CHEM, V279, P15040, DOI 10.1074/jbc.M400193200; Darrouzet E, 2000, P NATL ACAD SCI USA, V97, P4567, DOI 10.1073/pnas.97.9.4567; DIRAGO JP, 1988, J BIOL CHEM, V263, P12564; Esser L, 2004, J MOL BIOL, V341, P281, DOI 10.1016/j.jmb.2004.05.065; Gutierrez-Cirlos EB, 2002, J BIOL CHEM, V277, P1195, DOI 10.1074/jbc.M109097200; Huang LS, 2005, J MOL BIOL, V351, P573, DOI 10.1016/j.jmb.2005.05.053; Hunte C, 2000, STRUCTURE, V8, P669, DOI 10.1016/S0969-2126(00)00152-0; Izrailev S, 1999, BIOPHYS J, V77, P1753, DOI 10.1016/S0006-3495(99)77022-0; Kramer D, 2004, METHOD ENZYMOL, V382, P21; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; LJUNGDAHL O, 1987, BIOCHIM BIOPHYS ACTA, V891, P227; MITCHELL P, 1976, J THEOR BIOL, V62, P327, DOI 10.1016/0022-5193(76)90124-7; Nett JH, 2000, EUR J BIOCHEM, V267, P5777, DOI 10.1046/j.1432-1327.2000.01650.x; OHNISHI T, 1980, J BIOL CHEM, V255, P3278; RICH PR, 1984, BIOCHIM BIOPHYS ACTA, V768, P53, DOI 10.1016/0304-4173(84)90007-7; Snyder C, 1998, BBA-BIOENERGETICS, V1365, P125, DOI 10.1016/S0005-2728(98)00052-8; TRUMPOWER BL, 1979, J BIOL CHEM, V254, P8697; Trumpower BL, 2002, BBA-BIOENERGETICS, V1555, P166, DOI 10.1016/S0005-2728(02)00273-6; TRUMPOWER BL, 1994, ANNU REV BIOCHEM, V63, P675, DOI 10.1146/annurev.bi.63.070194.003331; Valkova-Valchanova M, 2000, BIOCHEMISTRY-US, V39, P15484, DOI 10.1021/bi000751d; VONJAGOW G, 1986, METHOD ENZYMOL, V126, P253; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; Xiao KH, 2000, J BIOL CHEM, V275, P38597, DOI 10.1074/jbc.M007444200; YU CA, 1972, J BIOL CHEM, V247, P1012; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612	29	41	43	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30925	30932		10.1074/jbc.M604694200	http://dx.doi.org/10.1074/jbc.M604694200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16908520	hybrid			2022-12-27	WOS:000241075900068
J	Kaneko, R; Kato, H; Kawamura, Y; Esumi, S; Hirayama, T; Hirabayashi, T; Yagi, T				Kaneko, Ryosuke; Kato, Hiroyuki; Kawamura, Yoshimi; Esumi, Shigeyuki; Hirayama, Teruyoshi; Hirabayashi, Takahiro; Yagi, Takeshi			Allelic gene regulation of Pcdh-alpha and Pcdh-gamma clusters involving both monoallelic and biallelic expression in single Purkinje cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOMIC ORGANIZATION; PROTOCADHERIN-ALPHA; X-CHROMOSOME; FAMILY; PATTERNS; SEQUENCE; MOUSE; INTERLEUKIN-2; INACTIVATION; TRANSCRIPTS	The molecular basis for providing the identity and diversity of single neurons is a key for realizing the brain system. Diverse protocadherin isoforms encoded by the Pcdh-alpha and Pcdh-gamma gene clusters are expressed in all of the vertebrates studied. For the Pcdh-alpha isoforms, differential expression patterns have been found in single Purkinje cells by unusual monoallelic and combinatorial types of gene regulation. Here we investigated total allelic gene regulation in the Pcdh-alpha and -gamma clusters, including the C-type variable exons (C1 to C5) and the Pcdh-gamma A and -gamma B variable exons in single Purkinje cells. Using split single-cell reverse transcription-PCR analysis, almost all of the Purkinje cells at postnatal day 21 biallelically expressed all the C-type isoforms, whereas the Pcdh-alpha isoforms showed both monoallelic and combinatorial expression. The Pcdh-gamma A and -gamma B isoforms also showed differential regulation in each cell with both monoallelic and combinatorial gene regulation. These data indicated that different types of allelic gene regulation ( monoallelic versus biallelic) occurred in the Pcdh-alpha and -gamma clusters, although they were spliced into the same constant exons. It has been reported that each C-type Pcdh-alpha or -gamma transcript has a different expression pattern during brain development, suggesting that the different C-type variable exons may code temporal diversity, although the Pcdh-alpha, -gamma A, and -gamma B isoforms were differential and combinatorial gene regulation within a single cell. Thus, the multiple gene regulations in the Pcdh-alpha and -gamma clusters had a potential mechanism for increasing the diversity of individual neurons in the brain.	Osaka Univ, Grad Sch Frontier Biosci, Labs Integrated Biol, KOKORO Biol Grp, Suita, Osaka 5650871, Japan; Kumamoto Univ, Grad Sch Med Sci, Dept Morphol Neurol Sci, Kumamoto 8608556, Japan	Osaka University; Kumamoto University	Yagi, T (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Labs Integrated Biol, KOKORO Biol Grp, 1-3 Yamadaoka, Suita, Osaka 5650871, Japan.	yagi@fbs.osaka-u.ac.jp	Kawamura, Yoshimi/L-1289-2013	Kawamura, Yoshimi/0000-0002-9864-7974				Bayley JP, 2003, EUR J IMMUNOL, V33, P2142, DOI 10.1002/eji.200323976; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Esumi S, 2005, NAT GENET, V37, P171, DOI 10.1038/ng1500; Frank M, 2005, MOL CELL NEUROSCI, V29, P603, DOI 10.1016/j.mcn.2005.05.001; GARTLER SM, 1983, ANNU REV GENET, V17, P155, DOI 10.1146/annurev.ge.17.120183.001103; Hamada S, 2001, NEUROSCI RES, V41, P207, DOI 10.1016/S0168-0102(01)00281-4; Hollander GA, 1998, SCIENCE, V279, P2118, DOI 10.1126/science.279.5359.2118; Kelly BL, 2000, J IMMUNOL, V165, P2982, DOI 10.4049/jimmunol.165.6.2982; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Murata Y, 2004, J BIOL CHEM, V279, P49508, DOI 10.1074/jbc.M408771200; Mutoh T, 2004, EXP CELL RES, V294, P494, DOI 10.1016/j.yexcr.2003.11.019; Noonan JP, 2004, GENOME RES, V14, P2397, DOI 10.1101/gr.2972804; Nutt SL, 1999, BIOL CHEM, V380, P601, DOI 10.1515/BC.1999.077; Nutt SL, 1999, NAT GENET, V21, P390, DOI 10.1038/7720; Oberdick J, 1998, TRENDS NEUROSCI, V21, P383, DOI 10.1016/S0166-2236(98)01325-3; PERNIS B, 1965, J EXP MED, V122, P853, DOI 10.1084/jem.122.5.853; Rhoades KL, 2000, CURR BIOL, V10, P789, DOI 10.1016/S0960-9822(00)00565-0; Sano Y, 2001, GENOME RES, V11, P1833, DOI 10.1101/gr.194301; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Sugino H, 2004, BIOCHEM BIOPH RES CO, V316, P437, DOI 10.1016/j.bbrc.2004.02.067; Sugino H, 2000, GENOMICS, V63, P75, DOI 10.1006/geno.1999.6066; Tada MN, 2004, GENE, V340, P197, DOI 10.1016/j.gene.2004.07.014; Taguchi Y, 2005, MOL BIOL EVOL, V22, P1433, DOI 10.1093/molbev/msi130; Takei Y, 2001, GENOMICS, V72, P321, DOI 10.1006/geno.2000.6468; Tasic B, 2002, MOL CELL, V10, P21, DOI 10.1016/S1097-2765(02)00578-6; Tilghman SM, 1999, CELL, V96, P185, DOI 10.1016/S0092-8674(00)80559-0; Wang XZ, 2002, GENE DEV, V16, P1890, DOI 10.1101/gad.1004802; Wu Q, 2001, GENOME RES, V11, P389, DOI 10.1101/gr.167301; Wu Q, 2005, GENETICS, V169, P2179, DOI 10.1534/genetics.104.037606; Wu Q, 2000, P NATL ACAD SCI USA, V97, P3124, DOI 10.1073/pnas.060027397; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Yagi T, 2000, GENE DEV, V14, P1169; Yanase H, 2004, GENOMICS, V83, P717, DOI 10.1016/j.ygeno.2003.09.022; ZHANG YH, 1992, NAT GENET, V1, P40, DOI 10.1038/ng0492-40	35	134	135	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30551	30560		10.1074/jbc.M605677200	http://dx.doi.org/10.1074/jbc.M605677200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16893882	hybrid			2022-12-27	WOS:000241075900031
J	Zhao, H; Kim, A; Song, SH; Dean, A				Zhao, Hui; Kim, AeRi; Song, Sang-Hyun; Dean, Ann			Enhancer blocking by chicken beta-globin 5 '-HS4 - Role of enhancer strength and insulator nucleosome depletion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOCUS-CONTROL REGION; RNA-POLYMERASE-II; TRANSCRIPTIONALLY SILENT CHROMATIN; HISTONE ACETYLATION PATTERN; HYPERSENSITIVE SITE 2; INTERGENIC TRANSCRIPTION; PROMOTER COMMUNICATION; BARRIER FUNCTION; IN-VIVO; GENE	The 5'-HS4 chicken beta-globin insulator functions as a positional enhancer blocker on chromatinized episomes in human cells, blocking the HS2 enhancer of the human beta-globin locus control region from activating a downstream epsilon-globin gene. 5'-HS4 interrupted formation of a domain of histone H3 and H4 acetylation encompassing the 6-kb minilocus and inhibited transfer of RNA polymerase from the enhancer to the gene promoter. We found that the enhancer blocking phenotype was amplified when the insulated locus contained a weakened HS2 enhancer in which clustered point mutations eliminated interaction of the transcription factor GATA-1. The GATA-1 mutation compromised recruitment of histone acetyltransferases and RNA polymerase II to HS2. Enhancer blocking correlated with a significant depletion of nucleosomes in the core region of the insulator as revealed by micrococcal nuclease and DNase I digestion studies. Nucleosome depletion at 5'-HS4 was dependent on interaction of the insulator protein CCCTC-binding factor (CTCF) and was required for enhancer blocking. These findings provide evidence that a domain of active chromatin is formed by spreading from an enhancer to a target gene and can be blocked by a nucleosome-free gap in an insulator.	NIDDK, Cellular & Dev Biol Lab, NIH, Bethesda, MD 20892 USA; Pusan Natl Univ, Coll Nat Sci, Dept Mol Biol, Pusan 609735, South Korea	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Pusan National University	Dean, A (corresponding author), NIDDK, Cellular & Dev Biol Lab, NIH, Bldg 50,Rm 3154,50 South Dr,MSC 8028, Bethesda, MD 20892 USA.	anndean@helix.nih.gov			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK015508, Z01DK015508] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Ashe HL, 1997, GENE DEV, V11, P2494, DOI 10.1101/gad.11.19.2494; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bi X, 2004, MOL CELL BIOL, V24, P2118, DOI 10.1128/MCB.24.5.2118-2131.2004; BRESNICK EH, 1993, J BIOL CHEM, V268, P18824; Bulger M, 2003, MOL CELL BIOL, V23, P5234, DOI 10.1128/MCB.23.15.5234-5244.2003; Bulger M, 2002, CURR OPIN GENET DEV, V12, P170, DOI 10.1016/S0959-437X(02)00283-6; CAI H, 1995, NATURE, V376, P533, DOI 10.1038/376533a0; Cantor AB, 2002, ONCOGENE, V21, P3368, DOI 10.1038/sj.onc.1205326; Chiu YH, 2003, GENETICS, V165, P115; Cho DH, 2005, MOL CELL, V20, P483, DOI 10.1016/j.molcel.2005.09.002; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; Dean A, 2006, TRENDS GENET, V22, P38, DOI 10.1016/j.tig.2005.11.001; Elefant F, 2000, J BIOL CHEM, V275, P13827, DOI 10.1074/jbc.275.18.13827; Elgin SCR, 2003, CURR BIOL, V13, pR895, DOI 10.1016/j.cub.2003.11.006; Elnitski L, 1997, J BIOL CHEM, V272, P369; Farrell CM, 2002, MOL CELL BIOL, V22, P3820, DOI 10.1128/MCB.22.11.3820-3831.2002; Filippova GN, 2001, NAT GENET, V28, P335, DOI 10.1038/ng570; Forsberg EC, 2001, BIOESSAYS, V23, P820, DOI 10.1002/bies.1117; Forsberg EC, 2000, P NATL ACAD SCI USA, V97, P14494, DOI 10.1073/pnas.97.26.14494; Fourel G, 2004, BIOESSAYS, V26, P523, DOI 10.1002/bies.20028; Gerasimova TI, 2000, MOL CELL, V6, P1025, DOI 10.1016/S1097-2765(00)00101-5; Gong QH, 1996, MOL CELL BIOL, V16, P6055; Gribnau J, 2000, MOL CELL, V5, P377, DOI 10.1016/S1097-2765(00)80432-3; Hatzis P, 2002, MOL CELL, V10, P1467, DOI 10.1016/S1097-2765(02)00786-4; HEBBES TR, 1994, EMBO J, V13, P1823, DOI 10.1002/j.1460-2075.1994.tb06451.x; Im H, 2005, P NATL ACAD SCI USA, V102, P17065, DOI 10.1073/pnas.0506164102; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Johnson KD, 2002, METHODS, V26, P27, DOI 10.1016/S1046-2023(02)00005-1; Johnson KD, 2002, P NATL ACAD SCI USA, V99, P11760, DOI 10.1073/pnas.192285999; Johnson KD, 2001, MOL CELL, V8, P465, DOI 10.1016/S1097-2765(01)00309-4; Kanduri C, 2000, CURR BIOL, V10, P449, DOI 10.1016/S0960-9822(00)00442-5; Kanduri M, 2002, MOL CELL BIOL, V22, P3339, DOI 10.1128/MCB.22.10.3339-3344.2002; Kim A, 2004, P NATL ACAD SCI USA, V101, P7028, DOI 10.1073/pnas.0307985101; Kim A, 2003, MOL CELL BIOL, V23, P8099, DOI 10.1128/MCB.23.22.8099-8109.2003; Krawczyk M, 2004, J IMMUNOL, V173, P6200, DOI 10.4049/jimmunol.173.10.6200; Lam LT, 1996, J BIOL CHEM, V271, P32421, DOI 10.1074/jbc.271.50.32421; Letting DL, 2003, MOL CELL BIOL, V23, P1334, DOI 10.1128/MCB.23.4.1334-1340.2003; Litt MD, 2001, EMBO J, V20, P2224, DOI 10.1093/emboj/20.9.2224; Masternak K, 2003, NAT IMMUNOL, V4, P132, DOI 10.1038/ni883; McDowell JC, 1999, MOL CELL BIOL, V19, P7600; Morshead KB, 2003, P NATL ACAD SCI USA, V100, P11577, DOI 10.1073/pnas.1932643100; Mutskov VJ, 2002, GENE DEV, V16, P1540, DOI 10.1101/gad.988502; Oki M, 2005, MOL CELL, V19, P707, DOI 10.1016/j.molcel.2005.07.022; Oki M, 2002, CURR OPIN CELL BIOL, V14, P299, DOI 10.1016/S0955-0674(02)00327-7; Orphanides G, 2000, NATURE, V407, P471, DOI 10.1038/35035000; Parnell TJ, 2000, EMBO J, V19, P5864, DOI 10.1093/emboj/19.21.5864; Prioleau MN, 1999, EMBO J, V18, P4035, DOI 10.1093/emboj/18.14.4035; Recillas-Targa F, 2002, P NATL ACAD SCI USA, V99, P6883, DOI 10.1073/pnas.102179399; Scott KC, 1999, GENETICS, V153, P787; Scott KS, 1995, EMBO J, V14, P6258, DOI 10.1002/j.1460-2075.1995.tb00316.x; Steinwaerder DS, 2000, GENE THER, V7, P556, DOI 10.1038/sj.gt.3301139; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; West AG, 2005, HUM MOL GENET, V14, pR101, DOI 10.1093/hmg/ddi104; West AG, 2004, MOL CELL, V16, P453, DOI 10.1016/j.molcel.2004.10.005; West AG, 2002, GENE DEV, V16, P271, DOI 10.1101/gad.954702; Yang XJ, 2004, BIOESSAYS, V26, P1076, DOI 10.1002/bies.20104; Yu Q, 2006, J BIOL CHEM, V281, P3980, DOI 10.1074/jbc.M510140200; Yusufzai TM, 2004, MOL CELL, V13, P291, DOI 10.1016/S1097-2765(04)00029-2; Zhao H, 2005, BIOCHEM CELL BIOL, V83, P516, DOI 10.1139/O05-054; Zhao H, 2004, NUCLEIC ACIDS RES, V32, P4903, DOI 10.1093/nar/gkh832	61	17	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30573	30580		10.1074/jbc.M606803200	http://dx.doi.org/10.1074/jbc.M606803200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16877759	hybrid			2022-12-27	WOS:000241075900033
J	Leighton, BH; Seal, RP; Watts, SD; Skyba, MO; Amara, SG				Leighton, Barbara H.; Seal, Rebecca P.; Watts, Spencer D.; Skyba, Mary O.; Amara, Susan G.			Structural rearrangements at the translocation pore of the human glutamate transporter, EAAT1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID TRANSPORTER; SCANNING MUTAGENESIS REVEALS; RAT-BRAIN; REENTRANT LOOP; FUNCTIONAL-CHARACTERIZATION; CONFORMATIONAL-CHANGES; GLT-1; SUBSTRATE; EXPRESSION; BINDING	Structure- function studies of mammalian and bacterial excitatory amino acid transporters ( EAATs), as well as the crystal structure of a related archaeal glutamate transporter, supportamodelin which TM7, TM8, and the re- entrant loops HP1 and HP2 participate in forming a substrate translocation pathway within each subunit of a trimer. However, the transport mechanism, including precise binding sites for substrates and co-transported ions and changes in the tertiary structure underlying transport, is still not known. In this study, we used chemical cross-linking of introduced cysteine pairs in a cysteine- less version of EAAT1 to examine the dynamics of key domains associated with the translocation pore. Here we show that cysteine substitution at Ala- 395, Ala- 367, and Ala- 440 results in functional single and double cysteine transporters and that in the absence of glutamate or DL- threo-beta-benzyloxyaspartate ( DL- TBOA), A395C in the highly conserved TM7 can be cross- linked to A367C in HP1 and to A440C in HP2. The formation of these disulfide bonds is reversible and occurs intra-molecularly. Interestingly, cross- linking A395C to A367C appears to abolish transport, whereas cross- linking A395C to A440C lowers the affinities for glutamate and DL- TBOA but does not change the maximal transport rate. Additionally, glutamate and DL- TBOA bindingpreventcross- linkinginbothdoublecysteinetransporters, whereas sodium binding facilitates cross- linking in the A395C/ A367C transporter. These data provide evidence that within each subunit of EAAT1, Ala- 395 inTM7resides close to a residue at the tip of each re- entrant loop ( HP1 and HP2) and that these residues are repositioned relative to one another at different steps in the transport cycle. Such behavior likely reflects rearrangements in the tertiary structure of the translocation pore during transport and thus provides constraints for modeling the structural dynamics associated with transport.	Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA 15261 USA; Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94107 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Howard Hughes Medical Institute; Oregon Health & Science University; Oregon Health & Science University; University of California System; University of California San Francisco	Amara, SG (corresponding author), Univ Pittsburgh, Dept Neurobiol, E1440 Biomed Sci Tower, Pittsburgh, PA 15261 USA.	amaras@pitt.edu		Seal, Rebecca/0000-0003-4955-703X; Amara, Susan/0000-0001-8914-1106	NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH011673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033273] Funding Source: NIH RePORTER; NIMH NIH HHS [F31 MH011673] Funding Source: Medline; NINDS NIH HHS [NS33273] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amara SG, 2002, NEUROCHEM INT, V41, P313, DOI 10.1016/S0197-0186(02)00018-9; ARRIZA JL, 1993, J BIOL CHEM, V268, P15329; ARRIZA JL, 1994, J NEUROSCI, V14, P5559; Arriza JL, 1997, P NATL ACAD SCI USA, V94, P4155, DOI 10.1073/pnas.94.8.4155; Bendahan A, 2000, J BIOL CHEM, V275, P37436, DOI 10.1074/jbc.M006536200; Borre L, 2004, J BIOL CHEM, V279, P2513, DOI 10.1074/jbc.M311446200; Bridges RJ, 2005, PHARMACOL THERAPEUT, V107, P271, DOI 10.1016/j.pharmthera.2005.01.002; Brocke L, 2002, J BIOL CHEM, V277, P3985, DOI 10.1074/jbc.M107735200; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Gendreau S, 2004, J BIOL CHEM, V279, P39505, DOI 10.1074/jbc.M408038200; Grewer C, 2005, BIOCHEMISTRY-US, V44, P11913, DOI 10.1021/bi050987n; GRUNEWALD M, 1995, J BIOL CHEM, V270, P17017, DOI 10.1074/jbc.270.28.17017; Grunewald M, 2002, J BIOL CHEM, V277, P26074, DOI 10.1074/jbc.M202248200; Grunewald M, 1998, NEURON, V21, P623, DOI 10.1016/S0896-6273(00)80572-3; Grunewald M, 2000, J BIOL CHEM, V275, P9684, DOI 10.1074/jbc.275.13.9684; Haugeto O, 1996, J BIOL CHEM, V271, P27715, DOI 10.1074/jbc.271.44.27715; Hinoi E, 2005, CNS NEUROL DISORD-DR, V4, P211, DOI 10.2174/1568007053544093; Kanai Y, 2004, PFLUG ARCH EUR J PHY, V447, P469, DOI 10.1007/s00424-003-1146-4; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; KANNER BI, 1978, BIOCHEMISTRY-US, V17, P3949, DOI 10.1021/bi00612a011; Kavanaugh MP, 1997, J BIOL CHEM, V272, P1703, DOI 10.1074/jbc.272.3.1703; Koch HP, 2005, J NEUROSCI, V25, P1730, DOI 10.1523/JNEUROSCI.4138-04.2005; Larsson HP, 2004, P NATL ACAD SCI USA, V101, P3951, DOI 10.1073/pnas.0306737101; Leighton BH, 2002, J BIOL CHEM, V277, P29847, DOI 10.1074/jbc.M202508200; Lolkema JS, 1998, CURR OPIN MICROBIOL, V1, P248, DOI 10.1016/S1369-5274(98)80018-0; PINES G, 1995, J BIOL CHEM, V270, P17093, DOI 10.1074/jbc.270.29.17093; PINES G, 1992, NATURE, V360, P464, DOI 10.1038/360464a0; Seal RP, 2000, NEURON, V25, P695, DOI 10.1016/S0896-6273(00)81071-5; Seal RP, 1998, NEURON, V21, P1487, DOI 10.1016/S0896-6273(00)80666-2; Slotboom DJ, 1999, P NATL ACAD SCI USA, V96, P14282, DOI 10.1073/pnas.96.25.14282; Slotboom DJ, 2001, J BIOL CHEM, V276, P10775, DOI 10.1074/jbc.M011064200; Sobczak M, 2005, CURR OPIN MICROBIOL, V8, P161, DOI 10.1016/j.mib.2005.02.005; STORCK T, 1992, P NATL ACAD SCI USA, V89, P10955, DOI 10.1073/pnas.89.22.10955; Tao Z, 2006, J BIOL CHEM, V281, P10263, DOI 10.1074/jbc.M510739200; UtsunomiyaTate N, 1996, J BIOL CHEM, V271, P14883, DOI 10.1074/jbc.271.25.14883; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Yernool D, 2003, BIOCHEMISTRY-US, V42, P12981, DOI 10.1021/bi030161q; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zarbiv R, 1998, J BIOL CHEM, V273, P14231, DOI 10.1074/jbc.273.23.14231; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zhang YM, 1999, P NATL ACAD SCI USA, V96, P1710, DOI 10.1073/pnas.96.4.1710; Zhang YM, 1998, P NATL ACAD SCI USA, V95, P751, DOI 10.1073/pnas.95.2.751	43	37	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					29788	29796		10.1074/jbc.M604991200	http://dx.doi.org/10.1074/jbc.M604991200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16877378	hybrid			2022-12-27	WOS:000240896300041
J	Liu, GM; Ding, W; Neiman, J; Mulder, KM				Liu, Guangming; Ding, Wei; Neiman, Jill; Mulder, Kathleen M.			Requirement of Smad3 and CREB-1 in mediating transforming growth factor-beta (TGF beta) induction of TGF beta 3 secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEIN; CAMP-RESPONSE ELEMENT; BREAST-CANCER CELLS; EPITHELIAL-CELLS; TRANSCRIPTION FACTOR; DIFFERENTIAL EXPRESSION; INDUCED PHOSPHORYLATION; SIGNAL-TRANSDUCTION; CRYSTAL-STRUCTURE; TUMOR-SUPPRESSOR	Because increased transforming growth factor-beta (TGF beta) production by tumor cells contributes to cancer progression through paracrine mechanisms, identification of critical points that can be targeted to block TGF beta production is important. Previous studies have identified the precise signaling components and promoter elements required for TGF beta induction of TGF beta 1 expression in epithelial cells (Yue, J., and Mulder, K. M. (2000) J. Biol. Chem. 275, 30765-30773). To determine how regulation of TGF beta 3 expression differs from that of TGF beta 1, we identified the precise signaling pathways and transcription factor-binding sites that are required for TGF beta 3 gene expression. By using mutational analysis in electrophoresis mobility shift assays (EMSAs), we demonstrated that the c-AMP-responsive element (CRE) site in the TGF beta 3 promoter was required for TGF beta-inducible TGF beta 3 expression. Electrophoresis mobility supershift assays indicated that CRE-binding protein 1 (CREB1) and Smad3 were the major components present in this TGF beta-inducible complex. Furthermore, by using chromatin immunoprecipitation assays, we demonstrated that CREB-1, ATF-2, and c-Jun bound constitutively at the TGF beta 3 promoter (-100 to +1), whereas Smad3 bound at this site only after TGF beta stimulation. In addition, inhibition of JNK and p38 suppressed TGF beta induction of TGF beta 3 transactivation, whereas inhibition of ERK and protein kinase A had no effect. Small interfering RNA-CREB1 and small interfering RNA-Smad3 significantly inhibited TGF beta stimulation of TGF beta 3 promoter reporter activity and TGF beta 3 production. Our results indicate that TGF beta activation of the TGF beta 3 promoter CRE site, which leads to TGF beta 3 production, is required for TGF beta RII, JNK, p38, and Smad3 but was independent of protein kinase A, ERK, and Smad4.	Penn State Univ, Coll Med, Dept Pharmacol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Mulder, KM (corresponding author), Penn State Univ, Coll Med, Dept Pharmacol, 500 Univ Dr, Hershey, PA 17033 USA.	kmm15@psu.edu			NCI NIH HHS [CA92889, CA100239, CA90765] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA090765, R01CA100239, R01CA092889] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bhat NR, 2002, J BIOL CHEM, V277, P29584, DOI 10.1074/jbc.M204994200; Bocharov EV, 2002, J BIOL CHEM, V277, P46273, DOI 10.1074/jbc.M206274200; Chaturvedi K, 2004, ENDOCRINOLOGY, V145, P706, DOI 10.1210/en.2003-1063; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; Cho HR, 2004, J KOREAN MED SCI, V19, P853, DOI 10.3346/jkms.2004.19.6.853; Copland IB, 2002, PLACENTA, V23, P311, DOI 10.1053/plac.2001.0778; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Devling TWP, 2005, P NATL ACAD SCI USA, V102, P7280, DOI 10.1073/pnas.0501475102; Feng XH, 1998, GENE DEV, V12, P2153, DOI 10.1101/gad.12.14.2153; Frey RS, 1997, CANCER LETT, V117, P41, DOI 10.1016/S0304-3835(97)00211-5; Frey RS, 1997, CANCER RES, V57, P628; Furumatsu T, 2005, J BIOL CHEM, V280, P8343, DOI 10.1074/jbc.M413913200; Gold LI, 2000, J PATHOL, V190, P579, DOI 10.1002/(SICI)1096-9896(200004)190:5<579::AID-PATH548>3.0.CO;2-I; Gustin JA, 2004, AM J PHYSIOL-CELL PH, V286, pC547, DOI 10.1152/ajpcell.00332.2002; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Hanafusa H, 1999, J BIOL CHEM, V274, P27161, DOI 10.1074/jbc.274.38.27161; Hart PJ, 2002, NAT STRUCT BIOL, V9, P203, DOI 10.1038/nsb766; HARTSOUGH MT, 1995, J BIOL CHEM, V270, P7117, DOI 10.1074/jbc.270.13.7117; Hartsough MT, 1997, PHARMACOL THERAPEUT, V75, P21, DOI 10.1016/S0163-7258(97)00020-X; Hentges S, 2000, ENDOCRINOLOGY, V141, P859, DOI 10.1210/en.141.3.859; Hocevar BA, 1999, EMBO J, V18, P1345, DOI 10.1093/emboj/18.5.1345; Hu PPC, 1999, MOL ENDOCRINOL, V13, P2039, DOI 10.1210/me.13.12.2039; Ionescu AM, 2003, EXP CELL RES, V288, P198, DOI 10.1016/S0014-4827(03)00181-2; Javelaud D, 2005, ONCOGENE, V24, P5742, DOI 10.1038/sj.onc.1208928; KIM SJ, 1989, J BIOL CHEM, V264, P402; Kloen P, 1997, CANCER, V80, P2230; LAFYATIS R, 1990, J BIOL CHEM, V265, P19128; Lammerts E, 2002, INT J CANCER, V102, P453, DOI 10.1002/ijc.10722; Liu GM, 2001, P NATL ACAD SCI USA, V98, P7510, DOI 10.1073/pnas.131195198; Liu XD, 1997, P NATL ACAD SCI USA, V94, P10669, DOI 10.1073/pnas.94.20.10669; LOPEZCASILLAS F, 1993, CELL, V73, P1435, DOI 10.1016/0092-8674(93)90368-Z; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Masutani H, 2004, MOL NEUROBIOL, V29, P229, DOI 10.1385/MN:29:3:229; Mora-Garcia P, 2003, STEM CELLS, V21, P123, DOI 10.1634/stemcells.21-2-123; MULDER KM, 1993, J CELL PHYSIOL, V154, P162, DOI 10.1002/jcp.1041540120; MULDER KM, 1992, J BIOL CHEM, V267, P5029; Mulder KM, 2000, CYTOKINE GROWTH F R, V11, P23, DOI 10.1016/S1359-6101(99)00026-X; Nishihara H, 2004, J BIOL CHEM, V279, P26176, DOI 10.1074/jbc.M313346200; Oki N, 2000, J BIOL CHEM, V275, P10831, DOI 10.1074/jbc.275.15.10831; Parada David, 2004, Arch Esp Urol, V57, P93; Park SW, 2005, ONCOGENE, V24, P6689, DOI 10.1038/sj.onc.1208816; PELTON RW, 1991, J CELL BIOL, V115, P1091, DOI 10.1083/jcb.115.4.1091; Ranganathan G, 2002, J BIOL CHEM, V277, P43281, DOI 10.1074/jbc.M202560200; ROBERTS AB, 1992, MOL REPROD DEV, V32, P91, DOI 10.1002/mrd.1080320203; Samatar AA, 2002, J BIOL CHEM, V277, P28118, DOI 10.1074/jbc.M203686200; Sano Y, 1999, J BIOL CHEM, V274, P8949, DOI 10.1074/jbc.274.13.8949; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Shen X, 1998, MOL BIOL CELL, V9, P3309, DOI 10.1091/mbc.9.12.3309; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Tang BW, 1998, NAT MED, V4, P802, DOI 10.1038/nm0798-802; Tudela C, 2002, INT J DEV BIOL, V46, P333; UNSICKER K, 1991, NEUROSCIENCE, V44, P613, DOI 10.1016/0306-4522(91)90082-Y; Weeber EJ, 2002, NEURON, V33, P845, DOI 10.1016/S0896-6273(02)00634-7; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Yamazaki H, 2002, AM J PHYSIOL-ENDOC M, V283, pE536, DOI 10.1152/ajpendo.00094.2001; Yang F, 2003, J BIOL CHEM, V278, P32173, DOI 10.1074/jbc.M305149200; Yue J, 2004, J CELL PHYSIOL, V199, P284, DOI 10.1002/jcp.10469; Yue JB, 1999, ONCOGENE, V18, P2033, DOI 10.1038/sj.onc.1202521; Yue JB, 1998, ONCOGENE, V17, P47, DOI 10.1038/sj.onc.1201903; Yue JB, 2000, J BIOL CHEM, V275, P30765, DOI 10.1074/jbc.M000039200; Yue JB, 2000, METH MOL B, V142, P125; Yue JB, 2001, PHARMACOL THERAPEUT, V91, P1, DOI 10.1016/S0163-7258(01)00143-7	62	40	47	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					29479	29490		10.1074/jbc.M600579200	http://dx.doi.org/10.1074/jbc.M600579200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16891311	hybrid			2022-12-27	WOS:000240896300010
J	Vincent, HA; Deutscher, MP				Vincent, Helen A.; Deutscher, Murray P.			Substrate recognition and catalysis by the exoribonuclease RNase R	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYNUCLEOTIDE PHOSPHORYLASE; MESSENGER-RNA; RIBONUCLEASE-II; QUALITY-CONTROL; DEGRADATION; BINDING	RNase R is a processive, 3' to 5' hydrolytic exoribonuclease that together with polynucleotide phosphorylase plays an important role in the degradation of structured RNAs. However, RNase R differs from other exoribonucleases in that it can by itself degrade RNAs with extensive secondary structure provided that a single-stranded 3' overhang is present. Using a variety of specifically designed substrates, we show here that a 3' overhang of at least 7 nucleotides is required for tight binding and activity, whereas optimum binding and activity are achieved when the overhang is 10 or more nucleotides in length. In contrast, duplex RNAs with no overhang or with a 4- nucleotide overhang bind extremely poorly to RNase R and are inactive as substrates. A duplex RNA with a 10- nucleotide 5' overhang also is not a substrate. Interestingly, this molecule is bound only weakly, indicating that RNase R does not simply recognize singlestranded RNA, but the RNA must thread into the enzyme with 3' to 5' polarity. We also show that ribose moieties are required for recognition of the substrate as a whole since RNase R is unable to bind or degrade single- stranded DNA. However, RNA molecules with deoxyribose or dideoxyribose residues at their 3' termini can be bound and degraded. Based on these data and a homology model of RNase R, derived from the structure of the closely related enzyme, RNase II, we present a model for how RNase R interacts with its substrates and degrades RNA.	Univ Miami, Sch Med, Dept Biochem & Mol Biol, Miami, FL 33101 USA	University of Miami	Deutscher, MP (corresponding author), Univ Miami, Sch Med, Dept Biochem & Mol Biol, POB 016129, Miami, FL 33101 USA.	mdeutsch@med.miami.edu	Vincent, Helen/GZK-3422-2022		NIGMS NIH HHS [GM16317] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CANNISTRARO VJ, 1994, J MOL BIOL, V243, P930, DOI 10.1006/jmbi.1994.1693; Carpousis AJ, 2002, BIOCHEM SOC T, V30, P150, DOI 10.1042/bst0300150; Cheng ZF, 2005, MOL CELL, V17, P313, DOI 10.1016/j.molcel.2004.11.048; Cheng ZF, 2003, P NATL ACAD SCI USA, V100, P6388, DOI 10.1073/pnas.1231041100; Cheng ZF, 2002, J BIOL CHEM, V277, P21624, DOI 10.1074/jbc.M202942200; Deutscher MP, 2006, NUCLEIC ACIDS RES, V34, P659, DOI 10.1093/nar/gkj472; DONOVAN WP, 1986, P NATL ACAD SCI USA, V83, P120, DOI 10.1073/pnas.83.1.120; Li ZW, 2002, EMBO J, V21, P1132, DOI 10.1093/emboj/21.5.1132; Lin PH, 2005, P NATL ACAD SCI USA, V102, P16590, DOI 10.1073/pnas.0500994102; Liou GG, 2002, J BIOL CHEM, V277, P41157, DOI 10.1074/jbc.M206618200; Lorentzen E, 2005, MOL CELL, V20, P473, DOI 10.1016/j.molcel.2005.10.020; Oussenko IA, 2000, J BACTERIOL, V182, P2639, DOI 10.1128/JB.182.9.2639-2642.2000; Tanaka N, 2005, BIOCHEMISTRY-US, V44, P9795, DOI 10.1021/bi050407m; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428; Zuo YH, 2001, NUCLEIC ACIDS RES, V29, P1017, DOI 10.1093/nar/29.5.1017	15	184	191	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					29769	29775		10.1074/jbc.M606744200	http://dx.doi.org/10.1074/jbc.M606744200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16893880	hybrid			2022-12-27	WOS:000240896300039
J	Konishi, H; Tashiro, K; Murata, Y; Nabeshi, H; Yamauchi, E; Taniguchi, H				Konishi, Hiroaki; Tashiro, Kyoko; Murata, Yasunobu; Nabeshi, Hiromi; Yamauchi, Emiko; Taniguchi, Hisaaki			CFBP is a novel tyrosine-phosphorylated protein that might function as a regulator of CIN85/CD2AP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CD2-ASSOCIATED PROTEIN; SIGNALING NETWORKS; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; DOWN-REGULATION; SH3 DOMAINS; RECEPTOR; CBL; COMPLEX; CYTOSKELETAL	To decipher the global network of the epidermal growth factor (EGF) receptor-mediated signaling pathway, a large scale proteomic analysis of tyrosine-phosphorylated proteins was conducted. Here, we focus on characterizing a novel protein, CFBP (CIN85/CD2AP family binding protein), identified in the study. CFBP was found to be phosphorylated at tyrosine 204 upon EGF stimulation, and the CIN85/CD2AP family was identified as a binding partner. A proline-rich motif of CFBP is recognized by one of the three Src-homology 3 domains of CIN85/CD2AP, and the affinity of the interaction is regulated by the tyrosine phosphorylation of CFBP. They co-localize in actinen-riched structures, and overexpression of CFBP induced morphological changes with actin reorganization. Furthermore, CFBP accelerated the EGF receptor's down-regulation by facilitating the recruitment of Cbl to the CD2AP/CIN85 complex. Two spliced variants of CFBP lacking either exon 5 or 8 are also expressed, and the variant lacking exon 5 without the proline-rich motif lacks the ability to bind to the CIN85/CD2AP family. The CFBP protein seems to play a key role in the ligand-mediated internalization and down-regulation of the EGF receptor.	Univ Tokushima, Ins Enzyme Res, Tokushima 7708503, Japan	Tokushima University	Konishi, H (corresponding author), Univ Tokushima, Ins Enzyme Res, 3-18-15 Kuramoto, Tokushima 7708503, Japan.	konishi@ier.tokushima-u.ac.jp	Taniguchi, Hisaaki/I-9171-2012; Murata, Yasunobu/Y-5799-2019	Murata, Yasunobu/0000-0001-5757-2497				Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; Borthwick EB, 2004, J MOL BIOL, V343, P1135, DOI 10.1016/j.jmb.2004.08.075; Dikic I, 2002, FEBS LETT, V529, P110, DOI 10.1016/S0014-5793(02)03188-5; Dikic I, 2003, CURR OPIN CELL BIOL, V15, P128, DOI 10.1016/S0955-0674(03)00004-8; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; Hutchings NJ, 2003, J BIOL CHEM, V278, P22396, DOI 10.1074/jbc.M302540200; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Johnson SA, 2005, NAT METHODS, V2, P17, DOI 10.1038/NMETH731; Kikuchi M, 2004, J BIOL CHEM, V279, P421, DOI 10.1074/jbc.M305623200; Kim JM, 2003, SCIENCE, V300, P1298, DOI 10.1126/science.1081068; Kirsch KH, 2001, J BIOL CHEM, V276, P4957, DOI 10.1074/jbc.M005784200; Kirsch KH, 1999, P NATL ACAD SCI USA, V96, P6211, DOI 10.1073/pnas.96.11.6211; Konishi H, 2001, P NATL ACAD SCI USA, V98, P6587, DOI 10.1073/pnas.111158798; Kowanetz K, 2004, MOL BIOL CELL, V15, P3155, DOI 10.1091/mbc.E03-09-0683; Kowanetz K, 2003, J BIOL CHEM, V278, P39735, DOI 10.1074/jbc.M304541200; Kurakin AV, 2003, J BIOL CHEM, V278, P34102, DOI 10.1074/jbc.M305264200; Liang Y, 2005, P NATL ACAD SCI USA, V102, P5838, DOI 10.1073/pnas.0501253102; Liu YH, 2005, J BIOL CHEM, V280, P8884, DOI 10.1074/jbc.M412200200; Lynch DK, 2003, J BIOL CHEM, V278, P21805, DOI 10.1074/jbc.M211407200; Matsubara M, 2004, EMBO J, V23, P712, DOI 10.1038/sj.emboj.7600093; Mayer BJ, 2001, J CELL SCI, V114, P1253; Monzo P, 2005, MOL BIOL CELL, V16, P2891, DOI 10.1091/mbc.E04-09-0773; Nelson JM, 1997, EXP CELL RES, V233, P383, DOI 10.1006/excr.1997.3571; Pandey A, 2000, P NATL ACAD SCI USA, V97, P179, DOI 10.1073/pnas.97.1.179; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Schiffer M, 2004, J BIOL CHEM, V279, P37004, DOI 10.1074/jbc.M403534200; Schmidt MHH, 2005, NAT REV MOL CELL BIO, V6, P907, DOI 10.1038/nrm1762; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Szymkiewicz I, 2004, BIOCHEM J, V383, P1, DOI 10.1042/BJ20040913; TANIGUCHI H, 1994, J BIOL CHEM, V269, P22481; Thelemann A, 2005, MOL CELL PROTEOMICS, V4, P356, DOI 10.1074/mcp.M400118-MCP200; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Tibaldi EV, 2003, INT IMMUNOL, V15, P313, DOI 10.1093/intimm/dxg032; Welsch T, 2001, AM J PHYSIOL-RENAL, V281, pF769, DOI 10.1152/ajprenal.2001.281.4.F769; Yamauchi E, 2003, NAT STRUCT BIOL, V10, P226, DOI 10.1038/nsb900	36	28	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					28919	28931		10.1074/jbc.M605693200	http://dx.doi.org/10.1074/jbc.M605693200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16895919	hybrid			2022-12-27	WOS:000240680500046
J	Oshima, H; Taketo, MM; Oshima, M				Oshima, Hiroko; Taketo, Makoto Mark; Oshima, Masanobu			Destruction of pancreatic beta-cells by transgenic induction of prostaglandin E-2 in the islets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIABETES-MELLITUS; CYCLOOXYGENASE-2; INTERLEUKIN-1; EXPRESSION; MICE; LANGERHANS; GLUCOSE; HYPERGLYCEMIA; INHIBITION; ACTIVATION	Type 2 diabetes mellitus is characterized by insulin resistance of peripheral tissues and dysfunction of pancreatic beta-cells. Furthermore, the number of pancreatic beta-cells decreases as a secondary effect of advanced type 2 diabetes, although the molecular mechanism has not been elucidated. Recently, it has been shown that hyperglycemic conditions induce the expression of cyclooxygenase-2 in pancreatic islets and increase the downstream product prostaglandin E-2 (PGE(2)). To investigate whether high glucose-induced PGE(2) has an adverse effect on pancreatic beta-cells, we generated transgenic mice (RIP-C2mE) that express cyclooxygenase-2 and microsomal prostaglandin E synthase-1 in their beta-cells using the rat insulin-2 gene promoter (RIP). The homozygous RIP-C2mE (Tg/Tg) mice showed severe hyperglycemia from six weeks of age. Although the heterozygous RIP-C2mE (Tg/-) mice showed normal blood glucose levels throughout their lifetime, this level increased significantly compared with that of wild-type mice when glucose was loaded. The relative number of beta-cells to the total islet cell number was reduced to 54 and 14% in the RIP-C2mE (Tg/-) and (Tg/Tg) mice, respectively, whereas that in the wild-type mice was 84%. Importantly, the proliferation rate in the islets of the RIP-C2mE (Tg/Tg) mice at four weeks of age decreased significantly in comparison to that in the wild-type mice. Because beta-cells replicate not only during the postnatal period but also in the adult pancreas at a basal level, it is possible that increased PGE2 signaling thus contributes to the reduction of the pancreatic beta-cell mass through inhibition of proliferation, thereby aggravating diabetes further.	Kanazawa Univ, Div Genet, Inst Canc Res, Kanazawa, Ishikawa 9200934, Japan; Kyoto Univ, Grad Sch Med, Dept Pharmacol, Kyoto 6068501, Japan	Kanazawa University; Kyoto University	Oshima, M (corresponding author), Kanazawa Univ, Div Genet, Inst Canc Res, 13-1 Takara Machi, Kanazawa, Ishikawa 9200934, Japan.	oshimam@kenroku.kanazawa-u.ac.jp	Oshima, Masanobu/F-9958-2014	Oshima, Masanobu/0000-0002-3304-0004; Oshima, Hiroko/0000-0001-6855-4008				BENDTZEN K, 1986, SCIENCE, V232, P1545, DOI 10.1126/science.3086977; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; CORBETT JA, 1993, BIOCHEMISTRY-US, V32, P13767, DOI 10.1021/bi00213a002; Deng SP, 2004, DIABETES, V53, P624, DOI 10.2337/diabetes.53.3.624; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Dubois RN, 1998, FASEB J, V12, P1063, DOI 10.1096/fasebj.12.12.1063; FINEGOOD DT, 1995, DIABETES, V44, P249, DOI 10.2337/diabetes.44.3.249; Giannoukakis N, 1999, DIABETES, V48, P1730, DOI 10.2337/diabetes.48.9.1730; Konheim YL, 2003, HUM GENET, V113, P377, DOI 10.1007/s00439-003-1000-y; Lingohr MK, 2002, TRENDS MOL MED, V8, P375, DOI 10.1016/S1471-4914(02)02377-8; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Mandrup-Poulsen T, 2003, ANN NY ACAD SCI, V1005, P32, DOI 10.1196/annals.1288.005; MandrupPoulsen T, 1996, DIABETOLOGIA, V39, P1005, DOI 10.1007/BF00400649; Murakami M, 2000, J BIOL CHEM, V275, P32783, DOI 10.1074/jbc.M003505200; Oshima H, 2004, EMBO J, V23, P1669, DOI 10.1038/sj.emboj.7600170; Persaud SJ, 2004, DIABETES, V53, pS190, DOI 10.2337/diabetes.53.2007.S190; Robertson RP, 1998, DIABETES, V47, P1379, DOI 10.2337/diabetes.47.9.1379; Sakuraba H, 2002, DIABETOLOGIA, V45, P85, DOI 10.1007/s125-002-8248-z; Schmidt MI, 1999, LANCET, V353, P1649, DOI 10.1016/S0140-6736(99)01046-6; Shanmugam N, 2006, DIABETOLOGIA, V49, P100, DOI 10.1007/s00125-005-0065-7; Sorli CH, 1998, P NATL ACAD SCI USA, V95, P1788, DOI 10.1073/pnas.95.4.1788; Svenstrup K, 2002, APMIS, V110, P372, DOI 10.1034/j.1600-0463.2002.100502.x; Tabatabaie T, 2000, BIOCHEM BIOPH RES CO, V273, P699, DOI 10.1006/bbrc.2000.2959; Tran POT, 1999, J BIOL CHEM, V274, P31245, DOI 10.1074/jbc.274.44.31245; Uchida T, 2005, NAT MED, V11, P175, DOI 10.1038/nm1187; UNGER RH, 1985, DIABETOLOGIA, V28, P119; Vozarova B, 2002, DIABETES, V51, P455, DOI 10.2337/diabetes.51.2.455	27	39	40	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					29330	29336		10.1074/jbc.M602424200	http://dx.doi.org/10.1074/jbc.M602424200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16873378	hybrid, Green Submitted			2022-12-27	WOS:000240680500088
J	Chen, GP; Frohlich, O; Yang, Y; Klein, JD; Sands, JM				Chen, Guangping; Frohlich, Otto; Yang, Yuan; Klein, Janet D.; Sands, Jeff M.			Loss of N-linked glycosylation reduces urea transporter UT-A1 response to vasopressin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL COLLECTING DUCT; PLASMA-MEMBRANE; EXPRESSION; TRAFFICKING; AQUAPORIN-2; SITES; WATER; IMCD; RATS; PERMEABILITY	The vasopressin-regulated urea transporter (UT)-A1 is a transmembrane protein with two glycosylated forms of 97 and 117 kDa; both are derived from a single 88-kDa core protein. However, the precise molecular sites and the function for UT-A1 N-glycosylation are not known. In this study, we compared Madin-Darby canine kidney cells stably expressing wildtype (WT) UT-A1 to Madin-Darby canine kidney cell lines stably expressing mutant UT-A1 lacking one (A1m1, A1m2) or both glycosylation sites (m1m2). Site-directed mutagenesis revealed that UT-A1 has two glycosylation sites at Asn-279 and -742. Urea flux is stimulated by 10 nM vasopressin (AVP) or 10 mu M forskolin (FSK) in WT cells. In contrast, m1m2 cells have a delayed and significantly reduced maximal urea flux. A 15-min treatment with AVP and FSK significantly increased UT-A1 cell surface expression in WT but not in m1m2 cells, as measured by biotinylation. We confirmed this finding using immunostaining. Membrane fractionation of the plasma membrane, Golgi, and endoplasmic reticulum revealed that AVP or FSK treatment increases UT-A1 abundance in both Golgi and plasma membrane compartments in WT but not in m1m2 cells. Pulse-chase experiments showed that UT-A1 half-life is reduced in m1m2 cells compared with WT cells. Our results suggest that mutation of the N-linked glycosylation sites reduces urea flux by reducing UT-A1 half-life and decreasing its accumulation in the apical plasma membrane. In vivo, inner medullary collecting duct cells may regulate urea uptake by altering UT-A1 glycosylation in response to AVP stimulation.	Emory Univ, Sch Med, Renal Div, Dept Med, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Physiol, Atlanta, GA 30322 USA	Emory University; Emory University	Chen, GP (corresponding author), Emory Univ, Sch Med, Renal Div, Dept Med, WMRB Rm 338,1639 Pierce Dr,NE, Atlanta, GA 30322 USA.	gchen3@emory.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063657, R01DK041707, P01DK061521] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK041707, P01 DK61521, R01-DK63657, R01 DK41707] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bradford AD, 2001, AM J PHYSIOL-RENAL, V281, pF133, DOI 10.1152/ajprenal.2001.281.1.F133; Diop NK, 2005, BIOCHEMISTRY-US, V44, P5420, DOI 10.1021/bi0479858; Fenton RA, 2004, P NATL ACAD SCI USA, V101, P7469, DOI 10.1073/pnas.0401704101; Frohlich O, 2004, AM J PHYSIOL-CELL PH, V286, pC1264, DOI 10.1152/ajpcell.00499.2003; FROHLICH O, 2006, IN PRESS AM J PHYSL, V291; Gatto C, 2001, AM J PHYSIOL-CELL PH, V281, pC982, DOI 10.1152/ajpcell.2001.281.3.C982; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Hendriks G, 2004, J BIOL CHEM, V279, P2975, DOI 10.1074/jbc.M310767200; Hoover RS, 2003, J AM SOC NEPHROL, V14, P271, DOI 10.1097/01.ASN.0000043903.93452.D0; Inoue T, 1999, AM J PHYSIOL-RENAL, V276, pF559, DOI 10.1152/ajprenal.1999.276.4.F559; Kim D, 2003, AM J PHYSIOL-RENAL, V285, pF303, DOI 10.1152/ajprenal.00438.2002; KLEIN JD, 2006, IN PRESS J AM SOC NE, V17; Laughery MD, 2003, J BIOL CHEM, V278, P34794, DOI 10.1074/jbc.M302899200; Lee TK, 2003, AM J PHYSIOL-GASTR L, V285, pG371, DOI 10.1152/ajpgi.00358.2002; Li HY, 2003, AM J PHYSIOL-CELL PH, V285, pC1188, DOI 10.1152/ajpcell.00162.2003; Li LB, 2004, J BIOL CHEM, V279, P21012, DOI 10.1074/jbc.M311972200; Lucien N, 2002, J BIOL CHEM, V277, P34101, DOI 10.1074/jbc.M205073200; Marr N, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000027355.41663.14; Matsuda K, 2004, J NEUROCHEM, V89, P928, DOI 10.1111/j.1471-4159.2004.02377.x; Mistry AC, 2005, AM J PHYSIOL-RENAL, V288, pF455, DOI 10.1152/ajprenal.00296.2004; Napp J, 2005, J BIOL CHEM, V280, P29506, DOI 10.1074/jbc.M504228200; Pech V, 2005, AM J PHYSIOL-RENAL, V289, pF531, DOI 10.1152/ajprenal.00125.2005; Petrecca K, 1999, J PHYSIOL-LONDON, V515, P41, DOI 10.1111/j.1469-7793.1999.041ad.x; Sands JM, 1998, AM J PHYSIOL-RENAL, V274, pF978, DOI 10.1152/ajprenal.1998.274.5.F978; Sands JM, 2002, J AM SOC NEPHROL, V13, P2795, DOI 10.1097/01.ASN.0000035084.94743.7C; SANDS JM, 1987, AM J PHYSIOL, V253, pF823, DOI 10.1152/ajprenal.1987.253.5.F823; Smith CP, 2004, AM J PHYSIOL-CELL PH, V287, pC1087, DOI 10.1152/ajpcell.00363.2003; Snyder PM, 2005, ENDOCRINOLOGY, V146, P5079, DOI 10.1210/en.2005-0894; Terris J, 1998, J AM SOC NEPHROL, V9, P729; WALL SM, 1992, AM J PHYSIOL, V262, pF989, DOI 10.1152/ajprenal.1992.262.6.F989; Yoshimi M, 2000, BIOCHEM BIOPH RES CO, V276, P965, DOI 10.1006/bbrc.2000.3565; YOU GF, 1993, NATURE, V365, P844, DOI 10.1038/365844a0	32	44	45	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2006	281	37					27436	27442		10.1074/jbc.M605525200	http://dx.doi.org/10.1074/jbc.M605525200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082PB	16849333	hybrid			2022-12-27	WOS:000240397700070
J	Shi, GB; Boyle, SC; Sparrow, DB; Dunwoodie, SL; Shioda, T; de Caestecker, MP				Shi, Genbin; Boyle, Scott C.; Sparrow, Duncan B.; Dunwoodie, Sally L.; Shioda, Toshi; de Caestecker, Mark P.			The transcriptional activity of CITED1 is regulated by phosphorylation in a cell cycle-dependent manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-PROTEIN; GENE-EXPRESSION; BINDING-PROTEIN; MSG1; FAMILY; DOMAIN; MEMBER; MRG1; RICH; TRANSACTIVATOR	CITED1 is the founding member of the CITED family of cofactors that are involved in regulating a wide variety of CBP/p300-dependent transcriptional responses. In the present study, we show that the phosphorylation status of CITED1 changes during the cell cycle and affects its transcriptional cofactor activity. Tryptic mapping and mutagenesis studies identified five phosphorylated serine residues in CITED1. Phosphorylation of these residues did not affect CRM1-dependent nuclear export, but did decrease CITED1 binding to p300 and inhibited CITED1-dependent transactivation of Smad4 and p300. These results suggest that CITED1 functions as a cell cycle-dependent transcriptional cofactor whose activity is regulated by phosphorylation.	Vanderbilt Univ, Med Ctr, Div Nephrol, Sch Med,Dept Med, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37232 USA; Massachusetts Gen Hosp, Ctr Canc, Dept Tumor Biol, Charlestown, MA 02129 USA; Univ New S Wales, Victor Chang Cardiac Res Inst, Sydney, NSW 2010, Australia	Vanderbilt University; Vanderbilt University; Harvard University; Massachusetts General Hospital; University of New South Wales Sydney; Victor Chang Cardiac Research Institute	de Caestecker, MP (corresponding author), Vanderbilt Univ, Med Ctr, Div Nephrol, Sch Med,Dept Med, S-3223,Med Ctr N,1161 21st St S, Nashville, TN 37232 USA.	Mark.de.Caestecker@vanderbilt.edu	Dunwoodie, Sally L/M-4019-2018; Sparrow, Duncan/B-3994-2008	Dunwoodie, Sally L/0000-0002-2069-7349; Sparrow, Duncan/0000-0002-1141-6613	NIDDK NIH HHS [R01DK61558] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061558] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Andrews JE, 2000, MECH DEVELOP, V95, P305, DOI 10.1016/S0925-4773(00)00362-2; Bhattacharya S, 1999, GENE DEV, V13, P64, DOI 10.1101/gad.13.1.64; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Braganca J, 2003, J BIOL CHEM, V278, P16021, DOI 10.1074/jbc.M208144200; Braganca J, 2002, J BIOL CHEM, V277, P8559, DOI 10.1074/jbc.M110850200; de Caestecker MP, 2000, J BIOL CHEM, V275, P2115, DOI 10.1074/jbc.275.3.2115; deCaestecker MP, 1997, J BIOL CHEM, V272, P13690, DOI 10.1074/jbc.272.21.13690; Dunwoodie SL, 1998, MECH DEVELOP, V72, P27, DOI 10.1016/S0925-4773(98)00011-2; Eid JE, 2000, CELL, V102, P839, DOI 10.1016/S0092-8674(00)00072-6; FIDLER IJ, 1973, NATURE-NEW BIOL, V242, P148, DOI 10.1038/newbio242148a0; Fox SB, 2004, CANCER RES, V64, P6075, DOI 10.1158/0008-5472.CAN-04-0708; Gawantka V, 1998, MECH DEVELOP, V77, P95, DOI 10.1016/S0925-4773(98)00115-4; Glenn DJ, 1999, J BIOL CHEM, V274, P36159, DOI 10.1074/jbc.274.51.36159; Graham John M., 2002, TheScientificWorldJOURNAL, V2, P1638; Harper Jane V., 2004, V296, P157; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Howlin J, 2006, ONCOGENE, V25, P1532, DOI 10.1038/sj.onc.1209183; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; Li HC, 1998, EXP CELL RES, V242, P478, DOI 10.1006/excr.1998.4123; LOVVORN HN, 2006, IN PRESS J PEDIAT SU; Ng PKS, 2003, COMP BIOCHEM PHYS B, V136, P163, DOI 10.1016/S1096-4959(03)00224-0; Plisov S, 2005, J AM SOC NEPHROL, V16, P1632, DOI 10.1681/ASN.2004060476; Prasad ML, 2005, MODERN PATHOL, V18, P48, DOI 10.1038/modpathol.3800235; Prasad ML, 2004, THYROID, V14, P169, DOI 10.1089/105072504773297830; Robinson J.P., 1997, CURRENT PROTOCOLS CY; Rodriguez TA, 2004, MOL CELL BIOL, V24, P228, DOI 10.1128/MCB.24.1.228-244.2004; Sedghizadeh PP, 2005, MED SCI MONITOR, V11, pBR189; Shioda T, 1996, P NATL ACAD SCI USA, V93, P12298, DOI 10.1073/pnas.93.22.12298; Shioda T, 1997, GENE, V204, P235, DOI 10.1016/S0378-1119(97)00551-9; Snowden AW, 2000, MOL CELL BIOL, V20, P2676, DOI 10.1128/MCB.20.8.2676-2686.2000; Tien ES, 2004, J BIOL CHEM, V279, P24053, DOI 10.1074/jbc.M401489200; Yahata T, 2000, J BIOL CHEM, V275, P8825, DOI 10.1074/jbc.275.12.8825; Yahata T, 2002, GENOMICS, V80, P601, DOI 10.1006/geno.2002.7005; Yahata T, 2001, GENE DEV, V15, P2598, DOI 10.1101/gad.906301; Younes MN, 2005, MOL CANCER THER, V4, P1146, DOI 10.1158/1535-7163.MCT-05-0078	36	18	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2006	281	37					27426	27435		10.1074/jbc.M602631200	http://dx.doi.org/10.1074/jbc.M602631200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082PB	16864582	hybrid			2022-12-27	WOS:000240397700069
J	Trible, RP; Emert-Sedlak, L; Smithgall, TE				Trible, Ronald P.; Emert-Sedlak, Lori; Smithgall, Thomas E.			HIV-1 Nef selectively activates Src family kinases Hck, Lyn, and c-Src through direct SH3 domain interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE KINASE; VIRUS TYPE-1 NEF; SIMIAN IMMUNODEFICIENCY VIRUS; HERPESVIRUS-SAIMIRI; CRYSTAL-STRUCTURE; SACCHAROMYCES-CEREVISIAE; IN-VIVO; PROMOTES SURVIVAL; TRANSGENIC MICE; CONSERVED CORE	Nef is an HIV-1 virulence factor that promotes viral pathogenicity by altering host cell signaling pathways. Nef binds several members of the Src kinase family, and these interactions have been implicated in the pathogenesis of HIV/AIDS. However, the direct effect of Nef interaction on Src family kinase (SFK) regulation and activity has not been systematically addressed. We explored this issue using Saccharomyces cerevisiae, a well defined model system for the study of SFK regulation. Previous studies have shown that ectopic expression of c-Src arrests yeast cell growth in a kinase-dependent manner. We expressed Fgr, Fyn, Hck, Lck, Lyn, and Yes as well as c-Src in yeast and found that each kinase was active and induced growth suppression. Co-expression of the negative regulatory kinase Csk suppressed SFK activity and reversed the growth-inhibitory effect. We then co-expressed each SFK with HIV-1 Nef in the presence of Csk. Nef strongly activated Hck, Lyn, and c-Src but did not detectably affect Fgr, Fyn, Lck, or Yes. Mutagenesis of the Nef PXXP motif essential for SH3 domain binding greatly reduced the effect of Nef on Hck, Lyn, and c-Src, suggesting that Nef activates these Src family members through allosteric displacement of intramolecular SH3-linker interactions. These data show that Nef selectively activates Hck, Lyn, and c-Src among SFKs, identifying these kinases as proximal effectors of Nef signaling and potential targets for anti-HIV drug discovery.	Univ Pittsburgh, Sch Med, Dept Mol Genet & Biochem, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Smithgall, TE (corresponding author), Univ Pittsburgh, Sch Med, Dept Mol Genet & Biochem, E1240 Biomed Sci Tower, Pittsburgh, PA 15261 USA.	tsmithga@pitt.edu			NATIONAL CANCER INSTITUTE [R01CA081398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057083] Funding Source: NIH RePORTER; NCI NIH HHS [CA81398, R01 CA081398-07, R01 CA081398] Funding Source: Medline; NIAID NIH HHS [R01 AI057083, AI057083] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adams JA, 2003, BIOCHEMISTRY-US, V42, P601, DOI 10.1021/bi020617o; Arold S, 1998, BIOCHEMISTRY-US, V37, P14683, DOI 10.1021/bi980989q; Arold S, 1997, STRUCTURE, V5, P1361, DOI 10.1016/S0969-2126(97)00286-4; Arold ST, 2001, TRENDS BIOCHEM SCI, V26, P356, DOI 10.1016/S0968-0004(01)01846-1; Baur AS, 1997, IMMUNITY, V6, P283, DOI 10.1016/S1074-7613(00)80331-3; BIESINGER B, 1995, J BIOL CHEM, V270, P4729, DOI 10.1074/jbc.270.9.4729; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; Briese L, 2005, J BIOMED SCI, V12, P451, DOI 10.1007/s11373-005-6797-z; Briggs SD, 1997, J BIOL CHEM, V272, P17899, DOI 10.1074/jbc.272.29.17899; Briggs SD, 2000, BIOCHEMISTRY-US, V39, P489, DOI 10.1021/bi992504j; Briggs SD, 2001, J BIOL CHEM, V276, P25605, DOI 10.1074/jbc.M103244200; BRUGGE JS, 1987, MOL CELL BIOL, V7, P2180, DOI 10.1128/MCB.7.6.2180; Cheng H, 1999, VIROLOGY, V264, P5, DOI 10.1006/viro.1999.9937; Choi HJ, 2004, J MOL BIOL, V343, P1255, DOI 10.1016/j.jmb.2004.09.015; Choi HJ, 2004, J BIOL CHEM, V279, P51688, DOI 10.1074/jbc.M410068200; Chong YP, 2005, GROWTH FACTORS, V23, P233, DOI 10.1080/08977190500178877; Chong YP, 2005, BBA-PROTEINS PROTEOM, V1754, P210, DOI 10.1016/j.bbapap.2005.07.027; Collette Y, 1997, RES VIROLOGY, V148, P52, DOI 10.1016/S0923-2516(97)81914-0; Collette Y, 2000, J BIOL CHEM, V275, P4171, DOI 10.1074/jbc.275.6.4171; Collette Y, 1996, J BIOL CHEM, V271, P6333, DOI 10.1074/jbc.271.11.6333; COOPER JA, 1987, ONCOGENE RES, V1, P297; Cowan-Jacob SW, 2005, STRUCTURE, V13, P861, DOI 10.1016/j.str.2005.03.012; Crowe S, 2003, J LEUKOCYTE BIOL, V74, P635, DOI 10.1189/jlb.0503204; DANIEL MD, 1992, SCIENCE, V258, P1938, DOI 10.1126/science.1470917; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Dutartre H, 1998, VIROLOGY, V247, P200, DOI 10.1006/viro.1998.9244; Fackler OT, 2002, IMMUNITY, V16, P493, DOI 10.1016/S1074-7613(02)00307-2; FLORIO M, 1994, MOL BIOL CELL, V5, P283, DOI 10.1091/mbc.5.3.283; Geffin R, 2000, AIDS RES HUM RETROV, V16, P1855, DOI 10.1089/08892220050195810; GESSLER M, 1984, BIOSCIENCE REP, V4, P757, DOI 10.1007/BF01128817; Geyer M, 2001, EMBO REP, V2, P580, DOI 10.1093/embo-reports/kve141; Greenway A, 1996, J VIROL, V70, P6701, DOI 10.1128/JVI.70.10.6701-6708.1996; GREENWAY A, 1995, J VIROL, V69, P1842, DOI 10.1128/JVI.69.3.1842-1850.1995; Greenway AL, 1999, J VIROL, V73, P6152, DOI 10.1128/JVI.73.7.6152-6158.1999; Hanna Z, 2001, J VIROL, V75, P9378, DOI 10.1128/JVI.75.19.9378-9392.2001; Hanna Z, 1998, CELL, V95, P163, DOI 10.1016/S0092-8674(00)81748-1; Hartley DK, 1999, J BIOL CHEM, V274, P20056, DOI 10.1074/jbc.274.29.20056; He JCJ, 2004, J CLIN INVEST, V114, P643, DOI 10.1172/JCI200421004; Joseph AM, 2005, CURR HIV RES, V3, P87, DOI 10.2174/1570162052773013; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Kharbanda S, 1996, CANCER RES, V56, P3617; Kirchhoff F, 1999, J VIROL, V73, P5497, DOI 10.1128/JVI.73.7.5497-5508.1999; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; Kjellen P, 2002, VIROLOGY, V297, P281, DOI 10.1006/viro.2002.1419; KLAGES S, 1994, P NATL ACAD SCI USA, V91, P2597, DOI 10.1073/pnas.91.7.2597; Komuro I, 2003, J EXP MED, V198, P443, DOI 10.1084/jem.20022018; KORNBLUTH S, 1987, P NATL ACAD SCI USA, V84, P4455, DOI 10.1073/pnas.84.13.4455; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Learmont JC, 1999, NEW ENGL J MED, V340, P1715, DOI 10.1056/NEJM199906033402203; LEE CH, 1995, EMBO J, V14, P5006, DOI 10.1002/j.1460-2075.1995.tb00183.x; Lee CH, 1996, CELL, V85, P931, DOI 10.1016/S0092-8674(00)81276-3; Lerner EC, 2002, NAT STRUCT BIOL, V9, P365, DOI 10.1038/nsb782; LOWELL CA, 1994, GENE DEV, V8, P387, DOI 10.1101/gad.8.4.387; Lund T, 1997, J VIROL, V71, P378, DOI 10.1128/JVI.71.1.378-382.1997; Martin JC, 1999, J ACQ IMMUN DEF SYND, V22, P413; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; MURPHY SM, 1993, MOL CELL BIOL, V13, P5290, DOI 10.1128/MCB.13.9.5290; NADA S, 1991, NATURE, V351, P69, DOI 10.1038/351069a0; OKADA M, 1991, J BIOL CHEM, V266, P24249; Orenstein JM, 2001, IMMUNOBIOLOGY, V204, P598, DOI 10.1078/0171-2985-00098; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Piguet V, 1999, REV MED VIROL, V9, P111, DOI 10.1002/(SICI)1099-1654(199904/06)9:2&lt;111::AID-RMV245&gt;3.0.CO;2-P; QUINTRELL N, 1987, MOL CELL BIOL, V7, P2267, DOI 10.1128/MCB.7.6.2267; Renkema GH, 2000, FRONT BIOSCI-LANDMRK, V5, pD268, DOI 10.2741/Renkema; SAKSELA K, 1995, EMBO J, V14, P484, DOI 10.1002/j.1460-2075.1995.tb07024.x; Sawai ET, 2000, J VIROL, V74, P2038, DOI 10.1128/JVI.74.4.2038-2045.2000; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; SUPERTIFURGA G, 1993, EMBO J, V12, P2625, DOI 10.1002/j.1460-2075.1993.tb05923.x; Takashima Y, 2003, BIOCHEMISTRY-US, V42, P3567, DOI 10.1021/bi0272499; Walkenhorst J, 1996, ONCOGENE, V12, P1513; WHATMORE AM, 1995, J VIROL, V69, P5117, DOI 10.1128/JVI.69.8.5117-5123.1995; Wiese N, 1996, J BIOL CHEM, V271, P847, DOI 10.1074/jbc.271.2.847; Ye HH, 2004, BIOCHEMISTRY-US, V43, P15775, DOI 10.1021/bi048712f; ZIEGLER SF, 1987, MOL CELL BIOL, V7, P2276, DOI 10.1128/MCB.7.6.2276	75	117	122	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2006	281	37					27029	27038		10.1074/jbc.M601128200	http://dx.doi.org/10.1074/jbc.M601128200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082PB	16849330	Green Accepted, hybrid			2022-12-27	WOS:000240397700029
J	Zhou, SP; Olson, JS; Fabian, M; Weiss, MJ; Gow, AJ				Zhou, Suiping; Olson, John S.; Fabian, Marian; Weiss, Mitchell J.; Gow, Andrew J.			Biochemical fates of alpha hemoglobin bound to alpha hemoglobin-stabilizing protein AHSP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-MECHANISM; BETA-THALASSEMIA; AUTOXIDATION; OXYHEMOGLOBIN; REDUCTION; DISSOCIATION; OXIDATION; CHAPERONE; BINDING; CHAINS	Alpha hemoglobin-stabilizing protein (AHSP) is an erythroid protein that binds free alpha hemoglobin (alpha Hb) to maintain its structure and limit its pro-oxidant activity. Prior studies have defined two different alpha Hb center dot AHSP complexes. Binding of AHSP to Fe(II) alpha Hb induces an unusual configuration in which the F helix of the globin becomes disordered and the heme ring becomes solvent-exposed. Over time, this intermediate oxidizes to form a stable hemichrome in which the proximal (F8) and distal (E7) histidines are coordinated to the heme iron atom. The addition of alpha Hb to either Fe( II) or Fe(III) alpha Hb center dot AHSP displaces AHSP to generate tetrameric (alpha(2)beta(2)) HbA species. The biochemical properties and in vivo significance of the two alpha Hb center dot AHSP complexes are poorly understood. Here we show that Fe( III) alpha Hb center dot AHSP forms from auto-oxidation of oxygenated alpha Hb bound to AHSP and that this process is greatly accelerated at physiologic temperature and oxygen pressures. In contrast to free Fe( III) alpha Hb hemichromes, AHSP-bound Fe( III) alpha Hb does not precipitate and can be recycled into functional HbA. This requires enzymatic reduction of AHSP-bound alpha Hb, either prior to or after extraction by beta subunits. In contrast, reaction of Fe( II) alpha Hb-AHSP with beta Hb generates functional HbA directly. Our findings support a model in which AHSP can either stabilize alpha Hb transiently en route to HbA formation during normal erythropoiesis or convert excessive free alpha Hb into a more chemically inert state from which recovery of alpha Hb is possible by redox cycling.	Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA; Univ Penn, Philadelphia, PA 19104 USA; Rutgers State Univ, Dept Pharmacol, Piscataway, NJ 08854 USA; Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Rutgers State University New Brunswick; Rice University	Weiss, MJ (corresponding author), Childrens Hosp Philadelphia, Div Hematol, 3615 Civic Ctr Blvd, Philadelphia, PA 19104 USA.	weissmi@email.chop.edu; gow@rci.rutgers.edu	Gow, Andrew/N-8566-2013; Weiss, Mitchell J/A-1245-2013; Gow, Andrew/AAR-2309-2020; Weiss, Mitchell J/W-9814-2018	Gow, Andrew/0000-0003-0876-5158; Gow, Andrew/0000-0003-0876-5158; Weiss, Mitchell J/0000-0003-2460-3036; Olson, John/0000-0002-0760-5403	NHLBI NIH HHS [HL 47020] Funding Source: Medline; NIDDK NIH HHS [R01 DK 61692, R01 DK061692] Funding Source: Medline; NIGMS NIH HHS [GM 55807, GM 35649] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061692] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055807, R01GM035649] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Antonini E., 1971, HEMOGLOBIN MYOGLOBIN; BANERJEE R, 1969, J MOL BIOL, V42, P337, DOI 10.1016/0022-2836(69)90047-3; Baudin-Creuza V, 2004, J BIOL CHEM, V279, P36530, DOI 10.1074/jbc.M405389200; BRANTLEY RE, 1993, J BIOL CHEM, V268, P6995; dos Santos CO, 2005, HEMATOLOGY, V10, P157, DOI 10.1080/10245330500067280; Feng L, 2005, NATURE, V435, P697, DOI 10.1038/nature03609; Feng L, 2004, CELL, V119, P629, DOI 10.1016/j.cell.2004.11.025; Gell D, 2002, J BIOL CHEM, V277, P40602, DOI 10.1074/jbc.M206084200; Gow AJ, 1999, P NATL ACAD SCI USA, V96, P9027, DOI 10.1073/pnas.96.16.9027; HAYASHI A, 1973, BIOCHIM BIOPHYS ACTA, V310, P309, DOI 10.1016/0005-2795(73)90110-4; Herold S, 2004, J BIOL CHEM, V279, P22841, DOI 10.1074/jbc.M313732200; HULTQUIST DE, 1971, NATURE-NEW BIOL, V229, P252, DOI 10.1038/newbio229252a0; Kihm AJ, 2002, NATURE, V417, P758, DOI 10.1038/nature00803; Kong Y, 2004, J CLIN INVEST, V114, P1457, DOI 10.1172/JCI200421982; KONG Y, 2003, BLOOD, V102, P46; McMahon TJ, 2000, J BIOL CHEM, V275, P16738, DOI 10.1074/jbc.M000532200; MISRA HP, 1972, J BIOL CHEM, V247, P3170; RACHMILEWITZ EA, 1971, J BIOL CHEM, V246, P3356; Tsuruga M, 1998, J BIOL CHEM, V273, P8607, DOI 10.1074/jbc.273.15.8607; Vasseur-Godbillon C, 2006, PROTEIN ENG DES SEL, V19, P91, DOI 10.1093/protein/gzj006; Wakasugi K, 2003, J BIOL CHEM, V278, P36505, DOI 10.1074/jbc.M305519200; WALLACE WJ, 1982, J BIOL CHEM, V257, P4966; ZAVODNIK I V, 1992, Molekulyarnaya Biologiya (Moscow), V26, P321; ZHANG L, 1991, J BIOL CHEM, V266, P24698	24	34	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32611	32618		10.1074/jbc.M607311200	http://dx.doi.org/10.1074/jbc.M607311200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16901899	hybrid			2022-12-27	WOS:000241414500059
J	Sagher, D; Brunell, D; Brot, N; Vallee, BL; Weissbach, H				Sagher, Daphna; Brunell, David; Brot, Nathan; Vallee, Bert L.; Weissbach, Herbert			Selenocompounds can serve as oxidoreductants with the methionine sulfoxide reductase enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC MECHANISM; THIOREDOXIN REDUCTASE; LIFE-SPAN; METALLOTHIONEIN; EXPRESSION; SUBSTRATE; OXIDATION; CLONING; NADPH	In a recent study on the reducing requirement for the methionine sulfoxide reductases (Msr) (Sagher, D., Brunell, D., Hejtmancik, J. F., Kantorow, M., Brot, N. & Weissbach, H. ( 2006) Proc. Natl. Acad. Sci. U. S. A. 103, 8656 - 8661), we have shown that thioredoxin, although an excellent reducing system for Escherichia coli MsrA and MsrB and bovine MsrA, is not an efficient reducing agent for either human MsrB2 (hMsrB2) or human MsrB3 (hMsrB3). In a search for another reducing agent for hMsrB2 and hMsrB3, it was recently found that thionein, the reduced, metal-free form of metallothionein, could function as a reducing system for hMsrB3, with weaker activity using hMsrB2. In the present study, we provide evidence that some selenium compounds are potent reducing agents for both hMsrB2 and hMsrB3.	Florida Atlantic Univ, Ctr Mol Biol & Biotechnol, Boca Raton, FL 33431 USA; Cornell Univ, Weill Med Coll, Hosp Special Surg, Dept Microbiol & Immunol, New York, NY 10021 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	State University System of Florida; Florida Atlantic University; Cornell University; Harvard University; Harvard Medical School	Weissbach, H (corresponding author), Florida Atlantic Univ, Ctr Mol Biol & Biotechnol, 777 Glades Rd, Boca Raton, FL 33431 USA.	hweissba@fau.edu						Antoine M, 2003, J BIOL CHEM, V278, P45352, DOI 10.1074/jbc.M307471200; BJORNSTEDT M, 1995, J BIOL CHEM, V270, P11761, DOI 10.1074/jbc.270.20.11761; BJORNSTEDT M, 1994, J BIOL CHEM, V269, P29382; Boschi-Muller S, 2000, J BIOL CHEM, V275, P35908, DOI 10.1074/jbc.M006137200; CHAUDIERE J, 1992, ARCH BIOCHEM BIOPHYS, V296, P328, DOI 10.1016/0003-9861(92)90580-P; Chen Y, 2001, EUR J BIOCHEM, V268, P3346, DOI 10.1046/j.1432-1327.2001.02250.x; Etienne F, 2003, BIOCHEM BIOPH RES CO, V312, P1005, DOI 10.1016/j.bbrc.2003.10.203; Francesconi KA, 2004, CLIN CHEM, V50, P2240, DOI 10.1373/clinchem.2004.039875; Kim HY, 2005, PLOS BIOL, V3, P2080, DOI 10.1371/journal.pbio.0030375; Kim HY, 2004, MOL BIOL CELL, V15, P1055, DOI 10.1091/mbc.E03-08-0629; KLEIN D, 1994, ANAL BIOCHEM, V221, P405, DOI 10.1006/abio.1994.1434; Koc A, 2004, P NATL ACAD SCI USA, V101, P7999, DOI 10.1073/pnas.0307929101; KUMAR S, 1992, EUR J BIOCHEM, V207, P435, DOI 10.1111/j.1432-1033.1992.tb17068.x; LAVINE TF, 1947, J BIOL CHEM, V169, P477; Lowther WT, 2000, BIOCHEMISTRY-US, V39, P13307, DOI 10.1021/bi0020269; Lowther WT, 2000, P NATL ACAD SCI USA, V97, P6463, DOI 10.1073/pnas.97.12.6463; Lowther WT, 2002, NAT STRUCT BIOL, V9, P348, DOI 10.1038/nsb783; MINETTI G, 1994, ITAL J BIOCHEM, V43, P273; Moskovitz J, 2003, P NATL ACAD SCI USA, V100, P7486, DOI 10.1073/pnas.1332607100; Moskovitz J, 1996, P NATL ACAD SCI USA, V93, P2095, DOI 10.1073/pnas.93.5.2095; Moskovitz J, 2001, P NATL ACAD SCI USA, V98, P12920, DOI 10.1073/pnas.231472998; RAHMAN MA, 1992, J BIOL CHEM, V267, P15549; Ruan H, 2002, P NATL ACAD SCI USA, V99, P2748, DOI 10.1073/pnas.032671199; Saghert D, 2006, P NATL ACAD SCI USA, V103, P8656, DOI 10.1073/pnas.0602826103; Weissbach H, 2005, BBA-PROTEINS PROTEOM, V1703, P203, DOI 10.1016/j.bbapap.2004.10.004; Zhao R, 2002, J BIOL CHEM, V277, P39456, DOI 10.1074/jbc.M206452200	26	42	45	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31184	31187		10.1074/jbc.M606962200	http://dx.doi.org/10.1074/jbc.M606962200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16916796	Bronze			2022-12-27	WOS:000241235300003
J	Goede, B; Naji, S; von Kampen, O; Ilg, K; Thomm, M				Goede, Bernd; Naji, Souad; von Kampen, Oliver; Ilg, Karin; Thomm, Michael			Protein-protein interactions in the archaeal transcriptional machinery - Binding studies of isolated RNA polymerase subunits and transcription factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-B; INITIATION; DNA; SITE; ARCHITECTURE; CONTACTS; HOMOLOG; COMPLEX; TFIIB; RPB4	Transcription in Archaea is directed by a pol II-like RNA polymerase and homologues of TBP and TFIIB (TFB) but the crystal structure of the archaeal enzyme and the subunits involved in recruitment of RNA polymerase to the promoter-TBP-TFB-complex are unknown. We described here the cloning expression and purification of 11 bacterially expressed subunits of the Pyrococcus furiosus RNAP. Protein interactions of subunits with each other and of archaeal transcription factors TFB and TFB with RNAP subunits were studied by Far-Western blotting and reconstitution of subcomplexes from single subunits in solution. In silico comparison of a consensus sequence of archaeal RNAP subunits with the sequence of yeast pol II subunits revealed a high degree of conservation of domains of the enzymes forming the cleft and catalytic center of the enzyme. Interaction studies with the large subunits were complicated by the low solubility of isolated subunits B, A', and A", but an interaction network of the smaller subunits of the enzyme was established. Far-Western analyses identified subunit D as structurally important key polypeptide of RNAP involved in interactions with subunits B, L, N, and P and revealed also a strong interaction of subunits E' and F. Stable complexes consisting of subunits E' and F, of D and L and a BDLNP-subcomplex were reconstituted and purified. Gel shift analyses revealed an association of the BDLNP subcomplex with promoter-bound TBP-TFB. These results suggest a major role of subunit B (Rpb2) in RNAP recruitment to the TBP-TFB promoter complex.	Univ Regensburg, Lehrstuhl Mikrobiol, D-93053 Regensburg, Germany; Univ Regensburg, Archaeenzentrum, D-93053 Regensburg, Germany; Univ Kiel, Lehrstuhl Allgemeine Mikrobiol, D-24107 Kiel, Germany	University of Regensburg; University of Regensburg; University of Kiel	Thomm, M (corresponding author), Univ Regensburg, Lehrstuhl Mikrobiol, Univ Str 31, D-93053 Regensburg, Germany.	michael.thomm@biologie.uni-regensburg.de						Armache KJ, 2003, P NATL ACAD SCI USA, V100, P6964, DOI 10.1073/pnas.1030608100; Arthur TM, 1998, J BIOL CHEM, V273, P31381, DOI 10.1074/jbc.273.47.31381; Bartlett MS, 2005, CURR OPIN MICROBIOL, V8, P677, DOI 10.1016/j.mib.2005.10.016; Bartlett MS, 2004, J BIOL CHEM, V279, P5894, DOI 10.1074/jbc.M311429200; Bell SD, 2000, J BIOL CHEM, V275, P12934, DOI 10.1074/jbc.275.17.12934; Bell SD, 2001, EMBO REP, V2, P133, DOI 10.1093/embo-reports/kve021; Burgess RR, 1996, METHOD ENZYMOL, V273, P145; Burgess RR, 2000, METHOD ENZYMOL, V328, P141, DOI 10.1016/S0076-6879(00)28396-1; Bushnell DA, 2003, P NATL ACAD SCI USA, V100, P6969, DOI 10.1073/pnas.1130601100; Chen HT, 2004, CELL, V119, P169, DOI 10.1016/j.cell.2004.09.028; Chen HT, 2003, MOL CELL, V12, P437, DOI 10.1016/S1097-2765(03)00306-X; Choder M, 2004, TRENDS BIOCHEM SCI, V29, P674, DOI 10.1016/j.tibs.2004.10.007; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Ehlers C, 2002, J BACTERIOL, V184, P1028, DOI 10.1128/jb.184.4.1028-1040.2002; Eloranta JJ, 1998, NUCLEIC ACIDS RES, V26, P5562, DOI 10.1093/nar/26.24.5562; Geiduschek EP, 2005, MOL MICROBIOL, V56, P1397, DOI 10.1111/j.1365-2958.2005.04627.x; Hanzelka BL, 2001, J BACTERIOL, V183, P1813, DOI 10.1128/JB.183.5.1813-1818.2001; Hausner W, 1996, J BIOL CHEM, V271, P30144, DOI 10.1074/jbc.271.47.30144; Hethke C, 1996, NUCLEIC ACIDS RES, V24, P2369, DOI 10.1093/nar/24.12.2369; Jasiak AJ, 2006, MOL CELL, V23, P71, DOI 10.1016/j.molcel.2006.05.013; Kim TK, 2000, SCIENCE, V288, P1418, DOI 10.1126/science.288.5470.1418; LANZENDORFER M, 1994, SYST APPL MICROBIOL, V16, P656; Magill CP, 2001, J BIOL CHEM, V276, P46693, DOI 10.1074/jbc.C100567200; Meka H, 2005, NUCLEIC ACIDS RES, V33, P6435, DOI 10.1093/nar/gki945; Miyao T, 1998, P NATL ACAD SCI USA, V95, P15281, DOI 10.1073/pnas.95.26.15281; PUHLER G, 1989, P NATL ACAD SCI USA, V86, P4569, DOI 10.1073/pnas.86.12.4569; Renfrow MB, 2004, J BIOL CHEM, V279, P2825, DOI 10.1074/jbc.M311433200; ROBERTS SGE, 1994, NATURE, V371, P717, DOI 10.1038/371717a0; SCHNABEL R, 1983, EMBO J, V2, P751, DOI 10.1002/j.1460-2075.1983.tb01495.x; Spitalny P, 2003, J BIOL CHEM, V278, P30497, DOI 10.1074/jbc.M303633200; Todone F, 2001, MOL CELL, V8, P1137, DOI 10.1016/S1097-2765(01)00379-3; Vierke G, 2003, J BIOL CHEM, V278, P18, DOI 10.1074/jbc.M209250200; Werner F, 2000, NUCLEIC ACIDS RES, V28, P4299, DOI 10.1093/nar/28.21.4299; Werner F, 2005, MOL CELL BIOL, V25, P8344, DOI 10.1128/MCB.25.18.8344-8355.2005; Werner F, 2002, MOL CELL, V10, P635, DOI 10.1016/S1097-2765(02)00629-9	36	32	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30581	30592		10.1074/jbc.M605209200	http://dx.doi.org/10.1074/jbc.M605209200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16885163	hybrid			2022-12-27	WOS:000241075900034
J	Ikegami, K; Mukai, M; Tsuchida, J; Heier, RL; MacGregor, GR; Setou, M				Ikegami, Koji; Mukai, Masahiro; Tsuchida, Jun-ichi; Heier, Robb L.; MacGregor, Grant R.; Setou, Mitsutoshi			TTLL7 is a mammalian beta-tubulin polyglutamylase required for growth of MAP2-positive neurites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE-ASSOCIATED PROTEINS; ALPHA-TUBULIN; AXONAL-TRANSPORT; RNA INTERFERENCE; TYROSINE LIGASE; NERVOUS-SYSTEM; PC12 CELLS; IN-VITRO; OUTGROWTH; BRAIN	Microtubules form a cytoskeletal framework that influences cell shape and provides structural support for the cell. Microtubules in the nervous system undergo a unique post-translational modification, polyglutamylation of the C termini of their tubulin subunits. The mammalian enzymes that perform beta-tubulin polyglutamylation as well as their physiological functions in the neuronal tissue remain elusive. We report identification of a mammalian polyglutamylase with specificity for beta-tubulin as well as its distribution and function in neurite growth. To identify putative tubulin polyglutamylases, we searched tubulin tyrosine ligase-like (TTLL) proteins for those predominantly expressed in the nervous system. Of 13 TTLL proteins, TTLL7 was transcribed at the highest level in the nervous system. Recombinant TTLL7 catalyzed tubulin polyglutamylation with high preference to beta-tubulin in vitro. When expressed in HEK293T cells, TTLL7 demonstrated specificity for beta-tubulin and not for beta-tubulin or nucleosome assembly protein 1. Consistent with these findings, knockdown of TTLL7 in a primary culture of superior cervical ganglion neurons caused a loss of polyglutamylated beta-tubulin. Following stimulation of PC12 cells with nerve growth factor to differentiate, the level of TTLL7 increased concomitantly with polyglutamylation of beta-tubulin. Short interference RNA-mediated knockdown of TTLL7 repressed nerve growth factor-stimulated MAP ( microtubule-associated protein) 2- positive neurite growth in PC12 cells. Consistent with having a role in the growth of MAP2-positive neurites, TTLL7 accumulated within a MAP2-enriched somatodendritic portion of superior cervical ganglion, as did polyglutamylated beta-tubulin. Anti-TTLL7 antibody revealed that TTLL7 was distributed in a somatodendritic compartment in the mouse brain. These findings indicate that TTLL7 is a beta-tubulin polyglutamylase and is required for the growth of MAP2- positive neurites in PC12 cells.	Natl Inst Physiol Sci, Okazaki, Aichi 4448787, Japan; Mitsubishi Kagaku Inst Life Sci, Machida, Tokyo 1948511, Japan; Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan; Mitsubishi Pharma Corp, Aoba Ku, Yokohama, Kanagawa 2270033, Japan; Univ Calif Irvine, Dept Dev & Cell Biol, Ctr Dev Biol, Irvine, CA 92697 USA; Univ Calif Irvine, Ctr Mol & Mitochondrial Med & Genet, Irvine, CA 92697 USA	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Mitsubishi Kagaku Institute of Life Sciences (MITILS); Japan Science & Technology Agency (JST); Mitsubishi Tanabe Pharma Corporation; University of California System; University of California Irvine; University of California System; University of California Irvine	Setou, M (corresponding author), Natl Inst Physiol Sci, 5-1 Higashiyama,Myodaiji Cho, Okazaki, Aichi 4448787, Japan.	setou@nips.ac.jp			NICHD NIH HHS [U01 HD045913-02, U01 HD045913-03, U01 HD045913-01] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD045913] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ARGARANA CE, 1978, MOL CELL BIOCHEM, V19, P17; AUDEBERT S, 1994, J CELL SCI, V107, P2313; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; BLACK MM, 1986, J CELL BIOL, V103, P545, DOI 10.1083/jcb.103.2.545; BLOOM GS, 1984, J CELL BIOL, V98, P320, DOI 10.1083/jcb.98.1.320; Bobinnec Y, 1998, CELL MOTIL CYTOSKEL, V39, P223, DOI 10.1002/(SICI)1097-0169(1998)39:3<223::AID-CM5>3.3.CO;2-3; Bobinnec Y, 1998, J CELL BIOL, V143, P1575, DOI 10.1083/jcb.143.6.1575; Bonnet C, 2001, J BIOL CHEM, V276, P12839, DOI 10.1074/jbc.M011380200; BOUCHER D, 1994, BIOCHEMISTRY-US, V33, P12471, DOI 10.1021/bi00207a014; BRUGG B, 1993, NEUROSCIENCE, V52, P489, DOI 10.1016/0306-4522(93)90401-Z; BRUGG B, 1988, J CELL BIOL, V107, P643, DOI 10.1083/jcb.107.2.643; CAMBRAYDEAKIN MA, 1987, CELL MOTIL CYTOSKEL, V8, P284, DOI 10.1002/cm.970080309; Campbell PK, 2002, GENETICS, V162, P307; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Dideberg O, 1998, TRENDS BIOCHEM SCI, V23, P57, DOI 10.1016/S0968-0004(97)01149-3; DRUBIN DG, 1985, J CELL BIOL, V101, P1799, DOI 10.1083/jcb.101.5.1799; EDDE B, 1990, SCIENCE, V247, P83, DOI 10.1126/science.1967194; ESMAELIAZAD B, 1994, J CELL SCI, V107, P869; Fontaine-Lenoir V, 2006, P NATL ACAD SCI USA, V103, P4711, DOI 10.1073/pnas.0600113103; Galperin MY, 1997, PROTEIN SCI, V6, P2639; GREENE LA, 1983, J CELL BIOL, V96, P76, DOI 10.1083/jcb.96.1.76; Harada A, 2002, J CELL BIOL, V158, P541, DOI 10.1083/jcb.200110134; HARADA A, 1994, NATURE, V369, P488, DOI 10.1038/369488a0; Ikegami K, 2003, NEUROSCIENCE, V122, P617, DOI 10.1016/j.neuroscience.2003.08.057; Janke C, 2005, SCIENCE, V308, P1758, DOI 10.1126/science.1113010; Larcher JC, 1996, J BIOL CHEM, V271, P22117, DOI 10.1074/jbc.271.36.22117; LEWIS SA, 1986, J CELL BIOL, V102, P2106, DOI 10.1083/jcb.102.6.2106; LHERNAULT SW, 1985, BIOCHEMISTRY-US, V24, P473, DOI 10.1021/bi00323a034; LITTAUER UZ, 1986, P NATL ACAD SCI USA, V83, P7162, DOI 10.1073/pnas.83.19.7162; Luduena RF, 1998, INT REV CYTOL, V178, P207; MACCIONI RB, 1988, EMBO J, V7, P1957, DOI 10.1002/j.1460-2075.1988.tb03033.x; MATUS A, 1981, P NATL ACAD SCI-BIOL, V78, P3010, DOI 10.1073/pnas.78.5.3010; Naito Y, 2004, NUCLEIC ACIDS RES, V32, pW124, DOI 10.1093/nar/gkh442; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; PENG I, 1986, J CELL BIOL, V102, P252, DOI 10.1083/jcb.102.1.252; Przyborski SA, 1997, DEV BRAIN RES, V100, P133, DOI 10.1016/S0165-3806(97)00031-X; REDEKER V, 1994, SCIENCE, V266, P1688, DOI 10.1126/science.7992051; Regnard C, 2003, J CELL SCI, V116, P4181, DOI 10.1242/jcs.00743; Regnard C, 1998, BIOCHEMISTRY-US, V37, P8395, DOI 10.1021/bi9804131; Regnard C, 2000, J BIOL CHEM, V275, P15969, DOI 10.1074/jbc.M000045200; Regnard C, 1999, J CELL SCI, V112, P4281; Setou M, 2002, NATURE, V417, P83, DOI 10.1038/nature743; Setou M, 2004, J NEUROBIOL, V58, P201, DOI 10.1002/neu.10324; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Szebenyi G, 2005, CURR BIOL, V15, P1820, DOI 10.1016/j.cub.2005.08.069; Ui-Tei K, 2004, NUCLEIC ACIDS RES, V32, P936, DOI 10.1093/nar/gkh247; WOLFF A, 1992, EUR J CELL BIOL, V59, P425	47	116	120	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30707	30716		10.1074/jbc.M603984200	http://dx.doi.org/10.1074/jbc.M603984200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16901895	Green Accepted, hybrid			2022-12-27	WOS:000241075900047
J	Samra, HS; Gao, F; He, F; Hoang, E; Chen, ZG; Gegenheimer, PA; Berrie, CL; Richter, ML				Samra, Hardeep S.; Gao, Fei; He, Feng; Hoang, Etter; Chen, Zugen; Gegenheimer, Peter A.; Berrie, Cindy L.; Richter, Mark L.			Structural analysis of the regulatory dithiol-containing domain of the chloroplast ATP synthase gamma subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLING FACTOR-I; NUCLEOTIDE-BINDING-SITES; ENERGY-DEPENDENT CHANGES; EPSILON-SUBUNIT; C-TERMINUS; ESCHERICHIA-COLI; F-1-ATPASE; CONFORMATION; INHIBITION; PHOTOPHOSPHORYLATION	The gamma subunit of the F-1 portion of the chloroplast ATP synthase contains a critically placed dithiol that provides a redox switch converting the enzyme from a latent to an active ATPase. The switch prevents depletion of intracellular ATP pools in the dark when photophosphorylation is inactive. The dithiol is located in a special regulatory segment of about 40 amino acids that is absent from the gamma subunits of the eubacterial and mitochondrial enzymes. Site-directed mutagenesis was used to probe the relationship between the structure of the gamma regulatory segment and its function in ATPase regulation via its interaction with the inhibitory epsilon subunit. Mutations were designed using a homology model of the chloroplast gamma subunit based on the analogous structures of the bacterial and mitochondrial homologues. The mutations included (a) substituting both of the disulfide-forming cysteines (Cys(199) and Cys(205)) for alanines, (b) deleting nine residues containing the dithiol, (c) deleting the region distal to the dithiol (residues 224-240), and (d) deleting the entire segment between residues 196 and 241 with the exception of a small spacer element, and (e) deleting pieces from a small loop segment predicted by the model to interact with the dithiol domain. Deletions within the dithiol domain and within parts of the loop segment resulted in loss of redox control of the ATPase activity of the F-1 enzyme. Deleting the distal segment, the whole regulatory domain, or parts of the loop segment had the additional effect of reducing the maximum extent of inhibition obtained upon adding the epsilon subunit but did not abolish epsilon binding. The results suggest a mechanism by which the gamma and epsilon subunits interact with each other to induce the latent state of the enzyme.	Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA; Univ Kansas, Dept Chem, Lawrence, KS 66045 USA	University of Kansas; University of Kansas	Richter, ML (corresponding author), Univ Kansas, Dept Mol Biosci, 1200 Sunnyside Ave, Lawrence, KS 66045 USA.	richter@ku.edu	Gegenheimer, Peter Albert/E-2271-2013	Gegenheimer, Peter Albert/0000-0001-9863-1545	NIGMS NIH HHS [GM08545] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Averboukh L, 1996, BIOTECHNIQUES, V20, P918; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Capaldi RA, 2000, BBA-BIOENERGETICS, V1458, P263, DOI 10.1016/S0005-2728(00)00078-5; CHEN ZG, 1992, FEBS LETT, V298, P69, DOI 10.1016/0014-5793(92)80024-B; Cipriano DJ, 2006, J BIOL CHEM, V281, P501, DOI 10.1074/jbc.M509986200; Cipriano DJ, 2002, J BIOL CHEM, V277, P16782, DOI 10.1074/jbc.M201349200; CRUZ JA, 1995, PLANT PHYSIOL, V109, P1379, DOI 10.1104/pp.109.4.1379; GAO F, 1995, J BIOL CHEM, V270, P9763, DOI 10.1074/jbc.270.17.9763; GIRAULT G, 1988, J BIOL CHEM, V263, P14690; Hara KY, 2001, J BIOL CHEM, V276, P23969, DOI 10.1074/jbc.M009303200; Hightower KE, 1996, BIOCHEMISTRY-US, V35, P4846, DOI 10.1021/bi952913p; Hisabori T, 1999, FEBS LETT, V463, P35, DOI 10.1016/S0014-5793(99)01602-6; Hisabori T, 1998, J BIOL CHEM, V273, P15901, DOI 10.1074/jbc.273.26.15901; HU NM, 1993, J BIOL CHEM, V268, P8536; Johnson EA, 2002, BIOCHEMISTRY-US, V41, P2446, DOI 10.1021/bi011939f; Keis S, 2006, J BACTERIOL, V188, P3796, DOI 10.1128/JB.00040-06; KETCHAM SR, 1984, J BIOL CHEM, V259, P7286; KOMATSUTAKAKI M, 1992, J BIOL CHEM, V267, P2360; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; MORONEY JV, 1984, J BIOL CHEM, V259, P7281; MORONEY JV, 1982, J BIOL CHEM, V257, P5915; NALIN CM, 1983, J BIOL CHEM, V258, P3376; Nowak KF, 2004, BIOCHEMISTRY-US, V43, P3273, DOI 10.1021/bi035820d; Nowak KF, 2002, BIOCHEMISTRY-US, V41, P15130, DOI 10.1021/bi026594v; Oster G, 2000, BBA-BIOENERGETICS, V1458, P482, DOI 10.1016/S0005-2728(00)00096-7; PENEFSKY HS, 1977, J BIOL CHEM, V252, P2891; RICHTER ML, 1984, J BIOL CHEM, V259, P7371; Richter ML, 2005, J BIOENERG BIOMEMBR, V37, P467, DOI 10.1007/s10863-005-9493-9; Richter ML, 2004, PHOTOSYNTH RES, V79, P319, DOI 10.1023/B:PRES.0000017157.08098.36; RICHTER ML, 1987, J BIOL CHEM, V262, P15037; RICHTER ML, 1985, BIOCHEMISTRY-US, V24, P5755, DOI 10.1021/bi00342a011; RICHTER ML, 1987, PROGR PHOTOSYNTHESIS, V3, P57; RICHTER ML, 1996, ADV PHOTOSYNTH, V4, P453; Rodgers AJW, 2000, NAT STRUCT BIOL, V7, P1051; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schulenberg B, 1997, EUR J BIOCHEM, V249, P134, DOI 10.1111/j.1432-1033.1997.t01-1-00134.x; SCHUMANN J, 1985, J BIOL CHEM, V260, P1817; SHAPIRO AB, 1991, J BIOL CHEM, V266, P17276; Shi XB, 2001, BIOCHEMISTRY-US, V40, P10825, DOI 10.1021/bi015551w; Sokolov M, 1999, J BIOL CHEM, V274, P13824, DOI 10.1074/jbc.274.20.13824; SOTEROPOULOS P, 1992, J BIOL CHEM, V267, P10348; STERNWEIS PC, 1980, BIOCHEMISTRY-US, V19, P526, DOI 10.1021/bi00544a021; Suzuki T, 2003, J BIOL CHEM, V278, P46840, DOI 10.1074/jbc.M307165200; TAUSSKY HH, 1953, J BIOL CHEM, V202, P675; Tsunoda SP, 2001, P NATL ACAD SCI USA, V98, P6560, DOI 10.1073/pnas.111128098; Tucker WC, 2004, J BIOL CHEM, V279, P47415, DOI 10.1074/jbc.C400269200; Tucker WC, 2001, EUR J BIOCHEM, V268, P2179, DOI 10.1046/j.1432-1327.2001.02110.x; Wilkens S, 1998, J BIOL CHEM, V273, P26645, DOI 10.1074/jbc.273.41.26645; XUING H, 1998, BIOCHEMISTRY-US, V37, P16423	50	27	28	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					31041	31049		10.1074/jbc.M603315200	http://dx.doi.org/10.1074/jbc.M603315200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16895914	hybrid			2022-12-27	WOS:000241075900080
J	Starnes, GL; Jewett, TJ; Carruthers, VB; Sibley, LD				Starnes, G. Lucas; Jewett, Travis J.; Carruthers, Vern B.; Sibley, L. David			Two separate, conserved acidic amino acid domains within the Toxoplasma gondii MIC2 cytoplasmic tail are required for parasite survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE ADHESINS; GLIDING MOTILITY; MICRONEME PROTEIN; ACTIN CYTOSKELETON; INVASION; GENE; ALDOLASE; THROMBOSPONDIN; SEQUENCE; INFECTION	Apicomplexan parasites rely on actin-based motility to drive host cell invasion. Motility and invasion also require thrombospondin-related anonymous protein ( TRAP) adhesins, which are secreted apically and translocated to the posterior end of the parasite before they are shed by the activity of a rhomboid protease. TRAP orthologs, including Toxoplasma gondii MIC2 ( microneme protein 2), possess a short cytoplasmic tail, which is essential for motility. Previous studies have shown that aldolase forms a critical bridge between actin filaments and the cytoplasmic domains of MIC2 and TRAP. The cytoplasmic tails of TRAP family members harbor a conserved penultimate tryptophan, which is essential for aldolase binding, and clustered acidic residues. Herein, we determined the role of the conserved acidic residues by using alanine point mutants to investigate aldolase binding in vitro and to test functionality in the parasite. Our studies revealed two separate acidic residue clusters in the cytoplasmic domain of MIC2 that are essential for parasite survival. One region, located at the extreme C terminus, is required for the direct interaction with aldolase, whereas the second upstream acidic region is not necessary for aldolase binding but is nonetheless essential to parasite survival. Both acidic domains are conserved throughout TRAP orthologs, implicating a central role for these motifs in apicomplexan motility.	Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63130 USA; Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	Washington University (WUSTL); University of Michigan System; University of Michigan	Sibley, LD (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, POB 8230,660 S Euclid Ave, St Louis, MO 63130 USA.	sibley@borcim.wustl.edu	Sibley, L. David/C-4616-2008	Carruthers, Vern/0000-0001-6859-8895	NIAID NIH HHS [R01 AI046675, R01 AI034036, AI017172, AI034036] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046675, R01AI034036] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Barragan A, 2003, TRENDS MICROBIOL, V11, P426, DOI 10.1016/S0966-842X(03)00205-1; Baum J, 2006, J BIOL CHEM, V281, P5197, DOI 10.1074/jbc.M509807200; Brecht S, 2001, J BIOL CHEM, V276, P4119, DOI 10.1074/jbc.M008294200; Brossier F, 2005, INT J BIOCHEM CELL B, V37, P2266, DOI 10.1016/j.biocel.2005.06.006; Brossier F, 2005, P NATL ACAD SCI USA, V102, P4146, DOI 10.1073/pnas.0407918102; Brossier F, 2003, J BIOL CHEM, V278, P6229, DOI 10.1074/jbc.M209837200; Buscaglia CA, 2006, J BIOL CHEM, V281, P1324, DOI 10.1074/jbc.M506346200; Buscaglia CA, 2003, MOL BIOL CELL, V14, P4947, DOI 10.1091/mbc.E03-06-0355; Carruthers VB, 2000, J BIOL CHEM, V275, P14346, DOI 10.1074/jbc.275.19.14346; Carruthers VB, 2002, ACTA TROP, V81, P111, DOI 10.1016/S0001-706X(01)00201-7; Carruthers VB, 1997, EUR J CELL BIOL, V73, P114; Dessens JT, 1999, EMBO J, V18, P6221, DOI 10.1093/emboj/18.22.6221; Dobrowolski JM, 1997, CELL MOTIL CYTOSKEL, V37, P253, DOI 10.1002/(SICI)1097-0169(1997)37:3&lt;253::AID-CM7&gt;3.0.CO;2-7; Dobrowolski JM, 1996, CELL, V84, P933, DOI 10.1016/S0092-8674(00)81071-5; Donald RGK, 1998, MOL BIOCHEM PARASIT, V91, P295, DOI 10.1016/S0166-6851(97)00210-7; Dowse TJ, 2005, INT J PARASITOL, V35, P747, DOI 10.1016/j.ijpara.2005.04.001; DUBREMETZ JF, 1993, PARASITOL RES, V79, P402, DOI 10.1007/BF00931830; Gaskins E, 2004, J CELL BIOL, V165, P383, DOI 10.1083/jcb.200311137; Huynh MH, 2004, CELL MICROBIOL, V6, P771, DOI 10.1111/j.1462-5822.2004.00403.x; Jewett TJ, 2003, MOL CELL, V11, P885, DOI 10.1016/S1097-2765(03)00113-8; Jewett TJ, 2004, J BIOL CHEM, V279, P9362, DOI 10.1074/jbc.M312590200; Kappe S, 1999, J CELL BIOL, V147, P937, DOI 10.1083/jcb.147.5.937; Meissner M, 2002, SCIENCE, V298, P837, DOI 10.1126/science.1074553; Menard R, 2001, CELL MICROBIOL, V3, P63, DOI 10.1046/j.1462-5822.2001.00097.x; Morrissette NS, 2002, MICROBIOL MOL BIOL R, V66, P21, DOI 10.1128/MMBR.66.1.21-38.2002; Opitz C, 2002, MOL MICROBIOL, V45, P597, DOI 10.1046/j.1365-2958.2002.03056.x; ROBSON KJH, 1988, NATURE, V335, P79, DOI 10.1038/335079a0; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Sahoo N, 2006, MOL BIOL CELL, V17, P895, DOI 10.1091/mbc.E05-06-0512; Sibley LD, 2004, SCIENCE, V304, P248, DOI 10.1126/science.1094717; Spano F, 1998, MOL BIOCHEM PARASIT, V92, P147, DOI 10.1016/S0166-6851(97)00243-0; Sultan AA, 1997, CELL, V90, P511, DOI 10.1016/S0092-8674(00)80511-5; TOMLEY FM, 1991, MOL BIOCHEM PARASIT, V49, P277, DOI 10.1016/0166-6851(91)90071-D; Wan KL, 1997, MOL BIOCHEM PARASIT, V84, P203, DOI 10.1016/S0166-6851(96)02796-X; Wang JA, 1996, J BIOL CHEM, V271, P6861, DOI 10.1074/jbc.271.12.6861; Wetzel DM, 2003, MOL BIOL CELL, V14, P396, DOI 10.1091/mbc.E02-08-0458; Yuda M, 1999, J EXP MED, V190, P1711, DOI 10.1084/jem.190.11.1711	37	41	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30745	30754		10.1074/jbc.M606523200	http://dx.doi.org/10.1074/jbc.M606523200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16923803	hybrid			2022-12-27	WOS:000241075900051
J	Xiao, ZS; Zhang, SQ; Mahlios, J; Zhou, G; Magenheimer, BS; Guo, DY; Dallas, SL; Maser, R; Calvet, JP; Bonewald, L; Quarles, LD				Xiao, Zhousheng; Zhang, Shiqin; Mahlios, Josh; Zhou, Gan; Magenheimer, Brenda S.; Guo, Dayong; Dallas, Sarah L.; Maser, Robin; Calvet, James P.; Bonewald, Lynda; Quarles, Leigh Darryl			Cilia-like structures and polycystin-1 in osteoblasts/osteocytes and associated abnormalities in skeletogenesis and Runx2 expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KIDNEY-DISEASE; TRANSCRIPTION FACTOR; BONE-FORMATION; MECHANOTRANSDUCTION; DIFFERENTIATION; CELLS; GENE; SKELETAL; CALCIUM; STRAIN	We examined the osteoblast/osteocyte expression and function of polycystin-1 (PC1), a transmembrane protein that is a component of the polycystin-2 (PC2)-ciliary mechano-sensor complex in renal epithelial cells. We found that MC3T3-E1 osteoblasts and MLO-Y4 osteocytes express transcripts for PC1, PC2, and the ciliary proteins Tg737 and Kif3a. Immunohistochemical analysis detected cilia-like structures in MC3T3-E1 osteoblastic and MLO-Y4 osteocyte-like cell lines as well as primary osteocytes and osteoblasts from calvaria. Pkd1(m1Bei) mice have inactivating missense mutations of Pkd1 gene that encode PC1. Pkd1m1Bei homozygous mutant mice demonstrated delayed endochondral and intramembranous bone formation, whereas heterozygous Pkd1(m1Bei) mutant mice had osteopenia caused by reduced osteoblastic function. Heterozygous and homozygous Pkd1m1Bei mutant mice displayed a gene dose-dependent decrease in the expression of Runx2 and osteoblast-related genes. In addition, overexpression of constitutively active PC1 C-terminal constructs in MC3T3-E1 osteoblasts resulted in an increase in Runx2 P1 promoter activity and endogenous Runx2 expression as well as an increase in osteoblast differentiation markers. Conversely, osteoblasts derived from Pkd1m1Bei homozygous mutant mice had significant reductions in endogenous Runx2 expression, osteoblastic markers, and differentiation capacity ex vivo. Co-expression of constitutively active PC1 C-terminal construct into Pkd1m1Bei homozygous osteoblasts was sufficient to normalize Runx2 P1 promoter activity. These findings are consistent with a possible functional role of cilia and PC1 in anabolic signaling in osteoblasts/ osteocytes.	Univ Kansas, Med Ctr, Kidney Inst, Kansas City, KS 66160 USA; Univ Missouri, Sch Dent, Dept Oral Biol, Kansas City, MO 64108 USA	University of Kansas; University of Kansas Medical Center; University of Missouri System; University of Missouri Kansas City	Quarles, LD (corresponding author), Univ Kansas, Med Ctr, Kidney Inst, 3901 Rainbow Blvd,6018 Wahl Hall E, Kansas City, KS 66160 USA.	dquarles@kumc.edu	Bonewald, Lynda/Q-3638-2019	Quarles, L. Darryl/0000-0002-5082-7896	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049712, P01AR046798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK057301, R01DK083303] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR049712, P01-AR46798, R01-AR049712, P01 AR046798] Funding Source: Medline; NIDDK NIH HHS [R01 DK083303, P50 DK057301, P50-DK057301] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Al-Bhalal L, 2005, ADV ANAT PATHOL, V12, P126, DOI 10.1097/01.pap.0000163959.29032.1f; Borton AJ, 2001, J BONE MINER RES, V16, P1754, DOI 10.1359/jbmr.2001.16.10.1754; Boulter C, 2001, P NATL ACAD SCI USA, V98, P12174, DOI 10.1073/pnas.211191098; Chung Choo-ryung J., 2004, Journal of Medical and Dental Sciences, V51, P105; Costessi A, 2005, BONE, V36, P418, DOI 10.1016/j.bone.2004.10.016; Delmas P, 2005, PFLUG ARCH EUR J PHY, V451, P264, DOI 10.1007/s00424-005-1431-5; Delmas P, 2004, BIOCHEM BIOPH RES CO, V322, P1374, DOI 10.1016/j.bbrc.2004.08.044; FEDERMAN M, 1974, CALC TISS RES, V17, P81, DOI 10.1007/BF02547216; Franceschi RT, 2003, J CELL BIOCHEM, V88, P446, DOI 10.1002/jcb.10369; Garner SC, 2001, ENDOCRINOLOGY, V142, P3996, DOI 10.1210/en.142.9.3996; Geng L, 2000, BBA-MOL BASIS DIS, V1535, P21, DOI 10.1016/S0925-4439(00)00079-X; Guay-Woodford LM, 2003, AM J PHYSIOL-RENAL, V285, pF1034, DOI 10.1152/ajprenal.00195.2003; Guillaume R, 2000, MECH DEVELOP, V93, P179, DOI 10.1016/S0925-4773(00)00257-4; Guillaume R, 1999, DEV DYNAM, V214, P337, DOI 10.1002/(SICI)1097-0177(199904)214:4<337::AID-AJA6>3.0.CO;2-O; Han YF, 2004, P NATL ACAD SCI USA, V101, P16689, DOI 10.1073/pnas.0407429101; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Herron BJ, 2002, NAT GENET, V30, P185, DOI 10.1038/ng812; Hou XY, 2002, J CLIN INVEST, V109, P533, DOI 10.1172/JC1200214099; Hughes-Fulford Millie, 2004, Sci STKE, V2004, pRE12; Iqbal J, 2005, BIOCHEM BIOPH RES CO, V328, P751, DOI 10.1016/j.bbrc.2004.12.087; Jensen CG, 2004, CELL BIOL INT, V28, P101, DOI 10.1016/j.cellbi.2003.11.007; Kalajzic I, 2004, BONE, V35, P74, DOI 10.1016/j.bone.2004.03.006; Kottgen M, 2005, PFLUG ARCH EUR J PHY, V451, P286, DOI 10.1007/s00424-005-1417-3; LANYON LE, 1987, J BIOMECH, V20, P1083, DOI 10.1016/0021-9290(87)90026-1; Le NH, 2004, J BIOL CHEM, V279, P27472, DOI 10.1074/jbc.M312183200; Li JL, 2005, J BIOL CHEM, V280, P42952, DOI 10.1074/jbc.M506415200; Lin FM, 2003, P NATL ACAD SCI USA, V100, P5286, DOI 10.1073/pnas.0836980100; Lin FM, 2004, CURR OPIN PEDIATR, V16, P171, DOI 10.1097/00008480-200404000-00010; Lu WN, 2001, HUM MOL GENET, V10, P2385, DOI 10.1093/hmg/10.21.2385; Marino JH, 2003, J IMMUNOL METHODS, V283, P291, DOI 10.1016/S0022-1759(03)00103-0; Nanci A, 1996, MICROSC RES TECHNIQ, V33, P214; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nauli SM, 2006, J AM SOC NEPHROL, V17, P1015, DOI 10.1681/ASN.2005080830; Nims N, 2003, BIOCHEMISTRY-US, V42, P13035, DOI 10.1021/bi035074c; Ontiveros C, 2003, J CELL BIOCHEM, V88, P427, DOI 10.1002/jcb.10410; Papachristou DJ, 2005, HISTOCHEM CELL BIOL, V124, P215, DOI 10.1007/s00418-005-0026-8; Pavalko FM, 2003, J CELL BIOCHEM, V88, P104, DOI 10.1002/jcb.10284; Pazour GJ, 2003, CURR OPIN CELL BIOL, V15, P105, DOI 10.1016/S0955-0674(02)00012-1; Praetorius HA, 2003, J MEMBRANE BIOL, V191, P69, DOI 10.1007/s00232-002-1042-4; Puri S, 2004, J BIOL CHEM, V279, P55455, DOI 10.1074/jbc.M402905200; Quarles LD, 1997, J CELL BIOCHEM, V65, P11; Rubin J, 2006, GENE, V367, P1, DOI 10.1016/j.gene.2005.10.028; Salingcarnboriboon R, 2006, ENDOCRINOLOGY, V147, P2296, DOI 10.1210/en.2005-1020; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; Sutters M, 2003, J LAB CLIN MED, V141, P91, DOI 10.1067/mlc.2003.13; Takaoki Muneo, 2004, Biol Sci Space, V18, P181; Vassilev PM, 2001, BIOCHEM BIOPH RES CO, V282, P341, DOI 10.1006/bbrc.2001.4554; Wang FS, 2002, J BIOL CHEM, V277, P10931, DOI 10.1074/jbc.M104587200; Ward CJ, 2003, HUM MOL GENET, V12, P2703, DOI 10.1093/hmg/ddg274; Whitfield JF, 2003, J CELL BIOCHEM, V89, P233, DOI 10.1002/jcb.10509; Wilson PD, 2004, NEW ENGL J MED, V350, P151, DOI 10.1056/NEJMra022161; Xiao GZ, 2005, J BIOL CHEM, V280, P30689, DOI 10.1074/jbc.M500750200; Xiao ZS, 2003, J CELL BIOCHEM, V88, P493, DOI 10.1002/jcb.10375; Xiao ZS, 2005, DEV BIOL, V283, P345, DOI 10.1016/j.ydbio.2005.04.028; Xiao ZS, 2004, J BIOL CHEM, V279, P20307, DOI 10.1074/jbc.M401109200; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Yoder BK, 2002, J AM SOC NEPHROL, V13, P2508, DOI 10.1097/01.ASN.0000029587.47950.25; Yoder BK, 2002, AM J PHYSIOL-RENAL, V282, pF541, DOI 10.1152/ajprenal.00273.2001; Zerath E, 1998, ADV SPACE RES, V21, P1049, DOI 10.1016/S0273-1177(98)00026-X; Ziros PG, 2002, J BIOL CHEM, V277, P23934, DOI 10.1074/jbc.M109881200	60	171	179	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30884	30895		10.1074/jbc.M604772200	http://dx.doi.org/10.1074/jbc.M604772200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16905538	hybrid, Green Accepted			2022-12-27	WOS:000241075900064
J	Hassink, GC; Barel, MT; Van Voorden, SB; Kikkert, M; Wiertz, EJ				Hassink, Gerco C.; Barel, Martine T.; Van Voorden, Sjaak B.; Kikkert, Marjolein; Wiertz, Emmanuel J.			Ubiquitination of MHC class I heavy chains is essential for dislocation by human cytomegalovirus-encoded US2 but not US11	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEX CLASS-I; ENDOPLASMIC-RETICULUM MEMBRANE; PEPTIDE-N-GLYCANASE; TO-CYTOSOL DISLOCATION; CELL-RECEPTOR SUBUNITS; PROTEIN TRANSLOCATION; QUALITY-CONTROL; ANTIGEN PRESENTATION; RETRO-TRANSLOCATION; MISFOLDED PROTEINS	The human cytomegalovirus-encoded glycoproteins US2 and US11 target newly synthesized major histocompatibility complex class I heavy chains for degradation by mediating their dislocation from the endoplasmic reticulum back into the cytosol, where they are degraded by proteasomes. A functional ubiquitin system is required for US2- and US11-dependent dislocation of the class I heavy chains. It has been assumed that the class I heavy chain itself is ubiquitinated during the dislocation reaction. To test this hypothesis, all lysines within the class I heavy chain were substituted. The lysine-less class I molecules could no longer be dislocated by US2 despite the fact that the interaction between the two proteins was maintained. Interestingly, US11 was still capable of dislocating the lysine-less heavy chains into the cytosol. Ubiquitination does not necessarily require lysine residues but can also occur at the N terminus of a protein. To investigate the potential role of N-terminal ubiquitination in heavy chain dislocation, a lysine-less ubiquitin moiety was fused to the N terminus of the class I molecule. This lysine-less fusion protein was still dislocated in the presence of US11. Ubiquitination could not be detected in vitro, either for the lysine-less heavy chains or for the lysine-less ubiquitin-heavy chain fusion protein. Our data show that although dislocation of the lysine-less class I heavy chains requires a functional ubiquitin system, the heavy chain itself does not serve as the ubiquitin acceptor. This finding sheds new light on the role of the ubiquitin system in the dislocation process.	Leiden Univ, Med Ctr, Dept Med Microbiol, NL-2300 RC Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Wiertz, EJ (corresponding author), Leiden Univ, Med Ctr, Dept Med Microbiol, Box 9600, NL-2300 RC Leiden, Netherlands.	wiertz@lumc.nl	Kikkert, Marjolein/AAK-5514-2020	Kikkert, Marjolein/0000-0002-5779-7386				BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Baker RT, 1996, CURR OPIN BIOTECH, V7, P541, DOI 10.1016/S0958-1669(96)80059-0; Barel MT, 2003, J IMMUNOL, V171, P6757, DOI 10.4049/jimmunol.171.12.6757; Barel MT, 2003, EUR J IMMUNOL, V33, P1707, DOI 10.1002/eji.200323912; Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; Biederer T, 1996, EMBO J, V15, P2069, DOI 10.1002/j.1460-2075.1996.tb00560.x; Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; Chen Y, 1998, J BIOL CHEM, V273, P11887, DOI 10.1074/jbc.273.19.11887; COTNER T, 1995, J BIOL CHEM, V270, P2379, DOI 10.1074/jbc.270.5.2379; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; de Virgilio M, 1998, J BIOL CHEM, V273, P9734, DOI 10.1074/jbc.273.16.9734; Elkabetz Y, 2004, J BIOL CHEM, V279, P3980, DOI 10.1074/jbc.M309938200; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fiebiger E, 2002, EMBO J, V21, P1041, DOI 10.1093/emboj/21.5.1041; Flierman D, 2003, J BIOL CHEM, V278, P34774, DOI 10.1074/jbc.M303360200; Furman MH, 2003, J BIOL CHEM, V278, P34804, DOI 10.1074/jbc.M300913200; Furman MH, 2002, J BIOL CHEM, V277, P3258, DOI 10.1074/jbc.M109765200; Gardner RG, 2001, MOL CELL BIOL, V21, P4276, DOI 10.1128/MCB.21.13.4276-4291.2001; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Gardner RG, 1999, J BIOL CHEM, V274, P31671, DOI 10.1074/jbc.274.44.31671; Gewurz BE, 2001, P NATL ACAD SCI USA, V98, P6794, DOI 10.1073/pnas.121172898; Gewurz BE, 2001, J VIROL, V75, P5197, DOI 10.1128/JVI.75.11.5197-5204.2001; Gillece P, 2000, P NATL ACAD SCI USA, V97, P4609, DOI 10.1073/pnas.090083497; Halaban R, 1997, P NATL ACAD SCI USA, V94, P6210, DOI 10.1073/pnas.94.12.6210; Hampton RY, 2002, ANNU REV CELL DEV BI, V18, P345, DOI 10.1146/annurev.cellbio.18.032002.131219; Hassink G, 2005, BIOCHEM J, V388, P647, DOI 10.1042/BJ20041241; Hirsch C, 2003, EMBO J, V22, P1036, DOI 10.1093/emboj/cdg107; Hondred D, 1999, PLANT PHYSIOL, V119, P713, DOI 10.1104/pp.119.2.713; Hughes EA, 1997, P NATL ACAD SCI USA, V94, P1896, DOI 10.1073/pnas.94.5.1896; JONES TR, 1995, J VIROL, V69, P4830, DOI 10.1128/JVI.69.8.4830-4841.1995; Katiyar S, 2005, MOL BIOL CELL, V16, P4584, DOI 10.1091/mbc.E05-04-0345; Katiyar S, 2004, P NATL ACAD SCI USA, V101, P13774, DOI 10.1073/pnas.0405663101; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Kikkert M, 2001, BIOCHEM J, V358, P369, DOI 10.1042/0264-6021:3580369; Koopmann JO, 2000, IMMUNITY, V13, P117, DOI 10.1016/S1074-7613(00)00013-3; KOPPELMAN B, 1990, J IMMUNOL, V145, P2730; Kreft SG, 2006, J BIOL CHEM, V281, P4646, DOI 10.1074/jbc.M512215200; KULKA RG, 1988, J BIOL CHEM, V263, P15726; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Loureiro J, 2006, NATURE, V441, P894, DOI 10.1038/nature04830; Meerovitch K, 1998, J BIOL CHEM, V273, P21025, DOI 10.1074/jbc.273.33.21025; Menendez-Benito V, 2005, HUM MOL GENET, V14, P2787, DOI 10.1093/hmg/ddi312; Mori H, 2002, J CELL BIOL, V157, P205, DOI 10.1083/jcb.200202048; Park H, 2001, P NATL ACAD SCI USA, V98, P11163, DOI 10.1073/pnas.201393498; Pilon M, 1998, MOL BIOL CELL, V9, P3455, DOI 10.1091/mbc.9.12.3455; Plemper RK, 1998, J BIOL CHEM, V273, P32848, DOI 10.1074/jbc.273.49.32848; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Reits EAJ, 2000, NATURE, V404, P774, DOI 10.1038/35008103; Schnell DJ, 2003, CELL, V112, P491, DOI 10.1016/S0092-8674(03)00110-7; Schubert U, 1998, J VIROL, V72, P2280, DOI 10.1128/JVI.72.3.2280-2288.1998; Schulze A, 2005, J MOL BIOL, V354, P1021, DOI 10.1016/j.jmb.2005.10.020; Shamu CE, 1999, J CELL BIOL, V147, P45, DOI 10.1083/jcb.147.1.45; Shamu CE, 2001, MOL BIOL CELL, V12, P2546, DOI 10.1091/mbc.12.8.2546; Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262; SOMMER T, 1993, NATURE, V365, P176, DOI 10.1038/365176a0; Suzuki T, 2001, BIOCHEM BIOPH RES CO, V287, P1083, DOI 10.1006/bbrc.2001.5688; Thilo C, 2006, J BIOL CHEM, V281, P8950, DOI 10.1074/jbc.M507121200; Tirosh B, 2003, J BIOL CHEM, V278, P6664, DOI 10.1074/jbc.M210158200; Tiwari S, 2001, J BIOL CHEM, V276, P16193, DOI 10.1074/jbc.M007640200; Tortorella D, 1998, J CELL BIOL, V142, P365, DOI 10.1083/jcb.142.2.365; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Wang XL, 2005, J VIROL, V79, P4099, DOI 10.1128/JVI.79.7.4099-4108.2005; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; WIERTZ TJ, 1996, NATURE, V384, P432; Yang M, 1998, J EXP MED, V187, P835, DOI 10.1084/jem.187.6.835; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Yewdell JW, 2003, NAT REV IMMUNOL, V3, P952, DOI 10.1038/nri1250; Yu H, 1997, J BIOL CHEM, V272, P20800, DOI 10.1074/jbc.272.33.20800; Yu H, 1999, J BIOL CHEM, V274, P36852, DOI 10.1074/jbc.274.52.36852	72	38	39	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					30063	30071		10.1074/jbc.M602248200	http://dx.doi.org/10.1074/jbc.M602248200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16877758	hybrid			2022-12-27	WOS:000240896300067
J	Matsushima, R; Harada, N; Webster, NJG; Tsutsumi, YM; Nakaya, Y				Matsushima, Rie; Harada, Nagakatsu; Webster, Nicholas J. G.; Tsutsumi, Yasuo M.; Nakaya, Yutaka			Effect of TRB3 on insulin and nutrient-stimulated hepatic p70 S6 kinase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL GTPASE-RHEB; B C-AKT; MAMMALIAN TARGET; AMINO-ACID; GLUCOSE-INTOLERANCE; TRIBBLES HOMOLOG; MTOR; PHOSPHORYLATION; ACTIVATION; RAPAMYCIN	Insulin and nutrients activate hepatic p70 S6 kinase ( S6K1) to regulate protein synthesis. Paradoxically, activation of S6K1 also leads to the development of insulin resistance. In this study, we investigated the effect of TRB3, which acts as an endogenous inhibitor of Akt, on S6K1 activity in vitro and in vivo. In cultured cells, overexpression of TRB3 completely inhibited insulinstimulated S6K1 activation by mammalian target of rapamycin, whereas knockdown of endogenous TRB3 increased both basal and insulin- stimulated activity. In C57BL/ 6 mice, adenoviral overexpression of TRB3 inhibited insulin- stimulated activation of hepatic S6K1. In contrast, overexpression of TRB3 did not inhibit nutrient- stimulated S6K1 activity. We also investigated the effect of starvation, feeding, or insulin treatment on TRB3 levels and S6K1 activity in the liver of C57BL/ 6 and db/ db mice. Both insulin and feeding activate S6K1 in db/ db mice, but only insulin activates in the C57BL/ 6 strain. TRB3 levels were 3.5fold higher in db/ db mice than C57BL/ 6 mice and were unresponsive to feeding or insulin, whereas both treatments reduced TRB3 in C57BL/ 6 mice. Akt was activated by insulin alone in the C57BL/ 6 strain and but not in db/ db mice. Both insulin and feeding activated mammalian target of rapamycin similarly in these mice; however, feeding was unable to activate the downstream targetS6K1inC57BL/ 6mice. These results suggest that the nutrient excess in the hyperphagic, hyperinsulinemic db/ dbmouse primes the hepatocyte to respond to nutrients resulting in elevated S6K1 activity. The combination of elevated TRB3 and constitutive S6K1 activity results in decreased insulin signaling via the IRS- 1/ phosphatidylinositol 3- kinase/ Akt pathway.	Univ Tokushima, Grad Sch, Dept Nutr & Metab, Inst Hlth Biosci, Tokushima 7708503, Japan; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Vet Affairs San Diego Healthcare Syst, Med Res Serv, San Diego, CA 92161 USA	Tokushima University; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Matsushima, R (corresponding author), Univ Tokushima, Grad Sch, Dept Nutr & Metab, Inst Hlth Biosci, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	amocoerie@sbcglobal.net	Tsutsumi, Yasuo M/G-1972-2012; Webster, Nick/AAI-8410-2021		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047400] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD047400] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aoki M, 2001, P NATL ACAD SCI USA, V98, P136, DOI 10.1073/pnas.011528498; Bachmann RA, 2006, J BIOL CHEM, V281, P7357, DOI 10.1074/jbc.M512218200; BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Byfield MP, 2005, J BIOL CHEM, V280, P33076, DOI 10.1074/jbc.M507201200; Cai SL, 2006, J CELL BIOL, V173, P279, DOI 10.1083/jcb.200507119; Coffer PJ, 1998, BIOCHEM J, V335, P1; Draznin B, 2000, ENDOCRINOLOGY, V141, P1310, DOI 10.1210/en.141.4.1310; Drenan RM, 2004, J BIOL CHEM, V279, P772, DOI 10.1074/jbc.M305912200; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Gingras AC, 2001, GENE DEV, V15, P2852; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hinault C, 2004, FASEB J, V18, P1894, DOI 10.1096/fj.03-1409fje; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; ICHIHARA A, 1982, MOL CELL BIOCHEM, V43, P145; Iiboshi Y, 1999, J BIOL CHEM, V274, P1092, DOI 10.1074/jbc.274.2.1092; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jonassen AK, 2004, BIOCHEM BIOPH RES CO, V315, P160, DOI 10.1016/j.bbrc.2004.01.029; Kanezaki Y, 2004, ENDOCR J, V51, P133, DOI 10.1507/endocrj.51.133; Katome T, 2003, J BIOL CHEM, V278, P28312, DOI 10.1074/jbc.M302094200; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; Li Y, 2004, MOL CELL BIOL, V24, P7965, DOI 10.1128/MCB.24.18.7965-7975.2004; Mayumi-Matsuda K, 1999, BIOCHEM BIOPH RES CO, V258, P260, DOI 10.1006/bbrc.1999.0576; McMahon LP, 2005, MOL ENDOCRINOL, V19, P175, DOI 10.1210/me.2004-0305; Miyake K, 2002, J CLIN INVEST, V110, P1483, DOI 10.1172/JCI200215880; Mothe-Satney I, 2004, J BIOL CHEM, V279, P42628, DOI 10.1074/jbc.M405173200; Mueckler M, 2005, J BIOL CHEM, V280, P39562, DOI 10.1074/jbc.M509050200; Murray JT, 2002, TRAFFIC, V3, P416, DOI 10.1034/j.1600-0854.2002.30605.x; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Patti ME, 1998, J CLIN INVEST, V101, P1519, DOI 10.1172/JCI1326; Proud CG, 1996, TRENDS BIOCHEM SCI, V21, P181, DOI 10.1016/0968-0004(96)10016-5; Prudente S, 2005, DIABETES, V54, P2807, DOI 10.2337/diabetes.54.9.2807; Saito K, 2005, J BIOCHEM, V137, P423, DOI 10.1093/jb/mvi046; Saltiel AR, 2001, CELL, V104, P517, DOI 10.1016/S0092-8674(01)00239-2; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schwarzer R, 2006, CELL SIGNAL, V18, P899, DOI 10.1016/j.cellsig.2005.08.002; Shah OJ, 2000, AM J PHYSIOL-ENDOC M, V279, pE715, DOI 10.1152/ajpendo.2000.279.4.E715; Siddhanta U, 1998, J CELL BIOL, V143, P1647, DOI 10.1083/jcb.143.6.1647; Sofer A, 2005, MOL CELL BIOL, V25, P5834, DOI 10.1128/MCB.25.14.5834-5845.2005; Stein MP, 2003, TRAFFIC, V4, P754, DOI 10.1034/j.1600-0854.2003.00133.x; Takahashi K, 2005, J BIOL CHEM, V280, P32768, DOI 10.1074/jbc.M506280200; Tremblay F, 2001, J BIOL CHEM, V276, P38052; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Volarevic S, 2001, PROG NUCLEIC ACID RE, V65, P101; Zhang XW, 2002, J BIOL CHEM, V277, P28127, DOI 10.1074/jbc.M202625200; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	50	55	61	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					29719	29729		10.1074/jbc.M511636200	http://dx.doi.org/10.1074/jbc.M511636200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16887816	hybrid			2022-12-27	WOS:000240896300034
J	Baldan, A; Tarr, P; Vales, CS; Frank, J; Shimotake, TK; Hawgood, S; Edwards, PA				Baldan, Angel; Tarr, Paul; Vales, Charisse S.; Frank, Joy; Shimotake, Thomas K.; Hawgood, Sam; Edwards, Peter A.			Deletion of the transmembrane transporter ABCG1 results in progressive pulmonary lipidosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BILIARY CHOLESTEROL SECRETION; HIGH-DENSITY-LIPOPROTEIN; BETA-C RECEPTOR; ALVEOLAR PROTEINOSIS; DIETARY-CHOLESTEROL; SURFACTANT PROTEINS; PHOSPHOLIPID EFFLUX; DEFICIENT MICE; MESSENGER-RNA; LUNG-DISEASE	We show that mice lacking the ATP-binding cassette transmembrane transporter ABCG1 show progressive and age-dependent severe pulmonary lipidosis that recapitulates the phenotypes of different respiratory syndromes in both humans and mice. The lungs of chow-fed Abcg1(-/-) mice, > 6-months old, exhibit extensive subpleural cellular accumulation, macrophage, and pneumocyte type 2 hypertrophy, massive lipid deposition in both macrophages and pneumocytes and increased levels of surfactant. No such abnormalities are observed at 3 months of age. However, gene expression profiling reveals significant changes in the levels of mRNAs encoding key genes involved in lipid metabolism in both 3- and 8- month-old Abcg1(-/-) mice. These data suggest that the lungs of young Abcg1(-/-) mice maintain normal lipid levels by repressing lipid biosynthetic pathways and that such compensation is inadequate as the mice mature. Studies with A-549 cells, a model for pneumocytes type 2, demonstrate that overexpression of ABCG1 specifically stimulates the efflux of cellular cholesterol by a process that is dependent upon phospholipid secretion. In addition, we demonstrate that Abcg1(-/-), but not wild-type macrophages, accumulate cholesterol ester droplets when incubated with surfactant. Together, these data provide a mechanism to explain the lipid accumulation in the lungs of Abcg1(-/-) mice. In summary, our results demonstrate that ABCG1 plays essential roles in pulmonary lipid homeostasis.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94118 USA; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94118 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Edwards, PA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, CHS 33-257,10833 Le Conte Ave, Los Angeles, CA 90095 USA.	pedwards@mednet.ucla.edu			PHS HHS [NIH30568, NIH68445] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Agassandian M, 2004, AM J RESP CELL MOL, V31, P227, DOI 10.1165/rcmb.2004-0038OC; Anderson RA, 1999, MOL GENET METAB, V68, P333, DOI 10.1006/mgme.1999.2904; Arai T, 2004, RESP MED, V98, P1227, DOI 10.1016/j.rmed.2004.08.011; BATENBURG JJ, 1992, AM J PHYSIOL, V262, P367; Bates SR, 2005, AM J PHYSIOL-LUNG C, V289, pL980, DOI 10.1152/ajplung.00234.2005; Bewig B, 2000, EUR RESPIR J, V15, P350, DOI 10.1034/j.1399-3003.2000.15b22.x; Bullard JE, 2005, AM J RESP CRIT CARE, V172, P1026, DOI 10.1164/rccm.200503-504OC; Chintagari NR, 2006, AM J RESP CELL MOL, V34, P677, DOI 10.1165/rcmb.2005-0418OC; Edwards PA, 2002, VASC PHARMACOL, V38, P249, DOI 10.1016/S1537-1891(02)00175-1; Fielding PE, 2000, BIOCHEMISTRY-US, V39, P14113, DOI 10.1021/bi0004192; Gelissen IC, 2006, ARTERIOSCL THROM VAS, V26, P534, DOI 10.1161/01.ATV.0000200082.58536.e1; Goerke J, 1998, BBA-MOL BASIS DIS, V1408, P79, DOI 10.1016/S0925-4439(98)00060-X; Hawgood S, 2002, AM J PHYSIOL-LUNG C, V283, pL1002, DOI 10.1152/ajplung.00118.2002; Hubacek J A, 2001, Hum Mutat, V18, P359, DOI 10.1002/humu.1206; Kennedy MA, 2005, CELL METAB, V1, P121, DOI 10.1016/j.cmet.2005.01.002; Kim HJ, 2002, J LIPID RES, V43, P1750, DOI 10.1194/jlr.M100433-JLR200; Klucken J, 2000, P NATL ACAD SCI USA, V97, P817, DOI 10.1073/pnas.97.2.817; Lian XM, 2004, AM J PHYSIOL-LUNG C, V286, pL801, DOI 10.1152/ajplung.00335.2003; LIEBER M, 1976, INT J CANCER, V17, P62, DOI 10.1002/ijc.2910170110; Nakamura K, 2004, J BIOL CHEM, V279, P45980, DOI 10.1074/jbc.M408652200; NISHINAKAMURA R, 1995, IMMUNITY, V2, P211, DOI 10.1016/1074-7613(95)90046-2; Nogee LM, 2004, ANNU REV PHYSIOL, V66, P601, DOI 10.1146/annurev.physiol.66.032102.134711; NOTTER RH, 2000, LUNG SURFACTANTS BAS; Oram JF, 2000, BBA-MOL CELL BIOL L, V1529, P321, DOI 10.1016/S1388-1981(00)00157-8; Reid KBM, 1998, IMMUNOBIOLOGY, V199, P200, DOI 10.1016/S0171-2985(98)80027-2; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Repa JJ, 2002, J BIOL CHEM, V277, P18793, DOI 10.1074/jbc.M109927200; Sampath H, 2005, ANNU REV NUTR, V25, P317, DOI 10.1146/annurev.nutr.25.051804.101917; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Shulenin S, 2004, NEW ENGL J MED, V350, P1296, DOI 10.1056/NEJMoa032178; Soccio RE, 2004, ARTERIOSCL THROM VAS, V24, P1150, DOI 10.1161/01.ATV.0000131264.66417.d5; Sommerer D, 2004, J PHARMACEUT BIOMED, V35, P199, DOI 10.1016/j.jpba.2003.12.016; Sparrow CP, 2002, J BIOL CHEM, V277, P10021, DOI 10.1074/jbc.M108225200; Tamminen M, 1999, ARTERIOSCL THROM VAS, V19, P847, DOI 10.1161/01.ATV.19.4.847; Ulven SM, 2005, PROSTAG LEUKOTR ESS, V73, P59, DOI 10.1016/j.plefa.2005.04.009; Vaughan AM, 2005, J BIOL CHEM, V280, P30150, DOI 10.1074/jbc.M505368200; Venkateswaran A, 2000, J BIOL CHEM, V275, P14700, DOI 10.1074/jbc.275.19.14700; Wang N, 2004, P NATL ACAD SCI USA, V101, P9774, DOI 10.1073/pnas.0403506101; White T, 1998, ANAL BIOCHEM, V258, P109, DOI 10.1006/abio.1997.2545; WRIGHT JR, 1989, CLIN CHEST MED, V10, P83; Wright JR, 2004, BIOL NEONATE, V85, P326, DOI 10.1159/000078172; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; WRIGHT JR, 1991, ANNU REV PHYSIOL, V53, P395, DOI 10.1146/annurev.physiol.53.1.395; Yu LQ, 2002, P NATL ACAD SCI USA, V99, P16237, DOI 10.1073/pnas.252582399; Yu LQ, 2002, J CLIN INVEST, V110, P671, DOI [10.1172/JCI200216001, 10.1172/JCI0216001]; Zhou JM, 2004, J LIPID RES, V45, P1758, DOI 10.1194/jlr.M400179-JLR200	46	89	92	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					29401	29410		10.1074/jbc.M606597200	http://dx.doi.org/10.1074/jbc.M606597200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16887795	hybrid			2022-12-27	WOS:000240680500095
J	Dikshit, P; Chatterjee, M; Goswami, A; Mishra, A; Jana, NR				Dikshit, Priyanka; Chatterjee, Mou; Goswami, Anand; Mishra, Amit; Jana, Nihar Ranjan			Aspirin induces apoptosis through the inhibition of proteasome function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; NF-KAPPA-B; COLON ADENOCARCINOMA CELLS; CYTOCHROME-C RELEASE; CANCER-CELLS; OXIDATIVE STRESS; SODIUM-SALICYLATE; MEDIATED APOPTOSIS; ANTICANCER AGENTS; MULTIPLE-MYELOMA	Aspirin and other nonsteroidal anti-inflammatory drugs inhibit cell proliferation and induce apoptosis in various cancer cell lines, which is considered to be an important mechanism for their anti-tumor activity and prevention of carcinogenesis. However, the molecular mechanisms through which these compounds induce apoptosis are not well understood. Here we have found that aspirin treatment of the mouse Neuro 2a cells impaired the proteasome function and caused severe mitochondrial abnormalities. Treatment with aspirin lead to a dose- and time-dependent decrease in proteasome activity and an increase in the accumulation of ubiquitylated proteins in the cells, which correlated with its effect on cell death. Aspirin exposure also resulted in an increase in the half-life of pd1EGFP, a model substrate of proteasome, as well as various intracellular substrates like Bax, I kappa B-alpha, p53, and p27(kip1). Aspirin-induced proteasomal malfunction might be responsible, at least in part, for the down-regulation of NF-kappa B activity and neurite outgrowth. Finally, we have shown that aspirin treatment caused changes in the mitochondrial membrane potential, release of cytochrome c from mitochondria, and activation of caspase-9 and -3, which could be because of the proteasomal dysfunction.	Natl Brain Res Ctr, Mol & Cellular Neurosci Lab, Manesar 122050, Gurgaon, India	Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC)	Jana, NR (corresponding author), Natl Brain Res Ctr, Mol & Cellular Neurosci Lab, Manesar 122050, Gurgaon, India.	nihar@nbrc.ac.in		Jana, Nihar/0000-0002-6549-4211; Mishra, Amit/0000-0001-9401-4400				Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; Adams J, 2004, CANCER CELL, V5, P417, DOI 10.1016/S1535-6108(04)00120-5; Bellosillo B, 1998, BLOOD, V92, P1406, DOI 10.1182/blood.V92.4.1406.416k17_1406_1414; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chan TA, 1998, P NATL ACAD SCI USA, V95, P681, DOI 10.1073/pnas.95.2.681; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Ding QX, 2001, J NEUROCHEM, V77, P1010, DOI 10.1046/j.1471-4159.2001.00302.x; Drexler HCA, 2000, FASEB J, V14, P65, DOI 10.1096/fasebj.14.1.65; Drexler HCA, 1997, P NATL ACAD SCI USA, V94, P855, DOI 10.1073/pnas.94.3.855; Gao JC, 2004, CANCER SCI, V95, P901, DOI 10.1111/j.1349-7006.2004.tb02200.x; Gao JJ, 2005, P NATL ACAD SCI USA, V102, P17207, DOI 10.1073/pnas.0506893102; GIOVANNUCCI E, 1995, NEW ENGL J MED, V333, P609, DOI 10.1056/NEJM199509073331001; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Goswami A, 2006, BIOCHEM BIOPH RES CO, V342, P184, DOI 10.1016/j.bbrc.2006.01.136; GREENBERG ER, 1993, JNCI-J NATL CANCER I, V85, P912, DOI 10.1093/jnci/85.11.912; Grilli M, 1996, SCIENCE, V274, P1383, DOI 10.1126/science.274.5291.1383; Gu Q, 2005, CARCINOGENESIS, V26, P541, DOI 10.1093/carcin/bgh345; Gupta RA, 1998, GASTROENTEROLOGY, V114, P1095, DOI 10.1016/S0016-5085(98)70330-0; Ho CC, 2003, EUR J CLIN INVEST, V33, P875, DOI 10.1046/j.1365-2362.2003.01240.x; Huang YC, 2002, MOL PHARMACOL, V62, P1515, DOI 10.1124/mol.62.6.1515; Insel PA, 1996, PHARMACOL BASIS THER, P617; Jana NR, 2004, J BIOL CHEM, V279, P11680, DOI 10.1074/jbc.M310369200; Jana NR, 2001, HUM MOL GENET, V10, P1049, DOI 10.1093/hmg/10.10.1049; Kim KM, 2005, J BIOL CHEM, V280, P41047, DOI 10.1074/jbc.M503713200; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; Lopes UG, 1997, J BIOL CHEM, V272, P12893, DOI 10.1074/jbc.272.20.12893; Marra DE, 2000, CIRCULATION, V102, P2124, DOI 10.1161/01.CIR.102.17.2124; Menendez-Benito V, 2005, HUM MOL GENET, V14, P2787, DOI 10.1093/hmg/ddi312; Meriin AB, 1998, J BIOL CHEM, V273, P6373, DOI 10.1074/jbc.273.11.6373; Mitsiades N, 2002, BLOOD, V99, P4079, DOI 10.1182/blood.V99.11.4079; Mitsiades N, 2002, P NATL ACAD SCI USA, V99, P14374, DOI 10.1073/pnas.202445099; Okada K, 1999, J BIOL CHEM, V274, P23787, DOI 10.1074/jbc.274.34.23787; Orlowski RZ, 1999, CELL DEATH DIFFER, V6, P303, DOI 10.1038/sj.cdd.4400505; Piazza GA, 1997, CANCER RES, V57, P2452; Pique M, 2000, FEBS LETT, V480, P193, DOI 10.1016/S0014-5793(00)01922-0; Rao CV, 2004, CURR CANCER DRUG TAR, V4, P29, DOI 10.2174/1568009043481632; Sadoul R, 1996, EMBO J, V15, P3845, DOI 10.1002/j.1460-2075.1996.tb00758.x; Shiff SJ, 1996, EXP CELL RES, V222, P179, DOI 10.1006/excr.1996.0023; SHIFF SJ, 1995, J CLIN INVEST, V96, P491, DOI 10.1172/JCI118060; Stark LA, 2001, FASEB J, V15, P1273, DOI 10.1096/fj.00-0529fje; Thun MJ, 2002, JNCI-J NATL CANCER I, V94, P252, DOI 10.1093/jnci/94.4.252; Tsutsumi S, 2004, CELL DEATH DIFFER, V11, P1009, DOI 10.1038/sj.cdd.4401436; Yin MJ, 1998, NATURE, V396, P77, DOI 10.1038/23948; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989; Zhou XM, 2001, CARCINOGENESIS, V22, P1393, DOI 10.1093/carcin/22.9.1393; Zimmermann KC, 2000, NEOPLASIA, V2, P505, DOI 10.1038/sj.neo.7900120	46	101	107	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					29228	29235		10.1074/jbc.M602629200	http://dx.doi.org/10.1074/jbc.M602629200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16880202	hybrid			2022-12-27	WOS:000240680500078
J	Rosenfeld, Y; Barra, D; Simmaco, M; Shai, Y; Mangoni, ML				Rosenfeld, Yosef; Barra, Donatella; Simmaco, Maurizio; Shai, Yechiel; Mangoni, Maria Luisa			A synergism between temporins toward gram-negative bacteria overcomes resistance imposed by the lipopolysaccharide protective layer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FROG RANA-TEMPORARIA; ANTIMICROBIAL PEPTIDES; ESCHERICHIA-COLI; SKIN SECRETIONS; MAMMALIAN DEFENSINS; BOMBINA-VARIEGATA; ACTIVE PEPTIDES; LIPID-BILAYERS; CECROPIN LOCUS; HOST-DEFENSE	Temporins are short and homologous antimicrobial peptides (AMPs) isolated from the frog skin of Rana genus. To date, very little is known about the biological significance of the presence of closely related AMPs in single living organisms. Here we addressed this question using temporins A, B, and L isolated from Rana temporaria. We found that temporins A and B are only weakly active toward Gram-negative bacteria. However, a marked synergism occurs when each is mixed with temporin L. To shed light on the underlying mechanisms involved in these activities, we used various experimental strategies to investigate: (i) the effect of the peptides' interaction on both the viability and membrane permeability of intact bacteria and spheroplasts; (ii) their interaction with lipopolysaccharides (LPS) and the effect of LPS on the oligomeric state of temporins, alone or combining one with another; (iii) their structure in solution and when bound to LPS, by using circular dichroism and ATR-FTIR spectroscopies. Our data reveal that temporin L synergizes with A and B by preventing their oligomerization in LPS. This should promote their translocation across the outer membrane into the cytoplasmic membrane. To the best of our knowledge, this is the first study that explains how a combination of native AMPs from the same species can overcome bacterial resistance imposed by the LPS leaflet.	Univ Roma La Sapienza, Fac Med & Chirurg 2, Unita Diagnost Mol Avanzata, Azienda Osped S Andrea, I-00189 Rome, Italy; Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; Univ Roma La Sapienza, Ist Pasteur, Fdn Cenci Bolognetti, Dipartimento Sci Biochim, I-00189 Rome, Italy	Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; Weizmann Institute of Science; Fondazione Cenci Bolognetti; Sapienza University Rome	Mangoni, ML (corresponding author), Univ Roma La Sapienza, Fac Med & Chirurg 2, Unita Diagnost Mol Avanzata, Azienda Osped S Andrea, Via Grottarossa,1035, I-00189 Rome, Italy.	marialuisa.mangoni@uniroma1.it	Simmaco, Maurizio/AAC-2870-2019; Barra, Donatella/D-1236-2011	Simmaco, Maurizio/0000-0003-4164-1472; Mangoni, Maria Luisa/0000-0002-5991-5868				AGGER WA, 1985, J CLIN MICROBIOL, V21, P909, DOI 10.1128/JCM.21.6.909-913.1985; Beisswenger C, 2005, CURR PROTEIN PEPT SC, V6, P255, DOI 10.2174/1389203054065428; Bera A, 2003, MOL BIOCHEM PARASIT, V127, P23, DOI 10.1016/S0166-6851(02)00300-6; Boman HG, 2000, IMMUNOL REV, V173, P5, DOI 10.1034/j.1600-065X.2000.917301.x; Brown KL, 2006, CURR OPIN IMMUNOL, V18, P24, DOI 10.1016/j.coi.2005.11.004; Conlon JM, 2004, BBA-PROTEINS PROTEOM, V1696, P1, DOI 10.1016/j.bbapap.2003.09.004; Cunningham AA, 1996, PHILOS T ROY SOC B, V351, P1539, DOI 10.1098/rstb.1996.0140; De Smet K, 2005, BIOTECHNOL LETT, V27, P1337, DOI 10.1007/s10529-005-0936-5; del Castillo FJ, 2001, J BACTERIOL, V183, P2137, DOI 10.1128/JB.183.6.2137-2140.2001; DEODHAR LP, 1991, J CLIN MICROBIOL, V29, P853, DOI 10.1128/JCM.29.5.853-856.1991; FREY S, 1991, BIOPHYS J, V60, P922, DOI 10.1016/S0006-3495(91)82126-9; Ganz T, 2005, COMB CHEM HIGH T SCR, V8, P209, DOI 10.2174/1386207053764594; Ghosh JK, 1997, J BIOL CHEM, V272, P31609, DOI 10.1074/jbc.272.50.31609; Giacometti A, 2006, ANTIMICROB AGENTS CH, V50, P2478, DOI 10.1128/AAC.01553-05; GIBSON BW, 1991, J BIOL CHEM, V266, P23103; Goraya J, 2000, EUR J BIOCHEM, V267, P894, DOI 10.1046/j.1432-1327.2000.01074.x; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; GUDMUNDSSON GH, 1991, J BIOL CHEM, V266, P11510; Gutsmann T, 2000, J MEMBRANE BIOL, V176, P223, DOI 10.1007/s002320001092; Hancock REW, 2002, FEMS MICROBIOL LETT, V206, P143, DOI 10.1016/S0378-1097(01)00480-3; Hara T, 2001, BIOCHEMISTRY-US, V40, P12395, DOI 10.1021/bi011413v; Hatha M, 2005, INT J FOOD MICROBIOL, V98, P131, DOI 10.1016/j.ijfoodmicro.2004.05.017; Hong J, 1999, BIOCHEMISTRY-US, V38, P16963, DOI 10.1021/bi991850y; Hong RW, 2003, ANTIMICROB AGENTS CH, V47, P1, DOI 10.1128/AAC.47.1.1-6.2003; JACKSON M, 1995, CRIT REV BIOCHEM MOL, V30, P95, DOI 10.3109/10409239509085140; Kliger Y, 2000, J MOL BIOL, V301, P905, DOI 10.1006/jmbi.2000.4004; Kragol G, 2001, BIOCHEMISTRY-US, V40, P3016, DOI 10.1021/bi002656a; KYLSTEN P, 1990, EMBO J, V9, P217, DOI 10.1002/j.1460-2075.1990.tb08098.x; Lauth X, 2005, J BIOL CHEM, V280, P9272, DOI 10.1074/jbc.M411154200; Lehrer RI, 2004, NAT REV MICROBIOL, V2, P727, DOI 10.1038/nrmicro976; Mangoni ML, 2006, CELL MOL LIFE SCI, V63, P1060, DOI 10.1007/s00018-005-5536-y; Mangoni ML, 2005, J BIOL CHEM, V280, P984, DOI 10.1074/jbc.M410795200; Mangoni ML, 2000, PEPTIDES, V21, P1673, DOI 10.1016/S0196-9781(00)00316-8; Mangoni ML, 2004, BIOCHEM J, V380, P859, DOI 10.1042/BJ20031975; Mangoni ML, 2000, EUR J BIOCHEM, V267, P1447, DOI 10.1046/j.1432-1327.2000.01143.x; Matsuzaki K, 1999, FEBS LETT, V449, P221, DOI 10.1016/S0014-5793(99)00443-3; Matsuzaki K, 1998, BIOCHEMISTRY-US, V37, P15144, DOI 10.1021/bi9811617; MIGNOGNA G, 1993, EMBO J, V12, P4829, DOI 10.1002/j.1460-2075.1993.tb06172.x; MOR A, 1994, BIOCHEMISTRY-US, V33, P6642, DOI 10.1021/bi00187a034; MOR A, 1994, J BIOL CHEM, V269, P31635; MOR A, 1994, EUR J BIOCHEM, V219, P145, DOI 10.1111/j.1432-1033.1994.tb19924.x; MORIKAWA N, 1992, BIOCHEM BIOPH RES CO, V189, P184, DOI 10.1016/0006-291X(92)91542-X; Nagaoka I, 2000, INFLAMM RES, V49, P73, DOI 10.1007/s000110050561; Oren Z, 1999, EUR J BIOCHEM, V259, P360, DOI 10.1046/j.1432-1327.1999.00047.x; Pag U, 2004, J ANTIMICROB CHEMOTH, V53, P230, DOI 10.1093/jac/dkh083; Papo N, 2005, J BIOL CHEM, V280, P10378, DOI 10.1074/jbc.M412865200; Papo N, 2002, J BIOL CHEM, V277, P33913, DOI 10.1074/jbc.M204928200; Park CB, 1998, BIOCHEM BIOPH RES CO, V244, P253, DOI 10.1006/bbrc.1998.8159; Park Y, 2005, J BIOCHEM MOL BIOL, V38, P507; Patrzykat A, 2002, ANTIMICROB AGENTS CH, V46, P605, DOI 10.1128/AAC.46.3.605-614.2002; Rinaldi AC, 2002, BIOCHEM J, V368, P91, DOI 10.1042/BJ20020806; Rollins-Smith LA, 2002, DEV COMP IMMUNOL, V26, P63, DOI 10.1016/S0145-305X(01)00041-6; Saavedra MJ, 2004, INT MICROBIOL, V7, P207; Sal-Man N, 2002, BIOCHEMISTRY-US, V41, P11921, DOI 10.1021/bi0260482; Scott MG, 1999, INFECT IMMUN, V67, P2005; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; Sharon M, 1999, BIOCHEMISTRY-US, V38, P15305, DOI 10.1021/bi991225t; SIMMACO M, 1991, EUR J BIOCHEM, V199, P217, DOI 10.1111/j.1432-1033.1991.tb16112.x; SIMMACO M, 1994, J BIOL CHEM, V269, P11956; Simmaco M, 1996, EUR J BIOCHEM, V242, P788, DOI 10.1111/j.1432-1033.1996.0788r.x; Sinha S, 2004, J MED MICROBIOL, V53, P527, DOI 10.1099/jmm.0.05269-0; Sitaram N, 2006, CURR MED CHEM, V13, P679, DOI 10.2174/092986706776055689; SORAVIA E, 1988, FEBS LETT, V228, P337, DOI 10.1016/0014-5793(88)80027-9; Sullivan CJ, 2005, ULTRAMICROSCOPY, V105, P96, DOI 10.1016/j.ultramic.2005.06.023; Tamm LK, 1997, Q REV BIOPHYS, V30, P365, DOI 10.1017/S0033583597003375; Thevissen K, 1999, APPL ENVIRON MICROB, V65, P5451; Trent MS, 2004, BIOCHEM CELL BIOL, V82, P71, DOI 10.1139/o03-070; WU CSC, 1981, BIOCHEMISTRY-US, V20, P566, DOI 10.1021/bi00506a019; Yamamoto T, 2004, J CLIN GASTROENTEROL, V38, P911, DOI 10.1097/00004836-200411000-00018; Yang D, 2002, TRENDS IMMUNOL, V23, P291, DOI 10.1016/S1471-4906(02)02246-9; Yu HB, 2005, APPL ENVIRON MICROB, V71, P4469, DOI 10.1128/AEM.71.8.4469-4477.2005; Zanetti M, 2005, CURR ISSUES MOL BIOL, V7, P179, DOI 10.21775/cimb.007.179; ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang LJ, 2000, BIOCHEMISTRY-US, V39, P14504, DOI 10.1021/bi0011173	77	112	114	3	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					28565	28574		10.1074/jbc.M606031200	http://dx.doi.org/10.1074/jbc.M606031200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16867990	hybrid			2022-12-27	WOS:000240680500010
J	Dikanov, SA; Kolling, DRJ; Endeward, B; Samoilova, RI; Prisner, TF; Nair, SK; Crofts, AR				Dikanov, Sergei A.; Kolling, Derrick R. J.; Endeward, Burkhard; Samoilova, Rimma I.; Prisner, Thomas F.; Nair, Satish K.; Crofts, Antony R.			Identification of hydrogen bonds to the Rieske cluster through the weakly coupled nitrogens detected by electron spin echo envelope modulation spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME BC(1) COMPLEX; IRON-SULFUR PROTEIN; NUCLEAR-QUADRUPOLE RESONANCE; PHTHALATE DIOXYGENASE; 2-DIMENSIONAL ESEEM; PSEUDOMONAS-CEPACIA; MUTATIONAL ANALYSIS; REDOX POTENTIALS; 2FE-2S CLUSTER; 2 HISTIDINES	The interactionofthereduced[2Fe-2S] cluster of isolated Rieske fragment from the bc(1) complex of Rhodobacter sphaeroides with nitrogens (N-14 and N-15) from the local protein environment has been studied by X- and S-band pulsed EPR spectroscopy. The two-dimensional electron spin echo envelope modulation spectra of uniformly N-15-labeled protein show two well resolved cross-peaks with weak couplings of similar to 0.3-0.4 and 1.1 MHz in addition to couplings in the range of 6-8 MHz from two coordinating N-delta of histidine ligands. The quadrupole coupling constants for weakly coupled nitrogens determined from S-band electron spin echo envelope modulation spectra identify them as N-delta of histidine ligands and peptide nitrogen (N-p), respectively. Analysis of the line intensities in orientation-selected S-band spectra indicated that N-p is the backbone N-atom of Leu-132 residue. The hyperfine couplings from N-epsilon and N-p demonstrate the predominantly isotropic character resulting from the transfer of unpaired spin density onto the 2s orbitals of the nitrogens. Spectra also show that other peptide nitrogens in the protein environment must carry a 5-10 times smaller amount of spin density than the Np of Leu-132 residue. The appearance of the excess unpaired spin density on the N-p of Leu-132 residue indicates its involvement in hydrogen bond formation with the bridging sulfur of the Rieske cluster. The configuration of the hydrogen bond therefore provides a preferred path for spin density transfer. Observation of similar splittings in the N-15 spectra of other Rieske-type proteins and [2Fe-2S] ferredoxins suggests that a hydrogen bond between the bridging sulfur and peptide nitrogen is a common structural feature of [2Fe-2S] clusters.	Univ Illinois, Dept Clin Vet Med, Urbana, IL 61801 USA; Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; Goethe Univ Frankfurt, Inst Phys & Theoret Chem, D-60438 Frankfurt, Germany; Russian Acad Sci, Inst Chem Kinet & Combust, Novosibirsk 630090, Russia; Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Goethe University Frankfurt; Russian Academy of Sciences; Voevodsky Institute of Chemical Kinetics & Combustion SB RAS; University of Illinois System; University of Illinois Urbana-Champaign	Dikanov, SA (corresponding author), Univ Illinois, Dept Clin Vet Med, Urbana, IL 61801 USA.	dikanov@uiuc.edu; a-crofts@life.uiuc.edu	Nair, Satish/AAY-2510-2021; Samoilova, Rimma Ivanovna/T-7956-2017	Samoilova, Rimma Ivanovna/0000-0002-1649-1487; Endeward, Burkhard/0000-0001-7790-1024; Prisner, Thomas F./0000-0003-2850-9573	FIC NIH HHS [1 R03 TW 01495] Funding Source: Medline; NCRR NIH HHS [S10-RR15878] Funding Source: Medline; NIGMS NIH HHS [GM 62954, GM 35438] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [R03TW001495] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR015878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062954, R01GM035438] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASHBY CIH, 1978, J AM CHEM SOC, V100, P6057, DOI 10.1021/ja00487a014; ASHBY CIH, 1980, J AM CHEM SOC, V102, P2990, DOI 10.1021/ja00529a020; Benetis NP, 2005, J MAGN RESON, V175, P124, DOI 10.1016/j.jmr.2005.03.012; Berry EA, 2000, ANNU REV BIOCHEM, V69, P1005, DOI 10.1146/annurev.biochem.69.1.1005; BLINC R, 1974, CHEM PHYS LETT, V28, P158, DOI 10.1016/0009-2614(74)80041-2; Bowman MK, 2004, BIOCHEMISTRY-US, V43, P430, DOI 10.1021/bi034620z; BRITT RD, 1991, BIOCHEMISTRY-US, V30, P1892, DOI 10.1021/bi00221a023; Carrell CJ, 1997, STRUCTURE, V5, P1613, DOI 10.1016/S0969-2126(97)00309-2; COLANERI MJ, 1992, J AM CHEM SOC, V114, P5335, DOI 10.1021/ja00039a051; Crofts AR, 2004, BBA-BIOENERGETICS, V1655, P77, DOI 10.1016/j.bbabio.2003.10.012; Crofts AR, 2004, ANNU REV PHYSIOL, V66, P689, DOI 10.1146/annurev.physiol.66.032102.150251; DAVIDSON E, 1992, BIOCHEMISTRY-US, V31, P3342, DOI 10.1021/bi00128a006; DAVIDSON E, 1992, BIOCHEMISTRY-US, V31, P3351, DOI 10.1021/bi00128a007; Denke E, 1998, J BIOL CHEM, V273, P9085, DOI 10.1074/jbc.273.15.9085; Dikanov SA, 1998, J BIOL INORG CHEM, V3, P18, DOI 10.1007/s007750050204; DIKANOV SA, 1995, J AM CHEM SOC, V117, P10579, DOI 10.1021/ja00147a023; Dikanov SA, 2004, J BIOL INORG CHEM, V9, P753, DOI 10.1007/s00775-004-0571-y; DIKANOV SA, 1982, CHEM PHYS LETT, V90, P149, DOI 10.1016/0009-2614(82)83630-0; Dikanov SA, 1996, J AM CHEM SOC, V118, P8408, DOI 10.1021/ja960781x; DIKANOV SA, 1995, J MAGN RESON SER B, V108, P99, DOI 10.1006/jmrb.1995.1110; DIKANOV SA, 1992, ELECT SPIN ECHO ENVE, P412; EDMONDS DT, 1971, PHYS LETT A, VA 34, P325, DOI 10.1016/0375-9601(71)90894-2; EDMONDS DT, 1973, J MAGN RESON, V12, P134, DOI 10.1016/0022-2364(73)90136-4; Elmi F, 2005, J PHYS CHEM A, V109, P1729, DOI 10.1021/jp046216v; GATTI DL, 1989, J MOL BIOL, V205, P421, DOI 10.1016/0022-2836(89)90352-5; Guergova-Kuras M, 1999, PROTEIN EXPRES PURIF, V15, P370, DOI 10.1006/prep.1998.1018; Guergova-Kuras M, 2000, BIOCHEMISTRY-US, V39, P7436, DOI 10.1021/bi992491+; Gurbiel RJ, 1996, BIOCHEMISTRY-US, V35, P7834, DOI 10.1021/bi960380u; GURBIEL RJ, 1989, BIOCHEMISTRY-US, V28, P4861, DOI 10.1021/bi00437a051; GURBIEL RJ, 1991, BIOCHEMISTRY-US, V30, P11579, DOI 10.1021/bi00113a013; Hong SJ, 1999, J BIOL CHEM, V274, P33931, DOI 10.1074/jbc.274.48.33931; HUNT MJ, 1976, J MAGN RESON, V22, P295, DOI 10.1016/0022-2364(76)90304-8; HUNT MJ, 1975, CHEM PHYS LETT, V34, P473, DOI 10.1016/0009-2614(75)85542-4; Iwasaki T, 2006, J AM CHEM SOC, V128, P2170, DOI 10.1021/ja0562393; Iwasaki T, 2004, J AM CHEM SOC, V126, P13902, DOI 10.1021/ja045898x; Iwasaki T, 2004, J AM CHEM SOC, V126, P4788, DOI 10.1021/ja031976p; Iwasaki T, 2006, PROTEIN SCI, V15, P2019, DOI 10.1110/ps.052035406; Iwata S, 1996, STRUCTURE, V4, P567, DOI 10.1016/S0969-2126(96)00062-7; JIANG F, 1990, J AM CHEM SOC, V112, P9035, DOI 10.1021/ja00181a002; Klingen AR, 2004, BIOCHEMISTRY-US, V43, P12383, DOI 10.1021/bi0488606; Leggate EJ, 2005, BIOCHEMISTRY-US, V44, P7048, DOI 10.1021/bi050189x; Li J, 1998, J PHYS CHEM A, V102, P6311, DOI 10.1021/jp980753w; Link TA, 1999, ADV INORG CHEM, V47, P83, DOI 10.1016/S0898-8838(08)60077-X; MASON JR, 1992, ANNU REV MICROBIOL, V46, P277, DOI 10.1146/annurev.mi.46.100192.001425; MIMS WB, 1978, J CHEM PHYS, V69, P4921, DOI 10.1063/1.436479; PALMER M, 1984, Z NATURFORSCH A, V39, P1108, DOI 10.1515/zna-1984-1115; RABBANI SR, 1987, J MAGN RESON, V72, P230, DOI 10.1016/0022-2364(87)90285-X; REIJERSE EJ, 1987, J MAGN RESON, V71, P83, DOI 10.1016/0022-2364(87)90129-6; Schroter T, 1998, EUR J BIOCHEM, V255, P100, DOI 10.1046/j.1432-1327.1998.2550100.x; Schweiger A., 2001, PRINCIPLES PULSE ELE, P578; Shergill JK, 1995, BIOCHEMISTRY-US, V34, P16533, DOI 10.1021/bi00051a001; SHERGILL JK, 1994, BBA-BIOENERGETICS, V1185, P35, DOI 10.1016/0005-2728(94)90190-2; Snyder C, 1998, BBA-BIOENERGETICS, V1365, P125, DOI 10.1016/S0005-2728(98)00052-8; TRUMPOWER BL, 1994, ANNU REV BIOCHEM, V63, P675, DOI 10.1146/annurev.bi.63.070194.003331; Ullmann GM, 2002, J BIOL INORG CHEM, V7, P632, DOI 10.1007/s00775-002-0342-6; VANDOREN SR, 1993, BIOCHEMISTRY-US, V32, P8083, DOI 10.1021/bi00083a005; WEBER A, 1998, P 29 C AMPERE 13 ISM, V2, P1138; WEIL JA, 1994, ELECT PARAMAGNETIC R, P308; Xia B, 1999, BIOCHEMISTRY-US, V38, P727, DOI 10.1021/bi981851a; [No title captured]	61	24	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2006	281	37					27416	27425		10.1074/jbc.M604103200	http://dx.doi.org/10.1074/jbc.M604103200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082PB	16854984	hybrid			2022-12-27	WOS:000240397700068
J	Zaitseva, J; Lu, JP; Olechoski, KL; Lamb, AL				Zaitseva, Jelena; Lu, Jingping; Olechoski, Kelli L.; Lamb, Audrey L.			Two crystal structures of the isochorismate pyruvate lyase from Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SALICYLATE BIOSYNTHESIS; MYCOBACTERIUM-TUBERCULOSIS; SIDEROPHORE BIOSYNTHESIS; CHORISMATE MUTASE; TRANSITION-STATE; ESCHERICHIA-COLI; SYNTHASE; PROGRAM; REARRANGEMENT; PURIFICATION	Enzymatic systems that exploit pericyclic reaction mechanisms are rare. A recent addition to this class is the enzyme PchB, an 11.4-kDa isochorismate pyruvate lyase from Pseudomonas aeruginosa. The apo and pyruvate-bound structures of PchB reveal that the enzyme is a structural homologue of chorismate mutases in the AroQ alpha class despite low sequence identity (20%). The enzyme is an intertwined dimer of three helices with connecting loops, and amino acids from each monomer participate in each of two active sites. The apo structure (2.35 angstrom resolution) has one dimer per asymmetric unit with nitrate bound in an open active site. The loop between the first and second helices is disordered, providing a gateway for substrate entry and product exit. The pyruvate-bound structure (1.95 angstrom resolution) has two dimers per asymmetric unit. One has two open active sites like the apo structure, and the other has two closed active sites with the loop between the first and second helices ordered for catalysis. Determining the structure of PchB is part of a larger effort to elucidate protein structures involved in siderophore biosynthesis, as these enzymes are crucial for bacterial iron uptake and virulence and have been identified as antimicrobial drug targets.	Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA	University of Kansas	Lamb, AL (corresponding author), Univ Kansas, Dept Mol Biosci, 1200 Sunnyside Ave, Lawrence, KS 66045 USA.	lamb@ku.edu		Lamb, Audrey/0000-0002-2352-2130				ANDREWS PR, 1973, BIOCHEMISTRY-US, V12, P3492, DOI 10.1021/bi00742a022; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; COPLEY SD, 1985, J AM CHEM SOC, V107, P5306, DOI 10.1021/ja00304a064; Crosa JH, 2002, MICROBIOL MOL BIOL R, V66, P223, DOI 10.1128/MMBR.66.2.223-249.2002; DeClue MS, 2005, J AM CHEM SOC, V127, P15002, DOI 10.1021/ja055871t; DeLano W.L, PYMOL MOL GRAPHICS S; Ferreras JA, 2005, NAT CHEM BIOL, V1, P29, DOI 10.1038/nchembio706; Gaille C, 2003, J BIOL CHEM, V278, P16893, DOI 10.1074/jbc.M212324200; Gaille C, 2002, J BIOL CHEM, V277, P21768, DOI 10.1074/jbc.M202410200; Gallagher DT, 2001, PROTEINS, V44, P304, DOI 10.1002/prot.1095; Harrison AJ, 2005, ACTA CRYSTALLOGR F, V61, P121, DOI 10.1107/S1744309104031215; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Kerbarh O, 2006, J MOL BIOL, V357, P524, DOI 10.1016/j.jmb.2005.12.078; Kerbarh O, 2005, J BACTERIOL, V187, P5061, DOI 10.1128/JB.187.15.5061-5066.2005; KLEYWEGT GJ, 1994, STRUCTURE, V2, P1241, DOI 10.1016/S0969-2126(94)00125-1; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P525, DOI 10.1016/S0076-6879(97)77029-0; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kunzler D, 2005, J BIOL CHEM, V280, P32827, DOI 10.1074/jbc.M506883200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE AY, 1995, J AM CHEM SOC, V117, P3627, DOI 10.1021/ja00117a038; Marahiel MA, 1997, CHEM REV, V97, P2651, DOI 10.1021/cr960029e; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Nakai T, 2000, J BIOCHEM, V128, P29, DOI 10.1093/oxfordjournals.jbchem.a022727; Okvist M, 2006, J MOL BIOL, V357, P1483, DOI 10.1016/j.jmb.2006.01.069; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Payne RJ, 2005, ORG BIOMOL CHEM, V3, P1825, DOI 10.1039/b503800f; Quadri LEN, 1998, CHEM BIOL, V5, P631, DOI 10.1016/S1074-5521(98)90291-5; Raymond KN, 2003, P NATL ACAD SCI USA, V100, P3584, DOI 10.1073/pnas.0630018100; SERINO L, 1995, MOL GEN GENET, V249, P217, DOI 10.1007/BF00290369; Serino L, 1997, J BACTERIOL, V179, P248, DOI 10.1128/jb.179.1.248-257.1997; Spraggon G, 2001, P NATL ACAD SCI USA, V98, P6021, DOI 10.1073/pnas.111150298; SRIYOSACHATI S, 1986, INFECT IMMUN, V52, P885, DOI 10.1128/IAI.52.3.885-891.1986; Strajbl M, 2003, J AM CHEM SOC, V125, P10228, DOI 10.1021/ja0356481; Visca P, 2002, MOL MICROBIOL, V45, P1177, DOI 10.1046/j.1365-2958.2002.03088.x; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Zhang XD, 2005, BIOCHEMISTRY-US, V44, P10443, DOI 10.1021/bi050886p	38	30	31	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33441	33449		10.1074/jbc.M605470200	http://dx.doi.org/10.1074/jbc.M605470200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16914555	hybrid			2022-12-27	WOS:000241621400054
J	Adams, DJ; Head, GA; Markus, MA; Lovicu, FJ; van der Weyden, L; Kontgen, F; Arends, MJ; Thiru, S; Mayorov, DN; Morris, BJ				Adams, David J.; Head, Geoffrey A.; Markus, M. Andrea; Lovicu, Frank J.; van der Weyden, Louise; Koentgen, Frank; Arends, Mark J.; Thiru, Sathia; Mayorov, Dmitry N.; Morris, Brian J.			Renin enhancer is critical for control of renin gene expression and cardiovascular function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANGIOTENSINOGEN-DEFICIENT MICE; BLOOD-PRESSURE; JUXTAGLOMERULAR CELLS; AUTONOMIC CONTROL; TRANSGENIC MICE; MACULA DENSA; MOUSE; RECEPTOR; PROMOTER; ELEMENTS	The important cardiovascular regulator renin contains a strong in vitro enhancer 2.7 kb upstream of its gene. Here we tested the in vivo role of the mouse Ren-1(c) enhancer. In reninexpressing As4.1 cells stably transfected with Ren-1c promoter with or without enhancer, expression of linked beta-geo reporter, stable expression, and colony formation were dependent on the presence of the enhancer. We then generated mice carrying a targeted deletion of the enhancer (REKO mice) and found marked depletion of renin in renal juxtaglomerular and submandibular ductal cells, as well as hyperplasia of macula densa cells. Plasma creatinine was increased, but electrolytes were normal. Male REKO mice implanted with telemetry devices had 9 +/- 1 mm Hg lower mean arterial pressure (p < 0.001), which was partly normalized by a high NaCl diet. Locomotor activity was lower, and baroreflex sensitivity was normal. Markedly reduced mean arterial pressure variability in the midfrequency band indicated a contribution of reduced sympathetic vasomotor tone to the hypotension. In conclusion, the renin enhancer is critical for renin gene expression and physiological sequelae, including response to alteration in salt intake. The REKO mouse may be useful as a low renin expression model.	Univ Sydney, Sch Med Sci, Basic & Clin Genom Lab, Sydney, NSW 2006, Australia; Bosch Inst, Sydney, NSW 2006, Australia; Baker Heart Res Inst, Melbourne, Vic 8008, Australia; Ozgene Pty Ltd, Bentley, WA 6102, Australia; Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England	University of Sydney; Baker Heart and Diabetes Institute; University of Cambridge	Morris, BJ (corresponding author), Univ Sydney, Sch Med Sci, Basic & Clin Genom Lab, Bldg F13, Sydney, NSW 2006, Australia.	brianm@medsci.usyd.edu.au	van der Weyden, Louise/AAV-5711-2021; Head, Geoffrey A./B-2177-2010	van der Weyden, Louise/0000-0002-0645-1879; Head, Geoffrey A./0000-0002-7623-137X; Adams, David/0000-0001-9490-0306; Markus, Andrea/0000-0003-2305-3394				BERTINIERI G, 1988, AM J PHYSIOL, V254, pH377, DOI 10.1152/ajpheart.1988.254.2.H377; BUHRLE CP, 1986, LAB INVEST, V54, P462; Butz GM, 2001, PHYSIOL GENOMICS, V5, P89, DOI 10.1152/physiolgenomics.2001.5.2.89; Chen YF, 2005, AM J PHYSIOL-REG I, V288, pR1071, DOI 10.1152/ajpregu.00231.2004; Clark AF, 1997, J BIOL CHEM, V272, P18185, DOI 10.1074/jbc.272.29.18185; DELLABRUNA R, 1995, KIDNEY INT, V47, P1266, DOI 10.1038/ki.1995.181; Esther CR, 1997, J CLIN INVEST, V99, P2375, DOI 10.1172/JCI119419; Feng YQ, 2005, MOL CELL BIOL, V25, P3864, DOI 10.1128/MCB.25.10.3864-3874.2005; Francastel C, 1999, CELL, V99, P259, DOI 10.1016/S0092-8674(00)81657-8; GOMEZ RA, 1990, AM J PHYSIOL, V259, pF660, DOI 10.1152/ajprenal.1990.259.4.F660; GOMEZ RA, 1989, AM J PHYSIOL, V257, pF850, DOI 10.1152/ajprenal.1989.257.5.F850; Gross V, 2000, J HYPERTENS, V18, P955, DOI 10.1097/00004872-200018070-00018; Gross V, 2002, HYPERTENSION, V40, P207, DOI 10.1161/01.HYP.0000027279.69240.75; Head GA, 2004, ENDOCRINOLOGY, V145, P4286, DOI 10.1210/en.2004-0421; Head GA, 2001, IEEE ENG MED BIOL, V20, P43, DOI 10.1109/51.917723; HEIN L, 1995, NATURE, V377, P744, DOI 10.1038/377744a0; Holmer SR, 1997, J HYPERTENS, V15, P1471, DOI 10.1097/00004872-199715120-00015; ICHIKI T, 1995, NATURE, V377, P748, DOI 10.1038/377748a0; Janssen BJA, 2002, AM J PHYSIOL-REG I, V282, pR1545, DOI 10.1152/ajpregu.00714.2001; Jenkins TA, 1997, CLIN EXP HYPERTENS, V19, P645, DOI 10.3109/10641969709083176; KIM HS, 1995, P NATL ACAD SCI USA, V92, P2735, DOI 10.1073/pnas.92.7.2735; Kim HS, 1999, J BIOL CHEM, V274, P14210, DOI 10.1074/jbc.274.20.14210; KON Y, 1992, ANAT RECORD, V232, P393, DOI 10.1002/ar.1092320309; KONTGEN F, 1993, METHOD ENZYMOL, V225, P878; KORNER PI, 1987, BRAIN RES, V435, P258, DOI 10.1016/0006-8993(87)91609-X; Massiera F, 2001, ENDOCRINOLOGY, V142, P5220, DOI 10.1210/en.142.12.5220; Merrill DC, 1996, J CLIN INVEST, V97, P1047, DOI 10.1172/JCI118497; MORRIS BJ, 2000, HDB PHYSL 7, V3, P3; Mullins LJ, 2000, J BIOL CHEM, V275, P40378, DOI 10.1074/jbc.M007315200; Navakatikyan MA, 2002, IEEE T BIO-MED ENG, V49, P662, DOI 10.1109/TBME.2002.1010849; Niimura F, 1995, J CLIN INVEST, V96, P2947, DOI 10.1172/JCI118366; NORWOOD VF, 1994, KIDNEY INT, V45, P1333, DOI 10.1038/ki.1994.174; Okuyama S, 1999, NEUROSCI LETT, V261, P167, DOI 10.1016/S0304-3940(99)00002-6; Pan L, 2005, HYPERTENSION, V45, P3, DOI 10.1161/01.HYP.0000149717.55920.45; Petrovic N, 1996, J BIOL CHEM, V271, P22499, DOI 10.1074/jbc.271.37.22499; Raghavendra V, 1998, NEUROPEPTIDES, V32, P275, DOI 10.1016/S0143-4179(98)90048-8; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Shi Q, 1999, CIRC RES, V85, P479, DOI 10.1161/01.RES.85.6.479; SIGMUND CD, 1991, HYPERTENSION, V18, P446, DOI 10.1161/01.HYP.18.4.446; SIGMUND CD, 1990, J BIOL CHEM, V265, P19916; SKOTT O, 1987, SCIENCE, V237, P1618, DOI 10.1126/science.3306925; Sun ZJ, 2003, HYPERTENSION, V41, P322, DOI 10.1161/01.HYP.0000050964.96018.FA; Sutherland HGE, 1997, MOL CELL BIOL, V17, P1607, DOI 10.1128/MCB.17.3.1607; TANIMOTO K, 1994, J BIOL CHEM, V269, P31334; van der Weyden L, 2000, HYPERTENSION, V36, P1093, DOI 10.1161/01.HYP.36.6.1093; Walters MC, 1996, GENE DEV, V10, P185, DOI 10.1101/gad.10.2.185; West AG, 2005, HUM MOL GENET, V14, pR101, DOI 10.1093/hmg/ddi104; Wolffe AP, 1996, CELL, V84, P817, DOI 10.1016/S0092-8674(00)81059-4; Yan Y, 1997, CIRC RES, V81, P558, DOI 10.1161/01.RES.81.4.558; Yanai K, 2000, J BIOL CHEM, V275, P5, DOI 10.1074/jbc.275.1.5; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789	51	47	47	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31753	31761		10.1074/jbc.M605720200	http://dx.doi.org/10.1074/jbc.M605720200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16895910	Bronze			2022-12-27	WOS:000241235300062
J	Panasyuk, G; Nemazanyy, I; Zhyvoloup, A; Bretner, M; Litchfield, DW; Filonenko, V; Gout, IT				Panasyuk, Ganna; Nemazanyy, Ivan; Zhyvoloup, Alexander; Bretner, Maria; Litchfield, David W.; Filonenko, Valeriy; Gout, Ivan T.			Nuclear export of S6K1II is regulated by protein kinase CK2 phosphorylation at Ser-17	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P70 S6 KINASE; INSULIN-RECEPTOR SUBSTRATE-1; CASEIN KINASE-2; LOCALIZATION; SUBUNITS; ACTIVATION; TRANSFORMATION; INHIBITOR; RAPAMYCIN; P70(S6K)	Ribosomal S6 kinases (S6Ks) are principal players in the regulation of cell growth and energy metabolism. Signaling via phosphatidylinositol 3- kinase and mammalian target of rapamycin pathways mediates the activation of S6K in response to various mitogenic stimuli. The family of S6Ks consists of two forms, S6K1 and -2, that have cytoplasmic and nuclear splicing variants, S6K1 II and S6K1 I, respectively. Nuclear-cytoplasmic shuttling of both isoforms induced by mitogenic stimuli has been reported recently. Here we present the identification of protein kinase CK2 (CK2) as a novel binding and regulatory partner for S6K1 II. The interaction between S6K1 II and CK2 beta regulatory subunit was initially identified in a yeast two-hybrid screen and further confirmed by co-immunoprecipitation of transiently expressed and endogenous proteins. The interaction between S6K1 II and CK2 was found to occur in serum-starved and serum-stimulated cells. In addition, we found that S6K1 II is a substrate for CK2. The localization of the CK2 phosphorylation site was narrowed down to Ser-17 in S6K1 II. Mutational analysis and the use of phosphospecific antibody indicate that Ser-17 is a major in vitro and in vivo phosphorylation site for CK2. Functional studies reveal that, in contrast to the wild type kinase, the phosphorylation-mimicking mutant of S6K1 II (S17E) retains its cytoplasmic localization in serum-stimulated cells. Treatment of cells with the nuclear export inhibitor leptomycin B revealed that the S17E mutant accumulates in the nucleus to the same extent as S6K1 II wild type. These results indicate that nuclear import of the S17E mutant is not affected, although the export is significantly enhanced. We also provide evidence that nuclear export of S6K1 is mediated by a CRM1-dependent mechanism. Taken together, this study establishes a functional link between S6K1 II and CK2 signaling, which involves the regulation of S6K1 II nuclear export by CK2-mediated phosphorylation of Ser-17.	UCL, Sch Med, Dept Biochem & Mol Biol, London WC1E 6BT, England; Natl Acad Sci Ukraine, Inst Mol Biol & Genet, UA-03143 Kiev, Ukraine; Ludwig Inst Canc Res, London W1W 7BS, England; Univ Western Ontario, Schulich Sch Med & Dent, Dept Biochem, London, ON N6A 5C1, Canada; Polish Acad Sci, Inst Biochem & Biophys, PL-02106 Warsaw, Poland	University of London; University College London; UCL Medical School; National Academy of Sciences Ukraine; Institute of Molecular Biology & Genetics of NASU; Ludwig Institute for Cancer Research; Western University (University of Western Ontario); Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Gout, IT (corresponding author), UCL, Sch Med, Dept Biochem & Mol Biol, Gower St, London WC1E 6BT, England.	i.gout@ucl.ac.uk	Panasyuk, Ganna/A-4133-2018; Filonenko, Valeriy V/D-5447-2015; Panasyuk, Ganna/AAF-4350-2021; Litchfield, David/E-4636-2015	Panasyuk, Ganna/0000-0002-5591-848X; Filonenko, Valeriy V/0000-0003-1839-3335; Panasyuk, Ganna/0000-0002-5591-848X; Litchfield, David/0000-0002-2425-6620; Bretner, Maria/0000-0002-9643-0843				ANDRES JL, 1987, J BIOL CHEM, V262, P14389; Avruch J, 2001, Prog Mol Subcell Biol, V26, P115; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P8351, DOI 10.1073/pnas.95.14.8351; Canton DA, 2001, BIOCHEM J, V358, P87, DOI 10.1042/0264-6021:3580087; Chou MM, 1996, CELL, V85, P573, DOI 10.1016/S0092-8674(00)81257-X; Conti E, 2001, CURR OPIN CELL BIOL, V13, P310, DOI 10.1016/S0955-0674(00)00213-1; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; Edelmann HML, 1996, J BIOL CHEM, V271, P963, DOI 10.1074/jbc.271.2.963; Faust M, 2002, CELL MOL LIFE SCI, V59, P2155, DOI 10.1007/s000180200022; Faust M, 2001, MOL CELL BIOCHEM, V227, P73, DOI 10.1023/A:1013129410551; Faust M, 2000, CELL TISSUE RES, V301, P329, DOI 10.1007/s004410000256; GIETZ RD, 1995, J BIOL CHEM, V270, P13017, DOI 10.1074/jbc.270.22.13017; Giraud J, 2004, J BIOL CHEM, V279, P3447, DOI 10.1074/jbc.M308631200; Graham KC, 2000, J BIOL CHEM, V275, P5003, DOI 10.1074/jbc.275.7.5003; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Kim JE, 2000, P NATL ACAD SCI USA, V97, P14340, DOI 10.1073/pnas.011511898; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Litchfield DW, 2001, MOL CELL BIOCHEM, V227, P21, DOI 10.1023/A:1013188101465; Loizou JI, 2004, CELL, V117, P17, DOI 10.1016/S0092-8674(04)00206-5; Marin O, 1999, J BIOL CHEM, V274, P29260, DOI 10.1074/jbc.274.41.29260; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Miyata Y, 2004, MOL CELL BIOL, V24, P4065, DOI 10.1128/MCB.24.9.4065-4074.2004; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Panasyuk G, 2004, BIOTECHNIQUES, V36, P40, DOI 10.2144/04361BM03; Penner CG, 1997, J CELL BIOCHEM, V64, P525; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; Pinna L A, 1997, Prog Cell Cycle Res, V3, P77; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; REINHARD C, 1994, EMBO J, V13, P1557, DOI 10.1002/j.1460-2075.1994.tb06418.x; Ruzzene M, 2002, BIOCHEM J, V364, P41, DOI 10.1042/bj3640041; Sarno S, 2005, MOL CELL BIOCHEM, V274, P69, DOI 10.1007/s11010-005-3079-z; SELDIN DC, 1995, SCIENCE, V267, P894, DOI 10.1126/science.7846532; Shi XY, 2001, J BIOL CHEM, V276, P2075, DOI 10.1074/jbc.M008583200; Tawfic S, 2001, HISTOL HISTOPATHOL, V16, P573, DOI 10.14670/HH-16.573; Val'ovka T I, 2000, Ukr Biokhim Zh (1999), V72, P31; Valentinis B, 2000, J BIOL CHEM, V275, P25451, DOI 10.1074/jbc.M002271200; Valovka T, 2003, MOL CELL BIOL, V23, P852, DOI 10.1128/MCB.23.3.852-863.2003; WENG QP, 1995, P NATL ACAD SCI USA, V92, P5744, DOI 10.1073/pnas.92.12.5744; WENG QP, 1995, MOL CELL BIOL, V15, P2333; Wilson LK, 1997, J BIOL CHEM, V272, P12961, DOI 10.1074/jbc.272.20.12961; Zhang XW, 2002, J BIOL CHEM, V277, P28127, DOI 10.1074/jbc.M202625200; Zien P, 2003, BIOCHEM BIOPH RES CO, V306, P129, DOI 10.1016/S0006-291X(03)00928-8	42	32	37	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31188	31201		10.1074/jbc.M602618200	http://dx.doi.org/10.1074/jbc.M602618200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16895915	Bronze			2022-12-27	WOS:000241235300004
J	Shao, CH; Zhang, FM; Kemp, MM; Linhardt, RJ; Waisman, DM; Head, JF; Seaton, BA				Shao, Chenghua; Zhang, Fuming; Kemp, Melissa M.; Linhardt, Robert J.; Waisman, David M.; Head, James F.; Seaton, Barbara A.			Crystallographic analysis of calcium-dependent heparin binding to annexin A2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; II TETRAMER; PROTEIN; SULFATE; CONFORMATION; MECHANISM; DYNAMICS; NMR	Annexin A2 and heparin bind to one another with high affinity and in a calcium-dependent manner, an interaction that may play a role in mediating fibrinolysis. In this study, three heparin-derived oligosaccharides of different lengths were co-crystallized with annexin A2 to elucidate the structural basis of the interaction. Crystal structures were obtained at high resolution for uncomplexed annexin A2 and three complexes of heparin oligosaccharides bound to annexin A2. The common heparin-binding site is situated at the convex face of domain IV of annexin A2. At this site, annexin A2 binds up to five sugar residues from the nonreducing end of the oligosaccharide. Unlike most heparin-binding consensus patterns, heparin binding at this site does not rely on arrays of basic residues; instead, main-chain and side-chain nitrogen atoms and two calcium ions play important roles in the binding. Especially significant is a novel calcium-binding site that forms upon heparin binding. Two sugar residues of the heparin derivatives provide oxygen ligands for this calcium ion. Comparison of all four structures shows that heparin binding does not elicit a significant conformational change in annexin A2. Finally, surface plasmon resonance measurements were made for binding interactions between annexin A2 and heparin polysaccharide in solution at pH 7.4 or 5.0. The combined data provide a clear basis for the calcium dependence of heparin binding to annexin A2.	Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA; Rensselaer Polytech Inst, Dept Chem & Biol Chem, Troy, NY 12180 USA; Rensselaer Polytech Inst, Dept Biol & Chem Engn, Troy, NY 12180 USA; Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 1X5, Canada	Boston University; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Dalhousie University	Seaton, BA (corresponding author), Boston Univ, Sch Med, Dept Physiol & Biophys, 715 Albany St, Boston, MA 02118 USA.	seatonba@bu.edu		Waisman, David/0000-0002-5097-9662; Head, James/0000-0002-6226-4146; Seaton, Barbara/0000-0003-4654-7709	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052622, R01HL062244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044554, R01GM038060, R29GM044554] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL062244, HL62244, R01 HL062244-06, R01 HL052622-09, R01 HL062244-05A1, R01 HL052622] Funding Source: Medline; NIGMS NIH HHS [R01 GM038060-18, R01 GM038060, GM44554, R01 GM038060-17, R01 GM038060-16A2, GM3806] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bell J, 2003, BLOOD COAGUL FIBRIN, V14, P229, DOI 10.1097/01.mbc.0000061292.28953.c5; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burger A, 1996, J MOL BIOL, V257, P839, DOI 10.1006/jmbi.1996.0205; Capila I, 2001, STRUCTURE, V9, P57, DOI 10.1016/S0969-2126(00)00549-9; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; DELANO WL, 2002, PHYMOL MOL GRAPHICS; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Hajjar KA, 2000, ANN NY ACAD SCI, V902, P265; Hakansson K, 2000, PROTEIN SCI, V9, P1607, DOI 10.1110/ps.9.9.1607; Hernaiz M, 2000, BIOCHEM BIOPH RES CO, V276, P292, DOI 10.1006/bbrc.2000.3453; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kang HM, 1999, TRENDS CARDIOVAS MED, V9, P92, DOI 10.1016/S1050-1738(99)00012-2; Kassam G, 1997, J BIOL CHEM, V272, P15093, DOI 10.1074/jbc.272.24.15093; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liang JF, 2000, THROMB RES, V97, P349, DOI 10.1016/S0049-3848(99)00188-7; MULLOY B, 1993, BIOCHEM J, V293, P849, DOI 10.1042/bj2930849; Mulloy B, 2000, GLYCOBIOLOGY, V10, P1147, DOI 10.1093/glycob/10.11.1147; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rosengarth A., 2004, ANNEXINS, V1, P129; SWAIRJO MA, 1995, NAT STRUCT BIOL, V2, P968, DOI 10.1038/nsb1195-968; Toida T, 1997, BIOCHEM J, V322, P499, DOI 10.1042/bj3220499; WAISMAN DM, 1995, MOL CELL BIOCHEM, V149, P301, DOI 10.1007/BF01076592	23	80	85	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31689	31695		10.1074/jbc.M604502200	http://dx.doi.org/10.1074/jbc.M604502200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16882661	Green Accepted			2022-12-27	WOS:000241235300054
J	Flaugh, SL; Mills, IA; King, J				Flaugh, Shannon L.; Mills, Ishara A.; King, Jonathan			Glutamine deamidation destabilizes human gamma D-crystallin and lowers the kinetic barrier to unfolding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN CARBOXYL METHYLTRANSFERASE; HUMAN SENILE CATARACTOGENESIS; HELICAL COILED-COILS; ALPHA-B-CRYSTALLIN; X-RAY-ANALYSIS; EYE LENS; GUANIDINE-HYDROCHLORIDE; ELECTROSTATIC INTERACTIONS; ASPARAGINE DEAMIDATION; MOLECULAR CHAPERONE	Human eye lens transparency requires life long stability and solubility of the crystallin proteins. Aged crystallins have high levels of covalent damage, including glutamine deamidation. Human gamma D-crystallin (H gamma D-Crys) is a two-domain beta-sheet protein of the lens nucleus. The two domains interact through interdomain side chain contacts, including Gln-54 and Gln-143, which are critical for stability and folding of the N-terminal domain of H gamma D-Crys. To test the effects of interface deamidation on stability and folding, single and double glutamine to glutamate substitutions were constructed. Equilibrium unfolding/refolding experiments of the proteins were performed in guanidine hydrochloride at pH 7.0, 37 degrees C, or urea at pH 3.0, 20 degrees C. Compared with wild type, the deamidation mutants were destabilized at pH 7.0. The proteins populated a partially unfolded intermediate that likely had a structured C-terminal domain and unstructured N-terminal domain. However, at pH 3.0, equilibrium unfolding transitions of wild type and the deamidation mutants were indistinguishable. In contrast, the double alanine mutant Q54A/Q143A was destabilized at both pH 7.0 and 3.0. Thermal stabilities of the deamidation mutants were also reduced at pH 7.0. Similarly, the deamidation mutants lowered the kinetic barrier to unfolding of the N-terminal domain. These data indicate that interface deamidation decreases the thermodynamic stability of H gamma D-Crys and lowers the kinetic barrier to unfolding due to introduction of a negative charge into the domain interface. Such effects may be significant for cataract formation by inducing protein aggregation or insolubility.	MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	King, J (corresponding author), MIT, Dept Biol, 31 Ames St,Rm 68-330, Cambridge, MA 02139 USA.	jaking@mit.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM017980, R01GM017980] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM17980] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andley UP, 1996, J BIOL CHEM, V271, P31973, DOI 10.1074/jbc.271.50.31973; Bagby S, 1998, J MOL BIOL, V276, P669, DOI 10.1006/jmbi.1997.1563; Basak A, 2003, J MOL BIOL, V328, P1137, DOI 10.1016/S0022-2836(03)00375-9; Bateman OA, 2003, EXP EYE RES, V77, P409, DOI 10.1016/S0014-4835(03)00173-8; BAX B, 1990, NATURE, V347, P776, DOI 10.1038/347776a0; Bilsel O, 1999, BIOCHEMISTRY-US, V38, P1018, DOI 10.1021/bi982365q; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; BOYLE D, 1994, EXP EYE RES, V58, P9, DOI 10.1006/exer.1994.1190; CARRELL RW, 1994, AM J RESP CRIT CARE, V150, pS171, DOI 10.1164/ajrccm/150.6_Pt_2.S171; CLARK AC, 1993, J BIOL CHEM, V268, P10773; Das BK, 1998, INT J BIOL MACROMOL, V23, P191, DOI 10.1016/S0141-8130(98)00048-8; DELAYE M, 1983, NATURE, V302, P415, DOI 10.1038/302415a0; Evans P, 2004, J MOL BIOL, V343, P435, DOI 10.1016/j.jmb.2004.08.050; FERNALD RD, 1983, NATURE, V301, P618, DOI 10.1038/301618a0; Fitch CA, 2002, BIOPHYS J, V82, P3289, DOI 10.1016/S0006-3495(02)75670-1; Flaugh SL, 2005, PROTEIN SCI, V14, P2030, DOI 10.1110/ps.051460505; Flaugh SL, 2005, PROTEIN SCI, V14, P571, DOI 10.1110/ps.041111405; Forsyth WR, 2002, PROTEINS, V48, P388, DOI 10.1002/prot.10174; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; Fu L, 2002, FEBS LETT, V513, P213, DOI 10.1016/S0014-5793(02)02313-X; GEIGER T, 1987, J BIOL CHEM, V262, P785; GREENE RF, 1974, J BIOL CHEM, V249, P5388; GROENEN PJTA, 1994, EUR J BIOCHEM, V225, P1, DOI 10.1111/j.1432-1033.1994.00001.x; Gupta R, 2004, J BIOL CHEM, V279, P44258, DOI 10.1074/jbc.M405648200; Gupta R, 2004, INVEST OPHTH VIS SCI, V45, P206, DOI 10.1167/iovs.03-0720; HAGIHARA Y, 1994, J MOL BIOL, V237, P336, DOI 10.1006/jmbi.1994.1234; Hanson SRA, 1998, EXP EYE RES, V67, P301, DOI 10.1006/exer.1998.0530; Hanson SRA, 2000, EXP EYE RES, V71, P195, DOI 10.1006/exer.2000.0868; Harms MJ, 2004, PROTEIN SCI, V13, P678, DOI 10.1110/ps.03427504; HOPE JN, 1994, J BIOL CHEM, V269, P21141; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Jaenicke R, 2001, CRIT REV BIOCHEM MOL, V36, P435, DOI 10.1080/20014091074237; Jiang X, 2001, BIOCHEMISTRY-US, V40, P11442, DOI 10.1021/bi011194d; Kim YH, 2002, BIOCHEMISTRY-US, V41, P14076, DOI 10.1021/bi026288h; Kmoch S, 2000, HUM MOL GENET, V9, P1779, DOI 10.1093/hmg/9.12.1779; KODAMA T, 1995, BBA-GEN SUBJECTS, V1245, P269, DOI 10.1016/0304-4165(95)00092-P; KOHN WD, 1995, J BIOL CHEM, V270, P25495, DOI 10.1074/jbc.270.43.25495; Kosinski-Collins MS, 2004, PROTEIN SCI, V13, P2223, DOI 10.1110/ps.04627004; Kosinski-Collins MS, 2003, PROTEIN SCI, V12, P480, DOI 10.1110/ps.0225503; Lampi KJ, 1998, EXP EYE RES, V67, P31, DOI 10.1006/exer.1998.0481; Lampi KJ, 2006, BIOCHEMISTRY-US, V45, P3146, DOI 10.1021/bi052051k; Lampi KJ, 1997, J BIOL CHEM, V272, P2268; Lampi KJ, 2002, MOL VIS, V8, P359; Lampi KJ, 2001, EXP EYE RES, V72, P279, DOI 10.1006/exer.2000.0950; Lapko VN, 2002, BIOCHEMISTRY-US, V41, P8638, DOI 10.1021/bi015924t; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Lund AL, 1996, EXP EYE RES, V63, P661, DOI 10.1006/exer.1996.0160; Macdonald JT, 2005, PROTEIN SCI, V14, P1282, DOI 10.1110/ps.041227805; MAYR EM, 1994, J MOL BIOL, V235, P84, DOI 10.1016/S0022-2836(05)80017-8; MCFADDEN PN, 1983, BIOCHEM BIOPH RES CO, V113, P418, DOI 10.1016/0006-291X(83)91742-4; MCFADDEN PN, 1986, MECH AGEING DEV, V34, P91, DOI 10.1016/0047-6374(86)90107-7; MITRAKI A, 1989, BIO-TECHNOL, V7, P690, DOI 10.1038/nbt0789-690; MONERA OD, 1994, BIOCHEMISTRY-US, V33, P3862, DOI 10.1021/bi00179a010; MONERA OD, 1994, PROTEIN SCI, V3, P1984, DOI 10.1002/pro.5560031110; *NAT COMM CLIN LAB, 2002, PERF STAND ANT SUSC, P22; Nguyen DM, 2004, J MOL BIOL, V341, P565, DOI 10.1016/j.jmb.2004.05.066; Nilsson MR, 2003, PROTEIN SCI, V12, P2637, DOI 10.1110/ps.0360403; Nilsson MR, 2002, PROTEIN SCI, V11, P342, DOI 10.1110/ps.48702; Palme S, 1997, PROTEIN SCI, V6, P1529; Pande A, 2000, P NATL ACAD SCI USA, V97, P1993, DOI 10.1073/pnas.040554397; Pande A, 2001, P NATL ACAD SCI USA, V98, P6116, DOI 10.1073/pnas.101124798; Searle BC, 2005, J PROTEOME RES, V4, P546, DOI 10.1021/pr049781j; SEN AC, 1992, J BIOL CHEM, V267, P11898; SLINGSBY C, 1990, BIOCHEMISTRY-US, V29, P6592, DOI 10.1021/bi00480a007; Takemoto L, 2000, MOL VIS, V6, P164; Takemoto L, 2001, EXP EYE RES, V72, P559, DOI 10.1006/exer.2001.0983; WETZEL R, 1994, TRENDS BIOTECHNOL, V12, P193, DOI 10.1016/0167-7799(94)90082-5; WISTOW G, 1983, J MOL BIOL, V170, P175, DOI 10.1016/S0022-2836(83)80232-0; Zhang ZL, 2003, EXP EYE RES, V77, P259, DOI 10.1016/S0014-4835(03)00159-3	70	89	90	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30782	30793		10.1074/jbc.M603882200	http://dx.doi.org/10.1074/jbc.M603882200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16891314	hybrid			2022-12-27	WOS:000241075900054
J	Samraj, AK; Keil, E; Ueffing, N; Schulze-Osthoff, K; Schmitz, I				Samraj, Ajoy K.; Keil, Eric; Ueffing, Nana; Schulze-Osthoff, Klaus; Schmitz, Ingo			Loss of caspase-9 provides genetic evidence for the type I/II concept of CD95-mediated apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; INDUCED CELL-DEATH; CD95 TYPE-I; MITOCHONDRIAL-FUNCTION; MEDIATED APOPTOSIS; SIGNALING PATHWAYS; JNK ACTIVATION; TNF-ALPHA; T-CELLS; FAS	The death receptor CD95 triggers apoptosis upon formation of a death-inducing signaling complex and the activation of caspase-8. Two types of CD95-mediated apoptosis have been distinguished that differ in their efficiency of death-inducing signaling complex formation and the requirement of mitochondria for caspase activation. The validity of the type I/II model, however, has been challenged, as Bcl-2 expression or the use of various CD95 agonists resulted in different apoptosis effects. By identifying a caspase-9-deficient T cell line, we now provide genetic evidence for the two-pathway model of CD95-mediated apoptosis and demonstrate that type II cells strongly depend on caspase-9. Caspase-9-deficient cells revealed strongly impaired apoptosis, caspase activation, and mitochondrial membrane depolarization upon CD95 triggering, whereas, surprisingly, activation of Bak and cytochrome c release were not inhibited. Furthermore, caspase-9-deficient cells did not switch to necrosis, and reconstitution of caspase-9 expression restored CD95 sensitivity. Finally, we also show that different death receptors have a distinct requirement for caspase-9.	Univ Dusseldorf, Inst Mol Med, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Schmitz, I (corresponding author), Univ Dusseldorf, Inst Mol Med, Univ Str 1, D-40225 Dusseldorf, Germany.	ingo-schmitz@uni-duesseldorf.de	Schulze-Osthoff, Klaus/N-9025-2013; Schmitz, Ingo/G-2093-2013	Schulze-Osthoff, Klaus/0000-0003-1443-2720; Schmitz, Ingo/0000-0002-5360-0419				Barnhart BC, 2003, SEMIN IMMUNOL, V15, P185, DOI 10.1016/S1044-5323(03)00031-9; Bossy-Wetzel E, 1998, EMBO J, V17, P37, DOI 10.1093/emboj/17.1.37; Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Gugasyan R, 2006, CELL DEATH DIFFER, V13, P1235, DOI 10.1038/sj.cdd.4401858; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Harper N, 2003, J BIOL CHEM, V278, P25534, DOI 10.1074/jbc.M303399200; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Huang DCS, 2000, CELL DEATH DIFFER, V7, P754, DOI 10.1038/sj.cdd.4400683; Huang DCS, 1999, P NATL ACAD SCI USA, V96, P14871, DOI 10.1073/pnas.96.26.14871; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Muppidi JR, 2004, IMMUNITY, V21, P461, DOI 10.1016/j.immuni.2004.10.001; Ozoren N, 2000, CANCER RES, V60, P6259; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Ricci JE, 2004, CELL, V117, P773, DOI 10.1016/j.cell.2004.05.008; Ricci JE, 2003, J CELL BIOL, V160, P65, DOI 10.1083/jcb.200208089; Rudner J, 2005, ONCOGENE, V24, P130, DOI 10.1038/sj.onc.1208191; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Scaffidi C, 1999, J BIOL CHEM, V274, P22532, DOI 10.1074/jbc.274.32.22532; Schmitz I, 2004, J IMMUNOL, V172, P2194, DOI 10.4049/jimmunol.172.4.2194; Schmitz I, 1999, CELL DEATH DIFFER, V6, P821, DOI 10.1038/sj.cdd.4400569; Schmitz I, 2003, J IMMUNOL, V171, P2930, DOI 10.4049/jimmunol.171.6.2930; Schmitz I, 2000, INT J BIOCHEM CELL B, V32, P1123, DOI 10.1016/S1357-2725(00)00048-0; Sohn D, 2005, J BIOL CHEM, V280, P5267, DOI 10.1074/jbc.M408585200; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Varfolomeev E, 2005, J BIOL CHEM, V280, P40599, DOI 10.1074/jbc.M509560200; Vercammen D, 1998, J EXP MED, V188, P919, DOI 10.1084/jem.188.5.919; Wang XD, 2001, GENE DEV, V15, P2922; Waterhouse NJ, 2003, CELL DEATH DIFFER, V10, P853, DOI 10.1038/sj.cdd.4401263; Waterhouse NJ, 2001, J CELL BIOL, V153, P319, DOI 10.1083/jcb.153.2.319; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wesselborg S, 1999, BLOOD, V93, P3053, DOI 10.1182/blood.V93.9.3053; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730	37	56	57	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					29652	29659		10.1074/jbc.M603487200	http://dx.doi.org/10.1074/jbc.M603487200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16895904	hybrid			2022-12-27	WOS:000240896300026
J	Kunzelmann, S; Praefcke, GJK; Herrmann, C				Kunzelmann, Simone; Praefcke, Gerrit J. K.; Herrmann, Christian			Transient kinetic investigation of GTP hydrolysis catalyzed by interferon-gamma-induced hGBP1 (human guanylate binding protein 1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN-1 HGBP1; DOMINANT OPTIC ATROPHY; NUCLEOTIDE-BINDING; MEDIATED ENDOCYTOSIS; ANTIVIRAL ACTIVITY; DYNAMIN; MECHANISM; MXA; IDENTIFICATION; MICROTUBULES	Within the family of large GTP-binding proteins, human guanylate binding protein 1 (hGBP1) belongs to a subgroup of interferon-inducible proteins. GTP hydrolysis activity of these proteins is much higher compared with members of other GTPase families and underlies mechanisms that are not understood. The large GTP-binding proteins form self-assemblies that lead to stimulation of the catalytic activity. The unique result of GTP hydrolysis catalyzed by hGBP1 is GDP and GMP. We investigated this reaction mechanism by transient kinetic methods using radioactively labeled GTP as well as fluorescent probes. Substrate binding and formation of the hGBP1 homodimer are fast as no lag phase is observed in the time courses of GTP hydrolysis. Instead, multiple turnover experiments show a rapid burst of Pi formation prior to the steady state phase, indicating a rate-limiting step after GTP cleavage. Both molecules are catalytically active and cleave off a phosphate ion in the first step. Then bifurcation into catalytic inactivation, probably by irreversible dissociation of the dimer, and into GDP hydrolysis is observed. The second cleavage step is even faster than the first step, implying a rapid rearrangement of the nucleotide within the catalytic center of hGBP1. We could also show that the release of the products, including the phosphate ions, is fast and not limiting the steady state activity. We suggest that slow dissociation of the GMP-bound homodimer gives rise to the burst behavior and controls the steady state. The assembled forms of the GDP- and GMP-bound states of hGBP1 are accessible only through GTP binding and hydrolysis and achieve a lifetime of a few seconds.	Ruhr Univ Bochum, Fak Chem & Biochem, D-44780 Bochum, Germany; Univ Cologne, Genet Inst, Ctr Mol Med Cologne, D-50674 Cologne, Germany	Ruhr University Bochum; University of Cologne	Herrmann, C (corresponding author), Ruhr Univ Bochum, Fak Chem & Biochem, D-44780 Bochum, Germany.	chr.herrmann@rub.de		Praefcke, Gerrit/0000-0001-8818-1499				Accola MA, 2002, J BIOL CHEM, V277, P21829, DOI 10.1074/jbc.M201641200; Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Anderson SL, 1999, VIROLOGY, V256, P8, DOI 10.1006/viro.1999.9614; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Binns DD, 2000, BIOCHEMISTRY-US, V39, P7188, DOI 10.1021/bi000033r; Bitoun M, 2005, NAT GENET, V37, P1207, DOI 10.1038/ng1657; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Brune M, 1998, BIOCHEMISTRY-US, V37, P10370, DOI 10.1021/bi9804277; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Fersht A., 1999, STRUCTURE MECH PROTE, P153; Flohr F, 1999, FEBS LETT, V463, P24, DOI 10.1016/S0014-5793(99)01598-7; Geeves MA, 2005, ADV PROTEIN CHEM, V71, P161, DOI 10.1016/S0065-3233(04)71005-0; Ghosh A, 2006, NATURE, V440, P101, DOI 10.1038/nature04510; Haller O, 2002, TRAFFIC, V3, P710, DOI 10.1034/j.1600-0854.2002.31003.x; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; HIRATSUKA T, 1983, BIOCHIM BIOPHYS ACTA, V742, P496, DOI 10.1016/0167-4838(83)90267-4; Janzen C, 2000, J VIROL, V74, P8202, DOI 10.1128/JVI.74.17.8202-8206.2000; JOHN J, 1990, BIOCHEMISTRY-US, V29, P6058, DOI 10.1021/bi00477a025; Kunzelmann S, 2005, METHOD ENZYMOL, V404, P512, DOI 10.1016/S0076-6879(05)04045-0; LENZEN C, 1995, METHOD ENZYMOL, V255, P95; MAEDA K, 1992, MOL BIOL CELL, V3, P1181, DOI 10.1091/mbc.3.10.1181; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; Modiano N, 2005, P NATL ACAD SCI USA, V102, P8680, DOI 10.1073/pnas.0503227102; NOWAK E, 1988, BIOCHEMISTRY-US, V27, P8613, DOI 10.1021/bi00423a016; Praefcke GJK, 2004, J MOL BIOL, V344, P257, DOI 10.1016/j.jmb.2004.09.026; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Praefcke GJK, 1999, J MOL BIOL, V292, P321, DOI 10.1006/jmbi.1999.3062; Prakash B, 2000, NATURE, V403, P567, DOI 10.1038/35000617; Sauter S M, 2004, Hum Mutat, V23, P98, DOI 10.1002/humu.9205; SCHWEMMLE M, 1994, J BIOL CHEM, V269, P11299; Sever S, 2000, J CELL BIOL, V150, P1137, DOI 10.1083/jcb.150.5.1137; Sever S, 1999, NATURE, V398, P481, DOI 10.1038/19024; SHPETNER HS, 1992, NATURE, V355, P733, DOI 10.1038/355733a0; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; TRENTHAM DR, 1976, Q REV BIOPHYS, V9, P217, DOI 10.1017/S0033583500002419; Uthaiah RC, 2003, J BIOL CHEM, V278, P29336, DOI 10.1074/jbc.M211973200; Zhang PJ, 2001, NAT CELL BIOL, V3, P922, DOI 10.1038/ncb1001-922	38	40	40	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					28627	28635		10.1074/jbc.M604911200	http://dx.doi.org/10.1074/jbc.M604911200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16873363	hybrid			2022-12-27	WOS:000240680500016
J	Zanzouri, M; Lauritzen, I; Duprat, F; Mazzuca, M; Lesage, F; Lazdunski, M; Patel, A				Zanzouri, Marc; Lauritzen, Inger; Duprat, Fabrice; Mazzuca, Michel; Lesage, Florian; Lazdunski, Michel; Patel, Amanda			Membrane potential-regulated transcription of the resting K+ conductance TASK-3 via the calcineurin pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBELLAR GRANULE CELLS; DOMAIN POTASSIUM CHANNEL; SUBUNIT MESSENGER-RNA; INDUCED DEPOLARIZATION; RECEPTOR SUBUNITS; RAT-BRAIN; NEURONS; EXPRESSION; ACID; NEUROTRANSMITTERS	The 2P domain K+ channel TASK-3 is highly expressed in cerebellar granule neurons where it has been proposed to underlie the K+ leak conductance, IKso. In a previous work we showed that expression of TASK-3 increases in cerebellar granule neurons as they mature in culture. Here we show that within the cerebellum, levels of TASK-3 mRNA increase as granule neurons migrate to their adult positions and receive excitatory mossy fiber input. To understand the mechanism of this increase in TASK-3 expression we used an in vitro model culturing the neurons in either depolarizing conditions mimicking neuronal activity (25K, 25 mM KCl) or in conditions which approach deafferentation (5K, 5 mM KCl). An important increase in TASK-3 mRNA is uniquely observed in 25K and is specific since other background K+ channel levels remain unchanged or decrease. The rise in TASK-3 mRNA leads to an increase in TASK-3 protein and the IKso conductance resulting in hyperpolarization. Blocking L-type calcium channels or their downstream effector calcineurin, abrogates TASK-3 expression and IKso, leading to hyperexcitability. This is the first study demonstrating that depolarization-induced Ca2+ entry can directly regulate cellular excitability by dynamically regulating the transcription of a resting K+ conductance. The appearance of this conductance may play an important role in the transition of depolarized immature neurons to their mature hyperpolarized state during neuronal development.	CNRS, UMR 6097, IPMC, F-06560 Valbonne, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Patel, A (corresponding author), CNRS, UMR 6097, IPMC, 660 Route Lucioles, F-06560 Valbonne, France.	patel@ipmc.cnrs.fr	Duprat, Fabrice/D-1221-2013; Lesage, Florian/P-9780-2019; Lesage, Florian/D-5097-2011; Lauritzen, Inger/AAE-9927-2022; Lauritzen, Inger/AFF-7261-2022	Duprat, Fabrice/0000-0001-8774-1220; Lesage, Florian/0000-0002-4406-7106; Lesage, Florian/0000-0002-4406-7106; lauritzen, inger/0000-0002-2011-1387				Aller MI, 2005, J NEUROSCI, V25, P11455, DOI 10.1523/JNEUROSCI.3153-05.2005; BALAZS R, 1988, DEV BRAIN RES, V40, P269, DOI 10.1016/0165-3806(88)90139-3; Berg AP, 2004, J NEUROSCI, V24, P6693, DOI 10.1523/JNEUROSCI.1408-04.2004; BESSHO Y, 1994, NEURON, V12, P87, DOI 10.1016/0896-6273(94)90154-6; Blaeser F, 2000, J BIOL CHEM, V275, P197, DOI 10.1074/jbc.275.1.197; Brickley SG, 2001, NATURE, V409, P88, DOI 10.1038/35051086; Buckler KJ, 2000, J PHYSIOL-LONDON, V525, P135, DOI 10.1111/j.1469-7793.2000.00135.x; Buckler KJ, 1997, J PHYSIOL-LONDON, V498, P649, DOI 10.1113/jphysiol.1997.sp021890; Carafoli E, 1999, BIOCHEM BIOPH RES CO, V266, P624, DOI 10.1006/bbrc.1999.1879; Chemin J, 2003, EMBO J, V22, P5403, DOI 10.1093/emboj/cdg528; Clarke CE, 2004, J PHYSIOL-LONDON, V560, P51, DOI 10.1113/jphysiol.2004.070292; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; Czirjak G, 2002, J BIOL CHEM, V277, P5426, DOI 10.1074/jbc.M107138200; Czirjak G, 2003, MOL PHARMACOL, V63, P646, DOI 10.1124/mol.63.3.646; Czirjak G, 2002, MOL ENDOCRINOL, V16, P621, DOI 10.1210/me.16.3.621; Czirjak G, 2001, AM J PHYSIOL-CELL PH, V281, pC700, DOI 10.1152/ajpcell.2001.281.2.C700; Duprat F, 1997, EMBO J, V16, P5464, DOI 10.1093/emboj/16.17.5464; Engblom AC, 2003, J BIOL CHEM, V278, P16543, DOI 10.1074/jbc.M300548200; GALLO V, 1987, J NEUROSCI, V7, P2203; Gault LM, 1997, J NEUROSCI, V17, P2391; Han J, 2002, J PHYSIOL-LONDON, V542, P431, DOI 10.1113/jphysiol.2002.017590; HAN TH, 1995, MOL CELL BIOL, V15, P2907; Herrup K, 1997, ANNU REV NEUROSCI, V20, P61, DOI 10.1146/annurev.neuro.20.1.61; Kang DW, 2004, J PHYSIOL-LONDON, V554, P64, DOI 10.1113/jphysiol.2003.054387; Kim Y, 2000, J BIOL CHEM, V275, P9340, DOI 10.1074/jbc.275.13.9340; Kramer D, 2003, MOL CELL NEUROSCI, V23, P325, DOI 10.1016/S1044-7431(03)00057-5; LAURIE DJ, 1992, J NEUROSCI, V12, P4151; Lauritzen I, 2003, J BIOL CHEM, V278, P32068, DOI 10.1074/jbc.M302631200; Leonoudakis D, 1998, J NEUROSCI, V18, P868; Lesage F, 1996, EMBO J, V15, P6400, DOI 10.1002/j.1460-2075.1996.tb01031.x; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Lossi L, 2002, NEUROSCIENCE, V112, P509, DOI 10.1016/S0306-4522(02)00112-4; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; Mao ZX, 1999, J BIOL CHEM, V274, P31102, DOI 10.1074/jbc.274.43.31102; Marley PD, 1996, BIOCHEM BIOPH RES CO, V221, P15, DOI 10.1006/bbrc.1996.0536; Mathie A, 2003, CEREBELLUM, V2, P11, DOI 10.1080/14734220310015593; Mellor JR, 1998, J PHYSIOL-LONDON, V506, P377, DOI 10.1111/j.1469-7793.1998.377bw.x; Meuth SG, 2003, J NEUROSCI, V23, P6460; Millar JA, 2000, P NATL ACAD SCI USA, V97, P3614, DOI 10.1073/pnas.050012597; NAKANISHI S, 2006, IN PRESS J PHYSL LON; Olson EN, 2000, BIOESSAYS, V22, P510, DOI 10.1002/(SICI)1521-1878(200006)22:6<510::AID-BIES4>3.3.CO;2-T; Patel AJ, 2004, PFLUG ARCH EUR J PHY, V448, P261, DOI 10.1007/s00424-004-1255-8; RESINK A, 1995, EUR J NEUROSCI, V7, P1700, DOI 10.1111/j.1460-9568.1995.tb00691.x; RESINK A, 1995, J NEUROCHEM, V64, P558; ROSS CA, 1990, TRENDS NEUROSCI, V13, P216, DOI 10.1016/0166-2236(90)90163-5; Sato M, 2005, P NATL ACAD SCI USA, V102, P5874, DOI 10.1073/pnas.0501972102; Sirois JE, 2002, J PHYSIOL-LONDON, V541, P717, DOI 10.1113/jphysiol.2002.018119; Takayasu Y, 2003, J NEUROSCI, V23, P6200; Talley EM, 2001, J NEUROSCI, V21, P7491, DOI 10.1523/JNEUROSCI.21-19-07491.2001; Talley EM, 2002, J BIOL CHEM, V277, P17733, DOI 10.1074/jbc.M200502200; Talley EM, 2000, NEURON, V25, P399, DOI 10.1016/S0896-6273(00)80903-4; Voogd J, 1998, TRENDS NEUROSCI, V21, P370, DOI 10.1016/S0166-2236(98)01318-6; Washburn CP, 2002, J NEUROSCI, V22, P1256, DOI 10.1523/JNEUROSCI.22-04-01256.2002; Watkins CS, 1996, J PHYSIOL-LONDON, V491, P401, DOI 10.1113/jphysiol.1996.sp021224; ZHENG T, 1993, DEV BRAIN RES, V75, P91, DOI 10.1016/0165-3806(93)90068-L	56	26	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					28910	28918		10.1074/jbc.M606092200	http://dx.doi.org/10.1074/jbc.M606092200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16864570	hybrid			2022-12-27	WOS:000240680500045
J	Hashmi, S; Zhang, J; Oksov, Y; Ji, QM; Lustigman, S				Hashmi, Sarwar; Zhang, Jun; Oksov, Yelena; Ji, Qiongmei; Lustigman, Sara			The Caenorhabditis elegans CPI-2a cystatin-like inhibitor has an essential regulatory role during oogenesis and fertilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE PROTEINASE-INHIBITORS; MOUSE EMBRYO IMPLANTATION; OOCYTE MEIOTIC MATURATION; CATHEPSIN-L; ONCHOCERCA-VOLVULUS; MOLECULAR-CLONING; YOLK PROTEINS; C-ELEGANS; EXPRESSION PATTERNS; PROTEASE INHIBITOR	In the present study, we characterized a sterile cpi-2a(ok1256) deletion mutant in Caenorhabditis elegans and showed that CPI-2a has an essential regulatory role during oogenesis and fertilization. We have also shown that the CPI2a inhibitor and both Ce-CPL-1 and Ce-CPZ-1 enzymes are present in the myo-epithelial sheath surrounding germ cells, oocytes, and embryos as well as in the yolk granules within normal oocytes. Staining of mutant worms with anti-yolk protein antibodies has indicted that the proteins are not present in the mature oocytes. Moreover, green fluorescent protein expression was absence or reduced in cpi-2a/yp170:gfp mutant oocytes, although it was expressed in one of the successfully developed embryos. Based on these results, we hypothesize that the sterility in cpi2a(ok1256) mutant worms is potentially caused by two possible mechanisms: 1) defects in the uptake and/or processing of yolk proteins by the growing oocytes and 2) indirect induction of defects in cell-cell signaling that is critical for promoting germ line development, oocyte maturation, ovulation, and fertilization. A defect in any of these processes would have detrimental effects on the development of normal embryos and consequently normal production of progenies as we observed in cpi-2a mutant worms. This is the first study that demonstrates the expression of cysteine proteases and their endogenous inhibitor in the gonadal sheath cells surrounding germ cells and oocytes, which indirectly have established their potential involvement in proteolytic processing of molecules within the gonadal sheath cells, such as components of the extracellular matrix or the cytoskeletal proteins, which are essential for proper cell-cell signaling activities of the gonadal sheath cells during normal maturation and ovulation processes.	New York Blood Ctr, Lab Mol Parasitol, Lindsley F Kimball Res Inst, New York, NY 10021 USA; New York Blood Ctr, Lab Electron Microscopy, Lindsley F Kimball Res Inst, New York, NY 10021 USA; New York Blood Ctr, Lab Biochem & Mol Genet, Lindsley F Kimball Res Inst, New York, NY 10021 USA	New York Blood Center; New York Blood Center; New York Blood Center	Hashmi, S (corresponding author), New York Blood Ctr, Lab Mol Parasitol, Lindsley F Kimball Res Inst, 310 E 67th St, New York, NY 10021 USA.	shashmi@nybloodcenter.org			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048057, R21AI048057] Funding Source: NIH RePORTER; NIAID NIH HHS [AI48057] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABRAHAMSON M, 1987, J BIOL CHEM, V262, P9688; ABRAHAMSON M, 1994, METHOD ENZYMOL, V244, P685; ABRAHAMSON M, 1986, J BIOL CHEM, V261, P1282; Afonso S, 1997, DEVELOPMENT, V124, P3415; Alexander CM, 1996, DEVELOPMENT, V122, P1723; BARRETT AJ, 1984, BIOCHEM BIOPH RES CO, V120, P631, DOI 10.1016/0006-291X(84)91302-0; BARRETT AJ, 1986, BIOCHEM J, V236, P312, DOI 10.1042/bj2360312; BARRETT AJ, 1981, METHOD ENZYMOL, V80, P535; BARRETT AJ, 1986, RES MONOG CELL TISSU, V12, P515; BODE VC, 1988, GENETICS, V118, P299; BRENNER S, 1974, GENETICS, V77, P71; Britton C, 2004, J CELL SCI, V117, P5133, DOI 10.1242/jcs.01387; BROMME D, 1991, BIOMED BIOCHIM ACTA, V50, P631; Carnevali O, 1999, BIOL REPROD, V61, P785, DOI 10.1095/biolreprod61.3.785; Carnevali O, 1999, BIOL REPROD, V60, P140, DOI 10.1095/biolreprod60.1.140; Chagas JR, 1997, MOL BIOCHEM PARASIT, V88, P85, DOI 10.1016/S0166-6851(97)00085-6; CHAMBERS AF, 1993, CRIT REV ONCOGENESIS, V4, P95; Chapman HA, 1997, ANNU REV PHYSIOL, V59, P63, DOI 10.1146/annurev.physiol.59.1.63; Cho WL, 1999, J BIOL CHEM, V274, P13311, DOI 10.1074/jbc.274.19.13311; CORNWALL GA, 1992, MOL ENDOCRINOL, V6, P1653, DOI 10.1210/me.6.10.1653; Coulibaly S, 1999, INT J CANCER, V83, P526, DOI 10.1002/(SICI)1097-0215(19991112)83:4<526::AID-IJC15>3.3.CO;2-D; Cram EJ, 2003, J CELL SCI, V116, P3871, DOI 10.1242/jcs.00705; DASTON GP, 1991, TERATOLOGY, V43, P253, DOI 10.1002/tera.1420430309; Fabra M, 2004, MOL REPROD DEV, V67, P282, DOI 10.1002/mrd.20018; FAGOTTO F, 1990, ARCH INSECT BIOCHEM, V14, P237, DOI 10.1002/arch.940140404; FAGOTTO F, 1990, ARCH INSECT BIOCHEM, V14, P217, DOI 10.1002/arch.940140403; FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X; Grant B, 1999, MOL BIOL CELL, V10, P4311, DOI 10.1091/mbc.10.12.4311; GRUBB JD, 1991, PLACENTA, V12, P143, DOI 10.1016/0143-4004(91)90018-B; Guiliano DB, 2004, MOL BIOCHEM PARASIT, V136, P227, DOI 10.1016/j.molbiopara.2004.03.015; Hall DH, 1999, DEV BIOL, V212, P101, DOI 10.1006/dbio.1999.9356; Hartmann S, 1997, EUR J IMMUNOL, V27, P2253, DOI 10.1002/eji.1830270920; Hashmi S, 2002, J BIOL CHEM, V277, P3477, DOI 10.1074/jbc.M106117200; Hashmi S, 2004, J BIOL CHEM, V279, P6035, DOI 10.1074/jbc.M312346200; Henskens YMC, 1996, BIOL CHEM H-S, V377, P71; Iwasaki K, 1996, J CELL BIOL, V134, P699, DOI 10.1083/jcb.134.3.699; Janke DL, 1997, GENOME RES, V7, P974, DOI 10.1101/gr.7.10.974; Johnstone IL, 1996, EMBO J, V15, P3633, DOI 10.1002/j.1460-2075.1996.tb00732.x; Jokimaa V, 2001, MOL HUM REPROD, V7, P73, DOI 10.1093/molehr/7.1.73; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kestemont P, 1999, FISH PHYSIOL BIOCHEM, V21, P59, DOI 10.1023/A:1007714314072; KIMBLE J, 1983, DEV BIOL, V96, P189, DOI 10.1016/0012-1606(83)90322-6; KRAMER JM, 1990, MOL CELL BIOL, V10, P2081, DOI 10.1128/MCB.10.5.2081; Kwon JY, 2001, BIOL REPROD, V65, P1701, DOI 10.1095/biolreprod65.6.1701; LAH TT, 1989, BIOCHIM BIOPHYS ACTA, V993, P63, DOI 10.1016/0304-4165(89)90144-X; Lee M, 2001, J BIOL CHEM, V276, P36404, DOI 10.1074/jbc.M105795200; Liu XD, 1996, J BIOL CHEM, V271, P33344, DOI 10.1074/jbc.271.52.33344; Lustigman S, 1996, J BIOL CHEM, V271, P30181, DOI 10.1074/jbc.271.47.30181; Lustigman S, 2002, TRENDS PARASITOL, V18, P135, DOI 10.1016/S1471-4922(01)02211-5; LUSTIGMAN S, 1991, MOL BIOCHEM PARASIT, V45, P65, DOI 10.1016/0166-6851(91)90028-5; LUSTIGMAN S, 1992, J BIOL CHEM, V267, P17339; Lustigmana S, 2004, MOL BIOCHEM PARASIT, V138, P165, DOI 10.1016/j.molbiopara.2004.08.003; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; Manoury B, 2001, CURR BIOL, V11, P447, DOI 10.1016/S0960-9822(01)00118-X; McCarter J, 1997, DEV BIOL, V181, P121, DOI 10.1006/dbio.1996.8429; McCarter J, 1999, DEV BIOL, V205, P111, DOI 10.1006/dbio.1998.9109; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Miller DM, 1995, METHOD CELL BIOL, V48, P365; Miller MA, 2001, SCIENCE, V291, P2144, DOI 10.1126/science.1057586; Morales FC, 2004, MOL BIOCHEM PARASIT, V134, P65, DOI 10.1016/j.molbiopara.2003.10.016; Myers CD, 1996, J CELL BIOL, V132, P1061, DOI 10.1083/jcb.132.6.1061; Newlands GFJ, 2001, PARASITOLOGY, V122, P371, DOI 10.1017/S0031182001007302; Oksjoki S, 2001, MOL HUM REPROD, V7, P27, DOI 10.1093/molehr/7.1.27; Ono K, 2004, MOL BIOL CELL, V15, P2782, DOI 10.1091/mbc.E04-03-0179; OPRESKO LK, 1987, CELL, V51, P557, DOI 10.1016/0092-8674(87)90125-5; ORLOWSKI M, 1983, MOL CELL BIOCHEM, V52, P49; Peloille S, 1997, EUR J BIOCHEM, V244, P140, DOI 10.1111/j.1432-1033.1997.00140.x; Pfaff AW, 2002, INT J PARASITOL, V32, P171, DOI 10.1016/S0020-7519(01)00350-2; RAWLINGS ND, 1990, J MOL EVOL, V30, P60, DOI 10.1007/BF02102453; RETZEK H, 1992, DNA CELL BIOL, V11, P661, DOI 10.1089/dna.1992.11.661; RIBOLLA PEM, 1993, INSECT BIOCHEM MOLEC, V23, P217, DOI 10.1016/0965-1748(93)90002-A; Rose KL, 1997, DEV BIOL, V192, P59, DOI 10.1006/dbio.1997.8728; Saftig P, 2000, ADV EXP MED BIOL, V477, P293; SCHEDL T, 1997, C ELEGANS, V2, P241; Schierack P, 2003, INFECT IMMUN, V71, P2422, DOI 10.1128/IAI.71.5.2422-2429.2003; SHARROCK WJ, 1990, J BIOL CHEM, V265, P14422; SHARROCK WJ, 1984, J MOL BIOL, V174, P419, DOI 10.1016/0022-2836(84)90329-2; SHARROCK WJ, 1983, DEV BIOL, V96, P182, DOI 10.1016/0012-1606(83)90321-4; SLOANE BF, 1990, BIOL CHEM H-S, V371, P193; STOKA V, 1995, FEBS LETT, V370, P101, DOI 10.1016/0014-5793(95)00798-E; TAKAHASHI SY, 1993, J BIOCHEM, V114, P267, DOI 10.1093/oxfordjournals.jbchem.a124165; Tepel C, 2000, J CELL SCI, V113, P4487; Troeberg L, 1996, EUR J BIOCHEM, V238, P728, DOI 10.1111/j.1432-1033.1996.0728w.x; TURK V, 1991, FEBS LETT, V285, P213, DOI 10.1016/0014-5793(91)80804-C; WOESSNER S, 1991, Sangre (Saragossa), V36, P301; Woessner S, 1982, Sangre (Barc), V27, P739; Xu XJ, 2006, EXP CELL RES, V312, P1475, DOI 10.1016/j.yexcr.2006.01.006; YAMAMOTO Y, 1993, COMP BIOCHEM PHYS B, V106, P35, DOI 10.1016/0305-0491(93)90004-O; Yoshizaki N, 1998, DEV GROWTH DIFFER, V40, P659	89	18	26	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					28415	28429		10.1074/jbc.M600254200	http://dx.doi.org/10.1074/jbc.M600254200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16857685	hybrid			2022-12-27	WOS:000240534400079
J	Lopez, JJ; Salido, GM; Pariente, JA; Rosado, JA				Lopez, Jose J.; Salido, Gines M.; Pariente, Jose A.; Rosado, Juan A.			Interaction of STIM1 with endogenously expressed human canonical TRP1 upon depletion of intracellular Ca2+ stores	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPACITATIVE CALCIUM-ENTRY; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; HUMAN PLATELETS; ACTIN CYTOSKELETON; PLASMA-MEMBRANE; GENE FAMILY; CHANNELS; ACTIVATION; CELLS; SENSOR	STIM1 ((s) under bar tromal (i) under bar nteraction (m) under bar olecule (1) under bar) has recently been proposed to communicate the intracellular Ca2+ stores with the plasma membrane to mediate store-operated Ca2+ entry. Here we describe for the first time that Ca2+ store depletion stimulates rapid STIM1 surface expression and association with endogenously expressed human canonical TRP1 (hTRPC1) independently of rises in cytosolic free Ca2+ concentration. These events require the support of the actin cytoskeleton in human platelets, as reported for the coupling between type II inositol 1,4,5-trisphosphate receptor in the Ca2+ stores and hTRPC1 in the plasma membrane, which has been suggested to underlie the activation of store-operated Ca2+ entry in these cells. Electrotransjection of cells with anti-STIM1 antibody, directed toward the N-terminal sequence that includes the Ca2+- binding region, prevented the migration of STIM1 toward the plasma membrane, the interaction between STIM1 and hTRPC1, the coupling between hTRPC1 and type II inositol 1,4,5-trisphosphate receptor, and reduced store-operated Ca2+ entry. These findings provide evidence for a role of STIM1 in the activation of store- operated Ca2+ entry probably acting as a Ca2+ sensor.	Univ Extremadura, Dept Physiol, Cellular Physiol Res Grp, Caceres 10071, Spain	Universidad de Extremadura	Rosado, JA (corresponding author), Univ Extremadura, Dept Physiol, Cellular Physiol Res Grp, Caceres 10071, Spain.	jarosado@unex.es	Rosado, Juan A/H-3488-2015; Lopez, Jose J/F-4602-2016; Salido, Gines M/A-4292-2009	Rosado, Juan A/0000-0002-9749-2325; Lopez, Jose J/0000-0002-5234-1478; Salido, Gines M/0000-0002-8687-2445; PARIENTE, JOSE ANTONIO/0000-0002-9094-9943				Ben-Amor N, 2006, J PHYSIOL-LONDON, V570, P309, DOI 10.1113/jphysiol.2005.100800; Berridge Michael, 2004, Sci STKE, V2004, ppe33; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bolotina VM, 2005, TRENDS BIOCHEM SCI, V30, P378, DOI 10.1016/j.tibs.2005.05.009; Boulay G, 1999, P NATL ACAD SCI USA, V96, P14955, DOI 10.1073/pnas.96.26.14955; Brownlow SL, 2003, BIOCHEM J, V375, P697, DOI 10.1042/BJ20030929; CARNELLO C, 2000, CURR BIOL, V10, P161; CHAKRABARTI R, 1989, J BIOL CHEM, V264, P15494; DHAR A, 1994, J BIOL CHEM, V269, P9123; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Heemskerk JWM, 1997, EUR J BIOCHEM, V249, P547, DOI 10.1111/j.1432-1033.1997.00547.x; HISATSUNE C, 2005, SCI STKE, pPE53, DOI DOI 10.1126/STKE.3132005PE53; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Manji SSM, 2000, BBA-PROTEIN STRUCT M, V1481, P147, DOI 10.1016/S0167-4838(00)00105-9; Marchant JS, 2005, CURR BIOL, V15, pR493, DOI 10.1016/j.cub.2005.06.035; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Putney Jr JW, 2004, SCI STKE, ppe37; Putney JW, 2005, J CELL BIOL, V169, P381, DOI 10.1083/jcb.200503161; Putney JW, 1999, BIOESSAYS, V21, P38; Putney JW, 2001, J CELL SCI, V114, P2223; Putney JW, 1999, P NATL ACAD SCI USA, V96, P14669, DOI 10.1073/pnas.96.26.14669; Redondo PC, 2003, BIOCHEM J, V370, P255, DOI 10.1042/BJ20021505; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Rosado JA, 2000, BIOCHEM J, V351, P429, DOI 10.1042/0264-6021:3510429; Rosado JA, 2000, J BIOL CHEM, V275, P7527, DOI 10.1074/jbc.275.11.7527; Rosado JA, 2000, BIOCHEM J, V350, P631, DOI 10.1042/0264-6021:3500631; Rosado JA, 2000, BIOCHEM J, V347, P183, DOI 10.1042/0264-6021:3470183; Rosado JA, 2005, J CELL PHYSIOL, V205, P262, DOI 10.1002/jcp.20399; Rosado JA, 2002, J BIOL CHEM, V277, P42157, DOI 10.1074/jbc.M207320200; Rosado JA, 2001, BIOCHEM J, V356, P191, DOI 10.1042/0264-6021:3560191; SCRUTON MC, 1996, PRACT APPROACH SER, P47; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P4040, DOI 10.1073/pnas.0510050103; Stamboulian S, 2005, DEV BIOL, V286, P326, DOI 10.1016/j.ydbio.2005.08.006; Treves S, 2004, J CELL BIOL, V166, P537, DOI 10.1083/jcb.200404079; Williams RT, 2001, BIOCHEM J, V357, P673, DOI 10.1042/0264-6021:3570673; WILSON AK, 1991, AM J PHYSIOL, V260, pC355, DOI 10.1152/ajpcell.1991.260.2.C355; Xu SZ, 2001, CIRC RES, V88, P84, DOI 10.1161/01.RES.88.1.84; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zhu X, 1996, CELL, V85, P661, DOI 10.1016/S0092-8674(00)81233-7	42	172	175	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					28254	28264		10.1074/jbc.M604272200	http://dx.doi.org/10.1074/jbc.M604272200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16870612	hybrid			2022-12-27	WOS:000240534400063
J	Vauloup-Fellous, C; Pene, V; Garaud-Aunis, J; Harper, F; Bardin, S; Suire, Y; Pichard, E; Schmitt, A; Sogni, P; Pierron, G; Briand, P; Rosenberg, AR				Vauloup-Fellous, Christelle; Pene, Veronique; Garaud-Aunis, Julie; Harper, Francis; Bardin, Sabine; Suire, Yannick; Pichard, Evelyne; Schmitt, Alain; Sogni, Philippe; Pierron, Gerard; Briand, Pascale; Rosenberg, Arielle R.			Signal peptide peptidase-catalyzed cleavage of hepatitis C virus core protein is dispensable for virus budding but destabilizes the viral capsid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-GRADIENT CENTRIFUGATION; HCV-INFECTED PATIENTS; INTRAMEMBRANE PROTEOLYSIS; INSECT CELLS; STRUCTURAL PROTEINS; ION-CHANNEL; P7 PROTEIN; ENDOPLASMIC-RETICULUM; FUNCTIONAL-ANALYSIS; ASPARTIC PROTEASES	The capsid of hepatitis C virus (HCV) particles is considered to be composed of the mature form (p21) of core protein. Maturation to p21 involves cleavage of the transmembrane domain of the precursor form (p23) of core protein by signal peptide peptidase (SPP), a cellular protease embedded in the endoplasmic reticulum membrane. Here we have addressed whether SPP-catalyzed maturation to p21 is a prerequisite for HCV particle morphogenesis in the endoplasmic reticulum. HCV structural proteins were expressed by using recombinant Semliki Forest virus replicon in mammalian cells or recombinant baculovirus in insect cells, because these systems have been shown to allow the visualization of HCV budding events and the isolation of HCV-like particles, respectively. Inhibition of SPP-catalyzed cleavage of core protein by either an SPP inhibitor or HCV core mutations not only did not prevent but instead tended to facilitate the observation of viral buds and the recovery of virus-like particles. Remarkably, although maturation to p21 was only partially inhibited by mutations in insect cells, p23 was the only form of core protein found in HCV-like particles. Finally, newly developed assays demonstrated that p23 capsids are more stable than p21 capsids. These results show that SPP-catalyzed cleavage of core protein is dispensable for HCV budding but decreases the stability of the viral capsid. We propose a model in which p23 is the form of HCV core protein committed to virus assembly, and cleavage by SPP occurs during and/or after virus budding to predispose the capsid to subsequent disassembly in a new cell.	INSERM, Inst Cochin, Equipe AVENIR, F-75014 Paris, France; Univ Paris 11, Fac Med, APHP, Hop Antoine Beclere, F-92141 Clamart, France; CNRS, FRE 2937, Inst Andre Lwoff, F-94801 Villejuif, France; INSERM, U 567, CNRS, UMR 8104,Inst Cochin,Plateforme Microscopie Elect, F-75014 Paris, France; Univ Paris Descartes, Fac Med, APHP, Grp Hosp Cochin St Vincent Paul, F-75014 Paris, France; Univ Paris Descartes, Fac Med, APHP, Grp Hosp Cochin St Vincent Paul, F-75014 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Antoine-Beclere - APHP; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Rosenberg, AR (corresponding author), INSERM, Inst Cochin, Equipe AVENIR, F-75014 Paris, France.	arielle@cochin.inserm.fr	Vauloup-Fellous, Christelle/AAE-5567-2021; Vauloup-Fellous, Christelle/D-1333-2015; Vauloup-Fellous, Christelle/AAG-2302-2021	Vauloup-Fellous, Christelle/0000-0002-3674-5093; Rosenberg, Arielle/0000-0003-2085-8146				Andre P, 2002, J VIROL, V76, P6919, DOI 10.1128/JVI.76.14.6919-6928.2002; Barba G, 1997, P NATL ACAD SCI USA, V94, P1200, DOI 10.1073/pnas.94.4.1200; Baumert TF, 1999, GASTROENTEROLOGY, V117, P1397, DOI 10.1016/S0016-5085(99)70290-8; Baumert TF, 1998, J VIROL, V72, P3827, DOI 10.1128/JVI.72.5.3827-3836.1998; Blanchard E, 2003, J VIROL, V77, P10131, DOI 10.1128/JVI.77.18.10131-10138.2003; Blanchard E, 2002, J VIROL, V76, P4073, DOI 10.1128/JVI.76.8.4073-4079.2002; Bosman C, 1998, RES VIROLOGY, V149, P311, DOI 10.1016/S0923-2516(99)89011-6; Casso DJ, 2005, GENETICS, V170, P139, DOI 10.1534/genetics.104.039933; Clayton RF, 2002, J VIROL, V76, P7672, DOI 10.1128/JVI.76.15.7672-7682.2002; Crawshaw SG, 2004, BIOCHEM J, V384, P9, DOI 10.1042/BJ20041216; De Beeck AO, 2003, REV MED VIROL, V13, P233, DOI 10.1002/rmv.391; DUBUISSON J, 1994, J VIROL, V68, P6147, DOI 10.1128/JVI.68.10.6147-6160.1994; Elbers K, 1996, J VIROL, V70, P4131, DOI 10.1128/JVI.70.6.4131-4135.1996; Falcon V, 2005, BIOCHEM BIOPH RES CO, V329, P1320, DOI 10.1016/j.bbrc.2005.02.107; FLINT SJ, 2003, PRINCIPLES VIROLOGY, P450; Forshey BM, 2002, J VIROL, V76, P5667, DOI 10.1128/JVI.76.11.5667-5677.2002; Friedmann E, 2004, J BIOL CHEM, V279, P50790, DOI 10.1074/jbc.M407898200; Girard C, 2004, J GEN VIROL, V85, P3659, DOI 10.1099/vir.0.79909-0; Griffin SDC, 2004, J GEN VIROL, V85, P451, DOI 10.1099/vir.0.19634-0; Griffin SDC, 2003, FEBS LETT, V535, P34, DOI 10.1016/S0014-5793(02)03851-6; Heimann M, 2006, J VIROL, V80, P1915, DOI 10.1128/JVI.80.4.1915-1921.2006; HELENIUS A, 1992, CELL, V69, P577, DOI 10.1016/0092-8674(92)90219-3; Hope RG, 2000, J GEN VIROL, V81, P1913, DOI 10.1099/0022-1317-81-8-1913; Hussy P, 1996, VIROLOGY, V224, P93, DOI 10.1006/viro.1996.0510; Ishida S, 2001, HEPATOL RES, V20, P335, DOI 10.1016/S1386-6346(01)00080-8; KANTO T, 1994, HEPATOLOGY, V19, P296; Kato T, 2004, HEPATOL RES, V30, P204, DOI 10.1016/j.hepres.2004.10.002; Kewalramani VN, 1996, VIROLOGY, V218, P159, DOI 10.1006/viro.1996.0176; Klein KC, 2004, J VIROL, V78, P9257, DOI 10.1128/JVI.78.17.9257-9269.2004; Kobayashi M, 2006, J VIROL, V80, P1817, DOI 10.1128/JVI.80.4.1817-1825.2006; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LANZREIN M, 1994, BIOCHEM J, V302, P313, DOI 10.1042/bj3020313; Lavillette D, 2006, J BIOL CHEM, V281, P3909, DOI 10.1074/jbc.M509747200; Lemberg MK, 2003, ANAL BIOCHEM, V319, P327, DOI 10.1016/S0003-2697(03)00298-7; Lemberg MK, 2002, MOL CELL, V10, P735, DOI 10.1016/S1097-2765(02)00655-X; Lemberg MK, 2001, J IMMUNOL, V167, P6441, DOI 10.4049/jimmunol.167.11.6441; LILJESTROM P, 1991, BIO-TECHNOL, V9, P1356, DOI 10.1038/nbt1291-1356; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; LINDENBACH BD, 2001, FIELDS VIROLOGY, V1, P991; Liu QY, 1997, J VIROL, V71, P657, DOI 10.1128/JVI.71.1.657-662.1997; MacKenzie JM, 2001, J VIROL, V75, P10787, DOI 10.1128/JVI.75.22.10787-10799.2001; Majeau N, 2005, J GEN VIROL, V86, P3055, DOI 10.1099/vir.0.81174-0; Martoglio B, 2003, HUM MOL GENET, V12, pR201, DOI 10.1093/hmg/ddg303; McLauchlan J, 2000, J VIRAL HEPATITIS, V7, P2; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; MIYAMOTO H, 1992, J GEN VIROL, V73, P715, DOI 10.1099/0022-1317-73-3-715; Moliaka YK, 2004, FEBS LETT, V557, P185, DOI 10.1016/S0014-5793(03)01489-3; Moradpour D, 1996, VIROLOGY, V222, P51, DOI 10.1006/viro.1996.0397; Mukhopadhyay S, 2002, J VIROL, V76, P11128, DOI 10.1128/JVI.76.21.11128-11132.2002; Nielsen SU, 2004, J GEN VIROL, V85, P1497, DOI 10.1099/vir.0.79967-0; Ogino T, 2004, J VIROL, V78, P11766, DOI 10.1128/JVI.78.21.11766-11777.2004; Okamoto K, 2004, J VIROL, V78, P6370, DOI 10.1128/JVI.78.12.6370-6380.2004; Okuda M, 2002, GASTROENTEROLOGY, V122, P366, DOI 10.1053/gast.2002.30983; Owsianka A, 2001, J GEN VIROL, V82, P1877, DOI 10.1099/0022-1317-82-8-1877; PARK J, 1993, VIROLOGY, V194, P843, DOI 10.1006/viro.1993.1328; Pavlovic D, 2003, P NATL ACAD SCI USA, V100, P6104, DOI 10.1073/pnas.1031527100; Petit MA, 2005, VIROLOGY, V336, P144, DOI 10.1016/j.virol.2005.03.023; Pietschmann T, 2002, J VIROL, V76, P4008, DOI 10.1128/JVI.76.8.4008-4021.2002; Schwer B, 2004, J VIROL, V78, P7958, DOI 10.1128/JVI.78.15.7958-7968.2004; Shimizu YK, 1996, HEPATOLOGY, V23, P205; TAKAHASHI K, 1992, VIROLOGY, V191, P431, DOI 10.1016/0042-6822(92)90204-3; Thomssen R, 2002, MED MICROBIOL IMMUN, V191, P17, DOI 10.1007/s00430-001-0106-x; Tscherne DM, 2006, J VIROL, V80, P1734, DOI 10.1128/JVI.80.4.1734-1741.2006; Urny J, 2003, GENE EXPR PATTERNS, V3, P685, DOI 10.1016/S1567-133X(03)00094-2; Vogt VM, 1996, CURR TOP MICROBIOL, V214, P95; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Weihofen A, 2003, J BIOL CHEM, V278, P16528, DOI 10.1074/jbc.M301372200; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Wu CM, 2004, BIOCHEM BIOPH RES CO, V322, P585, DOI 10.1016/j.bbrc.2004.07.160; Yasui K, 1998, J VIROL, V72, P6048, DOI 10.1128/JVI.72.7.6048-6055.1998; Yi M, 2006, P NATL ACAD SCI USA, V103, P2310, DOI 10.1073/pnas.0510727103; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	72	34	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					27679	27692		10.1074/jbc.M602587200	http://dx.doi.org/10.1074/jbc.M602587200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16849324	hybrid			2022-12-27	WOS:000240534400004
J	Gruegelsiepe, H; Brandt, O; Hartmann, RK				Gruegelsiepe, Heike; Brandt, Ole; Hartmann, Roland K.			Antisense inhibition of RNase P - Mechanistic aspects and application to live bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; GENE-EXPRESSION; RIBONUCLEASE-P; M1 RNA; OLIGONUCLEOTIDES; HYBRIDIZATION; PEPTIDES; POTENT	We explored bacterial RNase P as a drug target using antisense oligomers against the P15 loop region of Escherichia coli RNase P RNA. An RNA 14-mer, or locked nucleic acid (LNA) and peptide nucleic acid (PNA) versions thereof, disrupted local secondary structure in the catalytic core, forming hybrid duplexes over their entire length. Binding of the PNA and LNA 14-mers to RNase PRNA in vitro was essentially irreversible and even resisted denaturing PAGE. Association rates for the RNA, LNA, and PNA 14-mers were similar to 10(5) M-1 s(-1) with a rate advantage for PNA and were thus rather fast despite the need to disrupt local structure. Conjugates in which the PNA 14-mer was coupled to an invasive peptide via a novel monoglycine linker showed RNase P RNA-specific growth inhibition of E. coli cells. Cell growth could be rescued when expressing a second bacterial RNase P RNA with an unrelated sequence in the target region. We report here for the first time specific and growth-inhibitory drug targeting of RNase P in live bacteria. This is also the first example of a duplex-forming oligomer that invades a structured catalytic RNA and inactivates the RNA by (i) trapping it in a state in which the catalytic core is partially unfolded, (ii) sterically interfering with substrate binding, and (iii) perturbing the coordination of catalytically relevant Mg2+ ions.	Univ Marburg, Inst Pharmazeut Chem, D-35037 Marburg, Germany; Deutsch Krebsforschungszentrum, Dept Funct Genome Anal, D-69120 Heidelberg, Germany	Philipps University Marburg; Helmholtz Association; German Cancer Research Center (DKFZ)	Hartmann, RK (corresponding author), Univ Marburg, Inst Pharmazeut Chem, Marbacher Weg 6, D-35037 Marburg, Germany.	roland.hartmann@staff.uni-marburg.de						Brandt O, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng120; Brannvall M, 2003, J MOL BIOL, V325, P697, DOI 10.1016/S0022-2836(02)01195-6; Childs JL, 2002, P NATL ACAD SCI USA, V99, P11091, DOI 10.1073/pnas.172391199; Childs JL, 2003, RNA, V9, P1437, DOI 10.1261/rna.5780503; Dias N, 2002, J MOL BIOL, V320, P489, DOI 10.1016/S0022-2836(02)00474-6; Dong HJ, 1996, J MOL BIOL, V261, P303, DOI 10.1006/jmbi.1996.0461; Eckardt S, 1997, BIOCHEMISTRY-US, V36, P12711, DOI 10.1021/bi9707234; EGHOLM M, 1993, NATURE, V365, P566, DOI 10.1038/365566a0; Elayadi AN, 2002, BIOCHEMISTRY-US, V41, P9973, DOI 10.1021/bi025907j; Frank DN, 1998, ANNU REV BIOCHEM, V67, P153, DOI 10.1146/annurev.biochem.67.1.153; Geller BL, 2003, ANTIMICROB AGENTS CH, V47, P3233, DOI 10.1128/AAC.47.10.3233-3239.2003; Good L, 2001, NAT BIOTECHNOL, V19, P360, DOI 10.1038/86753; Good L, 1998, P NATL ACAD SCI USA, V95, P2073, DOI 10.1073/pnas.95.5.2073; Gruegelsiepe H, 2003, CHEMBIOCHEM, V4, P1049, DOI 10.1002/cbic.200300675; HARDT WD, 1993, NUCLEIC ACIDS RES, V21, P3521, DOI 10.1093/nar/21.15.3521; KIRSEBOM LA, 1994, EMBO J, V13, P4870, DOI 10.1002/j.1460-2075.1994.tb06814.x; Kolb FA, 2000, EMBO J, V19, P5905, DOI 10.1093/emboj/19.21.5905; Kurreck J, 2003, EUR J BIOCHEM, V270, P1628, DOI 10.1046/j.1432-1033.2003.03555.x; Nekhotiaeva N, 2004, MOL THER, V10, P652, DOI 10.1016/j.ymthe.2004.07.006; Nielsen KE, 2004, BIOCONJUGATE CHEM, V15, P449, DOI 10.1021/bc034145h; Rebuffat AG, 2002, FASEB J, V16, P1426, DOI 10.1096/fj.01-0706fje; Schmidt KS, 2004, NUCLEIC ACIDS RES, V32, P5757, DOI 10.1093/nar/gkh862; SEKIGUCHI M, 1967, P NATL ACAD SCI USA, V58, P2315, DOI 10.1073/pnas.58.6.2315; Singh SK, 1998, CHEM COMMUN, P1247, DOI 10.1039/a801571f; SMITH D, 1992, J BIOL CHEM, V267, P2429; Tackett AJ, 2002, NUCLEIC ACIDS RES, V30, P950, DOI 10.1093/nar/30.4.950; Tomac S, 1996, J AM CHEM SOC, V118, P5544, DOI 10.1021/ja960495l; Turner JJ, 2005, NUCLEIC ACIDS RES, V33, P27, DOI 10.1093/nar/gki142; Vaara M, 1996, ANTIMICROB AGENTS CH, V40, P1801, DOI 10.1128/AAC.40.8.1801; Wahlestedt C, 2000, P NATL ACAD SCI USA, V97, P5633, DOI 10.1073/pnas.97.10.5633; WAUGH DS, 1990, J BACTERIOL, V172, P6316, DOI 10.1128/jb.172.11.6316-6322.1990; Wegscheid B, 2006, EMBO REP, V7, P411, DOI 10.1038/sj.embor.7400641; Willkomm DK, 2003, CHEMBIOCHEM, V4, P1041, DOI 10.1002/cbic.200300674; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	35	35	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30613	30620		10.1074/jbc.M603346200	http://dx.doi.org/10.1074/jbc.M603346200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16901906	Green Published, hybrid			2022-12-27	WOS:000241075900037
J	Hoff, RH; Czyryca, PG; Sun, MH; Leyh, TS; Hengge, AC				Hoff, Richard H.; Czyryca, Przemyslaw G.; Sun, Meihao; Leyh, Thomas S.; Hengge, Alvan C.			Transition state of the sulfuryl transfer reaction of estrogen sulfotransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; SULFATE ESTERS; HYDROLYSIS; NITROPHENYL; PHOSPHORYL; SUBSTRATE; MECHANISM	Kinetic isotope effects have been measured for the estrogen sulfotransferase-catalyzed sulfuryl (SO3) transfer from p-nitrophenyl sulfate to the 5'-phosphoryl group of 3'-phosphoadenosine 5'-phosphate. (18)(V/K)(nonbridge) = 1.0016 +/- 0.0005, (18)(V/K) bridge = 1.0280 +/- 0.0006, and 15(V/K) = 1.0014 +/- 0.0004. ((15)(V/K) refers to the nitro group in p-nitrophenyl sulfate). The kinetic isotope effects indicate substantial S - O bond fission in the transition state, with partial charge neutralization of the leaving group. The small kinetic isotope effect in the nonbridging sulfuryl oxygen atoms suggests no significant change in bond orders of these atoms occurs, consistent with modest nucleophilic involvement. A comparison of the data for enzymatic and uncatalyzed sulfuryl transfer reactions suggests that both proceed through very similar transition states.	Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; US Mil Acad, Dept Chem & Life Sci, West Point, NY 10996 USA; Utah State Univ, Dept Chem & Biochem, Logan, UT 84322 USA	Yeshiva University; Albert Einstein College of Medicine; United States Department of Defense; United States Army; United States Military Academy; Utah System of Higher Education; Utah State University	Leyh, TS (corresponding author), Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA.	leyh@aecom.yu.edu; hengge@cc.usu.edu	Hengge, Alvan C/C-8667-2011	Hengge, Alvan C/0000-0002-5696-2087	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054469, R01GM056248, R29GM047297, R01GM047297] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM056248, GM054469, R01 GM047297, GM47297] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson MA, 2001, J AM CHEM SOC, V123, P9246, DOI 10.1021/ja011025g; BADDILEY J, 1958, J CHEM SOC, P1000, DOI 10.1039/jr9580001000; BAUMANN E, 1876, BER DTSCH CHEM GES, V9, P54, DOI DOI 10.1002/(ISSN)1099-0682; BEDFORD CT, 1995, BIOORGAN MED CHEM, V3, P167, DOI 10.1016/0968-0896(95)00015-9; BENKOVIC SJ, 1966, J AM CHEM SOC, V88, P5504, DOI 10.1021/ja00975a026; Bidwell LM, 1999, J MOL BIOL, V293, P521, DOI 10.1006/jmbi.1999.3153; BOURNE N, 1985, J AM CHEM SOC, V107, P4327, DOI 10.1021/ja00300a042; Chapman E, 2003, P NATL ACAD SCI USA, V100, P910, DOI 10.1073/pnas.0337638100; Dajani R, 1999, J BIOL CHEM, V274, P37862, DOI 10.1074/jbc.274.53.37862; DROZARIO P, 1984, J AM CHEM SOC, V106, P5027, DOI 10.1021/ja00329a078; FENDLER EJ, 1968, J ORG CHEM, V33, P3852, DOI 10.1021/jo01274a035; Gibby SG, 2004, J PHYS ORG CHEM, V17, P541, DOI 10.1002/poc.775; Hengge AC, 2002, ACCOUNTS CHEM RES, V35, P105, DOI 10.1021/ar000143q; HENGGE AC, 1995, J AM CHEM SOC, V117, P5919, DOI 10.1021/ja00127a003; HENGGE AC, 1994, J AM CHEM SOC, V116, P11256, DOI 10.1021/ja00104a007; HENGGE AC, 1995, BIOCHEMISTRY-US, V34, P13982, DOI 10.1021/bi00043a003; Hengge AC, 1996, BIOCHEMISTRY-US, V35, P7084, DOI 10.1021/bi960255i; Hoff RH, 2001, J AM CHEM SOC, V123, P9338, DOI 10.1021/ja0163974; HOPKINS A, 1983, J AM CHEM SOC, V105, P6062, DOI 10.1021/ja00357a017; Kakuta Y, 1997, NAT STRUCT BIOL, V4, P904, DOI 10.1038/nsb1197-904; Kakuta Y, 1998, J BIOL CHEM, V273, P27325, DOI 10.1074/jbc.273.42.27325; Marlier JF, 2001, ACCOUNTS CHEM RES, V34, P283, DOI 10.1021/ar000054d; Northrop D. B., 1977, ISOTOPE EFFECTS ENZY, P122; OLEARY MH, 1979, J AM CHEM SOC, V101, P3300, DOI 10.1021/ja00506a027; Pedersen LC, 2000, FEBS LETT, V475, P61, DOI 10.1016/S0014-5793(00)01479-4; ROBBINS PW, 1956, J AM CHEM SOC, V78, P2652, DOI 10.1021/ja01592a097; Zhang HP, 1998, J BIOL CHEM, V273, P10888, DOI 10.1074/jbc.273.18.10888	27	16	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30645	30649		10.1074/jbc.M604205200	http://dx.doi.org/10.1074/jbc.M604205200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16899461	hybrid			2022-12-27	WOS:000241075900040
J	Iwai, S; Hanamoto, D; Chaen, S				Iwai, Sosuke; Hanamoto, Daisuke; Chaen, Shigeru			A point mutation in the SH1 helix alters elasticity and thermal stability of myosin II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAVY-CHAIN; DICTYOSTELIUM-DISCOIDEUM; ATP HYDROLYSIS; MOTOR DOMAIN; IN-VITRO; ACTIN; MYH9; SUBFRAGMENT-1; FECHTNER; MOVEMENT	Movement generated by the myosin motor is generally thought to be driven by distortion of an elastic element within the myosin molecule and subsequent release of the resulting strain. However, the location of this elastic element in myosin remains unclear. The myosin motor domain consists of four major subdomains connected by flexible joints. The SH1 helix is the joint that connects the converter subdomain to the other domains, and is thought to play an important role in arrangements of the converter relative to the motor. To investigate the involvement of the SH1 helix in elastic distortion in myosin, we have introduced a point mutation into the SH1 helix of Dictyostelium myosin II (R689H), which in human nonmuscle myosin IIA causes nonsyndromic hereditary deafness, DFNA17. The mutation resulted in a significant impairment in motile activities, whereas actin-activated ATPase activity was only slightly affected. Single molecule mechanical measurements using optical trap showed that the step size was not shortened by the mutation, suggesting that the slower motility is caused by altered kinetics. The single molecule measurements demonstrated that the mutation significantly reduced cross-bridge stiffness. Motile activities produced by mixtures of wild-type and mutant myosins also suggested that the mutation affected the elasticity of myosin. These results suggest that the SH1 helix is involved in modulation of myosin elasticity, presumably by modulating the converter flexibility. Consistent with this, the mutation was also shown to reduce thermal stability and induce thermal aggregation of the protein, which might be implicated in the disease process.	Nihon Univ, Dept Integrated Sci Phys & Biol, Coll Humanities & Sci, Setagaya Ku, Tokyo 1568550, Japan	Nihon University	Chaen, S (corresponding author), Nihon Univ, Dept Integrated Sci Phys & Biol, Coll Humanities & Sci, Setagaya Ku, 3-25-40 Sakurajousui, Tokyo 1568550, Japan.	chaen@phys.chs.nihon-u.ac.jp		Iwai, Sosuke/0000-0002-0794-9767				Baker JE, 2002, BIOPHYS J, V82, P2134, DOI 10.1016/S0006-3495(02)75560-4; BURKE M, 1977, BIOCHEMISTRY-US, V16, P5559, DOI 10.1021/bi00644a026; Chaen S, 1996, J BIOCHEM-TOKYO, V120, P788; CLARKE M, 1974, J MOL BIOL, V86, P209, DOI 10.1016/0022-2836(74)90013-8; Cuda G, 1997, BIOPHYS J, V72, P1767, DOI 10.1016/S0006-3495(97)78823-4; del Pino IMP, 2000, PROTEINS, V40, P58, DOI 10.1002/(SICI)1097-0134(20000701)40:1<58::AID-PROT80>3.0.CO;2-M; DELOZANNE A, 1987, SCIENCE, V236, P1086, DOI 10.1126/science.3576222; DELOZANNE A, 1985, P NATL ACAD SCI USA, V82, P6807, DOI 10.1073/pnas.82.20.6807; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; FISHER AJ, 1995, BIOCHEMISTRY-US, V34, P8960, DOI 10.1021/bi00028a004; Franke JD, 2005, BLOOD, V105, P161, DOI 10.1182/blood-2004-06-2067; Geeves MA, 1999, ANNU REV BIOCHEM, V68, P687, DOI 10.1146/annurev.biochem.68.1.687; HARRIS DE, 1994, J MUSCLE RES CELL M, V15, P11, DOI 10.1007/BF00123828; Heath KE, 2001, AM J HUM GENET, V69, P1033, DOI 10.1086/324267; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Himmel DM, 2002, P NATL ACAD SCI USA, V99, P12645, DOI 10.1073/pnas.202476799; Houdusse A, 1999, CELL, V97, P459, DOI 10.1016/S0092-8674(00)80756-4; HOUK TW, 1974, ANAL BIOCHEM, V62, P66, DOI 10.1016/0003-2697(74)90367-4; Howard J., 2001, MECH MOTOR PROTEINS; Hu AH, 2002, J BIOL CHEM, V277, P46512, DOI 10.1074/jbc.M208506200; HUXLEY AF, 1957, PROG BIOPHYS MOL BIO, V7, P255, DOI 10.1016/S0096-4174(18)30128-8; Ito K, 2003, J BIOL CHEM, V278, P31049, DOI 10.1074/jbc.M304138200; Kelley MJ, 2000, NAT GENET, V26, P106, DOI 10.1038/79069; KODAMA T, 1986, J BIOCHEM-TOKYO, V99, P1465, DOI 10.1093/oxfordjournals.jbchem.a135616; Kohler J, 2002, P NATL ACAD SCI USA, V99, P3557, DOI 10.1073/pnas.062415899; Kunishima S, 2003, LAB INVEST, V83, P115, DOI 10.1097/01.LAB.0000050960.48774.17; Kunishima S, 2001, BLOOD, V97, P1147, DOI 10.1182/blood.V97.4.1147; Kurganov BI, 2002, BIOCHEMISTRY-MOSCOW+, V67, P409, DOI 10.1023/A:1015277805345; Lalwani AK, 2000, AM J HUM GENET, V67, P1121, DOI 10.1016/S0002-9297(07)62942-5; Liu X, 2000, BIOCHEM BIOPH RES CO, V271, P75, DOI 10.1006/bbrc.2000.2582; MOLLOY JE, 1995, NATURE, V378, P209, DOI 10.1038/378209a0; Palmiter KA, 1999, J PHYSIOL-LONDON, V519, P669, DOI 10.1111/j.1469-7793.1999.0669n.x; PARDEE JD, 1982, METHOD CELL BIOL, V24, P271; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; RITCHIE MD, 1993, P NATL ACAD SCI USA, V90, P8619, DOI 10.1073/pnas.90.18.8619; RUPPEL KM, 1994, J BIOL CHEM, V269, P18773; Sasaki N, 2003, BIOCHEMISTRY-US, V42, P90, DOI 10.1021/bi026051l; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; Seri M, 2000, NAT GENET, V26, P103; SERI M, 2001, MED BALTIMORE, V82, P203; SMITH CA, 1995, BIOCHEMISTRY-US, V34, P8973, DOI 10.1021/bi00028a005; SPUDICH JA, 1994, NATURE, V372, P515, DOI 10.1038/372515a0; Uyeda TQP, 2002, BIOCHEMISTRY-US, V41, P9525, DOI 10.1021/bi026177i; Veigel C, 1998, BIOPHYS J, V75, P1424, DOI 10.1016/S0006-3495(98)74061-5; WELLS JA, 1980, J BIOL CHEM, V255, P1135	45	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30736	30744		10.1074/jbc.M605365200	http://dx.doi.org/10.1074/jbc.M605365200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16901894	hybrid			2022-12-27	WOS:000241075900050
J	Orsi, A; Fioriti, L; Chiesa, R; Sitia, R				Orsi, Andrea; Fioriti, Luana; Chiesa, Roberto; Sitia, Roberto			Conditions of endoplasmic reticulum stress favor the accumulation of cytosolic prion protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED-PROTEIN; TRANSMEMBRANE FORM; ER STRESS; MESSENGER-RNA; TRANSLOCATION; XBP1; PRP; SIGNAL; ATF6; DEGRADATION	After signal sequence-dependent targeting to the endoplasmic reticulum (ER), prion protein (PrP) undergoes several post-translational modifications, including glycosylation, disulfide bond formation, and the addition of a glycosylphosphatidylinositol anchor. As a result, multiple isoforms are generated. Because of the intrinsic weakness of the PrP signal sequence, a fraction of newly synthesized molecules fails to translocate and localizes to the cytosol. The physiopathologic role of this cytosolic isoform is still being debated. Here we have shown that, in both cultured cell lines and primary neurons, ER stress conditions weaken PrP co-translational translocation, favoring accumulation of aggregation-prone cytosolic species, which retain the signal sequence but lack N-glycans and disulfides. Inhibition of pro-teasomes further increases the levels of cytosolic PrP. Overexpression of spliced XBP1 facilitates ER translocation, suggesting that downstream elements of the Ire1-XBP1 pathway are involved in PrP targeting. These studies reveal a link between ER stress and the formation of cytosolic PrP isoforms potentially endowed with novel signaling or cytotoxic functions.	Univ Vita Salute San Raffaele, DIBIT, Ist Sci San Raffaele, I-20132 Milan, Italy; Dulbecco Telethon Inst, I-20157 Milan, Italy; Ist Ric Farmacol Mario Negri, I-20157 Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Fondazione Telethon; Dulbecco Telethon Institute (DTI); Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Sitia, R (corresponding author), Univ Vita Salute San Raffaele, DIBIT, Ist Sci San Raffaele, Via Olgettina 58, I-20132 Milan, Italy.	r.sitia@hsr.it	Sitia, Roberto/AAB-5005-2019; Longo, Kenneth A/A-5631-2010; Fioriti, Luana/AAN-7207-2021; Chiesa, Roberto/G-1561-2017	Sitia, Roberto/0000-0001-7086-4152; Chiesa, Roberto/0000-0002-3842-3733; Orsi, Andrea/0000-0003-2839-1640; fioriti, luana/0000-0003-2429-8967	Telethon [TCP00083] Funding Source: Medline	Telethon(Fondazione Telethon)		Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Brodsky JL, 1998, INT REV CYTOL, V178, P277; BRODSKY JL, 1995, P NATL ACAD SCI USA, V92, P9643, DOI 10.1073/pnas.92.21.9643; Capellari S, 1999, J BIOL CHEM, V274, P34846, DOI 10.1074/jbc.274.49.34846; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; CAUGHEY B, 1989, J VIROL, V63, P175, DOI 10.1128/JVI.63.1.175-181.1989; Cenci S, 2006, EMBO J, V25, P1104, DOI 10.1038/sj.emboj.7601009; Chiesa R, 2001, NEUROBIOL DIS, V8, P743, DOI 10.1006/nbdi.2001.0433; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; DeArmond SJ, 1999, J NEUROPATH EXP NEUR, V58, P1000, DOI 10.1097/00005072-199909000-00010; Drisaldi B, 2003, J BIOL CHEM, V278, P21732, DOI 10.1074/jbc.M213247200; ENDO T, 1989, BIOCHEMISTRY-US, V28, P8380, DOI 10.1021/bi00447a017; Fioriti L, 2005, J BIOL CHEM, V280, P11320, DOI 10.1074/jbc.M412441200; Fons RD, 2003, J CELL BIOL, V160, P529, DOI 10.1083/jcb.200210095; Forman MS, 2003, TRENDS NEUROSCI, V26, P407, DOI 10.1016/S0166-2236(03)00197-8; Gass JN, 2002, J BIOL CHEM, V277, P49047, DOI 10.1074/jbc.M205011200; Gewurz BE, 2002, J BIOL CHEM, V277, P11306, DOI 10.1074/jbc.M107904200; Grenier C, 2006, J NEUROCHEM, V97, P1456, DOI 10.1111/j.1471-4159.2006.03837.x; Hegde RS, 1998, SCIENCE, V279, P827, DOI 10.1126/science.279.5352.827; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kim SJ, 2001, J BIOL CHEM, V276, P26132, DOI 10.1074/jbc.M101638200; Lee AH, 2003, P NATL ACAD SCI USA, V100, P9946, DOI 10.1073/pnas.1334037100; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; LEHMANN S, 1995, J BIOL CHEM, V270, P24589, DOI 10.1074/jbc.270.41.24589; Ma JY, 2002, SCIENCE, V298, P1781, DOI 10.1126/science.1073725; Ma JY, 2002, SCIENCE, V298, P1785, DOI 10.1126/science.1073619; Ma JY, 2001, P NATL ACAD SCI USA, V98, P14955, DOI 10.1073/pnas.011578098; Menendez-Benito V, 2005, HUM MOL GENET, V14, P2787, DOI 10.1093/hmg/ddi312; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Nozaki J, 2004, GENES CELLS, V9, P261, DOI 10.1111/j.1356-9597.2004.00721.x; OOI CE, 1992, CELL, V71, P87, DOI 10.1016/0092-8674(92)90268-H; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; RAMBOLD AS, 2006, MOL BIOL CELL; Rane NS, 2004, EMBO J, V23, P4550, DOI 10.1038/sj.emboj.7600462; Roucou X, 2005, CELL DEATH DIFFER, V12, P783, DOI 10.1038/sj.cdd.4401629; Roucou X, 2003, J BIOL CHEM, V278, P40877, DOI 10.1074/jbc.M306177200; Rudd PM, 1999, P NATL ACAD SCI USA, V96, P13044, DOI 10.1073/pnas.96.23.13044; SANDERS SL, 1992, CELL, V69, P353, DOI 10.1016/0092-8674(92)90415-9; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Stewart RS, 2005, J NEUROSCI, V25, P3469, DOI 10.1523/JNEUROSCI.0105-05.2005; Stewart RS, 2003, J BIOL CHEM, V278, P45960, DOI 10.1074/jbc.M307833200; Stewart RS, 2001, MOL BIOL CELL, V12, P881, DOI 10.1091/mbc.12.4.881; Stimson E, 1999, BIOCHEMISTRY-US, V38, P4885, DOI 10.1021/bi982330q; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Tirosh B, 2005, J EXP MED, V202, P505, DOI 10.1084/jem.20050575; Tirosh B, 2005, J VIROL, V79, P2768, DOI 10.1128/JVI.79.5.2768-2779.2005; VONHEIJNE G, 1991, J BIOL CHEM, V266, P15240; Wang XH, 2005, J BIOL CHEM, V280, P317, DOI 10.1074/jbc.M410649200; Weissmann C, 2004, NAT REV MICROBIOL, V2, P861, DOI 10.1038/nrmicro1025; Yedidia Y, 2001, EMBO J, V20, P5383, DOI 10.1093/emboj/20.19.5383; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2003, DEV CELL, V4, P265, DOI 10.1016/S1534-5807(03)00022-4	58	86	88	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30431	30438		10.1074/jbc.M605320200	http://dx.doi.org/10.1074/jbc.M605320200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16908519	hybrid			2022-12-27	WOS:000241075900017
J	Prickett, TD; Brautigan, DL				Prickett, Todd D.; Brautigan, David L.			The alpha 4 regulatory subunit exerts opposing allosteric effects on protein phosphatases PP6 and PP2A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTITUMOR DRUG FOSTRIECIN; CATALYTIC SUBUNIT; SERINE/THREONINE PHOSPHATASES; OKADAIC ACID; CRYSTAL-STRUCTURE; 2A; BINDING; TOR; PURIFICATION; ASSOCIATION	The protein Ser/Thr phosphatase family contains three enzymes called PP2A, PP4, and PP6 with separate biological functions inferred from genetics of the yeast homologues Pph21/22, Pph3, and Sit4. These catalytic subunits associate with a common subunit called alpha 4 ( related to yeast Tap42). Here, we characterized recombinant PP6 and PP2A catalytic monomers and alpha 4(.)phosphatase heterodimers. Monomeric PP6 and PP2A showed identical kinetics using either p-nitrophenyl phosphate (pNPP) or P-32-myelin basic protein (MBP) as substrates, with matching K-m and V-max values. Using pNPP as substrate, PP6 and PP2A gave the same IC50 with active site inhibitors okadaic acid, microcystin-LR, calyculin A, and cantharidin. However, with MBP as substrate, PP6 was inhibited at 5-fold lower concentrations of toxins relative to PP2A, suggesting PP6 might be a preferred in vivo target of toxins. Heterodimeric alpha 4(.)PP6 and alpha 4(.)PP2A were starkly different. With MBP as substrate the alpha 4(.)PP2A heterodimer had a 100-fold higher Vmax than alpha 4(.)PP6, and neither heterodimer was active with pNPP. Thus, these phosphatases are distinguished by their different responses to allosteric binding of the common regulatory subunit alpha 4. Transient expression of alpha 4 differentially increased or decreased phosphorylation of endogenous phosphoproteins, consistent with opposing effects on PP2A and PP6.	Univ Virginia, Sch Med, Ctr Cell Signaling, Charlottesville, VA 22908 USA; Univ Virginia, Sch Med, Dept Microbiol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia	Brautigan, DL (corresponding author), Univ Virginia, Sch Med, Ctr Cell Signaling, Charlottesville, VA 22908 USA.	db8g@virginia.edu			NATIONAL CANCER INSTITUTE [R01CA077584] Funding Source: NIH RePORTER; NCI NIH HHS [CA-77584] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bastians H, 1996, J CELL SCI, V109, P2865; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; Brautigan DL, 2005, BIOCHEMISTRY-US, V44, P11067, DOI 10.1021/bi0508845; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; Chen J, 1998, BIOCHEM BIOPH RES CO, V247, P827, DOI 10.1006/bbrc.1998.8792; Chung HY, 1999, BIOCHEMISTRY-US, V38, P10371, DOI 10.1021/bi990902g; Cohen PTW, 1997, TRENDS BIOCHEM SCI, V22, P245, DOI 10.1016/S0968-0004(97)01060-8; Evans DRH, 2001, FEBS LETT, V498, P110, DOI 10.1016/S0014-5793(01)02448-6; Gallego M, 2005, CURR OPIN CELL BIOL, V17, P197, DOI 10.1016/j.ceb.2005.01.002; Gauss CM, 1997, BIOORGAN MED CHEM, V5, P1751, DOI 10.1016/S0968-0896(97)00145-4; GOLDBERG J, 1995, NATURE, V376, P745, DOI 10.1038/376745a0; Goldberg Y, 1999, BIOCHEM PHARMACOL, V57, P321, DOI 10.1016/S0006-2952(98)00245-7; Hastie CJ, 1998, FEBS LETT, V431, P357, DOI 10.1016/S0014-5793(98)00775-3; Honkanen RE, 2002, CURR MED CHEM, V9, P2055, DOI 10.2174/0929867023368836; Huang XZ, 1998, J BIOL CHEM, V273, P1462, DOI 10.1074/jbc.273.3.1462; Inui S, 1998, BLOOD, V92, P539, DOI 10.1182/blood.V92.2.539.414k23_539_546; Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018; Kita A, 2002, STRUCTURE, V10, P715, DOI 10.1016/S0969-2126(02)00764-5; Kloeker S, 2003, PROTEIN EXPRES PURIF, V31, P19, DOI 10.1016/S1046-5928(03)00141-4; Lechward K, 2001, ACTA BIOCHIM POL, V48, P921; Lubert EJ, 2001, J BIOL CHEM, V276, P38582, DOI 10.1074/jbc.M106906200; Maynes JT, 2001, J BIOL CHEM, V276, P44078, DOI 10.1074/jbc.M107656200; Murata K, 1997, P NATL ACAD SCI USA, V94, P10624, DOI 10.1073/pnas.94.20.10624; Nanahoshi M, 1999, FEBS LETT, V446, P108, DOI 10.1016/S0014-5793(99)00189-1; Price NE, 2000, BIOCHEMISTRY-US, V39, P11312, DOI 10.1021/bi0008478; Prickett TD, 2004, J BIOL CHEM, V279, P38912, DOI 10.1074/jbc.M401444200; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Stark MJR, 1996, YEAST, V12, P1647, DOI 10.1002/(SICI)1097-0061(199612)12:16<1647::AID-YEA71>3.0.CO;2-Q; Wang HM, 2003, MOL BIOL CELL, V14, P4342, DOI 10.1091/mbc.E03-02-0072; WERA S, 1995, BIOCHEM J, V311, P17, DOI 10.1042/bj3110017	31	78	80	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30503	30511		10.1074/jbc.M601054200	http://dx.doi.org/10.1074/jbc.M601054200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16895907	hybrid			2022-12-27	WOS:000241075900026
J	Huang, Y; Wendt-Pienkowski, E; Shen, B				Huang, Yong; Wendt-Pienkowski, Evelyn; Shen, Ben			A dedicated phosphopantetheinyl transferase for the fredericamycin polyketide synthase from Streptomyces griseus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL CARRIER PROTEIN; BIOSYNTHETIC GENE-CLUSTER; FATTY-ACID SYNTHASE; ESCHERICHIA-COLI; BACILLUS-SUBTILIS; POSTTRANSLATIONAL MODIFICATION; HETEROLOGOUS EXPRESSION; CLONING; ACYLTRANSFERASE; OVERPRODUCTION	Polyketide synthases cannot be functional unless their apoacyl carrier proteins (apo-ACPs) are post-translationally modified by covalent attachment of the 4'-phosphopantetheine group to the highly conserved serine residue, and this reaction is catalyzed by phosphopantetheinyl transferases (PPTases). Cloning and sequence analysis of the 33-kb fredericamycin (FDM) biosynthetic gene cluster from Streptomyces griseus revealed fdmW, whose deduced gene product showed significant sequence homology to known PPTases. Biochemical characterization of FdmW in vitro confirmed that it is a PPTase. Inactivation of fdmW resulted in similar to 93% reduction of FDM production, and complementation of the fdmW::aac (3) IV mutant by expressing fdmW in trans restored FDM production to a level comparable with that of the wild-type strain. Although FdmW can phosphopantetheinylate various ACPs, it prefers its cognate substrate, the FdmH ACP, with a K-m of 5.8 mu M and a k(cat)/K-m of 8.1 mu M(-1.)min(-1), to heterologous ACPs, such as the TcmM ACP with a K-m of 1.0 x 10(2) mu M and a k(cat)/K-m of 0.6 mu M(-1.)min(-1). These findings suggest that FdmW is specific for FDM biosynthesis. FdmW therefore represents the first holo-ACP synthase-type PPTase identified from an aromatic polyketide biosynthetic gene cluster.	Univ Wisconsin, Div Pharmaceut Sci, Sch Pharm, Madison, WI 53705 USA; Univ Wisconsin, Natl Cooperat Drug Discovery Grp, Madison, WI 53705 USA; Univ Wisconsin, Dept Chem, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Shen, B (corresponding author), Univ Wisconsin, Div Pharmaceut Sci, Sch Pharm, 777 Highland Ave, Madison, WI 53705 USA.	bshen@pharmacy.wisc.edu		Huang, Yong/0000-0002-3163-1716	NATIONAL CANCER INSTITUTE [U19CA113297, R01CA035381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051687] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDERSON MS, 1987, J BIOL CHEM, V262, P5159; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; Buttner M. J., 2000, PRACTICAL STREPTOMYC, P1; Cheng YQ, 2003, P NATL ACAD SCI USA, V100, P3149, DOI 10.1073/pnas.0537286100; Crump MP, 1997, BIOCHEMISTRY-US, V36, P6000, DOI 10.1021/bi970006+; DelVecchio VG, 2002, P NATL ACAD SCI USA, V99, P443, DOI 10.1073/pnas.221575398; Fichtlscherer F, 2000, EUR J BIOCHEM, V267, P2666, DOI 10.1046/j.1432-1327.2000.01282.x; Finking R, 2002, J BIOL CHEM, V277, P50293, DOI 10.1074/jbc.M205042200; Flugel RS, 2000, J BIOL CHEM, V275, P959, DOI 10.1074/jbc.275.2.959; Galm U, 2002, ARCH MICROBIOL, V178, P102, DOI 10.1007/s00203-002-0429-z; Gehring AM, 1997, CHEM BIOL, V4, P17, DOI 10.1016/S1074-5521(97)90233-7; Gokhale RS, 1999, SCIENCE, V284, P482, DOI 10.1126/science.284.5413.482; Gross F, 2005, APPL MICROBIOL BIOT, V68, P66, DOI 10.1007/s00253-004-1836-7; HEATON MP, 1994, J BACTERIOL, V176, P681, DOI 10.1128/jb.176.3.681-690.1994; Ichinose K, 2003, MICROBIOL-SGM, V149, P1633, DOI 10.1099/mic.0.26310-0; Ichinose K, 1998, CHEM BIOL, V5, P647, DOI 10.1016/S1074-5521(98)90292-7; Jakobi K, 2004, J AM CHEM SOC, V126, P2298, DOI 10.1021/ja0390698; KAO CM, 1995, J AM CHEM SOC, V117, P9105, DOI 10.1021/ja00140a043; KHOSLA C, 1992, MOL MICROBIOL, V6, P3237, DOI 10.1111/j.1365-2958.1992.tb01778.x; Kremer L, 2001, J BIOL CHEM, V276, P27967, DOI 10.1074/jbc.M103687200; Lambalot RH, 1996, CHEM BIOL, V3, P923, DOI 10.1016/S1074-5521(96)90181-7; LAMBALOT RH, 1995, J BIOL CHEM, V270, P24658, DOI 10.1074/jbc.270.42.24658; Li AY, 2002, CHEM BIOL, V9, P1017, DOI 10.1016/S1074-5521(02)00223-5; Lomovskaya N, 1999, J BACTERIOL, V181, P305, DOI 10.1128/JB.181.1.305-318.1999; McAllister KA, 2000, J BIOL CHEM, V275, P30864, DOI 10.1074/jbc.M004475200; Mootz HD, 2001, J BIOL CHEM, V276, P37289, DOI 10.1074/jbc.M103556200; NAKANO MM, 1988, J BACTERIOL, V170, P5662, DOI 10.1128/jb.170.12.5662-5668.1988; Novakova R, 2002, GENE, V297, P197, DOI 10.1016/S0378-1119(02)00889-2; Parris KD, 2000, STRUCT FOLD DES, V8, P883, DOI 10.1016/S0969-2126(00)00178-7; Quadri LEN, 1998, BIOCHEMISTRY-US, V37, P1585, DOI 10.1021/bi9719861; Sambrook J., 2001, MOL CLONING LAB MANU, P1, DOI DOI 10.1002/HUMU.1186.ABS; Sanchez C, 2001, CHEM BIOL, V8, P725, DOI 10.1016/S1074-5521(01)00047-3; Shen B, 2000, TOP CURR CHEM, V209, P1; Silakowski B, 1999, J BIOL CHEM, V274, P37391, DOI 10.1074/jbc.274.52.37391; TAKIFF HE, 1992, J BACTERIOL, V174, P1544, DOI 10.1128/jb.174.5.1544-1553.1992; Walsh CT, 1997, CURR OPIN CHEM BIOL, V1, P309, DOI 10.1016/S1367-5931(97)80067-1; Wang LR, 2001, MICROBIOL-SGM, V147, P1535, DOI 10.1099/00221287-147-6-1535; Wendt-Pienkowski E, 2005, J AM CHEM SOC, V127, P16442, DOI 10.1021/ja054376u; Westrich L, 1999, FEMS MICROBIOL LETT, V170, P381, DOI 10.1111/j.1574-6968.1999.tb13398.x; Zhang L, 2003, J BIOL CHEM, V278, P40067, DOI 10.1074/jbc.M306121200; [No title captured]	41	27	29	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					29660	29668		10.1074/jbc.M604895200	http://dx.doi.org/10.1074/jbc.M604895200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16895912	hybrid			2022-12-27	WOS:000240896300027
J	Kol, S; Turrell, BR; de Keyzer, J; van der Laan, M; Nouwen, N; Driessen, AJM				Kol, Stefan; Turrell, Bryony R.; de Keyzer, Jeanine; van der Laan, Martin; Nouwen, Nico; Driessen, Arnold J. M.			YidC-mediated membrane insertion of assembly mutants of subunit C of the F1F0 ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI INNER MEMBRANE; ESCHERICHIA-COLI; PROTEIN INSERTION; ADENOSINE-TRIPHOSPHATASE; SACCHAROMYCES-CEREVISIAE; F-0 COMPLEX; SYNTHASE; BIOGENESIS; SECYEG; REQUIREMENTS	YidC is a member of the OxaI family of membrane proteins that has been implicated in the membrane insertion of inner membrane proteins in Escherichia coli. We have recently demonstrated that proteoliposomes containing only YidC support both the stable membrane insertion and the oligomerization of the c subunit of the F1F0 ATP synthase (F(0)c). Here we have shown that two mutants of F(0)c unable to form a functional F1F0 ATPase interact with YidC, require YidC for membrane insertion, but fail to oligomerize. These data show that oligomerization is not essential for the stable YidC- dependent membrane insertion of F(0)c consistent with a function of YidC as a membrane protein insertase.	Univ Groningen, Dept Mol Microbiol, Groningen Biomol Sci & Biotechnol Inst, NL-9751 NN Haren, Netherlands; Univ Groningen, Mat Sci Ctr Plus, NL-9751 NN Haren, Netherlands	University of Groningen; University of Groningen	Driessen, AJM (corresponding author), Univ Groningen, Dept Mol Microbiol, Groningen Biomol Sci & Biotechnol Inst, NL-9751 NN Haren, Netherlands.	a.j.m.driessen@rug.nl	Driessen, Arnold J.M./D-1876-2012	Driessen, Arnold J.M./0000-0001-9258-9104; van der Laan, Martin/0000-0003-0789-9912; Kol, Stefan/0000-0002-1992-8242				Akiyama Y, 1996, FEBS LETT, V399, P26, DOI 10.1016/S0014-5793(96)01283-5; Altamura N, 1996, FEBS LETT, V382, P111, DOI 10.1016/0014-5793(96)00165-2; Arechaga I, 2002, FEBS LETT, V515, P189, DOI 10.1016/S0014-5793(02)02447-X; Beck K, 2001, EMBO REP, V2, P709, DOI 10.1093/embo-reports/kve154; Capaldi RA, 2002, TRENDS BIOCHEM SCI, V27, P154, DOI 10.1016/S0968-0004(01)02051-5; Celebi N, 2006, J MOL BIOL, V357, P1428, DOI 10.1016/j.jmb.2006.01.030; Chen MY, 2002, J BIOL CHEM, V277, P7670, DOI 10.1074/jbc.M110644200; de Gier JWL, 2003, EMBO REP, V4, P939, DOI 10.1038/sj.embor.embor921; DeckersHebestreit G, 1996, ANNU REV MICROBIOL, V50, P791, DOI 10.1146/annurev.micro.50.1.791; DEVRIJE T, 1987, BIOCHIM BIOPHYS ACTA, V900, P63, DOI 10.1016/0005-2736(87)90278-1; DOWNIE JA, 1981, J BACTERIOL, V145, P200, DOI 10.1128/JB.145.1.200-210.1981; du Plessis DJF, 2006, J BIOL CHEM, V281, P12248, DOI 10.1074/jbc.M600048200; ENGELMAN DM, 1981, CELL, V23, P411, DOI 10.1016/0092-8674(81)90136-7; Fillingame RH, 2002, BBA-BIOENERGETICS, V1555, P29, DOI 10.1016/S0005-2728(02)00250-5; Hell K, 2001, EMBO J, V20, P1281, DOI 10.1093/emboj/20.6.1281; HERMOLIN J, 1995, J BIOL CHEM, V270, P2815, DOI 10.1074/jbc.270.6.2815; Herskovits AA, 2000, MOL MICROBIOL, V38, P927, DOI 10.1046/j.1365-2958.2000.02198.x; Houben ENG, 2000, FEBS LETT, V476, P229, DOI 10.1016/S0014-5793(00)01735-X; JANS DA, 1983, BIOCHEM J, V211, P717, DOI 10.1042/bj2110717; Krebstakies T, 2005, J BIOL CHEM, V280, P33338, DOI 10.1074/jbc.M506251200; Kuhn A, 2003, TRENDS CELL BIOL, V13, P510, DOI 10.1016/j.tcb.2003.08.005; KUHN A, 1995, FEMS MICROBIOL REV, V17, P185; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Lemaire C, 2000, J BIOL CHEM, V275, P23471, DOI 10.1074/jbc.M002045200; Luirink J, 2001, FEBS LETT, V501, P1, DOI 10.1016/S0014-5793(01)02616-3; Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199; MILLER MJ, 1989, J BIOL CHEM, V264, P305; Moore M, 2000, J BIOL CHEM, V275, P1529, DOI 10.1074/jbc.275.3.1529; Nagamori S, 2004, J CELL BIOL, V165, P53, DOI 10.1083/jcb.200402067; Ono S, 2004, J BIOL CHEM, V279, P33409, DOI 10.1074/jbc.M404993200; Preuss M, 2005, J BIOL CHEM, V280, P13004, DOI 10.1074/jbc.M414093200; Rubinstein JL, 2003, EMBO J, V22, P6182, DOI 10.1093/emboj/cdg608; Russel M, 1997, GENE, V192, P23, DOI 10.1016/S0378-1119(96)00801-3; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Scotti PA, 2000, EMBO J, V19, P542, DOI 10.1093/emboj/19.4.542; Senior AE, 2002, BBA-BIOENERGETICS, V1553, P188, DOI 10.1016/S0005-2728(02)00185-8; Stalz WD, 2003, J BIOL CHEM, V278, P27068, DOI 10.1074/jbc.M302027200; STEFFENS K, 1984, EUR J BIOCHEM, V138, P617, DOI 10.1111/j.1432-1033.1984.tb07959.x; van Bloois E, 2006, J BIOL CHEM, V281, P10002, DOI 10.1074/jbc.M511357200; van Bloois E, 2004, FEBS LETT, V576, P97, DOI 10.1016/j.febslet.2004.08.069; van der Laan M, 2005, CURR OPIN MICROBIOL, V8, P182, DOI 10.1016/j.mib.2005.02.004; van der Laan M, 2004, J CELL BIOL, V165, P213, DOI 10.1083/jcb.200402100; van der Laan M, 2004, J BIOL CHEM, V279, P1659, DOI 10.1074/jbc.M306527200; van der Laan M, 2003, P NATL ACAD SCI USA, V100, P5801, DOI 10.1073/pnas.0636761100; van der Laan M, 2001, EMBO REP, V2, P519, DOI 10.1093/embo-reports/kve106; VIK SB, 1987, J BIOL CHEM, V262, P8340; Vonck J, 2002, J MOL BIOL, V321, P307, DOI 10.1016/S0022-2836(02)00597-1; Weber J, 2003, FEBS LETT, V545, P61, DOI 10.1016/S0014-5793(03)00394-6; Yi L, 2003, BIOCHEMISTRY-US, V42, P10537, DOI 10.1021/bi034309h; Yi L, 2004, J BIOL CHEM, V279, P39260, DOI 10.1074/jbc.M405490200; Yi L, 2005, MOL MEMBR BIOL, V22, P101, DOI 10.1080/09687860500041718	52	28	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					29762	29768		10.1074/jbc.M605317200	http://dx.doi.org/10.1074/jbc.M605317200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16880204	Green Published, hybrid			2022-12-27	WOS:000240896300038
J	Yang, C; Rodionov, DA; Li, XQ; Laikova, ON; Gelfand, MS; Zagnitko, OP; Romine, MF; Obraztsova, AY; Nealson, KH; Osterman, AL				Yang, Chen; Rodionov, Dmitry A.; Li, Xiaoqing; Laikova, Olga N.; Gelfand, Mikhail S.; Zagnitko, Olga P.; Romine, Margaret F.; Obraztsova, Anna Y.; Nealson, Kenneth H.; Osterman, Andrei L.			Comparative genomics and experimental characterization of N-acetylglucosamine utilization pathway of Shewanella oneidensis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; MOLECULAR-CLONING; TRANSCRIPTOME ANALYSIS; CHITIN CATABOLISM; OUTER-MEMBRANE; SEQUENCE; TRANSPORTER; DEAMINASE; BINDING; SYSTEM	We used a comparative genomics approach implemented in the SEED annotation environment to reconstruct the chitin and GlcNAc utilization subsystem and regulatory network in most proteobacteria, including 11 species of Shewanella with completely sequenced genomes. Comparative analysis of candidate regulatory sites allowed us to characterize three different GlcNAc- specific regulons, NagC, NagR, and NagQ, in various proteobacteria and to tentatively assign a number of novel genes with specific functional roles, in particular new GlcNAc- related transport systems, to this subsystem. Genes SO3506 and SO3507, originally annotated as hypothetical in Shewanella onei-densis MR-1, were suggested to encode novel variants of GlcN-6-P deaminase and GlcNAc kinase, respectively. Reconstitution of the GlcNAc catabolic pathway in vitro using these purified recombinant proteins and GlcNAc-6-P deacetylase (SO3505) validated the entire pathway. Kinetic characterization of GlcN-6-P deaminase demonstrated that it is the subject of allosteric activation by GlcNAc- 6- P. Consistent with genomic data, all tested Shewanella strains except S. frigidimarina, which lacked representative genes for the GlcNAc metabolism, were capable of utilizing GlcNAc as the sole source of carbonandenergy. Thisstudyexpandstherangeofcarbonsubstrates utilized by Shewanella spp., unambiguously identifies several genes involved in chitin metabolism, and describes a novel variant of the classical three- step biochemical conversion of GlcNAc to fructose 6- phosphate first described in Escherichia coli.	Burnham Inst Med Res, La Jolla, CA 92037 USA; Russian Acad Sci, Inst Informat Transmiss Problems, Moscow 127994, Russia; State Sci Ctr GosNIIGenetika, Moscow 117545, Russia; Moscow MV Lomonosov State Univ, Dept Bioengn & Bioinformat, Moscow 119992, Russia; Fellowship Interpretat Genomes, Burr Ridge, IL 60527 USA; Pacific NW Natl Lab, Richland, WA 99352 USA; Univ So Calif, Dept Earth Sci, Los Angeles, CA 90089 USA	Sanford Burnham Prebys Medical Discovery Institute; Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences; Lomonosov Moscow State University; United States Department of Energy (DOE); Pacific Northwest National Laboratory; University of Southern California	Rodionov, DA (corresponding author), Burnham Inst Med Res, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	rodionov@burnham.org	Gelfand, Mikhail S/F-3425-2012; Rodionov, Dmitry/V-2688-2018	Romine, Margaret/0000-0002-0968-7641; Rodionov, Dmitry/0000-0002-0939-390X; Gelfand, Mikhail/0000-0003-4181-0846	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059146] Funding Source: NIH RePORTER; NIAID NIH HHS [1R01-AI059146-01A2] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alvarez-Anorve LI, 2005, J BACTERIOL, V187, P2974, DOI 10.1128/JB.187.9.2974-2982.2005; Asensio C., 1966, METHODS ENZYMOL, V9, P421; Benson DA, 2006, NUCLEIC ACIDS RES, V34, pD16, DOI 10.1093/nar/gkj157; Bustos-Jaimes I, 2002, J MOL BIOL, V319, P183, DOI 10.1016/S0022-2836(02)00096-7; CALCAGNO M, 1984, BIOCHIM BIOPHYS ACTA, V787, P165, DOI 10.1016/0167-4838(84)90076-1; Cheek S, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-6; Chimento DP, 2003, J MOL BIOL, V332, P999, DOI 10.1016/j.jmb.2003.07.005; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Datta A, 1975, Methods Enzymol, V42, P58; DUTKAMALEN S, 1988, BIOCHIMIE, V70, P287, DOI 10.1016/0300-9084(88)90073-9; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Fredrickson JK, 2005, CURR OPIN BIOTECH, V16, P269, DOI 10.1016/j.copbio.2005.04.001; Gelfand MS, 2003, FUNC GENOM, V3, P195; Gelfand MS, 2000, NUCLEIC ACIDS RES, V28, P695, DOI 10.1093/nar/28.3.695; Gerdes SY, 2006, J BACTERIOL, V188, P3012, DOI 10.1128/JB.188.8.3012-3023.2006; Heidelberg JF, 2002, NAT BIOTECHNOL, V20, P1118, DOI 10.1038/nbt749; Hinderlich S, 2000, EUR J BIOCHEM, V267, P3301, DOI 10.1046/j.1432-1327.2000.01360.x; Hofmann K., 1993, BIOL CHEM H-S, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Howard MB, 2003, J BACTERIOL, V185, P3352, DOI 10.1128/JB.185.11.3352-3360.2003; Keyhani NO, 1999, BBA-GEN SUBJECTS, V1473, P108, DOI 10.1016/S0304-4165(99)00172-5; Keyhani NO, 2000, J BIOL CHEM, V275, P33068, DOI 10.1074/jbc.M001041200; Li XB, 2004, P NATL ACAD SCI USA, V101, P627, DOI 10.1073/pnas.0307645100; Liu YQ, 2005, J BACTERIOL, V187, P2501, DOI 10.1128/JB.187.7.2501-2507.2005; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Meibom KL, 2004, P NATL ACAD SCI USA, V101, P2524, DOI 10.1073/pnas.0308707101; Mironov AA, 1999, NUCLEIC ACIDS RES, V27, P2981, DOI 10.1093/nar/27.14.2981; Mironov AA, 2000, MOL BIOL+, V34, P222, DOI 10.1007/BF02759643; MYERS CR, 1990, J BACTERIOL, V172, P6232, DOI 10.1128/jb.172.11.6232-6238.1990; MYERS CR, 1988, SCIENCE, V240, P1319, DOI 10.1126/science.240.4857.1319; NEALSON KH, 2003, PROKARYOTES EVOLVING; Neugebauer H, 2005, J BACTERIOL, V187, P8300, DOI 10.1128/JB.187.24.8300-8311.2005; Orikoshi H, 2005, APPL ENVIRON MICROB, V71, P1811, DOI 10.1128/AEM.71.4.1811-1815.2005; OSTERMAN A, 1994, BIOCHEMISTRY-US, V33, P13662, DOI 10.1021/bi00250a016; Osterman A, 2003, CURR OPIN CHEM BIOL, V7, P238, DOI 10.1016/S1367-5931(03)00027-9; OSTERMAN AL, 1995, BIOCHEMISTRY-US, V34, P13431, DOI 10.1021/bi00041a021; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; PERI KG, 1990, BIOCHEM CELL BIOL, V68, P123, DOI 10.1139/o90-017; PLUMBRIDGE J, 1995, EMBO J, V14, P3958, DOI 10.1002/j.1460-2075.1995.tb00067.x; Plumbridge J, 2004, MOL MICROBIOL, V52, P437, DOI 10.1111/j.1365-2958.2004.03986.x; Plumbridge J, 2001, NUCLEIC ACIDS RES, V29, P506, DOI 10.1093/nar/29.2.506; Qiu XY, 2006, J BACTERIOL, V188, P1199, DOI 10.1128/JB.188.3.1199-1204.2006; Rigali S, 2004, NUCLEIC ACIDS RES, V32, P3418, DOI 10.1093/nar/gkh673; Rigali S, 2002, J BIOL CHEM, V277, P12507, DOI 10.1074/jbc.M110968200; Souza JM, 1997, ARCH BIOCHEM BIOPHYS, V340, P338, DOI 10.1006/abbi.1997.9780; Tamber S, 2006, J BACTERIOL, V188, P45, DOI 10.1128/JB.188.1.45-54.2006; Tanaka T, 2005, J BACTERIOL, V187, P7038, DOI 10.1128/JB.187.20.7038-7044.2005; Teplyakov A, 2001, J MOL BIOL, V313, P1093, DOI 10.1006/jmbi.2001.5094; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TITGEMEYER F, 1994, MICROBIOL-UK, V140, P2349, DOI 10.1099/13500872-140-9-2349; Uchiyama T, 2003, J BACTERIOL, V185, P1776, DOI 10.1128/JB.185.6.1776-1782.2003; Vimr ER, 2004, MICROBIOL MOL BIOL R, V68, P132, DOI 10.1128/MMBR.68.1.132-153.2004; VOGLER AP, 1989, MOL GEN GENET, V219, P97, DOI 10.1007/BF00261163; White R J, 1975, Methods Enzymol, V41, P497; Xiao X, 2002, MOL GENET GENOMICS, V267, P429, DOI 10.1007/s00438-002-0640-2; Yamada-Okabe T, 2001, EUR J BIOCHEM, V268, P2498, DOI 10.1046/j.1432-1327.2001.02135.x; Ye YZ, 2005, BIOINFORMATICS, V21, pI478, DOI 10.1093/bioinformatics/bti1052	57	105	108	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					29872	29885		10.1074/jbc.M605052200	http://dx.doi.org/10.1074/jbc.M605052200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16857666	hybrid			2022-12-27	WOS:000240896300049
J	Kanda, M; Ihara, Y; Murata, H; Urata, Y; Kono, T; Yodoi, J; Seto, S; Yano, K; Kondo, T				Kanda, Munetake; Ihara, Yoshito; Murata, Hiroaki; Urata, Yoshishige; Kono, Takaaki; Yodoi, Junji; Seto, Shinji; Yano, Katsusuke; Kondo, Takahito			Glutaredoxin modulates platelet-derived growth factor-dependent cell signaling by regulating the redox status of low molecular weight protein-tyrosine phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-BETA-RECEPTOR; GLUTATHIONE/GLUTAREDOXIN REDUCTASE SYSTEM; TUMOR-SUPPRESSOR PTEN; ACTIVE-SITE CYSTEINE; SMOOTH-MUSCLE-CELLS; IN-VIVO; THIOLTRANSFERASE GLUTAREDOXIN; REVERSIBLE INACTIVATION; HYDROGEN-PEROXIDE; REACTIVE OXYGEN	Glutaredoxin (GRX) is a glutathione-disulfide oxidoreductase involved in various cellular functions, including the redox-dependent regulation of certain integral proteins. Here we demonstrated that overexpression of GRX suppressed the proliferation of myocardiac H9c2 cells treated with platelet-derived growth factor (PDGF)-BB. After stimulation with PDGF-BB, the phosphorylation of PDGF receptor (PDGFR) beta was suppressed in GRX gene-transfected cells, compared with controls. Conversely, the phosphorylation was enhanced by depletion of GRX by RNA interference. In this study we focused on the role of low molecular weight protein-tyrosine phosphatase (LMW-PTP) in the dephosphorylation of PDGFR beta via a redox-dependent mechanism. We found that depletion of LMW-PTP using RNA interference enhanced the PDGF-BB-induced phosphorylation of PDGFR beta, indicating that LMW-PTP works for PDGFR beta. The enhancement of the phosphorylation of PDGFR beta was well correlated with inactivation of LMW-PTP by cellular peroxide generated in the cells stimulated with PDGF-BB. In vitro, with hydrogen peroxide treatment, LMW-PTP showed decreased activity with the concomitant formation of dithiothreitol-reducible oligomers. GRX protected LMW-PTP from hydrogen peroxide-induced oxidation and inactivation in concert with glutathione, NADPH, and glutathione disulfide reductase. This strongly suggests that retention of activity of LMW-PTP by enhanced GRX expression suppresses the proliferation of cells treated with PDGF-BB via enhanced dephosphorylation of PDGFR beta. Thus, GRX plays an important role in PDGF-BB-dependent cell proliferation by regulating the redox state of LMW-PTP.	Nagasaki Univ, Grad Sch Biomed Sci, Dept Biochem & Mol Biol Dis, Atom Bomb Dis Inst, Nagasaki 8528523, Japan; Nagasaki Univ, Grad Sch Biomed Sci, Dept Internal Med 3, Nagasaki 8528523, Japan; Kyoto Univ, Inst Viral Res, Dept Biol Responses, Kyoto 6068507, Japan	Nagasaki University; Nagasaki University; Kyoto University	Ihara, Y (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Biochem & Mol Biol Dis, Atom Bomb Dis Inst, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.	y-ihara@net.nagasaki-u.ac.jp	Murata, Hiroaki/AAA-8374-2020	Murata, Hiroaki/0000-0002-6185-5059				Adachi T, 2004, J BIOL CHEM, V279, P29857, DOI 10.1074/jbc.M313320200; Arabaci G, 2002, BIOORG MED CHEM LETT, V12, P3047, DOI 10.1016/S0960-894X(02)00681-9; Arabaci G, 1999, J AM CHEM SOC, V121, P5085, DOI 10.1021/ja9906756; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Bandyopadhyay S, 1998, J BIOL CHEM, V273, P392, DOI 10.1074/jbc.273.1.392; Barrett WC, 1999, BIOCHEMISTRY-US, V38, P6699, DOI 10.1021/bi990240v; Beer SM, 2004, J BIOL CHEM, V279, P47939, DOI 10.1074/jbc.M408011200; Betsholtz C, 2004, CYTOKINE GROWTH F R, V15, P215, DOI 10.1016/j.cytogfr.2004.03.005; Brar SS, 1999, J BIOL CHEM, V274, P20017, DOI 10.1074/jbc.274.28.20017; Brostrom MA, 2002, J CELL BIOCHEM, V84, P736, DOI 10.1002/jcb.10085; Caplan JF, 2004, J BIOL CHEM, V279, P7740, DOI 10.1074/jbc.M313049200; Casagrande S, 2002, P NATL ACAD SCI USA, V99, P9745, DOI 10.1073/pnas.152168599; Caselli A, 1998, J BIOL CHEM, V273, P32554, DOI 10.1074/jbc.273.49.32554; CASELLI A, 1995, FEBS LETT, V374, P249, DOI 10.1016/0014-5793(95)01120-4; Chen AP, 2003, J BIOL CHEM, V278, P23381, DOI 10.1074/jbc.M212042200; Chiarugi P, 2003, TRENDS BIOCHEM SCI, V28, P509, DOI 10.1016/S0968-0004(03)00174-9; CHIARUGI P, 1995, FEBS LETT, V372, P49, DOI 10.1016/0014-5793(95)00947-8; Chiarugi P, 2001, J BIOL CHEM, V276, P33478, DOI 10.1074/jbc.M102302200; Chrestensen CA, 2000, J BIOL CHEM, V275, P26556, DOI 10.1074/jbc.M004097200; CIRRI P, 1995, BBA-GEN SUBJECTS, V1243, P129, DOI 10.1016/0304-4165(94)00055-3; Davis DA, 1997, J BIOL CHEM, V272, P25935, DOI 10.1074/jbc.272.41.25935; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; GAN ZR, 1986, J BIOL CHEM, V261, P996; Haj FG, 2003, J BIOL CHEM, V278, P739, DOI 10.1074/jbc.M210194200; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; HOLMGREN A, 1979, J BIOL CHEM, V254, P3672; HOLMGREN A, 1976, P NATL ACAD SCI USA, V73, P2275, DOI 10.1073/pnas.73.7.2275; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Johansson C, 2004, J BIOL CHEM, V279, P7537, DOI 10.1074/jbc.M312719200; Kageyama K, 2002, J BIOL CHEM, V277, P19255, DOI 10.1074/jbc.M112377200; KAZLAUSKAS A, 1993, P NATL ACAD SCI USA, V90, P6939, DOI 10.1073/pnas.90.15.6939; Kikawa KD, 2002, J BIOL CHEM, V277, P39274, DOI 10.1074/jbc.M207127200; Kovalenko M, 2000, J BIOL CHEM, V275, P16219, DOI 10.1074/jbc.275.21.16219; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Landino LM, 2004, BIOCHEM BIOPH RES CO, V323, P112, DOI 10.1016/j.bbrc.2004.08.065; Landino LM, 2004, BIOCHEM BIOPH RES CO, V314, P555, DOI 10.1016/j.bbrc.2003.12.126; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; LEVEEN P, 1994, GENET DEV, V8, P1857; Lillig CH, 2004, P NATL ACAD SCI USA, V101, P13227, DOI 10.1073/pnas.0401896101; Lind C, 1998, BIOCHEM BIOPH RES CO, V247, P481, DOI 10.1006/bbrc.1998.8695; Liu F, 1997, BIOCHEM J, V327, P139, DOI 10.1042/bj3270139; Liu J, 2005, REGUL PEPTIDES, V127, P11, DOI 10.1016/j.regpep.2004.10.018; Mahadev K, 2001, J BIOL CHEM, V276, P21938, DOI 10.1074/jbc.C100109200; Mahimainathan L, 2004, J BIOL CHEM, V279, P15258, DOI 10.1074/jbc.M314328200; Markova B, 2003, BIOCHEMISTRY-US, V42, P2691, DOI 10.1021/bi0265574; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Murata H, 2003, J BIOL CHEM, V278, P50226, DOI 10.1074/jbc.M310171200; Ostman A, 2001, TRENDS CELL BIOL, V11, P258, DOI 10.1016/S0962-8924(01)01990-0; Persson C, 2004, MOL CELL BIOL, V24, P2190, DOI 10.1128/MCB.24.5.2190-2201.2004; Prinz WA, 1997, J BIOL CHEM, V272, P15661, DOI 10.1074/jbc.272.25.15661; Ramponi G, 1997, BBA-PROTEIN STRUCT M, V1341, P137, DOI 10.1016/S0167-4838(97)00087-3; Raugei G, 2002, CELL MOL LIFE SCI, V59, P941, DOI 10.1007/s00018-002-8481-z; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; SARZANI R, 1991, HYPERTENSION, V17, P888, DOI 10.1161/01.HYP.17.6.888; Shelton MD, 2005, ANTIOXID REDOX SIGN, V7, P348, DOI 10.1089/ars.2005.7.348; Shimizu H, 2001, BIOCHEM BIOPH RES CO, V289, P602, DOI 10.1006/bbrc.2001.6007; Song JJ, 2002, J BIOL CHEM, V277, P46566, DOI 10.1074/jbc.M206826200; SORIANO P, 1994, GENE DEV, V8, P1888, DOI 10.1101/gad.8.16.1888; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Tallquist M, 2004, CYTOKINE GROWTH F R, V15, P205, DOI 10.1016/j.cytogfr.2004.03.003; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; van Montfort RLM, 2003, NATURE, V423, P773, DOI 10.1038/nature01681; Wang J, 2003, P NATL ACAD SCI USA, V100, P5103, DOI 10.1073/pnas.0931345100; WO YYP, 1992, J BIOL CHEM, V267, P10856; Yu ZB, 1998, J BIOL CHEM, V273, P3687, DOI 10.1074/jbc.273.6.3687	67	47	49	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					28518	28528		10.1074/jbc.M604359200	http://dx.doi.org/10.1074/jbc.M604359200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16893901	hybrid			2022-12-27	WOS:000240680500005
J	Pacheco-Alvarez, D; Cristobal, PS; Meade, P; Moreno, E; Vazquez, N; Munoz, E; Diaz, A; Juarez, ME; Gimenez, I; Gamba, G				Pacheco-Alvarez, Diana; Cristobal, Pedro San; Meade, Patricia; Moreno, Erika; Vazquez, Norma; Munoz, Eva; Diaz, Abigail; Juarez, Maria Eugenia; Gimenez, Ignacio; Gamba, Gerardo			The Na+: Cl- cotransporter is activated and phosphorylated at the amino-terminal domain upon intracellular chloride depletion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+-K+-2CL(-) COTRANSPORTER; REGULATORY PHOSPHORYLATION; FUNCTIONAL EXPRESSION; NA-K-2CL COTRANSPORT; MOLECULAR PHYSIOLOGY; NACL COTRANSPORTER; CELL-VOLUME; KINASE; WNK1; MODULATION	The renal N-a+:Cl- cotransporter rNCC is mutated in human disease, is the therapeutic target of thiazide-type diuretics, and is clearly involved in arterial blood pressure regulation. rNCC belongs to an electroneutral cation-coupled chloride cotransporter family (SLC12A) that has two major branches with inverse physiological functions and regulation: sodium-driven cotransporters (NCC and NKCC1/2) that mediate cellular Cl- influx are activated by phosphorylation, whereas potassium-driven cotransporters (KCCs) that mediate cellular Cl- efflux are activated by dephosphorylation. A cluster of three threonine residues at the amino-terminal domain has been implicated in the regulation of NKCC1/2 by intracellular chloride, cell volume, vasopressin, and WNK/STE-20 kinases. Nothing is known, however, about rNCC regulatory mechanisms. By using rNCC heterologous expression in Xenopus laevis oocytes, here we show that two independent intracellular chloride-depleting strategies increased rNCC activity by 3-fold. The effect of both strategies was synergistic and dose-dependent. Confocal microscopy of enhanced green fluorescent protein-tagged rNCC showed no changes in rNCC cell surface expression, whereas immunoblot analysis, using the R5-anti-NKCC1-phosphoantibody, revealed increased phosphorylation of rNCC amino-terminal domain threonine residues Thr(53) and Thr(58). Elimination of these threonines together with serine residue Ser(71) completely prevented rNCC response to intracellular chloride depletion. We conclude that rNCC is activated by a mechanism that involves amino-terminal domain phosphorylation.	Univ Nacl Autonoma Mexico, Mol Physiol Unit, Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Inst Inves Biomed, Mexico City, DF, Mexico; Univ Autonoma Estado Hidalgo, Inst Ciencias Salud, Hidalgo 42160, Mexico; Univ Zaragoza, Fac Med, Dept Pharmacol & Physiol, E-50009 Zaragoza, Spain	Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Universidad Nacional Autonoma de Mexico; Universidad Autonoma del Estado de Hidalgo; University of Zaragoza	Gamba, G (corresponding author), Univ Nacl Autonoma Mexico, Mol Physiol Unit, Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Inst Inves Biomed, Vasco Quiroga 15, Mexico City, DF, Mexico.	gamba@biomedicas.unam.mx	Giménez, Ignacio/B-6322-2013; Meade, Patricia/H-8825-2015; Gamba, Gerardo/P-4873-2016	Giménez, Ignacio/0000-0002-6043-4869; Meade, Patricia/0000-0002-3587-6622; Pacheco-Alvarez, Diana/0000-0001-5454-9267; Gamba, Gerardo/0000-0002-4378-9043; Moreno Martinez, Reyna Erika/0000-0002-7563-0379	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064635] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ACKERMAN MJ, 1994, J GEN PHYSIOL, V103, P153, DOI 10.1085/jgp.103.2.153; Adragna NC, 2004, J MEMBRANE BIOL, V201, P109, DOI 10.1007/s00232-004-0695-6; Cai H, 2006, KIDNEY INT, V69, P2162, DOI 10.1038/sj.ki.5000333; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; COSTANZO LS, 1985, AM J PHYSIOL, V248, pF527, DOI 10.1152/ajprenal.1985.248.4.F527; Darman RB, 2002, J BIOL CHEM, V277, P37542, DOI 10.1074/jbc.M206293200; Darman RB, 2001, J BIOL CHEM, V276, P34359, DOI 10.1074/jbc.C100368200; de Jong JC, 2003, J BIOL CHEM, V278, P24302, DOI 10.1074/jbc.M303101200; De Jong JC, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000017904.77985.03; Delpire E, 2000, NEWS PHYSIOL SCI, V15, P309, DOI 10.1152/physiologyonline.2000.15.6.309; Dowd BFX, 2003, J BIOL CHEM, V278, P27347, DOI 10.1074/jbc.M301899200; ELLISON DH, 1987, AM J PHYSIOL, V253, pF546, DOI 10.1152/ajprenal.1987.253.3.F546; Flatman PW, 2002, BBA-BIOMEMBRANES, V1566, P140, DOI 10.1016/S0005-2736(02)00586-2; Flemmer AW, 2002, J BIOL CHEM, V277, P37551, DOI 10.1074/jbc.M206294200; Gagnon KBE, 2006, AM J PHYSIOL-CELL PH, V290, pC134, DOI 10.1152/ajpcell.00037.2005; GAMBA G, 1993, P NATL ACAD SCI USA, V90, P2749, DOI 10.1073/pnas.90.7.2749; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; GAMBA G, 1994, J BIOL CHEM, V269, P17713; Gillen CM, 1999, AM J PHYSIOL-CELL PH, V276, pC328, DOI 10.1152/ajpcell.1999.276.2.C328; Gimenez I, 2005, AM J PHYSIOL-RENAL, V289, pF1341, DOI 10.1152/ajprenal.00214.2005; Gimenez I, 2003, J BIOL CHEM, V278, P26946, DOI 10.1074/jbc.M303435200; Hebert SC, 2004, PFLUG ARCH EUR J PHY, V447, P580, DOI 10.1007/s00424-003-1066-3; Hoover RS, 2003, J AM SOC NEPHROL, V14, P271, DOI 10.1097/01.ASN.0000043903.93452.D0; Kahle KT, 2005, P NATL ACAD SCI USA, V102, P16783, DOI 10.1073/pnas.0508307102; KEICHER E, 1994, J PHYSIOL-LONDON, V475, P45, DOI 10.1113/jphysiol.1994.sp020048; Kunchaparty S, 1999, AM J PHYSIOL-RENAL, V277, pF643, DOI 10.1152/ajprenal.1999.277.4.F643; Lauf PK, 2000, CELL PHYSIOL BIOCHEM, V10, P341, DOI 10.1159/000016357; Lenertz LY, 2005, J BIOL CHEM, V280, P26653, DOI 10.1074/jbc.M502598200; Lu J, 1999, J NEUROBIOL, V39, P558, DOI 10.1002/(SICI)1097-4695(19990615)39:4<558::AID-NEU9>3.0.CO;2-5; Lytle C, 2002, AM J PHYSIOL-CELL PH, V283, pC1422, DOI 10.1152/ajpcell.00130.2002; Lytle C, 1996, AM J PHYSIOL-CELL PH, V270, pC437, DOI 10.1152/ajpcell.1996.270.2.C437; Mastroianni N, 1996, AM J HUM GENET, V59, P1019; Mayan H, 2002, J CLIN ENDOCR METAB, V87, P3248, DOI 10.1210/jc.87.7.3248; Mercado A, 2004, NEUROCHEM RES, V29, P17, DOI 10.1023/B:NERE.0000010432.44566.21; Monroy A, 2000, AM J PHYSIOL-RENAL, V279, pF161, DOI 10.1152/ajprenal.2000.279.1.F161; Moreno E, 2004, J BIOL CHEM, V279, P16553, DOI 10.1074/jbc.M400602200; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; Piechotta K, 2003, J BIOL CHEM, V278, P52848, DOI 10.1074/jbc.M309436200; Plata C, 2002, J BIOL CHEM, V277, P11004, DOI 10.1074/jbc.M110442200; Plotkin MD, 1996, KIDNEY INT, V50, P174, DOI 10.1038/ki.1996.300; Rinehart J, 2005, P NATL ACAD SCI USA, V102, P16777, DOI 10.1073/pnas.0508303102; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Sabath E, 2004, AM J PHYSIOL-RENAL, V287, pF195, DOI 10.1152/ajprenal.00044.2004; Simon DB, 1996, NAT GENET, V12, P24, DOI 10.1038/ng0196-24; Song LY, 2002, MOL BRAIN RES, V103, P91, DOI 10.1016/S0169-328X(02)00190-0; Subramanya AR, 2006, AM J PHYSIOL-RENAL, V290, pF619, DOI 10.1152/ajprenal.00280.2005; Vazquez N, 2002, AM J PHYSIOL-RENAL, V282, pF599, DOI 10.1152/ajprenal.00284.2001; Vitari AC, 2005, BIOCHEM J, V391, P17, DOI 10.1042/BJ20051180; Wang XY, 2001, J CLIN INVEST, V108, P215, DOI 10.1172/JCI200110366; Wilson FH, 2003, P NATL ACAD SCI USA, V100, P680, DOI 10.1073/pnas.242735399; Xu BE, 2000, J BIOL CHEM, V275, P16795, DOI 10.1074/jbc.275.22.16795; Yang CL, 2003, J CLIN INVEST, V111, P1039, DOI 10.1172/JCI200317443	52	188	191	0	28	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					28755	28763		10.1074/jbc.M603773200	http://dx.doi.org/10.1074/jbc.M603773200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16887815	hybrid			2022-12-27	WOS:000240680500029
J	Yesilaltay, A; Kocher, O; Pal, R; Leiva, A; Quinones, V; Rigotti, A; Krieger, M				Yesilaltay, Ayce; Kocher, Olivier; Pal, Rinku; Leiva, Andrea; Quinones, Veronica; Rigotti, Attilio; Krieger, Monty			PDZK1 is required for maintaining hepatic scavenger receptor, class B, type I (SR-BI) steady state levels but not its surface localization or function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; DOMAIN-CONTAINING PROTEIN; TARGETED DISRUPTION; LIPID-METABOLISM; FREE-CHOLESTEROL; EXPRESSION; HDL; IDENTIFICATION; LIVER; GENE	PDZK1 is a multi-PDZ domain-containing adaptor protein that binds to the C terminus of the high density lipoprotein receptor, scavenger receptor, class B, type I (SR-BI), and controls the posttranscriptional, tissue-specific expression of this lipoprotein receptor. In the absence of PDZK1 (PDZK1(-/-) mice), murine hepatic SR-BI protein levels are very low (< 5% of control). As a consequence, abnormal plasma lipoprotein metabolism (similar to 1.5-1.7-fold increased total plasma cholesterol carried in both normal size and abnormally large high density lipoprotein particles) resembles, but is not as severely defective as, that in SR-BI(-/-) mice. Here we show that the total plasma cholesterol levels and size distribution of lipoproteins are virtually identical in SR-BI(-/-) and SR-BI(-/-)/ PDZK1(-/-) mice, indicating that most, if not all of the effects of PDZK1 on lipoprotein metabolism are likely because of the effects of PDZK1 on SR-BI. Hepatic overexpression of wild-type SR-BI in PDZK1(-/-) mice restored near or greater than normal levels of cell surface-expressed, functional SR-BI protein levels in the livers of SR-BI(-/-)/ PDZK1(-/-) mice and consequently restored apparently normal lipoprotein metabolism in the absence of PDZK1. Thus, PDZK1 is important for maintaining adequate steady state levels of SR-BI in the liver but is not essential for cell surface expression or function of hepatic SR-BI.	MIT, Dept Biol, Cambridge, MA 02139 USA; Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; Pontificia Univ Catolica Chile, Fac Med, Dept Gastroenterol, Santiago 8330024, Chile	Massachusetts Institute of Technology (MIT); Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Pontificia Universidad Catolica de Chile	Krieger, M (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave,Rm 68-483, Cambridge, MA 02139 USA.	krieger@mit.edu			FOGARTY INTERNATIONAL CENTER [R03TW006153] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064737, P01HL066105] Funding Source: NIH RePORTER; FIC NIH HHS [TW006153] Funding Source: Medline; NHLBI NIH HHS [HL66105, HL64737] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Anzai N, 2004, J BIOL CHEM, V279, P45942, DOI 10.1074/jbc.M406724200; Braun A, 2003, P NATL ACAD SCI USA, V100, P7283, DOI 10.1073/pnas.1237725100; Covey SD, 2003, ARTERIOSCL THROM VAS, V23, P1589, DOI 10.1161/01.ATV.0000083343.19940.A0; Gentzsch M, 2003, J BIOL CHEM, V278, P6440, DOI 10.1074/jbc.M211050200; Gisler SM, 2003, KIDNEY INT, V64, P1733, DOI 10.1046/j.1523-1755.2003.00266.x; Gisler SM, 2001, J BIOL CHEM, V276, P9206, DOI 10.1074/jbc.M008745200; GLASS C, 1983, P NATL ACAD SCI-BIOL, V80, P5435, DOI 10.1073/pnas.80.17.5435; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Ikemoto M, 2000, P NATL ACAD SCI USA, V97, P6538, DOI 10.1073/pnas.100114397; Ji Y, 1997, J BIOL CHEM, V272, P20982, DOI 10.1074/jbc.272.34.20982; Ji Y, 1999, J BIOL CHEM, V274, P33398, DOI 10.1074/jbc.274.47.33398; Jian B, 1998, J BIOL CHEM, V273, P5599, DOI 10.1074/jbc.273.10.5599; Kato Y, 2005, MOL PHARMACOL, V67, P734, DOI 10.1124/mol.104.002212; Kato Y, 2004, PHARM RES-DORDR, V21, P1886, DOI 10.1023/B:PHAM.0000045244.83999.43; Kocher O, 1998, LAB INVEST, V78, P117; Kocher O, 2003, J BIOL CHEM, V278, P52820, DOI 10.1074/jbc.M310482200; Kocher O, 2003, MOL CELL BIOL, V23, P1175, DOI 10.1128/MCB.23.4.1175-1180.2003; Kocher O, 1999, LAB INVEST, V79, P1161; KONOPKA JB, 1991, CELL REGUL, V2, P439, DOI 10.1091/mbc.2.6.439; Kozarsky KF, 1997, NATURE, V387, P414, DOI 10.1038/387414a0; Landschulz KT, 1996, J CLIN INVEST, V98, P984, DOI 10.1172/JCI118883; Mardones P, 2003, J BIOL CHEM, V278, P7884, DOI 10.1074/jbc.M211627200; Mardones P, 2001, J LIPID RES, V42, P170; Miettinen HE, 2001, J CLIN INVEST, V108, P1717, DOI 10.1172/JCI13288; Nakamura T, 2005, P NATL ACAD SCI USA, V102, P13404, DOI 10.1073/pnas.0506679102; PALMITER RD, 1986, ANNU REV GENET, V20, P465, DOI 10.1146/annurev.ge.20.120186.002341; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Rigotti A, 2003, ENDOCR REV, V24, P357, DOI 10.1210/er.2001-0037; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; ROTHMAN JH, 1986, P NATL ACAD SCI USA, V83, P3248, DOI 10.1073/pnas.83.10.3248; Silver DL, 2002, J BIOL CHEM, V277, P34042, DOI 10.1074/jbc.M206584200; SIMONET WS, 1993, J BIOL CHEM, V268, P8221; Stangl H, 2002, J ENDOCRINOL, V175, P663, DOI 10.1677/joe.0.1750663; STEIN Y, 1983, BIOCHIM BIOPHYS ACTA, V752, P98, DOI 10.1016/0005-2760(83)90237-0; Sun BM, 2004, MOL BIOL CELL, V15, P1397, DOI 10.1091/mbc.E03-09-0682; Temel RE, 1997, P NATL ACAD SCI USA, V94, P13600, DOI 10.1073/pnas.94.25.13600; Thomson RB, 2005, P NATL ACAD SCI USA, V102, P13331, DOI 10.1073/pnas.0506578102; Trigatti B, 1999, P NATL ACAD SCI USA, V96, P9322, DOI 10.1073/pnas.96.16.9322; Trigatti BL, 2003, ARTERIOSCL THROM VAS, V23, P1732, DOI 10.1161/01.ATV.0000091363.28501.84; Ueda Y, 2000, J BIOL CHEM, V275, P20368, DOI 10.1074/jbc.M000730200; Ueda Y, 1999, J BIOL CHEM, V274, P7165, DOI 10.1074/jbc.274.11.7165; Van Eck M, 2003, J BIOL CHEM, V278, P23699, DOI 10.1074/jbc.M211233200; Wang N, 1998, J BIOL CHEM, V273, P32920, DOI 10.1074/jbc.273.49.32920; Wang SS, 2000, CELL, V103, P169, DOI 10.1016/S0092-8674(00)00096-9; Wente W, 2005, J BIOL CHEM, V280, P32419, DOI 10.1074/jbc.M507198200; Yancey PG, 2000, J BIOL CHEM, V275, P36596, DOI 10.1074/jbc.M006924200; Yesilaltay A, 2006, ENDOCRINOLOGY, V147, P1577, DOI 10.1210/en.2005-1286; Yesilaltay A, 2005, CURR OPIN LIPIDOL, V16, P147, DOI 10.1097/01.mol.0000162319.54795.e5; Zhang SW, 2005, CIRCULATION, V111, P3457, DOI 10.1161/CIRCULATIONAHA.104.523563	50	40	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					28975	28980		10.1074/jbc.M603802200	http://dx.doi.org/10.1074/jbc.M603802200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16867981	hybrid			2022-12-27	WOS:000240680500052
J	Liew, CW; Rand, KD; Simpson, RJY; Yung, WW; Mansfield, RE; Crossley, M; Proetorius-Ibba, M; Nerlov, C; Poulsen, FM; Mackay, JP				Liew, Chu Wai; Rand, Kasper D.; Simpson, Raina J. Y.; Yung, Wendy W.; Mansfield, Robyn E.; Crossley, Merlin; Proetorius-Ibba, Mette; Nerlov, Claus; Poulsen, Flemming M.; Mackay, Joel P.			Molecular analysis of the interaction between the hematopoietic master transcription factors GATA-1 and PU.1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING; ERYTHROID-DIFFERENTIATION; ERYTHROLEUKEMIA-CELLS; FAMILY PROTEINS; ETS-DOMAIN; EXPRESSION; ACETYLATION; ACTIVATION; SPI-1/PU.1; INHIBITION	GATA-1 and PU.1 are transcription factors that control erythroid and myeloid development, respectively. The two proteins have been shown to function in an antagonistic fashion, with GATA-1 repressing PU.1 activity during erythropoiesis and PU.1 repressing GATA-1 function during myelopoiesis. It has also become clear that this functional antagonism involves direct interactions between the two proteins. However, the molecular basis for these interactions is not known, and a number of inconsistencies exist in the literature. We have used a range of biophysical methods to define the molecular details of the GATA-1-PU.1 interaction. A combination of NMR titration data and extensive mutagenesis revealed that the PU.1-Ets domain and the GATA-1 C-terminal zinc finger (CF) form a low affinity interaction in which specific regions of each protein are implicated. Surprisingly, the interaction cannot be disrupted by single alanine substitution mutations, suggesting that binding is distributed over an extended interface. The C-terminal basic tail region of CF appears to be sufficient to mediate an interaction with PU.1-Ets, and neither acetylation nor phosphorylation of a peptide corresponding to this region disrupts binding, indicating that the interaction is not dominated by electrostatic interactions. The CF basic tail shares significant sequence homology with the PU.1 interacting motif from c-Jun, suggesting that GATA-1 and c-Jun might compete to bind PU.1. Taken together, our data provide a molecular perspective on the GATA-1-PU.1 interaction, resolving several issues in the existing data and providing insight into the mechanisms through which these two proteins combine to regulate blood development.	Univ Copenhagen, Inst Mol Biol, Dept Prot Chem, DK-1168 Copenhagen, Denmark; Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia; Univ Copenhagen Hosp, Lab Gene Therapy Res, DK-2100 Copenhagen, Denmark; European Mol Biol Lab, Mouse Biol Unit, I-00016 Monterotondo, Italy	University of Copenhagen; University of Sydney; University of Copenhagen; European Molecular Biology Laboratory (EMBL)	Poulsen, FM (corresponding author), Univ Copenhagen, Inst Mol Biol, Dept Prot Chem, DK-1168 Copenhagen, Denmark.	fmp@apk.molbio.ku.dk	Crossley, Merlin/D-7888-2011; Mackay, Joel P/D-6834-2011; Rand, Kasper/ABG-7446-2021; Poulsen, Flemming M/E-6848-2010	Crossley, Merlin/0000-0003-2057-3642; Mackay, Joel P/0000-0001-7508-8033; Simpson, Richard/0000-0002-9834-0796; Rand, Kasper/0000-0002-6337-5489				Ayed A, 2001, NAT STRUCT BIOL, V8, P756, DOI 10.1038/nsb0901-756; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; BASSUK AG, 1995, IMMUNITY, V3, P223, DOI 10.1016/1074-7613(95)90092-6; Behre G, 1999, J BIOL CHEM, V274, P4939, DOI 10.1074/jbc.274.8.4939; Blobel GA, 1998, P NATL ACAD SCI USA, V95, P2061, DOI 10.1073/pnas.95.5.2061; Boyes J, 1998, NATURE, V396, P594, DOI 10.1038/25166; Cai ML, 1998, J BIOMOL NMR, V11, P97, DOI 10.1023/A:1008222131470; Cantor AB, 2001, CURR OPIN GENET DEV, V11, P513, DOI 10.1016/S0959-437X(00)00226-4; Carrere S, 1998, ONCOGENE, V16, P3261, DOI 10.1038/sj.onc.1201868; CROSSLEY M, 1994, J BIOL CHEM, V269, P16589; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eisbacher M, 2003, MOL CELL BIOL, V23, P3427, DOI 10.1128/MCB.23.10.3427-3441.2003; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; GALSON DL, 1993, MOL CELL BIOL, V13, P2929, DOI 10.1128/MCB.13.5.2929; GODDARD TD, 2001, SPARKY, V3; GRUENEBERG DA, 1992, SCIENCE, V257, P1089, DOI 10.1126/science.257.5073.1089; GUERRASIO A, 1994, LEUKEMIA, V8, P1034; HENKEL G, 1994, P NATL ACAD SCI USA, V91, P7737, DOI 10.1073/pnas.91.16.7737; Hong W, 2002, MOL CELL BIOL, V22, P3729, DOI 10.1128/MCB.22.11.3729-3743.2002; Hung HL, 1999, MOL CELL BIOL, V19, P3496; Jia X, 1999, J MOL BIOL, V292, P1083, DOI 10.1006/jmbi.1999.3123; Kambach C, 1999, CELL, V96, P375, DOI 10.1016/S0092-8674(00)80550-4; Kodandapani R, 1996, NATURE, V380, P456, DOI 10.1038/380456a0; Kowalski K, 2002, J BIOL CHEM, V277, P35720, DOI 10.1074/jbc.M204663200; KULESSA H, 1995, GENE DEV, V9, P1250, DOI 10.1101/gad.9.10.1250; MARTIN DIK, 1990, GENE DEV, V4, P1886, DOI 10.1101/gad.4.11.1886; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; MERIKA M, 1995, MOL CELL BIOL, V15, P2437; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; MoreauGachelin F, 1996, MOL CELL BIOL, V16, P2453; MOREAUGACHELIN F, 1989, ONCOGENE, V4, P1449; NAGULAPALLI S, 1995, J IMMUNOL, V155, P4330; Nemoto Y, 1996, J BIOL CHEM, V271, P13542, DOI 10.1074/jbc.271.23.13542; Nerlov C, 2000, BLOOD, V95, P2543, DOI 10.1182/blood.V95.8.2543.008k19_2543_2551; OMICHINSKI JG, 1993, SCIENCE, V261, P438, DOI 10.1126/science.8332909; Petrovick HS, 1998, MOL CELL BIOL, V18, P3915, DOI 10.1128/MCB.18.7.3915; Rao G, 1997, ONCOGENE, V14, P123, DOI 10.1038/sj.onc.1200807; Rekhtman N, 1999, GENE DEV, V13, P1398, DOI 10.1101/gad.13.11.1398; Rekhtman N, 2003, MOL CELL BIOL, V23, P7460, DOI 10.1128/MCB.23.21.7460-7474.2003; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Simpson RJY, 2003, J BIOL CHEM, V278, P28011, DOI 10.1074/jbc.M211146200; Stopka T, 2005, EMBO J, V24, P3712, DOI 10.1038/sj.emboj.7600834; Vangala RK, 2003, BLOOD, V101, P270, DOI 10.1182/blood-2002-04-1288; Velyvis A, 2003, NAT STRUCT BIOL, V10, P558, DOI 10.1038/nsb938; VISVADER JE, 1992, EMBO J, V11, P4557, DOI 10.1002/j.1460-2075.1992.tb05557.x; Worrall JAR, 2003, BIOCHEMISTRY-US, V42, P7068, DOI 10.1021/bi0342968; Yamada T, 1997, BLOOD, V89, P1383, DOI 10.1182/blood.V89.4.1383; Zhang P, 1999, P NATL ACAD SCI USA, V96, P8705, DOI 10.1073/pnas.96.15.8705; Zimmerman DE, 1997, J MOL BIOL, V269, P592, DOI 10.1006/jmbi.1997.1052	49	50	53	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					28296	28306		10.1074/jbc.M602830200	http://dx.doi.org/10.1074/jbc.M602830200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16861236	hybrid			2022-12-27	WOS:000240534400067
J	Garrey, SM; Voelker, R; Berglund, JA				Garrey, Stephen M.; Voelker, Rodger; Berglund, J. Andrew			An extended RNA binding site for the yeast branch point-binding protein and the role of its zinc knuckle domains in RNA binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; HIV-1 NUCLEOCAPSID PROTEIN; IMMUNODEFICIENCY-VIRUS TYPE-1; KH-DOMAIN; SACCHAROMYCES-CEREVISIAE; STAR PROTEIN; C-ELEGANS; IN-VIVO; THERMODYNAMIC PARAMETERS; SECONDARY STRUCTURE	The highly conserved branch point sequence (BPS) of UAC-UAAC in Saccharomyces cerevisiae is initially recognized by the branch point-binding protein (BBP). Using systematic evolution of ligands by exponential enrichment we have determined that yeast BBP binds the branch point sequence UACUAAC with highest affinity and prefers an additional adenosine downstream of the BPS. Furthermore, we also found that a stem-loop upstream of the BPS enhances binding both to an artificially designed RNA(30-fold effect) and to an RNA from a yeast intron (3-fold effect). The zinc knuckles of BBP are partially responsible for the enhanced binding to the stem-loop but do not appear to have a significant role in the binding of BBP to single-strand RNA substrates. C-terminal deletions of BBP reveal that the linker regions between the two zinc knuckles and between the N-terminal RNA binding domains (KH and QUA2 domains) and the first zinc knuckle are important for binding to RNA. The lack of involvement of the second highly conserved zinc knuckle in RNA binding suggests that this zinc knuckle plays a different role in RNA processing than enhancing the binding of BBP to the BPS.	Univ Oregon, Dept Chem, Eugene, OR 97403 USA; Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA	University of Oregon; University of Oregon	Berglund, JA (corresponding author), Univ Oregon, Dept Chem, Eugene, OR 97403 USA.	aberglund@molbio.uoregon.edu	Berglund, Andrew/AAS-1065-2021		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007759] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-07759] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abovich N, 1997, CELL, V89, P403, DOI 10.1016/S0092-8674(00)80221-4; ANTAO VP, 1992, NUCLEIC ACIDS RES, V20, P819, DOI 10.1093/nar/20.4.819; ANTAO VP, 1991, NUCLEIC ACIDS RES, V19, P5901, DOI 10.1093/nar/19.21.5901; Berglund JA, 1997, NUCLEIC ACIDS RES, V25, P1042, DOI 10.1093/nar/25.5.1042; Berglund JA, 1998, RNA, V4, P998, DOI 10.1017/S1355838298980499; Berglund JA, 1997, CELL, V89, P781, DOI 10.1016/S0092-8674(00)80261-5; Berglund JA, 1998, GENE DEV, V12, P858, DOI 10.1101/gad.12.6.858; BERKOWITZ RD, 1995, J VIROL, V69, P6445, DOI 10.1128/JVI.69.10.6445-6456.1995; BERKOWITZ RD, 1993, J VIROL, V67, P7190, DOI 10.1128/JVI.67.12.7190-7200.1993; BERKOWITZ RD, 1994, VIROLOGY, V202, P233, DOI 10.1006/viro.1994.1339; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Cavaloc Y, 1999, RNA, V5, P468, DOI 10.1017/S1355838299981967; Charpentier B, 1996, RNA, V2, P509; Chen TP, 1998, MOL CELL BIOL, V18, P4863, DOI 10.1128/MCB.18.8.4863; Chen TP, 1997, MOL CELL BIOL, V17, P5707, DOI 10.1128/MCB.17.10.5707; CLEVER J, 1995, J VIROL, V69, P2101, DOI 10.1128/JVI.69.4.2101-2109.1995; Clifford R, 2000, DEVELOPMENT, V127, P5265; DANNULL J, 1994, EMBO J, V13, P1525, DOI 10.1002/j.1460-2075.1994.tb06414.x; De Guzman RN, 1998, SCIENCE, V279, P384, DOI 10.1126/science.279.5349.384; Di Fruscio M, 1998, J BIOL CHEM, V273, P30122, DOI 10.1074/jbc.273.46.30122; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Fleckner J, 1997, GENE DEV, V11, P1864, DOI 10.1101/gad.11.14.1864; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Galarneau A, 2005, NAT STRUCT MOL BIOL, V12, P691, DOI 10.1038/nsmb963; GIBSON TJ, 1993, FEBS LETT, V324, P361, DOI 10.1016/0014-5793(93)80152-K; Howe KJ, 1997, P NATL ACAD SCI USA, V94, P12467, DOI 10.1073/pnas.94.23.12467; Jan E, 1999, EMBO J, V18, P258, DOI 10.1093/emboj/18.1.258; Jensen KB, 2000, P NATL ACAD SCI USA, V97, P5740, DOI 10.1073/pnas.090553997; Kuwabara PE, 2001, BIOESSAYS, V23, P596, DOI 10.1002/bies.1085; Larocque D, 2005, NAT NEUROSCI, V8, P27, DOI 10.1038/nn1359; Larocque D, 2002, NEURON, V36, P815, DOI 10.1016/S0896-6273(02)01055-3; Lehmann-Blount KA, 2005, J MOL BIOL, V346, P91, DOI 10.1016/j.jmb.2004.11.049; Li ZZ, 2000, J NEUROSCI, V20, P4944; LIBRI D, 1995, RNA, V1, P425; Lin KT, 2004, MOL CELL BIOL, V24, P9176, DOI 10.1128/MCB.24.20.9176-9185.2004; Lin Q, 1997, J BIOL CHEM, V272, P27274, DOI 10.1074/jbc.272.43.27274; Liu ZH, 2001, SCIENCE, V294, P1098, DOI 10.1126/science.1064719; Lopez PJ, 1999, RNA, V5, P1135, DOI 10.1017/S135583829999091X; Lukong KE, 2003, BBA-REV CANCER, V1653, P73, DOI 10.1016/j.bbcan.2003.09.001; Maguire ML, 2005, J MOL BIOL, V348, P265, DOI 10.1016/j.jmb.2005.02.058; Manceau V, 2006, FEBS J, V273, P577, DOI 10.1111/j.1742-4658.2005.05091.x; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; MICHAUD S, 1991, GENE DEV, V5, P2534, DOI 10.1101/gad.5.12b.2534; Morellet N, 1998, J MOL BIOL, V283, P419, DOI 10.1006/jmbi.1998.2098; NEWMAN A, 1987, EMBO J, V6, P3833, DOI 10.1002/j.1460-2075.1987.tb02720.x; Rain JC, 1997, EMBO J, V16, P1759, DOI 10.1093/emboj/16.7.1759; Rain JC, 1998, RNA, V4, P551, DOI 10.1017/S1355838298980335; Rutz B, 1999, RNA, V5, P819, DOI 10.1017/S1355838299982286; Ryder SP, 2004, RNA, V10, P1449, DOI 10.1261/rna.7780504; Ryder SP, 2004, NAT STRUCT MOL BIOL, V11, P20, DOI 10.1038/nsmb706; Saccomanno L, 1999, P NATL ACAD SCI USA, V96, P12605, DOI 10.1073/pnas.96.22.12605; Schumacher B, 2005, CELL, V120, P357, DOI 10.1016/j.cell.2004.12.009; SERAPHIN B, 1989, CELL, V59, P349, DOI 10.1016/0092-8674(89)90296-1; SIOMI H, 1993, NUCLEIC ACIDS RES, V21, P1193, DOI 10.1093/nar/21.5.1193; SMITH CWJ, 1998, RNA PROTEIN INTERACT, P40; Spingola M, 1999, RNA, V5, P221, DOI 10.1017/S1355838299981682; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; TUERK C, 1988, P NATL ACAD SCI USA, V85, P1364, DOI 10.1073/pnas.85.5.1364; Valcarcel J, 1996, SCIENCE, V273, P1706, DOI 10.1126/science.273.5282.1706; Vernet C, 1997, TRENDS GENET, V13, P479, DOI 10.1016/S0168-9525(97)01269-9; Wu J, 1999, J BIOL CHEM, V274, P29202, DOI 10.1074/jbc.274.41.29202; Wu JI, 2002, P NATL ACAD SCI USA, V99, P4233, DOI 10.1073/pnas.072090399; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	63	24	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2006	281	37					27443	27453		10.1074/jbc.M603137200	http://dx.doi.org/10.1074/jbc.M603137200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082PB	16861232	hybrid			2022-12-27	WOS:000240397700071
J	Dehe, PM; Dichtl, B; Schaft, D; Roguev, A; Pamblanco, M; Lebrun, R; Rodriguez-Gil, A; Mkandawire, M; Landsberg, K; Shevchenko, A; Shevchenko, A; Rosaleny, LE; Tordera, V; Chavez, S; Stewart, AF; Geli, V				Dehe, Pierre-Marie; Dichtl, Bernhard; Schaft, Daniel; Roguev, Assen; Pamblanco, Merce; Lebrun, Regine; Rodriguez-Gil, Alfonso; Mkandawire, Msau; Landsberg, Katarina; Shevchenko, Anna; Shevchenko, Andrej; Rosaleny, Lorena E.; Tordera, Vicente; Chavez, Sebastian; Stewart, A. Francis; Geli, Vincent			Protein interactions within the Set1 complex and their roles in the regulation of histone 3 lysine 4 methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; H3 LYSINE-4; METHYLTRANSFERASE COMPLEX; PAF1 COMPLEX; TRANSCRIPTIONAL ELONGATION; H2B UBIQUITYLATION; TRITHORAX FAMILY; COMPASS; UBIQUITINATION; TRIMETHYLATION	Set1 is the catalytic subunit and the central component of the evolutionarily conserved Set1 complex (Set1C) that methylates histone 3 lysine 4 (H3K4). Here we have determined protein/protein interactions within the complex and related the substructure to function. The loss of individual Set1 C subunits differentially affects Set1 stability, complex integrity, global H3K4 methylation, and distribution of H3K4 methylation along active genes. The complex requires Set1, Swd1, and Swd3 for integrity, and Set1 amount is greatly reduced in the absence of the Swd1-Swd3 heterodimer. Bre2 and Sdc1 also form a heteromeric subunit, which requires the SET domain for interaction with the complex, and Sdc1 strongly interacts with itself. Inactivation of either Bre2 or Sdc1 has very similar effects. Neither is required for complex integrity, and their removal results in an increase of H3K4 mono- and dimethylation and a severe decrease of trimethylation at the 5' end of active coding regions but a decrease of H3K4 dimethylation at the 3' end of coding regions. Cells lacking Spp1 have a reduced amount of Set1 and retain a fraction of trimethylated H3K4, whereas cells lacking Shg1 show slightly elevated levels of both di- and trimethylation. Set1C associates with both serine 5- and serine 2-phosphorylated forms of polymerase II, indicating that the association persists to the 3' end of transcribed genes. Taken together, our results suggest that Set1C subunits stimulate Set1 catalytic activity all along active genes.	Tech Univ Dresden, Biotec Res Ctr, BioInnovat Zentrum, D-01307 Dresden, Germany; Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; Univ Zurich, Inst Mol Biol, CH-8057 Zurich, Switzerland; CNRS, Lab Instabilite Genome & Cancerogenese, Inst Biol Struct & Microbiol, F-13402 Marseille, France; Univ Valencia, Dept Bioquim & Biol Mol, E-46100 Burjassot, Spain; Univ Seville, Fac Biol, Dept Genet, E-41012 Seville, Spain	Technische Universitat Dresden; Max Planck Society; University of Zurich; Centre National de la Recherche Scientifique (CNRS); University of Valencia; University of Sevilla	Stewart, AF (corresponding author), Tech Univ Dresden, Biotec Res Ctr, BioInnovat Zentrum, Am Tatzberg 47, D-01307 Dresden, Germany.	stewart@biotec.tu-dresden.de; geli@ibsm.cnrs-mrs.fr	Pamblanco, Merce/H-6688-2015; Stewart, A. Francis/E-7789-2010; IBIS, GENICA/O-1906-2015; Dehe, Pierre-Marie/D-4135-2017; Chavez, Sebastian S/F-7574-2011; Rodríguez-Gil, Alfonso/O-2475-2016; Rosaleny, Lorena E./AAF-6352-2019	Pamblanco, Merce/0000-0003-0180-5751; Dehe, Pierre-Marie/0000-0003-1558-6983; Chavez, Sebastian S/0000-0002-8064-4839; Rodríguez-Gil, Alfonso/0000-0003-4430-077X; Rosaleny, Lorena E./0000-0002-8481-7303; Dichtl, Bernhard/0000-0001-5514-4982				Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Bryk M, 2002, CURR BIOL, V12, P165, DOI 10.1016/S0960-9822(01)00652-2; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; Carvin CD, 2004, J BIOL CHEM, V279, P33057, DOI 10.1074/jbc.M405033200; Cheng HL, 2004, MOL CELL BIOL, V24, P2932, DOI 10.1128/MCB.24.7.2932-2943.2004; Corda Y, 1999, NAT GENET, V21, P204, DOI 10.1038/5991; Dehe PM, 2005, J MOL BIOL, V353, P477, DOI 10.1016/j.jmb.2005.08.059; Dichtl E, 2004, RNA, V10, P965, DOI 10.1261/rna.7090104; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; Gildea JJ, 2000, GENETICS, V156, P645; Gully D, 2006, PROTEOMICS, V6, P282, DOI 10.1002/pmic.200500115; HSU DR, 1995, DEVELOPMENT, V121, P3323; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Karimova G, 2005, J BACTERIOL, V187, P2233, DOI 10.1128/JB.187.7.2233-2243.2005; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Krogan NJ, 2002, J BIOL CHEM, V277, P10753, DOI 10.1074/jbc.C200023200; Laribee RN, 2005, CURR BIOL, V15, P1487, DOI 10.1016/j.cub.2005.07.028; Lee JH, 2005, J BIOL CHEM, V280, P41725, DOI 10.1074/jbc.M508312200; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Morillon A, 2005, MOL CELL, V18, P723, DOI 10.1016/j.molcel.2005.05.009; Mueller CL, 2004, MOL CELL, V14, P447, DOI 10.1016/S1097-2765(04)00257-6; Nagy PL, 2002, P NATL ACAD SCI USA, V99, P90, DOI 10.1073/pnas.221596698; Newlon MG, 1999, NAT STRUCT BIOL, V6, P222; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Ng HH, 2003, J BIOL CHEM, V278, P33625, DOI 10.1074/jbc.C300270200; Nislow C, 1997, MOL BIOL CELL, V8, P2421, DOI 10.1091/mbc.8.12.2421; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Poveda A, 2004, J BIOL CHEM, V279, P16033, DOI 10.1074/jbc.M314228200; Roguev A, 2004, MOL CELL PROTEOMICS, V3, P125, DOI 10.1074/mcp.M300081-MCP200; Roguev A, 2003, J BIOL CHEM, V278, P8487, DOI 10.1074/jbc.M209562200; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Santos-Rosa H, 2004, J BIOL CHEM, V279, P47506, DOI 10.1074/jbc.M407949200; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schlichter A, 2005, EMBO J, V24, P1222, DOI 10.1038/sj.emboj.7600607; Schneider J, 2005, MOL CELL, V19, P849, DOI 10.1016/j.molcel.2005.07.024; Shahbazian MD, 2005, MOL CELL, V19, P271, DOI 10.1016/j.molcel.2005.06.010; Sollier J, 2004, EMBO J, V23, P1957, DOI 10.1038/sj.emboj.7600204; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Tresaugues L, 2006, J MOL BIOL, V359, P1170, DOI 10.1016/j.jmb.2006.04.050; Wood A, 2005, MOL CELL, V20, P589, DOI 10.1016/j.molcel.2005.09.010; Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Zhang K, 2005, CELL, V122, P723, DOI 10.1016/j.cell.2005.06.021; Zhang L, 2005, EMBO J, V24, P2379, DOI 10.1038/sj.emboj.7600711	48	115	119	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					35404	35412		10.1074/jbc.M603099200	http://dx.doi.org/10.1074/jbc.M603099200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16921172	Green Published, hybrid			2022-12-27	WOS:000241933700074
J	Broniowska, KA; Zhang, YH; Hogg, N				Broniowska, Katarzyna A.; Zhang, Yanhong; Hogg, Neil			Requirement of transmembrane transport for S-nitrosocysteine-dependent modification of intracellular thiols	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; L-CYSTEINE; IN-VIVO; NITROSOTHIOL FORMATION; NORADRENALINE RELEASE; ENDOTHELIAL-CELLS; RAT HIPPOCAMPUS; NITROSOGLUTATHIONE; NITROSYLATION; MECHANISMS	S-Nitrosothiols have been implicated as intermediary transducers of nitric oxide bioactivity; however, the mechanisms by which these compounds affect cellular functions have not been fully established. In this study, we have examined the effect of S-nitrosothiol transport on intracellular thiol status and upon the activity of a target protein (caspase-3), in bovine aortic endothelial cells. We have previously demonstrated that the specific transport of amino acid-based S-nitrosothiols (S-nitroso-L-cysteine and S-nitrosohomocysteine) occurs via amino acid transport system L to generate high levels of intracellular protein S-nitrosothiols (Zhang, Y., and Hogg, N. (2004) Proc. Natl. Acad. Sci. U. S. A. 101, 7891 - 7896). In this study, we demonstrate that the transport of S-nitrosothiols is essential for these compounds to affect intracellular thiol levels and to modify intracellular protein activity. Importantly, the ability of these compounds to affect intracellular processes occurs independently of nitric oxide formation. These findings suggest that the major action of these compounds is not to liberate nitric oxide in the extracellular space but to be specifically transported into cells where they are able to modify cellular functions through nitric oxide-independent mechanisms.	Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Free Rad Res Ctr, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin	Hogg, N (corresponding author), Med Coll Wisconsin, Dept Biophys, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	nhogg@mcw.edu		Broniowska, Katarzyna/0000-0002-8000-9093	NIGMS NIH HHS [R29 GM055792, GM55792, R01 GM055792, R01 GM055792-10A2] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM055792, R01GM055792] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANTONINI E, 1971, FRONT BIOL, P1; Bryan NS, 2004, P NATL ACAD SCI USA, V101, P4308, DOI 10.1073/pnas.0306706101; Butzer U, 1999, FEBS LETT, V445, P274, DOI 10.1016/S0014-5793(99)00139-8; Crawford JH, 2004, BLOOD, V104, P1375, DOI 10.1182/blood-2004-03-0880; Davisson RL, 1996, CIRC RES, V79, P256, DOI 10.1161/01.RES.79.2.256; FIELD L, 1978, J CHEM SOC CHEM COMM, P249, DOI 10.1039/c39780000249; Gordge MP, 1998, BIOCHEM PHARMACOL, V55, P657, DOI 10.1016/S0006-2952(97)00498-X; HART TW, 1985, TETRAHEDRON LETT, V26, P2013, DOI 10.1016/S0040-4039(00)98368-0; Inoue K, 1999, J BIOL CHEM, V274, P27069, DOI 10.1074/jbc.274.38.27069; Jensen DE, 1998, BIOCHEM J, V331, P659, DOI 10.1042/bj3310659; Jourd'heuil D, 2000, BIOCHEM BIOPH RES CO, V273, P22, DOI 10.1006/bbrc.2000.2892; Kettenhofen N, 2005, FREE RADICAL BIO MED, V39, pS101; Kim YM, 1997, J BIOL CHEM, V272, P31138, DOI 10.1074/jbc.272.49.31138; LANDER HM, 1997, J BIOL CHEM, V272, P7323; Li HF, 1999, AM J PHYSIOL-CELL PH, V276, pC803, DOI 10.1152/ajpcell.1999.276.4.C803; Li S, 2005, J BIOL CHEM, V280, P20102, DOI 10.1074/jbc.M413164200; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; Mannick JB, 2001, J CELL BIOL, V154, P1111, DOI 10.1083/jcb.200104008; Mannick JB, 1999, SCIENCE, V284, P651, DOI 10.1126/science.284.5414.651; Marshall HE, 2001, BIOCHEMISTRY-US, V40, P1688, DOI 10.1021/bi002239y; Moellering D, 1999, FEBS LETT, V448, P292, DOI 10.1016/S0014-5793(99)00371-3; Poteser M, 2001, J BIOL CHEM, V276, P14797, DOI 10.1074/jbc.M008244200; Que LG, 2005, SCIENCE, V308, P1618, DOI 10.1126/science.1108228; Reynaert NL, 2004, P NATL ACAD SCI USA, V101, P8945, DOI 10.1073/pnas.0400588101; Rossig L, 1999, J BIOL CHEM, V274, P6823, DOI 10.1074/jbc.274.11.6823; Satoh S, 1997, J NEUROCHEM, V69, P2197; Satoh S, 1996, J CELL PHYSIOL, V169, P87, DOI 10.1002/(SICI)1097-4652(199610)169:1<87::AID-JCP9>3.0.CO;2-A; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P7674, DOI 10.1073/pnas.89.16.7674; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; Stamler JS, 1997, NEURON, V18, P691, DOI 10.1016/S0896-6273(00)80310-4; TOYOOKA T, 1983, J CHROMATOGR, V282, P495, DOI 10.1016/S0021-9673(00)91626-1; Wang SW, 2004, J BIOL CHEM, V279, P25535, DOI 10.1074/jbc.M400944200; Wang XD, 2004, P NATL ACAD SCI USA, V101, P11477, DOI 10.1073/pnas.0402201101; Zaman K, 2004, BIOCHEM J, V380, P67, DOI 10.1042/BJ20031687; Zeigler MM, 2003, J BIOL CHEM, V278, P12894, DOI 10.1074/jbc.M213125200; Zeng H, 2001, AM J PHYSIOL-HEART C, V281, pH432, DOI 10.1152/ajpheart.2001.281.1.H432; Zhang YH, 2005, FREE RADICAL BIO MED, V38, P874, DOI 10.1016/j.freeradbiomed.2004.12.012; Zhang YH, 2004, P NATL ACAD SCI USA, V101, P7891, DOI 10.1073/pnas.0401167101; Zhang YH, 2004, AM J PHYSIOL-LUNG C, V287, pL467, DOI 10.1152/ajplung.00350.2003	39	34	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					33835	33841		10.1074/jbc.M603248200	http://dx.doi.org/10.1074/jbc.M603248200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16893892	Green Accepted, hybrid			2022-12-27	WOS:000241767600004
J	Attrill, H; Imamura, A; Sharma, RS; Kiso, M; Crocker, PR; van Aalten, DMF				Attrill, Helen; Imamura, Akihiro; Sharma, Ritu S.; Kiso, Makoto; Crocker, Paul R.; van Aalten, Daan M. F.			Siglec-7 undergoes a major conformational change when complexed with the alpha(2,8)-disialylganglioside GT1b	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; MOLECULAR-DYNAMICS SIMULATIONS; MOUSE MONOCLONAL-ANTIBODY; NATURAL-KILLER-CELLS; IMMUNOGLOBULIN SUPERFAMILY; CD33-RELATED SIGLECS; CONFORMER SELECTION; INHIBITORY RECEPTOR; GANGLIOSIDE GD3; BINDING DOMAIN	The siglecs are a group of mammalian sialic acid binding receptors expressed predominantly in the immune system. The CD33-related siglecs show complex recognition patterns for sialylated glycans. Siglec-7 shows a preference for alpha(2,8)-disialylated ligands and provides a structural template for studying the key interactions that drive this selectivity. We have co-crystallized Siglec-7 with a synthetic oligosaccharide corresponding to the alpha(2,8)-disialylated ganglioside GT1b. The crystal structure of the complex offers a first glimpse into how this important family of lectins binds the structurally diverse gangliosides. The structure reveals that the C-C' loop, a region implicated in previous studies as driving siglec specificity, undergoes a dramatic conformational shift, allowing it to interact with the underlying neutral glycan core of the ganglioside. The structural data in combination with mutagenesis studies show that binding of the ganglioside is driven by extensive hydrophobic contacts together with key polar interactions and that the binding site structure is complementary to preferred solution conformations of GT1b.	Univ Dundee, Sch Life Sci, Div Biol Chem & Mol Microbiol, Dundee DD1 5EH, Scotland; Univ Dundee, Sch Life Sci, Div Cell Biol & Immunol, Dundee DD1 5EH, Scotland; Gifu Univ, Dept Appl Bioorgan Chem, Fac Appl Biol Sci, Gifu 5011193, Japan	University of Dundee; University of Dundee; Gifu University	van Aalten, DMF (corresponding author), Univ Dundee, Sch Life Sci, Div Biol Chem & Mol Microbiol, Dundee DD1 5EH, Scotland.	dava@davapc1.bioch.dundee.ac.uk		Attrill, Helen/0000-0003-3212-6364; van Aalten, Daan/0000-0002-1499-6908; Crocker, Paul/0000-0001-6230-0293	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 62116] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alphey MS, 2003, J BIOL CHEM, V278, P3372, DOI 10.1074/jbc.M210602200; Angata T, 2000, GLYCOBIOLOGY, V10, P431, DOI 10.1093/glycob/10.4.431; Angata T, 2002, BBA-GEN SUBJECTS, V1572, P294, DOI 10.1016/S0304-4165(02)00316-1; Attrill H, 2006, BIOCHEM J, V397, P271, DOI 10.1042/BJ20060103; Avril T, 2004, J IMMUNOL, V173, P6841, DOI 10.4049/jimmunol.173.11.6841; AVRIL T, 2006, IN PRESS J LEUKOCYTE; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Blixt O, 2003, J BIOL CHEM, V278, P31007, DOI 10.1074/jbc.M304331200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Crocker PR, 1999, BIOCHEM J, V341, P355, DOI 10.1042/0264-6021:3410355; Crocker PR, 2005, CURR OPIN PHARMACOL, V5, P431, DOI 10.1016/j.coph.2005.03.003; Crocker PR, 2002, CURR OPIN STRUC BIOL, V12, P609, DOI 10.1016/S0959-440X(02)00375-5; Crocker PR, 2001, IMMUNOLOGY, V103, P137, DOI 10.1046/j.0019-2805.2001.01241.x; de Graffenried CL, 2004, CURR OPIN CELL BIOL, V16, P356, DOI 10.1016/j.ceb.2004.06.007; Dimasi N, 2004, ACTA CRYSTALLOGR D, V60, P401, DOI 10.1107/S0907444903028439; Falco M, 1999, J EXP MED, V190, P793, DOI 10.1084/jem.190.6.793; Feizi T, 2003, CURR OPIN STRUC BIOL, V13, P602, DOI 10.1016/j.sbi.2003.09.001; Fotinou C, 2001, J BIOL CHEM, V276, P32274, DOI 10.1074/jbc.M103285200; Fox DA, 2001, IMMUNOL INVEST, V30, P67, DOI 10.1081/IMM-100104017; FRUTTIGER M, 1995, EUR J NEUROSCI, V7, P511, DOI 10.1111/j.1460-9568.1995.tb00347.x; Gabius HJ, 2004, CHEMBIOCHEM, V5, P740, DOI 10.1002/cbic.200300753; Gilleron M, 1998, EUR J BIOCHEM, V252, P416, DOI 10.1046/j.1432-1327.1998.2520416.x; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Hirabayashi J, 2004, GLYCOCONJUGATE J, V21, P35, DOI 10.1023/B:GLYC.0000043745.18988.a1; Ikehara Y, 2004, J BIOL CHEM, V279, P43117, DOI 10.1074/jbc.M403538200; ISHIDA H, 1993, CARBOHYD RES, V246, P75, DOI 10.1016/0008-6215(93)84025-2; Ito A, 2001, FEBS LETT, V504, P81, DOI 10.1016/S0014-5793(01)02733-8; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kannagi R, 2002, CURR OPIN STRUC BIOL, V12, P599, DOI 10.1016/S0959-440X(02)00365-2; Kelm S, 2002, J EXP MED, V195, P1207, DOI 10.1084/jem.20011783; Kelm S, 1997, INT REV CYTOL, V175, P137, DOI 10.1016/S0074-7696(08)62127-0; LI CM, 1994, NATURE, V369, P747, DOI 10.1038/369747a0; Lutteke T, 2005, NUCLEIC ACIDS RES, V33, pD242; Merritt EA, 1998, J MOL BIOL, V282, P1043, DOI 10.1006/jmbi.1998.2076; Merritt EA, 1997, PROTEIN SCI, V6, P1516, DOI 10.1002/pro.5560060716; Munday J, 1999, J LEUKOCYTE BIOL, V66, P705, DOI 10.1002/jlb.66.5.705; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Nicoll G, 2003, EUR J IMMUNOL, V33, P1642, DOI 10.1002/eji.200323693; Nicoll G, 1999, J BIOL CHEM, V274, P34089, DOI 10.1074/jbc.274.48.34089; Nitschke L, 1997, CURR BIOL, V7, P133, DOI 10.1016/S0960-9822(06)00057-1; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patel N, 1999, J BIOL CHEM, V274, P22729, DOI 10.1074/jbc.274.32.22729; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; PUKEL CS, 1982, J EXP MED, V155, P1133, DOI 10.1084/jem.155.4.1133; Rapoport E, 2003, BIOORG MED CHEM LETT, V13, P675, DOI 10.1016/S0960-894X(02)00998-8; Roseman S, 2001, J BIOL CHEM, V276, P41527, DOI 10.1074/jbc.R100053200; Sato C, 2001, J BIOL CHEM, V276, P28849, DOI 10.1074/jbc.M104148200; Sato C, 2000, J BIOL CHEM, V275, P15422, DOI 10.1074/jbc.275.20.15422; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Siebert HC, 2003, BIOCHEMISTRY-US, V42, P14762, DOI 10.1021/bi035477c; STANLEY P, 1975, CELL, V6, P121, DOI 10.1016/0092-8674(75)90002-1; Suresh MX, 2003, J THEOR BIOL, V222, P389, DOI 10.1016/S0022-5193(03)00050-X; URMACHER C, 1989, AM J DERMATOPATH, V11, P577, DOI 10.1097/00000372-198912000-00013; Varki A, 2006, GLYCOBIOLOGY, V16, p1R, DOI 10.1093/glycob/cwj008; Vasudevan SV, 2002, BIOPOLYMERS, V63, P168, DOI 10.1002/bip.10019; Vasudevan SV, 2002, J MOL STRUC-THEOCHEM, V583, P215, DOI 10.1016/S0166-1280(01)00813-2; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; WIKSTRAND CJ, 1994, PROG BRAIN RES, V101, P213; Yamaji T, 2002, J BIOL CHEM, V277, P6324, DOI 10.1074/jbc.M110146200	60	67	76	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32774	32783		10.1074/jbc.M601714200	http://dx.doi.org/10.1074/jbc.M601714200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16895906	hybrid			2022-12-27	WOS:000241414500076
J	Qi, XP; Lewin, AS; Sun, L; Hauswirth, WW; Guy, J				Qi, Xiaoping; Lewin, Alfred S.; Sun, Liang; Hauswirth, William W.; Guy, John			Mitochondrial protein nitration primes neurodegeneration in experimental autoimmune encephalomyelitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPERIMENTAL OPTIC NEURITIS; MULTIPLE-SCLEROSIS PATIENTS; NITRIC-OXIDE SYNTHASE; COMPLEX-I DEFICIENCY; AXONAL DEGENERATION; SUPEROXIDE-DISMUTASE; TYROSINE NITRATION; MASS-SPECTROMETRY; HYDROGEN-PEROXIDE; OXIDATIVE DAMAGE	The mechanisms of axonal and neuronal degeneration causing visual and neurologic disability in multiple sclerosis are poorly understood. Here we explored the contribution of mitochondria to neurodegeneration in the experimental autoimmune encephalomyelitis animal model of multiple sclerosis. Oxidative injury to the murine mitochondrion preceded the infiltration of inflammatory cells, classically heralded as the mediators of demyelination and axonal injury by transection. Nitration of mitochondrial proteins affected key subunits of complexes I and IV of the respiratory chain and a chaperone critical to the stabilization and translocation of proteins into the organelle. Oxidative products were associated with loss of mitochondrial membrane potential and apoptotic cell death. Reductions in the rate of synthesis of adenosine triphosphate were severe and even greater than those associated with disorders caused by mutated mitochondrial DNA. Mitochondrial vacuolization, swelling, and dissolution of cristae occurred in axons as early as 3 days after sensitization for experimental autoimmune encephalomyelitis. Our findings implicate mitochondrial dysfunction induced by protein inactivation and mediated by oxidative stress initiates a cascade of molecular events leading to apoptosis and neurodegeneration in experimental autoimmune encephalomyelitis that is not mediated by inflammatory cells.	Univ Florida, Coll Med, Dept Ophthalmol, Gainesville, FL 32610 USA; Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA; Univ Florida, Coll Med, Dept Neurol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Guy, J (corresponding author), Univ Florida, Coll Med, Dept Ophthalmol, Box 100284, Gainesville, FL 32610 USA.	johnguy@eye.ufl.edu		Lewin, Alfred/0000-0002-4192-9727	NATIONAL EYE INSTITUTE [R01EY012355, R01EY007982] Funding Source: NIH RePORTER; NEI NIH HHS [EY12355, EY07982] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Baker D, 2003, GENE THER, V10, P844, DOI 10.1038/sj.gt.3302025; Barreiro E, 2002, AM J RESP CELL MOL, V26, P438, DOI 10.1165/ajrcmb.26.4.4634; Barrientos A, 1999, J BIOL CHEM, V274, P16188, DOI 10.1074/jbc.274.23.16188; Bjartmar C, 2003, NEUROTOX RES, V5, P157, DOI 10.1007/BF03033380; Druzhyna NM, 2005, J BIOL CHEM, V280, P21673, DOI 10.1074/jbc.m411531200; Dutta R, 2006, ANN NEUROL, V59, P478, DOI 10.1002/ana.20736; Emahazion T, 1998, CYTOGENET CELL GENET, V82, P114, DOI 10.1159/000015081; Fernandez-Vizarra E, 2002, METHODS, V26, P292, DOI 10.1016/S1046-2023(02)00034-8; Giuliani F, 2003, Int MS J, V10, P122; Greenacre SAB, 2001, FREE RADICAL RES, V34, P541, DOI 10.1080/10715760100300471; Guy J, 1998, P NATL ACAD SCI USA, V95, P13847, DOI 10.1073/pnas.95.23.13847; GUY J, 1990, ARCH OPHTHALMOL-CHIC, V108, P1614, DOI 10.1001/archopht.1990.01070130116041; GUY J, 1993, OPHTHALMIC RES, V25, P253, DOI 10.1159/000267321; GUY J, 1989, ARCH OPHTHALMOL-CHIC, V107, P1359, DOI 10.1001/archopht.1989.01070020429048; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hobom M, 2004, BRAIN PATHOL, V14, P148, DOI 10.1111/j.1750-3639.2004.tb00047.x; Kalman B, 2003, NEUROMOL MED, V3, P147, DOI 10.1385/NMM:3:3:147; Kalman B, 2006, CURR NEUROL NEUROSCI, V6, P244, DOI 10.1007/s11910-006-0012-0; Kawai A, 2001, J CELL SCI, V114, P3565; Kornek B, 2000, AM J PATHOL, V157, P267, DOI 10.1016/S0002-9440(10)64537-3; Kumleh HH, 2006, J NEUROL SCI, V243, P65, DOI 10.1016/j.jns.2005.11.030; Ladha JS, 2005, CELL DEATH DIFFER, V12, P1417, DOI 10.1038/sj.cdd.4401668; Lisdero CL, 2004, METHOD ENZYMOL, V382, P67; Lu FM, 2000, J NEUROL SCI, V177, P95, DOI 10.1016/S0022-510X(00)00343-9; Maatta JA, 2000, SCAND J IMMUNOL, V51, P87; Melov S, 2000, ANN NY ACAD SCI, V908, P219; Meyer R, 2001, J NEUROSCI, V21, P6214, DOI 10.1523/JNEUROSCI.21-16-06214.2001; Murray J, 2003, J BIOL CHEM, V278, P37223, DOI 10.1074/jbc.M305694200; Owens T, 2003, CURR OPIN NEUROL, V16, P259, DOI 10.1097/00019052-200306000-00003; Petzold A, 2004, J NEUROL NEUROSUR PS, V75, P1178, DOI 10.1136/jnnp.2003.017236; Pitkanen S, 1996, J CLIN INVEST, V98, P345, DOI 10.1172/JCI118798; Qi XP, 2004, ANN NEUROL, V56, P182, DOI 10.1002/ana.20175; Qi XP, 1997, INVEST OPHTH VIS SCI, V38, P1203; Qi XP, 2003, ANN NEUROL, V53, P198, DOI 10.1002/ana.10426; RAO NA, 1981, INVEST OPHTH VIS SCI, V20, P159; RAO NA, 1977, INVEST OPHTH VIS SCI, V16, P338; Schilling B, 2005, FEBS LETT, V579, P2485, DOI 10.1016/j.febslet.2005.03.061; Smith KJ, 2002, LANCET NEUROL, V1, P232, DOI 10.1016/S1474-4422(02)00102-3; Tatoyan A, 1998, J BIOL CHEM, V273, P11044, DOI 10.1074/jbc.273.18.11044; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Trip SA, 2005, ANN NEUROL, V58, P383, DOI 10.1002/ana.20575; vanderLaan LJW, 1996, J NEUROIMMUNOL, V70, P145, DOI 10.1016/S0165-5728(96)00110-5; Zemojtel T, 2006, FEBS LETT, V580, P455, DOI 10.1016/j.febslet.2005.12.038	44	113	114	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31950	31962		10.1074/jbc.M603717200	http://dx.doi.org/10.1074/jbc.M603717200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16920708	Bronze			2022-12-27	WOS:000241235300081
J	Lepage, PK; Lussier, MP; Barajas-Martinez, H; Bousquet, SM; Blanchard, AP; Francoeur, N; Dumaine, R; Boulay, G				Lepage, Pascale K.; Lussier, Marc P.; Barajas-Martinez, Hector; Bousquet, Simon M.; Blanchard, Alexandre P.; Francoeur, Nancy; Dumaine, Robert; Boulay, Guylain			Identification of two domains involved in the assembly of transient receptor potential canonical channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHAKER POTASSIUM CHANNEL; CRYSTAL-STRUCTURE; CATION CHANNELS; TRPC CHANNELS; K+ CHANNEL; SUBUNIT; CALCIUM; PROTEINS; DETERMINANTS; NOMENCLATURE	Transient receptor potential canonical (TRPC) channels are associated with calcium entry activity in nonexcitable cells. TRPCs can form homo- or heterotetrameric channels, in which case they can assemble together within a subfamily groups. TRPC1, 4, and 5 represent one group, and TRPC3, 6, and 7 represent the other. The molecular determinants involved in promoting subunit tetramerization are not known. To identify them, we generated chimeras by swapping the different domains of TRPC4 with the same regions in TRPC6. We showed that TRPC4 coimmunoprecipitated with the chimeras containing the ankyrin repeats and coiled-coil domains of TRPC4 into TRPC6. However, chimeras containing only the ankyrin repeats or only the coiled-coil domain of TRPC4 did not coimmunoprecipitate with TRPC4. We also showed that a second domain of interaction composed of the pore region and the C-terminal tail is involved in the oligomerization of TRPC4. However, chimeras containing only the pore region or only the C-terminal tail of TRPC4 did not coimmunoprecipitate with TRPC4. Furthermore, we showed that the N terminus of TRPC6 coimmunoprecipitated with the C terminus of TRPC6. Overexpression in HEK293T cells of chimeras that contained an N terminus and a C terminus from different subfamily groups increased intracellular calcium entry subsequent to stimulation of G(q) protein-coupled receptors. These results suggest that two types of interactions are involved in the assembly of the four subunits of the TRPC channel. The first interaction occurs between the N termini and involves two regions. The second interaction occurs between the N terminus and the C terminus and does not appear to be necessary for the activity of TRPCs.	Univ Sherbrooke, Dept Pharmacol, Fac Med & Hlth Sci, Sherbrooke, PQ J1H 5N4, Canada; Univ Sherbrooke, Dept Physiol, Sherbrooke, PQ J1H 5N4, Canada; Univ Sherbrooke, Dept Biophys, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke; University of Sherbrooke; University of Sherbrooke	Boulay, G (corresponding author), Univ Sherbrooke, Dept Pharmacol, Fac Med & Hlth Sci, 3001,12 Ave N, Sherbrooke, PQ J1H 5N4, Canada.	Guylain.Boulay@USherbrooke.ca	Boulay, Guylain/D-9773-2010	Lussier, Marc/0000-0001-5568-0072				Ambudkar IS, 2006, TRENDS PHARMACOL SCI, V27, P25, DOI 10.1016/j.tips.2005.11.008; AUSUBEL FM, 2002, CURRENT PROTOCOLS MO; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Birnbaumer L, 1996, P NATL ACAD SCI USA, V93, P15195, DOI 10.1073/pnas.93.26.15195; Chang Q, 2004, J BIOL CHEM, V279, P54304, DOI 10.1074/jbc.M406222200; Clapham DE, 2005, PHARMACOL REV, V57, P427, DOI 10.1124/pr.57.4.6; Engelke M, 2002, FEBS LETT, V523, P193, DOI 10.1016/S0014-5793(02)02971-X; Erler I, 2004, J BIOL CHEM, V279, P34456, DOI 10.1074/jbc.M404778200; Goel M, 2002, J BIOL CHEM, V277, P48303, DOI 10.1074/jbc.M207882200; GREEN WN, 1995, TRENDS NEUROSCI, V18, P280, DOI 10.1016/0166-2236(95)93915-K; Hoenderop JGJ, 2005, PHYSIOL REV, V85, P373, DOI 10.1152/physrev.00003.2004; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Hurst RS, 1998, FEBS LETT, V422, P333, DOI 10.1016/S0014-5793(98)00035-0; Ju M, 2003, J BIOL CHEM, V278, P12769, DOI 10.1074/jbc.M212973200; Kreusch A, 1998, NATURE, V392, P945, DOI 10.1038/31978; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; Lintschinger B, 2000, J BIOL CHEM, V275, P27799; Liu XB, 2005, J BIOL CHEM, V280, P21600, DOI 10.1074/jbc.c400492200; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Lu Z, 2001, NATURE, V413, P809, DOI 10.1038/35101535; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; Lussier MP, 2005, J BIOL CHEM, V280, P19393, DOI 10.1074/jbc.M500391200; Mio K, 2005, BIOCHEM BIOPH RES CO, V333, P768, DOI 10.1016/j.bbrc.2005.05.181; Montell C, 2002, MOL CELL, V9, P229, DOI 10.1016/S1097-2765(02)00448-3; Niemeyer BA, 2005, N-S ARCH PHARMACOL, V371, P285, DOI 10.1007/s00210-005-1053-7; Sambrook J., 2001, MOL CLONING LAB MANU; SANFORD J, 1991, J BIOL CHEM, V266, P9570; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schaefer M, 2005, PFLUG ARCH EUR J PHY, V451, P35, DOI 10.1007/s00424-005-1467-6; Schulteis CT, 1998, J BIOL CHEM, V273, P26210, DOI 10.1074/jbc.273.40.26210; SHEN NV, 1993, NEURON, V11, P67; Strubing C, 2003, J BIOL CHEM, V278, P39014, DOI 10.1074/jbc.M306705200; Vannier B, 1998, J BIOL CHEM, V273, P8675, DOI 10.1074/jbc.273.15.8675; Xu XZS, 1997, CELL, V89, P1155, DOI 10.1016/S0092-8674(00)80302-5	36	40	42	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30356	30364		10.1074/jbc.M603930200	http://dx.doi.org/10.1074/jbc.M603930200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16916799	hybrid			2022-12-27	WOS:000241075900009
J	Wang, Q; Abreu, MTH; Siminovitch, K; Downey, GP; McCulloch, CA				Wang, Qin; Abreu, Maria Teresa Herrera; Siminovitch, Katherine; Downey, Gregory P.; McCulloch, Christopher A.			Phosphorylation of SHP-2 regulates interactions between the endoplasmic reticulum and focal adhesions to restrict interleukin-1-induced Ca2+ signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE-PHOSPHATASE SHP-2; CELL-ADHESION; GENE-EXPRESSION; ERK ACTIVATION; RECEPTOR; KINASE; FIBROBLASTS; TRANSDUCTION; SUPERFAMILY; MIGRATION	Interleukin-1 (IL-1)-induced Ca2+ signaling in fibroblasts is constrained by focal adhesions. This process involves the protein-tyrosine phosphatase SHP-2, which is critical for IL-1-induced phosphorylation of phospholipase C gamma 1, thereby enhancing IL-1-induced Ca2+ release and ERK activation. Currently, the mechanisms by which SHP-2 modulates Ca2+ release from the endoplasmic reticulum are not defined. We used immunoprecipitation and fluorescence protein-tagged SHP-2 or endoplasmic reticulum (ER)-protein expression vectors, and an ER-specific calcium indicator, to examine the functional relationships between SHP-2, focal adhesions, and IL-1-induced Ca2+ release from the ER. By total internal reflection fluorescence microscopy to image sub-plasma membrane compartments, SHP-2 co-localized with the ER-associated proteins calnexin and calreticulin at sites of focal adhesion formation in fibroblasts. IL-1 beta promoted time-dependent recruitment of SHP-2 and ER proteins to focal adhesions; this process was blocked in cells treated with small interfering RNA for SHP-2 and in cells expressing a Y542F SHP-2 mutant. IL-1 stimulated inositol 1,4,5-trisphosphate receptor-mediated Ca2+ release from the ER subjacent to the plasma membrane that was tightly localized around fibronectin-coated beads and was reduced 4-fold in cells expressing Tyr-542 SHP-2 mutant. In subcellular fractions enriched for ER proteins, immunoprecipitation demonstrated that IL-1-enhanced association of SHP-2 with the type 1 inositol 1,4,5-trisphosphate receptor was dependent on Tyr-542 of SHP-2. We conclude that Tyr-542 of SHP-2 modulates IL-1-induced Ca2+ signals and association of the ER with focal adhesions.	Univ Toronto, CIHR Grp Matrix Dynam, Toronto, ON M5S 3E2, Canada; Univ Toronto, Dept Med, Div Respirol, Toronto, ON M5G 2M9, Canada; Mt Sinai Hosp, Samuel Lunenfeld Inst, Toronto, ON M5G 1X5, Canada; Toronto Gen Hosp, Res Inst, Hlth Network, Toronto, ON M5G 2M9, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	McCulloch, CA (corresponding author), Univ Toronto, CIHR Grp Matrix Dynam, Rm 244,Fitzgerald Bld,150 Coll St, Toronto, ON M5S 3E2, Canada.	christopher.mcculloch@utoronto.ca	Siminovitch, Katherine/K-1475-2013	Downey, Gregory P/0000-0003-3253-5862				Abreu MTH, 2006, J CELL PHYSIOL, V207, P132, DOI 10.1002/jcp.20544; Alahari SK, 2002, INT REV CYTOL, V220, P145; Araki T, 2004, NAT MED, V10, P849, DOI 10.1038/nm1084; ARORA PD, 1995, J BIOL CHEM, V270, P6042, DOI 10.1074/jbc.270.11.6042; Arora PD, 2003, EXP CELL RES, V286, P366, DOI 10.1016/S0014-4827(03)00096-X; BENNETT AM, 1994, P NATL ACAD SCI USA, V91, P7335, DOI 10.1073/pnas.91.15.7335; Bhat-Nakshatri P, 1998, P NATL ACAD SCI USA, V95, P6971, DOI 10.1073/pnas.95.12.6971; Bootman MD, 2002, FASEB J, V16, DOI 10.1096/fj.02-0037rev; Boyle DL, 1997, ARTHRITIS RHEUM, V40, P1772, DOI 10.1002/art.1780401008; Brauchle M, 2000, EXP CELL RES, V258, P135, DOI 10.1006/excr.2000.4913; Carragher NO, 2004, TRENDS CELL BIOL, V14, P241, DOI 10.1016/j.tcb.2004.03.011; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Cohen P, 2002, NAT CELL BIOL, V4, pE127, DOI 10.1038/ncb0502-e127; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Fujioka Y, 1996, MOL CELL BIOL, V16, P6887; Heritage D, 2001, J BIOL CHEM, V276, P22655, DOI 10.1074/jbc.M102409200; HONIG J, 1989, J PERIODONTAL RES, V24, P362, DOI 10.1111/j.1600-0765.1989.tb00883.x; Howe AK, 2002, CURR OPIN GENET DEV, V12, P30, DOI 10.1016/S0959-437X(01)00260-X; Inagaki K, 2000, ONCOGENE, V19, P75, DOI 10.1038/sj.onc.1203204; Ioannou M, 1998, MOL PHARMACOL, V53, P1089; Irie-Sasaki J, 2001, NATURE, V409, P349, DOI 10.1038/35053086; Juliano RL, 2002, ANNU REV PHARMACOL, V42, P283, DOI 10.1146/annurev.pharmtox.42.090401.151133; Lo YYC, 1998, J BIOL CHEM, V273, P7059, DOI 10.1074/jbc.273.12.7059; Lomax RB, 2002, J BIOL CHEM, V277, P26479, DOI 10.1074/jbc.M201845200; Lu W, 2001, MOL CELL, V8, P759, DOI 10.1016/S1097-2765(01)00369-0; Luo L, 1997, BIOCHEM J, V324, P653, DOI 10.1042/bj3240653; Ma HT, 2003, BIOCHEM J, V376, P667, DOI 10.1042/BJ20031345; MacGillivray M, 2003, J BIOL CHEM, V278, P27190, DOI 10.1074/jbc.M213083200; MacGillivray MK, 2000, J BIOL CHEM, V275, P23509, DOI 10.1074/jbc.M003186200; Manes S, 1999, MOL CELL BIOL, V19, P3125; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; O'Neill LAJ, 2000, IMMUNOL TODAY, V21, P206, DOI 10.1016/S0167-5699(00)01611-X; Oakes SA, 2005, P NATL ACAD SCI USA, V102, P105, DOI 10.1073/pnas.0408352102; Oh ES, 1999, MOL CELL BIOL, V19, P3205; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; PLOPPER G, 1993, BIOCHEM BIOPH RES CO, V193, P571, DOI 10.1006/bbrc.1993.1662; QWARNSTROM EE, 1988, J BIOL CHEM, V263, P8261; Reunanen N, 1998, J BIOL CHEM, V273, P5137, DOI 10.1074/jbc.273.9.5137; Schoenwaelder SM, 2000, CURR BIOL, V10, P1523, DOI 10.1016/S0960-9822(00)00831-9; Sugiyama T, 2000, FEBS LETT, V466, P29, DOI 10.1016/S0014-5793(99)01732-9; Tran H, 2002, J CELL SCI, V115, P2031; Tsuda M, 1998, J BIOL CHEM, V273, P13223, DOI 10.1074/jbc.273.21.13223; Van Coppenolle F, 2004, J CELL SCI, V117, P4135, DOI 10.1242/jcs.01274; van den Berg WB, 1999, Z RHEUMATOL, V58, P136, DOI 10.1007/s003930050163; Wang Q, 2005, J BIOL CHEM, V280, P8397, DOI 10.1074/jbc.M410462200; Wang Q, 2003, FASEB J, V17, pA1072; Yu DH, 1998, J BIOL CHEM, V273, P21125, DOI 10.1074/jbc.273.33.21125; Zhang SQ, 2004, MOL CELL, V13, P341, DOI 10.1016/S1097-2765(04)00050-4	48	31	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					31093	31105		10.1074/jbc.M606392200	http://dx.doi.org/10.1074/jbc.M606392200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16905534	hybrid			2022-12-27	WOS:000241075900085
J	Worby, CA; Gentry, MS; Dixon, JE				Worby, Carolyn A.; Gentry, Matthew S.; Dixon, Jack E.			Laforin, a dual specificity phosphatase that dephosphorylates complex carbohydrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRESSIVE MYOCLONUS EPILEPSY; PROTEIN-TYROSINE-PHOSPHATASE; GLYCOGEN-TARGETING SUBUNITS; AMINO-ACID-SEQUENCE; BINDING DOMAIN; FUNCTIONAL-CHARACTERIZATION; POLYGLUCOSAN BODIES; BIOCHEMICAL ASPECTS; STARCH DEGRADATION; CLINICAL-FEATURES	Laforin is the only phosphatase in the animal kingdom that contains a carbohydrate-binding module. Mutations in the gene encoding laforin result in Lafora disease, a fatal autosomal recessive neurodegenerative disorder, which is diagnosed by the presence of intracellular deposits of insoluble complex carbohydrates known as Lafora bodies. We demonstrate that laforin interacts with proteins known to be involved in glycogen metabolism and rule out several of these proteins as potential substrates. Surprisingly, we find that laforin displays robust phosphatase activity against a phosphorylated complex carbohydrate. Furthermore, this activity is unique to laforin, since several other phosphatases are unable to dephosphorylate polysaccharides. Finally, fusing the carbohydrate-binding module of laforin to the dual specific phosphatase VHR does not result in the ability of this phosphatase to dephosphorylate polysaccharides. Therefore, we hypothesize that laforin is unique in its ability to utilize a phosphorylated complex carbohydrate as a substrate and that this function may be necessary for the maintenance of normal cellular glycogen.	Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Dixon, JE (corresponding author), Univ Calif San Diego, Dept Pharmacol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	jedixon@ucsd.edu			NATIONAL CANCER INSTITUTE [T32CA009523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK018024, R01DK018849] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA009523, T32CA09523] Funding Source: Medline; NIDDK NIH HHS [R01 DK018849-34, R37 DK018024-34, R37 DK018024, R01 DK018849] Funding Source: Medline; PHS HHS [18849, 18024] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Armstrong CG, 1997, FEBS LETT, V418, P210, DOI 10.1016/S0014-5793(97)01385-9; Baunsgaard L, 2005, PLANT J, V41, P595, DOI 10.1111/j.1365-313X.2004.02322.x; BERKOVIC SF, 1986, NEW ENGL J MED, V315, P296, DOI 10.1056/NEJM198607313150506; Blennow A, 2002, TRENDS PLANT SCI, V7, P445, DOI 10.1016/S1360-1385(02)02332-4; Brady MJ, 1997, J BIOL CHEM, V272, P20198, DOI 10.1074/jbc.272.32.20198; BUSARD HLSM, 1987, ANN NEUROL, V21, P599, DOI 10.1002/ana.410210613; BUSARD HLSM, 1987, CLIN NEUROPATHOL, V6, P1; CARPENTER S, 1981, NEUROLOGY, V31, P1564, DOI 10.1212/WNL.31.12.1564; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Chan EM, 2004, HUM MOL GENET, V13, P1117, DOI 10.1093/hmg/ddh130; Chan EM, 2003, NAT GENET, V35, P125, DOI 10.1038/ng1238; COLEMAN DL, 1974, ARCH NEUROL-CHICAGO, V31, P396, DOI 10.1001/archneur.1974.00490420062007; COLEMAN JE, 1992, ANNU REV BIOPH BIOM, V21, P441, DOI 10.1146/annurev.biophys.21.1.441; Cross DAE, 1997, FEBS LETT, V406, P211, DOI 10.1016/S0014-5793(97)00240-8; DENU JM, 1995, J BIOL CHEM, V270, P3796, DOI 10.1074/jbc.270.8.3796; DOHERTY MJ, 1995, FEBS LETT, V375, P294, DOI 10.1016/0014-5793(95)01184-G; Doherty MJ, 1996, FEBS LETT, V399, P339, DOI 10.1016/S0014-5793(96)01357-9; Edwards TA, 2003, GENE DEV, V17, P2508, DOI 10.1101/gad.1119403; Fernandez-Sanchez ME, 2003, HUM MOL GENET, V12, P3161, DOI 10.1093/hmg/ddg340; GAMBETTI P, 1971, ARCH NEUROL-CHICAGO, V25, P483, DOI 10.1001/archneur.1971.00490060017002; Ganesh S, 2000, HUM MOL GENET, V9, P2251, DOI 10.1093/oxfordjournals.hmg.a018916; Ganesh S, 2004, BIOCHEM BIOPH RES CO, V313, P1101, DOI 10.1016/j.bbrc.2003.12.043; Gasa R, 2000, J BIOL CHEM, V275, P26396, DOI 10.1074/jbc.M002427200; Gentry MS, 2005, P NATL ACAD SCI USA, V102, P8501, DOI 10.1073/pnas.0503285102; Halse R, 1999, J BIOL CHEM, V274, P776, DOI 10.1074/jbc.274.2.776; HARRIMAN DGF, 1955, BRAIN, V78, P325, DOI 10.1093/brain/78.3.325; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hudson ER, 2003, CURR BIOL, V13, P861, DOI 10.1016/S0960-9822(03)00249-5; Ianzano L, 2004, HUM MUTAT, V23, P170, DOI 10.1002/humu.10306; Ianzano Leonarda, 2005, Hum Mutat, V26, P397, DOI 10.1002/humu.9376; JANEWAY R, 1967, ARCH NEUROL-CHICAGO, V16, P565, DOI 10.1001/archneur.1967.00470240003001; Kerk D, 2006, PLANT J, V46, P400, DOI 10.1111/j.1365-313X.2006.02704.x; KRISMAN CR, 1985, ANAL BIOCHEM, V147, P491, DOI 10.1016/0003-2697(85)90303-3; Lafora GR, 1911, Z GESAMTE NEUROL PSY, V6, P1, DOI 10.1007/BF02863929; Lehesjoki AE, 2002, ADV NEUROL, V89, P193; Lohi H, 2005, HUM MOL GENET, V14, P2727, DOI 10.1093/hmg/ddi306; LOMAKO J, 1994, BIOFACTORS, V4, P167; LOMAKO J, 1993, FEBS LETT, V329, P263, DOI 10.1016/0014-5793(93)80234-L; Lorberth R, 1998, NAT BIOTECHNOL, V16, P473, DOI 10.1038/nbt0598-473; Maehama T, 2000, ANAL BIOCHEM, V279, P248, DOI 10.1006/abio.2000.4497; Mikkelsen R, 2004, BIOCHEM J, V377, P525, DOI 10.1042/BJ20030999; Minassian BA, 1998, NAT GENET, V20, P171, DOI 10.1038/2470; Minassian BA, 2002, ADV NEUROL, V89, P199; Niittyla T, 2006, J BIOL CHEM, V281, P11815, DOI 10.1074/jbc.M600519200; NISHIMURA RN, 1980, ANN NEUROL, V8, P409, DOI 10.1002/ana.410080412; Pagliarini DJ, 2004, J BIOL CHEM, V279, P38590, DOI 10.1074/jbc.M404959200; Paldi T, 2003, BIOCHEM J, V372, P905, DOI 10.1042/BJ20021527; Pederson BA, 2003, BIOCHEM BIOPH RES CO, V305, P826, DOI 10.1016/S0006-291X(03)00862-3; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Printen JA, 1997, SCIENCE, V275, P1475, DOI 10.1126/science.275.5305.1475; Ritte G, 2000, PLANT J, V21, P387, DOI 10.1046/j.1365-313x.2000.00683.x; Romsicki Y, 2003, ARCH BIOCHEM BIOPHYS, V414, P40, DOI 10.1016/S0003-9861(03)00178-4; SAKAI M, 1970, NEUROLOGY, V20, P160, DOI 10.1212/WNL.20.2.160; SAKAI M, 1969, ARCH NEUROL-CHICAGO, V21, P526, DOI 10.1001/archneur.1969.00480170098011; Satow R, 2002, BIOCHEM BIOPH RES CO, V295, P85, DOI 10.1016/S0006-291X(02)00641-1; SCHNABEL R, 1968, Pathologia Europaea, V3, P218; Serratosa JM, 1999, HUM MOL GENET, V8, P345, DOI 10.1093/hmg/8.2.345; Slack FJ, 1998, TRENDS BIOCHEM SCI, V23, P474, DOI 10.1016/S0968-0004(98)01299-7; Vikso-Nielsen A, 2002, CARBOHYD RES, V337, P327, DOI 10.1016/S0008-6215(01)00326-3; Wang JY, 2002, J BIOL CHEM, V277, P2377, DOI 10.1074/jbc.C100686200; WANG QM, 1994, J BIOL CHEM, V269, P14566; Wang W, 2004, BIOCHEM BIOPH RES CO, V325, P726, DOI 10.1016/j.bbrc.2004.10.083; Yang J, 2000, J BIOL CHEM, V275, P22635, DOI 10.1074/jbc.M003082200; YOKOI S, 1968, ARCH NEUROL-CHICAGO, V19, P15, DOI 10.1001/archneur.1968.00480010033002; YOKOI S, 1967, J NEUROPATH EXP NEUR, V26, P125; YOKOI S, 1975, CLIN CHIM ACTA, V62, P415; Yu TS, 2001, PLANT CELL, V13, P1907, DOI 10.1105/tpc.13.8.1907	68	150	151	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30412	30418		10.1074/jbc.M606117200	http://dx.doi.org/10.1074/jbc.M606117200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16901901	Green Accepted, hybrid			2022-12-27	WOS:000241075900015
J	Jiang, YP; Ballou, LM; Lu, ZJ; Wan, L; Kelly, DJ; Cohen, IS; Lin, RZ				Jiang, Ya-Ping; Ballou, Lisa M.; Lu, Zhongju; Wan, Li; Kelly, Damon J.; Cohen, Ira S.; Lin, Richard Z.			Reversible heart failure in G alpha(q) transgenic mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIOMYOPATHY; HYPERTROPHY; SUPPORT; MODEL	For many patients with cardiac insufficiency, the disease progresses inexorably to organ dilatation, pump failure, and death. Although there are examples of reversible heart failure in man, our understanding of how the myocardium repairs itself is limited. A well defined animal model of reversible heart failure would allow us to better investigate these restorative processes. Receptors that activate G alpha(q), a signal transduction molecule in the heterotrimeric G protein superfamily, are thought to play a key role in the development of heart failure. We demonstrated previously that mice expressing a recombinant G alpha(q) protein, the activity of which can be turned on or off at will in cardiac myocytes, develop a dilated cardiomyopathy with generalized edema and heart failure following activation of the protein ( Fan, G., Jiang, Y.-P., Lu, Z., Martin, D. W., Kelly, D. J., Zuckerman, J. M., Ballou, L. M., Cohen, I. S., and Lin, R. Z. ( 2005) J. Biol. Chem. 280, 40337 - 40346). Here we report that the contractile dysfunction and pathological structural changes in the myocardium improved significantly after termination of the G alpha(q) signal, even in animals with overt heart failure. Abnormalities in two proteins that regulate Ca2+ handling in myocytes, phospholamban and the voltage-dependent L-type Ca2+ channel, were also reversed, as was the increased expression of genes that are associated with heart failure. These results indicate that the heart has a substantial reparative capacity if the molecular signals responsible for the myocardial dysfunction can be identified and blocked.	SUNY Stony Brook, Dept Med, Div Hematol & Oncol, Stony Brook, NY 11794 USA; SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA; SUNY Stony Brook, Inst Mol Cardiol, Stony Brook, NY 11794 USA; SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA; Dept Vet Affairs Med Ctr, Northport, NY 11768 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Lin, RZ (corresponding author), SUNY Stony Brook, Dept Med, Div Hematol & Oncol, Stony Brook, NY 11794 USA.	richard.lin@sunysb.edu	wan, li/GRY-7634-2022; Lin, Richard/J-1754-2014; Lu, zhongjul/AAT-5531-2021	Lin, Richard/0000-0002-3473-7276; 	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL028958, R01HL067101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062722] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL67101, HL28958] Funding Source: Medline; NIDDK NIH HHS [DK62722] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akashi YJ, 2003, QJM-INT J MED, V96, P563, DOI 10.1093/qjmed/hcg096; Dipla K, 1998, CIRCULATION, V97, P2316, DOI 10.1161/01.CIR.97.23.2316; Fan GF, 2005, J BIOL CHEM, V280, P40337, DOI 10.1074/jbc.M506810200; Hollenberg SM, 1997, J HEART LUNG TRANSPL, V16, pS7; Lu ZJ, 2005, J BIOL CHEM, V280, P40347, DOI 10.1074/jbc.M508441200; Mende U, 1998, P NATL ACAD SCI USA, V95, P13893, DOI 10.1073/pnas.95.23.13893; Moorjani N, 2003, EUR J CARDIO-THORAC, V24, P920, DOI 10.1016/S1010-7940(03)00514-1; PARKER MM, 1984, ANN INTERN MED, V100, P483, DOI 10.7326/0003-4819-100-4-483; Zafeiridis A, 1998, CIRCULATION, V98, P656, DOI 10.1161/01.CIR.98.7.656	9	9	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					29988	29992		10.1074/jbc.M604699200	http://dx.doi.org/10.1074/jbc.M604699200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16893886	hybrid			2022-12-27	WOS:000240896300059
J	Kudrin, A; Scott, M; Martin, S; Chung, CW; Donn, R; McMaster, A; Ellison, S; Ray, D; Ray, K; Binks, M				Kudrin, Alex; Scott, Martin; Martin, Steven; Chung, Chun-wa; Donn, Rachelle; McMaster, Andrew; Ellison, Stuart; Ray, David; Ray, Keith; Binks, Michael			Human Macrophage Migration Inhibitory Factor A PROVEN IMMUNOMODULATORY CYTOKINE?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article								Macrophage migration inhibitory factor (MIF) is a pro-inflammatory mediator with the ability to induce various immunomodulatory responses and override glucocorticoid-driven immunosuppression. Some of these functions have been linked to the unusual enzymatic properties of the protein, namely tautomerase and oxidoreductase activities. However, there are conflicting reports regarding the functional role of these enzymatic properties in normal physiological homeostasis and disease progression. Therefore, we have produced a highly pure, virtually endotoxin-free recombinant MIF preparation and fully characterized this using a variety of biochemical and biophysical approaches. The recombinant protein, with demonstrable enzymatic activity, was then used to systematically examine the biological activity of MIF. Surprisingly, treatment with MIF alone failed to induce cytokine expression, with the exception of IL-8. However, co-treatment of lipopolysaccharide (LPS) in conjunction with MIF produced synergistic secretion of tumor necrosis factor-alpha, interleukin (IL)-1, and IL-8 compared with LPS alone. The potentiating effect of MIF was seen at physiologically relevant concentrations. These data suggest that MIF has no conventional cytokine activity but, rather, acts to modulate and amplify the response to LPS.	[Kudrin, Alex; Ray, Keith; Binks, Michael] GlaxoSmithKline, Dept Dis Biol Rheumatol & Inflammat, Stevenage SG1 2NY, Herts, England; [Scott, Martin; Martin, Steven; Chung, Chun-wa] GlaxoSmithKline, Discovery Res, Stevenage SG1 2NY, Herts, England; [Donn, Rachelle; Ray, David] Univ Manchester, Ctr Mol Med, Manchester M13 9PT, Lancs, England; [Donn, Rachelle; McMaster, Andrew; Ellison, Stuart] Univ Manchester, Arthrit Res Campaign Epidemiol Unit, Manchester M13 9PT, Lancs, England	GlaxoSmithKline; GlaxoSmithKline; University of Manchester; University of Manchester	Ray, K (corresponding author), GlaxoSmithKline, Dept Dis Biol, Stevenage SG1 2NY, Herts, England.	keith.p.ray@gsk.com		Donn, Rachelle/0000-0001-6976-9828; Ray, David/0000-0002-4739-6773				Bancroft CC, 2002, INT J CANCER, V99, P538, DOI 10.1002/ijc.10398; Baumann R, 2003, FASEB J, V17, P2221, DOI 10.1096/fj.03-0110com; Bendrat K, 1997, BIOCHEMISTRY-US, V36, P15356, DOI 10.1021/bi971153a; Berghe WV, 1998, J BIOL CHEM, V273, P3285, DOI DOI 10.1074/JBC.273.6.3285; BERNHAGEN J, 1994, BIOCHEMISTRY-US, V33, P14144, DOI 10.1021/bi00251a025; Calandra T, 2000, NAT MED, V6, P164, DOI 10.1038/72262; CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0; de Jong YP, 2001, NAT IMMUNOL, V2, P1061, DOI 10.1038/ni720; Donn R, 2004, ARTHRITIS RHEUM-US, V50, P1604, DOI 10.1002/art.20178; Doppler W, 2001, MOL CELL BIOL, V21, P3266, DOI 10.1128/MCB.21.9.3266-3279.2001; Fingerle-Rowson G, 2003, P NATL ACAD SCI USA, V100, P9354, DOI 10.1073/pnas.1533295100; Hermanowski-Vosatka A, 1999, BIOCHEMISTRY-US, V38, P12841, DOI 10.1021/bi991352p; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Ichiyama H, 2004, CYTOKINE, V26, P187, DOI 10.1016/j.cyto.2004.02.007; Jung H, 2001, J BIOL CHEM, V276, P15504, DOI 10.1074/jbc.M009620200; Kleemann R, 2000, NATURE, V408, P211, DOI 10.1038/35041591; Kleemann R, 1998, J MOL BIOL, V280, P85, DOI 10.1006/jmbi.1998.1864; Kleemann R, 2002, J INTERF CYTOK RES, V22, P351, DOI 10.1089/107999002753675785; Kleemann R, 2000, EUR J BIOCHEM, V267, P7183, DOI 10.1046/j.1432-1327.2000.01823.x; Lacey D, 2003, ARTHRITIS RHEUM, V48, P103, DOI 10.1002/art.10733; Lan HY, 1996, AM J PATHOL, V149, P1119; Leech M, 1999, ARTHRITIS RHEUM, V42, P1601, DOI 10.1002/1529-0131(199908)42:8<1601::AID-ANR6>3.0.CO;2-B; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Lubetsky JB, 2002, J BIOL CHEM, V277, P24976, DOI 10.1074/jbc.M203220200; Lue HQ, 2002, MICROBES INFECT, V4, P449, DOI 10.1016/S1286-4579(02)01560-5; Makita H, 1998, AM J RESP CRIT CARE, V158, P573, DOI 10.1164/ajrccm.158.2.9707086; Marguet D, 1999, NAT CELL BIOL, V1, P454, DOI 10.1038/15690; Mitchell RA, 1999, J BIOL CHEM, V274, P18100, DOI 10.1074/jbc.274.25.18100; Mitchell RA, 2002, P NATL ACAD SCI USA, V99, P345, DOI 10.1073/pnas.012511599; Mu ZM, 2002, J BIOL CHEM, V277, P43175, DOI 10.1074/jbc.M206066200; Nguyen MT, 2003, J BIOL CHEM, V278, P33654, DOI 10.1074/jbc.M301735200; Onodera S, 2000, J BIOL CHEM, V275, P444, DOI 10.1074/jbc.275.1.444; Onodera S, 2004, ARTHRITIS RHEUM-US, V50, P1437, DOI 10.1002/art.20190; Orita M, 2002, CURR PHARM DESIGN, V8, P1297, DOI 10.2174/1381612023394674; Petrenko O, 2005, MOL CELL, V17, P225, DOI 10.1016/j.molcel.2004.11.052; Philo JS, 2004, BIOPHYS CHEM, V108, P77, DOI 10.1016/j.bpc.2003.10.010; Roger T, 2005, EUR J IMMUNOL, V35, P3405, DOI 10.1002/eji.200535413; Roger T, 2001, NATURE, V414, P920, DOI 10.1038/414920a; Rosengren E, 1996, MOL MED, V2, P143, DOI 10.1007/BF03402210; Rossi AG, 1998, J CLIN INVEST, V101, P2869, DOI 10.1172/JCI1524; Santos LL, 2004, J RHEUMATOL, V31, P1038; Schober A, 2004, CIRCULATION, V109, P380, DOI 10.1161/01.CIR.0000109201.72441.09; Senter PD, 2002, P NATL ACAD SCI USA, V99, P144, DOI 10.1073/pnas.011569399; Shimizu T, 1999, BIOCHEM BIOPH RES CO, V264, P751, DOI 10.1006/bbrc.1999.1584; Sugie K, 1999, INT IMMUNOL, V11, P1149, DOI 10.1093/intimm/11.7.1149; Sugimoto H, 1999, BIOCHEMISTRY-US, V38, P3268, DOI 10.1021/bi982184o; Swope M, 1998, EMBO J, V17, P3534, DOI 10.1093/emboj/17.13.3534; Taylor AB, 1999, BIOCHEMISTRY-US, V38, P7444, DOI 10.1021/bi9904048; Tierney T, 2005, ENDOCRINOLOGY, V146, P35, DOI 10.1210/en.2004-0946; Tomura T, 1999, J IMMUNOL, V162, P195; Watarai H, 2000, P NATL ACAD SCI USA, V97, P13251, DOI 10.1073/pnas.230445397	51	45	51	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					29641	29651	PMID 16893895	10.1074/jbc.M601103200	http://dx.doi.org/10.1074/jbc.M601103200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	V45DH	16893895	hybrid			2022-12-27	WOS:000209796800001
J	Donaldson, JR; Courcelle, CT; Courcelle, J				Donaldson, Janet R.; Courcelle, Charmain T.; Courcelle, Justin			RuvABC is required to resolve Holliday junctions that accumulate following replication on damaged templates in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECOMBINATION-DEFICIENT MUTANTS; INDUCED DNA-DAMAGE; ULTRAVIOLET-LIGHT; LAGGING-STRAND; IN-VITRO; GENETIC-RECOMBINATION; FORK REVERSAL; LESION BYPASS; POL-V; POSTREPLICATION REPAIR	RuvABC is a complex that promotes branch migration and resolution of Holliday junctions. Although ruv mutants are hypersensitive to UV irradiation, the molecular event(s) that necessitate RuvABC processing in vivo are not known. Here, we used a combination of two-dimensional gel analysis and electron microscopy to reveal that although ruvAB and ruvC mutants are able to resume replication following arrest at UV-induced lesions, molecules that replicate in the presence of DNA damage accumulate unresolved Holliday junctions. The failure to resolve the Holliday junctions on the fully replicated molecules correlates with a delayed loss of genomic integrity that is likely to account for the loss of viability in these cells. The strand exchange intermediates that accumulate in ruv mutants are distinct from those observed at arrested replication forks and are not subject to resolution by RecG. These results indicate that the Holliday junctions observed in ruv mutants are intermediates of a repair pathway that is distinct from that of the recovery of arrested replication forks. A model is proposed in which RuvABC is required to resolve junctions that arise during the repair of a subset of nonarresting lesions after replication has passed through the template.	Portland State Univ, Dept Biol, Portland, OR 97207 USA	Portland State University	Donaldson, JR (corresponding author), Natl Inst Hlth, NIDDK, GBB 5 Mem Dr,MSC 0538, Bethesda, MD 20892 USA.	donaldsonjr@niddk.nih.gov			NIGMS NIH HHS [F32 GM068566] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM068566] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BELL L, 1983, ANAL BIOCHEM, V130, P527, DOI 10.1016/0003-2697(83)90628-0; BRIDGES BA, 1974, J BACTERIOL, V117, P1077, DOI 10.1128/JB.117.3.1077-1081.1974; CHAN GL, 1985, BIOCHEMISTRY-US, V24, P5723, DOI 10.1021/bi00342a006; Chow KH, 2004, J BIOL CHEM, V279, P3492, DOI 10.1074/jbc.M311012200; CONNOLLY B, 1991, P NATL ACAD SCI USA, V88, P6063, DOI 10.1073/pnas.88.14.6063; CONNOLLY B, 1990, P NATL ACAD SCI USA, V87, P8476, DOI 10.1073/pnas.87.21.8476; Courcelle CT, 2006, P NATL ACAD SCI USA, V103, P9154, DOI 10.1073/pnas.0600785103; Courcelle CT, 2005, J BACTERIOL, V187, P6953, DOI 10.1128/JB.187.20.6953-6961.2005; Courcelle J, 2003, SCIENCE, V299, P1064, DOI 10.1126/science.1081328; Courcelle J, 1999, MOL GEN GENET, V262, P543, DOI 10.1007/s004380051116; Courcelle J, 2004, RES MICROBIOL, V155, P231, DOI 10.1016/j.resmic.2004.01.018; Courcelle J, 1997, P NATL ACAD SCI USA, V94, P3714, DOI 10.1073/pnas.94.8.3714; Courcelle J, 1999, J BACTERIOL, V181, P916, DOI 10.1128/JB.181.3.916-922.1999; DAVIS BD, 1949, P NATL ACAD SCI USA, V35, P1, DOI 10.1073/pnas.35.1.1; DELUCIA P, 1969, NATURE, V224, P1164, DOI 10.1038/2241164a0; Dickman MJ, 2002, EUR J BIOCHEM, V269, P5492, DOI 10.1046/j.1432-1033.2002.03250.x; Donaldson JR, 2004, GENETICS, V166, P1631, DOI 10.1534/genetics.166.4.1631; DUNDERDALE HJ, 1991, NATURE, V354, P506, DOI 10.1038/354506a0; Eggleston AK, 2000, J BIOL CHEM, V275, P26467, DOI 10.1074/jbc.M001496200; Eggleston AK, 1997, CELL, V89, P607, DOI 10.1016/S0092-8674(00)80242-1; Flores MJ, 2002, MOL MICROBIOL, V44, P783, DOI 10.1046/j.1365-2958.2002.02913.x; Flores MJ, 2001, EMBO J, V20, P619, DOI 10.1093/emboj/20.3.619; Friedman KL, 1995, METHOD ENZYMOL, V262, P613; Fuchs RPP, 2001, BIOCHEM SOC T, V29, P191, DOI 10.1042/0300-5127:0290191; GANESAN AK, 1974, J MOL BIOL, V87, P103, DOI 10.1016/0022-2836(74)90563-4; Grompone G, 2004, EMBO REP, V5, P607, DOI 10.1038/sj.embor.7400167; Grompone G, 2002, MOL MICROBIOL, V44, P1331, DOI 10.1046/j.1365-2958.2002.02962.x; Harris RS, 1996, GENETICS, V142, P681; Heller RC, 2005, MOL CELL, V17, P733, DOI 10.1016/j.molcel.2005.01.019; Heller RC, 2006, NATURE, V439, P557, DOI 10.1038/nature04329; Heller RC, 2005, J BIOL CHEM, V280, P34143, DOI 10.1074/jbc.M507224200; Higuchi K, 2003, GENES CELLS, V8, P437, DOI 10.1046/j.1365-2443.2003.00646.x; Hishida T, 2004, GENE DEV, V18, P1886, DOI 10.1101/gad.1223804; HORI ZI, 1970, PHOTOCHEM PHOTOBIOL, V11, P99, DOI 10.1111/j.1751-1097.1970.tb05976.x; HORII ZI, 1973, J MOL BIOL, V80, P327, DOI 10.1016/0022-2836(73)90176-9; HOWARDFL.P, 1969, J BACTERIOL, V97, P1134, DOI 10.1128/JB.97.3.1134-1141.1969; Ishioka K, 1998, GENES CELLS, V3, P209, DOI 10.1046/j.1365-2443.1998.00185.x; Jaktaji RP, 2003, MOL MICROBIOL, V47, P1091, DOI 10.1046/j.1365-2958.2003.03357.x; JOHNSON RC, 1977, NATURE, V267, P80, DOI 10.1038/267080a0; LLOYD RG, 1993, NUCLEIC ACIDS RES, V21, P1719, DOI 10.1093/nar/21.8.1719; Lu YB, 1996, P NATL ACAD SCI USA, V93, P12902, DOI 10.1073/pnas.93.23.12902; Lucas I, 2000, NUCLEIC ACIDS RES, V28, P2187, DOI 10.1093/nar/28.10.2187; McGlynn P, 1999, NUCLEIC ACIDS RES, V27, P3049, DOI 10.1093/nar/27.15.3049; McGlynn P, 2001, P NATL ACAD SCI USA, V98, P8227, DOI 10.1073/pnas.111008698; McGlynn P, 2001, J BIOL CHEM, V276, P41938, DOI 10.1074/jbc.M107945200; McInerney P, 2004, J BIOL CHEM, V279, P21543, DOI 10.1074/jbc.M401649200; MENEGHINI R, 1976, BIOCHIM BIOPHYS ACTA, V425, P419, DOI 10.1016/0005-2787(76)90006-X; Napolitano R, 2000, EMBO J, V19, P6259, DOI 10.1093/emboj/19.22.6259; Nowosielska A, 2006, NUCLEIC ACIDS RES, V34, P2258, DOI 10.1093/nar/gkl222; OTSUJI N, 1974, J BACTERIOL, V117, P337, DOI 10.1128/JB.117.2.337-344.1974; Pages V, 2003, SCIENCE, V300, P1300, DOI 10.1126/science.1083964; PARSONS CA, 1993, J MOL BIOL, V232, P397, DOI 10.1006/jmbi.1993.1399; PARSONS CA, 1992, P NATL ACAD SCI USA, V89, P5452, DOI 10.1073/pnas.89.12.5452; Rafferty JB, 1996, SCIENCE, V274, P415, DOI 10.1126/science.274.5286.415; Rangarajan S, 2002, MOL MICROBIOL, V43, P617, DOI 10.1046/j.1365-2958.2002.02747.x; Reuven NB, 1999, J BIOL CHEM, V274, P31763, DOI 10.1074/jbc.274.45.31763; ROTHMAN RH, 1977, MOL GEN GENET, V155, P279, DOI 10.1007/BF00272806; RUPP WD, 1971, J MOL BIOL, V61, P25, DOI 10.1016/0022-2836(71)90204-X; RUPP WD, 1968, J MOL BIOL, V31, P291, DOI 10.1016/0022-2836(68)90445-2; RYDER L, 1994, J BACTERIOL, V176, P1570, DOI 10.1128/jb.176.6.1570-1577.1994; Sambrook J., 2001, MOL CLONING LAB MANU; Seigneur M, 2000, MOL MICROBIOL, V38, P565, DOI 10.1046/j.1365-2958.2000.02152.x; Seigneur M, 1998, CELL, V95, P419, DOI 10.1016/S0092-8674(00)81772-9; Servant L, 2002, J BIOL CHEM, V277, P50046, DOI 10.1074/jbc.M207101200; SETLOW RB, 1963, SCIENCE, V142, P1464, DOI 10.1126/science.142.3598.1464; SHAH R, 1994, NUCLEIC ACIDS RES, V22, P2490, DOI 10.1093/nar/22.13.2490; Shah R, 1997, EMBO J, V16, P1464, DOI 10.1093/emboj/16.6.1464; Shen X, 2003, J BIOL CHEM, V278, P52546, DOI 10.1074/jbc.M310127200; STORM PK, 1971, MUTAT RES, V13, P9, DOI 10.1016/0027-5107(71)90121-7; Tang MJ, 1999, P NATL ACAD SCI USA, V96, P8919, DOI 10.1073/pnas.96.16.8919; THRESHER R, 1992, METHOD ENZYMOL, V211, P481; TOUGU K, 1994, J BIOL CHEM, V269, P4675; TSANEVA IR, 1992, CELL, V69, P1171, DOI 10.1016/0092-8674(92)90638-S; WHITBY MC, 1993, CELL, V75, P341, DOI 10.1016/0092-8674(93)80075-P	74	35	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					28811	28821		10.1074/jbc.M603933200	http://dx.doi.org/10.1074/jbc.M603933200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16895921	hybrid			2022-12-27	WOS:000240680500035
J	Feller, A; Boeckstaens, M; Marini, AM; Dubois, E				Feller, Andre; Boeckstaens, Melanie; Marini, Anna Maria; Dubois, Evelyne			Transduction of the nitrogen signal activating Gln3-mediated transcription is independent of Npr1 kinase and Rsp5-Bul1/2 ubiquitin ligase in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID PERMEASE; UPTAKE SYSTEMS; AMMONIUM TRANSPORTERS; CATABOLITE REPRESSION; NUCLEAR-LOCALIZATION; CARBON STARVATION; GAP1 PERMEASE; YEAST; GENE; GLN3	Nitrogen Catabolite Repression (NCR) allows the adaptation of yeast cells to the quality of nitrogen supply by inhibiting the transcription of genes encoding proteins involved in transport and degradation of nonpreferred nitrogen sources. In cells using ammonium or glutamine, the GATA transcription factor Gln3 is sequestered in the cytoplasm by Ure2 whereas it enters the nucleus after a shift to a nonpreferred nitrogen source like proline or upon addition of rapamycin, the TOR complex inhibitor. Recently, the Npr1 kinase and the Rsp5, Bul1/2 ubiquitin ligase complex were reported to have antagonistic roles in the nuclear import and Gln3-mediated activation. The Npr1 kinase controls the activity of various permeases including transporters for nitrogen sources that stimulate NCR such as the Mep ammonium transport systems. Combining data from growth tests, Northern blot analysis and Gln3 immunolocalization, we show that the Npr1 kinase is not a direct negative regulator of Gln3-dependent transcription. The derepression of Gln3-activated genes in ammonium-grown npr1 cells results from the reduced uptake of the nitrogen-repressing compound because NCR could be restored in npr1 cells by repairing ammonium-uptake defects through different means. Finally, we show that the impairment of the ubiquitin ligase complex does not prevent induction of NCR genes under nonpreferred nitrogen conditions. The apparent Rsp5-, Bul1/2- dependent Gln3 activation keeps to the cellular status, as it is only observed in cells having left the balanced phase of exponential growth.	Univ Libre Bruxelles, Inst Rech Microbiol JM Wiame, Microbiol Lab, B-1070 Brussels, Belgium; Univ Libre Bruxelles, Inst Biol & Med Mol, Lab Physiol Mol Cellule, B-6041 Gosselies, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles	Dubois, E (corresponding author), Univ Libre Bruxelles, Inst Rech Microbiol JM Wiame, Microbiol Lab, Ave Emile Gryzon,1, B-1070 Brussels, Belgium.			Boeckstaens, Melanie/0000-0003-1629-7403				Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Bihler H, 1998, FEBS LETT, V432, P59, DOI 10.1016/S0014-5793(98)00832-1; Bihler H, 2002, BBA-BIOMEMBRANES, V1558, P109, DOI 10.1016/S0005-2736(01)00414-X; Cox KH, 2004, J BIOL CHEM, V279, P19294, DOI 10.1074/jbc.M309240200; Cox KH, 2004, J BIOL CHEM, V279, P10270, DOI 10.1074/jbc.M312023200; Cox KH, 2002, J BIOL CHEM, V277, P37559, DOI 10.1074/jbc.M204879200; Crespo JL, 2004, J BIOL CHEM, V279, P37512, DOI 10.1074/jbc.M407372200; De Craene JO, 2001, J BIOL CHEM, V276, P43939, DOI 10.1074/jbc.M102944200; DUBOIS E, 1979, MOL GEN GENET, V175, P67, DOI 10.1007/BF00267857; Foury F, 2001, J BIOL CHEM, V276, P7762, DOI 10.1074/jbc.M005804200; GRENSON M, 1983, EUR J BIOCHEM, V133, P141, DOI 10.1111/j.1432-1033.1983.tb07439.x; GRENSON M, 1983, EUR J BIOCHEM, V133, P135, DOI 10.1111/j.1432-1033.1983.tb07438.x; GRENSON M, 1982, EUR J BIOCHEM, V121, P643, DOI 10.1111/j.1432-1033.1982.tb05834.x; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; HEIN C, 1995, MOL MICROBIOL, V18, P77, DOI 10.1111/j.1365-2958.1995.mmi_18010077.x; JACOBS P, 1980, J MOL BIOL, V139, P691, DOI 10.1016/0022-2836(80)90055-8; JAUNIAUX JC, 1987, EUR J BIOCHEM, V164, P601, DOI 10.1111/j.1432-1033.1987.tb11169.x; Javelle A, 2003, TRENDS MICROBIOL, V11, P53, DOI 10.1016/S0966-842X(02)00012-4; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Magasanik B, 2005, P NATL ACAD SCI USA, V102, P16537, DOI 10.1073/pnas.0507116102; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; Marini AM, 1997, MOL CELL BIOL, V17, P4282, DOI 10.1128/MCB.17.8.4282; Mathie A, 2006, PHARMACOL THERAPEUT, V111, P567, DOI 10.1016/j.pharmthera.2005.11.004; Nikko E, 2003, J BIOL CHEM, V278, P50732, DOI 10.1074/jbc.M306953200; PRINGLE JR, 1991, METHOD ENZYMOL, V194, P565; Roberts SK, 1999, J BACTERIOL, V181, P291, DOI 10.1128/JB.181.1.291-297.1999; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Soetens O, 2001, J BIOL CHEM, V276, P43949, DOI 10.1074/jbc.M102945200; Springael JY, 1999, BIOCHEM BIOPH RES CO, V257, P561, DOI 10.1006/bbrc.1999.0505; Springael JY, 2002, FEBS LETT, V517, P103, DOI 10.1016/S0014-5793(02)02586-3; Springael JY, 1998, MOL BIOL CELL, V9, P1253, DOI 10.1091/mbc.9.6.1253; Tate JJ, 2005, J BIOL CHEM, V280, P27195, DOI 10.1074/jbc.M504052200; VANDENBOL M, 1987, EUR J BIOCHEM, V164, P607, DOI 10.1111/j.1432-1033.1987.tb11170.x; WIAME JM, 1985, ADV MICROB PHYSIOL, V26, P1, DOI 10.1016/S0065-2911(08)60394-X; Zhao H, 1996, P NATL ACAD SCI USA, V93, P2454, DOI 10.1073/pnas.93.6.2454	35	29	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					28546	28554		10.1074/jbc.M605551200	http://dx.doi.org/10.1074/jbc.M605551200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16864574	hybrid			2022-12-27	WOS:000240680500008
J	Pino, V; Ramsauer, VP; Salas, P; Carraway, CAC; Carraway, KL				Pino, Vanessa; Ramsauer, Victoria P.; Salas, Pedro; Carraway, Coralie A. Carothers; Carraway, Kermit L.			Membrane mucin Muc4 induces density-dependent changes in ERK activation in mammary epithelial and tumor cells - Role in reversal of contact inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE GROWTH-FACTOR; SURFACE SIALOMUCIN COMPLEX; INTRAMEMBRANE ERBB2 LIGAND; MUC4/SIALOMUCIN COMPLEX; MOLECULAR-CLONING; PHOSPHORYLATION; RECEPTOR; KINASE; CANCER; OVEREXPRESSION	The membrane mucin Muc4 has been shown to alter cellular behavior through both anti-adhesive effects on cell-cell and cell-extracellular matrix interactions and its ability to act as an intramembrane ligand for the receptor tyrosine kinase ErbB2. The ERK pathway is regulated by both cell-matrix and cell-cell adhesion. An analysis of the effects of Muc4 expression on ERK phosphorylation in mammary tumor and epithelial cells, which exhibit both adhesion-dependent growth and contact inhibition of growth, showed that the effects are density dependent, with opposing effects on proliferating cells and contact-inhibited cells. In these cells, cell-matrix interactions through integrins are required for activation of the ERK mitogenesis pathway. However, cell-cell interactions via cadherins inhibit the ERK pathway. Expression of Muc4 reverses both of these effects. In contact-inhibited cells, Muc4 appears to activate the ERK pathway at the level of Raf-1; this activation does not depend on Ras activation. The increase in ERK activity correlates with an increase in cyclin D-1 expression in these cells. This abrogation of contact inhibition is dependent on the number of mucin repeats in the mucin subunit of Muc4, indicative of an anti-adhesive effect. The mechanism by which Muc4 disrupts contact inhibition involves a Muc4-induced relocalization of E-cadherin from adherens junctions at the lateral membrane of the cells to the apical membrane. Muc4-induced abrogation of contact inhibition may be an important mechanism by which tumors progress from an early, more benign state to invasiveness.	Univ Miami, Sch Med, Dept Anat & Cell Biol, Miami, FL 33101 USA; Univ Miami, Sch Med, Dept Biochem & Mol Biol, Miami, FL 33101 USA	University of Miami; University of Miami	Carraway, KL (corresponding author), Univ Miami, Sch Med, Dept Anat & Cell Biol, R-124,POB 016960, Miami, FL 33101 USA.	kcarrawa@med.miami.edu	Salas, Pedro J./AAS-9455-2021; Palau, Victoria E/F-3520-2012	Palau, Victoria E/0000-0003-2761-7003; Salas, Pedro/0000-0002-7411-1366	NCI NIH HHS [CA52498, CA 74072] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA074072, R01CA052498] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AOKI J, 1991, J CELL BIOL, V115, P1751, DOI 10.1083/jcb.115.6.1751; Balkovetz DF, 1999, LIFE SCI, V64, P1393, DOI 10.1016/S0024-3205(99)00073-9; Balkovetz DF, 1997, J BIOL CHEM, V272, P3471, DOI 10.1074/jbc.272.6.3471; Carraway KL, 2002, PROG NUCLEIC ACID RE, V71, P149, DOI 10.1016/S0079-6603(02)71043-X; Carraway KL, 1999, J BIOL CHEM, V274, P5263, DOI 10.1074/jbc.274.9.5263; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Elliott BE, 2002, CAN J PHYSIOL PHARM, V80, P91, DOI 10.1139/y02-010; Fagotto F, 1996, DEV BIOL, V180, P445, DOI 10.1006/dbio.1996.0318; HULL SR, 1990, BIOCHEM J, V265, P121, DOI 10.1042/bj2650121; ISHIBASHI K, 1992, BIOCHEM BIOPH RES CO, V182, P960, DOI 10.1016/0006-291X(92)91825-B; Jepson S, 2002, ONCOGENE, V21, P7524, DOI 10.1038/sj.onc.1205970; Kandikonda S, 1996, CELL ADHES COMMUN, V4, P13, DOI 10.3109/15419069609010760; Komatsu M, 1997, J BIOL CHEM, V272, P33245, DOI 10.1074/jbc.272.52.33245; Komatsu M, 2001, ONCOGENE, V20, P461, DOI 10.1038/sj.onc.1204106; Komatsu M, 1999, CANCER RES, V59, P2229; Komatsu M, 2000, INT J CANCER, V87, P480, DOI 10.1002/1097-0215(20000815)87:4<480::AID-IJC4>3.0.CO;2-6; Li SX, 2004, AM J PHYSIOL-CELL PH, V287, pC432, DOI 10.1152/ajpcell.00020.2004; Moniaux N, 2004, BRIT J CANCER, V91, P1633, DOI 10.1038/sj.bjc.6602163; Nagy P, 2005, CANCER RES, V65, P473; NUSRAT A, 1994, J CLIN INVEST, V93, P2056, DOI 10.1172/JCI117200; Ramsauer VP, 2006, MOL BIOL CELL, V17, P2931, DOI 10.1091/mbc.E05-09-0895; Ramsauer VP, 2003, J BIOL CHEM, V278, P30142, DOI 10.1074/jbc.M303220200; SHENG Z, 1990, J BIOL CHEM, V265, P8505; SHENG ZQ, 1992, J BIOL CHEM, V267, P16341; SHIBAMOTO S, 1994, CELL ADHES COMMUN, V1, P295, DOI 10.3109/15419069409097261; St Croix B, 1998, J CELL BIOL, V142, P557, DOI 10.1083/jcb.142.2.557; Takahashi K, 1996, EXP CELL RES, V226, P214, DOI 10.1006/excr.1996.0221; VANDEURS B, 1987, J HISTOCHEM CYTOCHEM, V35, P461, DOI 10.1177/35.4.3546491; WU K, 1994, J BIOL CHEM, V269, P11950	29	22	24	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					29411	29420		10.1074/jbc.M604858200	http://dx.doi.org/10.1074/jbc.M604858200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16891313	hybrid			2022-12-27	WOS:000240680500096
J	Chrencik, JE; Brooun, A; Kraus, ML; Recht, MI; Kolatkar, AR; Han, GW; Seifert, JM; Widmer, H; Auer, M; Kuhn, P				Chrencik, Jill E.; Brooun, Alexei; Kraus, Michelle L.; Recht, Michael I.; Kolatkar, Anand R.; Han, Gye Won; Seifert, Jan Marcus; Widmer, Hans; Auer, Manfred; Kuhn, Peter			Structural and biophysical characterization of the EphB4(center dot)ephrinB2 protein-protein interaction and receptor specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE EPHB4; CRYSTAL-STRUCTURE; EXPRESSION; EPHRINS; BINDING; DESIGN; ANGIOGENESIS; ANTAGONIST; LIGANDS; FAMILY	Increasing evidence implicates the interaction of the EphB4 receptor with its preferred ligand, ephrinB2, in pathological forms of angiogenesis and in tumorigenesis. To identify the molecular determinants of the unique specificity of EphB4 for ephrinB2, we determined the crystal structure of the ligand binding domain of EphB4 in complex with the extracellular domain of ephrinB2. This structural analysis suggested that one amino acid, Leu-95, plays a particularly important role in defining the structural features that confer the ligand selectivity of EphB4. Indeed, all other Eph receptors, which promiscuously bind many ephrins, have a conserved arginine at the position corresponding to Leu-95 of EphB4. We have also found that amino acid changes in the EphB4 ligand binding cavity, designed based on comparison with the crystal structure of the more promiscuous EphB2 receptor, yield EphB4 variants with altered binding affinity for ephrinB2 and an antagonistic peptide. Isothermal titration calorimetry experiments with an EphB4 Leu-95 to arginine mutant confirmed the importance of this amino acid in conferring high affinity binding to both ephrinB2 and the antagonistic peptide ligand. Isothermal titration calorimetry measurements also revealed an interesting thermodynamic discrepancy between ephrinB2 binding, which is an entropically driven process, and peptide binding, which is an enthalpically driven process. These results provide critical information on the EphB4 center dot ephrinB2 protein interfaces and their mode of interaction, which will facilitate development of small molecule compounds inhibiting the EphB4 center dot ephrinB2 interaction as novel cancer therapeutics.	Scripps Res Inst, Dept Cellular Biol, La Jolla, CA 92037 USA; Palo Alto Res Ctr, Scripps PARC Inst Adv Biomed Sci, Palo Alto, CA 94304 USA; Novartis Inst Biomed Res GmbH & Co KG, Discovery Technol Innovat Screening Technol, A-1235 Vienna, Austria; Novartis Inst Biomed Res, CH-4002 Basel, Switzerland	Scripps Research Institute; Scripps Research Institute; Novartis; Novartis	Kuhn, P (corresponding author), Scripps Res Inst, Dept Cellular Biol, 10550 N Torrey Pines Rd,CB 265, La Jolla, CA 92037 USA.	pkuhn@scripps.edu	Han, Gye Won/GLQ-8673-2022; Han, Gye Won/GLT-1531-2022; Han, Gye Won/GLQ-8724-2022	Han, Gye Won/0000-0003-4107-835X; Auer, Manfred/0000-0001-8920-3522				ANDRES AC, 1994, ONCOGENE, V9, P1461; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berclaz G, 1996, BIOCHEM BIOPH RES CO, V226, P869, DOI 10.1006/bbrc.1996.1442; Berclaz G, 2003, ANN ONCOL, V14, P220, DOI 10.1093/annonc/mdg072; Blits-Huizinga CT, 2004, IUBMB LIFE, V56, P257, DOI 10.1080/15216540412331270076; Chrencik JE, 2006, STRUCTURE, V14, P321, DOI 10.1016/j.str.2005.11.011; Committee E., 1997, CELL, V90, P403; Day B, 2005, J BIOL CHEM, V280, P26526, DOI 10.1074/jbc.M504972200; Dodelet VC, 2000, ONCOGENE, V19, P5614, DOI 10.1038/sj.onc.1203856; Gale NW, 1996, NEURON, V17, P9, DOI 10.1016/S0896-6273(00)80276-7; Himanen JP, 2002, ACTA CRYSTALLOGR D, V58, P533, DOI 10.1107/S0907444902000264; Himanen JP, 1998, NATURE, V396, P486, DOI 10.1038/24904; Himanen JP, 2004, NAT NEUROSCI, V7, P501, DOI 10.1038/nn1237; Himanen JP, 2001, NATURE, V414, P933, DOI 10.1038/414933a; Holland SJ, 1996, NATURE, V383, P722, DOI 10.1038/383722a0; Hopkins AL, 2006, CURR OPIN STRUC BIOL, V16, P127, DOI 10.1016/j.sbi.2006.01.013; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kertesz N, 2006, BLOOD, V107, P2330, DOI 10.1182/blood-2005-04-1655; Koolpe M, 2005, J BIOL CHEM, V280, P17301, DOI 10.1074/jbc.M500363200; Liu WB, 2002, CANCER, V94, P934, DOI 10.1002/cncr.10122; Martiny-Baron G, 2004, NEOPLASIA, V6, P248, DOI 10.1593/neo.03457; Munarini N, 2002, J CELL SCI, V115, P25; Nakamoto M, 2002, MICROSC RES TECHNIQ, V59, P58, DOI 10.1002/jemt.10177; Nikolov DB, 2005, BIOCHEMISTRY-US, V44, P10947, DOI 10.1021/bi050789w; Nikolova Z, 1998, J CELL SCI, V111, P2741; Noren NK, 2004, P NATL ACAD SCI USA, V101, P5583, DOI 10.1073/pnas.0401381101; Ohtaka H, 2004, INT J BIOCHEM CELL B, V36, P1787, DOI 10.1016/j.biocel.2004.02.021; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Schmucker D, 2001, CELL, V105, P701, DOI 10.1016/S0092-8674(01)00391-9; Smith FM, 2004, J BIOL CHEM, V279, P9522, DOI 10.1074/jbc.M309326200; Takemoto M, 2002, EUR J NEUROSCI, V16, P1168, DOI 10.1046/j.1460-9568.2002.02166.x; Toth J, 2001, DEV CELL, V1, P83, DOI 10.1016/S1534-5807(01)00002-8; Turnbull WB, 2003, J AM CHEM SOC, V125, P14859, DOI 10.1021/ja036166s; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wilkinson DG, 2000, INT REV CYTOL, V196, P177; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515	37	73	81	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					28185	28192		10.1074/jbc.M605766200	http://dx.doi.org/10.1074/jbc.M605766200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16867992	hybrid			2022-12-27	WOS:000240534400056
J	Conway, JP; Kinter, M				Conway, James P.; Kinter, Michael			Dual role of peroxiredoxin I in macrophage-derived foam cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; THIOL-SPECIFIC ANTIOXIDANT; CYSTEINE-SULFINIC ACID; NECROSIS-FACTOR-ALPHA; SMOOTH-MUSCLE-CELLS; PROTEIN-KINASE-C; MOUSE PERITONEAL-MACROPHAGES; PEROXIDE-INDUCED APOPTOSIS; ACTIVATED RECEPTOR-GAMMA; OXIDATIVELY MODIFIED LDL	We and others have shown that foam cell formation initiated by exposing macrophages to oxidized low density lipoprotein (oxLDL) triggers the differential expression of a number of proteins. Specifically, our experiments have identified peroxiredoxin I (Prx I) as one of these up-regulated proteins. The peroxiredoxins, a family of peroxidases initially described for their antioxidant capability, have generated recent interest for their potential to regulate signaling pathways. Those studies, however, have not examined peroxiredoxin for a potential dual functionality as both cytoprotective antioxidant and signal modulator in a single, oxidant-stressed system. In this report, we examine the up-regulation of Prx I in macrophages in response to oxLDL exposure and its ability to function as both antioxidant enzyme and regulator of p38 MAPK activation. As an antioxidant, induction of Prx I expression led to improved cell survival following treatment with oxLDL or tert-butyl hydroperoxide. The improved survival coincided with a decrease in measurable reactive oxygen species (ROS), and both the increased survival and reduced ROS were reversed by Prx I small interfering RNA transfection. Additionally, our data show that activation of p38 MAPK in oxLDL-treated macrophages was dependent on the up-regulation of Prx I. Reduction of Prx I expression by small interfering RNA transfection resulted in a significant decrease in p38 MAPK activation, whereas the up-regulation of Prx I expression with either oxLDL or ethoxyquin led to increased p38 MAPK activation. These results are consistent with multiple roles for Prx I in macrophage-derived foam cells that include functionality as both an antioxidant and a regulator of oxidant-sensitive signal transduction.	Cleveland Clin Fdn, Dept Cell Biol, Lerner Res Inst, Cleveland, OH 44195 USA; Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Case Western Reserve University	Kinter, M (corresponding author), Cleveland Clin Fdn, Dept Cell Biol, Lerner Res Inst, NC 10,9500 Euclid Ave, Cleveland, OH 44195 USA.	kinterm@ccf.org		Conway, James/0000-0002-1725-8193; Kinter, Michael/0000-0001-7409-8918				Arstall MA, 1998, J MOL CELL CARDIOL, V30, P1019, DOI 10.1006/jmcc.1998.0666; Bea F, 2003, CIRC RES, V92, P386, DOI 10.1161/01.RES.0000059561.65545.16; Bilski P, 2002, FREE RADICAL BIO MED, V33, P938, DOI 10.1016/S0891-5849(02)00982-6; Bryk R, 2000, NATURE, V407, P211, DOI 10.1038/35025109; BUETLER TM, 1995, TOXICOL APPL PHARM, V135, P45, DOI 10.1006/taap.1995.1207; Chang JW, 2001, BIOCHEM BIOPH RES CO, V289, P507, DOI 10.1006/bbrc.2001.5989; Chang TS, 2004, J BIOL CHEM, V279, P50994, DOI 10.1074/jbc.M409482200; Chen WC, 2002, J NEUROSCI RES, V70, P794, DOI 10.1002/jnr.10435; Chevallet M, 2003, J BIOL CHEM, V278, P37146, DOI 10.1074/jbc.M305161200; Choi MH, 2005, NATURE, V435, P347, DOI 10.1038/nature03587; Chung YM, 2001, ANTICANCER RES, V21, P1129; Conway JP, 2005, MOL CELL PROTEOMICS, V4, P1522, DOI 10.1074/mcp.M500111-MCP200; Diepeveen SHA, 2005, J INTERN MED, V257, P438, DOI 10.1111/j.1365-2796.2005.01484.x; Feng JW, 2000, J LIPID RES, V41, P688; Fischer B, 2002, J IMMUNOL, V168, P2828, DOI 10.4049/jimmunol.168.6.2828; Gelissen IC, 1996, J BIOL CHEM, V271, P17852, DOI 10.1074/jbc.271.30.17852; GERRITY RG, 1980, ARTERY, V8, P208; Guo ZH, 2000, EXP NEUROL, V166, P173, DOI 10.1006/exnr.2000.7497; Han JH, 1998, AM J PATHOL, V152, P1647; Han JH, 1997, J BIOL CHEM, V272, P21654, DOI 10.1074/jbc.272.34.21654; Han JH, 2001, J BIOL CHEM, V276, P16567, DOI 10.1074/jbc.M011302200; Han KH, 2000, J CLIN INVEST, V106, P793, DOI 10.1172/JCI10052; Hattori F, 2003, J NEUROCHEM, V86, P860, DOI 10.1046/j.1471-4159.2003.01918.x; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Heinloth A, 2000, J AM SOC NEPHROL, V11, P1819, DOI 10.1681/ASN.V11101819; Hess A, 2003, J BIOL CHEM, V278, P45419, DOI 10.1074/jbc.M307871200; Hsu HY, 2000, J BIOL CHEM, V275, P41035, DOI 10.1074/jbc.M003464200; ISHII T, 1995, BIOCHEM BIOPH RES CO, V216, P970, DOI 10.1006/bbrc.1995.2715; Ishii T, 2004, CIRC RES, V94, P609, DOI 10.1161/01.RES.0000119171.44657.45; ISHII T, 1993, J BIOL CHEM, V268, P18633; Jing Q, 2000, CIRC RES, V87, P52, DOI 10.1161/01.RES.87.1.52; Jing Q, 1999, CIRC RES, V84, P831; Kang SW, 1998, J BIOL CHEM, V273, P6297, DOI 10.1074/jbc.273.11.6297; Kang SW, 2004, J BIOL CHEM, V279, P2535, DOI 10.1074/jbc.M307698200; Kim H, 2000, J BIOL CHEM, V275, P18266, DOI 10.1074/jbc.275.24.18266; Kim HJ, 2003, CELL BIOL TOXICOL, V19, P285, DOI 10.1023/B:CBTO.0000004952.07979.3d; Kim HS, 2001, AM J PHYSIOL-LUNG C, V280, pL1212, DOI 10.1152/ajplung.2001.280.6.L1212; Konig J, 2003, J BIOL CHEM, V278, P24409, DOI 10.1074/jbc.M301145200; Kwon J, 2004, P NATL ACAD SCI USA, V101, P16419, DOI 10.1073/pnas.0407396101; Lee K, 2002, BIOCHEM BIOPH RES CO, V296, P337, DOI 10.1016/S0006-291X(02)00801-X; Li BJ, 2002, J BIOL CHEM, V277, P12418, DOI 10.1074/jbc.M111443200; LIPTON BA, 1995, J LIPID RES, V36, P2232; Lupo G, 2001, BBA-MOL CELL BIOL L, V1531, P143, DOI 10.1016/S1388-1981(01)00102-0; Mu ZM, 2002, J BIOL CHEM, V277, P43175, DOI 10.1074/jbc.M206066200; Netto LES, 1996, J BIOL CHEM, V271, P15315, DOI 10.1074/jbc.271.26.15315; Noh DY, 2001, ANTICANCER RES, V21, P2085; Ogawa Y, 2004, INT J MOL MED, V14, P1007; Paromov VM, 2003, J BIOL CHEM, V278, P40859, DOI 10.1074/jbc.M306580200; Peshenko IV, 1998, FREE RADICAL BIO MED, V25, P654, DOI 10.1016/S0891-5849(98)00111-7; Plaisant F, 2003, FREE RADICAL BIO MED, V34, P862, DOI 10.1016/S0891-5849(02)01440-5; QUINN MT, 1985, P NATL ACAD SCI USA, V82, P5949, DOI 10.1073/pnas.82.17.5949; QUINN MT, 1987, P NATL ACAD SCI USA, V84, P2995, DOI 10.1073/pnas.84.9.2995; Rabilloud T, 2002, J BIOL CHEM, V277, P19396, DOI 10.1074/jbc.M106585200; SCHAFFNER T, 1980, AM J PATHOL, V100, P57; SCHMITT A, 1995, BBA-LIPID LIPID MET, V1256, P284, DOI 10.1016/0005-2760(95)00032-8; Shatrov VA, 2003, BIOCHEM J, V374, P505, DOI 10.1042/BJ20030420; Shau HY, 2000, ANTIOXID REDOX SIGN, V2, P347, DOI 10.1089/ars.2000.2.2-347; Shen JJ, 2004, CANCER RES, V64, P9018, DOI 10.1158/0008-5472.CAN-04-3262; SIOW RCM, 1995, FEBS LETT, V368, P239, DOI 10.1016/0014-5793(95)00650-X; STEINBRECHER UP, 1987, ARTERIOSCLEROSIS, V7, P135, DOI 10.1161/01.ATV.7.2.135; STEINBRECHER UP, 1989, J BIOL CHEM, V264, P15216; Tokay T, 2005, J NEUROCHEM, V94, P607, DOI 10.1111/j.1471-4159.2005.03102.x; Tsukamoto Kayo, 2002, J Atheroscler Thromb, V9, P57; Veal EA, 2004, MOL CELL, V15, P129, DOI 10.1016/j.molcel.2004.06.021; Vivancos AP, 2005, P NATL ACAD SCI USA, V102, P8875, DOI 10.1073/pnas.0503251102; Vogel Christoph F A, 2004, Cardiovasc Toxicol, V4, P363, DOI 10.1385/CT:4:4:363; Wagner E, 2002, BIOCHEM J, V366, P777, DOI 10.1042/BJ20020525; Wagsater D, 2004, BIOCHEM BIOPH RES CO, V325, P1187, DOI 10.1016/j.bbrc.2004.10.160; Wang N, 1996, J BIOL CHEM, V271, P8837, DOI 10.1074/jbc.271.15.8837; Wen ST, 1997, GENE DEV, V11, P2456, DOI 10.1101/gad.11.19.2456; Wiegant FAC, 1999, HUM EXP TOXICOL, V18, P460, DOI 10.1191/096032799678840273; Woo HA, 2005, J BIOL CHEM, V280, P3125, DOI 10.1074/jbc.C400496200; Woo HA, 2003, J BIOL CHEM, V278, P47361, DOI 10.1074/jbc.C300428200; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200; Yoshida H, 1998, ARTERIOSCL THROM VAS, V18, P794, DOI 10.1161/01.ATV.18.5.794; Zeng Y, 2001, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V23, P328; ZHANG HF, 1990, J LIPID RES, V31, P1361; Zmijewski JW, 2005, AM J PHYSIOL-HEART C, V289, pH852, DOI 10.1152/ajpheart.00015.2005	78	50	53	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					27991	28001		10.1074/jbc.M605026200	http://dx.doi.org/10.1074/jbc.M605026200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16880205	hybrid			2022-12-27	WOS:000240534400036
J	Tate, JJ; Rai, R; Cooper, TG				Tate, Jennifer J.; Rai, Rajendra; Cooper, Terrance G.			Ammonia-specific regulation of Gln3 localization in Saccharomyces cerevisiae by protein kinase Npr1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITROGEN CATABOLITE REPRESSION; RETROGRADE GENE-EXPRESSION; AMINO-ACID PERMEASES; METHIONINE SULFOXIMINE TREATMENT; TOR SIGNALING PATHWAY; UBIQUITIN LIGASE; NUCLEAR-LOCALIZATION; CARBON STARVATION; 2A PHOSPHATASES; UPTAKE SYSTEMS	Events directly regulating Gln3 intracellular localization and nitrogen catabolite repression (NCR)-sensitive transcription in Saccharomyces cerevisiae are interconnected with many cellular processes that influence the utilization of environmental metabolites. Among them are intracellular trafficking of the permeases that transport nitrogenous compounds and their control by the Tor1,2 signal transduction pathway. Npr1 is a kinase that phosphorylates and thereby stabilizes NCR-sensitive permeases, e. g. Gap1 and Mep2. It is also a phosphoprotein for which phosphorylation and kinase activity are regulated by Tor1,2 via Tap42 and Sit4. Npr1 has been reported to negatively regulate nuclear localization of Gln3 in SD (ammonia)-grown cells. Thus we sought to distinguish whether Npr1: (i) functions directly as a component of NCR control; or (ii) influences Gln3 localization indirectly, possibly as a consequence of participating in protein trafficking. If Npr1 functions directly, then the ability of all good nitrogen sources to restrict Gln3 to the cytoplasm should be lost in an npr1 Delta just as occurs when URE2 ( encoding this well studied negative Gln3 regulator) is deleted. We show that nuclear localization of Gln3-Myc(13) in an npr1 Delta occurred only with ammonia as the nitrogen source. Other good nitrogen sources, e. g. glutamine, serine, or asparagine, restricted Gln3-Myc(13) to the cytoplasm of both wild type and npr1 Delta cells. In other words, the npr1 Delta did not possess the uniform phenotype for all repressive nitrogen sources characteristic of ure2 Delta. This suggests that the connection between Gln3 localization and Npr1 is indirect, arising from the influence of Npr1 on the ability of cells to utilize ammonia as a repressive nitrogen source.	Univ Tennessee, Dept Mol Sci, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Cooper, TG (corresponding author), Univ Tennessee, Dept Mol Sci, Memphis, TN 38163 USA.	tcooper@utmem.edu		Cooper, Terrance G./0000-0002-7651-9963	NIGMS NIH HHS [R01 GM035642, R01 GM035642-18, GM-35642] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035642] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Bertram PG, 2000, J BIOL CHEM, V275, P35727, DOI 10.1074/jbc.M004235200; Blinder D, 1996, J BACTERIOL, V178, P4734, DOI 10.1128/jb.178.15.4734-4736.1996; BORNAES C, 1993, MOL CELL BIOL, V13, P7604, DOI 10.1128/MCB.13.12.7604; Boulay A, 2005, CLIN CANCER RES, V11, P5319, DOI 10.1158/1078-0432.CCR-04-2402; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; Cooper T., 1982, MOL BIOL YEAST SACCH, P39, DOI DOI 10.1101/087969180.11B.39; Cooper TG, 2004, TOP CURR GENET, V7, P225; Cooper TG, 2002, FEMS MICROBIOL REV, V26, P223, DOI 10.1111/j.1574-6976.2002.tb00612.x; Cox KH, 2004, J BIOL CHEM, V279, P19294, DOI 10.1074/jbc.M309240200; Cox KH, 2004, J BIOL CHEM, V279, P10270, DOI 10.1074/jbc.M312023200; Cox KH, 2002, J BIOL CHEM, V277, P37559, DOI 10.1074/jbc.M204879200; Cox KH, 2000, J BIOL CHEM, V275, P17611, DOI 10.1074/jbc.M001648200; Crespo JL, 2004, J BIOL CHEM, V279, P37512, DOI 10.1074/jbc.M407372200; Crespo JL, 2002, P NATL ACAD SCI USA, V99, P6784, DOI 10.1073/pnas.102687599; De Craene JO, 2001, J BIOL CHEM, V276, P43939, DOI 10.1074/jbc.M102944200; DiComo CJ, 1996, GENE DEV, V10, P1904, DOI 10.1101/gad.10.15.1904; DRILLIEN R, 1972, J BACTERIOL, V109, P203, DOI 10.1128/JB.109.1.203-208.1972; DRILLIEN R, 1973, BIOCHEM BIOPH RES CO, V53, P367, DOI 10.1016/0006-291X(73)90671-2; DUBOIS E, 1979, MOL GEN GENET, V175, P67, DOI 10.1007/BF00267857; Duvel K, 2003, MOL CELL, V11, P1467, DOI 10.1016/S1097-2765(03)00228-4; Galan JM, 1996, J BIOL CHEM, V271, P10946, DOI 10.1074/jbc.271.18.10946; Giannattasio S, 2005, J BIOL CHEM, V280, P42528, DOI 10.1074/jbc.M509187200; GRENSON M, 1983, EUR J BIOCHEM, V133, P141, DOI 10.1111/j.1432-1033.1983.tb07439.x; Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866; HEIN C, 1995, MOL MICROBIOL, V18, P77, DOI 10.1111/j.1365-2958.1995.mmi_18010077.x; Helliwell SB, 2001, J CELL BIOL, V153, P649, DOI 10.1083/jcb.153.4.649; Hofman-Bang J, 1999, MOL BIOTECHNOL, V12, P35, DOI 10.1385/MB:12:1:35; Inoki K, 2005, MICROBIOL MOL BIOL R, V69, P79, DOI 10.1128/MMBR.69.1.79-100.2005; Jacinto E, 2001, MOL CELL, V8, P1017, DOI 10.1016/S1097-2765(01)00386-0; Jiang Y, 1999, EMBO J, V18, P2782, DOI 10.1093/emboj/18.10.2782; Kaouass M, 1998, J BIOL CHEM, V273, P2109, DOI 10.1074/jbc.273.4.2109; Kulkarni A, 2006, FEMS YEAST RES, V6, P218, DOI 10.1111/j.1567-1364.2006.00031.x; KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F; Lorber MI, 2005, TRANSPLANTATION, V80, P244, DOI 10.1097/01.TP.0000164352.65613.24; Lorenz MC, 1998, EMBO J, V17, P1236, DOI 10.1093/emboj/17.5.1236; Magasanik B, 2005, P NATL ACAD SCI USA, V102, P16537, DOI 10.1073/pnas.0507116102; Marini AM, 1997, MOL CELL BIOL, V17, P4282, DOI 10.1128/MCB.17.8.4282; MICHNICK SW, 1991, SCIENCE, V252, P836, DOI 10.1126/science.1709301; Morgensztern D, 2005, ANTI-CANCER DRUG, V16, P797, DOI 10.1097/01.cad.0000173476.67239.3b; Omura F, 2004, FEMS MICROBIOL LETT, V230, P227, DOI 10.1016/S0378-1097(03)00918-2; Regenberg B, 1999, CURR GENET, V36, P317, DOI 10.1007/s002940050506; Schluter Michael, 2005, Am Heart Hosp J, V3, P182, DOI 10.1111/j.1541-9215.2005.04407.x; Schmidt A, 1998, EMBO J, V17, P6924, DOI 10.1093/emboj/17.23.6924; Smart WC, 1996, MOL CELL BIOL, V16, P5876; Springael JY, 1999, BIOCHEM BIOPH RES CO, V257, P561, DOI 10.1006/bbrc.1999.0505; Springael JY, 1998, MOL BIOL CELL, V9, P1253, DOI 10.1091/mbc.9.6.1253; Springael JY, 1999, J CELL SCI, V112, P1375; Tate JJ, 2002, J BIOL CHEM, V277, P20477, DOI 10.1074/jbc.M200962200; Tate JJ, 2003, J BIOL CHEM, V278, P36924, DOI 10.1074/jbc.M301829200; Tate JJ, 2005, J BIOL CHEM, V280, P27195, DOI 10.1074/jbc.M504052200; ter Schure EG, 2000, FEMS MICROBIOL REV, V24, P67, DOI 10.1016/S0168-6445(99)00030-3; THOMAS G, 2004, CURRENT TOPICS MICRO, V279; VANDENBOL M, 1990, MOL GEN GENET, V222, P393, DOI 10.1007/BF00633845; VANDENBOL M, 1987, EUR J BIOCHEM, V164, P607, DOI 10.1111/j.1432-1033.1987.tb11170.x; Wang HM, 2003, MOL BIOL CELL, V14, P4342, DOI 10.1091/mbc.E03-02-0072; Yashiroda H, 1996, MOL CELL BIOL, V16, P3255; Zhu X, 1996, CURR GENET, V30, P107, DOI 10.1007/s002940050108	58	24	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					28460	28469		10.1074/jbc.M604171200	http://dx.doi.org/10.1074/jbc.M604171200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16864577	Green Accepted, hybrid			2022-12-27	WOS:000240534400083
J	Poggio, S; Osorio, A; Dreyfus, G; Camarena, L				Poggio, Sebastian; Osorio, Aurora; Dreyfus, Georges; Camarena, Laura			Transcriptional specificity of RpoN1 and RpoN2 involves differential recognition of the promoter sequences and specific interaction with the cognate activator proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-NEGATIVE BACTERIA; ENHANCER-BINDING PROTEINS; COLI RNA-POLYMERASE; FORK JUNCTION DNA; TURN-HELIX MOTIF; ESCHERICHIA-COLI; RHODOBACTER-SPHAEROIDES; SIGMA-FACTOR; KLEBSIELLA-PNEUMONIAE; TERMINAL REGION	The four RpoN factors of Rhodobacter sphaeroides are functionally specialized. In this bacterium, RpoN1 and RpoN2 are specifically required for the transcription of the nitrogen fixation and flagellar genes, respectively. Analysis of the promoter sequences recognized by each of these RpoN proteins revealed some significant differences. To investigate the functional relevance of these differences, the flagellar promoter fliOp was sequentially mutagenized to resemble the nitrogen fixation promoter nifUp. Our results indicate that the promoter sequences recognized by these sigma factors have diverged enough so that particular positions of the promoter sequence are differentially recognized. In this regard, we demonstrate that the identity of the -11-position is critical for promoter discrimination by RpoN1 and RpoN2. Accordingly, purified RpoN proteins with a deletion of Region I, which has been involved in the recognition of the -11-position, did not show differential binding of fliOp and nifUp promoters. Substitution of the flagellar enhancer region located upstream fliOp by the enhancer region of nifUp allowed us to demonstrate that RpoN1 and RpoN2 interact specifically with their respective activator protein. In conclusion, two different molecular mechanisms underlie the transcriptional specialization of these sigma factors.	Natl Autonomous Univ Mexico, Inst Invest Biomed, Dept Biol Mol & Biotecnol, Mexico City 04510, DF, Mexico; Natl Autonomous Univ Mexico, Inst Fisiol Celular, Dept Mol Genet, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Camarena, L (corresponding author), Natl Autonomous Univ Mexico, Inst Invest Biomed, Dept Biol Mol & Biotecnol, Mexico City 04510, DF, Mexico.	rosal@servidor.unam.mx		Dreyfus, Georges/0000-0001-9502-5072; Poggio, Sebastian/0000-0001-9494-3365; Camarena, Rosa Laura/0000-0003-0344-6000				AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; Barrios H, 1999, NUCLEIC ACIDS RES, V27, P4305, DOI 10.1093/nar/27.22.4305; BEYNON J, 1983, CELL, V34, P665, DOI 10.1016/0092-8674(83)90399-9; Bordes P, 2003, P NATL ACAD SCI USA, V100, P2278, DOI 10.1073/pnas.0537525100; Brahmachary P, 2004, J BACTERIOL, V186, P4535, DOI 10.1128/JB.186.14.4535-4542.2004; Buck M, 2000, J BACTERIOL, V182, P4129, DOI 10.1128/JB.182.15.4129-4136.2000; BUCK M, 1992, NATURE, V358, P422, DOI 10.1038/358422a0; BUCK M, 1992, MOL MICROBIOL, V6, P1625, DOI 10.1111/j.1365-2958.1992.tb00887.x; BURGESS RR, 1969, NATURE, V221, P43, DOI 10.1038/221043a0; BURGESS RR, 1970, FED PROC, V29, P1164; Burrows PC, 2003, J BIOL CHEM, V278, P29728, DOI 10.1074/jbc.M303596200; CANNON W, 1993, MOL MICROBIOL, V8, P287, DOI 10.1111/j.1365-2958.1993.tb01573.x; Cannon W, 2003, J BIOL CHEM, V278, P19815, DOI 10.1074/jbc.M301296200; CANNON W, 1995, J MOL BIOL, V248, P781, DOI 10.1006/jmbi.1995.0260; Cannon W, 1999, GENE DEV, V13, P357, DOI 10.1101/gad.13.3.357; Cannon W, 1999, NUCLEIC ACIDS RES, V27, P2478, DOI 10.1093/nar/27.12.2478; Cannon WV, 2000, NAT STRUCT BIOL, V7, P594; CASTANO I, 1984, MOL GEN GENET, V195, P228, DOI 10.1007/BF00332751; Chaney M, 1999, MOL MICROBIOL, V33, P1200, DOI 10.1046/j.1365-2958.1999.01566.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DAVIS J, 1988, J BACTERIOL, V170, P320, DOI 10.1128/jb.170.1.320-329.1988; Doucleff M, 2005, J BIOL CHEM, V280, P41530, DOI 10.1074/jbc.M509010200; Girard L, 2000, MOL PLANT MICROBE IN, V13, P1283, DOI 10.1094/MPMI.2000.13.12.1283; GROSS CA, 1992, TRANSCRIPTIONAL REGU, P129; Guo YL, 2000, GENE DEV, V14, P2242, DOI 10.1101/gad.794800; Guo YL, 1999, EMBO J, V18, P3736, DOI 10.1093/emboj/18.13.3736; HELMANN JD, 1988, ANNU REV BIOCHEM, V57, P839, DOI 10.1146/annurev.bi.57.070188.004203; Hengge-Aronis R, 2002, CURR OPIN MICROBIOL, V5, P591, DOI 10.1016/S1369-5274(02)00372-7; HUALA E, 1989, J BACTERIOL, V171, P3354, DOI 10.1128/jb.171.6.3354-3365.1989; HUALA E, 1992, J BACTERIOL, V174, P1428, DOI 10.1128/jb.174.4.1428-1431.1992; Ishihama A, 2000, ANNU REV MICROBIOL, V54, P499, DOI 10.1146/annurev.micro.54.1.499; JEFFERSON RA, 1986, P NATL ACAD SCI USA, V83, P8447, DOI 10.1073/pnas.83.22.8447; KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5; Kelly MT, 2000, J BACTERIOL, V182, P513, DOI 10.1128/JB.182.2.513-517.2000; KULLIK I, 1991, J BACTERIOL, V173, P1125, DOI 10.1128/jb.173.3.1125-1138.1991; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Lee SY, 2003, GENE DEV, V17, P2552, DOI 10.1101/gad.1125603; Mackenzie C, 2001, PHOTOSYNTH RES, V70, P19, DOI 10.1023/A:1013831823701; MEIJER WG, 1992, J BACTERIOL, V174, P3855, DOI 10.1128/jb.174.12.3855-3866.1992; MERRICK M, 1992, J BACTERIOL, V174, P7221, DOI 10.1128/jb.174.22.7221-7226.1992; MERRICK MJ, 1993, MOL MICROBIOL, V10, P903, DOI 10.1111/j.1365-2958.1993.tb00961.x; Michiels J, 1998, J BACTERIOL, V180, P3620, DOI 10.1128/JB.180.14.3620-3628.1998; Mittenhuber G, 2002, J MOL MICROB BIOTECH, V4, P77; MORETT E, 1989, J MOL BIOL, V210, P65, DOI 10.1016/0022-2836(89)90291-X; North AK, 1997, J MOL BIOL, V267, P17, DOI 10.1006/jmbi.1996.0838; Poggio S, 2000, J BACTERIOL, V182, P5787, DOI 10.1128/JB.182.20.5787-5792.2000; Poggio S, 2005, MOL MICROBIOL, V58, P969, DOI 10.1111/j.1365-2958.2005.04900.x; Poggio S, 2002, MOL MICROBIOL, V46, P75, DOI 10.1046/j.1365-2958.2002.03158.x; POPHAM DL, 1989, SCIENCE, V243, P629, DOI 10.1126/science.2563595; QUANDT J, 1993, GENE, V127, P15, DOI 10.1016/0378-1119(93)90611-6; Rappas M, 2005, SCIENCE, V307, P1972, DOI 10.1126/science.1105932; SASSEDWIGHT S, 1988, P NATL ACAD SCI USA, V85, P8934, DOI 10.1073/pnas.85.23.8934; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; SISTROM WR, 1962, J GEN MICROBIOL, V28, P607, DOI 10.1099/00221287-28-4-607; Sockett R, 1990, FEMS S, V53, P473; Southern E, 2000, NUCLEIC ACIDS RES, V28, P2563, DOI 10.1093/nar/28.13.2563; Studholme DJ, 2000, J BACTERIOL, V182, P1616, DOI 10.1128/JB.182.6.1616-1623.2000; Syed A, 1998, J BACTERIOL, V180, P5619, DOI 10.1128/JB.180.21.5619-5625.1998; Wang L, 1998, J BACTERIOL, V180, P5626, DOI 10.1128/JB.180.21.5626-5631.1998; Wang L, 2001, J BIOL CHEM, V276, P8979, DOI 10.1074/jbc.M009587200; Wang YK, 1997, MOL MICROBIOL, V26, P373, DOI 10.1046/j.1365-2958.1997.5851955.x; Wigneshweraraj SR, 2001, J MOL BIOL, V306, P681, DOI 10.1006/jmbi.2000.4393; Wosten MMSM, 1998, FEMS MICROBIOL REV, V22, P127, DOI 10.1016/S0168-6445(98)00011-4; Xu H, 2001, CURR OPIN MICROBIOL, V4, P138, DOI 10.1016/S1369-5274(00)00179-X; Zhang X, 2002, MOL MICROBIOL, V45, P895, DOI 10.1046/j.1365-2958.2002.03065.x	66	19	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2006	281	37					27205	27215		10.1074/jbc.M601735200	http://dx.doi.org/10.1074/jbc.M601735200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082PB	16854992	hybrid			2022-12-27	WOS:000240397700048
J	Yamaguchi, J; Conlon, DM; Liang, JJ; Fisher, EA; Ginsberg, HN				Yamaguchi, Junji; Conlon, Donna M.; Liang, John J.; Fisher, Edward A.; Ginsberg, Henry N.			Translocation efficiency of apolipoprotein B is determined by the presence of beta-sheet domains, not pause transfer sequences	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; UBIQUITIN-PROTEASOME PATHWAY; NASCENT SECRETORY PROTEINS; ENDOPLASMIC-RETICULUM; INTRACELLULAR DEGRADATION; APO-B; CONTAINING LIPOPROTEINS; MOLECULAR CHAPERONES; APOPROTEIN B100; BINDING	Cotranslational translocation of apoB100 across the endoplasmic reticulum (ER) membrane is inefficient, resulting in exposure of nascent apoB on the cytosolic surface of the ER. This predisposes apoB100 to ubiquitinylation and targeting for proteasomal degradation. It has been suggested that pause transfer sequences (PTS) present throughout apoB cause inefficient translocation. On the other hand, our previous study demonstrated that the translocation efficiency of apoB100 is dependent on the presence of a beta-sheet domain between 29 and 34% of full-length apoB100 (Liang, J.-S., Wu, X., Jiang, H., Zhou, M., Yang, H., Angkeow, P., Huang, L.-S., Sturley, S. L., and Ginsberg, H. N. ( 1998) J. Biol. Chem. 273, 35216-35221); this region of apoB has no PTS. However, the effects of the beta-sheet domain may require the presence of PTS elsewhere in the N-terminal region of apoB100. To further investigate the roles of PTS and beta-sheet domains in the translocation of apoB100 across the ER, we transfected McArdle RH7777, HepG2, or Chinese hamster ovary cells with human albumin (ALB)/human apoB chimeric cDNA constructs: ALB/B12-17 (two PTS but no beta-sheet), ALB/B29-34 (beta-sheet but no PTS), ALB/B36-41 (two PTS and a beta-sheet), and ALB/B49-54 (neither PTS nor a beta-sheet). ALB/ALB1-40 served as a control. Compared with ALB/ALB1-40, secretion rates of ALB/B12-17, ALB/B29-34, and ALB/B36-41 were reduced. Secretion of ALB/B49-54 was similar to that of ALB/ALB1-40. However, only ALB/B29-34 and ALB/B36-41 had increased proteinase K sensitivity, ubiquitinylation, and increased physical interaction with Sec61 alpha. These results indicate that the translocation efficiency of apoB100 is determined mainly by the presence of beta-sheet domains. PTS do not appear to affect translocation, but may affect secretion by other mechanisms.	Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY 10032 USA; NYU, Sch Med, Dept Med, New York, NY 10016 USA	Columbia University; New York University	Ginsberg, HN (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Med, PH 10-305,630 W 168th St, New York, NY 10032 USA.	hng1@columbia.edu	Fisher, Edward/ABE-7469-2020	Fisher, Edward/0000-0001-9802-143X; Conlon, Donna/0000-0002-9471-3081	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007343, R01HL055638] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL55638, T32 HL07343] Funding Source: Medline; PHS HHS [R01 58541] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Benoist F, 1997, J BIOL CHEM, V272, P20435, DOI 10.1074/jbc.272.33.20435; Chen Y, 1998, J BIOL CHEM, V273, P11887, DOI 10.1074/jbc.273.19.11887; CHUCK SL, 1993, J BIOL CHEM, V268, P22794; CHUCK SL, 1992, CELL, V68, P9, DOI 10.1016/0092-8674(92)90202-N; CHUCK SL, 1990, NATURE, V346, P382, DOI 10.1038/346382a0; CLADARAS C, 1986, EMBO J, V5, P3495, DOI 10.1002/j.1460-2075.1986.tb04675.x; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Davis RA, 1999, BBA-MOL CELL BIOL L, V1440, P1, DOI 10.1016/S1388-1981(99)00083-9; DAVIS RA, 1990, J BIOL CHEM, V265, P10005; DIXON JL, 1991, J BIOL CHEM, V266, P5080; Du XB, 1998, J CELL BIOL, V141, P585, DOI 10.1083/jcb.141.3.585; Finke K, 1996, EMBO J, V15, P1482, DOI 10.1002/j.1460-2075.1996.tb00492.x; Fisher EA, 2002, J BIOL CHEM, V277, P17377, DOI 10.1074/jbc.R100068200; Fisher EA, 1997, J BIOL CHEM, V272, P20427, DOI 10.1074/jbc.272.33.20427; FURUKAWA S, 1992, J BIOL CHEM, V267, P22630; Gusarova V, 2001, J BIOL CHEM, V276, P24891, DOI 10.1074/jbc.M100633200; Hayes SA, 1996, J CELL BIOL, V132, P255, DOI 10.1083/jcb.132.3.255; Hegde RS, 1996, CELL, V85, P217, DOI 10.1016/S0092-8674(00)81098-3; Hegde RS, 1998, CELL, V92, P621, DOI 10.1016/S0092-8674(00)81130-7; Herscovitz H, 2001, J LIPID RES, V42, P51; Johnson AE, 2000, CELL, V102, P709, DOI 10.1016/S0092-8674(00)00059-3; Kalies KU, 1998, J CELL BIOL, V141, P887, DOI 10.1083/jcb.141.4.887; Kivlen MH, 1997, J LIPID RES, V38, P1149; Liang JS, 2003, J BIOL CHEM, V278, P23984, DOI 10.1074/jbc.M302683200; Liang JS, 2001, J BIOL CHEM, V276, P28606, DOI 10.1074/jbc.M100294200; Liang JS, 1998, J BIOL CHEM, V273, P35216, DOI 10.1074/jbc.273.52.35216; Liang JS, 2000, J BIOL CHEM, V275, P32003, DOI 10.1074/jbc.M004646200; Manchekar M, 2004, J BIOL CHEM, V279, P39757, DOI 10.1074/jbc.M406302200; Mann CJ, 1999, J MOL BIOL, V285, P391, DOI 10.1006/jmbi.1998.2298; MILNE R, 1989, J BIOL CHEM, V264, P19754; Mitchell DM, 1998, P NATL ACAD SCI USA, V95, P14733, DOI 10.1073/pnas.95.25.14733; Pariyarath R, 2001, J BIOL CHEM, V276, P541, DOI 10.1074/jbc.M007944200; PEASE RJ, 1995, J BIOL CHEM, V270, P7261, DOI 10.1074/jbc.270.13.7261; PEASE RJ, 1991, NATURE, V353, P448, DOI 10.1038/353448a0; RAPOPORT TA, 1992, SCIENCE, V258, P931, DOI 10.1126/science.1332192; SAKATA N, 1993, J BIOL CHEM, V268, P22967; Segrest JP, 2001, J LIPID RES, V42, P1346; SEGREST JP, 1994, ARTERIOSCLER THROMB, V14, P1674, DOI 10.1161/01.ATV.14.10.1674; Shelness GS, 2003, J BIOL CHEM, V278, P44702, DOI 10.1074/jbc.M307562200; Shelness GS, 1999, J NUTR, V129, p456S, DOI 10.1093/jn/129.2.456S; Wu XJ, 1996, J BIOL CHEM, V271, P10277, DOI 10.1074/jbc.271.17.10277; YANG CY, 1986, NATURE, V323, P738, DOI 10.1038/323738a0; Yao ZM, 1997, J LIPID RES, V38, P1937; Yeung SJ, 1996, BIOCHEMISTRY-US, V35, P13843, DOI 10.1021/bi9618777; ZHOU MY, 1995, J BIOL CHEM, V270, P25220, DOI 10.1074/jbc.270.42.25220; Zhou MY, 1998, J BIOL CHEM, V273, P24649, DOI 10.1074/jbc.273.38.24649	46	19	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2006	281	37					27063	27071		10.1074/jbc.M606809200	http://dx.doi.org/10.1074/jbc.M606809200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082PB	16854991	hybrid			2022-12-27	WOS:000240397700033
J	Faehnle, CR; Le Coq, J; Liu, XY; Viola, RE				Faehnle, Christopher R.; Le Coq, Johanne; Liu, Xuying; Viola, Ronald E.			Examination of key intermediates in the catalytic cycle of aspartate-beta-semialdehyde dehydrogenase from a Gram-positive infectious bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID BIOSYNTHESIS; ESCHERICHIA-COLI; BACILLUS-SUBTILIS; FAMILY; IDENTIFICATION; PURIFICATION; REFINEMENT; PROGRAM; GENES; MODEL	Aspartate-beta-semialdehyde dehydrogenase (ASADH) catalyzes a critical branch point transformation in amino acid biosynthesis. The products of the aspartate pathway are essential in microorganisms, and this entire pathway is absent in mammals, making this enzyme an attractive target for antibiotic development. The first structure of an ASADH from a Gram-positive bacterium, Streptococcus pneumoniae, has now been determined. The overall structure of the apoenzyme has a similar fold to those of the Gram-negative and archaeal ASADHs but contains some interesting structural variations that can be exploited for inhibitor design. Binding of the coenzyme NADP, as well as a truncated nucleotide analogue, into an alternative conformation from that observed in Gram-negative ASADHs causes an enzyme domain closure that precedes catalysis. The covalent acyl-enzyme intermediate was trapped by soaking the substrate into crystals of the coenzyme complex, and the structure of this elusive intermediate provides detailed insights into the catalytic mechanism.	Univ Toledo, Dept Chem, Toledo, OH 43606 USA	University of Toledo	Viola, RE (corresponding author), Univ Toledo, Dept Chem, 2801 W Bancroft St, Toledo, OH 43606 USA.	ron.viola@utoledo.edu	liu, xuying/G-7258-2012; Le Coq, Johanne/L-6321-2014; Viola, Ronald/C-5904-2011					Becker D, 2006, NATURE, V440, P303, DOI 10.1038/nature04616; BIELLMANN JF, 1980, EUR J BIOCHEM, V104, P53, DOI 10.1111/j.1432-1033.1980.tb04398.x; BIELLMANN JF, 1980, EUR J BIOCHEM, V104, P59, DOI 10.1111/j.1432-1033.1980.tb04399.x; Blanco J, 2003, P NATL ACAD SCI USA, V100, P12613, DOI 10.1073/pnas.1634958100; Blanco J, 2003, PROTEIN SCI, V12, P27, DOI 10.1110/ps.0230803; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CIRILLO JD, 1994, MOL MICROBIOL, V11, P629, DOI 10.1111/j.1365-2958.1994.tb00342.x; Cleland W W, 1979, Methods Enzymol, V63, P103; COHEN GN, 1980, MULTIFUNCTIONAL PROT, P49; Faehnle CR, 2005, J MOL BIOL, V353, P1055, DOI 10.1016/j.jmb.2005.09.027; Hadfield A, 1999, J MOL BIOL, V289, P991, DOI 10.1006/jmbi.1999.2828; Hadfield A, 2001, BIOCHEMISTRY-US, V40, P14475, DOI 10.1021/bi015713o; Harb OS, 1998, INFECT IMMUN, V66, P1898, DOI 10.1128/IAI.66.5.1898-1903.1998; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; KARSTEN WE, 1991, BIOCHIM BIOPHYS ACTA, V1077, P209, DOI 10.1016/0167-4838(91)90060-D; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Mei JM, 1997, MOL MICROBIOL, V26, P399, DOI 10.1046/j.1365-2958.1997.5911966.x; Moore RA, 2002, PROTEIN EXPRES PURIF, V25, P189, DOI 10.1006/prep.2002.1626; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Paidhungat M, 2000, J BACTERIOL, V182, P5505, DOI 10.1128/JB.182.19.5505-5512.2000; Pavelka MS, 1996, J BACTERIOL, V178, P6496, DOI 10.1128/jb.178.22.6496-6507.1996; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Tsodikov OV, 2002, J COMPUT CHEM, V23, P600, DOI 10.1002/jcc.10061; Viola RE, 2001, ACCOUNTS CHEM RES, V34, P339, DOI 10.1021/ar000057q; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	26	34	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					31031	31040		10.1074/jbc.M605926200	http://dx.doi.org/10.1074/jbc.M605926200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16895909	hybrid			2022-12-27	WOS:000241075900079
J	Badariotti, F; Kypriotou, M; Lelong, C; Dubos, MP; Renard, E; Galera, P; Favrel, P				Badariotti, Fabien; Kypriotou, Magdalini; Lelong, Christophe; Dubos, Marie-Pierre; Renard, Emmanuelle; Galera, Philippe; Favrel, Pascal			The phylogenetically conserved molluscan chitinase-like protein 1 (Cg-Clp1), homologue of human HC-gp39, stimulates proliferation and regulates synthesis of extracellular matrix components of mammalian chondrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFORMING GROWTH-FACTOR-BETA-1 TGF-BETA-1; RABBIT ARTICULAR CHONDROCYTES; COLLAGEN GENE-EXPRESSION; HUMAN COL2A1 GENE; BIVALVE MOLLUSK; PRIMARY CULTURES; IMMUNE-RESPONSE; CARTILAGE GP-39; DOWN-REGULATION; GROWTH-FACTORS	Members of chitinase- like proteins ( CLPs) have attracted much attention because of their ability to promote cell proliferation in insects ( imaginal disc growth factors) and mammals ( YKL-40). To gain insights into the molecular processes underlying the physiological control of growth and development in Lophotrochozoa, we report here the cloning and biochemical characterization of the first Lophotrochozoan CLP from the oyster Crassostrea gigas ( Cg-Clp1). Gene expression profiles monitored by real time quantitative reverse transcription-PCR in different adult tissues and during development support the involvement of this protein in the control of growth and development in C. gigas. Recombinant Cg-Clp1 demonstrates a strong affinity for chitin but no chitinolytic activity, as was described for the HC-gp39 mammalian homolog. Furthermore, transient expression of Cg-Clp1 in primary cultures of rabbit articular chondrocytes as well as the use of both purified recombinant protein and conditioned medium from Cg-Clp1-expressing rabbit articular chondrocytes established that Cg-Clp1 stimulates cell proliferation and regulates extracellular matrix component synthesis, showing for the first time a possible involvement of a CLP on type II collagen synthesis regulation. These observations together with the fact that Cg-Clp1 gene organization strongly resembles that of its mammalian homologues argue for an early evolutionary origin and a high conservation of this class of proteins at both the structural and functional levels.	Univ Caen, IBFA, UMR 100, IFREMER,Lab Biol & Biotechnol Marines, F-14032 Caen, France; Ctr Hosp Univ Niveau 3, Fac Med, Lab Biochim Tissu Conjonctif, F-14032 Caen, France	Ifremer; Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie	Favrel, P (corresponding author), Univ Caen, IBFA, UMR 100, IFREMER,Lab Biol & Biotechnol Marines, F-14032 Caen, France.	pascal.favrel@unicaen.fr		Favrel, Pascal/0000-0002-2504-9957				Adoutte A, 2000, P NATL ACAD SCI USA, V97, P4453, DOI 10.1073/pnas.97.9.4453; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Beauchef G, 2005, BIOCHEM BIOPH RES CO, V333, P1123, DOI 10.1016/j.bbrc.2005.06.020; BENYA PD, 1977, BIOCHEMISTRY-US, V16, P865, DOI 10.1021/bi00624a009; BURKE RD, 1983, CAN J ZOOL, V61, P1701, DOI 10.1139/z83-221; Chadjichristos C, 2003, J BIOL CHEM, V278, P39762, DOI 10.1074/jbc.M303541200; Chadjichristos C, 2002, J BIOL CHEM, V277, P43903, DOI 10.1074/jbc.M206111200; De Ceuninck F, 2001, BIOCHEM BIOPH RES CO, V285, P926, DOI 10.1006/bbrc.2001.5253; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; Falini G, 2004, TISSUE ENG, V10, P1, DOI 10.1089/107632704322791646; Filho BPD, 2002, INSECT BIOCHEM MOLEC, V32, P1723, DOI 10.1016/S0965-1748(02)00112-1; GALERA P, 1992, EXP CELL RES, V200, P379, DOI 10.1016/0014-4827(92)90186-C; GALERA P, 1992, J CELL PHYSIOL, V153, P596, DOI 10.1002/jcp.1041530322; Ghayor C, 2000, J BIOL CHEM, V275, P27421; Ghayor C, 2001, J BIOL CHEM, V276, P36881, DOI 10.1074/jbc.M105083200; Giard W, 1998, J COMP PHYSIOL B, V168, P81, DOI 10.1007/s003600050123; GOLDBERG H, 1992, J BIOL CHEM, V267, P19622; Gueguen Y, 2006, J BIOL CHEM, V281, P313, DOI 10.1074/jbc.M510850200; HAKALA BE, 1993, J BIOL CHEM, V268, P25803; Henrissat B, 1999, EXS, V87, P137; Hermann PM, 2000, J NEUROSCI, V20, P6355, DOI 10.1523/JNEUROSCI.20-17-06355.2000; Herpin A, 2005, MECH DEVELOP, V122, P695, DOI 10.1016/j.mod.2004.12.004; Herpin A, 2004, BBA-GENE STRUCT EXPR, V1680, P137, DOI 10.1016/j.bbaexp.2004.09.003; Herpin A, 2002, GENE, V301, P21, DOI 10.1016/S0378-1119(02)01082-X; Herpin A, 2004, DEV COMP IMMUNOL, V28, P461, DOI 10.1016/j.dci.2003.09.007; Kawamura K, 1999, DEVELOPMENT, V126, P211; Kypriotou M, 2003, DNA CELL BIOL, V22, P119, DOI 10.1089/104454903321515922; Lelong C, 2000, EUR J BIOCHEM, V267, P3986, DOI 10.1046/j.1432-1327.2000.01432.x; Levy F, 2004, MOL CELL PROTEOMICS, V3, P156, DOI 10.1074/mcp.M300114-MCP200; Ling H, 2004, BIOCHEM J, V380, P651, DOI 10.1042/BJ20040099; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marin F, 2005, J BIOL CHEM, V280, P33895, DOI 10.1074/jbc.M506526200; Poncet JM, 2000, MAR BIOTECHNOL, V2, P387; Recklies AD, 2002, BIOCHEM J, V365, P119, DOI 10.1042/BJ20020075; REDINI F, 1988, FEBS LETT, V234, P172, DOI 10.1016/0014-5793(88)81327-9; Renkema GH, 1998, EUR J BIOCHEM, V251, P504, DOI 10.1046/j.1432-1327.1998.2510504.x; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SMIT AB, 1988, NATURE, V331, P535, DOI 10.1038/331535a0; Sun YJ, 2001, J BIOL CHEM, V276, P17507, DOI 10.1074/jbc.M010416200; Suzuki T, 2000, BLOOD, V96, P2584; Tanwar MK, 2002, CANCER RES, V62, P4364; Tessmar-Raible K, 2003, CURR OPIN GENET DEV, V13, P331, DOI 10.1016/S0959-437X(03)00086-8; Tran A, 2000, EUR J GASTROEN HEPAT, V12, P989, DOI 10.1097/00042737-200012090-00004; Vierstraete E, 2004, P NATL ACAD SCI USA, V101, P470, DOI 10.1073/pnas.0304567101; WATANABE T, 1993, J BIOL CHEM, V268, P18567	45	48	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					29583	29596		10.1074/jbc.M605687200	http://dx.doi.org/10.1074/jbc.M605687200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16882657	hybrid			2022-12-27	WOS:000240896300020
J	Itoh, T; Hashimoto, W; Mikami, B; Murata, K				Itoh, Takafumi; Hashimoto, Wataru; Mikami, Bunzo; Murata, Kousaku			Crystal structure of unsaturated glucuronyl hydrolase complexed with substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SP GL1; CHONDROITIN AC LYASE; HYALURONAN DEGRADATION; ALPHA-GLUCOSIDASES; STERIC COURSE; GLYCOSAMINOGLYCAN; MECHANISM; BINDING; HYDROLYSIS; HYDRATION	Unsaturated glucuronyl hydrolase (UGL), which is a member of glycoside hydrolase family GH- 88, is a bacterial enzyme that degrades mammalian glycosaminoglycans and bacterial biofilms. The enzyme, which acts on unsaturated oligosaccharides with an alpha- glycoside bond produced by microbial polysaccharide lyases responsible for bacterial invasion of host cells, was believed to release 4- deoxy- L- threo- 5- hexosulose- uronate ( unsaturated glucuronic acid, or Delta GlcA) and saccharide with a new nonreducing terminus by hydrolyzing the glycosidic bond. We detail the crystal structures of wild-type inactive mutant UGLof Bacillus sp. GL1 and its complex with a substrate ( unsaturated chondroitin disaccharide), identify active site residues, and postulate a reaction mechanism catalyzed by UGL that triggers the hydration of the vinyl ether group in Delta GlcA, based on the structural analysis of the enzyme- substrate complex and biochemical analysis. The proposed catalytic mechanism of UGL is a novel case among known glycosidases. Under the proposed mechanism, Asp- 149 acts as a general acid and base catalyst to protonate the Delta GlcA C4 atom and to deprotonate the water molecule. The deprotonated water molecule attacks the Delta GlcA C5 atom to yield unstable hemiketal; this is followed by spontaneous conversion to an aldehyde ( 4- deoxy- L- threo- 5-hexosulose- uronate) and saccharide through hemiacetal formation and cleavage of the glycosidic bond. UGL is the first clarified alpha(6)/alpha(6)- barrel enzyme using aspartic acid as the general acid/ base catalyst.	Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Uji, Kyoto 6110011, Japan; Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Uji, Kyoto 6110011, Japan	Kyoto University; Kyoto University	Murata, K (corresponding author), Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Uji, Kyoto 6110011, Japan.	kmurata@kais.kyoto-u.ac.jp						Aoyama H, 2004, ORG LETT, V6, P509, DOI 10.1021/ol036228j; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHAI WG, 1995, CARBOHYD RES, V269, P111, DOI 10.1016/0008-6215(94)00350-O; Chou WK, 2003, J AM CHEM SOC, V125, P2455, DOI 10.1021/ja021309g; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; Convington A.K., 1968, ANAL CHEM, V40, P700; CREMER D, 1975, J AM CHEM SOC, V97, P1354, DOI 10.1021/ja00839a011; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; ERNST S, 1995, CRIT REV BIOCHEM MOL, V30, P387, DOI 10.3109/10409239509083490; Fethiere J, 1999, J MOL BIOL, V288, P635, DOI 10.1006/jmbi.1999.2698; FIFE TH, 1970, J AM CHEM SOC, V92, P1681, DOI 10.1021/ja00709a044; HASCALL VC, 1995, ADV EXP MED BIOL, V376, P205; Hashimoto W, 2003, J BIOL CHEM, V278, P7663, DOI 10.1074/jbc.M208100200; Hashimoto W, 1999, ARCH BIOCHEM BIOPHYS, V368, P367, DOI 10.1006/abbi.1999.1305; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Huang WJ, 2003, J MOL BIOL, V328, P623, DOI 10.1016/S0022-2836(03)00345-0; Huang WJ, 1999, J MOL BIOL, V294, P1257, DOI 10.1006/jmbi.1999.3292; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; Itoh T, 2004, J BIOL CHEM, V279, P31804, DOI 10.1074/jbc.M403288200; Jedrzejas MJ, 2002, J BIOL CHEM, V277, P28287, DOI 10.1074/jbc.M112009200; Jedrzejas MJ, 2001, MICROBIOL MOL BIOL R, V65, P187, DOI 10.1128/MMBR.65.2.187-207.2001; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KRESGE AJ, 1987, ACCOUNTS CHEM RES, V20, P364, DOI 10.1021/ar00142a002; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAUGHTON PM, 1969, SOLVENT ISOTOPE EFFE, P407; LEHMANN J, 1972, CARBOHYD RES, V23, P359, DOI 10.1016/S0008-6215(00)82706-8; Li SL, 2000, EMBO J, V19, P1228, DOI 10.1093/emboj/19.6.1228; Li SL, 2001, J BIOL CHEM, V276, P41407, DOI 10.1074/jbc.M106634200; LINDAHL U, 1978, ANNU REV BIOCHEM, V47, P385, DOI 10.1146/annurev.bi.47.070178.002125; LINKER A, 1955, J BIOL CHEM, V213, P237; LUDWIGS U, 1987, BIOCHEM J, V245, P795, DOI 10.1042/bj2450795; Lunin VV, 2004, J MOL BIOL, V337, P367, DOI 10.1016/j.jmb.2003.12.071; Maruyama Y, 2005, J MOL BIOL, V350, P974, DOI 10.1016/j.jmb.2005.05.055; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Morgan PM, 1997, J AM CHEM SOC, V119, P10269, DOI 10.1021/ja971718q; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; OYAMA K, 1976, J AM CHEM SOC, V98, P947, DOI 10.1021/ja00420a013; Parsons JF, 2003, BIOCHEMISTRY-US, V42, P5684, DOI 10.1021/bi027385d; Rye CS, 2000, CURR OPIN CHEM BIOL, V4, P573, DOI 10.1016/S1367-5931(00)00135-6; SCHLESSELMANN P, 1982, BIOCHEMISTRY-US, V21, P6606, DOI 10.1021/bi00268a044; Smith NL, 2005, P NATL ACAD SCI USA, V102, P17652, DOI 10.1073/pnas.0504782102; Speck A.L., 2001, PLATON MULTIPURPOSE; WEISER W, 1988, BIOCHEMISTRY-US, V27, P2294, DOI 10.1021/bi00407a008; Yoshinari S, 2006, BIOCHEM BIOPH RES CO, V346, P1024, DOI 10.1016/j.bbrc.2006.06.011; ZSISKA M, 1993, CARBOHYD RES, V243, P225, DOI 10.1016/0008-6215(93)87031-M	47	29	30	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					29807	29816		10.1074/jbc.M604975200	http://dx.doi.org/10.1074/jbc.M604975200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16893885	hybrid			2022-12-27	WOS:000240896300043
J	Cottrell, GS; Padilla, B; Pikios, S; Roosterman, D; Steinhoff, M; Gehringer, D; Grady, EF; Bunnett, NW				Cottrell, Graeme S.; Padilla, Benjamin; Pikios, Stella; Roosterman, Dirk; Steinhoff, Martin; Gehringer, Daphne; Grady, Eileen F.; Bunnett, Nigel W.			Ubiquitin-dependent down-regulation of the neurokinin-1 receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; SUBSTANCE-P RECEPTOR; CLATHRIN-MEDIATED ENDOCYTOSIS; BETA-ADRENERGIC-RECEPTOR; BETA(2)-ADRENERGIC RECEPTOR; ACTIVATED RECEPTOR-2; CARBOXYL-TAIL; KINASE-C; ARRESTIN; DESENSITIZATION	Transient stimulation with substance P (SP) induces endocytosis and recycling of the neurokinin-1 receptor (NK1R). The effects of sustained stimulation by high concentrations of SP on NK1R trafficking and Ca2+ signaling, as may occur during chronic inflammation and pain, are unknown. Chronic exposure to SP (100 nM, 3 h) completely desensitized Ca2+ signaling by wild-type NK1R (NK(1)Rwt). Resensitization occurred after 16 h, and cycloheximide prevented resensitization, implicating new receptor synthesis. Lysine ubiquitination of G-protein-coupled receptors is a signal for their trafficking and degradation. Lysine-deficient mutant receptors (NK1R Delta 5K/R, C-terminal tail lysines; and NK1R Delta 10K/R, all intracellular lysines) were expressed at the plasma membrane and were functional because they responded to SP by endocytosis and by mobilization of Ca2+ ions. SP desensitized NK(1)Rwt, NK1R Delta 5K/R, and NK1R Delta 10K/R. However, NK1R Delta 5K/R and NK1R Delta 10K/R resensitized 4 - 8-fold faster than NK1Rwt by cycloheximide-independent mechanisms. NK1R Delta 325 (a naturally occurring truncated variant) showed incomplete desensitization, followed by a marked sensitization of signaling. Upon labeling receptors in living cells using antibodies to extracellular epitopes, we observed that SP induced endocytosis of NK(1)Rwt, NK1R Delta 5K/R, and NK1R Delta 10K/R. After 4 h in SP-free medium, NK1R Delta 5K/R and NK1R Delta 10K/R recycled to the plasma membrane, whereas NK1Rwt remained internalized. SP induced ubiquitination of NK(1)Rwt and NK1R Delta 5K/R as determined by immunoprecipitation under nondenaturing and denaturing conditions and detected with antibodies for mono- and polyubiquitin. NK1R Delta 10K/R was not ubiquitinated. Whereas SP induced degradation of NK(1)Rwt, NK1R Delta 5K/R and NK1R Delta 10K/R showed similar to 50% diminished degradation. Thus, chronic stimulation with SP induces ubiquitination of the NK1R, which mediates its degradation and down-regulation.	Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Munster, Dept Dermatol, Interdisciplinary Ctr Clin Res, D-48149 Munster, Germany; Univ Munster, Ludwig Boltzmann Inst Cell Biol, D-48149 Munster, Germany	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Munster; University of Munster	Bunnett, NW (corresponding author), Univ Calif San Francisco, Dept Surg, 521 Parnassus Ave, San Francisco, CA 94143 USA.	nigel.bunnett@ucsf.edu	Steinhoff, Martin/F-6312-2013	Bunnett, Nigel W./0000-0003-3367-0644; Steinhoff, Martin/0000-0002-7090-2187; Cottrell, Graeme/0000-0001-9098-7627	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK043207, R01DK043207, R01DK057840, R01DK052388, R01DK039957, R37DK039957] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK39957, DK43207, DK52388, DK57840] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bohm SK, 1997, J BIOL CHEM, V272, P2363; Bohm SK, 1996, J BIOL CHEM, V271, P22003; BOYD ND, 1991, BIOCHEMISTRY-US, V30, P336, DOI 10.1021/bi00216a005; Chaturvedi K, 2001, J BIOL CHEM, V276, P12345, DOI 10.1074/jbc.M008054200; Daaka Y, 1997, P NATL ACAD SCI USA, V94, P2180, DOI 10.1073/pnas.94.6.2180; Daaka Y, 1998, J BIOL CHEM, V273, P685, DOI 10.1074/jbc.273.2.685; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; Dery O, 2001, AM J PHYSIOL-CELL PH, V280, pC1097, DOI 10.1152/ajpcell.2001.280.5.C1097; Dery O, 1999, J BIOL CHEM, V274, P18524, DOI 10.1074/jbc.274.26.18524; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; FONG TM, 1992, MOL PHARMACOL, V41, P24; Garland AM, 1996, MOL PHARMACOL, V49, P438; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Grady EF, 1996, J NEUROSCI, V16, P6975, DOI 10.1523/jneurosci.16-21-06975.1996; Hammes SR, 1999, BIOCHEMISTRY-US, V38, P9308, DOI 10.1021/bi9902236; Hanyaloglu AC, 2005, EMBO J, V24, P2265, DOI 10.1038/sj.emboj.7600688; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hislop JN, 2004, J BIOL CHEM, V279, P22522, DOI 10.1074/jbc.M311062200; Jacob C, 2005, J BIOL CHEM, V280, P16076, DOI 10.1074/jbc.M500109200; Jensen LE, 2003, FEBS LETT, V553, P190, DOI 10.1016/S0014-5793(03)00998-0; KAGE R, 1993, J NEUROCHEM, V60, P347, DOI 10.1111/j.1471-4159.1993.tb05857.x; Kim YM, 2002, J BIOL CHEM, V277, P30760, DOI 10.1074/jbc.M204528200; KWATRA MM, 1993, J BIOL CHEM, V268, P9161; Li HZ, 1997, P NATL ACAD SCI USA, V94, P9475, DOI 10.1073/pnas.94.17.9475; Lin FT, 1997, J BIOL CHEM, V272, P31051, DOI 10.1074/jbc.272.49.31051; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; McConalogue K, 1999, J BIOL CHEM, V274, P16257, DOI 10.1074/jbc.274.23.16257; McConalogue K, 1998, MOL BIOL CELL, V9, P2305, DOI 10.1091/mbc.9.8.2305; Milojevic T, 2006, MOL PHARMACOL, V69, P1083, DOI 10.1124/mol.105.015818; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Oppermann M, 1996, J BIOL CHEM, V271, P13266, DOI 10.1074/jbc.271.22.13266; Roosterman D, 2004, J BIOL CHEM, V279, P30670, DOI 10.1074/jbc.M402479200; Roth AF, 1996, J CELL BIOL, V134, P661, DOI 10.1083/jcb.134.3.661; Schmidlin F, 2002, P NATL ACAD SCI USA, V99, P3324, DOI 10.1073/pnas.052161299; Schmidlin F, 2003, AM J PHYSIOL-CELL PH, V285, pC945, DOI 10.1152/ajpcell.00541.2002; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Tanowitz M, 2002, J BIOL CHEM, V277, P50219, DOI 10.1074/jbc.C200536200; Tohgo A, 2003, J BIOL CHEM, V278, P6258, DOI 10.1074/jbc.M212231200; VIGNA SR, 1994, J NEUROSCI, V14, P834; Vigna SR, 1999, J NEUROCHEM, V73, P1925; Wojcikiewicz RJH, 2004, TRENDS PHARMACOL SCI, V25, P35, DOI 10.1016/j.tips.2003.11.008; Wojcikiewicz RJH, 2003, J BIOL CHEM, V278, P940, DOI 10.1074/jbc.M206607200; Zhang J, 1996, J BIOL CHEM, V271, P18302, DOI 10.1074/jbc.271.31.18302	49	48	50	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					27773	27783		10.1074/jbc.M603369200	http://dx.doi.org/10.1074/jbc.M603369200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16849335	hybrid			2022-12-27	WOS:000240534400013
J	Hati, S; Ziervogel, B; SternJohn, J; Wong, FC; Nagan, MC; Rosen, AE; Siliciano, PG; Chihade, JW; Musier-Forsyth, K				Hati, Sanchita; Ziervogel, Brigitte; SternJohn, Julius; Wong, Fai-Chu; Nagan, Maria C.; Rosen, Abbey E.; Siliciano, Paul G.; Chihade, Joseph W.; Musier-Forsyth, Karin			Pre-transfer editing by class II prolyl-tRNA synthetase - Role of aminoacylation active site in "selective release" of noncognate amino acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPECIES-SPECIFIC DIFFERENCES; STRUCTURAL BASIS; PROTEIN-SYNTHESIS; INSERTION DOMAIN; IN-VITRO; ADENYLATE; SIEVE; DISCRIMINATION; TRANSLOCATION; RECOGNITION	Aminoacyl-tRNA synthetases catalyze the attachment of cognate amino acids to specific tRNA molecules. To prevent potential errors in protein synthesis caused by misactivation of noncognate amino acids, some synthetases have evolved editing mechanisms to hydrolyze misactivated amino acids (pre-transfer editing) or misacylated tRNAs (post-transfer editing). In the case of post-transfer editing, synthetases employ a separate editing domain that is distinct from the site of amino acid activation, and the mechanism is believed to involve shuttling of the flexible CCA-3' end of the tRNA from the synthetic active site to the site of hydrolysis. The mechanism of pre-transfer editing is less well understood, and in most cases, the exact site of pre-transfer editing has not been conclusively identified. Here, we probe the pre-transfer editing activity of class II prolyl-tRNA synthetases from five species representing all three kingdoms of life. To locate the site of pre-transfer editing, truncation mutants were constructed by deleting the insertion domain characteristic of bacterial prolyl-tRNA synthetase species, which is the site of post-transfer editing, or the N- or C-terminal extension domains of eukaryotic and archaeal enzymes. In addition, the pre-transfer editing mechanism of Escherichia coli prolyl-tRNA synthetase was probed in detail. These studies show that a separate editing domain is not required for pre-transfer editing by prolyl-tRNA synthetase. The aminoacylation active site plays a significant role in preserving the fidelity of translation by acting as a filter that selectively releases non-cognate adenylates into solution, while protecting the cognate adenylate from hydrolysis.	Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; Carleton Coll, Dept Chem, Northfield, MN 55057 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Carleton College	Musier-Forsyth, K (corresponding author), Univ Minnesota, Dept Chem, 207 Pleasant St SE, Minneapolis, MN 55455 USA.	musier@chem.umn.edu		Nagan, Maria/0000-0003-2678-6825	NIGMS NIH HHS [GM49928] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM049928, R01GM049928, R55GM049928] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahel I, 2003, P NATL ACAD SCI USA, V100, P15422, DOI 10.1073/pnas.2136934100; BALDWIN AN, 1966, J BIOL CHEM, V241, P839; Beebe K, 2003, EMBO J, V22, P668, DOI 10.1093/emboj/cdg065; Beuning PJ, 2000, P NATL ACAD SCI USA, V97, P8916, DOI 10.1073/pnas.97.16.8916; Beuning PJ, 2001, J BIOL CHEM, V276, P30779, DOI 10.1074/jbc.M104761200; Bishop AC, 2003, P NATL ACAD SCI USA, V100, P490, DOI 10.1073/pnas.0237335100; Bullock TL, 2003, J MOL BIOL, V328, P395, DOI 10.1016/S0022-2836(03)00305-X; Burke B, 2001, J BIOL CHEM, V276, P20286, DOI 10.1074/jbc.M100456200; Chen JF, 2000, BIOCHEMISTRY-US, V39, P6726, DOI 10.1021/bi000108r; Cusack S, 1998, STRUCTURE, V6, P101, DOI 10.1016/S0969-2126(98)00011-2; DELARUE M, 1993, BIOESSAYS, V15, P675, DOI 10.1002/bies.950151007; Dock-Bregeon AC, 2000, CELL, V103, P877, DOI 10.1016/S0092-8674(00)00191-4; Dock-Bregeon AC, 2004, MOL CELL, V16, P375, DOI 10.1016/S1097-2765(04)00591-X; ELDRED EW, 1972, BIOCHEMISTRY-US, V11, P17, DOI 10.1021/bi00751a004; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Farrow MA, 2001, BIOCHEMISTRY-US, V40, P4478, DOI 10.1021/bi0024052; FERSHT AR, 1975, BIOCHEMISTRY-US, V14, P1, DOI 10.1021/bi00672a001; FERSHT AR, 1979, BIOCHEMISTRY-US, V18, P2627, DOI 10.1021/bi00579a030; FREIST W, 1989, BIOCHEMISTRY-US, V28, P6787, DOI 10.1021/bi00443a001; Freist W, 1998, J THEOR BIOL, V193, P19, DOI 10.1006/jtbi.1998.0672; Fukai S, 2000, CELL, V103, P793, DOI 10.1016/S0092-8674(00)00182-3; Fukunaga R, 2006, J MOL BIOL, V359, P901, DOI 10.1016/j.jmb.2006.04.025; Gruic-Sovulj I, 2005, J BIOL CHEM, V280, P23978, DOI 10.1074/jbc.M414260200; Heacock D, 1996, BIOORG CHEM, V24, P273, DOI 10.1006/bioo.1996.0025; Hendrickson TL, 2003, MOL B INT U, P34; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; ILLANGASEKARE M, 1995, SCIENCE, V267, P643, DOI 10.1126/science.7530860; JAKUBOWSKI H, 1992, MICROBIOL REV, V56, P412, DOI 10.1128/MMBR.56.3.412-429.1992; Kamtekar S, 2003, P NATL ACAD SCI USA, V100, P1673, DOI 10.1073/pnas.0437911100; Larkin DC, 2002, NUCLEIC ACIDS RES, V30, P2103, DOI 10.1093/nar/30.10.2103; LAUGHREA M, 1982, EXP GERONTOL, V17, P305, DOI 10.1016/0531-5565(82)90020-1; LEWINSOHN R, 1967, BIOCHIM BIOPHYS ACTA, V140, P24, DOI 10.1016/0005-2795(67)90378-9; Lin L, 1996, BIOCHEMISTRY-US, V35, P5596, DOI 10.1021/bi960011y; Lin L, 1996, NATURE, V384, P33, DOI 10.1038/384033b0; Lincecum TL, 2003, MOL CELL, V11, P951, DOI 10.1016/S1097-2765(03)00098-4; LIU MS, 1993, BIOTECHNIQUES, V15, P264; Martinis S A, 1997, Nucleic Acids Symp Ser, V36, P125; Mursinna RS, 2004, BIOCHEMISTRY-US, V43, P155, DOI 10.1021/bi034919h; Mursinna RS, 2001, BIOCHEMISTRY-US, V40, P5376, DOI 10.1021/bi002915w; MUSIERFORSYTH K, 1991, P NATL ACAD SCI USA, V88, P209, DOI 10.1073/pnas.88.1.209; Nomanbhoy TK, 1999, MOL CELL, V4, P519, DOI 10.1016/S1097-2765(00)80203-8; Nomanbhoy TK, 2001, BIOORG MED CHEM LETT, V11, P1485, DOI 10.1016/S0960-894X(01)00127-5; Nomanbhoy TK, 2000, P NATL ACAD SCI USA, V97, P5119, DOI 10.1073/pnas.090102197; Nordin BE, 2003, BIOCHEMISTRY-US, V42, P12989, DOI 10.1021/bi035052q; Nureki O, 1998, SCIENCE, V280, P578, DOI 10.1126/science.280.5363.578; ORGEL LE, 1963, P NATL ACAD SCI USA, V49, P517, DOI 10.1073/pnas.49.4.517; PAECHTHOROWITZ M, 1967, BIOCHIM BIOPHYS ACTA, V140, P14, DOI 10.1016/0005-2795(67)90377-7; Rho SB, 2002, EMBO J, V21, P6874, DOI 10.1093/emboj/cdf671; Roy H, 2004, EMBO J, V23, P4639, DOI 10.1038/sj.emboj.7600474; Sankaranarayanan R, 1999, CELL, V97, P371, DOI 10.1016/S0092-8674(00)80746-1; SCHMIDT E, 1994, SCIENCE, V264, P265, DOI 10.1126/science.8146659; SEGAL IH, 1975, ENZYME KINETICS, P100; Shiba K, 2002, J MOL BIOL, V320, P833, DOI 10.1016/S0022-2836(02)00567-3; Silvian LF, 1999, SCIENCE, V285, P1074, DOI 10.1126/science.285.5430.1074; STARZYK RM, 1987, SCIENCE, V237, P1614, DOI 10.1126/science.3306924; Stehlin C, 1997, BIOCHEMISTRY-US, V36, P2932, DOI 10.1021/bi962295s; Stehlin C, 1998, BIOCHEMISTRY-US, V37, P8605, DOI 10.1021/bi980364s; TSUI WC, 1981, NUCLEIC ACIDS RES, V9, P4627, DOI 10.1093/nar/9.18.4627; Wong FC, 2003, J BIOL CHEM, V278, P52857, DOI 10.1074/jbc.M309627200; Wong FC, 2002, BIOCHEMISTRY-US, V41, P7108, DOI 10.1021/bi012178j; Yaremchuk A, 2001, J MOL BIOL, V309, P989, DOI 10.1006/jmbi.2001.4712	61	51	55	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					27862	27872		10.1074/jbc.M605856200	http://dx.doi.org/10.1074/jbc.M605856200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16864571	hybrid			2022-12-27	WOS:000240534400022
J	Kelly, BL; Ferreira, A				Kelly, Brent L.; Ferreira, Adriana			beta-amyloid-induced dynamin 1 degradation is mediated by N-methyl-D-aspartate receptors in hippocampal neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; ACTIVATED NEUTRAL PROTEINASE; SYNAPTIC VESICLE TRAFFICKING; ALZHEIMERS-DISEASE; A-BETA; CORTICAL-NEURONS; MEMORY DEFICITS; MOUSE MODEL; CALCIUM NEUROTOXICITY; PRECURSOR PROTEIN	Alzheimer disease (AD) is a progressive, neurodegenerative disorder that leads to debilitating cognitive deficits. Although little is known about the early functional or ultrastructural changes associated with AD, it has been proposed that a stage of synaptic dysfunction might precede neurodegeneration in the development of this disease. Unfortunately, the molecular mechanisms that underlie such synaptic dysfunction remain largely unknown. Recently we have shown that beta-amyloid (A beta), the main component of senile plaques, induced a significant decrease in dynamin 1, a protein that plays a critical role in synaptic vesicle recycling, and hence, in the signaling properties of the synapse. We report here that this dynamin 1 degradation was the result of calpain activation induced by the sustained calcium influx mediated by N-methyl-D-aspartate receptors in hippocampal neurons. In addition, our results showed that soluble oligomericA beta, and not fibrillar A beta, was responsible for this sustained calcium influx, calpain activation, and dynamin 1 degradation. Considering the importance of dynamin 1 to synaptic function, these data suggest that A beta soluble oligomers might catalyze a stage of synaptic dysfunction that precedes synapse loss and neurodegeneration. These data also highlight the calpain system as a novel therapeutic target for early stage AD intervention.	Northwestern Univ, Norwestern Inst Neurosci, Chicago, IL 60611 USA; Northwestern Univ, Dept Cell & Mol Biol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Northwestern University; Feinberg School of Medicine	Ferreira, A (corresponding author), Northwestern Univ, Norwestern Inst Neurosci, Chicago, IL 60611 USA.	a-ferreira@northwestern.edu		Ferreira, Adriana/0000-0003-3705-3918	NIA NIH HHS [AG20506] Funding Source: Medline; NINDS NIH HHS [NS39080] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG020506] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AbdelHamid KM, 1997, NEUROSCIENCE, V81, P673, DOI 10.1016/S0306-4522(97)00162-0; Battaglia F, 2003, J MOL NEUROSCI, V20, P357, DOI 10.1385/JMN:20:3:357; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; Brewer GJ, 2006, NEUROBIOL AGING, V27, P306, DOI 10.1016/j.neurobiolaging.2005.01.019; BRORSON JR, 1994, J NEUROSCI, V14, P187; Bullock R, 2006, ALZ DIS ASSOC DIS, V20, P23, DOI 10.1097/01.wad.0000201847.29836.a5; Chen M, 2005, BIOCHEM BIOPH RES CO, V330, P714, DOI 10.1016/j.bbrc.2005.03.029; Chromy BA, 2003, BIOCHEMISTRY-US, V42, P12749, DOI 10.1021/bi030029q; Clark SG, 1997, P NATL ACAD SCI USA, V94, P10438, DOI 10.1073/pnas.94.19.10438; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Czogalla A, 2005, CELL MOL LIFE SCI, V62, P1913, DOI 10.1007/s00018-005-5097-0; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; FANELLI RJ, 1994, ANN NY ACAD SCI, V747, P336; Fifre A, 2006, J BIOL CHEM, V281, P229, DOI 10.1074/jbc.M507378200; Fitzjohn SM, 2001, J NEUROSCI, V21, P4691, DOI 10.1523/JNEUROSCI.21-13-04691.2001; Gafni J, 1997, NEURON, V19, P723, DOI 10.1016/S0896-6273(00)80384-0; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V122, P1131, DOI 10.1016/0006-291X(84)91209-9; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Goslin K., 1991, CULTURING NERVE CELL, P251; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hernandez-Fonseca K, 2005, J NEUROSCI RES, V82, P196, DOI 10.1002/jnr.20631; Honer WG, 2003, NEUROBIOL AGING, V24, P1047, DOI 10.1016/j.neurobiolaging.2003.04.005; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; HUETTNER JE, 1988, P NATL ACAD SCI USA, V85, P1307, DOI 10.1073/pnas.85.4.1307; Kelly BL, 2005, J BIOL CHEM, V280, P31746, DOI 10.1074/jbc.M503259200; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; KOENIG JH, 1989, J NEUROSCI, V9, P3844; KOSAKA T, 1983, J NEUROBIOL, V14, P207, DOI 10.1002/neu.480140305; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE EB, 2005, J BIOL CHEM, V16, P16; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; LEE SY, 2005, FASEB J, V25, P25; Leissring MA, 2001, NEUROBIOL DIS, V8, P469, DOI 10.1006/nbdi.2001.0382; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Liu F, 2005, J BIOL CHEM, V280, P37755, DOI 10.1074/jbc.M507475200; MATTSON MP, 1992, J NEUROSCI, V12, P376, DOI 10.1523/jneurosci.12-02-00376.1992; MATTSON MP, 1993, BRAIN RES, V621, P35, DOI 10.1016/0006-8993(93)90295-X; MURPHY SN, 1989, MOL PHARMACOL, V35, P671; Nakayama K, 2005, J NEUROSCI, V25, P4040, DOI 10.1523/JNEUROSCI.4115-04.2005; ODDO S, 2005, J BIOL CHEM, V10, P10; Ohno M, 2004, NEURON, V41, P27, DOI 10.1016/S0896-6273(03)00810-9; Park SY, 2005, J NEUROSCI, V25, P5365, DOI 10.1523/JNEUROSCI.1125-05.2005; PIKE CJ, 1991, BRAIN RES, V563, P311, DOI 10.1016/0006-8993(91)91553-D; Qiu ZH, 2003, J NEUROIMMUNOL, V139, P51, DOI 10.1016/S0165-5728(03)00158-9; Rapoport M, 2002, P NATL ACAD SCI USA, V99, P6364, DOI 10.1073/pnas.092136199; Rovira C, 2002, BIOCHEM BIOPH RES CO, V296, P1317, DOI 10.1016/S0006-291X(02)02072-7; Rutten BR, 2003, NEUROBIOL DIS, V12, P110, DOI 10.1016/S0969-9961(02)00015-3; SAIDO TC, 1991, BIOMED BIOCHIM ACTA, V50, P485; SAIDO TC, 1992, J BIOL CHEM, V267, P24585; SAITO KI, 1993, P NATL ACAD SCI USA, V90, P2628, DOI 10.1073/pnas.90.7.2628; Sattler R, 1998, J NEUROCHEM, V71, P2349; SCHEFF SW, 2005, NEUROBIOL AGING, V7, P7; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5; Selkoe DJ, 2001, P NATL ACAD SCI USA, V98, P11039, DOI 10.1073/pnas.211352598; SIMAN R, 1984, P NATL ACAD SCI-BIOL, V81, P3572, DOI 10.1073/pnas.81.11.3572; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Stutzmann GE, 2005, NEUROSCIENTIST, V11, P110, DOI 10.1177/1073858404270899; Stutzmann GE, 2004, J NEUROSCI, V24, P508, DOI 10.1523/JNEUROSCI.4386-03.2004; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Tiraboschi P, 2000, NEUROLOGY, V55, P1278, DOI 10.1212/WNL.55.9.1278; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tsuji T, 1998, NEUROSCI LETT, V248, P109, DOI 10.1016/S0304-3940(98)00348-6; TYMIANSKI M, 1993, J NEUROSCI, V13, P2085; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; Verkhratsky A, 2004, BIOL RES, V37, P693; Walsh DM, 2005, J NEUROSCI, V25, P2455, DOI 10.1523/JNEUROSCI.4391-04.2005; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; Yao PJ, 2004, TRENDS NEUROSCI, V27, P24, DOI 10.1016/j.tins.2003.10.012; Yao PJ, 2003, NEUROBIOL DIS, V12, P97, DOI 10.1016/S0969-9961(02)00009-8; Zhao FY, 2001, J BIOL CHEM, V276, P13810, DOI 10.1074/jbc.M006104200	74	200	211	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					28079	28089		10.1074/jbc.M605081200	http://dx.doi.org/10.1074/jbc.M605081200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16864575	hybrid			2022-12-27	WOS:000240534400045
J	Tso, SC; Kato, M; Chuang, JL; Chuang, DT				Tso, Shih-Chia; Kato, Masato; Chuang, Jacinta L.; Chuang, David T.			Structural determinants for cross-talk between pyruvate dehydrogenase kinase 3 and lipoyl domain 2 of the human pyruvate dehydrogenase complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIHYDROLIPOYL ACETYLTRANSFERASE; PHOSPHORYLATION SITES; MAMMALIAN PYRUVATE; PROTEIN-KINASE; ISOENZYMES; COMPONENT; BINDING; ROLES; HEART; ACID	Pyruvate dehydrogenase kinase isoforms (PDK1-4) are the molecular switch that down-regulates activity of the human pyruvate dehydrogenase complex through reversible phosphorylation. We showed previously that binding of the lipoyl domain 2 (L2) of the pyruvate dehydrogenase complex to PDK3 induces a "cross-tail" conformation in PDK3, resulting in an opening of the active site cleft and the stimulation of kinase activity. In the present study, we report that alanine substitutions of Leu-140, Glu-170, and Glu-179 in L2 markedly reduce binding affinities of these L2 mutants for PDK3. Unlike wildtype L2, binding of these L2 mutants to PDK3 does not preferentially reduce the affinity of PDK3 for ADP over ATP. The inefficient removal of product inhibition associated with ADP accounts for the decreased stimulation of PDK3 activity by these L2 variants. Serial truncations of the PDK3 C-terminal tail region either impede or abolish the binding of wild-type L2 to the PDK3 mutants, resulting in the reduction or absence of L2-enhanced kinase activity. Alanine substitutions of residues Leu-27, Phe-32, Phe-35, and Phe-48 in the lipoyl-binding pocket of PDK3 similarly nullify L2 binding and L2-stimulated PDK3 activity. Our results indicate that the above residues in L2 and residues in the C-terminal region and the lipoyl-binding pocket of PDK3 are critical determinants for the cross-talk between L2 and PDK3, which up-regulates PDK3 activity.	Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Chuang, DT (corresponding author), Univ Texas, SW Med Ctr, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	david.chuang@utsouthwestern.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062306, R56DK062306] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK62306] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Baker JC, 2000, J BIOL CHEM, V275, P15773, DOI 10.1074/jbc.M909488199; Bowker-Kinley MM, 1998, BIOCHEM J, V329, P191, DOI 10.1042/bj3290191; Harris RA, 2001, ADV ENZYME REGUL, V41, P269, DOI 10.1016/S0065-2571(00)00020-0; Hiromasa Y, 2006, J BIOL CHEM, V281, P12568, DOI 10.1074/jbc.M513514200; Holness MJ, 2003, BIOCHEM SOC T, V31, P1143; Kato M, 2005, EMBO J, V24, P1763, DOI 10.1038/sj.emboj.7600663; Klyuyeva A, 2005, BIOCHEMISTRY-US, V44, P13573, DOI 10.1021/bi0505868; Knoechel TR, 2006, BIOCHEMISTRY-US, V45, P402, DOI 10.1021/bi051402s; Kolobova E, 2001, BIOCHEM J, V358, P69, DOI 10.1042/0264-6021:3580069; Korotchkina LG, 2001, J BIOL CHEM, V276, P37223, DOI 10.1074/jbc.M103069200; LIU SJ, 1995, J BIOL CHEM, V270, P793, DOI 10.1074/jbc.270.2.793; Machius M, 2001, P NATL ACAD SCI USA, V98, P11218, DOI 10.1073/pnas.201220098; PATEL MS, 1990, FASEB J, V4, P3224, DOI 10.1096/fasebj.4.14.2227213; Popov KM, 1997, ADV SEC MESS PHOSPH, V31, P105; RADKE GA, 1993, BIOCHEM BIOPH RES CO, V190, P982, DOI 10.1006/bbrc.1993.1146; Reed LJ, 2001, J BIOL CHEM, V276, P38329, DOI 10.1074/jbc.R100026200; REED LJ, 1985, CURR TOP CELL REGUL, V27, P41; Roche TE, 2003, EUR J BIOCHEM, V270, P1050, DOI 10.1046/j.1432-1033.2003.03468.x; SALE GJ, 1981, EUR J BIOCHEM, V120, P535, DOI 10.1111/j.1432-1033.1981.tb05733.x; Steussy CN, 2001, J BIOL CHEM, V276, P37443, DOI 10.1074/jbc.M104285200; TEAGUE WM, 1979, BIOCHEM BIOPH RES CO, V87, P244, DOI 10.1016/0006-291X(79)91672-3; Tuganova A, 2005, BIOCHEM J, V387, P147, DOI 10.1042/BJ20040805; Tuganova A, 2002, BIOCHEM J, V366, P129, DOI 10.1042/BJ20020301; Wu PF, 1998, BIOCHEM J, V329, P197, DOI 10.1042/bj3290197; YEAMAN SJ, 1978, BIOCHEMISTRY-US, V17, P2364, DOI 10.1021/bi00605a017	25	11	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2006	281	37					27197	27204		10.1074/jbc.M604339200	http://dx.doi.org/10.1074/jbc.M604339200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082PB	16849321	hybrid			2022-12-27	WOS:000240397700047
J	Cintron, NS; Toft, D				Cintron, Nela S.; Toft, David			Defining the requirements for Hsp40 and Hsp70 in the Hsp90 chaperone pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; STEROID-RECEPTOR COMPLEXES; PROGESTERONE-RECEPTOR; MOLECULAR CHAPERONE; SACCHAROMYCES-CEREVISIAE; COCHAPERONE DNAJ; BINDING; HOMOLOG; YDJ1; SIS1	The Hsp90 chaperoning pathway and its model client substrate, the progesterone receptor ( PR), have been used extensively to study chaperone complex formation and maturation of a client substrate in a near native state. This chaperoning pathway can be reconstituted in vitro with the addition of five proteins plus ATP: Hsp40, Hsp70, Hop, Hsp90, and p23. The addition of these proteins is necessary to reconstitute hormone-binding capacity to the immuno-isolated PR. It was recently shown that the first step for the recognition of PR by this system is binding by Hsp40. We compared type I and type II Hsp40 proteins and created point mutations in Hsp40 and Hsp70 to understand the requirements for this first step. The type I proteins, Ydj1 and DjA1 ( HDJ2), and a type II, DjB1 (HDJ1), act similarly in promoting hormone binding and Hsp70 association to PR, while having different binding characteristics to PR. Ydj1 and DjA1 bind tightly to PR whereas the binding of DjB1 apparently has rapid on and off rates and its binding cannot be observed by antibody pull-down methods using either purified proteins or cell lysates. Mutation studies indicate that client binding, interactions between Hsp40 and Hsp70, plus ATP hydrolysis by Hsp70 are all required to promote conformational maturation of PR via the Hsp90 pathway.	Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, Mayo Grad Sch, Rochester, MN 55905 USA	Mayo Clinic	Toft, D (corresponding author), Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, Mayo Grad Sch, 200 1st St,SW, Rochester, MN 55905 USA.	toft.david@mayo.edu			NIDDK NIH HHS [DK59284] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059284] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Andres DA, 1997, ARCH BIOCHEM BIOPHYS, V346, P113, DOI 10.1006/abbi.1997.0296; Borges JC, 2005, J BIOL CHEM, V280, P13671, DOI 10.1074/jbc.M408349200; CAPLAN AJ, 1991, J CELL BIOL, V114, P609, DOI 10.1083/jcb.114.4.609; CAPLAN AJ, 1992, J BIOL CHEM, V267, P18890; Chadli A, 2006, MOL CELL BIOL, V26, P1722, DOI 10.1128/MCB.26.5.1722-1730.2006; Chen SY, 1996, MOL ENDOCRINOL, V10, P682, DOI 10.1210/me.10.6.682; Chen SY, 1998, J BIOL CHEM, V273, P35194, DOI 10.1074/jbc.273.52.35194; Chiosis G, 2004, DRUG DISCOV TODAY, V9, P881, DOI 10.1016/S1359-6446(04)03245-3; CONNEELY OM, 1987, BIOCHEM BIOPH RES CO, V149, P493, DOI 10.1016/0006-291X(87)90395-0; CYR DM, 1994, J BIOL CHEM, V269, P9798; Davis AR, 1998, INT J BIOCHEM CELL B, V30, P1203, DOI 10.1016/S1357-2725(98)00091-0; Dittmar KD, 1998, J BIOL CHEM, V273, P7358, DOI 10.1074/jbc.273.13.7358; Edwards MC, 1997, GENETICS, V147, P1063; Fan CY, 2005, J BIOL CHEM, V280, P695, DOI 10.1074/jbc.M410645200; Fan CY, 2004, MOL BIOL CELL, V15, P761, DOI 10.1091/mbc.E03-03-0146; Fan CY, 2003, CELL STRESS CHAPERON, V8, P309, DOI 10.1379/1466-1268(2003)008<0309:MFROHF>2.0.CO;2; Fliss AE, 1999, J BIOL CHEM, V274, P34045, DOI 10.1074/jbc.274.48.34045; Gee AC, 2001, MOL ENDOCRINOL, V15, P421, DOI 10.1210/me.15.3.421; Han WJ, 2003, J BIOL CHEM, V278, P19038, DOI 10.1074/jbc.M300756200; Hennessy F, 2005, PROTEIN SCI, V14, P1697, DOI 10.1110/ps.051406805; Hernandez MP, 2002, J BIOL CHEM, V277, P38294, DOI 10.1074/jbc.M206566200; Hernandez MP, 2002, J BIOL CHEM, V277, P11873, DOI 10.1074/jbc.M111445200; Hu JM, 2004, J VIROL, V78, P13122, DOI 10.1128/JVI.78.23.13122-13131.2004; Johnson BD, 1998, J BIOL CHEM, V273, P3679, DOI 10.1074/jbc.273.6.3679; Karzai AW, 1996, J BIOL CHEM, V271, P11236, DOI 10.1074/jbc.271.19.11236; Kim SY, 2002, J BIOL CHEM, V277, P44778, DOI 10.1074/jbc.M206176200; KIMURA Y, 1995, SCIENCE, V268, P1362, DOI 10.1126/science.7761857; Kosano H, 1998, J BIOL CHEM, V273, P32973, DOI 10.1074/jbc.273.49.32973; Landry SJ, 2003, BIOCHEMISTRY-US, V42, P4926, DOI 10.1021/bi027070y; Lassle M, 1997, J BIOL CHEM, V272, P1876, DOI 10.1074/jbc.272.3.1876; Lee S, 2002, J BIOL CHEM, V277, P21675, DOI 10.1074/jbc.M111075200; Lu Z, 1998, J BIOL CHEM, V273, P27824, DOI 10.1074/jbc.273.43.27824; LUKE MM, 1991, J CELL BIOL, V114, P623, DOI 10.1083/jcb.114.4.623; Morishima Y, 2003, J BIOL CHEM, V278, P48754, DOI 10.1074/jbc.M309814200; Murphy PJM, 2003, J BIOL CHEM, V278, P34764, DOI 10.1074/jbc.M304469200; OBrien MC, 1996, J BIOL CHEM, V271, P15874, DOI 10.1074/jbc.271.27.15874; Odunuga OO, 2004, BIOESSAYS, V26, P1058, DOI 10.1002/bies.20107; Ohtsuka K, 2000, CELL STRESS CHAPERON, V5, P98, DOI 10.1379/1466-1268(2000)005<0098:MHDHCO>2.0.CO;2; Prapapanich V, 1998, MOL CELL BIOL, V18, P944, DOI 10.1128/MCB.18.2.944; Prapapanich V, 1996, MOL ENDOCRINOL, V10, P420, DOI 10.1210/me.10.4.420; Pratt WB, 2004, ESSAYS BIOCHEM, V40, P41, DOI 10.1042/bse0400041; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; RAABE T, 1991, NUCLEIC ACIDS RES, V19, P6645, DOI 10.1093/nar/19.23.6645; SCHOWALTER DB, 1991, J BIOL CHEM, V266, P21165; SISSON TH, 1990, J IMMUNOL METHODS, V127, P215, DOI 10.1016/0022-1759(90)90071-3; SMITH DF, 1990, MOL ENDOCRINOL, V4, P1704, DOI 10.1210/mend-4-11-1704; Smith DF, 2004, CELL STRESS CHAPERON, V9, P109, DOI 10.1379/CSC-31.1; SMITH DF, 1993, MOL ENDOCRINOL, V7, P1418, DOI 10.1210/me.7.11.1418; SMITH DF, 1995, MOL CELL BIOL, V15, P6804; SMITH DF, 1993, MOL CELL BIOL, V13, P869, DOI 10.1128/MCB.13.2.869; Suh WC, 1999, J BIOL CHEM, V274, P30534, DOI 10.1074/jbc.274.43.30534; Suh WC, 1998, P NATL ACAD SCI USA, V95, P15223, DOI 10.1073/pnas.95.26.15223; SULLIVAN WP, 1986, ENDOCRINOLOGY, V119, P1549, DOI 10.1210/endo-119-4-1549; Sullivan WP, 2002, J BIOL CHEM, V277, P45942, DOI 10.1074/jbc.M207754200; Terada K, 2000, J BIOL CHEM, V275, P24728, DOI 10.1074/jbc.M002021200; Terada K, 2005, EMBO J, V24, P611, DOI 10.1038/sj.emboj.7600549; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Williams SP, 1998, NATURE, V393, P392, DOI 10.1038/30775; Workman P, 2004, CANCER LETT, V206, P149, DOI 10.1016/j.canlet.2003.08.032; Yan W, 1999, MOL CELL BIOL, V19, P7751; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024	62	52	53	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2006	281	36					26235	26244		10.1074/jbc.M605417200	http://dx.doi.org/10.1074/jbc.M605417200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	080LO	16854979	hybrid			2022-12-27	WOS:000240249500040
J	Cui, T; Schopfer, FJ; Zhang, J; Chen, K; Ichikawa, T; Baker, PRS; Batthyany, C; Chacko, BK; Feng, X; Patel, RP; Agarwal, A; Freeman, BA; Chen, YE				Cui, Taixing; Schopfer, Francisco J.; Zhang, Jifeng; Chen, Kai; Ichikawa, Tomonaga; Baker, Paul R. S.; Batthyany, Carlos; Chacko, Balu K.; Feng, Xu; Patel, Rakesh P.; Agarwal, Anupam; Freeman, Bruce A.; Chen, Yuqing E.			Nitrated fatty acids: Endogenous anti-inflammatory signaling mediators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; OXIDIZED LIPID DERIVATIVES; HUMAN BLOOD-PLASMA; NITRIC-OXIDE; NITROLINOLEIC ACID; NITROGEN-DIOXIDE; GENE-EXPRESSION; DNA-BINDING; PROTEINS; TRANSDUCTION	Nitroalkene derivatives of linoleic acid (LNO2) and oleic acid (OA-NO2) are present; however, their biological functions remain to be fully defined. Herein, we report that LNO2 and OA-NO2 inhibit lipopolysaccharide-induced secretion of proinflammatory cytokines in macrophages independent of nitric oxide formation, peroxisome proliferator-activated receptor-gamma activation, or induction of heme oxygenase-1 expression. The electrophilic nature of fatty acid nitroalkene derivatives resulted in alkylation of recombinant NF-kappa B p65 protein in vitro and a similar reaction with p65 in intact macrophages. The nitroalkylation of p65 by fatty acid nitroalkene derivatives inhibited DNA binding activity and repressed NF-kappa B-dependent target gene expression. Moreover, nitroalkenes inhibited endothelial tumor necrosis factor-alpha-induced vascular cell adhesion molecule 1 expression and monocyte rolling and adhesion. These observations indicate that nitroalkenes such as LNO2 and OA-NO2, derived from reactions of unsaturated fatty acids and oxides of nitrogen, are a class of endogenous anti-inflammatory mediators.	Univ Pittsburgh, Sch Med, Dept Pharmacol, Pittsburgh, PA 15213 USA; Univ Michigan, Ctr Med, Ctr Cardiovasc, Ann Arbor, MI 48109 USA; Univ Alabama, Dept Med, Div Nephrol, Birmingham, AL 35294 USA; Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Michigan System; University of Michigan; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Freeman, BA (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol, Pittsburgh, PA 15213 USA.	freerad@pitt.edu	Schopfer, Francisco/AAW-6505-2021; Schopfer, Francisco Jose/AAE-8125-2020; Freeman, Bruce A/H-9342-2012; Batthyany, Carlos I./A-6478-2009	Schopfer, Francisco Jose/0000-0001-9526-695X; Batthyany, Carlos/0000-0002-0627-1982; Patel, Rakesh/0000-0002-1526-4303; Cui, Taixing/0000-0002-9528-7299	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058115, R01HL075397, T32HL007457, R01HL068878, R01HL064937, R01HL070146, R37HL058115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM008248] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL064937-05A1, HL70146, R01 HL068878, R37 HL058115, HL068878, R01 HL075397, HL075397, HL58115, R01 HL064937, R01 HL070146, HL64937, R01 HL058115-09, T32HL07457, R01 HL058115] Funding Source: Medline; NIGMS NIH HHS [S06 GM008248, S06GM08248] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alvarez-Maqueda M, 2004, J BIOL CHEM, V279, P21929, DOI 10.1074/jbc.M400492200; Baker PRS, 2005, J BIOL CHEM, V280, P42464, DOI 10.1074/jbc.M504212200; Baker PRS, 2004, P NATL ACAD SCI USA, V101, P11577, DOI 10.1073/pnas.0402587101; Balazy M, 2001, J PHARMACOL EXP THER, V299, P611; Baldus S, 2002, FREE RADICAL BIO MED, V33, P1010, DOI 10.1016/S0891-5849(02)00993-0; Batthyany C, 2006, J BIOL CHEM, V281, P20450, DOI 10.1074/jbc.M602814200; Ceaser EK, 2004, BIOCHEM SOC T, V32, P151, DOI 10.1042/BST0320151; Cernuda-Morollon E, 2001, J BIOL CHEM, V276, P35530, DOI 10.1074/jbc.M104518200; Chawla A, 2001, NAT MED, V7, P48, DOI 10.1038/83336; Coles B, 2002, CIRC RES, V91, P375, DOI 10.1161/01.RES.0000032114.68919.EF; Coles B, 2002, J BIOL CHEM, V277, P5832, DOI 10.1074/jbc.M105209200; Crabb JW, 2002, PROTEIN SCI, V11, P831, DOI 10.1110/ps.4400102; Daynes RA, 2002, NAT REV IMMUNOL, V2, P748, DOI 10.1038/nri912; DECATERINA R, 1995, J CLIN INVEST, V96, P60, DOI 10.1172/JCI118074; ESTERBAUER H, 1975, Z NATURFORSCH C, V30, P466; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Feng X, 2001, J CLIN INVEST, V107, P1137, DOI 10.1172/JCI12040; Garcia-Pineres AJ, 2001, J BIOL CHEM, V276, P39713, DOI 10.1074/jbc.M101985200; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Han YS, 2005, J PHARMACOL EXP THER, V312, P1097, DOI 10.1124/jpet.104.079707; Ischiropoulos H, 2003, J CLIN INVEST, V111, P163, DOI 10.1172/JCI200317638; Ishii T, 2003, BIOCHEMISTRY-US, V42, P3474, DOI 10.1021/bi027172o; Kalyanaraman B, 2004, P NATL ACAD SCI USA, V101, P11527, DOI 10.1073/pnas.0404309101; Kang LT, 1997, ANAL BIOCHEM, V250, P119, DOI 10.1006/abio.1997.2202; Lee TS, 2003, J BIOL CHEM, V278, P19325, DOI 10.1074/jbc.M300498200; Levonen AL, 2004, BIOCHEM J, V378, P373, DOI 10.1042/BJ20031049; Ley K, 1996, CARDIOVASC RES, V32, P733, DOI 10.1016/0008-6363(96)00066-1; Lim DG, 2002, P NATL ACAD SCI USA, V99, P15941, DOI 10.1073/pnas.232409599; Lima ES, 2005, FREE RADICAL BIO MED, V39, P532, DOI 10.1016/j.freeradbiomed.2005.04.005; Lima ES, 2003, J LIPID RES, V44, P1660, DOI 10.1194/jlr.M200467-JLR200; Lima ES, 2002, BIOCHEMISTRY-US, V41, P10717, DOI 10.1021/bi025504j; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; O'Donnell VB, 1999, CHEM RES TOXICOL, V12, P83, DOI 10.1021/tx980207u; Osterud B, 2003, PHYSIOL REV, V83, P1069, DOI 10.1152/physrev.00005.2003; RUBBO H, 1994, J BIOL CHEM, V269, P26066; Rubbo H, 1995, ARCH BIOCHEM BIOPHYS, V324, P15, DOI 10.1006/abbi.1995.9935; Schopfer FJ, 2005, J BIOL CHEM, V280, P19289, DOI 10.1074/jbc.M414689200; Schopfer FJ, 2005, P NATL ACAD SCI USA, V102, P2340, DOI 10.1073/pnas.0408384102; Serhan CN, 2001, J CLIN INVEST, V107, P1481, DOI 10.1172/JCI13375; Smith WL, 2001, J CLIN INVEST, V107, P1491, DOI 10.1172/JCI13271; Straus DS, 2000, P NATL ACAD SCI USA, V97, P4844, DOI 10.1073/pnas.97.9.4844; SZWEDA LI, 1993, J BIOL CHEM, V268, P3342; Thomassen MJ, 1997, AM J RESP CELL MOL, V17, P279, DOI 10.1165/ajrcmb.17.3.2998m; UCHIDA K, 1992, P NATL ACAD SCI USA, V89, P4544, DOI 10.1073/pnas.89.10.4544; vanderVliet A, 1997, J BIOL CHEM, V272, P7617, DOI 10.1074/jbc.272.12.7617; Zhang HF, 2001, ARTERIOSCL THROM VAS, V21, P529, DOI 10.1161/01.ATV.21.4.529	46	279	294	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2006	281	47					35686	35698		10.1074/jbc.M603357200	http://dx.doi.org/10.1074/jbc.M603357200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	106KX	16887803	Green Accepted, hybrid			2022-12-27	WOS:000242100500013
J	Georgopoulou, N; Hurel, C; Politis, PK; Gaitanou, M; Matsas, R; Thomaidou, D				Georgopoulou, Niki; Hurel, Catherine; Politis, Panagiotis K.; Gaitanou, Maria; Matsas, Rebecca; Thomaidou, Dimitra			BM88 is a dual function molecule inducing cell cycle exit and neuronal differentiation of neuroblastoma cells via cyclin D1 down-regulation and retinoblastoma protein hypophosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVOUS-SYSTEM; TRANSCRIPTION FACTOR; CYTOPLASMIC SEQUESTRATION; INHIBITOR P21(WAF1/CIP1); CORTICAL PROGENITORS; FATE SPECIFICATION; RESTRICTION POINT; CEREBRAL-CORTEX; CDK INHIBITORS; GROWTH-FACTOR	Control of cell cycle progression/exit and differentiation of neuronal precursors is of paramount importance during brain development. BM88 is a neuronal protein associated with terminal neuron-generating divisions in vivo and is implicated in mechanisms underlying neuronal differentiation. Here we have used mouse neuroblastoma Neuro 2a cells as an in vitro model of neuronal differentiation to dissect the functional properties of BM88 by implementing gain- and loss-of-function approaches. We demonstrate that stably transfected cells overexpressing BM88 acquire a neuronal phenotype in the absence of external stimuli, as judged by enhanced expression of neuronal markers and neurite outgrowth-inducing signaling molecules. In addition, cell cycle measurements involving cell growth assays, BrdUrd incorporation, and fluorescence-activated cell sorting analysis revealed that the BM88-transfected cells have a prolonged G(1) phase, most probably corresponding to cell cycle exit at the G(0) restriction point, as compared with controls. BM88 overexpression also results in increased levels of the cell cycle regulatory protein p53, and accumulation of the hypophosphorylated form of the retinoblastoma protein leading to cell cycle arrest, with concomitant decreased levels and, in many cells, cytoplasmic localization of cyclin D1. Conversely, BM88 gene silencing using RNA interference experiments resulted in acceleration of cell proliferation accompanied by impairment of retinoic acid-induced neuronal differentiation of Neuro 2a cells. Taken together, our results suggest that BM88 plays an essential role in regulating cell cycle exit and differentiation of Neuro 2a cells toward a neuronal phenotype and further support its involvement in the proliferation/differentiation transition of neural stem/progenitor cells during embryonic development.	Hellenic Pasteur Inst, Lab Cellular & Mol Neurobiol, Athens 11521, Greece		Matsas, R (corresponding author), Hellenic Pasteur Inst, Lab Cellular & Mol Neurobiol, 127 Vassilissis Sofias Ave, Athens 11521, Greece.	rmatsa@mail.pasteur.gr; thomaidou@mail.pasteur.gr	Politis, Panagiotis/AAO-2423-2020	Politis, Panagiotis/0000-0002-2556-2857				Baek SH, 2003, P NATL ACAD SCI USA, V100, P3245, DOI 10.1073/pnas.0330217100; Bartek J, 1996, CURR OPIN CELL BIOL, V8, P805, DOI 10.1016/S0955-0674(96)80081-0; Basu A, 1998, MOL HUM REPROD, V4, P1099, DOI 10.1093/molehr/4.12.1099; Billon N, 1999, ONCOGENE, V18, P2872, DOI 10.1038/sj.onc.1202712; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Carey RG, 2002, J NEUROSCI, V22, P1583, DOI 10.1523/JNEUROSCI.22-05-01583.2002; Cesi V, 2002, CELL DEATH DIFFER, V9, P1232, DOI 10.1038/sj.cdd.4401103; Chae JH, 2004, MOL CELLS, V18, P271; Cheah P L, 2001, Malays J Pathol, V23, P9; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Coqueret O, 2003, TRENDS CELL BIOL, V13, P65, DOI 10.1016/S0962-8924(02)00043-0; Cremisi F, 2003, CURR OPIN NEUROBIOL, V13, P26, DOI 10.1016/S0959-4388(03)00005-9; Davison TS, 1998, ONCOGENE, V17, P651, DOI 10.1038/sj.onc.1202062; DelSal G, 1996, CRIT REV ONCOGENESIS, V7, P127, DOI 10.1615/CritRevOncog.v7.i1-2.80; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; DIAZNIDO J, 1991, J CELL SCI, P51; Dou CL, 1999, CEREB CORTEX, V9, P543, DOI 10.1093/cercor/9.6.543; Dubreuil V, 2000, DEVELOPMENT, V127, P5191; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; Dunkern TR, 2003, DNA REPAIR, V2, P49, DOI 10.1016/S1568-7864(02)00185-4; Dyer MA, 2000, DEVELOPMENT, V127, P3593; Dyer MA, 2001, J NEUROSCI, V21, P4259, DOI 10.1523/JNEUROSCI.21-12-04259.2001; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; Fabbro M, 2003, EXP CELL RES, V282, P59, DOI 10.1016/S0014-4827(02)00019-8; Farah MH, 2000, DEVELOPMENT, V127, P693; Furukawa Y, 1997, Hum Cell, V10, P159; Gaitanou M, 2001, BIOCHEM J, V355, P715, DOI 10.1042/bj3550715; Gaitanou M, 1997, J NEUROSCI RES, V48, P507, DOI 10.1002/(SICI)1097-4547(19970615)48:6<507::AID-JNR3>3.3.CO;2-2; Gallo R, 2002, J CELL BIOL, V158, P731, DOI 10.1083/jcb.200202024; Gill RM, 1998, EXP CELL RES, V244, P157, DOI 10.1006/excr.1998.4197; Gomez J, 1998, J NEUROSCI RES, V51, P119, DOI 10.1002/(SICI)1097-4547(19980101)51:1<119::AID-JNR13>3.0.CO;2-6; Gostissa M, 2003, CURR OPIN CELL BIOL, V15, P351, DOI 10.1016/S0955-0674(03)00038-3; Guardavaccaro D, 2000, MOL CELL BIOL, V20, P1797, DOI 10.1128/MCB.20.5.1797-1815.2000; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Haubst N, 2004, DEVELOPMENT, V131, P6131, DOI 10.1242/dev.01524; Heins N, 2001, MOL CELL NEUROSCI, V18, P485, DOI 10.1006/mcne.2001.1046; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Hu M, 1999, DEV BIOL, V207, P309, DOI 10.1006/dbio.1998.9031; Jiao JW, 2005, EMBO J, V24, P1068, DOI 10.1038/sj.emboj.7600589; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; Kiselyov VV, 2005, J NEUROCHEM, V94, P1169, DOI 10.1111/j.1471-4159.2005.03284.x; Koutmani Y, 2004, EUR J NEUROSCI, V20, P2509, DOI 10.1111/j.1460-9568.2004.03724.x; Koutsodontis G, 2001, J BIOL CHEM, V276, P29116, DOI 10.1074/jbc.M104130200; Le Gac G, 2006, J BIOL CHEM, V281, P24161, DOI 10.1074/jbc.M603724200; Liu YH, 2004, MOL CELL BIOL, V24, P2662, DOI 10.1128/MCB.24.7.2662-2672.2004; Lukaszewicz AS, 2002, J NEUROSCI, V22, P6610; MAMALAKI A, 1995, J BIOL CHEM, V270, P14201, DOI 10.1074/jbc.270.23.14201; Matsas R, 1997, ADV EXP MED BIOL, V429, P3; MCCONNELL SK, 1995, NEURON, V15, P761, DOI 10.1016/0896-6273(95)90168-X; Mendoza-Rodriguez CA, 2001, REV INVEST CLIN, V53, P266; Mittnacht S, 1998, CURR OPIN GENET DEV, V8, P21, DOI 10.1016/S0959-437X(98)80057-9; Musgrove EA, 2006, GROWTH FACTORS, V24, P13, DOI 10.1080/08977190500361812; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Ohnuma S, 2002, DEVELOPMENT, V129, P2435; Ohnuma S, 2001, CURR OPIN NEUROBIOL, V11, P66, DOI 10.1016/S0959-4388(00)00175-6; Ohnuma S, 2003, NEURON, V40, P199, DOI 10.1016/S0896-6273(03)00632-9; Oliver TG, 2003, P NATL ACAD SCI USA, V100, P7331, DOI 10.1073/pnas.0832317100; Papadodima O, 2005, J NEUROCHEM, V95, P146, DOI 10.1111/j.1471-4159.2005.03350.x; PATSAVOUDI E, 1995, J NEUROSCI RES, V40, P506, DOI 10.1002/jnr.490400410; PATSAVOUDI E, 1989, NEUROSCIENCE, V30, P463, DOI 10.1016/0306-4522(89)90266-2; PATSAVOUDI E, 1991, J NEUROCHEM, V56, P782, DOI 10.1111/j.1471-4159.1991.tb01992.x; Pinton P, 2001, EMBO J, V20, P2690, DOI 10.1093/emboj/20.11.2690; Quinn LM, 2001, GENE DEV, V15, P2741, DOI 10.1101/gad.916201; Sanchez I, 2005, SEMIN CELL DEV BIOL, V16, P311, DOI 10.1016/j.semcdb.2005.02.007; Schuurmans C, 2002, CURR OPIN NEUROBIOL, V12, P26, DOI 10.1016/S0959-4388(02)00286-6; Schuurmans C, 2004, EMBO J, V23, P2892, DOI 10.1038/sj.emboj.7600278; Seo S, 2005, GENE DEV, V19, P1723, DOI 10.1101/gad.1319105; Seo S, 2006, CELL CYCLE, V5, P374, DOI 10.4161/cc.5.4.2438; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sidera K, 2004, J BIOL CHEM, V279, P45379, DOI 10.1074/jbc.M405486200; Spencer ML, 2004, J BIOL CHEM, V279, P37069, DOI 10.1074/jbc.M402507200; Sumrejkanchanakij P, 2006, BIOCHEM BIOPH RES CO, V340, P302, DOI 10.1016/j.bbrc.2005.11.181; Sumrejkanchanakij P, 2003, ONCOGENE, V22, P8723, DOI 10.1038/sj.onc.1206870; Suzui M, 2002, CANCER RES, V62, P3997; Thomaidou D, 1997, J NEUROSCI, V17, P1075, DOI 10.1523/jneurosci.17-03-01075.1997; Tweddle DA, 2003, CANCER LETT, V197, P93, DOI 10.1016/S0304-3835(03)00088-0; Weissman TA, 2004, NEURON, V43, P647, DOI 10.1016/j.neuron.2004.08.015; WILLIAMS EJ, 1994, NEURON, V13, P583, DOI 10.1016/0896-6273(94)90027-2; Wu GS, 1996, CLIN CANCER RES, V2, P623; Yan GZ, 1997, J NEUROSCI, V17, P6122; Yano M, 2005, J BIOL CHEM, V280, P12690, DOI 10.1074/jbc.M411119200; Zhai WG, 2005, CELL, V123, P1241, DOI 10.1016/j.cell.2005.10.030	84	48	49	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33606	33620		10.1074/jbc.M602689200	http://dx.doi.org/10.1074/jbc.M602689200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16893893	hybrid			2022-12-27	WOS:000241621400070
J	Qin, LL; Zeng, HY; Zhao, DZ				Qin, Liuliang; Zeng, Huiyan; Zhao, Dezheng			Requirement of protein kinase D tyrosine phosphorylation for VEGF-A(165)-induced angiogenesis through its interaction and regulation of phospholipase C gamma phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; VASCULAR-PERMEABILITY FACTOR; PLECKSTRIN HOMOLOGY DOMAIN; NF-KAPPA-B; CELL PROLIFERATION; SIGNAL-TRANSDUCTION; D ACTIVATION; DNA-SYNTHESIS; VEGF-A; AUTOPHOSPHORYLATION SITE	Vascular endothelial cell growth factor-A(165)(VEGF-A(165)) is critical for angiogenesis. Although protein kinase C-mediated protein kinase D(PKD) activation was implicated in the response, the detailed mechanism remains unclear. In this study, we found that VEGF-A(165)-stimulated tyrosine phosphorylation of PKD and the dominant negative mutant of PKD, PKD(Y463F), inhibited VEGF-A(165)-induced human umbilical vein endothelial cell ( HUVEC) proliferation. In addition, PKD(S738A/S742A) overexpression inhibited VEGF-induced HUVEC migration. Furthermore, knockdown of PKD by its specific small interfering RNA inhibited VEGF-induced HUVEC proliferation and migration. Moreover transfection of PKD(Y463F), PKD(S738A/S742A), or PKD-small interfering RNA blocked VEGF-induced angiogenesis in vivo. Our signaling experiments show that KDR not Flt-1 mediated PKD tyrosine phosphorylation and KDR tyrosine residues 951 and 1059 were required for VEGF-A(165)-stimulated PKD serine and tyrosine phosphorylation, respectively. Whereas G protein G beta gamma subunits were required for both PKD serine phosphorylation and tyrosine phosphorylation, intracellular Ca2+ mobilization was required for VEGF-A(165)-stimulated PKD tyrosine phosphorylation and phospholipase C (PLC) activity was required for PKD serine phosphorylation. Surprisingly, the PLC inhibitor did not inhibit PKD tyrosine phosphorylation. Instead, PKD tyrosine 463 was required for VEGF-A(165)-stimulated PLC gamma tyrosine phosphorylation. Moreover, PKD interacted with PLC gamma even in unstimulated cells, and PKD tyrosine 463 phosphorylation was not required for this interaction. Together, we demonstrate that PKD interacts with PLC gamma and becomes tyrosine phosphorylated upon VEGF stimulation, leading to PLC gamma activation and angiogenic response of VEGF-A(165).	Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Div Gastroenterol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Zhao, DZ (corresponding author), 99 Brookline Ave, Boston, MA 02215 USA.	hzeng@bidmc.harvard.edu; dzhao@bidmc.harvard.edu			NCI NIH HHS [K01 CA 098581] Funding Source: Medline; NIDDK NIH HHS [K01 DK 064920] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K01CA098581] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK064920] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bernatchez PN, 1999, J BIOL CHEM, V274, P31047, DOI 10.1074/jbc.274.43.31047; BROCK TA, 1991, AM J PATHOL, V138, P213; Colavitti R, 2002, J BIOL CHEM, V277, P3101, DOI 10.1074/jbc.M107711200; Dvorak H.F., 1984, DEV ONCOL, V22, P96; DVORAK HF, 1990, PROG CLIN BIOL RES, V354, P317; Dvorak HF, 1999, CURR TOP MICROBIOL, V237, P97; DVORAK HF, 1979, J IMMUNOL, V122, P166; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Ferrara N, 1999, CURR TOP MICROBIOL, V237, P1; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Folkman J, 1996, CELL, V87, P1153, DOI 10.1016/S0092-8674(00)81810-3; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Gille H, 2001, J BIOL CHEM, V276, P3222, DOI 10.1074/jbc.M002016200; GUO DQ, 1995, J BIOL CHEM, V270, P6729, DOI 10.1074/jbc.270.12.6729; He YW, 2002, J LEUKOCYTE BIOL, V72, P440; Iglesias T, 1998, J BIOL CHEM, V273, P27662, DOI 10.1074/jbc.273.42.27662; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; Kanno S, 2000, ONCOGENE, V19, P2138, DOI 10.1038/sj.onc.1203533; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Matthews SA, 2000, J EXP MED, V191, P2075, DOI 10.1084/jem.191.12.2075; Matthews SA, 1999, J BIOL CHEM, V274, P26543, DOI 10.1074/jbc.274.37.26543; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; Nagy JA, 2006, LAB INVEST, V86, P767, DOI 10.1038/labinvest.3700436; Petrova TV, 1999, EXP CELL RES, V253, P117, DOI 10.1006/excr.1999.4707; Pettersson A, 2000, LAB INVEST, V80, P99, DOI 10.1038/labinvest.3780013; QUINN TP, 1993, P NATL ACAD SCI USA, V90, P7533, DOI 10.1073/pnas.90.16.7533; Rahimi N, 2000, J BIOL CHEM, V275, P16986, DOI 10.1074/jbc.M000528200; Rey O, 2001, J BIOL CHEM, V276, P32616, DOI 10.1074/jbc.M101649200; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Rykx A, 2003, FEBS LETT, V546, P81, DOI 10.1016/S0014-5793(03)00487-3; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; SENGER DR, 1986, CANCER RES, V46, P5629; Shalaby F, 1997, CELL, V89, P981, DOI 10.1016/S0092-8674(00)80283-4; Sidorenko SP, 1996, IMMUNITY, V5, P353, DOI 10.1016/S1074-7613(00)80261-7; Sinnett-Smith J, 2004, J BIOL CHEM, V279, P16883, DOI 10.1074/jbc.M313225200; Storz P, 2004, MOL CELL BIOL, V24, P2614, DOI 10.1128/MCB.24.7.2614-2626.2004; Storz P, 2003, J BIOL CHEM, V278, P17969, DOI 10.1074/jbc.M213224200; Storz P, 2003, EMBO J, V22, P109, DOI 10.1093/emboj/cdg009; Storz P, 2005, MOL CELL BIOL, V25, P8520, DOI 10.1128/MCB.25.19.8520-8530.2005; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Takahashi T, 1999, ONCOGENE, V18, P2221, DOI 10.1038/sj.onc.1202527; Takahashi T, 1997, ONCOGENE, V14, P2079, DOI 10.1038/sj.onc.1201047; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; TERMAN BI, 1992, BIOCHEM BIOPH RES CO, V187, P1579, DOI 10.1016/0006-291X(92)90483-2; Toker A., 1998, FRONT BIOSCI-LANDMRK, V3, P1134, DOI 10.2741/A350; Van Lint J, 2002, TRENDS CELL BIOL, V12, P193, DOI 10.1016/S0962-8924(02)02262-6; Van Lint J, 1998, J BIOL CHEM, V273, P7038, DOI 10.1074/jbc.273.12.7038; Waldron RT, 2000, J BIOL CHEM, V275, P17114, DOI 10.1074/jbc.M908959199; Waldron RT, 2003, J BIOL CHEM, V278, P154, DOI 10.1074/jbc.M208075200; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; Wong C, 2005, J BIOL CHEM, V280, P33262, DOI 10.1074/jbc.M503198200; Wu LW, 2000, J BIOL CHEM, V275, P6059, DOI 10.1074/jbc.275.9.6059; Yamaoka-Tojo M, 2004, CIRC RES, V95, P276, DOI 10.1161/01.RES.0000136522.58649.60; Zeng HY, 2006, J EXP MED, V203, P719, DOI 10.1084/jem.20051523; Zeng HY, 2003, J BIOL CHEM, V278, P20738, DOI 10.1074/jbc.M209712200; Zeng HY, 2002, J BIOL CHEM, V277, P46791, DOI 10.1074/jbc.M206133200; Zeng HY, 2002, J BIOL CHEM, V277, P4003, DOI 10.1074/jbc.M110842200; Zeng HY, 2001, J BIOL CHEM, V276, P26969, DOI 10.1074/jbc.M103213200; Zeng HY, 2001, J BIOL CHEM, V276, P32714, DOI 10.1074/jbc.M103130200; Zhao D., 2001, J BIOL CHEM, V26, P26; Zugaza JL, 1997, J BIOL CHEM, V272, P23952, DOI 10.1074/jbc.272.38.23952	62	48	48	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32550	32558		10.1074/jbc.M604853200	http://dx.doi.org/10.1074/jbc.M604853200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16891660	hybrid			2022-12-27	WOS:000241414500053
J	Ingley, E; Schneider, JR; Payne, CJ; McCarthy, DJ; Harder, KW; Hibbs, ML; Klinken, SP				Ingley, Evan; Schneider, Jessica R.; Payne, Christine J.; McCarthy, David J.; Harder, Kenneth W.; Hibbs, Margaret L.; Klinken, S. Peter			Csk-binding protein mediates sequential enzymatic down-regulation and degradation of Lyn in erythropoietin-stimulated cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOSPHINGOLIPID-ENRICHED MICRODOMAINS; SRC FAMILY KINASE; TYROSINE KINASE; NEGATIVE REGULATION; INDUCED DIFFERENTIATION; ERYTHROID-CELLS; LIPID RAFTS; SH2 DOMAIN; RECEPTOR; ACTIVATION	We have shown previously that the Src family kinase Lyn is involved in differentiation signals emanating from activated erythropoietin (Epo) receptors. The importance of Lyn to red cell maturation has been highlighted by Lyn(-/-) mice developing anemia. Here we show that Lyn interacts with C-terminal Src kinase-binding protein (Cbp), an adaptor protein that recruits negative regulators C-terminal Src kinase (Csk)/Csk-like protein-tyrosine kinase (Ctk). Lyn phosphorylated Cbp on several tyrosine residues, including Tyr(314), which recruited Csk/Ctk to suppress Lyn kinase activity. Intriguingly, phosphorylated Tyr(314) also bound suppressor of cytokine signaling 1 (SOCS1), another well characterized negative regulator of cell signaling, resulting in elevated ubiquitination, and degradation of Lyn. In Epo-responsive primary cells and cell lines, Lyn rapidly phosphorylated Cbp, suppressing Lyn kinase activity via Csk/Ctk within minutes of Epo stimulation; hours later, SOCS1 bound to Cbp and was involved in the ubiquitination and turnover of Lyn protein. Thus, a single phosphotyrosine residue on Cbp coordinates a two-phase process involving distinct negative regulatory pathways to inactivate, then degrade, Lyn.	Univ Western Australia, Cell Signalling Grp, Lab Canc Med, Western Australian Inst Med Res, Perth, WA 6000, Australia; Univ Western Australia, Western Australian Inst Med Res, Lab Canc Med, Perth, WA 6000, Australia; Univ Western Australia, Med Res Ctr, Perth, WA 6000, Australia; Royal Melbourne Hosp, Ludwig Inst Canc Res, Melbourne Tumour Biol Branch, Melbourne, Vic 3050, Australia	University of Western Australia; University of Western Australia; University of Western Australia; Ludwig Institute for Cancer Research; Royal Melbourne Hospital	Ingley, E (corresponding author), Univ Western Australia, Cell Signalling Grp, Lab Canc Med, Western Australian Inst Med Res, Level 6,Med Res Fdn Bldg,Rear 50 Murray St, Perth, WA 6000, Australia.	eingley@waimr.uwa.edu.au	Ingley, Evan/C-2401-2013; Hibbs, Margaret L/D-7013-2011	Ingley, Evan/0000-0002-8112-9134; Hibbs, Margaret L/0000-0002-3751-6751				Arai A, 2001, J BIOL CHEM, V276, P33282, DOI 10.1074/jbc.M102924200; Bao HF, 1999, BLOOD, V93, P3757, DOI 10.1182/blood.V93.11.3757.411a34_3757_3773; Bhattacharyya SP, 2001, IMMUNOL LETT, V75, P131, DOI 10.1016/S0165-2478(00)00289-3; Bouscary D, 2003, BLOOD, V101, P3436, DOI 10.1182/blood-2002-07-2332; Brdicka T, 2000, J EXP MED, V191, P1591, DOI 10.1084/jem.191.9.1591; Brunati AM, 2000, BLOOD, V96, P1550, DOI 10.1182/blood.V96.4.1550.h8001550_1550_1557; Chin H, 1998, BLOOD, V91, P3734; CHOW LML, 1994, P NATL ACAD SCI USA, V91, P4975, DOI 10.1073/pnas.91.11.4975; Constantinescu SN, 1999, TRENDS ENDOCRIN MET, V10, P18, DOI 10.1016/S1043-2760(98)00101-5; Corey SJ, 1999, BLOOD, V93, P1, DOI 10.1182/blood.V93.1.1; Crouin C, 2001, FEBS LETT, V495, P148, DOI 10.1016/S0014-5793(01)02373-0; DAMEN JE, 1995, EMBO J, V14, P5557, DOI 10.1002/j.1460-2075.1995.tb00243.x; Davidson D, 2003, MOL CELL BIOL, V23, P2017, DOI 10.1128/MCB.23.6.2017-2028.2003; GOUILLEUX F, 1995, EMBO J, V14, P2005, DOI 10.1002/j.1460-2075.1995.tb07192.x; Gregoli PA, 1997, BLOOD, V90, P630, DOI 10.1182/blood.V90.2.630.630_630_640; Harashima A, 2002, BLOOD, V100, P4440, DOI 10.1182/blood-2002-03-0864; Harder KW, 2001, IMMUNITY, V15, P603, DOI 10.1016/S1074-7613(01)00208-4; Harder KW, 2004, BLOOD, V104, P3901, DOI 10.1182/blood-2003-12-4396; Harris KF, 1999, P NATL ACAD SCI USA, V96, P13738, DOI 10.1073/pnas.96.24.13738; HAWLEY RG, 1994, GENE THER, V1, P136; Hirao A, 1997, EMBO J, V16, P2342, DOI 10.1093/emboj/16.9.2342; Ingley E, 1999, FEBS LETT, V459, P69, DOI 10.1016/S0014-5793(99)01188-6; Ingley E, 2005, ONCOGENE, V24, P336, DOI 10.1038/sj.onc.1208199; Ingley E, 2004, IUBMB LIFE, V56, P177, DOI 10.1080/15216540410001703956; Ingley E, 2001, J BIOL CHEM, V276, P43428, DOI 10.1074/jbc.M106645200; Ingley E, 2000, J BIOL CHEM, V275, P7887, DOI 10.1074/jbc.275.11.7887; Kawabuchi M, 2000, NATURE, V404, P999, DOI 10.1038/35010121; KLINGMULLER U, 1995, CELL, V80, P729, DOI 10.1016/0092-8674(95)90351-8; KLINKEN SP, 1988, P NATL ACAD SCI USA, V85, P8506, DOI 10.1073/pnas.85.22.8506; Kyo S, 2003, GENES CELLS, V8, P825, DOI 10.1046/j.1365-2443.2003.00679.x; Lecoq-Lafon C, 1999, BLOOD, V93, P2578, DOI 10.1182/blood.V93.8.2578.408k24_2578_2585; Liu E, 2003, EMBO J, V22, P5036, DOI 10.1093/emboj/cdg503; Lowell CA, 2004, MOL IMMUNOL, V41, P631, DOI 10.1016/j.molimm.2004.04.010; MIURA Y, 1994, J BIOL CHEM, V269, P29962; Odom S, 2004, J EXP MED, V199, P1491, DOI 10.1084/jem.20040382; Ohtake H, 2002, J IMMUNOL, V168, P2087, DOI 10.4049/jimmunol.168.5.2087; OKADA M, 1991, J BIOL CHEM, V266, P24249; Rane SG, 2002, ONCOGENE, V21, P3334, DOI 10.1038/sj.onc.1205398; Sarna MK, 2003, ONCOGENE, V22, P3221, DOI 10.1038/sj.onc.1206381; Sasaki A, 2000, J BIOL CHEM, V275, P29338, DOI 10.1074/jbc.M003456200; Shima T, 2003, P NATL ACAD SCI USA, V100, P14897, DOI 10.1073/pnas.2432139100; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; STOTZ A, 1990, GENE, V95, P91, DOI 10.1016/0378-1119(90)90418-Q; Tilbrook PA, 1996, J BIOL CHEM, V271, P3453; Tilbrook PA, 1997, EMBO J, V16, P1610, DOI 10.1093/emboj/16.7.1610; Tilbrook PA, 2001, CANCER RES, V61, P2453; TSAI S, 1994, GENE DEV, V8, P2831, DOI 10.1101/gad.8.23.2831; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; WATOWICH SS, 1992, P NATL ACAD SCI USA, V89, P2140, DOI 10.1073/pnas.89.6.2140; Williams JH, 1999, EMBO J, V18, P5559, DOI 10.1093/emboj/18.20.5559; WITTHUHN BA, 1993, CELL, V74, P227, DOI 10.1016/0092-8674(93)90414-L; Wojchowski DM, 1999, EXP CELL RES, V253, P143, DOI 10.1006/excr.1999.4673; Xu SL, 2005, MOL CELL BIOL, V25, P8486, DOI 10.1128/MCB.25.19.8486-8495.2005; Yasuda K, 2002, J IMMUNOL, V169, P2813, DOI 10.4049/jimmunol.169.6.2813; YOSHIMURA A, 1995, EMBO J, V14, P2816, DOI 10.1002/j.1460-2075.1995.tb07281.x; Zhang JG, 1999, P NATL ACAD SCI USA, V96, P2071, DOI 10.1073/pnas.96.5.2071; Zhang SQ, 2004, MOL CELL, V13, P341, DOI 10.1016/S1097-2765(04)00050-4	57	38	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31920	31929		10.1074/jbc.M602637200	http://dx.doi.org/10.1074/jbc.M602637200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16920712	Green Published			2022-12-27	WOS:000241235300078
J	Reinke, A; Chen, JCY; Aronova, S; Powers, T				Reinke, Aaron; Chen, Jenny C. -Y.; Aronova, Sofia; Powers, Ted			Caffeine targets TOR complex I and provides evidence for a regulatory link between the FRB and kinase domains of Tor1p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P70 S6 KINASE; SACCHAROMYCES-CEREVISIAE; MAMMALIAN TARGET; CELL-GROWTH; SIGNALING PATHWAY; BINDING PARTNER; RADIOSENSITIZING AGENT; PROTEIN-KINASES; SERINE RESIDUE; RAPAMYCIN TOR	The target of rapamycin (TOR) kinase is an important regulator of growth in eukaryotic cells. In budding yeast, Tor1p and Tor2p function as part of two distinct protein complexes, TORC1 and TORC2, where TORC1 is specifically inhibited by the antibiotic rapamycin. Significant insight into TORC1 function has been obtained using rapamycin as a specific small molecule inhibitor of TOR activity. Here we show that caffeine acts as a distinct and novel small molecule inhibitor of TORC1: (i) deleting components specific to TORC1 but not TORC2 renders cells hypersensitive to caffeine; (ii) rapamycin and caffeine display remarkably similar effects on global gene expression; and (iii) mutations were isolated in Tor1p, a component specific to TORC1, that confers significant caffeine resistance both in vivo and in vitro. Strongest resistance requires two simultaneous mutations in TOR1, the first at either one of two highly conserved positions within the FRB (rapamycin binding) domain and a second at a highly conserved position within the ATP binding pocket of the kinase domain. Biochemical and genetic analyses of these mutant forms of Tor1p support a model wherein functional interactions between the FRB and kinase domains, as well as between the FRB domain and the TORC1 component Kog1p, regulate TOR activity as well as contribute to the mechanism of caffeine resistance.	Univ Calif Davis, Coll Biol Sci, Sect Mol & Cellular Biol, Davis, CA 95616 USA	University of California System; University of California Davis	Powers, T (corresponding author), Univ Calif Davis, Coll Biol Sci, Sect Mol & Cellular Biol, Davis, CA 95616 USA.	tpowers@ucdavis.edu		Chen, CJ/0000-0003-3766-4612; Reinke, Aaron/0000-0001-7612-5342				Alaimo PJ, 2005, BIOORGAN MED CHEM, V13, P2825, DOI 10.1016/j.bmc.2005.02.021; Alarcon CM, 1999, MOL BIOL CELL, V10, P2531, DOI 10.1091/mbc.10.8.2531; Block WD, 2004, NUCLEIC ACIDS RES, V32, P1967, DOI 10.1093/nar/gkh508; BROWN EJ, 1995, NATURE, V377, P441, DOI 10.1038/377441a0; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; CHEN J, 1995, P NATL ACAD SCI USA, V92, P4947, DOI 10.1073/pnas.92.11.4947; CHEN JC, 2006, CURR GENET, V49, P1; Collins CA, 1999, GENE DEV, V13, P1970, DOI 10.1101/gad.13.15.1970; Cortez D, 2003, J BIOL CHEM, V278, P37139, DOI 10.1074/jbc.M307088200; Crespo JL, 2002, MICROBIOL MOL BIOL R, V66, P579, DOI 10.1128/MMBR.66.4.579-591.2002; deHart AKA, 2003, MOL BIOL CELL, V14, P4676, DOI 10.1091/mbc.E03-05-0323; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Helliwell SB, 1998, GENETICS, V148, P99; Ho HL, 2005, CURR GENET, V47, P273, DOI 10.1007/s00294-005-0570-8; Kaufmann WK, 2003, MUTAT RES-FUND MOL M, V532, P85, DOI 10.1016/j.mrfmmm.2003.08.012; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Komeili A, 2000, J CELL BIOL, V151, P863, DOI 10.1083/jcb.151.4.863; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; LORENZ MC, 1995, J BIOL CHEM, V270, P27531, DOI 10.1074/jbc.270.46.27531; Lum PY, 2004, CELL, V116, P121, DOI 10.1016/S0092-8674(03)01035-3; Martin H, 2000, J BIOL CHEM, V275, P1511, DOI 10.1074/jbc.275.2.1511; McMahon LP, 2002, MOL CELL BIOL, V22, P7428, DOI 10.1128/MCB.22.21.7428-7438.2002; McMahon LP, 2005, MOL ENDOCRINOL, V19, P175, DOI 10.1210/me.2004-0305; NASMYTH K, 1990, CELL, V62, P631, DOI 10.1016/0092-8674(90)90110-Z; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Powers T, 1999, MOL BIOL CELL, V10, P987, DOI 10.1091/mbc.10.4.987; Reinke A, 2004, J BIOL CHEM, V279, P14752, DOI 10.1074/jbc.M313062200; Saiardi A, 2005, P NATL ACAD SCI USA, V102, P1911, DOI 10.1073/pnas.0409322102; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sarkaria JN, 1999, CANCER RES, V59, P4375; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Scott PH, 1998, P NATL ACAD SCI USA, V95, P7772, DOI 10.1073/pnas.95.13.7772; Scott PH, 1998, J BIOL CHEM, V273, P34496, DOI 10.1074/jbc.273.51.34496; Shamji AF, 2000, CURR BIOL, V10, P1574, DOI 10.1016/S0960-9822(00)00866-6; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SIKORSKI RS, 1989, GENETICS, V122, P19; SIKORSKI RS, 1991, METHOD ENZYMOL, V194, P302; STAN R, 1994, J BIOL CHEM, V269, P32027; Torres J, 2002, J BIOL CHEM, V277, P43495, DOI 10.1074/jbc.M205408200; Wedaman KP, 2003, MOL BIOL CELL, V14, P1204, DOI 10.1091/mbc.E02-09-0609; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Wullschleger S, 2005, J BIOL CHEM, V280, P30697, DOI 10.1074/jbc.M505553200; Yonezawa K, 2004, BIOCHEM BIOPH RES CO, V313, P437, DOI 10.1016/j.bbrc.2003.07.018; Zhang Y, 2006, GENETICS, V172, P355, DOI 10.1534/genetics.105.051979; ZHENG XF, 1995, CELL, V82, P121, DOI 10.1016/0092-8674(95)90058-6	52	143	144	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31616	31626		10.1074/jbc.M603107200	http://dx.doi.org/10.1074/jbc.M603107200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16923813				2022-12-27	WOS:000241235300047
J	Yong, J; Tan, I; Lim, L; Leung, T				Yong, Jeffery; Tan, Ivan; Lim, Louis; Leung, Thomas			Phosphorylation of myosin phosphatase targeting subunit 3 (MYPT3) and regulation of protein phosphatase 1 by protein kinase A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AKAP SIGNALING COMPLEXES; LIGHT-CHAIN-PHOSPHATASE; SMOOTH-MUSCLE; BINDING SUBUNIT; RHO-KINASE; DEPHOSPHORYLATION; IDENTIFICATION; TRANSDUCTION; CLONING	Myosin phosphatase targeting subunit 3 (MYPT3) and transforming growth factor-beta-inhibited membrane-associated protein (TIMAP) are two closely related myosin-binding targeting subunits of protein phosphatase 1 (PP1c) with a characteristic CAAX ( where AA indicates aliphatic amino acid) box at the C termini. Here we show that MYPT3 can be a substrate for protein kinase A (PKA). We first mapped the multiple phosphorylation sites within a central conserved motif. Deletion or mutations of this motif resulted in enhancement of the associated PP1c activity, suggesting that phosphorylation of MYPT3 may play an important role in regulating PP1c catalytic activity. However, unlike the other known MYPTs, which upon phosphorylation inhibit PP1c, PKA phosphorylation of MYPT3 resulted in PP1c activation, indicating a different mode of action. There is a direct interaction between the central conserved phosphorylated site motif with the N-terminal ankyrin repeat region; this interaction was significantly reduced with MYPT3 phosphorylation or acidic phosphorylation site mutations, with concomitant alterations in biochemical and morphological consequences. We therefore propose a novel mechanism for the phosphorylation of MYPT3 by PKA and activation of the catalytic activity through direct interaction of a central region of MYPT3 with its N-terminal region.	Natl Univ Singapore, GSK, IMCB Grp, Inst Mol & Cell Biol, Singapore 138673, Singapore; UCL, Inst Neurol, Dept Mol Neurosci, London WC1N 1PJ, England	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); GlaxoSmithKline; National University of Singapore; University of London; University College London	Leung, T (corresponding author), Natl Univ Singapore, GSK, IMCB Grp, Inst Mol & Cell Biol, 61 Biopolis Dr, Singapore 138673, Singapore.	mcbthoml@imcb.a-star.edu.sg						Alto N, 2002, DIABETES, V51, pS385, DOI 10.2337/diabetes.51.2007.S385; Broustas CG, 2002, J BIOL CHEM, V277, P3053, DOI 10.1074/jbc.M106343200; Cao WS, 2002, AM J PHYSIOL-CELL PH, V283, pC327, DOI 10.1152/ajpcell.00442.2001; Ceulemans H, 2002, BIOESSAYS, V24, P371, DOI 10.1002/bies.10069; Cohen PTW, 2002, J CELL SCI, V115, P241; Diviani D, 2004, EMBO J, V23, P2811, DOI 10.1038/sj.emboj.7600287; Diviani D, 2001, J CELL SCI, V114, P1431; Dong JM, 1998, J BIOL CHEM, V273, P22554, DOI 10.1074/jbc.273.35.22554; Fu HW, 1999, RECENT PROG HORM RES, V54, P315; Fukata Y, 2001, TRENDS PHARMACOL SCI, V22, P32, DOI 10.1016/S0165-6147(00)01596-0; Gailly P, 1996, EUR J BIOCHEM, V239, P326, DOI 10.1111/j.1432-1033.1996.0326u.x; Garcia JGN, 1997, AM J RESP CELL MOL, V16, P489, DOI 10.1165/ajrcmb.16.5.9160829; Hartshorne DJ, 2004, J BIOL CHEM, V279, P37211, DOI 10.1074/jbc.R400018200; Hartshorne DJ, 1998, J MUSCLE RES CELL M, V19, P325, DOI 10.1023/A:1005385302064; Hirano K, 2003, MOL CELL BIOCHEM, V248, P105, DOI 10.1023/A:1024180101032; Howe AK, 2004, BBA-MOL CELL RES, V1692, P159, DOI 10.1016/j.bbamcr.2004.03.005; Ito M, 2004, MOL CELL BIOCHEM, V259, P197, DOI 10.1023/B:MCBI.0000021373.14288.00; Ito M, 1997, BIOCHEMISTRY-US, V36, P7607, DOI 10.1021/bi9702647; Johnson DF, 1996, EUR J BIOCHEM, V239, P317, DOI 10.1111/j.1432-1033.1996.0317u.x; Kawano Y, 1999, J CELL BIOL, V147, P1023, DOI 10.1083/jcb.147.5.1023; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Langeberg LK, 2005, J CELL SCI, V118, P3217, DOI 10.1242/jcs.02416; Leung T, 1998, MOL CELL BIOL, V18, P130, DOI 10.1128/MCB.18.1.130; LUO K, 1990, ONCOGENE, V5, P921; Muranyi A, 2002, BIOCHEM J, V366, P211, DOI 10.1042/BJ20020401; Muranyi A, 2001, FEBS LETT, V493, P80, DOI 10.1016/S0014-5793(01)02283-9; Patel KG, 2001, J NEUROSCI, V21, P7954; Shin HM, 2002, CIRC RES, V90, P546, DOI 10.1161/01.RES.0000012822.23273.EC; Skinner JA, 2001, BIOCHEM J, V356, P257, DOI 10.1042/0264-6021:3560257; Somlyo AP, 2000, J PHYSIOL-LONDON, V522, P177, DOI 10.1111/j.1469-7793.2000.t01-2-00177.x; Srinivas SP, 2004, EXP EYE RES, V79, P543, DOI 10.1016/j.exer.2004.06.027; Surks HK, 2003, CELL SIGNAL, V15, P937, DOI 10.1016/S0898-6568(03)00057-3; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Takizawa N, 2003, AM J PHYSIOL-CELL PH, V284, pC250, DOI 10.1152/ajpcell.00153.2002; Tan I, 2001, J BIOL CHEM, V276, P21209, DOI 10.1074/jbc.M102615200; Terrak M, 2004, NATURE, V429, P780, DOI 10.1038/nature02582; Vereshchagina N, 2004, MOL BIOL CELL, V15, P4395, DOI 10.1091/mbc.E04-02-0139; Wakatsuki T, 2003, J CELL SCI, V116, P1617, DOI 10.1242/jcs.00340; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Wooldridge AA, 2004, J BIOL CHEM, V279, P34496, DOI 10.1074/jbc.M405957200; WOOTEN MW, 2002, SCI STKE, pPL15	42	22	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31202	31211		10.1074/jbc.M607287200	http://dx.doi.org/10.1074/jbc.M607287200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16920702				2022-12-27	WOS:000241235300005
J	Asinas, AE; Weis, RM				Asinas, Abdalin E.; Weis, Robert M.			Competitive and cooperative interactions in receptor signaling complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI CHEMOTAXIS; BACTERIAL CHEMOTAXIS; COVALENT MODIFICATION; ASPARTATE RECEPTOR; CYTOPLASMIC DOMAIN; SENSORY RECEPTOR; KINASE CHEA; CHEMORECEPTORS; TRANSDUCTION; MODEL	In bacterial chemotaxis, clustered transmembrane receptors and the adaptor protein Che W regulate the kinase CheA. Receptors outnumber CheA, yet it is poorly understood how interactions among receptors contribute to regulation. To address this problem, receptor clusters were simulated using liposomes decorated with the cytoplasmic domains of receptors, which supported CheA binding and stimulation. Competitive and cooperative interactions were revealed through the use of known receptor signaling mutants, which were used in mixtures with the wild type domain. Competitive effects among the receptor domains sorted cleanly into two categories defined by either stronger or weaker interactions with CheA. Cooperative effects were also evident in CheA binding and activity. In the transition from the stimulating to the inhibiting states, both the cooperativity of the transition and the persistence of stimulation by the wild type domain increased with receptor modification, as in the intact receptor. We conclude that competitive and cooperative receptor interactions both contribute to CheA regulation and that liposome-mediated assembly is effective in addressing these general membrane phenomena.	Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Weis, RM (corresponding author), Univ Massachusetts, Dept Chem, LGRT 701,710 N Pleasant St, Amherst, MA 01003 USA.	rmweis@chem.umass.edu			NIGMS NIH HHS [5R01GM053210, T32 GM008515] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008515, R01GM053210] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ames P, 2002, P NATL ACAD SCI USA, V99, P7060, DOI 10.1073/pnas.092071899; Bilwes AM, 1999, CELL, V96, P131, DOI 10.1016/S0092-8674(00)80966-6; BORKOVICH KA, 1992, P NATL ACAD SCI USA, V89, P6756, DOI 10.1073/pnas.89.15.6756; BORKOVICH KA, 1990, CELL, V63, P1339, DOI 10.1016/0092-8674(90)90429-I; Bornhorst JA, 2003, J MOL BIOL, V326, P1597, DOI 10.1016/S0022-2836(03)00026-3; Boukhvalova MS, 2002, J BIOL CHEM, V277, P22251, DOI 10.1074/jbc.M110908200; Bray D, 1998, NATURE, V393, P85, DOI 10.1038/30018; DUNTEN P, 1991, J BIOL CHEM, V266, P1491; Falke JJ, 2001, TRENDS BIOCHEM SCI, V26, P257, DOI 10.1016/S0968-0004(00)01770-9; Francis NR, 2004, P NATL ACAD SCI USA, V101, P17480, DOI 10.1073/pnas.0407826101; GEGNER JA, 1992, CELL, V70, P975, DOI 10.1016/0092-8674(92)90247-A; GEGNER JA, 1991, P NATL ACAD SCI USA, V88, P750, DOI 10.1073/pnas.88.3.750; Gestwicki JE, 2002, NATURE, V415, P81, DOI 10.1038/415081a; Griswold IJ, 2002, NAT STRUCT BIOL, V9, P121, DOI 10.1038/nsb753; Irieda H, 2006, J BIOL CHEM, V281, P23880, DOI 10.1074/jbc.M600018200; Kentner D, 2006, MOL MICROBIOL, V61, P407, DOI 10.1111/j.1365-2958.2006.05250.x; Keymer JE, 2006, P NATL ACAD SCI USA, V103, P1786, DOI 10.1073/pnas.0507438103; Kim KK, 1999, NATURE, V400, P787, DOI 10.1038/23512; Kott L, 2004, BBA-PROTEINS PROTEOM, V1696, P131, DOI 10.1016/j.bbapap.2003.10.001; Lamanna AC, 2005, MOL MICROBIOL, V57, P774, DOI 10.1111/j.1365-2958.2005.04728.x; LeMoual H, 1996, J MOL BIOL, V261, P568, DOI 10.1006/jmbi.1996.0483; Levit MN, 2002, J BIOL CHEM, V277, P36748, DOI 10.1074/jbc.M204317200; Li GY, 2000, CELL, V100, P357, DOI 10.1016/S0092-8674(00)80671-6; Liberman L, 2004, J BACTERIOL, V186, P6643, DOI 10.1128/JB.186.19.6643-6646.2004; LONG DG, 1992, BIOCHEMISTRY-US, V31, P9904, DOI 10.1021/bi00156a007; Lybarger SR, 2005, MOL MICROBIOL, V56, P1078, DOI 10.1111/j.1365-2958.2005.04593.x; Lybarger SR, 2001, J BACTERIOL, V183, P3261, DOI 10.1128/JB.183.11.3261-3267.2001; MADDOCK JR, 1993, SCIENCE, V259, P1717; Mello BA, 2005, P NATL ACAD SCI USA, V102, P17354, DOI 10.1073/pnas.0506961102; MUTOH N, 1986, J BACTERIOL, V167, P992, DOI 10.1128/jb.167.3.992-998.1986; Park SY, 2006, NAT STRUCT MOL BIOL, V13, P400, DOI 10.1038/nsmb1085; Parkinson JS, 2005, CURR OPIN MICROBIOL, V8, P116, DOI 10.1016/j.mib.2005.02.008; SCHUSTER SC, 1993, NATURE, V365, P343, DOI 10.1038/365343a0; Shimizu TS, 2000, NAT CELL BIOL, V2, P792, DOI 10.1038/35041030; Shrout AL, 2003, BIOCHEMISTRY-US, V42, P13379, DOI 10.1021/bi0352769; Sourjik V, 2004, TRENDS MICROBIOL, V12, P569, DOI 10.1016/j.tim.2004.10.003; Sourjik V, 2004, NATURE, V428, P437, DOI 10.1038/nature02406; Studdert CA, 2004, P NATL ACAD SCI USA, V101, P2117, DOI 10.1073/pnas.0308622100; TERWILLIGER TC, 1984, J BIOL CHEM, V259, P7719; Ulrich LE, 2005, BIOINFORMATICS, V21, P45, DOI 10.1093/bioinformatics/bti1204; Weis RM, 2003, J BACTERIOL, V185, P3636, DOI 10.1128/JB.185.12.3636-3643.2003	41	22	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30512	30523		10.1074/jbc.M606267200	http://dx.doi.org/10.1074/jbc.M606267200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16920717	hybrid			2022-12-27	WOS:000241075900027
J	Jancura, D; Berka, V; Antalik, M; Bagelova, J; Gennis, RB; Palmer, G; Fabian, M				Jancura, Daniel; Berka, Vladimir; Antalik, Marian; Bagelova, Jaroslava; Gennis, Robert B.; Palmer, Graham; Fabian, Marian			Spectral and kinetic equivalence of oxidized cytochrome c oxidase as isolated and "activated" by reoxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-PARAMAGNETIC RESONANCE; PROTON TRANSLOCATION; CATALYTIC CENTER; PULSED FORM; SLOW FORMS; REDUCTION; EPR; MITOCHONDRIA; EQUILIBRIUM; PROTEIN	The spectral and kinetic characteristics of two oxidized states of bovine heart cytochrome c oxidase (CcO) have been compared. The first is the oxidized state of enzyme isolated in the fast form (O) and the second is the form that is obtained immediately after oxidation of fully reduced CcO with O-2 (O-H). No observable differences were found between O and O-H states in: (i) the rate of anaerobic reduction of heme a(3) for both the detergent-solubilized enzyme and for enzyme embedded in its natural membraneous environment, (ii) the one-electron distribution between heme a(3) and Cu-B in the course of the full anaerobic reduction, (iii) the optical and (iv) EPR spectra. Within experimental error of these characteristics both forms are identical. Based on these observations it is concluded that the reduction potentials and the ligation states of heme a(3) and Cu-B are the same for CcO in the O and O-H states.	Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA; Univ Texas, Hlth Sci Ctr, Dept Internal Med, Div Hematol, Houston, TX 77030 USA; Safarik Univ, Dept Biophys, Kosice 04154, Slovakia; Slovak Acad Sci, Inst Expt Phys, Dept Biophys, Kosice 04353, Slovakia; Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	Rice University; University of Texas System; University of Texas Health Science Center Houston; University of Pavol Jozef Safarik Kosice; Slovak Academy of Sciences; University of Illinois System; University of Illinois Urbana-Champaign	Fabian, M (corresponding author), Rice Univ, Dept Biochem & Cell Biol, 6100 Main,MS 140, Houston, TX 77005 USA.	fabian@rice.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL016101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055807] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL016101] Funding Source: Medline; NIGMS NIH HHS [GM55807] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AASA R, 1976, BIOCHIM BIOPHYS ACTA, V422, P260, DOI 10.1016/0005-2744(76)90137-6; Antalik M, 2005, BIOCHEMISTRY-US, V44, P14881, DOI 10.1021/bi050824z; ANTONINI E, 1977, P NATL ACAD SCI USA, V74, P3128, DOI 10.1073/pnas.74.8.3128; ARMSTRONG F, 1983, BIOCHIM BIOPHYS ACTA, V722, P61, DOI 10.1016/0005-2728(83)90157-3; BAKER GM, 1987, J BIOL CHEM, V262, P595; BEINERT H, 1982, OXIDASES RELATED RED, P139; BLAIR DF, 1983, CHEM SCRIPTA, V21, P43; Bloch D, 2004, P NATL ACAD SCI USA, V101, P529, DOI 10.1073/pnas.0306036101; BRANDT U, 1989, EUR J BIOCHEM, V182, P705, DOI 10.1111/j.1432-1033.1989.tb14882.x; BRUNORI M, 1979, J BIOL CHEM, V254, P769; Fabian M, 2004, J BIOL CHEM, V279, P16170, DOI 10.1074/jbc.M311834200; Fabian M, 2001, BIOCHEMISTRY-US, V40, P6061, DOI 10.1021/bi010059y; Farver O, 2000, EUR J BIOCHEM, V267, P950, DOI 10.1046/j.1432-1327.2000.01072.x; GEREN LM, 1995, J BIOL CHEM, V270, P2466, DOI 10.1074/jbc.270.6.2466; HARTZELL CR, 1973, P NATL ACAD SCI USA, V70, P2477, DOI 10.1073/pnas.70.9.2477; JACOBS EE, 1960, J BIOL CHEM, V235, P531; KOBAYASHI K, 1989, J BIOL CHEM, V264, P7976; LANNE B, 1979, BIOCHIM BIOPHYS ACTA, V545, P205, DOI 10.1016/0005-2728(79)90200-7; LENAZ G, 1967, METHOD ENZYMOL, V10, P499; Liao GL, 1996, BBA-BIOENERGETICS, V1274, P109, DOI 10.1016/0005-2728(96)00014-X; MALATESTA F, 1990, P NATL ACAD SCI USA, V87, P7410, DOI 10.1073/pnas.87.19.7410; MARGALIT R, 1973, EUR J BIOCHEM, V32, P492, DOI 10.1111/j.1432-1033.1973.tb02633.x; MASSEY V, 1959, BIOCHIM BIOPHYS ACTA, V34, P255, DOI 10.1016/0006-3002(59)90259-8; Michel H, 1999, BIOCHEMISTRY-US, V38, P15129, DOI 10.1021/bi9910934; MOODY AJ, 1991, BIOCHIM BIOPHYS ACTA, V1059, P189, DOI 10.1016/S0005-2728(05)80204-X; Moody AJ, 1996, BBA-BIOENERGETICS, V1276, P6; MOODY AJ, 1991, FEBS LETT, V293, P101, DOI 10.1016/0014-5793(91)81161-Z; MORGAN JE, 1989, BIOCHEMISTRY-US, V28, P6975, DOI 10.1021/bi00443a030; PALMER G, 1988, CHEM SCRIPTA, V28A, P41; PAN LP, 1993, BIOCHEMISTRY-US, V32, P8492, DOI 10.1021/bi00084a014; PEISACH J, 1971, J BIOL CHEM, V246, P3342; Ruitenberg M, 2002, NATURE, V417, P99, DOI 10.1038/417099a; SHAW RW, 1978, J BIOL CHEM, V253, P6637; SOULIMANE T, 1995, EUR J BIOCHEM, V227, P588, DOI 10.1111/j.1432-1033.1995.tb20429.x; Szundi I, 2001, BIOCHEMISTRY-US, V40, P2186, DOI 10.1021/bi002341v; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; VANGELDE.BF, 1969, BIOCHIM BIOPHYS ACTA, V189, P1, DOI 10.1016/0005-2728(69)90219-9; Verkhovsky MI, 1999, NATURE, V400, P480, DOI 10.1038/22813; VERKHOVSKY MI, 1995, BIOCHEMISTRY-US, V34, P7483, DOI 10.1021/bi00022a023; Wang KF, 2002, BIOCHEMISTRY-US, V41, P2298, DOI 10.1021/bi0114630; WIKSTROM MKF, 1977, NATURE, V266, P271, DOI 10.1038/266271a0; WINKLER JR, 1995, BIOPHYS CHEM, V54, P199, DOI 10.1016/0301-4622(94)00156-E; WRIGGLESWORTH JM, 1988, BIOCHIM BIOPHYS ACTA, V936, P452, DOI 10.1016/0005-2728(88)90023-0	43	41	42	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30319	30325		10.1074/jbc.M605955200	http://dx.doi.org/10.1074/jbc.M605955200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16905536	hybrid			2022-12-27	WOS:000241075900005
J	Southall, SM; Doel, JJ; Richardson, DJ; Oubrie, A				Southall, Stacey M.; Doel, Justin J.; Richardson, David J.; Oubrie, Arthur			Soluble aldose sugar dehydrogenase from Escherichia coli - A highly exposed active site conferring broad substrate specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUINOPROTEIN GLUCOSE-DEHYDROGENASE; L-ASCORBIC-ACID; ACINETOBACTER-CALCOACETICUS; PYRROLOQUINOLINE-QUINONE; CRYSTAL-STRUCTURE; L-SORBOSONE; MECHANISM; REDUCTASE; COFACTOR; PQQ	A water-soluble aldose sugar dehydrogenase (Asd) has been purified for the first time from Escherichia coli. The enzyme is able to act upon a broad range of aldose sugars, encompassing hexoses, pentoses, disaccharides, and trisaccharides, and is able to oxidize glucose to gluconolactone with subsequent hydrolysis to gluconic acid. The enzyme shows the ability to bind pyrroloquinoline quinone (PQQ) in the presence of Ca2+ in a manner that is proportional to its catalytic activity. The x-ray structure has been determined in the apo-form and as the PQQ-bound active holoenzyme. The beta-propeller fold of this protein is conserved between E. coli Asd and Acinetobacter calcoaceticus soluble glucose dehydrogenase (sGdh), with major structural differences lying in loop and surface-exposed regions. Many of the residues involved in binding the cofactor are conserved between the two enzymes, but significant differences exist in residues likely to contact substrates. PQQ is bound in a large cleft in the protein surface and is uniquely solvent-accessible compared with other PQQ enzymes. The exposed and charged nature of the active site and the activity profile of this enzyme indicate possible factors that underlie a low affinity for glucose but generic broad substrate specificity for aldose sugars. These structural and catalytic properties of the enzymes have led us to propose that E. coli Asd provides a prototype structure for a new subgroup of PQQ-dependent soluble dehydrogenases that is distinct from the A. calcoaceticus sGdh subgroup.	Univ E Anglia, Ctr Met Prot Spect & Biol, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England	University of East Anglia	Southall, SM (corresponding author), Univ E Anglia, Ctr Met Prot Spect & Biol, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England.	Stacey.Southall@icr.ac.uk	Richardson, David J/E-2275-2011	Oubrie, Arthur/0000-0001-6765-9246	Biotechnology and Biological Sciences Research Council [B18695] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Abramson J, 2000, NAT STRUCT BIOL, V7, P910; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bamford VA, 2002, BIOCHEMISTRY-US, V41, P2921, DOI 10.1021/bi015765d; Bertero MG, 2003, NAT STRUCT BIOL, V10, P681, DOI 10.1038/nsb969; Brunger AT, 1997, METHOD ENZYMOL, V277, P366, DOI 10.1016/S0076-6879(97)77021-6; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Dewanti AR, 1998, BIOCHEMISTRY-US, V37, P6810, DOI 10.1021/bi9722610; DOKTER P, 1986, BIOCHEM J, V239, P163, DOI 10.1042/bj2390163; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Felton LM, 2005, NATURE, V433, pE10, DOI 10.1038/nature03322; Haltia T, 2003, BIOCHEM J, V369, P77, DOI 10.1042/BJ20020782; Igarashi S, 2004, BIOMOL ENG, V21, P81, DOI 10.1016/j.bioeng.2003.12.001; Iverson TM, 1999, SCIENCE, V284, P1961, DOI 10.1126/science.284.5422.1961; Jormakka M, 2002, SCIENCE, V295, P1863, DOI 10.1126/science.1068186; Jormakka M, 2004, STRUCTURE, V12, P95, DOI 10.1016/j.str.2003.11.020; Kasahara T, 2005, NATURE, V433, pE11, DOI 10.1038/nature03324; Kasahara T, 2003, NATURE, V422, P832, DOI 10.1038/422832a; Lamzin VS, 1997, METHOD ENZYMOL, V277, P269, DOI 10.1016/S0076-6879(97)77016-2; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie A. G. W., 1992, CRYSTALLOGRAPHY, V26; Maniatis T., 1989, MOL CLONING LAB MAN; Miyazaki T, 2006, APPL ENVIRON MICROB, V72, P1487, DOI 10.1128/AEM.72.2.1487-1495.2006; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Olsthoorn AJJ, 1998, EUR J BIOCHEM, V255, P255, DOI 10.1046/j.1432-1327.1998.2550255.x; Olsthoorn AJJ, 1996, ARCH BIOCHEM BIOPHYS, V336, P42, DOI 10.1006/abbi.1996.0530; Olsthoorn AJJ, 1997, EUR J BIOCHEM, V247, P659, DOI 10.1111/j.1432-1033.1997.00659.x; Olsthoorn AJJ, 1998, BIOCHEMISTRY-US, V37, P13854, DOI 10.1021/bi9808868; Oubrie A, 1999, EMBO J, V18, P5187, DOI 10.1093/emboj/18.19.5187; Oubrie A, 1999, P NATL ACAD SCI USA, V96, P11787, DOI 10.1073/pnas.96.21.11787; Oubrie A, 2003, BBA-PROTEINS PROTEOM, V1647, P143, DOI 10.1016/S1570-9639(03)00087-6; Oubrie A, 1999, J MOL BIOL, V289, P319, DOI 10.1006/jmbi.1999.2766; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; PAZUR JH, 1964, BIOCHEMISTRY-US, V3, P578, DOI 10.1021/bi00892a018; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; Rucker R, 2005, NATURE, V433, pE10, DOI 10.1038/nature03323; Satoh A, 2002, J BIOL CHEM, V277, P2830, DOI 10.1074/jbc.M109090200; Solnica B, 2003, CLIN CHIM ACTA, V331, P29, DOI 10.1016/S0009-8981(03)00079-2; Sugisawa T, 2005, BIOSCI BIOTECH BIOCH, V69, P659, DOI 10.1271/bbb.69.659; Tang ZP, 2001, CRIT CARE MED, V29, P1062, DOI 10.1097/00003246-200105000-00038; Unkrig V., 1996, [No title captured], Patent No. [5,484,708, 5484708]; Yankovskaya V, 2003, SCIENCE, V299, P700, DOI 10.1126/science.1079605	43	37	39	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30650	30659		10.1074/jbc.M601783200	http://dx.doi.org/10.1074/jbc.M601783200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16864586	hybrid			2022-12-27	WOS:000241075900041
J	Tocheva, EI; Fortin, PD; Eltis, LD; Murphy, MEP				Tocheva, Elitza I.; Fortin, Pascal D.; Eltis, Lindsay D.; Murphy, Michael E. P.			Structures of ternary complexes of BphK, a bacterial glutathione S-transferase that reductively dechlorinates polychlorinated biphenyl metabolites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SP STRAIN LB400; MICROBIAL-DEGRADATION; DEHALOGENATION; PURIFICATION; ROLES; BOND; EVOLUTION; MOLSCRIPT; CLEAVAGE; REVEALS	Prokaryotic glutathione S-transferases are as diverse as their eukaryotic counterparts but are much less well characterized. BphK from Burkholderia xenovorans LB400 consumes two GSH molecules to reductively dehalogenate chlorinated 2-hydroxy-6oxo-6-phenyl-2,4-dienoates (HOPDAs), inhibitory polychlorinated biphenyl metabolites. Crystallographic structures of two ternary complexes of BphK were solved to a resolution of 2.1 angstrom. In the BphK-GSH-HOPDA complex, GSH and HOPDA molecules occupy the G- and H-subsites, respectively. The thiol nucleophile of the GSH molecule is positioned for S(N)2 attack at carbon 3 of the bound HOPDA. The respective sulfur atoms of conserved Cys-10 and the bound GSH are within 3.0 angstrom, consistent with product release and the formation of a mixed disulfide intermediate. In the BphK-(GSH)(2) complex, a GSH molecule occupies each of the two subsites. The three sulfur atoms of the two GSH molecules and Cys-10 are aligned suitably for a disulfide exchange reaction that would regenerate the resting enzyme and yield disulfide-linked GSH molecules. A second conserved residue, His-106, is adjacent to the thiols of Cys-10 and the GSH bound to the G-subsite and thus may stabilize a transition state in the disulfide exchange reaction. Overall, the structures support and elaborate a proposed dehalogenation mechanism for BphK and provide insight into the plasticity of the H-subsite.	Univ British Columbia, Inst Life Sci, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Murphy, MEP (corresponding author), Univ British Columbia, Inst Life Sci, Dept Microbiol & Immunol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	michael.murphy@ubc.ca	Eltis, Lindsay D/J-8272-2015; Murphy, Michael/R-6805-2017	Eltis, Lindsay D/0000-0002-6774-8158; Murphy, Michael/0000-0003-2589-0014; Fortin, Pascal/0000-0001-9796-791X				Allocati N, 2000, BIOCHEM J, V351, P341, DOI 10.1042/0264-6021:3510341; Allocati N, 2006, BIOCHEM J, V394, P11, DOI 10.1042/BJ20051367; Anandarajah K, 2000, BIOCHEMISTRY-US, V39, P5303, DOI 10.1021/bi9923813; ARCA P, 1990, FEBS LETT, V263, P77, DOI 10.1016/0014-5793(90)80709-R; Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bartels F, 1999, MICROBIOL-SGM, V145, P2821, DOI 10.1099/00221287-145-10-2821; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURGI HB, 1974, TETRAHEDRON, V30, P1563, DOI 10.1016/S0040-4020(01)90678-7; Casalone E, 1998, FEBS LETT, V423, P122, DOI 10.1016/S0014-5793(98)00080-5; CATELANI D, 1974, BIOCHEM J, V143, P431, DOI 10.1042/bj1430431; DeLano W.L, PYMOL MOL GRAPHICS S; DIILIO C, 1988, BIOCHEM J, V255, P971, DOI 10.1042/bj2550971; DIRR H, 1994, EUR J BIOCHEM, V220, P645, DOI 10.1111/j.1432-1033.1994.tb18666.x; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Fortin PD, 2006, J BACTERIOL, V188, P4424, DOI 10.1128/JB.01849-05; Furukawa K, 2000, J GEN APPL MICROBIOL, V46, P283, DOI 10.2323/jgam.46.283; Gilmartin N, 2005, FEMS MICROBIOL LETT, V249, P23, DOI 10.1016/j.femsle.2005.05.056; Hall A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [citeulike-article-id:691774, DOI 10.1021/BK-1999-0734.CH008]; HOFER B, 1994, GENE, V144, P9, DOI 10.1016/0378-1119(94)90196-1; IIZUKA M, 1989, J BACTERIOL, V171, P6039, DOI 10.1128/jb.171.11.6039-6042.1989; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kiefer PM, 2002, BIOCHEMISTRY-US, V41, P1315, DOI 10.1021/bi0117504; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; MANNERVIK B, 1988, CRC CR REV BIOCH MOL, V23, P283, DOI 10.3109/10409238809088226; Masai E, 2003, J BACTERIOL, V185, P1768, DOI 10.1128/JB.185.6.1768-1775.2003; Masai E, 1999, J IND MICROBIOL BIOT, V23, P364, DOI 10.1038/sj.jim.2900747; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishida M, 1998, J MOL BIOL, V281, P135, DOI 10.1006/jmbi.1998.1927; Oakley AJ, 2005, CURR OPIN STRUC BIOL, V15, P716, DOI 10.1016/j.sbi.2005.10.005; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perito B, 1996, BIOCHEM J, V318, P157, DOI 10.1042/bj3180157; Polekhina G, 2001, BIOCHEMISTRY-US, V40, P1567, DOI 10.1021/bi002249z; Rossjohn J, 1998, STRUCT FOLD DES, V6, P721, DOI 10.1016/S0969-2126(98)00074-4; Seah SYK, 2000, J BIOL CHEM, V275, P15701, DOI 10.1074/jbc.275.21.15701; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vuilleumier S, 2002, APPL MICROBIOL BIOT, V58, P138, DOI 10.1007/s00253-001-0836-0; Vuilleumier S, 1997, J BACTERIOL, V179, P1431, DOI 10.1128/jb.179.5.1431-1441.1997; Warner JR, 2005, BIOCHEMISTRY-US, V44, P10360, DOI 10.1021/bi050666b; WILCE MCJ, 1994, BBA-PROTEIN STRUCT M, V1205, P1, DOI 10.1016/0167-4838(94)90086-8; Yeates TO, 1997, METHOD ENZYMOL, V276, P344, DOI 10.1016/S0076-6879(97)76068-3	45	21	23	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30933	30940		10.1074/jbc.M603125200	http://dx.doi.org/10.1074/jbc.M603125200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16920719	hybrid			2022-12-27	WOS:000241075900069
J	Banci, L; Bertini, I; Cantini, F; DellaMalva, N; Herrmann, T; Rosato, A; Wurthrich, K				Banci, Lucia; Bertini, Ivano; Cantini, Francesca; DellaMalva, Nunzia; Herrmann, Torsten; Rosato, Antonio; Wuerthrich, Kurt			Solution structure and intermolecular interactions of the third metal-binding domain of ATP7A, the Menkes disease protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMR STRUCTURE DETERMINATION; TORSION ANGLE DYNAMICS; P-TYPE ATPASE; COPPER CHAPERONE; BACKBONE DYNAMICS; CATALYTIC-ACTIVITY; BACILLUS-SUBTILIS; TRANSPORT; IDENTIFICATION; TRAFFICKING	The third metal-binding domain of the human Menkes protein (MNK3), a copper(I)-transporting ATPase, has been expressed in Escherichia coli and characterized in solution. The solution structure of MNK3, its copper(I)-binding properties, and its interaction with the physiological partner, HAH1, have been studied. MNK3is the domain most dissimilar in structure from the other domains of the Menkes protein. This is reflected in a significant rearrangement of the last strand of the four-stranded beta-sheet when compared with the other known homologous proteins or protein domains. MNK3 is also peculiar with respect to its interaction with the copper(I) ion, as it was found to be a comparatively weak binder. Copper(I) transfer from metal-loaded HAH1 was observed experimentally, but the metal distribution was shifted toward binding by HAH1. This is at variance with what is observed for the other Menkes domains.	Univ Florence, Magnet Resonance Ctr, I-50019 Sesto Fiorentino, Italy; Univ Florence, Dept Chem, I-50019 Sesto Fiorentino, Italy; FiorGen Fdn, I-50019 Sesto Fiorentino, Italy; Eidgenossiche Tech Hochschule Zurich, Inst Molekularbiol & Biophys, CH-8093 Zurich, Switzerland; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	University of Florence; University of Florence; Scripps Research Institute	Bertini, I (corresponding author), Univ Florence, Magnet Resonance Ctr, Via L Sacconi 6, I-50019 Sesto Fiorentino, Italy.	ivanobertini@cerm.unifi.it	Rosato, Antonio/D-8548-2011; Rosato, Antonio/M-3250-2019; Cantini, Francesca/O-1220-2015; Herrmann, Torsten/B-9978-2008	Rosato, Antonio/0000-0001-6172-0368; Rosato, Antonio/0000-0001-6172-0368; Cantini, Francesca/0000-0003-0526-6732; Wuthrich, Kurt/0000-0001-8739-6965; Herrmann, Torsten/0000-0003-2115-4781; BANCI, LUCIA/0000-0003-0562-5774				Achila D, 2006, P NATL ACAD SCI USA, V103, P5729, DOI 10.1073/pnas.0504472103; Arnesano F, 2002, GENOME RES, V12, P255, DOI 10.1101/gr.196802; Arnesano F, 2001, J BIOL CHEM, V276, P41365, DOI 10.1074/jbc.M104807200; Banci L, 2005, J BIOL CHEM, V280, P38259, DOI 10.1074/jbc.M506219200; Banci L, 2005, J MOL BIOL, V352, P409, DOI 10.1016/j.jmb.2005.07.034; Banci L, 2005, FEBS J, V272, P865, DOI 10.1111/j.1742-4658.2004.04526.x; Banci L, 2004, BIOCHEMISTRY-US, V43, P3396, DOI 10.1021/bi036042s; Banci L, 2003, ACCOUNTS CHEM RES, V36, P215, DOI 10.1021/ar010120r; Banci L, 2003, J MOL BIOL, V331, P473, DOI 10.1016/S0022-2836(03)00769-1; Banci L, 2003, BIOCHEMISTRY-US, V42, P1939, DOI 10.1021/bi027096p; Banci L, 2006, NAT CHEM BIOL, V2, P367, DOI 10.1038/nchembio797; BULL PC, 1994, TRENDS GENET, V10, P246, DOI 10.1016/0168-9525(94)90172-4; CASE DA, 2004, AMBER 8 0; DeSilva TM, 2005, PROTEINS, V61, P1038, DOI 10.1002/prot.20639; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Gitschier J, 1998, NAT STRUCT BIOL, V5, P47, DOI 10.1038/nsb0198-47; Goodyer ID, 1999, HUM MOL GENET, V8, P1473, DOI 10.1093/hmg/8.8.1473; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Harrison MD, 2000, TRENDS BIOCHEM SCI, V25, P29, DOI 10.1016/S0968-0004(99)01492-9; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Huffman DL, 2000, J BIOL CHEM, V275, P18611, DOI 10.1074/jbc.C000172200; Huster D, 2003, J BIOL CHEM, V278, P32212, DOI 10.1074/jbc.M305408200; Ishima R, 2000, NAT STRUCT BIOL, V7, P740, DOI 10.1038/78963; Jones CE, 2003, J STRUCT BIOL, V143, P209, DOI 10.1016/j.jsb.2003.08.008; Klomp LWJ, 1997, J BIOL CHEM, V272, P9221, DOI 10.1074/jbc.272.14.9221; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Linder M, 1991, BIOCH COPPER; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; O'Halloran TV, 2000, J BIOL CHEM, V275, P25057, DOI 10.1074/jbc.R000006200; Petris MJ, 1996, EMBO J, V15, P6084, DOI 10.1002/j.1460-2075.1996.tb00997.x; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; Puig S, 2002, CURR OPIN CHEM BIOL, V6, P171, DOI 10.1016/S1367-5931(02)00298-3; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Rosenzweig AC, 2001, ACCOUNTS CHEM RES, V34, P119, DOI 10.1021/ar000012p; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Strausak D, 2003, J BIOL CHEM, V278, P20821, DOI 10.1074/jbc.M212437200; van Dongen EMWM, 2004, BIOCHEM BIOPH RES CO, V323, P789, DOI 10.1016/j.bbrc.2004.08.160; Voskoboinik I, 2001, J BIOL CHEM, V276, P28620, DOI 10.1074/jbc.M103532200; Voskoboinik N, 1999, J BIOL CHEM, V274, P22008, DOI 10.1074/jbc.274.31.22008; VULPE CD, 1995, ANNU REV NUTR, V15, P293, DOI 10.1146/annurev.nu.15.070195.001453; Walker JM, 2004, J BIOL CHEM, V279, P15376, DOI 10.1074/jbc.M400053200; Wimmer R, 1999, J BIOL CHEM, V274, P22597, DOI 10.1074/jbc.274.32.22597; WISHART DS, 1994, J BIOMOL NMR, V4, P171	46	33	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					29141	29147		10.1074/jbc.M603176200	http://dx.doi.org/10.1074/jbc.M603176200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16873374	hybrid			2022-12-27	WOS:000240680500068
J	Rosengren, KJ; Daly, NL; Fornander, LM; Jonsson, LMH; Shirafuji, Y; Qu, XQ; Vogel, HJ; Ouellette, AJ; Craik, DJ				Rosengren, K. Johan; Daly, Norelle L.; Fornander, Liselotte M.; Jonsson, Linda M. H.; Shirafuji, Yoshinori; Qu, Xiaoqing; Vogel, Hans J.; Ouellette, Andre J.; Craik, David J.			Structural and functional characterization of the conserved salt bridge in mammalian Paneth cell alpha-defensins - Solution structures of mouse cryptdin-4 AND (E15D)-cryptdin-4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMR STRUCTURE CALCULATION; MEMBRANE PERMEABILIZATION; TEMPERATURE COEFFICIENTS; ANTIMICROBIAL PEPTIDES; DISULFIDE ARRAY; SMALL-INTESTINE; HOST-DEFENSE; AMINO-ACIDS; GERM-FREE; NEUTROPHILS	alpha-Defensins are mediators of mammalian innate immunity, and knowledge of their structure-function relationships is essential for understanding their mechanisms of action. We report here the NMR solution structures of the mouse Paneth cell alpha-defensin cryptdin-4 (Crp4) and a mutant (E15D)-Crp4 peptide, in which a conserved Glu(15) residue was replaced by Asp. Structural analysis of the two peptides confirms the involvement of this Glu in a conserved salt bridge that is removed in the mutant because of the shortened side chain. Despite disruption of this structural feature, the peptide variant retains a well defined native fold because of a rearrangement of side chains, which result in compensating favorable interactions. Furthermore, salt bridge-deficient Crp4 mutants were tested for bactericidal effects and resistance to proteolytic degradation, and all of the variants had similar bactericidal activities and stability to proteolysis. These findings support the conclusion that the function of the conserved salt bridge in Crp4 is not linked to bactericidal activity or proteolytic stability of the mature peptide.	Univ Kalmar, Dept Chem & Biomed Sci, SE-39182 Kalmar, Sweden; Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; Univ Queensland, Australian Res Council, Special Res Ctr Funct & Appl Genom, Brisbane, Qld 4072, Australia; Univ Calif Irvine, Sch Med, Dept Pathol & Lab Med, Irvine, CA 92697 USA; Univ Calif Irvine, Sch Med, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA; Univ Calgary, Dept Biol Sci, Struct Biol Res Grp, Calgary, AB T2N 1N4, Canada	Linnaeus University; University of Kalmar; University of Queensland; University of Queensland; University of California System; University of California Irvine; University of California System; University of California Irvine; University of Calgary	Rosengren, KJ (corresponding author), Univ Kalmar, Dept Chem & Biomed Sci, SE-39182 Kalmar, Sweden.	johan.rosengren@hik.se	Daly, Norelle L/D-4302-2013; Haugaard-Kedstrom, Linda/F-3705-2011; Rosengren, K. Johan/P-4450-2016; Craik, David/B-1695-2010; Haugaard-Kedstrom, Linda/O-7121-2014	Daly, Norelle L/0000-0002-4697-6602; Haugaard-Kedstrom, Linda/0000-0003-0113-6535; Rosengren, K. Johan/0000-0002-5007-8434; Craik, David/0000-0003-0007-6796; Haugaard-Kedstrom, Linda/0000-0003-0113-6535	NIDDK NIH HHS [DK44632] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R55DK044632, R01DK044632] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ayabe T, 2002, J BIOL CHEM, V277, P5219, DOI 10.1074/jbc.M109410200; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Bateman A, 1996, J BIOL CHEM, V271, P10654, DOI 10.1074/jbc.271.18.10654; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUNDI A, 1979, BIOPOLYMERS, V18, P285, DOI 10.1002/bip.1979.360180206; Cierpicki T, 2001, J BIOMOL NMR, V21, P249, DOI 10.1023/A:1012911329730; Cierpicki T, 2002, J MAGN RESON, V157, P178, DOI 10.1006/jmre.2002.2597; GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; HILL CP, 1991, SCIENCE, V251, P1481, DOI 10.1126/science.2006422; Jing WG, 2004, BIOCHEMISTRY-US, V43, P15759, DOI 10.1021/bi048645p; JONES DE, 1992, J BIOL CHEM, V267, P23216; Joshi MD, 1997, PROTEIN SCI, V6, P2667; Keller R., 2004, COMPUTER AIDED RESON, V1; LEHRER RI, 1988, J IMMUNOL METHODS, V108, P153, DOI 10.1016/0022-1759(88)90414-0; Linge JP, 1999, J BIOMOL NMR, V13, P51, DOI 10.1023/A:1008365802830; Maemoto A, 2004, J BIOL CHEM, V279, P44188, DOI 10.1074/jbc.M406154200; MATTHEW JB, 1985, CRC CR REV BIOCH MOL, V18, P91, DOI 10.3109/10409238509085133; McManus AM, 2000, BIOCHEMISTRY-US, V39, P15757, DOI 10.1021/bi000457l; OUELLETTE AJ, 1992, FEBS LETT, V304, P146, DOI 10.1016/0014-5793(92)80606-H; OUELLETTE AJ, 1994, INFECT IMMUN, V62, P5040, DOI 10.1128/IAI.62.11.5040-5047.1994; PARDI A, 1988, J MOL BIOL, V201, P625, DOI 10.1016/0022-2836(88)90643-2; PARDI A, 1992, BIOCHEMISTRY-US, V31, P11357, DOI 10.1021/bi00161a013; Rosengren KJ, 2003, J BIOL CHEM, V278, P8606, DOI 10.1074/jbc.M211147200; Salzman NH, 2003, INFECT IMMUN, V71, P1109, DOI 10.1128/IAI.71.3.1109-1115.2003; Satchell DP, 2003, PEPTIDES, V24, P1795, DOI 10.1016/j.peptides.2003.08.020; Satchell DP, 2003, J BIOL CHEM, V278, P13838, DOI 10.1074/jbc.M212115200; SATOH Y, 1986, DIGESTION, V34, P115, DOI 10.1159/000199319; SATOH Y, 1988, CELL TISSUE RES, V251, P87, DOI 10.1007/BF00215451; Selsted M E, 1993, Genet Eng (N Y), V15, P131; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; SELSTED ME, 1989, J BIOL CHEM, V264, P4003; Shirafuji Y, 2003, J BIOL CHEM, V278, P7910, DOI 10.1074/jbc.M210600200; TANG YQ, 1993, J BIOL CHEM, V268, P6649; Tang YQ, 1999, SCIENCE, V286, P498, DOI 10.1126/science.286.5439.498; WAGNER G, 1990, PROG NUCL MAG RES SP, V22, P101, DOI 10.1016/0079-6565(90)80003-Z; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Wu ER, 1998, PEPTIDES, V19, P793, DOI 10.1016/S0196-9781(98)00016-3; Wu ZB, 2005, J BIOL CHEM, V280, P43039, DOI 10.1074/jbc.M510562200; Xie C, 2005, J BIOL CHEM, V280, P32921, DOI 10.1074/jbc.M503084200	42	37	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					28068	28078		10.1074/jbc.M604992200	http://dx.doi.org/10.1074/jbc.M604992200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16857681	hybrid			2022-12-27	WOS:000240534400044
J	Berasi, SP; Huard, C; Li, DM; Shih, HH; Sun, Y; Zhong, WY; Paulsen, JE; Brown, EL; Gimeno, RE; Martinez, RV				Berasi, Stephen P.; Huard, Christine; Li, Dongmei; Shih, Heather H.; Sun, Ying; Zhong, Wenyan; Paulsen, Janet E.; Brown, Eugene L.; Gimeno, Ruth E.; Martinez, Robert V.			Inhibition of gluconeogenesis through transcriptional activation of EGR1 and DUSP4 by AMP-activated kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL-COA CARBOXYLASE; PROTEIN-KINASE; INSULIN-RESISTANCE; GENE-EXPRESSION; CELLULAR-ENERGY; GLUCOSE; PHOSPHORYLATION; LIVER; GROWTH; PEPCK	Increased hepatic gluconeogenesis is an important contributor to the fasting hyperglycemia found in Type 2 diabetic patients. Low energy states activate the intracellular energy sensor AMP-activated kinase (AMPK). AMPK activation by the AMP mimetic AICAR (5-aminoimidazole-4-carboxamide riboside) has been shown to inhibit hepatic gluconeogenesis. We used transcriptional profiling to search for AICAR-regulated genes in hepatocyte cell lines. We report that a dual specificity phosphatase, Dusp4, is induced by AMPK in AML12, H4IIE, and Fao cells at both mRNA and protein levels. AMPK also induces the immediate early transcription factor Egr1 (early growth response 1), a known transcriptional activator of Dusp4, and it directly binds the Dusp4 promoter at its known binding site. Both reporter gene assays and real time PCR demonstrate that exogenous DUSP4 inhibits the promoter activity and expression of both glucose-6-phosphatase (Glc-6-P) and phosphoenolpyruvate carboxykinase (Pepck) to an extent similar to both AICAR and constitutively active AMPK. Conversely, depletion of EGR1 or DUSP4 using siRNA not only partially abrogates the inhibition of Pepck expression by AICAR, but also importantly affects glucose production by Fao cells. In Fao cells, small interfering RNA targeted EGR1 also depletes DUSP4 expression following treatment with AICAR, further supporting a direct link between EGR1 and DUSP4 activation. Expression of a constitutively active form of p38, a known effector of cAMP-mediated gluconeogenesis, rescues the DUSP4-mediated repression of PEPCK. These results suggest that the inhibition of hepatic gluconeogenesis by AMPK may, in part, be mediated by an immediate early gene response involving EGR1 and its target, DUSP4.	Wyeth Ayerst Res, Dept Biol Technol, Cambridge, MA 02140 USA; Wyeth Ayerst Res, Dept Cardiovasc & Metab Dis, Cambridge, MA 02140 USA	Pfizer; Pfizer	Martinez, RV (corresponding author), Wyeth Ayerst Res, Dept Biol Technol, 87 Cambridgepk Dr, Cambridge, MA 02140 USA.	rxmartinez@wyeth.com						Andreelli F, 2006, ENDOCRINOLOGY, V147, P2432, DOI 10.1210/en.2005-0898; Banerjee RR, 2004, SCIENCE, V303, P1195, DOI 10.1126/science.1092341; Cao WH, 2005, J BIOL CHEM, V280, P42731, DOI 10.1074/jbc.M506223200; Chen PL, 2001, J BIOL CHEM, V276, P29440, DOI 10.1074/jbc.M103463200; Chu YF, 1996, J BIOL CHEM, V271, P6497, DOI 10.1074/jbc.271.11.6497; CLARKE PR, 1990, EMBO J, V9, P2439, DOI 10.1002/j.1460-2075.1990.tb07420.x; Foretz M, 2005, DIABETES, V54, P1331, DOI 10.2337/diabetes.54.5.1331; Foretz M, 1998, J BIOL CHEM, V273, P14767, DOI 10.1074/jbc.273.24.14767; GUAN KL, 1995, J BIOL CHEM, V270, P7197, DOI 10.1074/jbc.270.13.7197; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hong YH, 2003, J BIOL CHEM, V278, P27495, DOI 10.1074/jbc.M304112200; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jakobsen SN, 2001, J BIOL CHEM, V276, P46912, DOI 10.1074/jbc.C100483200; Jorgensen SB, 2004, DIABETES, V53, P3074, DOI 10.2337/diabetes.53.12.3074; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kawaguchi T, 2001, P NATL ACAD SCI USA, V98, P13710, DOI 10.1073/pnas.231370798; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Kotlyarov A, 2002, MOL CELL BIOL, V22, P4827, DOI 10.1128/MCB.22.13.4827-4835.2002; Leff T, 2003, BIOCHEM SOC T, V31, P224; Levkovitz Y, 2002, J NEUROSCI, V22, P3845, DOI 10.1523/JNEUROSCI.22-10-03845.2002; Lochhead PA, 2000, DIABETES, V49, P896, DOI 10.2337/diabetes.49.6.896; Moller DE, 2001, NATURE, V414, P821, DOI 10.1038/414821a; MUNDAY MR, 1988, EUR J BIOCHEM, V175, P331, DOI 10.1111/j.1432-1033.1988.tb14201.x; Muse ED, 2004, J CLIN INVEST, V114, P232, DOI 10.1172/JCI200421270; Nakatani Y, 2004, J BIOL CHEM, V279, P45803, DOI 10.1074/jbc.M406963200; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Stein CJ, 2004, J CLIN ENDOCR METAB, V89, P2522, DOI 10.1210/jc.2004-0288; Sutherland C, 1996, PHILOS T ROY SOC B, V351, P191, DOI 10.1098/rstb.1996.0016; Vincent MF, 1996, DIABETOLOGIA, V39, P1148, DOI 10.1007/BF02658500; Winder WW, 1997, J APPL PHYSIOL, V82, P219, DOI 10.1152/jappl.1997.82.1.219; Woods A, 2000, MOL CELL BIOL, V20, P6704, DOI 10.1128/MCB.20.18.6704-6711.2000; Wu Chaodong, 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P51, DOI 10.2174/1568008053174769; Xu HY, 2005, J BIOL CHEM, V280, P36013, DOI 10.1074/jbc.M508027200; Xu HY, 2003, J BIOL CHEM, V278, P30187, DOI 10.1074/jbc.M302010200; Yang WB, 2001, J BIOL CHEM, V276, P38341, DOI 10.1074/jbc.C100316200; Yu JX, 2004, MOL CELL, V15, P83, DOI 10.1016/j.molcel.2004.06.030; Zhang T, 2001, J BIOL CHEM, V276, P45604, DOI 10.1074/jbc.M107075200	38	65	66	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2006	281	37					27167	27177		10.1074/jbc.M602416200	http://dx.doi.org/10.1074/jbc.M602416200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082PB	16849326	hybrid			2022-12-27	WOS:000240397700044
J	Veit, G; Hansen, U; Keene, DR; Bruckner, P; Chiquet-Ehrismann, R; Chiquet, M; Koch, M				Veit, Guido; Hansen, Uwe; Keene, Douglas R.; Bruckner, Peter; Chiquet-Ehrismann, Ruth; Chiquet, Matthias; Koch, Manuel			Collagen XII interacts with Avian tenascin-X through its NC3 domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE-SPECIFIC EXPRESSION; EHLERS-DANLOS-SYNDROME; CHICK MYOTENDINOUS ANTIGEN; OLIGOMERIC MATRIX PROTEIN; EXTRACELLULAR-MATRIX; EMBRYONIC-DEVELOPMENT; SPLICE VARIANTS; CELL-ADHESION; IX COLLAGEN; VI COLLAGEN	Large oligomeric proteins often contain several binding sites for different molecules and can therefore induce formation of larger protein complexes. Collagen XII, a multidomain protein with a small collagenous region, interacts with fibrillar collagens through its C-terminal region. However, no interactions to other extracellular proteins have been identified involving the non-collagenous N-terminal NC3 domain. To further elucidate the components of protein complexes present close to collagen fibrils, different extracellular matrix proteins were tested for interaction in a solid phase assay. Binding to the NC3 domain of collagen XII was found for the avian homologue of tenascin-X that in humans is linked to Ehlers-Danlos disease. The binding was further characterized by surface plasmon resonance spectroscopy and supported by immunohistochemical co-localization in chick and mouse tissue. On the ultrastructural level, detection of collagen XII and tenascin-X by immunogold labeling confirmed this finding.	Univ Cologne, Fac Med, Ctr Biochem, D-50931 Cologne, Germany; Univ Cologne, Fac Med, Dept Dermatol, D-50931 Cologne, Germany; Univ Cologne, Fac Med, Ctr Mol Med Cologne, D-50931 Cologne, Germany; Univ Klinikum Munster, Inst Physiol Chem & Pathobiochem, D-48129 Munster, Germany; Shriners Hosp Children, Res Ctr, Portland, OR 97239 USA; Friedrich Miescher Inst, CH-4002 Basel, Switzerland	University of Cologne; University of Cologne; University of Cologne; University of Munster; Friedrich Miescher Institute for Biomedical Research	Koch, M (corresponding author), Univ Cologne, Fac Med, Ctr Biochem, Joseph Stelzmann Str 52, D-50931 Cologne, Germany.	Manuel.Koch@uni-koeln.de	Bruckner, Peter/F-4817-2019; Veit, Guido/C-9596-2009; Koch, Manuel/AAG-9914-2021	Bruckner, Peter/0000-0002-5566-5611; Veit, Guido/0000-0002-6758-2696; Koch, Manuel/0000-0002-2962-7814; Chiquet, Matthias/0000-0001-7812-4853				Aubert-Foucher E, 2001, BIOCHEM BIOPH RES CO, V286, P1131, DOI 10.1006/bbrc.2001.5522; BOHME K, 1995, DEV DYNAM, V204, P432; Bristow J, 2005, AM J MED GENET C, V139C, P24, DOI 10.1002/ajmg.c.30071; Budde B, 2005, MOL CELL BIOL, V25, P10465, DOI 10.1128/MCB.25.23.10465-10478.2005; Burch GH, 1997, NAT GENET, V17, P104, DOI 10.1038/ng0997-104; CHIQUET M, 1984, J CELL BIOL, V98, P1937, DOI 10.1083/jcb.98.6.1937; CHIQUET M, 1984, J CELL BIOL, V98, P1926, DOI 10.1083/jcb.98.6.1926; Elefteriou F, 1999, EUR J BIOCHEM, V263, P840, DOI 10.1046/j.1432-1327.1999.00563.x; Elefteriou F, 2001, FEBS LETT, V495, P44, DOI 10.1016/S0014-5793(01)02361-4; FASSLER R, 1994, P NATL ACAD SCI USA, V91, P5070, DOI 10.1073/pnas.91.11.5070; Fluck M, 2000, J CELL SCI, V113, P3583; Font B, 1998, EUR J BIOCHEM, V254, P580, DOI 10.1046/j.1432-1327.1998.2540580.x; GORDON MK, 1987, P NATL ACAD SCI USA, V84, P6040, DOI 10.1073/pnas.84.17.6040; Groenen MAM, 2000, GENOME RES, V10, P137; Hagios C, 1999, EXP CELL RES, V253, P607, DOI 10.1006/excr.1999.4658; Hagios C, 1996, J CELL BIOL, V134, P1499, DOI 10.1083/jcb.134.6.1499; Holden P, 2001, J BIOL CHEM, V276, P6046, DOI 10.1074/jbc.M009507200; JONES FS, 1989, P NATL ACAD SCI USA, V86, P1905, DOI 10.1073/pnas.86.6.1905; Jones FS, 2000, DEV DYNAM, V218, P235, DOI 10.1002/(SICI)1097-0177(200006)218:2<235::AID-DVDY2>3.3.CO;2-7; Kania AM, 1999, J BIOL CHEM, V274, P22053, DOI 10.1074/jbc.274.31.22053; Kapyla J, 2004, J BIOL CHEM, V279, P51677, DOI 10.1074/jbc.M409412200; Kassner A, 2003, MATRIX BIOL, V22, P131, DOI 10.1016/S0945-053X(03)00008-8; KEENE DR, 1991, J CELL BIOL, V113, P971, DOI 10.1083/jcb.113.4.971; KOCH M, 1992, EUR J BIOCHEM, V207, P847, DOI 10.1111/j.1432-1033.1992.tb17116.x; KOCH M, 1995, J CELL BIOL, V130, P1005, DOI 10.1083/jcb.130.4.1005; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lethias C, 1996, MATRIX BIOL, V15, P11, DOI 10.1016/S0945-053X(96)90122-5; Lethias C, 2001, J BIOL CHEM, V276, P16432, DOI 10.1074/jbc.M010210200; Mao JR, 2002, NAT GENET, V30, P421, DOI 10.1038/ng850; MATSUMOTO K, 1994, J CELL BIOL, V125, P483, DOI 10.1083/jcb.125.2.483; Minamitani T, 2004, EXP CELL RES, V298, P305, DOI 10.1016/j.yexcr.2004.04.030; Minamitani T, 2004, EXP CELL RES, V297, P49, DOI 10.1016/j.yexcr.2004.03.002; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; NISHIYAMA T, 1994, J BIOL CHEM, V269, P28193; Nolte M, 1999, FEBS LETT, V452, P379, DOI 10.1016/S0014-5793(99)00666-3; OH SP, 1993, DEV DYNAM, V196, P37, DOI 10.1002/aja.1001960105; Pihlajamaa T, 2004, J BIOL CHEM, V279, P24265, DOI 10.1074/jbc.M402865200; SAKAI LY, 1994, METHOD ENZYMOL, V245, P29; SHAW LM, 1991, TRENDS BIOCHEM SCI, V16, P191, DOI 10.1016/0968-0004(91)90074-6; TRUEB J, 1992, BIOCHIM BIOPHYS ACTA, V1171, P97, DOI 10.1016/0167-4781(92)90145-P; Veit G, 2006, J BIOL CHEM, V281, P3494, DOI 10.1074/jbc.M509333200; WALCHLI C, 1994, J CELL SCI, V107, P669; YAMAGATA M, 1991, J CELL BIOL, V115, P209, DOI 10.1083/jcb.115.1.209	43	76	77	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2006	281	37					27461	27470		10.1074/jbc.M603147200	http://dx.doi.org/10.1074/jbc.M603147200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082PB	16861231	hybrid			2022-12-27	WOS:000240397700073
J	Locatelli-Hoops, S; Remmel, N; Klingenstein, R; Breiden, B; Rossocha, M; Schoeniger, M; Koenigs, C; Saenger, W; Sandhoff, K				Locatelli-Hoops, Silvia; Remmel, Natascha; Klingenstein, Ralf; Breiden, Bernadette; Rossocha, Maksim; Schoeniger, Maike; Koenigs, Christine; Saenger, Wolfram; Sandhoff, Konrad			Saposin A mobilizes lipids from low cholesterol and high bis(monoacylglycerol) phosphate-containing membranes - Patient variant Saposin A lacks lipid extraction capacity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSYLCERAMIDE BETA-GLUCOSIDASE; ACTIVATOR PROTEIN GENE; NIEMANN-PICK-DISEASE; GAUCHERS-DISEASE; PROSAPOSIN GENE; DEGRADATION; DEFICIENCY; MUTATION; BINDING; RECONSTITUTION	Saposin A (Sap-A) is one of five known sphingolipid activator proteins required for the lysosomal degradation of sphingolipids and for the loading of lipid antigens onto antigen-presenting molecules of the CD1 type. Sap-A assists in the degradation of galactosylceramide by galactosylceramide-beta-galactosidase in vivo, which takes place at the surface of intraendosomal/intralysosomal vesicles. Sap-A is believed to mediate the interaction between the enzyme and its membrane-bound substrate. Its dysfunction causes a variant form of Krabbe disease. In the present study we prepared glycosylated Sap-A free of other Saps, taking advantage of the Pichia pastoris expression system. Using liposomes and surface plasmon resonance spectroscopy, we tested the binding and lipid mobilization capacity of Sap-A under different conditions. Along the endocytic pathway, the pH value decreases, and the lipid composition of intraendosomal and intralysosomal membranes changes drastically. In the inner membranes the cholesterol concentration decreases, and that of the anionic phospholipid bis(monoacylglycero) phosphate increases. Here, we show that Sap-A is able to bind to liposomes and to mobilize lipids out of them at acidic pH values below pH 4.7. Low cholesterol levels and increasing concentrations of bis(monoacylglycero)phosphate favor lipid extraction significantly. Galactosylceramide as a bilayer component is not essential for lipid mobilization by Sap-A, which requires intact disulfide bridges for activity. We also show for the first time that glycosylation of Sap-A is essential for its lipid extraction activity. Variant Sap-A proteins, which cause storage of galactosylceramide in humans (Krabbe disease, Spiegel, R., Bach, G., Sury, V., Mengistu, G., Meidan, B., Shalev, S., Shneor, Y., Mandel, H., and Zeigler, M. (2005) Mol. Genet. Metab. 84, 160-166) and in mutant mice (Matsuda, J., Vanier, M. T., Saito, Y., Tohyama, J., and Suzuki, K. (2001) Hum. Mol. Genet. 10, 1191-1199) are deficient in lipid extraction capacity.	Kekule Inst Organ Chem & Biochem, D-53121 Bonn, Germany; Free Univ Berlin, Inst Chem, Abt Kristallog, D-14195 Berlin, Germany	University of Bonn; Free University of Berlin	Sandhoff, K (corresponding author), Kekule Inst Organ Chem & Biochem, Gerhard Domagk Str 1, D-53121 Bonn, Germany.	sandhoff@uni-bonn.de	Breiden, Bernadette/F-2422-2014; Breiden, Bernadette/S-3005-2019	Breiden, Bernadette/0000-0002-4838-4109; Breiden, Bernadette/0000-0002-4838-4109; Rossmann, Maxim/0000-0001-8811-3277				BERENT SL, 1981, BIOCHIM BIOPHYS ACTA, V664, P572, DOI 10.1016/0005-2760(81)90134-X; Bitto E, 2000, BIOCHEMISTRY-US, V39, P13469, DOI 10.1021/bi001275u; BLEISTEIN J, 1980, H-S Z PHYSIOL CHEM, V361, P595; BOHLEY P, 1992, EXPERIENTIA, V48, P151, DOI 10.1007/BF01923508; BRADOVA V, 1993, HUM GENET, V92, P143, DOI 10.1007/BF00219682; Burkhardt JK, 1997, EUR J CELL BIOL, V73, P10; CHRISTOMANOU H, 1989, KLIN WOCHENSCHR, V67, P999, DOI 10.1007/BF01716064; CHRISTOMANOU H, 1986, BIOL CHEM H-S, V367, P879, DOI 10.1515/bchm3.1986.367.2.879; Chu ZT, 2005, EXP CELL RES, V303, P300, DOI 10.1016/j.yexcr.2004.09.029; Cooper MA, 2000, ANAL BIOCHEM, V277, P196, DOI 10.1006/abio.1999.4389; Fujita N, 1996, HUM MOL GENET, V5, P711, DOI 10.1093/hmg/5.6.711; HAJRA AK, 1966, J LIPID RES, V7, P379; Harzer K, 2003, FEBS LETT, V537, P177, DOI 10.1016/S0014-5793(03)00100-5; HARZER K, 1989, EUR J PEDIATR, V149, P31, DOI 10.1007/BF02024331; Henseler M, 1996, J BIOL CHEM, V271, P8416, DOI 10.1074/jbc.271.14.8416; HO MW, 1971, P NATL ACAD SCI USA, V68, P2810, DOI 10.1073/pnas.68.11.2810; Honing S, 2005, MOL CELL, V18, P519, DOI 10.1016/j.molcel.2005.04.019; KISHIMOTO Y, 1992, J LIPID RES, V33, P1255; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; Kolter T, 2005, ANNU REV CELL DEV BI, V21, P81, DOI 10.1146/annurev.cellbio.21.122303.120013; Kolter T, 2005, J BIOL CHEM, V280, P41125, DOI 10.1074/jbc.R500015200; Lang C, 1995, APPL MICROBIOL BIOT, V44, P147, DOI 10.1007/s002530050533; MACDONALD RC, 1991, BIOCHIM BIOPHYS ACTA, V1061, P297, DOI 10.1016/0005-2736(91)90295-J; Matsuda J, 2001, HUM MOL GENET, V10, P1191, DOI 10.1093/hmg/10.11.1191; Matsuda J, 2004, HUM MOL GENET, V13, P2709, DOI 10.1093/hmg/ddh281; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; Mobius W, 2003, TRAFFIC, V4, P222; MORIMOTO S, 1989, P NATL ACAD SCI USA, V86, P3389, DOI 10.1073/pnas.86.9.3389; MORIMOTO S, 1990, J BIOL CHEM, V265, P1933; Patterson M. C., 2001, METABOLIC MOL BASES, VIII, P3611; Patterson MC, 2003, NEUROLOGIST, V9, P301, DOI 10.1097/01.nrl.0000094627.78754.5b; PONTING CP, 1994, PROTEIN SCI, V3, P359; PRENCE EM, 1995, BIOCHEM J, V310, P571, DOI 10.1042/bj3100571; QI XY, 1994, J BIOL CHEM, V269, P16746; Qi XY, 2001, J BIOL CHEM, V276, P27010, DOI 10.1074/jbc.M101075200; Salvioi R, 2000, FEBS LETT, V472, P17, DOI 10.1016/S0014-5793(00)01417-4; Sandhoff K, 1996, TRENDS CELL BIOL, V6, P98, DOI 10.1016/0962-8924(96)80999-8; Sandhoff K., 2001, METABOLIC ANDMOLECUL, P3371; SARMIENTOS F, 1986, EUR J BIOCHEM, V160, P527, DOI 10.1111/j.1432-1033.1986.tb10071.x; SCHNABEL D, 1992, J BIOL CHEM, V267, P3312; SCHNABEL D, 1991, FEBS LETT, V284, P57, DOI 10.1016/0014-5793(91)80760-Z; Spiegel R, 2005, MOL GENET METAB, V84, P160, DOI 10.1016/j.ymgme.2004.10.004; Stahelin RV, 2001, BIOCHEM J, V359, P679, DOI 10.1042/0264-6021:3590679; STREMMEL W, 1976, H-S Z PHYSIOL CHEM, V357, P803, DOI 10.1515/bchm2.1976.357.1.803; Umebayashi K, 2003, CELL STRUCT FUNCT, V28, P443, DOI 10.1247/csf.28.443; VACCARO AM, 1993, BIOCHIM BIOPHYS ACTA, V1149, P55, DOI 10.1016/0005-2736(93)90024-T; VACCARO AM, 1993, FEBS LETT, V336, P159, DOI 10.1016/0014-5793(93)81631-9; Vaccaro AM, 1995, J BIOL CHEM, V270, P30576, DOI 10.1074/jbc.270.51.30576; Vaccaro AM, 1997, J BIOL CHEM, V272, P16862, DOI 10.1074/jbc.272.27.16862; Vanier MT, 1999, NEUROCHEM RES, V24, P481, DOI 10.1023/A:1022575511354; WENGER DA, 1982, BIOCHIM BIOPHYS ACTA, V712, P639, DOI 10.1016/0005-2760(82)90293-4; Werth N, 2001, J BIOL CHEM, V276, P12685, DOI 10.1074/jbc.M007970200; WHERRETT JR, 1972, J BIOL CHEM, V247, P4114; Wilkening G, 2000, J BIOL CHEM, V275, P35814, DOI 10.1074/jbc.M006568200; Wilkening G, 1998, J BIOL CHEM, V273, P30271, DOI 10.1074/jbc.273.46.30271; Winau F, 2004, NAT IMMUNOL, V5, P169, DOI 10.1038/ni1035; You HX, 2004, CHEM PHYS LIPIDS, V132, P15, DOI 10.1016/j.chemphyslip.2004.09.002; Zhou DP, 2004, SCIENCE, V303, P523, DOI 10.1126/science.1092009	58	57	57	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32451	32460		10.1074/jbc.M607281200	http://dx.doi.org/10.1074/jbc.M607281200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16905746	hybrid			2022-12-27	WOS:000241414500043
J	Tidow, H; Veprintsev, DB; Freund, SMV; Fersht, AR				Tidow, Henning; Veprintsev, Dmitry B.; Freund, Stefan M. V.; Fersht, Alan R.			Effects of oncogenic mutations and DNA response elements on the binding of p53 to p53-binding protein 2 (53BP2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FULL-LENGTH P53; CORE DOMAIN; TUMOR-SUPPRESSOR; MUTANT P53; COOPERATIVE BINDING; APOPTOTIC FUNCTION; CRYSTAL-STRUCTURE; CANCER MUTATIONS; STRUCTURAL BASIS; WILD-TYPE	The tumor suppressor p53 is frequently mutated in human cancers. Upon activation it can induce cell cycle arrest or apoptosis. ASPP2 can specifically stimulate the apoptotic function of p53 but not cell cycle arrest, but the mechanism of enhancing the activation of pro-apoptotic genes over cell cycle arrest genes remains unknown. In this study, we analyzed the binding of 53BP2 (p53-binding protein 2, the C-terminal domain of ASPP2) to p53 core domain and various mutants using biophysical techniques. We found that several p53 core domain mutations (R181E, G245S, R249S, R273H) have different effects on the binding of DNA response elements and 53BP2. Further, we investigated the existence of a ternary complex consisting of 53BP2, p53, and DNA response elements to gain insight into the specific pro-apoptotic activation of p53. We found that binding of 53BP2 and DNA to p53 is mutually exclusive in the case of GADD45, p21, Bax, and PIG3. Both pro-apoptotic and non-apoptotic response elements were competed off p53 by 53BP2 with no indication of a ternary complex.	MRC, Ctr Prot Engn, Cambridge CB2 2QH, England	University of Cambridge	Fersht, AR (corresponding author), MRC, Ctr Prot Engn, Hills Rd, Cambridge CB2 2QH, England.	arf25@cam.ac.uk	Veprintsev, Dmitry B/H-2228-2012; Fersht, Alan R/B-2189-2008; Tidow, Henning/K-3420-2015	Veprintsev, Dmitry B/0000-0002-3583-5409; Tidow, Henning/0000-0002-4702-9332	MRC [MC_U105474168] Funding Source: UKRI; Medical Research Council [MC_U105474168] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ang HC, 2006, J BIOL CHEM, V281, P21934, DOI 10.1074/jbc.M604209200; Baroni TE, 2004, P NATL ACAD SCI USA, V101, P4930, DOI 10.1073/pnas.0401162101; Bates S, 1999, CELL MOL LIFE SCI, V55, P28, DOI 10.1007/s000180050267; Brachmann RK, 1998, EMBO J, V17, P1847, DOI 10.1093/emboj/17.7.1847; Bullock AN, 2000, ONCOGENE, V19, P1245, DOI 10.1038/sj.onc.1203434; Canadillas JMP, 2006, P NATL ACAD SCI USA, V103, P2109, DOI 10.1073/pnas.0510941103; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; CROOK T, 1994, CELL, V79, P817, DOI 10.1016/0092-8674(94)90071-X; Dehner A, 2005, ANGEW CHEM INT EDIT, V44, P5247, DOI 10.1002/anie.200501887; DeLano W.L, PYMOL MOL GRAPHICS S; Ekblad CMS, 2004, PROTEIN SCI, V13, P617, DOI 10.1110/ps.03461404; Fernandez-Fernandez MR, 2005, P NATL ACAD SCI USA, V102, P4735, DOI 10.1073/pnas.0501459102; Friedlander P, 1996, MOL CELL BIOL, V16, P4961; Friedler A, 2005, J BIOL CHEM, V280, P8051, DOI 10.1074/jbc.M411176200; Friedler A, 2005, STRUCTURE, V13, P629, DOI 10.1016/j.str.2005.01.020; Gorina S, 1996, SCIENCE, V274, P1001, DOI 10.1126/science.274.5289.1001; Hainaut P, 2000, ADV CANCER RES, V77, P81; Hansson LO, 2002, P NATL ACAD SCI USA, V99, P10305, DOI 10.1073/pnas.122347199; IWABUCHI K, 1994, P NATL ACAD SCI USA, V91, P6098, DOI 10.1073/pnas.91.13.6098; Joerger AC, 2005, J BIOL CHEM, V280, P16030, DOI 10.1074/jbc.M500179200; Joerger AC, 2004, J BIOL CHEM, V279, P1291, DOI 10.1074/jbc.M309732200; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kitayner M, 2006, MOL CELL, V22, P741, DOI 10.1016/j.molcel.2006.05.015; Klein C, 2001, J BIOL CHEM, V276, P49020, DOI 10.1074/jbc.M107516200; Ladbury JE, 1996, CHEM BIOL, V3, P791, DOI 10.1016/S1074-5521(96)90063-0; Lane D, 2001, NATURE, V414, P25, DOI 10.1038/35102132; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lu X, 2005, CURR OPIN GENET DEV, V15, P27, DOI 10.1016/j.gde.2004.12.008; Ludwig RL, 1996, MOL CELL BIOL, V16, P4952; MORI S, 1995, J MAGN RESON SER B, V108, P94, DOI 10.1006/jmrb.1995.1109; Nikolova PV, 1998, P NATL ACAD SCI USA, V95, P14675, DOI 10.1073/pnas.95.25.14675; Qian H, 2002, ONCOGENE, V21, P7901, DOI 10.1038/sj.onc.1205974; Rippin TM, 2002, J MOL BIOL, V319, P351, DOI 10.1016/S0022-2836(02)00326-1; Ryan KM, 2001, CURR OPIN CELL BIOL, V13, P332, DOI 10.1016/S0955-0674(00)00216-7; Saller E, 1999, EMBO J, V18, P4424, DOI 10.1093/emboj/18.16.4424; Samuels-Lev Y, 2001, MOL CELL, V8, P781, DOI 10.1016/S1097-2765(01)00367-7; Sanchez-Puig N, 2005, MOL CELL, V17, P11, DOI 10.1016/j.molcel.2004.11.019; Slee EA, 2003, TOXICOL LETT, V139, P81, DOI 10.1016/S0378-4274(02)00421-6; Smith PD, 1999, ONCOGENE, V18, P2451, DOI 10.1038/sj.onc.1202565; Trigiante G, 2006, NAT REV CANCER, V6, P217, DOI 10.1038/nrc1818; Veprintsev DB, 2006, P NATL ACAD SCI USA, V103, P2115, DOI 10.1073/pnas.0511130103; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2000, CELL, V103, P691, DOI 10.1016/S0092-8674(00)00171-9; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Weinberg RL, 2004, J MOL BIOL, V341, P1145, DOI 10.1016/j.jmb.2004.06.071; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Wong KB, 1999, P NATL ACAD SCI USA, V96, P8438, DOI 10.1073/pnas.96.15.8438; Zupnick A, 2006, J BIOL CHEM, V281, P20464, DOI 10.1074/jbc.M603387200	48	38	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32526	32533		10.1074/jbc.M604725200	http://dx.doi.org/10.1074/jbc.M604725200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16887812	hybrid			2022-12-27	WOS:000241414500050
J	Gao, SQ; Zhang, R; Greenberg, ME; Sun, M; Chen, X; Levison, BS; Salomon, RG; Hazen, SL				Gao, Shengqiang; Zhang, Renliang; Greenberg, Michael E.; Sun, Mingjiang; Chen, Xi; Levison, Bruce S.; Salomon, Robert G.; Hazen, Stanley L.			Phospholipid hydroxyalkenals, a subset of recently discovered endogenous CD36 ligands, spontaneously generate novel furan-containing phospholipids lacking CD36 binding activity in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCAVENGER RECEPTOR CD36; ACTIVATING-FACTOR ACETYLHYDROLASE; RETINAL-PIGMENT EPITHELIUM; LOW-DENSITY LIPOPROTEINS; FOAM CELL-FORMATION; OXIDIZED PHOSPHOLIPIDS; FATTY-ACIDS; PHAGOCYTOSIS; LDL; ATHEROSCLEROSIS	We recently identified a novel family of oxidized choline glycerophospholipid (oxPC) molecular species enriched in atheroma that serve as endogenous ligands for the scavenger receptor CD36 (oxPC(CD36)), facilitating macrophage cholesterol accumulation and foam cell formation (Podrez, E. A., Poliakov, E., Shen, Z., et al. ( 2002) J. Biol. Chem. 277, 38517 38523). A high affinity CD36 recognition motif was defined within oxPCCD36, an oxidatively truncated sn-2 acyl group with a terminal gamma-hydroxy ( or oxo)-alpha, beta-unsaturated carbonyl. The fate of these species once formed in vivo is unknown. Here we show that a subset of oxPCCD36, a phosphatidylcholine molecular species possessing sn-2 esterified fatty acyl hydroxyalkenal groups, can undergo a slow intramolecular cyclization and dehydration reaction to form novel oxPC species possessing a sn-2 acyl group that incorporates a terminal furyl moiety (oxPC-furan). Using high performance liquid chromatography with on-line tandem mass spectrometry in combination with unambiguous organic synthesis, we confirm that oxPC-furans, ultimately derived from phospholipids with sn-2 esterified docosahexaenoic, arachidonic, or linoleic acids, are formed during exposure of model membranes and isolated lipoproteins to physiological oxidant systems. In vivo generation of oxPC-furans at sites of enhanced oxidant stress is also demonstrated, such as within brain tissues following cerebral ischemia. Cell binding studies reveal that in contrast to their oxPCCD36 precursors, oxPC-furans lack CD36 binding activity. Taken together, the present studies identify oxPC-furans as a novel family of oxidized phospholipids that are formed in vivo from phospholipid hydroxyalkenals but that lack CD36 binding activity.	Cleveland Clin Fdn, Ctr Cardiovasc Diagnost & Prevent, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Cell Biol, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland, OH 44195 USA; Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University	Hazen, SL (corresponding author), Cleveland Clin Fdn, Ctr Cardiovasc Diagnost & Prevent, 9500 Euclid Ave,NE-10, Cleveland, OH 44195 USA.	hazens@ccf.org	Salomon, Robert G/C-3463-2008; Hazen, Stanley L/ABD-5845-2021	Salomon, Robert/0000-0001-9456-3557; Levison, Bruce/0000-0002-1816-368X	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR018390] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053315, P01HL076491, R01HL070621, R01HL061878, P50HL077107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021249] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR018390] Funding Source: Medline; NHLBI NIH HHS [P01 HL076491, HL70621, R01 HL053315, HL61878, HL53315, P01 HL077107] Funding Source: Medline; NIGMS NIH HHS [GM21249, R01 GM021249] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aldini G, 2002, BIOCHEM BIOPH RES CO, V298, P699, DOI 10.1016/S0006-291X(02)02545-7; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Daviet L, 1997, THROMB HAEMOSTASIS, V78, P65; Dean RT, 1997, BIOCHEM J, V324, P1; Deng YJ, 2000, J ORG CHEM, V65, P6660, DOI 10.1021/jo000809u; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Finneman SC, 2001, J EXP MED, V194, P1289, DOI 10.1084/jem.194.9.1289; Gu XR, 2003, J ORG CHEM, V68, P3749, DOI 10.1021/jo026721t; Huh HY, 1996, BLOOD, V87, P2020; Jimenez B, 2000, NAT MED, V6, P41, DOI 10.1038/71517; Lesnefsky EJ, 2000, ANAL BIOCHEM, V285, P246, DOI 10.1006/abio.2000.4783; Marathe GK, 2003, J BIOL CHEM, V278, P3937, DOI 10.1074/jbc.M211126200; Moore KJ, 2005, J CLIN INVEST, V115, P2192, DOI 10.1172/JCI24061; MORRIS LJ, 1966, CHEM IND-LONDON, P1493; Nakata A, 1999, ARTERIOSCL THROM VAS, V19, P1333, DOI 10.1161/01.ATV.19.5.1333; NOZAKI S, 1995, J CLIN INVEST, V96, P1859, DOI 10.1172/JCI118231; Podrez EA, 1999, J CLIN INVEST, V103, P1547, DOI 10.1172/JCI5549; Podrez EA, 2000, J CLIN INVEST, V105, P1095, DOI 10.1172/JCI8574; Podrez EA, 2002, J BIOL CHEM, V277, P38517, DOI 10.1074/jbc.M205924200; Podrez EA, 2002, J BIOL CHEM, V277, P38503, DOI 10.1074/jbc.M203318200; REN Y, 1995, J EXP MED, V181, P1857, DOI 10.1084/jem.181.5.1857; Requena JR, 1996, NEPHROL DIAL TRANSPL, V11, P48; Ryeom SW, 1996, J CELL SCI, V109, P387; Salomon RG, 2005, ANN NY ACAD SCI, V1043, P327, DOI 10.1196/annals.1333.040; SAVILL J, 1992, J CLIN INVEST, V90, P1513, DOI 10.1172/JCI116019; SAVILL J, 1991, CHEST, V99, pS6, DOI 10.1378/chest.99.3_Supplement.6S-a; Schaur R. J., 2003, Molecular Aspects of Medicine, V24, P149, DOI 10.1016/S0098-2997(03)00009-8; Spiteller G, 2005, LIPIDS, V40, P755, DOI 10.1007/s11745-005-1438-5; STREMLER KE, 1989, J BIOL CHEM, V264, P5331; Sun MJ, 2004, J AM CHEM SOC, V126, P5699, DOI 10.1021/ja038756w; Sun MJ, 2006, J BIOL CHEM, V281, P4222, DOI 10.1074/jbc.M509769200; Sun MJ, 2002, J ORG CHEM, V67, P3575, DOI 10.1021/jo0105383; Swigut T, 2003, J VIROL, V77, P8116, DOI 10.1128/JVI.77.14.8116-8126.2003; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Watson AD, 1997, J BIOL CHEM, V272, P13597, DOI 10.1074/jbc.272.21.13597; White DC, 2005, APPL ENVIRON MICROB, V71, P8426, DOI 10.1128/AEM.71.12.8426-8433.2005; WIMMER MJ, 1975, J BIOL CHEM, V250, P710; Yamaguchi A, 2000, THROMB RES, V97, P317, DOI 10.1016/S0049-3848(99)00179-6	40	27	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31298	31308		10.1074/jbc.M604039200	http://dx.doi.org/10.1074/jbc.M604039200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16908526	Bronze			2022-12-27	WOS:000241235300014
J	Gee, K; Angel, JB; Ma, W; Mishra, S; Gajanayaka, N; Parato, K; Kumar, A				Gee, Katrina; Angel, Jonathan B.; Ma, Wei; Mishra, Sasmita; Gajanayaka, Niranjala; Parato, Karl; Kumar, Ashok			Intracellular HIV-Tat expression induces IL-10 synthesis by the CREB-1 transcription factor through Ser(133) phosphorylation and its regulation by the ERK1/2 MAPK in human monocytic cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; N-TERMINAL KINASE; PERIPHERAL-BLOOD LYMPHOCYTES; T-CELL; MONONUCLEAR-CELLS; GENE-EXPRESSION; INTERLEUKIN-10 PRODUCTION; DISEASE PROGRESSION; HUMAN MACROPHAGES; INTERFERON-GAMMA	Human immunodeficiency virus (HIV)-Tat plays an important role in virus replication and in various aspects of host immune responses, including dysregulation of cytokine production. IL-10, an anti-inflammatory cytokine, is up-regulated during the course of HIV infection representing an important pathway by which HIV may induce immunodeficiency. Here we show that extracellular as well as intracellular Tat induced IL-10 expression in normal human monocytes and promonocytic THP-1 cells. The signaling pathways involved in the regulation of IL-10 production by endogenous Tat remain unknown. To understand the molecular mechanism underlying intracellular Tat-induced IL-10 transcription, we employed a retroviral expression system to investigate the role of MAPKs and the transcription factor(s) involved. Our results suggest that an inhibitor specific for the ERK1/2, PD98059, selectively blocked intracellular Tat-induced IL-10 expression in THP-1 cells. Furthermore, intracellular Tat activated the CREB-1 transcription factor through Ser(133) phosphorylation that was regulated by ERK MAPK as determined by IL-10 promoter analysis and gel shift assays. Overall, our results suggest that intracellular HIV-Tat induces IL-10 transcription by ERK MAPK-dependent CREB-1 transcription factor activation through Ser(133) phosphorylation.	Childrens Hosp Eastern Ontario, Res Inst, Div Virol, Dept Pathol & Lab Med, Ottawa, ON K1H 8L1, Canada; Childrens Hosp Eastern Ontario, Res Inst, Dept Biochem, Ottawa, ON K1H 8L1, Canada; Childrens Hosp Eastern Ontario, Res Inst, Dept Immunol & Microbiol, Ottawa, ON K1H 8L1, Canada; Childrens Hosp Eastern Ontario, Res Inst, Div Virol & Mol Immunol, Ottawa, ON K1H 8L1, Canada; Univ Ottawa, Ottawa Hlth Res Inst, Ottawa, ON K1H 8L6, Canada; Univ Ottawa, Div Infect Dis, Dept Med, Ottawa, ON K1H 8L6, Canada	University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Kumar, A (corresponding author), Childrens Hosp Eastern Ontario, Res Inst, Div Virol, Dept Pathol & Lab Med, 401 Smyth Rd, Ottawa, ON K1H 8L1, Canada.	akumar@uottawa.ca	Gee, Katrina/H-3093-2016	Angel, Jonathan B/0000-0003-3102-4462; Gee, Katrina/0000-0002-7535-2882				Abraham S, 2005, J NEUROIMMUNOL, V160, P219, DOI 10.1016/j.jneuroim.2004.11.009; AKRIDGE RE, 1994, J IMMUNOL, V153, P5782; Ancuta P, 2001, J IMMUNOL, V166, P4244, DOI 10.4049/jimmunol.166.6.4244; Angel JB, 1998, J INFECT DIS, V177, P898, DOI 10.1086/515244; Badou A, 2000, J VIROL, V74, P10551, DOI 10.1128/JVI.74.22.10551-10562.2000; BARILLARI G, 1993, P NATL ACAD SCI USA, V90, P7941, DOI 10.1073/pnas.90.17.7941; Benkhart EM, 2000, J IMMUNOL, V165, P1612, DOI 10.4049/jimmunol.165.3.1612; Bennasser Y, 2002, VIROLOGY, V303, P174, DOI 10.1006/viro.2002.1676; Bennasser Y, 2002, FASEB J, V16, P546, DOI 10.1096/fj.01-0775com; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; BOGDAN C, 1991, J EXP MED, V174, P1549, DOI 10.1084/jem.174.6.1549; Borgatti P, 1997, EUR J IMMUNOL, V27, P2805, DOI 10.1002/eji.1830271110; Brenner S, 2003, J BIOL CHEM, V278, P5597, DOI 10.1074/jbc.M207448200; BRIERE F, 1994, J EXP MED, V179, P757, DOI 10.1084/jem.179.2.757; Brigati C, 2003, FEMS MICROBIOL LETT, V220, P57, DOI 10.1016/S0378-1097(03)00067-3; Brightbill HD, 2000, J IMMUNOL, V164, P1940, DOI 10.4049/jimmunol.164.4.1940; Chen PQ, 1997, J BIOL CHEM, V272, P22385, DOI 10.1074/jbc.272.36.22385; Conkright MD, 2003, MOL CELL, V11, P1101, DOI 10.1016/S1097-2765(03)00134-5; Crowe S, 2003, J LEUKOCYTE BIOL, V74, P635, DOI 10.1189/jlb.0503204; CUPP C, 1993, ONCOGENE, V8, P2231; DAYTON AI, 1986, CELL, V44, P941, DOI 10.1016/0092-8674(86)90017-6; Deisseroth K, 2002, NEURON, V34, P179, DOI 10.1016/S0896-6273(02)00664-5; DEL PG, 1993, J IMMUNOL, V150, P353; DIAZMITOMA F, 1995, CLIN EXP IMMUNOL, V102, P31; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7689; ENSOLI B, 1993, J VIROL, V67, P277, DOI 10.1128/JVI.67.1.277-287.1993; Fauci AS, 1996, NATURE, V384, P529, DOI 10.1038/384529a0; Foey AD, 1998, J IMMUNOL, V160, P920; Fukao T, 2002, NAT IMMUNOL, V3, P875, DOI 10.1038/ni825; Gavaravarapu S, 2000, BIOCHEM BIOPH RES CO, V269, P758, DOI 10.1006/bbrc.2000.2358; Gibellini D, 1998, J IMMUNOL, V160, P3891; Gonzalez E, 2001, J IMMUNOL, V166, P4560, DOI 10.4049/jimmunol.166.7.4560; Ito M, 1998, AIDS RES HUM RETROV, V14, P845, DOI 10.1089/aid.1998.14.845; Johannessen M, 2004, CELL SIGNAL, V16, P1211, DOI 10.1016/j.cellsig.2004.05.001; Kanazawa S, 2000, IMMUNITY, V12, P61, DOI 10.1016/S1074-7613(00)80159-4; Kollmann TR, 1996, P NATL ACAD SCI USA, V93, P3126, DOI 10.1073/pnas.93.7.3126; Kumar A, 1998, CLIN EXP IMMUNOL, V114, P78; Kumar A, 1998, J IMMUNOL, V161, P776; Landay AL, 1996, J INFECT DIS, V173, P1085, DOI 10.1093/infdis/173.5.1085; Lee JC, 1996, J LEUKOCYTE BIOL, V59, P152, DOI 10.1002/jlb.59.2.152; Lim SP, 2000, J VIROL, V74, P1632, DOI 10.1128/JVI.74.4.1632-1640.2000; Ma W, 2004, J IMMUNOL, V172, P318, DOI 10.4049/jimmunol.172.1.318; Ma W, 2001, J BIOL CHEM, V276, P13664, DOI 10.1074/jbc.M011157200; Mitola S, 1997, BLOOD, V90, P1365, DOI 10.1182/blood.V90.4.1365.1365_1365_1372; Mocellin S, 2003, TRENDS IMMUNOL, V24, P36, DOI 10.1016/S1471-4906(02)00009-1; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Muller F, 1998, J INFECT DIS, V177, P586, DOI 10.1086/514222; Nishihara H, 2004, J BIOL CHEM, V279, P26176, DOI 10.1074/jbc.M313346200; Ostrowski MA, 2001, J INFECT DIS, V184, P1268, DOI 10.1086/324005; Patterson BK, 1999, CLIN IMMUNOL, V91, P254, DOI 10.1006/clim.1999.4713; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Rahimi AAR, 2005, J IMMUNOL, V174, P7823, DOI 10.4049/jimmunol.174.12.7823; Schols D, 1996, J VIROL, V70, P4953, DOI 10.1128/JVI.70.8.4953-4960.1996; SHARMA V, 1995, BIOCHEM BIOPH RES CO, V208, P704, DOI 10.1006/bbrc.1995.1395; Shin HD, 2000, P NATL ACAD SCI USA, V97, P14467, DOI 10.1073/pnas.97.26.14467; Stylianou E, 1999, CLIN EXP IMMUNOL, V116, P115; Weissman JD, 1998, P NATL ACAD SCI USA, V95, P11601, DOI 10.1073/pnas.95.20.11601; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0; WHITE MRH, 1995, J CELL SCI, V108, P441; Xiao H, 2000, P NATL ACAD SCI USA, V97, P11466, DOI 10.1073/pnas.97.21.11466; Yang YD, 2003, J VIROL, V77, P6700, DOI 10.1128/JVI.77.12.6700-6708.2003; Zhou JH, 2001, J IMMUNOL, V167, P4436, DOI 10.4049/jimmunol.167.8.4436	64	42	45	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31647	31658		10.1074/jbc.M512109200	http://dx.doi.org/10.1074/jbc.M512109200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16920714				2022-12-27	WOS:000241235300050
J	Rould, MA; Wan, Q; Joel, PB; Lowey, S; Trybus, KM				Rould, Mark A.; Wan, Qun; Joel, Peteranne B.; Lowey, Susan; Trybus, Kathleen M.			Crystal structures of expressed non-polymerizable monomeric actin in the ADP and ATP states	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEINS; FILAMENT; COMPLEX; CRYSTALLOGRAPHY; LOCALIZATION; HYDROLYSIS; BINDING; CELLS; MODEL	Actin filament growth and disassembly, as well as affinity for actin-binding proteins, is mediated by the nucleotide-bound state of the component actin monomers. The structural differences between ATP-actin and ADP-actin, however, remain controversial. We expressed a cytoplasmic actin in Sf9 cells, which was rendered non-polymerizable by virtue of two point mutations in subdomain 4 (A204E/P243K). This homogeneous monomer, called AP-actin, was crystallized in the absence of toxins, binding proteins, or chemical modification, with ATP or ADP at the active site. The two surface mutations do not perturb the structure. Significant differences between the two states are confined to the active site region and sensor loop. The active site cleft remains closed in both states. Minor structural shifts propagate from the active site toward subdomain 2, but dissipate before reaching the DNase binding loop ( D- loop), which remains disordered in both the ADP and ATP states. This result contrasts with previous structures of actin made monomeric by modification with tetramethylrhodamine, which show formation of an alpha-helix at the distal end of the D- loop in the ADP-bound but not the ATP-bound form (Otterbein, L. R., Graceffa, P., and Dominguez, R. (2001) Science 293, 708-711). Our reanalysis of the TMR-modified actin structures suggests that the nucleotide-dependent formation of the D- loop helix may result from signal propagation through crystal packing interactions. Whereas the observed nucleotide-dependent changes in the structure present significantly different surfaces on the exterior of the actin monomer, current models of the actin filament lack any actin-actin interactions that involve the region of these key structural changes.	Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA	University of Vermont	Trybus, KM (corresponding author), Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA.	kathleen.trybus@uvm.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038113, R29HL038113] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL38113] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Belmont LD, 1999, P NATL ACAD SCI USA, V96, P29, DOI 10.1073/pnas.96.1.29; Bookwalter CS, 2006, J BIOL CHEM, V281, P16777, DOI 10.1074/jbc.M512935200; Brunger AT, 1997, METHOD ENZYMOL, V277, P366, DOI 10.1016/S0076-6879(97)77021-6; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carlier M F, 1990, Adv Biophys, V26, P51, DOI 10.1016/0065-227X(90)90007-G; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Chik JK, 1996, J MOL BIOL, V263, P607, DOI 10.1006/jmbi.1996.0602; Dominguez R, 2004, TRENDS BIOCHEM SCI, V29, P572, DOI 10.1016/j.tibs.2004.09.004; Dominguez R, 2003, BIOPHYS J, V85, P2073, DOI 10.1016/S0006-3495(03)74635-9; Graceffa P, 2003, J BIOL CHEM, V278, P34172, DOI 10.1074/jbc.M303689200; HODEL A, 1992, ACTA CRYSTALLOGR A, V48, P851, DOI 10.1107/S0108767392006044; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Joel PB, 2004, BIOCHEMISTRY-US, V43, P11554, DOI 10.1021/bi048899a; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; KELLEHER JF, 1995, J CELL BIOL, V131, P385, DOI 10.1083/jcb.131.2.385; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Klenchin VA, 2003, NAT STRUCT BIOL, V10, P1058, DOI 10.1038/nsb1006; Kudryashov DS, 2003, BIOPHYS J, V85, P2466, DOI 10.1016/S0006-3495(03)74669-4; Kudryashov DS, 2005, P NATL ACAD SCI USA, V102, P13105, DOI 10.1073/pnas.0506429102; Kudryashov DS, 2004, BIOPHYS J, V87, P1136, DOI 10.1529/biophysj.104.042242; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LUZZATI V, 1952, ACTA CRYSTALLOGR, V5, P802, DOI 10.1107/S0365110X52002161; Minehardt TJ, 2006, BIOPHYS J, V90, P2445, DOI 10.1529/biophysj.105.072900; Nolen BJ, 2004, P NATL ACAD SCI USA, V101, P15627, DOI 10.1073/pnas.0407149101; Otterbein LR, 2001, SCIENCE, V293, P708, DOI 10.1126/science.1059700; Page R, 1998, J MOL BIOL, V280, P463, DOI 10.1006/jmbi.1998.1879; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; POLLARD TD, 1984, FEBS LETT, V170, P94, DOI 10.1016/0014-5793(84)81376-9; Robinson RC, 2001, SCIENCE, V294, P1679, DOI 10.1126/science.1066333; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Rould MA, 2003, METHOD ENZYMOL, V374, P145, DOI 10.1016/S0076-6879(03)74007-5; ROULD MA, 2006, IN PRESS METHODS MOL, V364; Sablin EP, 2002, P NATL ACAD SCI USA, V99, P10945, DOI 10.1073/pnas.152329899; Simanshu DK, 2005, J MOL BIOL, V352, P876, DOI 10.1016/j.jmb.2005.07.069; STRZELECKAGOLASZEWSKA H, 1993, EUR J BIOCHEM, V211, P731, DOI 10.1111/j.1432-1033.1993.tb17603.x; Volkman L, 1996, VIROLOGY, V225, P369, DOI 10.1006/viro.1996.0611; Vorobiev S, 2003, P NATL ACAD SCI USA, V100, P5760, DOI 10.1073/pnas.0832273100	38	101	102	3	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31909	31919		10.1074/jbc.M601973200	http://dx.doi.org/10.1074/jbc.M601973200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16920713	Bronze			2022-12-27	WOS:000241235300077
J	Lopez-Soto, A; Quinones-Lombrana, A; Lopez-Arbesu, R; Lopez-Larrea, C; Gonzalez, S				Lopez-Soto, Alejandro; Quinones-Lombrana, Adolfo; Lopez-Arbesu, Ruben; Lopez-Larrea, Carlos; Gonzalez, Segundo			Transcriptional regulation of ULBP1, a human ligand of the NKG2D receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I-RELATED CHAIN; NATURAL CYTOTOXICITY RECEPTORS; GENE PROMOTER; FACTOR SP3; T-CELLS; BINDING-PROTEINS; KILLER-CELLS; FACTOR AP-2; NK CELLS; EXPRESSION	Tumor cells expressing ligands of the NKG2D receptor stimulate anti-tumor immunity mediated by natural killer and T cells. In humans, NKG2D ligands (NKG2DL) are encoded by MIC and ULBP proteins. NKG2DL exhibit highly restricted expression in healthy tissues but are widely expressed in tumors. However, regulation of each NKG2DL differs substantially in different cancer cells. In this study, we characterized the mechanisms that regulate the expression of ULBP1. We show that the transcription of ULBP1 strictly depends on the binding of Sp1 and Sp3 to a CRE(1) site located in the ULBP1 minimal promoter. The mutation or deletion of this Sp1/Sp3 binding site abolished the transcription of ULBP1. It also diminished the transactivation of ULBP1 promoter by Sp3 overexpression, but not by Sp1, indicating that Sp3 is the main transcription factor that regulates ULBP1 through the CRE(1) site. Experiments in SL2 cells showed that the ULBP1 promoter was inactive in the absence of the Sp proteins and indicate that Sp3 is the essential activator of ULBP1 transcription, because the overexpression of Sp3 up-regulated its promoter activity > 500-fold. Additionally, we demonstrated that AP-2 alpha repressed the expression of ULBP1 in HeLa cells by interfering with the binding of Sp3 and Sp1 to the ULBP1 promoter. These data indicate that Sp1, Sp3, and AP-2 alpha may play an important role in the immunosurveillance against cancer. Finally, the definition of ULBP1 regulation may have implications for development of new therapeutic strategies against cancer cells.	Univ Oviedo, Dept Biol Func, Fac Med, Inst Univ Oncol Principado Asturias, Oviedo, Spain; Hosp Univ Cent Asturias, Unidad Histocompatibilidad & Transplantes, Oviedo, Spain	University of Oviedo; Instituto Universitario de Oncologia de Asturias; Central University Hospital Asturias	Gonzalez, S (corresponding author), Univ Oviedo, Dept Biol Func, Fac Med, Inst Univ Oncol Principado Asturias, Oviedo, Spain.	segundog@uniovi.es	López-Soto, Alejandro/A-9779-2018; Gonzalez, Segundo/AAK-8719-2021; Quinones Lombrana, Adolfo/AAJ-6592-2021; Lombrana, Adolfo Quinones/AAF-1086-2019	López-Soto, Alejandro/0000-0002-6360-5205; Gonzalez, Segundo/0000-0003-4631-9255; Quinones Lombrana, Adolfo/0000-0001-6935-2934; Lombrana, Adolfo Quinones/0000-0002-3784-3760; Lopez-Larrea, Carlos/0000-0001-9988-1730				Ammanamanchi S, 2003, J BIOL CHEM, V278, P35775, DOI 10.1074/jbc.M305961200; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Anttila MA, 2000, BRIT J CANCER, V82, P1974; Bacon L, 2004, J IMMUNOL, V173, P1078, DOI 10.4049/jimmunol.173.2.1078; BAHRAM S, 1994, P NATL ACAD SCI USA, V91, P6259, DOI 10.1073/pnas.91.14.6259; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Braun H, 2001, NUCLEIC ACIDS RES, V29, P4994, DOI 10.1093/nar/29.24.4994; Carbone E, 2005, BLOOD, V105, P251, DOI 10.1182/blood-2004-04-1422; Cerwenka A, 2001, IMMUNOL REV, V181, P158, DOI 10.1034/j.1600-065X.2001.1810113.x; Chazaud C, 1996, MECH DEVELOP, V54, P83, DOI 10.1016/0925-4773(95)00463-7; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(01)00095-4; Dennig J, 1996, EMBO J, V15, P5659, DOI 10.1002/j.1460-2075.1996.tb00950.x; Diefenbach A, 2001, IMMUNOL REV, V181, P170, DOI 10.1034/j.1600-065X.2001.1810114.x; Douglas DB, 2004, CANCER RES, V64, P1611, DOI 10.1158/0008-5472.CAN-0318-2; DYNAN WS, 1983, CELL, V35, P79, DOI 10.1016/0092-8674(83)90210-6; Friedlander P, 1996, MOL CELL BIOL, V16, P4961; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Gershenwald JE, 2001, ONCOGENE, V20, P3363, DOI 10.1038/sj.onc.1204450; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; Gonzalez S, 1996, J IMMUNOL, V157, P2282; Greenwel P, 1997, J BIOL CHEM, V272, P19738, DOI 10.1074/jbc.272.32.19738; Groh V, 1999, P NATL ACAD SCI USA, V96, P6879, DOI 10.1073/pnas.96.12.6879; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; HAGEN G, 1992, NUCLEIC ACIDS RES, V20, P5519, DOI 10.1093/nar/20.21.5519; HAGEN G, 1994, EMBO J, V13, P3843, DOI 10.1002/j.1460-2075.1994.tb06695.x; Heimberger AB, 2005, CLIN CANCER RES, V11, P267; Huang HC, 1999, P NATL ACAD SCI USA, V96, P962, DOI 10.1073/pnas.96.3.962; JAN CN, 2003, BIOCHEM BIOPH RES CO, V305, P129; Kennett SB, 1997, NUCLEIC ACIDS RES, V25, P3110, DOI 10.1093/nar/25.15.3110; Koutsodontis G, 2004, ONCOGENE, V23, P9190, DOI 10.1038/sj.onc.1208141; Li DQ, 2002, CANCER RES, V62, P4023; Li L, 2004, BIOCHEM CELL BIOL, V82, P460, DOI 10.1139/O04-045; Li M, 2004, BIOCHEM J, V382, P323, DOI 10.1042/BJ20040593; McPherson LA, 1999, NUCLEIC ACIDS RES, V27, P4040, DOI 10.1093/nar/27.20.4040; MITCHELL PJ, 1987, CELL, V50, P847, DOI 10.1016/0092-8674(87)90512-5; MOSER M, 1995, DEVELOPMENT, V121, P2779; Pende D, 2002, CANCER RES, V62, P6178; Pende D, 2001, EUR J IMMUNOL, V31, P1076, DOI 10.1002/1521-4141(200104)31:4<1076::AID-IMMU1076>3.0.CO;2-Y; Poggi A, 2004, CANCER RES, V64, P9172, DOI 10.1158/0008-5472.CAN-04-2417; Radosavljevic M, 2002, GENOMICS, V79, P114, DOI 10.1006/geno.2001.6673; Raffaghello L, 2004, NEOPLASIA, V6, P558, DOI 10.1593/neo.04316; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Ropponen KM, 2001, J CLIN PATHOL, V54, P533, DOI 10.1136/jcp.54.7.533; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Ruiz M, 2004, CANCER RES, V64, P631, DOI 10.1158/0008-5472.CAN-03-2751; Salih HR, 2003, BLOOD, V102, P1389, DOI 10.1182/blood-2003-01-0019; Sapetschnig A, 2004, J BIOL CHEM, V279, P42095, DOI 10.1074/jbc.M404989200; Sapetschnig A, 2002, EMBO J, V21, P5206, DOI 10.1093/emboj/cdf510; Sowa Y, 1999, ANN NY ACAD SCI, V886, P195, DOI 10.1111/j.1749-6632.1999.tb09415.x; Sowa Y, 1997, BIOCHEM BIOPH RES CO, V241, P142, DOI 10.1006/bbrc.1997.7786; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Sutherland CL, 2006, BLOOD, V108, P1313, DOI 10.1182/blood-2005-11-011320; Vetter CS, 2002, J INVEST DERMATOL, V118, P600, DOI 10.1046/j.1523-1747.2002.01700.x; Wajapeyee N, 2003, J BIOL CHEM, V278, P52093, DOI 10.1074/jbc.M305624200; Waldhauer I, 2006, CANCER RES, V66, P2520, DOI 10.1158/0008-5472.CAN-05-2520; Wang X, 2006, J CELL BIOL, V172, P409, DOI 10.1083/jcb.200510002; Wu J, 2003, J IMMUNOL, V170, P4196, DOI 10.4049/jimmunol.170.8.4196; Yang WS, 1998, J LIPID RES, V39, P2054; Zeng YX, 1997, NAT GENET, V15, P78, DOI 10.1038/ng0197-78	61	53	56	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30419	30430		10.1074/jbc.M604868200	http://dx.doi.org/10.1074/jbc.M604868200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16901903	hybrid			2022-12-27	WOS:000241075900016
J	Cristea, IM; Carroll, JWN; Rout, MP; Rice, CM; Chait, BT; MacDonald, MR				Cristea, Ileana M.; Carroll, John-William N.; Rout, Michael P.; Rice, Charles M.; Chait, Brian T.; MacDonald, Margaret R.			Tracking and elucidating Alphavirus-host protein interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEINS; GTPASE-ACTIVATING PROTEIN; VIRUS RNA-SYNTHESIS; BINDING-PROTEIN; ENDORIBONUCLEASE G3BP; REPLICATION COMPLEX; GENE-EXPRESSION; PORE COMPLEX; PHOSPHORYLATION; INFECTION	Viral infections cause profound alterations in host cells. Here, we explore the interactions between proteins of the Alphavirus Sindbis and host factors during the course of mammalian cell infection. Using a mutant virus expressing the viral nsP3 protein tagged with green fluorescent protein (GFP) we directly observed nsP3 localization and isolated nsP3-interacting proteins at various times after infection. These results revealed that host factor recruitment to nsP3-containing complexes was time dependent, with a specific early and persistent recruitment of G3BP and a later recruitment of 14-3-3 proteins. Expression of GFP-tagged G3BP allowed reciprocal isolation of nsP3 in Sindbis infected cells, as well as the identification of novel G3BP-interacting proteins in both uninfected and infected cells. Noteworthy interactions include nuclear pore complex components whose interactions with G3BP were reduced upon Sindbis infection. This suggests that G3BP is a nuclear transport factor, as hypothesized previously, and that viral infection may alter RNA transport. Immunoelectron microscopy showed that a portion of Sindbis nsP3 is localized at the nuclear envelope, suggesting a possible site of G3BP recruitment to nsP3-containing complexes. Our results demonstrate the utility of using a standard GFP tag to both track viral protein localization and elucidate specific viral-host interactions over time in infected mammalian cells.	Rockefeller Univ, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10021 USA; Rockefeller Univ, Lab Virol & Infect Dis, New York, NY 10021 USA; Rockefeller Univ, Lab Cellular & Struct Biol, New York, NY 10021 USA	Rockefeller University; Rockefeller University; Rockefeller University	Chait, BT (corresponding author), Rockefeller Univ, Lab Mass Spectrometry & Gaseous Ion Chem, 1230 York Ave, New York, NY 10021 USA.	chait@rockefeller.edu; macdonm@rockefeller.edu	Rout, Michael/Y-7090-2018	Rout, Michael/0000-0003-2010-706X	NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR022220, P41RR000862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI024134, R01AI063233, R01AI024134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062427] Funding Source: NIH RePORTER; NCRR NIH HHS [RR022220, RR00862] Funding Source: Medline; NIAID NIH HHS [AI063233, AI24134] Funding Source: Medline; NIGMS NIH HHS [GM062427] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson P, 2002, J CELL SCI, V115, P3227; Archambault V, 2004, MOL CELL, V14, P699, DOI 10.1016/j.molcel.2004.05.025; BARTON DJ, 1991, J VIROL, V65, P1496, DOI 10.1128/JVI.65.3.1496-1506.1991; Bick MJ, 2003, J VIROL, V77, P11555, DOI 10.1128/JVI.77.21.11555-11562.2003; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; CHAMBERS TJ, 1989, VIROLOGY, V169, P100, DOI 10.1016/0042-6822(89)90045-7; Choi KC, 2004, J VIROL, V78, P13153, DOI 10.1128/JVI.78.23.13153-13162.2004; Clark AR, 2003, FEBS LETT, V546, P37, DOI 10.1016/S0014-5793(03)00439-3; Cristea IM, 2005, MOL CELL PROTEOMICS, V4, P1933, DOI 10.1074/mcp.M500227-MCP200; Cristea IM, 2004, BLOOD, V103, P3624, DOI 10.1182/blood-2003-09-3295; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; Frolova E, 2006, J VIROL, V80, P4122, DOI 10.1128/JVI.80.8.4122-4134.2006; Frolova EI, 2002, J VIROL, V76, P11254, DOI 10.1128/JVI.76.22.11254-11264.2002; FROSHAUER S, 1988, J CELL BIOL, V107, P2075, DOI 10.1083/jcb.107.6.2075; Gallouzi IE, 1998, MOL CELL BIOL, V18, P3956, DOI 10.1128/MCB.18.7.3956; Griffin D.E., 2001, FIELDS VIROLOGY, P917; GRIFFITHS G, 1983, METHOD ENZYMOL, V96, P466; GRIMLEY PM, 1968, J VIROL, V2, P1326, DOI 10.1128/JVI.2.11.1326-1338.1968; HARLOW E, 1988, ANTIBODIES LABORATOR, P312; Irvine K, 2004, INT J DEV BIOL, V48, P1065, DOI 10.1387/ijdb.041893ki; Kaariainen L, 2002, PROG NUCLEIC ACID RE, V71, P187, DOI 10.1016/S0079-6603(02)71044-1; Katsafanas GC, 2004, J BIOL CHEM, V279, P52210, DOI 10.1074/jbc.M411033200; Kennedy D, 1996, Biomed Pept Proteins Nucleic Acids, V2, P93; Kujala P, 2001, J VIROL, V75, P3873, DOI 10.1128/JVI.75.8.3873-3884.2001; LASTARZA MW, 1994, VIROLOGY, V202, P224, DOI 10.1006/viro.1994.1338; LI GP, 1990, VIROLOGY, V179, P416, DOI 10.1016/0042-6822(90)90310-N; LIANG Z, 2005, GENE THER MOL BIOL, V9, P317; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; McInerney GM, 2005, MOL BIOL CELL, V16, P3753, DOI 10.1091/mbc.E05-02-0124; Nakatsue T, 1998, BIOCHEM BIOPH RES CO, V253, P59, DOI 10.1006/bbrc.1998.9724; Parker F, 1996, MOL CELL BIOL, V16, P2561; PERANEN J, 1991, J VIROL, V65, P1623; Prigent M, 2000, J BIOL CHEM, V275, P36441, DOI 10.1074/jbc.M004751200; RICE CM, 1982, J MOL BIOL, V154, P325, DOI 10.1016/0022-2836(82)90067-5; RICE CM, 1987, J VIROL, V61, P3809, DOI 10.1128/JVI.61.12.3809-3819.1987; Salonen A, 2003, J VIROL, V77, P1691, DOI 10.1128/JVI.77.3.1691-1702.2003; SCHLESINGER S, 2001, FIELDS VIROLOGY, P895; Shi ST, 2000, EMBO J, V19, P4701, DOI 10.1093/emboj/19.17.4701; Shi ST, 2003, J VIROL, V77, P10584, DOI 10.1128/JVI.77.19.10584-10593.2003; Soncini C, 2001, ONCOGENE, V20, P3869, DOI 10.1038/sj.onc.1204553; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Suntharalingam M, 2003, DEV CELL, V4, P775, DOI 10.1016/S1534-5807(03)00162-X; Suyama M, 2000, EMBO REP, V1, P53, DOI 10.1093/embo-reports/kvd009; TOKUYASU KT, 1986, J MICROSC-OXFORD, V143, P139, DOI 10.1111/j.1365-2818.1986.tb02772.x; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Tourriere H, 2001, MOL CELL BIOL, V21, P7747, DOI 10.1128/MCB.21.22.7747-7760.2001; Wright CF, 2001, J BIOL CHEM, V276, P40680, DOI 10.1074/jbc.M102399200	48	141	142	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					30269	30278		10.1074/jbc.M603980200	http://dx.doi.org/10.1074/jbc.M603980200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16895903	hybrid			2022-12-27	WOS:000240896300087
J	Felts, RL; Reilly, TJ; Tanner, JJ				Felts, Richard L.; Reilly, Thomas J.; Tanner, John J.			Structure of Francisella tularensis AcpA - Prototype of a unique superfamily of acid phosphatases and phospholipases C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE-SITE RESIDUES; PSEUDOMONAS-AERUGINOSA; ALKALINE-PHOSPHATASE; RESPIRATORY BURST; HUMAN ARYLSULFATASE; CRYSTAL-STRUCTURE; PROTEIN; VIRULENCE; HYDROLYSIS; TULAREMIA	AcpA is a respiratory burst-inhibiting acid phosphatase from the Centers for Disease Control and Prevention Category A bioterrorism agent Francisella tularensis and prototype of a superfamily of acid phosphatases and phospholipases C. We report the 1.75-angstrom resolution crystal structure of AcpA complexed with the inhibitor orthovanadate, which is the first structure of any F. tularensis protein and the first for any member of this superfamily. The core domain is a twisted 8-stranded beta-sheet flanked by three alpha-helices on either side, with the active site located above the carboxyl-terminal edge of the beta-sheet. This architecture is unique among acid phosphatases and resembles that of alkaline phosphatase. Unexpectedly, the active site features a serine nucleophile and metal ion with octahedral coordination. Structure-based sequence analysis of the AcpA superfamily predicts that the hydroxyl nucleophile and metal center are also present in AcpA-like phospholipases C. These results imply a phospholipase C catalytic mechanism that is radically different from that of zinc metallophospholipases.	Univ Missouri, Dept Chem, Columbia, MO 65211 USA; Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA; Univ Missouri, Vet Med Diagnost Lab, Columbia, MO 65211 USA; Univ Missouri, Dept Biochem, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Tanner, JJ (corresponding author), Univ Missouri, Dept Chem, 125 Chem Bldg,601 S Coll Ave, Columbia, MO 65211 USA.	tannerjj@missouri.edu		Tanner, John/0000-0001-8314-113X	NIAID NIH HHS [U54 AI057160] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057160] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BAGGIOLINI M, 1990, TRENDS BIOCHEM SCI, V15, P69, DOI 10.1016/0968-0004(90)90179-F; Baron GS, 1998, MOL MICROBIOL, V29, P247, DOI 10.1046/j.1365-2958.1998.00926.x; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chruszcz M, 2003, J INORG BIOCHEM, V96, P386, DOI 10.1016/S0162-0134(03)00176-4; COLEMAN JE, 1992, ANNU REV BIOPH BIOM, V21, P441, DOI 10.1146/annurev.biophys.21.1.441; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Felts RL, 2005, BBA-PROTEINS PROTEOM, V1752, P107, DOI 10.1016/j.bbapap.2005.05.005; Galperin MY, 2001, PROTEINS, V45, P318, DOI 10.1002/prot.1152; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; HENDRY P, 1990, PROG INORG CHEM, V38, P201; Hernychova L, 2001, PROTEOMICS, V1, P508, DOI 10.1002/1615-9861(200104)1:4<508::AID-PROT508>3.3.CO;2-B; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Holtz KM, 1999, J BIOL CHEM, V274, P8351, DOI 10.1074/jbc.274.13.8351; Kleywegt GJ, 1999, ACTA CRYSTALLOGR D, V55, P941, DOI 10.1107/S0907444999001031; KNOWLES JR, 1980, ANNU REV BIOCHEM, V49, P877, DOI 10.1146/annurev.bi.49.070180.004305; Krissinel E, 2005, LECT NOTES COMPUT SC, V3695, P163; Lai XH, 2004, MICROB PATHOGENESIS, V37, P225, DOI 10.1016/j.micpath.2004.07.002; Larsson P, 2005, NAT GENET, V37, P153, DOI 10.1038/ng1499; Lauriano CM, 2004, P NATL ACAD SCI USA, V101, P4246, DOI 10.1073/pnas.0307690101; Levitt DG, 2001, ACTA CRYSTALLOGR D, V57, P1013, DOI 10.1107/S0907444901006394; Lohse DL, 1997, BIOCHEMISTRY-US, V36, P4568, DOI 10.1021/bi963094r; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Luberto C, 2003, J BIOL CHEM, V278, P32733, DOI 10.1074/jbc.M300932200; Lukatela G, 1998, BIOCHEMISTRY-US, V37, P3654, DOI 10.1021/bi9714924; Martin SF, 1999, BIOCHEMISTRY-US, V38, P4403, DOI 10.1021/bi9821216; Morris RJ, 2002, ACTA CRYSTALLOGR D, V58, P968, DOI 10.1107/S0907444902005462; OSTROFF RM, 1990, J BACTERIOL, V172, P5915, DOI 10.1128/jb.172.10.5915-5923.1990; OSTROFF RM, 1989, INFECT IMMUN, V57, P1369, DOI 10.1128/IAI.57.5.1369-1373.1989; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; Raynaud C, 2002, MOL MICROBIOL, V45, P203, DOI 10.1046/j.1365-2958.2002.03009.x; Reilly TJ, 2006, PROTEIN EXPRES PURIF, V45, P132, DOI 10.1016/j.pep.2005.05.001; Reilly TJ, 1996, J BIOL CHEM, V271, P10973, DOI 10.1074/jbc.271.18.10973; Rossolini GM, 1998, CELL MOL LIFE SCI, V54, P833, DOI 10.1007/s000180050212; Santic M, 2005, CELL MICROBIOL, V7, P969, DOI 10.1111/j.1462-5822.2005.00526.x; Simonsen A, 2001, CURR OPIN CELL BIOL, V13, P485, DOI 10.1016/S0955-0674(00)00240-4; Sjostedt A, 2003, CURR OPIN MICROBIOL, V6, P66, DOI 10.1016/S1369-5274(03)00002-X; Stonehouse MJ, 2002, MOL MICROBIOL, V46, P661, DOI 10.1046/j.1365-2958.2002.03194.x; TITBALL RW, 1993, MICROBIOL REV, V57, P347, DOI 10.1128/MMBR.57.2.347-366.1993; Turro Claudia, 2003, Met Ions Biol Syst, V40, P323; Twine S, 2005, INFECT IMMUN, V73, P8345, DOI 10.1128/IAI.73.12.8345-8352.2005; VANETTEN RL, 1991, J BIOL CHEM, V266, P2313; VINCENT JB, 1992, TRENDS BIOCHEM SCI, V17, P105, DOI 10.1016/0968-0004(92)90246-6; VINCENT JB, 1995, PHOSPHOTASES CELL ME; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2	50	47	47	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					30289	30298		10.1074/jbc.M606391200	http://dx.doi.org/10.1074/jbc.M606391200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16899453	hybrid			2022-12-27	WOS:000240896300089
J	Martinez-Jimenez, CP; Gomez-Lechon, MJ; Castell, JV; Jover, R				Martinez-Jimenez, Celia P.; Gomez-Lechon, M. Jose; Castell, Jose V.; Jover, Ramiro			Underexpressed coactivators PGC1 alpha and SRC1 impair hepatocyte nuclear factor 4 alpha function and promote dedifferentiation in human hepatoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENRICHED TRANSCRIPTION FACTORS; QUANTITATIVE RT-PCR; GENE-EXPRESSION; GAMMA COACTIVATOR-1-ALPHA; HEPATOCELLULAR-CARCINOMA; RESPONSE ELEMENT; BINDING PROTEIN; LIVER; PGC-1-ALPHA; HNF4	Hepatocyte nuclear factor 4 alpha ( HNF4 alpha) plays critical roles during liver development and in the transcriptional regulation of many hepatic genes in adult liver. Here we have demonstrated that in human hepatoma HepG2 cells, HNF4 alpha is expressed at levels as high as in human liver but its activity on target genes is very low or absent. We have discovered that the low expression of key coactivators ( PGC1 alpha, SRC1, SRC2, and PCAF) might account for the lack of function of HNF4 alpha in HepG2 cells. Among them, PGC1 alpha and SRC1 are the two most important HNF4 alpha coactivators as revealed by reporter assays with an ApoCIII promoter construct. Moreover, the expression of these two coactivators was found to be down- regulated in all human hepatomas investigated. Overexpression of SRC1 and PGC1 alpha by recombinant adenoviruses led to a significant up- regulation of well characterized HNF4 alpha - dependent genes ( ApoCIII, ApoAV, PEPCK, AldoB, OTC, and CYP7A1) and forced HepG2 cells toward a more differentiated phenotype as demonstrated by increased ureogenic rate. The positive effect of PGC1 alpha was seen to be dependent on HNF4 alpha. Finally, insulin treatment of human hepatocytes and HepG2 cells caused repression of PGC1 alpha and a concomitant down- regulation of ApoCIII, PEPCK, AldoB, and OTC. Altogether, our results suggest that SRC1, and notably PGC1 alpha, are key coactivators for the proper function of HNF4 alpha in human liver and for an integrative control of multiple hepatic genes involved in metabolism and homeostasis. The down- regulation of key HNF4 alpha coactivators could be a determinant factor for the dedifferentiation of human hepatomas.	Hosp La Fe, Unidad Hepatol Expt, Ctr Invest, Valencia 46009, Spain; Univ Valencia, Fac Med, Dept Bioquim & Biol Mol, Valencia 46010, Spain	Hospital Universitari i Politecnic La Fe; University of Valencia	Martinez-Jimenez, CP (corresponding author), Hosp La Fe, Unidad Hepatol Expt, Ctr Invest, Ave Campanar 21, Valencia 46009, Spain.	ramiro.jover@uv.es	Jover, Ramiro/O-9796-2017; Martinez Jimenez, Celia P./K-8751-2012; Castell, Jose V/I-9529-2016	Jover, Ramiro/0000-0002-4914-5804; Martinez Jimenez, Celia P./0000-0002-9534-6201; Castell, Jose V/0000-0003-1179-6430				Amicone L, 1997, EMBO J, V16, P495, DOI 10.1093/emboj/16.3.495; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Bailly A, 1998, J CELL SCI, V111, P2411; Bhalla S, 2004, J BIOL CHEM, V279, P45139, DOI 10.1074/jbc.M405423200; Bulla GA, 2004, BIOSCIENCE REP, V24, P595, DOI 10.1007/s10540-005-2794-8; BULLA GA, 1994, MOL CELL BIOL, V14, P7086, DOI 10.1128/MCB.14.11.7086; Bulla GA, 1999, NUCLEIC ACIDS RES, V27, P1190, DOI 10.1093/nar/27.4.1190; Butura A, 2004, BIOCHEM PHARMACOL, V67, P1249, DOI 10.1016/j.bcp.2003.10.033; Castell JV, 1997, GENE THER, V4, P455, DOI 10.1038/sj.gt.3300416; Chaya D, 1997, MOL CELL BIOL, V17, P6311, DOI 10.1128/MCB.17.11.6311; CHEN WS, 1994, GENE DEV, V8, P2466, DOI 10.1101/gad.8.20.2466; Daitoku H, 2003, DIABETES, V52, P642, DOI 10.2337/diabetes.52.3.642; Dell H, 1999, J BIOL CHEM, V274, P9013, DOI 10.1074/jbc.274.13.9013; Dong XY, 2004, INT J CANCER, V112, P239, DOI 10.1002/ijc.20363; Eeckhoute J, 2001, MOL ENDOCRINOL, V15, P1200, DOI 10.1210/me.15.7.1200; Esterbauer H, 1999, GENOMICS, V62, P98, DOI 10.1006/geno.1999.5977; Gomez-Lechon MJ, 2001, EUR J BIOCHEM, V268, P1448, DOI 10.1046/j.1432-1327.2001.02011.x; GOMEZLECHON M, 2000, HEPATOCYTE REV, P11; GRIFFO G, 1993, J CELL BIOL, V121, P887, DOI 10.1083/jcb.121.4.887; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Inoue Y, 2002, J BIOL CHEM, V277, P25257, DOI 10.1074/jbc.M203126200; Iordanidou P, 2005, J BIOL CHEM, V280, P21810, DOI 10.1074/jbc.M501221200; Jover R, 2001, HEPATOLOGY, V33, P668, DOI 10.1053/jhep.2001.22176; Kawakami Y, 2005, P NATL ACAD SCI USA, V102, P2414, DOI 10.1073/pnas.0407510102; Knutti D, 2000, MOL CELL BIOL, V20, P2411, DOI 10.1128/MCB.20.7.2411-2422.2000; Knutti D, 2001, TRENDS ENDOCRIN MET, V12, P360, DOI 10.1016/S1043-2760(01)00457-X; Ktistaki E, 1997, SCIENCE, V277, P109, DOI 10.1126/science.277.5322.109; Lazarevich N, 2004, HEPATOLOGY, V39, P1038, DOI 10.1002/hep.20155; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Li JX, 2000, GENE DEV, V14, P464; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Louet JF, 2002, J BIOL CHEM, V277, P37991, DOI 10.1074/jbc.M205087200; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Parviz F, 2003, NAT GENET, V34, P292, DOI 10.1038/ng1175; Perez G, 2003, TOXICOL IN VITRO, V17, P643, DOI 10.1016/S0887-2333(03)00109-7; Prieur X, 2005, MOL ENDOCRINOL, V19, P3107, DOI 10.1210/me.2005-0048; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Rhee J, 2006, J BIOL CHEM, V281, P14683, DOI 10.1074/jbc.M512636200; Rodriguez-Antona C, 2000, ARCH BIOCHEM BIOPHYS, V376, P109, DOI 10.1006/abbi.2000.1697; Rodriguez-Antona C, 2002, XENOBIOTICA, V32, P505, DOI 10.1080/00498250210128675; Sandoval J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh091; SLADEK FM, 1993, RECEPTOR, V3, P223; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; Sladek FM, 1999, MOL CELL BIOL, V19, P6509; Spath GF, 1997, MOL CELL BIOL, V17, P1913; Spiegelman BM, 2004, CELL, V119, P157, DOI 10.1016/j.cell.2004.09.037; Stafford JM, 2001, J BIOL CHEM, V276, P3811, DOI 10.1074/jbc.M009389200; Stoffel M, 1997, P NATL ACAD SCI USA, V94, P13209, DOI 10.1073/pnas.94.24.13209; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang JC, 1998, J BIOL CHEM, V273, P30847, DOI 10.1074/jbc.273.47.30847; Xu L, 2001, CANCER RES, V61, P3176; Xu PL, 2004, MOL ENDOCRINOL, V18, P1887, DOI 10.1210/me.2003-0334; Xu XR, 2001, P NATL ACAD SCI USA, V98, P15089, DOI 10.1073/pnas.241522398; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	57	51	52	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					29840	29849		10.1074/jbc.M604046200	http://dx.doi.org/10.1074/jbc.M604046200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16891307	hybrid			2022-12-27	WOS:000240896300046
J	Graham, ES; Ball, N; Scotter, EL; Narayan, P; Dragunow, M; Glass, M				Graham, E. Scott; Ball, Nicola; Scotter, Emma L.; Narayan, Pritika; Dragunow, Mike; Glass, Michelle			Induction of Krox-24 by endogenous cannabinoid type 1 receptors in Neuro2a cells is mediated by the MEK-ERK MAPK pathway and is suppressed by the phosphatidylinositol 3-kinase pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-REGULATED KINASE; TRANSCRIPTION FACTOR EGR-1; ACID AMIDE HYDROLASE; ENDOCANNABINOID SYSTEM; SYNAPTIC-TRANSMISSION; NEUROBLASTOMA-CELLS; CHOLINERGIC NEURONS; GENE-EXPRESSION; NERVOUS-SYSTEM; BASAL GANGLIA	Neuro2a cells endogenously express cannabinoid type 1 (CB1) receptors. CB1 stimulation with HU210 activated ERK and induced the transcription factor Krox-24. A functional MEK-ERK pathway is an important requirement for CB1-mediated Krox-24 induction as blockade of MEK signaling by UO126 reduces both basal and CB1-mediated activation of Krox-24. CB1 receptor stimulation did not activate either JNK or p38 MAPK pathways or the pro-proliferation phosphatidylinositol 3-kinase (PI3K)-Akt pathway. However, serum removal or blockade of PI3K signaling by LY294002 transiently stimulated basal Krox-24 expression and increased CB1-mediated induction of Krox-24. This was consistent with a transient increase in pMEK, pERK, and pCREB levels following PI3K blockade. These data demonstrate that CB1-mediated activation of the Krox-24 transcription factor is negatively regulated through the PI3K-Akt pathway and reveals several points of signaling cross-talk between these two important kinase pathways.	Univ Auckland, Dept Pharmacol, Auckland, New Zealand; Univ Auckland, Natl Res Ctr Growth & Dev, Auckland, New Zealand	University of Auckland; University of Auckland	Glass, M (corresponding author), Univ Auckland, Dept Pharmacol, Private Bag 92019, Auckland, New Zealand.	m.glass@auckland.ac.nz	Scotter, Emma/C-4833-2012; Glass, Michelle/AAE-7799-2019	Scotter, Emma/0000-0003-4064-3599; Glass, Michelle/0000-0002-5997-6898; Narayan, Pritika/0000-0002-8713-1470; Graham, Scott/0000-0002-2925-9126				Azad SC, 2003, LEARN MEMORY, V10, P116, DOI 10.1101/lm.53303; Bodor AL, 2005, J NEUROSCI, V25, P6845, DOI 10.1523/JNEUROSCI.0442-05.2005; BOUABOULA M, 1995, BIOCHEM J, V312, P637, DOI 10.1042/bj3120637; Chiu JJ, 1999, CIRC RES, V85, P238, DOI 10.1161/01.RES.85.3.238; Demuth DG, 2006, LIFE SCI, V78, P549, DOI 10.1016/j.lfs.2005.05.055; Derkinderen P, 2003, J NEUROSCI, V23, P2371; Dragunow M, 1996, BEHAV GENET, V26, P293, DOI 10.1007/BF02359385; Dumaz N, 2005, FEBS J, V272, P3491, DOI 10.1111/j.1742-4658.2005.04763.x; Ebihara S, 2003, MOL BRAIN RES, V110, P126, DOI 10.1016/S0169-328X(02)00648-4; Egertova M, 2000, J COMP NEUROL, V422, P159, DOI 10.1002/(SICI)1096-9861(20000626)422:2<159::AID-CNE1>3.0.CO;2-1; Egertova M, 2003, NEUROSCIENCE, V119, P481, DOI 10.1016/S0306-4522(03)00145-3; Egertova M, 1998, P ROY SOC B-BIOL SCI, V265, P2081, DOI 10.1098/rspb.1998.0543; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Galve-Roperh I, 2002, MOL PHARMACOL, V62, P1385, DOI 10.1124/mol.62.6.1385; Glass M, 2000, NEUROSCIENCE, V97, P505, DOI 10.1016/S0306-4522(00)00008-7; GLASS M, 1995, NEUROREPORT, V6, P241, DOI 10.1097/00001756-199501000-00004; Graham ES, 1999, MOL CELL ENDOCRINOL, V156, P45, DOI 10.1016/S0303-7207(99)00146-X; Harkany T, 2003, EUR J NEUROSCI, V18, P1979, DOI 10.1046/j.1460-9568.2003.02898.x; Helliwell RJA, 2004, J CLIN ENDOCR METAB, V89, P5168, DOI 10.1210/jc.2004-0388; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; Huang CC, 2001, J PHYSIOL-LONDON, V532, P731, DOI 10.1111/j.1469-7793.2001.0731e.x; Hughes PE, 1998, MOL BRAIN RES, V53, P138, DOI 10.1016/S0169-328X(97)00288-X; Jiang W, 2005, J CLIN INVEST, V115, P3104, DOI 10.1172/JCI25509; Jordan JD, 2005, J BIOL CHEM, V280, P11413, DOI 10.1074/jbc.M411521200; Jun T., 1999, SCI STKE, V1999, pPE1; Karanian DA, 2005, EUR J PHARMACOL, V508, P47, DOI 10.1016/j.ejphar.2004.12.009; Katona I, 2006, J NEUROSCI, V26, P5628, DOI 10.1523/JNEUROSCI.0309-06.2006; Kim SH, 2005, J PHARMACOL EXP THER, V313, P88, DOI 10.1124/jpet.104.079509; Kofalvi A, 2005, J NEUROSCI, V25, P2874, DOI 10.1523/JNEUROSCI.4232-04.2005; KRISHNARAJU K, 1995, MOL CELL BIOL, V15, P5499; Leterrier C, 2004, J BIOL CHEM, V279, P36013, DOI 10.1074/jbc.M403990200; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Matyas F, 2006, NEUROSCIENCE, V137, P337, DOI 10.1016/j.neuroscience.2005.09.005; McAllister SD, 2002, PROSTAG LEUKOTR ESS, V66, P161, DOI 10.1054/plef.2001.0344; Nyiri G, 2005, NEUROSCIENCE, V136, P811, DOI 10.1016/j.neuroscience.2005.01.026; Nyiri G, 2005, EUR J NEUROSCI, V21, P3034, DOI 10.1111/j.1460-9568.2005.04146.x; Pignatelli M, 2003, BIOCHEM J, V373, P739, DOI 10.1042/BJ20021918; Pignatelli M, 1999, FEBS LETT, V461, P37, DOI 10.1016/S0014-5793(99)01420-9; Riegel AC, 2004, J NEUROSCI, V24, P11070, DOI 10.1523/JNEUROSCI.3695-04.2004; Rommel C, 1999, SCIENCE, V286, P1738, DOI 10.1126/science.286.5445.1738; Sanchez MG, 2003, CELL SIGNAL, V15, P851, DOI 10.1016/S0898-6568(03)00036-6; Straiker A, 2005, J PHYSIOL-LONDON, V569, P501, DOI 10.1113/jphysiol.2005.091918; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; Szabo G, 1996, DNA CELL BIOL, V15, P1081, DOI 10.1089/dna.1996.15.1081; Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178; Tsou K, 1998, NEUROSCIENCE, V83, P393, DOI 10.1016/S0306-4522(97)00436-3; Valjent E, 2001, EUR J NEUROSCI, V14, P342, DOI 10.1046/j.0953-816x.2001.01652.x; van der Heide LP, 2003, J NEUROCHEM, V86, P86, DOI 10.1046/j.1471-4159.2003.01828.x; van der Stelt M, 2002, MOL NEUROBIOL, V26, P317, DOI 10.1385/MN:26:2-3:317; Yanai R, 2006, EXP EYE RES, V83, P76, DOI 10.1016/j.exer.2005.10.033; Yoshida T, 2006, J NEUROSCI, V26, P4740, DOI 10.1523/JNEUROSCI.0054-06.2006; Zhao Q, 2005, J BIOL CHEM, V280, P26735, DOI 10.1074/jbc.M412828200; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741	53	45	45	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					29085	29095		10.1074/jbc.M602516200	http://dx.doi.org/10.1074/jbc.M602516200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16864584	hybrid			2022-12-27	WOS:000240680500063
J	He, X; Fan, HY; Narlikar, GJ; Kingston, RE				He, Xi; Fan, Hua-Ying; Narlikar, Geeta J.; Kingston, Robert E.			Human ACF1 alters the remodeling strategy of SNF2h	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE-FOLD PROTEINS; HUMAN SWI/SNF; TRANSCRIPTIONAL ACTIVATION; NUCLEOSOME MOBILIZATION; CHROMATIN-STRUCTURE; IN-VITRO; COMPLEX; ISWI; DNA; SUBUNITS	The human ACF chromatin- remodeling complex (hACF) contains the ATPase motor protein SNF2h and the non-catalytic hACF1 subunit. Here, we have compared the ability of SNF2h and a reconstituted hACF complex containing both SNF2h and hACF1 to remodel a series of nucleosomes containing different lengths of DNA overhang. Both SNF2h and hACF functioned in a manner consistent with sliding a canonical nucleosome. However, the non-catalytic subunit, hACF1, altered the remodeling properties of SNF2h by changing the nature of the requirement for a DNA overhang in the nucleosomal substrate and altering the DNA accessibility profile of the remodeled products. Surprisingly, addition of hACF1 to SNF2h increased the amount of DNA overhang needed to observe measurable amounts of DNA accessibility, but decreased the amount of overhang needed for a measurable binding interaction. We propose that these hACF1 functions might contribute to making the hACF complex more efficient at nucleosome spacing compared with SNF2h. In contrast, the SWI/SNF complex and its ATPase subunit BRG1 generated DNA accessibility profiles that were similar to each other, but different significantly from those of hACF and SNF2h. Thus, we observed divergent remodeling behaviors in these two remodeling families and found that the manner in which hACF1 alters the remodeling behavior of the ATPase is not shared by SWI/SNF subunits.	Massachusetts Gen Hosp, Dept Biol Mol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Kingston, RE (corresponding author), Massachusetts Gen Hosp, Dept Biol Mol, Simches Res Bldg,CPZN7811B,185 Cambridge St, Boston, MA 02114 USA.	kingston@molbio.mgh.harvard.edu			NCI NIH HHS [K01 CA093660, CA-093660] Funding Source: Medline; NIGMS NIH HHS [GM48405] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K01CA093660] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM048405, R01GM048405] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aalfs JD, 2001, J BIOL CHEM, V276, P34270, DOI 10.1074/jbc.M104163200; Aoyagi S, 2002, MOL CELL BIOL, V22, P3653, DOI 10.1128/MCB.22.11.3653-3662.2002; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Bozhenok L, 2002, EMBO J, V21, P2231, DOI 10.1093/emboj/21.9.2231; Collins N, 2002, NAT GENET, V32, P627, DOI 10.1038/ng1046; Corona DFV, 2000, EMBO J, V19, P3049, DOI 10.1093/emboj/19.12.3049; Deuring R, 2000, MOL CELL, V5, P355, DOI 10.1016/S1097-2765(00)80430-X; Dorigo B, 2004, SCIENCE, V306, P1571, DOI 10.1126/science.1103124; Eberharter A, 2004, EMBO J, V23, P4029, DOI 10.1038/sj.emboj.7600382; Eberharter A, 2001, EMBO J, V20, P3781, DOI 10.1093/emboj/20.14.3781; Fan HY, 2005, MOL CELL, V17, P805, DOI 10.1016/j.molcel.2005.02.024; Fan HY, 2003, MOL CELL, V11, P1311, DOI 10.1016/S1097-2765(03)00192-8; Fyodorov DV, 2004, GENE DEV, V18, P170, DOI 10.1101/gad.1139604; Fyodorov DV, 2002, NATURE, V418, P897, DOI 10.1038/nature00929; Fyodorov DV, 2002, MOL CELL BIOL, V22, P6344, DOI 10.1128/MCB.22.18.6344-6353.2002; Goldmark JP, 2000, CELL, V103, P423, DOI 10.1016/S0092-8674(00)00134-3; Hamiche A, 1999, CELL, V97, P833, DOI 10.1016/S0092-8674(00)80796-5; Havas K, 2001, CELL MOL LIFE SCI, V58, P673, DOI 10.1007/PL00000891; Hayes JJ, 1997, METHODS, V12, P2, DOI 10.1006/meth.1997.0441; Hsiao PW, 2003, MOL CELL BIOL, V23, P6210, DOI 10.1128/MCB.23.17.6210-6220.2003; Imbalzano AN, 1996, J BIOL CHEM, V271, P20726, DOI 10.1074/jbc.271.34.20726; Inoue H, 2002, J BIOL CHEM, V277, P41674, DOI 10.1074/jbc.M205961200; Ito T, 1999, GENE DEV, V13, P1529, DOI 10.1101/gad.13.12.1529; Ito T, 1997, CELL, V90, P145, DOI 10.1016/S0092-8674(00)80321-9; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kadam S, 2000, GENE DEV, V14, P2441, DOI 10.1101/gad.828000; Kagalwala MN, 2004, EMBO J, V23, P2092, DOI 10.1038/sj.emboj.7600220; Kukimoto I, 2004, MOL CELL, V13, P265, DOI 10.1016/S1097-2765(03)00523-9; KWON H, 1994, NATURE, V370, P477, DOI 10.1038/370477a0; Langst G, 1999, CELL, V97, P843, DOI 10.1016/S0092-8674(00)80797-7; Langst G, 2001, J CELL SCI, V114, P2561; LeRoy G, 1998, SCIENCE, V282, P1900, DOI 10.1126/science.282.5395.1900; Logie C, 1997, EMBO J, V16, P6772, DOI 10.1093/emboj/16.22.6772; Logie C, 1999, BIOCHEMISTRY-US, V38, P2514, DOI 10.1021/bi982109d; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Loyola A, 2003, MOL CELL BIOL, V23, P6759, DOI 10.1128/MCB.23.19.6759-6768.2003; Mizuguchi G, 1997, MOL CELL, V1, P141, DOI 10.1016/S1097-2765(00)80015-5; Morillon A, 2003, CELL, V115, P425, DOI 10.1016/S0092-8674(03)00880-8; Narlikar GJ, 2001, MOL CELL, V8, P1219, DOI 10.1016/S1097-2765(01)00412-9; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Phelan ML, 1999, MOL CELL, V3, P247, DOI 10.1016/S1097-2765(00)80315-9; Poot RA, 2000, EMBO J, V19, P3377, DOI 10.1093/emboj/19.13.3377; Santoro R, 2002, NAT GENET, V32, P393, DOI 10.1038/ng1010; Sif S, 1998, GENE DEV, V12, P2842, DOI 10.1101/gad.12.18.2842; Strohner R, 2001, EMBO J, V20, P4892, DOI 10.1093/emboj/20.17.4892; Strohner R, 2005, NAT STRUCT MOL BIOL, V12, P683, DOI 10.1038/nsmb966; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; TURNER BM, 1993, CELL, V75, P5, DOI 10.1016/S0092-8674(05)80078-9; Whitehouse I, 2003, MOL CELL BIOL, V23, P1935, DOI 10.1128/MCB.23.6.1935-1945.2003; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; Xiao H, 2001, MOL CELL, V8, P531, DOI 10.1016/S1097-2765(01)00345-8; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Zofall M, 2004, MOL CELL BIOL, V24, P10047, DOI 10.1128/MCB.24.22.10047-10057.2004	53	49	49	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					28636	28647		10.1074/jbc.M603008200	http://dx.doi.org/10.1074/jbc.M603008200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16877760	hybrid			2022-12-27	WOS:000240680500017
J	Joly, D; Berissi, S; Bertrand, A; Strehl, L; Patey, N; Knebelmann, B				Joly, Dominique; Berissi, Sophie; Bertrand, Amelie; Strehl, Laetitia; Patey, Natacha; Knebelmann, Bertrand			Laminin 5 regulates polycystic kidney cell proliferation and cyst formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUBULAR EPITHELIAL-CELLS; ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; ALPHA-2-BETA-1 INTEGRIN; MEMBRANE-PROTEIN; GAMMA-2 CHAIN; DISEASE; GROWTH; MIGRATION; ADHESION	Renal cyst formation is the hallmark of autosomal dominant polycystic kidney disease (ADPKD). ADPKD cyst-lining cells have an increased proliferation rate and are surrounded by an abnormal extracellular matrix (ECM). We have previously shown that Laminin 5 (Ln-5, a alpha(3)beta(3)gamma(2) trimer) is aberrantly expressed in the pericystic ECM of ADPKD kidneys. We report that ADPKD cells in primary cultures produce and secrete Ln-5 that is incorporated to the pericystic ECM in an in vitro model of cystogenesis. In monolayers, purified Ln-5 induces ERK activation and proliferation of ADPKD cells, whereas upon epidermal growth factor stimulation blocking endogenously produced Ln-5 with anti-gamma(2) chain antibody reduces the sustained ERK activation and inhibits proliferation. In three-dimensional gel culture, addition of purified Ln-5 stimulates cell proliferation and cyst formation, whereas blocking endogenous Ln-5 strongly inhibits cyst formation. Ligation of alpha(6)beta(4) integrin, a major Ln-5 receptor aberrantly expressed by ADPKD cells, induces beta(4) integrin phosphorylation, ERK activation, cell proliferation, and cyst formation. These findings indicate that Ln-5 is an important regulator of ADPKD cell proliferation and cystogenesis and suggest that Ln-5 gamma(2) chain and Ln-5-alpha(6)beta(4) integrin interaction both contribute to these phenotypic changes.	Univ Paris Descartes, Fac Med, INSERM, U813,Hop Necker Enfants Malades,AP HP,Serv Nephro, F-75015 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Knebelmann, B (corresponding author), Univ Paris Descartes, Fac Med, INSERM, U813,Hop Necker Enfants Malades,AP HP,Serv Nephro, 149 Rue Sevres, F-75015 Paris, France.	knebelmann@necker.fr						Adachi T, 2002, J CELL PHYSIOL, V192, P151, DOI 10.1002/jcp.10124; BEAVAN LA, 1991, ARCH BIOCHEM BIOPHYS, V284, P392, DOI 10.1016/0003-9861(91)90314-9; Boletta A, 2003, TRENDS CELL BIOL, V13, P484, DOI 10.1016/S0962-8924(03)00169-7; CHEN QM, 1994, J BIOL CHEM, V269, P26602; Chiu SJ, 2002, J BIOMED SCI, V9, P261, DOI 10.1159/000059427; Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R; COWLEY BD, 1993, KIDNEY INT, V43, P522, DOI 10.1038/ki.1993.79; CUPPAGE FE, 1980, KIDNEY INT, V17, P372, DOI 10.1038/ki.1980.43; Daemi N, 2000, INT J CANCER, V85, P850, DOI 10.1002/(SICI)1097-0215(20000315)85:6<850::AID-IJC19>3.0.CO;2-B; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; Decline F, 2001, J CELL SCI, V114, P811; Eliceiri BP, 1998, J CELL BIOL, V140, P1255, DOI 10.1083/jcb.140.5.1255; Ghosh S, 2000, MICROSC RES TECHNIQ, V51, P238, DOI 10.1002/1097-0029(20001101)51:3<238::AID-JEMT4>3.0.CO;2-3; Giannelli G, 1997, SCIENCE, V277, P225, DOI 10.1126/science.277.5323.225; Gilles C, 2001, J CELL SCI, V114, P2967; Gonzales M, 1999, MOL BIOL CELL, V10, P259, DOI 10.1091/mbc.10.2.259; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; HILL CS, 1995, CELL, V80, P199, DOI 10.1016/0092-8674(95)90403-4; Hood JD, 2003, J CELL BIOL, V162, P933, DOI 10.1083/jcb.200304105; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; Joly D, 2003, AM J PATHOL, V163, P1791, DOI 10.1016/S0002-9440(10)63539-0; Kingsley K, 2002, BIOCHEM BIOPH RES CO, V293, P1000, DOI 10.1016/S0006-291X(02)00331-5; Koshikawa N, 2005, J BIOL CHEM, V280, P88, DOI 10.1074/jbc.M411824200; Mainiero F, 1997, EMBO J, V16, P2365, DOI 10.1093/emboj/16.9.2365; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; NAULI SM, 2003, NAT GENET; Nievers MG, 1999, MATRIX BIOL, V18, P5, DOI 10.1016/S0945-053X(98)00003-1; O'Brien LE, 2001, NAT CELL BIOL, V3, P831, DOI 10.1038/ncb0901-831; Richards WG, 1998, J CLIN INVEST, V101, P935, DOI 10.1172/JCI2071; ROUSSELLE P, 1994, J CELL BIOL, V125, P205, DOI 10.1083/jcb.125.1.205; SAELMAN EUM, 1995, J CELL SCI, V108, P3531; Schenk S, 2003, J CELL BIOL, V161, P197, DOI 10.1083/jcb.200208145; Slade MJ, 1998, BBA-MOL CELL RES, V1401, P203, DOI 10.1016/S0167-4889(97)00125-0; Streets AJ, 2003, J AM SOC NEPHROL, V14, P1804, DOI 10.1097/01.ASN.0000076075.49819.9B; Sweeney WE, 1998, AM J PHYSIOL-RENAL, V275, pF387, DOI 10.1152/ajprenal.1998.275.3.F387; TAUB M, 1990, KIDNEY INT, V37, P1090, DOI 10.1038/ki.1990.90; Weaver VM, 2002, CANCER CELL, V2, P205, DOI 10.1016/S1535-6108(02)00125-3; Wilson PD, 1999, LAB INVEST, V79, P1311; Wilson PD, 2004, NEW ENGL J MED, V350, P151, DOI 10.1056/NEJMra022161; WILSON PD, 1992, J CELL PHYSIOL, V150, P360, DOI 10.1002/jcp.1041500220; Yoder BK, 2002, J AM SOC NEPHROL, V13, P2508, DOI 10.1097/01.ASN.0000029587.47950.25; Zahir N, 2003, J CELL BIOL, V163, P1397, DOI 10.1083/jcb.200302023	44	30	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					29181	29189		10.1074/jbc.M606151200	http://dx.doi.org/10.1074/jbc.M606151200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16870608	hybrid			2022-12-27	WOS:000240680500073
J	Li, TG; Kong, XY; Owsley, E; Ellis, E; Strom, S; Chiang, JYL				Li, Tiangang; Kong, Xiaoying; Owsley, Erika; Ellis, Ewa; Strom, Stephen; Chiang, John Y. L.			Insulin regulation of cholesterol 7 alpha-hydroxylase expression in human hepatocytes - Roles of forkhead box O1 and sterol regulatory element-binding protein 1c	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR FKHR; BILE-ACID SYNTHESIS; CHOLESTEROL 7-ALPHA-HYDROXYLASE; GENE-EXPRESSION; PHOSPHOENOLPYRUVATE CARBOXYKINASE; NUCLEAR FACTOR-4; FATTY-ACID; X-RECEPTOR; LIVER; FOXO1	Bile acid synthesis and pool size increases in diabetes, whereas insulin inhibits bile acid synthesis. The objective of this study is to elucidate the mechanism of insulin regulation of cholesterol 7 alpha-hydroxylase gene expression in human hepatocytes. Real-time PCR assays showed that physiological concentrations of insulin rapidly stimulated cholesterol 7 alpha-hydroxylase (CYP7A1) mRNA expression in primary human hepatocytes but inhibited CYP7A1 expression after extended treatment. The insulin-regulated forkhead box O1 (FoxO1) and steroid regulatory element-binding protein-1c (SREBP-1c) strongly inhibited hepatocyte nuclear factor 4 alpha and peroxisome proliferator-activated receptor gamma-coactivator-1 alpha trans-activation of the CYP7A1 gene. FoxO1 binds to an insulin response element in the rat CYP7A1 promoter, which is not present in the human CYP7A1 gene. Insulin rapidly phosphorylates and inactivates FoxO1, whereas insulin induces nuclear SREBP-1c expression in human primary hepatocytes. Chromatin immunoprecipitation assay shows that insulin reduced FoxO1 and peroxisome proliferators-activated receptor gamma-coactivator-1 alpha but increased SREBP-1c recruitment to CYP7A1 chromatin. We conclude that insulin has dual effects on human CYP7A1 gene transcription; physiological concentrations of insulin rapidly inhibit FoxO1 activity leading to stimulation of the human CYP7A1 gene, whereas prolonged insulin treatment induces SREBP-1c, which inhibits human CYP7A1 gene transcription. Insulin may play a major role in the regulation of bile acid synthesis and dyslipidemia in diabetes.	Northeastern Ohio Univ Coll Med & Pharm, Dept Microbiol Immunol & Biochem, Rootstown, OH 44272 USA; Univ Pittsburgh, Med Ctr, Dept Pathol, Pittsburgh, PA 15213 USA	Northeast Ohio Medical University (NEOMED); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Chiang, JYL (corresponding author), Northeastern Ohio Univ Coll Med & Pharm, Dept Microbiol Immunol & Biochem, 4209 State Route 44,Rootstown, Rootstown, OH 44272 USA.	jchiang@neoucom.edu	Ellis, Ewa C S/D-5370-2014; Chiang, John Y. L./G-2658-2011	Ellis, Ewa C S/0000-0002-3057-5337; Chiang, John Y. L./0000-0001-9360-7650; Strom, Stephen/0000-0002-2889-3387	NIDDK NIH HHS [R01 DK044442, DK44442, R56 DK044442, R01 DK058379, R37 DK058379, DK92310, DK58379] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044442, R37DK058379, R56DK044442, R01DK058379, N01DK092310] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Altomonte J, 2004, J CLIN INVEST, V114, P1493, DOI 10.1172/JCI200419992; ANDERSEN E, 1988, EUR J CLIN INVEST, V18, P166, DOI 10.1111/j.1365-2362.1988.tb02408.x; BENNION LJ, 1977, NEW ENGL J MED, V296, P1365, DOI 10.1056/NEJM197706162962401; Cagen LM, 2005, BIOCHEM J, V385, P207, DOI 10.1042/BJ20040162; Cariou B, 2005, ENDOCRINOLOGY, V146, P981, DOI 10.1210/en.2004-1595; Chiang JYL, 2002, ENDOCR REV, V23, P443, DOI 10.1210/er.2000-0035; Chiang JYL, 2003, AM J PHYSIOL-GASTR L, V284, pG349, DOI 10.1152/ajpgi.00417.2002; Chiang JYL, 2001, GENE, V262, P257, DOI 10.1016/S0378-1119(00)00518-7; CRESTANI M, 1995, J LIPID RES, V36, P2419; Crestani M, 1998, J LIPID RES, V39, P2192; De Fabiani E, 2000, BIOCHEM J, V347, P147; Engelking LJ, 2004, J CLIN INVEST, V113, P1168, DOI 10.1172/JCI200420978; Foretz M, 1999, MOL CELL BIOL, V19, P3760; Foufelle F, 2002, BIOCHEM J, V366, P377, DOI 10.1042/BJ20020430; Hall RK, 2000, J BIOL CHEM, V275, P30169, DOI 10.1074/jbc.M004898200; HASSAN AS, 1980, P SOC EXP BIOL MED, V164, P449; Hegarty BD, 2005, P NATL ACAD SCI USA, V102, P791, DOI 10.1073/pnas.0405067102; Hirota K, 2003, J BIOL CHEM, V278, P13056, DOI 10.1074/jbc.C200553200; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Ishida H, 2000, J BIOCHEM, V127, P57, DOI 10.1093/oxfordjournals.jbchem.a022584; LI T, 2004, AM J PHYSIOL-GASTR L, V288, P74; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; OBRIEN RM, 1995, MOL CELL BIOL, V15, P1747; OBrien RM, 1996, PHYSIOL REV, V76, P1109, DOI 10.1152/physrev.1996.76.4.1109; Osborne TF, 2000, J BIOL CHEM, V275, P32379, DOI 10.1074/jbc.R000017200; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Reaven G, 2004, RECENT PROG HORM RES, V59, P207, DOI 10.1210/rp.59.1.207; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Schmoll D, 2000, J BIOL CHEM, V275, P36324, DOI 10.1074/jbc.M003616200; Song KH, 2006, J BIOL CHEM, V281, P10081, DOI 10.1074/jbc.M513420200; Song KH, 2006, HEPATOLOGY, V43, P117, DOI 10.1002/hep.20919; Stayrook KR, 2005, ENDOCRINOLOGY, V146, P984, DOI 10.1210/en.2004-0965; Stroup D, 2000, J LIPID RES, V41, P1; Tobin KAR, 2002, J BIOL CHEM, V277, P10691, DOI 10.1074/jbc.M109771200; TWISK J, 1995, HEPATOLOGY, V21, P501, DOI 10.1016/0270-9139(95)90113-2; VILLANUEVA GR, 1990, J LAB CLIN MED, V115, P441; Wang DP, 1996, J LIPID RES, V37, P1831; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Yamagata K, 2004, J BIOL CHEM, V279, P23158, DOI 10.1074/jbc.M314322200; Yamamoto T, 2004, J BIOL CHEM, V279, P12027, DOI 10.1074/jbc.M310333200; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200; Zhang XH, 2002, J BIOL CHEM, V277, P45276, DOI 10.1074/jbc.M208063200	44	69	72	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					28745	28754		10.1074/jbc.M605815200	http://dx.doi.org/10.1074/jbc.M605815200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16885156	Green Accepted, hybrid			2022-12-27	WOS:000240680500028
J	Stanton, SE; McReynolds, LJ; Evans, T; Schreiber-Agus, N				Stanton, Sasha E.; McReynolds, Lisa J.; Evans, Todd; Schreiber-Agus, Nicole			Yaf2 inhibits caspase 8-mediated apoptosis and regulates cell survival during zebrafish embryogenesis*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; GROUP PROTEINS; POLYCOMB; DEATH; INTERACTS; GENES; RYBP; POSTIMPLANTATION; DEGENERATION; ACTIVATION	Rybp (DEDAF) is a member of the Rybp/Yaf2 protein family and has been shown to encode proapoptotic functions and to be essential for mouse embryogenesis. The related Yaf2 protein has not been studied extensively at the cellular or organismal levels. Here we describe zebrafish yaf2 (zyaf2) and show that it is widely expressed during early embryogenesis, with subsequent enrichment of transcripts in the anterior head region. Depletion of zYaf2 during embryogenesis using specific morpholinos activates a wide-spread program of apoptosis and causes developmental arrest before the one somite stage. Partial depletion of Yaf2, achieved by injecting lower dosages of morpholino, circumvents the early arrest but leads to CNS degeneration associated with excessive apoptosis. These phenotypes can be rescued by co-injection of human YAF2 mRNA with the morpholinos or by treatment with a pan-caspase inhibitor or a caspase 8-specific inhibitor. Finally, the observed activation of caspase 8 in the morphants is in accord with the ability of Yaf2 to inhibit caspase 8-mediated apoptosis in cultured cells. Our findings implicate Yaf2 as a survival factor during early zebrafish development and organogenesis. This may suggest that Yaf2 and Rybp can encode opposing functions in the regulation of apoptosis.	Albert Einstein Coll Med, Dept Mol Genet, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Schreiber-Agus, N (corresponding author), Albert Einstein Coll Med, Dept Mol Genet, Bronx, NY 10461 USA.	agus@aecom.yu.edu			NCI NIH HHS [CA92558] Funding Source: Medline; NHLBI NIH HHS [HL64282, HL56182] Funding Source: Medline; NIGMS NIH HHS [T32 GM07288] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R55CA092558, R01CA092558] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056182, R37HL056182, R01HL064282] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abdelilah S, 1996, DEVELOPMENT, V123, P217; Bannasch D, 2001, ONCOGENE, V20, P5913, DOI 10.1038/sj.onc.1204747; Bejarano F, 2005, MECH DEVELOP, V122, P1118, DOI 10.1016/j.mod.2005.06.001; Cernilogar FM, 2005, BIOCHEM CELL BIOL, V83, P322, DOI 10.1139/o05-040; Chen M, 2002, APOPTOSIS, V7, P313, DOI 10.1023/A:1016167228059; Cole LK, 2001, DEV BIOL, V240, P123, DOI 10.1006/dbio.2001.0432; Danen-van Oorschot AAAM, 2004, CELL DEATH DIFFER, V11, P564, DOI 10.1038/sj.cdd.4401391; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Dejardin J, 2005, PROG MOLEC, V38, P31; FurutaniSeiki M, 1996, DEVELOPMENT, V123, P229; Garcia E, 1999, EMBO J, V18, P3404, DOI 10.1093/emboj/18.12.3404; Gil J, 2005, DNA CELL BIOL, V24, P117, DOI 10.1089/dna.2005.24.117; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; Greenwood J, 2005, SEMIN CELL DEV BIOL, V16, P215, DOI 10.1016/j.semcdb.2004.12.002; Holley SA, 2002, SEMIN CELL DEV BIOL, V13, P481, DOI 10.1016/S1084952102001015; Ikegami R, 1999, DEV BIOL, V209, P409, DOI 10.1006/dbio.1999.9243; Inohara N, 2000, CELL DEATH DIFFER, V7, P509, DOI 10.1038/sj.cdd.4400679; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Kalenik JL, 1997, NUCLEIC ACIDS RES, V25, P843, DOI 10.1093/nar/25.4.843; Kane DA, 1996, DEVELOPMENT, V123, P57; Kaneko T, 2003, GENE, V315, P183, DOI 10.1016/S0378-1119(03)00800-X; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lee JC, 2005, APOPTOSIS, V10, P1483, DOI 10.1007/s10495-005-1833-z; Madge B, 2003, CANCER LETT, V193, P171, DOI 10.1016/S0304-3835(02)00696-1; Mehlen P, 2005, J NEUROBIOL, V64, P357, DOI 10.1002/neu.20167; Negron JF, 2004, DEV DYNAM, V231, P161, DOI 10.1002/dvdy.20124; Ni T, 2005, IUBMB LIFE, V57, P779, DOI 10.1080/15216540500389013; Nowak M, 2005, CELL DEATH DIFFER, V12, P52, DOI 10.1038/sj.cdd.4401519; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Pirity MK, 2005, MOL CELL BIOL, V25, P7193, DOI 10.1128/MCB.25.16.7193-7202.2005; Pirrotta V, 2006, E SCHERING RES FDN W, V57, P97; Raaphorst FM, 2005, INT J HEMATOL, V81, P281, DOI 10.1532/IJH97.05023; Reed John C., 1999, Current Opinion in Oncology, V11, P68, DOI 10.1097/00001622-199901000-00014; Ribble D, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-12; Rodriguez M, 1997, BIOCHEM CELL BIOL, V75, P579, DOI 10.1139/bcb-75-5-579; Sanders LH, 2003, DEV DYNAM, V227, P291, DOI 10.1002/dvdy.10308; Sawa C, 2002, J BIOL CHEM, V277, P22484, DOI 10.1074/jbc.M203060200; Schlisio S, 2002, EMBO J, V21, P5775, DOI 10.1093/emboj/cdf577; Scott GK, 2006, CANCER RES, V66, P1277, DOI 10.1158/0008-5472.CAN-05-3632; Tibbetts MD, 2003, NAT IMMUNOL, V4, P404, DOI 10.1038/ni0503-404; Trimarchi JM, 2001, P NATL ACAD SCI USA, V98, P1519, DOI 10.1073/pnas.041597698; Twomey C, 2005, J CELL MOL MED, V9, P345, DOI 10.1111/j.1582-4934.2005.tb00360.x; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Yabu T, 2001, BIOCHEM J, V360, P39, DOI 10.1042/0264-6021:3600039; Zheng LX, 2001, J BIOL CHEM, V276, P31945, DOI 10.1074/jbc.M102799200	46	28	30	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					28782	28793		10.1074/jbc.M603348200	http://dx.doi.org/10.1074/jbc.M603348200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16891308	hybrid			2022-12-27	WOS:000240680500032
J	Murakami, Y; Yamagoe, S; Noguchi, K; Takebe, Y; Takahashi, N; Uehara, Y; Fukazawa, H				Murakami, Yuko; Yamagoe, Satoshi; Noguchi, Kohji; Takebe, Yutaka; Takahashi, Naoko; Uehara, Yoshimasa; Fukazawa, Hidesuke			Ets-1-dependent expression of vascular endothelial growth factor receptors is activated by latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus through interaction with Daxx	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAMP RESPONSE ELEMENT; TRANSCRIPTIONAL ACTIVATION; GENE-EXPRESSION; MOLECULAR-BIOLOGY; BINDING PROTEIN; CELLS; ETS-1; FLT-1; LANA; ANGIOGENESIS	Vascular endothelial growth factor ( VEGF) and its receptors are highly expressed in Kaposi's sarcoma(KS) lesion and play a key role in angiogenesis. Latency-associated nuclear antigen ( LANA) of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8) has multiple functions related to viral latency and KSHV-induced oncogenesis. In this report, we have identified Daxx as a LANA-binding protein by co-immunoprecipitation analysis of HeLa cells stably expressing LANA. LANA associated with Daxx in a PEL cell line infected with KSHV. LANA and Daxx also bound in vitro, suggesting direct interaction. From the results of binding assays, a region containing the Glu/Asp-rich domain within LANA, and a central region including the second paired amphipathic helix within Daxx contributed to the interaction. To address the physiological significance of this interaction, we focused on a Daxx-mediated VEGF receptor gene regulation. We found that Daxx repressed Ets-1-dependent Flt-1/VEGF receptor-1 gene expression, and that LANA inhibited the repression by Daxx in a reporter assay. Analyses of flow cytometry and real-time PCR revealed that expression of VEGF receptor-1 and -2 in LANA-expressing human umbilical vein endothelial cells(HUVECs) significantly increased. Co-immunoprecipitation and immunoblotting experiments suggested that LANA-bound Daxx to inhibit the interaction between Daxx and Ets-1. Chromatin immunoprecipitation assays showed that Daxx associated with VEGF receptor-1 promoter in HUVECs, and that LANA expression reduced this association. These results suggested that LANA contributes to a high expression of VEGF receptors in KS lesion by interfering with the interaction between Daxx and Ets-1.	Natl Inst Infect Dis, Dept Bioact Mol, Shinjuku Ku, AIDS Res Ctr, Tokyo 1628640, Japan; Natl Inst Infect Dis, Lab Mol Virol & Epidemiol, Shinjuku Ku, AIDS Res Ctr, Tokyo 1628640, Japan	National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID)	Yamagoe, S (corresponding author), Natl Inst Infect Dis, Dept Bioact Mol, Shinjuku Ku, AIDS Res Ctr, Toyama 1-23-1, Tokyo 1628640, Japan.	syamagoe@nih.go.jp						An JB, 2004, BLOOD, V103, P222, DOI 10.1182/blood-2003-05-1538; Bais C, 2003, CANCER CELL, V3, P131, DOI 10.1016/S1535-6108(03)00024-2; Ballestas ME, 1999, SCIENCE, V284, P641, DOI 10.1126/science.284.5414.641; Chen ZQ, 1997, CANCER RES, V57, P2013; Dupin N, 1999, P NATL ACAD SCI USA, V96, P4546, DOI 10.1073/pnas.96.8.4546; Elvert G, 2003, J BIOL CHEM, V278, P7520, DOI 10.1074/jbc.M211298200; Emelyanov AV, 2002, J BIOL CHEM, V277, P11156, DOI 10.1074/jbc.M111763200; Everett RD, 2001, ONCOGENE, V20, P7266, DOI 10.1038/sj.onc.1204759; Flore O, 1998, NATURE, V394, P588, DOI 10.1038/29093; Friborg J, 1999, NATURE, V402, P889, DOI 10.1038/47266; Fujimuro M, 2003, NAT MED, V9, P300, DOI 10.1038/nm829; Garber AC, 2001, J VIROL, V75, P7882, DOI 10.1128/JVI.75.17.7882-7892.2001; Hollenbach AD, 1999, EMBO J, V18, P3702, DOI 10.1093/emboj/18.13.3702; Jang MS, 2002, BIOCHEM BIOPH RES CO, V295, P495, DOI 10.1016/S0006-291X(02)00699-X; Kappel A, 2000, BLOOD, V96, P3078; Katano H, 1999, AM J PATHOL, V155, P47, DOI 10.1016/S0002-9440(10)65097-3; Kim EJ, 2003, NUCLEIC ACIDS RES, V31, P5356, DOI 10.1093/nar/gkg741; KOIZUMI S, 1990, ONCOGENE, V5, P675; Krithivas A, 2000, J VIROL, V74, P9637, DOI 10.1128/JVI.74.20.9637-9645.2000; Krithivas A, 2002, J VIROL, V76, P11596, DOI 10.1128/JVI.76.22.11596-11604.2002; Li RZ, 2000, ONCOGENE, V19, P745, DOI 10.1038/sj.onc.1203385; Lim C, 2000, J GEN VIROL, V81, P2645, DOI 10.1099/0022-1317-81-11-2645; Lim C, 2003, J BIOL CHEM, V278, P7397, DOI 10.1074/jbc.M211912200; Lim C, 2001, J BIOL CHEM, V276, P31016, DOI 10.1074/jbc.M102431200; Masood R, 2002, AM J PATHOL, V160, P23, DOI 10.1016/S0002-9440(10)64344-1; Masood R, 1997, P NATL ACAD SCI USA, V94, P979, DOI 10.1073/pnas.94.3.979; Moore PS, 1998, AM J EPIDEMIOL, V147, P217, DOI 10.1093/oxfordjournals.aje.a009440; MORISHITA K, 1995, J BIOL CHEM, V270, P27948, DOI 10.1074/jbc.270.46.27948; Oikawa T, 2003, GENE, V303, P11, DOI 10.1016/S0378-1119(02)01156-3; Platt GM, 1999, J VIROL, V73, P9789, DOI 10.1128/JVI.73.12.9789-9795.1999; Radkov SA, 2000, NAT MED, V6, P1121, DOI 10.1038/80459; Russo JJ, 1996, P NATL ACAD SCI USA, V93, P14862, DOI 10.1073/pnas.93.25.14862; SACCHI N, 1988, LEUKEMIA, V2, P12; Sato Y, 2000, ANN NY ACAD SCI, V902, P201; Spronk CAEM, 2000, NAT STRUCT BIOL, V7, P1100; Tang DG, 2004, SEMIN THROMB HEMOST, V30, P109; Wakiya K, 1996, J BIOL CHEM, V271, P30823, DOI 10.1074/jbc.271.48.30823; Wasylyk C, 2002, MOL CELL BIOL, V22, P2687, DOI 10.1128/MCB.22.8.2687-2702.2002; WERNERT N, 1992, AM J PATHOL, V140, P119; Yamagoe S, 2003, MOL CELL BIOL, V23, P1025, DOI 10.1128/MCB.23.3.1025-1033.2003; Yang XL, 1997, CELL, V89, P1067, DOI 10.1016/S0092-8674(00)80294-9	41	46	47	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					28113	28121		10.1074/jbc.M602026200	http://dx.doi.org/10.1074/jbc.M602026200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16861237	hybrid			2022-12-27	WOS:000240534400049
J	Romanenko, V; Nakamoto, T; Srivastava, A; Melvin, JE; Begenisich, T				Romanenko, Victor; Nakamoto, Tetsuji; Srivastava, Alaka; Melvin, James E.; Begenisich, Ted			Molecular identification and physiological roles of parotid acinar cell maxi-K channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY VOLUME DECREASE; ACTIVATED POTASSIUM CHANNEL; INTERMEDIATE CONDUCTANCE; MOUSE HIPPOCAMPUS; SECRETORY-CELLS; GENE-EXPRESSION; CATION CHANNELS; MEMBRANE; MICE; PROTEINS	The physiological success of fluid-secreting tissues relies on a regulated interplay between Ca2+-activated Cl- and K+ channels. Parotid acinar cells express two types of Ca2+-activated K+ channels: intermediate conductance IK1 channels and maxi-K channels. The IK1 channel is encoded by the K(Ca)3.1 gene, and the K(Ca)1.1 gene is a likely candidate for the maxi-K channel. To confirm the genetic identity of the maxi-K channel and to probe its specific roles, we studied parotid glands in mice with the K(Ca)1.1 gene ablated. Parotid acinar cells from these animals lacked maxi-K channels, confirming their genetic identity. The stimulated parotid gland fluid secretion rate was normal, but the sodium and potassium content of the secreted fluid was altered. In addition, we found that the regulatory volume decrease in acinar cells was substantially impaired in K(Ca)1.1-null animals. We examined fluid secretion from animals with both K channel genes deleted. The secretion rate was severely reduced, and the ion content of the secreted fluid was significantly changed. We measured the membrane potentials of acinar cells from wild-type mice and from animals with either or both K+ channel genes ablated. They revealed that the observed functional effects on fluid secretion reflected alterations in cell membrane voltage. Our findings show that the maxi-K channels are critical for the regulatory volume decrease in these cells and that they play an important role in the sodium uptake and potassium secretion process in the ducts of these fluid-secreting salivary glands.	Univ Rochester, Med Ctr, Dept Pharmacol & Physiol, Rochester, NY 14642 USA; Univ Rochester, Med Ctr, Ctr Oral Biol, Aab Inst Biomed Sci, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Begenisich, T (corresponding author), Univ Rochester, Med Ctr, Dept Pharmacol & Physiol, POB 711, Rochester, NY 14642 USA.	Ted_Begenisich@URMC.rochester.edu	Romanenko, Victor/A-1956-2009		NIDCR NIH HHS [DE016960, DE13539] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016960, P01DE013539] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Begenisich T, 2004, J BIOL CHEM, V279, P47681, DOI 10.1074/jbc.M409627200; BERS DM, 1994, METHOD CELL BIOL, V40, P3; Bruce JIE, 2002, J BIOL CHEM, V277, P1340, DOI 10.1074/jbc.M106609200; Evans RL, 2000, J BIOL CHEM, V275, P26720; Fernandes C, 2004, EUR J NEUROSCI, V19, P2576, DOI 10.1111/j.0953-816X.2004.03358.x; Fernandez-Fernandez JM, 2002, AM J PHYSIOL-CELL PH, V283, pC1705, DOI 10.1152/ajpcell.00245.2002; FOSKETT JK, 1994, J EXP ZOOL, V268, P104, DOI 10.1002/jez.1402680206; FOSKETT JK, 1989, SCIENCE, V244, P1582, DOI 10.1126/science.2500708; GRAY PTA, 1988, J PHYSIOL-LONDON, V406, P35, DOI 10.1113/jphysiol.1988.sp017367; Gribkoff V K, 1997, Adv Pharmacol, V37, P319; Harmer AR, 2005, AM J PHYSIOL-GASTR L, V288, pG118, DOI 10.1152/ajpgi.00096.2004; Hayashi T, 1996, J MEMBRANE BIOL, V151, P19, DOI 10.1007/s002329900054; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; Ishii TM, 1997, P NATL ACAD SCI USA, V94, P11651, DOI 10.1073/pnas.94.21.11651; ISHIKAWA T, 1994, PFLUG ARCH EUR J PHY, V428, P516, DOI 10.1007/BF00374573; Krane CM, 2001, J BIOL CHEM, V276, P23413, DOI 10.1074/jbc.M008760200; Logsdon NJ, 1997, J BIOL CHEM, V272, P32723, DOI 10.1074/jbc.272.52.32723; MANGOS JA, 1973, AM J PHYSIOL, V225, P18, DOI 10.1152/ajplegacy.1973.225.1.18; MARUYAMA Y, 1986, JPN J PHYSIOL, V36, P219, DOI 10.2170/jjphysiol.36.219; Meredith AL, 2004, J BIOL CHEM, V279, P36746, DOI 10.1074/jbc.M405621200; Nehrke K, 2003, AM J PHYSIOL-CELL PH, V284, pC535, DOI 10.1152/ajpcell.00044.2002; Park K, 2001, ARCH ORAL BIOL, V46, P801, DOI 10.1016/S0003-9969(01)00047-4; PARK KP, 1994, J MEMBRANE BIOL, V141, P193; PETERSEN OH, 1984, NATURE, V307, P693, DOI 10.1038/307693a0; Pollak DD, 2006, NEUROSCIENCE, V138, P149, DOI 10.1016/j.neuroscience.2005.11.004; Pollak DD, 2006, GENES BRAIN BEHAV, V5, P200, DOI 10.1111/j.1601-183X.2006.00207.x; Schreiber R, 1999, J BIOL CHEM, V274, P11811, DOI 10.1074/jbc.274.17.11811; Shusterman V, 2002, AM J PHYSIOL-HEART C, V282, pH2076, DOI 10.1152/ajpheart.00917.2001; Tabibiazar R, 2005, ARTERIOSCL THROM VAS, V25, P302, DOI 10.1161/01.ATV.0000151372.86863.a5; Takahata T, 2003, AM J PHYSIOL-CELL PH, V284, pC127, DOI 10.1152/ajpcell.00250.2002; Thompson J, 2006, J GEN PHYSIOL, V127, P159, DOI 10.1085/jgp.200509457; WEGMAN EA, 1992, AM J PHYSIOL, V263, pG786, DOI 10.1152/ajpgi.1992.263.5.G786; Wehner F, 2004, REV PHYSIOL BIOCH P, V148, P1, DOI 10.1007/s10254-003-0009-x; Weskamp M, 2000, J MEMBRANE BIOL, V178, P11, DOI 10.1007/s002320010010; YOUNG JA, 1966, PFLUG ARCH GES PHYS, V291, P85, DOI 10.1007/BF00362654	35	37	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					27964	27972		10.1074/jbc.M603871200	http://dx.doi.org/10.1074/jbc.M603871200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16873365	hybrid			2022-12-27	WOS:000240534400033
J	Su, X; Lodhi, IJ; Saltiel, AR; Stahl, PD				Su, Xiong; Lodhi, Irfan J.; Saltiel, Alan R.; Stahl, Philip D.			Insulin-stimulated interaction between insulin receptor substrate 1 and p85 alpha and activation of protein kinase B/Akt require Rab5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL GTPASE RAB5; CLATHRIN-MEDIATED ENDOCYTOSIS; PLECKSTRIN HOMOLOGY DOMAIN; NUCLEOTIDE EXCHANGE FACTOR; EPIDERMAL-GROWTH-FACTOR; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHOINOSITIDE 3-KINASE; 3T3-L1 ADIPOCYTES; MEMBRANE; TRAFFICKING	Binding of insulin to the insulin receptor initiates a cascade of protein phosphorylation and effector recruitment events leading to the activation of multiple distinct signaling pathways. Previous studies suggested that the diversity and specificity of insulin signal transduction are accomplished by both subcellular localization of receptor and the selective activation of downstream signaling molecules. The small GTPase Rab5 is a key regulator of endocytosis. Three Rab5 isoforms (Rab5a, -5b, and -5c) have been identified. Here we exploited the RNA interference technique to specifically knock down individual Rab5 isoforms to determine the cellular function of Rab5 in distinct insulin signaling pathways. Small interference RNA against a single Rab5 isoform had no effect on protein kinase B (PKB)/Akt or MAPK activation by insulin in NIH3T3 cells overexpressing human insulin receptor. However, simultaneous knockdown of all three Rab5 isoforms dramatically attenuated PKB/Akt activation by insulin without affecting MAPK activation. This inhibition of PKB/Akt activation was because of the impaired interaction between insulin receptor substrate 1 and the p85 alpha subunit of phosphatidylinositol 3-kinase. These results indicate a requirement of Rab5 in presenting p85 to insulin receptor substrate 1. Additional evidence supporting a role for Rab5 was suggested by studies with GAPex-5, a vps9 domain containing exchange factor. Down-regulation of GAPex-5 impaired insulin-stimulated PKB/Akt activation. Collectively, this study indicates the involvement of Rab5 in insulin signaling.	Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; Univ Michigan, Inst Life Sci, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Inst Life Sci, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	Washington University (WUSTL); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Stahl, PD (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, Campus Box 8228,660 S Euclid, St Louis, MO 63110 USA.	pstahl@cellbiology.wustl.edu	Stahl, Philip/D-6315-2012; Saltiel, Alan/L-3632-2019	Saltiel, Alan/0000-0002-9726-9828; Lodhi, Irfan/0000-0002-6246-9862	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061618, R21DK065844] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042259] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01DK061618-04, 5R21DK065844-02] Funding Source: Medline; NIGMS NIH HHS [2R01GM42259-33] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson DH, 2005, METHOD ENZYMOL, V403, P552, DOI 10.1016/S0076-6879(05)03048-X; Barbieri MA, 2000, J CELL BIOL, V151, P539, DOI 10.1083/jcb.151.3.539; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; Bevan P, 2001, J CELL SCI, V114, P1429; BUCCI C, 1995, FEBS LETT, V366, P65, DOI 10.1016/0014-5793(95)00477-Q; Ceresa BP, 1998, MOL CELL BIOL, V18, P3862, DOI 10.1128/MCB.18.7.3862; Chamberlain MD, 2005, METHOD ENZYMOL, V403, P541, DOI 10.1016/S0076-6879(05)03047-8; Chamberlain MD, 2004, J BIOL CHEM, V279, P48607, DOI 10.1074/jbc.M409769200; Chiang SH, 2001, NATURE, V410, P944, DOI 10.1038/35073608; Chiariello M, 1999, FEBS LETT, V453, P20, DOI 10.1016/S0014-5793(99)00686-9; Christoforidis S, 1999, NAT CELL BIOL, V1, P249, DOI 10.1038/12075; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Clark SF, 1998, J CELL BIOL, V140, P1211, DOI 10.1083/jcb.140.5.1211; Clark SF, 2000, J BIOL CHEM, V275, P3819, DOI 10.1074/jbc.275.6.3819; Devon RS, 2005, NEUROBIOL DIS, V18, P243, DOI 10.1016/j.nbd.2004.10.002; Di Guglielmo GM, 1998, MOL CELL BIOCHEM, V182, P59, DOI 10.1023/A:1006883311233; Fiory F, 2004, J BIOL CHEM, V279, P11137, DOI 10.1074/jbc.M308751200; HELLERHARRISON RA, 1995, J BIOL CHEM, V270, P24442, DOI 10.1074/jbc.270.41.24442; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Huang J, 2001, P NATL ACAD SCI USA, V98, P13084, DOI 10.1073/pnas.241368698; Hunker CM, 2006, BIOCHEM BIOPH RES CO, V340, P967, DOI 10.1016/j.bbrc.2005.12.099; Inoue G, 1998, J BIOL CHEM, V273, P11548, DOI 10.1074/jbc.273.19.11548; Knight JB, 2000, ENDOCRINOLOGY, V141, P208, DOI 10.1210/en.141.1.208; KNUTSON VP, 1982, P NATL ACAD SCI-BIOL, V79, P2822, DOI 10.1073/pnas.79.9.2822; KUBLAOUI B, 1995, J BIOL CHEM, V270, P59, DOI 10.1074/jbc.270.1.59; Kurosu H, 2001, J BIOCHEM-TOKYO, V130, P73, DOI 10.1093/oxfordjournals.jbchem.a002964; Lanzetti L, 2004, NATURE, V429, P309, DOI 10.1038/nature02542; Lanzetti L, 2001, EXP CELL RES, V271, P45, DOI 10.1006/excr.2001.5369; Lee YH, 2004, ARCH PHARM RES, V27, P361, DOI 10.1007/BF02980074; LEVYTOLEDANO R, 1993, ENDOCRINOLOGY, V133, P1803, DOI 10.1210/en.133.4.1803; LI GP, 1993, J BIOL CHEM, V268, P24475; Milburn CC, 2003, BIOCHEM J, V375, P531, DOI 10.1042/BJ20031229; Murata H, 2003, J BIOL CHEM, V278, P21607, DOI 10.1074/jbc.M302934200; Nave BT, 1996, BIOCHEM J, V318, P55, DOI 10.1042/bj3180055; Otomo A, 2003, HUM MOL GENET, V12, P1671, DOI 10.1093/hmg/ddg184; Pitterle DM, 1999, AM J PHYSIOL-ENDOC M, V276, pE94, DOI 10.1152/ajpendo.1999.276.1.E94; Rao AW, 1998, J BIOL CHEM, V273, P25450, DOI 10.1074/jbc.273.39.25450; Rodman JS, 2000, J CELL SCI, V113, P183; Saltiel AR, 2002, TRENDS CELL BIOL, V12, P65, DOI 10.1016/S0962-8924(01)02207-3; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sato M, 2005, NAT CELL BIOL, V7, P559, DOI 10.1038/ncb1261; Seachrist JL, 2003, LIFE SCI, V74, P225, DOI 10.1016/j.lfs.2003.09.009; Shepherd PR, 1998, BIOCHEM J, V333, P471, DOI 10.1042/bj3330471; Shepherd PR, 2005, ACTA PHYSIOL SCAND, V183, P3, DOI 10.1111/j.1365-201X.2004.01382.x; Shin HW, 2005, J CELL BIOL, V170, P607, DOI 10.1083/jcb.200505128; Simpson JC, 2005, BIOCHEM SOC SYMP, V72, P99, DOI 10.1042/bss0720099; Su X, 2004, J BIOL CHEM, V279, P21740, DOI 10.1074/jbc.M314166200; Tall GG, 2001, DEV CELL, V1, P73, DOI 10.1016/S1534-5807(01)00008-9; Topp JD, 2004, J BIOL CHEM, V279, P24612, DOI 10.1074/jbc.M313504200; Vainshtein I, 2001, J BIOL CHEM, V276, P8073, DOI 10.1074/jbc.M008436200; van der Bliek AM, 2005, NAT CELL BIOL, V7, P548, DOI 10.1038/ncb0605-548; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Wang B, 1996, BIOCHEM BIOPH RES CO, V227, P27, DOI 10.1006/bbrc.1996.1462; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; White MF, 1998, MOL CELL BIOCHEM, V182, P3, DOI 10.1023/A:1006806722619; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	58	53	56	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					27982	27990		10.1074/jbc.M602873200	http://dx.doi.org/10.1074/jbc.M602873200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16880210	hybrid			2022-12-27	WOS:000240534400035
J	Caruthers, JM; Feng, YN; McKay, DB; Cohen, SN				Caruthers, Jonathan M.; Feng, Yanan; McKay, David B.; Cohen, Stanley N.			Retention of core catalytic functions by a conserved minimal ribonuclease E peptide that lacks the domain required for tetramer formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA STABILITY; ESCHERICHIA-COLI-AMS; 16S RIBOSOMAL-RNA; C-TERMINAL HALF; CAFA PROTEIN; GENE; DEGRADOSOME; DEGRADATION; CLEAVAGE; DECAY	Ribonuclease E (RNase E) is a multifunctional endoribonuclease that has been evolutionarily conserved in both Gram-positive and Gram-negative bacteria. X-ray crystallography and biochemical studies have concluded that the Escherichia coli RNase E protein functions as a homotetramer formed by Zn linkage of dimers within a region extending from amino acid residues 416 through 529 of the 116-kDa protein. Using fragments of RNase E proteins from E. coli and Haemophilus influenzae, we show here that RNase E derivatives that are as short as 395 amino acid residues and that lack the Zn-link region shown previously to be essential for tetramer formation (i.e. amino acid residues 400 415) are catalytically active enzymes that retain the 5' to 3' scanning ability and cleavage site specificity characteristic of full-length RNase E and that also confer colony forming ability on rne null mutant bacteria. Further truncation leads to loss of these properties. Our results, which identify a minimal catalytically active RNase E sequence, indicate that contrary to current models, a tetrameric quaternary structure is not required for RNase E to carry out its core enzymatic functions.	Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	McKay, DB (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.	dave.mckay@stanford.edu; sncohen@stanford.edu			NIGMS NIH HHS [GM 71696, GM 54158] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071696, R01GM054158] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		APIRION D, 1978, J BIOL CHEM, V253, P1738; BABITZKE P, 1991, P NATL ACAD SCI USA, V88, P1, DOI 10.1073/pnas.88.1.1; Baginsky S, 2001, METHOD ENZYMOL, V342, P408, DOI 10.1016/S0076-6879(01)42562-6; Bernstein JA, 2004, P NATL ACAD SCI USA, V101, P2758, DOI 10.1073/pnas.0308747101; Callaghan AJ, 2005, NATURE, V437, P1187, DOI 10.1038/nature04084; Callaghan AJ, 2005, BIOCHEMISTRY-US, V44, P4667, DOI 10.1021/bi0478244; Callaghan AJ, 2004, J MOL BIOL, V340, P965, DOI 10.1016/j.jmb.2004.05.046; CARPOUSIS AJ, 1994, CELL, V76, P889, DOI 10.1016/0092-8674(94)90363-8; CASAREGOLA S, 1992, J MOL BIOL, V228, P30, DOI 10.1016/0022-2836(92)90489-7; Coburn GA, 1999, PROG NUCLEIC ACID RE, V62, P55; Diwa AA, 2002, MOL MICROBIOL, V46, P959, DOI 10.1046/j.1365-2958.2002.03231.x; Feng YA, 2002, P NATL ACAD SCI USA, V99, P14746, DOI 10.1073/pnas.202590899; GEGENHEIMER P, 1977, J BIOL CHEM, V252, P3064; GHORA BK, 1978, CELL, V15, P1055, DOI 10.1016/0092-8674(78)90289-1; Grunberg-Manago M, 1999, ANNU REV GENET, V33, P193, DOI 10.1146/annurev.genet.33.1.193; Huang HJ, 1998, NATURE, V391, P99, DOI 10.1038/34219; Jiang XQ, 2004, P NATL ACAD SCI USA, V101, P9211, DOI 10.1073/pnas.0401382101; Kaberdin VR, 2005, BIOCHEM BIOPH RES CO, V327, P382, DOI 10.1016/j.bbrc.2004.12.017; Kaberdin VR, 1998, P NATL ACAD SCI USA, V95, P11637, DOI 10.1073/pnas.95.20.11637; KUWANO M, 1977, MOL GEN GENET, V154, P279, DOI 10.1007/BF00571283; Lee K, 2003, MOL MICROBIOL, V48, P349, DOI 10.1046/j.1365-2958.2003.03435.x; Lee K, 2002, MOL MICROBIOL, V43, P1445, DOI 10.1046/j.1365-2958.2002.02848.x; Lee KS, 2003, CELL, V114, P623, DOI 10.1016/j.cell.2003.08.003; Leroy A, 2002, MOL MICROBIOL, V45, P1231, DOI 10.1046/j.1365-2958.2002.03104.x; Li ZW, 1999, EMBO J, V18, P2878, DOI 10.1093/emboj/18.10.2878; Lin-Chao S, 1999, P NATL ACAD SCI USA, V96, P12406, DOI 10.1073/pnas.96.22.12406; LINCHAO S, 1991, CELL, V65, P1233, DOI 10.1016/0092-8674(91)90018-T; Lopez PJ, 1999, MOL MICROBIOL, V33, P188, DOI 10.1046/j.1365-2958.1999.01465.x; Mackie GA, 1998, NATURE, V395, P720, DOI 10.1038/27246; MCDOWALL KJ, 1995, NATURE, V374, P287, DOI 10.1038/374287a0; McDowall KJ, 1996, J MOL BIOL, V255, P349, DOI 10.1006/jmbi.1996.0027; MCPHERSON A, 1989, SCI AM, V260, P62, DOI 10.1038/scientificamerican0389-62; MELEFORS O, 1991, MOL MICROBIOL, V5, P857, DOI 10.1111/j.1365-2958.1991.tb00759.x; Miczak A, 1996, P NATL ACAD SCI USA, V93, P3865, DOI 10.1073/pnas.93.9.3865; MUDD EA, 1990, MOL MICROBIOL, V4, P2127, DOI 10.1111/j.1365-2958.1990.tb00574.x; ONO M, 1979, J MOL BIOL, V129, P343, DOI 10.1016/0022-2836(79)90500-X; Ow MC, 2000, MOL MICROBIOL, V38, P854, DOI 10.1046/j.1365-2958.2000.02186.x; PY B, 1994, MOL MICROBIOL, V14, P717, DOI 10.1111/j.1365-2958.1994.tb01309.x; Py B, 1996, NATURE, V381, P169, DOI 10.1038/381169a0; Steege DA, 2000, RNA, V6, P1079, DOI 10.1017/S1355838200001023; TARASEVICIENE L, 1995, J BIOL CHEM, V270, P26391, DOI 10.1074/jbc.270.44.26391; TARASEVICIENE L, 1991, MOL MICROBIOL, V5, P851, DOI 10.1111/j.1365-2958.1991.tb00758.x; Tock MR, 2000, J BIOL CHEM, V275, P8726, DOI 10.1074/jbc.275.12.8726; Wachi M, 1999, BIOCHEM BIOPH RES CO, V259, P483, DOI 10.1006/bbrc.1999.0806; Walsh AP, 2001, NUCLEIC ACIDS RES, V29, P1864, DOI 10.1093/nar/29.9.1864	45	22	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2006	281	37					27046	27051		10.1074/jbc.M602467200	http://dx.doi.org/10.1074/jbc.M602467200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082PB	16854990	hybrid			2022-12-27	WOS:000240397700031
J	Colton, SL; Xu, XXS; Wang, YA; Wang, G				Colton, Stephanie L.; Xu, Xiaoxin S.; Wang, Y. Alan; Wang, Gan			The involvement of ataxia-telangiectasia mutated protein activation in nucleotide excision repair-facilitated cell survival with cisplatin treatment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERSTRAND CROSS-LINKS; GROUP-C PROTEIN; DNA-DAMAGE RECOGNITION; ATM ACTIVATION; XPC PROTEIN; PHOSPHORYLATION; COMPLEX; PSORALEN; CHK2; TRANSCRIPTION	DNA damage can lead to either DNA repair with cell survival or to apoptotic cell death. Although the biochemical processes underlying DNA repair and apoptosis have been extensively studied, the mechanisms by which cells determine whether the damage will be repaired or the apoptotic pathway will be activated is largely unknown. We have studied the role of nucleotide excision repair (NER) in cisplatin DNA damage-induced apoptotic cell death using both normal human fibroblasts and NER-defective xeroderma pigmentosum (XP) XPA and XPG cells. The caspase-3 activation experiment demonstrated a greatly increased casapse-3 activation in the NER-defective cells following cisplatin treatment. The flow cytometry experiment revealed an altered cell cycle arrest pattern of the NER-defective cells following cisplatin treatment. The results obtained from the Western blot experiment showed that NER defects resulted in enhanced CHK1 phosphorylation and p21 induction after cisplatin treatment. The cisplatin treatment-induced ATM phosphorylation, however, was attenuated in NER-defective cells. The results obtained from our immunoprecipitation experiment further demonstrated that the ATM protein interacted with the TFIIH basal transcription factor and the XPG protein of the NER pathway. It also showed that a functional XPC protein was required for the association of the ATM protein to genomic DNA. These results suggest that the NER process may prevent the cisplatin treatment-induced apoptosis by activating the ATM protein, and that the presence of the XPC protein is essential for recruiting the ATM protein to the DNA template.	Wayne State Univ, IEHS, Detroit, MI 48201 USA; Wayne State Univ, Karmanos Canc Res Inst, Detroit, MI 48201 USA	Wayne State University; Wayne State University	Wang, G (corresponding author), Wayne State Univ, IEHS, 2727 2nd Ave,Rm 4000, Detroit, MI 48201 USA.	g.wang@wayne.edu			NIEHS NIH HHS [T32 ES01216, P30 ES06639, R01ES09699] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009699, P30ES006639] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Barre FX, 1999, J MOL BIOL, V286, P1379, DOI 10.1006/jmbi.1999.2550; Bartek J, 2001, FEBS LETT, V490, P117, DOI 10.1016/S0014-5793(01)02114-7; Batty DP, 2000, GENE, V241, P193, DOI 10.1016/S0378-1119(99)00489-8; Berardi P, 2004, CELL MOL LIFE SCI, V61, P2173, DOI 10.1007/s00018-004-4179-8; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Capasso H, 2002, J CELL SCI, V115, P4555, DOI 10.1242/jcs.00133; Chaturvedi P, 1999, ONCOGENE, V18, P4047, DOI 10.1038/sj.onc.1202925; Chen ZW, 2004, BIOCHEM J, V379, P71, DOI 10.1042/BJ20031143; Chen ZW, 2003, CARCINOGENESIS, V24, P1111, DOI 10.1093/carcin/bgg051; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; EASTMAN A, 1985, BIOCHEMISTRY-US, V24, P5027, DOI 10.1021/bi00340a011; EASTMAN A, 1987, PHARMACOL THERAPEUT, V34, P155, DOI 10.1016/0163-7258(87)90009-X; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES; Furuta T, 2002, CANCER RES, V62, P4899; HARPER JW, 1993, CELL, V75, P805; Heffernan TP, 2002, MOL CELL BIOL, V22, P8552, DOI 10.1128/MCB.22.24.8552-8561.2002; Irvine Ryan A, 2004, Methods Mol Biol, V287, P45; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Kastan MB, 2000, COLD SPRING HARB SYM, V65, P521, DOI 10.1101/sqb.2000.65.521; Kumagai A, 2004, J BIOL CHEM, V279, P49599, DOI 10.1074/jbc.M408353200; Kumaresan KR, 2002, BIOCHEMISTRY-US, V41, P890, DOI 10.1021/bi011614z; Kuraoka I, 2000, J BIOL CHEM, V275, P26632, DOI 10.1074/jbc.C000337200; Lakin ND, 1996, ONCOGENE, V13, P2707; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Li L, 1997, MUTAT RES-DNA REPAIR, V383, P197, DOI 10.1016/S0921-8777(97)00002-5; Li L, 2000, NUCLEIC ACIDS RES, V28, P1424, DOI 10.1093/nar/28.6.1424; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; Liu QH, 2000, GENE DEV, V14, P1448; Masutani C, 1997, MOL CELL BIOL, V17, P6915, DOI 10.1128/MCB.17.12.6915; MASUTANI C, 1994, EMBO J, V13, P1831, DOI 10.1002/j.1460-2075.1994.tb06452.x; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; McGowan CH, 2004, CURR OPIN CELL BIOL, V16, P629, DOI 10.1016/j.ceb.2004.09.005; Meek DW, 2004, DNA REPAIR, V3, P1049, DOI 10.1016/j.dnarep.2004.03.027; Mu D, 2000, MOL CELL BIOL, V20, P2446, DOI 10.1128/MCB.20.7.2446-2454.2000; MU D, 1995, J BIOL CHEM, V270, P2415, DOI 10.1074/jbc.270.6.2415; Niida H, 2006, MUTAGENESIS, V21, P3, DOI 10.1093/mutage/gei063; Norbury CJ, 2004, ONCOGENE, V23, P2797, DOI 10.1038/sj.onc.1207532; ODONOVAN A, 1994, NATURE, V371, P432, DOI 10.1038/371432a0; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; PARK CH, 1994, P NATL ACAD SCI USA, V91, P5017, DOI 10.1073/pnas.91.11.5017; Paull TT, 2005, CELL CYCLE, V4, P737, DOI 10.4161/cc.4.6.1715; Pichierri P, 2004, EMBO J, V23, P1178, DOI 10.1038/sj.emboj.7600113; SANCAR A, 1995, J BIOL CHEM, V270, P15915, DOI 10.1074/jbc.270.27.15915; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Shechter D, 2004, DNA REPAIR, V3, P901, DOI 10.1016/j.dnarep.2004.03.020; SHEN K, 2006, IN PRESS J CELL BIOL; Sugasawa K, 1998, MOL CELL, V2, P223, DOI 10.1016/S1097-2765(00)80132-X; Sugasawa K, 2002, DNA REPAIR, V1, P95, DOI 10.1016/S1568-7864(01)00008-8; Sugasawa K, 2001, GENE DEV, V15, P507, DOI 10.1101/gad.866301; Tapias A, 2004, J BIOL CHEM, V279, P19074, DOI 10.1074/jbc.M312611200; Uchida A, 2002, DNA REPAIR, V1, P449, DOI 10.1016/S1568-7864(02)00031-9; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; vanderSpek PJ, 1996, NUCLEIC ACIDS RES, V24, P2551, DOI 10.1093/nar/24.13.2551; Vermeulen K, 2005, ANN HEMATOL, V84, P627, DOI 10.1007/s00277-005-1065-x; Volker M, 2001, MOL CELL, V8, P213, DOI 10.1016/S1097-2765(01)00281-7; Wang D, 2003, BIOCHEMISTRY-US, V42, P6747, DOI 10.1021/bi034264k; Wang G, 2004, NUCLEIC ACIDS RES, V32, P2231, DOI 10.1093/nar/gkh541; Wang X, 2001, MOL CELL BIOL, V21, P713, DOI 10.1128/MCB.21.3.713-720.2001; Wood RD, 1999, BIOCHIMIE, V81, P39, DOI 10.1016/S0300-9084(99)80036-4; Wood RD, 1997, J BIOL CHEM, V272, P23465, DOI 10.1074/jbc.272.38.23465; Xu XZ, 2002, MOL CELL BIOL, V22, P4419, DOI 10.1128/MCB.22.12.4419-4432.2002; You ZS, 2005, MOL CELL BIOL, V25, P5363, DOI 10.1128/MCB.25.13.5363-5379.2005; Zhang NX, 2000, NUCLEIC ACIDS RES, V28, P4800, DOI 10.1093/nar/28.23.4800; Zhang YW, 2006, CELL CYCLE, V5, P125, DOI 10.4161/cc.5.2.2308; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	73	44	46	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2006	281	37					27117	27125		10.1074/jbc.M602826200	http://dx.doi.org/10.1074/jbc.M602826200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082PB	16849332	hybrid			2022-12-27	WOS:000240397700039
J	Dammeyer, T; Frankenberg-Dinkel, N				Dammeyer, Thorben; Frankenberg-Dinkel, Nicole			Insights into phycoerythrobilin biosynthesis point toward metabolic channeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA REDUCTASE; FERREDOXIN OXIDOREDUCTASE; ESCHERICHIA-COLI; SPECTROSCOPIC CHARACTERIZATION; MARINE SYNECHOCOCCUS; CHROMATIC ADAPTATION; BILIVERDIN-IX; PHYCOCYANOBILIN; PURIFICATION; CHROMOPHORE	Phycoerythrobilin is a linear tetrapyrrole molecule found in cyanobacteria, red algae, and cryptomonads. Together with other bilins such as phycocyanobilin it serves as a light-harvesting pigment in the photosynthetic light-harvesting structures of cyanobacteria called phycobilisomes. The biosynthesis of both pigments starts with the cleavage of heme by heme oxygenases to yield biliverdin IX alpha, which is further reduced at specific positions by ferredoxin-dependent bilin reductases (FDBRs), a new family of radical enzymes. The biosynthesis of phycoerythrobilin requires two subsequent two-electron reductions, each step being catalyzed by one FDBR. This is in contrast to the biosynthesis of phycocyanobilin, where the FDBR phycocyanobilin: ferredoxin oxidoreductase (PcyA) catalyzes a four-electron reduction. The first reaction in phycoerythrobilin biosynthesis is the reduction of the 15,16-double bond of biliverdin IX alpha by 15,16-dihydrobiliverdin: ferredoxin oxidoreductase (PebA). This reaction reduces the conjugated pi-electron system thereby blue-shifting the absorbance properties of the linear tetrapyrrole. The second FDBR, phycoerythrobilin: ferredoxin oxidoreductase (PebB), then reduces the A-ring 2,3,3(1),3(2)-diene structure of 15,16-dihydrobiliverdin to yield phycoerythrobilin. Both FDBRs from the limnic filamentous cyanobacterium Fremyella diplosiphon and the marine cyanobacterium Synechococcus sp. WH8020 were recombinantly produced in Escherichia coli and purified, and their enzymatic activities were determined. By using various natural bilins, the substrate specificity of each FDBR was established, revealing conformational preconditions for their unique specificity. Preparation of the semi-reduced intermediate, 15,16-dihydrobiliverdin, enabled us to perform steady state binding experiments indicating distinct spectroscopic and fluorescent properties of enzyme.bilin complexes. A combination of substrate/product binding analyses and gel permeation chromatography revealed evidence for metabolic channeling.	Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, D-38106 Braunschweig, Germany	Braunschweig University of Technology	Frankenberg-Dinkel, N (corresponding author), Ruhr Univ Bochum, D-44780 Bochum, Germany.	nicole.frankenberg@rub.de	Frankenberg-Dinkel, Nicole/C-1058-2011	Frankenberg-Dinkel, Nicole/0000-0002-7757-6839; Dammeyer, Thorben/0000-0002-3542-1273				Alvey RM, 2003, PLANT CELL, V15, P2448, DOI 10.1105/tpc.015016; BEALE SI, 1984, PLANT PHYSIOL, V76, P7, DOI 10.1104/pp.76.1.7; Beutler M, 2002, PHOTOSYNTH RES, V72, P39, DOI 10.1023/A:1016026607048; CHAPMAN DJ, 1967, J AM CHEM SOC, V89, P5976, DOI 10.1021/ja00999a058; CLARKE AR, 1995, ENZYMOLOGY LABFAX, P191; COBLEY JG, 1993, PLASMID, V30, P90, DOI 10.1006/plas.1993.1037; Everroad C, 2006, J BACTERIOL, V188, P3345, DOI 10.1128/JB.188.9.3345-3356.2006; Falk H., 1989, CHEM LINEAR OLIGOPYR; Fischer AJ, 2004, P NATL ACAD SCI USA, V101, P17334, DOI 10.1073/pnas.0407645101; Frankenberg N, 2003, J BIOL CHEM, V278, P9219, DOI 10.1074/jbc.M211643200; Frankenberg N, 2001, PLANT CELL, V13, P965, DOI 10.1105/tpc.13.4.965; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GLAZER AN, 1994, J APPL PHYCOL, V6, P105, DOI 10.1007/BF02186064; Goller AH, 2005, CHEMPHYSCHEM, V6, P1259, DOI 10.1002/cphc.200400667; Hagiwara Y, 2006, P NATL ACAD SCI USA, V103, P27, DOI 10.1073/pnas.0507266103; HEIRWEGH KPM, 1991, ANAL BIOCHEM, V195, P273, DOI 10.1016/0003-2697(91)90329-R; Lamparter T, 2003, J BIOL CHEM, V278, P33786, DOI 10.1074/jbc.M305563200; Luer C, 2005, J BIOL CHEM, V280, P18568, DOI 10.1074/jbc.M500440200; McDowell MT, 2001, PLANT PHYSIOL, V126, P1546, DOI 10.1104/pp.126.4.1546; Moser J, 2001, EMBO J, V20, P6583, DOI 10.1093/emboj/20.23.6583; Mukougawa K, 2006, FEBS LETT, V580, P1333, DOI 10.1016/j.febslet.2006.01.051; Murphy JT, 1997, CURR BIOL, V7, P870, DOI 10.1016/S0960-9822(06)00375-7; OI VT, 1982, J CELL BIOL, V93, P981, DOI 10.1083/jcb.93.3.981; Palenik B, 2001, APPL ENVIRON MICROB, V67, P991, DOI 10.1128/AEM.67.2.991-994.2001; Rufer AC, 2005, ACTA CRYSTALLOGR F, V61, P263, DOI 10.1107/S1744309105004823; SCHLUCHTER WM, 1994, THESIS PENNSYLVANIA; SHIN M, 1978, J BIOCHEM-TOKYO, V83, P357, DOI 10.1093/oxfordjournals.jbchem.a131921; STOCKER R, 1987, P NATL ACAD SCI USA, V84, P5918, DOI 10.1073/pnas.84.16.5918; Storf M, 2001, BIOCHEMISTRY-US, V40, P12444, DOI 10.1021/bi010776s; Tasler R, 2005, FEBS J, V272, P1927, DOI 10.1111/j.1742-4658.2005.04623.x; Tu SL, 2004, J AM CHEM SOC, V126, P8682, DOI 10.1021/ja049280z; Waterbury JB, 1986, CAN B FISH AQUAT SCI, V214, P71	32	44	47	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2006	281	37					27081	27089		10.1074/jbc.M605154200	http://dx.doi.org/10.1074/jbc.M605154200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082PB	16857683	hybrid			2022-12-27	WOS:000240397700035
J	Harikumar, KG; Pinon, DI; Miller, LJ				Harikumar, Kaleeckal G.; Pinon, Delia I.; Miller, Laurence J.			Fluorescent indicators distributed throughout the pharmacophore of cholecystokinin provide insights into distinct modes of binding and activation of type A and B cholecystokinin receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIRECT IDENTIFICATION; PEPTIDE AGONIST; TRYPTOPHAN RESIDUES; ERYTHROID SPECTRIN; LIGAND; SITE; ORGANIZATION; DYNAMICS; AFFINITY; GASTRIN	Ligand probes with fluorescent indicators positioned throughout the pharmacophoric domain can provide important insights into the molecular basis of receptor binding and activation as reflected in the microenvironment of each indicator while docked at a receptor. We developed three cholecystokinin-like probes with Aladan situated at the N terminus, in the mid-region, and at the C terminus (positions 24, 29, and 33, respectively). These were studied in solution and docked at type A and B cholecystokinin receptors. This study demonstrated clear differences in mechanisms of cholecystokinin binding and activation of these structurally related receptors with distinct agonist structure-activity relationships. The fluorescence characteristics of Aladan are highly sensitive to the polarity of its microenvironment. The mid-region probe was least accessible to the aqueous milieu as determined by fluorescence emission spectra and iodide quenching, which was not altered by changes in conformation from active to inactive. Accessibility of the Nand C-terminal probes was affected by receptor conformation. The position 24 probe was more easily quenched in the active than in the G protein-uncoupled conformation for both receptors. However, the position 33 probe docked at the type A cholecystokinin receptor was more easily quenched in the active conformation, whereas the same probe docked at the type B cholecystokinin receptor was more easily quenched in the inactive conformation. Fluorescence anisotropy and red edge excitation shift determinations confirmed these observations and supported the proposed movements. Although both type A and B cholecystokinin receptors bind cholecystokinin with high affinity, resulting in fully efficacious biological responses, these receptors utilize distinct molecular modes of binding.	Mayo Clin, Ctr Canc, Scottsdale, AZ 85259 USA; Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Scottsdale, AZ 85259 USA	Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic Phoenix	Miller, LJ (corresponding author), Mayo Clin, Ctr Canc, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA.	miller@mayo.edu			NIDDK NIH HHS [DK32878] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK032878, R37DK032878] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anders J, 1999, BIOCHEMISTRY-US, V38, P6043, DOI 10.1021/bi990269z; Arlander SJH, 2004, MOL PHARMACOL, V66, P545, DOI 10.1124/mol.104.001396; Chattopadhyay A, 2003, PROTEIN SCI, V12, P2389, DOI 10.1110/ps.03302003; Chattopadhyay A, 2003, CHEM PHYS LIPIDS, V122, P3, DOI 10.1016/S0009-3084(02)00174-3; Cheng ZJ, 2003, J BIOL CHEM, V278, P52972, DOI 10.1074/jbc.M310090200; Cohen BE, 2002, SCIENCE, V296, P1700, DOI 10.1126/science.1069346; Ding XQ, 2002, MOL PHARMACOL, V61, P1041, DOI 10.1124/mol.61.5.1041; Ding XQ, 2001, J BIOL CHEM, V276, P4236, DOI 10.1074/jbc.M003798200; Dong MQ, 2005, MOL PHARMACOL, V67, P1892, DOI 10.1124/mol.105.012179; Dong MQ, 2005, BIOCHEMISTRY-US, V44, P6693, DOI 10.1021/bi050130q; Dong MQ, 1999, J BIOL CHEM, V274, P4778, DOI 10.1074/jbc.274.8.4778; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hadac EM, 1998, J BIOL CHEM, V273, P12988, DOI 10.1074/jbc.273.21.12988; Hadac EM, 1996, PANCREAS, V13, P130, DOI 10.1097/00006676-199608000-00003; Harikumar KG, 2005, J BIOL CHEM, V280, P1044, DOI 10.1074/jbc.M409480200; Harikumar KG, 2002, J BIOL CHEM, V277, P18552, DOI 10.1074/jbc.M201164200; Ji ZS, 1997, J BIOL CHEM, V272, P24393, DOI 10.1074/jbc.272.39.24393; Kelkar DA, 2005, BIOPOLYMERS, V77, P325, DOI 10.1002/bip.20233; Kennedy K, 1997, J BIOL CHEM, V272, P2920, DOI 10.1074/jbc.272.5.2920; KOLAKOWSKI LF, 1994, RECEPTOR CHANNEL, V2, P1; KOPIN AS, 1995, J BIOL CHEM, V270, P5019, DOI 10.1074/jbc.270.10.5019; MILLER LJ, 1981, J BIOL CHEM, V256, P2417; MOYLE WR, 1994, NATURE, V368, P251, DOI 10.1038/368251a0; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; MUTT V, 1981, PEPTIDES, V2, P209, DOI 10.1016/0196-9781(81)90033-4; Noble F, 1999, PHARMACOL REV, V51, P745; Noble F, 1999, THERAPIE, V54, P121; POWERS SP, 1988, INT J PEPT PROT RES, V31, P429; Rehfeld JF, 2000, REGUL PEPTIDES, V93, P79, DOI 10.1016/S0167-0115(00)00179-8; Schmitz F, 1996, MOL PHARMACOL, V50, P436; Silvente-Poirot S, 1996, J BIOL CHEM, V271, P14698, DOI 10.1074/jbc.271.25.14698; Sundd M, 2002, NAT STRUCT BIOL, V9, P500, DOI 10.1038/nsb0702-500; vanKesteren RE, 1996, J BIOL CHEM, V271, P3619; WEBER G, 1979, BIOCHEMISTRY-US, V18, P3075, DOI 10.1021/bi00581a025	34	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2006	281	37					27072	27080		10.1074/jbc.M605098200	http://dx.doi.org/10.1074/jbc.M605098200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082PB	16857665	hybrid			2022-12-27	WOS:000240397700034
J	Thangaraju, M; Ananth, S; Martin, PM; Roon, P; Smith, SB; Sterneck, E; Prasad, PD; Ganapathy, V				Thangaraju, Muthusamy; Ananth, Sudha; Martin, Pamela M.; Roon, Penny; Smith, Sylvia B.; Sterneck, Esta; Prasad, Puttur D.; Ganapathy, Vadivel			c/ebp delta null mouse as a model for the double knock-out of slc5a8 and slc5a12 in kidney	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN-DELTA; NA+-COUPLED TRANSPORTER; FUNCTIONAL IDENTIFICATION; TUMOR-SUPPRESSOR; MICE LACKING; LACTATE; EXPRESSION; PHYSIOLOGY; FAMILY; ACID	slc5a8 and slc5a12 represent the high affinity and low affinity Na+/lactate co-transporters, respectively, in the kidney. Here we show that these transporters are expressed in the apical membrane of the proximal tubular cells in mouse kidney, indicating that these transporters are likely to mediate the first step in the renal reabsorption of lactate. Interestingly, the renal expression of both transporters is almost completely ablated in mice homozygous for the deletion of the transcription factor c/ebp delta. This effect is tissue-specific since the expression of the transporters is not affected in non-renal tissues. The functional role of C/EBP delta in the expression of SLC5A8 and SLC5A12 is demonstrable in HEK293 cells in reporter assays using gene-specific promoters. The ablation of the transporters in the kidney is accompanied by a marked increase in urinary excretion of lactate as well as a decrease in blood levels of lactate in c/ebp delta(-/-). These data provide evidence for an obligatory role for slc5a8 and slc5a12 in the renal absorption of lactate. In addition, we show that urinary excretion of urate is significantly elevated in c/ebp delta(-/-) mice even though the expression of URAT1, the transporter responsible for the apical membrane uptake of urate in renal proximal tubule, is not altered. These data provide in vivo evidence for the functional coupling between lactate reabsorption and urate reabsorption in the kidney. Thus, the fortuitous double knock-out of slc5a8 and slc5a12 in kidney in c/ebp delta(-/-) mice reveals the physiologic role of these transporters in the renal handling of lactate and urate.	Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA 30912 USA; Med Coll Georgia, Dept Cellular Biol & Anat, Augusta, GA 30912 USA; NCI, Lab Prot Dynam & Signaling, Canc Res Ctr, NIH, Frederick, MD 21702 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ganapathy, V (corresponding author), Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA 30912 USA.	vganapat@mail.mcg.edu		Sterneck, Esta/0000-0001-7716-8766				Brooks GA, 2002, BIOCHEM SOC T, V30, P258, DOI 10.1042/bst0300258; Dun Y, 2006, CELL TISSUE RES, V324, P189, DOI 10.1007/s00441-005-0116-x; Ganapathy V, 2005, BIOCHEM SOC T, V33, P237, DOI 10.1042/BST0330237; Gigliotti AP, 2003, EXP BIOL MED, V228, P278, DOI 10.1177/153537020322800306; Gopal E, 2005, BIOCHEM J, V388, P309, DOI 10.1042/BJ20041916; Gopal E, 2004, J BIOL CHEM, V279, P44522, DOI 10.1074/jbc.M405365200; Gupta N, 2006, LIFE SCI, V78, P2419, DOI 10.1016/j.lfs.2005.10.028; Hediger MA, 2005, PHYSIOLOGY, V20, P125, DOI 10.1152/physiol.00039.2004; Huang AM, 2004, ONCOGENE, V23, P1549, DOI 10.1038/sj.onc.1207285; Johnson PF, 2005, J CELL SCI, V118, P2545, DOI 10.1242/jcs.02459; Martin PM, 2006, J NEUROCHEM, V98, P279, DOI 10.1111/j.1471-4159.2006.03878.x; Miyauchi S, 2004, J BIOL CHEM, V279, P13293, DOI 10.1074/jbc.C400059200; Palacin M, 2004, PFLUG ARCH EUR J PHY, V447, P490, DOI 10.1007/s00424-003-1062-7; Pellerin L, 2005, MOL NEUROBIOL, V32, P59, DOI 10.1385/MN:32:1:059; Srinivas SR, 2005, BIOCHEM J, V392, P655, DOI 10.1042/BJ20050927; Sterneck E, 1998, P NATL ACAD SCI USA, V95, P10908, DOI 10.1073/pnas.95.18.10908; Takeji M, 2004, J AM SOC NEPHROL, V15, P2383, DOI 10.1097/01.ASN.0000136426.01160.2F; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; ULLRICH KJ, 1993, CLIN INVESTIGATOR, V71, P843; Wright SH, 2004, PHYSIOL REV, V84, P987, DOI 10.1152/physrev.00040.2003	20	69	75	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2006	281	37					26769	26773		10.1074/jbc.C600189200	http://dx.doi.org/10.1074/jbc.C600189200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082PB	16873376	hybrid			2022-12-27	WOS:000240397700002
J	Seiradake, E; Lortat-Jacob, H; Billet, O; Kremer, EJ; Cusack, S				Seiradake, Elena; Lortat-Jacob, Hugues; Billet, Olivier; Kremer, Eric J.; Cusack, Stephen			Structural and mutational analysis of human Ad37 and canine adenovirus 2 fiber heads in complex with the D1 domain of coxsackie and adenovirus receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; SIALIC-ACID; CELLULAR RECEPTOR; BINDING; PROTEIN; VECTORS; MODEL; CAR; TRANSDUCTION; ATTACHMENT	Adenovirus fibers from most serotypes bind the D1 domain of coxsackie and adenovirus receptor (CAR), although the binding residues are not strictly conserved. To understand this further, we determined the crystal structures of canine adenovirus serotype 2 (CAV-2) and the human adenovirus serotype 37 (HAd37) in complex with human CAR D1 at 2.3 and 1.5 A resolution, respectively. Structure comparison with the HAd12 fiber head-CAR D1 complex showed that the overall topology of the interaction is conserved but that the interfaces differ in number and identity of interacting residues, shape complementarity, and degree of conformational adaptation. Using surface plasmon resonance, we characterized the binding affinity to CAR D1 of wild type and mutant CAV-2 and HAd37 fiber heads. We found that CAV-2 has the highest affinity but fewest direct interactions, with the reverse being true for HAd37. Moreover, we found that conserved interactions can have a minor contribution, whereas serotype-specific interactions can be essential. These results are discussed in the light of virus evolution and design of adenovirus vectors for gene transfer.	European Mol Biol Lab, Grenoble Outstn, F-38042 Grenoble 9, France; Univ Grenoble 1, CNRS, UMR 5075, CEA,Inst Biol Struct, Grenoble, France; CNRS, UMR 5535, F-34293 Montpellier, France; Inst Genet Mol Montpellier, F-34293 Montpellier, France; Inst Federatif Rech 122, F-34293 Montpellier, France	European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite de Montpellier	Cusack, S (corresponding author), European Mol Biol Lab, Grenoble Outstn, 6 Rue Jules Horowitz,BP 181, F-38042 Grenoble 9, France.	eric.kremer@igmm.cnrs.fr; cusack@embl-grenoble.fr	Kremer, Eric J/D-3734-2013; Kremer, EJ/P-9838-2019	Kremer, EJ/0000-0001-6114-7530; Cusack, Stephen/0000-0002-9324-0796				Abrescia NGA, 2004, NATURE, V432, P68, DOI 10.1038/nature03056; Albinsson B, 1999, VIRUS RES, V64, P125, DOI 10.1016/S0168-1702(99)00087-8; Amalfitano Andrea, 2002, Current Gene Therapy, V2, P111, DOI 10.2174/1566523024605618; Arnberg N, 2000, J VIROL, V74, P42, DOI 10.1128/JVI.74.1.42-48.2000; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Benko M, 2003, CURR TOP MICROBIOL, V272, P3; Benson SD, 2004, MOL CELL, V16, P673, DOI 10.1016/j.molcel.2004.11.016; Benson SD, 1999, CELL, V98, P825, DOI 10.1016/S0092-8674(00)81516-0; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Bewley MC, 1999, SCIENCE, V286, P1579, DOI 10.1126/science.286.5444.1579; BOTH GW, 2002, ADENOVIRAL VECTORS G, P447; Burmeister WP, 2004, J VIROL, V78, P7727, DOI 10.1128/JVI.78.14.7727-7736.2004; Chakrabarti S, 2002, BLOOD, V100, P1619, DOI 10.1182/blood-2002-02-0377; Chillon M, 2001, HUM GENE THER, V12, P1815, DOI 10.1089/104303401750476302; Cohen CJ, 2001, P NATL ACAD SCI USA, V98, P15191, DOI 10.1073/pnas.261452898; Cusack S, 2005, CURR OPIN STRUC BIOL, V15, P237, DOI 10.1016/j.sbi.2005.03.004; Denby L, 2004, HUM GENE THER, V15, P1054, DOI 10.1089/1043034042431083; Durmort C, 2001, VIROLOGY, V285, P302, DOI 10.1006/viro.2001.0967; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fabry CMS, 2005, EMBO J, V24, P1645, DOI 10.1038/sj.emboj.7600653; Gaggar A, 2003, NAT MED, V9, P1408, DOI 10.1038/nm952; Glasgow JN, 2004, VIROLOGY, V324, P103, DOI 10.1016/j.virol.2004.03.028; Honda T, 2000, MOL BRAIN RES, V77, P19, DOI 10.1016/S0169-328X(00)00036-X; Howitt J, 2003, J BIOL CHEM, V278, P26208, DOI 10.1074/jbc.M301492200; Iwase K, 1999, J COMPUT AID MOL DES, V13, P499, DOI 10.1023/A:1008011422113; Jiang SK, 2004, BIOCHEMISTRY-US, V43, P1847, DOI 10.1021/bi035490x; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Keriel A, 2006, J VIROL, V80, P1487, DOI 10.1128/JVI.80.3.1487-1496.2006; Kirby I, 2001, J VIROL, V75, P7210, DOI 10.1128/JVI.75.15.7210-7214.2001; Klonjkowski B, 1997, HUM GENE THER, V8, P2103, DOI 10.1089/hum.1997.8.17-2103; Kojaoghlanian T, 2003, REV MED VIROL, V13, P155, DOI 10.1002/rmv.386; Kremer EJ, 2000, J VIROL, V74, P505, DOI 10.1128/JVI.74.1.505-512.2000; Kremer EJ, 2005, CURR GENOMICS, V6, P13, DOI 10.2174/1389202053202111; Kremer EJ, 2004, J GENE MED, V6, pS139, DOI 10.1002/jgm.497; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Law LK, 2005, MOL THER, V12, P599, DOI 10.1016/j.ymthe.2005.05.017; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Leissner P, 2001, GENE THER, V8, P49, DOI 10.1038/sj.gt.3301343; Leslie AGW, 1999, ACTA CRYSTALLOGR D, V55, P1696, DOI 10.1107/S090744499900846X; Lortat-Jacob H, 2001, J BIOL CHEM, V276, P9009, DOI 10.1074/jbc.M009304200; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; NEUFELD EF, 1991, ANNU REV BIOCHEM, V60, P257, DOI 10.1146/annurev.biochem.60.1.257; Paillard F, 1997, HUM GENE THER, V8, P2007, DOI 10.1089/hum.1997.8.17-2007; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Prota AE, 2003, P NATL ACAD SCI USA, V100, P5366, DOI 10.1073/pnas.0937718100; Raschperger E, 2006, EXP CELL RES, V312, P1566, DOI 10.1016/j.yexcr.2006.01.025; Roelvink PW, 1999, SCIENCE, V286, P1568, DOI 10.1126/science.286.5444.1568; Roelvink PW, 1998, J VIROL, V72, P7909, DOI 10.1128/JVI.72.10.7909-7915.1998; ROSSMANN MG, 1989, J BIOL CHEM, V264, P14587; Rux JJ, 2000, MOL THER, V1, P18, DOI 10.1006/mthe.1999.0001; Rux JJ, 2003, J VIROL, V77, P9553, DOI 10.1128/JVI.77.17.9553-9566.2003; Saban SD, 2005, J MOL BIOL, V349, P526, DOI 10.1016/j.jmb.2005.04.034; Segerman A, 2003, J VIROL, V77, P1157, DOI 10.1128/JVI.77.2.1157-1162.2003; Seiradake E, 2005, J VIROL, V79, P14088, DOI 10.1128/JVI.79.22.14088-14094.2005; Shayakhmetov DM, 2000, J VIROL, V74, P10274, DOI 10.1128/JVI.74.22.10274-10286.2000; Sirena D, 2004, J VIROL, V78, P4454, DOI 10.1128/JVI.78.9.4454-4462.2004; Soudais C, 2000, J VIROL, V74, P10639, DOI 10.1128/JVI.74.22.10639-10649.2000; Soudais C, 2003, FASEB J, V17, P391, DOI 10.1096/fj.03-0438fje; Soudais C, 2001, FASEB J, V15, P2283, DOI 10.1096/fj.01-0321fje; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Tomko RP, 1997, P NATL ACAD SCI USA, V94, P3352, DOI 10.1073/pnas.94.7.3352; van Raaij MJ, 1999, NATURE, V401, P935, DOI 10.1038/44880; van Raaij MJ, 1999, VIROLOGY, V262, P333, DOI 10.1006/viro.1999.9849; van Raaij MJ, 2000, STRUCTURE, V8, P1147, DOI 10.1016/S0969-2126(00)00528-1; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Walters RW, 2002, CELL, V110, P789, DOI 10.1016/S0092-8674(02)00912-1; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; Wu E, 2004, J VIROL, V78, P3897, DOI 10.1128/JVI.78.8.3897-3905.2004; Wu E, 2003, J VIROL, V77, P7225, DOI 10.1128/JVI.77.13.7225-7235.2003; Wu E, 2001, VIROLOGY, V279, P78, DOI 10.1006/viro.2000.0703; XIA D, 1994, STRUCTURE, V2, P1259, DOI 10.1016/S0969-2126(94)00126-X; Zubieta C, 2005, MOL CELL, V17, P121, DOI 10.1016/j.molcel.2004.11.041	73	71	71	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33704	33716		10.1074/jbc.M605316200	http://dx.doi.org/10.1074/jbc.M605316200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16923808	hybrid, Green Published			2022-12-27	WOS:000241621400078
J	Vigneswara, V; Lowenson, JD; Powell, CD; Thakur, M; Bailey, K; Clarke, S; Ray, DE; Carter, WG				Vigneswara, Vasanthy; Lowenson, Jonathan D.; Powell, Claire D.; Thakur, Matthew; Bailey, Kevin; Clarke, Steven; Ray, David E.; Carter, Wayne G.			Proteomic identification of novel substrates of a protein isoaspartyl methyltransferase repair enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE-ASSOCIATED PROTEIN-2; MICROCHANNEL PLATE DETECTORS; O-METHYLTRANSFERASE; DAMAGED PROTEINS; ALPHA-SYNUCLEIN; DEFICIENT MICE; CARBOXYL METHYLTRANSFERASE; ENDOPLASMIC-RETICULUM; IN-VIVO; NEUROTRANSMITTER RELEASE	We report the use of a proteomic strategy to identify hitherto unknown substrates for mammalian protein L-isoaspartate O-methyltransferase. This methyltransferase initiates the repair of isoaspartyl residues in aged or stress-damaged proteins in vivo. Tissues from mice lacking the methyltransferase (Pcmt1(-/-)) accumulate more isoaspartyl residues than their wild-type littermates, with the most "damaged" residues arising in the brain. To identify the proteins containing these residues, brain homogenates from Pcmt1(-/-) mice were methylated by exogenous repair enzyme and the radiolabeled methyl donor S-adenosyl-[methyl-H-3] methionine. Methylated proteins in the homogenates were resolved by both one-dimensional and two-dimensional electrophoresis, and methyltransferase substrates were identified by their increased radiolabeling when isolated from Pcmt1(-/-) animals compared with Pcmt1(-/-) littermates. Mass spectrometric analyses of these isolated brain proteins reveal for the first time that microtubule-associated protein-2, calreticulin, clathrin light chains a and b, ubiquitin carboxyl-terminal hydrolase L1, phosphatidylethanolamine-binding protein, stathmin, beta-synuclein, and alpha-synuclein, are all substrates for the L-isoaspartate methyltransferase in vivo. Our methodology for methyltransferase substrate identification was further supplemented by demonstrating that one of these methyltransferase targets, microtubule-associated protein-2, could be radiolabeled within Pcmt1(-/-) brain extracts using radioactive methyl donor and exogenous methyltransferase enzyme and then specifically immunoprecipitated with microtubule-associated protein-2 antibodies to recover co-localized protein with radioactivity. We comment on the functional significance of accumulation of relatively high levels of isoaspartate within these methyltransferase targets in the context of the histological and phenotypical changes associated with the methyltransferase knock-out mice.	Univ Nottingham, Queens Med Ctr, Sch Biomed Sci, MRC,Appl Neurosci Grp, Nottingham NG7 2UH, England; Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	University of Nottingham; University of California System; University of California Los Angeles	Carter, WG (corresponding author), Univ Nottingham, Queens Med Ctr, Sch Biomed Sci, MRC,Appl Neurosci Grp, Nottingham NG7 2UH, England.	wayne.carter@nottingham.ac.uk	Lowenson, Jonathan/AAN-6768-2020	Thakur, Matthew/0000-0002-1325-1795	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026020, R37GM026020] Funding Source: NIH RePORTER; MRC [G0100165] Funding Source: UKRI; Medical Research Council [G0100165] Funding Source: Medline; NIGMS NIH HHS [GM 026020] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASWAD DW, 1983, J NEUROCHEM, V40, P1718, DOI 10.1111/j.1471-4159.1983.tb08147.x; Bedard K, 2005, INT REV CYTOL, V245, P91, DOI 10.1016/S0074-7696(05)45004-4; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; BERNHARDT R, 1984, J COMP NEUROL, V226, P203, DOI 10.1002/cne.902260205; BRENNAN TV, 1994, J BIOL CHEM, V269, P24586; Cabin DE, 2002, J NEUROSCI, V22, P8797; Chandra S, 2004, P NATL ACAD SCI USA, V101, P14966, DOI 10.1073/pnas.0406283101; Clarke S, 2003, AGEING RES REV, V2, P263, DOI 10.1016/S1568-1637(03)00011-4; DiPaolo G, 1996, J CELL BIOL, V133, P1383, DOI 10.1083/jcb.133.6.1383; Doyle HA, 2003, J IMMUNOL, V171, P2840, DOI 10.4049/jimmunol.171.6.2840; Farrar C, 2005, AGING CELL, V4, P1, DOI 10.1111/j.1474-9728.2004.00136.x; Farrar CE, 2005, J COMP NEUROL, V493, P524, DOI 10.1002/cne.20780; Frayne J, 1999, CELL TISSUE RES, V298, P415, DOI 10.1007/s004419900113; FREITAG C, 1981, J BIOL CHEM, V256, P6102; GALLETTI P, 1995, BIOCHEM J, V306, P313, DOI 10.1042/bj3060313; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; GOUD B, 1985, J CELL BIOL, V100, P521, DOI 10.1083/jcb.100.2.521; Hilfiker S, 1999, PHILOS T ROY SOC B, V354, P269, DOI 10.1098/rstb.1999.0378; Iancu-Rubin C, 2005, TRENDS CELL BIOL, V15, P346, DOI 10.1016/j.tcb.2005.05.008; Ikegaya Y, 2001, HIPPOCAMPUS, V11, P287, DOI 10.1002/hipo.1043; Ingrosso D, 2000, EUR J BIOCHEM, V267, P4397, DOI 10.1046/j.1432-1327.2000.01485.x; Jockusch WJ, 2005, NEURON, V46, P869, DOI 10.1016/j.neuron.2005.05.004; JOHNSON BA, 1987, J BIOL CHEM, V262, P12283; JOHNSON BA, 1987, J BIOL CHEM, V262, P5622; JOHNSON GVW, 1992, J NEUROSCI RES, V33, P505, DOI 10.1002/jnr.490330402; Kim E, 1997, P NATL ACAD SCI USA, V94, P6132, DOI 10.1073/pnas.94.12.6132; Kim E, 1999, J BIOL CHEM, V274, P20671, DOI 10.1074/jbc.274.29.20671; Kittler JT, 2000, J NEUROSCI, V20, P7972; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lanthier J, 2004, EXP CELL RES, V293, P96, DOI 10.1016/j.yexcr.2003.10.003; Lanthier J, 2002, J NEUROCHEM, V83, P581, DOI 10.1046/j.1471-4159.2002.01150.x; Layfield R, 2005, ESSAYS BIOCHEM, V41, P157, DOI 10.1042/EB0410157; Lees JE, 1999, ELECTROPHORESIS, V20, P2139, DOI 10.1002/(SICI)1522-2683(19990701)20:10<2139::AID-ELPS2139>3.0.CO;2-R; LEWIS SA, 1989, NATURE, V342, P498, DOI 10.1038/342498a0; Lindner H, 2001, EXP GERONTOL, V36, P1551, DOI 10.1016/S0531-5565(01)00140-1; Liu SM, 2004, EMBO J, V23, P4506, DOI 10.1038/sj.emboj.7600451; Lowenson JD, 2001, J BIOL CHEM, V276, P20695, DOI 10.1074/jbc.M100987200; MACLAREN DC, 1995, PROTEIN EXPRES PURIF, V6, P99, DOI 10.1006/prep.1995.1013; MCFADDEN PN, 1987, P NATL ACAD SCI USA, V84, P2595, DOI 10.1073/pnas.84.9.2595; MIZOBUCHI M, 1994, J NEUROCHEM, V62, P322; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Najbauer J, 1996, BIOCHEMISTRY-US, V35, P5183, DOI 10.1021/bi953063g; O'Connor MB, 1998, J BIOL CHEM, V273, P12909, DOI 10.1074/jbc.273.21.12909; OHTA K, 1987, BIOCHIMIE, V69, P1227, DOI 10.1016/0300-9084(87)90150-7; Ojika K, 2000, PROG NEUROBIOL, V60, P37, DOI 10.1016/S0301-0082(99)00021-0; POTTER SM, 1992, BIOCHEMISTRY-US, V31, P6339, DOI 10.1021/bi00142a025; Rappoport JZ, 2003, TRAFFIC, V4, P460, DOI 10.1034/j.1600-0854.2003.00100.x; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Reissner KJ, 2006, J BIOL CHEM, V281, P8389, DOI 10.1074/jbc.M510716200; Reissner KJ, 2003, CELL MOL LIFE SCI, V60, P1281, DOI 10.1007/s00018-003-2287-5; Richards P, 2002, PROTEOMICS, V2, P256, DOI 10.1002/1615-9861(200203)2:3<256::AID-PROT256>3.0.CO;2-K; Richards PG, 2000, MOL PHARMACOL, V58, P577, DOI 10.1124/mol.58.3.577; Robinson NE, 2004, J PEPT RES, V63, P426, DOI 10.1111/j.1399-3011.2004.00151.x; Schwartz R, 2001, GENOME RES, V11, P703, DOI 10.1101/gr.GR-1587R; SHIBAYAMAIMAZU T, 1993, BRAIN RES, V622, P17, DOI 10.1016/0006-8993(93)90796-P; Shimizu T, 2005, BIOL PHARM BULL, V28, P1590, DOI 10.1248/bpb.28.1590; Shimizu T, 2002, J NEUROSCI RES, V69, P341, DOI 10.1002/jnr.10301; TESHIMA G, 1995, DEAMIDATION ISOASPAR, P167; Totterdell S, 2004, BRAIN RES, V1004, P61, DOI 10.1016/j.brainres.2003.10.072; Trakul N, 2005, J BIOL CHEM, V280, P24931, DOI 10.1074/jbc.M413929200; Williams DB, 2006, J CELL SCI, V119, P615, DOI 10.1242/jcs.02856; Yamamoto A, 1998, J NEUROSCI, V18, P2063; Yeung K, 1999, NATURE, V401, P173, DOI 10.1038/43686; Young AL, 2001, J BIOL CHEM, V276, P37161, DOI 10.1074/jbc.M106682200	64	58	60	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32619	32629		10.1074/jbc.M605421200	http://dx.doi.org/10.1074/jbc.M605421200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16923807	hybrid			2022-12-27	WOS:000241414500060
J	De Cristofaro, R; Peyvandi, F; Baronciani, L; Palla, R; Lavoretano, S; Lombardi, R; Di Stasio, E; Federici, AB; Mannucci, PM				De Cristofaro, Raimondo; Peyvandi, Flora; Baronciani, Luciano; Palla, Roberta; Lavoretano, Silvia; Lombardi, Rossana; Di Stasio, Enrico; Federici, Augusto B.; Mannucci, Pier Mannuccio			Molecular mapping of the chloride-binding site in von Willebrand factor (VWF) - Energetics and conformational effects on the VWF/ADAMTS-13 interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE GLYCOPROTEIN-IB; FACTOR A2 DOMAIN; FACTOR A1 DOMAIN; VONWILLEBRAND-FACTOR; CRYSTAL-STRUCTURE; DISEASE; CLEAVAGE; COMPLEX; SURFACE; ALPHA	Physiological concentrations of NaCl inhibit the hydrolysis of von Willebrand factor (VWF) by ADAMTS-13. This effect is because of the specific binding of chloride ions to VWF. Urea-induced unfolding was measured in the presence of NaCl, CH3COONa, and NaClO4 at pH 8.0, 25 degrees C, for multimeric VWF, the recombinant A1-A2-A3 VWF domains, and the A1 domain. Chloride stabilizes the folded conformation of the A1-A2-A3 and A1 domains more efficiently than acetate but less strongly than perchlorate. Spectroscopic evidence showed that chloride binds to both the A1 and A1-A2 domain but not to the isolated A2 domain. Binding of Cl- to both wild type (WT) and the natural mutant p. R1306W A1-A2-A3 domains of VWF has a large heat capacity change equal to -1 and -0.4 kcal mol(-1) K-1 for WT and p. R1306W A1-A2-A3 domains, respectively. This result implies that a burial of a vast apolar surface area is caused by conformational transitions linked to chloride binding. At any temperature, chloride affinity was higher for WT than for the mutant p. R1306W form. Chloride ions inhibit hydrolysis by ADAMTS-13 of the A1-A2-A3 and A1-A2 domains in the presence of either urea or high shear stress, whereas this effect was either absent or negligible in experiments using A2 and A2-A3 domains. These findings show that the A1 domain contains the binding site of chloride ions that control allosterically the proteolysis by ADAMTS-13 of the Tyr(1605)-Met(1606) bond in the A2 domain and that the R1306W mutation of type 2B VWD quenches the binding of chloride ion to the A1 domain.	Catholic Univ, Sch Med, Hemostasis Res Ctr, Inst Internal Med & Geriatr, I-00168 Rome, Italy; Univ Milan, A Bianchi Bonomi Hemophilia & Thrombosis Ctr, I-20122 Milan, Italy; Univ Milan, Dept Med & Med Specialities, IRCCS, Maggiore Hosp, I-20122 Milan, Italy; Catholic Univ, Sch Med, Inst Biochem & Clin Biochem, I-00168 Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	De Cristofaro, R (corresponding author), Catholic Univ, Sch Med, Hemostasis Res Ctr, Inst Internal Med & Geriatr, Largo F Vito,1, I-00168 Rome, Italy.	rdecristofaro@rm.unicatt.it	De Cristofaro, Raimondo/K-3942-2018; Peyvandi, Flora/AAK-7437-2020; di stasio, enrico/AAL-3082-2020	De Cristofaro, Raimondo/0000-0002-8066-8849; Peyvandi, Flora/0000-0001-7423-9864; Palla, Roberta/0000-0001-8837-2367				Adachi T, 2006, BIOCHEM BIOPH RES CO, V339, P1178, DOI 10.1016/j.bbrc.2005.11.126; ANDREWS RK, 1989, BIOCHEMISTRY-US, V28, P8326, DOI 10.1021/bi00447a010; Baronciani L, 2005, J THROMB HAEMOST, V3, P2689, DOI 10.1111/j.1538-7836.2005.01638.x; Baronciani L, 2003, BLOOD CELL MOL DIS, V30, P264, DOI 10.1016/S1079-9796(03)00033-0; Baskakov IV, 1999, PROTEIN SCI, V8, P1314, DOI 10.1110/ps.8.6.1314; BOLEN DW, 1988, BIOCHEMISTRY-US, V27, P8069, DOI 10.1021/bi00421a015; Celikel R, 2000, NAT STRUCT BIOL, V7, P881; Chen Y, 1998, BIOCHEMISTRY-US, V37, P9976, DOI 10.1021/bi980274n; Chung DW, 2002, BIOCHEMISTRY-US, V41, P11065, DOI 10.1021/bi0204692; Collins KD, 2004, METHODS, V34, P300, DOI 10.1016/j.ymeth.2004.03.021; COLOMBATTI A, 1991, BLOOD, V77, P2305; De Cristofaro R, 2005, J BIOL CHEM, V280, P23295, DOI 10.1074/jbc.M501143200; DEMARCO L, 1990, J CLIN INVEST, V86, P785, DOI 10.1172/JCI114775; Dong JF, 2005, J THROMB HAEMOST, V3, P1710, DOI 10.1111/j.1538-7836.2005.01360.x; Dong JF, 2002, BLOOD, V100, P4033, DOI 10.1182/blood-2002-05-1401; Dumas JJ, 2004, J BIOL CHEM, V279, P23327, DOI 10.1074/jbc.M401659200; Emsley J, 1998, J BIOL CHEM, V273, P10396, DOI 10.1074/jbc.273.17.10396; Federici AB, 1997, THROMB HAEMOSTASIS, V78, P1132; Furlan M, 1996, BLOOD, V87, P4223, DOI 10.1182/blood.V87.10.4223.bloodjournal87104223; Hassenpflug WA, 2006, BLOOD, V107, P2339, DOI 10.1182/blood-2005-04-1758; HILBERT L, 1994, BLOOD, V83, P1542; Hinshelwood J, 2000, J MOL BIOL, V301, P1267, DOI 10.1006/jmbi.2000.4044; HOWARD MA, 1971, THROMB DIATH HAEMOST, V26, P362; Hoylaerts MF, 1997, BIOCHEM J, V324, P185, DOI 10.1042/bj3240185; Hubbard SJ, 1998, BBA-PROTEIN STRUCT M, V1382, P191, DOI 10.1016/S0167-4838(97)00175-1; Lammle B, 2005, J THROMB HAEMOST, V3, P1663, DOI 10.1111/j.1538-7836.2005.01425.x; LIVINGSTONE JR, 1991, BIOCHEMISTRY-US, V30, P4237, DOI 10.1021/bi00231a019; Miyata S, 1996, J BIOL CHEM, V271, P9046, DOI 10.1074/jbc.271.15.9046; Nishio K, 2004, P NATL ACAD SCI USA, V101, P10578, DOI 10.1073/pnas.0402041101; Nolasco LH, 2005, BLOOD, V106, P4199, DOI 10.1182/blood-2005-05-2111; PETERSON DM, 1987, BLOOD, V69, P625; PTITSYN OB, 1995, TRENDS BIOCHEM SCI, V20, P376, DOI 10.1016/S0968-0004(00)89081-7; Rastegar-Lari G, 2002, BIOCHEMISTRY-US, V41, P6668, DOI 10.1021/bi020044f; READ MS, 1989, BLOOD, V74, P1031; RUGGERI ZM, 1980, NEW ENGL J MED, V302, P1047, DOI 10.1056/NEJM198005083021902; Ruggeri ZM, 1997, J CLIN INVEST, V99, P559, DOI 10.1172/JCI119195; SADLER JE, 1991, J BIOL CHEM, V266, P22777; SPOLAR RS, 1992, BIOCHEMISTRY-US, V31, P3947, DOI 10.1021/bi00131a009; SPOLAR RS, 1989, P NATL ACAD SCI USA, V86, P8382, DOI 10.1073/pnas.86.21.8382; Sutherland JJ, 2004, J MOL MODEL, V10, P259, DOI 10.1007/s00894-004-0194-9; Takayama Y, 2005, J BIOL CHEM, V280, P18504, DOI 10.1074/jbc.M410265200; Varughese KI, 2002, CURR PROTEIN PEPT SC, V3, P301, DOI 10.2174/1389203023380620; Zanardelli S, 2006, J BIOL CHEM, V281, P1555, DOI 10.1074/jbc.M508316200	43	15	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30400	30411		10.1074/jbc.M603321200	http://dx.doi.org/10.1074/jbc.M603321200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16899464	hybrid			2022-12-27	WOS:000241075900014
J	Kabuta, T; Suzuki, Y; Wada, K				Kabuta, Tomohiro; Suzuki, Yasuyuki; Wada, Keiji			Degradation of amyotrophic lateral sclerosis-linked mutant Cu,Zn-superoxide dismutase proteins by macroautophagy and the proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CU/ZN SUPEROXIDE-DISMUTASE; MOTOR-NEURON DEGENERATION; CELL-DEATH; ALPHA-SYNUCLEIN; AUTOPHAGY; MICE; SOD1; HUNTINGTIN; ALS; SUPEROXIDE-DISMUTASE-1	Mutations in the Cu, Zn-superoxide dismutase (SOD1) gene cause similar to 20% of familial cases of amyotrophic lateral sclerosis (fALS). Accumulating evidence indicates that a gain of toxic function of mutant SOD1 proteins is the cause of the disease. It has also been shown that the ubiquitin-proteasome pathway plays a role in the clearance and toxicity of mutant SOD1. In this study, we investigated the degradation pathways of wild-type and mutant SOD1 in neuronal and nonneuronal cells. We provide here the first evidence that wild-type and mutant SOD1 are degraded by macroautophagy as well as by the proteasome. Based on experiments with inhibitors of these degradation pathways, the contribution of macroautophagy to mutant SOD1 clearance is comparable with that of the proteasome pathway. Using assays that measure cell viability and cell death, we observed that under conditions where expression of mutant SOD1 alone does not induce toxicity, macroautophagy inhibition induced mutant SOD1-mediated cell death, indicating that macroautophagy reduces the toxicity of mutant SOD1 proteins. We therefore propose that both macroautophagy and the proteasome are important for the reduction of mutant SOD1-mediated neurotoxicity in fALS. Inhibition of macroautophagy also increased SOD1 levels in detergent-soluble and -insoluble fractions, suggesting that both detergent- soluble and -insoluble SOD1 are degraded by macroautophagy. These findings may provide further insights into the mechanisms of pathogenesis of fALS.	Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Degenerat Neurol Dis, Kodaira, Tokyo 1878502, Japan	National Center for Neurology & Psychiatry - Japan	Wada, K (corresponding author), Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Degenerat Neurol Dis, 4-1-1 Ogawahigashi, Kodaira, Tokyo 1878502, Japan.	wada@ncnp.go.jp	Kabuta, Tomohiro/B-2948-2015; Wada, Keiji/AAV-1500-2021	Kabuta, Tomohiro/0000-0002-3058-2596; 				Aquilano K, 2003, J NEUROCHEM, V85, P1324, DOI 10.1046/j.1471-4159.2003.01783.x; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Asher G, 2005, GENE DEV, V19, P316, DOI 10.1101/gad.319905; BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; Di Noto L, 2005, J BIOL CHEM, V280, P39907, DOI 10.1074/jbc.M506247200; Garcia-Echeverria C, 2002, MINI-REV MED CHEM, V2, P247, DOI 10.2174/1389557023406142; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hoffman EK, 1996, J NEUROL SCI, V139, P15, DOI 10.1016/S0022-510X(96)00031-7; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabuta T, 2002, J BIOL CHEM, V277, P6846, DOI 10.1074/jbc.M107058200; Kato S, 2000, AMYOTROPH LATERAL SC, V1, P163, DOI 10.1080/14660820050515160; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lee JP, 2002, J NEUROCHEM, V82, P1229, DOI 10.1046/j.1471-4159.2002.01056.x; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lino MM, 2002, J NEUROSCI, V22, P4825, DOI 10.1523/JNEUROSCI.22-12-04825.2002; Matsumoto G, 2005, J CELL BIOL, V171, P75, DOI 10.1083/jcb.200504050; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Miyazaki K, 2004, J BIOL CHEM, V279, P11327, DOI 10.1074/jbc.M312389200; Niwa J, 2002, J BIOL CHEM, V277, P36793, DOI 10.1074/jbc.M206559200; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Ostrowska H, 2000, INT J BIOCHEM CELL B, V32, P747, DOI 10.1016/S1357-2725(00)00021-2; Pramatarova A, 2001, J NEUROSCI, V21, P3369, DOI 10.1523/JNEUROSCI.21-10-03369.2001; Qin ZH, 2003, HUM MOL GENET, V12, P3231, DOI 10.1093/hmg/ddg346; RABOUILLE C, 1993, J CELL BIOL, V120, P897, DOI 10.1083/jcb.120.4.897; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Shringarpure R, 2003, J BIOL CHEM, V278, P311, DOI 10.1074/jbc.M206279200; Urushitani M, 2006, NAT NEUROSCI, V9, P108, DOI 10.1038/nn1603; Urushitani M, 2002, J NEUROCHEM, V83, P1030, DOI 10.1046/j.1471-4159.2002.01211.x; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200	46	174	175	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30524	30533		10.1074/jbc.M603337200	http://dx.doi.org/10.1074/jbc.M603337200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16920710	hybrid			2022-12-27	WOS:000241075900028
J	Laplante, P; Raymond, MA; Labelle, A; Abe, JI; Iozzo, RV; Hebert, MJ				Laplante, Patrick; Raymond, Marc-Andre; Labelle, Andree; Abe, Jun-Ichi; Iozzo, Renato V.; Hebert, Marie-Josee			Perlecan proteolysis induces an alpha 2 beta 1 integrin- and Src family kinase-dependent anti-apoptotic pathway in fibroblasts in the absence of focal adhesion kinase activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIABILITY SIGNALING PATHWAY; I COLLAGEN MATRICES; ENDOTHELIAL APOPTOSIS; PULMONARY-FIBROSIS; PHOSPHATIDYLINOSITOL 3-KINASE; SYSTEMIC-SCLEROSIS; CARDIAC ALLOGRAFTS; VASCULAR-DISEASE; GROWTH-FACTOR; P85 SUBUNIT	Dysregulation of apoptosis in endothelial cells (EC) and fibroblasts contributes to fibrosis. We have shown previously that apoptosis of EC triggers the proteolysis of extracellular matrix components and the release of a C-terminal fragment of perlecan, which in turn inhibits apoptosis of fibroblasts. Here we have defined the receptors and pathways implicated in this anti-apoptotic response in fibroblasts. Neutralizing alpha 2 beta 1 integrin activity in fibroblasts exposed to either medium conditioned by apoptotic EC (SSC) or a recombinant perlecan C-terminal fragment (LG3) prevented resistance to apoptosis and is associated with decreased levels of Akt phosphorylation. Co-incubation of fibroblasts for 24 h with SSC or LG3 in the presence of PP2 (AG1879), a biochemical inhibitor of Src family kinases (SFKs) and focal adhesion kinase, showed a significantly decreased anti-apoptotic response. However, focal adhesion kinase gene silencing with RNA interference did not inhibit the anti-apoptotic response in fibroblasts. Src phosphorylation was increased in fibroblasts exposed to SSC, and transfection of fibroblasts with constitutively active Src mutants induced an anti-apoptotic response that was not further increased by SSC. Also, Src(-/-)Fyn(-/-) fibroblasts failed to mount an anti-apoptotic response in presence of SSC for 24 h but developed a complete anti-apoptotic response when exposed to SSC for 7 days. These results suggest that extracellular matrix fragments produced by apoptotic EC initiate a state of resistance to apoptosis in fibroblasts via an alpha 2 beta 1 integrin/SFK (Src and Fyn)/phosphatidylinositol 3-kinase (PI3K)-dependent pathway. In the long term, additional SFK members are recruited for sustaining the anti-apoptotic response, which could play crucial roles in abnormal fibrogenic healing.	Univ Montreal, CRCHUM, Montreal, PQ H2L 4M1, Canada; Univ Rochester, Cardiovasc Res Ctr, Rochester, NY 14642 USA; Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA	Universite de Montreal; University of Rochester; Jefferson University	Hebert, MJ (corresponding author), Univ Montreal, CRCHUM, 1560 Sherbrooke E, Montreal, PQ H2L 4M1, Canada.	marie-josee.hebert.chum@ssss.gouv.qc.ca	Iozzo, Renato/AAS-1980-2020	Iozzo, Renato/0000-0002-5908-5112				Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Armulik A, 2004, MOL BIOL CELL, V15, P2558, DOI 10.1091/mbc.E03-09-0700; Arora PD, 1999, AM J PATHOL, V155, P2087, DOI 10.1016/S0002-9440(10)65527-7; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Bix G, 2004, J CELL BIOL, V166, P97, DOI 10.1083/jcb.200401150; Cailhier JF, 2006, AM J TRANSPLANT, V6, P247, DOI 10.1111/j.1600-6143.2005.01165.x; Chen HC, 1996, J BIOL CHEM, V271, P26329, DOI 10.1074/jbc.271.42.26329; Choy JC, 2004, AM J PATHOL, V165, P127, DOI 10.1016/S0002-9440(10)63281-6; Desmouliere A, 2003, LAB INVEST, V83, P1689, DOI 10.1097/01.LAB.0000101911.53973.90; DESMOULIERE A, 1995, AM J PATHOL, V146, P56; DombroskyFerlan PM, 1997, ONCOGENE, V14, P2019, DOI 10.1038/sj.onc.1201031; Duxbury MS, 2003, BIOCHEM BIOPH RES CO, V311, P786, DOI 10.1016/j.bbrc.2003.10.060; Fukai F, 1998, EXP CELL RES, V242, P92, DOI 10.1006/excr.1998.4076; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Haber PS, 1999, AM J PATHOL, V155, P1087, DOI 10.1016/S0002-9440(10)65211-X; Iozzo RV, 2001, J CLIN INVEST, V108, P165, DOI 10.1172/JCI13560; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; Jun JB, 2003, CURR OPIN RHEUMATOL, V15, P756, DOI 10.1097/00002281-200311000-00012; KUHN C, 1991, AM J PATHOL, V138, P1257; Laplante P, 2005, J IMMUNOL, V174, P5740, DOI 10.4049/jimmunol.174.9.5740; Madden HL, 2000, AM J RESP CRIT CARE, V162, P1553, DOI 10.1164/ajrccm.162.4.2001015; Maquart F, 2005, BIOCHIMIE, V87, P353, DOI 10.1016/j.biochi.2004.10.006; Michel JB, 2003, ARTERIOSCL THROM VAS, V23, P2146, DOI 10.1161/01.ATV.0000099882.52647.E4; Moissoglu K, 2005, BIOCHEM BIOPH RES CO, V330, P673, DOI 10.1016/j.bbrc.2005.03.025; Mongiat M, 2003, J BIOL CHEM, V278, P4238, DOI 10.1074/jbc.M210445200; Nho RS, 2005, J BIOL CHEM, V280, P26630, DOI 10.1074/jbc.M411798200; PLEIMAN CM, 1994, SCIENCE, V263, P1609, DOI 10.1126/science.8128248; Pollman MJ, 1998, NAT MED, V4, P222, DOI 10.1038/nm0298-222; Raymond MA, 2005, BIOCHEM BIOPH RES CO, V338, P1374, DOI 10.1016/j.bbrc.2005.10.105; Raymond MA, 2004, FASEB J, V18, P705, DOI 10.1096/fj.03-0573fje; Raymond MA, 2002, BIOCHEM BIOPH RES CO, V291, P261, DOI 10.1006/bbrc.2002.6449; Sgonc R, 1996, J CLIN INVEST, V98, P785, DOI 10.1172/JCI118851; Shimizu A, 2002, LAB INVEST, V82, P673, DOI 10.1097/01.LAB.0000017370.74529.89; Shimizu A, 2002, KIDNEY INT, V61, P1867, DOI 10.1046/j.1523-1755.2002.00309.x; Suzuki J, 2000, CARDIOVASC RES, V45, P783, DOI 10.1016/S0008-6363(99)00356-9; Thannickal VJ, 2004, ANNU REV MED, V55, P395, DOI 10.1146/annurev.med.55.091902.103810; THOMAS SM, 1995, NATURE, V376, P267, DOI 10.1038/376267a0; Tian B, 2002, J BIOL CHEM, V277, P24667, DOI 10.1074/jbc.M203565200; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Velling T, 2004, EMBO REP, V5, P901, DOI 10.1038/sj.embor.7400234; Vittal R, 2005, AM J PATHOL, V166, P367, DOI 10.1016/S0002-9440(10)62260-2; Xia H, 2004, J BIOL CHEM, V279, P33024, DOI 10.1074/jbc.M313265200; ZHANG K, 1994, AM J PATHOL, V145, P114	44	62	62	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30383	30392		10.1074/jbc.M606412200	http://dx.doi.org/10.1074/jbc.M606412200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16882656	hybrid			2022-12-27	WOS:000241075900012
J	Adhikari, S; Toretsky, JA; Yuan, LS; Roy, R				Adhikari, Sanjay; Toretsky, Jeffery A.; Yuan, Linshan; Roy, Rabindra			Magnesium, essential for base excision repair enzymes, inhibits substrate binding of N-methylpurine-DNA glycosylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDONUCLEASE-III; ALKYLATION SENSITIVITY; ESCHERICHIA-COLI; RESIDUES; PURIFICATION; MUTATION; PROTEIN; RAT	N-Methylpurine-DNA glycosylase (MPG) initiates base excision repair in DNA by removing a wide variety of alkylated, deaminated, and lipid peroxidation-induced purine adducts. MPG activity and other DNA glycosylases do not have an absolute requirement for a cofactor. In contrast, all downstream activities of major base excision repair proteins, such as apurinic/apyrimidinic endonuclease, DNA polymerase beta, and ligases, require Mg2+. Here we have demonstrated that Mg2+ can be significantly inhibitory toward MPG activity depending on its concentration but independent of substrate type. The pre-steady-state kinetics suggests that Mg2+ at high but physiologic concentrations decreases the amount of active enzyme concentrations. Steady-state inhibition kinetics showed that Mg2+ affected K-m, but not V-max, and the inhibition could be reversed by EDTA but not by DNA. At low concentration, Mg2+ stimulated the enzyme activity only with hypoxanthine but not ethenoadenine. Real-time binding experiments using surface plasmon resonance spectroscopy showed that the pronounced inhibition of activity was due to inhibition in substrate binding. Nonetheless, the glycosidic bond cleavage step was not affected. These results altogether suggest that Mg2+ inhibits MPG activity by abrogating substrate binding. Because Mg2+ is an absolute requirement for the downstream activities of the major base excision repair enzymes, it may act as a regulator for the base excision repair pathway for efficient and balanced repair of damaged bases, which are often less toxic and/or mutagenic than their subsequent repair product intermediates.	Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20057 USA	Georgetown University	Roy, R (corresponding author), Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Dept Oncol, LL Level,S-122,3800 Reservoir Rd,NW, Washington, DC 20057 USA.	rr228@georgetown.edu			NCI NIH HHS [CA 92306, R01 CA092306, CA 88004] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA088004, R01CA092306] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abner CW, 2001, J BIOL CHEM, V276, P13379, DOI 10.1074/jbc.M010641200; BENNETT SE, 1992, J BIOL CHEM, V267, P22512; BJELLAND S, 1994, J BIOL CHEM, V269, P30489; BJORAS M, 1995, BIOCHEMISTRY-US, V34, P4577, DOI 10.1021/bi00014a010; BREIMER LH, 1984, J BIOL CHEM, V259, P5543; Bronzetti Giorgio, 1995, Journal of Environmental Pathology Toxicology and Oncology, V14, P197; DOSANJH MK, 1994, BIOCHEMISTRY-US, V33, P1624, DOI 10.1021/bi00173a002; Eide L, 2001, BIOCHEMISTRY-US, V40, P6653, DOI 10.1021/bi0028901; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES, P59; HATCHET Z, 1994, J BIOL CHEM, V269, P18814; Izumi T, 2003, TOXICOLOGY, V193, P43, DOI 10.1016/S0300-483X(03)00289-0; KROEGER H, 1974, J CELL PHYSIOL, V83, P19, DOI 10.1002/jcp.1040830104; Labahn J, 1996, CELL, V86, P321, DOI 10.1016/S0092-8674(00)80103-8; LARSON K, 1985, MUTAT RES, V233, P211; Lau AY, 1998, CELL, V95, P249, DOI 10.1016/S0092-8674(00)81755-9; Lau AY, 2000, P NATL ACAD SCI USA, V97, P13573, DOI 10.1073/pnas.97.25.13573; Li-Smerin YY, 2001, J PHYSIOL-LONDON, V533, P729, DOI 10.1111/j.1469-7793.2001.t01-1-00729.x; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LINDAHL T, 1988, ANNU REV BIOCHEM, V57, P133, DOI 10.1146/annurev.bi.57.070188.001025; Liu X, 2002, J MOL BIOL, V321, P265, DOI 10.1016/S0022-2836(02)00623-X; Lukacs Geza L., 1996, Scanning Microscopy, V10, P1191; MCCARTHY TV, 1984, EMBO J, V3, P545, DOI 10.1002/j.1460-2075.1984.tb01844.x; Morland I, 2005, DNA REPAIR, V4, P381, DOI 10.1016/j.dnarep.2004.11.002; Porello SL, 1998, BIOCHEMISTRY-US, V37, P14756, DOI 10.1021/bi981594+; Posnick LM, 1999, J BACTERIOL, V181, P6763, DOI 10.1128/JB.181.21.6763-6771.1999; Rinne ML, 2005, NUCLEIC ACIDS RES, V33, P2859, DOI 10.1093/nar/gki601; ROY R, 1994, BIOCHEMISTRY-US, V33, P15131, DOI 10.1021/bi00254a024; Roy R, 1998, BIOCHEMISTRY-US, V37, P580, DOI 10.1021/bi972313l; Roy R, 2000, J BIOL CHEM, V275, P4278, DOI 10.1074/jbc.275.6.4278; Roy R, 1996, CARCINOGENESIS, V17, P2177, DOI 10.1093/carcin/17.10.2177; SAPARBAEV M, 1994, P NATL ACAD SCI USA, V91, P5873, DOI 10.1073/pnas.91.13.5873; Singer B, 1997, CHEM RES TOXICOL, V10, P713, DOI 10.1021/tx970011e; Sobol RW, 2003, J BIOL CHEM, V278, P39951, DOI 10.1074/jbc.M306592200; Sousa MC, 2001, ACTA CRYSTALLOGR D, V57, P1950, DOI 10.1107/S090744490101575X; Speina E, 2005, ACTA BIOCHIM POL, V52, P167; Strauss PR, 1997, J BIOL CHEM, V272, P1302, DOI 10.1074/jbc.272.2.1302; Waters TR, 1999, J BIOL CHEM, V274, P67, DOI 10.1074/jbc.274.1.67	37	39	40	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					29525	29532		10.1074/jbc.M602673200	http://dx.doi.org/10.1074/jbc.M602673200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16901897	hybrid			2022-12-27	WOS:000240896300014
J	Bedet, C; Bruusgaard, JC; Vergo, S; Groth-Pedersen, L; Eimer, S; Triller, A; Vannier, C				Bedet, Cecile; Bruusgaard, Jo C.; Vergo, Sandra; Groth-Pedersen, Line; Eimer, Stefan; Triller, Antoine; Vannier, Christian			Regulation of gephyrin assembly and glycine receptor synaptic stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLYBDENUM COFACTOR BIOSYNTHESIS; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; CLUSTERING INTERACTIONS; FLUORESCENT PROTEIN; POTASSIUM CHANNEL; STRUCTURAL BASIS; SPLICE VARIANTS; PLASMA-MEMBRANE; BETA-SUBUNIT	Gephyrin is required for the formation of clusters of the glycine receptor ( GlyR) in the neuronal postsynaptic membrane. It can make trimers and dimers through its N- and C-terminal G and E domains, respectively. Gephyrin oligomerization could thus create a submembrane lattice providing GlyR-binding sites. We investigated the relationships between the stability of cell surface GlyR and the ability of gephyrin splice variants to form oligomers. Using truncated and full-length gephyrins we found that the 13-amino acid sequence ( cassette 5) prevents G domain trimerization. Moreover, E domain dimerization is inhibited by the gephyrin central L domain. All of the gephyrin variants bind GlyR beta subunit cytoplasmic loop with high affinity regardless of their cassette composition. Coexpression experiments in COS-7 cells demonstrated that GlyR bound to gephyrin harboring cassette 5 cannot be stabilized at the cell surface. This gephyrin variant was found to deplete synapses from both GlyR and gephyrin in transfected neurons. These data suggest that the relative expression level of cellular variants influence the overall oligomerization pattern of gephyrin and thus the turnover of synaptic GlyR.	Ecole Normale Super, INSERM, Lab Biol Cellulaire Synapse Normale & Pathol, U789, F-75005 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Vannier, C (corresponding author), Ecole Normale Super, INSERM, Lab Biol Cellulaire Synapse Normale & Pathol, U789, 46 Rue Ulm, F-75005 Paris, France.	vannier@wotan.ens.fr	Eimer, Stefan/B-1865-2013	Bruusgaard, Jo Christiansen/0000-0001-8163-5849; TRILLER, Antoine/0000-0002-7530-1233				Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Choquet D, 2003, NAT REV NEUROSCI, V4, P251, DOI 10.1038/nrn1077; Craig AM, 2001, NAT NEUROSCI, V4, P569, DOI 10.1038/88388; David-Watine B, 2001, GENE, V271, P239, DOI 10.1016/S0378-1119(01)00511-X; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Feng GP, 1998, SCIENCE, V282, P1321, DOI 10.1126/science.282.5392.1321; Ferguson KM, 2000, MOL CELL, V6, P373, DOI 10.1016/S1097-2765(00)00037-X; Hanus C, 2004, J NEUROSCI, V24, P1119, DOI 10.1523/JNEUROSCI.4380-03.2004; Jugloff DGM, 2000, J BIOL CHEM, V275, P1357, DOI 10.1074/jbc.275.2.1357; KAMDAR KP, 1994, GENETICS, V137, P791; Kim EY, 2006, EMBO J, V25, P1385, DOI 10.1038/sj.emboj.7601029; KIRSCH J, 1991, J BIOL CHEM, V266, P22242; KIRSCH J, 1993, NATURE, V366, P745, DOI 10.1038/366745a0; Kneussel M, 2000, TRENDS NEUROSCI, V23, P429, DOI 10.1016/S0166-2236(00)01627-1; Kneussel M, 1999, J NEUROSCI, V19, P9289, DOI 10.1523/jneurosci.19-21-09289.1999; Kneussel M, 1999, J NEUROCHEM, V72, P1323, DOI 10.1046/j.1471-4159.1999.0721323.x; Liu MTW, 2000, J BIOL CHEM, V275, P1814, DOI 10.1074/jbc.275.3.1814; Meier J, 2000, MOL CELL NEUROSCI, V16, P566, DOI 10.1006/mcne.2000.0899; Meier J, 2000, J CELL SCI, V113, P2783; Meier J, 2004, J NEUROSCI, V24, P1398, DOI 10.1523/JNEUROSCI.4260-03.2004; Meier J, 2001, NAT NEUROSCI, V4, P253, DOI 10.1038/85099; MEYER G, 1995, NEURON, V15, P563, DOI 10.1016/0896-6273(95)90145-0; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nusser Z, 2000, CURR OPIN NEUROBIOL, V10, P337, DOI 10.1016/S0959-4388(00)00086-6; PFEIFFER F, 1982, J BIOL CHEM, V257, P9389; PRIOR P, 1992, NEURON, V8, P1161, DOI 10.1016/0896-6273(92)90136-2; Ramming M, 2000, P NATL ACAD SCI USA, V97, P10266, DOI 10.1073/pnas.97.18.10266; Rees MI, 2003, J BIOL CHEM, V278, P24688, DOI 10.1074/jbc.M301070200; Rosenberg M, 2001, J NEUROSCI, V21, P5036, DOI 10.1523/JNEUROSCI.21-14-05036.2001; SCHMITT B, 1987, BIOCHEMISTRY-US, V26, P805, DOI 10.1021/bi00377a022; Schrader N, 2004, J BIOL CHEM, V279, P18733, DOI 10.1074/jbc.M311245200; Schwarz G, 2001, J MOL BIOL, V312, P405, DOI 10.1006/jmbi.2001.4952; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Sola M, 2004, EMBO J, V23, P2510, DOI 10.1038/sj.emboj.7600256; Sola M, 2001, J BIOL CHEM, V276, P25294, DOI 10.1074/jbc.M101923200; STALLMEYER B, 1995, PLANT J, V8, P751, DOI 10.1046/j.1365-313X.1995.08050751.x; VANNIER C, 2004, EXCITATORY INHIBITOR, P59; Wong W, 2002, J BIOL CHEM, V277, P20423, DOI 10.1074/jbc.M109412200; Xiang S, 2001, STRUCTURE, V9, P299, DOI 10.1016/S0969-2126(01)00588-3	39	45	49	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					30046	30056		10.1074/jbc.M602155200	http://dx.doi.org/10.1074/jbc.M602155200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16882665	hybrid			2022-12-27	WOS:000240896300065
J	Faraco, JH; Appelbaum, L; Marin, W; Gaus, SE; Mourrain, P; Mignot, E				Faraco, Juliette H.; Appelbaum, Lior; Marin, Wilfredo; Gaus, Stephanie E.; Mourrain, Philippe; Mignot, Emmanuel			Regulation of hypocretin (orexin) expression in embryonic zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SLEEP-LIKE STATE; NERVOUS-SYSTEM; NEURONS; NARCOLEPSY; RECEPTOR; REGION; GENE; CONSERVATION; MODULATION; DROSOPHILA	Hypocretins/ orexins are neuropeptides involved in the regulation of sleep and energy balance in mammals. Conservation of gene sequence, hypothalamic localization of cell bodies, and projection patterns in adult zebrafish suggest that the architecture and function of the hypocretin system are conserved in fish. We report on the complete genomic structure of the zebrafish and Tetraodon hypocretin genes and the complete predicted hypocretin protein sequences from five teleosts. Using whole mount in situ hybridization, we have traced the development of hypocretin cells in zebrafish from onset of expression at 22 h post- fertilization through the first week of development. Promoter elements of similar size from zebrafish and Tetraodon were capable of driving efficient and specific expression of enhanced green fluorescent protein in developing zebrafish embryos, thus defining a minimal promoter region able to accurately mimic the native hypocretin pattern. This enhanced green fluorescent protein expression also revealed a complex pattern of projections within the hypothalamus, to the midbrain, and to the spinal cord. To further analyze the promoter, a series of deletion and substitution constructs were injected into embryos, and resulting promoter activity was monitored in the first week of development. Acritical region of 250 base pairs was identified containing a core 13- base pair element essential for hypocretin expression.	Stanford Univ, Ctr Narcolepsy Res, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA; Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; INSERM, U784, F-75230 Paris, France	Stanford University; Howard Hughes Medical Institute; Stanford University; Institut National de la Sante et de la Recherche Medicale (Inserm)	Mignot, E (corresponding author), Stanford Univ, Ctr Narcolepsy Res, Dept Psychiat & Behav Sci, 701B Welch Rd, Palo Alto, CA 94304 USA.	mignot@stanford.edu	Mourrain, Philippe/N-4671-2017					Amiot C, 2005, EUR J NEUROSCI, V22, P531, DOI 10.1111/j.1460-9568.2005.04224.x; Amsterdam A, 2005, DEV DYNAM, V234, P255, DOI 10.1002/dvdy.20541; Arenzana FJ, 2005, BRAIN RES BULL, V66, P421, DOI 10.1016/j.brainresbull.2005.03.006; ASAHI S, 2000, P 36 S JAP PEPT S JA, P37; Bellipanni Gianfranco, 2002, Gene Expression Patterns, V2, P251, DOI 10.1016/S1567-133X(02)00056-X; Bernard R, 2006, J PHARMACOL EXP THER, V317, P163, DOI 10.1124/jpet.105.097071; Beuckmann CT, 2002, J MOL MED, V80, P329, DOI 10.1007/s00109-002-0322-x; Blanchette M, 2003, NUCLEIC ACIDS RES, V31, P3840, DOI 10.1093/nar/gkg606; Blouin AM, 2005, NEUROLOGY, V65, P1189, DOI 10.1212/01.wnl.0000175219.01544.c8; Chabas D, 2003, ANNU REV GENOM HUM G, V4, P459, DOI 10.1146/annurev.genom.4.070802.110432; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Crocker A, 2005, NEUROLOGY, V65, P1184, DOI 10.1212/01.WNL.0000168173.71940.ab; Dickmeis T, 2004, GENOME RES, V14, P228, DOI 10.1101/gr.1819204; Ellingsen S, 2005, DEVELOPMENT, V132, P3799, DOI 10.1242/dev.01951; Eriksson KS, 1998, EUR J NEUROSCI, V10, P3799, DOI 10.1046/j.1460-9568.1998.00394.x; Fisher S, 2006, SCIENCE, V312, P276, DOI 10.1126/science.1124070; Galas L, 2001, J COMP NEUROL, V429, P242, DOI 10.1002/1096-9861(20000108)429:2<242::AID-CNE5>3.0.CO;2-Z; Gomez-Skarmeta JL, 2006, DEV DYNAM, V235, P870, DOI 10.1002/dvdy.20659; Goode DK, 2005, GENOMICS, V86, P172, DOI 10.1016/j.ygeno.2005.04.006; HAUPTMANN G, 1994, TRENDS GENET, V10, P266, DOI 10.1016/0168-9525(90)90008-T; Holzschuh J, 2001, MECH DEVELOP, V101, P237, DOI 10.1016/S0925-4773(01)00287-8; Huang ZL, 2001, P NATL ACAD SCI USA, V98, P9965, DOI 10.1073/pnas.181330998; Huesa G, 2005, J COMP NEUROL, V488, P476, DOI 10.1002/cne.20610; JOWETT T, 1994, TRENDS GENET, V10, P73, DOI 10.1016/0168-9525(94)90220-8; JUJI T, 1984, TISSUE ANTIGENS, V24, P316, DOI 10.1111/j.1399-0039.1984.tb02144.x; Kaslin J, 2004, J NEUROSCI, V24, P2678, DOI 10.1523/JNEUROSCI.4908-03.2004; Kaslin J, 2001, J COMP NEUROL, V440, P342, DOI 10.1002/cne.1390; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kumazawa Y, 1999, BIOL BIODIVERSITY, P35; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Mignot E, 2002, ARCH NEUROL-CHICAGO, V59, P1553, DOI 10.1001/archneur.59.10.1553; Mignot E, 2001, AM J HUM GENET, V68, P686, DOI 10.1086/318799; Miyoshi K, 2001, GENOMICS, V71, P150, DOI 10.1006/geno.2000.6433; Moriguchi T, 2002, J BIOL CHEM, V277, P16985, DOI 10.1074/jbc.M107962200; Nambu T, 1999, BRAIN RES, V827, P243, DOI 10.1016/S0006-8993(99)01336-0; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nishino S, 2000, LANCET, V355, P39, DOI 10.1016/S0140-6736(99)05582-8; OGAWA YKT, 2003, SLEEP BIOL RHYTHMS, V1, P143; Peitsaro N, 2000, J NEUROCHEM, V75, P718, DOI 10.1046/j.1471-4159.2000.0750718.x; Peyron C, 1998, J NEUROSCI, V18, P9996; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; Plessy C, 2005, TRENDS GENET, V21, P207, DOI 10.1016/j.tig.2005.02.006; Renier C, 2006, SLEEP, V29, pA360; Sakurai T, 1999, J BIOL CHEM, V274, P17771, DOI 10.1074/jbc.274.25.17771; Shibahara M, 1999, PEPTIDES, V20, P1169, DOI 10.1016/S0196-9781(99)00120-5; Shigemoto Y, 2004, BRAIN RES, V1023, P121, DOI 10.1016/j.brainres.2004.07.031; Singletary KG, 2005, BRAIN RES, V1041, P231, DOI 10.1016/j.brainres.2005.01.095; STUART GW, 1988, DEVELOPMENT, V103, P403; Taheri S, 2002, ANNU REV NEUROSCI, V25, P283, DOI 10.1146/annurev.neuro.25.112701.142826; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; van den Pol AN, 1998, J NEUROSCI, V18, P7962; van den Pol AN, 1999, J NEUROSCI, V19, P3171; Waleh NS, 2001, GENE, V262, P123, DOI 10.1016/S0378-1119(00)00544-8; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Yokogawa T, 2006, SLEEP, V29, pA36; Zhdanova IV, 2006, ZEBRAFISH, V3, P215, DOI 10.1089/zeb.2006.3.215; Zhdanova IV, 2001, BRAIN RES, V903, P263, DOI 10.1016/S0006-8993(01)02444-1	58	92	96	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					29753	29761		10.1074/jbc.M605811200	http://dx.doi.org/10.1074/jbc.M605811200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16867991	hybrid			2022-12-27	WOS:000240896300037
J	Gao, BX; Lee, SM; Fang, DY				Gao, Beixue; Lee, Sang-Myeong; Fang, Deyu			The tyrosine kinase C-Abl protects c-Jun from ubiquitination-mediated degradation in T cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYMPHOCYTE FUNCTION; LIGASE ITCH; PHOSPHORYLATION; MICE; IMATINIB	The cross-talk of ubiquitination with other types of posttranscriptional modifications, such as phosphorylation, regulates the stability of many proteins. We have previously demonstrated that c-Jun is a substrate of Itch, a HECT- type E3 ubiquitin ligase. c-Jun is also a substrate of the tyrosine kinase c-Abl. Here we report that genetic ablation of c-Abl accelerated c- Jun degradation. Phosphorylation of the tyrosine within the PPXY motif by c-Abl inhibited c- Jun ubiquitination and its binding by Itch. The nuclear localization of c-Abl, triggered by T- cell activation signals, was essential for its activity in regulating c- Jun transcription activity. These findings define a potential molecular mechanism for the immunodeficiency in mice lacking the c-abl gene.	Univ Missouri, Sch Med, Dept Otolaryngol Head & Neck Surg, Columbia, MO 65212 USA; Univ Missouri, Sch Med, Dept Mol Microbiol & Immunol, Columbia, MO 65212 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Fang, DY (corresponding author), Univ Missouri, Sch Med, Dept Otolaryngol Head & Neck Surg, Columbia, MO 65212 USA.	FangD@Missouri.edu	Fang, Deyu/I-7245-2013	Fang, Deyu/0000-0002-4211-2751				Banerjee A, 1999, BIOCHEMISTRY-US, V38, P5438, DOI 10.1021/bi981572n; Barila D, 2000, EMBO J, V19, P273, DOI 10.1093/emboj/19.2.273; BENNETT JP, 1979, NATURE, V282, P851, DOI 10.1038/282851a0; Echarri A, 2001, CURR BIOL, V11, P1759, DOI 10.1016/S0960-9822(01)00538-3; Espanel X, 2001, J BIOL CHEM, V276, P14514, DOI 10.1074/jbc.M008568200; Fang DY, 2004, P NATL ACAD SCI USA, V101, P14782, DOI 10.1073/pnas.0404445101; Fang DY, 2002, NAT IMMUNOL, V3, P281, DOI 10.1038/ni763; Gallagher E, 2006, P NATL ACAD SCI USA, V103, P1717, DOI 10.1073/pnas.0510664103; Gao M, 2005, MOL CELL, V19, P581, DOI 10.1016/j.molcel.2005.08.017; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; Hantschel O, 2004, NAT REV MOL CELL BIO, V5, P33, DOI 10.1038/nrm1280; Hardin JD, 1996, CELL IMMUNOL, V172, P100, DOI 10.1006/cimm.1996.0220; HARDIN JD, 1995, CELL IMMUNOL, V165, P44, DOI 10.1006/cimm.1995.1185; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Kharbanda S, 1998, ONCOGENE, V16, P1773, DOI 10.1038/sj.onc.1201934; KRAFT AS, 1983, NATURE, V301, P621, DOI 10.1038/301621a0; Lewis JM, 1996, P NATL ACAD SCI USA, V93, P15174, DOI 10.1073/pnas.93.26.15174; Mattiuzzi GN, 2003, CLIN CANCER RES, V9, P976; MAYER BJ, 1991, P NATL ACAD SCI USA, V88, P627, DOI 10.1073/pnas.88.2.627; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; PENDERGAST AM, 1991, CELL, V66, P161, DOI 10.1016/0092-8674(91)90148-R; Peng B, 2004, J CLIN ONCOL, V22, P935, DOI 10.1200/JCO.2004.03.050; Perry WL, 1998, NAT GENET, V18, P143, DOI 10.1038/ng0298-143; SCHWARTZBERG PL, 1991, CELL, V65, P1165, DOI 10.1016/0092-8674(91)90012-N; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Van Etten RA, 1999, TRENDS CELL BIOL, V9, P179, DOI 10.1016/S0962-8924(99)01549-4; Wang JYJ, 2004, NAT CELL BIOL, V6, P3, DOI 10.1038/ncb0104-3; Wertz IE, 2004, SCIENCE, V303, P1371, DOI 10.1126/science.1093549; Wong S, 2004, ANNU REV IMMUNOL, V22, P247, DOI 10.1146/annurev.immunol.22.012703.104753; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0; Yang C, 2006, MOL CELL, V21, P135, DOI 10.1016/j.molcel.2005.11.014; Yoshida K, 2005, CELL CYCLE, V4, P777, DOI 10.4161/cc.4.6.1746; Yoshida K, 2005, NAT CELL BIOL, V7, P278, DOI 10.1038/ncb1228; Zipfel PA, 2004, CURR BIOL, V14, P1222, DOI 10.1016/j.cub.2004.07.021	37	36	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					29711	29718		10.1074/jbc.M604596200	http://dx.doi.org/10.1074/jbc.M604596200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16901904	hybrid			2022-12-27	WOS:000240896300033
J	Smith, PL; Maloney, KN; Pothen, RG; Clardy, J; Clapham, DE				Smith, Paula L.; Maloney, Katherine N.; Pothen, Randy G.; Clardy, Jon; Clapham, David E.			Bisandrographolide from Andrographis paniculata activates TRPV4 channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICE LACKING TRPV4; EPOXYEICOSATRIENOIC ACIDS; CARDIOVASCULAR ACTIVITY; CAPSAICIN RECEPTOR; ANESTHETIZED RAT; ION-CHANNEL; KERATINOCYTES; HEAT; SKIN; 14-DEOXY-11,12-DIDEHYDROANDROGRAPHOLIDE	Many transient receptor potential ( TRP) channels are activated or blocked by various compounds found in plants; two prominent examples include the activation of TRPV1 channels by capsaicin and the activation of TRPM8 channels by menthol. We sought to identify additional plant compounds that are active on other types of TRP channels. Wescreenedalibraryofextractsfrom50Chinese herbal plants using a calcium-imaging assay to find compounds active on TRPV3 and TRPV4 channels. An extract from the plant Andrographis paniculata potently activated TRPV4 channels. The extract was fractionated further, and the active compound was identified as bisandrographolide A ( BAA). We used purified compoundtocharacterizetheactivityofBAAoncertainTRPVchannel subtypes. Although BAA activated TRPV4 channels with an EC50 of 790 - 950 nM, it did not activate or block activation of TRPV1, TRPV2, or TRPV3 channels. BAA activated a large TRPV4- like current in immortalized mouse keratinocytes ( 308 cells) that have been shown to express TRPV4 protein endogenously. This compound also activated TRPV4 currents in cell- free outside- out patches from HEK293T cells overexpressing TRPV4 cDNA, suggesting that BAA can activate the channel in a membrane- delimited manner. Another related compound, andrographolide, found in abundance in the plant Andrographis was unable to activate or block activation of TRPV4 channels. These experiments show that BAAactivates TRPV4 channels, and we discuss the possibility that activation ofTRPV4byBAAcould play a role in some of the effects of Andrographis extract described in traditional medicine.	Childrens Hosp, Howard Hughes Med Inst, Dept Cardiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Clapham, DE (corresponding author), Childrens Hosp, Howard Hughes Med Inst, Dept Cardiol, 1309 Enders Res Bldg,320 Longwood Ave, Boston, MA 02115 USA.	dclapham@enders.tch.harvard.edu	Clapham, David/R-5974-2019; Clapham, David/S-1123-2019	Clapham, David/0000-0002-4459-9428	NATIONAL CANCER INSTITUTE [R01CA024487] Funding Source: NIH RePORTER; NCCIH NIH HHS [R21AT00197] Funding Source: Medline; NCI NIH HHS [CA24487] Funding Source: Medline; NHLBI NIH HHS [T32 HL007572] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alessandri-Haber N, 2003, NEURON, V39, P497, DOI 10.1016/S0896-6273(03)00462-8; *CAMBR SOFT CORP, 2004, TRAD CHIN MED DAT VE; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chung MK, 2004, J BIOL CHEM, V279, P21569, DOI 10.1074/jbc.M401872200; Chung MK, 2003, J BIOL CHEM, V278, P32037, DOI 10.1074/jbc.M303251200; Delany NS, 2001, PHYSIOL GENOMICS, V4, P165, DOI 10.1152/physiolgenomics.2001.4.3.165; Earley S, 2005, CIRC RES, V97, P1270, DOI 10.1161/01.RES.0000194321.60300.d6; Gopinath Preethi, 2005, BMC Womens Health, V5, P2, DOI 10.1186/1472-6874-5-2; Guler AD, 2002, J NEUROSCI, V22, P6408; Hellwig N, 2005, J CELL SCI, V118, P917, DOI 10.1242/jcs.01675; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Ladd PA, 2003, J BIOL CHEM, V278, P35184, DOI 10.1074/jbc.M301666200; Lansdown ABG, 2002, WOUND REPAIR REGEN, V10, P271, DOI 10.1046/j.1524-475X.2002.10502.x; Lee HS, 2005, J NEUROSCI, V25, P1304, DOI 10.1523/JNEUROSCI.4745.04.2005; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; MATSUDA T, 1994, CHEM PHARM BULL, V42, P1216, DOI 10.1248/cpb.42.1216; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Mizuno A, 2003, AM J PHYSIOL-CELL PH, V285, pC96, DOI 10.1152/ajpcell.00559.2002; Moqrich A, 2005, SCIENCE, V307, P1468, DOI 10.1126/science.1108609; Nilius B, 2004, AM J PHYSIOL-CELL PH, V286, pC195, DOI 10.1152/ajpcell.00365.2003; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Suzuki M, 2003, J BIOL CHEM, V278, P22664, DOI 10.1074/jbc.M302561200; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Xia YF, 2004, J IMMUNOL, V173, P4207, DOI 10.4049/jimmunol.173.6.4207; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692; YUSPA SH, 1983, J INVEST DERMATOL, V81, pS162, DOI 10.1111/1523-1747.ep12540999; Zhang CY, 1997, J ETHNOPHARMACOL, V56, P97, DOI 10.1016/S0378-8741(97)01509-2; Zhang CY, 1998, PHARMACOL RES, V38, P413, DOI 10.1006/phrs.1998.0373; Zhang CY, 1996, CLIN EXP PHARMACOL P, V23, P675, DOI 10.1111/j.1440-1681.1996.tb01756.x; Zhang CY, 1999, PHYTOTHER RES, V13, P157, DOI 10.1002/(SICI)1099-1573(199903)13:2&lt;157::AID-PTR388&gt;3.0.CO;2-B; Zhang CY, 1998, CLIN EXP PHARMACOL P, V25, P424, DOI 10.1111/j.1440-1681.1998.tb02226.x; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	37	104	108	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					29897	29904		10.1074/jbc.M605394200	http://dx.doi.org/10.1074/jbc.M605394200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16899456	hybrid			2022-12-27	WOS:000240896300051
J	Bayascas, JR; Sakamoto, K; Armit, L; Arthur, JSC; Alessi, DR				Bayascas, Jose R.; Sakamoto, Kei; Armit, Laura; Arthur, J. Simon C.; Alessi, Dario R.			Evaluation of approaches to generation of tissue-specific knock-in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIVO ROLE; CRE RECOMBINASE; BINDING POCKET; AGC KINASES; PDK1; ACTIVATION; DOMAIN; PIF; DEFICIENCY; PROTEIN	We explored three approaches to create tissue-specific knock-in mice by generating knock-in mice in which a substrate-docking site of the PDK1 protein kinase was ablated in Cre-expressing tissues in a way that prevented activation of one of its substrates, p70 ribosomal S6 kinase (S6K), but not another (protein kinase B (PKB)). Employing two of the approaches, termed the "heterozygous" and "minigene" methods, we generated mice in which Cre-expressing skeletal and cardiac muscle produced the mutant rather than wild type PDK1. Consistent with this, injection of these mice with insulin only induced activation of PKB but not S6K in muscle tissues. We have also demonstrated that insulin-stimulated glucose uptake proceeds normally in knock-in mice, consistent with the notion that PKB mediates this process. In contrast to conditional knock-out of PDK1 in muscle, the knock-in mice did not develop dilated cardiomyopathy, suggesting that PKB plays a key role in protecting mice from heart failure. The third knock-in strategy that was evaluated, termed the "inversion" method, did not proceed with high efficiency. We discuss the merits and disadvantages of each of the conditional knock-in approaches, along with the applications for which they may be most suited, and suggest how they could be further refined.	Univ Dundee, Sch Life Sci, MRC Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland	University of Dundee	Bayascas, JR (corresponding author), Univ Dundee, Sch Life Sci, MRC Prot Phosphorylat Unit, Dow St, Dundee DD1 5EH, Scotland.	j.bayascas@dundee.ac.uk	Arthur, J. Simon/B-8058-2010; sakamoto, kei/C-8806-2019; Bayascas, Jose R/C-9450-2011	Arthur, J. Simon/0000-0002-8135-1958; sakamoto, kei/0000-0001-8839-5980; Bayascas, Jose R/0000-0002-6096-2151; Alessi, Dario/0000-0002-2140-9185	MRC [MC_U127015387] Funding Source: UKRI; Medical Research Council [MC_U127015387, MC_U127088492] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Balendran A, 1999, CURR BIOL, V9, P393, DOI 10.1016/S0960-9822(99)80186-9; Biondi RM, 2001, EMBO J, V20, P4380, DOI 10.1093/emboj/20.16.4380; Biondi RM, 2002, EMBO J, V21, P4219, DOI 10.1093/emboj/cdf437; Biondi RM, 2000, EMBO J, V19, P979, DOI 10.1093/emboj/19.5.979; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Collins BJ, 2003, EMBO J, V22, P4202, DOI 10.1093/emboj/cdg407; Collins BJ, 2005, J CELL SCI, V118, P5023, DOI 10.1242/jcs.02617; Forster A, 2005, NAT METHODS, V2, P27, DOI 10.1038/NMETH727; Frodin M, 2002, EMBO J, V21, P5396, DOI 10.1093/emboj/cdf551; Goadsby PJ, 2004, NEURON, V41, P679, DOI 10.1016/S0896-6273(04)00112-6; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Ishiki M, 2005, ENDOCRINOLOGY, V146, P5071, DOI 10.1210/en.2005-0850; Joyner AL, 1993, GENE TARGETING PRACT; Lawlor MA, 2002, EMBO J, V21, P3728, DOI 10.1093/emboj/cdf387; Lester HA, 2003, CURR OPIN DRUG DISC, V6, P633; McManus EJ, 2004, EMBO J, V23, P2071, DOI 10.1038/sj.emboj.7600218; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Mikkola HKA, 2004, METH MOLEC MED, V105, P3; Mora A, 2003, EMBO J, V22, P4666, DOI 10.1093/emboj/cdg469; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Schnutgen F, 2003, NAT BIOTECHNOL, V21, P562, DOI 10.1038/nbt811; Skvorak K, 2006, GENESIS, V44, P345, DOI 10.1002/dvg.20222; STEWART CL, 1987, EMBO J, V6, P383, DOI 10.1002/j.1460-2075.1987.tb04766.x; Vanhaesebroeck B, 2004, CELL, V118, P274, DOI 10.1016/j.cell.2004.07.018; Williams MR, 2000, CURR BIOL, V10, P439, DOI 10.1016/S0960-9822(00)00441-3; Zhang ZW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf089	28	29	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					28772	28781		10.1074/jbc.M606789200	http://dx.doi.org/10.1074/jbc.M606789200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16887794	Green Published, hybrid			2022-12-27	WOS:000240680500031
J	Zhao, XX; Wang, DM; Zhao, ZW; Xiao, YY; Sengupta, S; Xiao, YJ; Zhang, RL; Lauber, K; Wesselborg, S; Feng, L; Rose, TM; Shen, Y; Zhang, JJ; Prestwich, G; Xu, Y				Zhao, Xiaoxian; Wang, Dongmei; Zhao, Zhenwen; Xiao, Yingyi; Sengupta, Saubhik; Xiao, Yijin; Zhang, Renliang; Lauber, Kirsten; Wesselborg, Sebastian; Feng, Li; Rose, Tyler M.; Shen, Yue; Zhang, Junjie; Prestwich, Glenn; Xu, Yan			Caspase-3-dependent activation of calcium-independent phospholipase A(2) enhances cell migration in non-apoptotic ovarian cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOPHOSPHATIDIC ACID; P388D(1) MACROPHAGES; EXTRACELLULAR-MATRIX; MESOTHELIAL CELLS; EPITHELIAL TUMORS; ARACHIDONIC-ACID; SPLICE VARIANTS; PROTEIN-KINASE; EXPRESSION; LAMININ	Calcium-independent phospholipase A(2) (iPLA(2)) plays a pivotal role in phospholipid remodeling and many other biological processes, including inflammation and cancer development. iPLA(2) can be activated by caspase-3 via a proteolytic process in apoptotic cells. In this study we identify novel signaling and functional loops of iPLA2 activation leading to migration of non-apoptotic human ovarian cancer cells. The extracellular matrix protein, laminin-10/11, but not collagen I, induces integrin- and caspase-3-dependent cleavage and activation of overexpressed and endogenous iPLA(2). The truncated iPLA2 (amino acids 514-806) generates lysophosphatidic acid and arachidonic acid. Arachidonic acid is important for enhancing cell migration toward laminin-10/11. Lysophosphatidic acid activates Akt that in turn acts in a feedback loop to block the cleavage of poly-(ADP-ribose) polymerase and DNA fragmentation factor as well as prevent apoptosis. By using pharmacological inhibitors, blocking antibodies, and genetic approaches (such as point mutations, dominant negative forms of genes, and siRNAs against specific targets), we show that beta(1), but not beta(4), integrin is involved in iPLA(2) activation and cell migration to laminin-10/11. The role of caspase-3 in iPLA(2) activation and cell migration are supported by several lines of evidence. 1) Point mutation of Asp(513) (a cleavage site of caspase-3 in iPLA(2)) to Ala blocks laminin-10/11-induced cleavage and activation of overexpressed iPLA2, whereas mutation of Asp(733) to Ala has no such effect, 2) treatment of inhibitors or a small interfering RNA against caspase-3 results in decreased cell migration toward laminin-10/11, and 3) selective caspase-3 inhibitor blocks cleavage of endogenous iPLA(2) induced by laminin-10/11. Importantly, small interfering RNA-mediated down-regulation of endogenous iPLA(2) expression in ovarian carcinoma HEY cells results in decreased migration toward laminin, suggesting that our findings are pathophysiologically important.	Indiana Univ, Dept Obstet & Gynecol, Indianapolis, IN 46202 USA; Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA; Cleveland Clin, Mass Spectrometry Core 2, Cleveland, OH 44195 USA; Univ Tubingen, Dept Internal Med 1, D-72076 Tubingen, Germany; Univ Utah, Dept Med Chem, Salt Lake City, UT 84108 USA; Natl Inst Biol Sci, Beijing 102206, Peoples R China; Cleveland Clin, Dept Obstet & Gynecol, Cleveland, OH 44195 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Eberhard Karls University of Tubingen; Utah System of Higher Education; University of Utah; National Institute of Biological Sciences, Beijing; Cleveland Clinic Foundation	Xu, Y (corresponding author), Indiana Univ, Dept Obstet & Gynecol, 975 W Walnut St IB355A, Indianapolis, IN 46202 USA.	xu2@iupui.edu		Wesselborg, Sebastian/0000-0002-5236-942X; Zhang, Junjie/0000-0001-8809-1485	NCI NIH HHS [R01-CA89228, R01 CA095042] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA095042, R01CA089228] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ACKERMANN EJ, 1994, J BIOL CHEM, V269, P9227; Atsumi G, 2000, J BIOL CHEM, V275, P18248, DOI 10.1074/jbc.M000271200; Balsinde J, 1999, ANNU REV PHARMACOL, V39, P175, DOI 10.1146/annurev.pharmtox.39.1.175; BALSINDE J, 1995, P NATL ACAD SCI USA, V92, P8527, DOI 10.1073/pnas.92.18.8527; Balsinde J, 1997, J BIOL CHEM, V272, P29317, DOI 10.1074/jbc.272.46.29317; BARTOLAZZI A, 1993, ANTICANCER RES, V13, P1; Baudhuin LM, 2002, MOL PHARMACOL, V62, P660, DOI 10.1124/mol.62.3.660; BOUDREAU N, 1995, SCIENCE, V267, P891, DOI 10.1126/science.7531366; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; BYERS LJ, 1995, CANCER LETT, V88, P67, DOI 10.1016/0304-3835(94)03625-S; CANNISTRA SA, 1995, GYNECOL ONCOL, V58, P216, DOI 10.1006/gyno.1995.1214; Carnevale KA, 2001, J IMMUNOL, V167, P3414, DOI 10.4049/jimmunol.167.6.3414; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Feng L, 2002, CHEM BIOL, V9, P795, DOI 10.1016/S1074-5521(02)00168-0; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; GARDNER MJ, 1995, CANCER LETT, V91, P229, DOI 10.1016/0304-3835(95)03743-G; Gilroy DW, 2004, FASEB J, V18, P489, DOI 10.1096/fj.03-0837com; KauffmanZeh A, 1997, NATURE, V385, P544, DOI 10.1038/385544a0; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; Kikkawa Y, 2000, J CELL SCI, V113, P869; Kudo I, 2002, PROSTAG OTH LIPID M, V68-9, P3, DOI 10.1016/S0090-6980(02)00020-5; Larsson PKA, 1998, J BIOL CHEM, V273, P207, DOI 10.1074/jbc.273.1.207; Lauber K, 2003, CELL, V113, P717, DOI 10.1016/S0092-8674(03)00422-7; Laye JP, 2003, DRUG DISCOV TODAY, V8, P710, DOI 10.1016/S1359-6446(03)02754-5; Leslie CC, 1997, J BIOL CHEM, V272, P16709, DOI 10.1074/jbc.272.27.16709; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Ma ZM, 2001, PROG NUCLEIC ACID RE, V67, P1, DOI 10.1016/S0079-6603(01)67023-5; Maatta M, 2001, J HISTOCHEM CYTOCHEM, V49, P711; Manguikian AD, 2004, J BIOL CHEM, V279, P52881, DOI 10.1074/jbc.M410659200; Murakami M, 2002, J BIOCHEM, V131, P285, DOI 10.1093/oxfordjournals.jbchem.a003101; O'Brien MA, 2001, BIOTECHNIQUES, V30, P886, DOI 10.2144/01304pf01; Ramanadham S, 2004, BIOCHEMISTRY-US, V43, P918, DOI 10.1021/bi035536m; Ren J, 2006, CANCER RES, V66, P3006, DOI 10.1158/0008-5472.CAN-05-1292; Rose TM, 2006, ACS CHEM BIOL, V1, P83, DOI 10.1021/cb5000014; ROWINSKY EK, 1995, NEW ENGL J MED, V332, P1004, DOI 10.1056/NEJM199504133321507; Sengupta S, 2003, FASEB J, V17, P1570, DOI 10.1096/fj.02-1145fje; Sethi T, 1999, NAT MED, V5, P662, DOI 10.1038/9511; Tang J, 1997, J BIOL CHEM, V272, P8567, DOI 10.1074/jbc.272.13.8567; Tay HK, 2004, J BIOL CHEM, V279, P22505, DOI 10.1074/jbc.M308788200; Vivinus-Nebot M, 1999, J CELL BIOL, V144, P563, DOI 10.1083/jcb.144.3.563; von der Mark H, 2002, J BIOL CHEM, V277, P6012, DOI 10.1074/jbc.M102188200; Winstead MV, 2000, BBA-MOL CELL BIOL L, V1488, P28, DOI 10.1016/S1388-1981(00)00107-4; Xiao YJ, 2001, ANAL BIOCHEM, V290, P302, DOI 10.1006/abio.2001.5000; Yang JY, 2001, MOL CELL BIOL, V21, P5346, DOI 10.1128/MCB.21.16.5346-5358.2001; Yoshida Y, 2001, INT J ONCOL, V18, P913; Zahir N, 2003, J CELL BIOL, V163, P1397, DOI 10.1083/jcb.200302023; Zhang HM, 2002, CIRC RES, V90, P1251, DOI 10.1161/01.RES.0000024690.69379.5C; Zheng TS, 1999, CELL DEATH DIFFER, V6, P1043, DOI 10.1038/sj.cdd.4400593; Zhou SY, 1997, P NATL ACAD SCI USA, V94, P11345, DOI 10.1073/pnas.94.21.11345	50	88	92	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					29357	29368		10.1074/jbc.M513105200	http://dx.doi.org/10.1074/jbc.M513105200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16882668	hybrid			2022-12-27	WOS:000240680500091
J	Drenan, RM; Doupnik, CA; Jayaraman, M; Buchwalter, AL; Kaltenbronn, KM; Huettner, JE; Linder, ME; Blumer, KJ				Drenan, Ryan M.; Doupnik, Craig A.; Jayaraman, Muralidharan; Buchwalter, Abigail L.; Kaltenbronn, Kevin M.; Huettner, James E.; Linder, Maurine E.; Blumer, Kendall J.			R7BP augments the function of RGS7(center dot)G beta 5 complexes by a plasma membrane-targeting mechanis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN BETA-SUBUNIT; GTPASE ACCELERATING PROTEIN; NUCLEAR EXPORT SIGNAL; RGS PROTEINS; PHOSPHOLIPID SCRAMBLASE-1; ACTIVATING PROTEINS; ALPHA-SUBUNITS; MICE LACKING; K+ CHANNELS; IN-VIVO	The RGS7 (R7) family of G protein regulators, G beta 5, and R7BP form heterotrimeric complexes that potently regulate the kinetics of G protein-coupled receptor signaling. Reversible palmitoylation of R7BP regulates plasma membrane/ nuclear shuttling of R7 center dot G beta 5 center dot R7BP heterotrimers. Here we have investigated mechanisms whereby R7BP controls the function of the R7 family. We show that unpalmitoylated R7BP undergoes nuclear/ cytoplasmic shuttling and that a C-terminal polybasic motif proximal to the palmitoylation acceptor sites of R7BP mediates nuclear localization, palmitoylation, and plasma membrane targeting. These results suggest a novel mechanism whereby palmitoyltransferases and nuclear import receptors both utilize the C-terminal domain of R7BP to determine the trafficking fate of R7 center dot G beta 5 center dot R7BP heterotrimers. Analogous mechanisms may regulate other signaling proteins whose distribution between the plasma membrane and nucleus is controlled by palmitoylation. Lastly, we show that cytoplasmic RGS7 center dot G beta 5 center dot R7BP heterotrimers and RGS7 center dot G beta 5 heterodimers are equivalently inefficient regulators of G proteincoupled receptor signaling relative to plasma membrane-bound heterotrimers bearing palmitoylated R7BP. Therefore, R7BP augments the function of the complex by a palmitoylation-regulated plasma membrane- targeting mechanism.	Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; Univ S Florida, Coll Med, Dept Physiol & Biophys, Tampa, FL 33612 USA	Washington University (WUSTL); State University System of Florida; University of South Florida	Blumer, KJ (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	kblumer@cellbiology.wustl.edu	Linder, Maurine/AAU-9999-2021; Doupnik, Craig A/I-3617-2012; Jayaraman, Muralidharan/H-8563-2019; Huettner, James E/C-5219-2012; Blumer, Kendall J/C-5268-2012	Linder, Maurine/0000-0003-2202-9712; Doupnik, Craig A/0000-0002-7314-0747; Jayaraman, Muralidharan/0000-0003-3274-877X; 	NHLBI NIH HHS [HL075632] Funding Source: Medline; NIGMS NIH HHS [GM51466, GM44592] Funding Source: Medline; NINDS NIH HHS [NS30888, R01 NS030888] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051466, R01GM044592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030888] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Acconcia F, 2005, MOL BIOL CELL, V16, P231, DOI 10.1091/mbc.e04-07-0547; Basse F, 1996, J BIOL CHEM, V271, P17205, DOI 10.1074/jbc.271.29.17205; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Berzat AC, 2005, J BIOL CHEM, V280, P33055, DOI 10.1074/jbc.M507362200; BYRAPPA S, 1995, GENOME RES, V5, P404, DOI 10.1101/gr.5.4.404; Cabrera JL, 1998, BIOCHEM BIOPH RES CO, V249, P898, DOI 10.1006/bbrc.1998.9218; Cabrera-Vera TM, 2004, P NATL ACAD SCI USA, V101, P16339, DOI 10.1073/pnas.0407416101; Carvalho J, 2003, J BIOL CHEM, V278, P16878, DOI 10.1074/jbc.M300429200; Chen CK, 2000, NATURE, V403, P557, DOI 10.1038/35000601; Chen CK, 2003, P NATL ACAD SCI USA, V100, P6604, DOI 10.1073/pnas.0631825100; Chuang HH, 1998, P NATL ACAD SCI USA, V95, P11727, DOI 10.1073/pnas.95.20.11727; Donati RJ, 2003, LIFE SCI, V73, P1, DOI 10.1016/S0024-3205(03)00249-2; Dong BH, 2004, J VIROL, V78, P8983, DOI 10.1128/JVI.78.17.8983-8993.2004; Doupnik CA, 2004, METHOD ENZYMOL, V389, P131; Doupnik CA, 1997, P NATL ACAD SCI USA, V94, P10461, DOI 10.1073/pnas.94.19.10461; Drenan RM, 2005, J CELL BIOL, V169, P623, DOI 10.1083/jcb.200502007; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Goel R, 2002, J BIOL CHEM, V277, P18640, DOI 10.1074/jbc.M108995200; Gold SJ, 1997, J NEUROSCI, V17, P8024; Graves PR, 2001, ONCOGENE, V20, P1839, DOI 10.1038/sj.onc.1204259; HEPLER JR, 2005, SCI STKE, pPE38; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Hooks SB, 2003, J BIOL CHEM, V278, P10087, DOI 10.1074/jbc.M211382200; Hu G, 2003, J BIOL CHEM, V278, P14550, DOI 10.1074/jbc.M212046200; Hu G, 2002, P NATL ACAD SCI USA, V99, P9755, DOI 10.1073/pnas.152094799; Hunt TW, 1996, NATURE, V383, P175, DOI 10.1038/383175a0; Jakacka M, 2002, MOL ENDOCRINOL, V16, P2188, DOI 10.1210/me.2001-0174; Jones TLZ, 2004, METHOD ENZYMOL, V389, P33; Kang JH, 2005, CELL, V123, P833, DOI 10.1016/j.cell.2005.09.011; Koster M, 2005, CURR OPIN BIOTECH, V16, P28, DOI 10.1016/j.copbio.2004.11.002; Kovoor A, 2005, J NEUROSCI, V25, P2157, DOI 10.1523/JNEUROSCI.2840-04.2005; Krispel CM, 2003, J NEUROSCI, V23, P6965, DOI 10.1523/JNEUROSCI.23-18-06965.2003; Larminie C, 2004, MOL BRAIN RES, V122, P24, DOI 10.1016/j.molbrainres.2003.11.014; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Li L, 2003, P NATL ACAD SCI USA, V100, P4807, DOI 10.1073/PNAS.0831079100; Lishko PV, 2002, J BIOL CHEM, V277, P24376, DOI 10.1074/jbc.M203237200; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Makino ER, 1999, P NATL ACAD SCI USA, V96, P1947, DOI 10.1073/pnas.96.5.1947; Martemyanov KA, 2005, J BIOL CHEM, V280, P5133, DOI 10.1074/jbc.C400596200; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Nishiguchi KM, 2004, NATURE, V427, P75, DOI 10.1038/nature02170; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Posner BA, 1999, J BIOL CHEM, V274, P31087, DOI 10.1074/jbc.274.43.31087; Povsic TJ, 2003, J BIOL CHEM, V278, P51334, DOI 10.1074/jbc.M309968200; Rahman Z, 1999, J NEUROSCI, V19, P2016; Rahman Z, 2003, NEURON, V38, P941, DOI 10.1016/S0896-6273(03)00321-0; Rai D, 2005, MOL ENDOCRINOL, V19, P1606, DOI 10.1210/me.2004-0468; Rose JJ, 2000, J NEUROCHEM, V75, P2103, DOI 10.1046/j.1471-4159.2000.0752103.x; Scott MGH, 2002, J BIOL CHEM, V277, P37693, DOI 10.1074/jbc.M207552200; Shenoy SK, 2003, BIOCHEM J, V375, P503, DOI 10.1042/BJ20031076; Silverman RH, 2002, CANCER RES, V62, P397; Song JH, 2006, J BIOL CHEM, V281, P15361, DOI 10.1074/jbc.M600749200; Tao WK, 2001, GENE DEV, V15, P1796, DOI 10.1101/gad.894301; Wang P, 2003, J BIOL CHEM, V278, P11648, DOI 10.1074/jbc.M208109200; WATSON AJ, 1994, J BIOL CHEM, V269, P22150; Watson N, 1996, NATURE, V383, P172, DOI 10.1038/383172a0; Wiedmer T, 2003, BIOCHEMISTRY-US, V42, P1227, DOI 10.1021/bi026679w; Williams CL, 2003, CELL SIGNAL, V15, P1071, DOI 10.1016/S0898-6568(03)00098-6; Witherow DS, 2000, J BIOL CHEM, V275, P24872, DOI 10.1074/jbc.M001535200; Zachariou V, 2003, P NATL ACAD SCI USA, V100, P13656, DOI 10.1073/pnas.2232594100; Zhang D., 2000, J DESERT RES, V20, P59; Zhou QS, 2005, J BIOL CHEM, V280, P35062, DOI 10.1074/jbc.M504821200	63	61	63	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					28222	28231		10.1074/jbc.M604428200	http://dx.doi.org/10.1074/jbc.M604428200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16867977	hybrid			2022-12-27	WOS:000240534400060
J	Hsiao, YS; Jogl, G; Tong, L				Hsiao, Yu-Shan; Jogl, Gerwald; Tong, Liang			Crystal structures of murine carnitine acetyltransferase in ternary complexes with its substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEROTONIN N-ACETYLTRANSFERASE; CHOLINE-ACETYLTRANSFERASE; PALMITOYLTRANSFERASE; RESOLUTION; BINDING; SYSTEM; ACYLTRANSFERASES; MACROMOLECULES; SELECTIVITY; METABOLISM	Carnitine acyltransferases catalyze the reversible exchange of acyl groups between coenzyme A (CoA) and carnitine. They have important roles in many cellular processes, especially the oxidation of long-chain fatty acids in the mitochondria for energy production, and are attractive targets for drug discovery against diabetes and obesity. To help define in molecular detail the catalytic mechanism of these enzymes, we report here the high resolution crystal structure of wild-type murine carnitine acetyltransferase (CrAT) in a ternary complex with its substrates acetyl-CoA and carnitine, and the structure of the S554A/M564G double mutant in a ternary complex with the substrates CoA and hexanoylcarnitine. Detailed analyses suggest that these structures may be good mimics for the Michaelis complexes for the forward and reverse reactions of the enzyme, representing the first time that such complexes of CrAT have been studied in molecular detail. The structural information provides significant new insights into the catalytic mechanism of CrAT and possibly carnitine acyltransferases in general.	Columbia Univ, Dept Sci Biol, New York, NY 10027 USA	Columbia University	Tong, L (corresponding author), Columbia Univ, Dept Sci Biol, New York, NY 10027 USA.	tong@como.bio.columbia.edu	Jogl, Gerwald/AAJ-5783-2021	Jogl, Gerwald/0000-0002-5465-5315; Tong, Liang/0000-0002-0563-6468	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067238] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK067238-05A2, R01 DK067238, DK67238] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anderson RC, 1998, CURR PHARM DESIGN, V4, P1; BIEBER LL, 1988, ANNU REV BIOCHEM, V57, P261, DOI 10.1146/annurev.bi.57.070188.001401; Bonnefont Jean-Paul, 2004, Molecular Aspects of Medicine, V25, P495, DOI 10.1016/j.mam.2004.06.004; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cai YY, 2004, EMBO J, V23, P2047, DOI 10.1038/sj.emboj.7600221; CARSON M, 1987, J MOL GRAPHICS, V5, P103, DOI 10.1016/0263-7855(87)80010-3; COLUCCI WJ, 1988, BIOORG CHEM, V16, P307, DOI 10.1016/0045-2068(88)90018-1; Cordente AG, 2004, J BIOL CHEM, V279, P33899, DOI 10.1074/jbc.M402685200; Cronin CN, 1997, BIOCHEM BIOPH RES CO, V238, P784, DOI 10.1006/bbrc.1997.7390; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Foster DW, 2004, ANN NY ACAD SCI, V1033, P1, DOI 10.1196/annals.1320.001; Govindasamy L, 2004, J STRUCT BIOL, V148, P226, DOI 10.1016/j.jsb.2004.06.005; Govindasamy L, 2004, J STRUCT BIOL, V146, P416, DOI 10.1016/j.jsb.2004.01.011; Hassett RP, 2000, ANAL BIOCHEM, V287, P176, DOI 10.1006/abio.2000.4799; Hickman AB, 1999, CELL, V97, P361, DOI 10.1016/S0092-8674(00)80745-X; Hsiao YS, 2004, J BIOL CHEM, V279, P31584, DOI 10.1074/jbc.M403484200; Hsiao YS, 2006, BIOCHEM BIOPH RES CO, V346, P974, DOI 10.1016/j.bbrc.2006.06.006; Jogl G, 2004, ANN NY ACAD SCI, V1033, P17, DOI 10.1196/annals.1320.002; Jogl G, 2005, J BIOL CHEM, V280, P738, DOI 10.1074/jbc.M409894200; Jogl G, 2003, CELL, V112, P113, DOI 10.1016/S0092-8674(02)01228-X; Jogl G, 2001, ACTA CRYSTALLOGR D, V57, P1127, DOI 10.1107/S0907444901006783; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kerner J, 2000, BBA-MOL CELL BIOL L, V1486, P1, DOI 10.1016/S1388-1981(00)00044-5; Lenhard JM, 2002, ADV DRUG DELIVER REV, V54, P1199, DOI 10.1016/S0169-409X(02)00092-3; LESLIE AGW, 1988, P NATL ACAD SCI USA, V85, P4133, DOI 10.1073/pnas.85.12.4133; MATTEVI A, 1992, SCIENCE, V255, P1544, DOI 10.1126/science.1549782; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; Mengi Sushma A, 2004, Am J Cardiovasc Drugs, V4, P201, DOI 10.2165/00129784-200404040-00001; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nyman LR, 2005, MOL GENET METAB, V86, P179, DOI 10.1016/j.ymgme.2005.07.021; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ramsay Rona R., 2004, Molecular Aspects of Medicine, V25, P475, DOI 10.1016/j.mam.2004.06.002; Ramsay RR, 2003, TRENDS BIOCHEM SCI, V28, P343, DOI 10.1016/S0968-0004(03)00137-3; Ramsay RR, 2001, BBA-PROTEIN STRUCT M, V1546, P21, DOI 10.1016/S0167-4838(01)00147-9; Ronnett GV, 2005, PHYSIOL BEHAV, V85, P25, DOI 10.1016/j.physbeh.2005.04.014; Rufer AC, 2006, STRUCTURE, V14, P713, DOI 10.1016/j.str.2006.01.008; Scheibner KA, 2002, J BIOL CHEM, V277, P18118, DOI 10.1074/jbc.M200595200; Steiber Alison, 2004, Molecular Aspects of Medicine, V25, P455, DOI 10.1016/j.mam.2004.06.006; Thupari JN, 2002, P NATL ACAD SCI USA, V99, P9498, DOI 10.1073/pnas.132128899; Watt W, 1999, STRUCTURE, V7, P1135, DOI 10.1016/S0969-2126(99)80180-4	41	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					28480	28487		10.1074/jbc.M602622200	http://dx.doi.org/10.1074/jbc.M602622200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16870616	Green Accepted, hybrid			2022-12-27	WOS:000240534400085
J	Oikonomopoulou, K; Hansen, KK; Saifeddine, M; Tea, I; Blaber, M; Blaber, SI; Scarisbrick, I; Andrade-Gordon, P; Cottrell, GS; Bunnett, NW; Diamandis, EP; Hollenberg, MD				Oikonomopoulou, Katerina; Hansen, Kristina K.; Saifeddine, Mahmoud; Tea, Illa; Blaber, Michael; Blaber, Sachiko I.; Scarisbrick, Isobel; Andrade-Gordon, Patricia; Cottrell, Graeme S.; Bunnett, Nigel W.; Diamandis, Eleftherios P.; Hollenberg, Morley D.			Proteinase-activated receptors, targets for kallikrein signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAST-CELL TRYPTASE; HUMAN TISSUE KALLIKREINS; THROMBIN-RECEPTOR; SERINE-PROTEASE; PLASMINOGEN-ACTIVATOR; MOLECULAR-CLONING; SUBSTRATE-SPECIFICITY; EPITHELIAL-CELLS; SERUM BIOMARKER; NERVOUS-SYSTEM	Serine proteinases like thrombin can signal to cells by the cleavage/activation of proteinase-activated receptors (PARs). Although thrombin is a recognized physiological activator of PAR(1) and PAR(4), the endogenous enzymes responsible for activating PAR(2) in settings other than the gastrointestinal system, where trypsin can activate PAR2, are unknown. We tested the hypothesis that the human tissue kallikrein (hK) family of proteinases regulates PAR signaling by using the following: 1) a high pressure liquid chromatography (HPLC)-mass spectral analysis of the cleavage products yielded upon incubation of hK5,-6, and -14 with synthetic PAR N-terminal peptide sequences representing the cleavage/activation motifs of PAR1, PAR2, and PAR4; 2) PAR-dependent calcium signaling responses in cells expressing PAR1, PAR2, and PAR4 and in human platelets; 3) a vascular ring vasorelaxation assay; and 4) a PAR(4)-dependent rat and human platelet aggregation assay. We found that hK5, -6, and -14 all yielded PAR peptide cleavage sequences consistent with either receptor activation or inactivation/disarming. Furthermore, hK14 was able to activate PAR1, PAR2, and PAR4 and to disarm/inhibit PAR1. Although hK5 and -6 were also able to activate PAR(2), they failed to cause PAR(4)-dependent aggregation of rat and human platelets, although hK14 did. Furthermore, the relative potencies and maximum effects of hK14 and -6 to activate PAR(2)-mediated calcium signaling differed. Our data indicate that in physiological settings, hKs may represent important endogenous regulators of the PARs and that different hKs can have differential actions on PAR(1), PAR(2), and PAR(4).	Univ Calgary, Fac Med, Dept Pharmacol & Therapeut, Proteinases & Inflammat Network,Mucosal Inflammat, Calgary, AB T2N 4N1, Canada; Univ Calgary, Dept Med, Calgary, AB T2N 4N1, Canada; Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 1L5, Canada; Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada; Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA; Mayo Clin, Coll Med, Program Mol Neurosci, Dept Neurol, Rochester, MN 55905 USA; Mayo Clin, Coll Med, Dept Phys Med & Rehabil, Rochester, MN 55905 USA; Johnson & Johnson Pharmaceut Res & Dev, Spring House, PA 19477 USA; Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of Calgary; University of Calgary; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; State University System of Florida; Florida State University; Mayo Clinic; Mayo Clinic; Johnson & Johnson; Johnson & Johnson USA; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Hollenberg, MD (corresponding author), Univ Calgary, Fac Med, Dept Pharmacol & Therapeut, Proteinases & Inflammat Network,Mucosal Inflammat, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	mhollenb@ucalgary.ca	Blaber, Michael/E-7478-2011; Blaber, Michael/N-1083-2019; Hollenberg, Morley/AFV-6966-2022; Blaber, Michael/ABA-5031-2021	Blaber, Michael/0000-0002-6856-1643; Diamandis, Eleftherios/0000-0002-1589-820X; Bunnett, Nigel W./0000-0003-3367-0644; Cottrell, Graeme/0000-0001-9098-7627	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK039957, R01DK039957] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 39957, DK 57480] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Al-Ani B, 2003, J PHARMACOL EXP THER, V304, P1120, DOI 10.1124/jpet.102.043844; Al-Ani B, 2002, J PHARMACOL EXP THER, V300, P702, DOI 10.1124/jpet.300.2.702; ALANI B, 1995, CAN J PHYSIOL PHARM, V73, P1203, DOI 10.1139/y95-172; Angelo PF, 2006, J BIOL CHEM, V281, P3116, DOI 10.1074/jbc.M510096200; Blaber SI, 2004, FASEB J, V18, P920, DOI 10.1096/fj.03-1212fje; Blaber SI, 2002, BIOCHEMISTRY-US, V41, P1165, DOI 10.1021/bi015781a; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Borgono CA, 2004, NAT REV CANCER, V4, P876, DOI 10.1038/nrc1474; Borgono CA, 2004, MOL CANCER RES, V2, P257; Borgono CA, 2003, CANCER RES, V63, P9032; Caubet C, 2004, J INVEST DERMATOL, V122, P1235, DOI 10.1111/j.0022-202X.2004.22512.x; Choong PFM, 2003, CLIN ORTHOP RELAT R, pS46, DOI 10.1097/01.blo.0000093845.72468.bd; Compton SJ, 2002, BIOCHEM J, V368, P495, DOI 10.1042/BJ20020706; Compton SJ, 2002, CAN J PHYSIOL PHARM, V80, P987, DOI 10.1139/Y02-125; Compton SJ, 2000, J BIOL CHEM, V275, P39207, DOI 10.1074/jbc.M007215200; Compton SJ, 2001, BRIT J PHARMACOL, V134, P705, DOI 10.1038/sj.bjp.0704303; Corvera CU, 1999, J PHYSIOL-LONDON, V517, P741, DOI 10.1111/j.1469-7793.1999.0741s.x; Cottrell GS, 2004, J BIOL CHEM, V279, P13532, DOI 10.1074/jbc.M312090200; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Covic L, 2002, NAT MED, V8, P1161, DOI 10.1038/nm760; Diamandis EP, 2000, CLIN BIOCHEM, V33, P579, DOI 10.1016/S0009-9120(00)00182-X; Dulon S, 2005, AM J RESP CELL MOL, V32, P411, DOI 10.1165/rcmb.2004-0274OC; Dulon S, 2003, AM J RESP CELL MOL, V28, P339, DOI 10.1165/rcmb.4908; Ekholm E, 1999, ARCH DERMATOL RES, V291, P195, DOI 10.1007/s004030050393; Felber LM, 2005, BIOL CHEM, V386, P291, DOI 10.1515/BC.2005.035; Frenette G, 1997, INT J CANCER, V71, P897, DOI 10.1002/(SICI)1097-0215(19970529)71:5<897::AID-IJC31>3.0.CO;2-2; Hollenberg MD, 2004, BRIT J PHARMACOL, V143, P443, DOI 10.1038/sj.bjp.0705946; Hollenberg MD, 2002, PHARMACOL REV, V54, P203, DOI 10.1124/pr.54.2.203; Hollenberg MD, 1997, CAN J PHYSIOL PHARM, V75, P832, DOI 10.1139/cjpp-75-7-832; Hoogerwerf WA, 2002, BMC MOL BIOL, V3, DOI 10.1186/1471-2199-3-2; Iwakiri K, 2004, J INVEST DERMATOL, V122, P937, DOI 10.1111/j.0022-202X.2004.22415.x; KAO JPY, 1989, J BIOL CHEM, V264, P8179; Kawabata A, 1999, J PHARMACOL EXP THER, V288, P358; Kim H, 2001, BRIT J CANCER, V84, P643, DOI 10.1054/bjoc.2000.1649; Komatsu N, 2003, J INVEST DERMATOL, V121, P542, DOI 10.1046/j.1523-1747.2003.12363.x; Kong WY, 1997, P NATL ACAD SCI USA, V94, P8884, DOI 10.1073/pnas.94.16.8884; Kuliopulos A, 1999, BIOCHEMISTRY-US, V38, P4572, DOI 10.1021/bi9824792; Kuwae K, 2002, J CLIN PATHOL-MOL PA, V55, P235, DOI 10.1136/mp.55.4.235; Ma L, 2005, P NATL ACAD SCI USA, V102, P216, DOI 10.1073/pnas.0406682102; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; Magklara A, 2003, BIOCHEM BIOPH RES CO, V307, P948, DOI 10.1016/S0006-291X(03)01271-3; Michael IP, 2005, J BIOL CHEM, V280, P14628, DOI 10.1074/jbc.M408132200; MINTA A, 1989, J BIOL CHEM, V264, P8171; Mirza H, 1997, BLOOD, V90, P3914, DOI 10.1182/blood.V90.10.3914; Molino M, 1997, J BIOL CHEM, V272, P11133; Molino M, 1997, J BIOL CHEM, V272, P4043, DOI 10.1074/jbc.272.7.4043; MURAMATSU I, 1992, CAN J PHYSIOL PHARM, V70, P996, DOI 10.1139/y92-137; Noorbakhsh F, 2003, NAT REV NEUROSCI, V4, P981, DOI 10.1038/nrn1255; NYSTEDT S, 1994, P NATL ACAD SCI USA, V91, P9208, DOI 10.1073/pnas.91.20.9208; O'Brien PJ, 2001, ONCOGENE, V20, P1570, DOI 10.1038/sj.onc.1204194; Olsson AY, 2002, BIOCHEM BIOPH RES CO, V299, P305; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Quinton TM, 2004, J BIOL CHEM, V279, P18434, DOI 10.1074/jbc.M401431200; RASMUSSEN UB, 1991, FEBS LETT, V288, P123, DOI 10.1016/0014-5793(91)81017-3; Ruf W, 2003, J THROMB HAEMOST, V1, P1495, DOI 10.1046/j.1538-7836.2003.00300.x; SANTULLI RJ, 1995, P NATL ACAD SCI USA, V92, P9151, DOI 10.1073/pnas.92.20.9151; Scarisbrick IA, 2002, BRAIN, V125, P1283, DOI 10.1093/brain/awf142; Seatter MJ, 2004, CELL SIGNAL, V16, P21, DOI 10.1016/S0898-6568(03)00095-0; Steinhoff M, 2005, ENDOCR REV, V26, P1, DOI 10.1210/er.2003-0025; Takayama TK, 2001, BIOCHEMISTRY-US, V40, P15341, DOI 10.1021/bi015775e; Tanimoto H, 2001, TUMOR BIOL, V22, P11, DOI 10.1159/000030150; Vergnolle N, 2004, BRIT J PHARMACOL, V141, P1264, DOI 10.1038/sj.bjp.0705750; Vergnolle N, 2002, J IMMUNOL, V169, P1467, DOI 10.4049/jimmunol.169.3.1467; Vergnolle N, 2001, TRENDS PHARMACOL SCI, V22, P146, DOI 10.1016/S0165-6147(00)01634-5; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Wallace John L., 1995, Methods (Orlando), V7, P55, DOI 10.1006/meth.1995.1008; Wang JR, 2003, RADIAT RES, V160, P524, DOI 10.1667/RR3080; Yousef GM, 2004, ANTICANCER RES, V24, P43; Yousef GM, 2003, CANCER RES, V63, P3958; Yousef GM, 2003, CLIN CHIM ACTA, V329, P1, DOI 10.1016/S0009-8981(03)00004-4; Yousef GM, 2001, ENDOCR REV, V22, P184, DOI 10.1210/er.22.2.184	71	211	224	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32095	32112		10.1074/jbc.M513138200	http://dx.doi.org/10.1074/jbc.M513138200			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16885167	hybrid			2022-12-27	WOS:000241414500007
J	Wood, JE; Schneider, H; Rudd, CE				Wood, Joanne E.; Schneider, Helga; Rudd, Christopher E.			TcR and TcR-CD28 engagement of protein kinase B (PKB/AKT) and glycogen synthase kinase-3 (GSK-3) operates independently of guanine nucleotide exchange factor VAV-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL-RECEPTOR; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNALING PATHWAY; TYROSINE PHOSPHORYLATION; CD28; ACTIVATION; PROLIFERATION; DISTINCT; SURVIVAL; BINDING	TcR zeta/CD3 and TcR zeta/CD3-CD28 signaling requires the guanine nucleotide exchange factor (GEF) Vav-1 as well as the activation of phosphatidylinositol 3-kinase, protein kinase B (PKB/AKT), and its inactivation of glycogen synthase kinase-3 (GSK-3). Whether these two pathways are connected or operate independently of each other in T-cells has been unclear. Here, we report that anti-CD3 and anti-CD3/CD28 can induce PKB and GSK-3 alpha phosphorylation in the Vav-1(-/-) Jurkat cell line J. Vav.1 and in primary CD4-positive Vav-1(-/-) T-cells. Reduced GSK-3 alpha phosphorylation was observed in Vav-1,2,3(-/-) T-cells together with a complete loss of FOXO1 phosphorylation. Furthermore, PKB and GSK-3 phosphorylation was unperturbed in the presence of GEF-inactive Vav-1 that inhibited interleukin-2 gene activation and a form of Src homology 2 domain-containing lymphocytic protein of 76-kDa (SLP-76) that is defective in binding to Vav-1. The pathway also was intact under conditions of c-Jun N-terminal kinase (JNK) inhibition and disruption of the actin cytoskeleton by cytochalasin D. Both events are downstream targets of Vav-1. Overall, our findings indicate that the TcR and TcR-CD28 driven PKB-GSK-3 pathway can operate independently of Vav-1 in T-cells.	Univ London Imperial Coll Sci Technol & Med, Dept Immunol, Mol Immunol Sect, London W12 0NN, England; Univ Cambridge, Dept Pathol, Div Immunol, Cell Signalling Sect, Cambridge CB2 1QP, England	Imperial College London; University of Cambridge	Rudd, CE (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Immunol, Mol Immunol Sect, London W12 0NN, England.	cer51@cam.ac.uk	Rudd, Christopher E/ABF-7259-2021; Rudd, Christopher E/GOH-2021-2022	Rudd, Christopher E/0000-0001-5295-9019	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Abraham RT, 2004, NAT REV IMMUNOL, V4, P301, DOI 10.1038/nri1330; Appleman LJ, 2002, J IMMUNOL, V168, P2729, DOI 10.4049/jimmunol.168.6.2729; Auer KL, 1998, MOL BIOL CELL, V9, P561, DOI 10.1091/mbc.9.3.561; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; BLUESTONE JA, 1995, IMMUNITY, V2, P555, DOI 10.1016/1074-7613(95)90000-4; Burr JS, 2001, J IMMUNOL, V166, P5331, DOI 10.4049/jimmunol.166.9.5331; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; CAI YC, 1995, IMMUNITY, V3, P417, DOI 10.1016/1074-7613(95)90171-X; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cao YJ, 2002, EMBO J, V21, P4809, DOI 10.1093/emboj/cdf499; Cefai D, 1996, INT IMMUNOL, V8, P1609, DOI 10.1093/intimm/8.10.1609; Collins TL, 1997, IMMUNOL TODAY, V18, P221; Crespo P, 1996, ONCOGENE, V13, P455; Dahl AM, 2000, J EXP MED, V191, P2031, DOI 10.1084/jem.191.12.2031; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; Harada Y, 2001, J IMMUNOL, V166, P3797, DOI 10.4049/jimmunol.166.6.3797; Hehner SP, 2000, J BIOL CHEM, V275, P18160, DOI 10.1074/jbc.275.24.18160; Hill MM, 2002, CURR BIOL, V12, P1251, DOI 10.1016/S0960-9822(02)00973-9; Holdorf AD, 1999, J EXP MED, V190, P375, DOI 10.1084/jem.190.3.375; Inabe K, 2002, J EXP MED, V195, P189, DOI 10.1084/jem.20011571; JUNE CH, 1994, IMMUNOL TODAY, V15, P321, DOI 10.1016/0167-5699(94)90080-9; Kane LP, 2001, NAT IMMUNOL, V2, P37, DOI 10.1038/83144; Kim HH, 1998, J BIOL CHEM, V273, P296, DOI 10.1074/jbc.273.1.296; Klasen S, 1998, INT IMMUNOL, V10, P481, DOI 10.1093/intimm/10.4.481; Lawlor MA, 2001, J CELL SCI, V114, P2903; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Manetz TS, 2001, MOL CELL BIOL, V21, P3763, DOI 10.1128/MCB.21.11.3763-3774.2001; Martin M, 2001, J EXP MED, V194, P1675, DOI 10.1084/jem.194.11.1675; Michel F, 2000, J IMMUNOL, V165, P3820, DOI 10.4049/jimmunol.165.7.3820; Moller A, 2001, J BIOL CHEM, V276, P20022, DOI 10.1074/jbc.M011139200; Musci MA, 1997, J IMMUNOL, V159, P1639; Ohteki T, 2000, J EXP MED, V192, P99, DOI 10.1084/jem.192.1.99; Okkenhaug K, 2001, NAT IMMUNOL, V2, P325, DOI 10.1038/86327; Onodera H, 1996, J BIOL CHEM, V271, P22225, DOI 10.1074/jbc.271.36.22225; PAGES F, 1994, NATURE, V369, P327, DOI 10.1038/369327a0; Persad S, 2001, J BIOL CHEM, V276, P27462, DOI 10.1074/jbc.M102940200; Piccolella E, 2003, J IMMUNOL, V170, P2895, DOI 10.4049/jimmunol.170.6.2895; PRASAD KVS, 1994, P NATL ACAD SCI USA, V91, P2834, DOI 10.1073/pnas.91.7.2834; Raab M, 2001, IMMUNITY, V15, P921, DOI 10.1016/S1074-7613(01)00248-5; Raab M, 1997, IMMUNITY, V6, P155, DOI 10.1016/S1074-7613(00)80422-7; Reynolds LF, 2002, J EXP MED, V195, P1103, DOI 10.1084/jem.20011663; Rivas FV, 2004, MOL CELL BIOL, V24, P1628, DOI 10.1128/MCB.24.4.1628-1639.2004; Rudd CE, 1999, CELL, V96, P5, DOI 10.1016/S0092-8674(00)80953-8; Rudd CE, 2003, NAT REV IMMUNOL, V3, P544, DOI 10.1038/nri1131; Schwartz RH, 1997, CURR OPIN IMMUNOL, V9, P351, DOI 10.1016/S0952-7915(97)80081-7; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; TARAKHOVSKY A, 1995, NATURE, V374, P467, DOI 10.1038/374467a0; Toker A, 2000, J BIOL CHEM, V275, P8271, DOI 10.1074/jbc.275.12.8271; Turner M, 2002, NAT REV IMMUNOL, V2, P476, DOI 10.1038/nri840; Tybulewicz VL, 2005, CURR OPIN IMMUNOL, V17, P267, DOI 10.1016/j.coi.2005.04.003; Vigorito E, 2004, BIOCHEM SOC T, V32, P781, DOI 10.1042/BST0320781; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Woodgett JR, 2005, CURR OPIN CELL BIOL, V17, P150, DOI 10.1016/j.ceb.2005.02.010; Wu J, 1996, IMMUNITY, V4, P593, DOI 10.1016/S1074-7613(00)80485-9	58	36	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32385	32394		10.1074/jbc.M604878200	http://dx.doi.org/10.1074/jbc.M604878200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16905544	hybrid			2022-12-27	WOS:000241414500036
J	Carayol, N; Chen, J; Yang, F; Jin, TC; Jin, LJ; States, D; Wang, CY				Carayol, Nathalie; Chen, Ji; Yang, Fan; Jin, Taocong; Jin, Lijian; States, David; Wang, Cun-Yu			A dominant function of IKK/NF-kappa B signaling in global lipopolysaccharide-induced gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC INFLAMMATORY DISEASES; NECROSIS-FACTOR-ALPHA; PORPHYROMONAS-GINGIVALIS; TNF RECEPTOR; SELECTIVE-INHIBITION; ECTODERMAL DYSPLASIA; PERIODONTAL-DISEASE; INDUCED APOPTOSIS; IMMUNE-RESPONSES; KINASE COMPLEX	Porphyromonas gingivalis is an etiologic pathogen of periodontitis that is one of the most common inflammatory diseases. Recently, we found that P. gingivalis LPS activated the transcription factor nuclear factor-kappa B (NF-kappa B) through the I kappa B kinase complex (IKK). NF-kappa B is a transcription factor that controls inflammation and host responses. In this study, we examined the role of IKK/NF-kappa B in P. gingivalis LPS-induced gene expression on a genome-wide basis using a combination of microarray and biochemical approaches. A total of 88 early response genes were found to be induced by P. gingivalis LPS in a human THP.1 monocytic cell lines. Interestingly, the induction of most of these genes was abolished or attenuated under the inactivation of IKK/NF-kappa B. Among those IKK/NF-kappa B-dependent genes, 20 genes were NF-kappa B-inducible genes reported previously, and 59 genes represented putative novel NF-kappa B target genes. Using transcription factor binding analysis, we found that most of these putative NF-kappa B target genes contained one or multiple NF-kappa B-binding sites. Also, some transcription factor-binding motifs were overrepresented in the promoter of both known and putative NF-kappa B-dependent genes, indicating that these genes may be regulated in a similar fashion. Furthermore, we found that several transcription factors associated with metabolic and inflammatory responses, including nuclear receptors, activator of protein-1, and early growth responses, were induced by P. gingivalis LPS through IKK/NF-kappa B, indicating that IKK/NF-kappa B may utilize these transcription factors to mediate secondary responses. Taken together, our results demonstrate that IKK/NF-kappa B signaling plays a dominant role in P. gingivalis LPS-induced early response gene expression, suggesting that IKK/NF-kappa B is a therapeutic target for periodontitis.	Univ Michigan, Dept Biol & Mat Sci, Lab Mol Signaling & Apoptosis, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA; Univ Michigan, Bioinformat Training Program, Ann Arbor, MI 48109 USA; Univ Hong Kong, Fac Dent, Hong Kong, Hong Kong, Peoples R China	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Hong Kong	Wang, CY (corresponding author), Univ Michigan, Dept Biol & Mat Sci, Lab Mol Signaling & Apoptosis, Ann Arbor, MI 48109 USA.	cunywang@umich.edu	Jin, Lijian/B-2148-2009	Jin, Lijian/0000-0003-4305-1337	NIDCR NIH HHS [R01DE16513, R01DE15973] Funding Source: Medline; NLM NIH HHS [R01-LM08106] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016513] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015973] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM008106] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Assuma R, 1998, J IMMUNOL, V160, P403; Bannerman DD, 2002, J BIOL CHEM, V277, P8048, DOI 10.1074/jbc.M111249200; Birney E, 2003, COLD SPRING HARB SYM, V68, P213, DOI 10.1101/sqb.2003.68.213; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Chang J, 2005, J DENT RES, V84, P994, DOI 10.1177/154405910508401105; Chen S, 2002, J DENT RES, V81, P98, DOI 10.1177/154405910208100203; Chen SQ, 2001, J CELL BIOL, V152, P87, DOI 10.1083/jcb.152.1.87; Darveau RP, 1997, PERIODONTOL 2000, V14, P12, DOI 10.1111/j.1600-0757.1997.tb00190.x; Decker EL, 2003, NUCLEIC ACIDS RES, V31, P911, DOI 10.1093/nar/gkg186; Devin A, 2000, IMMUNITY, V12, P419, DOI 10.1016/S1074-7613(00)80194-6; Doffinger R, 2001, NAT GENET, V27, P277, DOI 10.1038/85837; Fribley A, 2004, MOL CELL BIOL, V24, P9695, DOI 10.1128/MCB.24.22.9695-9704.2004; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gibson FC, 2006, J DENT RES, V85, P106, DOI 10.1177/154405910608500202; Harhaj EW, 2000, ONCOGENE, V19, P1448, DOI 10.1038/sj.onc.1203445; Huang GTJ, 2004, MICROB PATHOGENESIS, V37, P303, DOI 10.1016/j.micpath.2004.10.003; Hull C, 2002, J IMMUNOL, V169, P2611, DOI 10.4049/jimmunol.169.5.2611; Jain A, 2001, NAT IMMUNOL, V2, P223, DOI 10.1038/85277; Jimi E, 2004, NAT MED, V10, P617, DOI 10.1038/nm1054; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Li YG, 1999, P NATL ACAD SCI USA, V96, P1042, DOI 10.1073/pnas.96.3.1042; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Madrid LV, 2000, MOL CELL BIOL, V20, P1626, DOI 10.1128/MCB.20.5.1626-1638.2000; MANGAN DF, 1993, J PERIODONTOL, V64, P461; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; MAYO MW, 2000, BIOCHIM BIOPHYS ACTA, V1470, P55; Muthukuru M, 2006, INFECT IMMUN, V74, P1431, DOI 10.1128/IAI.74.2.1431-1435.2006; Niederman R, 2001, J CLIN PERIODONTOL, V28, P569, DOI 10.1034/j.1600-051x.2001.028006569.x; Pei LM, 2005, J BIOL CHEM, V280, P29256, DOI 10.1074/jbc.M502606200; Ramamurthy NS, 2002, J PERIODONTAL RES, V37, P1, DOI 10.1034/j.1600-0765.2002.00342.x; Salvi G E, 1998, Ann Periodontol, V3, P40, DOI 10.1902/annals.1998.3.1.40; Salvi GE, 1997, PERIODONTOL 2000, V14, P173, DOI 10.1111/j.1600-0757.1997.tb00197.x; Southerland JH, 2006, PERIODONTOL 2000, V40, P130, DOI 10.1111/j.1600-0757.2005.00138.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tang ED, 2003, J BIOL CHEM, V278, P37297, DOI 10.1074/jbc.M303389200; Teng YTA, 2006, J DENT RES, V85, P198, DOI 10.1177/154405910608500301; Vasselon T, 2002, INFECT IMMUN, V70, P1033, DOI 10.1128/IAI.70.3.1033-1041.2002; Wang CY, 1999, MOL CELL BIOL, V19, P5923; Wang CY, 1999, NAT MED, V5, P412, DOI 10.1038/7410; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Yang F, 2004, J IMMUNOL, V172, P2446, DOI 10.4049/jimmunol.172.4.2446; Yang F, 2003, J IMMUNOL, V170, P5630, DOI 10.4049/jimmunol.170.11.5630; You ZB, 2001, J BIOL CHEM, V276, P26398, DOI 10.1074/jbc.M102464200; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1; Zhou Q, 2005, INFECT IMMUN, V73, P935, DOI 10.1128/IAI.73.2.935-943.2005	50	56	58	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					31142	31151		10.1074/jbc.M603417200	http://dx.doi.org/10.1074/jbc.M603417200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16914552	hybrid			2022-12-27	WOS:000241075900089
J	Chang, CB; Brivanlou, AH; Harland, RM				Chang, Chenbei; Brivanlou, Ali H.; Harland, Richard M.			Function of the two xenopus Smad4s in early frog development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFORMING-GROWTH-FACTOR; TUMOR SUPPRESSORS SMAD2; TGF-BETA; SKI ACTS; C-SKI; SPEMANNS ORGANIZER; PROTEINS; ONCOPROTEIN; MUTATIONS; PATHWAY	Signals from the transforming growth factor beta family members are transmitted in the cell through specific receptor-activated Smads and a common partner Smad4. Two Smad4 genes (alpha and beta/10, or smad4 and smad4.2) have been isolated from Xenopus, and conflicting data are reported for Smad4 beta/10 actions in mesodermal and neural induction. To further understand the functions of the Smad4s in early frog development, we analyzed their activities in detail. We report that Smad10 is a mutant form of Smad4 beta that harbors a missense mutation of a conserved arginine to histidine in the MH1 domain. The mutation results in enhanced association of Smad10 with the nuclear transcription corepressor Ski and leads to its neural inducing activity through inhibition of bone morphogenetic protein (BMP) signaling. In contrast to Smad10, both Smad4 alpha and Smad4 beta enhanced BMP signals in ectodermal explants. Using antisense morpholino oligonucleotides (MOs) to knockdown endogenous Smad4 protein levels, we discovered that Smad4 beta was required for both activin- and BMP-mediated mesodermal induction in animal caps, whereas Smad4 beta affected only the BMP signals. Neither Smad4 was involved directly in neural induction. Expression of Smad4 beta-MO in early frog embryos resulted in reduction of mesodermal markers and defects in axial structures, which were rescued by either Smad4 alpha or Smad4 beta. Smad4 alpha-MO induced only minor deficiency at late stages. As Smad4 beta, but not Smad4 alpha, is expressed at high levels maternally and during early gastrulation, our data suggest that although Smad4 alpha and Smad4 beta may have similar activities, they are differentially utilized during frog embryogenesis, with only Smad4 beta being essential for mesoderm induction.	Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA; Rockefeller Univ, Mol Embryol Lab, New York, NY 10021 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Ctr Integrat Genom, Berkeley, CA 94720 USA	University of Alabama System; University of Alabama Birmingham; Rockefeller University; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Chang, CB (corresponding author), Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA.	cchang@uab.edu			NICHD NIH HHS [R01 HD43345] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD043345] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Akiyoshi S, 1999, J BIOL CHEM, V274, P35269, DOI 10.1074/jbc.274.49.35269; Chang CB, 1997, DEVELOPMENT, V124, P827; Chang H, 2002, ENDOCR REV, V23, P787, DOI 10.1210/er.2002-0003; Chu GC, 2004, DEVELOPMENT, V131, P3501, DOI 10.1242/dev.01248; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Eppert K, 1996, CELL, V86, P543, DOI 10.1016/S0092-8674(00)80128-2; Harland R, 2000, CURR OPIN GENET DEV, V10, P357, DOI 10.1016/S0959-437X(00)00096-4; Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Harms PW, 2003, GENE DEV, V17, P2624, DOI 10.1101/gad.1127703; Hata A, 1997, NATURE, V388, P82, DOI 10.1038/40424; He J, 2003, J BIOL CHEM, V278, P30540, DOI 10.1074/jbc.M304016200; He W, 2006, CELL, V125, P929, DOI 10.1016/j.cell.2006.03.045; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Howell M, 1999, DEV BIOL, V214, P354, DOI 10.1006/dbio.1999.9430; Khokha MK, 2005, DEV CELL, V8, P401, DOI 10.1016/j.devcel.2005.01.013; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; LeSuer JA, 1999, DEVELOPMENT, V126, P137; LeSueur JA, 2002, DEV CELL, V2, P771, DOI 10.1016/S1534-5807(02)00172-7; Levy L, 2005, MOL CELL BIOL, V25, P8108, DOI 10.1128/MCB.25.18.8108-8125.2005; Liberati NT, 2001, J BIOL CHEM, V276, P22595, DOI 10.1074/jbc.M010778200; Luo KX, 1999, GENE DEV, V13, P2196, DOI 10.1101/gad.13.17.2196; Masuyama N, 1999, J BIOL CHEM, V274, P12163, DOI 10.1074/jbc.274.17.12163; Moren A, 2000, ONCOGENE, V19, P4396, DOI 10.1038/sj.onc.1203798; Prunier C, 2003, J BIOL CHEM, V278, P26249, DOI 10.1074/jbc.M304459200; Schutte M, 1996, CANCER RES, V56, P2527; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Sirard C, 2000, J BIOL CHEM, V275, P2063, DOI 10.1074/jbc.275.3.2063; Sun Y, 1999, MOL CELL, V4, P499, DOI 10.1016/S1097-2765(00)80201-4; Suzuki H, 2004, ONCOGENE, V23, P5068, DOI 10.1038/sj.onc.1207690; Takeda M, 2004, MOL BIOL CELL, V15, P963, DOI 10.1091/mbc.E03-07-0478; Wang W, 2000, P NATL ACAD SCI USA, V97, P14394, DOI 10.1073/pnas.97.26.14394; Watanabe M, 2000, EMBO REP, V1, P176, DOI 10.1093/embo-reports/kvd029; Whitman M, 1998, GENE DEV, V12, P2445, DOI 10.1101/gad.12.16.2445; Wisotzkey RG, 1998, DEVELOPMENT, V125, P1433; Xu J, 2000, P NATL ACAD SCI USA, V97, P4820, DOI 10.1073/pnas.97.9.4820; Xu WD, 2000, P NATL ACAD SCI USA, V97, P5924, DOI 10.1073/pnas.090097797; Yeo CY, 2001, MOL CELL, V7, P949, DOI 10.1016/S1097-2765(01)00249-0; Zhao GQ, 2003, GENESIS, V35, P43, DOI 10.1002/gene.10167	40	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30794	30803		10.1074/jbc.M607054200	http://dx.doi.org/10.1074/jbc.M607054200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16908518	hybrid			2022-12-27	WOS:000241075900055
J	Esue, O; Carson, AA; Tseng, Y; Wirtz, D				Esue, Osigwe; Carson, Ashley A.; Tseng, Yiider; Wirtz, Denis			A direct interaction between actin and vimentin filaments mediated by the tail domain of vimentin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYNAMIC CROSS-LINKING; INTERMEDIATE-FILAMENTS; MECHANICAL-PROPERTIES; IN-VITRO; VISCOELASTIC PROPERTIES; KERATIN FILAMENTS; ALPHA-ACTININ; PROTEIN; EXPRESSION; CELLS	The assembly and organization of the three major eukaryotic cytoskeleton proteins, actin, microtubules, and intermediate filaments, are highly interdependent. Through evolution, cells have developed specialized multifunctional proteins that mediate the cross-linking of these cytoskeleton filament networks. Here we test the hypothesis that two of these filamentous proteins, F-actin and vimentin filament, can interact directly, i.e. in the absence of auxiliary proteins. Through quantitative rheological studies, we find that a mixture of vimentin/actin filament network features a significantly higher stiffness than that of networks containing only actin filaments or only vimentin filaments. Maximum inter-filament interaction occurs at a vimentin/actin molar ratio of 3 to 1. Mixed networks of actin and tailless vimentin filaments show low mechanical stiffness and much weaker inter-filament interactions. Together with the fact that cells featuring prominent vimentin and actin networks are much stiffer than their counterparts lacking an organized actin or vimentin network, these results suggest that actin and vimentin filaments can interact directly through the tail domain of vimentin and that these inter-filament interactions may contribute to the overall mechanical integrity of cells and mediate cytoskeletal cross-talk.	Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; Univ Florida, Dept Chem Engn, Gainesville, FL 32611 USA; Johns Hopkins Univ, Howard Hughes Med Inst, Grad Training Program, Baltimore, MD 21218 USA; Johns Hopkins Univ, Inst Nanobiotechnol, Baltimore, MD 21218 USA	Johns Hopkins University; State University System of Florida; University of Florida; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University	Wirtz, D (corresponding author), Johns Hopkins Univ, Dept Chem & Biomol Engn, 3400 N Charles St, Baltimore, MD 21218 USA.	wirtz@jhu.edu	Wirtz, Denis/A-3257-2010		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075305] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM075305] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLAN V, 1994, CURR BIOL, V4, P1000, DOI 10.1016/S0960-9822(00)00225-6; Anastasi E, 1999, EUR J ENDOCRINOL, V141, P644, DOI 10.1530/eje.0.1410644; BADER BL, 1991, J CELL BIOL, V115, P1293, DOI 10.1083/jcb.115.5.1293; Bousquet O, 2001, J CELL BIOL, V155, P747, DOI 10.1083/jcb.200104063; CARY RB, 1994, J CELL SCI, V107, P1609; Chang L, 2004, NAT REV MOL CELL BIO, V5, P601, DOI 10.1038/nrm1438; CHU YW, 1993, P NATL ACAD SCI USA, V90, P4261, DOI 10.1073/pnas.90.9.4261; Correia I, 1999, J CELL BIOL, V146, P831, DOI 10.1083/jcb.146.4.831; Coulombe PA, 2000, TRENDS CELL BIOL, V10, P420, DOI 10.1016/S0962-8924(00)01828-6; CROOP J, 1975, J CELL BIOL, V65, P271, DOI 10.1083/jcb.65.2.271; ECKELT A, 1992, EUR J CELL BIOL, V58, P319; Eckes B, 1998, J CELL SCI, V111, P1897; ENGEL A, 1985, J ULTRA MOL STRUCT R, V90, P323, DOI 10.1016/S0022-5320(85)80010-1; Esue O, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.048301; FRANKE WW, 1982, DIFFERENTIATION, V23, P43, DOI 10.1111/j.1432-0436.1982.tb01266.x; Freshney RI, 1994, CULTURE ANIMAL CELLS; Fuchs E, 2001, GENE DEV, V15, P1, DOI 10.1101/gad.861501; GEISLER N, 1983, FEBS LETT, V163, P22, DOI 10.1016/0014-5793(83)81153-3; Goldman RD, 1996, J CELL BIOL, V134, P971, DOI 10.1083/jcb.134.4.971; Helfand BT, 2002, J CELL BIOL, V157, P795, DOI 10.1083/jcb.200202027; Helfand BT, 2004, J CELL SCI, V117, P133, DOI 10.1242/jcs.00936; Herrmann H, 1996, J MOL BIOL, V264, P933, DOI 10.1006/jmbi.1996.0688; Herrmann H, 2004, METHOD CELL BIOL, V78, P3; HERRMANN H, 1989, DEVELOPMENT, V105, P279; HIROKAWA N, 1984, J CELL BIOL, V98, P1523, DOI 10.1083/jcb.98.4.1523; HISANAGA S, 1988, J MOL BIOL, V202, P297, DOI 10.1016/0022-2836(88)90459-7; HISANAGA S, 1989, J NEUROSCI, V9, P959; HOLLENBECK PJ, 1989, J CELL SCI, V92, P621; Hutton E, 1998, J CELL BIOL, V143, P487, DOI 10.1083/jcb.143.2.487; JANMEY PA, 1991, J CELL BIOL, V113, P155, DOI 10.1083/jcb.113.1.155; KOUKLIS PD, 1991, J CELL BIOL, V114, P773, DOI 10.1083/jcb.114.4.773; Leung CL, 1999, J CELL BIOL, V147, P1275, DOI 10.1083/jcb.147.6.1275; Leung CL, 1999, J CELL BIOL, V144, P435, DOI 10.1083/jcb.144.3.435; Leung CL, 2002, TRENDS CELL BIOL, V12, P37, DOI 10.1016/S0962-8924(01)02180-8; MCCORMICK MB, 1993, J CELL BIOL, V122, P395, DOI 10.1083/jcb.122.2.395; Palmer A, 1999, BIOPHYS J, V76, P1063, DOI 10.1016/S0006-3495(99)77271-1; Prahlad V, 1998, J CELL BIOL, V143, P159, DOI 10.1083/jcb.143.1.159; ROGERS KR, 1995, EUR J CELL BIOL, V66, P136; Shah JV, 1998, BIOL BULL, V194, P402, DOI 10.2307/1543125; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; STEVEN AC, 1983, J BIOL CHEM, V258, P8323; Svitkina TM, 1996, J CELL BIOL, V135, P991, DOI 10.1083/jcb.135.4.991; TINT IS, 1991, J CELL SCI, V98, P375; Trickey WR, 2004, J ORTHOPAED RES, V22, P131, DOI 10.1016/S0736-0266(03)00150-5; Tseng Y, 2004, J BIOL CHEM, V279, P1819, DOI 10.1074/jbc.M306090200; Tseng Y, 2001, J MOL BIOL, V310, P351, DOI 10.1006/jmbi.2001.4716; WACHSSTOCK DH, 1993, BIOPHYS J, V65, P205, DOI 10.1016/S0006-3495(93)81059-2; WANG E, 1981, P NATL ACAD SCI-BIOL, V78, P2363, DOI 10.1073/pnas.78.4.2363; Wang N, 2002, J MUSCLE RES CELL M, V23, P535, DOI 10.1023/A:1023470709071; Wang N, 2000, AM J PHYSIOL-CELL PH, V279, pC188, DOI 10.1152/ajpcell.2000.279.1.C188; Weber KL, 2002, J CELL SCI, V115, P1373; Wickert U, 2005, EUR J CELL BIOL, V84, P379, DOI 10.1016/j.ejcb.2005.01.004; WICKSTROM ML, 1995, TOXICOL PATHOL, V23, P326, DOI 10.1177/019262339502300309; WILLARD M, 1981, J CELL BIOL, V89, P198, DOI 10.1083/jcb.89.2.198; Xu JY, 1998, J BIOL CHEM, V273, P9570, DOI 10.1074/jbc.273.16.9570; Xu JY, 2000, J BIOL CHEM, V275, P35886, DOI 10.1074/jbc.M002377200; Yang YM, 1996, CELL, V86, P655, DOI 10.1016/S0092-8674(00)80138-5	57	110	117	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30393	30399		10.1074/jbc.M605452200	http://dx.doi.org/10.1074/jbc.M605452200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16901892	hybrid			2022-12-27	WOS:000241075900013
J	Liang, MH; Chuang, DM				Liang, Min-Huei; Chuang, De-Maw			Differential roles of glycogen synthase kinase-3 isoforms in the regulation of transcriptional activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TISSUE-PLASMINOGEN ACTIVATOR; CELL-SURVIVAL; C-JUN; APOPTOSIS; BETA; PHOSPHORYLATION; INDUCTION; EGR-1; GROWTH	Glycogen synthase kinase-3 (GSK-3) exists as two structurally similar isoforms, alpha and beta, whose activities are negatively regulated by serine phosphorylation but positively controlled by tyrosine phosphorylation. We used GSK-3 isoform-specific small interfering RNAs, dominant negative mutants, and pharmacological inhibitors to search for the differential roles for both GSK-3 isoforms in regulating transcriptional activation in cultured rat cerebral cortical neurons. GSK-3 alpha and GSK-3 beta were shown to have differentially regulated transactivation such that GSK-3 alpha silencing/inhibition was more robust than GSK-3 beta silencing/inhibition in causing cAMP-responsive element-and NF-kappa B-dependent transactivation. Moreover, protein-DNA array studies identified two novel GSK-3-regulated transcription factors, early growth response 1 and Smad3/4, which were oppositely affected by GSK-3 alpha or GSK-3 beta silencing or inhibition. Taken together, our results underscore critical variations in the function and regulation of GSK-3 alpha and GSK-3 beta. The development of GSK-3 isoform-specific inhibitors is thus crucial for therapeutic intervention of GSK-3-related neuropathological conditions.	Natl Inst Mental Hlth, Mol Neurobiol Sect, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Chuang, DM (corresponding author), Natl Inst Mental Hlth, Mol Neurobiol Sect, Bethesda, MD 20892 USA.	chuang@mail.nih.gov			NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002698, Z01MH002468] Funding Source: NIH RePORTER; NIMH NIH HHS [Z01MH002468-18] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Akassoglou K, 2002, NEURON, V33, P861, DOI 10.1016/S0896-6273(02)00617-7; Bijur GN, 2003, NEUROREPORT, V14, P2415, DOI 10.1097/00001756-200312190-00025; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Bournat JC, 2000, J NEUROSCI RES, V61, P21, DOI 10.1002/1097-4547(20000701)61:1<21::AID-JNR3>3.0.CO;2-7; Buisson A, 2003, CELL MOL NEUROBIOL, V23, P539, DOI 10.1023/A:1025072013107; Bullock BP, 1998, BIOCHEMISTRY-US, V37, P3795, DOI 10.1021/bi970982t; Carmel JB, 2004, EXP NEUROL, V185, P81, DOI 10.1016/j.expneurol.2003.09.007; Cibelli G, 2002, J NEUROSCI RES, V67, P450, DOI 10.1002/jnr.10141; Deng J, 2004, MOL CARCINOGEN, V39, P139, DOI 10.1002/mc.10169; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Docagne F, 2002, MOL CELL NEUROSCI, V21, P634, DOI 10.1006/mcne.2002.1206; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; FIOL CJ, 1994, J BIOL CHEM, V269, P32187; GOODE N, 1992, J BIOL CHEM, V267, P16878; Gould TD, 2004, INT J NEUROPSYCHOPH, V7, P387, DOI 10.1017/S1461145704004535; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Grimes CA, 2001, J NEUROCHEM, V78, P1219, DOI 10.1046/j.1471-4159.2001.00495.x; Hallahan DE, 1995, J BIOL CHEM, V270, P30303, DOI 10.1074/jbc.270.51.30303; Harada T, 2001, NAT CELL BIOL, V3, P453, DOI 10.1038/35074516; Hashimoto R, 2002, J NEUROCHEM, V80, P589, DOI 10.1046/j.0022-3042.2001.00728.x; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Huang RP, 1998, CELL DEATH DIFFER, V5, P96, DOI 10.1038/sj.cdd.4400322; Jope RS, 2002, MOL PSYCHIATR, V7, pS35, DOI 10.1038/sj.mp.4001017; Lee JH, 2004, J NEUROCHEM, V91, P634, DOI 10.1111/j.1471-4159.2004.02770.x; Levkovitz Y, 2001, J NEUROSCI, V21, P5893, DOI 10.1523/JNEUROSCI.21-16-05893.2001; Liu CT, 1998, CANCER GENE THER, V5, P3; Melchor JP, 2003, J NEUROSCI, V23, P8867; O'Brien WT, 2004, J NEUROSCI, V24, P6791, DOI 10.1523/JNEUROSCI.4753-03.2004; Pawlak R, 2003, NAT NEUROSCI, V6, P168, DOI 10.1038/nn998; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; Pignatelli M, 2003, BIOCHEM J, V373, P739, DOI 10.1042/BJ20021918; Qin JZ, 1999, J BIOL CHEM, V274, P37957, DOI 10.1074/jbc.274.53.37957; Sasaki C, 2001, NEUROL RES, V23, P588, DOI 10.1179/016164101101199054; Schneider A, 1999, NAT MED, V5, P554, DOI 10.1038/8432; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Soeda S, 2001, MOL BRAIN RES, V91, P96, DOI 10.1016/S0169-328X(01)00133-4; Su Y, 2004, BIOCHEMISTRY-US, V43, P6899, DOI 10.1021/bi035627j; Tabrizi P, 1999, ARTERIOSCL THROM VAS, V19, P2801, DOI 10.1161/01.ATV.19.11.2801; Tsirka SE, 1996, NATURE, V384, P123, DOI 10.1038/384123b0; WANG QM, 1994, BIOCHEMISTRY-US, V33, P143, DOI 10.1021/bi00167a018; WANG QM, 1994, J BIOL CHEM, V269, P14566; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x	46	110	112	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30479	30484		10.1074/jbc.M607468200	http://dx.doi.org/10.1074/jbc.M607468200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16912034	hybrid			2022-12-27	WOS:000241075900023
J	Moran, P; Li, W; Fan, B; Vij, R; Eigenbrot, C; Kirchhofer, D				Moran, Paul; Li, Wei; Fan, Bin; Vij, Rajesh; Eigenbrot, Charles; Kirchhofer, Daniel			Pro-urokinase-type plasminogen activator is a substrate for hepsin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE GROWTH-FACTOR; SERINE-PROTEASE INHIBITOR; BENIGN PROSTATIC HYPERPLASIA; OVARIAN-CANCER; CLINICOPATHOLOGICAL PARAMETERS; BLOOD-COAGULATION; MICE DEFICIENT; CELL-GROWTH; IN-VIVO; EXPRESSION	Hepsin, a type II transmembrane serine protease, is strongly up-regulated in prostate cancer. Hepsin overexpression in a mouse prostate cancer model resulted in tumor progression and metastasis, associated with basement membrane disorganization. We investigated whether hepsin enzymatic activity was linked to the basement membrane defects by examining its ability to initiate the plasminogen/plasmin proteolytic pathway. Because plasminogen is not processed by hepsin, we investigated the upstream activators, urokinase-type plasminogen activator (uPA) and tissue-type plasminogen activator. Enzymatic assays with a recombinant soluble form of hepsin demonstrated that hepsin did not cleave pro-tissue-type plasminogen activator but efficiently converted pro-uPA into high molecular weight uPA by cleavage at the Lys(158)-Ile(159) (P-1-P-1') peptide bond. uPA generated by hepsin displayed enzymatic activity toward small synthetic and macromolecular substrates indistinguishable from uPA produced by plasmin. The catalytic efficiency of pro-uPA activation by hepsin (k(cat)/K-m 4.8 x 105 m(-1) s(-1)) was similar to that of plasmin, which is considered the most potent pro-uPA activator and was about 6-fold higher than that of matriptase. Conversion of pro-uPA was also demonstrated with cell surface-expressed full-length hepsin. A stable hepsin-overexpressing LnCaP cell line converted pro-uPA into high molecular weight uPA at a rate of 6.6 +/- 1.9 nM uPA h(-1), which was about 3-fold higher than LnCaP cells expressing lower hepsin levels on their surface. In conclusion, the ability of hepsin to efficiently activate pro-uPA suggests that it may initiate plasmin-mediated proteolytic pathways at the tumor/stroma interface that lead to basement membrane disruption and tumor progression.	Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA; Genentech Inc, Dept Antibody Technol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Kirchhofer, D (corresponding author), Genentech Inc, Dept Prot Engn, 1 DNA Way, San Francisco, CA 94080 USA.	dak@gene.com						Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z; Bachmann F., 1994, HEMOSTASIS THROMBOSI, V3rd, P1592; BRUNNER G, 1992, BLOOD, V79, P2099; Chen ZX, 2003, J UROLOGY, V169, P1316, DOI 10.1097/01.ju.0000050648.40164.0d; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; COLLEN D, 1986, J BIOL CHEM, V261, P1259; Dano K, 2005, THROMB HAEMOSTASIS, V93, P676, DOI 10.1160/TH05-01-0054; Delaria KA, 1997, J BIOL CHEM, V272, P12209, DOI 10.1074/jbc.272.18.12209; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; GORETZKI L, 1992, FEBS LETT, V297, P112, DOI 10.1016/0014-5793(92)80339-I; Hall CL, 2004, PROSTATE, V59, P167, DOI 10.1002/pros.20009; Helenius MA, 2001, CANCER RES, V61, P5340; Herter S, 2005, BIOCHEM J, V390, P125, DOI 10.1042/BJ20041955; HONGO JAS, 1995, HYBRIDOMA, V14, P253, DOI 10.1089/hyb.1995.14.253; Huai Q, 2006, SCIENCE, V311, P656, DOI 10.1126/science.1121143; ICHINOSE A, 1986, J BIOL CHEM, V261, P3486; Jin JS, 2006, MODERN PATHOL, V19, P447, DOI 10.1038/modpathol.3800495; Johnson MD, 2003, EXPERT REV MOL DIAGN, V3, P331, DOI 10.1586/14737159.3.3.331; Kawaguchi T, 1997, J BIOL CHEM, V272, P27558, DOI 10.1074/jbc.272.44.27558; KAZAMA Y, 1995, J BIOL CHEM, V270, P66, DOI 10.1074/jbc.270.1.66; Kirchhofer D, 2005, FEBS LETT, V579, P1945, DOI 10.1016/j.febslet.2005.01.085; Kirchhofer D, 2003, J BIOL CHEM, V278, P36341, DOI 10.1074/jbc.M304643200; Klezovitch O, 2004, CANCER CELL, V6, P185, DOI 10.1016/j.ccr.2004.07.008; Knudsen BS, 2004, ADV CANCER RES, V91, P31, DOI 10.1016/S0065-230X(04)91002-0; KOBAYASHI H, 1991, J BIOL CHEM, V266, P5147; Lee SL, 2000, J BIOL CHEM, V275, P36720, DOI 10.1074/jbc.M007802200; LIJNEN HR, 1987, EUR J BIOCHEM, V169, P359, DOI 10.1111/j.1432-1033.1987.tb13620.x; Lin CY, 1999, J BIOL CHEM, V274, P18237, DOI 10.1074/jbc.274.26.18237; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; List K, 2005, GENE DEV, V19, P1934, DOI 10.1101/gad.1300705; List K, 2000, BIOCHEMISTRY-US, V39, P508, DOI 10.1021/bi991701f; Luo J, 2001, CANCER RES, V61, P4683; Magee JA, 2001, CANCER RES, V61, P5692; MIYAZAWA K, 1993, J BIOL CHEM, V268, P10024; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; NAULAND U, 1994, EUR J BIOCHEM, V223, P497, DOI 10.1111/j.1432-1033.1994.tb19018.x; Oberst MD, 2002, CLIN CANCER RES, V8, P1101; Olivero AG, 2005, J BIOL CHEM, V280, P9160, DOI 10.1074/jbc.M409068200; Riddick ACP, 2005, BRIT J CANCER, V92, P2171, DOI 10.1038/sj.bjc.6602630; Ried S, 1999, J BIOL CHEM, V274, P16377, DOI 10.1074/jbc.274.23.16377; Saleem M, 2006, CANCER EPIDEM BIOMAR, V15, P217, DOI 10.1158/1055-9965.EPI-05-0737; Sheng SJ, 2001, CANCER METAST REV, V20, P287, DOI 10.1023/A:1015539612576; Shia S, 2005, J MOL BIOL, V346, P1335, DOI 10.1016/j.jmb.2004.12.048; Somoza JR, 2003, STRUCTURE, V11, P1123, DOI 10.1016/S0969-2126(03)00148-5; Srikantan V, 2002, CANCER RES, V62, P6812; STACK MS, 1994, J BIOL CHEM, V269, P9416; Stamey TA, 2001, J UROLOGY, V166, P2171, DOI 10.1016/S0022-5347(05)65528-0; Stephan C, 2004, J UROLOGY, V171, P187, DOI 10.1097/01.ju.0000101622.74236.94; Takeuchi T, 2000, J BIOL CHEM, V275, P26333, DOI 10.1074/jbc.M002941200; Tanimoto H, 1997, CANCER RES, V57, P2884; TORRESROSADO A, 1993, P NATL ACAD SCI USA, V90, P7181, DOI 10.1073/pnas.90.15.7181; VanVeldhuizen PJ, 1996, AM J MED SCI, V312, P8, DOI 10.1097/00000441-199607000-00002; Vu TKH, 1997, J BIOL CHEM, V272, P31315, DOI 10.1074/jbc.272.50.31315; Welsh JB, 2001, CANCER RES, V61, P5974; WOLF BB, 1993, J BIOL CHEM, V268, P16327; Wu QY, 1998, J CLIN INVEST, V101, P321, DOI 10.1172/JCI1617; Xuan JA, 2006, CANCER RES, V66, P3611, DOI 10.1158/0008-5472.CAN-05-2983; Yasuda S, 2005, BLOOD, V105, P3893, DOI 10.1182/blood-2003-10-3501; Yu IS, 2000, THROMB HAEMOSTASIS, V84, P865, DOI 10.1055/s-0037-1614129	59	76	87	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30439	30446		10.1074/jbc.M605440200	http://dx.doi.org/10.1074/jbc.M605440200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16908524	hybrid			2022-12-27	WOS:000241075900018
J	Puckerin, A; Liu, LY; Permaul, N; Carman, P; Lee, J; Diverse-Pierluissi, MA				Puckerin, Akil; Liu, Lanying; Permaul, Natasha; Carman, Paul; Lee, Jessica; Diverse-Pierluissi, Maria A.			Arrestin is required for agonist-induced trafficking of voltage-dependent calcium channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-INTERACTION SITE; KNOCK-OUT MICE; BETA-ARRESTIN; CA2+ CHANNELS; PRESYNAPTIC INHIBITION; GABA(B) RECEPTOR; SENSORY NEURONS; MODULATION; NEUROTRANSMISSION; BETA-ARRESTIN-2	Many metabotropic receptors in the nervous system act through signaling pathways that result in the inhibition of voltage-dependent calcium channels. Our previous findings showed that activation of seven-transmembrane receptors results in the internalization of calcium channels. This internalization takes place within a few seconds, raising the question of whether the endocytic machinery is in close proximity to the calcium channel to cause such rapid internalization. Here we show that voltage-dependent calcium channels are pre-associated with arrestin, a protein known to play a role in receptor trafficking. Upon GABA(B) receptor activation, receptors are recruited to the arrestin-channel complex and internalized. beta-Arrestin 1 selectively binds to the SNARE-binding region of the calcium channel. Peptides containing the arrestin-binding site of the channel disrupt agonist-induced channel internalization. Taken together these data suggest a novel neuronal role for arrestin.	CUNY Mt Sinai Sch Med, Dept Pharmacol & Biol Chem, New York, NY 10029 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Diverse-Pierluissi, MA (corresponding author), 1 Gustave L Levy Pl,Box 1603, New York, NY 10029 USA.	maria.diverse@mssm.edu			NATIONAL CANCER INSTITUTE [R24CA095823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037443] Funding Source: NIH RePORTER; NCI NIH HHS [1R24 CA095823] Funding Source: Medline; NINDS NIH HHS [NS 37443] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahn S, 2004, J BIOL CHEM, V279, P7807, DOI 10.1074/jbc.C300443200; Altier C, 2006, NAT NEUROSCI, V9, P31, DOI 10.1038/nn1605; ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Bohn LM, 2003, J NEUROSCI, V23, P10265; Bohn LM, 2002, J NEUROSCI, V22, P10494; Bradaia A, 2005, P NATL ACAD SCI USA, V102, P3034, DOI 10.1073/pnas.0406632102; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; DiversePierluissi M, 1996, NEURON, V16, P579, DOI 10.1016/S0896-6273(00)80077-X; DiversePierluissi M, 1997, P NATL ACAD SCI USA, V94, P5417, DOI 10.1073/pnas.94.10.5417; Dolphin AC, 2003, PHARMACOL REV, V55, P607, DOI 10.1124/pr.55.4.3; DUNLAP K, 1981, J PHYSIOL-LONDON, V317, P519, DOI 10.1113/jphysiol.1981.sp013841; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; GRUNER W, 1994, J NEUROSCI, V14, P2800; Gurevich EV, 2002, NEUROSCIENCE, V109, P421, DOI 10.1016/S0306-4522(01)00511-5; GUREVICH VV, 1993, J BIOL CHEM, V268, P16879; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; Huang LYM, 1996, NEURON, V17, P135, DOI 10.1016/S0896-6273(00)80287-1; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; Jarvis SE, 2000, J BIOL CHEM, V275, P6388, DOI 10.1074/jbc.275.9.6388; Kohout TA, 2004, J BIOL CHEM, V279, P23214, DOI 10.1074/jbc.M402125200; Komori N, 1999, NEUROSCIENCE, V93, P1421, DOI 10.1016/S0306-4522(99)00277-8; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Lu Q, 1999, J BIOL CHEM, V274, P34566, DOI 10.1074/jbc.274.49.34566; Mochida S, 2003, P NATL ACAD SCI USA, V100, P2819, DOI 10.1073/pnas.262787699; Mochida S, 1996, NEURON, V17, P781, DOI 10.1016/S0896-6273(00)80209-3; RANE SG, 1989, NEURON, V3, P239, DOI 10.1016/0896-6273(89)90037-8; Richman RW, 2004, J BIOL CHEM, V279, P24649, DOI 10.1074/jbc.M312182200; Schiff ML, 2000, NATURE, V408, P723, DOI 10.1038/35047093; Sheng ZH, 1997, P NATL ACAD SCI USA, V94, P5405, DOI 10.1073/pnas.94.10.5405; Szabo EZ, 2005, P NATL ACAD SCI USA, V102, P2790, DOI 10.1073/pnas.0407444102; Tombler E, 2006, J BIOL CHEM, V281, P1827, DOI 10.1074/jbc.M508829200; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Zamponi GW, 2001, CELL BIOCHEM BIOPHYS, V34, P79, DOI 10.1385/CBB:34:1:79	35	22	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					31131	31141		10.1074/jbc.M605000200	http://dx.doi.org/10.1074/jbc.M605000200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16912040	Green Published, hybrid			2022-12-27	WOS:000241075900088
J	Durand, A; Merrick, M				Durand, Anne; Merrick, Mike			In vitro analysis of the Escherichia coli AmtB-GlnK complex reveals a stoichiometric interaction and sensitivity to ATP and 2-oxoglutarate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PROTEIN; AMMONIUM TRANSPORTER AMTB; P-II; GLUTAMINE-SYNTHETASE; MEMBRANE SEQUESTRATION; CRYSTAL-STRUCTURE; T-LOOP; PII; BINDING; KINASE	In Escherichia coli, the ammonia channel AmtB and the PII signal transduction protein GlnK constitute an ammonium sensory system that effectively couples the intracellular nitrogen regulation system to external changes in ammonium availability. Binding of GlnK toAmtBapparently inactivates the channel, thereby controlling ammonium influx in response to the intracellular nitrogen status. Wedesigned an N- terminally histidinetagged version of AmtB with a native C- terminal region in order to purify the AmtB- GlnK complex. Purification revealed a stable and direct interaction between AmtB and GlnK, thereby showing for the first time that stability of the complex does not require other proteins. The stoichiometry of the complex was determined by two independent approaches, both of which indicated a 1: 1 ratio of AmtB to GlnK. We also showed by mass spectrometry that only the fully deuridylylated form of GlnK co- purifies with AmtB. The purified complex allowed in vitro studies of dissociation and association of AmtB and GlnK. The interaction of GlnK with AmtB is dependent on ATP and is also sensitive to 2- oxoglutarate. Our in vitro data suggest that in vivo association and dissociation of the complex might not only be dependent on the uridylylation status of GlnK but may also be influenced by intracellular pools of ATP and 2- oxoglutarate.	John Innes Ctr, Dept Mol Microbiol, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Merrick, M (corresponding author), John Innes Ctr, Dept Mol Microbiol, Norwich NR4 7UH, Norfolk, England.	mike.merrick@bbsrc.ac.uk						Andrade SLA, 2005, P NATL ACAD SCI USA, V102, P14994, DOI 10.1073/pnas.0506254102; Arcondeguy T, 2001, MICROBIOL MOL BIOL R, V65, P80, DOI 10.1128/MMBR.65.1.80-105.2001; Atkinson MR, 1999, MOL MICROBIOL, V32, P301, DOI 10.1046/j.1365-2958.1999.01349.x; Benelli EM, 2002, EUR J BIOCHEM, V269, P3296, DOI 10.1046/j.1432-1033.2002.03011.x; Blakey D, 2002, BIOCHEM J, V364, P527, DOI 10.1042/BJ20011761; Carr PD, 1996, ACTA CRYSTALLOGR D, V52, P93, DOI 10.1107/S0907444995007293; CHEAH E, 1994, STRUCTURE, V2, P981, DOI 10.1016/S0969-2126(94)00100-6; Chen YM, 2006, J BIOL CHEM, V281, P5726, DOI 10.1074/jbc.M510945200; Conroy MJ, 2004, EMBO REP, V5, P1153, DOI 10.1038/sj.embor.7400296; Coutts G, 2002, EMBO J, V21, P536, DOI 10.1093/emboj/21.4.536; Detsch C, 2003, MICROBIOL-SGM, V149, P3289, DOI 10.1099/mic.0.26512-0; Ehlers C, 2005, MOL MICROBIOL, V55, P1841, DOI 10.1111/j.1365-2958.2005.04511.x; Forchhammer K, 2004, FEMS MICROBIOL REV, V28, P319, DOI 10.1016/j.femsre.2003.11.001; Heinrich A, 2004, MOL MICROBIOL, V52, P1303, DOI 10.1111/j.1365-2958.2004.04058.x; Huergo LF, 2006, MOL MICROBIOL, V59, P326, DOI 10.1111/j.1365-2958.2005.04944.x; Jaggi R, 1996, FEBS LETT, V391, P223, DOI 10.1016/0014-5793(96)00737-5; Javelle A, 2005, BIOCHEM SOC T, V33, P170, DOI 10.1042/BST0330170; Javelle A, 2005, BIOCHEM J, V390, P215, DOI 10.1042/BJ20042094; Javelle A, 2004, J BIOL CHEM, V279, P8530, DOI 10.1074/jbc.M312399200; Jiang P, 1997, J BACTERIOL, V179, P4342, DOI 10.1128/jb.179.13.4342-4353.1997; Jiang P, 1998, BIOCHEMISTRY-US, V37, P12802, DOI 10.1021/bi980666u; Jiang P, 1998, BIOCHEMISTRY-US, V37, P12795, DOI 10.1021/bi9802420; Jiang P, 1999, J BACTERIOL, V181, P1906, DOI 10.1128/JB.181.6.1906-1911.1999; Jiang P, 1998, BIOCHEMISTRY-US, V37, P12782, DOI 10.1021/bi980667m; KAMBEROV ES, 1995, J BIOL CHEM, V270, P17797, DOI 10.1074/jbc.270.30.17797; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; Little R, 2002, J BIOL CHEM, V277, P15472, DOI 10.1074/jbc.M112262200; Liu YM, 2006, J PHYS CHEM A, V110, P1375, DOI 10.1021/jp054261c; LODATO DT, 1987, BIOCHEMISTRY-US, V26, P2243, DOI 10.1021/bi00382a026; Maheswaran M, 2004, J BIOL CHEM, V279, P55202, DOI 10.1074/jbc.M410971200; Martinez-Argudo I, 2002, J BACTERIOL, V184, P3746, DOI 10.1128/JB.184.13.3746-3748.2002; Ninfa AJ, 2005, CURR OPIN MICROBIOL, V8, P168, DOI 10.1016/j.mib.2005.02.011; Pioszak AA, 2000, BIOCHEMISTRY-US, V39, P13450, DOI 10.1021/bi000795m; Ruppert U, 2002, MOL MICROBIOL, V44, P855, DOI 10.1046/j.1365-2958.2002.02927.x; SENIOR PJ, 1975, J BACTERIOL, V123, P407, DOI 10.1128/JB.123.2.407-418.1975; SON HS, 1987, J BIOL CHEM, V262, P8690; Soupene E, 1998, P NATL ACAD SCI USA, V95, P7030, DOI 10.1073/pnas.95.12.7030; SPACKMAN DH, 1958, ANAL CHEM, V30, P1190, DOI 10.1021/ac60139a006; Stips J, 2004, EUR J BIOCHEM, V271, P3379, DOI 10.1111/j.1432-1033.2004.04272.x; Strosser J, 2004, MOL MICROBIOL, V54, P132, DOI 10.1111/j.1365-2958.2004.04247.x; Thomas G, 2000, TRENDS GENET, V16, P11, DOI 10.1016/S0168-9525(99)01887-9; Thornton J, 2006, FEMS MICROBIOL LETT, V258, P114, DOI 10.1111/j.1574-6968.2006.00202.x; vanHeeswijk WC, 1996, MOL MICROBIOL, V21, P133, DOI 10.1046/j.1365-2958.1996.6281349.x; von Wiren N, 2004, TOP CURR GENET, V9, P95; Winkler F, 2006, PFLUG ARCH EUR J PHY, V451, P701, DOI 10.1007/s00424-005-1511-6; Xu YB, 1998, J MOL BIOL, V282, P149, DOI 10.1006/jmbi.1998.1979; Xu YB, 2001, EUR J BIOCHEM, V268, P2028, DOI 10.1046/j.1432-1327.2001.02074.x; Zheng L, 2004, P NATL ACAD SCI USA, V101, P17090, DOI 10.1073/pnas.0406475101	48	42	43	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					29558	29567		10.1074/jbc.M602477200	http://dx.doi.org/10.1074/jbc.M602477200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16864585	hybrid			2022-12-27	WOS:000240896300017
J	Nakagawa, T; Uozumi, N; Nakano, M; Mizuno-Horikawa, Y; Okuyama, N; Taguchi, T; Gu, JG; Kondo, A; Taniguchi, N; Miyoshi, E				Nakagawa, Tsutomu; Uozumi, Naofumi; Nakano, Miyako; Mizuno-Horikawa, Yoko; Okuyama, Noriko; Taguchi, Tomohiko; Gu, Jianguo; Kondo, Akihiro; Taniguchi, Naoyuki; Miyoshi, Eiji			Fucosylation of N-glycans regulates the secretion of hepatic glycoproteins into bile ducts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANINE KIDNEY-CELLS; GDP-L-FUCOSE; CHOLESTEROL CRYSTALLIZATION; HEPATOCELLULAR-CARCINOMA; MEMBRANE TRAFFICKING; CDNA CLONING; GLYCOSYLATION; PROTEIN; ALPHA; OLIGOSACCHARIDES	Fucosylated alpha-fetoprotein (AFP) is a highly specific tumor marker for hepatocellular carcinoma (HCC). However, the molecular mechanism by which serum level of fucosylated AFP increases in patients with HCC remains largely unknown. Here, we report that the fucosylation of glycoproteins could be a possible signal for secretion into bile ducts in the liver. We compared oligosaccharide structures on glycoproteins in human bile with those in serum by several types of lectin blot analyses. Enhanced binding of biliary glycoproteins to lectins that recognize a fucose residue was observed over a wide range of molecular weights compared with serum glycoproteins. A structural analysis of oligosaccharides by two-dimensional mapping high performance liquid chromatography and matrix- assisted laser desorption ionization time-of flight mass spectrometry confirmed the increases in the fucosylation of biliary glycoproteins. Purification followed by structural analysis on alpha 1- antitrypsin, alpha 1- acid glycoprotein and haptoglobin, which are synthesized in the liver, showed higher fucosylation in bile than in serum. To find direct evidence for fucosylation and sorting signal into bile ducts, we used alpha 1 - 6 fucosyltransferase (Fut8)- deficient mice because fucosylation of glycoproteins produced in mouse liver was mainly an alpha 1 - 6 linkage. Interestingly, the levels of alpha 1- antitrypsin and alpha 1- acid glycoprotein were quite low in bile of Fut8- deficient mice as compared with wild- type mice. An immunohistochemical study showed dramatic changes in the localization of these glycoproteins in the liver of Fut8- deficient mice. Taken together, these results suggest that fucosylation is a possible signal for the secretion of glycoproteins into bile ducts in the liver. Adisruption in this system might involve an increase in fucosylated AFP in the serum of patients with HCC.	Osaka Univ, Dept Biochem, Grad Sch Med, Suita, Osaka 5650871, Japan; Osaka Univ, Dept Glycotherapeut, Grad Sch Med, Suita, Osaka 5650871, Japan; Osaka Univ, Dept Dis Glycom, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan	Osaka University; Osaka University; Osaka University; Japan Science & Technology Agency (JST)	Miyoshi, E (corresponding author), Osaka Univ, Dept Biochem, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	miyoshi34@biochem.med.osaka-u.ac.jp	Kameyama, Akihiko/A-9641-2008; Gu, Jianguo/ABC-9257-2020; Taniguchi, Naoyuki/A-7086-2016; Taniguchi, Naoyuki/I-4182-2014; Taguchi, Tomohiko/I-5014-2019	Kameyama, Akihiko/0000-0002-8229-4449; Taniguchi, Naoyuki/0000-0001-5889-5968; Taguchi, Tomohiko/0000-0003-0464-6370				ABEI M, 1993, GASTROENTEROLOGY, V104, P539; Benting JH, 1999, J CELL BIOL, V146, P313, DOI 10.1083/jcb.146.2.313; BrinkmanVanderLinden ECM, 1996, J BIOL CHEM, V271, P14492, DOI 10.1074/jbc.271.24.14492; Delacour D, 2005, J CELL BIOL, V169, P491, DOI 10.1083/jcb.200407073; FISCHER LJ, 1985, DRUG METAB DISPOS, V13, P121; GROEN AK, 1988, HEPATOLOGY, V8, P347, DOI 10.1002/hep.1840080226; Gut A, 1998, EMBO J, V17, P1919, DOI 10.1093/emboj/17.7.1919; HASE S, 1984, J BIOCHEM-TOKYO, V95, P197, DOI 10.1093/oxfordjournals.jbchem.a134585; Hauri HP, 2000, FEBS LETT, V476, P32, DOI 10.1016/S0014-5793(00)01665-3; KITAGAWA Y, 1994, EXP CELL RES, V213, P449, DOI 10.1006/excr.1994.1222; KONDO A, 1990, AGR BIOL CHEM TOKYO, V54, P2169, DOI 10.1080/00021369.1990.10870232; Kristiansen TZ, 2004, MOL CELL PROTEOMICS, V3, P715, DOI 10.1074/mcp.M400015-MCP200; Martinez-Maza R, 2001, J BIOL CHEM, V276, P2168, DOI 10.1074/jbc.M006774200; MIYOSHI E, 1995, J BIOL CHEM, V270, P28311; Naitoh A, 1999, J GASTROEN HEPATOL, V14, P436, DOI 10.1046/j.1440-1746.1999.01882.x; Noda K, 2003, CANCER RES, V63, P6282; Noda K, 2002, ANAL BIOCHEM, V310, P100, DOI 10.1016/S0003-2697(02)00313-5; NODA K, 2002, HEPATOLOGY, V28, P202; PARCZYK K, 1991, FEBS LETT, V278, P267, DOI 10.1016/0014-5793(91)80132-M; Pous C, 1998, J CELL BIOL, V142, P153, DOI 10.1083/jcb.142.1.153; SCHEIFFELE P, 1995, NATURE, V378, P96, DOI 10.1038/378096a0; TAKETA K, 1990, HEPATOLOGY, V12, P1420, DOI 10.1002/hep.1840120625; TOMIYA N, 1988, ANAL BIOCHEM, V171, P73, DOI 10.1016/0003-2697(88)90126-1; Uozumi N, 1996, J BIOL CHEM, V271, P27810, DOI 10.1074/jbc.271.44.27810; Vagin O, 2004, J BIOL CHEM, V279, P39026, DOI 10.1074/jbc.M405453200; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; YAMASHITA G, 1995, J LIPID RES, V36, P1325; Yamashita K, 1999, BBA-GEN SUBJECTS, V1473, P147, DOI 10.1016/S0304-4165(99)00175-0; Yanagidani S, 1997, J BIOCHEM-TOKYO, V121, P626; YOSHIHARA S, 1995, INT J PANCREATOL, V17, P181	31	94	100	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					29797	29806		10.1074/jbc.M605697200	http://dx.doi.org/10.1074/jbc.M605697200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16899455	hybrid			2022-12-27	WOS:000240896300042
J	Kravchenko, VV; Kaufmann, GF; Mathison, JC; Scott, DA; Katz, AZ; Wood, MR; Brogan, AP; Lehmann, M; Mee, JM; Iwata, K; Pan, Q; Fearns, C; Knaus, UG; Meijler, MM; Janda, KD; Ulevitch, RJ				Kravchenko, Vladimir V.; Kaufmann, Gunnar F.; Mathison, John C.; Scott, David A.; Katz, Alexander Z.; Wood, Malcolm R.; Brogan, Andrew P.; Lehmann, Mandy; Mee, Jenny M.; Iwata, Kazunori; Pan, Qilin; Fearns, Colleen; Knaus, Ulla G.; Meijler, Michael M.; Janda, Kim D.; Ulevitch, Richard J.			N-(3-oxo-acyl)homoserine lactones signal cell activation through a mechanism distinct from the canonical pathogen-associated molecular pattern recognition receptor pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-3-OXODODECANOYL HOMOSERINE LACTONE; C-JUN INDUCTION; NF-KAPPA-B; PSEUDOMONAS-AERUGINOSA; PROTEIN-SYNTHESIS; GENE-EXPRESSION; PHORBOL ESTER; TARGET GENES; VIRULENCE; APOPTOSIS	Innate immune system receptors function as sensors of infection and trigger the immune responses through ligand-specific signaling pathways. These ligands are pathogen-associated products, such as components of bacterial walls and viral nuclear acids. A common response to such ligands is the activation of mitogen-activated protein kinase p38, whereas double-stranded viral RNA additionally induces the phosphorylation of eukaryotic translation initiation factor 2 alpha(eIF2 alpha). Here we have shown that p38 and eIF2 alpha phosphorylation represent two biochemical markers of the effects induced by N-(3-oxo-acyl) homoserine lactones, the secreted products of a number of Gram-negative bacteria, including the human opportunistic pathogen Pseudomonas aeruginosa. Furthermore, N-(3-oxo-dodecanoyl) homoserine lactone induced distension of mitochondria and the endoplasmic reticulum as well as c-jun gene transcription. These effects occurred in a wide variety of cell types including alveolar macrophages and bronchial epithelial cells, requiring the structural integrity of the lactone ring motif and its natural stereochemistry. These findings suggest that N-(3-oxo-acyl) homoserine lactones might be recognized by receptors of the innate immune system. However, we provide evidence that N-(3-oxo-dodecanoyl) homoserine lactone-mediated signaling does not require the presence of the canonical innate immune system receptors, Toll-like receptors, or two members of the NLR/Nod/Caterpillar family, Nod1 and Nod2. These data offer a new understanding of the effects of N-(3-oxo-dodecanoyl) homoserine lactone on host cells and its role in persistent airway infections caused by P. aeruginosa.	Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Core Microscopy Facil, La Jolla, CA 92037 USA; Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Worm Inst Res & Med, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Janda, KD (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	kdjanda@scripps.edu; ulevitch@scripps.edu	Ulevitch, Richard J/Q-3393-2017	Meijler, Michael/0000-0001-7095-1467	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI055781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM037696] Funding Source: NIH RePORTER; NIAID NIH HHS [AI055781] Funding Source: Medline; NIGMS NIH HHS [5P01GM037696] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; Aridor M, 1999, NAT MED, V5, P745, DOI 10.1038/10466; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; BossyWetzel E, 1997, EMBO J, V16, P1695, DOI 10.1093/emboj/16.7.1695; BRENNER DA, 1989, NATURE, V337, P661, DOI 10.1038/337661a0; BUSCHER M, 1988, ONCOGENE, V3, P301; Charlton TS, 2000, ENVIRON MICROBIOL, V2, P530, DOI 10.1046/j.1462-2920.2000.00136.x; Chen LC, 2004, BBA-MOL CELL BIOL L, V1683, P38, DOI 10.1016/j.bbalip.2004.04.003; Chen YJ, 2000, J BIOMED SCI, V7, P122, DOI 10.1159/000025437; Clemens MJ, 2000, CELL DEATH DIFFER, V7, P603, DOI 10.1038/sj.cdd.4400695; COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; Erickson DL, 2002, INFECT IMMUN, V70, P1783, DOI 10.1128/IAI.70.4.1783-1790.2002; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; HAM J, 1995, NEURON, V14, P927, DOI 10.1016/0896-6273(95)90331-3; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; Han JA, 2002, EMBO J, V21, P5635, DOI 10.1093/emboj/cdf591; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Herrlich P, 1997, BIOL CHEM, V378, P1217; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Hooi DSW, 2004, INFECT IMMUN, V72, P6463, DOI 10.1128/IAI.72.11.6463-6470.2004; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Hsu LC, 2004, NATURE, V428, P341, DOI 10.1038/nature02405; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Johnson R, 1996, MOL CELL BIOL, V16, P4504; JONES S, 1993, EMBO J, V12, P2477, DOI 10.1002/j.1460-2075.1993.tb05902.x; Kaufmann GF, 2005, P NATL ACAD SCI USA, V102, P309, DOI 10.1073/pnas.0408639102; Kravchenko VV, 2003, J BIOL CHEM, V278, P26612, DOI 10.1074/jbc.M303001200; Lazdunski AM, 2004, NAT REV MICROBIOL, V2, P581, DOI 10.1038/nrmicro924; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li L, 2004, ONCOGENE, V23, P4894, DOI 10.1038/sj.onc.1207612; Lieberman David, 2003, Am J Respir Med, V2, P459; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; MATHISON JC, 1990, J CLIN INVEST, V85, P1108, DOI 10.1172/JCI114542; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; MUNOZ E, 1992, EUR J IMMUNOL, V22, P2101, DOI 10.1002/eji.1830220821; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Pain VM, 1996, EUR J BIOCHEM, V236, P747, DOI 10.1111/j.1432-1033.1996.00747.x; PEARSON JP, 1994, P NATL ACAD SCI USA, V91, P197, DOI 10.1073/pnas.91.1.197; PEARSON JP, 1995, P NATL ACAD SCI USA, V92, P1490, DOI 10.1073/pnas.92.5.1490; ROLSTON KVI, 1992, CANCER INVEST, V10, P43, DOI 10.3109/07357909209032787; Rumbaugh KP, 1999, INFECT IMMUN, V67, P5854, DOI 10.1128/IAI.67.11.5854-5862.1999; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; Shaulian E, 2000, CELL, V103, P897, DOI 10.1016/S0092-8674(00)00193-8; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shiner EK, 2005, FEMS MICROBIOL REV, V29, P935, DOI 10.1016/j.femsre.2005.03.001; Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627; Smith RS, 2003, J CLIN INVEST, V112, P1460, DOI 10.1172/JCI200320364; Smith RS, 2002, J IMMUNOL, V169, P2636, DOI 10.4049/jimmunol.169.5.2636; Smith RS, 2001, J IMMUNOL, V167, P366, DOI 10.4049/jimmunol.167.1.366; Son DS, 2004, ENDOCRINOLOGY, V145, P1218, DOI 10.1210/en.2003-0860; Steinhauser ME, 1999, J IMMUNOL, V162, P392; Subbaramaiah K, 1999, J BIOL CHEM, V274, P10911, DOI 10.1074/jbc.274.16.10911; Tan SL, 1998, J NEUROCHEM, V71, P95; Tateda K, 2003, INFECT IMMUN, V71, P5785, DOI 10.1128/IAI.71.10.5785-5793.2003; Telford G, 1998, INFECT IMMUN, V66, P36, DOI 10.1128/IAI.66.1.36-42.1998; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Yamaguchi K, 2005, J BIOL CHEM, V280, P32569, DOI 10.1074/jbc.M503201200; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yamamoto M, 2004, MOL IMMUNOL, V40, P861, DOI 10.1016/j.molimm.2003.10.006; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262	68	103	104	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					28822	28830		10.1074/jbc.M606613200	http://dx.doi.org/10.1074/jbc.M606613200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16893899	hybrid			2022-12-27	WOS:000240680500036
J	Griffin, SV; Olivier, JP; Pippin, JW; Roberts, JM; Shankland, SJ				Griffin, Sian V.; Olivier, J. Paul; Pippin, Jeffrey W.; Roberts, James M.; Shankland, Stuart J.			Cyclin I protects podocytes from apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLOMERULAR EPITHELIAL-CELLS; FAS-MEDIATED APOPTOSIS; PUROMYCIN AMINONUCLEOSIDE; DEPENDENT KINASES; GROWTH-FACTOR; RENAL-CELLS; CASPASE 3; INHIBITOR; PROLIFERATION; P21	The limited regenerative capacity of the glomerular podocyte following injury underlies the development of glomerulosclerosis and progressive renal failure in a diverse range of kidney diseases. We discovered that, in the kidney, cyclin I is uniquely expressed in the glomerular podocyte, and have constructed cyclin I knock-out mice to explore the biological function of cyclin I in these cells. Cyclin I knock-out (-/-) podocytes showed an increased susceptibility to apoptosis both in vitro and in vivo. Following induction of experimental glomerulonephritis, podocyte apoptosis was increased 4-fold in the cyclin I -/- mice, which was associated with dramatically decreased renal function. Our previous data showed that the Cdk inhibitor p21(Cip1/Waf1) protects podocytes from certain apoptotic stimuli. In cultured cyclin I -/- podocytes, the level of p21(Cip1/Waf1) was lower at base line, had a shorter half-life, and declined more rapidly in response to apoptotic stimuli than in wild- type cells. Enforced expression of p21(Cip1/Waf1) reversed the susceptibility of cyclin I -/- podocytes to apoptosis. Cyclin I protects podocytes from apoptosis, and we provide preliminary data to suggest that this is mediated by stabilization of p21(Cip1/Waf1).	Univ Washington, Sch Med, Dept Med, Div Nephrol, Seattle, WA 98195 USA; Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Shankland, SJ (corresponding author), Univ Washington, Sch Med, Dept Med, Div Nephrol, Seattle, WA 98195 USA.	stuartjs@u.washington.edu	Roberts, James/AAI-3283-2020	Roberts, James/0000-0002-2671-3207	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051096, R01DK060525, R01DK056799] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK56799, DK51096, DK60525] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BAKER AJ, 1994, J CLIN INVEST, V94, P2105, DOI 10.1172/JCI117565; Barisoni L, 2003, CURR OPIN NEPHROL HY, V12, P251, DOI 10.1097/00041552-200305000-00005; Bates S, 1996, ONCOGENE, V13, P1103; Bendjennat M, 2003, CELL, V114, P599, DOI 10.1016/j.cell.2003.08.001; Ding GH, 2002, AM J PHYSIOL-RENAL, V283, pF173, DOI 10.1152/ajprenal.00240.2001; Durvasula RV, 2004, KIDNEY INT, V65, P30, DOI 10.1111/j.1523-1755.2004.00362.x; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; EVANS T, 1983, CELL, V33, P389, DOI 10.1016/0092-8674(83)90420-8; Fornoni A, 2001, AM J PATHOL, V158, P275, DOI 10.1016/S0002-9440(10)63966-1; HARPER JW, 1993, CELL, V75, P805; Hughes J, 1999, AM J PHYSIOL-RENAL, V277, pF948, DOI 10.1152/ajprenal.1999.277.6.F948; Jascur T, 2005, MOL CELL, V17, P237, DOI 10.1016/j.molcel.2004.11.049; Jensen MR, 2000, GENE, V256, P59, DOI 10.1016/S0378-1119(00)00361-9; Kim YG, 1999, KIDNEY INT, V55, P2349, DOI 10.1046/j.1523-1755.1999.00504.x; Kim YH, 2001, KIDNEY INT, V60, P957, DOI 10.1046/j.1523-1755.2001.060003957.x; Kriz W, 1998, KIDNEY INT, V54, P687, DOI 10.1046/j.1523-1755.1998.00044.x; Kriz W, 1996, NEPHROL DIAL TRANSPL, V11, P1738, DOI 10.1093/oxfordjournals.ndt.a027660; Kriz W, 2002, MICROSC RES TECHNIQ, V57, P189, DOI 10.1002/jemt.10072; Kriz W, 1999, CURR OPIN NEPHROL HY, V8, P489, DOI 10.1097/00041552-199907000-00014; Lawson BR, 2004, J EXP MED, V199, P547, DOI 10.1084/jem.20031685; Lemley KV, 2002, KIDNEY INT, V61, P1475, DOI 10.1046/j.1523-1755.2002.00269.x; Martin-Caballero J, 2001, CANCER RES, V61, P6234; Mundel P, 2002, J AM SOC NEPHROL, V13, P3005, DOI 10.1097/01.ASN.0000039661.06947.FD; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; MUNDLOS S, 1993, DEVELOPMENT, V119, P1329; NAKAMURA T, 1995, EXP CELL RES, V221, P534, DOI 10.1006/excr.1995.1406; NODA A, 1994, EXP CELL RES, V211, P90, DOI 10.1006/excr.1994.1063; Nowak G, 2003, AM J PHYSIOL-RENAL, V285, pF440, DOI 10.1152/ajprenal.00233.2002; Ophascharoensuk V, 1998, KIDNEY INT, V54, P416, DOI 10.1046/j.1523-1755.1998.00003.x; Ophascharoensuk V, 1998, NAT MED, V4, P575, DOI 10.1038/nm0598-575; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; PINES J, 1995, BIOCHEM J, V308, P697, DOI 10.1042/bj3080697; RENNKE HG, 1994, KIDNEY INT, V45, pS58; Sanwal V, 2001, EXP MOL PATHOL, V70, P54, DOI 10.1006/exmp.2000.2345; Schiffer M, 2004, J BIOL CHEM, V279, P37004, DOI 10.1074/jbc.M403534200; Schiffer M, 2001, J CLIN INVEST, V108, P807, DOI 10.1172/JCI12367; Scoltock AB, 2004, EXP CELL RES, V297, P212, DOI 10.1016/j.yexcr.2004.03.025; Shiiki H, 1998, PATHOBIOLOGY, V66, P221, DOI 10.1159/000028027; Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.1.225; Suzuki A, 2000, CELL DEATH DIFFER, V7, P721, DOI 10.1038/sj.cdd.4400706; Suzuki A, 1998, ONCOGENE, V17, P931, DOI 10.1038/sj.onc.1202021; Suzuki A, 1999, ONCOGENE, V18, P1239, DOI 10.1038/sj.onc.1202409; Suzuki T, 2001, FREE RADICAL BIO MED, V31, P615, DOI 10.1016/S0891-5849(01)00641-4; Truong LD, 1996, KIDNEY INT, V50, P200, DOI 10.1038/ki.1996.303; Wada T, 2005, J AM SOC NEPHROL, V16, P2615, DOI 10.1681/ASN.2005020142; White KE, 2002, DIABETES, V51, P3083, DOI 10.2337/diabetes.51.10.3083; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Yang DH, 1996, LAB INVEST, V74, P571	48	46	48	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					28048	28057		10.1074/jbc.M513336200	http://dx.doi.org/10.1074/jbc.M513336200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16847066	hybrid			2022-12-27	WOS:000240534400042
J	Liu, XF; Kim, K; Leighton, T; Theil, EC				Liu, Xiaofeng; Kim, Kijeong; Leighton, Terrance; Theil, Elizabeth C.			Paired Bacillus anthracis Dps (mini-ferritin) have different reactivities with peroxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H-CHAIN FERRITIN; DNA-BINDING PROTEIN; OXIDATIVE STRESS-RESPONSE; HYDROGEN-PEROXIDE; ESCHERICHIA-COLI; IRON STORAGE; DEINOCOCCUS-RADIODURANS; HALOBACTERIUM-SALINARUM; FERROXIDASE REACTION; CRYSTAL-STRUCTURES	Dps (DNA protection during starvation) proteins, mini-ferritins in the ferritin superfamily, catalyze Fe2+/H2O2/O-2 reactions and make minerals inside protein nanocages to minimize radical oxygen-chemistry (metal/osmotic/temperature/nutrient/oxidant) and sometimes to confer virulence. Paired Dps proteins in Bacillus, rare in other bacteria, have 60% sequence identity. To explore functional differences in paired Bacilli Dps protein, we measured ferroxidase activity and DNA protection (hydroxyl radical) for Dps protein dodecamers from Bacillus anthracis (Ba) since crystal structures and iron mineralization (iron-stain) were known. The self-assembled (200 kDa) Ba Dps1 (Dlp-1) and Ba Dps2 (Dlp-2) proteins had similar Fe2+/O-2 kinetics, with space for minerals of 500 iron atoms/protein, and protected DNA. The reactions with Fe2+ were novel in several ways: 1) Ba Dps2 reactions (Fe2+/H2O2) proceeded via an A(650) nm intermediate, with similar rates to maxi-ferritins (Fe2+/O-2), indicating a new Dps protein reaction pathway, 2) Ba Dps2 reactions (Fe2+/O-2 versus Fe2+/O-2 + H2O2) differed 3-fold contrasting with Escherichia coli Dps reactions, with 100-fold differences, and 3) Ba Dps1, inert in Fe2+/H2O2 catalysis, inhibited protein-independent Fe2+/H2O2 reactions. Sequence similarities between Ba Dps1 and Bacillus subtilis DpsA(Dps1), which is regulated by general stress factor (SigmaB) and Fur, and between Ba Dps2 and B. subtilis MrgA, which is regulated by H2O2 (PerR), suggest the function of Ba Dps1 is iron sequestration and the function of Ba Dps2 is H2O2 destruction, important in host/pathogen interactions. Destruction of H2O2 by Ba Dps2 proceeds via an unknown mechanism with an intermediate similar spectrally (A(650) nm) and kinetically to the maxi-ferritin diferric peroxo complex.	Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA; Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; Chung Ang Univ, Coll Med, Dept Microbiol, Seoul 156756, South Korea	Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; University of California System; University of California Berkeley; Chung Ang University; Chung Ang University Hospital	Liu, XF (corresponding author), Childrens Hosp, Oakland Res Inst, 5700 Martin Luther King,Jr Way, Oakland, CA 94609 USA.	etheil@chori.org			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK020251, R37DK020251, R01DK020251] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-20251] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALMIRON M, 1992, GENE DEV, V6, P2646, DOI 10.1101/gad.6.12b.2646; ALTUVIA S, 1994, MOL MICROBIOL, V13, P265, DOI 10.1111/j.1365-2958.1994.tb00421.x; Antelmann H, 1997, J BACTERIOL, V179, P7251, DOI 10.1128/jb.179.23.7251-7256.1997; Bou-Abdallah F, 2005, J AM CHEM SOC, V127, P3885, DOI 10.1021/ja044355k; Bou-Abdallah F, 2005, J MOL BIOL, V347, P543, DOI 10.1016/j.jmb.2005.01.007; Bou-Abdallah F, 2002, BIOCHEM J, V364, P57, DOI 10.1042/bj3640057; Boylan JA, 2003, P NATL ACAD SCI USA, V100, P11684, DOI 10.1073/pnas.2032956100; Carrondo MA, 2003, EMBO J, V22, P1959, DOI 10.1093/emboj/cdg215; Ceci P, 2004, NUCLEIC ACIDS RES, V32, P5935, DOI 10.1093/nar/gkh915; Ceci P, 2003, J BIOL CHEM, V278, P20319, DOI 10.1074/jbc.M302114200; Chasteen ND, 1999, J STRUCT BIOL, V126, P182, DOI 10.1006/jsbi.1999.4118; CHEN L, 1995, P NATL ACAD SCI USA, V92, P8190, DOI 10.1073/pnas.92.18.8190; Chiancone E, 2004, BIOMETALS, V17, P197, DOI 10.1023/B:BIOM.0000027692.24395.76; Cozzi A, 2004, BLOOD, V103, P2377, DOI 10.1182/blood-2003-06-1842; DOWDS BCA, 1994, FEMS MICROBIOL LETT, V124, P255; Fetter J, 1997, J BIOL INORG CHEM, V2, P652, DOI 10.1007/s007750050180; Gohar M, 2005, PROTEOMICS, V5, P3696, DOI 10.1002/pmic.200401225; Grant RA, 1998, NAT STRUCT BIOL, V5, P294, DOI 10.1038/nsb0498-294; Grove A, 2005, J MOL BIOL, V347, P495, DOI 10.1016/j.jmb.2005.01.055; Hintze KJ, 2005, P NATL ACAD SCI USA, V102, P15048, DOI 10.1073/pnas.0505148102; Horsburgh MJ, 2001, INFECT IMMUN, V69, P3744, DOI 10.1128/IAI.69.6.3744-3754.2001; Hwang J, 2000, SCIENCE, V287, P122, DOI 10.1126/science.287.5450.122; Ilari A, 2005, BIOCHEMISTRY-US, V44, P5579, DOI 10.1021/bi050005e; Jameson GNL, 2002, BIOCHEMISTRY-US, V41, P13435, DOI 10.1021/bi026478s; JENKINS DE, 1988, J BACTERIOL, V170, P3910, DOI 10.1128/jb.170.9.3910-3914.1988; Jin WL, 2001, BIOCHEMISTRY-US, V40, P7525, DOI 10.1021/bi002509c; JONES MM, 1967, NATURE, V216, P509, DOI 10.1038/216509a0; Katona LI, 2004, J BACTERIOL, V186, P6443, DOI 10.1128/JB.186.19.6443-6456.2004; Kauko A, 2004, J MOL BIOL, V338, P547, DOI 10.1016/j.jmb.2004.03.009; Liu XF, 2004, P NATL ACAD SCI USA, V101, P8557, DOI 10.1073/pnas.0401146101; Liu XF, 2003, P NATL ACAD SCI USA, V100, P3653, DOI 10.1073/pnas.0636928100; Liu XF, 2005, ACCOUNTS CHEM RES, V38, P167, DOI 10.1021/ar0302336; MABROUK PA, 1991, J AM CHEM SOC, V113, P4053, DOI 10.1021/ja00011a001; Martinez A, 1997, J BACTERIOL, V179, P5188, DOI 10.1128/jb.179.16.5188-5194.1997; Michan C, 1999, J BACTERIOL, V181, P2759; Minsky A, 2002, NAT REV MOL CELL BIO, V3, P50, DOI 10.1038/nrm700; Moenne-Loccoz P, 1999, BIOCHEMISTRY-US, V38, P5290, DOI 10.1021/bi990095l; Moore CM, 2005, MOL MICROBIOL, V57, P27, DOI 10.1111/j.1365-2958.2005.04642.x; Nair S, 2004, J BACTERIOL, V186, P4192, DOI 10.1128/JB.186.13.4192-4198.2004; O'Rourke EJ, 2003, P NATL ACAD SCI USA, V100, P2789, DOI 10.1073/pnas.0337641100; Olsen KN, 2005, MICROBIOL-SGM, V151, P925, DOI 10.1099/mic.0.27552-0; Papinutto E, 2002, J BIOL CHEM, V277, P15093, DOI 10.1074/jbc.M112378200; Pereira AS, 1998, BIOCHEMISTRY-US, V37, P9871, DOI 10.1021/bi980847w; Reindel S, 2002, BBA-PROTEINS PROTEOM, V1598, P140, DOI 10.1016/S0167-4838(02)00361-8; Ren B, 2003, J MOL BIOL, V329, P467, DOI 10.1016/S0022-2836(03)00466-2; Roy S, 2004, J MOL BIOL, V339, P1103, DOI 10.1016/j.jmb.2004.04.042; Stillman TJ, 2005, MOL MICROBIOL, V57, P1101, DOI 10.1111/j.1365-2958.2005.04757.x; Stillman TJ, 2003, J BIOL CHEM, V278, P26275, DOI 10.1074/jbc.M207354200; Su MH, 2005, BIOCHEMISTRY-US, V44, P5572, DOI 10.1021/bi0472705; SUN SJ, 1993, BIOCHEMISTRY-US, V32, P9362, DOI 10.1021/bi00087a015; Surguladze N, 2005, BIOCHEM J, V388, P731, DOI 10.1042/BJ20041853; Takagi H, 1998, J BIOL CHEM, V273, P18685, DOI 10.1074/jbc.273.30.18685; Theil E. C., 2001, HDB METALLOPROTEINS, P771; THEIL EC, 1987, ANNU REV BIOCHEM, V56, P289, DOI 10.1146/annurev.biochem.56.1.289; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; TREFFRY A, 1995, BIOCHEMISTRY-US, V34, P15204, DOI 10.1021/bi00046a028; TRIKHA J, 1995, J MOL BIOL, V248, P949, DOI 10.1006/jmbi.1995.0274; WALDO GS, 1993, BIOCHEMISTRY-US, V32, P13262, DOI 10.1021/bi00211a039; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; Wiedenheft B, 2005, P NATL ACAD SCI USA, V102, P10551, DOI 10.1073/pnas.0501497102; Wolf SG, 1999, NATURE, V400, P83, DOI 10.1038/21918; Zeth K, 2004, P NATL ACAD SCI USA, V101, P13780, DOI 10.1073/pnas.0401821101; Zhao GH, 2002, J BIOL CHEM, V277, P27689, DOI 10.1074/jbc.M202094200; Zhao GH, 2006, BIOCHEMISTRY-US, V45, P3429, DOI 10.1021/bi052443r; Zhao GH, 2001, BIOCHEMISTRY-US, V40, P10832, DOI 10.1021/bi011052j	65	47	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					27827	27835		10.1074/jbc.M601398200	http://dx.doi.org/10.1074/jbc.M601398200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16861227	hybrid			2022-12-27	WOS:000240534400018
J	Yang, JJ; Bitoun, JP; Ding, HG				Yang, Juanjuan; Bitoun, Jacob P.; Ding, Huangen			Interplay of IscA and IscU in biogenesis of iron-sulfur clusters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FE-S CLUSTER; CYSTEINE DESULFURASE ACTIVITY; ESCHERICHIA-COLI; ASSEMBLY PROTEIN; THIOREDOXIN REDUCTASE; CRYSTAL-STRUCTURE; AZOTOBACTER-VINELANDII; SCAFFOLD PROTEIN; 4FE-4S CLUSTERS; MARITIMA ISCU	Increasing evidence suggests that sulfur in ubiquitous iron-sulfur clusters is derived from L-cysteine via cysteine desulfurases. In Escherichia coli, the major cysteine desulfurase activity for biogenesis of iron-sulfur clusters has been attributed to IscS. The gene that encodes IscS is a member of an operon iscSUA, which also encodes two highly conserved proteins: IscU and IscA. Previous studies suggested that both IscU and IscA may act as the iron-sulfur cluster assembly scaffold proteins. However, recent evidence indicated that IscA is an iron-binding protein that can provide iron for the iron-sulfur cluster assembly in IscU ( Ding, H., Harrison, K., and Lu, J. (2005) J. Biol. Chem. 280, 30432 - 30437). To further elucidate the function of IscA in biogenesis of iron-sulfur clusters, we evaluate the iron-sulfur cluster binding activity of IscA and IscU under physiologically relevant conditions. When equal amounts of IscA and IscU are incubated with an equivalent amount of ferrous iron in the presence of IscS, L-cysteine and dithiothreitol, iron-sulfur clusters are assembled in IscU, but not in IscA, suggesting that IscU is a preferred iron-sulfur cluster assembly scaffold protein. In contrast, when equal amounts of IscA and IscU are incubated with an equivalent amount of ferrous iron in the presence of IscS and dithiothreitol but without L-cysteine, nearly all iron is bound to IscA. The iron binding in IscA appears to prevent the formation of the biologically inaccessible ferric hydroxide under aerobic conditions. Subsequent addition of L-cysteine efficiently mobilizes the iron center in IscA and transfers the iron for the iron-sulfur cluster assembly in IscU. The results suggest an intriguing interplay between IscA and IscU in which IscA acts as an iron chaperon that recruits "free" iron and delivers the iron for biogenesis of iron-sulfur clusters in IscU under aerobic conditions.	Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Ding, HG (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	hding@lsu.edu	Ding, Huangen/AAJ-8550-2020	Ding, Huangen/0000-0002-4815-7336				Abdel-Ghany SE, 2005, PLANT PHYSIOL, V138, P161, DOI 10.1104/pp.104.058602; Adinolfi S, 2002, HUM MOL GENET, V11, P1865, DOI 10.1093/hmg/11.16.1865; Agar JN, 2000, BIOCHEMISTRY-US, V39, P7856, DOI 10.1021/bi000931n; ARAKAWA S, 1979, BIOCHIM BIOPHYS ACTA, V580, P382, DOI 10.1016/0005-2795(79)90150-8; Bilder PW, 2004, BIOCHEMISTRY-US, V43, P133, DOI 10.1021/bi035440s; Bonomi F, 2005, J BIOL CHEM, V280, P29513, DOI 10.1074/jbc.M504344200; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; COWART RE, 1993, ANAL BIOCHEM, V211, P151, DOI 10.1006/abio.1993.1246; Crichton R R, 1990, Adv Protein Chem, V40, P281, DOI 10.1016/S0065-3233(08)60288-0; Cupp-Vickery JR, 2004, J MOL BIOL, V338, P127, DOI 10.1016/j.jmb.2004.02.027; Cupp-Vickery JR, 2003, J MOL BIOL, V330, P1049, DOI 10.1016/S0022-2836(03)00690-9; Ding BJ, 2005, BIOCHEM J, V389, P797, DOI 10.1042/BJ20050405; Ding H, 2004, J BIOL CHEM, V279, P37499, DOI 10.1074/jbc.M404533200; Ding HG, 2005, J BIOL CHEM, V280, P30432, DOI 10.1074/jbc.M504638200; Ding HG, 2004, BIOCHEM J, V379, P433, DOI 10.1042/BJ20031702; Duby G, 2002, HUM MOL GENET, V11, P2635, DOI 10.1093/hmg/11.21.2635; Flint DH, 1996, J BIOL CHEM, V271, P16068; Imlay JA, 2006, MOL MICROBIOL, V59, P1073, DOI 10.1111/j.1365-2958.2006.05028.x; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kato S, 2002, P NATL ACAD SCI USA, V99, P5948, DOI 10.1073/pnas.082123599; Krebs C, 2001, BIOCHEMISTRY-US, V40, P14069, DOI 10.1021/bi015656z; KREDICH NM, 1996, ESCHERICHIA COLI SAL, P514; Kurihara T, 2003, BBA-PROTEINS PROTEOM, V1647, P303, DOI 10.1016/S1570-9639(03)00078-5; Li DS, 1999, FEBS LETT, V456, P13, DOI 10.1016/S0014-5793(99)00896-0; Mansy SS, 2004, J BIOL CHEM, V279, P10469, DOI 10.1074/jbc.M312051200; Mansy SS, 2002, J BIOL CHEM, V277, P21397, DOI 10.1074/jbc.M201439200; Mihara H, 2000, J BIOCHEM-TOKYO, V127, P559, DOI 10.1093/oxfordjournals.jbchem.a022641; Morimoto K, 2002, FEBS LETT, V519, P123, DOI 10.1016/S0014-5793(02)02736-9; MOURA I, 1980, J BIOL CHEM, V255, P2493; Muhlenhoff U, 2000, BBA-BIOENERGETICS, V1459, P370, DOI 10.1016/S0005-2728(00)00174-2; Mulrooney SB, 1997, PROTEIN EXPRES PURIF, V9, P372, DOI 10.1006/prep.1996.0698; Nuth M, 2002, J AM CHEM SOC, V124, P8774, DOI 10.1021/ja0264596; Ollagnier-de-Choudens S, 2004, J BIOL INORG CHEM, V9, P828, DOI 10.1007/s00775-004-0581-9; Ollagnier-de-Choudens S, 2001, J BIOL CHEM, V276, P22604, DOI 10.1074/jbc.M102902200; ONATE YA, 1993, BIOCHIM BIOPHYS ACTA, V1164, P113, DOI 10.1016/0167-4838(93)90237-L; Outten FW, 2003, J BIOL CHEM, V278, P45713, DOI 10.1074/jbc.M308004200; Park S, 2003, J BACTERIOL, V185, P1942, DOI 10.1128/JB.185.6.1942-1950.2003; Ramelot TA, 2004, J MOL BIOL, V344, P567, DOI 10.1016/j.jmb.2004.08.038; Rogers PA, 2001, J BIOL CHEM, V276, P30980, DOI 10.1074/jbc.M101037200; Rouault TA, 2005, NAT REV MOL CELL BIO, V6, P345, DOI 10.1038/nrm1620; Schwartz CJ, 2000, P NATL ACAD SCI USA, V97, P9009, DOI 10.1073/pnas.160261497; Schwartz CJ, 2001, P NATL ACAD SCI USA, V98, P14895, DOI 10.1073/pnas.251550898; SIEGEL LM, 1965, ANAL BIOCHEM, V11, P126, DOI 10.1016/0003-2697(65)90051-5; Silberg JJ, 2004, J BIOL CHEM, V279, P53924, DOI 10.1074/jbc.M410117200; Smith AD, 2005, BIOCHEMISTRY-US, V44, P12955, DOI 10.1021/bi051257i; Smith AD, 2001, J AM CHEM SOC, V123, P11103, DOI 10.1021/ja016757n; Takahashi Y, 1999, J BIOCHEM, V126, P917, DOI 10.1093/oxfordjournals.jbchem.a022535; Tapley TL, 2004, J BIOL CHEM, V279, P28435, DOI 10.1074/jbc.M400803200; Tong WH, 2000, EMBO J, V19, P5692, DOI 10.1093/emboj/19.21.5692; Urbina HD, 2001, J BIOL CHEM, V276, P44521, DOI 10.1074/jbc.M106907200; Veine DM, 1998, PROTEIN SCI, V7, P1441, DOI 10.1002/pro.5560070621; Wollenberg M, 2003, EUR J BIOCHEM, V270, P1662, DOI 10.1046/j.1432-1033.2003.03522.x; Wu G, 2002, J BIOL INORG CHEM, V7, P526, DOI 10.1007/s00775-001-0330-2; Wu SP, 2003, BIOCHEMISTRY-US, V42, P5784, DOI 10.1021/bi026939+; Yang WY, 2002, J BIOL CHEM, V277, P12868, DOI 10.1074/jbc.M109485200; ZHENG LM, 1993, P NATL ACAD SCI USA, V90, P2754, DOI 10.1073/pnas.90.7.2754; Zheng LM, 1998, J BIOL CHEM, V273, P13264, DOI 10.1074/jbc.273.21.13264	57	61	66	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					27956	27963		10.1074/jbc.M601356200	http://dx.doi.org/10.1074/jbc.M601356200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16877383	hybrid, Green Published			2022-12-27	WOS:000240534400032
J	Zhang, J; Smith, KM; Tackaberry, T; Sun, XJ; Carpenter, P; Slugoski, MD; Robins, MJ; Nielsen, LPC; Nowak, I; Baldwin, SA; Young, JD; Cass, CE				Zhang, Jing; Smith, Kyla M.; Tackaberry, Tracey; Sun, Xuejun; Carpenter, Pat; Slugoski, Melissa D.; Robins, Morris J.; Nielsen, Lars P. C.; Nowak, Ireneusz; Baldwin, Stephen A.; Young, James D.; Cass, Carol E.			Characterization of the transport mechanism and permeant binding profile of the uridine permease Fui1p of Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EQUILIBRATIVE NUCLEOSIDE TRANSPORTER-2; IN-VIVO PHOSPHORYLATION; PLASMA-MEMBRANE ATPASE; YEAST URACIL PERMEASE; NUCLEOBASE TRANSPORTERS; RECOGNITION MOTIFS; HIGH-AFFINITY; PROTEINS; RESIDUES; SYSTEM	The uptake of Urd into the yeast Saccharomyces cerevisiae is mediated by Fui1p, a Urd-specific nucleoside transporter encoded by the FUI1 gene and a member of the yeast Fur permease family, which also includes the uracil, allantoin, and thiamine permeases. When Fui1p was produced in a double-permease knockout strain (fur4 Delta fui1 Delta) of yeast, Urd uptake was stimulated at acidic pH and sensitive to the protonophore carbonyl cyanide m-chlorophenylhydrazone. Electrophysiological analysis of recombinant Fui1p produced in Xenopus oocytes demonstrated that Fui1p- mediated Urd uptake was dependent on proton cotransport with a 1:1 stoichiometry. Mutagenesis analysis of three charged amino acids (Glu(259), Lys(288), and Asp(474) in putative transmembrane segments 3, 4, and 7, respectively) revealed that only Lys288 was required for maintaining high Urd transport efficiency. Analysis of binding energies between Fui1p and different Urd analogs indicated that Fuip1 interacted with C( 3')-OH, C(2')-OH, C(5)-H, and N(3)-H of Urd. Fui1p- mediated transport of Urd was inhibited by analogs with modifications at C-5', but was not inhibited significantly by analogs with modifications at C-3', C-5, and N-3orinversionsofconfigurationatC-2' andC-3'. This characterization of Fui1p contributes to the emerging knowledge of the structure and function of the Fur family of permeases, including the Fui1p orthologs of pathogenic fungi.	Cross Canc Inst, Dept Oncol, Edmonton, AB T6H 1Z2, Canada; Univ Alberta, Membrane Prot Res Grp, Edmonton, AB T6G 2M7, Canada; Univ Alberta, Dept Oncol, Edmonton, AB T6G 2M7, Canada; Univ Alberta, Dept Physiol, Edmonton, AB T6G 2M7, Canada; Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84602 USA; Univ Leeds, Inst Membrane & Syst Biol, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England	University of Alberta; University of Alberta; University of Alberta; University of Alberta; Brigham Young University; University of Leeds	Cass, CE (corresponding author), Cross Canc Inst, Dept Oncol, 11540 Univ Ave, Edmonton, AB T6H 1Z2, Canada.	carol.cass@cancerboard.ab.ca						ACTON EM, 1979, J MED CHEM, V22, P518, DOI 10.1021/jm00191a012; Arastu-Kapur S, 2003, J BIOL CHEM, V278, P33327, DOI 10.1074/jbc.M305141200; Ausubel F.A., 1997, CURRENT PROTOCOLS MO, DOI DOI 10.1.4; Baldwin SA, 1999, MOL MED TODAY, V5, P216, DOI 10.1016/S1357-4310(99)01459-8; Blondel MO, 2004, MOL BIOL CELL, V15, P883, DOI 10.1091/mbc.E03-04-0202; BRUNELLI JP, 1993, YEAST, V9, P1309, DOI 10.1002/yea.320091204; CASS CE, 1999, MEMBRANE TRANSPORTER; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; de Koning HP, 2001, ACTA TROP, V80, P245, DOI 10.1016/S0001-706X(01)00177-2; De Montigny J, 1998, YEAST, V14, P1051, DOI 10.1002/(SICI)1097-0061(199808)14:11<1051::AID-YEA287>3.0.CO;2-1; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Eddy AA, 1998, BIOCHEM J, V336, P125, DOI 10.1042/bj3360125; Garnier C, 1996, MOL MICROBIOL, V21, P1061, DOI 10.1046/j.1365-2958.1996.621430.x; Grewer C, 2003, J BIOL CHEM, V278, P2585, DOI 10.1074/jbc.M207956200; HOPKINS P, 1988, FEMS MICROBIOL LETT, V49, P173; HUANG QQ, 1993, J BIOL CHEM, V268, P20613; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Kaback HR, 1997, P NATL ACAD SCI USA, V94, P5539, DOI 10.1073/pnas.94.11.5539; Kimura K, 2003, NAT PROD REP, V20, P252, DOI 10.1039/b202149h; Landfear SM, 2004, EUKARYOT CELL, V3, P245, DOI 10.1128/EC.3.2.245-254.2004; Marchal C, 2000, J BIOL CHEM, V275, P23608, DOI 10.1074/jbc.M001735200; Muth TR, 2000, EMBO J, V19, P234, DOI 10.1093/emboj/19.2.234; Pastor-Anglada M, 2004, LEUKEMIA, V18, P385, DOI 10.1038/sj.leu.2403271; Patil SD, 2000, CANCER CHEMOTH PHARM, V46, P394, DOI 10.1007/s002800000171; Pinson B, 1996, EUR J BIOCHEM, V239, P439, DOI 10.1111/j.1432-1033.1996.0439u.x; Pinson B, 1997, J BIOL CHEM, V272, P28918, DOI 10.1074/jbc.272.46.28918; Pinsoni B, 1999, BIOCHEM J, V339, P37, DOI 10.1042/0264-6021:3390037; Rapp RP, 2004, PHARMACOTHERAPY, V24, p4S, DOI 10.1592/phco.24.3.4S.33151; Ritzel MWL, 2001, MOL MEMBR BIOL, V18, P65, DOI 10.1080/09687680010026313; Seron K, 1999, J BACTERIOL, V181, P1793; SERRANO R, 1986, NATURE, V319, P689, DOI 10.1038/319689a0; SERRANO R, 1984, CURR TOP CELL REGUL, V23, P87; Slugoski MD, 2004, YEAST, V21, P1269, DOI 10.1002/yea.1178; Smith KM, 2004, J PHYSIOL-LONDON, V558, P807, DOI 10.1113/jphysiol.2004.068189; Unkles SE, 2004, P NATL ACAD SCI USA, V101, P17549, DOI 10.1073/pnas.0405054101; Vernis L, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng121; Vickers MF, 2000, J BIOL CHEM, V275, P25931, DOI 10.1074/jbc.M000239200; Vickers MF, 2004, NUCLEOS NUCLEOT NUCL, V23, P361, DOI 10.1081/NCN-120028333; Vickers MF, 2002, BIOCHEM CELL BIOL, V80, P639, DOI 10.1139/O02-148; VICKERS MF, 2000, EMERGING THERAPEUTIC, V4, P515; Visser F, 2005, J BIOL CHEM, V280, P11025, DOI 10.1074/jbc.M410348200; Visser F, 2005, MOL PHARMACOL, V67, P1291, DOI 10.1124/mol.104.005884; VOLLAND C, 1994, J BIOL CHEM, V269, P9833; VOLLAND C, 1992, J BIOL CHEM, V267, P23767; Wagner R, 1998, FEMS MICROBIOL LETT, V159, P69, DOI 10.1111/j.1574-6968.1998.tb12843.x; Wallace LJM, 2002, J BIOL CHEM, V277, P26149, DOI 10.1074/jbc.M202835200; Xiao GQ, 2001, MOL PHARMACOL, V59, P339, DOI 10.1124/mol.59.2.339; Zhang J, 2005, MOL PHARMACOL, V68, P830, DOI 10.1124/mol.105.012187; Zhang J, 2003, MOL PHARMACOL, V64, P1512, DOI 10.1124/mol.64.6.1512	49	10	10	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					28210	28221		10.1074/jbc.M605129200	http://dx.doi.org/10.1074/jbc.M605129200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16854981	hybrid			2022-12-27	WOS:000240534400059
J	Brouns, SJJ; Walther, J; Snijders, APL; de Werken, HJGV; Willemen, HLDM; Worm, P; de Vos, MGJ; Andersson, A; Lundgren, M; Mazon, HFM; van den Heuvel, RHH; Nilsson, P; Salmon, L; de Vos, WM; Wright, PC; Bernander, R; van der Oost, J				Brouns, Stan J. J.; Walther, Jasper; Snijders, Ambrosius P. L.; de Werken, Harmen J. G. van; Willemen, Hanneke L. D. M.; Worm, Petra; de Vos, Marjon G. J.; Andersson, Anders; Lundgren, Magnus; Mazon, Hortense F. M.; van den Heuvel, Robert H. H.; Nilsson, Peter; Salmon, Laurent; de Vos, Willem M.; Wright, Phillip C.; Bernander, Rolf; van der Oost, John			Identification of the missing links in prokaryotic pentose oxidation pathways - Evidence for enzyme recruitment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-ARABINOSE METABOLISM; ARCHAEON SULFOLOBUS-SOLFATARICUS; ENTNER-DOUDOROFF PATHWAY; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; THERMOACIDOPHILIC CRENARCHAEON; FUMARYLACETOACETATE HYDROLASE; PSEUDOMONAS-SACCHAROPHILA; GLUTAMATE-DEHYDROGENASE; CAULOBACTER-CRESCENTUS	The pentose metabolism of Archaea is largely unknown. Here, we have employed an integrated genomics approach including DNA microarray and proteomics analyses to elucidate the catabolic pathway for D-arabinose in Sulfolobus solfataricus. During growth on this sugar, a small set of genes appeared to be differentially expressed compared with growth on D-glucose. These genes were heterologously overexpressed in Escherichia coli, and the recombinant proteins were purified and biochemically studied. This showed that D-arabinose is oxidized to 2-oxoglutarate by the consecutive action of a number of previously uncharacterized enzymes, including a D-arabinose dehydrogenase, a D-arabinonate dehydratase, a novel 2-keto-3-deoxy-D-arabinonate dehydratase, and a 2,5-dioxopentanoate dehydrogenase. Promoter analysis of these genes revealed a palindromic sequence upstream of the TATA box, which is likely to be involved in their concerted transcriptional control. Integration of the obtained biochemical data with genomic context analysis strongly suggests the occurrence of pentose oxidation pathways in both Archaea and Bacteria, and predicts the involvement of additional enzyme components. Moreover, it revealed striking genetic similarities between the catabolic pathways for pentoses, hexaric acids, and hydroxyproline degradation, which support the theory of metabolic pathway genesis by enzyme recruitment.	Wageningen Univ, Microbiol Lab, Dept Agrotechnol & Food Sci, NL-6703 CT Wageningen, Netherlands; Univ Sheffield, Biol & Environm Syst Grp, Dept Chem & Proc Engn, Sheffield S1 3JD, S Yorkshire, England; Royal Inst Technol, Dept Biotechnol, SE-10691 Stockholm, Sweden; Uppsala Univ, Dept Mol Evolut, Evolutionary Biol Ctr, SE-75236 Uppsala, Sweden; Univ Utrecht, Dept Biomol Mass Spectrometry, Bijvoet Ctr Biomol Res, NL-3584 CA Utrecht, Netherlands; Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CA Utrecht, Netherlands; Univ Paris 11, Lab Chim Bioorgan & Bioinorgan, CNRS,UMR 8142, ICMMO, F-91405 Orsay, France	Wageningen University & Research; University of Sheffield; Royal Institute of Technology; Uppsala University; Utrecht University; Utrecht University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Brouns, SJJ (corresponding author), Wageningen Univ, Microbiol Lab, Dept Agrotechnol & Food Sci, Hesselink Van Suchtelenweg 4, NL-6703 CT Wageningen, Netherlands.	stan.brouns@wur.nl	Andersson, Anders/J-9310-2019; Salmon, Laurent/T-5179-2018; van+der+Oost, John/Y-2548-2019; Nilsson, Peter/E-4547-2010; Werken, Harmen van de/G-8979-2013	Andersson, Anders/0000-0002-3627-6899; Salmon, Laurent/0000-0003-1946-8458; Nilsson, Peter/0000-0002-4657-8532; Werken, Harmen van de/0000-0002-9794-1477; de Vos, Marjon GJ/0000-0003-0601-908X; Snijders, Bram/0000-0002-5416-8592; Brouns, Stan/0000-0002-9573-1724; Wright, Phillip/0000-0002-8834-0426; Venkatasubramanian, Siddharth/0000-0002-5860-0768				Albers SV, 2006, APPL ENVIRON MICROB, V72, P102, DOI 10.1128/AEM.72.1.102-111.2006; Andersson A, 2005, BIOINFORMATICS, V21, P325, DOI 10.1093/bioinformatics/bti001; BABBITT PC, 1995, SCIENCE, V267, P1159, DOI 10.1126/science.7855594; BARTOLUCCI S, 1987, J BIOL CHEM, V262, P7725; Bateman RL, 2001, J BIOL CHEM, V276, P15284, DOI 10.1074/jbc.M007621200; Brouns SJJ, 2006, J BACTERIOL, V188, P2392, DOI 10.1128/JB.188.7.2392-2399.2006; Chen LM, 2005, J BACTERIOL, V187, P4992, DOI 10.1128/JB.187.14.4992-4999.2005; CHIANG C, 1960, NATURE, V188, P79, DOI 10.1038/188079a0; CLINE AL, 1965, J BIOL CHEM, V240, P4493; CONSALVI V, 1991, EUR J BIOCHEM, V196, P459, DOI 10.1111/j.1432-1033.1991.tb15837.x; Crestia D, 2001, J MOL CATAL B-ENZYM, V11, P207, DOI 10.1016/S1381-1177(00)00074-6; DAGLEY S, 1965, BIOCHEM J, V95, P48, DOI 10.1042/bj0950048; DAHMS AS, 1969, BIOCHEM BIOPH RES CO, V36, P809, DOI 10.1016/0006-291X(69)90681-0; Deshpande AD, 2004, CURR SCI INDIA, V87, P1684; DUNCAN MJ, 1979, J GEN MICROBIOL, V113, P177, DOI 10.1099/00221287-113-1-177; DUNCAN MJ, 1979, J BACTERIOL, V137, P415, DOI 10.1128/JB.137.1.415-419.1979; EGAN SE, 1992, J BACTERIOL, V174, P4638, DOI 10.1128/JB.174.14.4638-4646.1992; Elferink MGL, 2001, MOL MICROBIOL, V39, P1494, DOI 10.1046/j.1365-2958.2001.02336.x; ELSINGHORST EA, 1994, J BACTERIOL, V176, P7223, DOI 10.1128/JB.176.23.7223-7232.1994; Esposito L, 2003, BIOCHEMISTRY-US, V42, P14397, DOI 10.1021/bi035271b; FOSSITT D, 1964, J BIOL CHEM, V239, P2110; Gleissner M, 1997, J BIOL CHEM, V272, P8417, DOI 10.1074/jbc.272.13.8417; GROGAN DW, 1989, J BACTERIOL, V171, P6710, DOI 10.1128/jb.171.12.6710-6719.1989; HESS D, 1995, EUR J BIOCHEM, V233, P227, DOI 10.1111/j.1432-1033.1995.227_1.x; Hosoya S, 2002, FEMS MICROBIOL LETT, V210, P193, DOI 10.1111/j.1574-6968.2002.tb11180.x; Hottes AK, 2004, J BACTERIOL, V186, P1448, DOI 10.1128/JB.186.5.1448-1461.2004; IMANAKA T, 1993, J FERMENT BIOENG, V76, P161, DOI 10.1016/0922-338X(93)90001-O; JEFFCOAT R, 1969, BIOCHEM J, V115, P977, DOI 10.1042/bj1150977; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Johnsen U, 2004, J BACTERIOL, V186, P6198, DOI 10.1128/JB.186.18.6198-6207.2004; Kappler U, 2005, MICROBIOL-SGM, V151, P35, DOI 10.1099/mic.0.27515-0; Kawarabayasi Y, 2001, DNA RES, V8, P123, DOI 10.1093/dnares/8.4.123; Kim S, 2006, J BIOCHEM, V139, P591, DOI 10.1093/jb/mvj057; Kim SH, 2005, BIOCHEM J, V387, P271, DOI 10.1042/BJ20041053; Komorowski L, 2002, BIOL CHEM, V383, P1791, DOI 10.1515/BC.2002.200; KRAUS GA, 1984, SYNTHESIS-STUTTGART, P885; Lebbink JHG, 1995, PROTEIN ENG, V8, P1287, DOI 10.1093/protein/8.12.1287; LEE N, 1986, GENE, V47, P231, DOI 10.1016/0378-1119(86)90067-3; Londei P, 2005, FEMS MICROBIOL REV, V29, P185, DOI 10.1016/j.femsre.2004.10.002; LUBELSKA JM, 2006, IN PRESS EXTREMOPHIL; Lundgren M, 2005, CURR OPIN MICROBIOL, V8, P662, DOI 10.1016/j.mib.2005.10.008; Lundgren M, 2004, P NATL ACAD SCI USA, V101, P7046, DOI 10.1073/pnas.0400656101; Macritchie JA, 1997, TETRAHEDRON-ASYMMETR, V8, P3895, DOI 10.1016/S0957-4166(97)00571-5; MATHIAS AL, 1989, J BACTERIOL, V171, P5206, DOI 10.1128/jb.171.9.5206-5209.1989; Meisenzahl AC, 1997, J BACTERIOL, V179, P592, DOI 10.1128/jb.179.3.592-600.1997; Mobley P W, 1975, Methods Enzymol, V41, P173; Moore RA, 2004, INFECT IMMUN, V72, P4172, DOI 10.1128/IAI.72.7.4172-4187.2004; NOVICK NJ, 1982, J BACTERIOL, V149, P364, DOI 10.1128/JB.149.1.364-367.1982; Osterman A, 2003, CURR OPIN CHEM BIOL, V7, P238, DOI 10.1016/S1367-5931(03)00027-9; PALLERONI NJ, 1956, J BIOL CHEM, V223, P499; PALLERONI NJ, 1957, J BACTERIOL, V74, P180, DOI 10.1128/JB.74.2.180-185.1957; PEDROSA FO, 1974, J BACTERIOL, V119, P336, DOI 10.1128/JB.119.1.336-338.1974; PORTSMOUTH D, 1967, J BIOL CHEM, V242, P2751; RAMASWAMY SG, 1984, J BIOL CHEM, V259, P249; ROSENFELD SA, 1984, MOL GEN GENET, V194, P410, DOI 10.1007/BF00425552; Schmidt A, 2001, ANAL CHEM, V73, P6040, DOI 10.1021/ac010451h; Schmidt S, 2003, TRENDS BIOCHEM SCI, V28, P336, DOI 10.1016/S0968-0004(03)00114-2; SHARMA BS, 1973, J BACTERIOL, V116, P1346, DOI 10.1128/JB.116.3.1346-1354.1973; She Q, 2001, P NATL ACAD SCI USA, V98, P7835, DOI 10.1073/pnas.141222098; Siebers B, 2005, CURR OPIN MICROBIOL, V8, P695, DOI 10.1016/j.mib.2005.10.014; SINGH RMM, 1965, J BIOL CHEM, V240, P4344; Snijders APL, 2006, PROTEOMICS, V6, P1518, DOI 10.1002/pmic.200402070; Snijders APL, 2005, ELECTROPHORESIS, V26, P3191, DOI 10.1002/elps.200500218; Snijders APL, 2005, J PROTEOME RES, V4, P578, DOI 10.1021/pr0497733; SPERBER N, 1947, J AM CHEM SOC, V69, P915, DOI 10.1021/ja01196a053; StLouis M, 1997, HUM MUTAT, V9, P291, DOI 10.1002/(SICI)1098-1004(1997)9:4<291::AID-HUMU1>3.0.CO;2-9; Tahallah N, 2001, RAPID COMMUN MASS SP, V15, P596, DOI 10.1002/rcm.275; Tame JRH, 2002, BIOCHEMISTRY-US, V41, P2982, DOI 10.1021/bi015717t; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Thompson W, 2003, NUCLEIC ACIDS RES, V31, P3580, DOI 10.1093/nar/gkg608; Uhrigshardt H, 2002, FEBS LETT, V513, P223, DOI 10.1016/S0014-5793(02)02317-7; WARREN L, 1960, NATURE, V186, P237, DOI 10.1038/186237a0; Watanabe S, 2006, J BIOL CHEM, V281, P2612, DOI 10.1074/jbc.M506477200; WEIMBERG R, 1961, J BIOL CHEM, V236, P629; WEIMBERG R, 1955, J BIOL CHEM, V217, P607; WOJTKIEWICZ B, 1988, EUR J BIOCHEM, V172, P197, DOI 10.1111/j.1432-1033.1988.tb13873.x; YONEYA T, 1961, J BIOL CHEM, V236, P3272	77	88	93	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2006	281	37					27378	27388		10.1074/jbc.M605549200	http://dx.doi.org/10.1074/jbc.M605549200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082PB	16849334	hybrid			2022-12-27	WOS:000240397700064
J	Cheng, VWT; Ma, E; Zhao, Z; Rothery, RA; Weiner, JH				Cheng, Victor W. T.; Ma, Elysia; Zhao, Zhongwei; Rothery, Richard A.; Weiner, Joel H.			The iron-sulfur clusters in Escherichia coli succinate dehydrogenase direct electron flow	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTOCOCCUS-AEROGENES FERREDOXIN; FUMARATE REDUCTASE; REDOX POTENTIALS; DIMETHYLSULFOXIDE REDUCTASE; UBIQUINONE OXIDOREDUCTASE; CATALYTIC-ACTIVITY; PROTEIN CONTROL; 4FE-4S CLUSTER; HYDROGEN-BONDS; SITE	Succinate dehydrogenase is an indispensable enzyme involved in the Krebs cycle as well as energy coupling in the mitochondria and certain prokaryotes. During catalysis, succinate oxidation is coupled to ubiquinone reduction by an electron transfer relay comprising a flavin adenine dinucleotide cofactor, three iron-sulfur clusters, and possibly a heme b(556). At the heart of the electron transport chain is a [4Fe-4S] cluster with a low midpoint potential that acts as an energy barrier against electron transfer. Hydrophobic residues around the [4Fe-4S] cluster were mutated to determine their effects on the midpoint potential of the cluster as well as electron transfer rates. SdhB-I150E and SdhB-I150H mutants lowered the midpoint potential of this cluster; surprisingly, the His variant had a lower midpoint potential than the Glu mutant. Mutation of SdhB-Leu-220 to Ser did not alter the redox behavior of the cluster but instead lowered the midpoint potential of the [3Fe-4S] cluster. To correlate the midpoint potential changes in these mutants to enzyme function, we monitored aerobic growth in succinate minimal medium, anaerobic growth in glycerol-fumarate minimal medium, non-physiological and physiological enzyme activities, and heme reduction. It was discovered that a decrease in midpoint potential of either the [4Fe-4S] cluster or the [3Fe-4S] cluster is accompanied by a decrease in the rate of enzyme turnover. We hypothesize that this occurs because the midpoint potentials of the [Fe-S] clusters in the native enzyme are poised such that direction of electron transfer from succinate to ubiquinone is favored.	Univ Alberta, Dept Biochem, Membrane Prot Res Grp, Edmonton, AB T6G 2H7, Canada	University of Alberta	Weiner, JH (corresponding author), Univ Alberta, Dept Biochem, Membrane Prot Res Grp, 473 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	joel.weiner@ualberta.ca		Rothery, Richard/0000-0003-3265-1783; Zhao, Zhongwei/0000-0003-4081-7077				ADMAN E, 1975, P NATL ACAD SCI USA, V72, P4854, DOI 10.1073/pnas.72.12.4854; AGARWAL A, 1995, P NATL ACAD SCI USA, V92, P9440, DOI 10.1073/pnas.92.21.9440; Alric J, 2006, J AM CHEM SOC, V128, P4136, DOI 10.1021/ja058131t; Bertero MG, 2003, NAT STRUCT BIOL, V10, P681, DOI 10.1038/nsb969; CAMMACK R, 1986, BIOCHIM BIOPHYS ACTA, V870, P545, DOI 10.1016/0167-4838(86)90264-5; Cecchini G, 2003, FEBS LETT, V545, P31, DOI 10.1016/S0014-5793(03)00390-9; Cecchini G, 2002, BBA-BIOENERGETICS, V1553, P140, DOI 10.1016/S0005-2728(01)00238-9; Chen KS, 2002, NAT STRUCT BIOL, V9, P188, DOI 10.1038/nsb751; Cheng VWT, 2005, BIOCHEMISTRY-US, V44, P8068, DOI 10.1021/bi050362p; CONDON C, 1985, J BIOL CHEM, V260, P9427; Denke E, 1998, J BIOL CHEM, V273, P9085, DOI 10.1074/jbc.273.15.9085; GRAY KA, 1992, BIOCHEMISTRY-US, V31, P11864, DOI 10.1021/bi00162a027; Guigliarelli B, 1996, BIOCHEMISTRY-US, V35, P4828, DOI 10.1021/bi952459p; Guo J, 2003, J BIOL CHEM, V278, P47629, DOI 10.1074/jbc.M306312200; Hudson JM, 2005, J AM CHEM SOC, V127, P6977, DOI 10.1021/ja043404q; Jang SB, 2000, BIOCHEMISTRY-US, V39, P641, DOI 10.1021/bi991694v; JENSEN GM, 1994, BIOCHEMISTRY-US, V33, P10911, DOI 10.1021/bi00202a010; Jeuken LJC, 2002, J AM CHEM SOC, V124, P5702, DOI 10.1021/ja012638w; KITA K, 1989, J BIOL CHEM, V264, P2672; KOWAL AT, 1995, BIOCHEMISTRY-US, V34, P12284, DOI 10.1021/bi00038a024; LANGEN R, 1992, J BIOL CHEM, V267, P25625; Leggate EJ, 2005, BIOCHEMISTRY-US, V44, P7048, DOI 10.1021/bi050189x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maklashina E, 1998, J BACTERIOL, V180, P5989, DOI 10.1128/JB.180.22.5989-5996.1998; MAKLASHINA E, 2006, J BIOL CHEM; MANODORI A, 1992, BIOCHEMISTRY-US, V31, P2703, DOI 10.1021/bi00125a010; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; Messner KR, 2002, METHOD ENZYMOL, V349, P354, DOI 10.1016/S0076-6879(02)49351-2; Messner KR, 2002, J BIOL CHEM, V277, P42563, DOI 10.1074/jbc.M204958200; NICHOLLS DG, 2002, BIOENERGETICS, V3, P89; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; RAYMENT I, 1992, J MOL BIOL, V228, P672, DOI 10.1016/0022-2836(92)90849-F; Rothery RA, 2005, FEBS J, V272, P313, DOI 10.1111/j.1742-4658.2004.04469.x; ROTHERY RA, 1991, BIOCHEMISTRY-US, V30, P8296, DOI 10.1021/bi00098a003; Rothery RA, 1998, BIOCHEM J, V332, P35, DOI 10.1042/bj3320035; SAMBASIVARAO D, 1991, J BACTERIOL, V173, P5935, DOI 10.1128/jb.173.19.5935-5943.1991; Sambrook J., 2001, MOL CLONING LAB MANU; Singer T P, 1980, Methods Enzymol, V66, P253; Stephens PJ, 1996, CHEM REV, V96, P2491, DOI 10.1021/cr950045w; WESTENBERG DJ, 1993, J BIOL CHEM, V268, P815; Yankovskaya V, 2003, SCIENCE, V299, P700, DOI 10.1126/science.1079605	41	39	39	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2006	281	37					27662	27668		10.1074/jbc.M604900200	http://dx.doi.org/10.1074/jbc.M604900200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082PB	16864590	hybrid			2022-12-27	WOS:000240397700091
J	Winer, IS; Bommer, GT; Gonik, N; Fearon, ER				Winer, Ira S.; Bommer, Guido T.; Gonik, Nathan; Fearon, Eric R.			Lysine residues Lys-19 and Lys-49 of beta-catenin regulate its levels and function in T cell factor transcriptional activation and neoplastic transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN LIGASE; CANCER; COMPLEX; PHOSPHORYLATION; PATHWAY; BINDING; TARGET; AXIN; DEGRADATION; DISTINCT	Wnt signaling regulates cell fate determination, proliferation, and survival, among other processes. Certain Wnt ligands stabilize the beta-catenin protein, leading to the ability of beta-catenin to activate T cell factor-regulated genes. In the absence of Wnts, beta-catenin is phosphorylated at defined serine and threonine residues in its amino (N) terminus. The phosphorylated beta-catenin is recognized by a beta-transducin repeat-containing protein (beta TrCP) and associated ubiquitin ligase components. The serine/threonine residues and beta TrCP-binding site in the N-terminal region of beta-catenin constitute a key regulatory motif targeted by somatic mutations in human cancers, resulting in constitutive stabilization of the mutant beta-catenin proteins. Structural studies have implicated beta-catenin lysine 19 as the major target for beta TrCP-dependent ubiquitination, but Lys-19 mutations in cancer have not been reported. We studied the consequences of single amino acid substitutions of the only 2 lysine residues in the N-terminal 130 amino acids of beta-catenin. Mutation of Lys-19 minimally affected beta-catenin levels and functional activity, and mutation of Lys-49 led to reduced beta-catenin levels and function. In contrast, beta-catenin proteins with substitutions at both Lys-19 and Lys-49 positions were present at elevated levels and had the ability to potently activate T cell factor-dependent transcription and promote neoplastic transformation. We further more demonstrate that the K19/K49 double mutant forms of beta-catenin are stabilized as a result of reduced beta TrCP-dependent ubiquitination. Our findings suggest that Lys-19 is a primary in vivo site of beta TrCP-dependent ubiquitination and Lys-49 may be a secondary or cryptic site. Moreover, our results inform understanding of why single amino acid substitutions at lysine 19 or 49 have not been reported in human cancer.	Univ Michigan, Sch Med, Div Mol Med & Genet, Cell & Mol Biol Grad Program,Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Div Mol Med & Genet, Cell & Mol Biol Grad Program,Dept Med, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Div Mol Med & Genet, Cell & Mol Biol Grad Program,Dept Human Genet, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Div Mol Med & Genet, Cell & Mol Biol Grad Program,Dept Pathol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Ctr Canc, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Fearon, ER (corresponding author), Univ Michigan, Sch Med, Div Mol Med & Genet, Cell & Mol Biol Grad Program,Dept Internal Med, 109 Zina Pitcher,1504 BSRB, Ann Arbor, MI 48109 USA.	fearon@umich.edu	Winer, Ira/M-4973-2019; Bommer, Guido/A-8425-2011	Winer, Ira/0000-0001-6056-8296; Bommer, Guido/0000-0001-6898-4884	NATIONAL CANCER INSTITUTE [P30CA046592, R01CA085463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007863] Funding Source: NIH RePORTER; NCI NIH HHS [CA46592, CA85463] Funding Source: Medline; NIGMS NIH HHS [T32GM07863] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cliffe A, 2003, CURR BIOL, V13, P960, DOI 10.1016/S0960-9822(03)00370-1; Feng Y, 2003, CANCER RES, V63, P8726; Fraser E, 2002, J BIOL CHEM, V277, P2176, DOI 10.1074/jbc.M109462200; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Gottardi CJ, 2004, J CELL BIOL, V167, P339, DOI 10.1083/jcb.200402153; Kolligs FT, 2000, GENE DEV, V14, P1319; Kolligs FT, 2002, CANCER CELL, V1, P145, DOI 10.1016/S1535-6108(02)00035-1; Kolligs FT, 1999, MOL CELL BIOL, V19, P5696; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Li L, 1999, EMBO J, V18, P4233, DOI 10.1093/emboj/18.15.4233; Liu CM, 1999, P NATL ACAD SCI USA, V96, P6273, DOI 10.1073/pnas.96.11.6273; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Muller T, 1999, J BIOL CHEM, V274, P10173, DOI 10.1074/jbc.274.15.10173; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; Papkoff J, 1996, MOL CELL BIOL, V16, P2128; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; PEIFER M, 1993, SCIENCE, V262, P1667, DOI 10.1126/science.8259511; Sadot E, 2002, J CELL SCI, V115, P2771; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Wolf D, 2002, J BIOL CHEM, V277, P25562, DOI 10.1074/jbc.M201196200; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X	27	43	43	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2006	281	36					26181	26187		10.1074/jbc.M604217200	http://dx.doi.org/10.1074/jbc.M604217200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	080LO	16849322	hybrid			2022-12-27	WOS:000240249500034
J	Kim, JY; Zeng, WZ; Kiselyov, K; Yuan, JP; Dehoff, MH; Mikoshiba, K; Worley, PF; Muallem, S				Kim, Joo Young; Zeng, Weizong; Kiselyov, Kirill; Yuan, Joseph P.; Dehoff, Marlin H.; Mikoshiba, Katsuhiko; Worley, Paul F.; Muallem, Shmuel			Homer 1 mediates store- and inositol 1,4,5-trisphosphate receptor-dependent translocation and retrieval of TRPC3 to the plasma membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPERATED CA2+ ENTRY; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; METABOTROPIC GLUTAMATE RECEPTORS; N-TERMINAL DOMAIN; CHANNEL FUNCTION; IP3 RECEPTOR; CATION CHANNEL; CALCIUM INFLUX; HTRP3 CHANNELS; HEK-293 CELLS	Store-operated Ca2+ channels (SOCs) mediate receptor-stimulated Ca2+ influx. Accumulating evidence indicates that members of the transient receptor potential (TRP) channel family are components of SOCs in mammalian cells. Agonist stimulation activates SOCs and TRP channels directly and by inducing translocation of channels in intracellular vesicles to the plasma membrane (PM). The mechanism of TRP channel translocation in response to store depletion and agonist stimulation is not known. Here we use TRPC3 as a model to show that IP3 and the scaffold Homer 1 (H1) regulate the rate of translocation and retrieval of TRPC3 from the PM. In resting cells, TRPC3 exists in TRPC3-H1b/c-IP(3)Rs complexes that are located in part at the PM and in part in intracellular vesicles. Binding of IP3 to the IP(3)Rs dissociates the interaction between IP(3)Rs and H1 but not between H1 and TRPC3 to form IP(3)Rs-TRPC3-H1b/c. TIRFM and biotinylation assays show robust receptor- and store-dependent translocation of the TRPC3 to the PM and their retrieval upon termination of cell stimulation. The translocation requires depletion of stored Ca2+ and is prevented by inhibition of the IP(3)Rs. In HEK293, dissociating the H1b/c-IP3R complex with H1a results in TRPC3 translocation to the PM, where it is spontaneously active. The TRPC3-H1b/c-IP(3)Rs complex is reconstituted by infusing H1c into these cells. Reconstitution is inhibited by IP3. Deletion of H1 in mice markedly reduces the rates of translocation and retrieval of TRPC3. Conversely, infusion of H1c into H1(-/-) cells eliminates spontaneous channel activity and increases the rate of channel activation by agonist stimulation. The effects of H1c are inhibited by IP3. These findings together with our earlier studies demonstrating gating of TRPC3 by IP(3)Rs were used to develop a model in which assembly of the TRPC3-H1b/c-IP(3)Rs complexes by H1b/c mediates both the translocation of TRPC3-containing vesicles to the PM and gating of TRPC3 by IP(3)Rs.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA; Yonsei Univ, Coll Med, Dept Pharmacol, Inst Gastroenterol, Seoul 120752, South Korea; Yonsei Univ, Coll Med, Brain Korea 21 Project Med Sci, Seoul 120752, South Korea; Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; Univ Tokyo, Inst Med Sci, Dept Mol Neurobiol, Minato Ku, Tokyo 1088639, Japan	Johns Hopkins University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Tokyo	Worley, PF (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.	pworley@jhmi.edu; Shmuel.Muallem@UTSouthwestern.edu	Mikoshiba, Katsuhiko/N-7943-2015; Kim, Joo Young/X-7562-2019	Kim, Joo Young/0000-0003-2623-1491; Kiselyov, Kirill/0000-0001-6683-2895	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038938] Funding Source: NIH RePORTER; NIDCR NIH HHS [DE 12309] Funding Source: Medline; NIDDK NIH HHS [DK 38938] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bandyopadhyay BC, 2005, J BIOL CHEM, V280, P12908, DOI 10.1074/jbc.M410013200; BERRIDGE MJ, 1995, BIOCHEM J, V312, P1, DOI 10.1042/bj3120001; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Birnbaumer L, 2000, RECENT PROG HORM RES, V55, P127; Bosanac I, 2005, MOL CELL, V17, P193, DOI 10.1016/j.molcel.2004.11.047; Boulay G, 1999, P NATL ACAD SCI USA, V96, P14955, DOI 10.1073/pnas.96.26.14955; Cayouette S, 2004, J BIOL CHEM, V279, P7241, DOI 10.1074/jbc.M312042200; Delmas P, 2002, NEURON, V34, P209, DOI 10.1016/S0896-6273(02)00641-4; Fagni Laurent, 2002, Sci STKE, V2002, pre8, DOI 10.1126/stke.2002.137.re8; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Gudermann Thomas, 2004, Novartis Found Symp, V258, P103; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Hurst RS, 1998, FEBS LETT, V422, P333, DOI 10.1016/S0014-5793(98)00035-0; Kiselyov K, 1998, NATURE, V396, P478, DOI 10.1038/24890; Kiselyov K, 1999, MOL CELL, V4, P423, DOI 10.1016/S1097-2765(00)80344-5; Lee MG, 1997, J BIOL CHEM, V272, P15765, DOI 10.1074/jbc.272.25.15765; Li HS, 1999, NEURON, V24, P261, DOI 10.1016/S0896-6273(00)80838-7; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liu XB, 2005, J BIOL CHEM, V280, P21600, DOI 10.1074/jbc.c400492200; Liu XB, 2003, J BIOL CHEM, V278, P11337, DOI 10.1074/jbc.M213271200; MUALLEM S, 1986, J BIOL CHEM, V261, P2660; Nilius B, 2001, PHYSIOL REV, V81, P1415, DOI 10.1152/physrev.2001.81.4.1415; Obukhov AG, 2004, J CELL PHYSIOL, V201, P227, DOI 10.1002/jcp.20057; PANDOL SJ, 1987, J BIOL CHEM, V262, P16963; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Patterson RL, 1999, CELL, V98, P487, DOI 10.1016/S0092-8674(00)81977-7; Patterson RL, 2002, CELL, V111, P529, DOI 10.1016/S0092-8674(02)01045-0; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; RANDRIAMAMPITA C, 1993, NATURE, V364, P809, DOI 10.1038/364809a0; Roderick HL, 2003, CURR BIOL, V13, pR976, DOI 10.1016/j.cub.2003.11.048; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Singh BB, 2004, MOL CELL, V15, P635, DOI 10.1016/j.molcel.2004.07.010; Smani T, 2004, NAT CELL BIOL, V6, P113, DOI 10.1038/ncb1089; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Tang J, 2001, J BIOL CHEM, V276, P21303, DOI 10.1074/jbc.M102316200; Tiruppathi C, 2002, CIRC RES, V91, P70, DOI 10.1161/01.RES.0000023391.40106.A8; Trebak M, 2003, J BIOL CHEM, V278, P16244, DOI 10.1074/jbc.M300544200; Trebak M, 2002, J BIOL CHEM, V277, P21617, DOI 10.1074/jbc.M202549200; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; van Rossum DB, 2005, NATURE, V434, P99, DOI 10.1038/nature03340; Vazquez G, 2001, P NATL ACAD SCI USA, V98, P11777, DOI 10.1073/pnas.201238198; Venkatachalam K, 2001, J BIOL CHEM, V276, P33980, DOI 10.1074/jbc.C100321200; Wu XY, 2004, J BIOL CHEM, V279, P43392, DOI 10.1074/jbc.M408959200; Wu XY, 2000, AM J PHYSIOL-CELL PH, V278, pC526, DOI 10.1152/ajpcell.2000.278.3.C526; Wu XY, 2002, J BIOL CHEM, V277, P13597, DOI 10.1074/jbc.M110881200; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7; Yao Y, 1999, CELL, V98, P475, DOI 10.1016/S0092-8674(00)81976-5; Yildirim E, 2005, P NATL ACAD SCI USA, V102, P3307, DOI 10.1073/pnas.0409908102; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5; Zeng WZ, 1998, J BIOL CHEM, V273, P34687, DOI 10.1074/jbc.273.52.34687; Zeng WZ, 2003, CURR BIOL, V13, P872, DOI 10.1016/S0960-9822(03)00330-0; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zhang ZM, 2001, P NATL ACAD SCI USA, V98, P3168, DOI 10.1073/pnas.051632698	55	48	49	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32540	32549		10.1074/jbc.M602496200	http://dx.doi.org/10.1074/jbc.M602496200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16887806	hybrid			2022-12-27	WOS:000241414500052
J	Gong, XQ; Shao, Q; Lounsbury, CS; Bai, DL; Laird, DW				Gong, Xiang-Qun; Shao, Qing; Lounsbury, Crystal S.; Bai, Donglin; Laird, Dale W.			Functional characterization of a GJA1 frameshift mutation causing oculodentodigital dysplasia and palmoplantar keratoderma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENTO-DIGITAL DYSPLASIA; JUNCTIONAL INTERCELLULAR COMMUNICATION; NEONATAL MICE LACKING; CONNEXIN PHOSPHORYLATION; CONGENITAL CATARACT; MEMBRANE CHANNELS; TUMOR CELLS; CURLY HAIR; GAP; DISEASE	A frameshift mutation generated from a dinucleotide deletion (780-781del) in the GJA1 gene encoding Cx43 results in a frameshift yielding 46 aberrant amino acids after residue 259 and a shortened protein of 305 residues compared with the 382 in wild-type Cx43. This frameshift mutant (fs260) causes oculodentodigital dysplasia (ODDD) that includes the added condition of palmoplantar keratoderma. When expressed in a variety of cell lines, the fs260 mutant was typically localized to the endoplasmic reticulum and other intracellular compartments. The fs260 mutant, but not the G138R ODDD-linked Cx43 mutant or a Cx43 mutant truncated at residue 259 (T259), reduced the number of apparent gap junction plaques formed from endogenous Cx43 in normal rat kidney cells or keratinocytes. Interestingly, mutation of a putative FF endoplasmic reticulum retention motif encoded within the 46 aberrant amino acid domain failed to restore efficient assembly of the fs260 mutant into gap junctions. Dual whole cell patch-clamp recording revealed that fs260-expressing N2A cells exerted severely reduced electrical coupling in comparison to wild-type Cx43 or the T259 mutant, whereas single patch capacitance recordings showed that fs260 could also dominantly inhibit the function of wild-type Cx43. Co-expression studies further revealed that the dominant negative effect of fs260 on wild-type Cx43 was dose-dependent, and at a predicted 1:1 expression ratio the fs260 mutant reduced wild-type Cx43-mediated gap junctional conductance by over 60%. These results suggest that the 46 aberrant amino acid residues associated with the frameshift mutant are, at least in part, responsible for the manifestation of palmoplantar keratoderma symptoms.	Univ Western Ontario, Dept Anat & Cell Biol, London, ON N6A 5C1, Canada; Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Laird, DW (corresponding author), Univ Western Ontario, Dept Anat & Cell Biol, Dent Sci Bldg,Rm 00077, London, ON N6A 5C1, Canada.	dale.laird@schulich.uwo.ca	Laird, Dale w/E-4176-2015; Laird, Dale W/AAL-2407-2020; Bai, Donglin/A-5799-2008; Bai, Donglin/ABB-9924-2021	Laird, Dale W/0000-0002-4568-3285; Bai, Donglin/0000-0003-1112-6947; Bai, Donglin/0000-0003-1112-6947				Debeer P, 2005, EUR J MED GENET, V48, P377, DOI 10.1016/j.ejmg.2005.05.003; deRoos ADG, 1996, PFLUG ARCH EUR J PHY, V431, P556, DOI 10.1007/s004240050035; Duffy HS, 2002, J PHYSIOL-PARIS, V96, P243, DOI 10.1016/S0928-4257(02)00012-8; Duffy HS, 2002, J BIOL CHEM, V277, P36706, DOI 10.1074/jbc.M207016200; Falk MM, 1997, EMBO J, V16, P2703, DOI 10.1093/emboj/16.10.2703; Flenniken AM, 2005, DEVELOPMENT, V132, P4375, DOI 10.1242/dev.02011; Frasson Maria, 2004, Ophthalmic Genet, V25, P227, DOI 10.1080/13816810490513424; Harks EGA, 2001, J PHARMACOL EXP THER, V298, P1033; Herve JC, 2004, BBA-BIOMEMBRANES, V1662, P22, DOI 10.1016/j.bbamem.2003.10.022; Kelly SC, 2006, EUR J DERMATOL, V16, P241; Kelsell DP, 2001, AM J HUM GENET, V68, P559, DOI 10.1086/318803; Kim DY, 1999, J BIOL CHEM, V274, P5581, DOI 10.1074/jbc.274.9.5581; Kjaer AW, 2004, AM J MED GENET A, V127A, P152, DOI 10.1002/ajmg.a.20614; Kretz M, 2004, EUR J CELL BIOL, V83, P647, DOI 10.1078/0171-9335-00422; Kumar NM, 1999, NOVART FDN SYMP, V219, P6; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; Laird DW, 2005, BBA-BIOMEMBRANES, V1711, P172, DOI 10.1016/j.bbamem.2004.09.009; LAIRD DW, 1990, J CELL SCI, V97, P109; LAIRD DW, 1995, J CELL BIOL, V131, P1193, DOI 10.1083/jcb.131.5.1193; Lampe PD, 2000, J CELL BIOL, V149, P1503, DOI 10.1083/jcb.149.7.1503; Lampe PD, 2004, INT J BIOCHEM CELL B, V36, P1171, DOI 10.1016/S1357-2725(03)00264-4; Lan Z, 2005, BIOCHEMISTRY-US, V44, P2385, DOI 10.1021/bi048306w; Maass K, 2004, MOL BIOL CELL, V15, P4597, DOI 10.1091/mbc.E04-04-0324; Mackay D, 1999, AM J HUM GENET, V64, P1357, DOI 10.1086/302383; Maher AC, 2005, CELL COMMUN ADHES, V12, P219, DOI 10.1080/15419060500511818; McLachlan E, 2005, CELL COMMUN ADHES, V12, P279, DOI 10.1080/15419060500514143; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Minogue PJ, 2005, J BIOL CHEM, V280, P40788, DOI 10.1074/jbc.M504765200; Moreno AP, 2005, BBA-BIOMEMBRANES, V1711, P164, DOI 10.1016/j.bbamem.2005.02.016; Moreno AP, 2002, CIRC RES, V90, P450, DOI 10.1161/hh0402.105667; Morley GE, 1996, BIOPHYS J, V70, P1294, DOI 10.1016/S0006-3495(96)79686-8; Pal JD, 2000, AM J PHYSIOL-CELL PH, V279, pC596, DOI 10.1152/ajpcell.2000.279.3.C596; Paznekas WA, 2003, AM J HUM GENET, V72, P408, DOI 10.1086/346090; Pizzuti Antonio, 2004, Hum Mutat, V23, P286, DOI 10.1002/humu.9220; Qin H, 2002, J BIOL CHEM, V277, P29132, DOI 10.1074/jbc.M200797200; REAUME AG, 1995, SCIENCE, V267, P1831, DOI 10.1126/science.7892609; Richard G, 2003, CLIN EXP DERMATOL, V28, P397, DOI 10.1046/j.1365-2230.2003.01312.x; Richardson RR, 2004, J MED GENET, V41, P60, DOI 10.1136/jmg.2003.012005; Roscoe W, 2005, J BIOL CHEM, V280, P11458, DOI 10.1074/jbc.M409564200; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Seki A, 2004, HEART RHYTHM, V1, P227, DOI 10.1016/j.hrthm.2004.03.066; Shibayama J, 2005, CIRC RES, V96, pE83, DOI 10.1161/01.RES.0000168369.79972.d2; Solan JL, 2005, BBA-BIOMEMBRANES, V1711, P154, DOI 10.1016/j.bbamem.2004.09.013; Thomas T, 2004, J BIOL CHEM, V279, P19157, DOI 10.1074/jbc.M314117200; Unger VM, 1999, SCIENCE, V283, P1176, DOI 10.1126/science.283.5405.1176; van Steensel MAM, 2005, AM J MED GENET A, V132A, P171, DOI 10.1002/ajmg.a.30412; VanSlyke JK, 2002, J CELL BIOL, V157, P381, DOI 10.1083/jcb.200111045; Vasconcellos JPC, 2005, ARCH OPHTHALMOL-CHIC, V123, P1422, DOI 10.1001/archopht.123.10.1422; Vitiello C, 2005, AM J MED GENET A, V133A, P58, DOI 10.1002/ajmg.a.30554; Wei CJ, 2004, ANNU REV CELL DEV BI, V20, P811, DOI 10.1146/annurev.cellbio.19.111301.144309; Willecke K, 2002, BIOL CHEM, V383, P725, DOI 10.1515/BC.2002.076	51	53	57	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31801	31811		10.1074/jbc.M605961200	http://dx.doi.org/10.1074/jbc.M605961200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16891658	Bronze			2022-12-27	WOS:000241235300067
J	Ichihara-Tanaka, K; Oohira, A; Rumsby, M; Muramatsu, T				Ichihara-Tanaka, Keiko; Oohira, Atsuhiko; Rumsby, Martin; Muramatsu, Takashi			Neuroglycan C is a novel midkine receptor involved in process elongation of oligodendroglial precursor-like cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROITIN SULFATE PROTEOGLYCAN; BINDING GROWTH-FACTOR; ACTIVATED PROTEIN-KINASE; PART-TIME PROTEOGLYCAN; DIFFERENTIATION FACTOR; PLEIOTROPHIN; BRAIN; EXPRESSION; SURVIVAL; CG-4	Midkine is a heparin-binding growth factor that promotes cell attachment and process extension in undifferentiated bipolar CG-4 cells, an oligodendroglial precursor cell line. We found that CG-4 cells expressed a non-proteoglycan form of neuroglycan C, known as a part-time transmembrane proteoglycan. We demonstrated that neuroglycan C before or after chondroitinase ABC treatment bound to a midkine affinity column. Neuroglycan C lacking chondroitin sulfate chains was eluted with 0.5 M NaCl as a major fraction from the column. We confirmed that CG-4 cells expressed two isoforms of neuroglycan C, I, and III, by isolating cDNA. Among three functional domains of the extracellular part of neuroglycan C, the chondroitin sulfate attachment domain and acidic amino acid cluster box domain showed affinity for midkine, but the epidermal growth factor domain did not. Furthermore, cell surface neuroglycan C could be cross-linked with soluble midkine. Process extension on midkine-coated dishes was inhibited by either a monoclonal antineuroglycan C antibody C1 or a glutathione S-transferase-neuroglycan C fusion protein. Finally, stable transfectants of B104 neuroblastoma cells overexpressing neuroglycan C-I or neuroglycan C-III attached to the midkine substrate, spread well, and gave rise to cytoskeletal changes. Based on these results, we conclude that neuroglycan C is a novel component of midkine receptors involved in process elongation.	Aichi Gakuin Univ, Dept Hlth Sci, Fac Psychol & Phys Sci, Aichi 4700198, Japan; Nagoya Univ, Grad Sch Med, Dept Biochem, Showa Ku, Nagoya, Aichi 4668550, Japan; Aichi Human Serv Ctr, Dept Perinatol, Inst Dev Res, Kasugai, Aichi 4800392, Japan; Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England	Aichi Gakuin University; Nagoya University; University of York - UK	Muramatsu, T (corresponding author), Aichi Gakuin Univ, Dept Hlth Sci, Fac Psychol & Phys Sci, 12 Araike Cho, Aichi 4700198, Japan.	tmurama@dpc.aichi-gakuin.ac.jp	Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763				Akhter S, 1998, J BIOCHEM-TOKYO, V123, P1127; Aono S, 2006, J NEUROSCI RES, V83, P110, DOI 10.1002/jnr.20698; Aono S, 2000, J BIOL CHEM, V275, P337, DOI 10.1074/jbc.275.1.337; Aono S, 2004, J BIOL CHEM, V279, P46536, DOI 10.1074/jbc.M403263200; Horiba M, 2000, J CLIN INVEST, V105, P489, DOI 10.1172/JCI7208; ICHIHARATANAKA K, 1990, J BIOL CHEM, V265, P401; Inoh K, 2004, BIOCHEM BIOPH RES CO, V317, P108, DOI 10.1016/j.bbrc.2004.03.015; Juttner R, 2005, NEURON, V46, P233, DOI 10.1016/j.neuron.2005.02.027; Kadomatsu KJ, 2004, CANCER LETT, V204, P127, DOI 10.1016/S0304-3835(03)00450-6; Kaneda N, 1996, J BIOCHEM-TOKYO, V119, P1150; Kawai H, 2004, AM J PATHOL, V165, P1603, DOI 10.1016/S0002-9440(10)63417-7; Kinugasa Y, 2004, BIOCHEM BIOPH RES CO, V321, P1045, DOI 10.1016/j.bbrc.2004.07.066; Kojima S, 1997, J BIOL CHEM, V272, P9410; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI YS, 1990, SCIENCE, V250, P1690, DOI 10.1126/science.2270483; LOUIS JC, 1992, J NEUROSCI RES, V31, P193, DOI 10.1002/jnr.490310125; Maeda N, 1999, J BIOL CHEM, V274, P12474, DOI 10.1074/jbc.274.18.12474; Maruyama K, 2004, ARTHRITIS RHEUM-US, V50, P1420, DOI 10.1002/art.20175; MATSUMOTO K, 1994, NEUROSCI LETT, V178, P216, DOI 10.1016/0304-3940(94)90762-5; Muramatsu H, 2004, J CELL SCI, V117, P5405, DOI 10.1242/jcs.01423; MURAMATSU H, 1993, DEV BIOL, V159, P392, DOI 10.1006/dbio.1993.1250; Muramatsu H, 2000, BIOCHEM BIOPH RES CO, V270, P936, DOI 10.1006/bbrc.2000.2549; Muramatsu T, 2002, J BIOCHEM, V132, P359, DOI 10.1093/oxfordjournals.jbchem.a003231; Oohira A, 2004, GLYCOCONJUGATE J, V21, P53, DOI 10.1023/B:GLYC.0000043748.90896.83; Owada K, 1999, J NEUROCHEM, V73, P2084; Qi MS, 2001, J BIOL CHEM, V276, P15868, DOI 10.1074/jbc.M005911200; RAUVALA H, 1989, EMBO J, V8, P2933, DOI 10.1002/j.1460-2075.1989.tb08443.x; Rumsby M, 2001, NEUROSCI RES COMMUN, V28, P31, DOI 10.1002/1520-6769(200101/02)28:1<31::AID-NRC4>3.0.CO;2-F; Rumsby M, 1999, GLIA, V26, P361, DOI 10.1002/(SICI)1098-1136(199906)26:4<361::AID-GLIA10>3.0.CO;2-Q; Sakaguchi N, 2003, NEUROSCI RES, V45, P219, DOI 10.1016/S0168-0102(02)00226-2; Sato W, 2001, J IMMUNOL, V167, P3463, DOI 10.4049/jimmunol.167.6.3463; Shuo T, 2003, GLYCOCONJUGATE J, V20, P267, DOI 10.1023/B:GLYC.0000025821.22618.33; Stoica GE, 2001, J BIOL CHEM, V276, P16772, DOI 10.1074/jbc.M010660200; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Trinczek B, 2004, J BIOL CHEM, V279, P5915, DOI 10.1074/jbc.M304528200; Ueoka C, 2000, J BIOL CHEM, V275, P37407, DOI 10.1074/jbc.M002538200; WATANABE E, 1995, J BIOL CHEM, V270, P26876, DOI 10.1074/jbc.270.45.26876; Yamauchi S, 2002, J BIOL CHEM, V277, P20583, DOI 10.1074/jbc.M200909200; Yasuda Y, 1998, NEUROSCI RES, V32, P313, DOI 10.1016/S0168-0102(98)00098-4; Zou P, 2003, GLYCOBIOLOGY, V13, P35, DOI 10.1093/glycob/cwg001	40	33	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30857	30864		10.1074/jbc.M602228200	http://dx.doi.org/10.1074/jbc.M602228200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16901907	hybrid			2022-12-27	WOS:000241075900061
J	Kihara, M; Chatani, E; Iwata, K; Yamamoto, K; Matsuura, T; Nakagawa, A; Naiki, H; Goto, Y				Kihara, Miho; Chatani, Eri; Iwata, Kentaro; Yamamoto, Kaori; Matsuura, Takanori; Nakagawa, Atsushi; Naiki, Hironobu; Goto, Yuji			Conformation of amyloid fibrils of beta(2)-microglobulin probed by tryptophan mutagenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BETA-2-MICROGLOBULIN REVEALS; PROTEIN; MATURATION; EXTENSION; PROGRAM; SULFATE; MODEL; CHAIN	beta(2)-Microglobulin (beta 2-m), a protein responsible for dialysis-related amyloidosis, adopts an immunoglobulin domain fold in its native state. Although beta 2-m has Trp residues at positions 60 and 95, both are located near the surface of the domain. Hence, beta 2-m does not have a conserved Trp common to other immunoglobulin domains, which is buried in close proximity to the disulfide bond. To study the structure of amyloid fibrils in relation to their native fold, we prepared a series of Trp mutants. Trp(60) and Trp(95) were both replaced with Phe, and a single Trp was introduced at various positions. Among various mutants, W39-beta 2-m, in which a Trp was introduced at the position corresponding to the conserved Trp, exhibited a remarkable quenching of fluorescence in the native state, as observed for other immunoglobulin domains. An x-ray structural analysis revealed that W39-beta 2-m assumes the native fold with Trp39 located in the vicinity of the disulfide bond. Comparison of the fluorescence spectra of various mutants for the native and fibrillar forms indicated that, while the Trp residues introduced in the middle of the beta 2-m sequence tend to be buried in the fibrils, those located in the C-terminal region are more exposed. In addition, the fluorescence spectra of fibrils prepared at pH 2.5 and 7.0 revealed a large difference in the fluorescence intensity for W60-beta 2-m, implying a major structural difference between them.	Osaka Univ, Inst Prot Res, Suita, Osaka 565, Japan; Japan Sci & Technol Agcy, CREST, Suita, Osaka 5650871, Japan; Univ Fukui, Fac Med Sci, Dept Pathol Sci, Matsuoka, Fukui 9101193, Japan; Japan Sci & Technol Agcy, CREST, Matsuoka, Fukui 9101193, Japan	Osaka University; Japan Science & Technology Agency (JST); University of Fukui; Japan Science & Technology Agency (JST)	Goto, Y (corresponding author), Osaka Univ, Inst Prot Res, Suita, Osaka 565, Japan.	ygoto@protein.osaka-u.ac.jp	Naiki, Hironobu/G-5599-2014; Nakagawa, Atsushi/D-4329-2009; Nakagawa, Atsushi/M-5731-2019; Matsuura, Takanori/J-1413-2012	Nakagawa, Atsushi/0000-0002-1700-7861; Nakagawa, Atsushi/0000-0002-1700-7861; Matsuura, Takanori/0000-0003-2001-9537				AMZEL LM, 1979, ANNU REV BIOCHEM, V48, P961, DOI 10.1146/annurev.bi.48.070179.004525; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ban T, 2004, J MOL BIOL, V344, P757, DOI 10.1016/j.jmb.2004.09.078; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Chatani E, 2005, J MOL BIOL, V352, P941, DOI 10.1016/j.jmb.2005.07.043; Chiba T, 2003, J BIOL CHEM, V278, P47016, DOI 10.1074/jbc.M304473200; Chiti F, 2001, J MOL BIOL, V307, P379, DOI 10.1006/jmbi.2000.4478; Corazza A, 2004, J BIOL CHEM, V279, P9176, DOI 10.1074/jbc.M310779200; COWGILL RW, 1970, BIOCHIM BIOPHYS ACTA, V207, P556; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dzwolak W, 2004, PROTEIN SCI, V13, P1927, DOI 10.1110/ps.03607204; Esposito G, 2000, PROTEIN SCI, V9, P831, DOI 10.1110/ps.9.5.831; Floege J, 2001, KIDNEY INT, V59, pS164, DOI 10.1046/j.1523-1755.2001.59780164.x; GEJYO F, 1985, BIOCHEM BIOPH RES CO, V129, P701, DOI 10.1016/0006-291X(85)91948-5; GOTO Y, 1988, BIOCHEMISTRY-US, V27, P1670, DOI 10.1021/bi00405a043; Hoshino M, 2002, NAT STRUCT BIOL, V9, P332, DOI 10.1038/nsb792; Ivanova MI, 2004, P NATL ACAD SCI USA, V101, P10584, DOI 10.1073/pnas.0403756101; Jones EM, 2005, CELL, V121, P63, DOI 10.1016/j.cell.2005.01.034; Jones S, 2003, J MOL BIOL, V330, P935, DOI 10.1016/S0022-2836(03)00688-0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kad NM, 2003, J MOL BIOL, V330, P785, DOI 10.1016/S0022-2836(03)00583-7; Katou H, 2002, PROTEIN SCI, V11, P2218, DOI 10.1110/ps.0213202; Kihara M, 2005, J BIOL CHEM, V280, P12012, DOI 10.1074/jbc.M411949200; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kozhukh GV, 2002, J BIOL CHEM, V277, P1310, DOI 10.1074/jbc.M108753200; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Leslie AGW, 1999, ACTA CRYSTALLOGR D, V55, P1696, DOI 10.1107/S090744499900846X; McParland VJ, 2002, NAT STRUCT BIOL, V9, P326, DOI 10.1038/nsb791; MCPHERSON A, 1992, J CRYST GROWTH, V122, P161, DOI 10.1016/0022-0248(92)90239-F; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Naiki H, 1997, AMYLOID, V4, P223, DOI 10.3109/13506129709003833; Narimoto T, 2004, FEBS LETT, V576, P313, DOI 10.1016/j.febslet.2004.09.024; Ohhashi Y, 2005, J BIOL CHEM, V280, P32843, DOI 10.1074/jbc.M506501200; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; Tanaka M, 2005, CELL, V121, P49, DOI 10.1016/j.cell.2005.03.008; Trinh CH, 2002, P NATL ACAD SCI USA, V99, P9771, DOI 10.1073/pnas.152337399; TSUNENAGA M, 1987, BIOCHEMISTRY-US, V26, P6044, DOI 10.1021/bi00393a015; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Verdone G, 2002, PROTEIN SCI, V11, P487, DOI 10.1110/ps.29002; Yamaguchi K, 2005, J MOL BIOL, V352, P952, DOI 10.1016/j.jmb.2005.07.061; Yamamoto S, 2004, BIOCHEMISTRY-US, V43, P11075, DOI 10.1021/bi049262u	43	41	42	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					31061	31069		10.1074/jbc.M605358200	http://dx.doi.org/10.1074/jbc.M605358200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16901902	hybrid			2022-12-27	WOS:000241075900082
J	Lopez, D; Calero, O; Jimenez, M; Garcia-Calvo, M; Del Val, M				Lopez, Daniel; Calero, Olga; Jimenez, Mercedes; Garcia-Calvo, Margarita; Del Val, Margarita			Antigen processing of a short viral antigen by proteasomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDES; SITES; 20S	Mass spectrometry (MS)-based methods coupled to reverse phase chromatography separation are a useful technology to analyze complex peptide pools that are comprised of different peptides with unrelated sequences. In antigen presentation, proteasomes generate a set of short peptides that are closely related and overlapping and in some instances may even have identical retention times and identical masses. In these situations, micro-liquid chromatography-MS/MS focused on each theoretical parent ion followed by manual interpretation optimizes the identification of generated peptides. The results suggest that the degradation of short antigens by the proteasome occurs by sequential cleavage.	Inst Salud Carlos III, Unidad Proteom, Madrid 28220, Spain; Inst Salud Carlos III, Unidad Inmunol Viral, Ctr Nacl Microbiol, Madrid 28220, Spain; Merck Res Labs, Dept Enzymol, Rahway, NJ 07065 USA	Instituto de Salud Carlos III; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Merck & Company	Lopez, D (corresponding author), Inst Salud Carlos III, Unidad Proteom, Madrid 28220, Spain.	dlopez@isciii.es	López, Daniel/I-2632-2014; Del Val, Margarita/E-4769-2010	López, Daniel/0000-0003-0268-5878; Del Val, Margarita/0000-0001-6769-4279				Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; DELVAL M, 1988, J VIROL, V62, P3965, DOI 10.1128/JVI.62.11.3965-3972.1988; EGGERS M, 1995, J EXP MED, V182, P1865, DOI 10.1084/jem.182.6.1865; Kisselev AF, 2002, J BIOL CHEM, V277, P22260, DOI 10.1074/jbc.M112360200; Kisselev AF, 2003, J BIOL CHEM, V278, P35869, DOI 10.1074/jbc.M303725200; Kisselev AF, 1999, J BIOL CHEM, V274, P3363, DOI 10.1074/jbc.274.6.3363; Kloetzel PM, 2004, BBA-MOL CELL RES, V1695, P225, DOI 10.1016/j.bbamcr.2004.10.004; Lopez D, 1997, J IMMUNOL, V159, P5769; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; Purcell AW, 2004, MOL CELL PROTEOMICS, V3, P193, DOI 10.1074/mcp.R300013-MCP200; Saveanu L, 2002, MOL IMMUNOL, V39, P203, DOI 10.1016/S0161-5890(02)00102-5; Skribanek Z, 2002, J PEPT SCI, V8, P398, DOI 10.1002/psc.395; York IA, 1999, IMMUNOL REV, V172, P49, DOI 10.1111/j.1600-065X.1999.tb01355.x	13	8	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30315	30318		10.1074/jbc.M605973200	http://dx.doi.org/10.1074/jbc.M605973200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16861221	Green Published, hybrid			2022-12-27	WOS:000241075900004
J	Saura, M; Zaragoza, C; Bao, C; Herranz, B; Rodriguez-Puyol, M; Lowenstein, CJ				Saura, Marta; Zaragoza, Carlos; Bao, Clare; Herranz, Beatriz; Rodriguez-Puyol, M.; Lowenstein, Charles J.			Stat3 mediates interelukin-6 inhibition of human endothelial nitric-oxide synthase expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; CHROMOSOMAL LOCALIZATION; MOLECULAR-CLONING; MESSENGER-RNA; GROWTH-FACTOR; GENE; INFLAMMATION; RISK; TRANSCRIPTION	Chronic activation of the acute phase response (APR) is associated with atherosclerosis. Elevated levels of interleukin-6, the major inducer of the APR, are associated with an increased risk of cardiovascular events. One of the clinical hallmarks of atherogenesis is endothelial dysfunction, characterized by a decrease in endothelial production of nitric oxide ( NO). We hypothesized that interleukin-6 (IL-6) decreases endothelial NO synthase ( eNOS) expression. We now show that IL-6 treatment of human aortic endothelial cells ( HAEC) decreases steady-state levels of human eNOS mRNA and protein. This decrease in eNOS expression is caused in part by IL-6 inhibition of transactivation of the human eNOS promoter. To explore the mechanism by which IL-6 affects eNOS expression, we examined activation of signal transducer and transactivator-3 (Stat3). The IL-6 receptor (IL-6R) is expressed in HAEC, and Stat3 is phosphorylated in response to IL-6 stimulation of the IL-6R. We identified four consensus sequences for Stat3 binding (SIE) in the eNOS promoter at positions -1520, -1024, -840, and -540. Transfection of eNOS promoter mutants revealed that the SIE at -1024 mediates Stat3 inhibition of eNOS promoter activity. Gel-shift analysis of nuclear extracts from HAEC treated with IL-6 confirms that Stat3 binds to a complex containing the SIE at -1024. RNA silencing of STAT3 blocks the inhibitory effect of IL-6 on eNOS expression. Our data show that IL-6 has direct effects upon endothelial cells, inhibiting eNOS expression in part through Stat3. Decreased levels of eNOS may be an important component of the pro-atherogenic effect of the APR.	Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Univ Alcala de Henares, Dept Physiol, Madrid 28871, Spain; CNIC, Madrid 28760, Spain	Johns Hopkins University; Universidad de Alcala; Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Lowenstein, CJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, 950 Ross Bldg,720 Rutland Ave, Baltimore, MD 21205 USA.	clowenst@jhmi.edu	Puyol, Manuel Rodriguez/AAG-7049-2020; Zaragoza Sanchez, Carlos/G-8718-2011; Zaragoza, Carlos/AAH-9275-2019	Puyol, Manuel Rodriguez/0000-0002-5230-6664; Lowenstein, Charles/0000-0003-0485-7514; Zaragoza, Carlos/0000-0002-1706-8592; Herranz Sanchez, Beatriz/0000-0002-7847-7058	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL065608, P01HL056091, R01HL074061, R01HL063706] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; Alonso J, 1997, MOL CELL BIOL, V17, P5719, DOI 10.1128/MCB.17.10.5719; Arnet UA, 1996, J BIOL CHEM, V271, P15069, DOI 10.1074/jbc.271.25.15069; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Caldenhoven E, 1996, J BIOL CHEM, V271, P13221, DOI 10.1074/jbc.271.22.13221; Desiderio S, 2003, ANN NY ACAD SCI, V987, P280, DOI 10.1111/j.1749-6632.2003.tb06062.x; Dudzinski DM, 2006, ANNU REV PHARMACOL, V46, P235, DOI 10.1146/annurev.pharmtox.44.101802.121844; Fleming I, 1999, CARDIOVASC RES, V43, P532, DOI 10.1016/S0008-6363(99)00094-2; Fulton D, 2001, J PHARMACOL EXP THER, V299, P818; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Ihle JN, 1998, ANN NY ACAD SCI, V865, P1, DOI 10.1111/j.1749-6632.1998.tb11157.x; Karantzoulis-Fegaras F, 1999, J BIOL CHEM, V274, P3076, DOI 10.1074/jbc.274.5.3076; Koenig W, 1999, CIRCULATION, V99, P237, DOI 10.1161/01.CIR.99.2.237; Libby P, 2001, CIRCULATION, V104, P365, DOI 10.1161/01.CIR.104.3.365; LOSCALZO J, 1995, PROG CARDIOVASC DIS, V38, P87, DOI 10.1016/S0033-0620(05)80001-5; MARSDEN PA, 1992, FEBS LETT, V307, P287, DOI 10.1016/0014-5793(92)80697-F; MARSDEN PA, 1993, J BIOL CHEM, V268, P17478; Michel T, 1997, J CLIN INVEST, V100, P2146, DOI 10.1172/JCI119750; Navarro-Antolin J, 2000, J BIOL CHEM, V275, P3075, DOI 10.1074/jbc.275.5.3075; Paffen E, 2006, CARDIOVASC RES, V71, P30, DOI 10.1016/j.cardiores.2006.03.004; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Rader DJ, 2000, NEW ENGL J MED, V343, P1179, DOI 10.1056/NEJM200010193431609; Ridker PM, 2001, NEW ENGL J MED, V344, P1959, DOI 10.1056/NEJM200106283442601; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; ROBINSON LJ, 1994, GENOMICS, V19, P350, DOI 10.1006/geno.1994.1068; ROSENKRANZWEISS P, 1994, J CLIN INVEST, V93, P2236, DOI 10.1172/JCI117221; Saura M, 2002, CIRC RES, V91, P806, DOI 10.1161/01.RES.0000040397.23817.E5; Schaefer TS, 1997, MOL CELL BIOL, V17, P5307, DOI 10.1128/MCB.17.9.5307; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; SEARLES CD, 2006, IN PRESS AM J PHYSL; Stuehr DJ, 1999, BBA-BIOENERGETICS, V1411, P217, DOI 10.1016/S0005-2728(99)00016-X; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Tai SC, 2004, ARTERIOSCL THROM VAS, V24, P405, DOI 10.1161/01.ATV.0000109171.50229.33; Tracy RP, 1997, ARTERIOSCL THROM VAS, V17, P1121, DOI 10.1161/01.ATV.17.6.1121; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; Venugopal SK, 2002, CIRCULATION, V106, P1439, DOI 10.1161/01.CIR.0000033116.22237.F9; Verma S, 2005, NAT CLIN PRACT CARD, V2, P29, DOI 10.1038/ncpcardio0074; Verma S, 2002, CIRCULATION, V106, P913, DOI 10.1161/01.CIR.0000029802.88087.5E; Walford G, 2003, J THROMB HAEMOST, V1, P2112, DOI 10.1046/j.1538-7836.2003.00345.x; Yoo JY, 2002, CELL, V108, P331, DOI 10.1016/S0092-8674(02)00636-0; YOSHIZUMI M, 1993, CIRC RES, V73, P205, DOI 10.1161/01.RES.73.1.205; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	43	63	64	1	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					30057	30062		10.1074/jbc.M606279200	http://dx.doi.org/10.1074/jbc.M606279200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16887796	hybrid			2022-12-27	WOS:000240896300066
J	Veereshwarayya, V; Kumar, P; Rosen, KM; Mestril, R; Querfurth, HW				Veereshwarayya, Vimal; Kumar, Pravir; Rosen, Kenneth M.; Mestril, Ruben; Querfurth, Henry W.			Differential effects of mitochondrial heat shock protein 60 and related molecular chaperones to prevent intracellular beta-amyloid-induced inhibition of complex IV and limit apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; ALZHEIMERS-DISEASE; CELL-DEATH; A-BETA; CYTOCHROME-OXIDASE; DROSOPHILA; BRAIN; SUPPRESSION; EXPRESSION; NEURONS	Defects in mitochondrial oxidative metabolism, in particular decreased activity of cytochrome c oxidase, have been reported in Alzheimer disease tissue and in cultured cells that overexpress amyloid precursor protein. Mitochondrial dysfunction contributes to neurodegeneration in Alzheimer disease partly through formation of reactive oxygen species and the release of sequestered molecules that initiate programmed cell death pathways. The heat shock proteins (HSP) are cytoprotective against a number of stressors, including accumulations of mis-folded proteins and reactive oxygen species. We reported on the property of Hsp70 to protect cultured neurons from cell death caused by intraneuronal beta-amyloid. Here we demonstrate that Hsp60, Hsp70, and Hsp90 both alone and in combination provide differential protection against intracellular beta-amyloid stress through the maintenance of mitochondrial oxidative phosphorylation and functionality of tricarboxylic acid cycle enzymes. Notably, beta-amyloid was found to selectively inhibit complex IV activity, an effect selectively neutralized by Hsp60. The combined effect of HSPs was to reduce the free radical burden, preserve ATP generation, decrease cytochrome c release, and prevent caspase-9 activation, all important mediators of beta-amyloid-induced neuronal dysfunction and death.	Tufts Univ, Sch Med, Caritas St Elizabeths Med Ctr, Dept Neurol, Brighton, MA 02135 USA; Loyola Univ, Med Ctr, Cardiovasc Inst, Maywood, IL 60153 USA	St. Elizabeth's Medical Center; Tufts University; Loyola University Chicago	Querfurth, HW (corresponding author), Tufts Univ, Sch Med, Caritas St Elizabeths Med Ctr, Dept Neurol, 736 Cambridge St, Brighton, MA 02135 USA.	henry.querfurth@tufts.edu	Kumar, Pravir/AAR-1207-2020; Kumar, Pravir/B-2164-2015	Kumar, Pravir/0000-0001-7444-2344; Mestril, Ruben/0000-0003-3631-2236	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041373] Funding Source: NIH RePORTER; NINDS NIH HHS [NS41373] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AMIN J, 1988, MOL CELL BIOL, V8, P3761, DOI 10.1128/MCB.8.9.3761; Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; BALER R, 1993, MOL CELL BIOL, V13, P2486, DOI 10.1128/MCB.13.4.2486; Bonini NM, 2002, P NATL ACAD SCI USA, V99, P16407, DOI 10.1073/pnas.152330499; BUTTERWORTH RF, 1990, METAB BRAIN DIS, V5, P179, DOI 10.1007/BF00997071; Casley CS, 2002, J NEUROCHEM, V80, P91, DOI 10.1046/j.0022-3042.2001.00681.x; Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje; Chan HYE, 2000, HUM MOL GENET, V9, P2811, DOI 10.1093/hmg/9.19.2811; Cook DG, 1997, NAT MED, V3, P1021, DOI 10.1038/nm0997-1021; Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511; Dou F, 2003, P NATL ACAD SCI USA, V100, P721, DOI 10.1073/pnas.242720499; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Glabe CC, 2005, SUB CELL BIOCHEM, V38, P167; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hongpaisan J, 2004, J NEUROSCI, V24, P10878, DOI 10.1523/JNEUROSCI.3278-04.2004; HOSOKAWA N, 1990, CELL STRUCT FUNCT, V15, P393, DOI 10.1247/csf.15.393; Hu YM, 1999, EMBO J, V18, P3586, DOI 10.1093/emboj/18.13.3586; Ibanez V, 1998, NEUROLOGY, V50, P1585, DOI 10.1212/WNL.50.6.1585; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Kazemi-Esfarjani P, 2000, SCIENCE, V287, P1837, DOI 10.1126/science.287.5459.1837; Kieran D, 2004, NAT MED, V10, P402, DOI 10.1038/nm1021; KISH SJ, 1992, J NEUROCHEM, V59, P776, DOI 10.1111/j.1471-4159.1992.tb09439.x; LeBlanc Andrea C., 2005, Current Alzheimer Research, V2, P389, DOI 10.2174/156720505774330573; Lin KM, 2001, CIRCULATION, V103, P1787, DOI 10.1161/01.CIR.103.13.1787; Magrane J, 2004, J NEUROSCI, V24, P1700, DOI 10.1523/JNEUROSCI.4330-03.2004; Manfredi G, 2001, METHOD CELL BIOL, V65, P133, DOI 10.1016/S0091-679X(01)65008-8; Mark RJ, 1997, J NEUROCHEM, V68, P255; Mastrogiacomo F, 1996, ANN NEUROL, V39, P592, DOI 10.1002/ana.410390508; Mattson MP, 1998, INT REV NEUROBIOL, V42, P103, DOI 10.1016/S0074-7742(08)60609-1; MUTISYA EM, 1994, J NEUROCHEM, V63, P2179; Nollen EAA, 1999, MOL CELL BIOL, V19, P2069; Parcellier A, 2003, BIOCHEM BIOPH RES CO, V304, P505, DOI 10.1016/S0006-291X(03)00623-5; PARKER WD, 1994, NEUROLOGY, V44, P1090, DOI 10.1212/WNL.44.6.1090; PELHAM HRB, 1982, CELL, V30, P517, DOI 10.1016/0092-8674(82)90249-5; Pereira C, 1999, NEUROBIOL DIS, V6, P209, DOI 10.1006/nbdi.1999.0241; PERISIC O, 1989, CELL, V59, P797, DOI 10.1016/0092-8674(89)90603-X; Perkins G, 1997, J STRUCT BIOL, V119, P260, DOI 10.1006/jsbi.1997.3885; Polla BS, 1996, P NATL ACAD SCI USA, V93, P6458, DOI 10.1073/pnas.93.13.6458; RABINDRAN SK, 1993, SCIENCE, V259, P230, DOI 10.1126/science.8421783; Rong Y, 2000, ANTICANCER RES, V20, P4339; Sakahira H, 2002, P NATL ACAD SCI USA, V99, P16412, DOI 10.1073/pnas.182426899; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; SIMS NR, 1987, BRAIN RES, V436, P30, DOI 10.1016/0006-8993(87)91553-8; Skovronsky DM, 1998, J CELL BIOL, V141, P1031, DOI 10.1083/jcb.141.4.1031; SORBI S, 1983, ANN NEUROL, V13, P72, DOI 10.1002/ana.410130116; Swerdlow RH, 2002, INT REV NEUROBIOL, V53, P341; Turner RS, 1996, J BIOL CHEM, V271, P8966, DOI 10.1074/jbc.271.15.8966; VEERESHWARAYYA V, 2005, 35 ANN M SOC NEUR WA; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Zamostiano R, 1999, NEUROSCI LETT, V264, P9, DOI 10.1016/S0304-3940(99)00168-8	52	105	119	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					29468	29478		10.1074/jbc.M602533200	http://dx.doi.org/10.1074/jbc.M602533200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16887805	hybrid			2022-12-27	WOS:000240896300009
J	Yorimitsu, T; Nair, U; Yang, ZF; Klionsky, DJ				Yorimitsu, Tomohiro; Nair, Usha; Yang, Zhifen; Klionsky, Daniel J.			Endoplasmic reticulum stress triggers autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLE TARGETING PATHWAY; UNFOLDED-PROTEIN RESPONSE; SACCHAROMYCES-CEREVISIAE; SECRETORY PATHWAY; MOLECULAR MACHINERY; YEAST VACUOLE; CYTOPLASM; DEGRADATION; VESICLE; CARGO	Eukaryotic cells have evolved strategies to respond to stress conditions. For example, autophagy in yeast is primarily a response to the stress of nutrient limitation. Autophagy is a catabolic process for the degradation and recycling of cytosolic, long lived, or aggregated proteins and excess or defective organelles. In this study, we demonstrate a new pathway for the induction of autophagy. In the endoplasmic reticulum ( ER), accumulation of misfolded proteins causes stress and activates the unfolded protein response to induce the expression of chaperones and proteins involved in the recovery process. ER stress stimulated the assembly of the pre-autophagosomal structure. In addition, autophagosome formation and transport to the vacuole were stimulated in an Atg protein-dependent manner. Finally, Atg1 kinase activity reflects both the nutritional status and autophagic state of the cell; starvation-induced autophagy results in increased Atg1 kinase activity. We found that Atg1 had high kinase activity during ER stress-induced autophagy. Together, these results indicate that ER stress can induce an autophagic response.	Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Klionsky, DJ (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.	klionsky@umich.edu			NIGMS NIH HHS [GM53396, R01 GM053396] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053396] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abeliovich H, 2003, MOL BIOL CELL, V14, P477, DOI 10.1091/mbc.E02-07-0413; Back SH, 2005, METHODS, V35, P395, DOI 10.1016/j.ymeth.2005.03.001; Budovskaya YV, 2005, P NATL ACAD SCI USA, V102, P13933, DOI 10.1073/pnas.0501046102; Cheong H, 2005, MOL BIOL CELL, V16, P3438, DOI 10.1091/mbc.E04-10-0894; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Friedlander R, 2000, NAT CELL BIOL, V2, P379, DOI 10.1038/35017001; Hamasaki M, 2005, TRAFFIC, V6, P56, DOI 10.1111/j.1600-0854.2004.00245.x; Hamasaki M, 2003, CELL STRUCT FUNCT, V28, P49; Harding TM, 1996, J BIOL CHEM, V271, P17621, DOI 10.1074/jbc.271.30.17621; Huang WP, 2000, J BIOL CHEM, V275, P5845, DOI 10.1074/jbc.275.8.5845; Hutchins MU, 2001, J BIOL CHEM, V276, P20491, DOI 10.1074/jbc.M101150200; Ishihara N, 2001, MOL BIOL CELL, V12, P3690, DOI 10.1091/mbc.12.11.3690; Iwata A, 2005, P NATL ACAD SCI USA, V102, P13135, DOI 10.1073/pnas.0505801102; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; KAMADA Y, 1995, GENE DEV, V9, P1559, DOI 10.1101/gad.9.13.1559; Kim J, 2002, J BIOL CHEM, V277, P763, DOI 10.1074/jbc.M109134200; Kim J, 2001, J CELL BIOL, V153, P381, DOI 10.1083/jcb.153.2.381; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; KLIONSKY DJ, 1992, J CELL BIOL, V119, P287, DOI 10.1083/jcb.119.2.287; Kostova Z, 2003, EMBO J, V22, P2309, DOI 10.1093/emboj/cdg227; KOUROKU Y, 2006, IN PRESS CELL DEATH; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Mizushima N, 2005, CELL DEATH DIFFER, V12, P1535, DOI 10.1038/sj.cdd.4401728; NORMINGTON K, 1989, CELL, V57, P1223, DOI 10.1016/0092-8674(89)90059-7; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Reggiori F, 2004, MOL BIOL CELL, V15, P2189, DOI 10.1091/mbc.E03-07-0479; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Scott SV, 2000, J BIOL CHEM, V275, P25840, DOI 10.1074/jbc.M002813200; Scott SV, 1996, P NATL ACAD SCI USA, V93, P12304, DOI 10.1073/pnas.93.22.12304; Shintani T, 2004, J BIOL CHEM, V279, P29889, DOI 10.1074/jbc.M404399200; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; Spear ED, 2003, MOL BIOL CELL, V14, P2756, DOI 10.1091/mbc.E02-11-0717; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Yorimitsu T, 2005, MOL BIOL CELL, V16, P1593, DOI 10.1091/mbc.E04-11-1035	44	772	802	2	83	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					30299	30304		10.1074/jbc.M607007200	http://dx.doi.org/10.1074/jbc.M607007200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16901900	Green Accepted, hybrid			2022-12-27	WOS:000240896300090
J	Jian, JL; Zhu, CS; Xu, ZW; Ouyang, WM; Ma, DC; Zhang, Y; Chen, LJ; Yang, AG; Jin, BQ				Jian, Jin-Long; Zhu, Can-Sheng; Xu, Zhu-Wei; Ouyang, Wei-Ming; Ma, Dong-Chu; Zhang, Yuan; Chen, Li-Jie; Yang, An-Gang; Jin, Bo-Quan			Identification and characterization of the CD226 gene promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL DIFFERENTIATION; NKT CELLS; DNAM-1; AP-1; ACTIVATION; ADHESION; PLATELET; TLISA1; TPA; LYMPHOCYTES	CD226 is one of the main activating receptors on natural killer cells, and it can induce cytotoxicity to target cells through interaction with its ligands CD155 or CD112. CD226 is also involved in T cell differentiation, activation, and cytotoxicity. The expression of CD226 on natural killer cells and T cells can be regulated by cytokines and chemical stimuli; however, the mechanism of the regulation of the CD226 gene is still unknown. In this study, we have identified two promoters in the human CD226 gene named P1 and P2, which are located at -810 to -287 bp and +33 to +213 bp, respectively, and a negative regulation element between P1 and P2. Both P1 and P2 can be regulated by phorbol ester (12-O-tetradecanoylphorbol-13-acetate) and calcium ionophore (A23187). Bioinformatics analysis shows that, within this CD226 gene region, there are putative binding sites for transcription factors AP-1, Sp1, PEA3, and Ets-1. We have found that transcription factor activating protein-1 (AP-1) can up-regulate CD226 promoters P1 and P2 in human hepatocarcinoma cells, a hepatocarcinoma cell line with low expression of endogenous AP-1 and Ets-1. Interestingly, the transcription factor Ets-1 promotes AP-1-induced P2 activity but inhibits AP-1-induced P1 activity for which a 10-bp AP-1/Ets-1 composite site (CCTTCCTTCC) in P1 may be responsible.	Fourth Mil Med Univ, Dept Immunol, Xian 710032, Shannxi Provinc, Peoples R China; No Hosp, Dept Expt Med, Shenyang 110015, Liaoning Provin, Peoples R China	Air Force Military Medical University	Jin, BQ (corresponding author), Fourth Mil Med Univ, Dept Immunol, 17 Changle Rd, Xian 710032, Shannxi Provinc, Peoples R China.	immu_jin@fmmu.edu.cn		Ma, Dongchu/0000-0002-3229-9719				ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Bottino C, 2003, J EXP MED, V198, P557, DOI 10.1084/jem.20030788; BURNS GF, 1985, J EXP MED, V161, P1063, DOI 10.1084/jem.161.5.1063; Castriconi R, 2004, CANCER RES, V64, P9180, DOI 10.1158/0008-5472.CAN-04-2682; D'Orazio D, 1997, GENE, V201, P179, DOI 10.1016/S0378-1119(97)00445-9; Deng T, 2005, J IMMUNOL, V174, P1281, DOI 10.4049/jimmunol.174.3.1281; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; GUTMAN A, 1990, EMBO J, V9, P2241, DOI 10.1002/j.1460-2075.1990.tb07394.x; Hai M, 2001, J NEUROSCI RES, V65, P508, DOI 10.1002/jnr.1181; JIN B, 1989, IMMUNOLOGY, V66, P570; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kojima H, 2003, J BIOL CHEM, V278, P36748, DOI 10.1074/jbc.M300702200; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; Logan SK, 1996, J BIOL CHEM, V271, P774, DOI 10.1074/jbc.271.2.774; Ma DC, 2005, EUR J HAEMATOL, V74, P228, DOI 10.1111/j.1600-0609.2004.00345.x; Pende D, 2005, BLOOD, V105, P2066, DOI 10.1182/blood-2004-09-3548; Ralston KJ, 2004, J BIOL CHEM, V279, P33816, DOI 10.1074/jbc.M401040200; Reymond N, 2004, J EXP MED, V199, P1331, DOI 10.1084/jem.20032206; SCOTT JL, 1989, J BIOL CHEM, V264, P13475; Sherrington PD, 1997, J BIOL CHEM, V272, P21735, DOI 10.1074/jbc.272.35.21735; Shibuya A, 1996, IMMUNITY, V4, P573, DOI 10.1016/S1074-7613(00)70060-4; Shibuya A, 1998, J IMMUNOL, V161, P1671; Shibuya K, 1999, IMMUNITY, V11, P615, DOI 10.1016/S1074-7613(00)80136-3; Shibuya K, 2003, J EXP MED, V198, P1829, DOI 10.1084/jem.20030958; Shirakawa J, 2005, INT IMMUNOL, V17, P217, DOI 10.1093/intimm/dxh199; Tao L, 2001, J CELL BIOCHEM, V82, P522, DOI 10.1002/jcb.1173; WASYLYK B, 1990, NATURE, V346, P191, DOI 10.1038/346191a0; Xiao ZS, 2003, J CELL BIOCHEM, V88, P493, DOI 10.1002/jcb.10375; Yang S, 2005, J IMMUNOL, V175, P4914, DOI 10.4049/jimmunol.175.8.4914	29	15	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					28731	28736		10.1074/jbc.M601786200	http://dx.doi.org/10.1074/jbc.M601786200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16887814	hybrid			2022-12-27	WOS:000240680500026
J	Yu, M; Luo, JC; Yang, WT; Wang, YP; Mizuki, M; Kanakura, Y; Besmer, P; Neel, BG; Gu, HH				Yu, Min; Luo, Jincai; Yang, Wentian; Wang, Yongping; Mizuki, Masao; Kanakura, Yuzuru; Besmer, Peter; Neel, Benjamin G.; Gu, Haihua			The scaffolding adapter Gab2, via Shp-2, regulates kit-evoked mast cell proliferation by activating the Rac/JNK pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SRC FAMILY KINASE; C-KIT; EPIDERMAL-GROWTH; SIGNALING PATHWAY; PROTEIN GAB2; RECEPTOR; RHO; PHOSPHORYLATION; IDENTIFICATION; ASSOCIATION	The scaffolding adapter Gab2 mediates cell signaling and responses evoked by various extracellular stimuli including several growth factors. Kit, the receptor for stem cell factor (SCF), plays a critical role in the proliferation and differentiation of a variety of cell types, including mast cells. Kit, via Tyr(567) and Tyr(719), activates Src family kinases (SFK) and PI3K respectively, which converge on the activation of a Rac/JNK pathway required for mast cell proliferation. However, how Kit Tyr(567) signals to Rac/JNK is not well understood. By analyzing Gab2(-/-) mast cells, we find that Gab2 is required for SCF-evoked proliferation, activation of Rac/JNK, and Ras. Upon Kit activation in wild-type mast cells, Gab2 becomes tyrosyl-phosphorylated and associates with Kit and Shp-2. Tyr(567), an SFK binding site in Kit, and SFK activity were required for Gab2 tyrosyl phosphorylation and association with Shp-2. By re-expressing Gab2 or a Gab2 mutant that cannot bind Shp-2 in Gab2(-/-) mast cells or acutely by deleting Shp-2 in mast cells, we found that Gab2 requires Shp-2 for SCF-evoked Rac/JNK, Ras activation, and mast cell proliferation. Lastly, by analyzing mast cells from mice with compound Gab2 and Kit Y719F mutations (i.e., Gab2(-/-): KitY719F/Y719F mice), we find that Gab2, acting in a parallel pathway to PI3K from Kit Tyr(719), regulates mast cell proliferation and development in specific tissues. Our data show that Gab2 via Shp-2 is critical for transmitting signals from Kit Tyr(567) to activate the Rac/JNK pathway controlling mast cell proliferation, which likely contributes to mast cell development in specific tissues.	Beth Israel Deaconess Med Ctr, Canc Biol Program, Div Hematol Oncol, Dept Med, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; Osaka Univ, Grad Sch Med, Dept Hematol & Oncol, Suita, Osaka 5650871, Japan; Sloan Kettering Inst, Dev Biol Program, New York, NY 10021 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Osaka University; Memorial Sloan Kettering Cancer Center	Gu, HH (corresponding author), NRB 1030N,77 Ave Louis Pasteur, Boston, MA 02115 USA.	hgu@bidmc.harvard.edu	Jin Cai, Luo/A-7900-2011		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050693, R01DK055748] Funding Source: NIH RePORTER; NIAID NIH HHS [R01-AI51612] Funding Source: Medline; NIDDK NIH HHS [DK50693, HL/DK55748] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Agosti V, 2004, J EXP MED, V199, P867, DOI 10.1084/jem.20031983; Ashman LK, 1999, INT J BIOCHEM CELL B, V31, P1037, DOI 10.1016/S1357-2725(99)00076-X; Barnard D, 1998, ONCOGENE, V17, P1539, DOI 10.1038/sj.onc.1202061; Bentires-Alj M, 2006, NAT MED, V12, P114, DOI 10.1038/nm1341; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Blume-Jensen P, 2000, NAT GENET, V24, P157, DOI 10.1038/72814; Brummer T, 2006, J BIOL CHEM, V281, P626, DOI 10.1074/jbc.M509567200; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Cai T, 2002, J CELL BIOL, V159, P103, DOI 10.1083/jcb.200205017; Chen CC, 2005, P NATL ACAD SCI USA, V102, P11408, DOI 10.1073/pnas.0504197102; Fukao T, 2002, NAT IMMUNOL, V3, P295, DOI 10.1038/ni768; Galli SJ, 2000, CURR OPIN HEMATOL, V7, P32, DOI 10.1097/00062752-200001000-00007; Gu HH, 2000, MOL CELL BIOL, V20, P7109, DOI 10.1128/MCB.20.19.7109-7120.2000; Gu HH, 2001, NATURE, V412, P186, DOI 10.1038/35084076; Gu HH, 2003, TRENDS CELL BIOL, V13, P122, DOI 10.1016/S0962-8924(03)00002-3; Gu HH, 1998, MOL CELL, V2, P729, DOI 10.1016/S1097-2765(00)80288-9; Gurish MF, 2001, J EXP MED, V194, P1243, DOI 10.1084/jem.194.9.1243; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hong L, 2004, MOL CELL BIOL, V24, P1401, DOI 10.1128/MCB.24.3.1401-1410.2004; Kimura Y, 2004, P NATL ACAD SCI USA, V101, P6015, DOI 10.1073/pnas.0305363101; Kissel H, 2000, EMBO J, V19, P1312, DOI 10.1093/emboj/19.6.1312; Kong M, 2003, J BIOL CHEM, V278, P5837, DOI 10.1074/jbc.M208286200; Kontaridis MI, 2004, MOL CELL BIOL, V24, P5340, DOI 10.1128/MCB.24.12.5340-5352.2004; Kozlowski M, 1998, MOL CELL BIOL, V18, P2089, DOI 10.1128/MCB.18.4.2089; Lambert JM, 2002, NAT CELL BIOL, V4, P621, DOI 10.1038/ncb833; Lennartsson J, 2005, STEM CELLS, V23, P16, DOI 10.1634/stemcells.2004-0117; Lennartsson J, 1999, ONCOGENE, V18, P5546, DOI 10.1038/sj.onc.1202929; Linnekin D, 1997, J BIOL CHEM, V272, P27450, DOI 10.1074/jbc.272.43.27450; Liu Y, 2001, MOL CELL BIOL, V21, P3047, DOI 10.1128/MCB.21.9.3047-3056.2001; Lock LS, 2000, J BIOL CHEM, V275, P31536, DOI 10.1074/jbc.M003597200; Mao YW, 2005, J CELL BIOL, V170, P305, DOI 10.1083/jcb.200505061; Meng SS, 2005, BIOCHEM J, V391, P143, DOI 10.1042/BJ20050229; Mitin N, 2005, CURR BIOL, V15, pR563, DOI 10.1016/j.cub.2005.07.010; Montagner A, 2005, J BIOL CHEM, V280, P5350, DOI 10.1074/jbc.M410012200; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Nicholson SE, 2000, P NATL ACAD SCI USA, V97, P6493, DOI 10.1073/pnas.100135197; Nishida K, 2002, BLOOD, V99, P1866, DOI 10.1182/blood.V99.5.1866; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Price DJ, 1997, J BIOL CHEM, V272, P5915, DOI 10.1074/jbc.272.9.5915; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ronnstrand L, 2004, CELL MOL LIFE SCI, V61, P2535, DOI 10.1007/s00018-004-4189-6; Rosenkranz AR, 1998, J IMMUNOL, V161, P6463; ROTTAPEL R, 1991, MOL CELL BIOL, V11, P3043, DOI 10.1128/MCB.11.6.3043; Saitoh S, 2000, IMMUNITY, V12, P525, DOI 10.1016/S1074-7613(00)80204-6; Shifrin VI, 1997, J BIOL CHEM, V272, P2957, DOI 10.1074/jbc.272.5.2957; Tan BL, 2003, BLOOD, V101, P4725, DOI 10.1182/blood-2002-08-2521; Thommes K, 1999, BIOCHEM J, V341, P211, DOI 10.1042/0264-6021:3410211; Timokhina I, 1998, EMBO J, V17, P6250, DOI 10.1093/emboj/17.21.6250; Ueda S, 2002, BLOOD, V99, P3342, DOI 10.1182/blood.V99.9.3342; Wada T, 2005, NAT MED, V11, P394, DOI 10.1038/nm1203; Welch HCE, 2003, FEBS LETT, V546, P93, DOI 10.1016/S0014-5793(03)00454-X; Yang FC, 2000, IMMUNITY, V12, P557, DOI 10.1016/S1074-7613(00)80207-1; Yang WT, 2006, DEV CELL, V10, P317, DOI 10.1016/j.devcel.2006.01.002; Yu M, 2006, J IMMUNOL, V176, P2421, DOI 10.4049/jimmunol.176.4.2421; Yu WM, 2002, BLOOD, V99, P2351, DOI 10.1182/blood.V99.7.2351; Zhao CM, 2003, J BIOL CHEM, V278, P34641, DOI 10.1074/jbc.M304594200	57	65	66	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					28615	28626		10.1074/jbc.M603742200	http://dx.doi.org/10.1074/jbc.M603742200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16873377	hybrid			2022-12-27	WOS:000240680500015
J	Niewolik, D; Pannicke, U; Lu, HH; Ma, YM; Wang, LCV; Kulesza, P; Zandi, E; Lieber, MR; Schwarz, K				Niewolik, Doris; Pannicke, Ulrich; Lu, Haihui; Ma, Yunmei; Wang, Ling-Chi Vicky; Kulesza, Peter; Zandi, Ebrahim; Lieber, Michael R.; Schwarz, Klaus			DNA-PKcs dependence of Artemis endonucleolytic activity, differences between hairpins and 5 ' or 3 ' overhangs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE CATALYTIC SUBUNIT; SEVERE COMBINED IMMUNODEFICIENCY; COMBINED IMMUNE-DEFICIENCY; STRAND BREAK REPAIR; PROTEIN-KINASE; V(D)J RECOMBINATION; PHOSPHORYLATION SITES; LIGASE-IV; HYPOMORPHIC MUTATIONS; OMENN-SYNDROME	During V(D)J recombination, the RAG proteins create DNA hairpins at the V, D, or J coding ends, and the structure-specific nuclease Artemis is essential to open these hairpins prior to joining. Artemis also is an endonuclease for 5' and 3' overhangs at many DNA double strand breaks caused by ionizing radiation, and Artemis functions as part of the nonhomologous DNA end joining pathway in repairing these. All of these activities require activation of the Artemis protein by interaction with and phosphorylation by the DNA-dependent protein kinase catalytic subunit (DNA-PKcs). In this study, we have identified a region of the Artemis protein involved in the interaction with DNA-PKcs. Furthermore, the biochemical and functional analyses of C-terminally truncated Artemis variants indicate that the hairpin opening and DNA overhang endonucleolytic features of Artemis are triggered by DNA-PKcs in two modes. First, autoinhibition mediated by the C-terminal tail of Artemis is relieved by phosphorylation of this tail by DNA-PKcs. Thus, C-terminally truncated Artemis derivatives imitate DNA-PKcs-activated wild type Artemis protein and exhibit intrinsic hairpin opening activity. Second, DNA-PKcs may optimally configure 5' and 3' overhang substrates for the endonucleolytic function of Artemis.	Univ So Calif, Dept Pathol, Los Angeles, CA 90089 USA; Univ Hosp, Inst Clin Transfus Med & Immunogenet, D-89081 Ulm, Germany; Univ Hosp, Dept Transfus Med, D-89081 Ulm, Germany; Univ So Calif, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA; Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; Univ So Calif, Dept Mol Microbiol & Immunol, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90089 USA	University of Southern California; Ulm University; Ulm University; University of Southern California; University of Southern California; University of Southern California	Lieber, MR (corresponding author), Univ So Calif, Dept Pathol, Los Angeles, CA 90089 USA.	lieber@usc.edu; klaus.schwarz@uni-ulm.de	Pannicke, Ulrich/D-7348-2014; Wang, Lihong V./A-7147-2009	Wang, Lihong V./0000-0001-9783-4383; Lieber, Michael/0000-0003-3700-6345; Lieber, Michael/0000-0001-8809-0909				Ahnesorg P, 2006, CELL, V124, P301, DOI 10.1016/j.cell.2005.12.031; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Block WD, 2004, NUCLEIC ACIDS RES, V32, P4351, DOI 10.1093/nar/gkh761; Buck D, 2006, CELL, V124, P287, DOI 10.1016/j.cell.2005.12.030; Buck D, 2006, EUR J IMMUNOL, V36, P224, DOI 10.1002/eji.200535401; Callebaut I, 2002, NUCLEIC ACIDS RES, V30, P3592, DOI 10.1093/nar/gkf470; Cui XP, 2005, MOL CELL BIOL, V25, P10842, DOI 10.1128/MCB.25.24.10842-10852.2005; Ding Q, 2003, MOL CELL BIOL, V23, P5836, DOI 10.1128/MCB.23.16.5836-5848.2003; Douglas P, 2005, DNA REPAIR, V4, P1006, DOI 10.1016/j.dnarep.2005.05.003; Douglas P, 2002, BIOCHEM J, V368, P243, DOI 10.1042/BJ20020973; Ege M, 2005, BLOOD, V105, P4179, DOI 10.1182/blood-2004-12-4861; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; Gell D, 1999, NUCLEIC ACIDS RES, V27, P3494, DOI 10.1093/nar/27.17.3494; Gellert M, 2002, ANNU REV BIOCHEM, V71, P101, DOI 10.1146/annurev.biochem.71.090501.150203; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; Hammarsten O, 2000, J BIOL CHEM, V275, P1541, DOI 10.1074/jbc.275.3.1541; Jung D, 2004, CELL, V116, P299, DOI 10.1016/S0092-8674(04)00039-X; KULESZA P, 1999, THESIS WASHINGTON U; Lee KJ, 2004, DNA REPAIR, V3, P267, DOI 10.1016/j.dnarep.2003.11.005; Lieber MR, 2004, DNA REPAIR, V3, P817, DOI 10.1016/j.dnarep.2004.03.015; Ma YM, 2005, DNA REPAIR, V4, P845, DOI 10.1016/j.dnarep.2005.04.013; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; Ma YM, 2005, J BIOL CHEM, V280, P33839, DOI 10.1074/jbc.M507113200; Ma YM, 2006, METHOD ENZYMOL, V408, P502, DOI 10.1016/S0076-6879(06)08031-1; Moshous D, 2001, CELL, V105, P177, DOI 10.1016/S0092-8674(01)00309-9; Moshous D, 2003, J CLIN INVEST, V111, P381, DOI 10.1172/JCI200316774; Noordzij JG, 2003, BLOOD, V101, P1446, DOI 10.1182/blood-2002-01-0187; O'Driscoll M, 2001, MOL CELL, V8, P1175, DOI 10.1016/S1097-2765(01)00408-7; Pannicke U, 2004, EMBO J, V23, P1987, DOI 10.1038/sj.emboj.7600206; Poinsignon C, 2004, J EXP MED, V199, P315, DOI 10.1084/jem.20031142; Pufall MA, 2002, ANNU REV CELL DEV BI, V18, P421, DOI 10.1146/annurev.cellbio.18.031502.133614; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Rooney S, 2004, IMMUNOL REV, V200, P115, DOI 10.1111/j.0105-2896.2004.00165.x; Schwarz K, 2003, BIOESSAYS, V25, P1061, DOI 10.1002/bies.10344; Singleton BK, 1999, MOL CELL BIOL, V19, P3267; Soubeyrand S, 2006, J MOL BIOL, V358, P1200, DOI 10.1016/j.jmb.2006.02.061; van der Burg M, 2006, J CLIN INVEST, V116, P137, DOI 10.1172/JCI26121; Villa A, 1998, CELL, V93, P885, DOI 10.1016/S0092-8674(00)81448-8; Villa A, 2001, BLOOD, V97, P81, DOI 10.1182/blood.V97.1.81; WIGLER M, 1979, CELL, V16, P777, DOI 10.1016/0092-8674(79)90093-X; Yu YP, 2003, DNA REPAIR, V2, P1239, DOI 10.1016/S1568-7864(03)00143-5; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	43	81	84	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					33900	33909		10.1074/jbc.M606023200	http://dx.doi.org/10.1074/jbc.M606023200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16914548	hybrid			2022-12-27	WOS:000241767600011
J	Dasari, VR; Anandatheerthavarada, HK; Robin, MA; Boopathi, E; Biswas, G; Fang, JK; Nebert, DW; Avadhani, NG				Dasari, Venkata Ramesh; Anandatheerthavarada, Hindupur K.; Robin, Marie-Anne; Boopathi, Ettickan; Biswas, Gopa; Fang, Ji-Kang; Nebert, Daniel W.; Avadhani, Narayan G.			Role of protein kinase C-mediated protein phosphorylation in mitochondrial translocation of mouse CYP1A1, which contains a non-canonical targeting signal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCIBLE CYTOCHROMES P450; BETA-NAPHTHOFLAVONE; RAT-LIVER; ACTIVATION; LOCALIZATION; SEQUENCE; P-450; TRAFFICKING; METABOLISM; MODULATION	A large number of mitochondrial proteins lack canonical mitochondrial-targeting signals. The bimodal transport of cytochromes P450 (CYPs) to endoplasmic reticulum and mitochondria (MT), reported previously by us, likely represents one mode of non-canonical protein targeting to MT. Herein, we have studied the mechanism of mouse MT-CYP1A1 targeting to gain insight into the regulatory features and evolutionary conservation of bimodal targeting mechanism. Mouse MT-CYP1A1 consists of two NH2-terminal-truncated molecular species, + 91A1 and + 331A1. Mutations Pro-2 -> Leu and Tyr-5 -> Leu, which increase the signal recognition particle (SRP) binding, diminished MT targeting of the protein in intact cells. By contrast, mutations Leu-7 -> Asn and Leu-17 -> 3 Asn, which decreased SRP-binding affinity, enhanced MT targeting, thus suggesting that SRP binding is an important regulatory step that modulates bimodal targeting. Protein kinase C(PKC)-mediated phosphorylation of nascent chains at Thr-35 vastly decreased affinity for SRP binding suggesting an important regulatory step. In support of these results, COS cell transfection experiments show that phosphomimetic mutation Thr-353Asp or induced cellular PKC caused increased CYP1A1 targeting to MT and correspondingly lower levels to the endoplasmic reticulum. Results suggest evolutionary conservation of chimeric signals and bimodal targeting of CYP1A1 in different species. The mouse MT-CYP1A1 is an extrinsic membrane protein, which exhibited high FDX1 plus FDXR-mediated N-demethylation of a number of tricyclic antidepressants, pain killers, antipsychotics, and narcotics that are poor substrates for microsomal CYP1A1.	Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; Univ Penn, Sch Vet Med, Mari Lowe Ctr Comparat Oncol, Philadelphia, PA 19104 USA; Univ Cincinnati, Med Ctr, Dept Environm Hlth, Cincinnati, OH 45267 USA; Univ Cincinnati, Med Ctr, Ctr Environm Genet, Cincinnati, OH 45267 USA	University of Pennsylvania; University of Pennsylvania; University of Cincinnati; University of Cincinnati	Avadhani, NG (corresponding author), Univ Penn, Sch Vet Med, Dept Anim Biol, 3800 Spruce St, Philadelphia, PA 19104 USA.	narayan@vet.upenn.edu	Dasari, Venkata Ramesh/B-3098-2009	Dasari, Venkata Ramesh/0000-0003-0819-2935; Ettickan, Boopathi/0000-0001-9431-7719	NIEHS NIH HHS [ES-08147] Funding Source: Medline; NIGMS NIH HHS [GM-34883] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034883] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Addya S, 1997, J CELL BIOL, V139, P589, DOI 10.1083/jcb.139.3.589; Anandatheerthavarada HK, 1998, BIOCHEMISTRY-US, V37, P1150, DOI 10.1021/bi972046j; Anandatheerthavarada HK, 1999, EMBO J, V18, P5494, DOI 10.1093/emboj/18.20.5494; Anandatheerthavarada HK, 2003, J CELL BIOL, V161, P41, DOI 10.1083/jcb.200207030; Anandatheerthavarada HK, 1997, ARCH BIOCHEM BIOPHYS, V339, P136, DOI 10.1006/abbi.1996.9855; Bhagwat SV, 1999, TOXICOL APPL PHARM, V156, P231, DOI 10.1006/taap.1999.8646; Boopathi E, 2000, J BIOL CHEM, V275, P34415, DOI 10.1074/jbc.M004431200; BURKE MD, 1985, BIOCHEM PHARMACOL, V34, P3337, DOI 10.1016/0006-2952(85)90355-7; CHUCK SL, 1992, CELL, V68, P9, DOI 10.1016/0092-8674(92)90202-N; CLARK BJ, 1991, J BIOL CHEM, V266, P5898; Colombo S, 2005, J CELL BIOL, V168, P735, DOI 10.1083/jcb.200407082; Egashira T, 1999, JPN J PHARMACOL, V81, P115, DOI 10.1254/jjp.81.115; Gabaldon T, 2004, BBA-BIOENERGETICS, V1659, P212, DOI 10.1016/j.bbabio.2004.07.011; GONZALEZ FJ, 1990, PHARMACOL THERAPEUT, V45, P1, DOI 10.1016/0163-7258(90)90006-N; HEINE UI, 1991, CELL REGUL, V2, P467, DOI 10.1091/mbc.2.6.467; IOANNIDES C, 1990, DRUG METAB REV, V22, P1, DOI 10.3109/03602539008991444; Kalsotra A, 2004, TOXICOL APPL PHARM, V199, P295, DOI 10.1016/j.taap.2003.12.033; KIMURA S, 1984, J BIOL CHEM, V259, P705; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Kurys G, 2000, J BIOL CHEM, V275, P30653, DOI 10.1074/jbc.M002373200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Little MH, 2001, AM J PHYSIOL-CELL PH, V281, pC486, DOI 10.1152/ajpcell.2001.281.2.C486; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; NASH T, 1953, BIOCHEM J, V55, P416, DOI 10.1042/bj0550416; Nebert DW, 2004, J BIOL CHEM, V279, P23847, DOI 10.1074/jbc.R400004200; NIRANJAN BG, 1984, J BIOL CHEM, V259, P2495; Niwa T, 1999, XENOBIOTICA, V29, P187, DOI 10.1080/004982599238731; Ohlmeier S, 2004, J BIOL CHEM, V279, P3956, DOI 10.1074/jbc.M310160200; Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006; Rane NS, 2004, EMBO J, V23, P4550, DOI 10.1038/sj.emboj.7600462; RAZA H, 1988, J BIOL CHEM, V263, P9533; Robin MA, 2003, J BIOL CHEM, V278, P18960, DOI 10.1074/jbc.M301807200; Robin MA, 2002, J BIOL CHEM, V277, P40583, DOI 10.1074/jbc.M203292200; Roh HK, 2001, BRIT J CLIN PHARMACO, V52, P265, DOI 10.1046/j.0306-5251.2001.01437.x; Scharfe C, 2000, NUCLEIC ACIDS RES, V28, P155, DOI 10.1093/nar/28.1.155; SOURKES TL, 1981, BASIC NEUROCHEMISTRY, P737; Stojanovski D, 2003, EXP PHYSIOL, V88, P57, DOI 10.1113/eph8802501; Tagaya Y, 1997, P NATL ACAD SCI USA, V94, P14444, DOI 10.1073/pnas.94.26.14444; Taylor SW, 2003, NAT BIOTECHNOL, V21, P281, DOI 10.1038/nbt793; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Truscott KN, 2003, CURR BIOL, V13, pR326, DOI 10.1016/S0960-9822(03)00239-2; WATKINS PB, 1989, J CLIN INVEST, V83, P688, DOI 10.1172/JCI113933; WRIGHTON SA, 1985, BIOCHEMISTRY-US, V24, P2171, DOI 10.1021/bi00330a010; YANG HYL, 1988, MOL PHARMACOL, V34, P67	45	31	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30834	30847		10.1074/jbc.M510725200	http://dx.doi.org/10.1074/jbc.M510725200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16899466	hybrid			2022-12-27	WOS:000241075900059
J	Nagashima, K; Kubota, Y; Shibata, T; Sakaguchi, C; Shinagawa, H; Hishida, T				Nagashima, Kohji; Kubota, Yoshino; Shibata, Tatsuya; Sakaguchi, Chikako; Shinagawa, Hideo; Hishida, Takashi			Degradation of Escherichia coli RecN aggregates by ClpXP protease and its implications for DNA damage tolerance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STALLED REPLICATION FORKS; DOUBLE-STRAND BREAKS; SMC PROTEINS; RECOGNITION SIGNALS; SISTER CHROMATIDS; TAGGING SYSTEM; IN-VIVO; REPAIR; GENE; GENOME	Protein degradation in bacteria plays a dynamic and critical role in the cellular response to environmental stimuli such as heat shock and DNA damage and in removing damaged proteins or protein aggregates. Escherichia coli recN is a member of the structural maintenance of chromosomes family and is required for DNA double strand break (DSB) repair. This study shows that RecN protein has a short half-life and its degradation is dependent on the cytoplasmic protease ClpXP and a degradation signal at the C terminus of RecN. In cells with DNA DSBs, green fluorescent protein-RecN localized in discrete foci on nucleoids and formed visible aggregates in the cytoplasm, both of which disappeared rapidly in wild-type cells when DSBs were repaired. In contrast, in Delta clpX cells, RecN aggregates persisted in the cytoplasm after release from DNA damage. Furthermore, analysis of cells experiencing chronic DNA damage revealed that proteolytic removal of RecN aggregates by ClpXP was important for cell viability. These data demonstrate that ClpXP is a critical factor in the cellular clearance of cytoplasmic RecN aggregates from the cell and therefore plays an important role in DNA damage tolerance.	Osaka Univ, Lab Genome Dynam, Res Inst Microbial Dis, Suita, Osaka 5650871, Japan; BioAcademia Inc, Osaka 5650085, Japan	Osaka University	Hishida, T (corresponding author), Osaka Univ, Lab Genome Dynam, Res Inst Microbial Dis, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan.	hishida@biken.osaka-u.ac.jp		Hishida, Takashi/0000-0002-9752-6599				Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; FINCH PW, 1985, J BACTERIOL, V164, P653, DOI 10.1128/JB.164.2.653-658.1985; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Gonzalez M, 2000, EMBO J, V19, P5251, DOI 10.1093/emboj/19.19.5251; Gottesman S, 1999, CURR OPIN MICROBIOL, V2, P142, DOI 10.1016/S1369-5274(99)80025-3; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; GOTTESMAN S, 1993, J BIOL CHEM, V268, P22618; Haering CH, 2003, BIOESSAYS, V25, P1178, DOI 10.1002/bies.10361; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Hirano T, 2005, PHILOS T R SOC B, V360, P507, DOI 10.1098/rstb.2004.1606; Hishida T, 2004, GENE DEV, V18, P1886, DOI 10.1101/gad.1223804; IWASAKI H, 1989, MOL GEN GENET, V219, P328, DOI 10.1007/BF00261196; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Kidane D, 2004, MOL MICROBIOL, V52, P1627, DOI 10.1111/j.1365-2958.2004.04102.x; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; Lehmann AR, 2005, DNA REPAIR, V4, P309, DOI 10.1016/j.dnarep.2004.07.009; Levchenko I, 1997, GENE DEV, V11, P1561, DOI 10.1101/gad.11.12.1561; LLOYD RG, 1983, MOL GEN GENET, V190, P162, DOI 10.1007/BF00330340; Losada A, 2005, GENE DEV, V19, P1269, DOI 10.1101/gad.1320505; Meddows TR, 2005, MOL MICROBIOL, V57, P97, DOI 10.1111/j.1365-2958.2005.04677.x; Miller J. H., 1992, LAB MANUAL HDB ESCHE; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Nasmyth K, 2001, ANNU REV GENET, V35, P673, DOI 10.1146/annurev.genet.35.102401.091334; Neher SB, 2003, GENE DEV, V17, P1084, DOI 10.1101/gad.1078003; PICKSLEY SM, 1984, MOL GEN GENET, V195, P267, DOI 10.1007/BF00332758; Porankiewicz J, 1999, MOL MICROBIOL, V32, P449, DOI 10.1046/j.1365-2958.1999.01357.x; Qu JN, 1996, J BACTERIOL, V178, P3457, DOI 10.1128/jb.178.12.3457-3461.1996; Sambrook J., 2002, MOL CLONING LAB MANU; SARGENTINI NJ, 1983, RADIAT RES, V93, P461, DOI 10.2307/3576026; Shibata T, 2005, GENES CELLS, V10, P181, DOI 10.1111/j.1365-2443.2005.00831.x; Tatsuta T, 1998, MOL MICROBIOL, V30, P583, DOI 10.1046/j.1365-2958.1998.01091.x; Wang JM, 1998, J STRUCT BIOL, V124, P151, DOI 10.1006/jsbi.1998.4058; WANG TCV, 1988, J BACTERIOL, V170, P2555, DOI 10.1128/jb.170.6.2555-2559.1988; Yazdi PT, 2002, GENE DEV, V16, P571, DOI 10.1101/gad.970702	39	27	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30941	30946		10.1074/jbc.M606566200	http://dx.doi.org/10.1074/jbc.M606566200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16914543	hybrid			2022-12-27	WOS:000241075900070
J	Fischer, K; Llamas, A; Tejada-Jimenez, M; Schrader, N; Kuper, J; Ataya, FS; Galvan, A; Mendel, RR; Fernandez, E; Schwarz, G				Fischer, Katrin; Llamas, Angel; Tejada-Jimenez, Manuel; Schrader, Nils; Kuper, Jochen; Ataya, Farid S.; Galvan, Aurora; Mendel, Ralf R.; Fernandez, Emilio; Schwarz, Guenter			Function and structure of the molybdenum cofactor carrier protein from Chlamydomonas reinhardtii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFITE OXIDASE; NITRATE REDUCTASE; CRYSTALLOGRAPHIC STRUCTURE; XANTHINE DEHYDROGENASE; MOLYBDOPTERIN COFACTOR; CRYSTAL-STRUCTURES; BIOSYNTHESIS; IDENTIFICATION; INSIGHTS; BINDING	The molybdenum cofactor (Moco) forms the catalytic site in all eukaryotic molybdenum enzymes and is synthesized by a multistep biosynthetic pathway. The mechanism of transfer, storage, and insertion of Moco into the appropriate apo-enzyme is poorly understood. In Chlamydomonas reinhardtii, a Moco carrier protein (MCP) has been identified and characterized recently. Here we show biochemical evidence that MCP binds Moco as well as the tungstate-substituted form of the cofactor (Wco) with high affinity, whereas molybdopterin, the ultimate cofactor precursor, is not bound. This binding selectivity points to a specific metal-mediated interaction with MCP, which protects Moco and Wco from oxidation with t1/2 of 24 and 96 h, respectively. UV-visible spectroscopy showed defined absorption bands at 393, 470, and 570 nm pointing to ene-diothiolate and protein side-chain charge transfer bonds with molybdenum. We have determined the crystal structure of MCP at 1.6 angstrom resolution using seleno-methionated and native protein. The monomer constitutes a Rossmann fold with two homodimers forming a symmetrical tetramer in solution. Based on conserved surface residues, charge distribution, shape, in silico docking studies, structural comparisons, and identification of an anion-binding site, a prominent surface depression was proposed as a Moco-binding site, which was confirmed by structure-guided mutagenesis coupled to substrate binding studies.	Univ Cologne, Inst Biochem, D-50674 Cologne, Germany; Tech Univ Carolo Wilhelmina Braunschweig, Inst Plant Biol, D-38106 Braunschweig, Germany; Univ Cordoba, Dept Bioquim & Biol Mol, Cordoba 14071, Spain; Max Planck Inst Mol Physiol, Dept Biol Struct, D-44247 Dortmund, Germany; European Mol Biol Lab, Outstn, D-22603 Hamburg, Germany	University of Cologne; Braunschweig University of Technology; Universidad de Cordoba; Max Planck Society; European Molecular Biology Laboratory (EMBL)	Schwarz, G (corresponding author), Univ Cologne, Inst Biochem, Otto Fischer Str 12-14, D-50674 Cologne, Germany.	gschwarz@uni-koeln.de	Fernandez, Emilio/H-2892-2015; Schwarz, Guenter/ABE-9643-2021; Llamas, Angel/L-1638-2014; Schrader, Katrin/GWM-7389-2022; Tejada-Jimenez, Manuel/A-9727-2017; Ataya, Farid Shokry/O-6570-2019; Llamas, Angel/B-7104-2015; Galvan Cejudo, Aurora/A-9483-2010	Schwarz, Guenter/0000-0002-2118-9338; Llamas, Angel/0000-0001-6042-9472; Schrader, Katrin/0000-0003-4532-8918; Tejada-Jimenez, Manuel/0000-0003-1702-6015; Ataya, Farid Shokry/0000-0002-0981-7805; Llamas, Angel/0000-0001-6042-9472; Fernandez Reyes, Emilio/0000-0001-5957-5392; Ataya, Farid/0000-0002-0247-5742; Galvan Cejudo, Aurora/0000-0002-7564-2281				Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; AGUILAR M, 1992, FEBS LETT, V307, P162, DOI 10.1016/0014-5793(92)80758-9; AMY NK, 1979, J BACTERIOL, V140, P114, DOI 10.1128/JB.140.1.114-124.1979; Ataya FS, 2003, J BIOL CHEM, V278, P10885, DOI 10.1074/jbc.M211320200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bertero MG, 2003, NAT STRUCT BIOL, V10, P681, DOI 10.1038/nsb969; Bittner F, 2001, J BIOL CHEM, V276, P40381, DOI 10.1074/jbc.C100472200; Eilers T, 2001, J BIOL CHEM, V276, P46989, DOI 10.1074/jbc.M108078200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enemark JH, 2002, MET IONS BIOL SYST, V39, P621; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Fischer K, 2005, PLANT CELL, V17, P1167, DOI 10.1105/tpc.104.029694; Garrett RM, 1996, J BIOL CHEM, V271, P7387, DOI 10.1074/jbc.271.13.7387; HAWKES TR, 1984, BIOCHEM J, V219, P481, DOI 10.1042/bj2190481; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; JOHNSON JL, 1980, P NATL ACAD SCI-BIOL, V77, P3715, DOI 10.1073/pnas.77.6.3715; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Joshi MS, 1996, J BACTERIOL, V178, P4310, DOI 10.1128/jb.178.14.4310-4312.1996; Kalakoutskii KL, 1997, PLANTA, V201, P64, DOI 10.1007/s004250050230; Kisker C, 1997, CELL, V91, P973, DOI 10.1016/S0092-8674(00)80488-2; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kukimoto-Niino M, 2004, PROTEIN SCI, V13, P3038, DOI 10.1110/ps.041012404; Kuper J, 2000, P NATL ACAD SCI USA, V97, P6475, DOI 10.1073/pnas.110568497; Kuper J, 2004, NATURE, V430, P803, DOI 10.1038/nature02681; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Leimkuhler S, 2001, J BIOL CHEM, V276, P1837, DOI 10.1074/jbc.M007304200; Leslie AGW, 1999, ACTA CRYSTALLOGR D, V55, P1696, DOI 10.1107/S090744499900846X; Llamas A, 2000, PLANT CELL ENVIRON, V23, P1247, DOI 10.1046/j.1365-3040.2000.00631.x; LLAMAS A, 2006, J BIOL MED; Magalon A., 2002, J BIOL CHEM, V7, P7; Mendel RR, 1999, CRIT REV PLANT SCI, V18, P33, DOI 10.1016/S0735-2689(99)00386-X; Mendel RR, 2002, MET IONS BIOL SYST, V39, P317; MOMANY C, 1995, J MOL BIOL, V252, P643, DOI 10.1006/jmbi.1995.0526; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NASON A, 1971, P NATL ACAD SCI USA, V68, P3242, DOI 10.1073/pnas.68.12.3242; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; RAJAGOPALAN KV, 1992, J BIOL CHEM, V267, P10199; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Santamaria-Araujo JA, 2004, J BIOL CHEM, V279, P15994, DOI 10.1074/jbc.M311815200; Schwarz G, 2005, CELL MOL LIFE SCI, V62, P2792, DOI 10.1007/s00018-005-5269-y; Schwarz G, 1997, J BIOL CHEM, V272, P26811, DOI 10.1074/jbc.272.43.26811; Temple CA, 2000, ARCH BIOCHEM BIOPHYS, V383, P281, DOI 10.1006/abbi.2000.2089; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Vergnes A, 2004, J BIOL CHEM, V279, P41398, DOI 10.1074/jbc.M407087200; WAHL RC, 1982, J BIOL CHEM, V257, P3958; Witte CP, 1998, FEBS LETT, V431, P205, DOI 10.1016/S0014-5793(98)00756-X	53	54	56	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					30186	30194		10.1074/jbc.M603919200	http://dx.doi.org/10.1074/jbc.M603919200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16873364	hybrid			2022-12-27	WOS:000240896300079
J	Frey, N; Brixius, K; Schwinger, RHG; Benis, T; Karpowski, A; Lorenzen, HP; Luedde, M; Katus, HA; Franz, WM				Frey, Norbert; Brixius, Klara; Schwinger, Robert H. G.; Benis, Thomas; Karpowski, Alex; Lorenzen, Hans P.; Luedde, Mark; Katus, Hugo A.; Franz, Wolfgang M.			Alterations of tension-dependent ATP utilization in a transgenic rat model of hypertrophic cardiomyopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC TROPONIN-T; PROTEIN-KINASE-C; MOUSE MODEL; DIASTOLIC DYSFUNCTION; CELLULAR MECHANISMS; THIN FILAMENT; IN-VIVO; MUTATIONS; MUSCLE; PHOSPHORYLATION	Although it is established that familial hypertrophic cardiomyopathy ( FHC) is caused by mutations in several sarcomeric proteins, including cardiac troponin T ( TnT), its pathogenesis is still not completely understood. Previously, we established a transgenic rat model of FHC expressing a human TnT molecule with a truncation mutation ( DEL- TnT). This study investigated whether contractile dysfunction and electrical vulnerability observed in DEL- TnT rats might be due to alterations of intracellular Ca2+ homeostasis, myofibrillar Ca2+ sensitivity, and/ or myofibrillar ATP utilization. Simultaneous measurements of the force of contraction and intracellular Ca2+ transients were performed in right ventricular trabeculae of DEL- TnT hearts at 0.25 and 1.0 Hz. Rats expressing wild-type human TnT as well as nontransgenic rats served as controls. In addition, calcium- dependent ATPase activity and tension development were investigated in skinned cardiac muscle fibers. Force of contraction was significantly decreased in DEL- TnT compared with nontransgenic rats and TnT. Time parameters of Ca2+ transients were unchanged at 0.25 Hz but prolonged at 1.0 Hz in DEL- TnT. The amplitude of the fura-2 transient was similar in all groups investigated, whereas diastolic and systolic fura-2 ratios were found elevated in rats expressing nontruncated human troponin T. In DEL- TnT rats, myofibrillar Ca2+ dependent tension development as well as Ca2+ sensitivity of tension were significantly decreased, whereas tension- dependent ATP consumption ("tension cost") was markedly increased. Thus, a C-terminal truncation of the cardiac TnT molecule impairs the force- generating capacity of the cycling cross- bridges resulting in increased tension- dependent ATP utilization. Taken together, our data support the hypothesis of energy compromise a contributing factor in the pathogenesis of FHC.	Univ Heidelberg, Dept Med 3, D-69120 Heidelberg, Germany; Univ Cologne, Clin Internal Med 3, Lab Muscle Res & Mol Cardiol, D-50924 Cologne, Germany; Klinikum Weiden, Med Klin 2, D-92637 Weiden, Germany; Univ Hamburg, Dept Surg, D-20249 Hamburg, Germany; Klinikum Hannover Oststadt, Dept Med 1, D-30659 Hannover, Germany; Univ Munich, Med Clin & Policlin 1, D-81377 Munich, Germany	Ruprecht Karls University Heidelberg; University of Cologne; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University of Munich	Frey, N (corresponding author), Univ Heidelberg, Dept Med 3, Neuenheimer Feld 410, D-69120 Heidelberg, Germany.	Norbert_Frey@med.uni-heidelberg.de	Frey, Norbert/A-9695-2010; Frey, Norbert/M-7749-2019	Frey, Norbert/0000-0001-7611-378X				Alpert NR, 2002, AM J PHYSIOL-HEART C, V283, pH1446, DOI 10.1152/ajpheart.00274.2002; Arad M, 2002, HUM MOL GENET, V11, P2499, DOI 10.1093/hmg/11.20.2499; Ashrafian H, 2003, TRENDS GENET, V19, P263, DOI 10.1016/S0168-9525(03)00081-7; BASSANI JWM, 1994, J PHYSIOL-LONDON, V476, P279, DOI 10.1113/jphysiol.1994.sp020130; Bottinelli R, 1998, CIRC RES, V82, P106; Brixius K, 2000, J PHARMACOL EXP THER, V295, P1284; Brixius K, 1997, J APPL PHYSIOL, V83, P652, DOI 10.1152/jappl.1997.83.2.652; Crilley JG, 2003, J AM COLL CARDIOL, V41, P1776, DOI 10.1016/S0735-1097(02)03009-7; Cuda G, 1997, J MUSCLE RES CELL M, V18, P275, DOI 10.1023/A:1018613907574; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; Franz WM, 2001, LANCET, V358, P1627, DOI 10.1016/S0140-6736(01)06657-0; Frey N, 2000, NAT MED, V6, P1221, DOI 10.1038/81321; Frey N, 2000, CARDIOVASC RES, V47, P254, DOI 10.1016/S0008-6363(00)00114-0; Gomes AV, 2004, MOL CELL BIOCHEM, V263, P115, DOI 10.1023/B:MCBI.0000041853.20588.a0; GREASER ML, 1971, J BIOL CHEM, V246, P4226; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GUTH K, 1986, PFLUG ARCH EUR J PHY, V407, P552, DOI 10.1007/BF00657515; HEELEY DH, 1987, J BIOL CHEM, V262, P9971; HILL AV, 1910, J PHYSIOL-LONDON, V40, P463; Javadpour MM, 2003, J CLIN INVEST, V112, P768, DOI 10.1172/JC1200315967; Knollmann BC, 2003, CIRC RES, V92, P428, DOI 10.1161/01.RES.0000059562.91384.1A; Lehman W, 2001, J MOL BIOL, V307, P739, DOI 10.1006/jmbi.2001.4514; Lehrer SS, 1998, J MOL BIOL, V277, P1081, DOI 10.1006/jmbi.1998.1654; Lodi R, 1999, P NATL ACAD SCI USA, V96, P11492, DOI 10.1073/pnas.96.20.11492; Malnic B, 1998, J BIOL CHEM, V273, P10594, DOI 10.1074/jbc.273.17.10594; Marian AJ, 2001, J MOL CELL CARDIOL, V33, P655, DOI 10.1006/jmcc.2001.1340; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; Miller T, 2001, J BIOL CHEM, V276, P3743, DOI 10.1074/jbc.M006746200; Montgomery DE, 2001, J PHYSIOL-LONDON, V536, P583, DOI 10.1111/j.1469-7793.2001.0583c.xd; Montgomery DE, 2001, AM J PHYSIOL-HEART C, V280, pH1011, DOI 10.1152/ajpheart.2001.280.3.H1011; Moolman JC, 1997, J AM COLL CARDIOL, V29, P549, DOI 10.1016/S0735-1097(96)00530-X; NOLAND TA, 1989, J BIOL CHEM, V264, P20778; Oberst L, 1998, J CLIN INVEST, V102, P1498, DOI 10.1172/JCI4088; OHTSUKI I, 1986, ADV PROTEIN CHEM, V38, P1, DOI 10.1016/S0065-3233(08)60525-2; Perry SV, 1998, J MUSCLE RES CELL M, V19, P575; POTTER JD, 1995, J BIOL CHEM, V270, P2557, DOI 10.1074/jbc.270.6.2557; Schwinger RHG, 2000, BASIC RES CARDIOL, V95, P12, DOI 10.1007/s003950050003; Semsarian C, 2002, J CLIN INVEST, V109, P1013, DOI 10.1172/JCI200214677; Solaro RJ, 1996, J MOL CELL CARDIOL, V28, P217; Spindler M, 1998, J CLIN INVEST, V101, P1775, DOI 10.1172/JCI1940; Stelzer JE, 2004, AM J PHYSIOL-HEART C, V287, pH1756, DOI 10.1152/ajpheart.00172.2004; Sumandea MP, 2003, J BIOL CHEM, V278, P35135, DOI 10.1074/jbc.M306325200; Sweeney HL, 1998, P NATL ACAD SCI USA, V95, P14406, DOI 10.1073/pnas.95.24.14406; Tanaka T, 1997, J MOL CELL CARDIOL, V29, P121, DOI 10.1006/jmcc.1996.0257; Tardiff JC, 1998, J CLIN INVEST, V101, P2800, DOI 10.1172/JCI2389; THIERFELDER L, 1994, CELL, V77, P701, DOI 10.1016/0092-8674(94)90054-X; Tobacman LS, 1999, J BIOL CHEM, V274, P28363, DOI 10.1074/jbc.274.40.28363; Tyska MJ, 2000, CIRC RES, V86, P737, DOI 10.1161/01.RES.86.7.737; Vahebi S, 2005, CIRC RES, V96, P740, DOI 10.1161/01.RES.0000162457.56568.7d; Zobel C, 1998, J MOL MED, V76, P533, DOI 10.1007/s001090050247	50	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					29575	29582		10.1074/jbc.M507740200	http://dx.doi.org/10.1074/jbc.M507740200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16882671	hybrid			2022-12-27	WOS:000240896300019
J	Lad, Y; McHugh, B; Hodkinson, PS; MacKinnon, AC; Haslett, C; Ginsberg, MH; Sethi, T				Lad, Yatish; McHugh, Brian; Hodkinson, Philip S.; MacKinnon, Alison C.; Haslett, Christopher; Ginsberg, Mark H.; Sethi, Tariq			Phospholipase C epsilon suppresses integrin activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TALIN-BINDING; CELL-ADHESION; R-RAS; AFFINITY MODULATION; KINASE PATHWAY; MAP KINASE; PROTEIN; DOMAIN; RECEPTOR; IDENTIFICATION	Phospholipase C epsilon(PLC epsilon) is a newly described effector of the small GTP-binding protein H-Ras. Utilizing H-Ras effector mutants, we show that mutants H-Ras(G12V/E37G) and H-Ras(G12V/D38N) suppressed integrin activation in an ERK-independent manner. H-Ras(G12V/D38N) specifically activated the PLC epsilon effector pathway and suppressed integrin activation. Inhibition of PLC epsilon activation with a kinase-dead PLC epsilon mutant prevented H-Ras(G12V/D38N) from suppressing integrin activation, and low level expression of H-Ras(G12V/D38N) could synergize with wild-type PLC epsilon to suppress integrins. In addition, knockdown of endogenous PLC epsilon with small interfering RNA blocked H-Ras(G12V/D38N)-mediated integrin suppression. Suppressing integrin function with the H-Ras(G12V/D38N) mutant reduced cell adhesion to von Willebrand factor and fibronectin; this reduction in cell adhesion was blocked by coexpression of the kinase-dead PLC epsilon mutant. These results show that H-Ras suppresses integrin affinity via independent Raf and PLC epsilon signaling pathways and demonstrate a new physiological function for PLC epsilon in the regulation of integrin activation.	Univ Edinburgh, Queens Med Res Inst, Med Res Council Ctr Inflammat Res, Edinburgh EH16 4SA, Midlothian, Scotland; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of Edinburgh; University of California System; University of California San Diego	Sethi, T (corresponding author), Univ Edinburgh, Queens Med Res Inst, Med Res Council Ctr Inflammat Res, 47 Little France Crescent, Edinburgh EH16 4SA, Midlothian, Scotland.	t.sethi@ed.ac.uk		McHugh, Brian/0000-0003-4747-0643	MRC [G84/6336] Funding Source: UKRI; Medical Research Council [G9900991B] Funding Source: researchfish; Medical Research Council [G84/6336] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Akasaka K, 1996, J BIOL CHEM, V271, P5353, DOI 10.1074/jbc.271.10.5353; Bai YF, 2004, CANCER RES, V64, P8808, DOI 10.1158/0008-5472.CAN-04-3143; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; Brinkmann T, 2002, J BIOL CHEM, V277, P12525, DOI 10.1074/jbc.M109176200; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; Chou FL, 2003, J BIOL CHEM, V278, P52587, DOI 10.1074/jbc.M309322200; de Bruyn KMT, 2003, J BIOL CHEM, V278, P22412, DOI 10.1074/jbc.M212036200; DIAZMECO MT, 1994, J BIOL CHEM, V269, P31706; Feig LA, 1996, TRENDS BIOCHEM SCI, V21, P438, DOI 10.1016/S0968-0004(96)10058-X; HAN LM, 1995, MOL CELL BIOL, V15, P1318; Hansen M, 2002, ONCOGENE, V21, P4448, DOI 10.1038/sj.onc.1205538; HORWITZ A, 1986, NATURE, V320, P531, DOI 10.1038/320531a0; Hughes PE, 2002, MOL BIOL CELL, V13, P2256, DOI 10.1091/mbc.01-10-0480; Hughes PE, 1998, TRENDS CELL BIOL, V8, P359, DOI 10.1016/S0962-8924(98)01339-7; Hughes PE, 1997, CELL, V88, P521, DOI 10.1016/S0092-8674(00)81892-9; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Illenberger D, 1998, EMBO J, V17, P6241, DOI 10.1093/emboj/17.21.6241; JANMEY PA, 1994, ANNU REV PHYSIOL, V56, P169, DOI 10.1146/annurev.ph.56.030194.001125; Jin TG, 2001, J BIOL CHEM, V276, P30301, DOI 10.1074/jbc.M103530200; Kelley GG, 2006, J BIOL CHEM, V281, P2639, DOI 10.1074/jbc.M507681200; Kelley GG, 2001, EMBO J, V20, P743, DOI 10.1093/emboj/20.4.743; Kuriyama M, 1996, J BIOL CHEM, V271, P607, DOI 10.1074/jbc.271.2.607; Leblanc V, 1998, MOL CELL BIOL, V18, P5567, DOI 10.1128/MCB.18.9.5567; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Lopez I, 2001, J BIOL CHEM, V276, P2758, DOI 10.1074/jbc.M008119200; MAJERUS PW, 1990, CELL, V63, P459, DOI 10.1016/0092-8674(90)90442-H; Malumbres M, 1998, FRONT BIOSCI-LANDMRK, V3, P887; Martel V, 2001, J BIOL CHEM, V276, P21217, DOI 10.1074/jbc.M102373200; OTOOLE TE, 1990, CELL REGUL, V1, P883, DOI 10.1091/mbc.1.12.883; Patil S, 1999, J BIOL CHEM, V274, P28575, DOI 10.1074/jbc.274.40.28575; Ramos JW, 1996, J CELL BIOL, V134, P227, DOI 10.1083/jcb.134.1.227; Rebstein PJ, 1997, EXP CELL RES, V231, P276, DOI 10.1006/excr.1996.3466; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; Sethi T, 1999, MOL BIOL CELL, V10, P1799, DOI 10.1091/mbc.10.6.1799; SHATTIL SJ, 1987, J BIOL CHEM, V262, P992; Shattil SJ, 1998, BLOOD, V91, P2645, DOI 10.1182/blood.V91.8.2645.2645_2645_2657; Shibatohge M, 1998, J BIOL CHEM, V273, P6218, DOI 10.1074/jbc.273.11.6218; Shibayama H, 1998, CELL IMMUNOL, V187, P27, DOI 10.1006/cimm.1998.1318; Song C, 2001, J BIOL CHEM, V276, P2752, DOI 10.1074/jbc.M008324200; Song CH, 2002, ONCOGENE, V21, P8105, DOI 10.1038/sj.onc.1206003; Sorli SC, 2005, ONCOGENE, V24, P90, DOI 10.1038/sj.onc.1208168; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Webb CP, 1998, P NATL ACAD SCI USA, V95, P8773, DOI 10.1073/pnas.95.15.8773; WHITE MA, 1995, CELL, V80, P533, DOI 10.1016/0092-8674(95)90507-3; Wing MR, 2001, J BIOL CHEM, V276, P48257, DOI 10.1074/jbc.C100574200; Wolthuis RMF, 1998, MOL CELL BIOL, V18, P2486, DOI 10.1128/MCB.18.5.2486; Yan B, 2001, J BIOL CHEM, V276, P28164, DOI 10.1074/jbc.M104161200; ZHANG XF, 1993, NATURE, V364, P308, DOI 10.1038/364308a0; Zhang ZH, 1996, CELL, V85, P61, DOI 10.1016/S0092-8674(00)81082-X	52	10	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					29501	29512		10.1074/jbc.M513471200	http://dx.doi.org/10.1074/jbc.M513471200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16895916	hybrid			2022-12-27	WOS:000240896300012
J	De Rivoyre, M; Ruel, L; Varjosalo, M; Loubat, A; Bidet, M; Therond, P; Mus-Veteau, I				De Rivoyre, Matthieu; Ruel, Laurent; Varjosalo, Markku; Loubat, Agnes; Bidet, Michel; Therond, Pascal; Mus-Veteau, Isabelle			Human receptors patched and smoothened partially transduce hedgehog signal when expressed in Drosophila cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SONIC HEDGEHOG; CUBITUS INTERRUPTUS; SCHNEIDER-2 CELLS; PROTEIN COSTAL2; PHOSPHORYLATION; MUTATIONS; KINASE; CANCER; INTERNALIZATION; IDENTIFICATION	In humans, dysfunctions of the Hedgehog receptors Patched and Smoothened are responsible for numerous pathologies. However, signaling mechanisms involving these receptors are less well characterized in mammals than in Drosophila. To obtain structure-function relationship information on human Patched and Smoothened, we expressed these human receptors in Drosophila Schneider 2 cells. We show here that, as its Drosophila counterpart, human Patched is able to repress the signaling pathway in the absence of Hedgehog ligand. In response to Hedgehog, human Patched is able to release Drosophila Smoothened inhibition, suggesting that human Patched is expressed in a functional state in Drosophila cells. We also provide experiments showing that human Smo, when expressed in Schneider cells, is able to bind the alkaloid cyclopamine, suggesting that it is expressed in a native conformational state. Furthermore, contrary to Drosophila Smoothened, human Smoothened does not interact with the kinesin Costal 2 and thus is unable to transduce the Hedgehog signal. Moreover, cell surface fluorescent labeling suggest that human Smoothened is enriched at the Schneider 2 plasma membrane in response to Hedgehog. These results suggest that human Smoothened is expressed in a functional state in Drosophila cells, where it undergoes a regulation of its localization comparable with its Drosophila homologue. Thus, we propose that the upstream part of the Hedgehog pathway involving Hedgehog interaction with Patched, regulation of Smoothened by Patched, and Smoothened enrichment at the plasma membrane is highly conserved between Drosophila and humans; in contrast, signaling downstream of Smoothened is different.	CNRS, UMR 6543, Ctr Biochim, Inst Signaling Dev Biol & Canc Res, F-06108 Nice 02, France; Univ Nice, UMR 6548, CNRS, Lab Physiol Cellulaire & Mol, F-06108 Nice 2, France; Univ Helsinki, Dept Virol, Biomedicum, Haartman Inst, FIN-00014 Helsinki, Finland; Fac Med, INSERM U364, F-06107 Nice 02, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; University of Helsinki; Institut National de la Sante et de la Recherche Medicale (Inserm)	Therond, P (corresponding author), CNRS, UMR 6543, Ctr Biochim, Inst Signaling Dev Biol & Canc Res, Parv Valrose, F-06108 Nice 02, France.	Pascal.THEROND@unice.fr; Isabelle.Mus-Veteau@unice.fr	Michel, BIDET/B-6966-2009; Therond, pascal/AAE-4811-2019; Varjosalo, Markku/K-6424-2015; Mus-veteau, Isabelle/M-8875-2016	Varjosalo, Markku/0000-0002-1340-9732; Mus-veteau, Isabelle/0000-0001-5739-7684				Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; Benting J, 2000, ANAL BIOCHEM, V278, P59, DOI 10.1006/abio.1999.4409; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Briscoe J, 2005, DEV CELL, V8, P143, DOI 10.1016/j.devcel.2005.01.008; Chen CH, 1999, CELL, V98, P305, DOI 10.1016/S0092-8674(00)81960-1; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen MH, 2005, MOL CELL BIOL, V25, P7042, DOI 10.1128/MCB.25.16.7042-7053.2005; Chen W, 2004, SCIENCE, V306, P2257, DOI 10.1126/science.1104135; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Corcoran RB, 2006, P NATL ACAD SCI USA, V103, P8408, DOI 10.1073/pnas.0602852103; De Rivoyre M, 2005, FEBS LETT, V579, P1529, DOI 10.1016/j.febslet.2005.01.054; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; HOOPER JE, 1989, CELL, V59, P751, DOI 10.1016/0092-8674(89)90021-4; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; IALTABA AR, 2002, NAT REV CANCER, V2, P361; Incardona JP, 2002, CURR BIOL, V12, P983, DOI 10.1016/S0960-9822(02)00895-3; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jia JH, 2004, NATURE, V432, P1045, DOI 10.1038/nature03179; Kalderon D, 2004, CURR BIOL, V14, pR67, DOI 10.1016/j.cub.2003.12.047; Kurihara R, 2006, J BIOL CHEM, V281, P12908, DOI 10.1074/jbc.M510871200; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; Lum L, 2003, SCIENCE, V299, P2039, DOI 10.1126/science.1081403; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Merchant M, 2005, MOL CELL BIOL, V25, P7054, DOI 10.1128/MCB.25.16.7054-7068.2005; Murone M, 1999, EXP CELL RES, V253, P25, DOI 10.1006/excr.1999.4676; Ogden SK, 2003, CURR BIOL, V13, P1998, DOI 10.1016/j.cub.2003.10.004; Perret BG, 2003, PROTEIN EXPRES PURIF, V31, P123, DOI 10.1016/S1046-5928(03)00140-2; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Robbins DJ, 1997, CELL, V90, P225, DOI 10.1016/S0092-8674(00)80331-1; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Ruel L, 2003, NAT CELL BIOL, V5, P907, DOI 10.1038/ncb1052; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Strutt H, 2001, CURR BIOL, V11, P608, DOI 10.1016/S0960-9822(01)00179-8; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Therond PP, 1996, P NATL ACAD SCI USA, V93, P4224, DOI 10.1073/pnas.93.9.4224; Torroja C, 2005, J NEUROBIOL, V64, P334, DOI 10.1002/neu.20168; Torroja C, 2004, DEVELOPMENT, V131, P2395, DOI 10.1242/dev.01102; TOTA MR, 1995, J BIOL CHEM, V270, P26466, DOI 10.1074/jbc.270.44.26466; Varjosalo M, 2006, DEV CELL, V10, P177, DOI 10.1016/j.devcel.2005.12.014; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Zhang C, 2004, P NATL ACAD SCI USA, V101, P17900, DOI 10.1073/pnas.0408093101	47	16	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					28584	28595		10.1074/jbc.M512986200	http://dx.doi.org/10.1074/jbc.M512986200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16867986	hybrid			2022-12-27	WOS:000240680500012
J	Kakimoto, T; Katoh, H; Negishi, M				Kakimoto, Tetsuhiro; Katoh, Hironori; Negishi, Manabu			Regulation of neuronal morphology by Toca-1, an F-BAR/EFC protein that induces plasma membrane invagination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALDRICH-SYNDROME PROTEIN; N-WASP; INTERSTITIAL BRANCHES; HIPPOCAMPAL-NEURONS; ACTIN CYTOSKELETON; AXONAL GROWTH; GTPASE; ENDOCYTOSIS; RAPOSTLIN; EFFECTOR	Actin reorganization is important for regulation of neuronal morphology. Neural Wiskott-Aldrich syndrome protein (N-WASP) is an important regulator of actin polymerization and also known to be strongly expressed in brain. Recently, Toca-1 (transducer of Cdc42-dependent actin assembly) has been shown to be required for Cdc42 to activate N-WASP from biochemical experiments. Toca-1 has three functional domains: an F-BAR/EFC domain at the N terminus, an HR1 at the center, and an SH3 domain at the C terminus. The F-BAR/EFC domain induces tubular invagination of plasma membrane, while Toca-1 binds both N-WASP and Cdc42 through the SH3 domain and the HR1, respectively. However, the physiological role of Toca-1 is completely unknown. Here we have investigated the neural function of Toca-1. Toca-1 is strongly expressed in neurons including hippocampal neurons in developing brain at early times. Knockdown of Toca-1 in PC12 cells significantly enhances neurite elongation. Consistently, overexpression of Toca-1 suppresses neurite elongation through the F-BAR/EFC domain with a membrane invaginating property, suggesting an implication of membrane trafficking in the neural function of Toca-1. In addition, knockdown of N-WASP, to our surprise, also enhances neurite elongation in PC12 cells, which is in clear contrast to the previous report that dominant negative mutants of N-WASP suppress neurite extension in PC12 cells. On the other hand, knockdown of Toca-1 in cultured rat hippocampal neurons enhances axon branching a little but not axon elongation, while knockdown of N-WASP enhances both axon elongation and branching. These results suggest that a vesicle trafficking regulator Toca-1 regulates different aspects of neuronal morphology from N-WASP.	Kyoto Univ, Grad Sch Biostudies, Lab Mol Neurobiol, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University	Negishi, M (corresponding author), Kyoto Univ, Grad Sch Biostudies, Lab Mol Neurobiol, Sakyo Ku, Kyoto 6068501, Japan.	mnegishi@pharm.kyoto-u.ac.jp	kakimoto, tetsuhiro/W-1403-2019	Kakimoto, Tetsuhiro/0000-0003-1349-5690; Katoh, Hironori/0000-0002-8191-8117				Banzai Y, 2000, J BIOL CHEM, V275, P11987, DOI 10.1074/jbc.275.16.11987; Dent EW, 1999, J NEUROSCI, V19, P8894, DOI 10.1523/JNEUROSCI.19-20-08894.1999; Fujita H, 2002, J BIOL CHEM, V277, P45428, DOI 10.1074/jbc.M208090200; Futerman AH, 1996, TRENDS NEUROSCI, V19, P144, DOI 10.1016/S0166-2236(96)80025-7; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Ishikawa Y, 2003, J NEUROSCI, V23, P11065; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Jareb M, 1997, J NEUROSCI, V17, P8955; Kakimoto T, 2004, J BIOL CHEM, V279, P14104, DOI 10.1074/jbc.M312763200; Kamioka Y, 2004, J BIOL CHEM, V279, P40091, DOI 10.1074/jbc.M404899200; Katoh H, 2006, BRAIN RES, V1073, P103, DOI 10.1016/j.brainres.2005.12.085; Katoh H, 2003, NATURE, V424, P461, DOI 10.1038/nature01817; Martinez-Quiles N, 2001, NAT CELL BIOL, V3, P484, DOI 10.1038/35074551; Miki H, 2003, J BIOCHEM, V134, P309, DOI 10.1093/jb/mvg146; Miki H, 1996, EMBO J, V15, P5326, DOI 10.1002/j.1460-2075.1996.tb00917.x; Negishi M, 2002, J BIOCHEM, V132, P157, DOI 10.1093/oxfordjournals.jbchem.a003205; Oinuma I, 2004, SCIENCE, V305, P862, DOI 10.1126/science.1097545; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Strasser GA, 2004, NEURON, V43, P81, DOI 10.1016/j.neuron.2004.05.015; Szebenyi G, 1998, J NEUROSCI, V18, P7930; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091	22	43	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					29042	29053		10.1074/jbc.M604025200	http://dx.doi.org/10.1074/jbc.M604025200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16885158	hybrid			2022-12-27	WOS:000240680500059
J	Rouget, C; Papin, C; Mandart, E				Rouget, Christel; Papin, Catherine; Mandart, Elisabeth			Cytoplasmic CstF-77 protein belongs to a masking complex with cytoplasmic polyadenylation element-binding protein in Xenopus oocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA TRANSLATION; CLEAVAGE STIMULATION FACTOR; SPECIFICITY FACTOR; PROCESSING BODIES; COILED BODIES; POLY(A) POLYMERASE; 3'-END FORMATION; STRESS GRANULES; FORKED PROTEIN; LAEVIS OOCYTES	Regulated mRNA translation is a hallmark of oocytes and early embryos, of which cytoplasmic polyadenylation is a major mechanism. This process involves multiple protein components, including the CPSF (cleavage and polyadenylation specificity factor), which is also required for nuclear polyadenylation. The CstF (cleavage stimulatory factor), with CPSF, is required for the pre-mRNA cleavage before nuclear polyadenylation. However, some evidence suggests that the CstF-77 subunit might have a function independent of nuclear polyadenylation, which could be related to the cell cycle. As such, we addressed the question whether CstF-77 might have a role in cytoplasmic polyadenylation. We investigated the function of the CstF-77 protein in Xenopus oocytes, and show that CstF-77 has indeed a role in the cytoplasm. The Xenopus CstF-77 protein (X77K) localizes mainly to the nucleus, but also in punctuate cytoplasmic foci. We show that X77K resides in a cytoplasmic complex with eIF4E, CPEB (cytoplasmic polyadenylation element-binding protein), CPSF-100 and XGLD2, but is not required for cytoplasmic polyadenylation per se. Impairment of X77K function in ovo leads to an acceleration of the G(2)/M transition, with a premature synthesis of Mos and AuroraA proteins. However, the kinetic of Mos mRNA polyadenylation is not modified. Furthermore, X77K represses mRNA translation in vitro. These results suggest that X77K could be involved in masking of mRNA prior to polyadenylation.	CNRS, CRBM, F-34293 Montpellier 05, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Mandart, E (corresponding author), CNRS, CRBM, 1919 Route Mende, F-34293 Montpellier 05, France.	elisabeth.mandart@crbm.cnrs.fr						Andrei MA, 2005, RNA, V11, P717, DOI 10.1261/rna.2340405; Audibert A, 1998, MECH DEVELOP, V72, P53, DOI 10.1016/S0925-4773(98)00017-3; Audibert A, 1999, MECH DEVELOP, V82, P41, DOI 10.1016/S0925-4773(99)00011-8; Barnard DC, 2004, CELL, V119, P641, DOI 10.1016/j.cell.2004.10.029; BIENROTH S, 1991, J BIOL CHEM, V266, P19768; BILGER A, 1994, GENE DEV, V8, P1106, DOI 10.1101/gad.8.9.1106; Bleoo S, 2001, MOL BIOL CELL, V12, P3046, DOI 10.1091/mbc.12.10.3046; BONNEAUD N, 1994, J CELL SCI, V107, P913; Brendolise C, 2002, MOL GENET GENOMICS, V267, P515, DOI 10.1007/s00438-002-0684-3; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Cao QP, 2002, EMBO J, V21, P3852, DOI 10.1093/emboj/cdf353; Charlesworth A, 2004, J BIOL CHEM, V279, P17650, DOI 10.1074/jbc.M313837200; Charlesworth A, 2002, EMBO J, V21, P2798, DOI 10.1093/emboj/21.11.2798; Collier B, 2005, EMBO J, V24, P2656, DOI 10.1038/sj.emboj.7600738; Dickson KS, 1999, MOL CELL BIOL, V19, P5707; Edmonds M, 2002, PROG NUCLEIC ACID RE, V71, P285, DOI 10.1016/S0079-6603(02)71046-5; Gall JG, 2003, NAT REV MOL CELL BIO, V4, P975, DOI 10.1038/nrm1262; Gall JG, 1999, MOL BIOL CELL, V10, P4385, DOI 10.1091/mbc.10.12.4385; GILMARTIN GM, 1991, MOL CELL BIOL, V11, P2432, DOI 10.1128/MCB.11.5.2432; HAKE LE, 1994, CELL, V79, P617, DOI 10.1016/0092-8674(94)90547-9; Hofmann I, 2002, MOL BIOL CELL, V13, P1665, DOI 10.1091/mbc.01-12-0567; Kaufmann I, 2004, EMBO J, V23, P616, DOI 10.1038/sj.emboj.7600070; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Ladomery M, 1997, NUCLEIC ACIDS RES, V25, P965, DOI 10.1093/nar/25.5.965; Mandart E, 1998, MOL GEN GENET, V258, P16, DOI 10.1007/s004380050702; MANDART E, 1995, MOL CELL BIOL, V15, P6979; MCGREW LL, 1990, EMBO J, V9, P3743, DOI 10.1002/j.1460-2075.1990.tb07587.x; Mendez R, 2001, NAT REV MOL CELL BIO, V2, P521, DOI 10.1038/35080081; Minshall N, 2001, RNA, V7, P1728, DOI 10.1017/S135583820101158X; Minshall N, 2004, NUCLEIC ACIDS RES, V32, P1325, DOI 10.1093/nar/gkh303; MINVIELLESEBASTIA L, 1994, SCIENCE, V266, P1702, DOI 10.1126/science.7992054; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; MURTHY KGK, 1992, J BIOL CHEM, V267, P14804; MURTHY KGK, 1995, GENE DEV, V9, P2672, DOI 10.1101/gad.9.21.2672; Nakahata S, 2001, J BIOL CHEM, V276, P20945, DOI 10.1074/jbc.M010528200; Nakamura A, 2004, DEV CELL, V6, P69, DOI 10.1016/S1534-5807(03)00400-3; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; Padmanabhan K, 2006, GENE DEV, V20, P199, DOI 10.1101/gad.1383106; Papin C, 2000, DEV BIOL, V217, P166, DOI 10.1006/dbio.1999.9531; Preker PJ, 1998, TRENDS BIOCHEM SCI, V23, P15, DOI 10.1016/S0968-0004(97)01156-0; Proudfoot N, 2004, CURR OPIN CELL BIOL, V16, P272, DOI 10.1016/j.ceb.2004.03.007; Reverte CG, 2001, DEV BIOL, V231, P447, DOI 10.1006/dbio.2001.0153; Rouhana L, 2005, RNA, V11, P1117, DOI 10.1261/rna.2630205; Rouillard JM, 2000, MOL GEN GENET, V262, P1103, DOI 10.1007/PL00008653; SAGATA N, 1988, NATURE, V335, P519, DOI 10.1038/335519a0; SALLES FJ, 1995, PCR METH APPL, V4, P317; Schul W, 1999, MOL BIOL CELL, V10, P3815, DOI 10.1091/mbc.10.11.3815; Schul W, 1996, EMBO J, V15, P2883, DOI 10.1002/j.1460-2075.1996.tb00649.x; Stebbins-Boaz B, 1999, MOL CELL, V4, P1017, DOI 10.1016/S1097-2765(00)80230-0; TAKAGAKI Y, 1990, GENE DEV, V4, P2112, DOI 10.1101/gad.4.12a.2112; TAKAGAKI Y, 1994, NATURE, V372, P471, DOI 10.1038/372471a0; Takagaki Y, 2000, MOL CELL BIOL, V20, P1515, DOI 10.1128/MCB.20.5.1515-1525.2000; Wallace AM, 1999, P NATL ACAD SCI USA, V96, P6763, DOI 10.1073/pnas.96.12.6763; Wang LT, 2002, NATURE, V419, P312, DOI 10.1038/nature01039; WEISS EA, 1991, EMBO J, V10, P215, DOI 10.1002/j.1460-2075.1991.tb07938.x; Wilczynska A, 2005, J CELL SCI, V118, P981, DOI 10.1242/jcs.01692; WILUSZ J, 1990, MOL CELL BIOL, V10, P1244, DOI 10.1128/MCB.10.3.1244; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999	58	14	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2006	281	39					28687	28698		10.1074/jbc.M601116200	http://dx.doi.org/10.1074/jbc.M601116200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	086NO	16882666	Green Submitted, hybrid			2022-12-27	WOS:000240680500022
J	Fan, HP; Fan, FJ; Bao, L; Pei, G				Fan, Hua-Ping; Fan, Feng-Juan; Bao, Lan; Pei, Gang			SNAP-25/syntaxin 1A complex functionally modulates neurotransmitter gamma-aminobutyric acid reuptake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; CFTR CHLORIDE CHANNELS; SYNTAXIN 1A; GABA TRANSPORTER; SEROTONIN TRANSPORTER; H3 DOMAIN; EXPRESSION; TRAFFICKING; KV2.1; ACTIVATION	Neurotransmitter gamma-aminobutyric acid (GABA) release to the synaptic clefts is mediated by the formation of a soluble N-ethylmaleimidesensitive factor attachment protein receptor (SNARE) complex, which includes two target SNAREs syntaxin 1A and SNAP-25 and one vesicle SNARE VAMP-2. The target SNAREs syntaxin 1A and SNAP-25 form a heterodimer, the putative intermediate of the SNARE complex. Neurotransmitter GABA clearance from synaptic clefts is carried out by the reuptake function of its transporters to terminate the postsynaptic signaling. Syntaxin 1A directly binds to the neuronal GABA transporter GAT-1 and inhibits its reuptake function. However, whether other SNARE proteins or SNARE complex regulates GABA reuptake remains unknown. Here we demonstrate that SNAP-25 efficiently inhibits GAT-1 reuptake function in the presence of syntaxin 1A. This inhibition depends on SNAP-25/syntaxin 1A complex formation. The H3 domain of syntaxin 1A is identified as the binding sites for both SNAP-25 and GAT-1. SNAP-25 binding to syntaxin 1A greatly potentiates the physical interaction of syntaxin 1A with GAT-1 and significantly enhances the syntaxin 1A-mediated inhibition of GAT-1 reuptake function. Furthermore, nitric oxide, which promotes SNAP-25 binding to syntaxin 1A to form the SNARE complex, also potentiates the interaction of syntaxin 1A with GAT-1 and suppresses GABA reuptake by GAT-1. Thus our findings delineate a further molecular mechanism for the regulation of GABA reuptake by a target SNARE complex and suggest a direct coordination between GABA release and reuptake.	Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, Shanghai 200031, Peoples R China; Chinese Acad Sci, Grad Sch, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences	Bao, L (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	baolan@sibs.ac.cn; gpei@sibs.ac.cn	Fan, Huaping/B-8762-2012	Fan, Fengjuan/0000-0001-8727-5258				An SJ, 2004, SCIENCE, V306, P1042, DOI 10.1126/science.1102559; Bao L, 2003, NEURON, V37, P121, DOI 10.1016/S0896-6273(02)01103-0; Beckman ML, 1998, J NEUROSCI, V18, P6103; Beckman ML, 1999, J NEUROSCI, V19; Bernstein EM, 1999, J BIOL CHEM, V274, P889, DOI 10.1074/jbc.274.2.889; Borden LA, 1996, NEUROCHEM INT, V29, P335, DOI 10.1016/0197-0186(95)00158-1; Cai GQ, 2005, FEBS J, V272, P1625, DOI 10.1111/j.1742-4658.2005.04595.x; Chamberlain LH, 2001, P NATL ACAD SCI USA, V98, P5619, DOI 10.1073/pnas.091502398; Cormet-Boyaka E, 2002, P NATL ACAD SCI USA, V99, P12477, DOI 10.1073/pnas.192203899; Cui NG, 2004, J BIOL CHEM, V279, P53259, DOI 10.1074/jbc.M410171200; Cupello A, 1997, NEUROCHEM RES, V22, P1517, DOI 10.1023/A:1021966814942; Deken SL, 2000, NAT NEUROSCI, V3, P998, DOI 10.1038/79939; DINGLEDINE R, 1985, J PHYSIOL-LONDON, V366, P387, DOI 10.1113/jphysiol.1985.sp015804; Fasshauer D, 2004, J BIOL CHEM, V279, P7613, DOI 10.1074/jbc.M312064200; Fergestad T, 2001, J NEUROSCI, V21, P9142, DOI 10.1523/JNEUROSCI.21-23-09142.2001; Gao H, 2004, MOL CELL, V14, P303, DOI 10.1016/S1097-2765(04)00216-3; Geerlings A, 2000, FEBS LETT, V470, P51, DOI 10.1016/S0014-5793(00)01297-7; Haase J, 2001, BIOCHEM SOC T, V29, P722, DOI 10.1042/BST0290722; Horton N, 2001, MOL MEMBR BIOL, V18, P39; Hua YY, 2001, P NATL ACAD SCI USA, V98, P8065, DOI 10.1073/pnas.131214798; ISAACSON JS, 1993, NEURON, V10, P165, DOI 10.1016/0896-6273(93)90308-E; JURSKY F, 1994, J EXP BIOL, V196, P283; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; Leung YM, 2005, BIOCHEM J, V387, P195, DOI 10.1042/BJ20041625; Leung YM, 2003, J BIOL CHEM, V278, P17532, DOI 10.1074/jbc.M213088200; Lin YF, 2004, P NATL ACAD SCI USA, V101, P7799, DOI 10.1073/pnas.0402496101; Liu J, 2004, J BIOL CHEM, V279, P55924, DOI 10.1074/jbc.M410024200; Loranger SS, 2002, J BIOL CHEM, V277, P34303, DOI 10.1074/jbc.M202125200; Meffert MK, 1996, NEURON, V16, P1229, DOI 10.1016/S0896-6273(00)80149-X; MEFFERT MK, 1994, NEURON, V12, P1235, DOI 10.1016/0896-6273(94)90440-5; Michaelevski I, 2003, J BIOL CHEM, V278, P34320, DOI 10.1074/jbc.M304943200; Misura KMS, 2001, J BIOL CHEM, V276, P13273, DOI 10.1074/jbc.M009636200; Mochida S, 2000, NEUROSCI RES, V36, P175, DOI 10.1016/S0168-0102(99)00128-5; Naren AP, 1998, P NATL ACAD SCI USA, V95, P10972, DOI 10.1073/pnas.95.18.10972; Ohkuma S, 1996, MOL BRAIN RES, V36, P137, DOI 10.1016/0169-328X(95)00256-R; Quick MW, 2002, INT J DEV NEUROSCI, V20, P219, DOI 10.1016/S0736-5748(02)00021-7; Quick MW, 1997, J NEUROSCI, V17, P2967; Scholze P, 2002, J BIOL CHEM, V277, P43682, DOI 10.1074/jbc.M205602200; Sipila S, 2004, J NEUROSCI, V24, P5877, DOI 10.1523/JNEUROSCI.1287-04.2004; SOLIS JM, 1992, J NEUROSCI, V12, P3466; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Soudijn W, 2000, CURR MED CHEM, V7, P1063, DOI 10.2174/0929867003374363; Sung U, 2003, J NEUROSCI, V23, P1697; Tran NNP, 1998, J PHYSIOL-LONDON, V507, P163, DOI 10.1111/j.1469-7793.1998.163bu.x; Wang P, 2003, J BIOL CHEM, V278, P6363, DOI 10.1074/jbc.M210350200; Whitworth TL, 2001, J BIOL CHEM, V276, P42932, DOI 10.1074/jbc.M107638200; Xiao JN, 2004, J NEUROSCI RES, V75, P143, DOI 10.1002/jnr.10840; Xu NJ, 2003, J NEUROSCI, V23, P4775; Zhu Y, 2005, J NEUROSCI RES, V79, P503, DOI 10.1002/jnr.20385	49	22	24	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2006	281	38					28174	28184		10.1074/jbc.M601382200	http://dx.doi.org/10.1074/jbc.M601382200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084LM	16861228	hybrid			2022-12-27	WOS:000240534400055
J	Xu, YR; Shao, Y; Voorhees, JJ; Fisher, GJ				Xu, Yiru; Shao, Yuan; Voorhees, John J.; Fisher, Gary J.			Oxidative inhibition of receptor-type protein-tyrosine phosphatase kappa by ultraviolet irradiation activates epidermal growth factor receptor in human keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABSORBING AMINO-ACIDS; INDUCED EGF-RECEPTOR; HYDROGEN-PEROXIDE; SIGNALING PATHWAY; C-FOS; SKIN; OXYGEN; PHOSPHORYLATION; RADIATION; KINASES	Ultraviolet (UV) irradiation rapidly increases tyrosine phosphorylation (i.e. activates) of epidermal growth factor receptors (EGFR) in human skin. EGFR-dependent signaling pathways drive increased expression of matrix metalloproteinases, whose actions fragment collagen and elastin fibers, the primary structural protein components in skin connective tissue. Connective tissue fragmentation, which results from chronic exposure to solar UV irradiation, is a major determinant of premature skin aging (photoaging). UV irradiation generates reactive oxygen species, which readily react with conserved cysteine residues in the active site of protein-tyrosine phosphatases (PTP). We report here that EGFR activation by UV irradiation results from oxidative inhibition of receptor type PTP-kappa (RPTP-kappa). RPTP-kappa directly counters intrinsic EGFR tyrosine kinase activity, thereby maintaining EGFR in an inactive state. Reversible, oxidative inactivation of RPTP-kappa activity by UV irradiation shifts the kinase-phosphatase balance in favor of EGFR activation. These data delineate a novel mechanism of EGFR regulation and identify RPTP-kappa as a key molecular target for antioxidant protection against skin aging.	Univ Michigan, Sch Med, Dept Dermatol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Fisher, GJ (corresponding author), Med Sci 1, Rm 6447, 1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	dianemch@umich.edu	Voorhees, John/AAM-9966-2020	Voorhees, John/0000-0003-1856-785X	NIEHS NIH HHS [1R01ES012920, R01 ES012920, R01 ES012920-03] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012920] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Berneburg M, 2000, PHOTODERMATOL PHOTO, V16, P239, DOI 10.1034/j.1600-0781.2000.160601.x; Bertling CJ, 1996, PHOTOCHEM PHOTOBIOL, V64, P137, DOI 10.1111/j.1751-1097.1996.tb02433.x; Bonizzi G, 1999, MOL CELL BIOL, V19, P1950; CADET J, 1990, BIOORGANIC PHOTOCHEM, P184; Carpenter G, 1999, J CELL BIOL, V146, P697, DOI 10.1083/jcb.146.4.697; CHUI T, 2005, AM J PHYSIOL, V288, pG182; CREED D, 1984, PHOTOCHEM PHOTOBIOL, V39, P563; CREED D, 1984, PHOTOCHEM PHOTOBIOL, V39, P537; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; Evinger AJ, 2005, STEROIDS, V70, P361, DOI 10.1016/j.steroids.2005.02.015; Filardo EJ, 2002, J STEROID BIOCHEM, V80, P231, DOI 10.1016/S0960-0760(01)00190-X; Fisher GJ, 2000, J CLIN INVEST, V106, P663, DOI 10.1172/JCI9362; Fisher GJ, 1998, J CLIN INVEST, V101, P1432, DOI 10.1172/JCI2153; Fisher GJ, 2002, ARCH DERMATOL, V138, P1462, DOI 10.1001/archderm.138.11.1462; FOOTE CS, 1982, PATHOLOGY OXYGEN, P21; Gulati P, 2004, EMBO REP, V5, P812, DOI 10.1038/sj.embor.7400190; Halder RM, 2003, DERMATOL CLIN, V21, P725, DOI 10.1016/S0733-8635(03)00085-8; HALLIWELL B, 1990, FREE RADICAL BIO MED, P22; Herrlich P, 2000, BIOCHEM PHARMACOL, V59, P35, DOI 10.1016/S0006-2952(99)00298-1; Huang CS, 1996, J BIOL CHEM, V271, P31262, DOI 10.1074/jbc.271.49.31262; Huang Y, 2004, ENDOCRINOLOGY, V145, P3297, DOI 10.1210/en.2003-1658; Ichihashi M, 2003, TOXICOLOGY, V189, P21, DOI 10.1016/S0300-483X(03)00150-1; JURKIEWICZ BA, 1994, PHOTOCHEM PHOTOBIOL, V59, P1, DOI 10.1111/j.1751-1097.1994.tb04993.x; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kamata H, 1999, CELL SIGNAL, V11, P1, DOI 10.1016/S0898-6568(98)00037-0; Kang S, 2003, J INVEST DERMATOL, V120, P835, DOI 10.1046/j.1523-1747.2003.12122.x; Knebel A, 1996, EMBO J, V15, P5314, DOI 10.1002/j.1460-2075.1996.tb00916.x; Kulms D, 2000, PHOTODERMATOL PHOTO, V16, P195, DOI 10.1034/j.1600-0781.2000.160501.x; Kwon J, 2004, P NATL ACAD SCI USA, V101, P16419, DOI 10.1073/pnas.0407396101; LO YYC, 1995, J BIOL CHEM, V270, P11727, DOI 10.1074/jbc.270.20.11727; NISHI J, 1991, J INVEST DERMATOL, V97, P115, DOI 10.1111/1523-1747.ep12478534; Persson C, 2005, METHODS, V35, P37, DOI 10.1016/j.ymeth.2004.07.006; Peus D, 1998, J INVEST DERMATOL, V110, P966, DOI 10.1046/j.1523-1747.1998.00210.x; Peus D, 1999, FREE RADICAL BIO MED, V27, P1197, DOI 10.1016/S0891-5849(99)00198-7; Peus D, 2000, PHOTOCHEM PHOTOBIOL, V72, P135, DOI 10.1562/0031-8655(2000)072<0135:UIEGFR>2.0.CO;2; RHEE S, 2000, SCI STEKE 2000; SAEZ E, 1995, CELL, V82, P721, DOI 10.1016/0092-8674(95)90469-7; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; SCHRECK R, 1992, FREE RADICAL RES COM, V17, P221, DOI 10.3109/10715769209079515; Thomas SM, 2005, NEOPLASIA, V7, P426, DOI 10.1593/neo.04454; van Montfort RLM, 2003, NATURE, V423, P773, DOI 10.1038/nature01681; Wang HQ, 2003, J BIOL CHEM, V278, P45737, DOI 10.1074/jbc.M300574200; Xu YR, 2005, J BIOL CHEM, V280, P42694, DOI 10.1074/jbc.M507722200; XU YR, 2005, J DERMATOL SC S2 DEC, pS1, DOI DOI 10.1016/J.DESCS.2005.06.002; Yamauchi T, 1997, NATURE, V390, P91, DOI 10.1038/36369; Zhang Q, 2004, CANCER RES, V64, P6166, DOI 10.1158/0008-5472.CAN-04-0504; Zheng Z S, 1993, Exp Dermatol, V2, P257, DOI 10.1111/j.1600-0625.1993.tb00042.x; Zwick E, 1999, TRENDS PHARMACOL SCI, V20, P408, DOI 10.1016/S0165-6147(99)01373-5	49	210	218	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2006	281	37					27389	27397		10.1074/jbc.M602355200	http://dx.doi.org/10.1074/jbc.M602355200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082PB	16849327	Green Accepted, hybrid			2022-12-27	WOS:000240397700065
